<SEC-DOCUMENT>0000950170-22-004670.txt : 20220325
<SEC-HEADER>0000950170-22-004670.hdr.sgml : 20220325
<ACCEPTANCE-DATETIME>20220325160611
ACCESSION NUMBER:		0000950170-22-004670
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		87
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220325
DATE AS OF CHANGE:		20220325

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Hyperfine, Inc.
		CENTRAL INDEX KEY:			0001833769
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39949
		FILM NUMBER:		22771396

	BUSINESS ADDRESS:	
		STREET 1:		351 NEW WHITFIELD STREET
		CITY:			GUILFORD
		STATE:			CT
		ZIP:			06437
		BUSINESS PHONE:		866-796-6767

	MAIL ADDRESS:	
		STREET 1:		351 NEW WHITFIELD STREET
		CITY:			GUILFORD
		STATE:			CT
		ZIP:			06437

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HealthCor Catalio Acquisition Corp.
		DATE OF NAME CHANGE:	20201124
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>hypr-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2022-03-25T14:35:18.1158+00:00 --><!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:hypr="http://hyperfine.io/20211231" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_02a11929-03c5-47f7-a6dc-944d24429dd7" name="dei:DocumentFiscalPeriodFocus" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1">FY</ix:nonNumeric><ix:nonFraction id="F_30138270-ef84-453b-af3c-a94b07124d59" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_7c1f6cb9-db4f-44a0-8eef-0eeaa1e8c6da" name="hypr:NumberOfVotesPerShareEntitledToClassOfCommonStock" contextRef="C_96dd3b27-0bd2-4e00-a097-4fc98922b833" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">1</ix:nonFraction><ix:nonFraction id="F_1c13b237-b33f-482f-9778-a6fd264becc6" name="us-gaap:CommonStockValue" contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_34fdc04b-c2cb-413b-abda-23a19ba3ed8d" name="us-gaap:CommonStockValue" contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_6b9cea9f-2dca-4d8b-bc71-1e411360de94" name="us-gaap:CommitmentsAndContingencies" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_0d93ec06-e2be-489a-ac3b-531777fb08ff" name="us-gaap:OpenTaxYear" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1">2017 2018 2019</ix:nonNumeric><ix:nonNumeric id="F_82c7fa41-ba63-47ec-bb72-bbe45f458cc5" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" contextRef="C_7bf581fe-f268-40a4-9d35-1ecba7754739" xsi:nil="true"></ix:nonNumeric><ix:nonFraction id="F_b67239e3-f61f-4cba-b264-e5903882a0e2" name="us-gaap:CommitmentsAndContingencies" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_7ec0eccf-356a-44c9-b3c6-e8a10dd2b780" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_081f21bd-0581-46af-927f-65563961f468" name="dei:EntityCentralIndexKey" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1">0001833769</ix:nonNumeric><ix:nonNumeric id="F_6916c379-e209-4d81-bc90-d4c44d60c3de" name="dei:AmendmentFlag" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" format="ixt:booleanfalse">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="hypr-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_ccfbba15-73af-4c55-9b92-86db3883e6e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1c2f3fc1-c9e7-40c0-86e4-fd3a7bdf44bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e9c6aa3c-7348-4f82-973e-f19a18dd2b91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_42721900-2218-40df-95d4-cb7a647e1a07"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:ClassBOrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-22</xbrli:startDate><xbrli:endDate>2021-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_89e586a8-ee0a-4268-89f0-554f600718eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fad97c6a-6c78-4438-bbf2-78f5774e74c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7ff32017-f2ed-48aa-9ebf-c6e5f3edd992"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a7d85790-8273-4800-91ae-17cbe035c271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hypr:AllocationOfExpenseIncurredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:LiminalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e7a1c7aa-d329-429a-b3c9-637f64056a81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ed6f3ccf-47d7-4f6b-a138-e38661edb807"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2002-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f483c871-8db6-4367-9cdb-c9ee827a41fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f3f7bbf1-1516-476a-9c86-2591116d1012"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:PIPEInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_88d7f310-a8d6-4fc6-888b-0a034f2de16c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3c9581e7-07d4-4e55-bccf-5e8bd25bbbb7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d03d8509-9cd9-41c6-ad48-7df3d9451e56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_09eef7e3-8ef7-4872-9505-3cdfab129205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a1217e52-b226-462c-8502-52f8c592156b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:HyperfineConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9328b463-fd12-44fd-b26c-a8b2835078a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:ShareBasedPaymentArrangementSeparateOptionAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0748c7ce-7d19-4746-8d34-695f218ca5aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:ResearchDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3666fba2-b98c-4e2a-8471-61fd11c1c18a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_474a603f-d6db-4d8d-92d3-70cb2d1e090f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f64f1671-f740-47b2-bdee-89e73fc16d87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_00ed74b2-7850-4508-bc80-e83b416ee826"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:FourBionicsTwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4ee5d355-9181-4953-8217-8e5ef9995358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_604f763d-b166-4d76-93fc-9435e4fa41ff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f5b7fd28-718c-44aa-9bed-942c827825a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:PIPEInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-22</xbrli:startDate><xbrli:endDate>2021-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d3db78a5-9170-438c-85d3-79a5e0440f3d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b6b6072c-15e7-4e45-9a9f-aea0353e0e42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hypr:EarnOutSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a1f35ddb-eb58-49b6-a2b6-56b35e52474f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fca29af6-e6e3-4712-95bc-d0e946d2ca70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9975d5e6-b660-419f-abf6-e2a46827db35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:LiminalConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">us-gaap:DividendDeclaredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_caae9469-5585-4e17-9b3f-2def45052046"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:TradeShowAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0449cc1b-e603-4161-b7c3-fb5362667dbf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:LiminalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-07</xbrli:startDate><xbrli:endDate>2021-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e0c91aab-9546-4751-89ce-b88e18335be2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b5a4b802-89f3-4579-863a-5eecf71671f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-21</xbrli:startDate><xbrli:endDate>2021-12-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9bead3a6-4985-410f-99b5-30235563115f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ef2546a8-4c0e-4b36-9c52-90a9b0abd33f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_464908b0-1fa1-4326-90d3-0c2106209a10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b17a194-f917-4277-981e-1a50762d4429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7bcd7cb4-1dc9-4c68-a43e-62994fd1ac21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1ae6ab52-d904-4842-a161-d9892fd7ed09"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_79b8e3d1-0c6c-4ae4-9639-ebe2dada5fbe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d6171afc-03fd-445e-ac62-3ae933435993"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_96dd3b27-0bd2-4e00-a097-4fc98922b833"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-21</xbrli:startDate><xbrli:endDate>2021-12-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_37fd5a65-0913-4f4d-81f7-910f82c3ea2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_80cfe749-acb3-416a-9bfa-17252d7bfb03"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">hypr:FederalOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c45f29de-244b-43b1-84da-2f83aa0a16d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hypr:HyperfinePayrollProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f284e816-cacb-4f3c-bea6-47fac4904183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e01451b3-5582-4ac0-8725-58320e1c8896"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9f696af7-210f-43ef-9b46-8a8e5818aaa6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7cb5eab9-0fdd-4dc3-8931-9772493bd16f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f96e34c7-c8df-43a2-b54b-74085b8e63c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0e92975e-291a-4d95-b890-e43efecfb475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_164ab371-7976-4ab1-b472-197262c28f3c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f61cbd06-6f47-40f0-bf5b-f5c8aaa869bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8798fe66-4ab2-4809-8278-b52ed9e1d7cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f9ad2466-6588-4aad-9c83-c52d2116818a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">hypr:SubscriptionAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2f407302-608a-4972-886c-07025c0d9e38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f5de6d93-0dcb-4c74-a001-200800fe2bd9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:StockOptionsTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8b92779c-b81b-4034-9f67-08e85cb2c22d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2deb5363-ab1f-4a7d-bf8d-b4b73bf8fc16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">hypr:FederalOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e1bced35-5643-4d57-a6ea-b24e0a212bf8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e1d998b-c680-42bd-bbd7-9bc2ff70463c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_07853f31-4dbf-448b-a757-6ceeb0365107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:ClassAOrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7f6ecd42-2a1a-4c28-acf6-496ab6a2707e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3ad8f729-5552-455b-b2fb-acfa4b71867b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-21</xbrli:startDate><xbrli:endDate>2021-12-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e8929d7a-f4b3-4599-a490-21ed76128b01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8947e16c-53a9-404b-b4aa-6eea41055362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c41d64ad-bb4c-4c76-99f9-e336bc1ab030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1a8cf60f-453e-465e-86fc-c6ed0ff3919e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerHMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_06ca1284-0a43-490c-94fa-34c74c4f5fbd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:HyperfineConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f8f8bfd0-b2c9-4228-859d-e035e36fdaff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:LiminalConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fa39ca24-c5b2-4cc3-9108-625304c8561d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:TradeShowAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b9bd646d-669a-4b5c-9bdd-74063cca61b6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a7be29aa-140e-44cb-a9f4-ff103f126abe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:CatalyzerCorporation4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dbe7ddab-0056-49e4-9a0e-48437f4d7b7e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:ConnecticutOthersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8e87568d-825c-49a7-8077-18ebeca513ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hypr:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bbc35c1e-828e-43bf-b1bb-089209526261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1dd44ac9-6110-4a83-a30a-28c9fbf87799"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cd314d5f-1d0e-45e6-bee2-447dde950094"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a27dd307-2fcd-40ef-8e2c-ce7ce0a4e528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bae04bbe-9b11-42f5-97ae-1c488ef30d01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:ServiceAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1cf87dff-a097-4d35-8816-c1468d5730fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c17d825-000e-4c3d-a83a-3be01c1f2e4e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8dd83f7f-8142-464d-9d9c-cf5fce19a67d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_77379a12-290a-4832-afc5-a9209e02e808"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7e37528b-2b21-4306-ae2b-4ba44246def5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f544b39f-f467-43d9-bd6c-b63e721ee22c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a5356276-34ee-4730-b9c0-7fa02ce0c4f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_78bf0f13-f3b7-455a-a4d0-d20db26ececd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_66a4ed44-133c-453e-b237-1b588d0b3bee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bb1fde1a-0016-49f0-92be-2a618f68f12f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerHMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_931d86b2-1bb0-4d61-bc67-022ee2881f97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bcf76ade-60dc-4368-aef5-2520cbade643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_61d98dd2-ccb5-4863-8e6c-5b1ad14f4dab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:StockOptionsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b7398889-0087-4e71-ba2b-1aa0b09285fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_018e05a7-18c4-47ac-8a4f-82f9d45da649"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:ConnecticutResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6a857b9a-6bad-404d-9dcd-a5265f3492cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6f66f0df-20b7-4c2e-926e-312d15b30150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ab4a120e-032e-4174-ab0f-41881ca87629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">hypr:PreTwoThaousandEighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9e7001e3-4007-4798-9dd4-73bb5ecbae12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_567125e1-75b2-41be-99d3-e7b8a2774dc7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fcabd41f-ce0d-46f0-bf8c-30aa40ebb4df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:HyperfineConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_29df5b7f-0392-4e69-85ba-668edf603563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:LiminalConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_821ac2f9-b484-46bf-bf7f-00231566dd23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-05-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_565f6ec5-b566-4aa1-8ca6-fbee686327c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6def0aef-40a2-42c1-9b66-b534c9b3b53f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5e5c7322-5a27-4422-aed8-e69929560490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_734af1ad-a0ec-4f29-bf39-f1b5327db6c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6cfe4f83-75d3-42af-b919-f037bac001d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">hypr:PreTwoThaousandEighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_32bbb1e2-b724-403f-b397-48d9add24af7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d78a6553-a61c-42e1-b9da-7148c3162bcc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerHMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_234b982a-29e0-45ff-b5c3-d5349882acd9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">hypr:PostTwoThaousandSeventeenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b788d1a7-f5e7-4c74-b5e4-0cd24b556c97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aa627098-fe3c-4ac0-80bb-2be20fe7c7a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:SalesAndMarketingDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7bf581fe-f268-40a4-9d35-1ecba7754739"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1405c4fb-fd46-4fa7-b51a-b3abdd66f278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d9e344e0-6fb0-4ac2-9f20-f9805be8a275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hypr:HealthCorCatalioAcquisitionCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-22</xbrli:startDate><xbrli:endDate>2021-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_130e4222-f593-4c10-abb6-2bba9719b0a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:CatalyzerCorporation4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_952282ac-2ad8-4203-8f79-2b4a0432930d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_834be932-c2f9-4d94-9f67-fbab4d5554fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6b4b4ea7-d957-4077-89a8-2769e16523e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a2443b46-1c16-4eec-bafc-07f659935c43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:ResearchDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1c800ff0-677d-4568-ac8b-02a9fb77a094"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6b7f94c9-9ecc-4502-b9fd-362b0c906fa7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-22</xbrli:startDate><xbrli:endDate>2021-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9f4271cf-301e-459f-8dfd-8d9530cbb4eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_49d0dcc9-816b-4e28-8bc4-f9b5575f3a10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c5071d04-a665-4335-a174-7aa1af89882e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e027434a-4a2f-4bf7-b6ac-ecd878be99df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7ccf2627-1cdc-47b7-ba29-626a157390fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8ce579da-efe4-411c-8e78-a08e6c50c59f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c727f466-00a1-41e9-b455-84621ea4e2de"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a1fab29a-58b5-4b1a-9ccd-64a673d6e459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_297a1e64-a6f1-490a-8a0d-a68d408b9cba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ecb93ba3-ee1e-4bc3-bfc2-c730d729e8b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e06069a2-6817-48a5-94fd-de1580cc4fdc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_422b1f66-f3bb-40cb-87eb-764fff40d1b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">hypr:SubscriptionAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-21</xbrli:startDate><xbrli:endDate>2021-12-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9dd1a0ec-1e2f-4d91-be47-e5f4b90724e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_02ac6247-634e-47e7-9137-1d9fcf817084"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b4ed0d3a-434f-44d7-b565-e029c1f85e01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_62a0c92e-5cb0-440b-9b64-ce1f6af679d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f655045d-1b98-47a5-91ea-b2ff21c11594"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:FourBionicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aeb82c50-d014-42e5-8b78-49b806cb3896"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_65a01c03-68fd-4859-bbe0-614b1a291979"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-11</xbrli:startDate><xbrli:endDate>2022-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_12fc5c7b-599e-4371-aa1e-7952b537da56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_19b3a16d-0fb7-4f0f-9123-775d37384548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3157ed03-ddbf-421e-bca7-442ffc10828a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9d460b90-c42a-4930-b08d-e43fe406d95b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_37f84241-8f15-4d3a-a3bf-88a442090df1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8a9c17f1-6da6-4401-8abe-806f2a333b9e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3ef7cc75-c5bb-4fbe-b9a3-8cee4d7281da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:LeasedDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5cc0bd53-ddda-46e6-831e-25d4e45fd73a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d0d9904d-6ebb-411f-ae8e-b672fda8238c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1fb3196d-7a74-43b8-be05-e3fb252761c5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hypr:LiminalPayrollProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ccc706be-2158-4bcc-a2db-096a92c02315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:StockOptionsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2d523d48-3880-4f1d-9796-c510fd76bd9c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_329773ff-8990-4d8c-9536-2fe5f936e9fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_73aeac21-ef41-47a9-b437-94807e5860aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:TechnologyAndServicesExchangeAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a3cbddd1-811a-44fb-b01c-1b817fbb617d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:LegacyHyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0b3254eb-3e95-4520-9848-13187dd9cc8a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hypr:AmendedAndRestatedTechnologyServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8befb59f-1789-41eb-a34c-a140ffe80389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fba03c4e-b08a-41a6-8e92-9f1c641cb1f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7ee4d8d9-a42c-47a9-ae5d-57c993f15c61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ac74fc9c-0276-46e3-b74a-5c86d622563b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hypr:ImmediatelyPriorToEffectiveTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_44f21ac9-708e-4b24-aef7-cd1a9620d836"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ac456664-e171-4780-a346-eaa8d31a6318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_51a3f382-19a1-459c-833b-5929003f7207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:LiminalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_883d8081-2c10-4853-b218-6c373ae4a619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:SalesAndMarketingDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_309c8fe7-b2ee-4206-93c1-c4ef1763fe17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:FederalNetOperatingLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb3f4280-8358-43b6-8ea1-38d00c89ec05"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_10346531-8b79-4c49-b961-3e5de4647ca2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:ResearchDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bf3fc9fc-c2f0-475a-be3e-816156a07b77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:LiminalConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a16400b6-45e9-4557-826d-8a135305733f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_167b678f-7a7b-434b-9324-e4fb5b75ab31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_05b3c083-6683-4f86-ae50-8fd835965199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:CatalyzerCorporation4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f47f49e7-ad5a-4384-8c30-4bc6120b30ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-22</xbrli:startDate><xbrli:endDate>2021-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_851619a8-8879-4e00-8eac-c603bca28425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d8b08268-c399-4392-8b30-13c303f13c89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:EarnOutSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_39d87f95-6e1f-4dc1-b752-0e7cc15f6e53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a54c8d03-257a-444a-adcc-4832043c42ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_605093d2-ac5d-4510-b28c-7b383c6172c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_05f68334-93da-4481-827d-a3e3770c9d3d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_97ecd105-2e03-4bed-bb2d-15098fa42355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:HyperfineConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_815be668-99bc-4c0f-839f-a4c555f975bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_36c4ccc8-ec82-451c-9859-29fefff0e27b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_19fcd92e-329b-4a10-8362-cba65df265a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1d288b0c-2753-40e9-b635-efa4cad33f7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">us-gaap:DividendDeclaredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c4fe83e0-a6cc-4633-9e60-f7fc58c68e23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_01fa950d-ab40-4e18-a2a5-4c14c465c02f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_391814da-f713-4ae8-a4bf-709c59085048"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7b149139-c5d8-4447-a71e-c7ede770bd5e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1db82a87-b4de-4246-b8c2-3df23f8b625f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:FourBionicsTwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_216ba9b6-bd20-4c7c-bc41-1051866b4a16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hypr:HealthCorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-22</xbrli:startDate><xbrli:endDate>2021-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e6d3149f-9dd6-457f-8d72-4c2c61b3f90a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_017a55aa-4d9f-4145-84bc-31cdf605a0fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:EarnOutSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_25f955f4-3de2-435b-8a68-92a8fb8291b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_94219b96-2190-45cb-82d0-1a597525c988"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201912Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_32845ad3-df15-4c41-a913-d909409b7057"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a545f35c-3630-4b98-a6b2-43950943b602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_39161efa-1760-453a-85f8-4f68df3f9557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c6b2444b-b0c0-4bbf-809e-048942ba73c6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hypr:AllocationOfExpenseIncurredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:LiminalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e3d3098a-c48a-4d18-a4a7-21241395278d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dca47efa-de44-4ea2-a6f7-5e416bbbb918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6be4d64c-5ea1-40cf-ab05-f2d63f1883e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerHMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_adbc5d68-9134-4f22-9fcc-4c8fff3121d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-07</xbrli:startDate><xbrli:endDate>2021-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7c1ef51b-34f4-4a4a-a6cd-9433c0850ab4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_06522640-5ead-4ce5-b43c-dc8582220df8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:ClassBOrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_76318e1f-9e53-4997-93eb-1c3580b52cb2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f04be01a-f1c8-4197-9e8c-a8e60e22ac2c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_93ccae92-7e08-46e4-9661-cf630796ab3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hypr:OutstandingLegacyHyperfineConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2a19dcc8-c5cc-40ef-8059-d3bbd58d9d5b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:HyperfineConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_04f3284a-f447-4bbf-92f2-20e3aa560cb7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4a978a0-dd7d-4dae-a821-3df28ca4dc3d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fa4c4e98-cf41-4a9f-86eb-de3be3b950dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1de70b38-0a9c-4b91-b7ee-29ac5dddc712"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c87cc42e-ffd7-45c9-913f-2f4babc09628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesBCAndDConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1f1550e6-aea9-41b1-944e-48553f861650"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9bef19fe-1963-493a-8639-cca45451e242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:LegacyHyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-07</xbrli:startDate><xbrli:endDate>2021-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0e50299d-06bc-4ca9-8fae-2ba1b516eb00"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_36b0658e-9bd7-419a-b34b-1d6173b955ca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:IncentiveUnitActivityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c3117b2a-9a28-41fd-bf6c-462cc8023630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b4699d10-1e01-42d1-a12d-ef54497a4f0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f7c260f7-942b-467a-a100-8891e93ffd0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">hypr:PostTwoThaousandSeventeenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_90c968b9-9872-40c2-9fd2-339d167beac3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_348458fb-d208-4443-8d7d-e3f7edf293b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:CatalyzerCorporation4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_def64c3f-dcfb-4af6-bc2f-54f251b76af2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_40866da5-dfe6-427d-8f75-d38b502866b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f684ca2d-8a75-4e94-959f-b7de192cf33e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:FederalAndStateNetOperatingLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d27d7f2c-d654-4af6-9a83-2fc82df0f902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_592456c7-7eda-4630-a583-9725554adb90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bba669ae-db49-4d96-9060-d3c7c8e07261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_59ee9e89-2d6f-4237-ae48-00fdfeea2299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">us-gaap:DividendDeclaredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb1f65d2-d11d-4188-86cc-6490cfa8ec4f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_58ed8b62-4e40-4fb5-b611-d1a03002120d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_92873d62-f54e-4814-829f-fd7332644094"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hypr:AmendedAndRestatedTechnologyServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_97df9222-63f0-4205-8539-e49cb6ad1192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a7656f8d-8697-4470-947f-f125a450641a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hypr:ImmediatelyPriorToEffectiveTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6fdadebf-3247-42bc-88ce-f78d1aae83b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9644069d-7efd-4fd5-a809-33471f45d26c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a77bfc0c-9f2a-400b-b003-b38132751429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46f6a47d-e180-42ed-8d1e-464d0ec632b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:FederalAndStateNetOperatingLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_56f1b540-02fa-40f2-9894-b43cec93b036"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2d6850ed-6867-4384-9a94-ec4d712f20d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-22</xbrli:startDate><xbrli:endDate>2021-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2206b217-69b7-412b-a10f-a8ac64842af3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:ConnecticutResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b5d108c6-9922-4ef6-a9f4-1b52927fa472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:ConnecticutOthersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb31b9d8-c1f7-4a18-b802-8fbd3122b173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201815Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e797df8-f52f-4d4a-b1a1-ccf242640db1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hypr:PayrollProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_df21cc65-f66b-40a5-900a-c433563430fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-22</xbrli:startDate><xbrli:endDate>2021-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_00411e89-7f5a-45df-b336-70ea9ce55a9e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:LegacyHyperfineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_224ae57f-8193-4d6a-adfd-42c3a9ce9f1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_14ca06d1-7275-41cf-91d6-7ff75a37e6d9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c9211565-b84a-4c97-88de-605f5525382b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0a6a19d6-344a-4cea-bec3-409efe86ebfd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:LegacyHyperfineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_Ownership"><xbrli:measure>hypr:Ownership</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>hypr:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Vote"><xbrli:measure>hypr:Vote</xbrli:measure></xbrli:unit><xbrli:unit id="U_D"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:unit id="U_Option"><xbrli:measure>hypr:Option</xbrli:measure></xbrli:unit><xbrli:unit id="U_Site"><xbrli:measure>hypr:Site</xbrli:measure></xbrli:unit><xbrli:unit id="U_Subsidiary"><xbrli:measure>hypr:Subsidiary</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.250pt double;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:Times New Roman;">UNITED STATES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:Times New Roman;">SECURITIES AND EXCHANGE COMMISSION</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Washington, D.C. 20549</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:41.067%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:41.065%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:Times New Roman;">FORM </span><span style="font-size:14.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_35e6d3b9-ba42-4c4f-bb33-b726b39c18b2" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:Times New Roman;">10-K</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:41.067%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:41.065%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Mark One)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7212d12c-c4dc-4ba6-8007-92570ab98058" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:DocumentAnnualReport" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the fiscal year ended </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8112b994-85fc-4a7a-8419-53460e58d5ec" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_72ec8536-069c-4f27-a590-6ca7b3dcf863" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:CurrentFiscalYearEndDate" format="ixt:datemonthdayen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">December 31</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">, </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aabadddf-5e46-4c67-8433-709bb078f964" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></ix:nonNumeric></span><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"></span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">OR</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e92e6d3e-86d8-47fd-8506-636c4b126499" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:DocumentTransitionReport" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the transition period from</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">             </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">            </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Commission file number: </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7637299d-9a3c-4ff4-8f69-fcdf143cbdf2" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">001-39949</span></ix:nonNumeric></span></p>
  <p style="margin-left:41.067%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:41.065%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:17.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_63d28d4f-b864-4931-9bfa-466bfb521202" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:17.0pt;font-family:Times New Roman;">Hyperfine, Inc.</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:17.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;">(Exact name of registrant as specified in its charter)</span></p>
  <p style="margin-left:41.067%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:41.065%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:50.0%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_45055ce4-160a-4b44-b9a3-48833c0b9993" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c6de790c-fcb8-4fee-b570-4ec0bd3509d6" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">98-1569027</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(State or other jurisdiction of</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(I.R.S. Employer</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Identification No.)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_90877108-d721-48f0-b57e-e84baecefaed" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;">351 New Whitfield Street</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6e8badd1-37f1-47ec-837e-501f2c040a87" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;">Guilford</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;">, </span><span style="font-size:8.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e912afae-18c6-4eb7-87ef-6ab6c3803984" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;">Connecticut</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;"> </span><span style="font-size:8.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4b40f3a6-1bc7-42fb-be5f-44a268bb445d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;">06437</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;">(Address of principal executive offices) (Zip Code)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;">Registrant&#x2019;s telephone number, including area code: (</span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4277faa6-3347-4ed0-8377-96b0849cc857" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;">203</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;">) </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7036112f-5e20-4697-97fa-735c6e7a6296" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;">458-7100 </span></ix:nonNumeric></span><span style="font-size:7.5pt;font-family:Times New Roman;"></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(b) of the Exchange Act:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.0%;"></td>
    <td style="width:34.0%;"></td>
    <td style="width:33.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Title of each class</span></p><p style="border-top:1.000pt solid;margin-left:58.5pt;padding-top:1.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.8097222222222222in;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Trading</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Symbol(s)</span></p><p style="border-top:1.000pt solid;margin-left:69.3pt;padding-top:1.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.9597222222222221in;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name of each exchange on which registered</span></p><p style="border-top:1.000pt solid;margin-left:7.65pt;padding-top:1.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.10972222222222222in;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5c40ecb4-c14d-41fe-a578-471165108b52" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Class A common stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a0110460-0600-479f-b358-3ddbd160b162" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPR</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">The </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_da9bc3b3-dff8-4735-9bb7-831f28321f6e" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Nasdaq</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#160;Stock Market LLC</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(g) of the Exchange Act: None</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:41.067%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:41.065%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  &#9744;    </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c578b406-7152-4dc4-ae62-4da121ed8724" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityWellKnownSeasonedIssuer"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">  &#9746;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.    Yes  &#9744;    </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_72860667-757d-4ea0-9d52-93936fed7107" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityVoluntaryFilers"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">  &#9746;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cfeb45ba-d20a-4291-ba0b-9b0f7de3a321" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">  &#9746;    No  &#9744;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0140f587-42da-4441-8da8-38bb0541b03a" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">  &#9746;    No  &#9744;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:16.361%;"></td>
    <td style="width:62.222%;"></td>
    <td style="width:19.759%;"></td>
    <td style="width:1.657%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Large accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e1dcf1be-5746-4a88-95b7-027f088de87d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9746;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_993bedc6-5cdd-4aa8-8a10-d00a6efd0b86" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntitySmallBusiness" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_582db811-147d-4d80-92ba-f4b1ab6cbc27" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityEmergingGrowthCompany" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fd6b7361-2ebd-448a-b250-9ceabb4f1ecf" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityExTransitionPeriod" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#x2019;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cdcd58ea-41b9-448a-ab31-b389de500fd7" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:IcfrAuditorAttestationFlag" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  &#9744;    No  </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fa84b7d4-984d-4d2a-ac69-e317c46fea52" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:EntityShellCompany" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">The aggregate market value of the registrant&#x2019;s voting and non-voting common equity held by non-affiliates of the registrant (without admitting that any person whose shares are not included in such calculation is an affiliate) computed by reference to the price at which the common equity was last sold as of the last business day of the registrant&#x2019;s most recently completed second fiscal quarter was approximately $</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_40a48208-f2b2-48e5-b104-95514ea0ea02" contextRef="C_a5356276-34ee-4730-b9c0-7fa02ce0c4f2" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">203.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">As of March 1, 2022, the registrant had </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_50c88836-4529-4696-8d16-858af7957f8c" contextRef="C_8dd83f7f-8142-464d-9d9c-cf5fce19a67d" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">55,277,061</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> shares of Class A common stock outstanding and </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bfbd3e58-6d2d-43c2-b94d-f99e534486a1" contextRef="C_b4699d10-1e01-42d1-a12d-ef54497a4f0a" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,055,288</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> shares of Class B common stock outstanding.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.250pt double;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="toc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">TABLE OF CONTENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:12.996%;"></td>
    <td style="width:81.002%;"></td>
    <td style="width:6.002%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_i"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART I</span></a><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1_business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Business</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1A.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1B.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Unresolved Staff Comments</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 2.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Properties</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 3.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 4.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART II</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 5.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_5_market_for_registrant"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Market for Registrant&#x2019;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securitie</span></a><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">s</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 6.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_6_reserved"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">[Reserved]</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 7.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7_mda"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">79</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 7A.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7a_quantitative_and_qualitative_dis"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">89</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 8.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_8_financial_statements_and_supp"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9_changes_in_and_dis_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9A.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9a_controls_and_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9B.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9b_other_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Other Information</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">91</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9C.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9c_disclosure_regarding_foreign_jur"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">91</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_iii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART III</span></a><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">92</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 10.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_10_directors_executive_officers"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">92</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 11.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Executive Compensation</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">97</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 12.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_12_security_ownership_of_certain"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">106</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 13.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_13_certain_relation_and_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">109</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 14.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_14_principal_acc_fees_and_services"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Principal Accountant Fees and Services</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART IV</span></a><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">115</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 15</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#partiv_item15"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibits and Financial Statement Schedules</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">115</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:24.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:24.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 16.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_16_form_10_k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form 10-K Summary</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">118</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Signatures</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">119</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">EXPLANATORY NOTE</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 22, 2021, HealthCor Catalio Acquisition Corp., a blank check company incorporated as a Cayman Islands exempted company with limited liability (&#x201c;HealthCor&#x201d; and after the Business Combination described herein, the &#x201c;Company&#x201d;), after domesticating as a Delaware corporation on December 21, 2021, consummated the previously announced business combination (the &#x201c;Business Combination&#x201d;) pursuant to the terms of the Business Combination Agreement, dated as of July 7, 2021 (the &#x201c;Business Combination Agreement&#x201d;), by and among HealthCor, Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor (&#x201c;Merger Sub I&#x201d;), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor (&#x201c;Merger Sub II&#x201d;), Hyperfine, Inc., a Delaware corporation (&#x201c;Legacy Hyperfine&#x201d;), and Liminal Sciences, Inc., a Delaware corporation (&#x201c;Liminal&#x201d;). </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 22, 2021, immediately upon the consummation of the Business Combination, and such completion, the &#x201c;Closing&#x201d;), Merger Sub I merged with and into Legacy Hyperfine (the &#x201c;Hyperfine Merger&#x201d;), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal (the &#x201c;Liminal Merger&#x201d;), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor. In connection with the Business Combination, HealthCor changed its name to &#x201c;Hyperfine, Inc.,&#x201d; Legacy Hyperfine changed its name to &#x201c;Hyperfine Operations, Inc.&#x201d; and Liminal changed its name to &#x201c;Liminal Operations, Inc.&#x201d; and subsequently to &#34;Liminal Sciences, Inc.&#34; Following the Closing, the Company&#x2019;s Class A common stock is listed on the Nasdaq Global Market under the symbol &#x201c;HYPR&#x201d;. Unless the context requires otherwise, references in this report to the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; and &#x201c;our&#x201d; refer to Hyperfine, Inc. and its wholly-owned subsidiaries, including Legacy Hyperfine and Liminal, as the case may be.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;) and Section 21E of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), that relate to future events or our future financial performance regarding, among other things, the plans, strategies and prospects, both business and financial, of the Company. These statements are based on the beliefs and assumptions of our management team. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words &#x201c;believes,&#x201d; &#x201c;estimates,&#x201d; &#x201c;expects,&#x201d; &#x201c;projects,&#x201d; &#x201c;forecasts,&#x201d; &#x201c;may,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;seeks,&#x201d; &#x201c;plans,&#x201d; &#x201c;scheduled,&#x201d; &#x201c;anticipates&#x201d; or &#x201c;intends&#x201d; or similar expressions. Forward-looking statements contained in this Annual Report on Form 10-K include, but are not limited to, statements about:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the anticipated benefits of the Business Combination;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the success, cost and timing of our product development activities;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the commercialization and adoption of our existing products and the success of our future product offerings;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the potential attributes and benefits of our products and services;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to obtain and maintain regulatory approval for our products, and any related restrictions and limitations of any approved product;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to identify, in-license or acquire additional technology;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to maintain our existing licensing, manufacturing and supply agreements;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to compete with other companies currently marketing or engaged in the development of magnetic resonance imaging technologies, many of which have greater financial and marketing resources than us;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the size and growth potential of the markets for our products and services, and the ability of each to serve those markets, either alone or in partnership with others;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the pricing of our products and services and reimbursement for medical procedures conducted using our products and services;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in applicable laws or regulations;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our estimates regarding expenses, revenue, capital requirements and needs for additional financing;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to raise financing in the future;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our financial performance;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our success in retaining or recruiting, or changes required in, our officers, key employees or directors;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">intense competition and competitive pressures from other companies in the industry in which we operate;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">market conditions and global and economic factors;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our intellectual property rights;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the effect of legal, tax and regulatory changes; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.8968727694042435%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impact of the COVID-19 pandemic on our business and operations.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These and other factors that could cause actual results to differ from those implied by the forward-looking statements in this Annual Report on Form 10-K are more fully described in Item 1A under the heading &#x201c;Risk Factors.&#x201d; The risks described under the heading &#x201c;Risk Factors&#x201d; are not exhaustive. Other sections of this Annual Report on Form 10-K, such as t</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">he description of our Business set forth in Item 1 and our Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations set forth in Item 7 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">describe additional factors that could adversely affect our business, financial condition or results of operations. New risk factors emerge from time to time, and it is not possible to predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward-looking statements attributable to the Company or persons acting on the Company&#x2019;s behalf are expressly qualified in their entirety by the foregoing cautionary statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:66.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="summary_of_risk_factors"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SUMMARY OF RISK FACTORS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business is subject to numerous risks and uncertainties that you should consider before investing in our securities. Some of the principal risk factors are summarized below:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are an early-stage life sciences technology company with a history of net losses, which we expect to continue, and we may not be able to generate meaningful revenues or achieve and sustain profitability in the future.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have a limited operating history, which may make it difficult to evaluate the prospects for our future viability and predict our future performance. As such, you cannot rely upon our historical operating performance to make an investment or voting decision regarding us.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may need to raise additional capital to fund commercialization plans for our products, including manufacturing, sales and marketing activities, expand our investments in research and development, and commercialize new products and applications.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our success depends upon market acceptance of our products and services, our ability to develop and commercialize existing and new products and services and generate revenues, and our ability to identify new markets for our technology.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Medical device development is costly and involves continual technological change, which may render our current or future products obsolete.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will be dependent upon the success of our sales and customer acquisition and retention strategies.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we do not successfully manage the commercialization of our products and services, including continuing to build our sales force, and the development and launch of new products and services, we will not meet the long term forecasts and our business, operating and financial results and condition could be adversely affected.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to attract, recruit, train, retain, motivate and integrate key personnel as we expand our organization, our operations may be disrupted and we may not achieve our goals.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have limited experience in marketing and selling our products and related services, and if we are unable to successfully commercialize our products and related services, our business and operating results will be adversely affected.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely on a single contract manufacturer, Benchmark Electronics, Inc. (&#x201c;Benchmark&#x201d;), to test, assemble and supply our finished products. If Benchmark fails to fulfill its obligations under its existing contractual arrangements with us or does not perform satisfactorily, our ability to source our devices could be negatively and adversely affected.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely on a limited number of suppliers for our products. A loss of any of these suppliers could negatively affect our business.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pricing pressures from contract suppliers or manufacturers on which we rely may impose pricing pressures.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we do not successfully optimize and operate our sales and potential future distribution channels or we do not effectively expand and update our infrastructure, our operating results and customer experience may be negatively impacted.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The market for our products and services is new, rapidly evolving, and increasingly competitive, as the healthcare industry in the United States is undergoing significant structural change, which makes it difficult to forecast demand for our products and services.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As international expansion of our business occurs, it will expose us to market, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The COVID-19 pandemic has and could continue to negatively affect various aspects of our business, make it more difficult for us to meet our obligations to our customers, and result in reduced demand for our products and services, which could have a material adverse effect on our business, financial condition, results of operations, or cash flows.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unfavorable global economic conditions could adversely affect our business, financial condition or results of operations.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are subject to extensive government regulation, which could restrict the development, marketing, sale and distribution of our products and could cause us to incur significant costs.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There is no guarantee that the FDA will grant 510(k) clearance or PMA approval of our future products, and failure to obtain necessary clearances or approvals for our future products would adversely affect our ability to grow our business.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we fail to obtain regulatory authorizations in other countries for existing products or products under development, we will not be able to commercialize these products in those countries.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be subject to enforcement action if we engage in improper or off-label marketing or promotion of our commercial medical device products, including fines, penalties and injunctions.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because we do not require extensive training for users of our current products, although they are limited under the FDA&#x2019;s marketing clearances to use by, and that images generated from the scanner be interpreted by, trained healthcare practitioners, there exists a potential for misuse of these products, misinterpretation of images by untrained professionals or misuse of these products by untrained professionals, which could ultimately harm our reputation and business.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are subject to complex and evolving U.S. and foreign laws and regulations regarding privacy, data protection, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in customer growth or engagement, or otherwise harm our business.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under federal or state law, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to obtain and maintain and enforce sufficient intellectual property protection for our products and technology, or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize products similar or identical to ours, and our ability to successfully commercialize our products may be impaired.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We currently rely on licenses from third parties, and in the future may rely on additional licenses from other third parties, and if we lose any of these licenses, then we may be subjected to future litigation.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We identified material weaknesses in our internal control over financial reporting. If our remediation measures are ineffective, or if we experience additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls in the future, we may not be able to report our financial condition or results of operations accurately or in a timely manner and we may be unable to maintain compliance with applicable stock exchange listing requirements, which may adversely affect investor confidence in us and, as a result, materially and adversely affect our business and the value of our Class A common stock.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because we are a &#x201c;controlled company&#x201d; within the meaning of the Nasdaq listing rules, our stockholders may not have certain corporate governance protections that are available to stockholders of companies that are not controlled companies.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The dual class structure of our common stock has the effect of concentrating voting power with Jonathan M. Rothberg, Ph.D., Vice Chairman of our board of directors and the Founder of Legacy Hyperfine and Liminal, which will limit an investor&#x2019;s ability to influence the outcome of important transactions, including a change in control.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These and other material risks we face are described more fully in Item 1A, Risk Factors, which investors should carefully review prior to making an investment decision with respect to the Company or its securities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="part_i"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PA</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">RT I</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">All brand names or trademarks appearing in this report are the property of their respective holders. Use or display by us of other parties&#x2019; trademarks, trade dress, or products in this report is not intended to, and does not, imply a relationship with, or endorsements or sponsorship of, us by the trademark or trade dress owners. Unless the context requires otherwise, references in this report to the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; and &#x201c;our&#x201d; refer to Hyperfine, Inc and its wholly-owned subsidiaries, including Legacy Hyperfine and Liminal, as the case may be.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_1_business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1. B</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">USINESS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Overview</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to December 22, 2021, we were a blank check company incorporated as a Cayman Islands exempted company organized for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. On December 21, 2021, we changed our jurisdiction of incorporation from the Cayman Islands to the State of Delaware by deregistering as an exempted company in the Cayman Islands and continuing and domesticating as a corporation, incorporated under the laws of the State of Delaware. On December 22, 2021, we completed the Business Combination pursuant to the Business Combination Agreement dated July 7, 2021 that we entered into with Legacy Hyperfine and Liminal. Upon the completion of the Business Combination, we changed our name to &#x201c;Hyperfine, Inc.&#x201d; and the business of Legacy Hyperfine and Liminal became our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are an innovative digital health business with a mission to provide affordable and accessible imaging and monitoring and through magnetic resonance imaging (&#x201c;MRI&#x201d;) to revolutionize healthcare for people around the world. Our Swoop&#174; Portable Magnetic Resonance (&#x201c;MR&#x201d;) Imaging System</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">TM</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;Swoop scanner&#x201d;) produces high-quality images at a lower magnetic field strength than conventional MRI systems, and can be used by healthcare professionals to make effective clinical diagnoses on a patient in a variety of settings where MRI devices have previously been inaccessible. The easy-to-use interface and portable design of our Swoop scanner make it accessible for use anywhere in a hospital, clinic or patient care site. We are working to realize our vision of providing affordable and accessible imaging of health conditions around the world.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MRI is a medical imaging technique used in radiology to image the anatomy and the physiological processes of the human body. It is typically used in a variety of clinical settings for medical diagnosis, staging of disease and follow-up treatment. Unlike X-ray computed tomography (&#x201c;CT&#x201d;) or positron emission tomography (&#x201c;PET&#x201d;), MRI does not expose patients to harmful ionizing radiation. We believe MRI offers the most sensitive and objective measures of brain tissue and injury. Despite its advantages, many healthcare institutions throughout the world lack the facilities, qualified operators and capital necessary to acquire and maintain expensive MRI devices. For healthcare institutions that do have conventional MRI systems, disadvantages of conventional MRI systems include their high cost, facility requirements for a specialized MRI suite, and the scheduling delays, personnel resources and risk of adverse events that result from the need to transport critically ill patients to the MRI suite. The Swoop scanner is intended for use at the patient&#x2019;s bedside in any hospital room or clinical setting, such as a physician&#x2019;s office or a local urgent care facility. The demand for MRI has been augmented by the aging population and rising prevalence of cancer and cardiovascular, neurologic and orthopedic conditions. Healthcare professionals and insurers are recognizing imaging as a cost-effective and non-invasive diagnostic tool for evaluation and ongoing monitoring. Swoop is a next generation of these devices designed to drive costs down and expand the current $15.9 billion imaging market.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe the adoption of the Swoop scanner by healthcare professionals has benefits across healthcare communities both in the high and low resource settings. Through our collaborations with the healthcare community, we have begun to optimize our software ecosystem to harness Artificial Intelligence (&#x201c;AI&#x201d;) to transform the system into a true bedside clinical decision support platform. These efforts seek to improve image quality, help users analyze images, and reduce time to diagnosis. Our technology allows us to provide decision support and rapid feedback for diagnostic insight for clinicians of various levels of expertise. In the future, we hope to develop an ecosystem of products, expanding the capabilities of our core MRI product platform while introducing a brain sensing platform, subject to regulatory authorization, to offer a more complete solution and increase access to lifesaving technology across the care continuum.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine received 510(k) clearance from the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) in 2020 for its Swoop Portable MR Imaging System</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#153;</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical, in order to provide imaging information to trained physicians that may be useful in determining a diagnosis. The system is commercially available in the United States. In 2021, we also obtained a Medical Device License issued by Health Canada and expanded into the Canadian market. In addition, we are seeking necessary regulatory authorizations in other major markets, including the United Kingdom, Australia and other countries. We recently received regulatory authorization in New Zealand and Pakistan. We are building our direct commercial infrastructure in the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">United States and also have plans to sell our products in other countries either through direct sales or through distributors. Furthermore, we possess a portfolio of 141 issued patents worldwide as well as 293 patents pending as of February 15, 2022.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine and Liminal were founded in 2014 and 2018, respectively, by Dr. Jonathan Rothberg, a serial entrepreneur who received the Presidential Medal of Technology &amp; Innovation in 2016 for inventing a novel next generation DNA sequencing method and has founded more than 10 healthcare and technology companies, including 454 Life Sciences, Ion Torrent, CuraGen, Butterfly Network and Quantum-Si. Legacy Hyperfine has raised over $160 million in equity investments and partnership milestones from leading institutional investors, including GV (formerly Google Ventures), and grants, including the Bill &amp; Melinda Gates Foundation (the &#34;BMGF&#34;).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Liminal was founded as a wholly-owned subsidiary of 4Bionics LLC (&#34;4Bionics&#34;). 4Bionics was an early startup incubator founded in 2018 and controlled by the Rothberg family, and was designed for the funding and development needs of seed stage companies. When Liminal was founded, Legacy Hyperfine was focused on developing its own products. As Liminal was developing its platform for non-invasive monitoring and sensing of key brain health vitals, Legacy Hyperfine was beginning to commercialize the Swoop scanner and expanded its vision to include intervention and sensing to cover the care continuum. We believe that the synergies between Legacy Hyperfine&#x2019;s MRI platform and Liminal&#x2019;s brain sensing technology provide Hyperfine with the potential to connect the care continuum from MRI imaging to sensing, and could ultimately provide patients with affordable care and healthcare practitioners with a single source access to brain scanning and monitoring.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our Competitive Strengths</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that our competitive strengths include the following:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">There is a large and growing MRI market and we have the potential to augment conventional MRI capacity and benefit patients around the world.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We believe our solution addresses a vast unmet need across the global market by expanding accessibility to MRI and augmenting the existing capacity of conventional high-field MRI systems as imaging rates continue to increase across the population and the need for efficient utilization of MRI scanners increases. Our solution is designed to complement conventional MRI scanners currently used in the market, as it seamlessly integrates into relevant hospital systems. Our system was designed to allow users to upload images directly onto hospital systems, such as the picture archiving and communication system (&#x201c;PACS&#x201d;) or directly onto our cloud PACS, which then makes images available for diagnostic purposes.</span></div></div>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe the Swoop scanner can expand the existing $15.9 billion global imaging market (expected to grow at a 5.2% CAGR from 2021 to 2028) by making MRI available to a larger set of patients in both developed and emerging markets, as well as increase the utilization of conventional MRIs through decreased wait times and facilitation of patient flow. Our primary focus is to expand the availability of MRI globally and across the care continuum, particularly to patients who are in intensive care units and in the emergency department, where timeliness is critical and an MRI scan can be essential for diagnosis and urgent intervention. The Swoop scanner can be wheeled directly to a patient&#x2019;s bedside and offers a prompt solution for those patients who require an MRI scan but are too critically ill to be transported for a conventional MRI scan, and who may otherwise be forced to forego a scan or wait until their condition stabilizes.</span></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have also initiated a global research program supported by grant funding from the BMGF to assess the clinical feasibility of our Swoop scanner in providing immediate point-of-care brain imaging to infants between the ages of 0-24 months in low-medium income countries. We were awarded a $1.6 million grant from the BMGF for the provision and equipping of 20 sites with our portable point-of-care MRI system to enable the performance of a multi-site study focused on optimizing diagnostic image quality (the &#x201c;Project&#x201d;). During the third quarter of 2021, we were awarded an additional $3.3 million grant, of which $2.5 million was received from the BMGF in September 2021,with the remainder expected to be received by April 2022. Both of these grants are designed to support the deployment of a total of 25 Swoop devices and other services to investigators, which commenced in the spring of 2021, and is expected to fund the program for approximately two years. The ongoing investigation is designed to provide data to validate the use of our Swoop system in measuring the impact of maternal anemia, malnutrition, infection and birth related injury.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">The Swoop scanner is designed to create value for stakeholders across the care continuum:</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img37592182_0.jpg" alt="img37592182_0.jpg" style="width:570px;height:204px;" />&#160;</p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our innovative technology has the potential to markedly improve quality of care for patients worldwide.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We believe our smaller, portable, low cost yet effective MRI scanner can broaden access to quality care, leading to improved health outcomes. In many cases, other imaging modalities, such as computerized tomography (&#x201c;CT&#x201d;) scanners, are used due to lack of availability of MRI scanners or their lower cost profile, even though CT provides lower soft tissue contrast for evaluating abnormalities in the brain. Our point of care Swoop scanner, however, has a significantly lower price point than both conventional MRI and CT scanners, making the Swoop scanner affordable for hospitals and care centers that are not financially able to acquire a conventional MRI or CT scanner. Compared to CT scans, MRI has a greater range of soft tissue contrast, depicts anatomy in greater detail and is more sensitive and specific for abnormalities within the brain itself. Our Swoop scanner is designed primarily for urgent cases, and it can benefit non-urgent cases as well. Among the neurological conditions for which the Swoop scanner can provide first-line diagnostic capability, we expect the Swoop scanner&#x2019;s top three clinical use cases will continue to be: point-of-care MRI in acute mental change assessment and follow-up in an ICU setting; stroke workflow; and pediatric and adult point-of-care assessment of hydrocephalus, an abnormal buildup of fluid within the brain.</span></div></div>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our solution has the potential to improve the diagnosis and lives of the approximately 15 million annual new stroke sufferers worldwide. The Swoop scanner does not emit ionizing radiation and therefore does not have the increased risk of cancer that comes with CT imaging. This is particularly important for conditions that require regular follow-up with multiple scans per year, such as hydrocephalus. In certain circumstances, such as in the management of patients with delirium or altered mental status, familiarity, or keeping the surrounding environment as similar as possible, can be critical, which we believe makes bedside scanners like our Swoop scanner particularly useful since patients do not need to be moved to often distant radiology suites for conventional MRI scans. Studies show that 37% of patients report anxiety-related reactions when moved to an isolated room for imaging. With our system, we can offer a quieter, calmer experience with the option of a family member or other caregiver to be present by the patient&#x2019;s bedside during the scanning process.</span></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our point of care scanner also helps avoid the risk of patient injury during transport through the ability to bring the scanner to the patient. By performing scans for urgent and critically ill patients at the bedside, we can help prevent the adverse incidents that occur to approximately 33% of critically ill patient cases during transport. The Swoop scanner also obviates the labor-intensive and high-risk process of transporting patients on ventilators or who are connected to other life-sustaining devices.</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our proprietary, disruptive and revolutionary product is designed with healthcare professionals in mind.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We have commercially launched our Swoop scanner, a point of care MRI device capable of producing diagnostic quality images at a lower magnetic field strength than conventional MRI scanners. The use of an ultra-low magnetic field strength provides a significant reduction in safety concerns regarding projectiles and therefore should reduce the length of pre-safety checks typically conducted by healthcare professionals. We designed our product with the physician workflow in mind, reducing the on average 25.8 hour conventional MRI process to a total of 90 minutes of workflow time with our Swoop scanner. With a 94% reduction in total workflow time, physicians can reduce the time to diagnoses for timely treatment, which can result in improved health outcomes for the patient.</span></div></div>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For healthcare professionals who are already facing demanding time constraints, dealing with lengthy and sometimes confusing MRI protocols adds to their time spent on logistics rather than caring for patients. Additionally, conventional MRIs require specially trained technicians who are fully dedicated to operate those systems and increase the time and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">cost related to nurses and porters transporting patients to the MRI unit. Our Swoop scanner is designed to simplify the image acquisition process. We have designed our scanner to be user-friendly and require minimal training to be operated. Our platform can be controlled by a tablet, smartphone or any other WiFi capable device. The Swoop scanner&#x2019;s portability and accessibility at the bedside can further allow more time for healthcare professionals to focus on other important activities related to patient care, diagnosis and treatment.</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our state-of-the-art product provides an attractive return on investment for various care settings.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We created the Swoop scanner not to replace conventional MRI devices but rather to supplement their existing capacity. By enabling imaging at the bedside, patients can be treated earlier and discharged sooner, potentially leading to increased hospital savings consistent with the growing shift to value-based care. In addition, by conducting more in-patient MRI scans at the bedside, our Swoop scanner can help free up capacity in the MRI suite for additional outpatient procedures, which generate higher revenues for hospitals or other healthcare facilities than in-patient imaging. In studies we have conducted in hospital settings, use of our Swoop scanner has helped to make capacity available that has resulted in 20% increased usage of the existing MRI suite for additional outpatient procedures.</span></div></div>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As healthcare costs continue to rise, we believe our Swoop scanner will allow for significant potential cost reductions that can benefit the entire imaging ecosystem. Our Swoop scanner has dramatically reduced hardware costs through design trade-off and compensation with the use of modern computational power and deep learning advances. The cost benefits of our Swoop scanner are not limited to a customer&#x2019;s initial purchase of the scanner, as our customers continue to benefit by not having to spend on additional cooling, power and maintenance expenses throughout the lifetime of conventional MRI. Unlike conventional MRI systems, use of the Swoop scanner also does not require a specialized radio frequency (RF) room to safely house the MRI scanner, allowing space to be used for other important patient care activities. The use of the Swoop scanner in the ICU can also increase utilization by allowing critically ill patients to receive immediate access to an MRI instead of increasing congestion in the schedule of the conventional MRI systems due to complications in the patients&#x2019; condition and unexpected changes in their condition or treatment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our validated platform and business model allows for potential widespread adoption.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Over 41 conference presentations and publications have discussed the clinical benefits for point of care, low-field MRI for patients with stroke, hydrocephalus, hematoma, multiple sclerosis and tumor resection. We generate sales revenue by selling the Swoop scanner with subscription services including cloud based tools, repairs and maintenance, and, if and when available, upgrades. We also offer the opportunity to bundle the system within the subscription fees. We believe this makes a convenient and positive experience for our customers. As more healthcare professionals adopt our technology, we anticipate improvements in gross margin due to the recurring subscription base of the business.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">We have a strong executive leadership team and experienced financial partner with deep expertise in Healthcare.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Founder of Legacy Hyperfine and Liminal, Dr. Jonathan Rothberg, has dedicated his career to enabling breakthrough technologies to revolutionize healthcare. He has founded more than 10 healthcare and technology companies and has received numerous awards, including the Presidential Medal of Technology &amp; Innovation in 2016. He is supported by a world-class management team, including our executive officers and other senior management, with decades of cumulative experience in healthcare and consumer end-markets. We believe this leadership team positions us well to be a disruptive force in revolutionizing MRI.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our Strategies</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our strategies include the following:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Engage the medical imaging market through strategic partnerships for accelerated international expansion.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> In line with our vision to democratize healthcare imaging by providing affordable and accessible imaging of health conditions around the world, we are building an international sales strategy that includes direct sales to customers and through distribution partners in target regions. Through our multi-factor market analysis of countries and regions, we analyze the market based on available MRIs per population base and plan to deploy a sales and distribution approach designed to maximize our potential for commercial success. In preparation for our commercial launch in a particular country or region, we plan to build out the foundations necessary for business and regulatory functions to support our commercialization strategy.</span></div></div>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In our plans for international commercial expansion, the countries in which we plan initially to commercialize our Swoop scanner include the United Kingdom, Australia, New Zealand and Pakistan. Through grant funding from the BMGF, we are deploying Swoop scanners in these target areas for research and clinical settings. The utilization of our Swoop scanners as part of the programs will allow us to begin building relationship across key stakeholders in these</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">countries or regions to better understand and meet required regulatory hurdles in anticipation of filing for regulatory authorization and ultimately expand into clinical use with patients. In addition, we are considering commercial expansion into several of the larger European Union (&#34;EU&#34;) countries following our initial international commercial expansion. We believe these countries have the market size, regulatory environment, commercial access, and mature healthcare systems necessary, subject to regulatory authorization, for a successful launch of our Swoop scanner.</span></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our commitment to the vision of providing affordable and accessible imaging that enables earlier detection and remote management of health conditions around the world is in part made possible by grant funding from the BMGF. Through our engagement with nonprofit organizations, we aim to deploy the Swoop scanner to low-middle resource settings without readily-accessible MRI technology. The grants provided by the BMGF are designed to support the deployment of 25 Swoop scanners to investigators, which commenced in the spring of 2021, and are expected to fund the program for two years. The ongoing investigation is designed to provide data to validate the potential use of our Swoop scanner in measuring the impact of maternal anemia, malnutrition, infection and birth related injury.</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Expand clinical validation data and publications.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> There are over 41 conference presentations and publications discussing the clinical benefits of our Swoop scanner. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Journal of American Medical Association</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (JAMA) published a detailed study conducted at the Yale New Haven Hospital on how the Swoop scanner successfully detected abnormal neuroimaging findings at the bedside of patients in the ICU, demonstrating the capability of low-field, point of care MRI to obtain neuroimaging at the bedside in intensive care settings. We also recently partnered with Penn Medicine in an ongoing study to examine the efficacy of the Swoop scanner in the care of patients with hydrocephalus and whether the Swoop scanner provides for a simple, safe and cost effective way to follow patients through their treatment.</span></div></div>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Swoop scanner has been used for diagnoses across various neurological pathologies, and we believe that the Swoop scanner could ultimately enable a new paradigm in the standard of care for these diseases that could be lifesaving. We believe early diagnosis of these diseases has cost saving benefits for multiple stakeholders including patients, providers and payors, as it can lead to earlier intervention of treatment and fewer patient visits.</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Examples of use cases for our Swoop scanner include:</span></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Acute changes in mental status, which in an ICU setting refers to the sudden onset of a change in cognitive function or level of consciousness. The incidence rate for acute changes in mental status in ICU patients is high, with a substantial portion developing into a coma.</span></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Large vessel occlusion (&#x201c;LVO&#x201d;) stroke, which includes acute blockages of the intracranial internal carotid artery (&#x201c;ICA&#x201d;), proximal posterior, middle, anterior cerebral arteries, intracranial vertebral artery and basilar artery, leading to stroke. LVO stroke is responsible for between 24-46% of acute ischemic strokes (&#x201c;AIS&#x201d;) and leads to a 4.5 times increase in the risk of death from a future stroke.</span></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Postoperative hematoma, which is the collection of blood due to an injury of one or more blood vessels and is a potentially severe complication of cranial surgery. It has an overall mortality rate of 32% after neurosurgical operation.</span></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Hydrocephalus, which is the buildup of cerebrospinal fluid (&#x201c;CSF&#x201d;) in cerebral ventricles, which leads to an increase in size and subsequent intracranial pressure. It occurs in two of every 1,000 births in the United States or may develop in adults over time as a result of injury or disease with an incidence rate of 17 per 100,000 adult patients in the United States.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Focus on our customers through success programs. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Swoop scanner is designed to make the customer experience as easy as possible through our integrated, easy-to-use interface that portrays images on a tablet device. In addition to this design, our team is focused on customer success programs to help integrate the Swoop scanner into any hospital or clinic workflow. We believe that the use of our Swoop scanner within hospitals will provide us with opportunities to cross sell our product and services across departments and reduce customer acquisition costs as customers become more accustomed to the use of our Swoop scanner across their facilities and observe the improved health outcomes and reduced costs that the use of our Swoop scanner may provide. We expect our customer success programs also to increase our customer referral rates across the medical imaging market as our product continues to become validated and supported by healthcare professionals in the field.</span></div></div>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our customer success program is designed to ensure that our customers achieve their desired outcomes while using our Swoop scanner. Our team seeks to foster long-term relationships, highlight key product benefits and manage expectations with our customers. The program is designed to guide customers to achieve maximum utilization of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product and enhance their experience through ongoing educational tools and opportunities. Our customer success team aims to ensure a smooth path to obtain customer loyalty and continue to grow our install base with subscription renewals, follow-up sales, and new Swoop scanner placements.</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Demonstrate our commitment to continued technical innovation and leadership across the care continuum.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Our advanced technology in imaging is supported by an internal team of scientists and engineers dedicated to continuous innovation. We believe that as the Swoop scanner becomes integrated into ICUs and sites across medical practices, we will gain more insights into our product&#x2019;s usability and potentially develop automated analysis of images that we believe will lead to further efficiencies in patient diagnosis. We plan to continue developing our technology to expand into new imaging applications to enable us to reach the broader care continuum through diagnosis and treatment. In the future, we plan to introduce a further enhanced MRI system designed to conduct neuroimaging and imaging of other extremities for interventional procedures.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Brain Sensing Platform</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to our efforts to disrupt the MRI market, we see a significant opportunity to help patients in the neuromonitoring space. Current methods to monitor the brain directly include drilling a hole through the skull to insert sensors. This method introduces risk to the patient and is highly impractical outside of specialized hospitals, which severely limits access to critical information about a patient&#x2019;s neurological health. We intend to develop non-invasive brain sensing technology that is more affordable, accessible, and safer, to enable healthcare professionals to more easily monitor key brain vital signs such as cerebral blood flow and intracranial pressure throughout patient care. We expect this new form of neural monitoring will provide clinicians with valuable feedback and insight into various neurologic conditions such as altered mental status, stroke and traumatic brain injury. We expect this technology will be synergistic with our MRI platform as we connect the care continuum from MRI imaging to sensing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Industry and Market</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MRI is a non-ionizing radiation risk imaging modality widely used by healthcare professionals across various clinical settings for medical diagnosis of a patient, staging of disease and continued assessment following treatment. MRI is noninvasive, and in some cases, eliminates the need for surgical intervention or invasive procedures when used correctly, and offers superior soft tissue contrast resolution compared to other imaging modalities like CT. It is a more sensitive and potentially objective measure of brain tissue and injury. MRI is used to examine central nervous system (&#x201c;CNS&#x201d;), musculoskeletal, and other diseases. The prevalence and incidence rates of these diseases has increased across the globe. According to a United Nations report, up to one billion people, nearly one in six of the world&#x2019;s population, suffer from neurological disorders, including Alzheimer&#x2019;s and Parkinson&#x2019;s disease, stroke, multiple sclerosis, epilepsy, migraine, brain injuries and neuroinfections, with some 6.8 million dying of these disorders each year.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The demand for MRI has been augmented by the aging population and rising prevalence of cancer, cardiovascular, neurological and orthopedic conditions. Healthcare professionals and insurers are recognizing imaging as a cost-effective and non-invasive diagnostic for prevention and ongoing monitoring. Swoop is the next generation of these devices that we believe will drive costs down and expand the current $15.9 billion imaging market. Given the significant patient populations in need of diagnostic imaging, we have positioned ourselves in an underpenetrated market with substantial room for growth. In total, we estimate that the global imaging market will increase to a more than $20 billion opportunity across all of our potential use cases. This estimate includes over 100,000 hospitals and outpatient locations that we believe could serve as installation sites for our system. While the current imaging market is mainly limited to high-resource countries, we believe our scanner can help make MRI technology more accessible globally, leading to an increase in both MRI penetration rates and the size of the overall market opportunity.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Market needs</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Despite MRI&#x2019;s advantages to diagnose and monitor patients through treatment, access to MRI scanners can be problematic. Numerous challenges are associated with the use of conventional MRI devices:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">High cost</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: The average cost of conventional MRI scanners is $1.2 million, and conventional MRIs can cost more than $3 million, significantly more than our Swoop scanner. In addition, conventional MRIs typically are not offered with our lower cost of entry subscription-based pricing model.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Complex site requirements and upgrades</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: Due to the use of strong (1.5&#x2212;3.0 T) magnetic fields in conventional MRIs, there are various requirements and restrictions on radiation therapy (&#34;RT&#34;) facilities size, location, and ongoing maintenance, including the need to build a specialized radio frequency room to safely house the MRI scanner.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Scheduling delays</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: A high level of coordination is required between the MRI facility and the ICU to have patients scheduled for a conventional MRI scan. This is further complicated with patients who are unstable in the ICU and require multiple medical procedures in a timely manner.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Consumption of valuable personnel resources</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: Several personnel between departments within an institution are required to transport a patient across departments and additional personnel are required for transport a patient across facilities, including doctors, technicians, nurses, and emergency medical technicians.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risk of adverse events during transportation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: Adverse incidents occur to approximately 33% of critically ill patient cases during transport.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Maintaining connection to life support equipment</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: Patients in the ICU are often connected to life-sustaining devices that complicate the conventional MRI procedure and transportation to and from the conventional MRI scanner.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Due to these challenges, adoption of conventional MRIs has been limited across medical settings in the United States and globally, especially in rural locations where many individuals only have access to small clinics. MRI systems also include additional charges of establishing an MRI suite, patient support areas, machine installation and servicing, software upgrading, and maintenance that burden hospitals and clinics with limited ongoing funding.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are significant benefits of diagnosing a disease in its early stages, which can reduce time to treatment and improve the quality of life for those patients. We have taken advantage of technological advances in electronics and computing to develop an MRI device that is not only portable, but also uses a very low magnetic field strength, 64 mT (0.064T), which is much lower than the 1.5T or higher field strength of conventional MRI scanners. Our advanced technology provides the ability for healthcare professionals to conduct an MRI scan at the patient&#x2019;s bedside in the hospital or any clinical setting to begin early diagnosis, intervention and ongoing treatment. Many small- and medium-sized hospitals also consider leasing advanced MRI systems to provide MRI imaging services without undertaking the potentially more costly long-term commitment of purchasing an MRI system. Our Swoop scanner is available for purchase or subscription bundle by medical facilities in the United States with flexible payment options.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">According to a 2008 report from the World Health Organization, 90% of the world does not have access to MRI at all largely due to socio-economic factors. Many low-resource countries recognize the benefit of investing in their healthcare infrastructure and it is expected to cause a spur in growth for the global MRI market. For example, China is one of the fastest growing markets that is building their healthcare infrastructure in rural areas. The ability for these countries to build the facilities needed to house these large systems and train highly specialized personnel to operate conventional MRI systems presents a challenge.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Potential market expansion</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Brain Sensing Platform</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">One area for potential market expansion is non-invasive neural monitoring or sensing to assess critical brain health metrics such as cerebral blood flow and intracranial pressure in any clinical, outpatient or home setting. Understanding the vital signs of the brain is paramount in the diagnosis and management of brain disorders yet current care has limited access to important measurements of brain health. Post-operative and general neurological conditions such as stroke, traumatic brain injury, hydrocephalus, removal of brain and spinal tumors, neural tube defects, seizures, CNS vascular anomalies and CNS infections, require extensive monitoring in the ICU and longer-term care to ensure the patient does not experience infection or worsening of their condition. Our technology currently in development has the potential to provide hospitals with real-time monitoring and continuous trend analysis to provide data-backed treatment. To accomplish this, we are building a flexible and extendable noninvasive brain-monitoring platform, creating access to critical brain vital signs throughout the patient care from diagnosis to full recovery. Our approach is to create the neurological equivalent of the stick-on electrocardiogram heart monitor that is a staple in virtually every medical environment. There is a large unmet need in the market for continuous monitoring of chronic neurological conditions. According to market research, the market for global non-invasive brain trauma monitoring devices is expected to grow from approximately $10.1 billion in 2019 to $18.3 billion by 2027, at a CAGR of 7.7%. In addition, we have the potential to ultimately expand our capability to diagnose and manage chronic conditions beyond acute neurological conditions. Our next generation device is expected to contain electroencephalography alongside hemodynamic assessment capabilities to improve quality of care for chronic conditions such as epilepsy, which affects around 50 million people of all ages worldwide. We are currently in product development of our brain sensing technology and hardware platform. We are working toward a clinical proof of concept to demonstrate the technological performance and have begun the process of engaging with the FDA to clarify the regulatory pathway.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Products and Services</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our Swoop Portable MR Imaging System</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Swoop Portable MR Imaging System is designed to address an unmet need in point-of-care medical imaging through a unique combination of hardware and software services. Our hardware is powered by the use of modern computational power and deep learning advances. Our software addresses the traditional ease-of-use and integration challenges often presented by specialized medical technologies. Our system operates from a tablet, smartphone or other WiFi capable device and integrates with picture archiving and communication system (&#x201c;PACS&#x201d;) to enable fast and confident clinical decision-making.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img37592182_1.jpg" alt="img37592182_1.jpg" style="width:389px;height:179px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Features</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Point-of-care neuroimaging&#x2009;-&#x2009;FDA cleared for MRI of the brain and head in patients of all ages</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Neuroimaging at the point of care has only been possible using CT, which delivers a significant amount of ionizing radiation. Exposing patients to radiation increases the risk of developing cancer, which limits CT&#x2019;s use to critically ill patients and makes it particularly hazardous for pediatric patients. CT can visualize bones or blood vessels well when the patient is injected with a contrast agent but is not as sensitive as MRI at imaging the anatomy of the brain.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The gold standard for neuroimaging is MRI, which can provide excellent high-resolution images of the soft tissues on the brain without being obscured by the skull. MRI can provide critical insight into trauma and disease in the brain but historically has simply not been available at the point of care. Because of their size, weight and safety issues, conventional MRI systems were only available in hospitals and major medical centers and outpatient imaging providers, and so patients typically must be transported to the MRI.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have developed a new category of medical imaging&#x2009;-&#x2009;point of care MRI&#x2009;-&#x2009;that is smaller, lighter weight, and lower cost than conventional MRI, yet maintains the soft tissue visualization capabilities that is critical for neuroimaging. Advanced neuroimaging is now available for patients of all ages at the point of care since we launched our FDA-cleared portable Swoop MRI system in 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img37592182_2.jpg" alt="img37592182_2.jpg" style="width:462px;height:195px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Low field system</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To engineer this new category of point of care MRI, we made several significant design changes with respect to conventional MRI, particularly the magnetic field strength. Over the past 40 years, the goal for improving conventional MRI systems has been to attain higher magnetic field strength. In 2017, the FDA cleared the first 7T MRI, after 20 years of development to establish clinical relevance. It was noted that the added field strength allows for better visualization of smaller structures and subtle pathologies that may improve disease diagnosis. We have taken a different approach by developing our Swoop scanner to have a very low field magnet of 0.064T, which enables MRI to become portable because, unlike conventional MRIs, the field strength of the magnet in our system does not require a specialized radio frequency room to safely house the MRI scanner. This field strength comes from a unique optimization of the magnet size, weight, field uniformity and patented design of the permanent magnet structure that provides sufficient image clarity for diagnostic purposes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are additional benefits of operating an MRI system with low field magnet, as it reduces the risk of iron-containing objects becoming projectile and injuring patients or operators, which is a typical concern of conventional MRI systems. Furthermore, the radiofrequency pulses used in conventional MRI are responsible for 55% of the FDA-reported adverse events from MRI, causing skin and internal burns in some patients. Operating at 0.064T means using lower energy radiofrequency pulses and significantly reduced associated safety risks.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Motion correction</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Conventional MRI scans regularly suffer from quality problems due to patient motion, with approximately 30% of all scans from inpatient or emergency department exams having moderate or severe image quality issues. Portable MRI at the point of care can provide MRI insights to more critically ill patients than previously possible. We have developed a motion compensation technology to improve image quality in the most challenging and often most in need patients that we recently received FDA clearance for clinical use. We believe that with continued development, our technology can produce diagnostic scans without requiring the operator to make expert adjustments to the scanning procedure due to typical patient movements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Noise-cancellation technology</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Designing a low-field magnet is not sufficient to enable portable MRI. Portable MRI must also address the electromagnetic interference that surrounds us and makes effective conventional MRI outside of a shielded room impossible. Conventional MRI systems are permanently installed in a special room where the walls, floor and ceiling are encased in copper or aluminum to provide a special environment for conventional MRI machines to operate, in which all of the man-made and natural electromagnetic interference is prevented from entering. Installation of these shielded rooms typically costs more than $100,000.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have developed proprietary and patented noise cancellation technology to enable portable MRI. Our technology works by measuring the external electromagnetic interference and subtracting that from the interference that swamps the MRI signals. The image below shows one slice of an MRI image acquired a) outside a shielded room without noise cancellation, b) outside a shielded room with noise cancellation and c) inside a shielded room without noise cancellation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img37592182_3.jpg" alt="img37592182_3.jpg" style="width:425px;height:124px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Delivery of multiple sequences with tissue contrasts</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MRI has the unique capability of providing images with different soft tissue contrasts through a variety of different sequences that can highlight a range of pathologies clearly. Our Swoop portable MRI system generates images with contrast weightings with which physicians are most familiar and which are most clinically useful for the target use cases: T1-weighted, T2-weighted, Fluid-attenuated T2-weighted (T2-FLAIR), and diffusion-weighted (&#x201c;DWI&#x201d;) with apparent diffusion coefficient (&#x201c;ADC&#x201d;) map images. These contrasts are standard in conventional MRI and allow for differentiation of various tissue types aiding in establishing the diagnosis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Image quality</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We deliver diagnostic quality images to healthcare professionals. The images from our Swoop portable MRI system are higher in contrast resolution than other portable medical neuroimaging systems, such as portable CT scanners. Our portable MRI system also delivers comparable image resolution at 1.5 mm x 1.5 mm x 5 mm relative to the typical image resolution of a conventional MRI at 1.0 mm x 1.0 mm x 5 mm. Our MRI signal is produced at 0.064-Tesla (&#x201c;T&#x201d;) compared to 1.5T or higher produced by conventional, fixed MRI scanners. We believe that Swoop provides the potential to improve the quality of care for patients who have limited to no accessibility to conventional MRI, which includes 90% of the world&#x2019;s population.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Controlled by an easy-to-use wireless tablet</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe it is important to consider usability when significantly changing the way in which a medical device is used, specifically in MRI where conventionally the operator is required to have several years of training. As we seek to reach new markets and new users with our Swoop scanner, we have sought to make the operation of the device as simple and easy to use as possible. We believe this is particularly important when used in emergency situations such as stroke, where time can be critical.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The interfaces to the device are simple intuitive buttons, joystick controls to drive the scanner, and a familiar tablet controller for image acquisition and viewing. The user interface provided on the touch-screen display provides a playlist of protocols based on the use case that can be started, stopped and rearranged, as needed. In addition to being easy-to-use and the consequential acceleration of hospital workflows that can result, our system provides for standardized images across all placement sites due to our uniform manufacturing specifications and a consistent set of sequences that are not customized by individual operators. Conventional MRIs are sequenced by highly-trained technologists and can have variations in image resolution and contrast weighting across sites due to institutional policies and radiologist preferences. We believe the standardization of images across scanners and sites will greatly benefit the ability of radiologists and other healthcare professionals to efficiently read our images and to ultimately build a repository of homogenized image data from which to extract value using data mining and deep learning.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Integration with picture archiving and communication system (PACS) and secure image upload to the Cloud</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Similar to many hospital medical devices, our product is designed to seamlessly integrate with the hospital informational technology (&#x201c;IT&#x201d;) infrastructure, such that scans can be ordered easily and sent to PACS to be read by a radiologist. For applications where access to such infrastructure is not available, we also offer our own secure cloud based PACS where healthcare professionals including teleradiology service providers can view images from anywhere in the world. We believe that the combination of portable MRI, where scans can be obtained outside the conventional MRI suite, and teleradiology can significantly improve patient care and increase access.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fully Automated MRI Post-Processing Software</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We received FDA clearance for BrainInsight, our first AI applications in January 2021. These applications for automatic labelling, spatial measurements, and volumetric quantification operate on images from our Swoop portable MRI system, automatically add additional insights and associate those insights to the images in the PACS. Using this approach, we intend to grow our portfolio of applications with internal and external development and leveraging the uniquely standardized (and fully anonymized) record of image data we plan to create with our portable MRI system. We believe that bringing the power of AI to MRI has the potential to significantly improve the efficiency of medical imaging in a wide array of use cases, which can benefit the patient by potentially helping to improve outcomes and result in shorter hospital stays.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Design</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Location flexibility</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Despite the weight of our Swoop scanner being 1,400 lbs., its powered drive system means that it can be transported around the hospital with minimal effort. The Swoop scanner can be moved from bed-to-bed and easily positioned in tight spaces because it can be turned on the spot with a zero turn radius.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Open layout designed to reduce patient anxiety</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For an MRI scan in a traditional setting, a patient arrives at the radiology department of a hospital and typically enters through a door covered with radiation warning and other hazard symbols. The patient then proceeds through to a waiting room where they undergo a lengthy safety questionnaire and are asked to remove all clothes and jewelry down to their underwear and put on a hospital gown. Wait times vary from a half hour to several hours before the patient enters the console room and then is led through a large metal door into the RF screen room by themselves. Typical conventional MRI systems</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">are long tubes where the patient is positioned on a motorized bed and RF coils are attached around the patient who has been instructed to lay still. The MRI technician uses the motorized bed to push the patient into the long tube of the large superconducting magnet, leaves the room, closes the metal door to the scan room and tells the patient over an intercom that the scan is about to start. The patient hears the steady mechanical thumping of the cryocooler in the magnet room until the scanning starts, which is then accompanied by often extremely loud acoustic noises. The conventional MRI procedure is often a daunting experience for the patient that can cause significant anxiety, especially for pediatric patients who are separated from their family during this time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unlike conventional MRI, our Swoop portable MRI is entirely contained in a system that is just 55 inches tall and 34 inches wide and is designed to scan patients in their own beds. Parents, family, or caregivers can be close by the patient as they are scanned with just their head in the transparent head RF coil. The system is quiet enough to allow constant verbal contact with the patient, and which overall can create a considerably less distressing experience for the patient than conventional MRI.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Powered by a standard wall outlet</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To be operable throughout any hospital environment, our Swoop scanner plugs into a standard wall outlet (100-230 VAC, 50/60 Hz, 15A) and uses less than 900W of electricity. This is achieved with low-power electronics, including efficient power supplies and power amplifiers, coupled with a zero-power consumption permanent magnet. Our Swoop scanner does not require many of the components of conventional MRI, including the liquid helium used in conventional MRI superconducting magnets or the associated safety and supporting infrastructure, the chilled water-cooling systems for the power electronics and gradient coils and the room air conditioning needed to extract the heat generated in the separate electronics machine room, or the special 480 V, 3-phase, 200A power supply.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Services</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Unlimited training / support resources</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Through our subscription model, we offer a number of services to complement the advanced features of our product. As part of our subscription, we offer unlimited user training during the subscription period to make it as easy as possible for healthcare professionals to operate our system. We offer this support primarily as reassurance to our customers although we are confident our customers will be able to operate our user-friendly device with ease and efficiency; in our experience so far, the user training on the system is generally simple and only requires a few hours. Our subscription also provides for unlimited service and maintenance support during the subscription period to offer peace of mind for our customers. In addition to these support services, our subscription includes our Cloud PACS, an unlimited Cloud archive that users can use to upload images for storage purposes, and grants access to our future software upgrades. Recent upgrades include our FDA cleared motion correction technology that improves the quality of images in the presence of motion, as well as other potential future upgrades designed to improve the patient workflow and diagnosis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liminal Platform</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Liminal&#x2019;s noninvasive platform is being developed, subject to regulatory authorization, to aid in the diagnosis and management of brain disorders. We believe that understanding the vital signs of the brain for diagnosis and treatment is essential, but the current standard of care is invasive, which limits access. Although there are some non-invasive techniques for measuring the brain such as transcranial doppler (TCD), which has been available since the 1980s, they require specialized technicians to obtain measurements, making them expensive and only available in specialized centers. We are in the early phases of creating our first AEG</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">TM</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> device through the development of novel acoustic sensing techniques and innovative algorithms for measuring key metrics of brain health. We are working to develop a way to monitor the brain and enable access to key brain vital signs, such as cerebral blood flow and intercranial pressure, more easily than currently available technologies. The device is designed to gather continuous data, and is intended to be easy to use and be applied without specialized training. This technology is designed to provide the clinician with valuable feedback and insight into many brain conditions. Its features are designed to increase the accessibility of key brain vitals which could allow clinicians to diagnose earlier, monitor more effectively and intervene.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Similar to Legacy Hyperfine&#x2019;s Swoop scanner, we expect the use of the AEG</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">TM</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> device will not require any specialized training and will expand access to real-time brain monitoring in patients across the care continuum. We are designing the AEG</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">TM</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> device to enable first responders in the field to use the sensors with ease and to enable healthcare practitioners to monitor the brain during triage, operations, treatment and recovery.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img37592182_4.jpg" alt="img37592182_4.jpg" style="width:247px;height:175px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our goal is to create an easy to use but powerful brain monitoring platform that can be used anytime, anywhere. We believe this technology will be synergistic with Legacy Hyperfine&#x2019;s MRI platform in developing products for patients across the care continuum in sensing, imaging and intervention, in addition to further expanding the growth potential for both businesses in imaging and sensing. We are currently in product development of our brain sensing technology and hardware platform. We are working toward a clinical proof of concept to demonstrate the technological performance and have begun the process of engaging with the FDA to clarify the regulatory pathway. Liminal has not commercialized or obtained regulatory authorization for any of its products and its operations to date have been limited to developing its technology and products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our People</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine was founded in 2014 and Liminal was founded in 2018 by Dr. Jonathan Rothberg. Our mission is to provide affordable and accessible imaging and monitoring through MRI to revolutionize healthcare for people around the world.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of February 15, 2022, we had 193 employees, 186 of whom were full-time employees and of whom 56 work in sales, clinical and marketing, 97 work in research, development, manufacturing and operations, and 33 work in general and administrative capacities. As of February 15, 2022, 190 of our employees were located in the United States, two were located in the United Kingdom and one was located in Pakistan. None of our employees are represented by a labor union or are subject to a collective bargaining agreement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dr. Rothberg and our business have been recognized for leadership. Legacy Hyperfine and Liminal were founded in 2014 and 2018, respectively, by Dr. Jonathan Rothberg, a serial entrepreneur that received the Presidential Medal of Technology &amp; Innovation in 2016 for inventing a novel next generation DNA sequencing method and has founded more than 10 healthcare and technology companies, including 454 Life Sciences, Ion Torrent, CuraGen, Butterfly Network and Quantum-Si.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Environmental, Social and Governance Practices</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As we work toward our mission, we are increasingly focused on providing transparency around our environmental, social and governance (&#x201c;ESG&#x201d;) practices and identifying risks related thereto. We are committed to human capital management, patient advocacy and community outreach efforts, corporate governance, and implementing environmental sustainability initiatives.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Environmental Stewardship:</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We recognize the importance of taking measures to reduce our environmental footprint. As we grow our business, we have initiated certain projects to begin tracking our environmental impact, and where feasible, have taken measures to increase our sustainability efforts. Some of our efforts include our commitment to reduce, reuse or recycle where possible or appropriate and energy efficient projects to lower energy use within our office areas and laboratories.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Human Capital Management:</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We believe that our people are the reason for our success and we have organized ourselves to maximize productivity and performance. We maintain a high bar for talent and actively work to build diversity within our workforce. Critical to achieving our strategic goals is our ability to build and retain an exceptional team in which each member plays a unique and important role. Employees of Legacy Hyperfine and Liminal continue as employees following the Business Combination.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We recognize that maintaining an engaged and top-notch workforce and a connection with the communities we serve is critical to our success. Comradery and cohesion are at the core of who we are as a company and are integral facets of our human capital management strategy. We are inspired by each other and the possibilities of what we can achieve together. We understand that in order to drive innovation, we must continuously improve our human capital management strategies and find ways to foster engagement and growth within our organization. To this end, below are some of our initiatives:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Professional Development Programs and Opportunities:</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Our greatest asset is our employees and we aspire to provide them with opportunities so they can continue to grow and excel in their functions and our company. Professional growth of our employees leads to engagement, development and allows us to leverage opportunities so we can hire and promote key talent from within. Through development planning, we strive for employees at all levels to focus on strengthening the skills required in their current role and potentially their next role. We are focused on building a culture of continuous coaching, feedback and open communication between managers and their direct reports throughout the entire year. We provide managers and employees with training on how to conduct effective forward-looking performance conversations and to set effective goals that are realistic, measurable, attainable, relevant and timebound.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Diversity, Equity and Inclusion:</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Our commitment to maintaining a top-performing company means investing in and creating ongoing opportunities for employee development in a diverse and inclusive workplace. We believe that a diverse workforce not only positively impacts our performance, fosters innovation, inspires us to achieve greater results, increases our collective capabilities and strengthens our culture, but it also cultivates an essential pipeline of experienced leaders for management. Hiring for diversity of thought, background and experience, and diversity of personal characteristics such as gender, race and ethnicity is intentional and continues to be an area of focus as we build and grow our workforce.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Compensation, Equity and Benefits:</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We have designed a broad-based compensation program that is designed to attract, retain and motivate our employees to deliver sustainable long-term value. We seek to deliver performance-driven, market competitive reward opportunities commensurate with company and individual performance. Many of our employees receive equity grants and cash bonuses in addition to base salaries and our benefits package. We believe that providing employees with an ownership interest in our company further strengthens the level of employee engagement. Furthermore, equity awards help align the interests of our employees with the long-term interests of our stockholders. We also offer employees a health insurance package.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Governance, Ethics, and Compliance:</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Our board of directors is committed to robust corporate governance practices, risk oversight, stockholder rights, diversity, equity and inclusion, corporate sustainability, ethics and compliance in order to protect the long-term interests of our company, stockholders and the patients we serve. Our board of directors adopted corporate governance principles applicable to us, including responsible oversight and management of the Company, effective controls and processes, compliance with SEC and Nasdaq Stock Market rules and regulations, maintaining an engaged board of directors and a board structure that recognizes the importance of diversity, appropriate compensation practices, and succession planning, among other matters.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will continue to evolve and strengthen our human capital management strategies, increase our environmental efforts, maintain and continue to improve our corporate governance practices, and anticipate reporting on other corporate sustainability measures over time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sales, Pricing and Marketing</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Marketing</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our marketing efforts are focused on accelerating awareness of our products and capabilities in order to create a strong reputation with clinicians and healthcare administrators. Our go-to-market approach features a targeted sales organization complemented by an array of promotional activities including media coverage, tradeshow exhibition, advertising, and live product demonstration. We principally target acute care hospitals and health systems. In the future, we plan to leverage this approach for both our Swoop Scanner and our future products that have similar end markets.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We recognize the role of education in accelerating clinical adoption of our products across the patient care pathway, including healthcare professionals who currently may not themselves be primary users of MRI technology. To support adoption of our product and in addition to our simplified product interface, we have developed training curriculum and tutorials and built a team of clinically trained customer success managers to guide and coach clinicians on the unique features of our device and on the specific clinical application of our technologies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sales and Pricing</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Swoop scanner is commercially available in the United States, and we are seeking necessary regulatory authorizations in other major markets, including the United Kingdom, Australia and other countries. We recently received regulatory authorization in New Zealand and Pakistan. We are building our direct commercial infrastructure in the United States and also have plans to sell our products in other countries either through direct sales or through distributors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are commercializing our device through two business models: (i) the subscription bundle model, and (ii) the subscription plus ownership model. For both models, we offer subscriptions with software upgrades for 36 or 60 months and an annual pre-payment discount. We have specifically selected these business models to create convenience and widespread adoption.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Subscription bundle model:</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> This model includes a 36-month subscription or a 60-month subscription. The subscription bundle model includes the use of a Swoop scanner and an off-the-shelf tablet for use with the scanner, plus the same subscription benefits provided in the subscription plus ownership model. The subscription fee is based on the term of the subscription, whether prepayment is made, and whether the Swoop scanner will be for commercial or research use.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Subscription plus ownership model</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: This model provides for the sale of the Swoop scanner, along with an off-the-shelf tablet for use with the scanner, to the customer for an initial payment, which is substantially less expensive than the average cost of $1.2 million for conventional MRI scanners. In addition to purchasing ownership of the system, the customer purchases a 36-month subscription or a 60-month subscription. The subscription fee is based on the term of the subscription, whether prepayment is made, and whether the Swoop scanner will be for commercial or research use.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe our subscription-based model has the potential to generate a more predictable recurring revenue stream while helping to foster an ongoing relationship with our customers. To help ensure our customers receive the highest level of customer service, we plan to continue to sell directly to customers and providing ongoing customer support. However, as we expand internationally subject to regulatory authorization in those countries, we may leverage distributors to sell our product depending on the commercial strategy for each country assessed on a country-by-country basis. Through our subscription-based model, we aim to provide MRI systems that are much less expensive than conventional MRI systems and achieve our vision of increasing accessibility to MRI worldwide.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Suppliers and Manufacturing</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Swoop scanner is built using both custom-made and off-the-shelf components supplied by outside manufacturers and vendors located in the United States, Europe and Asia. One key custom-made component in our Swoop scanner is the magnet, which is manufactured by a single source supplier in Europe. The majority of the other components for the Swoop scanner are off-the-shelf or made using standard processes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We purchase some of our components and materials used in manufacturing, including magnets, field programmable gate arrays (&#x201c;FPGAs&#x201d;), central processing units (&#x201c;CPUs&#x201d;) and molded plastics, from single sources. Although we believe that alternative sources of these components and materials would be available, it would take time to identify and validate replacement components, which could negatively affect our ability to supply the Swoop scanner on a timely basis. We cannot give assurances that any alternative supplier would be able to recreate the manufacturing processes currently in use. To mitigate this risk, we typically carry a significant inventory of critical components. We also plan to work with our Swoop scanner device manufacturer, Benchmark Electronics, Inc. (&#34;Benchmark&#34;), to add an additional magnet supplier to the manufacturing process to mitigate the risk to supply of our magnets by the current use of a single supplier.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All of our Swoop scanner devices are manufactured, tested, shipped and supported by Benchmark from its facilities in Nashua, NH. We believe that this manufacturing strategy is efficient and conserves capital. However, in the event it becomes necessary to utilize a different contract manufacturer for our Swoop products, we would experience additional costs, delays and difficulties in doing so, and our business could be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Key Agreements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Manufacture and Supply Agreement with Benchmark Electronics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2018, Legacy Hyperfine entered into a Manufacture and Supply Agreement with Benchmark (the &#x201c;MSA&#x201d;). Under the MSA, Benchmark agreed to manufacture our products pursuant to binding purchase orders. Each month, we have agreed to provide Benchmark with a binding purchase order for a period specified by the MSA, as well as a non-binding forecast for each month within such period. If we do not provide the monthly purchase order and forecast update, then the first forecast month of the then-current forecast becomes binding so that a rolling binding commitment to purchase product for the specified period is maintained. The parties have agreed to meet periodically regarding any minimum order quantities of components under the MSA. We also have certain inventory related obligations, including the obligation to purchase excess and obsolete components from Benchmark. Excess components are determined based upon the amount of component inventory that exceeds the build plan for the specified period discussed above. We would be required to purchase such excess inventory and be credited back against future purchases of finished products as the inventory of components is reduced to the amount needed to meet the rolling build plan. Obsolete materials are immediately invoiced once identified. As of February 15, 2022, we have paid approximately $2.2 million for excess components.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the terms of the MSA, we granted Benchmark a non-exclusive, non-transferable, revocable, fully-paid, royalty-free license, without the right to sublicense, to use our technology solely to manufacture our products. The MSA provides that we will own any right, title and interest in any improvements or modifications to our technology made in the course of performance of Benchmark&#x2019;s obligations under the MSA. We and Benchmark also agreed to indemnify each other against certain third-party claims.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The MSA has an initial three-year term and will renew automatically for additional two-year terms unless either party gives 180 days&#x2019; prior written notice before the end of the then-current term to the other party electing not to renew the agreement. The MSA or any purchase order under the MSA may be terminated by either party for convenience upon 90 days&#x2019; prior written notice to the other party. The MSA may also be terminated by either party by written notice upon the occurrence of (i) a breach by the other party under the agreement which is not cured within 30 days after written notice by the terminating party, (ii) the other party becomes insolvent, dissolves, liquidates or ceases to conduct business or (iii) the occurrence of payment-related breaches. Benchmark may also terminate the agreement upon the filing of any petition against us under bankruptcy or similar laws, where such petition is not vacated within 10 days via court order.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Competition</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Several large companies, such as General Electric, Siemens, Philips, Hologic, Varian, Fuji, Toshiba, Canon and Hitachi currently dominate the medical imaging market. High regulatory, distribution, manufacturing and service-related long-term contractual costs represent significant barriers to entry for any new player. We expect that the existing market participants will remain key players in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a general matter, we view competition on two levels:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Conventional MRI systems with which the general public is familiar; and</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The development of other portable MRI systems with the same or better attributes.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The primary competition comes from established market participants offering conventional MRI systems. While in developing countries we are experiencing keen interest, the United States and other Western regions already have major market participants that are well entrenched in the market with strong political influence and the ability to delay deployment of our systems.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are not aware of any competing company that has achieved a portable MRI system. To our knowledge, there are several companies currently in the process of developing this technology, including Promaxo, Neuro42 and Huami.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Intellectual Property</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Protection of our intellectual property is a strategic priority for our business. We rely on a combination of patents, trademarks, trade secrets and other intellectual property rights protections and contractual restrictions to protect our proprietary technologies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patents owned and in-licensed by us are generally directed to the architecture of Legacy Hyperfine&#x2019;s MRI systems and related technology, and Liminal&#x2019;s non-invasive brain sensing and treatment devices and related technology. We have developed a portfolio of issued patents and pending patent applications directed to commercial products and technologies for potential development. We believe that our intellectual property is a core strength of our business, and our strategy includes the continued development of our patent portfolio.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our Swoop&#174; and Related Technology</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of February 15, 2022, Legacy Hyperfine owned approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">141</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> issued patents and approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">293</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> pending patent applications. Of Legacy Hyperfine&#x2019;s approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">141</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> issued patents, approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were issued U.S. utility patents and approximately two were issued U.S. design patents. Of Legacy Hyperfine&#x2019;s approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">293</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> pending patent applications, approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">81</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were pending U.S. utility patent applications. In addition, Legacy Hyperfine owned approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> issued patents in foreign jurisdictions, including Australia, Canada, Japan, China, Taiwan, Korea, Hong Kong, Israel, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">France, Germany, Ireland, Switzerland/Liechtenstein, </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the United Kingdom</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">212</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> pending patent applications in foreign jurisdictions, including Australia, Canada, Europe, Japan, China, Taiwan, Korea, Hong Kong, Israel, and New Zealand, corresponding to the foregoing. In total, Legacy Hyperfine owns approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">69</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> patent families generally directed to its MRI system, including magnet design and manufacturing, electronics and circuitry, mechanical aspects, safety features, noise compensation technology, image formation and analysis software, and various other aspects of MRI systems.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These issued patents and pending patent applications (if they were to issue as patents) have expected expiration dates ranging between 2035 and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2042</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine patents and pending patent applications (including types of patent protection and jurisdictions where Legacy Hyperfine has been granted patents or has patent applications pending) directed to its material products are detailed in the table below.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:96.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.355%;"></td>
    <td style="width:2.304%;"></td>
    <td style="width:12.225%;"></td>
    <td style="width:2.346%;"></td>
    <td style="width:17.619%;"></td>
    <td style="width:2.346%;"></td>
    <td style="width:19.448%;"></td>
    <td style="width:2.346%;"></td>
    <td style="width:34.866%;"></td>
    <td style="width:0.145%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.021in;border-bottom:0.750pt solid rgba(0,0,0,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Family</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.021in;border-bottom:0.750pt solid rgba(255,255,255,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.021in;border-bottom:0.750pt solid rgba(0,0,0,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Patent</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Protection Type</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.021in;border-bottom:0.750pt solid rgba(255,255,255,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.021in;border-bottom:0.750pt solid rgba(0,0,0,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Jurisdictions with</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Pending Applications</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.021in;border-bottom:0.750pt solid rgba(255,255,255,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.021in;border-bottom:0.750pt solid rgba(0,0,0,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Jurisdictions with</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Granted Patents</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.021in;border-bottom:0.750pt solid rgba(255,255,255,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.021in;border-bottom:0.750pt solid rgba(0,0,0,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Title</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.021in;border-bottom:0.750pt solid rgba(255,255,255,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA (2), CN, EP, HK, IL, JP, KR, US</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU (2), CA, CN, HK, JP (2), US (4)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Low field magnetic resonance imaging methods and apparatus</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CA, CN, EP, HK, IL, JP, KR, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, HK, IL, JP (2), US (6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Noise suppression methods and apparatus</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA (2), CN, EP, HK (2), KR, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, JP (2), US (2)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pulse sequences for low field magnetic resonance</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Low field magnetic resonance methods and apparatus</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Methods and apparatus for thermal management of an MRI component by reducing eddy currents</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CA, EP, HK (2), KR</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CN, JP, MX, TW, US (5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Magnetic coil power methods and apparatus</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">EP, HK (2), KR, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, JP, TW, US (2)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Radio frequency coil methods and apparatus</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CA, CN, EP, HK, IL, KR, US (2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CN, HK, JP, TW (2), US (6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Automatic configuration of a low field magnetic resonance imaging system</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CN, EP, HK, JP, KR, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CA, TW (2), US (2)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Radio frequency coil tuning methods and apparatus</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CN, EP, HK (2), JP, KR, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, HK, JP, IL, TW, US (3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ferromagnetic augmentation for magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, HK, IL, IN, JP, KR, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CH/LI, DE, FR, GB, IE, TW, US (6)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Systems and methods for automated detection in magnetic resonance images</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA (2), EP, IL, MX, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CA, CN, HK, JP, KR, TW (2), US (4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Methods and apparatus for magnetic field shimming</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA (6), CN, EP, HK, IL, JP, KR,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">TW (2)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Portable low-field magnetic resonance imaging methods and apparatus</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, counterpart foreign cases in 13 family</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Electromagnetic shielding for magnetic resonance imaging methods and apparatus</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, counterpart foreign cases in 13 family</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (4)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Portable magnetic resonance imaging methods and apparatus</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, HK, IL, JP, KR, TW, US (4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Methods and apparatus for patient positioning in magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (1), counterpart foreign cases in 13 family</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (12)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Low-field magnetic resonance imaging methods and apparatus</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Counterpart foreign cases in 13 family</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Rotatable magnet methods and apparatus for a magnetic resonance imaging system</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, HK, IL, JP, KR, TW, US (3)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (3)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Radio-frequency coil signal chain for a low-field MRI system</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:96.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.355%;"></td>
    <td style="width:2.304%;"></td>
    <td style="width:12.225%;"></td>
    <td style="width:2.346%;"></td>
    <td style="width:17.619%;"></td>
    <td style="width:2.346%;"></td>
    <td style="width:19.448%;"></td>
    <td style="width:2.346%;"></td>
    <td style="width:34.866%;"></td>
    <td style="width:0.145%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.016in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.016in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.016in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.016in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.016in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, HK, IL, JP, KR, TW, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.016in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.016in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">TW, US (2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.016in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.016in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deployable guard for portable magnetic resonance imaging devices</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.016in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, HK, IL, JP, KR, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">TW, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">B0 magnet methods and apparatus for a magnetic resonance imaging system</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, HK, JP, KR, TW, US (2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deep learning techniques for magnetic resonance image reconstruction</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, HK, JP, KR, TW, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Medical imaging device messaging service</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, HK, JP, KR, TW, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Low-field diffusion weighted imaging</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, HK, JP, KR, TW, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deep learning techniques for suppressing artefacts in magnetic resonance images</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, EP, NZ, TW, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">System and methods for grounding patients during magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, NZ, TW, US (2)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Correcting for hysteresis in magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, NZ, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Techniques for dynamic control of a magnetic resonance imaging system</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (2), PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">System and methods for detecting electromagnetic interference in patients during magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, NZ, TW, US,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Systems and methods for magnetic resonance imaging of infants</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, counterpart foreign cases in 32 family</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deep learning techniques for alignment of magnetic resonance images</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, NZ, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deep learning techniques for generating magnetic resonance images from spatial frequency data</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Low noise gradient amplification components for mr systems</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, NZ, US (2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Systems, devices, and methods for magnetic resonance imaging of infants</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, counterpart foreign cases in 16 family</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patient support bridge methods and apparatus</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (2), PCT</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Systems and methods for detecting patient motion during magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.019in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, counterpart foreign cases in 32 family</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Multi-coil magnetic resonance imaging using deep learning</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Eddy current mitigation systems and methods</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (3), PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Artefact reduction in magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:96.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.355%;"></td>
    <td style="width:2.304%;"></td>
    <td style="width:12.225%;"></td>
    <td style="width:2.346%;"></td>
    <td style="width:17.619%;"></td>
    <td style="width:2.346%;"></td>
    <td style="width:19.448%;"></td>
    <td style="width:2.346%;"></td>
    <td style="width:34.866%;"></td>
    <td style="width:0.145%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (2), PCT</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Techniques for displaying medical image data</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Systems and methods for generating three-dimensional medical images using ray tracing</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (2), counterpart foreign cases in 32 family</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Self ensembling techniques for generating magnetic resonance images from spatial frequency data</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">TW, US, PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Magnetic resonance imaging magnet assembly systems and methods</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (2), PCT</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ferromagnetic frame for magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (2), PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Permanent magnet assembly for magnetic resonance imaging with non-ferromagnetic frame</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Swaged component magnet assembly for magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Techniques for noise suppression in an environment of a magnetic resonance imaging system</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Design</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Frame for magnets in magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Design</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Frame for magnets in magnetic resonance imaging</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (2), PCT</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Gradient waveform design for low-field magnetic resonance imaging systems</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Systems and methods for low-field fast spin echo imaging</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">52</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT, TW</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Systems and methods for providing operating power to a magnetic resonance imaging (MRI) system</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deep learning methods for noise suppression in medical imaging</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">54</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">55</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">58</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.035in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.035in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.035in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.035in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.035in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.035in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.035in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.035in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.035in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.035in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">63</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">64</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">66</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">67</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">68</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">69</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">US (2)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.038in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liminal Non-Invasive Brain Sensor and Related Technology</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of February 15, 2022, Liminal owned approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> pending patent applications. Of Liminal&#x2019;s approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> pending patent applications, approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were pending U.S. utility patent applications. In addition, Liminal owned approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> pending patent applications in foreign jurisdictions, including Australia, Canada, China, Europe, Israel, Japan, Korea, and Taiwan, corresponding to the foregoing. In total, Liminal owns approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> patent families generally directed to its brain sensing products, including stimulation and monitoring components, electronics and circuitry, mechanical aspects, and software including AI software algorithms, and various additional features. These pending patent applications (if they were to issue as patents) have expected expiration dates ranging between 2039 and 2041.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Liminal&#x2019;s patents and pending patent applications (including types of patent protection and jurisdictions where Liminal has been granted patents or has patent applications pending) directed to its material products are detailed in the table below.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.428%;"></td>
    <td style="width:2.28%;"></td>
    <td style="width:12.445%;"></td>
    <td style="width:2.322%;"></td>
    <td style="width:18.936%;"></td>
    <td style="width:2.322%;"></td>
    <td style="width:13.342%;"></td>
    <td style="width:2.322%;"></td>
    <td style="width:38.537%;"></td>
    <td style="width:1.066%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.035in;border-bottom:0.750pt solid rgba(0,0,0,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Family</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.035in;border-bottom:0.750pt solid rgba(255,255,255,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.035in;border-bottom:0.750pt solid rgba(0,0,0,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Patent</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Protection Type</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.035in;border-bottom:0.750pt solid rgba(255,255,255,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.035in;border-bottom:0.750pt solid rgba(0,0,0,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Jurisdictions with</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Pending Applications</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.035in;border-bottom:0.750pt solid rgba(255,255,255,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.035in;border-bottom:0.750pt solid rgba(0,0,0,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Jurisdictions with</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Granted Patents</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.035in;border-bottom:0.750pt solid rgba(255,255,255,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.035in;border-bottom:0.750pt solid rgba(0,0,0,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Title</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.035in;border-bottom:0.750pt solid rgba(255,255,255,1);padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, TW, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for a wearable device including stimulation and monitoring components</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, TW, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for a wearable device for substantially non-destructive acoustic stimulation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, TW, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for a wearable device for acoustic stimulation</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">AU, CA, EP, TW, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for a wearable device for treating a health condition using ultrasound stimulation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, TW, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for a device for steering acoustic stimulation using machine learning</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, TW, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for a device using a statistical model trained on annotated signal data</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">AU, CA, EP, TW, US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for a device for energy efficient monitoring of the brain</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">AU, CA, EP, TW, US,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for monitoring brain health</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">9</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">TW, US, counterpart foreign cases in 8 family</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for monitoring brain health</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">AU, CA, CN, EP, IL, JP, KR, US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for a brain acoustic resonance intracranial pressure monitor</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.010in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">11</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">US, counterpart foreign cases in 10 family</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for a skull lamb waves intracranial pressure monitor</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.030in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">US, counterpart foreign cases in 10 family</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for a brain acoustic resonance seizure monitor</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">13</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">US, counterpart foreign cases in 10 family</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for tumor detection</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">14</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">US, counterpart foreign cases in 10 family</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Systems and methods for mapping distribution of intracranial pressure</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">15</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">TW, US, PCT</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Device and methods for treating neurological disorders and brain conditions</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">16</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Ultrasound annular array device for neuromodulation</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">17</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Methods and apparatus for pulsatility-mode sensing</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">18</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">US, PCT</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Methods and apparatus for smart beam-steering</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.033in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.015in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">20</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(204,238,255,1);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Utility (prov)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">US</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Title not publicly available</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.052in;word-break:break-word;padding-left:0.003in;vertical-align:top;padding-bottom:0.024in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to patents, we also rely on trade secrets, technical know-how, and continuing innovation to develop and maintain our competitive position. We seek to protect our proprietary information and other intellectual property by generally</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">requiring our employees, consultants, contractors, suppliers, outside scientific collaborators and other advisors to execute non-disclosure and assignment of invention agreements on commencement of their employment or engagement. Agreements with our employees also forbid them from using or incorporating the proprietary rights of third parties during their engagement with us. We also generally require confidentiality or material transfer agreements from third parties that receive our confidential data or materials.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">License Agreements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have entered into licenses in the ordinary course of business relating to our technologies or other intellectual property rights or assets.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Exclusive License Agreements with The General Hospital Corporation (d/b/a Massachusetts General Hospital)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine entered into an exclusive license agreement with The General Hospital Corporation (d/b/a Massachusetts General Hospital) (&#x201c;MGH&#x201d;) effective in May 2014 (the &#x201c;May Agreement&#x201d;) and an exclusive license agreement with MGH effective in June 2014 (the &#x201c;June Agreement&#x201d;), respectively, under each of which Legacy Hyperfine acquired an exclusive and worldwide license to specified patent rights owned by MGH relating to MRI technology. The licenses granted to us are subject to the right of MGH and not-for-profit academic, government and other not-for-profit institutions to make and to use the subject matter described or claimed in the rights granted under the licensed patents for research and educational purposes and, for any licensed patents that are supported by federal funding, the licenses granted to us are subject to certain rights, conditions and limitations imposed by U.S. law, including a royalty-free, non-exclusive license granted to the U.S. government and a requirement that any products used or sold in the United States must be manufactured substantially in the United States.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the terms of each of the license agreements, we have agreed to pay MGH an annual maintenance fee and agreed to reimburse MGH for certain patent related fees and costs incurred by MGH, including past patent fees and costs. If we enter into a sublicense under either license agreement, we will be obligated to pay MGH a percentage in the mid-teens of certain consideration paid to us by the sublicensee. As of February 15, 2022, the aggregate amounts paid under the May Agreement and June Agreement were $25,522 and $19,762, respectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are required to use commercially reasonable efforts to develop and commercialize licensed products and licensed processes under each of the license agreements. In particular, we were required to achieve a specified development and commercialization milestone by a specified date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the terms of each of the license agreements, MGH has retained the right to practice the licensed patent rights within the licensed fields for research and educational purposes only.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each of the license agreements expires upon the expiration of the last to expire licensed patent, which is set to expire in 2035. We have the right to terminate either agreement for any reason by giving advance written notice to MGH. MGH has the right to terminate either agreement if we fail, subject to a specified cure period, to pay any amounts due and payable under either agreement to MGH, we otherwise materially breach either agreement and fail to cure such breach within a specified cure period, we fail to maintain insurance coverage as required under either agreement, we become insolvent, or make an assignment for the benefit of our creditors, or have a petition in bankruptcy filed for or against us, or we or a sublicensee challenges the licensed patent rights in a legal or administrative proceeding. Either agreement otherwise terminates upon the expiration or abandonment of all licensed patents and patent applications.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Government Regulation</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Diagnostic and therapeutic medical devices like those we developed and distributed are subject to regulation by numerous regulatory bodies, including the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) and comparable international regulatory agencies. These agencies require developers of medical devices to comply with applicable laws and regulations governing the development, testing, manufacturing, packaging, labeling, marketing and distribution of medical devices. Devices are generally subject to varying levels of regulatory control, the most comprehensive of which requires that a clinical evaluation program be conducted before a device can be approved for marketing and commercial distribution. In addition, healthcare regulatory bodies in the United States and around the world impose a range of requirements related to paying for medical devices and the procedures in which they are used, including laws intended to prevent fraud, waste, and abuse of healthcare dollars.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">U.S. Laws and Regulations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States, medical devices are subject to extensive regulation at the federal level by the FDA under the Federal Food, Drug, and Cosmetic Act (&#x201c;FDCA&#x201d;) and its implementing regulations. The laws and regulations govern, among other things, medical device design and development, nonclinical and clinical testing, pre-market clearance, authorization or approval, establishment registration and product listing, product manufacturing, product packaging and labeling, product storage, advertising and promotion, product distribution, recalls and field actions, servicing and post-market clinical surveillance. A number of U.S. states also impose licensing and compliance regimes on companies that manufacture or distribute prescription devices into or within the state.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Some of our products are also subject to the Radiation Control for Health and Safety Act, administered by the FDA, which imposes performance standards and record keeping, reporting, product testing and product labeling requirements for electronic products that emit radiation, such as magnetic resonance imaging systems.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the commercialization and use of our devices in the United States is subject to regulation by the U.S. Department of Health and Human Services (&#x201c;HHS&#x201d;) and state agencies responsible for reimbursement and regulation of payment for healthcare items and services. Federal laws and regulations apply primarily in connection with government payer programs such as the Medicare and Medicaid programs, but state laws apply more broadly, encompassing healthcare items and services covered by private payers. At the state and federal level, the government&#x2019;s interest is in regulating the quality and cost of healthcare and protecting the independent clinical judgment of licensed healthcare providers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Federal Trade Commission (&#x201c;FTC&#x201d;) also oversees the advertising and promotion of our products pursuant to broad authority to police deceptive advertising for goods or services within the United States. Under the Federal Trade Commission Act, the FTC is empowered, among other things, to (a) prevent unfair methods of competition and unfair or deceptive acts or practices in or affecting commerce; (b) seek monetary redress and other relief for conduct injurious to consumers; and (c) gather and compile information and conduct investigations relating to the organization, business, practices, and management of entities engaged in commerce. In the context of performance claims for products such as our goods and services, compliance with the FTC Act includes ensuring that there is scientific data to substantiate the claims being made, that the advertising is neither false nor misleading, and that any user testimonials or endorsements we or our agents disseminate related to the goods or services comply with disclosure and other regulatory requirements. In addition, with respect to our commercial products and any future products that are marketed as clinical products, FDA&#x2019;s regulations applicable to medical device products prohibit them from being promoted for uses not within the scope of a given product&#x2019;s intended use(s), among other promotional and labeling rules applicable to products subject to the FDCA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, medical device systems that include wireless radio frequency transmitters and/or receivers are subject to equipment authorization requirements in the United States. The Federal Communications Commission (&#x201c;FCC&#x201d;) requires advance clearance of all radio frequency devices before they can be sold or marketed in the United States. These clearances ensure that the proposed products comply with FCC radio frequency emission and power level standards and will not cause interference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">When Liminal&#x2019;s products are marketed for clinical monitoring or therapeutic uses, they will be regulated by the FDA as medical devices. It is presently unclear what level of risk the agency will assign to such products, what special controls may be imposed on such products (if any), and what regulatory requirements would be applicable to such products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">FDA Regulation of Medical Devices</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Medical devices must undergo pre-market review by and receive clearance, authorization, or approval from the FDA prior to commercialization, unless the device is of a type exempted from such review by statute, regulation, or an FDA exercise of enforcement discretion. The FDA classifies medical devices into three classes based on risk. Regulatory control increases from Class I (lowest risk) to Class III (highest risk). The FDA generally must clear or approve the commercial sale of most new medical devices that fall within product categories designated as Class II and III. Commercial sales of most Class II and III medical devices within the United States must be preceded either by pre-market notification and FDA clearance pursuant to Section 510(k) of the FDCA (Class II) or by the granting of a pre-market approval (&#x201c;PMA&#x201d;) (Class III), after a pre-market application is submitted. Both 510(k) notifications and PMA applications must be submitted to FDA with significant user fees (over $12,000 for a 510(k) and $374,000 for a PMA in FY 2022), although reduced fees for small businesses are available. Class I devices are generally exempt from pre-market review and notification, as are some moderate-risk Class II devices. Manufacturers of all classes of devices must comply with FDA&#x2019;s Quality System Regulation (&#x201c;QSR&#x201d;), establishment registration, medical device listing, labeling requirements, and medical device reporting (&#x201c;MDR&#x201d;) regulations, which are collectively referred to as medical device general controls. Class II devices may also be subject to special controls such as performance standards, post-market surveillance, FDA guidelines, or particularized labeling. Some Class I and Class II devices may be exempted by regulation from the requirement of compliance with substantially all of the QSR.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">510(k) Clearance Pathway</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A 510(k) pre-market notification must contain information sufficient to demonstrate that the new device is substantially equivalent to a device commercially distributed prior to May 28, 1976 or to a device that has been determined by the FDA to be substantially equivalent to such a so-called &#x201c;pre-amendments&#x201d; device. To obtain 510(k) clearance for a non-exempt Class II device, the product developer must submit a pre-market notification to FDA demonstrating that its product is substantially equivalent to such a predicate device. The FDA&#x2019;s 510(k) clearance process generally takes from three to 12 months from the date the application is submitted, but it may take significantly longer if FDA has significant questions or needs more information about the new device or its manufacturing or quality controls.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As part of the 510(k) notification process for Class II devices that have an existing classification regulation available for purposes of the regulatory filing, the FDA may require the following:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Development of comprehensive product description and indications for use.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Completion of extensive nonclinical tests and/or animal studies, performed in accordance with the FDA&#x2019;s Good Laboratory Practice (&#x201c;GLP&#x201d;) regulations, as well as any performance standards or other testing requirements established by FDA through regulations or device-specific guidance.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Comprehensive review of one or more predicate devices and development of data supporting the new product&#x2019;s substantial equivalence to such predicate devices.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assuming successful completion of all required testing, a detailed 510(k) notification is submitted to the FDA requesting clearance to market the product. This premarket notification includes all relevant data from pertinent nonclinical studies and clinical trials (if applicable), together with detailed information relating to the product&#x2019;s manufacturing controls and proposed labeling, and other relevant documentation. The FDA evaluates all 510(k) submissions prior to filing for substantive review based on specific acceptance criteria and may issue a refuse-to-accept notification if the submission is deficient with respect to any of the established criteria. If the FDA determines that the applicant&#x2019;s device is substantially equivalent to the identified predicate device(s), the agency will issue a 510(k) clearance letter that authorizes commercial marketing of the device for one or more specific indications for use. If the FDA determines that the applicant&#x2019;s device is not substantially equivalent to the predicate device(s), the agency will issue a not-substantially-equivalent letter stating that the new device may not be commercially distributed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">After a new medical device receives 510(k) clearance from the FDA, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, requires a new 510(k) clearance or could require the submission of a PMA. The FDA requires each manufacturer to make the determination of whether a device modification requires a new 510(k) notification or PMA in the first instance, but the FDA may review any such decision. If the FDA disagrees with a manufacturer&#x2019;s decision not to seek a new 510(k) clearance or PMA for a particular change, the FDA may retroactively require the manufacturer to submit a 510(k) pre-market notification or a PMA. The FDA may also require the manufacturer to cease U.S. marketing and/or recall any distributed units of the modified device until 510(k) clearance or PMA approval for the modification is obtained.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">De Novo Classification</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If a previously unclassified new medical device does not qualify for the 510(k) pre-market notification process because no predicate device to which it is substantially equivalent can be identified, the device is automatically classified into Class III. However, if such a device would be considered low or moderate risk (in other words, it does not rise to the level of requiring the approval of a PMA), it may be eligible for the De Novo classification process. The De Novo classification process allows a device developer to request that the novel medical device be reclassified as either a Class I or Class II device, rather than having it regulated as a high-risk Class III device subject to the PMA requirements. If the manufacturer seeks reclassification into Class II, the classification request must include a draft proposal for special controls that are necessary to provide a reasonable assurance of the safety and effectiveness of the medical device.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the FDCA, the FDA is required to classify a device within 120 days following receipt of the De Novo classification request from an applicant; however, the most recent FDA performance review goals state that in fiscal year 2022, FDA will attempt to issue a decision within 150 days of receipt on 70% of De Novo requests received during fiscal year 2022. De Novo classification requests are subject to user fees, unless a specific exemption applies (over $112,000 in FY 2022).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As with the 510(k) pre-market notification process described above, any modification to a device authorized through the De Novo process that could significantly affect the safety or effectiveness of such device, or that would constitute a major change in its intended use, requires a new 510(k) clearance or could require the submission of a PMA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2021, FDA issued a final rule that would formally codify requirements for the medical device De Novo process and the procedures and criteria for product developers to file a De Novo classification request (86 Fed. Reg. 54,826). Over the twenty years preceding the final rule, the De Novo process has been implemented by FDA pursuant to statutory authorities and somewhat organically through informal guidance and iterative changes by Congress. Although the final rule does not affect marketed products such as our marketed products, and likely will not be expected to impact products in current development, the FDA&#x2019;s goals in promulgating the final rule are to create a predictable, consistent, and transparent De Novo classification process for innovative medical device developers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As an alternative to the De Novo classification process, a company could also file a reclassification petition seeking to change the automatic Class III designation of a novel post-amendment device under Section 513(f)(3) of the FDCA. FDA can also initiate reclassification of an existing device type on its own initiative. In December 2018, FDA issued a final rule to clarify the administrative process through which the FDA reclassifies a medical device. To reclassify a device under Section 513(e) of the FDCA, the FDA must first publish a proposed reclassification order that includes a summary of the valid scientific evidence that supports the reclassification; convene a device classification panel meeting; and consider comments to the public docket before it then publishes a final reclassification order in the Federal Register.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Pre-market Approval Pathway</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our point-of-care MRI systems have been classified and are regulated as Class II devices, although future products that we develop may be classified as Class III devices. Products classified by FDA as Class III generally require marketing approval via a PMA. A PMA application must be supported by valid scientific evidence, which typically requires extensive data, including technical, nonclinical, clinical, manufacturing and labeling data, to demonstrate to the FDA&#x2019;s satisfaction the safety and efficacy of the device for its intended use(s). A PMA application also must include a complete description of the device and its components, a detailed description of the methods, facilities and controls used to manufacture the device, and proposed labeling. After a PMA application is submitted and found to be sufficiently complete, it is considered &#x201c;filed&#x201d; and the FDA begins an in-depth review of the submitted information. During this substantive review period, the FDA may request additional information or clarification of information already provided. Also during the review period, an advisory panel of experts from outside the FDA may be convened to review and evaluate the application and provide recommendations to the FDA. In addition, the FDA generally will conduct a pre-approval inspection of the manufacturing facility to evaluate compliance with the QSR, which requires manufacturers to implement and follow design, testing, control, documentation and other quality assurance procedures.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FDA review of a PMA application is required to be completed within 180 days of the application&#x2019;s filing date although the process generally takes between one and three years, but may take significantly longer. The current user fee agreement between FDA and the medical device industry sets as a target for PMA reviews to be completed in under one year. The FDA can delay, limit or deny approval of a PMA application for many reasons, including:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the product may not be safe or effective for its intended use(s) to the FDA&#x2019;s satisfaction;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the data from the applicant&#x2019;s nonclinical studies and clinical trials may be insufficient to support approval;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the manufacturing process or facilities that the applicant uses may not meet applicable requirements; and</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in FDA approval policies or adoption of new regulations may require additional data to demonstrate the safety or effectiveness of the device.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If an FDA evaluation of a PMA application or manufacturing facilities is favorable, the FDA will either issue an approval letter, or approvable letter, which usually contains a number of conditions which must be met in order to secure final approval of the PMA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">When and if those conditions have been fulfilled to the satisfaction of the FDA, the agency will issue a PMA approval letter authorizing commercial marketing of a device, subject to the conditions of approval and the limitations established in the approval letter. If the FDA&#x2019;s evaluation of a PMA application or manufacturing facilities is not favorable, the FDA will deny approval of the PMA or issue a not approvable letter. The FDA may also determine that additional trials are necessary, in which case the PMA approval may be delayed for several months or years while the trials are conducted and data is submitted in an amendment to the PMA. The PMA process can be expensive, uncertain and lengthy. PMA approval may also be granted with post-approval requirements such as the need for additional patient follow-up for an indefinite period of time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">New PMA applications or PMA supplements may be required for modifications to the manufacturing process, labeling, device specifications, materials or design of a device that is approved through the PMA process. PMA supplements often require submission of the same type of information as an initial PMA application, except that the supplement is limited to information needed to support any changes from the device covered by the approved PMA application and may or may not require as extensive clinical data or the convening of an advisory panel.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Clinical Investigations Using Devices in Development</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Clinical trials are almost always required to support a PMA application and are sometimes required for a De Novo classification request or 510(k) pre-market notification. In order to conduct a clinical investigation involving human subjects for the purpose of demonstrating the safety and effectiveness of a medical device, an investigator acting on behalf of the company must, among other things, apply for and obtain Institutional Review Board (&#x201c;IRB&#x201d;) approval of the proposed investigation. In addition, if the clinical study involves a &#x201c;significant risk&#x201d; (as defined by the FDA) to human health, the company sponsoring the investigation (referred to as the &#x201c;sponsor&#x201d;) must also submit and obtain FDA approval of an Investigational Device Exemption (&#x201c;IDE&#x201d;) application. An IDE application must be supported by appropriate data, such as animal and laboratory testing results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound. The IDE application must be approved in advance by the FDA for a specified number of study participants, unless the product is deemed a non-significant risk device and eligible for abbreviated IDE requirements. Generally, clinical trials for a significant risk device may begin once the IDE application is approved by the FDA and the study protocol and informed consent are approved by a duly-appointed IRB for clinical trial site. FDA&#x2019;s IDE regulations govern investigational device labeling, prohibit promotion, and specify an array of Good Clinical Practice (&#x201c;GCP&#x201d;) requirements, which include, among other things, recordkeeping, reporting and monitoring responsibilities of study sponsors and study investigators. Clinical trials must further comply with the FDA&#x2019;s regulations for IRB approval and for informed consent and other human subject protections. Required records and reports are subject to inspection by the FDA. The results of clinical testing may be unfavorable or, even if the intended safety and efficacy success criteria are achieved, may not be considered sufficient for the FDA to grant approval or clearance of a product.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The commencement or completion of any of our clinical trials may be delayed or halted, or be inadequate to support approval of a PMA application (or FDA&#x2019;s grant of a De Novo classification request or clearance of a 510(k) notification, as applicable), for numerous reasons, including, but not limited to, the following:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA, the IRB(s), or other regulatory authorities do not approve a clinical trial protocol or a clinical trial, or place a clinical trial on hold;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">participants do not enroll in clinical trials at the expected rate;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">participants do not comply with trial protocols;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">participant follow-up is not at the expected rate;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">patients experience adverse side effects;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">participants die during a clinical trial, even though their death may not be related to the investigational products;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">IRBs and third-party clinical investigators may delay or reject the sponsor&#x2019;s trial protocol;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">third-party clinical investigators decline to participate in a trial or do not perform a trial on the sponsor&#x2019;s anticipated schedule or consistent with the clinical trial protocol, GCPs or other FDA requirements;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the sponsor or third-party organizations do not perform data collection, monitoring and analysis in a timely or accurate manner or consistent with the clinical trial protocol or investigational or statistical plans;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">third-party clinical investigators have significant financial interests related to the sponsor or the study that the FDA deems to make the study results unreliable, or the sponsor or investigators fail to disclose such interests;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unfavorable regulatory inspections of the sponsor&#x2019;s clinical trial sites or manufacturing facilities, which may, among other things, require the sponsor to undertake corrective action or suspend or terminate the sponsor&#x2019;s clinical trials;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in governmental regulations or administrative actions applicable to the sponsor&#x2019;s trial protocols;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the interim or final results of the clinical trial are inconclusive or unfavorable as to safety or effectiveness; and</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA concludes that the results from the sponsor&#x2019;s trial and/or trial design are inadequate to demonstrate safety and effectiveness of the product.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Ongoing Post-Market Regulatory Requirements and FDA Enforcement</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In 2020, Legacy Hyperfine received 510(k) clearance from the FDA for its point-of-care MRI system. In addition, our proprietary BrainInsight product is fully automated MRI post-processing medical software that is regulated as a picture archiving and communications system, which may include both hardware and software components, and which is classified by FDA as a Class II medical device. BrainInsight received 510(k) marketing clearance in January 2021 for use in automatic labeling, spatial measurement, and volumetric quantification of brain structures from a set of low-field MR images and to return annotated and segmented images, color overlays, and reports. More recently, in November 2021, Legacy Hyperfine received 510(k) clearance for its new advanced image reconstruction technology using deep learning.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">After a medical device is authorized for marketing and placed in commercial distribution (or, for 510(k)-exempt products, placed into commerce without first obtaining FDA clearance or approval), numerous regulatory requirements apply. These general controls that must be met for all device classes include:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establishment registration and device listing;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the QSR, which requires manufacturers, including third-party manufacturers, to follow design, testing, control, storage, supplier/contractor selection, complaint handling, documentation and other quality assurance procedures;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">labeling regulations, which govern the mandatory elements of the device labels and packaging (including Unique Device Identifier markings for certain categories of products);</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FDA&#x2019;s prohibitions against the promotion of products for uncleared, unapproved or &#x201c;off-label&#x201d; uses and other requirements related to promotional activities;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the MDR regulations, which require that manufacturers report to the FDA if a device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">voluntary and mandatory device recalls to address problems when a device is defective and/or could be a risk to health;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">correction and removal reporting regulations, which require that manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health; and</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">post-market surveillance regulations, which apply to certain Class II or III devices when necessary to protect the public health or to provide additional safety and effectiveness data for the device.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FDA&#x2019;s MDR requirements also extend to healthcare facilities that use medical devices in providing care to patients, or &#x201c;device user facilities,&#x201d; which include hospitals, ambulatory surgical facilities, nursing homes, outpatient diagnostic facilities, or outpatient treatment facilities, but not physician offices. A device user facility must report any device-related death to both the FDA and the device manufacturer, or any device-related serious injury to the manufacturer (or, if the manufacturer is unknown, to the FDA) within 10 days of the event. Device user facilities are not required to report device malfunctions that would likely cause or contribute to death or serious injury if the malfunction were to recur but may voluntarily report such malfunctions through MedWatch, the FDA&#x2019;s Safety Information and Adverse Event Reporting Program.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To ensure compliance with regulatory requirements, medical device manufacturers are subject to market surveillance and periodic, pre-scheduled and unannounced inspections by the FDA and certain state authorities. Failure to comply with applicable regulatory requirements can result in enforcement action by the FDA, which may lead to any of the following sanctions:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Warning Letters or Untitled Letters that require corrective action;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">fines and civil penalties;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unanticipated expenditures;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in approving/clearing or refusal to approve/clear any of our future products;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FDA refusal to issue certificates to foreign governments needed to export our products for sale in other countries;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">suspension or withdrawal of FDA approval or clearance (as may be applicable);</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product recall or seizure;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">partial suspension or total shutdown of production;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">operating restrictions;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">injunctions or consent decrees; and</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">civil or criminal prosecution.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We and any of our contract manufacturers, and some suppliers of components or device accessories, are required to manufacture medical device products in compliance with current Good Manufacturing Practice requirements set forth in the QSR, unless explicitly exempted by regulation. The QSR requires a quality system for the design, manufacture, packaging, labeling, storage, installation and servicing of marketed devices, and includes extensive requirements with respect to quality management and organization, device design, buildings, equipment, purchase and handling of components or services, production and process controls, packaging and labeling controls, device evaluation, distribution, installation, complaint handling, servicing, and record keeping. The FDA evaluates compliance with the QSR through periodic pre-scheduled or unannounced inspections that may include registered manufacturing facilities of our subcontractors. Following such inspections, FDA may issue reports known as Forms FDA 483 or Notices of Inspectional Observations, which list instances where the FDA inspector believes the manufacturer has failed to comply with applicable regulations and/or procedures. If the observations are sufficiently serious or the manufacturer fails to respond appropriately, the FDA may issue Warning Letters, which are notices of intended enforcement actions against the manufacturer. For less serious violations that may not rise to the level of regulatory significance, FDA may issue Untitled Letters. FDA may take more significant administrative or legal action if a manufacturer continues to be in substantial noncompliance with applicable regulations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For example, if the FDA believes we or any of our contract manufacturers or regulated suppliers are not in compliance with these requirements and patients are being subjected to serious risks, it can shut down manufacturing operations, require recalls of our medical device products, refuse to approve new marketing applications, initiate legal proceedings to detain or seize products, enjoin future violations, or assess civil and criminal penalties against us or our officers or other employees. Any such action by the FDA would have a material adverse effect on our business. We may be unable to comply with all applicable FDA regulations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">U.S. Fraud and Abuse Laws and Other Compliance Requirements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Successfully commercializing a medical device or technology depends not on only FDA approval, but also on broad health insurance or third party payor coverage. Government and private payors institute coverage criteria to ensure the appropriate utilization of products and services and to control costs. Limited third party payor coverage for a technology or procedure may limit adoption and commercial viability, while broader coverage supports optimal market uptake. Favorable coverage decisions by government payors like Medicare or Medicaid is critical because private payors typically follow the government&#x2019;s lead regarding reimbursement. However, manufacturers whose technology is reimbursed by government payors are subject to various U.S. federal and state laws pertaining to healthcare fraud and abuse. These laws can be implicated by inappropriate sales and marketing arrangements with healthcare providers. Many commonly accepted commercial practices are illegal in the healthcare industry and violations of these laws are punishable by criminal and civil sanctions, including, in some instances, exclusion from participation in U.S. federal and state healthcare programs, including Medicare and Medicaid.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Anti-kickback Laws.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The federal Anti-Kickback Statute prohibits persons from knowingly and willfully soliciting, receiving, offering or providing remuneration directly or indirectly to induce either the referral of an individual, or the furnishing, recommending, or arranging of a good or service, for which payment may be made under a federal healthcare program such as Medicare and Medicaid. The definition of &#x201c;remuneration&#x201d; has been broadly interpreted to include anything of value, including such items as gifts, discounts, the furnishing of supplies or equipment, credit arrangements, waiver of payments, and providing anything at less than its fair market value. The Department of Health and Human Services&#x2009;-&#x2009;Office of the Inspector General, has issued regulations, commonly known as safe harbors, which set forth certain provisions that, if satisfied in their entirety, will assure healthcare providers and other parties that they will not be prosecuted under the federal Anti-Kickback Statute. The failure of a transaction or arrangement to fit precisely within one or more safe harbors does not necessarily mean that it is illegal or that prosecution will be pursued. However, conduct and business arrangements that do not fully satisfy each applicable safe harbor element may result in increased scrutiny by government enforcement authorities or invite litigation by private citizens under federal whistleblower laws. The Anti-Kickback law is broadly interpreted and aggressively enforced with the result that beneficial commercial arrangements can be criminalized in the healthcare industry because of the Anti-Kickback law.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The penalties for violating the federal Anti-Kickback Statute include imprisonment for up to ten years, fines of up to $100,000 per violation and possible exclusion from federal healthcare programs such as Medicare and Medicaid. Many states have adopted prohibitions similar to the federal Anti-Kickback Statute, some of which apply to the referral of patients for healthcare services reimbursed by any source, not only by the government programs such as Medicare and Medicaid.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Federal False Claims Act.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The federal False Claims Act prohibits knowingly presenting, or causing to be presented a false claim or the knowing use of false statements or records to obtain payment from the federal government. When an entity is determined to have violated the False Claims Act, it must pay three times the actual damages sustained by the government, plus mandatory civil penalties of between $11,181 and $22,363 for each separate false claim. Suits filed under the False Claims Act, known as &#x201c;qui tam&#x201d; actions, can be brought by any individual on behalf of the government and such individuals (known as &#x201c;relators&#x201d; or, more commonly, as &#x201c;whistleblowers&#x201d;) may share in any amounts paid by the entity to the government in fines or settlement. In addition, certain states have enacted laws modeled after the federal False Claims Act. Qui tam actions have increased significantly in recent years, causing greater numbers of healthcare companies to have to defend a false claim action, even before the validity of the claim is established and even if the government decides not to intervene in the lawsuit. Healthcare companies may decide to agree to large settlements with the government and/or whistleblowers to avoid the cost and negative publicity associated with litigation. In addition, the Affordable Care Act amended federal law to provide that a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. Criminal prosecution is possible for knowingly making or presenting a false or fictitious or fraudulent claim to the federal government.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Federal Physician Self-Referral Law.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Federal Physician Self-Referral Law, also referred to as the Stark Law, prohibits a physician (or an immediate family member of a physician) who has a financial relationship with an entity from referring patients to that entity for certain designated health services, including durable medical equipment and supplies, payable by Medicare, unless an exception applies. The Stark Law also prohibits such an entity from presenting or causing to be presented a claim to the Medicare program for such designated health services provided pursuant to a prohibited referral, and provides that certain collections related to any such claims must be refunded in a timely manner. Exceptions to the Stark Law include, among other things, exceptions for certain financial relationships, including both ownership and compensation arrangements. The Stark Law is a strict liability statute: to the extent that the statute is implicated and an exception does not apply, the statute is violated. In addition to the Stark Law, many states have implemented similar physician self-referral prohibitions that may extend to Medicaid, third party payors, and self-pay patients. Violations of the Stark Law must be</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">reported and unauthorized claims must be refunded to Medicare in order to avoid potential liability under the federal False Claims Act for avoiding a known obligation to return identified overpayments. Violations of the Stark Law, the Anti-Kickback Statute, the Civil Monetary Penalties Law and/or the federal False Claims Act can also form the basis for exclusion from participation in federal and state healthcare programs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Civil Monetary Penalties Law</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Civil Monetary Penalties Law (&#x201c;CMPL&#x201d;) authorizes the imposition of substantial civil money penalties against an entity that engages in certain prohibited activities including but not limited to violations of the Stark Law or Anti-Kickback Statute, knowing submission of a false or fraudulent claim, employment of an excluded individual, and the provision or offer of anything of value to a Medicare or Medicaid beneficiary that the transferring party knows or should know is likely to influence beneficiary selection of a particular provider for which payment may be made in whole or part by a federal healthcare program, commonly known as the Beneficiary Inducement CMP. Remuneration is defined under the CMPL as any transfer of items or services for free or for less than fair market value. There are certain exceptions to the definition of remuneration for offerings that meet the Financial Need, Preventative Care, or Promoting Access to Care exceptions (as defined in the CMPL). Sanctions for violations of the CMPL include civil monetary penalties and administrative penalties up to and including exclusion from participation in federal healthcare programs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">State Analogs of Federal Fraud and Abuse Laws</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Many U.S. states have their own laws intended to protect against fraud and abuse in the healthcare industry and more broadly. In some cases these laws prohibit or regulate additional conduct beyond what federal law affects. Penalties for violating these laws can range from fines to criminal sanctions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">HIPAA.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Health Insurance Portability and Accountability Act of 1996, as amended by the American Recovery and Reinvestment Act of 2009, and implementing regulations (&#x201c;HIPAA&#x201d;), created two new federal crimes: healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute is a felony and may result in fines, imprisonment or exclusion from government sponsored programs. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">FCPA and Other Anti-Bribery and Anti-Corruption Laws.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The U.S. Foreign Corrupt Practices Act (&#x201c;FCPA&#x201d;) prohibits U.S. corporations and their representatives from offering, promising, authorizing or making payments to any foreign government official, government staff member, political party or political candidate in an attempt to obtain or retain business abroad. The scope of the FCPA would include interactions with certain healthcare professionals or organizations in many countries. Our present and future business has been and will continue to be subject to various other U.S. and foreign laws, rules and/or regulations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Physician Payment Sunshine Act.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Manufacturers of U.S. FDA-regulated devices reimbursable by federal healthcare programs are subject to the Physician Payment Sunshine Act, which requires manufacturers to track and annually report certain payments and other transfers of value made to U.S.-licensed physicians or U.S. teaching hospitals. As a manufacturer of U.S. FDA regulated devices reimbursable by federal healthcare programs, we are subject to this law. We are also required to report certain ownership interests held by physicians and their immediate family members. In 2018, the law was extended to require tracking and reporting of transfers of value to physician assistants, nurse practitioners, and other mid-level practitioners. The law carries penalties of up to $1.15 million per year for violations, depending on the circumstances, and payments reported also have the potential to draw scrutiny on payments to and relationships with physicians, which may have implications under the Anti-Kickback Statute, Stark Law and other healthcare laws.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, there has been a recent trend of increased federal and state regulation of payments and other transfers of value provided to healthcare professionals and entities. Similar to the federal law, certain states also have adopted marketing and/or transparency laws relevant to device manufacturers, some of which are broader in scope. Certain states also mandate that device manufacturers implement compliance programs. Other states impose restrictions on device manufacturer marketing practices and require tracking and reporting of gifts, compensation, and other remuneration to healthcare professionals and entities. The need to build and maintain a robust compliance program with different compliance and/or reporting requirements increases the possibility that a healthcare company may violate one or more of the requirements, resulting in fines and penalties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">U.S. and European Data Security and Data Privacy Laws</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">HIPAA, as well as a number of other federal and state privacy-related laws, extensively regulate the use and disclosure of individually identifiable health information, known as &#x201c;protected health information&#x201d; or &#x201c;PHI.&#x201d; HIPAA applies to health plans, healthcare providers who engage in certain standard healthcare transactions electronically, such as electronic billing, and healthcare clearinghouses, all of which are referred to as &#x201c;covered entities&#x201d; under HIPAA. State imposed health</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">information privacy and security laws typically apply based on licensure, for example, licensed providers or licensed entities are limited in their ability to use and share health information.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, all states have enacted legislation protecting the privacy and security of &#x201c;personal information&#x201d; such as identifiable financial or health information, social security number and credit card information. These laws overlap and apply simultaneously with federal privacy and security requirements and regulated entities must comply with all of them. The California Consumer Privacy Act (&#x201c;CCPA&#x201d;), which went into effect January 1, 2020, is one of the most restrictive state privacy laws, protecting a wide variety of personal information and granting significant rights to California residents with respect to their personal information. In dealing with health information for the development of its technology or for commercial purposes, we will be indirectly affected by HIPAA and state-imposed health information privacy and security laws because these laws regulate the ability of our customers and research collaborators to share health information with us. Additionally, we must identify and comply with all applicable state laws for the protection of personal information with respect to employee information or other personal information that we collect.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the European Union, increasingly stringent data protection and privacy rules that have and will continue to have substantial impact on the use of personal and patient data across the healthcare industry became stronger in May 2018. The EU General Data Protection Regulation, (&#x201c;GDPR&#x201d;) applies across the European Union and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR fine framework can be up to 20 million euros, or up to 4% of our total global turnover of the preceding fiscal year, whichever is higher. The GDPR sets out a number of requirements that must be complied with when handling the personal data of such European Union-based data subjects including: providing expanded disclosures about how their personal data will be used; higher standards for organizations to demonstrate that they have obtained valid consent or have another legal basis in place to justify their data processing activities; the obligation to appoint data protection officers in certain circumstances; new rights for individuals to be &#x201c;forgotten&#x201d; and rights to data portability, as well as enhanced current rights (e.g. access requests); the principal of accountability and demonstrating compliance through policies, procedures, training and audit; and the new mandatory data breach regime. In particular, medical or health data, genetic data and biometric data where the latter is used to uniquely identify an individual are all classified as &#x201c;special category&#x201d; data under the GDPR and are afforded greater protection and require additional compliance measures. Noncompliance could result in the imposition of fines, penalties, data lockup or orders to stop noncompliant activities. We may be subject to GDPR if we undertake operations in the EU, offer products or services to individuals in the EU or monitor the behavior of individuals within the EU. Our research activities in the EU currently implicate the GDPR and if we undertake commercial operations in the EU, offer products or services to individuals in the EU or monitor the behavior of individuals within the EU, we will have additional compliance obligations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We could also be subject to evolving European Union laws on data export, for transfers of data outside the European Union to themselves, group companies or third parties. The GDPR only permits exports of data outside the European Union to jurisdictions that ensure an adequate level of data protection. The United States has not been deemed to offer an adequate level of protection, so in order for us to transfer personal data from the EU to the United States, we must identify a legal basis for data transfer (e.g., the European Union Commission approved Standard Contractual Clauses). On July 16, 2020, the Court of Justice of the European Union or the CJEU, issued a landmark opinion in the case </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Maximilian Schrems vs. Facebook</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (Case C-311/18), called </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Schrems II.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> This decision (a) calls into question commonly relied upon data transfer mechanisms as between the European Union member states and the United States (such as the Standard Contractual Clauses) and (b) invalidates the EU-U.S. Privacy Shield on which many companies had relied as an acceptable mechanism for transferring such data from the EU to the United States. The CJEU is the highest court in Europe and the </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Schrems II</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> decision heightens the burden on data importers to assess U.S. national security laws on their business and future actions of European Union data protection authorities are difficult to predict.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, the United Kingdom&#x2019;s decision to leave the European Union, often referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom. In particular, while the Data Protection Act of 2018 that &#x201c;implements&#x201d; and complements the GDPR achieved Royal Assent on May 23, 2018 and is now effective in the United Kingdom, it is still unclear whether transfer of data from the European Economic Area to the United Kingdom will remain lawful under GDPR.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">International Regulation of Medical Devices</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">International marketing and distribution of medical devices are subject to regulation by foreign governments, and such regulations may vary substantially from country to country. The time required to obtain marketing authorization in a foreign country may be longer or shorter than that required for FDA clearance or approval, and the requirements may differ. There is</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a trend towards harmonization of quality system standards among the European Union, United States, Canada and various other industrialized countries.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The primary regulatory environment in Europe is that of the European Economic Area (the &#x201c;EEA&#x201d;), which is comprised of the 27 Member States of the European Union (the &#x201c;EU&#x201d;), Iceland, Liechtenstein and Norway. In the EEA, medical devices were previously required to comply with the Essential Requirements defined in Annex I to the EU Medical Devices Directive (&#x201c;MDD&#x201d;) (applicable in the non-EU EEA Member States via the Agreement on the European Economic Area), a coordinated system for the authorization of medical devices. The directives and standards outlined in the MDD regulate the design, manufacture, clinical trials, labeling and adverse event reporting for medical devices. Devices that comply with the requirements of a relevant directive are entitled to bear the CE conformity marking, indicating that the device conforms to the essential requirements of the applicable directives and, accordingly, can be commercially distributed throughout the EEA. The method of assessing conformity varies depending on the class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a &#x201c;Notified Body,&#x201d; an organization designated by an EU country to assess a product&#x2019;s conformity with the applicable legal requirements. This third-party assessment may consist of an audit of the manufacturer&#x2019;s quality system and specific testing of the manufacturer&#x2019;s product. An assessment by a Notified Body of one country within the EU is required in order for a manufacturer to commercially distribute the product throughout the EU.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In 2017, European Union regulatory bodies finalized a new Medical Device Regulation, which replaced the existing MDD framework and provided three years for transition and compliance, for a final effective date of May 26, 2020. As a result of the COVID-19 pandemic, however, the European Parliament voted in April 2020 to postpone implementation of the Medical Device Regulation by one year, giving the medical device industry and Notified Bodies until May 26, 2021 to come into compliance. The Medical Device Regulation changes several aspects of the existing regulatory framework for medical device marketing in Europe and is expected to result in increased regulatory oversight of all medical devices marketed in the EU, which may, in turn, increase the costs, time and requirements that need to be met in order to place an innovative or high-risk medical device on the European market. In particular, the new regulations, among other things:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">strengthen the rules on placing devices on the market and reinforce surveillance once they are available;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establish explicit provisions on manufacturers&#x2019; responsibilities for the follow-up of the quality, performance and safety of devices placed on the market;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">improve the traceability of medical devices throughout the supply chain to the end-user or patient through a unique identification number;</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">set up a central database to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; and</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">strengthen the rules for the assessment of certain high-risk devices, which may have to undergo an additional check by experts before they are placed on the market.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">European medical device manufacturers and distributors are currently benefiting from a grace period for legacy MDD certificates that lasts until May 26, 2024. For a product to qualify for the grace period, there must be no significant changes to such a legacy medical device as described in its existing MDD certificate; the recertification process under the Medical Device Regulation requires a demonstration that the performance and the safety of the currently marketed medical device has been maintained and that the system meets the new regulatory requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outside of the European Union, regulatory authorization needs to be sought on a country-by-country basis in order for the company to market their products. Some countries have adopted medical device regulatory regimes, such as the Classification Rules for Medical Devices published by the Hong Kong Department of Health, the Health Sciences Authority of Singapore regulation of medical devices under the Health Products Act, and Health Canada&#x2019;s risk classification system for invasive devices, among others. Each country may have its own processes and requirements for medical device licensing, approval/clearance, and regulation, therefore requiring the company to seek marketing authorizations on a country-by-country basis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, as previously noted, the United Kingdom left the European Union on January 31, 2020, with a transitional period that expired on December 31, 2020. The United Kingdom and the European Union entered into a trade agreement known as the Trade and Cooperation Agreement (&#x201c;TCA&#x201d;), which came into effect on January 1, 2021. The TCA does not specifically refer to medical devices. However, as a result of Brexit, the Medical Device Regulation will not be implemented in the UK, and previous legislation that mirrored the Medical Device Regulation in the UK law has been revoked. The regulatory regime</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">for medical devices in the UK will continue to be based on the requirements derived from EU legislation as of January 21, 2020, and the UK may choose to retain regulatory flexibility or align with the Medical Device Regulation going forward. CE markings will continue to be recognized in the UK, and certificates issued by EU recognized Notified Bodies will be valid in the UK, until June 30, 2023. For medical devices placed on the UK market after this period, the UK Conformity Assessment (&#x201c;UKCA&#x201d;) marking will be mandatory. In contrast, UKCA marking and certificates issued by UK Notified Bodies will not be recognized on the EU market. The TCA does provide for cooperation and exchange of information in the area of product safety and compliance, including market surveillance, enforcement activities and measures, standardization related activities, exchanges of officials, and coordinated product recalls (or other similar actions). Depending on which countries products will ultimately be sold in, manufacturers may start seeking alternative sources for components if this would allow them to benefit from no tariffs. The rules for placing medical devices on the Northern Ireland market will differ from those in the UK.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, outside the United States, a range of anti-bribery and anti-corruption laws, as well as some industry-specific laws and codes of conduct, apply to the medical device industry and interactions with government officials and entities and healthcare professionals. Such laws include, but are not limited to the UK Bribery Act of 2010. Further, the European Union member countries have emphasized a greater focus on healthcare fraud and abuse and have indicated greater attention to the industry by the European Anti-Fraud Office. Countries in Asia have also become more active in their enforcement of anti-bribery laws and with respect to procurement and supply chain fraud.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Corporate Information</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">HealthCor was incorporated as a Cayman Islands exempted company on November 18, 2020 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses. Legacy Hyperfine was incorporated under the laws of the State of Delaware on February 25, 2014 under the name &#x201c;Hyperfine Research, Inc.&#x201d; On May 25, 2021, the name of Legacy Hyperfine was changed to &#x201c;Hyperfine, Inc.&#x201d; Liminal was incorporated under the laws of the State of Delaware on September 21, 2018 under the name &#x201c;EpilepsyCo Inc.&#x201d; On July 20, 2020, the name of Liminal was changed to &#x201c;Liminal Sciences, Inc.&#x201d; On December 21, 2021, HealthCor changed its jurisdiction of incorporation from the Cayman Islands to the State of Delaware by deregistering as an exempted company in the Cayman Islands and continuing and domesticating as a corporation, incorporated under the laws of the State of Delaware. On December 22, 2021, HealthCor, Legacy Hyperfine and Liminal completed the Business Combination, pursuant to which each of Legacy Hyperfine and Liminal became a wholly owned subsidiary of HealthCor, HealthCor&#x2019;s corporate name was changed to Hyperfine, Inc., Legacy Hyperfine&#x2019;s corporate name was changed to Hyperfine Operations, Inc., Liminal&#x2019;s corporate name was changed to Liminal Operations, Inc. (which was subsequently changed to Liminal Sciences, Inc.), and the business of Legacy Hyperfine and Liminal became the business of the Company. Our principal executive offices are located at 351 New Whitfield Street, Guilford, Connecticut 06437, and our telephone number is (203) 458-7100.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Information Available on the Internet</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our internet address is https://hyperfine.io, to which we regularly post copies of our press releases as well as additional information about us. Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and all amendments to those reports, will be available to you free of charge through the Investors section of our website as soon as reasonably practicable after such materials have been electronically filed with, or furnished to, the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). The SEC maintains an internet site (http://www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. We include our web site address in this report only as an inactive textual reference. Information contained in our website does not constitute a part of this report or our other filings with the SEC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1A.	RISK FACTORS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Except for the historical information contained herein, this report contains forward-looking statements that involve risks and uncertainties. These statements include projections about our finances, plans and objectives for the future, future operating and economic performance and other statements regarding future performance. These statements are not guarantees of future performance or events. Our actual results could differ materially from those discussed in this report. Factors that could cause or contribute to these differences include, but are not limited to, those discussed in the following section, as well as those discussed in Part II, Item 7 entitled &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; and elsewhere throughout this report.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">You should consider carefully the following risk factors, together with all of the other information included in this report. If any of the following risks, either alone or taken together, or other risks not presently known to us or that we currently believe to not be significant, develop into actual events, then our business, financial condition, results of operations or prospects could be materially adversely affected. If that happens, the market price of our common stock could decline, and stockholders may lose all or part of their investment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Unless the context otherwise requires, references in this section to &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our&#x201d; and the &#x201c;Company&#x201d; refer to Hyperfine, Inc. and its subsidiaries following the Business Combination, or to Legacy Hyperfine, Liminal, or HealthCor prior to the Business Combination, as the case may be.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Our Financial Condition and Capital Requirements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are an early-stage life sciences technology company with a history of net losses, which we expect to continue, and we may not be able to generate meaningful revenues or achieve and sustain profitability in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are an early-stage life sciences technology company, and have incurred significant losses since Legacy Hyperfine and Liminal formed in 2014 and 2018, respectively, and expect to continue to incur losses in the future. We incurred net losses of $64.9 million and $23.4 million for the years ended December 31, 2021 and 2020, respectively. As of December 31, 2021, we had an accumulated deficit of $136.3 million. These losses and accumulated deficit were primarily due to the substantial investments made to develop and improve our technology and products. Over the next several years, we expect to continue to devote substantially all of our resources towards continuing development and commercialization of our products and research and development efforts for additional products. These efforts may prove more costly than we currently anticipate. We have just begun generating product revenue but may never generate revenue sufficient to offset our expenses, or at all. In addition, as a public company, we will incur significant legal, accounting, administrative, insurance and other expenses that we did not incur as a private company. Accordingly, we cannot assure you that we will achieve profitability in the future or that, if we become profitable, will sustain profitability.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have a limited operating history, which may make it difficult to evaluate the prospects for our future viability and predict our future performance. As such, you cannot rely upon our historical operating performance to make an investment or voting decision regarding us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have generated limited revenue from the sale of our products and services to date and have incurred significant losses. Our prospects must be considered in light of the uncertainties, risks, expenses, and difficulties frequently encountered by companies in their early stages of operations. We have not yet achieved wide market acceptance for our products, produced our products at scale, refined our sales model, or conducted at scale sales and marketing activities necessary for successful mass product adoption. Consequently, predictions about our future success or viability are highly uncertain and may not be as accurate as they could be if we had a longer operating history or a company history of successfully developing and commercializing products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, as a business with a limited operating history, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown obstacles. We will need to transition from a company in the early commercialization stage to large scale commercialization, and we may not be successful in such a transition. We have encountered in the past, and will encounter in the future, risks and uncertainties frequently experienced by growing companies with limited operating histories in emerging and rapidly changing industries. If our assumptions regarding these risks and uncertainties, which we will use to plan and operate our business, are incorrect or change, or if we do not address these risks successfully, our results of operations could differ materially from our expectations, and our business, financial condition and results of operations could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may need to raise additional capital to fund commercialization plans for our products, including manufacturing, sales and marketing activities, expand our investments in research and development, and commercialize new products and applications.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our operations have consumed substantial amounts of cash since inception. We expect to use the funds received in connection with the Business Combination to develop and further commercialize our products, develop new products, and for working capital and general corporate purposes. We may require additional capital to further develop and commercialize our products and to develop new products. In addition, our operating plans may change as a result of many factors that may currently be unknown to us, and we may need to seek additional funds sooner than planned.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We cannot guarantee that future financing will be available in sufficient amounts or on terms acceptable to us, if at all. Moreover, the terms of any future financing may adversely affect the holdings or the rights of our stockholders and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our Class A common stock to decline. The incurrence of indebtedness could result in increased fixed payment obligations, and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. We could also be required to seek funds through arrangements with collaborative partners or otherwise at an earlier stage than otherwise would be desirable, and we may be required to relinquish rights to some of our technologies or products or otherwise agree to terms that are unfavorable to us, any of which may have a material adverse effect on our business, operating results and prospects. In addition, raising additional capital through the issuance of equity or convertible debt securities would cause dilution to holders of our equity securities, and may affect the rights of then-existing holders of our equity securities. Even if we believe that we have sufficient funds for our current or future operating plans, we may seek additional capital if market conditions are favorable or if we have specific strategic considerations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our operating results may fluctuate significantly in the future, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or any guidance we may provide.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our quarterly and annual operating results may fluctuate significantly, which makes it difficult for us to predict our future operating results. These fluctuations may occur due to a variety of factors, many of which are outside our control, including, but not limited to:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing and amount of expenditures that we may incur to develop, commercialize or acquire additional products and technologies or for other purposes, such as the expansion of our sales team and our facilities;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in governmental funding of life sciences research and development or changes that impact budgets or budget cycles;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pricing actions, such as the pricing adjustments we made to our subscription plus ownership model during the first quarter of 2022 in which we increased the price of the device while lowering the price of the monthly subscription;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seasonal spending patterns of our customers;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing of when we recognize any revenues;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">future accounting pronouncements or changes in our accounting policies;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the outcome of any future litigation or governmental investigations involving the Company, our industry or both;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">higher than anticipated service, replacement and warranty costs;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impact of the COVID-19 pandemic on the economy, investment in the life sciences and medical technology industries, our business operations, and resources and operations of our suppliers, future distributors and current and potential customers; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impact of political instability and military conflict, such as the conflict in Ukraine, which has resulted in instability in the global financial markets and export controls, and which could result in supply disruptions for us, including because one key custom-made component in our Swoop scanner is the magnet, which is manufactured by a single source supplier in Europe, and which could also have a material adverse impact on our sales in affected markets; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">general industry, economic and market conditions and other factors, including factors unrelated to our operating performances or the operating performance of our competitors.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The cumulative effects of the factors discussed above could result in large fluctuations and unpredictability in our quarterly and annual operating results. As a result, comparing our operating results on a period-to-period basis may not be meaningful.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This variability and unpredictability could also result in us failing to meet the expectations of industry or financial analysts or investors for any period. If we are unable to further commercialize products or generate revenue, or if our operating results fall below the expectations of analysts or investors or below any guidance we may provide, or if the guidance we provide is below the expectations of analysts or investors, the market price of our Class A common stock could decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Our Businesses</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our success depends upon market acceptance of our products and services, our ability to develop and commercialize existing and new products and services and generate revenues, and our ability to identify new markets for our technology.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have developed, and are engaged in the development of, MRI solutions and non-invasive neural monitoring technology. We are commercializing our Swoop</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">&#174;</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Portable MRI System</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#153;</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> to address limitations of current imaging technologies. Other product candidates, such as our non-invasive brain vital sensors, are currently under development. Our success will depend on the acceptance of our products and services in the U.S. and international healthcare markets. The marketplace may not be receptive to our products and services over competing products, including conventional MRI systems used in hospitals, imaging centers and physicians&#x2019; offices, and we may be unable to compete effectively. Factors that could affect our ability to successfully further commercialize our current products and services and to commercialize any potential future products and services include:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">challenges of developing (or acquiring externally-developed) technology solutions that are adequate and competitive in meeting the requirements of next-generation design challenges; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">dependence upon physicians&#x2019; and other healthcare practitioners&#x2019; acceptance of our products.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We cannot assure investors that our current products and services or any future products and services will gain broad market acceptance. If the market for our current products and services or any future products and services fails to develop or develops more slowly than expected, or if any of our products or services do not achieve or sustain market acceptance, our business and operating results would be materially and adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Medical device development is costly and involves continual technological change, which may render our current or future products obsolete.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The market for point-of-care medical devices is characterized by rapid technological change, medical advances and evolving industry standards. Any one of these factors could reduce the demand for our devices or services or require substantial resources and expenditures for research, design and development to avoid technological or market obsolescence.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our success will depend on our ability to enhance our current technology, products and services and develop or acquire and market new technologies to keep pace with technological developments and evolving industry standards, while responding to changes in customer needs. A failure to adequately develop or acquire device enhancements or new devices that will address changing technologies and customer requirements adequately, or to introduce such devices on a timely basis, may have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We might have insufficient financial resources to improve existing devices, advance technologies and develop new devices at competitive prices. Technological advances by one or more competitors or future entrants into the field may result in our current devices becoming non-competitive or obsolete, which may decrease revenues and profits and adversely affect our business and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may encounter significant competition across our existing and future planned products and services and in each market in which we sell or plan to sell our products and services from various companies, many of which have greater financial and marketing resources than us. Our primary competitors include several large companies which currently dominate the medical imaging market, including General Electric, Siemens, Philips, Hologic, Varian, Fuji, Toshiba, Canon and Hitachi.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, our competitors, some of which are well-established manufacturers with significant resources, may engage in aggressive marketing tactics. Competitors may also possess the ability to commercialize additional lines of products, bundle products or offer higher discounts and incentives to customers in order to gain a competitive advantage. If the prices of competing products are lowered as a result, we may not be able to compete effectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We will be dependent upon the success of our sales and customer acquisition and retention strategies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business is dependent upon the success of our sales and customer acquisition and retention strategies, and our marketing efforts are focused on developing a strong reputation with healthcare providers and increasing awareness of our products and services. If we fail to maintain a high quality of service or a high quality of device technology, we may fail to retain existing users or add new users. If we do not successfully continue our sales efforts and promotional activities, particularly to health systems and large institutions, or if existing users decrease their level of engagement, our revenue, financial results and business may be significantly harmed. Our future success depends upon continued expansion of our commercial operations in the United States and internationally, as well as entering additional markets to commercialize our products and services. We believe that our growth will depend on the further development and commercialization of our current products and services and regulatory authorization for our future products and services. If we fail to expand the use of our products and services in a timely manner, we may not be able to expand our market share or to grow our revenue. Our financial performance will be substantially dictated by our success in adding, retaining and engaging active users of our products. If customers do not perceive our products or services to be useful, reliable and trustworthy, we may not be able to attract or retain customers or otherwise maintain or increase the frequency and duration of their engagement. As our business model is predicated on device hardware sales, software subscriptions, and subscriptions for use of device hardware and software, there is risk that any decline in sales, subscriptions and subscription renewal rates will adversely impact our business. A decrease in customer retention, growth or engagement with our products and services may have a material and adverse impact on our revenue, business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any number of factors could negatively affect customer retention, growth and engagement, including:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">customers choosing competing products or choosing to use conventional MRI systems over our products;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure to introduce new and improved products and services;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">inability to continue to develop products that customers find effective and that achieve a high level of market acceptance;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in customer sentiment about the quality or usefulness of our products and services or concerns related to safety, security, privacy and data sharing or other factors;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adverse changes in our products that are mandated by legislation or regulatory agencies, both in the United States and internationally; or</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">technical or other problems preventing us from delivering products or services in a rapid and reliable manner or otherwise affecting the user experience.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we do not successfully manage the commercialization of our products and services, including continuing to build our sales force, and the development and launch of new products and services, we will not meet the long term forecasts and our business, operating and financial results and condition could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We face risks associated with commercializing existing products and services and launching new products and services. If we encounter commercialization, development or manufacturing challenges or discovers errors during our product development cycle, the product launch dates of new products may be delayed, which will cause delays in our ability to achieve our forecasted results. The expenses or losses associated with unsuccessful product development or launch activities or lack of market acceptance of our products and services could adversely affect our business or financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We expect to generate an increasing portion of our revenue internationally in the future and may become subject to various additional risks relating to our international activities, which could adversely affect our business, operating results and financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that a substantial percentage of our future revenue will come from international sources as we seek regulatory authorization for our products beyond the United States and expands our sales and marketing opportunities internationally. Our success will depend, in part, upon our ability to succeed in differing legal, regulatory, economic, social and political conditions by developing, implementing and maintaining policies and strategies that are effective in each location where we do business. We have limited experience operating internationally and engaging in international business involves a number of difficulties and risks, including:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the challenges associated with building local brand awareness, obtaining local key opinion leader support and clinical support, implementing reimbursement strategies and building local marketing and sales teams;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">required compliance with foreign regulatory requirements and laws, including regulations and laws relating to patient data and medical devices;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">trade relations among the United States and those foreign countries in which our current or future customers, distributors, manufacturers and suppliers have operations, including protectionist measures such as tariffs and import or export licensing requirements, whether imposed by the United States or such foreign countries, in particular the strained trade relations between United States and China since 2018;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulties and costs of staffing and managing foreign operations;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulties protecting, procuring or enforcing intellectual property rights internationally;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">required compliance with anti-bribery laws, such as the U.S. Foreign Corrupt Practices Act, data privacy requirements, labor laws and anti-competition regulations;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">laws and business practices that may favor local companies;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain foreign legal systems;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">political and economic instability; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potentially adverse tax consequences, tariffs, customs charges, bureaucratic requirements and other trade barriers.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For example, our business may be impacted by the conflict in Ukraine, any economic or other sanctions imposed on Russia and others for aggression in Ukraine, and any economic or other countermeasures by affected countries. Any such conflict may also impact our ability to secure raw materials and finished products and create supply chain disruptions. For example, one key custom-made component in our Swoop scanner is the magnet, which is manufactured by a single source supplier in Europe. In the event of interruption from any of our suppliers or manufacturers, we may not be able to obtain capacity from other sources or develop alternate or secondary sources without incurring material additional costs and substantial delays. As we seek to expand into international markets, the conflict in Ukraine and any related economic or other sanctions or related countermeasures could limit our ability to expand our business and have a material adverse impact on demand for our products and sales in affected markets. In addition, sanctions imposed on Russia and others in response to such conflict may also adversely impact the financial markets and the global economy, and any economic countermeasures by Russia and others could exacerbate market and economic instability.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we dedicate significant resources to our international operations and are unable to manage these risks effectively, our business, operating results and financial condition may be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are subject to export and import control laws and regulations that could impair our ability to compete in international markets or subject us to liability if we violate such laws and regulations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are required to comply with export and import control laws, which may affect our ability to enter into or complete transactions with certain customers, business partners, and other persons. In certain circumstances, export control regulations may prohibit the export of certain products, services, and technologies. We may be required to obtain an export license before exporting a controlled item, and granting of a required license cannot be assured. Compliance with the import laws that apply</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to our businesses may restrict our access to, and may increase the cost of obtaining, certain products and could interrupt our supply of imported inventory.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exported technologies necessary to develop and manufacture certain products are subject to U.S. export control laws and similar laws of other jurisdictions. We may be subject to adverse regulatory consequences, including government oversight of facilities and export transactions, monetary penalties, and other sanctions for violations of these laws. In certain instances, these regulations may prohibit us from developing or manufacturing certain of our products for specific applications outside the United States. Failure to comply with any of these laws and regulations could result in civil and criminal, monetary, and nonmonetary penalties; disruptions to our business; limitations on our ability to import and export products and services; or damage to our reputation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we experience decreasing prices for our products and are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may experience decreasing prices for our products due to pricing pressure from managed care organizations and other third-party payors and suppliers, increased market power of our payors as the medical device industry consolidates, and increased competition among suppliers, including manufacturing services providers. If the prices for our products and services decrease and we are unable to reduce our expenses, including the cost of sourcing materials, logistics and the cost to manufacture our products, our business, results of operations, financial condition and cash flows may be adversely affected. To the extent that we engage in enterprise sales, we may be subject to procurement discounts, which could have a negative impact on the prices of our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to attract, recruit, train, retain, motivate and integrate key personnel as we expand our organization, our operations may be disrupted and we may not achieve our goals.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our future success depends on our ability to attract, recruit, train, retain, motivate and integrate key personnel, including our Vice Chairman and the Founder of Legacy Hyperfine and Liminal, Dr. Jonathan Rothberg, our Executive Chairman, Scott Huennekens, and our President and Chief Executive Officer, Dave Scott, as well as our recently expanded management team and our research and development, manufacturing, software engineering and sales and marketing personnel. As our development and commercialization plans and strategies develop, we will need additional managerial, operational, sales, marketing, financial, legal and other resources. Competition for qualified personnel in the medical device industry is intense. Due to this intense competition, we may be unable to attract and retain the qualified personnel necessary for the development of our business or to recruit suitable replacement personnel.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that our management team must be able to act decisively to apply and adapt our business model in the rapidly changing markets in which we compete. In addition, we rely upon technical and scientific employees or third-party contractors to effectively establish, manage and grow our business. Consequently, we believe that our future viability will depend largely on our ability to attract and retain highly skilled managerial, sales, scientific and technical personnel. In order to do so, we may need to pay higher compensation or fees to our employees or consultants than we currently expect, and such higher compensation payments may have a negative effect on our operating results. Competition for experienced, high-quality personnel is intense, and we cannot assure investors that we will be able to recruit and retain such personnel. Our growth depends, in particular, on attracting and retaining highly-trained sales personnel with the necessary technical background and ability to understand our products and services at a technical level to effectively identify and sell to potential new customers and develop new products. Because of the technical nature of our products and the dynamic market in which we compete, any failure to attract, recruit, train, retain, motivate and integrate qualified personnel could materially harm our operating results and growth prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our management may need to divert a disproportionate amount of our attention away from our day-to-day activities and devote a substantial amount of time to managing these growth activities. We may not be able to effectively manage the expansion of our operations, which may result in weaknesses in our infrastructure, operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. Our expected growth could require significant capital expenditures and may divert financial resources from other projects, such as the development of additional products. If our management is unable to effectively manage our growth, our expenses may increase more than expected, our ability to generate and/or grow revenue could be reduced and we may not be able to implement our business strategy. Our future financial performance and our ability to commercialize products and services and compete effectively will depend, in part, on our ability to effectively manage any future growth.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have limited experience in marketing and selling our products and related services, and if we are unable to successfully commercialize our products and related services, our business and operating results will be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have limited experience marketing and selling our products and related services. We began selling our Swoop MRI scanner in 2020 and currently sell the device directly to customers through direct sales. Future sales of our products will depend in large part on our ability to effectively market and sell our products and services, successfully manage and expand our sales force, and increase the scope of our marketing efforts. We may also enter into distribution arrangements in the future. Because we have limited experience in marketing and selling our products, our ability to forecast demand, the infrastructure required to support such demand and the sales cycle to customers is unproven. If we do not build an efficient and effective marketing and sales force, our business and operating results will be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We rely on a single contract manufacturer, Benchmark Electronics, Inc. (&#x201c;Benchmark&#x201d;), to test, assemble and supply our finished products. If Benchmark fails to fulfill its obligations under its existing contractual arrangements with us or does not perform satisfactorily, our ability to source our devices could be negatively and adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2018, Legacy Hyperfine entered into a Manufacture and Supply Agreement with Benchmark (the &#x201c;MSA&#x201d;). Under the MSA, Benchmark agreed to manufacture our products pursuant to binding purchase orders. The parties have agreed to meet periodically regarding any minimum order quantities of components under the MSA. We also have certain inventory related obligations, including the obligation to purchase excess and obsolete components from Benchmark. See </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#x201c;Item 1. Business - Key Agreements - Manufacture and Supply Agreement with Benchmark Electronics, Inc.&#x201d;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event it becomes necessary to utilize a different contract manufacturer for our component products, we would experience additional costs, delays and difficulties in obtaining such components as a result of identifying and entering into an agreement with a new contract manufacturer as well as preparing such new manufacturer to meet the logistical requirements associated with manufacturing our devices, and our business would suffer.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We rely on a limited number of suppliers for our products. A loss of any of these suppliers could negatively affect our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely on a limited number of suppliers to manufacture components for our products, including in some cases only a single supplier for some of our components. One key custom-made component in our Swoop scanner is the magnet, which is manufactured by a single source supplier in Europe. Our reliance on a limited number of suppliers increases our risks, since we do not currently have alternative or replacement suppliers beyond these key parties. In the event of interruption from any of our suppliers, we may not be able to increase capacity from other sources or develop alternate or secondary sources without incurring material additional costs and substantial delays.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we experience a significant increase in demand for our products, or if we need to replace an existing supplier or manufacturer, we may be unable to supplement or replace them on terms that are acceptable to us, which may undermine our ability to deliver our products to customers in a timely manner. Identifying suitable suppliers and manufacturers is an extensive process that requires us to become satisfied with their quality control, technical capabilities, responsiveness and service, financial stability, regulatory compliance, and labor and other ethical practices. Accordingly, a loss of any of our suppliers or our device manufacturer could have an adverse effect on our business, financial condition and operating results.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Pricing pressures from contract suppliers or manufacturers on which we rely may impose pricing pressures.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third party suppliers utilized by our manufacturer such as Benchmark Electronics, Inc. may also impose pricing pressures. Because we currently also rely on Benchmark Electronics, Inc. to manufacture, test and ship all of the Swoop scanners and on a limited number of suppliers to supply our components, including a single source supplier of the magnet used in the scanner, such pricing pressures from a third party such as Benchmark Electronics, Inc. could increase our costs and could force us to increase the prices of our products if we are unable to enter into alternative arrangements with other suppliers or manufacturers, potentially leading to decreased customer demand.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we do not successfully optimize and operate our sales and potential future distribution channels or we do not effectively expand and update our infrastructure, our operating results and customer experience may be negatively impacted.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we do not adequately predict market demand or otherwise optimize and operate our sales and potential future distribution channels successfully, it could result in excess or insufficient inventory or fulfillment capacity, increased costs, or immediate shortages in product or component supply, or harm our business in other ways. In addition, if we do not maintain adequate</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">infrastructure to enable us to, among other things, manage our purchasing and inventory, it could negatively impact our operating results and customer experience.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The market for our products and services is new, rapidly evolving, and increasingly competitive, as the healthcare industry in the United States is undergoing significant structural change, which makes it difficult to forecast demand for our products and services.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The market for our products and services is new and rapidly evolving, and it is uncertain whether we will achieve and sustain high levels of demand and market adoption. Our future financial performance will depend in part on growth in this market and on our ability to adapt to the changing demands of customers. It is difficult to predict the future growth rate and size of our target market. As a result, our commercial expectations may not be achieved. Negative publicity concerning our products could limit market acceptance of our products and services. If our customers do not perceive the benefits of our products and services, or if our products and services do not attract new customers, then our market may not develop at all, or we may develop more slowly than we expect. Our success will depend to a substantial extent on the willingness of healthcare organizations to increase their use of our technology and our ability to demonstrate the value of our technology relative to competing products and services to existing and potential customers. If healthcare organizations do not recognize or acknowledge the benefits of our products and services or if we are unable to reduce healthcare costs or drive positive health outcomes, then the market for our solutions might not develop at all, or might develop more slowly than we expect. Similarly, negative publicity regarding patient confidentiality and privacy in the context of technology-enabled healthcare or concerns experienced by competitors could limit market acceptance of our products and services.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The healthcare industry in the United States is undergoing significant structural change and is rapidly evolving. Our products and services are offered on a subscription basis, and the adoption of subscription business models is still relatively new, especially in the healthcare industry. If companies do not shift to subscription business models and subscription health management tools do not achieve widespread adoption, or if there is a reduction in demand for subscription products and services or subscription health management tools, our business, financial condition, and results of operations could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Quality problems could lead to recalls or safety alerts and/or reputational harm and could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Quality of our products is very important to us and our customers due to the serious and costly consequences of product failure. Our business exposes us to potential product liability risks that are inherent in the design, manufacture, and marketing of medical devices. Product or component failures, manufacturing nonconformities, design defects, off-label use, or inadequate disclosure of product-related risks or product-related information with respect to our products, if they were to occur, could result in inaccurate imaging and safety risks. These problems could lead to the recall of, or the issuance of a safety alert relating to, our products, and could result in product liability claims and lawsuits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, the manufacture and production of our products must occur in a highly controlled and clean environment to minimize particles and other yield- and quality-limiting contaminants. Weaknesses in process control or minute impurities in materials may cause defective products. If we are not able to maintain stringent quality controls, or if contamination problems arise, our development and commercialization efforts could be delayed, which would harm our business and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we fail to meet any applicable product quality standards and our products are the subject of recalls or safety alerts, our reputation could be damaged, we could lose customers, and our revenue and results of operations could decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are not able to develop and release new products and services, or successful enhancements, new features and modifications to our existing products and services, to successfully implement our software subscription solutions or to achieve adequate clinical utility, our business, financial condition and results of operations could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The markets in which we operate are characterized by rapid technological change, frequent new product and service introductions and enhancements, changing customer demands, and evolving industry standards. The introduction of products and services embodying new technologies can quickly make existing products and services, including software subscriptions, obsolete and unmarketable. Additionally, changes in laws and regulations could impact the usefulness of our products and could necessitate changes or modifications to our products to accommodate such changes. We invest substantial resources in researching and developing new products and enhancing existing products by incorporating additional features, improving functionality, and adding other improvements to meet customers&#x2019; evolving needs. The success of any enhancements or improvements to our existing products or any new products depends on several factors, including timely completion, competitive pricing, adequate quality testing, integration with new and existing technologies and third-party partners&#x2019;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">technologies and overall market acceptance. We may not succeed in developing, marketing and delivering on a timely and cost-effective basis enhancements or improvements to our existing products or any new products that respond to continued changes in market demands or new customer requirements, and any enhancements or improvements to our products or any new solutions may not achieve market acceptance. Since developing our products is complex, the timetable for the release of new products and enhancements to existing products is difficult to predict, and we may not offer new products and updates as rapidly as our customers require or expect. Any new products that we develop may not be introduced in a timely or cost-effective manner, may contain errors or defects, or may not achieve the broad market acceptance necessary to generate sufficient revenue. Moreover, even if we introduce new products, we may experience a decline in revenue from our existing products that is not offset by revenue from the new products. For example, customers may delay making purchases of new products to permit them to make a more thorough evaluation of these products or until industry and marketplace reviews become widely available. Customers may also delay purchasing a new product because their existing product or other device continues to meet their needs. Some customers may hesitate to migrate to a new product due to concerns regarding the performance of the new product. In addition, we may lose existing customers who choose a competitor&#x2019;s products and services. This could result in a temporary or permanent revenue shortfall and adversely affect our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The introduction of new products and solutions by competitors, the development of entirely new technologies to replace existing offerings or shifts in healthcare benefits trends could make our products obsolete or adversely affect our business, financial condition and results of operations. We may experience difficulties with software development, industry standards, design or marketing that could delay or prevent our development, introduction or implementation of new products, enhancements, additional features or capabilities. If customers do not widely purchase and adopt our products, we may not be able to realize a return on our investment. If we do not accurately anticipate customer demand or if we are unable to develop, license or acquire new features and capabilities on a timely and cost-effective basis, or if such enhancements do not achieve market acceptance, it could result in adverse publicity, loss of revenue or market acceptance or claims by customers brought against us, each of which could have a material and adverse effect on our reputation, business, results of operations and financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are party to Technology and Services Exchange Agreements with certain affiliated companies, pursuant to which the parties agreed to share personnel and certain non-core technologies. The sharing arrangements under the agreements may prevent us from fully utilizing our personnel and/or the technologies shared under the agreements. Furthermore, if these agreements were to terminate, or if we were to lose access to these technologies and services, our business could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We entered into Technology and Services Exchange Agreements (each, a &#x201c;TSEA&#x201d; and collectively, the &#x201c;TSEA&#x201d;) with other participant companies controlled by the Rothbergs. A TSEA by and among Butterfly Network, Inc., AI Therapeutics, Inc., Quantum-Si Incorporated, 4Bionics, Tesseract Health, Inc., Detect, Inc. (f/k/a Homodeus Inc.), Legacy Hyperfine and Liminal was signed in November 2020; a TSEA by and among Quantum-Si Incorporated, AI Therapeutics, Inc., 4Bionics, Tesseract Health, Inc., Detect, Inc., Legacy Hyperfine and Liminal was signed in February 2021 (and which Protein Evolution, Inc. joined in August 2021); and a TSEA by and among Legacy Hyperfine, Liminal, AI Therapeutics, Inc., Tesseract Health, Inc. and Detect, Inc. was signed in July 2021 and became effective upon the Closing. Under the TSEA, we and the other participant companies may, in their discretion, permit the use of certain non-core technologies, which include any technologies, information or equipment owned or otherwise controlled by the participant company that are not specifically related to the core business area of the participant, such as software, hardware, electronics, fabrication and supplier information, vendor lists and contractor lists, with the other participant companies. The TSEA provides that ownership of each non-core technology shared by us or another participant company will remain with the company that originally shared the non-core technology. In addition, any participant company (including us) may, in its discretion, permit its personnel to be engaged by another participant company to perform professional, technical or consulting services for such participant. Unless otherwise agreed to by us and the other participant company, all rights, title and interest in and to any inventions, works-of-authorship, idea, data or know-how invented, made, created or developed by the personnel (employees, contractors or consultants) in the course of conducting services for a participant company (&#x201c;Created IP&#x201d;) will be owned by the participant company for which the work was performed, and the recipient participant company grants to the party that had its personnel provide the services that resulted in the creation of the Created IP a royalty-free, perpetual, limited, worldwide, non-exclusive, sub-licensable (and with respect to software, sub-licensable in object code only) license to utilize the Created IP only in the core business field of the originating participant company, including a license to create and use derivative works based on the Created IP in the originating participant&#x2019;s core business field, subject to any agreed upon restrictions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The technology and personnel-sharing arrangements under the TSEA may prevent us from fully utilizing our personnel if such personnel are also being used by the other participant companies and may also cause our personnel to enter into agreements with or provide services to other companies that interfere with their obligations to us. Created IP under the TSEA</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">may be relevant to our business and created by our personnel but owned by the other participant companies. Furthermore, if the TSEA were to terminate, or if we were to lose access to the technologies and services available pursuant to the TSEA, our business could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may acquire other companies or technologies, which could fail to result in a commercial product or net sales, divert our management&#x2019;s attention, result in additional dilution to our stockholders and otherwise disrupt our operations and harm our operating results.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may in the future seek to acquire or invest in businesses, applications or technologies that we believe could complement or expand our portfolio, enhance our technical capabilities or otherwise offer growth opportunities. However, we cannot assure you that we would be able to successfully complete any acquisition we choose to pursue, or that we would be able to successfully integrate any acquired business, product or technology in a cost-effective and non-disruptive manner. The pursuit of potential acquisitions may divert the attention of management and cause us to incur various costs and expenses in identifying, investigating and pursuing suitable acquisitions, whether or not they are consummated. We may not be able to identify desirable acquisition targets or be successful in entering into an agreement with any particular target or obtain the expected benefits of any acquisition or investment.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To date, the growth of our operations has been largely organic, and we have limited experience in acquiring other businesses or technologies. We may not be able to successfully integrate any acquired personnel, operations and technologies, or effectively manage the combined business following an acquisition. Acquisitions could also result in dilutive issuances of equity securities, the use of our available cash, or the incurrence of debt, which could harm our operating results. In addition, if an acquired business fails to meet our expectations, our operating results, business and financial condition may suffer.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">As international expansion of our business occurs, it will expose us to market, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our long-term strategy is to increase our international presence, including securing the necessary regulatory authorizations in the United Kingdom and Australia. We recently received regulatory authorization in Canada, New Zealand and Pakistan. This strategy may include establishing and maintaining physician outreach and education capabilities outside of the United States and expanding our relationships with international customers. Doing business internationally involves a number of risks, including:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Difficulties in staffing and managing our international operations;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Multiple, conflicting and changing laws and regulations such as tax laws, privacy laws, export and import restrictions, employment laws, regulatory requirements and other governmental approvals, permits and licenses;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Reduced or varied protection for intellectual property rights in some countries;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Obtaining regulatory clearance where required for our products in various countries;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Requirements to maintain data and the processing of that data on servers located within such countries;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Limits on our ability to penetrate international markets if we are required to manufacture our products locally;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial risks, such as longer payment cycles, difficulty collecting accounts receivable, foreign tax laws and complexities of foreign value-added tax systems, the effect of local and regional financial pressures on demand and payment for our products and exposure to foreign currency exchange rate fluctuations;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restrictions on the site-of-service for use of our products and the economics related thereto for physicians and other healthcare practitioners;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Natural disasters and economic instability, including outbreak of disease, boycotts, curtailment of trade and other market restrictions; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Wars, terrorism and political unrest, such as the conflict in Ukraine, which has resulted in instability in the global financial markets and export controls, and which could result in supply disruptions for us, including because one key custom-made component in our Swoop scanner is the magnet, which is manufactured by a single source supplier in Europe, and which could also have a material adverse impact on our sales in affected markets; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Regulatory and compliance risks that relate to maintaining accurate information and control over activities subject to regulation under the U.S. Foreign Corrupt Practices Act, and comparable laws and regulations in other countries.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any of these factors could significantly harm our future international expansion and operations and, consequently, have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The COVID-19 pandemic has and could continue to negatively affect various aspects of our business, make it more difficult for us to meet our obligations to our customers, and result in reduced demand for our products and services, which could have a material adverse effect on our business, financial condition, results of operations, or cash flows.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, a novel strain of coronavirus was reported to have surfaced in Wuhan, China, and it has since spread throughout other parts of the world, including the United States. Any outbreak of contagious diseases, or other adverse public health developments, could have a material adverse effect on our business operations. These impacts to our operations have included, and could again in the future include disruptions or restrictions on the ability of our employees&#x2019; and customers&#x2019; to travel or of us to pursue collaborations and other business transactions, travel to customers and/or conduct live demonstrations of our products at promotional events, oversee the activities of our third-party manufacturers and suppliers and make shipments of materials. We may also be impacted by the temporary closure of the facilities of suppliers, manufacturers or customers. In addition, many hospitals and other healthcare providers continue to focus their attention on addressing COVID-19, which we believe has resulted in lower sales volume. The COVID-19 pandemic may also continue to have an impact on customers, as elective healthcare visits and procedures have been postponed and there is greater focus on areas of care with lower profitability, leading, as a consequence, to lower expenditures on new products and devices by healthcare institutions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In an effort to halt the outbreak of COVID-19, a number of countries, including the United States, have placed significant restrictions on travel and many businesses have announced extended closures. These travel restrictions and business closures have and may in the future adversely impact our operations locally and worldwide, including our ability to manufacture, market, sell or distribute our products, and such restrictions and closure have caused or may cause temporary closures of facilities of suppliers, manufacturers or customers. During the COVID-19 pandemic, our suppliers agreed to shift new work to domestic suppliers to help reduce the risk of manufacturing delays. Our supplier and sub tier suppliers have been adversely affected by COVID-19. Any disruption in the operations of our employees, suppliers, customers, manufacturers or access to customers would likely impact our sales and operating results. In addition, travel restrictions have made it more difficult for us to monitor the quality of our third party manufacturing operations when we are unable to conduct in-person quality audits of those facilities. We have also experienced increases in product costs as raw materials have been constrained. Prices have risen sharply over the past year, and lead times have extended dramatically, particularly on semiconductor products. Over the next 12 months, we expect prices to increase due to the raw material demand surges across numerous industries, along with labor and transportation related constraints. We also expect lead times to reduce as component production levels recover to meet demand. In addition, future regulatory authorizations by the FDA may take longer because of COVID-19 pandemic-related delays. We are continuing to monitor and assess the effects of the COVID-19 pandemic on our commercial operations. However, we cannot at this time accurately predict what effects these conditions will ultimately have on our operations due to uncertainties relating to variants such as Omicron, the severity of the disease, the duration of the outbreak, and the length of the travel restrictions and business closures imposed by the governments of impacted countries. In addition, the COVID-19 pandemic could continue to adversely affect the economies and financial markets of many countries, which could result in an economic downturn that could affect demand for our products and likely impact our operating results.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Unfavorable global economic conditions could adversely affect our business, financial condition or results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets, including changes in inflation, interest rates and overall economic conditions and uncertainties. For instance, if inflation or other factors were to significantly increase our business costs, it may not be feasible to pass price increases on to our customers. Inflation could also adversely affect the ability of our customers to purchase our products. An economic downturn, including as a result of COVID-19, could result in a variety of risks to our business, including weakened demand for our products and our inability to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy could also strain our manufacturers and suppliers, possibly resulting in supply disruption, or cause future customers</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to delay making payments for our products. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The enactment of legislation implementing changes in the U.S. Taxation of international business activities, the adoption of other tax reform policies or changes in tax legislation or policies in jurisdictions outside of the United States could materially impact our results of operations and financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are subject to income tax in the numerous jurisdictions in which we operate. Reforming the taxation of international businesses has been a priority for politicians, and a wide variety of potential changes have been proposed. Some proposals, several of which have been enacted, impose incremental taxes on gross revenue, regardless of profitability. Furthermore, it is reasonable to expect that global taxing authorities will be reviewing current legislation for potential modifications in reaction to the implementation of the 2017 Tax Cuts and Jobs Act (the &#x201c;Tax Act&#x201d;) in the United States. Due to the expanding scale of our international business activities, changes in the taxation of such activities may increase our worldwide effective tax rate and the amount of taxes we pay and harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States, the Tax Act enacted on December 22, 2017 significantly affected U.S. Tax law by changing how the United States imposes income tax on multinational corporations. The U.S. Department of Treasury has broad authority to issue regulations and interpretative guidance that may significantly impact how we will apply the law and impact our results of operations in the period issued.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Tax Act requires complex computations not previously provided in U.S. Tax law. As such, the application of accounting guidance for such items remains uncertain. Further, compliance with the Tax Act and the accounting for such provisions requires an accumulation of information not previously required or regularly produced. As additional regulatory guidance is issued by the applicable taxing authorities, as accounting treatment is clarified, and as we perform additional analysis on the application of the law, our effective tax rate could be materially different.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">U.S. Taxation of international business activities or the adoption of tax reform policies could materially impact our future financial position and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Limitations on the ability of taxpayers to claim and utilize foreign tax credits and the deferral of certain tax deductions until earnings outside of the United States are repatriated to the United States, as well as changes to U.S. Tax laws that may be enacted in the future, could impact the tax treatment of future foreign earnings. Should the scale of our international business activities expand, any changes in the U.S. Taxation of such activities could increase our worldwide effective tax rate and harm our future financial position and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may face exposure to foreign currency exchange rate fluctuations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">While we have historically transacted in U.S. Dollars with the majority of our customers and suppliers, we have transacted in some foreign currencies and may transact in more foreign currencies in the future. Accordingly, changes in the value of foreign currencies relative to the U.S. Dollar may affect our revenue and operating results. As a result of such foreign currency exchange rate fluctuations, it could be more difficult to detect underlying trends in our business and operating results. In addition, to the extent that fluctuations in currency exchange rates cause our operating results to differ from our expectations or the expectations of our investors, the trading price of our stock could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our ability to use net operating losses to offset future taxable income may be subject to certain limitations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, Legacy Hyperfine had federal net operating loss carryforwards (&#x201c;NOLs&#x201d;) to offset future taxable income of approximately $103.4 million, of which $12.1 million will begin to expire in 2034 if not utilized. Liminal had federal NOLs to offset future taxable income of approximately $12.3 million. A lack of future taxable income would adversely affect our ability to utilize these NOLs. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;), a corporation that undergoes an &#x201c;ownership change&#x201d; is subject to limitations on its ability to utilize its pre-change NOLs and other pre-change tax attributes (such as research tax credits) to offset post-change taxable income. For these purposes, an ownership change generally occurs where the equity ownership of one or more stockholders or groups of stockholders who owns at least 5% of a corporation&#x2019;s stock increases its ownership by more than 50 percentage points over its lowest ownership percentage within a three-year period (calculated on a rolling basis). Our existing NOLs may be subject to limitations arising out of previous ownership changes and we may be limited as to the amount that can be utilized each year as a result of such previous ownership changes, including the Business Combination and related transactions. In addition, future changes in our stock ownership, including future offerings, as well as other changes that may be outside of our control, could result in additional ownership changes under Section 382 of the Code. Our NOLs may also be impaired</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">under similar provisions of state law. We have recorded a full valuation allowance related to our NOLs and other deferred tax assets due to the uncertainty of the ultimate realization of the future benefits of those assets.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> In addition to the limitations discussed above under Sections 382 of the Code, the utilization of NOLs incurred in taxable years beginning after December 31, 2017, are subject to limitations adopted by the Tax Cuts and Jobs Act, as modified by the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;). Under the Tax Act, in general, NOLs generated in taxable years beginning after December 31, 2017 may offset no more than 80 percent of such year&#x2019;s taxable income and there is no ability for such NOLs to be carried back to a prior taxable year. The CARES Act modifies the Tax Act with respect to the Tax Act&#x2019;s limitation on the deduction of NOLs and provides that NOLs arising in taxable years beginning after December 31, 2017 and before January 1, 2021, may be carried back to each of the five taxable years preceding the tax year of such loss, but NOLs arising in taxable years beginning after December 31, 2020 may not be carried back. In addition, the CARES Act eliminates the limitation on the deduction of NOLs to 80 percent of current year taxable income for taxable years beginning before January 1, 2021. As a result of such limitation, we may be required to pay federal income tax in some future year notwithstanding that we had a net loss for all years in the aggregate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Healthcare Industry Shifts and Changing Regulations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are subject to extensive government regulation, which could restrict the development, marketing, sale and distribution of our products and could cause us to incur significant costs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our medical devices and associated services are subject to extensive pre-market and post-market regulation by the FDA and various other federal, state, local and foreign government authorities. Government regulation of medical devices is meant to assure their safety and effectiveness, and includes requirements for, among other things:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">design, development and manufacturing processes;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">labeling, content and language of instructions for use and storage;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product testing, nonclinical studies and clinical trials;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory clearances and approvals, including pre-market clearance or pre-market approval;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establishment registration, device listing and ongoing compliance with the QSR requirements;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">advertising and promotion;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">marketing, sales and distribution;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">conformity assessment procedures;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product traceability and record-keeping procedures;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">review of product complaints, complaint reporting, recalls and field safety corrective actions;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or serious injury;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">post-market studies (if applicable); and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product import and export.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The laws and regulations to which we and our products are subject are complex and subject to periodic changes. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Before a new medical device, or a significant modification of a medical device, including a new use of or claim for an existing product, can be marketed in the United States, we must first receive either 510(k) clearance or premarket approval (&#x201c;PMA&#x201d;) from the FDA, unless an exemption applies. In the 510(k) clearance process, the FDA must determine that a proposed device is &#x201c;substantially equivalent&#x201d; to a device legally on the market, known as a &#x201c;predicate&#x201d; device, with respect to intended use, technology and safety and effectiveness, in order to clear the proposed device for marketing. Clinical data is</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">sometimes required to support substantial equivalence. Legacy Hyperfine received 510(k) clearance from the FDA for its point-of-care MRI system in 2020. In addition, Legacy Hyperfine&#x2019;s proprietary BrainInsight product is a fully automated MR imaging post-processing medical software that is regulated as a picture archiving and communications system, which may include both hardware and software components, and which is classified by FDA as a Class II medical device. BrainInsight received 510(k) marketing clearance in January 2021 for use in automatic labeling, spatial measurement, and volumetric quantification of brain structures from a set of low-field MR images and to return annotated and segmented images, color overlays, and reports. More recently, in November 2021, Legacy Hyperfine received 510(k) clearance for its new advanced image reconstruction technology using deep learning.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be required to obtain a new 510(k) clearance or PMA approval for significant post-market modifications to our products, including any modifications made to the commercially marketed our devices. In addition, Liminal does not have any commercial products. When Liminal&#x2019;s products are marketed for clinical monitoring or therapeutic uses, they will be regulated by the FDA as medical devices. Because the products are still in development, it is presently unclear what level of risk the agency will assign to such products, what special controls may be imposed on such products (if any), and what regulatory requirements would be applicable to such products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Obtaining 510(k) clearance or PMA approval for medical devices can be expensive and time-consuming, and entails significant user fees, unless an exemption is available. The FDA&#x2019;s process for obtaining 510(k) clearance usually takes three to 12 months, but it can last longer. In the PMA approval process, the FDA must determine that a proposed device is safe and effective for its intended use based, in part, on extensive data, including but not limited to, technical, nonclinical, clinical trial, manufacturing and labeling data. The process for obtaining a PMA is more costly and uncertain and approval can take anywhere from at least one year to, in some cases, multiple years from the time the application is initially filed with the FDA. Modifications to products that are approved through a PMA application generally require further FDA approval. Some of our future products may require PMA approval. In addition, the FDA may demand that we obtain a PMA prior to marketing future changes of our existing products. Further, we may not be able to obtain additional 510(k) clearances or PMAs for new products or for modifications to, or additional indications for, our products in a timely fashion or at all. Delays in obtaining future clearances or approvals could adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn could harm our revenue and future profitability.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In order to conduct a clinical investigation involving human subjects for the purpose of demonstrating the safety and effectiveness of a medical device, if necessary, for a PMA application or 510(k) notification, a company must, among other things, apply for and obtain institutional review board (&#x201c;IRB&#x201d;) approval of the proposed investigation. In addition, if the clinical study involves a &#x201c;significant risk&#x201d; (as defined by the FDA) to human health, the sponsor of the investigation must also submit and obtain FDA approval of an investigational device exemption (&#x201c;IDE&#x201d;) application and follow applicable IDE regulations. Unless IDE-exempt, nonsignificant risk devices are still subject to certain abbreviated IDE requirements, however, an IDE application is not required if such abbreviated requirements are met. We may not be able to obtain any necessary FDA and/or IRB approval to undertake clinical trials in the United States for future devices we develop and intend to market in the United States. If we do obtain such approvals, the FDA may find that our studies do not comply with the IDE or other regulations governing clinical investigations or the data from any such trials may not support clearance or approval of the investigational device. Moreover, certainty that clinical trials will meet desired endpoints, produce meaningful or useful data and be free of unexpected adverse effects, or that the FDA will accept the validity of foreign clinical study data (if applicable) cannot be assured, and such uncertainty could preclude or delay market clearance or authorizations resulting in significant financial costs and reduced revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are also subject to numerous post-marketing regulatory requirements, which include quality system regulations related to the manufacture of our devices, labeling regulations and medical device reporting (&#x201c;MDR&#x201d;) regulations. The last of these regulations requires us to report to the FDA if our devices cause or contribute to a death or serious injury, or malfunction in a way that would likely cause or contribute to a death or serious injury if the malfunction recurred. If we fail to comply with present or future regulatory requirements that are applicable to us, we may be subject to enforcement action by the FDA, which may include any of the following sanctions:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">customer notification, or orders for repair, replacement or refunds;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">voluntary or mandatory recall or seizure of our current or future products;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">administrative detention by the FDA of medical devices believed to be adulterated or misbranded;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">operating restrictions, suspension or shutdown of production;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">52</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">refusal of our requests for 510(k) clearance or PMA of new products, new intended uses or modifications to existing products;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">rescission of 510(k) clearance or suspension or withdrawal of PMAs that have already been granted; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">criminal prosecution.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The occurrence of any of these events may have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our employees, independent contractors, consultants, manufacturers and suppliers may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are exposed to the risk that our employees, independent contractors, consultants, manufacturers and suppliers may engage in fraudulent or illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violates: (i) the laws of the FDA and other similar foreign regulatory bodies, including those laws requiring the reporting of true, complete and accurate information to such regulators; (ii) manufacturing standards; (iii) healthcare fraud and abuse laws in the United States and similar foreign fraudulent misconduct laws; or (iv) laws that require the true, complete and accurate reporting of financial information or data. These laws may impact, among other things, future sales, marketing and education programs. In particular, the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commissions, certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We adopted a code of business conduct and ethics in connection with the Business Combination. It is not always possible to identify and deter misconduct by our employees and other third parties, and the precautions we take to detect and prevent these activities may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us and we are not successful in defending ourselves or asserting our rights, those actions could result in the imposition of significant fines or other sanctions, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, disgorgement, individual imprisonment, additional integrity reporting and oversight obligations, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings and curtailment of operations, any of which could adversely affect our ability to operate our business and our results of operations. Whether or not we are successful in defending against any such actions or investigations, we could incur substantial costs, including legal fees, and divert the attention of management in defending ourselves against any of these claims or investigations, which could have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">There is no guarantee that the FDA will grant 510(k) clearance or PMA approval of our future products, and failure to obtain necessary clearances or approvals for our future products would adversely affect our ability to grow our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Some of our new or modified products will require FDA clearance of a 510(k) notification or FDA approval of a PMA application. The FDA may refuse our requests for 510(k) clearance or PMA of new products or may not clear or approve these products for the indications that are necessary or desirable for successful commercialization. Early stage review may also result in delays or other issues. For example, the FDA has issued guidance intended to explain the procedures and criteria used in assessing whether 510(k) and PMA submissions should be accepted for substantive review. Under the &#x201c;Refuse to Accept&#x201d; guidance, the FDA conducts an early review against specific acceptance criteria to inform 510(k) and PMA submitters if the submission is administratively complete, or if not, to identify the missing element(s). Submitters are given the opportunity to provide the FDA with any information identified as missing. If the information is not provided within a specified time, the submission will not be accepted for FDA review. The FDA may also change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions that may prevent or delay approval or clearance of our products under development or impact our ability to gain clearance or approval for modifications to our currently approved or cleared products in a timely manner. Significant delays in receiving clearance or approval, or the failure to receive clearance or approval for our new products would have an adverse effect on our ability to expand our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent initiatives by the FDA to enhance and modernize various regulatory pathways for device products and its overall approach to safety and innovation in the medical technology industry creates the possibility of changing product development costs, requirements, and other factors and additional uncertainty for our future products and business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Regulatory requirements may change in the future in a way that adversely affects us. Any change in the laws or regulations that govern the clearance and approval processes or the post-market compliance requirements relating to our current and future products could make it more difficult and costly to obtain clearance or approval for new products, or to produce, market and distribute existing products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For example, the FDA and other government agencies have been focusing on the cybersecurity risks associated with certain medical devices and encouraging device manufacturers to take a more proactive approach to assessing the cybersecurity risks of their devices both during development and on a periodic basis after the devices are in commercial distribution. These regulatory efforts could lead to new FDA requirements in the future or additional product liability or other litigation risks if any of our products is considered to be susceptible to third-party tampering. In December 2016, Congress passed the 21st Century Cures Act, which made multiple changes to the FDA&#x2019;s rules for medical devices as well as for clinical trials, and in August 2017, Congress passed the Medical Device User Fee reauthorization package, which affects medical device regulation both pre- and post-approval and could have certain impacts on our business. Since that time, the FDA has announced a series of efforts to modernize and streamline the 510(k) notification and regulatory review process and monitoring post-market safety, and issued a final rule to formalize the De Novo classification process to provide clarity to innovative device developers. Changes in the FDA 510(k) process could make clearance more difficult to obtain, increase delay, add uncertainty and have other significant adverse effects on our ability to obtain and maintain clearance for our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">It is unclear at this time whether and how various activities initiated or announced by the FDA to modernize the U.S. medical device regulatory system could affect our business, as some of the FDA&#x2019;s new medical device safety and innovation initiatives have not been formalized and remain subject to change. For example, a 2018 Medical Device Safety Action Plan announced by former FDA Commissioner Gottlieb included a particular focus on post-market surveillance and how to respond when new safety concerns emerge once a product is on the market. The increased attention that the medical technology industry is receiving from FDA leadership that understands the challenging and rapidly changing nature of the U.S. healthcare system creates the possibility of unanticipated regulatory and other potential changes to our products and our overall business. In response to the COVID-19 public health emergency, the FDA&#x2019;s device and diagnostic center leadership has exercised a significant amount of enforcement discretion to meet the medical community&#x2019;s and patients&#x2019; needs for remote monitoring and other innovative solutions that involve digital health products. In December 2021, FDA issued draft guidance documents describing a phased transition process for medical devices that were developed or modified during the course of the pandemic to treat COVID-19 patients or allow greater access to patients, including medical imaging devices that were developed or modified in accordance with FDA&#x2019;s </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Enforcement Policy for Imaging Systems During the COVID-19 Public Health Emergency</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. It is unclear how these policies could impact the medical device industry in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we fail to obtain regulatory authorizations in other countries for existing products or products under development, we will not be able to commercialize these products in those countries.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In order for us to market our products in countries outside of the United States, we must comply with extensive safety and quality regulations in other countries regarding the quality, safety and efficacy of our products. These regulations, including the requirements for marketing authorizations, and the time required for regulatory review, vary from country to country. Failure to obtain regulatory authorization in any foreign country in which we plan to market our products may harm our ability to generate revenue and harm our business. Marketing authorization requirements vary between countries and can involve additional product testing and additional administrative review periods. The time required to obtain marketing authorization in other countries might differ from that required to obtain FDA clearance or other marketing authorization. The regulatory process in other countries may include all of the risks detailed above regarding FDA clearance in the United States. Regulatory authorization of a product in one country does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory authorization in one country may negatively impact the regulatory process in others. Failure to obtain regulatory authorization in other countries or any delay or setback in obtaining such authorization could have the same adverse effects described above regarding FDA clearance in the United States.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The primary regulatory environment in Europe is that of the European Economic Area (&#x201c;EEA&#x201d;), which is comprised of the Member States of the European Union, Iceland, Liechtenstein and Norway. We cannot be certain that we will be successful in meeting and continuing to meet the requirements to market a medical device in the EEA in light of the current transition period between the prior system, called the Medical Device Directive (&#x201c;MDD&#x201d;), to the current system, called the Medical Device Regulation. The Medical Device Regulation went into force in May 2017 but allowed a three-year transition period</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">54</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">until May 2020 for Member States, regulatory authorities, and medical device stakeholders to come into compliance with the new requirements. A one-year delay of the compliance date of the Medical Device Regulation was implemented in response to the COVID-19 pandemic, which made May 2021 the final deadline for industry compliance. Compared to the MDD, the Medical Device Regulation promotes a shift from the pre-approval stage (i.e., the path to CE Marking) to a life-cycle approach and places greater emphasis on clinical data and clinical evaluations to assure the safety and performance of new medical devices. Moreover, the Medical Device Regulation includes elements intended to strengthen the conformity assessment procedures, assert greater control over notified bodies and their standards, increase overall system transparency, and impose more robust device vigilance requirements on manufacturers and distributors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Among other changes, many device manufacturers will need to switch notified bodies to one that has received its designation under the Medical Device Regulation, which will require those manufacturers to undergo an audit and have all their documentation reviewed by the new notified body before it can assess their medical device products under the new standards. The new rules and procedures that have been created under the overhauled European regulations will likely result in increased regulatory oversight of all medical devices marketed in the European Union, and this may, in turn, increase the costs, time and requirements that need to be met in order to place an innovative or high-risk medical device on the EEA market.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we, our current or future contract manufacturers, or our current or future component suppliers are unable to manufacture our products in sufficient quantities, on a timely basis, at acceptable costs and in compliance with regulatory and quality requirements, the manufacturing and distribution of our devices could be interrupted, and our product sales and operating results could suffer.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">When producing and distributing commercial medical device products, we, our contract manufacturer, and our component suppliers are required to comply with the FDA&#x2019;s Quality System Regulation (&#x201c;QSR&#x201d;), which is a complex regulatory framework that covers the procedures and documentation of the design, testing, production, control, quality assurance, labeling, packaging, sterilization, storage, shipping and servicing of our devices. Compliance with applicable regulatory requirements is subject to continual review and is monitored rigorously through periodic, sometimes unannounced, inspections by the FDA. We cannot assure investors that our facilities or our third-party manufacturers&#x2019; or suppliers&#x2019; facilities would pass any future quality system inspection. Failure of us or our third-party manufacturers and component suppliers to adhere to QSR requirements or take adequate and timely corrective action in response to an adverse quality system inspection finding could delay production of our products and lead to fines, difficulties in obtaining regulatory clearances, recalls, enforcement actions, including injunctive relief or consent decrees, or other consequences, which could have a material adverse effect on our business, financial condition or results of operations. Any such failure, including the failure of our current or any future contract manufacturers, to achieve and maintain the required high manufacturing standards could result in further delays or failures in product testing or delivery, cost overruns, increased warranty costs or other problems that could harm our business and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, any of our products shipped internationally are also required to comply with the International Organization for Standardization (&#x201c;ISO&#x201d;) quality system standards as well as European Directives and norms in order to produce products for sale in the European Union. In addition, many countries such as Canada and Japan have very specific additional regulatory requirements for quality assurance and manufacturing. If we fail to continue to comply with current good manufacturing requirements, as well as ISO or other regulatory standards, we may be required to cease all or part of our operations until we comply with these regulations. Maintaining compliance with multiple regulators adds complexity and cost to our manufacturing and compliance processes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our current or future products may be subject to product recalls even after receiving FDA clearance or approval. A recall of our products, either voluntarily or at the direction of the FDA, or the discovery of serious safety issues with our products, could have a significant adverse impact on us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA and similar governmental bodies in other countries have the authority to require the recall of our products if we or our third party manufacturers fail to comply with relevant regulations pertaining to, among other things, manufacturing practices, labeling, advertising or promotional activities, or if new information is obtained concerning the safety or efficacy of these products. For example, under the FDA&#x2019;s Medical Device Reporting regulations, we are required to report to the FDA any incident in which our marketed products may have caused or contributed to a death or serious injury or in which our marketed products malfunctioned in a manner likely to cause or contribute to death or serious injury if that malfunction were to recur. Repeated adverse events or product malfunctions may result in a voluntary or involuntary product recall, or administrative or judicial seizure or injunction, when warranted. A government-mandated recall may be ordered if the FDA finds that there is a reasonable probability that the device would cause serious, adverse health consequences or death. A voluntary recall by us could occur as a result of any material deficiency in a device, such as manufacturing defects, labeling</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">55</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">deficiencies, packaging defects or other failures to comply with applicable regulations. In general, if we decide to make a change to our marketed product, we are responsible for determining whether to classify the change as a recall. It is possible that the FDA could disagree with our initial classification. The FDA requires that certain classifications of recalls be reported to the FDA within 10 working days after the recall is initiated. If a change to a device addresses a violation of the federal Food, Drug, and Cosmetic Act (&#x201c;FDCA&#x201d;), that change would generally constitute a medical device recall and require submission of a recall report to the FDA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Recalls of any of our products would divert managerial and financial resources and have an adverse effect on our reputation, results of operations and financial condition, which could impair our ability to produce our products in a cost-effective and timely manner in order to meet our customers&#x2019; demands. We may also be subject to product liability claims, be required to bear other costs, or be required to take other actions that may have a negative impact on our future sales and our ability to generate profits. Companies are required to maintain certain records of recalls, even if they are not reportable to the FDA. We may initiate voluntary recalls involving our products in the future that we determine do not require notification to the FDA. If the FDA disagrees with our determinations, the FDA could require us to report those actions as recalls. A future recall, withdrawal, or seizure of any product could materially and adversely affect consumer confidence in our brands, lead to decreased demand for our products and negatively affect our sales. In addition, the FDA could take enforcement action for failing to report recalls when they were conducted by us or one of our agents.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may be subject to enforcement action if we engage in improper or off-label marketing or promotion of our commercial medical device products, including fines, penalties and injunctions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our promotional materials and training methods must comply with FDA and other applicable laws and regulations, including the prohibition of the promotion of unapproved, or off-label, uses of lawfully marketed medical device products. Physicians may, however, use our commercial products off-label, as the FDA does not restrict or regulate a physician&#x2019;s practice of medicine. Medical device manufacturers and distributors are permitted to promote their products in a way that is consistent with the FDA-authorized labeling and indications for use. However, if the FDA determines that our promotional materials or training materials promote a 510(k)-cleared or approved medical device in a manner inconsistent with our labeling, the agency could request that we modify our training or promotional materials or subject us to regulatory or enforcement actions, including the issuance of an Untitled Letter, a Warning Letter, injunction, seizure, civil fine or criminal penalties. In addition to ensuring that the claims we make are consistent with our regulatory clearances or approvals, the FDA also ensures that promotional labeling for all regulated medical devices is neither false nor misleading.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our promotional or training materials to constitute promotion of an off-label use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement. In that event, our reputation could be damaged, and adoption of our products could be impaired. Although our policy is to refrain from making statements or from disseminating promotional material that could be considered off-label promotion of our commercial medical device products, the FDA or another regulatory agency could disagree and conclude that we have engaged in off-label promotion. In addition, the off-label use of our products may increase the risk of product liability claims. Product liability claims are expensive to defend and could divert our management&#x2019;s attention, result in substantial damage awards against us, and harm our reputation. Recent court decisions have impacted the FDA&#x2019;s enforcement activity regarding off-label promotion in light of First Amendment considerations, although there are still significant risks in this area in part due to the potential False Claims Act exposure. Further, this area is subject to ongoing policy changes at the federal level, resulting in some degree of uncertainty for regulated businesses. For example, in August 2021 the FDA issued a final rule revising the agency&#x2019;s regulation governing the types of evidence relevant to determining the &#x201c;intended use&#x201d; of a drug or device under the FDCA, which has significant implications for when a manufacturer or distributor has engaged in off-label marketing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Digital marketing and social media efforts may expose us to additional regulatory scrutiny, including from the Federal Trade Commission (the &#x201c;FTC&#x201d;) and other consumer protection agencies and regulators.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to the laws and regulations enforced by the FDA, advertising for various services and for non-restricted medical devices is subject to federal truth-in-advertising laws enforced by the FTC, as well as comparable state consumer protection laws. Our efforts to promote prescription medical device products via social media initiatives may subject us to additional scrutiny of our practices. For example, the FTC and other consumer protection agencies scrutinize all forms of advertising (whether in digital or traditional formats) for business services, consumer-directed products, and non-restricted medical devices to ensure that advertisers are not making false, misleading or unsubstantiated claims or failing to disclose material relationships between the advertiser and its products&#x2019; endorsers, among other potential issues. The FDA oversees the advertising and promotional labeling for restricted medical devices and ensures, among other things, that there is effective communication of, and a fair and balanced presentation of, the risks and benefits of such high-risk medical devices.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the Federal Trade Commission Act (&#x201c;FTC Act&#x201d;), the FTC is empowered, among other things, to (a) prevent unfair methods of competition and unfair or deceptive acts or practices in or affecting commerce; (b) seek monetary redress and other relief for conduct injurious to consumers; and (c) gather and compile information and conduct investigations relating to the organization, business, practices, and management of entities engaged in commerce. The FTC has very broad enforcement authority, and failure to abide by the substantive requirements of the FTC Act and other consumer protection laws can result in administrative or judicial penalties, including injunctions affecting the manner in which we would be able to market services or products in the future, or criminal prosecution. We plan to increase our advertising activities that may be subject to these federal and state truth-in-advertising laws. Any actual or perceived non-compliance with those laws could lead to an investigation by the FTC or a comparable state agency, or could lead to allegations of misleading advertising by private plaintiffs. Any such action against us could disrupt our business operations, cause damage to our reputation, and result in a material adverse effects on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Because we do not require extensive training for users of our current products, although they are limited under the FDA&#x2019;s marketing clearances to use by, and that images generated from the scanner be interpreted by, trained healthcare practitioners, there exists a potential for misuse of these products, misinterpretation of images by untrained professionals or misuse of these products by untrained professionals, which could ultimately harm our reputation and business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Federal regulations allow us to sell our medical device products to or on the order of practitioners licensed by law to use or order the use of a prescription device. The definition of &#x201c;licensed practitioners&#x201d; varies from state to state. As a result, our current products may be purchased or operated by physicians with varying levels of training and, in many states, by non-physicians, including nurse practitioners, chiropractors and technicians. The FDA clearances of the products require interpretation of images by trained physicians and use of that information in determining a diagnosis. Outside the United States, many jurisdictions do not require specific qualifications or training for purchasers, or operators or interpreters, of medical device products. We do not supervise the procedures performed with our products, nor can we require that direct medical supervision occur. Although product training is offered, we do not require purchasers or operators of our non-invasive products to attend training sessions. The lack of required training and the purchase and use of our non-invasive products by non-physicians may result in product misuse and adverse treatment outcomes, which could harm our reputation and expose us to costly product liability litigation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are subject to federal, state and foreign laws prohibiting &#x201c;kickbacks&#x201d; and false or fraudulent claims, and other fraud and abuse laws, transparency laws, and other healthcare laws and regulations, which, if violated, could subject us to substantial penalties. Additionally, any challenge to or investigation into our practices under these laws could cause adverse publicity and be costly to respond to, and thus could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our relationships with customers and third-party payors are subject to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain our sales, marketing and other promotional activities by limiting the kinds of financial arrangements, including sales programs and certain customer and product support programs, we may have with hospitals, physicians or other purchasers of medical devices. Other federal and state laws generally prohibit individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other third-party payors that are false or fraudulent, or are for items or services that were not provided as claimed. These laws include, among others, the federal healthcare Anti-Kickback Statute, the federal civil False Claims Act, other federal healthcare false statement and fraud statutes, the Open Payments program, the Civil Monetary Penalties Law, and analogous fraud and abuse and transparency laws in most states, as described in &#x201c;</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Item 1. Business -&#x2009;Government Regulation</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.&#x201d; Although the federal laws generally apply only to products or services for which payment may be made by a federal healthcare program, state laws often apply regardless of whether federal funds may be involved.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">While we believe and strive to ensure that our business arrangements with third parties and other activities and programs comply with all applicable laws, these laws are complex, and our activities may be found not to be compliant with one or more of these laws, which may result in significant civil, criminal and/or administrative penalties, fines, damages and exclusion from participation in federal healthcare programs. Even an unsuccessful challenge or investigation into our practices could cause adverse publicity, and be costly to respond to, and thus could have a material adverse effect on our business, financial condition and results of operations. Our compliance with Medicare and Medicaid regulations may be reviewed by federal or state agencies, including the Office of Inspector General for the U.S. Department of Health and Human Services (&#x201c;OIG&#x201d;), Centers for Medicare &amp; Medicaid Services (&#x201c;CMS&#x201d;), and the Department of Justice, or may be subject to whistleblower lawsuits under federal and state false claims laws. To ensure compliance with Medicare, Medicaid and other regulations, government agencies conduct periodic audits of the Company to ensure compliance with various supplier standards and billing requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Similarly, our international operations are subject to the provisions of the FCPA, which prohibits U.S. companies and their intermediaries from making payments in violation of law to non-U.S. government officials for the purpose of obtaining or retaining business or securing any other improper advantage. In many countries, the healthcare professionals that medical device distributors regularly interact with may meet the definition of a foreign official for purposes of the FCPA. International business operations are also subject to various other international anti-bribery laws such as the U.K. Anti-Bribery Act. Despite meaningful measures that we undertake to facilitate lawful conduct, which include training and compliance programs and internal policies and procedures, we may not always prevent unauthorized, reckless or criminal acts by our employees or agents, or employees or agents of businesses or operations we may acquire. Violations of these laws, or allegations of such violations, could disrupt operations, involve significant management distraction and have a material adverse effect on our business, financial condition and results of operations, among other adverse consequences.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are found to have violated laws protecting the confidentiality of health information, we could be subject to civil or criminal penalties, which could increase our liabilities and harm our reputation or our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are a number of federal and state laws protecting the confidentiality of certain health information and restricting the use and disclosure of that protected information. In particular, the U.S. Department of Health and Human Services promulgated privacy rules under the Health and Insurance Portability and Accountability Act (&#x201c;HIPAA&#x201d;). These privacy rules protect medical records and other personal health information by limiting their use and disclosure, giving individuals the right to access, amend and seek accounting of their own health information and limiting most use and disclosures of health information to the minimum amount reasonably necessary to accomplish the intended purpose. We are not subject to HIPAA, but our customers and research collaborators and other healthcare provider partners are, which means that there are restrictions on our ability to receive and use health information from our healthcare provider partners. If we are found to be in violation of applicable privacy rule requirements, we could subject our customers or healthcare provider partners to civil or criminal penalties, which could increase our liabilities, harm our reputation and have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are subject to complex and evolving U.S. and foreign laws and regulations regarding privacy, data protection, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in customer growth or engagement, or otherwise harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are subject to a variety of laws and regulations in the United States and abroad that involve matters central to our business, including laws and regulations relating to privacy, data sharing and data protection, artificial intelligence and use of machine learning, rights of publicity, content, intellectual property, advertising, marketing, distribution, data security, data retention and deletion, personal information, electronic contracts and other communications, competition, protection of minors, consumer protection, telecommunications, product liability, taxation, economic or other trade prohibitions or sanctions, corrupt practices, fraud, waste and abuse restrictions, and securities law compliance. The introduction of new products or expansion of our activities in certain jurisdictions may subject us to additional laws and regulations. For example, in addition to data protection laws passed by the federal government, many states and foreign countries have implemented their own data protection laws, some of which may apply simultaneously and conflict with federal law. Many of these laws create consumer rights including the right to know what personal information is collected, the right to know whether the data is sold or disclosed and to whom, the right to request that a company delete personal information collected, the right to opt-out of the sale of personal information and the right to non-discrimination in terms of price or service when a consumer exercises a privacy right. If we fail to comply with these regulations, we could be subject to civil sanctions, including fines and penalties for noncompliance.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, foreign data protection, privacy, and other laws and regulations can be more restrictive than those in the United States. Data localization laws in some countries generally mandate that certain types of data collected in a particular country be stored and/or processed within that country. We could be subject to audits in Europe and around the world, particularly in the areas of consumer and data protection, as we continue to grow and expand our operations. Legislators and regulators may make legal and regulatory changes, or interpret and apply existing laws, in ways that make our products less useful to customers, require us to incur substantial costs, expose us to unanticipated civil or criminal liability, or cause us to change our business practices. These changes or increased costs could negatively impact our business and results of operations in material ways. For example, the general data privacy regulation (&#x201c;GDPR&#x201d;) imposes requirements in the EEA relating to, among other things, consent to process personal data of individuals, the information provided to individuals regarding the processing of their personal data, the security and confidentiality of personal data, notifications in the event of data breaches and use of third party processors. If we fail to comply with these standards, we could be subject to criminal penalties and civil sanctions, including fines and penalties and amounts could be significant.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">58</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under federal or state law, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cyber incidents can result from deliberate attacks or unintentional events. We collect and store on our networks sensitive information, including intellectual property, proprietary business information and personally identifiable information of individuals, such as our employees and customers. The secure maintenance of this information and technology is critical to our business operations. As a pre-commercial company, Liminal&#x2019;s security infrastructure is evolving consistent with its business operations and security risk profile. Legacy Hyperfine has implemented multiple layers of security measures to protect the confidentiality, integrity and availability of these data and the systems and devices that store and transmit such data. Legacy Hyperfine utilizes current security technologies, including encryption and data depersonalization, and its defenses are monitored and routinely tested. Despite these efforts, threats from malicious persons and groups, new vulnerabilities and advanced new attacks against information systems create risk of cybersecurity incidents. These incidents can include, but are not limited to, gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and may not immediately produce signs of intrusion, we may be unable to anticipate these incidents or techniques, timely discover them, or implement adequate preventative measures.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cybersecurity threats can come from a variety of sources, and may range in sophistication from an individual hacker to malfeasance by employees, consultants or other service providers to state-sponsored attacks. Cyber threats may be generic, or they may be custom-crafted against our information systems. Over the past several years, cyber-attacks have become more prevalent and much harder to detect and defend against. Our network and storage applications, as well as those of our contractors, may be vulnerable to cyber-attack, malicious intrusion, malfeasance, loss of data privacy or other significant disruption and may be subject to unauthorized access by hackers, employees, consultants or other service providers. In addition, hardware, software or applications that we develop or procure from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise information security. Unauthorized parties may also attempt to gain access to our systems or facilities through fraud, trickery or other forms of deceiving employees, contractors and temporary staff.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There can be no assurance that we will not be subject to cybersecurity incidents that bypass our security measures, impact the integrity, availability or privacy of health information or other data subject to privacy laws or disrupt our information systems, devices or business, including our ability to deliver services to our users. As a result, cybersecurity, physical security and the continued development and enhancement of our controls, processes and practices designed to protect our enterprise, information systems and data from attack, damage or unauthorized access remain a priority for us. As cyber threats continue to evolve, we may be required to expend significant additional resources to continue to modify or enhance our protective measures or to investigate and remediate any cybersecurity vulnerabilities. The occurrence of any of these events could result in:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">harm to customers and end-users;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">business interruptions and delays;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the loss, misappropriation, corruption or unauthorized access of data;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">litigation, including potential class action litigation, and potential liability under privacy, security and consumer protection laws or other applicable laws;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">reputational damage;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">increase to insurance premiums; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">foreign, federal and state governmental inquiries, any of which could have a material, adverse effect on our financial position and results of operations and harm our business reputation.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Security breaches, loss of data and other disruptions could compromise sensitive information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the ordinary course of our business, we collect and store sensitive data, and intellectual property and proprietary business information owned or controlled by us or our users. This data encompasses a wide variety of business-critical information, including research and development information, commercial information, and business and financial information. We face four primary risks relative to protecting this critical information: loss of access; inappropriate disclosure; inappropriate modification; and inadequate monitoring of our controls over the first three risks.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The secure processing, storage, maintenance, and transmission of this critical information is vital to our operations and business strategy, and we devote significant resources to protecting such information. Although we take measures to protect sensitive information from unauthorized access or disclosure, our information technology and infrastructure may be vulnerable to attacks by hackers or viruses, breaches, interruptions due to employee error, malfeasance, lapses in compliance with privacy and security mandates, or other disruptions. Any such breach or interruption could compromise our networks and the information stored there could be accessed by unauthorized parties, publicly disclosed, lost, or stolen.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any such security breach or interruption, as well as any action by us or our employees or contractors that might be inconsistent with the rapidly evolving data privacy and security laws and regulations applicable within the United States and elsewhere where we conduct business, could result in enforcement actions by U.S. states, the U.S. federal government or foreign governments, liability or sanctions under data privacy laws that protect personally identifiable information, regulatory penalties, other legal proceedings such as but not limited to private litigation, the incurrence of significant remediation costs, disruptions to our development programs, business operations and collaborations, diversion of management efforts and damage to us and our brands&#x2019; reputation, which could harm our business and operations. Because of the rapidly moving nature of technology and the increasing sophistication of cybersecurity threats, our measures to prevent, respond to and minimize such risks may be unsuccessful.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">With respect to medical information, we follow HIPAA guidelines when applicable and separate personal information from medical information, and employ additional measures such as encryption tools to protect the privacy of our users and medical data. However, hackers may attempt to penetrate our computer systems, and, if successful, misappropriate personal or confidential business information. In addition, an associate, contractor or other third party with whom we do business may attempt to circumvent our security measures in order to obtain such information, and may purposefully or inadvertently cause a breach involving such information. While we continue to implement additional protective measures to reduce the risk of and detect cyber incidents, cyber-attacks are becoming more sophisticated and frequent, and the techniques used in such attacks change rapidly.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the European Parliament and the Council of the European Union adopted the comprehensive GDPR in 2016 to replace the current European Union Data Protection Directive and related country-specific legislation. The GDPR took effect in May 2018 and governs the collection and use of personal data in the European Union. The GDPR, which is wide-ranging in scope, imposes requirements relating to the consent of the individuals to whom the personal data relates, the information provided to the individuals, the security and confidentiality of the personal data, data breach notification and the use of third party processors in connection with the processing of the personal data. The GDPR also imposes strict rules on the transfer of personal data out of the European Union to the United States, enhances enforcement authority and imposes large penalties for noncompliance, including the potential for fines of up to &#x20ac;20 million or 4% of the annual global revenues of the infringer, whichever is greater. While we comply with the GDPR, including reviewing our security procedures and entering into data processing agreements with relevant contractors, there can be no assurance that as our operations evolve, our efforts to comply or to remain in compliance will be fully successful.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, unauthorized access, loss or dissemination of sensitive personal data, such as health information, could also disrupt our operations, including our ability to conduct research and development activities, process and prepare company financial information, manage various general and administrative aspects of our business and damage our reputation, any of which could adversely affect our business and reputation. In addition, there can be no assurance that we will promptly detect any such disruption or security breach, if at all. To the extent that any disruption or security breach were to result in a loss of or damage to our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability and the further development of our products could be delayed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Broad-based domestic and international government initiatives to reduce spending, particularly those related to healthcare costs, may reduce reimbursement rates for medical procedures, which will reduce the cost-effectiveness of our products and services.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Healthcare reforms, changes in healthcare policies and changes to third-party coverage and reimbursements, including legislation enacted reforming the U.S. healthcare system and both domestic and foreign healthcare cost containment legislation, and any future changes to such legislation, may affect demand for our products and services and may have a material adverse effect on our financial condition and results of operations. The ongoing implementation of the Affordable Care Act, in the United States, as well as state-level healthcare reform proposals could reduce medical procedure volumes and impact the demand for medical device products or the prices at which we can sell products. These reforms include a national pilot program on payment bundling to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain healthcare services through bundled payment models. The impact of this healthcare reform legislation, and practices including price regulation, competitive pricing, comparative effectiveness of therapies, technology assessments, and managed care arrangements are uncertain. There can be no assurance that current levels of reimbursement will not be decreased in the future, or that future legislation, regulation, or reimbursement policies of third parties will not adversely affect the demand for our products and services or our ability to sell products and provide services on a profitable basis. The adoption of significant changes to the healthcare system in the United States, the EEA or other jurisdictions in which we may market our products and services, could limit the prices we are able to charge for our products and services or the amounts of reimbursement available for our products and services, could limit the acceptance and availability of our products and services, reduce medical procedure volumes and increase operational and other costs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, following judicial and Congressional challenges to certain aspects of the Affordable Care Act, certain sections of the Affordable Care Act, as a result, have not been fully implemented or were effectively repealed. However, following several years of litigation in the federal courts, in June 2021, the U.S. Supreme Court upheld the Affordable Care Act when it dismissed a legal challenge to the constitutionality of the Affordable Care Act. Further legislative and regulatory changes under the Affordable Care Act remain possible, although the new Democrat-led presidential administration has been taking steps to strengthen the Affordable Care Act and the 117th Congress is not expected to have the same interest in repealing the law, in part due to the healthcare economic impacts of the ongoing COVID-19 pandemic. In addition to the Affordable Care Act, there have been and will likely continue to be other federal and state changes that affect the provision of healthcare goods and services in the United States. While we are unable to predict what changes may ultimately be enacted, to the extent that future changes affect how our products and services are paid for and reimbursed by government and private payers, our business could be adversely impacted. Moreover, complying with any new legislation or reversing changes implemented under the Affordable Care Act could be time-intensive and expensive, resulting in a material adverse effect on the business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to our Intellectual Property</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to obtain and maintain and enforce sufficient intellectual property protection for our products and technology, or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize products similar or identical to ours, and our ability to successfully commercialize our products may be impaired.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely on patent protection as well as trademark, copyright, trade secret and other intellectual property right protection and contractual restrictions to protect our proprietary products and technologies, all of which provide limited protection and may not adequately protect our rights or permit us to gain or keep any competitive advantage. If we fail to obtain, maintain and sufficiently enforce our intellectual property, third parties may be able to compete more effectively against us. In addition, we may incur substantial litigation costs in our attempts to recover damages or restrict use of our intellectual property.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent our intellectual property offers inadequate protection, or is found to be invalid or unenforceable, we would be exposed to a greater risk of direct competition. If our intellectual property does not provide adequate coverage against our competitors&#x2019; products, our competitive position could be adversely affected, as could our business, financial condition, results of operations and prospects. Both the patent application process and the process of managing patent and other intellectual property disputes can be time-consuming and expensive.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our success depends in large part on our and our licensors&#x2019; ability to obtain and maintain protection of the intellectual property we may own solely or jointly with, or license from, third parties, particularly patents, in the United States and other countries directed to our products and technologies. We apply for patents covering our products and technologies and uses thereof, as we deem appropriate. However, obtaining and enforcing patents is costly, time-consuming and complex, and we may fail to apply for patents on important products and technologies in a timely fashion or at all, or we may fail to apply for patents in potentially relevant jurisdictions. We may not be able to file and prosecute all necessary or desirable patent applications, or maintain, enforce and license any patents that may issue from such patent applications, at a reasonable cost or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">in a timely manner or in all jurisdictions. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. Moreover, we may not develop additional proprietary products, methods and technologies that are patentable. We may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the rights to patents licensed from or to third parties. Therefore, these patents and applications may not be prosecuted, obtained and enforced by such third parties in a manner consistent with the best interests of our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the patent position of life sciences and medical technology companies generally is highly uncertain, involves complex legal and factual questions, and has been the subject of much litigation in recent years. Changes in either the patent laws or in interpretations of patent laws in the United States or other countries or regions may diminish the value of our intellectual property. As a result, the issuance, scope, validity, enforceability, and commercial value of our patent rights presents some degree of uncertainty. It is possible that some of our pending patent applications will not result in issued patents in a timely fashion or at all, and even if patents are granted, they may not provide a basis for intellectual property protection of commercially viable products or services, may not provide any competitive advantages, or may be challenged, narrowed and/or invalidated by third parties. There exists some degree of uncertainty over the breadth of claims that may be allowed or enforced in our patents or in third-party patents. It is possible that third parties will attempt to design around our current or future patents such that we cannot prevent such third parties from using similar technologies and commercializing similar products to compete with us. Some of our owned or licensed patents or patent applications may be challenged at a future point in time and we may not be successful in defending any such challenges made against our patents or patent applications. Any successful third-party challenge to our patents could result in the narrowing, unenforceability or invalidity of such patents and increased competition to our business. The outcome of patent litigation or other proceedings can be uncertain, and any attempt by us to enforce our patent rights against others or to challenge the patent rights of others may not be successful, or, regardless of success, may take substantial time and result in substantial cost, and may divert our efforts and attention from other aspects of our business. Any of the foregoing events could have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The U.S. law relating to the patentability of certain inventions in the life sciences and medical technology industry is uncertain and rapidly changing, which may adversely impact our existing patents or our ability to obtain patents in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes in either the patent laws or interpretation of the patent laws in the United States or in other jurisdictions could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. For instance, under the Leahy-Smith America Invents Act (the &#x201c;America Invents Act&#x201d;), enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a patent application is entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. These changes include allowing third-party submission of prior art to the United States Patent and Trademark Office (&#x201c;USPTO&#x201d;) during patent prosecution and additional procedures to challenge the validity of a patent through USPTO administered post-grant proceedings, including post-grant review, inter partes review, and derivation proceedings. The America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Various courts, including the U.S. Supreme Court, have rendered decisions that impact the scope of patentability of certain inventions or discoveries relating to life sciences and medical technology. Specifically, these decisions stand for the proposition that patent claims that recite laws of nature, natural phenomena, and abstract ideas are not themselves patentable unless those patent claims have sufficient additional features that provide practical assurance that the processes are genuine inventive applications of those laws, phenomena, and abstract ideas rather than patent drafting efforts designed to monopolize the law of nature, natural phenomenon, or abstract idea itself. What constitutes a &#x201c;sufficient&#x201d; additional feature is somewhat uncertain. Furthermore, in view of these decisions, since December 2014, the USPTO has published and continues to publish revised guidelines for patent examiners to apply when examining process claims for patent eligibility.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to some degree of uncertainty with regard to Company&#x2019;s ability to obtain patents in the future, this combination of events has created a degree of uncertainty with respect to the value of patents, once obtained. Depending on relevant laws enacted by the U.S. Congress, and decisions by the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that may have a material adverse effect on our ability to obtain new patents and to defend and enforce our existing patents and patents that we might obtain in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our patent portfolio may be negatively impacted by current uncertainties in the state of the law, new court rulings or changes in guidance or procedures issued by the USPTO or other similar patent offices around the world. From time to time, the U.S. Supreme Court, other federal courts, the U.S. Congress or the USPTO may change the standards of patentability, scope and validity of patents within the life sciences and medical technology and any such changes, or any similar adverse changes in the patent laws of other jurisdictions, could have a negative impact on our business, financial condition, prospects and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be able to protect our intellectual property rights throughout the world.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The laws of some foreign countries do not offer intellectual property rights to the same extent as the laws of the United States, and we and our licensors may encounter difficulties in obtaining, enforcing and defending such rights in foreign jurisdictions. Consequently, we and our licensors may not be able to prevent third parties from practicing our or our licensors&#x2019; inventions in some or all countries outside the United States, or from selling or importing products made using our or our licensors&#x2019; inventions in other jurisdictions. Competitors and other third parties may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and technologies and may also export infringing products to territories where we have patent protection, but enforcement practices or laws are not as strong as those in the United States. These products may compete with our products. Our and our licensors&#x2019; patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. In addition, certain countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to other parties. Furthermore, many countries limit the enforceability of patents against other parties, including government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of any patents.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain other countries are not as developed or as favorable as the United States in the enforcement of patents and other intellectual property rights, which could make it difficult for us to stop the misappropriation or other violations of our intellectual property rights including infringement of our patents in such countries. The legal systems in certain countries may also favor state-sponsored companies or companies headquartered in particular jurisdictions over our first-in-time patents and other intellectual property rights. The absence of harmonized intellectual property protection laws and effective enforcement makes it difficult to ensure consistent respect for patent, trade secret, and other intellectual property rights on a worldwide basis. As a result, it is possible that we will not be able to enforce our rights against third parties that misappropriate our proprietary technology in those countries.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceedings to enforce our or our licensors&#x2019; patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business, could put us and our licensors&#x2019; patents at risk of being invalidated or interpreted narrowly and our and our licensors&#x2019; patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We and our licensors may not prevail in any lawsuits that we or our licensors initiate, or that are initiated against us or our licensors, and the damages or other remedies awarded, if any, may not be commercially meaningful. In addition, changes in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain adequate protection for our products, services and other technologies and the enforcement of intellectual property. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. Any of the foregoing events could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Issued patents covering our products could be found invalid or unenforceable if challenged.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our owned and licensed patents and patent applications may be subject to validity, enforceability and priority disputes. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. Some of our patents or patent applications (including licensed patents and patent applications) may be challenged at a future point in time in opposition, derivation, reexamination, inter partes review, post-grant review or interference or other similar proceedings, as applicable. Any successful third-party challenge to our patents in this or any other proceeding could result in the unenforceability or invalidity of such patents, which may lead to increased competition to our business, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, if we or our licensors initiate legal proceedings against a third party to enforce a patent covering our products, the defendant could counterclaim that such patent covering our products, as applicable, is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. There are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent intentionally</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">63</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">withheld relevant information from the relevant patent office, or knowingly made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include ex parte re-examination, inter partes review, post-grant review, derivation and equivalent proceedings in non-U.S. jurisdictions, such as opposition proceedings. Such proceedings could result in revocation of or amendment to our patents in such a way that they no longer cover and protect our products. With respect to the validity of our patents, for example, we cannot be certain that there is no invalidating prior art of which we, our licensors, our patent counsel and the patent examiner were unaware during prosecution. The outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. If a defendant or other third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on certain aspects of our products and technologies, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license intellectual property, or develop or commercialize current or future products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may not be aware of all third-party intellectual property rights potentially relating to our products. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until approximately 18 months after filing or, in some cases, not until such patent applications issue as patents. We might not have been the first to make the inventions covered by each of our pending patent applications and we might not have been the first to file patent applications for these inventions. To determine the priority of these inventions, we may have to participate, as applicable, in interference proceedings, derivation proceedings or other post-grant proceedings declared by the USPTO, or other similar proceedings in non-U.S. jurisdictions that could result in substantial cost to us and the loss of valuable patent protection. The outcome of such proceedings is uncertain. No assurance can be given that other patent applications will not have priority over our patent applications. In addition, changes to the patent laws of the United States allow for various post-grant opposition proceedings that have not been extensively tested, and their outcome is therefore uncertain. Furthermore, if third parties bring these proceedings against our patents, regardless of the merit of such proceedings and regardless of whether we are successful, we could experience significant costs and our management may be distracted.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any of the foregoing events could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to protect the confidentiality of our trade secrets, the value of our technology could be materially adversely affected and our business could be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely heavily on trade secrets and confidentiality agreements to protect our unpatented know-how, technology and other confidential proprietary information, and to maintain our competitive position. However, trade secrets and know-how can be difficult to protect. In particular, we anticipate that with respect to our technologies, these trade secrets and know-how will over time be disseminated within the industry through independent development, the publication of journal articles describing the methodology, and the movement of personnel from academic to industry scientific positions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to pursuing patents on our technology, we take steps to protect our intellectual property and proprietary technology by entering into agreements, including confidentiality agreements, non-disclosure agreements and intellectual property assignment agreements, with our employees, consultants, academic institutions, corporate partners and, when needed, our advisers. However, we cannot be certain that such agreements have been entered into with all relevant parties, and we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed or that competitors or other third parties will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. For example, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Such agreements may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of unauthorized use or disclosure or other breaches of the agreements, and we may not be able to prevent such unauthorized disclosure, which could materially and adversely impact our ability to establish or maintain a competitive advantage in the market, and our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Monitoring unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or will be, adequate. If we were to enforce a claim that a third party had wrongfully obtained and was using our trade secrets, it would be expensive and time-consuming, it could distract our personnel, and the outcome would be unpredictable. In addition, courts outside the United States may be less willing to protect trade secrets or may not recognize certain claims of intellectual property infringement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">64</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also seek to preserve the integrity and confidentiality of our confidential proprietary information by maintaining physical security of our premises and physical and electronic security of our information technology systems, but it is possible that these security measures could be breached. If any of our confidential proprietary information were to be lawfully obtained or independently developed by a competitor or other third party, absent patent and copyright protection, we would have no right to prevent such competitor from using that technology or information to compete with us, which could harm our competitive position. Competitors or third parties could purchase our products and attempt to replicate some or all of the competitive advantages we derive from our development efforts, design around our protected technology, develop their own competitive technologies that fall outside the scope of our intellectual property rights or independently develop our technologies without reference to our trade secrets. If any of our trade secrets were to be disclosed to or independently discovered by a competitor or other third party, it could materially and adversely affect our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may be subject to claims challenging the inventorship and ownership of our patents and other intellectual property.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We or our licensors may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or in-licensed patents, trade secrets or other intellectual property as an inventor or co-inventor. For example, we or our licensors may have inventorship disputes arise from alleged inventors such as employees, consultants, advisors or others who are involved in developing our products, some of whom may have conflicting intellectual property ownership obligations. In addition, counterparties to our consulting, sponsored research, software development and other agreements may assert that they have an ownership interest in intellectual property developed under such arrangements. In particular, certain software development agreements pursuant to which certain third parties have developed parts of our proprietary software may not include provisions that expressly assign to us ownership of all intellectual property developed for us by such third parties. Furthermore, certain of our sponsored research agreements pursuant to which we provide certain research services for third parties do not assign to us all intellectual property developed under such agreements. As such, we may not have the right to use all such developed intellectual property under such agreements, we may be required to obtain licenses from third parties and such licenses may not be available on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to obtain such licenses and such licenses are necessary for the development, manufacture and commercialization of our products and technologies, we may need to cease the development, manufacture or commercialization of our products and technologies. Litigation may be necessary to defend against these and other claims challenging inventorship of our or our licensors&#x2019; ownership of our owned or in-licensed patents, trade secrets or other intellectual property. If we or our licensors fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. In such an event, we may be required to obtain licenses from third parties and such licenses may not be available on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to obtain and maintain such licenses, we may need to cease the development, manufacture or commercialization of our products and technologies. Even if we are successful in defending against such claims, litigation could result in substantial costs and loss of time and be a distraction to management and other employees, and certain customers or partners may defer engaging with us until the particular dispute is resolved. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be able to protect and enforce our trademarks and trade names, or build name recognition in our markets of interest thereby harming our competitive position.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registered or unregistered trademarks or trade names that we own may be challenged, infringed, circumvented, declared generic or otherwise fail to function as a mark, lapsed or determined to be confusingly similar to or dilutive of other marks. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition. In addition, third parties have filed, and may in the future file, for registration of trademarks similar or identical to our trademarks, thereby impeding our ability to build brand identity and possibly leading to consumer confusion. If such third parties were to succeed in registering or developing common law rights in any other trademarks that are similar or identical to our trademarks, and if we are not successful in challenging such rights and defending against challenges to Company&#x2019;s trademarks, we may not be able to use such trademarks to develop brand recognition of our technologies, products or services. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Further, we have and may in the future enter into agreements with owners of such third party trade names or trademarks to avoid potential trademark litigation which may limit our ability to use our trade names or trademarks in certain fields of business. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively, and our business, financial condition, results of operations and prospects may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">diversion of resources. Any of the foregoing events could have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent terms may be inadequate to protect our competitive position on our products for an adequate amount of time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a utility patent is generally 20 years from its earliest U.S. non-provisional filing date. While extensions may be available, the life of a patent, and the protection it affords, is limited. In the United States, a patent&#x2019;s term may, in certain cases, be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the USPTO in examining and granting a patent, or may be shortened if a patent is terminally disclaimed over a commonly owned patent or a patent naming a common inventor and having an earlier expiration date. Even if patents covering our products are obtained, once the patent life has expired, we may be open to competition from competitive products. If one of our products requires extended development, testing and/or regulatory review, patents protecting such products might expire before or shortly after such products are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to our products, which could have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed to us alleged trade secrets of their other clients or former employers, which could subject us to costly litigation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As is common in the life sciences and medical industry, we engage the services of consultants and independent contractors to assist us in the development of our products. Many of these consultants and independent contractors were previously employed at, or may have previously or may be currently providing consulting or other services to, universities or other technology, biotechnology or pharmaceutical companies, including our competitors or potential competitors. We may become subject to claims that we, a consultant or an independent contractor inadvertently or otherwise used or disclosed trade secrets or other information proprietary to their former employers or their former or current clients. We may similarly be subject to claims stemming from similar actions of an employee, such as one who was previously employed by another company, including a competitor or potential competitor. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to our management team. If we are not successful we could lose access or exclusive access to valuable intellectual property.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may become involved in lawsuits to defend against third-party claims of infringement, misappropriation or other violations of intellectual property rights or to protect or enforce our intellectual property, any of which could be expensive, time consuming and unsuccessful, and may prevent or delay our development and commercialization efforts.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our commercial success depends in part on our ability and the ability of future collaborators to develop, manufacture, market and sell our product and use our products and technologies without infringing, misappropriating or otherwise violating the intellectual property rights of third parties. There is a substantial amount of litigation involving patents and other intellectual property rights in the life sciences and medical technology sector, as well as administrative proceedings for challenging patents, including interference, derivation, inter partes review, post grant review, and reexamination proceedings before the USPTO, or oppositions and other comparable proceedings in foreign jurisdictions. We may be exposed to, or threatened with, future litigation by third parties having patent or other intellectual property rights alleging that our products, manufacturing methods, software and/or technologies infringe, misappropriate or otherwise violate their intellectual property rights. Numerous issued patents and pending patent applications that are owned by third parties exist in the fields in which we are developing our products and technologies. It is not always clear to industry participants, including us, the claim scope that may issue from pending patent applications owned by third parties or which patents cover various types of products, technologies or their methods of use or manufacture. Thus, because of the large number of patents issued and patent applications filed in our fields, there may be a risk that third parties, including our competitors, may allege they have patent rights encompassing our products, technologies or methods and that we are employing technology protected by such patent rights without authorization.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If third parties, including our competitors, believe that our products or technologies infringe, misappropriate or otherwise violate their intellectual property rights, such third parties may seek to enforce against us their intellectual property rights, including patent rights, by filing against us an intellectual property-related lawsuit, including a patent infringement lawsuit. Even if we believe third-party intellectual property claims are without merit, there is no assurance that a court would find in our favor on questions of infringement, validity, enforceability, or priority. If any third parties were to assert these or any other patents against us and we are unable to successfully defend against any such assertions, we may be required, including by court order, to cease the development and commercialization of the infringing products or technology and we may be required to redesign such products and technologies so they do not infringe such patents, which may not be possible or may require substantial monetary expenditures and time. We could also be required to pay damages, which could be significant,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">66</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">including treble damages and attorneys&#x2019; fees if we are found to have willfully infringed such patents. We could also be required to obtain a license to such patents in order to continue the development and commercialization of the infringing product or technology. However, such a license may not be available on commercially reasonable terms or at all, including because certain of these patents may be held by or exclusively licensed to our competitors. Even if such a license were available, it may require substantial payments or cross-licenses under our intellectual property rights, and it may only be available on a nonexclusive basis, in which case third parties, including our competitors, could use the same licensed intellectual property to compete with us. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operation and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may choose to challenge, including in connection with any allegation of patent infringement by a third party, the patentability, validity, ownership or enforceability of any third-party patent that we believe may have applicability in our field, and any other third-party patent that may at some future time possibly be asserted against us. Such challenges may be brought either in court or by requesting that the USPTO, European Patent Office (&#x201c;EPO&#x201d;), or other foreign patent offices review the patent claims, such as in an ex-parte reexamination, inter partes review, post-grant review proceeding or opposition proceeding or other similar proceedings. However, there can be no assurance that any such challenge by us or any third party will be successful. Even if such proceedings are successful, these proceedings are expensive and may consume our time or other resources, distract our management and technical personnel, and the costs of these opposition proceedings could be substantial. There can be no assurance that our defenses of non-infringement, invalidity or unenforceability will succeed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third parties, including our competitors, could be infringing, misappropriating or otherwise violating our solely owned and/or in-licensed intellectual property rights. Monitoring unauthorized use of intellectual property is difficult and costly. We may not be able to detect unauthorized use of, or take appropriate steps to enforce, our intellectual property rights. From time to time, we seek to analyze our competitors&#x2019; products and services, and may in the future seek to enforce our rights based on potential infringement, misappropriation or violation of our intellectual property. However, the steps we take to protect our intellectual property rights may not be adequate to enforce our rights against such infringement, misappropriation or violation of our intellectual property. Any inability to meaningfully enforce our intellectual property rights could harm our ability to compete and reduce demand for our products and technologies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Litigation proceedings may be necessary for us to enforce our patent and other intellectual property rights. In any such proceeding, a court may refuse to stop the other party from using the technology at issue on the grounds that our owned and in-licensed patents do not cover the technology in question. Further, in such a proceeding, the defendant could counterclaim that our intellectual property is invalid or unenforceable and the court may agree, in which case we could lose valuable intellectual property rights, which could allow third parties to commercialize technology or products similar to ours and compete directly with us, without payment to us. Alternatively or additionally such a proceeding could result in requiring us to license rights from the prevailing party in order to be able to manufacture or commercialize our products without infringing such party&#x2019;s intellectual property rights, and if we are unable to obtain such a license, we may be required to cease commercialization of our products and technologies, any of which could have a material adverse effect on our business, financial condition, results of operations and prospects. The outcome in any such proceeding is somewhat unpredictable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Regardless of whether we are defending against or asserting an intellectual property-related claim in an intellectual property-related proceeding that may be necessary in the future, and regardless of outcome, substantial costs and diversion of resources may result which could have a material adverse effect on our business, financial condition, results of operations and prospects. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our Class A common stock. Some of our competitors and other third parties may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. We may not have sufficient financial or other resources to adequately conduct these types of litigation or proceedings. Any of the foregoing, or any uncertainties resulting from the initiation and continuation of any litigation, could have a material adverse effect on our business, financial condition, results of operations and prospects. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">67</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Obtaining and maintaining our patent protection depends on compliance with various required procedures, document submissions, fee payments and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and/or applications will be due to be paid to the USPTO and various governmental patent agencies outside of the United States at several stages over the lifetime of the patents and/or applications. The USPTO and various non-U.S. governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In certain circumstances, we rely on our licensors to pay these fees due to the U.S. and non-U.S. patent agencies and to take the necessary action to comply with these requirements with respect to our licensed intellectual property. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. However, there are situations in which non-compliance can result in an irrevocable abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors may be able to enter the market without infringing our patents and this circumstance could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We currently rely on licenses from third parties, and in the future may rely on additional licenses from other third parties, and if we lose any of these licenses, then we may be subjected to future litigation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are, and may in the future become, a party to license agreements that grant us rights to use certain intellectual property, including patents and patent applications, typically in certain specified fields of use. We may need to obtain additional licenses from others to advance our research, development and commercialization activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our success may depend in part on the ability of our licensors and any future licensors to obtain, maintain and enforce patent protection for our licensed intellectual property. Without protection for the intellectual property we license, other companies might be able to offer substantially identical products and technologies for sale, which could materially adversely affect our competitive business position and harm our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our current license agreements impose, and future agreements may impose, various diligence, commercialization, milestone payment, royalty, insurance and other obligations on us and require us to meet development timelines, or to exercise commercially reasonable efforts to develop and commercialize licensed products, in order to maintain the licenses. If we fail to comply with these obligations, our licensor(s) may have the right to terminate our license, in which event we would not be able to develop or market products or technology covered by the licensed intellectual property. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, disputes may also arise between us and our licensors regarding intellectual property subject to a license agreement, including:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope of rights granted under the license agreement and other interpretation-related issues;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our financial or other obligations under the license agreement;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">whether, and the extent to which, our products, technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our diligence obligations under the license agreement and what activities satisfy those diligence obligations;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensor(s); and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the priority of invention of patented technology.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we do not prevail in such disputes, we may lose any or all of our rights under such license agreements, experience significant delays in the development and commercialization of our products and technologies, or incur liability for damages, any of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. In addition, we may seek to obtain additional licenses from our licensor(s) and, in connection with obtaining such licenses, we may agree to amend our existing licenses in a manner that may be more favorable to the licensor(s), including by agreeing to terms that could enable third parties, including our competitors, to receive licenses to a portion of the intellectual property that is subject to our existing licenses and to compete with our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">68</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the agreements under which we currently and in the future license intellectual property or technology from third parties are complex and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize any affected products or services, which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Absent the license agreements, we may infringe patents subject to those agreements, and if the license agreements are terminated, we may be subject to litigation by the licensor. Litigation could result in substantial costs and distract our management. If we do not prevail, we may be required to pay damages, including treble damages, attorneys&#x2019; fees or costs and expenses and royalties, which could adversely affect our ability to offer products or services, our ability to continue operations and our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we cannot license rights to use technologies on reasonable terms, we may not be able to commercialize new products in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may identify third-party technology that we may need to license or acquire in order to develop or commercialize our products or technologies. However, we may be unable to secure such licenses or acquisitions. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. In return for the use of a third party&#x2019;s technology, we may agree to pay the licensor royalties based on sales of our products or services. Royalties are a component of cost of products or technologies and affect the margins on our products. We may also need to negotiate licenses to patents or patent applications before or after introducing a commercial product. We may not be able to obtain necessary licenses to patents or patent applications, and our business may suffer if we are unable to enter into the necessary licenses on acceptable terms or at all, if any necessary licenses are subsequently terminated, if the licensor fails to abide by the terms of the license or fails to prevent infringement by third parties, or if the licensed intellectual property rights are found to be invalid or unenforceable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Certain of our in-licensed patents are, and our future owned and in-licensed patents may be, subject to a reservation of rights by one or more third parties, including government march-in rights, that may limit our ability to exclude third parties from commercializing products similar or identical to ours.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, our owned and in-licensed patents may be subject to a reservation of rights by one or more third parties. When new technologies are developed with government funding, in order to secure ownership of such patent rights, the recipient of such funding is required to comply with certain government regulations, including timely disclosing the inventions claimed in such patent rights to the U.S. government and timely electing title to such inventions. Any failure to timely elect title to such inventions may permit the U.S. government to, at any time, take title to such inventions. Additionally, the U.S. government generally obtains certain rights in any resulting patents, including a non-exclusive royalty-free license authorizing the government to use the invention or to have others use the invention on its behalf. If the government decides to exercise these rights, it is not required to engage us as its contractor in connection with doing so. In addition, these rights may permit the U.S. government to disclose our confidential information to third parties and to exercise march-in rights to use or allow third parties to use our licensed technology free of charge. The U.S. government can exercise its march-in rights if it determines that action is necessary because we fail to achieve practical application of the government-funded technology, because action is necessary to alleviate health or safety needs, to meet requirements of federal regulations, or to give preference to U.S. industry. In addition, our rights in such inventions may be subject to certain requirements to manufacture products embodying such inventions in the United States. Any exercise by the government of any of the foregoing rights could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">69</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our products contain third-party open source software components and failure to comply with the terms of the underlying open source software licenses could restrict our ability to sell our products and provide third parties access to our proprietary software.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our products may contain software licensed by third parties under open source software licenses. Use and distribution of open source software may entail greater risks than use of third-party commercial software, as open source software licensors generally do not provide warranties or other contractual protections regarding infringement claims or the quality of the code. Some open source software licenses contain requirements that the licensee make its source code publicly available if the licensee creates modifications or derivative works using the open source software, depending on the type of open source software the licensee uses and how the licensee uses it. If we combine our proprietary software with open source software in a certain manner, we could, under certain open source software licenses, be required to release the source code of our proprietary software to the public for free. This would allow our competitors and other third parties to create similar products with less development effort and time and ultimately could result in a loss of our product sales and revenue, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, some companies that use third-party open source software have faced claims challenging their use of such open source software and their compliance with the terms of the applicable open source license. We may be subject to suits by third parties claiming ownership of what we believe to be open source software, or claiming non-compliance with the applicable open source licensing terms. Use of open source software may also present additional security risks because the public availability of such software may make it easier for hackers and other third parties to compromise or attempt to compromise our technology and systems.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we review our use of open source software to avoid subjecting our proprietary software to conditions we do not intend, the terms of many open source software licenses have not been interpreted by United States courts, and there is a risk that these licenses could be construed in a way that could impose unanticipated conditions or restrictions on our ability to commercialize our products and proprietary software. Moreover, our processes for monitoring and controlling our use of open source software in our products may not be effective. If we are held to have breached the terms of an open source software license, we could be subject to damages or be required to seek licenses from third parties to continue offering our products on terms that are not economically feasible, to re-engineer our products, to discontinue the sale of our products if re-engineering could not be accomplished on a timely basis, or to make generally available, in source code form, our proprietary code, any of which could adversely affect our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Intellectual property rights do not necessarily address all potential threats.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">others may be able to make products that are similar to products and technologies we may develop or utilize similar technology that are not covered by the claims of the patents that we own or license now or in the future;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we, or our licensor(s), might not have been the first to make the inventions covered by the issued patent or pending patent application that we license or may own in the future;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we, or our licensor(s), might not have been the first to file patent applications covering certain of our or their inventions;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing, misappropriating or otherwise violating our owned or licensed intellectual property rights;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it is possible that our pending licensed patent applications or those that we may own in the future will not lead to issued patents;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">issued patents that we own, in-license, or otherwise hold rights to may be held invalid or unenforceable or have their scope narrowed, including as a result of legal challenges by our competitors;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may not develop additional proprietary technologies that are patentable;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the patents of others may harm our business; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may choose not to file a patent application for certain trade secrets or know-how, and a third party may subsequently file a patent application covering such intellectual property.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Should any of these events occur, they could materially adversely affect our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Litigation Risks</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business exposes us to the risk of product liability claims that are inherent in the testing, manufacturing and marketing of medical devices, including those which may arise from the misuse (including system hacking or other unauthorized access by third parties to our systems) or malfunction of, or design flaws in, our hardware and software products. This liability may vary based on the FDA classification associated with our devices and with the state law governing product liability standards applied to specification developers and/or manufacturers in a given negligence or strict liability lawsuit. We may be subject to product liability claims if our products cause, or merely appear to have caused, an injury. Claims may be made by patients, healthcare providers or others selling our products. The risk of product liability claims may also increase if our products are subject to a product recall or seizure. Product liability claims may be brought by individuals or by groups seeking to represent a class.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we have insurance at levels that we believe to be appropriate, this insurance is subject to deductibles and coverage limitations. Our current product liability insurance may not continue to be available to us on acceptable terms, if at all, and, if available, the coverage may not be adequate to protect us against any future product liability claims. Further, if additional medical device products are approved or cleared for marketing, or if we launch additional 510(k)-exempt device products or products that are not FDA-regulated medical devices, we may seek additional insurance coverage. If we are unable to obtain insurance at an acceptable cost or on acceptable terms with adequate coverage or otherwise protect against potential product liability claims, we will be exposed to significant liabilities, which may harm our business. A product liability claim, recall or other claim with respect to uninsured liabilities or for amounts in excess of insured liabilities could result in significant costs and significant harm to our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be subject to claims against us even if the apparent injury is due to the actions of others or misuse of the device or a partner device. Healthcare providers may use our products in a manner inconsistent with the products&#x2019; labeling and that differs from the manner in which they were used in clinical studies and authorized by the FDA. Off-label use of products by healthcare providers is common, and any such off-label use of our products could subject us to additional liability, or require design changes to limit this potential off-label use once discovered. Defending a suit, regardless of merit, could be costly, could divert management attention and might result in adverse publicity, which could result in the withdrawal of, or result in reduced acceptance of, our products in the market.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, we have entered into various agreements where we indemnify third parties for certain claims relating to our products. These indemnification obligations may require us to pay significant sums of money for claims that are covered by these indemnification obligations. We are not currently subject to any product liability claims; however, any future product liability claims against us, regardless of their merit, may result in negative publicity about us that could ultimately harm our reputation and could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Our Securities and to Being a Public Company</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We identified material weaknesses in our internal control over financial reporting. If our remediation measures are ineffective, or if we experience additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls in the future, we may not be able to report our financial condition or results of operations accurately or in a timely manner and we may be unable to maintain compliance with applicable stock exchange listing requirements, which may adversely affect investor confidence in us and, as a result, materially and adversely affect our business and the value of our Class A common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with Legacy Hyperfine&#x2019;s and Liminal&#x2019;s combined financial statement close process for the years ended December 31, 2020 and 2019, we identified a material weakness in our internal control over financial reporting. We outsourced our accounting and financial reporting to 4Catalyzer and as of and during the years ended December 31, 2020 and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">71</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2019, did not have our own finance function to appropriately perform the supervision and review of the information received from 4Catalyzer and assess its reasonableness and accuracy.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, HealthCor previously recorded a portion of its Class A ordinary shares subject to possible redemption in permanent equity. Notwithstanding the presence of maximum redemption thresholds or charter provisions common in SPACs that provide a limitation on redemptions that would cause a SPAC&#x2019;s net tangible assets to be less than $5,000,001, in accordance with SEC Staff guidance on redeemable equity instruments, ASC 480-10-S99, &#x201c;</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Distinguishing Liabilities from Equity</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;, and EITF Topic D-98, &#x201c;</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Classification and Measurement of Redeemable Securities</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;, and, according to the SEC Staff communications with certain independent auditors, redemption provisions not solely within the control of the issuing company require ordinary shares subject to redemption to be classified outside of permanent equity. Although HealthCor did not specify a maximum redemption threshold in its Articles and Restated Memorandum and Articles of Association (the &#x201c;HealthCor Articles&#x201d;), the HealthCor Articles provided that HealthCor could not redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. In light of the recent SEC Staff communications with certain independent auditors, HealthCor&#x2019;s management re-evaluated the effectiveness of its disclosure controls and procedures as of September 30, 2021. Based upon that evaluation, HealthCor concluded that the misclassification of the Class A ordinary shares was quantitatively material to individual line items within the balance sheet. This resulted in a restatement of the initial carrying value of the Class A ordinary shares subject to possible redemption, with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and ordinary shares.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The foregoing represents a material weakness in our internal controls over financial reporting. A &#x201c;material weakness&#x201d; is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented, or detected and corrected on a timely basis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In light of the material weakness identified and the resulting restatement, we plan to enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements. Our management is in the process of developing a remediation plan, which includes, without limitation, the hiring of additional accounting and finance personnel with technical public company accounting and financial reporting experience. The material weaknesses will not be considered remediated until management designs and implements effective controls that operate for a sufficient period of time and management has concluded through testing that these controls are effective.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects or that other material weaknesses and control deficiencies will not be discovered in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If our efforts are not successful or other material weaknesses or control deficiencies occur in the future, we may be unable to report our financial results accurately on a timely basis or help prevent fraud, which could cause our reported financial results to be materially misstated and result in the loss of investor confidence or delisting and cause the market price of our shares to decline. We cannot assure you that the initiatives we have taken to date, or any initiatives we may take in the future, will be sufficient to avoid potential future material weaknesses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Because we are a &#x201c;controlled company&#x201d; within the meaning of the Nasdaq listing rules, our stockholders may not have certain corporate governance protections that are available to stockholders of companies that are not controlled companies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">So long as more than 50% of the voting power for the election of our directors is held by an individual, a group or another company, we will qualify as a &#x201c;controlled company&#x201d; under the Nasdaq listing rules. As of February 15, 2022, Dr. Rothberg controls approximately 84.8% of the voting power of our outstanding capital stock. As a result, we are a &#x201c;controlled company&#x201d; under the Nasdaq rules and are not subject to the requirements that would otherwise require us to have: (i) a majority of our board of directors consist of independent directors; (ii) director nominees selected, or recommended for our board of directors&#x2019; selection, either by a majority of the independent directors or a nominating committee comprised solely of independent directors; and (iii) a compensation committee comprised solely of independent directors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dr. Rothberg may have his interest in the Company diluted due to future equity issuances or his own actions in selling shares of our Class B common stock, in each case, which could result in a loss of the &#x201c;controlled company&#x201d; exemption under the Nasdaq listing rules. We would then be required to comply with those provisions of the Nasdaq listing rules.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">72</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The dual class structure of our common stock has the effect of concentrating voting power with Jonathan M. Rothberg, Ph.D., Vice Chairman of our board of directors and the Founder of Legacy Hyperfine and Liminal, which will limit an investor&#x2019;s ability to influence the outcome of important transactions, including a change in control.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shares of our Class B common stock have 20 votes per share, while shares of our Class A common stock have one vote per share. Dr. Rothberg holds all of the issued and outstanding shares of our Class B common stock, and as of February 15, 2022, Dr. Rothberg holds approximately 84.8% of the voting power of our capital stock and is able to control matters submitted to our stockholders for approval, including the election of directors, amendments of our organizational documents and any merger, consolidation, sale of all or substantially all of our assets or other major corporate transactions. Dr. Rothberg may have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. This concentrated control may have the effect of delaying, preventing or deterring a change in control of the Company, could deprive our stockholders of an opportunity to receive a premium for their capital stock as part of a sale of the Company, and might ultimately affect the market price of shares of our Class A common stock. If additional shares of our Class B common stock are issued, your shares and your votes may be significantly diluted.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Potential conflicts of interest may arise among the holders of our Class B common stock and the holders of our Class A common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dr. Rothberg holds all of our Class B common stock following the Business Combination. As a result, conflicts of interest may arise among Dr. Rothberg, on the one hand, and the Company and holders of our Class A common stock on the other hand. Dr. Rothberg has the ability to influence our business and affairs through his ownership of the high vote shares of our common stock, his general ability to elect our board of directors, and provisions in the Charter requiring his approval for certain corporate actions (in addition to approval by our board of directors). If the holders of our Class A common stock are dissatisfied with the performance of our board of directors, they have no ability to remove any of our directors, with or without cause.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, through his ability to elect our board of directors and as well as his service on our board of directors, Dr. Rothberg has the ability to influence the determination of the amount and timing of our investments and dispositions, cash expenditures, indebtedness, issuances of shares of common stock, tax liabilities and amounts of reserves.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Delaware law and provisions in our Charter and bylaws could make a takeover proposal more difficult.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our organizational documents are governed by Delaware law. Certain provisions of Delaware law and of our Charter and bylaws could discourage, delay, defer or prevent a merger, tender offer, proxy contest or other change of control transaction that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares of our Class A common stock held by our stockholders. These provisions provide for, among other things:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the ability of our board of directors to issue one or more series of preferred stock;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">stockholder action by written consent only until the first time when Dr. Rothberg and his permitted transferees cease to beneficially own shares of Class B common stock representing 50% or more of the voting power of the outstanding shares of our capital stock;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">certain limitations on convening special stockholder meetings;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">advance notice for nominations of directors by stockholders and for stockholders to include matters to be considered at our annual meetings;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">amendment of certain provisions of the organizational documents only by the affirmative vote of holders of (i) a majority of the voting power of the shares of our capital stock so long as Dr. Rothberg and his permitted transferees beneficially own shares of Class B common stock representing 50% or more of the voting power of the outstanding shares of our capital stock and (ii) at least two-thirds of the voting power of the shares of capital stock from and after the time that Dr. Rothberg and his permitted transferees cease to beneficially own shares of Class B common stock representing 50% or more of the voting power of our voting stock; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a dual-class common stock structure with 20 votes per share of our Class B common stock, the result of which is that Dr. Rothberg has the ability to control the outcome of matters requiring stockholder approval, even though Dr. Rothberg owns less than a majority of the outstanding shares of our capital stock.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">73</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These anti-takeover provisions as well as certain provisions of Delaware law could make it more difficult for a third party to acquire the Company, even if the third party&#x2019;s offer may be considered beneficial by many of our stockholders. As a result, our stockholders may be limited in their ability to obtain a premium for their shares. If prospective takeovers are not consummated for any reason, we may experience negative reactions from the financial markets, including negative impacts on the price of our Class A common stock. These provisions could also discourage proxy contests and make it more difficult for our stockholders to elect directors of their choosing and to cause us to take other corporate actions that our stockholders desire.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our Charter designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings and the federal district courts as the sole and exclusive forum for other types of actions and proceedings, in each case, that may be initiated by our stockholders, which could limit our stockholders&#x2019; ability to obtain what such stockholders believe to be a favorable judicial forum for disputes with the Company or our directors, officers or other employees.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Charter provides that, unless we consent to the selection of an alternative forum, any (i) derivative action or proceeding brought on behalf of us; (ii) action asserting a claim of breach of a fiduciary duty owed by, or any other wrongdoing by, any current or former director, officer, other employee or stockholder of us; (iii) action asserting a claim against us arising pursuant to any provision of the DGCL or our Charter or our bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery; (iv) action to interpret, apply, enforce, or determine the validity of any provisions in the certificate of incorporation of bylaws; or (v) action asserting a claim governed by the internal affairs doctrine, shall, to the fullest extent permitted by law, be exclusively brought in the Court of Chancery of the State of Delaware or, if such court does not have subject matter jurisdiction thereof, the federal district court of the State of Delaware. Subject to the foregoing, the federal district courts of the United States are the exclusive forum for the resolution of any action, suit or proceeding asserting a cause of action under the Securities Act. The exclusive forum provision does not apply to suits brought to enforce any liability or duty created by the Exchange Act. Any person or entity purchasing or otherwise acquiring or holding an interest in any shares of our capital stock shall be deemed to have notice of and to have consented to the forum provisions in our Charter. These choice-of-forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that he, she or it believes to be favorable for disputes with the Company or our directors, officers or other employees or stockholders, which may discourage such lawsuits. We note that there is uncertainty as to whether a court would enforce these provisions and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Alternatively, if a court were to find these provisions of our Charter inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management and board of directors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Charter does not limit the ability of the Sponsor to compete with the Company.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">HealthCor's sponsor, HC Sponsor LLC (the &#34;Sponsor&#34;) and its affiliates engage in a broad spectrum of activities, including investments in the life sciences and medical technology industries. In the ordinary course of their business activities, the Sponsor and its affiliates may engage in activities where their interests conflict with our interests or those of our stockholders. The Charter does not provide that the Sponsor and its affiliates have any duty to refrain from engaging, directly or indirectly, in the same business activities or similar business activities or lines of business in which we operate. The Sponsor and its affiliates also may pursue acquisition opportunities that may be complementary to our business, and, as a result, those acquisition opportunities may not be available to the Company. In addition, the Sponsor may have an interest in pursuing acquisitions, divestitures and other transactions that, in its judgment, could enhance its investment, even though such transactions might involve risks to you.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and we may take or continue to take advantage of certain exemptions from disclosure requirements available to emerging growth companies or smaller reporting companies, which could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are an &#x201c;emerging growth company&#x201d; within the meaning of the Securities Act, as modified by the JOBS Act, and we may take or continue to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">74</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, our stockholders may not have access to certain information they may deem important. We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier, including if the market value of our Class A common stock held by non-affiliates is $700 million or more as of the last business day of the most recently completed second fiscal quarter, in which case we would no longer be an emerging growth company as of the end of that fiscal year. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is not an emerging growth company or is an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards used.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, we are a &#x201c;smaller reporting company&#x201d; as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We are required to reflect a determination that we are no longer a smaller reporting company in our quarterly report on Form 10-Q for the first fiscal quarter of the next fiscal year after the fiscal year in which (i) the market value of our common stock held by non-affiliates is greater than or equal to $250 million as of the end of that fiscal year&#x2019;s second fiscal quarter, and (ii) if our annual revenues are not greater than or equal to $100 million during the last completed fiscal year, the market value of our common stock held by non-affiliates is $700 million or more as of the end of that fiscal year&#x2019;s second fiscal quarter. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with other public companies difficult or impossible.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our Class A common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Securities research analysts may establish and publish their own periodic projections for us. Those projections may vary widely and may not accurately predict the results we actually achieve. Our share price may decline if our actual results do not match the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on us downgrades our stock or publishes inaccurate or unfavorable research about our business, our share price could decline. In addition, securities research analysts may compare us to companies that are not appropriately comparable, which could lead to lower than expected valuations. If one or more analysts cease coverage of us or fail to publish reports on us regularly, our share price or trading volume could decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our business and operations could be negatively affected if we become subject to any securities litigation or shareholder activism, which could cause us to incur significant expense, hinder execution of our business and growth strategy and impact our stock price.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the past, following periods of volatility in the market price of a company&#x2019;s securities, securities class action litigation has often been brought against that company. Shareholder activism, which could take many forms or arise in a variety of situations, has been increasing recently. Volatility in the stock price of our Class A common stock or other reasons may in the future cause us to become the target of securities litigation or shareholder activism. Securities litigation and shareholder activism, including potential proxy contests, could result in substantial costs and divert management&#x2019;s and the board of directors&#x2019; attention and resources from our business. Additionally, such securities litigation and shareholder activism could give rise to perceived uncertainties as to our future, adversely affect our relationships with service providers and make it more difficult to attract and retain qualified personnel. Also, we may be required to incur significant legal fees and other expenses related to any securities litigation and activist shareholder matters. Further, our stock price could be subject to significant fluctuation or otherwise be adversely affected by the events, risks and uncertainties of any securities litigation and shareholder activism.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The grant of registration rights pursuant to the Registration Rights Agreement, the PIPE Subscription Agreements and the Letter Agreement, and the future exercise of such rights, may adversely affect the market price of our Class A common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">At the Closing, we, the Sponsor, certain affiliates of the Sponsor and certain stockholders of Legacy Hyperfine and Liminal entered into the Registration Rights Agreement, pursuant to which, among other things, the parties to the Registration Rights Agreement agreed not to effect any sale or distribution of any our equity securities held by any of them (except with respect to shares of our Class A common stock acquired in open market transactions or pursuant to the PIPE Investment) during the respective lock-up period described therein and were granted certain registration rights with respect to their respective shares of our common stock, in each case, on the terms and subject to the conditions therein. The parties to the Registration Rights Agreement and their permitted transferees have customary registration rights (including demand and piggy-back rights, subject to cooperation and cut-back provisions). In particular, the Registration Rights Agreement provides that promptly, but in any event within forty-five (45) days following the Closing Date, we are required to use our commercially reasonable efforts to file a registration statement under the Securities Act to permit the public resale of all registrable securities as permitted by Rule 415 of the Securities Act and to cause such registration statement to be declared effective as soon as practicable after the filing thereof, but in no event later than forty-five (45) days following the filing deadline (or sixty (60) days following the filing deadline if the registration statement is reviewed by and receives comments from the Securities and Exchange Commission (the &#x201c;SEC&#x201d;)). The registration statement was filed on January 24, 2022 and declared effective by the SEC on February 1, 2022.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, pursuant to the Subscription Agreements and the Letter Agreement, we agreed (i) to file within 45 days after the closing of the Business Combination a registration statement with the SEC for the resale of the PIPE Securities by the PIPE Investors and the Letter Agreement Shares by Jefferies LLC, (ii) to use commercially reasonable efforts to cause such registration statement to be declared effective as soon as practicable after the filing thereof, but no later than the earlier of (a) the 45th calendar day (or 60th calendar day if the SEC notifies us that it will &#x201c;review&#x201d; the registration statement) and (b) the 10th business day after the date we are notified (orally or in writing, whichever is earlier) by the SEC that the registration statement will not be &#x201c;reviewed&#x201d; or will not be subject to further review and (iii) to maintain the effectiveness of such registration statement until the earlier of (a) five years from the date of effectiveness of the initial registration statement, (b) the date on which PIPE Investors cease to hold the securities covered thereby, and (c) the date all of the securities covered thereby can be sold publicly without restriction or limitation under Rule 144 under the Securities Act. We will bear the cost of registering these securities. The registration statement was filed on January 24, 2022 and declared effective by the SEC on February 1, 2022. The registration and availability of such a significant number of securities for trading in the public market may have an adverse effect on the market price of our Class A common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The obligations associated with being a public company will involve significant expenses and will require significant resources and management attention, which may divert from our business operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a public company, we are subject to the reporting requirements of the Exchange Act and the Sarbanes-Oxley Act. The Exchange Act requires the filing of annual, quarterly and current reports with respect to a public company&#x2019;s business and financial condition. The Sarbanes-Oxley Act requires, among other things, that a public company establish and maintain effective internal control over financial reporting. As a result, we are incurring, and will continue to incur significant legal, accounting and other expenses that Legacy Hyperfine and Liminal did not previously incur. Our management team and many of our other employees will need to devote substantial time to compliance, and may not effectively or efficiently manage our transition into a public company.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We do not intend to pay cash dividends for the foreseeable future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We currently intend to retain our future earnings, if any, to finance the further development and expansion of our business and do not intend to pay cash dividends in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements, and future agreements and financing instruments, business prospects and such other factors as our board of directors deems relevant.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">76</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1B. UNRESOLVED S</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">TAFF COMMENTS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 2. P</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ROPERTIES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We currently maintain our principal executive offices at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">351 New Whitfield Street, Guilford, Connecticut 06437</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. We also </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">occupy office and laboratory space in Palo Alto, California. We lease office space under operating leases. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We consider our current office space adequate for our current operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 3. LEGAL </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PROCEEDINGS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are not currently a party to any material legal proceedings.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 4. MINE SAFE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">TY DISCLOSURES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PAR</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">T II</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_5_market_for_registrant"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 5. MARKET FOR REGISTRANT&#x2019;S COMMO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">N EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Market Information</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to the closing of the Business Combination on December 22, 2021, HealthCor's Class A ordinary shares were traded on Nasdaq under the symbol &#34;HCAQ&#34;. On December 22, 2021, in connection with the closing of the Business Combination, we changed our name to &#34;Hyperfine, Inc.&#34; On December 23, 2021, our Class A common stock began trading on the Nasdaq Global Market under the symbol &#x201c;HYPR&#x201d;.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Stockholders</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of February 15, 2022, we had 55,277,061 outstanding shares of Class A common stock held by approximately 199 holders of record, 15,055,288 outstanding shares of Class B common stock held by approximately two holders of record, and no outstanding shares of preferred stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unregistered Sales of Securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Issuer Purchases of Equity Securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_6_reserved"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 6. [R</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ESERVED]</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_7_mda"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 7. MANAGEMENT&#x2019;S DISCUSSION AND</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF HYPERFINE</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The following discussion and analysis of the financial condition and results of operations Hyperfine, Inc. and its subsidiaries (for purposes of this section, collectively referred as the &#x201c;Company&#x201d;, &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d;) should be read together with the audited combined and consolidated financial statements as of and for the years ended December 31, 2021 and 2020, together with the related notes thereto, included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements and involves numerous risks and uncertainties, including, but not limited to, those described under the heading &#x201c;Risk Factors.&#x201d; Actual results may differ materially from those contained in any forward-looking statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Overview</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are an innovative digital health business with a mission to provide affordable and accessible imaging and monitoring through magnetic resonance imaging (&#x201c;MRI&#x201d;) to revolutionize healthcare for people around the world. Our Swoop</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">&#174;</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Portable Magnetic Resonance (&#x201c;MR&#x201d;) Imaging System</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">TM</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;Swoop&#x201d;) produces high-quality images at a lower magnetic field strength than conventional MRI systems, and can be used by healthcare professionals to make effective clinical diagnoses on a patient in a variety of settings where MRI devices have previously been inaccessible. The easy-to-use interface and portable design of our Swoop system make it accessible for use anywhere in a hospital, clinic or patient care site. We are working to realize our vision of providing affordable and accessible imaging of health conditions around the world.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MRI is a medical imaging technique used in radiology to image the anatomy and the physiological processes of the human body. It is typically used in a variety of clinical settings for medical diagnosis, staging of disease and follow-up treatment. Unlike X-ray computed tomography (&#x201c;CT&#x201d;) or positron emission tomography (&#x201c;PET&#x201d;), MRI does not expose patients to harmful ionizing radiation. We believe MRI offers the most sensitive and objective measures of brain tissue and injury. Despite its advantages, many healthcare institutions throughout the world lack the facilities, qualified operators and capital necessary to acquire and maintain expensive MRI devices. The Swoop system is intended for use at the patient&#x2019;s bedside in any hospital room or clinical setting, such as a physician&#x2019;s office or a local urgent care facility. The demand for MRI has been augmented by the aging population and rising prevalence of cancer and cardiovascular, neurological and orthopedic conditions. Healthcare professionals and insurers are recognizing imaging as a cost-effective and non-invasive diagnostic tool for evaluation and ongoing monitoring. Swoop is a next generation of these devices designed to drive costs down and expand the current $15.9 billion imaging market.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe the adoption of the Swoop system by healthcare professionals has benefits across healthcare communities in both high and low resource settings. Through our collaborations with the healthcare community, we have begun to optimize Hyperfine&#x2019;s software ecosystem to harness Artificial Intelligence (&#x201c;AI&#x201d;) to transform the system into a true bedside clinical decision support platform. These efforts seek to improve image quality, help users analyze images, and reduce time to diagnosis. Our technology allows us to provide decision support and immediate feedback for diagnostic insight for clinicians of all levels of expertise. In the future, we hope to develop an ecosystem of products, expanding the capabilities of our core MRI product platform while introducing a brain sensing platform to offer a more complete solution and increase access to life saving technology across the care continuum.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine received 510(k) clearance from the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) in 2020 for its Swoop Portable MR Imaging System, which is commercially available in the United States. In 2021, we also obtained a Medical Device License issued by Health Canada and expanded into the Canadian market. We also recently received regulatory authorization in New Zealand and Pakistan. In addition, we are initially seeking necessary regulatory authorizations in other major markets, including the United Kingdom, Australia and other countries. We are building our direct commercial infrastructure in the United States and also have plans to sell our products in other countries either through direct sales or through distributors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">COVID-19</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the World Health Organization declared the global outbreak of COVID-19 to be a pandemic. We continue to closely monitor the recent developments surrounding the continued spread and potential resurgence of COVID-19. The COVID-19 pandemic has had, and is expected to continue to have, an adverse impact on our operations, particularly as a result of preventive and precautionary measures that we, other businesses, and governments are taking.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">COVID-19 created multiple commercial challenges in 2020 and has continued to do so in 2021 and 2022. We expect to see restrictions on our salesforce&#x2019;s ability to visit sites to continue during 2022. Commercially, many hospitals and other healthcare providers decreased spending and limited physical access to facilities, slowing our ability to demonstrate our</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">79</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Swoop device. In addition, many hospitals and other healthcare providers continue to focus their attention on addressing COVID-19, which we believe has resulted in lower sales volume. Trade shows and conferences moved to a virtual platform creating difficulty in demonstrating our device to key stakeholders. We moved to create a product demonstration roadshow using demonstration trucks, but were not able to scale due to truck shortages. It was not uncommon to host virtual product demonstrations with 6-10 physicians, something that would ordinarily not happen or would take many weeks of planning to produce. With physician society conferences offline and slowing our commercial launch, we used the concept of &#x201c;Demo at Your Door&#x201d; &#x2014; providing target customers hands-on device experience at a place of their choosing. Virtual demonstrations, even though they generated a lot of interest in our product, often did not result in sales, and all sales required an in-person product demonstration. As more conferences begin to be held in-person, we expect to improve our ability to provide product demonstrations to potential customers. It is unclear whether or not conferences will have the same in-person attendance as they would have had in the past.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because the manufacturing of our Swoop system was developed, and our commercial launch of our Swoop system occurred, during the COVID-19 pandemic market and manufacturing conditions, we did not have to materially adjust our existing resource allocation or our factors of production because of the COVID-19 pandemic. However, if there are further waves of the COVID-19 pandemic driven by variants like Delta, Omicron or otherwise, we may experience a greater negative impact in our supply chain than we have previously.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the COVID-19 pandemic and the variants that followed, our suppliers agreed to shift new work to domestic suppliers to help reduce the risk of manufacturing delays. Our supplier and sub tier suppliers have been adversely affected by COVID-19. Although we work closely with our suppliers to attempt to ensure continuity of supply, the supply of certain components and raw materials used in our product has been and may continue to be slowed as a direct result of COVID-19 and its variants. We have also experienced increases in product costs as raw materials have been constrained. Prices have risen sharply over the past year, and lead times have extended dramatically, particularly on semiconductor products. Over the next 12 months, we expect prices to increase due to the raw material demand surges across numerous industries, along with labor and transportation related constraints. We also expect lead times to reduce as component production levels recover to meet demand. We helped to minimize the impact of the COVID-19 pandemic on the manufacturing of our product and operations by using our manufacturer&#x2019;s preferred suppliers, increasing communications with suppliers and freight carriers, and providing advanced forecasts and purchase orders for new and existing devices.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, future regulatory authorizations by the FDA or other regulatory authorities may take longer because of COVID-19 pandemic-related delays, though we have not been impacted by such delays to date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Please refer to the section titled, &#34;Item 1A. Risk Factors&#x201d; included elsewhere in this Annual Report on Form 10-K for more information. We are unable to predict the full impact that the COVID-19 pandemic will have on our future results of operations, liquidity and financial condition due to numerous uncertainties, including the duration of the pandemic and actions that may be taken by government authorities across the United States. We will continue to monitor the performance of our business and reassess the impacts of COVID-19.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Key Performance Metrics</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We review the key performance measures discussed below to evaluate the business and measure performance, identify trends, formulate plans and make strategic decisions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Installed Base</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Swoop total installed base consists of three components, discussed in further detail below: Commercial system installations (which make up total revenue), grant fulfillment installations, and research unit installations. The Swoop total installed base (or total installed units) is the number of Swoop devices deployed to hospitals, other healthcare providers, and research institutions. We view the total installed base as a key metric of the growth of our business and is measured from period over period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Presented below is a breakout of total Swoop systems installed during 2020 and 2021:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:66.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.09%;"></td>
    <td style="width:1.391%;"></td>
    <td style="width:0.576%;"></td>
    <td style="width:11.756%;"></td>
    <td style="width:0.576%;"></td>
    <td style="width:1.391%;"></td>
    <td style="width:0.576%;"></td>
    <td style="width:11.746%;"></td>
    <td style="width:0.576%;"></td>
    <td style="width:1.391%;"></td>
    <td style="width:0.576%;"></td>
    <td style="width:11.776%;"></td>
    <td style="width:0.576%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">TOTAL INSTALLED UNITS</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">TOTAL</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Commercial systems installations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">23</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">27</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Grant fulfillment installations</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">18</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">18</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">41</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">45</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research units</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">15</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">25</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total Installed Units</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">19</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">51</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">70</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:66.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Commercial system installations</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> reflect device sales and subscription services through commercial agreements (commercial sales) or through research transfer agreements (&#34;RTA&#34;) sales. Commercial sales are made to hospitals and other healthcare providers as direct sales of devices and software subscription services or through subscriptions for the use of the device and software. RTA sales represent the sale of Swoop units for research use purposes. Our revenue for the years ended December 31, 2021, and 2020 is derived from commercial sales and RTA sales.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Grant fulfillment installations</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> consist of shipments of Swoop units to hospitals and other clinical facilities designated by the Bill &amp; Melinda Gates Foundation (&#x201c;BMGF&#x201d;). The corresponding funding for these installations from BMGF is recorded as a reduction in the research and development expenses when realized during the period.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research units </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">represent installed units, at no cost to the institutions, to expand clinical use cases. The installation of research units is recorded as a fixed asset with the related depreciation recorded as R&amp;D expense over the life of the research unit.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Factors Affecting Results of Operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following factors have been important to our business and we expect them to impact our results of operations and financial condition in future periods:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Strategic partnerships and accelerated international expansion</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that market expansion is a key to our continued growth and the success of our device. In line with our vision to democratize healthcare imaging by providing affordable and accessible imaging of health conditions around the world, we are building an international sales strategy that includes direct sales to customers and sales through distribution partners in target regions. In 2021, we obtained a Medical Device License issued by Health Canada and expanded into the Canadian market. We recently also received regulatory authorization in New Zealand and Pakistan. In our plans for international commercial expansion, the other countries in which we plan initially to commercialize our Swoop system include, subject to the regulatory authorization, the United Kingdom and Australia. Through the Bill and Melinda Gates Foundation (&#x201c;BMGF&#x201d;) partnership, we are deploying Swoop systems in these target areas for research and clinical settings. The utilization of our Swoop systems as part of the programs will allow us to begin building relationships across key stakeholders in these countries or regions to better understand and meet required regulatory hurdles in anticipation of filing for regulatory authorization and ultimately expand into clinical use with patients. In addition, we are considering commercial expansion into several of the larger EU countries following our initial international commercial expansion. We believe these countries have the market size, regulatory environment, commercial access, and mature healthcare systems necessary, subject to regulatory authorization, for a successful launch of our Swoop system. We believe our partnership with the BMGF demonstrates our commitment to the vision of providing affordable and accessible imaging that enables earlier detection and remote management of health conditions around the world. Through our engagement with nonprofit organizations, we aim to deploy the Swoop system to low-middle resource settings without readily-accessible MRI technology. During 2020, we were awarded a $1.6 million grant from the BMGF for the provision and equipping of 20 sites with the Hyperfine portable point-of-care MRI system to enable the performance of a multi-site study focused on optimizing diagnostic image quality (the &#x201c;Project&#x201d;). During the third quarter of 2021, we were awarded an additional $3.3 million grant, of which $2.5 million was received from the BMGF in September 2021, with the remainder expected to be received by April 2022. Both of the grants are designed to support the deployment of a total of 25 Swoop devices and other services to investigators, which commenced in the spring of 2021, and is expected to fund the program for approximately two years. At December 31, 2021, 18 Swoop system units were provisioned and delivered to BMGF. These grants are designed to provide data to validate the use of our Swoop system in measuring the impact of maternal anemia, malnutrition, infection and birth related injury.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Technical innovation</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have developed our device through extensive research and development activities. Our Swoop system is designed to make the customer experience as easy as possible through our integrated, easy-to-use interface that portrays images on a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">81</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">tablet, smartphone or other WiFi capable device. In addition to this design, our team is focused on customer success programs that help integrate the Swoop system into any hospital or clinic workflow. We believe that as the Swoop system becomes integrated into ICUs and sites across medical practices, we will gain more insights into our product&#x2019;s usability and potentially develop automated analysis of images that we believe will lead to further efficiencies in patient diagnosis. We plan to continue developing our technology to expand into new imaging applications to enable us to reach the broader care continuum through diagnosis and treatment. In the future, we plan to introduce a further enhanced MRI system designed to conduct neuroimaging and imaging of other extremities for interventional procedures. In addition to our efforts to disrupt the MRI market, we see a significant opportunity to help patients in the neuromonitoring space. Although we expect these activities in technical innovation of the current device and new devices will increase our research and development expenses, we expect it to positively impact our results of operations and profitability in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Description of Certain Components of Financial Data</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sales</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We derive our sales from the following sources: device sales and service sales as described in more detail below. Our revenue recognition policies are discussed in more detail under &#x201c;</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; in Note 2 to our combined and consolidated financial statements and notes thereto for the years ended December 31, 2021 and 2020 included elsewhere in this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Device: Device sales primarily consist of sales of our MRI devices.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Service: Service sales primarily consists of sales from subscriptions of bundled devices, maintenance, and software.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cost of sales</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cost of sales consists of product and service costs including personnel cost and benefits including stock-based compensation, product costs, production setup expenses, depreciation and amortization expenses, inventory excess and obsolescence expenses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and development</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development costs consist of production costs for prototype, test and pre-production units, lab supplies, consulting and personnel costs, including salaries, stock-based compensation, bonuses and benefit costs. Most of our research and development expenses are related to developing new products and services as well as to enhance our current product and software capabilities. Consulting expenses are related to research and development activities as well as clinical and regulatory activities. Fabrication services include certain third-party engineering costs. Research and development expenses are expensed as incurred. We expect to continue to make substantial investments in product development. As a result, research and development expenses are expected to increase in absolute dollars as the research and development efforts increase.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and administrative</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses primarily consist of personnel costs and benefits including stock-based compensation, patent and filing fees, office expenses, technology expenses and outside services. Outside services consist of professional services, legal and other professional fees. We expect that general and administrative expenses will increase in absolute dollars as a result of operating as a public company, including adding hires in accounting, human resources, and legal. Other related costs include additional facilities expenses and general corporate overhead to support the employee base.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sales and marketing</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sales and marketing costs primarily consist of personnel costs and benefits including stock-based compensation, advertising, promotional costs, as well as costs for conferences, meetings, and other events. We expect sales and marketing expenses will increase in absolute dollars in the near term as we build our internal sales and marketing teams, promote our brand through marketing and advertising initiatives and expand our market presence and awareness.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interest income</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income primarily consists of interest earned on our cash equivalents invested in money market securities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">82</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other expense, net</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other expense, net primarily relates to interest on a related party note payable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Provision for income taxes</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We utilize the asset and liability method of accounting for income taxes, as set forth in Accounting Standards Codification (&#34;ASC&#34;) 740, Income Taxes. Under this method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities using the enacted statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established against net deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some or all of the net deferred tax assets will not be realized. We recorded a full valuation allowance as of December 31, 2021 and 2020. Based on available evidence, we believe that it is more-likely-than-not that we will be unable to utilize all of our deferred tax assets in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#34;CARES Act&#34;) was enacted which included provisions related to net operating loss (&#34;NOL&#34;) carryovers and carrybacks. The CARES Act amended the NOL carryback rules by allowing NOLs arising in tax years beginning after December 31, 2017 and before January 1, 2021 to be carried back to each of the 5 years preceding the year of the loss to generate a refund of previously paid income taxes. In addition, the CARES Act temporarily removed the 80% limitation under which NOLs generated post-2017 could be used to offset no more than 80% of taxable income, and allows for full use of such NOLs for tax years before January 1, 2021. We have evaluated the relevant provisions of the CARES Act and have determined that we do not expect to recognize any benefit related to these provisions due to our net operating losses in the current year and all prior years. Therefore, there are no income tax effects to be recognized in the combined and consolidated financial statements for the years ended December 31, 2021 and 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Results of Operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following is a discussion of our results of operations for the periods shown below, and our accounting policies are described under </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#34;Summary of Significant Accounting Policies&#34;</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in Note 2 in our combined and consolidated financial statements for the years ended December 31, 2021 and 2020 included elsewhere in this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:56.612%;"></td>
    <td style="width:1.372%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:11.076%;"></td>
    <td style="width:0.785%;"></td>
    <td style="width:1.372%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:11.076%;"></td>
    <td style="width:0.785%;"></td>
    <td style="width:1.372%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:9.982%;"></td>
    <td style="width:2.694%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">($ Amounts in thousands)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Device</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">715</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">200</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">257.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Service</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">781</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">94</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">730.9</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Total sales</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,496</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">294</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">408.8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cost of Sales</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Device</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,058</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">763</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">169.7</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Service</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">605</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7,462.5</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cost of sales</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,663</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">771</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">245.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Gross margin</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(1,167</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(477</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">144.7</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">25,842</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">14,593</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">77.1</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">27,497</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5,921</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">364.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10,362</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,500</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">314.5</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">63,701</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">23,014</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">176.8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(64,868</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(23,491</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">176.1</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Interest income</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">18</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">70</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(74.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other expense, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(1</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(6</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(83.3</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Loss before provision for income taxes</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(64,851</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(23,427</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">176.8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Provision for income taxes</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Net loss and comprehensive loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(64,851</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(23,427</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">176.8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Comparison of the Years Ended December 31, 2021 and 2020 ($ Amounts in thousands)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Sales</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.508%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:9.663%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:9.633%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:9.693%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:9.027%;"></td>
    <td style="width:1.939%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Device</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">715</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">200</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">515</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">257.5</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Service</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">781</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">94</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">687</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">730.9</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Total sales</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,496</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">294</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,202</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">408.8</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total sales increased by $1.2 million, or 408.8%, for the year ended December 31, 2021 compared to the year ended December 31, 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Device sales increased by $0.5 million, or 257.5%, for the year ended December 31, 2021 compared to the year ended December 31, 2020. This increase was driven by an increase in the volume of device sales. In the first quarter of 2022, we have taken a pricing action by increasing the price of the device while lowering the price of the annual subscription. We expect this pricing action will result in higher device revenue per unit and lower service revenue per unit for sales under the subscription plus ownership model beginning in the first quarter of 2022.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Service sales increased by $0.7 million, or 730.9%, for the year ended December 31, 2021 compared to the year ended December 31, 2020. This increase was driven by an increase in the volume of devices installed as generally all commercial systems installations generate service revenue. Service sales revenue is generally recognized over time as we are providing the customer with ongoing access to our resources throughout the subscription period. This type of revenue is recurring in nature and we expect will continue to grow as more devices are sold.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cost of sales</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.483%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:9.662%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:9.632%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:9.692%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:9.056%;"></td>
    <td style="width:1.938%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Device</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,058</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">763</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,295</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">169.7</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Service</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">605</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">597</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7,462.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Total cost of sales</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,663</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">771</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,892</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">245.4</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total cost of sales increased by $1.9 million, or 245.4%, for the year ended December 31, 2021 compared to the year ended December 31, 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cost of device sales increased by $1.3 million, or 169.7%, for the year ended December 31, 2021 compared to the year ended December 31, 2020. This increase was driven primarily by third party manufacturing costs as a result of increased volume of products sold. The increase is comprised of a $0.8 million increase in product hardware costs and a $0.5 million increase in internal overheads and labor costs mostly related to customer support and engineering as a result of an increase in the volume of products sold.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cost of service sales increased by $0.6 million, for the year ended December 31, 2021 compared to the year ended December 31, 2020. This increase was driven primarily by $0.4 million increase in internal overheads and labor costs and a $0.2 million increase in depreciation of devices installed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.503%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:9.672%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:9.672%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:9.682%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.203%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:8.996%;"></td>
    <td style="width:1.938%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">25,842</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">14,593</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">11,249</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">77.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses increased by $11.2 million, or 77.1%, for the year ended December 31, 2021 compared to the year ended December 31, 2020. This increase was driven primarily by an increase in personnel related costs of $8.1 million as a result of increased headcount, an increase in professional services of $1.1 million, an increase in stock-based compensation of $0.5 million, and an increase in travel expenses of $0.5 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.935%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.562%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.552%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.572%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:8.836%;"></td>
    <td style="width:1.938%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">27,497</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5,921</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21,576</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">364.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses increased by $21.6 million, or 364.4%, for the year ended December 31, 2021 compared to the year ended December 31, 2020. This increase was driven primarily by an increase in professional services of $4.3 million, an increase in personnel related expenses of $6.7 million, an increase in legal costs of $1.6 million, an increase in stock-based compensation of $5.3 million, an increase in recruiting expenses of $1.5 million as well as an increase of $0.7 million of technology related costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Sales and marketing</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.925%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.564%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.554%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.574%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:8.838%;"></td>
    <td style="width:1.939%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10,362</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,500</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7,862</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">314.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sales and marketing expenses increased by $7.9 million, or 314.5%, for the year ended December 31, 2021 compared to the year ended December 31, 2020. This increase was driven primarily by an increase in personnel related expenses of $3.3 million due to increased headcount as the business had a full year of commercial operations, an increase in product advertising and marketing expenses of $3.0 million, an increase in professional and other outside service of $0.6 million, and an increase in travel expense of $0.3 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Interest income</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.866%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.542%;"></td>
    <td style="width:0.576%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.532%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.393%;"></td>
    <td style="width:0.785%;"></td>
    <td style="width:1.213%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:8.14%;"></td>
    <td style="width:2.694%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Interest income</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">18</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">70</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(52</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(74.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income decreased by $0.1 million, or 74.3%, for the year ended December 31, 2021 compared to the year ended December 31, 2020. This decrease was driven primarily by lower interest rates in money market accounts in 2021 as compared to 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Other expense, net</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.861%;"></td>
    <td style="width:1.212%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.352%;"></td>
    <td style="width:0.785%;"></td>
    <td style="width:1.212%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.352%;"></td>
    <td style="width:0.785%;"></td>
    <td style="width:1.212%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.561%;"></td>
    <td style="width:0.566%;"></td>
    <td style="width:1.212%;"></td>
    <td style="width:0.566%;"></td>
    <td style="width:8.14%;"></td>
    <td style="width:2.693%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other expense, net</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(83.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other expense decreased by $0.01 million, or 83.3%, for the year ended December 31, 2021 compared to the year ended December 31, 2020. This decrease was driven primarily by realized gains on foreign currencies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">LIQUIDITY AND CAPITAL RESOURCES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have funded our operations primarily with proceeds from the issuance of common and preferred stock. We have incurred significant cash burn and recurring net losses, which includes a net loss of $64.9 million for the year ended December 31, 2021, and an accumulated deficit of $136.3 million as of December 31, 2021. In addition, on December 22, 2021, we completed the Business Combination with HealthCor, and as a result we received gross proceeds of approximately $162.1 million and net proceeds of approximately $141.5 million. As of December 31, 2021, we had cash and cash equivalents of $188.5 million. As we continue to invest in research and development of our products and sales and marketing, we expect to continue to incur a significant cash burn and recurring net losses for the foreseeable future until such time that our product and services sales generate enough gross profit to cover our operating expenses. However, we can provide no assurance that our product and service sales will generate a net profit in the future or that our cash resources will be sufficient to continue our commercialization and development activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect to continue to incur net losses as we continue to invest in research and development and sales and marketing of our products. Our ability to access capital when needed is not assured and, if capital is not available when, and in the amounts needed, we could be required to delay, scale back or abandon some or all of our development programs, commercialization of our products, and other operations which could materially harm our operations, financial condition and operating results. We</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">85</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expect that our existing cash and cash equivalents, together with proceeds from the sales of our products and services, will enable us to conduct our planned operations for at least the next 12 months. We expect we will require an accelerated amount of spending to enhance the sales and marketing teams, continue to drive development of our products, and build inventory. Other factors that could accelerate cash needs include: (i) delays in achieving scientific and technical milestones; (ii) unforeseen capital expenditures and fabrication costs related to manufacturing; (iii) changes we may make in our business or commercialization and hiring strategy; (iv) the impact of the COVID-19 pandemic; (v) costs of running a public company; and (vi) other items affecting our forecasted level of expenditures and use of cash resources including potential acquisitions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect to use our funds to further invest in the development of our products and services, commercial expansion, and for working capital and general corporate purposes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, we had cash and cash equivalents of $188.5 million. Our future capital requirements may vary from those currently planned and will depend on various factors including further development costs, commercialization strategy, international expansion, and regulatory costs. If we need additional funds and are unable to obtain funding on a timely basis, we may need to curtail significantly our product development and commercialization efforts to provide sufficient funds to continue our operations, which could adversely affect our business prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash flows</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes our cash flows for the periods indicated:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.421%;"></td>
    <td style="width:1.6%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:13.241%;"></td>
    <td style="width:0.785%;"></td>
    <td style="width:1.6%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:13.241%;"></td>
    <td style="width:0.785%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(In thousands)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(47,182</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(21,525</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net cash used in investing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(2,711</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(1,568</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">176,767</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">60,938</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Net increase in cash, cash equivalents, and restricted cash</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">126,874</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">37,845</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net cash used in operating activities</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the year ended December 31, 2021, net cash used in operating activities of $47.2 million was due primarily to a net loss of $64.9 million, non-cash items of $8.7 million and changes in operating assets and liabilities of $9.0 million. Non-cash items were primarily stock-based compensation expense of $6.9 million. Changes in operating assets and liabilities were driven primarily by an increase in inventory of $2.7 million, partially offset by an increase in accrued expense and other current liabilities of $6.9 million and amounts due to related parties of $1.8 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the year ended December 31, 2020, net cash used in operating activities of $21.5 million was due primarily to a net loss of $23.4 million, non-cash items of $1.6 million and changes in operating assets and liabilities of $0.3 million. Non-cash items were primarily stock-based compensation expense of $1.1 million. Changes in operating assets and liabilities were driven primarily by an increase in inventory of $1.9 million and amounts due from related parties of $0.8 million, partially offset by an increase in deferred grant funding of $1.6 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net cash used for investing activities</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the year ended December 31, 2021, net cash used in investing activities of $2.7 million was from fixed assets purchased.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the year ended December 31, 2020, net cash used in investing activities of $1.6 million was from fixed assets purchased.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net cash provided by financing activities</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the year ended December 31, 2021, net cash provided by financing activities of $176.8 million was primarily due to proceeds from issuance of Series D convertible preferred stock of $30.5 million, and net proceed from equity infusion from the Business Combination of $141.5 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the year ended December 31, 2020, net cash provided by financing activities of $60.9 million was primarily due to proceeds from issuance of Series D convertible preferred stock of $59.8 million and investment proceeds from 4Bionics of $1.0 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">86</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Contractual obligations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We sponsor a 401(k) defined contribution plan covering all eligible U.S. employees. Contributions to the 401(k) plan are discretionary. We did not make any matching contributions to the 401(k) plan for the years ended December 31, 2021 and 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2020, we received a $1.6 million grant from the BMGF for the provision and equipping of 20 sites with the Hyperfine portable point-of-care MRI system to enable the performance of a multi-site study focused on optimizing diagnostic image quality. During the third quarter of 2021, we were awarded an additional $3.3 million grant, of which $2.5 million was received from the BMGF in September 2021. Refer to Note 16 to our combined and consolidated financial statements and notes thereto for the years ended December 31, 2021 and 2020 included elsewhere in this Annual Report on Form 10-K for a discussion of the BMGF grant. Any grant funds, plus any income, that have not been used for, or committed to, the Project must be returned promptly to BMGF upon expiration of or termination of the agreement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We had no other significant contractual obligations as of December 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For information on contingencies, refer to Note 16 to our combined and consolidated financial statements and notes thereto for the years ended December 31, 2021 and 2020 included elsewhere in this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Critical Accounting Policies and Significant Judgments and Estimates</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (&#34;U.S. GAAP&#34;). The preparation of our financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. While our significant accounting policies are described in more detail in Note 2 in our combined and consolidated financial statements for the years ended December 31, 2021 and 2020 included elsewhere in this Annual Report on Form 10-K, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue recognition</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We make judgments applying the guidance related to the estimation of variable consideration. We have certain subscription contracts that provide variable discounts to customers (subject to a maximum). These discounts vary and represent variable consideration, and we use the expected value method to estimate this variable consideration. Given the high degree of uncertainty around the occurrence of these events, we determine the variable consideration to be fully constrained until the uncertainty associated with these discounts is resolved. We will recognize revenue from subscription revenue straight line over the subscription period. We will re-evaluate the transaction price in each reporting period as uncertain events are resolved and other changes in circumstances occur.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Inventories</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inventories primarily consist of finished goods which are produced by the Company&#x2019;s third-party contract manufacturers and raw materials ordered in advance by the third-party contract manufacturer due to long delivery-lead time and were billed to the Company. Inventories are stated at the lower of actual cost, determined using the average cost method, or net realizable value (&#x201c;NRV&#x201d;). We routinely evaluate quantities and value of our inventories in light of current market conditions and market trends and record a write-down against the cost of inventories for NRV below cost. NRV is based upon an estimated average selling price reduced by the estimated costs of disposal and transportation. The determination of NRV involves numerous judgments including estimating selling prices, existing customer orders, and estimated costs of disposal and transportation. If actual market conditions differ from our estimates, future results of operations could be materially affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The valuation of inventory also requires us to estimate excess and obsolete inventory. We periodically review the age, condition and turnover of our inventory to determine whether any inventory has become obsolete or has declined in value and incur a charge to operations for known and anticipated inventory obsolescence. We also consider how quickly customers will transition from older products to newer products, including whether older products can be re-manufactured into new products. The evaluation takes into consideration the effect that new products might have on the sale of existing products, product obsolescence, product merchantability and other factors. Market conditions are subject to change and if actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required, which would have a negative impact on gross margin.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-based compensation</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our stock-based compensation program includes restricted stock unit and stock option grants to our employees, directors and consultants. Stock options are granted at exercise prices not less than the estimated fair market value of our common stock at the dates of grant. For purposes of restricted stock unit grants, the grant date fair value is calculated as the fair market value of the stock on the date of grant.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair values of stock option grants are estimated using a Black-Scholes option-pricing model. Key inputs and assumptions include the expected term of the option, stock price volatility, risk-free interest rate, dividend yield, stock price and exercise price. Many of the assumptions require significant judgment and changes in assumptions could have a significant impact in the determination of stock-based compensation expense.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Key assumptions include:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Risk free interest rate: The risk-free interest rate for periods within the contractual life of the awards is based on the U.S. Treasury yield curve in effect at the time of the grant.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected dividend yield: We have never declared or paid any cash dividends and do not expect to pay any cash dividends in the foreseeable future.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term: We calculate expected term using the &#x201c;simplified&#x201d; method, which is the simple average of the vesting period and the contractual term. The simplified method is applied as we do not have sufficient historical data to provide a reasonable basis for an estimate of the expected term. We calculate the expected term for employee awards that take into account the effects of employees' expected exercise and post-vesting employment termination behavior.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility: We determined expected annual volatility based on the historical stock volatility of a group of similar companies that are publicly traded over a period equivalent to the expected term of the stock- based awards.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Generally, stock options granted to employees fully vest four years from the grant date and have a term of 10 years and stock options granted to non-employees fully vest one year from the grant date or upon performance of a service and have a term of 10 years.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the year ended December 31, 2020, Liminal was a wholly owned subsidiary of 4Bionics, and as such, 4Bionics granted equity awards in the form of incentive units to Liminal employees and nonemployees under 4Bionics&#x2019; stock-based compensation program. On April 2, 2021, 4Bionics executed a plan of liquidation and dissolution and its ownership in Liminal was distributed to its members and to the holders of incentive units. Immediately subsequent to the dissolution, all outstanding unvested incentive unit awards under 4Bionics' 2019 Equity Incentive Plan were replaced with preferred stock awards indexed to and settled in the preferred stock of the former 4Bionics subsidiaries Liminal, Detect, Inc. (f/k/a Homodeus Inc.), Tesseract Health, Inc. and Protein Evolution, Inc. The preferred stock awards are subject to service vesting conditions only. No incremental value was provided to participants as a result of the modification of the awards as the modification date fair value of the incentive unit awards was equal to the modification date fair value of the stock underlying the restricted stock awards. Moreover, the remaining vesting period before and after the modification was unchanged. No incremental compensation expense was recognized as a result of the modification.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to the dissolution of 4Bionics, a portion of total 4Bionics stock-based compensation expense was allocated to Liminal based on the level of service provided by the relevant employees and nonemployees to Liminal over the term of the award. Subsequent to the dissolution of 4Bionics, we recognize the stock-based compensation expense related to the replacement preferred stock awards and no allocation methodology is required. In connection with the Closing of the Business Combination, all replacement preferred stock awards were accelerated to fully vest. We recognized stock-based compensation expense of $0.6 million related to the incentive unit awards and replacement preferred stock awards during the year ended December 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Recently Issued Accounting Pronouncements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2 to our combined and consolidated financial statements and notes thereto for the years ended December 31, 2021 and 2020 included elsewhere in this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">88</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_7a_quantitative_and_qualitative_dis"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 7A. QUANTITATIVE AND QUALITATI</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">VE DISCLOSURES ABOUT MARKET RISK</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are exposed to market risk in the ordinary course of business. Market risk represents the risk of loss that may impact our results of operations or financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in interest rates. We do not hold, issue or enter into any financial instruments for speculative or trading purposes. We do not have significant exposure to foreign currencies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interest rate risk</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our cash equivalents as of December 31, 2021 consisted of $48.6 million in money market funds. Such interest-earning instruments carry a degree of interest rate risk. The goals of our investment policy are liquidity and capital preservation. We believe that we do not have any material exposure to changes in the fair value of these assets as a result of changes in interest rates due to the short-term nature of our cash equivalents. We do not believe that a hypothetical 10% change in interest rates would have a material effect on our cash flows or operating results.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">89</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_8_financial_statements_and_supp"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 8. FINANCIAL STATEMENTS </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">AND SUPPLEMENTARY DATA</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">See financial statements included in Item 15 &#34;Exhibits and Financial Statement Schedules&#34; of this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_9_changes_in_and_dis_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">UNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_9a_controls_and_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9A. CONTROLS AN</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">D PROCEDURES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Evaluation of Disclosure Controls and Procedures</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of December 31, 2021. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of December 31, 2021, solely due to the material weaknesses in our internal control over financial reporting discussed below, our disclosure controls and procedures were not effective at the reasonable assurance level to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#x2019;s rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Management&#x2019;s Annual Report on Internal Control over Financial Reporting</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Annual Report on Form 10-K does not include a report of management&#x2019;s assessment regarding internal control over financial reporting as allowed by the SEC for reverse acquisitions between an issuer and a private operating company when it is not possible to conduct an assessment of the private operating company&#x2019;s internal control over financial reporting in the period between the consummation date of the reverse acquisition and the date of management&#x2019;s assessment of internal control over financial reporting (see Section 215.02 of the SEC Division of Corporation Finance&#x2019;s Regulation S-K Compliance &amp; Disclosure Interpretations). As discussed elsewhere in this Annual Report on Form 10-K, we completed a Business Combination on December 22, 2021 pursuant to which we acquired Legacy Hyperfine and Liminal. Prior to the Business Combination, we were a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. As a result, previously existing internal controls are no longer applicable or comprehensive enough as of the assessment date, as our operations prior to the Business Combination were insignificant compared to those of the consolidated entity post-Business Combination. As a result, management was unable, without incurring unreasonable effort or expense, to complete an assessment of our internal control over financial reporting as of December 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Material Weakness in Internal Control Over Financial Reporting</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have identified two material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our financial statements will not be prevented or detected on a timely basis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As previously disclosed, prior to the Closing of the Business Combination in December 2021, Legacy Hyperfine and Liminal were private companies and had limited accounting and financial reporting personnel and other resources with which to address its internal controls and procedures. We outsourced our accounting and financial reporting to 4Catalyzer Corporation (&#x201c;4Catalyzer&#x201d;) and did not have our own finance function to appropriately perform the supervision and review of the information received from 4Catalyzer and assess its reasonableness and accuracy. As a result, in connection with the combined financial statement close process of Legacy Hyperfine and Liminal for the years ended December 31, 2020 and 2019, we identified a material weakness in our internal control over financial reporting.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, as previously disclosed, HealthCor previously recorded a portion of its Class A ordinary shares subject to possible redemption in permanent equity. Notwithstanding the presence of maximum redemption thresholds or charter provisions common in SPACs that provide a limitation on redemptions that would cause a SPAC&#x2019;s net tangible assets to be less than $5,000,001, in accordance with SEC Staff guidance on redeemable equity instruments, ASC 480-10-S99, &#x201c;Distinguishing Liabilities from Equity&#x201d;, and EITF Topic D-98, &#x201c;Classification and Measurement of Redeemable Securities&#x201d;, and, according to SEC Staff communications with certain independent auditors, redemption provisions not solely within the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">control of the issuing company require ordinary shares subject to redemption to be classified outside of permanent equity. Although we did not specify a maximum redemption threshold in HealthCor&#x2019;s Amended and Restated Memorandum and Articles of Association (the &#x201c;HealthCor Articles&#x201d;), the HealthCor Articles provided that we could not redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001. In light of the SEC Staff communications with certain independent auditors, our management re-evaluated the effectiveness of our disclosure controls and procedures, and based upon that evaluation, we concluded that the misclassification of the Class A ordinary shares was quantitatively material to individual line items within the balance sheet. This resulted in a restatement of the initial carrying value of the Class A ordinary shares subject to possible redemption, with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and ordinary shares. We concluded that the foregoing represents a material weakness in our internal controls over financial reporting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Notwithstanding these material weaknesses, management has concluded that our audited combined and consolidated financial statements included in this Annual Report on Form 10-K are fairly stated in all material respects in accordance with U.S. GAAP for each of the periods presented therein.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Plan for Remediation of the Material Weaknesses in Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In response to these material weaknesses, our management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation of material weaknesses in internal control over financial reporting. Our management developed and started to execute a remediation plan, which included the hiring of accounting and finance resources including the Chief Financial Officer and Vice President, Controller with technical public company accounting and financial reporting experience, as well as other team members. We also have access to accounting training, literature, research materials and increased communication among our personnel and outsourced third-party professionals with whom we may consult regarding the application of complex accounting transactions. Our remediation plan can only be accomplished over time and will be continually reviewed to determine that we are achieving our objectives. There is no assurance that these initiatives will ultimately have the intended effects. The material weaknesses will not be considered remediated until our management designs and implements effective controls that operate for a sufficient period of time and our management has concluded through testing that these controls are effective.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Changes in Internal Controls</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other than the changes made to remediate the material weakness described above, there were no changes in our internal control over financial reporting, identified in connection with the evaluation of such internal control that occurred during the fourth quarter ended December 31, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_9b_other_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9B. OTHE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">R INFORMATION</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Effective March 21, 2022, Mark Hughes, our Chief Operating Officer, transitioned from the position as Chief Operating Officer to his new position as Vice President, Hardware Engineering and Operations. Mr. Hughes&#x2019; annual base salary will remain $325,000. As a result of this transition, Mr. Hughes has ceased to serve as an executive officer of the Company.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_9c_disclosure_regarding_foreign_jur"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9C. </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Disclosure Regarding Foreign Ju</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">risdictions that Prevent Inspections</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">91</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="part_iii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PAR</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">T III</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_10_directors_executive_officers"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 10. DIRECTORS, EXECUTIVE OFFICER</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">S AND CORPORATE GOVERNANCE</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Board of Directors and Management</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Effective as of the Closing Date, and in connection with closing of the Business Combination, each the executive officers of HealthCor resigned and were replaced by certain members of the management team of Legacy Hyperfine, and each of the directors of HealthCor resigned and the stockholders elected seven directors to serve on the Company&#x2019;s board of directors (the &#x201c;Hyperfine Board&#x201d;). Accordingly, the following table sets forth certain information concerning our executive officers and directors as of February 15, 2022:</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:26.899%;"></td>
    <td style="width:4.602%;"></td>
    <td style="width:10.474%;"></td>
    <td style="width:3.72%;"></td>
    <td style="width:52.767%;"></td>
    <td style="width:1.537%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;border-bottom:0.750pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;border-bottom:0.750pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Age</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;border-bottom:0.750pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Position</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;border-bottom:0.750pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Executive Officers:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dave Scott</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President, Chief Executive Officer and Director</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Alok Gupta</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Financial Officer</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Khan Siddiqui, M.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Medical Officer and Chief Strategy Officer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Neela Paykel</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General Counsel, Chief Compliance Officer and Corporate Secretary</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Scott White</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Commercial Officer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Non-Employee Directors:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">R. Scott Huennekens</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Executive Chairman</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Jonathan M. Rothberg, Ph.D.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">58</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vice Chairman</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">John Dahldorf</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ruth Fattori</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">69</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Maria Sainz</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Daniel J. Wolterman</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.041666666666666664in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Executive Officers</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dave Scott</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as our President since March 2022 and as our Chief Executive Officer and as a director of the Company since the Closing of the Business Combination in December 2021 and had served as Chief Executive Officer of Legacy Hyperfine since May 2021. Prior to joining the Company, Mr. Scott led advanced Research and Development innovation teams as an Executive at Apple, Inc.&#x2019;s confidential Special Projects Group from October 2019 to May 2021. From 2015 to 2019, Mr. Scott was the Chief Operating Officer and EVP of Research and Development for Verb Surgical, an independent start-up company formed by Google and Johnson &amp; Johnson to develop surgical platforms, including advanced surgical robotics. Mr. Scott previously served as Divisional VP of Research and Development for Abbott Medical Optics and as VP of Research and Development at OptiMedica, later acquired by Abbott Medical Optics. In addition, Mr. Scott led Intuitive Surgical&#x2019;s advanced imaging technologies team, which designed, developed and brought to market the visualization platform for the da Vinci&#174; robotic surgical system. Mr. Scott has been awarded over 25 patents in X-ray imaging, medical endoscopy and laser surgery applications. Mr. Scott serves on the Board of Directors at the Alfred Mann Foundation and holds a Bachelor of Science in Aerospace Engineering from the University of Kansas and a Master of Science in Aerospace Engineering from the University of Colorado, Boulder. Mr. Scott&#x2019;s qualifications to serve on the Hyperfine Board include his leadership experience in the medical technology industry, as well as his knowledge of our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Alok Gupta</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as our Chief Financial Officer since the Closing of the Business Combination in December 2021 and had served as Chief Financial Officer of Legacy Hyperfine since August 2021. Prior to joining the Company, Mr. Gupta served as the Chief Financial Officer and Chief Strategy Officer of Halio, Inc., an electrochromic smart glass company providing an intelligent platform for daylight management, from October 2019 to August 2021. From 2014 to 2019, Mr. Gupta was Managing Director at Mizuho Securities. Mr. Gupta received a Bachelor of Science degree in Mechanical Engineering from Jiwaji University, a Master of Science degree in Manufacturing Systems Engineering from Oklahoma State University and a Master of Business Administration degree from the University of California, Los Angeles.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Khan Siddiqui, M.D.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as our Chief Medical Officer and Chief Strategy Officer since the Closing of the Business Combination in December 2021 and had served as Chief Medical Officer and Chief Strategy Officer of Legacy Hyperfine since January 2020. Dr. Siddiqui also serves on a medical advisory board of 4Catalyzer that provides services to 4Catalyzer companies. Prior to joining the Company, Dr. Siddiqui founded and served in leadership roles at higi, Inc. as the Chief</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">92</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Executive Officer from 2012 to 2013 and the Chief Medical Officer and Chief Technology Officer from 2013 to 2021. Dr. Siddiqui received an M.D. degree from Aga Khan University in Karachi, Pakistan and completed a fellowship in imaging informatics at the University of Maryland Medical Center.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Neela Paykel</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as our General Counsel and Corporate Secretary since the Closing of the Business Combination in December 2021, has served as our Chief Compliance Officer since March 2022, and had served as General Counsel of Legacy Hyperfine since May 2021. Prior to joining the Company, Ms. Paykel served as the deputy general counsel at Waymo, LLC, an autonomous vehicle technology company, from November 2018 to April 2021. From 2016 to 2018, Ms. Paykel was the Vice President, Legal Affairs and Compliance at Proteus Digital Health. Ms. Paykel received a Bachelor of Arts in International Business Administration from Illinois Wesleyan University and a Juris Doctor degree from The George Washington University Law School.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Scott White</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as our Chief Commercial Officer since the Closing of the Business Combination in December 2021 and had served as Chief Commercial Officer of Legacy Hyperfine since September 2021. Prior to joining the Company, Mr. White served as the Vice President of Global Sales for Rapid Micro Biosystems, Inc., a newly public biotech company focused on microbiology automation, from 2018 to September 2021. From 2017 to 2018, Mr. White was the Market President for Compass Surgical Partners, LLC, a private healthcare management firm. Mr. White also previously served as the Managing Partner for the Florida Market of Surgery Center Development Co., LLC, a private management company for outpatient surgery centers, from 2015 to 2017. Mr. White received a Bachelor of Science in Business Administration from the University of Florida and a Master in Business Administration from the University of Miami.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Non-Employee Directors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">R. Scott Huennekens</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as the Executive Chairman of the Hyperfine Board since the Closing of the Business Combination in December 2021 and had served as the Executive Chairman of Legacy Hyperfine&#x2019;s board of directors since April 2021. Mr. Huennekens also serves as member of the board of directors of Acutus Medical, Inc., Envista Holdings Corporation and NuVasive, Inc., and was previously on the board of REVA Medical, Inc. and ViewRay, Inc. From August 2015 to December 2018, Mr. Huennekens was the President, Chief Executive Officer and Chairman of the board for Verb Surgical. Prior to joining Verb Surgical in 2015, Mr. Huennekens was President, Chief Executive Officer and a board member of Volcano Corporation for 13 years. Mr. Huennekens received a Bachelor of Science degree in Business Administration from the University of Southern California, and a Master of Business Administration degree from Harvard Graduate School of Business. Mr. Huennekens&#x2019; qualifications to serve on the Hyperfine Board include his extensive executive experience in the biomedical technology industry and his significant corporate governance experience.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Jonathan M. Rothberg, Ph.D.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> is the Founder of Legacy Hyperfine and Liminal and has served as Vice Chairman of the Hyperfine Board since the Closing of the Business Combination in December 2021 and had served on the board of directors of Legacy Hyperfine since 2014 and the board of directors of Liminal since 2018. Dr. Rothberg previously served as Legacy Hyperfine&#x2019;s Chief Executive Officer from 2014 to 2021. Dr. Rothberg is a scientist and entrepreneur who was awarded the National Medal of Technology and Innovation, the nation&#x2019;s highest honor for technological achievement, by President Obama for inventing and commercializing high-speed DNA sequencing. Dr. Rothberg is the Founder of the 4Catalyzer medical technology incubator and the Founder and Chairman of its companies: Legacy Hyperfine, Liminal, Quantum-Si Incorporated, Butterfly Network, Inc., AI Therapeutics, Inc. (formerly LAM Therapeutics, Inc.), Tesseract Health, Inc. and Detect, Inc. (formerly Homodeus Inc.). These companies focus on using inflection points in medicine, such as deep learning, next-generation sequencing, and the silicon supply chain, to address global healthcare challenges. Dr. Rothberg previously founded and served as Chairman, Chief Executive Officer, and Chief Technology Officer of Ion Torrent Systems, Inc. from 2007 to 2010, and founded and served as Chairman and Chief Executive Officer of RainDance Technologies, Inc. from 2004 to 2009. From 1999 to 2007, Dr. Rothberg co-founded and served as Chairman of ClarifI, Inc., and from 1999 to 2006, he founded and served as Chairman, Chief Executive Officer and Chief Technology Officer of 454 Life Sciences Corporation. With 454 Life Sciences, Dr. Rothberg brought to market the first new way to sequence genomes since Sanger and Gilbert won the Nobel Prize for their method in 1980. With 454&#x2019;s technology, Dr. Rothberg sequenced the first individual human genome, and with Svante Paabo he initiated the first large-scale effort to sequence ancient DNA (The Neanderthal Genome Project). Prior to 454 Life Sciences, Dr. Rothberg founded and served as Chairman and Chief Executive Officer of CuraGen Corporation from 1993 to 2004. Dr. Rothberg&#x2019;s contributions to the field of genome sequencing include the first non-bacterial cloning method (cloning by limited dilution) and the first massively parallel DNA sequencing method (parallel sequencing by synthesis on a single substrate), concepts that have formed the basis for all subsequent next generation sequencing technologies. Dr. Rothberg is an Ernst and Young Entrepreneur of the Year, is the recipient of The Wall Street Journal&#x2019;s First Gold Medal for Innovation, SXSW Best in Show, Nature Methods First Method of the Year Award, the Connecticut Medal of Technology, the DGKL Biochemical Analysis Prize, and an Honorary Doctorate of Science from Mount Sinai. Dr. Rothberg is a member of the National Academy of Engineering, the Connecticut Academy of Science and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">93</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Engineering, is a trustee of Carnegie Mellon University and an Adjunct Professor of Genetics at Yale University. Dr. Rothberg serves as Chairman of the board of directors of Butterfly Network, Inc. (NYSE: BFLY) and Executive Chairman of the board of directors of Quantum-Si Incorporated (Nasdaq: QSI). Dr. Rothberg has served as Interim Chief Executive Officer of Quantum-Si Incorporated since February 2022. Dr. Rothberg received his Ph.D., M.Phil. and M.S. in biology from Yale University and his B.S. in chemical engineering from Carnegie Mellon University. Dr. Rothberg&#x2019;s qualifications to serve on the Hyperfine Board include his significant scientific, executive and board leadership experience in the technology industry, as well as his knowledge of our business as the Founder of Legacy Hyperfine and Liminal.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">John Dahldorf</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served on the Hyperfine Board since the Closing of the Business Combination in December 2021. Since 2017, Mr. Dahldorf serves as the Chief Financial Officer of Santa Cruz Nutritionals. From 2015 to 2017, Mr. Dahldorf was the Chief Financial Officer of Acutus Medical, Inc. Mr. Dahldorf received a Bachelor of Finance and Master of Business Administration from Western Illinois University. Mr. Dahldorf&#x2019;s qualifications to serve on the Hyperfine Board include his extensive financial and accounting experience.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Ruth Fattori</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served on the Hyperfine Board since the Closing of the Business Combination in December 2021 and had served on the board of directors of Legacy Hyperfine since August 2021. Since January 2019, Ms. Fattori serves as the managing Partner of Pecksland Partners, a consulting firm dedicated to advising board of directors, CEOs and senior executives on human resources issues. Ms. Fattori also serves as a Senior Advisor at the Boston Consulting Group supporting their CEO Advisory program and People and Organization Practice. From February 2013 through December 2018, Ms. Fattori served in various roles at PepsiCo, Inc., most recently as Executive Vice President and Chief Human Resources Officer. From 2010 to February 2013, Ms. Fattori served as Managing Partner of Pecksland Partners, and from 2008 to 2009 she was Executive Vice President and Chief Administrative Officer for MetLife. Earlier, Ms. Fattori was the Executive Vice President and Chief Human Resources Officer at Motorola. Ms. Fattori serves on the board of directors of Quantum-Si Incorporated. Ms. Fattori received a Bachelor of Science in mechanical engineering from Cornell University. Ms. Fattori&#x2019;s qualifications to serve on the Hyperfine Board include her extensive executive and human resources management experience.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Maria Sainz</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served on the Hyperfine Board since the Closing of the Business Combination in December 2021. Ms. Sainz also serves as member of the board of directors of ShockWave Medical, Inc., Avanos Medical, Inc. and Atrion Corporation, and was previously on the board of Orthofix Medical Inc., Iridex Corporation and MRI Interventions, Inc. Ms. Sainz served as the President and CEO of Aegea Medical, a medical device company in the women&#x2019;s health space focused on the development of technology for endometrial ablation, from May 2018 through February 2021. Prior to that, she served as the President and CEO of Cardiokinetix, a medical device company, from 2012 until 2017. Ms. Sainz received a Bachelor of Arts in Linguistics from the University Complutense in Madrid, Spain and a Masters in International Business from the American Graduate School of International Management. Ms. Sainz&#x2019;s qualifications to serve on the Hyperfine Board include her leadership experience in the healthcare industry.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Daniel J. Wolterman</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served on the Hyperfine Board since the Closing of the Business Combination in December 2021. Mr. Wolterman is currently Chief Executive Officer of Wolterman Consulting LLC, a provider of strategic and operational consulting services to healthcare providers and other entities. From January 2018 to May 2019, Mr. Wolterman served as Chief Executive Officer of ColubrisMX, Inc. and X-Cath, Inc., both privately held medical device companies. Mr. Wolterman previously served as President and Chief Executive Officer of Memorial Hermann Health System, the largest not-for-profit health system in Southeast Texas, from 2002 until his retirement from Memorial Hermann in May 2016. Mr. Wolterman has more than 40 years of experience in the healthcare industry and a long history of community involvement. &#x200a;Mr. Wolterman has served as a member of the board of directors of NuVasive, Inc. since July 2015 and the chairman of the board of directors of NuVasive, Inc. since May 2021. Mr. Wolterman previously served on the board of directors of Invuity, Inc. and Volcano Corporation. In addition, Mr. Wolterman was the 2016 Inductee into the Texas Business Hall of Fame. Mr. Wolterman received a Bachelor of Science degree in business administration and a Master of Business Administration degree from the University of Cincinnati and a Master of Healthcare Administration degree from Xavier University. Mr. Wolterman&#x2019;s qualifications to serve on the Hyperfine Board include his leadership experience in the healthcare industry.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are no family relationships between or among any of our directors or executive officers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Role of Board in Risk Oversight</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The board of directors have extensive involvement in the oversight of risk management related to us and our business and will accomplish this oversight through the regular reporting to the board of directors by the audit committee. The audit committee will represent the board of directors by periodically reviewing our accounting, reporting and financial practices, including the integrity of its financial statements, the surveillance of administrative and financial controls and its compliance with legal and regulatory requirements. Through its regular meetings with management, including the finance, legal, internal audit and information technology functions, the audit committee will review and discuss all significant areas of our business</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">94</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and summarize for the board of directors all areas of risk and the appropriate mitigating factors. In addition, the board of directors will receive periodic detailed operating performance reviews from management.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Controlled Company Exemption</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Jonathan M. Rothberg, Ph.D. beneficially owns a majority of the voting power of all outstanding shares of our common stock. As a result, we are a &#x201c;controlled company&#x201d; within the meaning of the Nasdaq Listing Rules. Under the Nasdaq Listing Rules, a company of which more than 50% of the voting power for the election of directors is held by an individual, group or another company is a &#x201c;controlled company&#x201d; and may elect not to comply with certain corporate governance standards, including the requirements (1) that a majority of its board of directors consist of independent directors, (2) that its board of directors have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee&#x2019;s purpose and responsibilities and (3) that director nominees must either be selected, or recommended for the board&#x2019;s selection, either by independent directors constituting a majority of the board&#x2019;s independent directors in a vote in which only independent directors participate, or a nominating and corporate governance committee comprised solely of independent directors with a written charter addressing the committee&#x2019;s purpose and responsibilities. As a result, you may not have the same protections afforded to stockholders of companies that are subject to all of these corporate governance requirements. If we cease to be a &#x201c;controlled company&#x201d; and our shares continue to be listed on Nasdaq, we will be required to comply with these standards and, depending on the board&#x2019;s independence determination with respect to our then-current directors, we may be required to add additional directors to our board in order to achieve such compliance within the applicable transition periods.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Composition of the Board of Directors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business and affairs will be managed under the direction of our board of directors. Our board of directors is declassified and the directors will be elected annually.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Independence of the Board of Directors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Nasdaq rules generally require that independent directors must comprise a majority of a listed company&#x2019;s board of directors. As a controlled company, we are largely exempt from such requirements. Based upon information requested from and provided by each proposed director concerning his or her background, employment and affiliations, including family relationships, we have determined that John Dahldorf, Maria Sainz, Daniel J. Wolterman, and Ruth Fattori, representing four of our directors, are &#x201c;independent&#x201d; as that term is defined under the applicable rules and regulations of the SEC and the listing requirements and rules of Nasdaq.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Board Committees</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The standing committees of the Hyperfine Board consist of an audit committee, a compensation committee and a nominating and corporate governance committee. Hyperfine Board may from time to time establish other committees.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our chief executive officer and other executive officers will regularly report to the non-executive directors and the audit, the compensation and the nominating and corporate governance committees to ensure effective and efficient oversight of our activities and to assist in proper risk management and the ongoing evaluation of management controls. We believe that the leadership structure of the Hyperfine Board will provide appropriate risk oversight of our activities given the controlling interests held by Jonathan M. Rothberg, Ph.D.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Audit Committee</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our audit committee consists of John Dahldorf, who serves as the chairperson, Maria Sainz and Daniel J. Wolterman. Each member of the audit committee qualifies as an independent director under the Nasdaq Listing Rules and the independence requirements of Rule 10A-3 under the Exchange Act. The Hyperfine Board has determined that Mr. Dahldorf qualifies as an &#x201c;audit committee financial expert&#x201d; as such term is defined in Item 407(d)(5) of Regulation S-K and possesses financial sophistication, as defined under the rules of Nasdaq.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The purpose of the audit committee is to prepare the audit committee report required by the SEC to be included in our proxy statement and to assist the board of directors in overseeing and monitoring (1) the quality and integrity of the financial statements, (2) compliance with legal and regulatory requirements, (3) our independent registered public accounting firm&#x2019;s qualifications and independence, and (4) the performance of our independent registered public accounting firm.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">95</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The board of directors has adopted a written charter for the audit committee which is available on our website at https://hyperfine.io under Investors&#x2009;&#x2014;&#x2009;Corporate Governance&#x2009;&#x2014;&#x2009;Documents &amp; Charters.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Compensation Committee</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our compensation committee consists of Ruth Fattori, who serves as the chairperson, and John Dahldorf.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The purpose of the compensation committee is to assist the board of directors in discharging its responsibilities relating to (1) setting our compensation program and compensation of our executive officers and directors, (2) monitoring our incentive and equity-based compensation plans and (3) preparing the compensation committee report required to be included in our proxy statement under the rules and regulations of the SEC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The board of directors has adopted a written charter for the compensation committee, which is available on our website at https://hyperfine.io under Investors&#x2009;&#x2014;&#x2009; Corporate Governance&#x2009;&#x2014;&#x2009;Documents &amp; Charters.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Nominating and Corporate Governance Committee</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our nominating and corporate governance committee consists of Daniel J. Wolterman, who serves as the chairperson, Ruth Fattori and Maria Sainz.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The purpose of the nominating and corporate governance committee is to assist the board of directors in discharging its responsibilities relating to (1) identifying individuals qualified to become new board of directors members, consistent with criteria approved by the board of directors, (2) reviewing the qualifications of incumbent directors to determine whether to recommend them for reelection and selecting, or recommending that the board of directors select, the director nominees for the next annual meeting of stockholders, (3) identifying members of the board of directors qualified to fill vacancies on any committee of the board of directors and recommending that the board of directors appoint the identified member or members to the applicable committee, (4) reviewing and recommending to the board of directors corporate governance principles applicable to us, (5) overseeing the evaluation of the board of directors, (6) overseeing the process of succession planning for the Chief Executive Officer and, as warranted, other senior officers of Hyperfine and (7) handling such other matters that are specifically delegated to the committee by the board of directors from time to time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The board of directors has adopted a written charter for the nominating and corporate governance committee which is available on our website at https://hyperfine.io under Investors&#x2009;&#x2014;&#x2009; Corporate Governance&#x2009;&#x2014;&#x2009;Documents &amp; Charters.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Code of Business Conduct and Ethics</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have adopted a code of business conduct and ethics that applies to all of our directors, officers and employees, including our principal executive officer, principal financial officer and principal accounting officer, which is available on our website at https://hyperfine.io under Investors&#x2009;&#x2014; Corporate Governance&#x2009;&#x2014;&#x2009;Documents &amp; Charters. Our code of business conduct is a &#x201c;code of ethics,&#x201d; as defined in Item 406(b) of Regulation S-K. We will make any legally required disclosures regarding amendments to, or waivers of, provisions of our code of ethics in a Current Report on Form 8-K within four business days following the date of the amendment or waiver, unless website posting or the issuance of a press release of such amendment or waiver is then permitted by Nasdaq rules.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Corporate Governance Guidelines</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors has adopted corporate governance guidelines that serve as a flexible framework within which our board of directors and our committees operate. These guidelines cover a number of areas including board membership criteria and director qualifications, director responsibilities, board agenda, meetings of non-management directors, committee responsibilities and assignments, board member access to management and independent advisors, director communications with third parties, director compensation, director orientation and continuing education, evaluation of our chief executive officer management succession planning. A copy of our corporate governance guidelines is posted on our website at https://hyperfine.io under Investors&#x2009;&#x2014;&#x2009; Corporate Governance&#x2009;&#x2014;&#x2009;Documents &amp; Charters.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:66.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">96</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 11. EXECUTIV</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">E COMPENSATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Executive and Director Compensation of HealthCor</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following disclosure concerns the compensation of HealthCor&#x2019;s executive officers and directors from inception (i.e. pre-Business Combination).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None of HealthCor&#x2019;s executive officers or directors have received any cash compensation for services rendered to HealthCor. Since the consummation of HealthCor&#x2019;s initial public offering and until the earlier of the consummation of the initial business combination or HealthCor&#x2019;s liquidation, HealthCor agreed to reimburse the Sponsor for office space and secretarial and administrative services provided to HealthCor, in an amount up to $10,000 per month. In addition, the Sponsor, executive officers and directors and their respective affiliates were reimbursed for any out-of-pocket expenses incurred in connection with activities conducted on HealthCor&#x2019;s behalf, such as identifying potential target businesses and performing due diligence on suitable business combinations. HealthCor&#x2019;s audit committee was responsible for reviewing all payments made by HealthCor to the Sponsor, executive officers and directors and their respective affiliates on a quarterly basis. Any such payments prior to the Business Combination were made using funds held outside of the Trust Account. Other than quarterly audit committee review of such reimbursements, HealthCor did not have any additional controls in place for governing reimbursement payments to its directors and executive officers for their out-of-pocket expenses incurred on behalf of HealthCor and in connection with identifying and consummating an initial business combination. Other than these payments and reimbursements, no compensation of any kind, including finder&#x2019;s and consulting fees, was paid by HealthCor to the Sponsor, executive officers and directors or any of their respective affiliates, prior to completion of the Business Combination.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Executive and Director Compensation of Hyperfine</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This section provides an overview of Hyperfine&#x2019;s executive compensation programs, including a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table below. The number of securities and exercise prices, as applicable, described in this section have been adjusted based on the Hyperfine Exchange Ratio or Liminal Exchange Ratio, as applicable, to reflect the number of securities and exercise prices following the Business Combination.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, Hyperfine&#x2019;s named executive officers (&#x201c;Named Executive Officers&#x201d; or &#x201c;NEOs&#x201d;) were:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dave Scott, President and Chief Executive Officer,</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Khan Siddiqui, M.D., Chief Medical Officer and Chief Strategy Officer, and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Neela Paykel, General Counsel, Chief Compliance Officer and Corporate Secretary.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The objective of our compensation program is to provide a total compensation package to each NEO that will enable us to attract, motivate and retain outstanding individuals, align the interests of our executive team with those of our equity holders, encourage individual and collective contributions to the successful execution of our short- and long-term business strategies and reward NEOs for performance. Prior to the completion of the Business Combination in December 2021, Legacy Hyperfine&#x2019;s board of directors historically determined the compensation for the NEOs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For 2021, the compensation program for the NEOs consisted of a base salary and incentive compensation delivered in the form of cash bonuses and time-based stock option awards, each as described below:</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Base Salary</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Base salary is paid to attract and retain qualified talent and is set at a level that is commensurate with the executive&#x2019;s duties and authorities, contributions, prior experience and sustained performance.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash Bonuses</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Cash bonuses are paid to incentivize the NEOs to achieve annual financial and operating performance metrics and have been paid at the discretion of the board of directors. Other than the CEO, the bonus is approved by the compensation committee.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">97</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Summary Compensation Table</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table shows information concerning the annual compensation for services provided to us by our NEOs for the year ended December 31, 2020 and 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:20.9%;"></td>
    <td style="width:0.994%;"></td>
    <td style="width:8.954%;"></td>
    <td style="width:0.994%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:9.968%;"></td>
    <td style="width:0.994%;"></td>
    <td style="width:2.087%;"></td>
    <td style="width:0.994%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:10.982%;"></td>
    <td style="width:0.994%;"></td>
    <td style="width:2.087%;"></td>
    <td style="width:0.994%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:12.95%;"></td>
    <td style="width:0.994%;"></td>
    <td style="width:4.174%;"></td>
    <td style="width:0.994%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:14.719%;"></td>
    <td style="width:0.576%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Name and Position</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Salary ($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Bonus ($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Option Awards ($)(1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total ($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Dave Scott, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">President and Chief Executive Officer</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">252,147</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,000,000</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5,848,819</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8,100,966</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Khan Siddiqui, M.D., </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">Chief Medical Officer and Chief Strategy Officer</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">331,250</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">144,000</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">108,195</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(6)(7)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">583,445</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">255,208</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">150,000</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">494,241</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">899,449</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Neela Paykel, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">General Counsel, Chief Compliance Officer and Corporate Secretary</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">233,333</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">152,500</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">201,683</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(10)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">587,516</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1) The amount represents the aggregate grant date fair value for option awards computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, or ASC 718. A discussion of our methodology for determining grant date fair value may be found in Note 12 to our audited combined and consolidated financial statements for the year ended December 31, 2021 included in this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2) Mr. Scott joined Legacy Hyperfine on May 24, 2021. His current annual base salary is $750,000.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(3) Mr. Scott received a one-time signing bonus of $1,500,000, with the first installment of $750,000 paid upon his start date and the second installment of $750,000 paid upon the six-month anniversary of his start date, and a $500,000 discretionary bonus with respect to 2021 performance. Dr. Siddiqui received a $50,000 discretionary transaction bonus paid in connection with the consummation of the Business Combination and a $94,000 discretionary bonus with respect to 2021 performance. Ms. Paykel received a one-time signing bonus of $25,000, a $25,000 discretionary transaction bonus paid in connection with the consummation of the Business Combination and a $102,500 discretionary bonus with respect to 2021 performance.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4) Mr. Scott was granted options to purchase shares of Legacy Hyperfine common stock in April 2021 with an exercise price per share equal to the fair market value of the common stock on the grant date. 1,899,500 of the shares underlying the options have an exercise price per share of $3.27 and vest, subject to continued service, as to 25% on June 30, 2022, with the remainder vesting in 36 equal monthly installments thereafter, and 949,750 of the shares underlying the options have an exercise price per share of $3.27 and vest, subject to continued service, upon the achievement of performance conditions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(5) Dr. Siddiqui joined Legacy Hyperfine as its Chief Medical Officer and Chief Strategy Officer on January 27, 2020. His current annual base salary is $375,000.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(6) Dr. Siddiqui was granted options to purchase shares of Legacy Hyperfine common stock in April 2021 with an exercise price per share equal to the fair market value of the common stock on the grant date. The 54,037 shares underlying the options have an exercise price per share of $3.27 and vest, subject to continued service, in 48 monthly installments beginning on January 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(7) Dr. Siddiqui was granted options to purchase shares of Liminal common stock in May 2021 with an exercise price per share equal to the fair market value of the common stock on the grant date. The 1,796 shares underlying the options have an exercise price per share of $5.24 and vest, subject to continued service, in 48 monthly installments beginning on October 31, 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(8) Dr. Siddiqui was granted options to purchase shares of Legacy Hyperfine common stock in January 2020 with an exercise price per share equal to the fair market value of the common stock on the grant date. The 235,145 shares underlying the options have an exercise price per share of $3.76 and vest, subject to continued service, as follows: 25% of the shares vested on December 31, 2020, with the remainder vesting in equal monthly installments over the following 36 months.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(9) Ms. Paykel joined Legacy Hyperfine in May 2021. Her current annual base salary is $350,000.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(10) Ms. Paykel was granted options to purchase shares of Legacy Hyperfine common stock in April 2021 with an exercise price per share equal to the fair market value of the common stock on the grant date. The 98,250 shares underlying the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">98</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">options have an exercise price per share of $3.27 and vest, subject to continued service, as to 25% on June 30, 2022, with the remainder vesting in equal monthly installments over the following three years.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Outstanding Equity Awards at 2021 Fiscal Year-End</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table shows information regarding outstanding equity awards held by the NEOs as of December 31, 2021. The number of securities and exercise prices, as applicable, described in this section have been adjusted based on the Hyperfine Exchange Ratio and the Liminal Exchange Ratio, as applicable, to reflect the number of securities and exercise prices following the Business Combination.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:25.169%;"></td>
    <td style="width:1.401%;"></td>
    <td style="width:12.957%;"></td>
    <td style="width:1.401%;"></td>
    <td style="width:0.576%;"></td>
    <td style="width:12.023%;"></td>
    <td style="width:0.576%;"></td>
    <td style="width:2.266%;"></td>
    <td style="width:1.401%;"></td>
    <td style="width:0.576%;"></td>
    <td style="width:12.073%;"></td>
    <td style="width:0.566%;"></td>
    <td style="width:1.401%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:11.506%;"></td>
    <td style="width:0.566%;"></td>
    <td style="width:1.401%;"></td>
    <td style="width:12.977%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Option Awards<br />Grant Date</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Number of Securities Underlying Unexercised Options Exercisable (#)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:5.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Number of Securities Underlying Unexercised Options Unexercisable (#)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Option Exercise Price</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Option Expiration Date</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Dave Scott</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4/27/2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:5.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,899,500</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.27</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4/27/2031</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4/27/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:5.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">474,875</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.27</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4/27/2031</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4/27/2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:5.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">474,875</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.27</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4/27/2031</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Khan Siddiqui, M.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1/27/2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">52,397</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">52,403</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.76</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1/27/2030</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1/27/2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">65,169</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">65,176</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.76</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1/27/2030</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4/14/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">13,507</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">40,530</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.27</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4/14/2031</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5/12/2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">561</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(7)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,235</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5.24</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5/12/2031</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Neela Paykel</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4/27/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">98,250</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.27</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4/27/2031</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1) Represents an option to purchase 1,899,500 shares of Class A common stock granted on April 27, 2021. The shares underlying this option vest, subject to continued service, as follows: 25% of the shares vest on June 30, 2022, with the remainder vesting in equal monthly installments over the following 36 months.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2) Represents an option to purchase 474,875 shares of Class A common stock granted on April 27, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a business combination that results in the operating business of Legacy Hyperfine and Liminal becoming a publicly traded company (a &#x201c;SPAC transaction&#x201d;) within two years of Mr. Scott&#x2019;s start date and the common stock of the Company achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within two years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Legacy Hyperfine and Liminal (&#x201c;IPO&#x201d;) within two years of Mr. Scott&#x2019;s start date and the common stock of the Company achieving a closing price per share that equals or exceeds 1.5 times $3.92 (as adjusted) within two years of the closing of the IPO; or (3) the closing of a private financing round within two years of Mr. Scott&#x2019;s start date in which $50 million or more is raised and the Company&#x2019;s stock price per share equals or exceeds 1.5 times $3.92 (as adjusted).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(3) Represents an option to purchase 474,875 shares of Class A common stock granted on April 27, 2021. The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Scott&#x2019;s start date and the Company&#x2019;s common stock achieving a price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Scott&#x2019;s start date and the Company&#x2019;s common stock achieving a price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Scott&#x2019;s start date in which $50 million or more is raised and the Company&#x2019;s stock price per share equals or exceeds 3.0 times $3.92 (as adjusted).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4) Represents an option to purchase 104,800 shares of Class A common stock granted on January 27, 2020. The shares underlying this option vest, subject to continued service, as follows: 25% of the shares vested on December 31, 2020, with the remainder vesting in equal monthly installments over the following 36 months.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(5) Represents an option to purchase 130,345 shares of Class A common stock granted on January 27, 2020. The shares underlying this option vest, subject to continued service, as follows: 25% of the shares vested on December 31, 2020, with the remainder vesting in equal monthly installments over the following 36 months.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(6) Represents an option to purchase 54,037 shares of Class A common stock granted on April 14, 2021. The shares underlying this option vest, subject to continued service, in 48 equal monthly installments beginning on January 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">99</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(7) Represents an option to purchase 1,796 shares of Class A common stock granted on May 12, 2021. The shares underlying this option vest, subject to continued service, in 48 equal monthly installments beginning on October 31, 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(8) Represents an option to purchase 98,250 shares of Class A common stock granted on April 27, 2021. The shares underlying this option vest, subject to continued service, as follows: 25% of the shares vest on June 30, 2022, with the remainder vesting in equal monthly installments over the following 36 months.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Employment Arrangements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine entered into an Offer Letter of Employment with Mr. Scott as Legacy Hyperfine&#x2019;s President and Chief Executive Officer on April 25, 2021, an Offer Letter of Employment with Alok Gupta as Legacy Hyperfine&#x2019;s Chief Financial Officer on July 17, 2021, an Offer Letter of Employment with Mr. Hughes on June 7, 2019, an Offer Letter of Employment with Dr. Siddiqui as Legacy Hyperfine&#x2019;s Chief Medical Officer and Chief Strategy Officer on January 4, 2020, an Offer Letter of Employment with Neela Paykel as Legacy Hyperfine&#x2019;s General Counsel on April 13, 2021, and an Offer Letter of Employment with Scott White as Legacy Hyperfine&#x2019;s Chief Commercial Officer on August 24, 2021, the material terms of which are described below. In addition, each named executive officer has entered into a confidentiality agreement obligating the officer to refrain from disclosing any of our proprietary information received during the course of employment.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dave Scott</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine entered into an Offer Letter of Employment with Mr. Scott on April 25, 2021, as amended, to begin employment as Legacy Hyperfine&#x2019;s President and Chief Executive Officer on May 24, 2021. Pursuant to the terms of his Offer Letter, Mr. Scott&#x2019;s initial annual base salary was $400,000. Effective December 22, 2021, Mr. Scott&#x2019;s annual base salary is $750,000. Mr. Scott is eligible to receive a minimum discretionary bonus of $400,000 for 2021 based on the successful completion of the Company&#x2019;s initial public offering or a business combination that results in the operating business of the Company becoming a publicly traded company and the attainment of other goals, objectives and performance metrics. Beginning in 2022, Mr. Scott is eligible to receive an annual discretionary bonus with a target of 100% of Mr. Scott&#x2019;s base salary and a cap of 200% of Mr. Scott&#x2019;s base salary, provided that he is employed with Hyperfine through the scheduled date of payment of such bonus.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to his Offer Letter, Mr. Scott received a one-time signing bonus of $1,500,000, with the first installment of $750,000 paid upon his start date and the second installment of $750,000 paid upon the six-month anniversary of his start date. If Mr. Scott is terminated by the Company for cause (as defined in his Offer Letter) or resigns without good reason (as defined in his Offer Letter) prior to the six-month anniversary of his start date, Mr. Scott is required to repay the sign-on bonus. If Mr. Scott is terminated by the Company without cause or resigns with good reason, he will not be required to repay the sign-on bonus.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, pursuant to the Offer Letter, Mr. Scott was granted 1,899,500 time-based stock options with an exercise price of $3.27 per share, with 25% of the award to vest on June 30, 2022, and the remainder of the options vesting in equal monthly installments over the following 36 months. If Mr. Scott&#x2019;s employment terminates because of his death, such options will vest such that no less than 50% of the shares subject to the award will be vested on the termination date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Mr. Scott was also granted 474,875 performance-based stock options with an exercise price of $3.27 per share, which options vest upon the first to occur of: (1) the completion of a business combination that results in the operating business of Legacy Hyperfine and Liminal becoming a publicly traded company (a &#x201c;SPAC transaction&#x201d;) within two years of Mr. Scott&#x2019;s start date and the Company&#x2019;s common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within two years of the closing of the SPAC transaction; (2) the completion of the initial public offering of Legacy Hyperfine and Liminal (&#x201c;IPO&#x201d;) within two years of Mr. Scott&#x2019;s start date and the Company&#x2019;s common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 (as adjusted) within two years of the closing of the IPO; or (3) the closing of a private financing round (a &#x201c;Financing&#x201d;) within two years of Mr. Scott&#x2019;s start date in which $50 million or more is raised and the Company&#x2019;s stock price per share equals or exceeds 1.5 times $3.92 (as adjusted). In addition, Mr. Scott was granted 474,875 performance-based stock options with an exercise price of $3.27 per share, which options vest upon the first to occur of: (1) the completion of a SPAC transaction within two years of Mr. Scott&#x2019;s start date and the Company&#x2019;s common stock achieving a price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Scott&#x2019;s start date and the Company&#x2019;s common stock achieving a price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Scott&#x2019;s start date in which $50 million or more is raised and the Company&#x2019;s stock price per share equals or exceeds 3.0 times $3.92 (as adjusted). Mr. Scott&#x2019;s Offer Letter provides that, subject to approval by the board of directors, Mr. Scott will be granted 474,875 performance-based stock options, which options will vest upon the first to occur of: (1) the completion of a SPAC</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">transaction within two years of Mr. Scott&#x2019;s start date and the Company&#x2019;s common stock achieving a price per share of $50.00 or more for at least 20 out of 30 consecutive trading days within six years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Scott&#x2019;s start date and the Company&#x2019;s common stock achieving a price per share that equals or exceeds 5.0 times $3.92 (as adjusted) within six years of the closing of the IPO; or (3) the closing of a private financing round within six years of Mr. Scott&#x2019;s start date in which $50 million or more is raised and Hyperfine&#x2019;s stock price per share equals or exceeds 5.0 times $3.92 (as adjusted).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Following the closing of a SPAC transaction or IPO within two years of Mr. Scott&#x2019;s start date, Mr. Scott will receive a grant of restricted stock units (&#x201c;RSUs&#x201d;) in the Company with a value of $2,500,000, subject to the approval of the board of directors, Mr. Scott&#x2019;s continued service on the grant date and time-based vesting conditions. In the event a SPAC transaction or IPO had not occurred, Mr. Scott would have been awarded a transaction bonus of $2,500,000 for a successful financing round of Legacy Hyperfine of $50 million or more within two years of his start date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the Offer Letter, if Mr. Scott&#x2019;s employment is terminated without cause or if Mr. Scott resigns with good reason, Mr. Scott will receive severance equal to 12 months base salary and target bonus and payment of an amount equal to COBRA premiums for 12 months. He will receive 12 months accelerated vesting of outstanding time-based vesting equity awards, and any vested options, including options with performance-based vesting that have previously vested, will be eligible to be exercised until the earlier of the third anniversary of Mr. Scott&#x2019;s termination of employment or their originally scheduled expiration date. Mr. Scott will also receive 36 months of accelerated vesting of any outstanding RSUs granted in connection with a SPAC transaction or IPO described above. If a SPAC transaction, IPO or Financing has not occurred and the Company terminates Mr. Scott&#x2019;s employment within 24 months of his start date, Mr. Scott will receive $2,500,000 in lieu of the RSU grant described above.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If during the period beginning three months prior to and ending eighteen months following the date of a change in control, the Company terminates Mr. Scott&#x2019;s employment without cause or if he resigns with good reason, Mr. Scott will receive severance equal to two times the sum of his base salary and target bonus, paid as a lump sum, plus payment of an amount equal to COBRA premiums for 24 months. He will receive 100% accelerated vesting for all time-based vesting equity awards and for the award of 474,875 performance-based stock options that includes the performance vesting criteria of a price per share that equals or exceeds 1.5 times $3.92 (as adjusted). The awards subject to such accelerated vesting shall be eligible to be exercised until the earlier of the third anniversary of Mr. Scott&#x2019;s termination of employment or their originally scheduled expiration date. In addition, if a SPAC transaction, IPO or financing round has not occurred and the Company terminates Mr. Scott&#x2019;s employment without cause or Mr. Scott terminates his employment for good reason during a change in control period and within 36 months of his start date, Mr. Scott will receive $2,500,000 in lieu of the RSU grant described above.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Alok Gupta</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine entered into an Offer Letter of Employment with Mr. Gupta on July 17, 2021 as Legacy Hyperfine&#x2019;s Chief Financial Officer. Pursuant to the terms of his Offer Letter, Mr. Gupta&#x2019;s annual base salary was $400,000. Mr. Gupta is eligible to receive an annual discretionary bonus with a target of 40% of his base salary, to be prorated for calendar year 2021, provided that he is employed with Hyperfine through the scheduled date of payment of such bonus.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to his Offer Letter, Mr. Gupta will receive a one-time payment of $85,000 to be paid upon the six-month anniversary of his start date to cover the costs of relocation. If Mr. Gupta resigns without good reason prior to the 12-month anniversary of his start date, Mr. Gupta is required to repay the relocation payment. Mr. Gupta also received a bonus of $25,000 in January 2022 in connection with the completion of the Business Combination.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Mr. Gupta&#x2019;s Offer Letter provides that, subject to approval by our board of directors or compensation committee, at the first meeting of the compensation committee following the registration of our equity compensation plan with the SEC after the closing of a SPAC Transaction, Mr. Gupta will be granted 100,000 RSUs, with 25% of the award to vest on September 30, 2022 and the remainder of the RSUs vesting in equal quarterly installments over the following three years, subject to Mr. Gupta&#x2019;s continued employment on each vesting date. In addition, subject to approval by our board of directors or compensation committee, Mr. Gupta will be granted 200,000 stock options at the first meeting of the compensation committee following the closing of a SPAC Transaction, with an exercise price equal to the closing price of the stock on such date, with 25% of the award to vest on September 30, 2022, and the remainder of the options vesting in equal monthly installments over the following three years, subject to Mr. Gupta&#x2019;s continued employment on each vesting date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Mark Hughes</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine entered into an Offer Letter of Employment with Mr. Hughes on June 7, 2019 to begin employment as Legacy Hyperfine&#x2019;s Head of Research and Program Management on July 1, 2019. Beginning January 1, 2020, Mr. Hughes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">served as Legacy Hyperfine&#x2019;s Chief Operating Officer. In March 2022, Mr. Hughes transitioned from Chief Operating Officer to the position of Vice President, Hardware Engineering and Operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Khan Siddiqui, M.D.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine entered into an Offer Letter of Employment with Dr. Siddiqui as Legacy Hyperfine&#x2019;s Chief Medical Officer and Chief Strategy Officer on January 4, 2020. Pursuant to the terms of his Offer Letter, Dr. Siddiqui&#x2019;s annual base salary was $300,000. As of August 1, 2021, Dr. Siddiqui&#x2019;s annual base salary is $375,000. Dr. Siddiqui is eligible to receive an annual discretionary bonus with a target of 50% of his annual base salary, provided that he is employed with Hyperfine through the scheduled date of payment of such bonus.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to his Offer Letter, Dr. Siddiqui was granted 235,145 stock options with an exercise price of $3.76 per share, with 25% of each award to vest on December 31, 2020, and the remainder of the options vesting in equal monthly installments, over the following three years, subject to Dr. Siddiqui&#x2019;s continued employment on each vesting date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Neela Paykel</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine entered into an Offer Letter of Employment with Ms. Paykel on April 13, 2021 as Legacy Hyperfine&#x2019;s General Counsel. Pursuant to the terms of her Offer Letter, Ms. Paykel&#x2019;s annual base salary is $350,000. Ms. Paykel is eligible to receive an annual discretionary bonus with a target of 40% of her base salary, to be prorated for calendar year 2021, provided that she is employed with Hyperfine through the scheduled date of payment of such bonus. Ms. Paykel also received a bonus of $25,000 in January 2022 in connection with the completion of the Business Combination.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to her Offer Letter, Ms. Paykel received a one-time payment of $25,000 as a sign-on bonus. If Ms. Paykel voluntarily terminates her employment prior to the 12-month anniversary of her start date, Ms. Paykel is required to repay the sign-on bonus.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to her Offer Letter, Ms. Paykel was granted 98,250 stock options with an exercise price of $3.27 per share, with 25% of the award to vest on June 30, 2022, and the remainder of the options vesting in equal monthly installments over the following three years, subject to Ms. Paykel&#x2019;s continued employment on each vesting date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Scott White</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine entered into an Offer Letter of Employment with Mr. White on August 24, 2021 to serve as Legacy Hyperfine&#x2019;s Chief Commercial Officer starting on September 27, 2021. Pursuant to the terms of his Offer Letter, Mr. White&#x2019;s annual base salary is $325,000. Mr. White is eligible to receive an annual discretionary bonus with a target of 40% of his base salary, to be prorated for calendar year 2021, provided that he is employed with Hyperfine through the scheduled date of payment of such bonus.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to his Offer Letter, Mr. White received a one-time payment of $25,000 as a sign-on bonus. If Mr. White voluntarily terminates his employment prior to the 12-month anniversary of his start date, Mr. White is required to repay the sign-on bonus.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Mr. White&#x2019;s Offer Letter provides that, subject to approval by the board of directors or compensation committee, at the first meeting of the board of directors or the compensation committee following the registration of Hyperfine&#x2019;s equity compensation plan with the Securities and Exchange Commission after the closing of a SPAC Transaction, Mr. White will be granted 20,000 RSUs, with 25% of the award to vest on September 30, 2022 and the remainder of the RSUs vesting in equal quarterly installments over the following three years, subject to Mr. White&#x2019;s continued employment on each vesting date. In addition, subject to approval by the board of directors or compensation committee, Mr. White will be granted 40,000 stock options at the first meeting of the board of directors following the closing of a SPAC Transaction, with an exercise price equal to the closing price of the stock on such date, with 25% of the award to vest on September 30, 2022, and the remainder of the options vesting in equal monthly installments over the following three years, subject to Mr. White&#x2019;s continued employment on each vesting date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Employee Benefits</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our NEOs participate in employee benefit programs available to its employees generally, including a tax-qualified 401(k) plan. Hyperfine did not maintain any executive-specific benefit or perquisite programs in 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Severance Plan</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 22, 2021, the board of directors adopted the Hyperfine, Inc. Executive Severance Plan (the &#x201c;Severance Plan&#x201d;). Current participants in the Severance Plan include all employees with the title of Vice President, including Executive Vice President, Senior Vice President and Vice President.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the Severance Plan, if we terminate a participant&#x2019;s employment without cause (as defined in the Severance Plan) at any time other than during the twelve (12) month period following a change in control (as such term is defined in the Severance Plan) (the &#x201c;Change in Control Period&#x201d;), then the participant is eligible to receive the following benefits:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Severance payable in the form of salary continuation or a lump sum payment. The severance amount is equal to participant&#x2019;s then-current base salary times a multiplier determined based on the participant&#x2019;s title or role with us.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will pay for company contribution for continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#x201c;COBRA&#x201d;) during the severance period.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the Severance Plan, if we terminate a participant&#x2019;s employment without cause or a participant resigns for good reason, during the Change in Control Period, then the participant is eligible to receive the following benefits:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Severance payable in a single lump sum. The severance amount is equal to participant&#x2019;s then-current base salary and then-current target annual bonus opportunity, times a change in control multiplier determined based on the participant&#x2019;s title or role with us.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will pay for company contribution for continuation coverage under COBRA during the severance period.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any outstanding unvested equity awards held by the participant under any then-current outstanding equity incentive plan(s) will become fully vested as of the date the termination of such participant&#x2019;s employment becomes effective.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A participant&#x2019;s rights to any severance benefits under the Severance Plan are conditioned upon the participant executing and not revoking a valid separation and general release of claims agreement in a form provided by us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Director Compensation</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table shows the total compensation paid or accrued during the fiscal year ended 2021 to each of our non-employee directors. Directors who are employed by us are not compensated for their service on our board of directors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.794%;"></td>
    <td style="width:1.411%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:11.669%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:2.286%;"></td>
    <td style="width:1.411%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:11.699%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:2.286%;"></td>
    <td style="width:1.411%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:11.728%;"></td>
    <td style="width:0.567%;"></td>
    <td style="width:2.286%;"></td>
    <td style="width:1.411%;"></td>
    <td style="width:1.153%;"></td>
    <td style="width:11.728%;"></td>
    <td style="width:0.567%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fees Earned or Paid in Cash ($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Stock Awards (1)($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Option Awards (2)($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total ($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">R. Scott Huennekens</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">83,037</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">179,995</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,437,008</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,700,040</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Jonathan M. Rothberg, Ph.D</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,370</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">179,995</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,908,126</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,089,491</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">John Dahldorf</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,123</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">179,995</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">182,118</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Ruth Fattori</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,918</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">179,995</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">181,913</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Maria Sainz</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,781</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">179,995</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">181,776</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Daniel J. Wolterman</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,918</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">179,995</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">181,913</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1) The amount represents the aggregate grant date fair value for stock awards computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, or ASC 718. A discussion of our methodology for determining grant date fair value may be found in Note 12 to our audited combined and consolidated financial statements for the year ended December 31, 2021 included in this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2) The amount represents the aggregate grant date fair value for option awards computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, or ASC 718. A discussion of our methodology for determining grant date fair value may be found in Note 12 to our audited combined and consolidated financial statements for the year ended December 31, 2021 included in this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(3) Mr. Huennekens received $81,667 during 2021 pursuant to a Consulting Agreement entered into between Legacy Hyperfine and Mr. Huennekens on April 25, 2021, and $1,370 pursuant to Hyperfine&#x2019;s non-employee director compensation policy.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4) The aggregate grant date fair value for this award was determined by multiplying 19,586, the number of shares granted, by $9.19, the closing price of our Class A common stock on the Nasdaq Global Market on December 23, 2021, the date of the grant. The RSUs were granted pursuant to our non-employee director compensation policy and vest in equal annual</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">103</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">installments over three years beginning on December 23, 2022, subject to the director&#x2019;s continued service through the applicable vesting date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(5) Mr. Huennekens was granted options to purchase shares of Legacy Hyperfine common stock in April 2021 with an exercise price per share equal to the fair market value of the common stock on the grant date. 712,312 of the shares underlying the options have an exercise price of $3.27 per share and vest, subject to continued service, as to 25% on June 30, 2022, with the remainder vesting in 36 equal monthly installments thereafter, and 474,874 of the shares underlying the options have an exercise price of $3.27 per share and vest, subject to continued service, upon the achievement of performance conditions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(6) Dr. Rothberg was granted options to purchase shares of Legacy Hyperfine common stock in April 2021 with an exercise price per share equal to the fair market value of the common stock on the grant date. The 982,500 shares underlying the options have an exercise price of $3.27 per share and vested and became exercisable on December 15, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table shows the aggregate number of shares subject to options and restricted stock units held by each of our non-employee directors as of December 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:59.125%;"></td>
    <td style="width:1.998%;"></td>
    <td style="width:0.577%;"></td>
    <td style="width:17.286%;"></td>
    <td style="width:0.577%;"></td>
    <td style="width:1.998%;"></td>
    <td style="width:0.577%;"></td>
    <td style="width:17.286%;"></td>
    <td style="width:0.577%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Number of Stock Options Held at Fiscal Year- End</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Number of Restricted Stock Units Held at Fiscal Year-End</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">R. Scott Huennekens</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,187,186</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">19,586</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Jonathan M. Rothberg, Ph.D</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">982,500</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">19,586</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">John Dahldorf</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">19,586</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Ruth Fattori</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">19,586</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Maria Sainz</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">19,586</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Daniel J. Wolterman</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">19,586</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Director Compensation Policy</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 22, 2021, we adopted a non-employee director compensation policy. Pursuant to the policy, the annual retainer for non-employee directors is $50,000. Annual retainers for committee membership are as follows:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:74.185%;"></td>
    <td style="width:2.515%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:21.561%;"></td>
    <td style="width:0.577%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Position</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Retainer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Audit committee chairperson</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">20,000</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Audit committee member</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10,000</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Compensation committee chairperson</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">15,000</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Compensation committee member</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7,500</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Nominating and corporate governance committee chairperson</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10,000</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Nominating and corporate governance committee member</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5,000</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These fees are payable in arrears in quarterly installments as soon as practicable following the last business day of each fiscal quarter, provided that the amount of such payment will be prorated for any portion of such quarter that a director is not serving on our board of directors, on such committee or in such position. Non-employee directors are also reimbursed for reasonable out-of-pocket business expenses incurred in connection with attending meetings of the board and any committee of the board on which they serve and in connection with other business related to the board. Directors may also be reimbursed for reasonable out-of-pocket business expenses in accordance with our travel and other expense policies, as may be in effect from time to time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, we grant to new non-employee directors upon their initial election to our board of directors (including any non-employee director whose election to our board of directors was approved at the Special Meeting of Stockholders held on December 21, 2021) a number of RSUs (each RSU relating to one share of our Class A common stock) having an aggregate fair market value equal to $180,000, determined by dividing (A) $180,000 by (B) the closing price of our Class A common stock on Nasdaq on the date of the grant (rounded down to the nearest whole share), on the first business day after the date that the non-employee director is first appointed or elected to the board. Each of these grants shall vest in equal annual installments over three years from the date of the grant, subject to the non-employee director&#x2019;s continued service as a director on the applicable vesting dates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, in connection with each of our annual meetings of stockholders, each non-employee director automatically receives an option to purchase shares of our Class A common stock having an aggregate grant date fair value of $100,000, valued based on a Black-Scholes valuation method (rounded down to the nearest whole share), each year beginning in 2022 on the first business day after our annual meeting of stockholders. Each of these options has a term of 10 years from the date of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">104</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">award and vests at the end of the period beginning on the date of each regular annual meeting of stockholders (or the first business day of the third fiscal quarter, as applicable) and ending on the date of the next regular annual meeting of stockholders, subject to the non-employee director&#x2019;s continued service as a director through the applicable vesting dates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Consulting Agreement with Scott Huennekens</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine entered into a Consulting Agreement with Scott Huennekens on April 25, 2021 to provide consulting services to Legacy Hyperfine as the Executive Chairman of Legacy Hyperfine&#x2019;s board of directors. Pursuant to the terms of the Consulting Agreement, Mr. Huennekens is paid $10,000 per month. In addition, Mr. Huennekens was granted 712,312 stock options with an exercise price of $3.27 per share, with 25% of the award to vest on June 30, 2022, and the remainder of the options vesting in equal monthly installments over the following 36 months, subject to Mr. Huennekens&#x2019; continued service on each vesting date. Mr. Huennekens was also granted 237,437 performance-based stock options with an exercise price of $3.27 per share, which options vest upon the first to occur of: (1) the completion of a SPAC transaction within two years of Mr. Huennekens&#x2019; start date and the Company&#x2019;s common stock achieving a closing price per share of $15.00 or more for at least 20 out of 30 consecutive trading days within three years of the closing of the SPAC transaction; (2) the completion of an initial public offering within two years of Mr. Huennekens&#x2019; start date and the Company&#x2019;s common stock achieving a closing price per share that equals or exceeds 1.5 times $3.92 (as adjusted) within three years of the closing of the initial public offering; or (3) the closing of a private financing round within three years of Mr. Huennekens&#x2019; start date in which $50 million or more is raised and Hyperfine&#x2019;s stock price per share equals or exceeds 1.5 times $3.92 (as adjusted). In addition, Mr. Huennekens was granted 237,437 performance-based stock options with an exercise price of $3.27 per share, which options vest upon the first to occur of: (1) the completion of a SPAC transaction within two years of Mr. Huennekens&#x2019; start date and the Company&#x2019;s common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an initial public offering within two years of Mr. Huennekens&#x2019; start date and the Company&#x2019;s common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the initial public offering; or (3) the closing of a private financing round within four years of Mr. Huennekens&#x2019; start date in which $50 million or more is raised and Hyperfine&#x2019;s stock price per share equals or exceeds 3.0 times $3.92 (as adjusted).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">105</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_12_security_ownership_of_certain"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 12. SECURITY OWNERSHIP OF CERTAIN BE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">NEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth information known to the Company regarding the beneficial ownership of the Company&#x2019;s common stock as of February 15, 2022 by:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">each person known to the Company to be the beneficial owner of more than 5% of outstanding Company common stock;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">each of the Company&#x2019;s executive officers and directors; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">all current executive officers and directors of the Company as a group.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options that are currently exercisable or exercisable within 60 days and restricted stock units that vest within 60 days. Shares of Class A common stock issuable upon exercise of options currently exercisable within 60 days and restricted stock units that vest within 60 days are deemed outstanding solely for purposes of calculating the percentage of total ownership and total voting power of the beneficial owner thereof.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The beneficial ownership of Company common stock is based on 55,277,061 shares of the Company&#x2019;s Class A common stock and 15,055,288 shares of the Company&#x2019;s Class B common stock issued and outstanding as of February 15, 2022.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unless otherwise indicated, the Company believes that each person named in the table below has sole voting and investment power with respect to all shares of the Company&#x2019;s common stock beneficially owned by them. Unless otherwise indicated, the business address of each of the following entities or individuals is c/o Hyperfine, Inc., 351 New Whitfield Street, Guilford, Connecticut 06437.</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.553%;"></td>
    <td style="width:1.55%;"></td>
    <td style="width:0.616%;"></td>
    <td style="width:9.48%;"></td>
    <td style="width:0.616%;"></td>
    <td style="width:1.55%;"></td>
    <td style="width:0.616%;"></td>
    <td style="width:4.859%;"></td>
    <td style="width:2.117%;"></td>
    <td style="width:1.103%;"></td>
    <td style="width:0.616%;"></td>
    <td style="width:9.54%;"></td>
    <td style="width:0.616%;"></td>
    <td style="width:1.55%;"></td>
    <td style="width:0.616%;"></td>
    <td style="width:4.83%;"></td>
    <td style="width:2.117%;"></td>
    <td style="width:1.103%;"></td>
    <td style="width:0.636%;"></td>
    <td style="width:8.198%;"></td>
    <td style="width:2.117%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Name and Address of Beneficial Owner</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Number of<br />Shares<br />of Class A<br />Common Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Number of<br />Shares Class B<br />Common Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Voting<br />Power**</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Directors and Executive Officers:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Jonathan M. Rothberg, Ph.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,208,113</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.9</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,055,288</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84.8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dave Scott</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Alok Gupta</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Khan Siddiqui, M.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">183,296</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Neela Paykel</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Scott White</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">R. Scott Huennekens</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">John Dahldorf</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ruth Fattori</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">891</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Maria Sainz</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Daniel J. Wolterman</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">All Current Directors and Executive Officers of the Company as a Group (11 Individuals)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,392,300</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.2</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,055,288</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84.8</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Five Percent Holders:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Jonathan M. Rothberg, Ph.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,208,113</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.9</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,055,288</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84.8</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">HC Sponsor LLC</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,534,000</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">* Indicates beneficial ownership of less than 1%.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">** Percentage of total voting power represents voting power with respect to all shares of the Company&#x2019;s Class A common stock and the Company&#x2019;s Class B common stock as a single class. Each share of the Company&#x2019;s Class B common stock is entitled to 20 votes per share and each share of the Company&#x2019;s Class A common stock is entitled to 1 vote per share.</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Consists of shares of the Company&#x2019;s Class A common stock and Class B common stock held by Jonathan M. Rothberg, Ph.D., Dr. Rothberg&#x2019;s spouse, 4C Holdings I, LLC, 4C Holdings V, LLC, 2012 JMR Trust Common, LLC and 23rd Century Capital LLC, and options to purchase 982,500 shares of the Company&#x2019;s Class A common </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">106</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">stock exercisable within 60 days of February 15, 2022 held by Dr. Rothberg. Dr. Rothberg, the Founder of Legacy Hyperfine and Liminal, is the sole manager of 4C Holdings I, LLC, 4C Holdings V, LLC and 2012 JMR Trust Common, LLC and has sole voting and investment control of the Company&#x2019;s Class A common stock and Class B common stock owned by those entities. Dr. Rothberg&#x2019;s son is the manager of 23rd Century Capital LLC. Dr. Rothberg disclaims beneficial ownership of the shares held by his spouse and 23rd Century Capital LLC.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Consists of options to purchase 183,296 shares of the Company&#x2019;s Class A common stock exercisable within 60 days of February 15, 2022 held by Dr. Siddiqui.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Consists of shares of the Company&#x2019;s Class A common stock held by Ms. Fattori.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(4)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">See footnotes 1 through 3.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(5)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Consists of 5,534,000 shares held directly by the HC Sponsor LLC and 1,000,000 shares purchased in the PIPE Investment by entities affiliated with HC Sponsor LLC (such affiliates, the &#x201c;HC Affiliates&#x201d;). HC Sponsor LLC is managed by its manager, HealthCor Sponsor Investments LLC, which is managed by its manager, HealthCor Group, LLC, which also indirectly manages the HC Affiliates. Arthur Cohen and Joseph Healey are the controlling members of HealthCor Group, LLC. As such, Messrs. Cohen and Healey have voting and investment discretion with respect to the shares held by each of HC Sponsor LLC and the HC Affiliates and may be deemed to have shared beneficial ownership of these shares.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Equity Compensation Plan Information</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table provides certain aggregate information with respect to all of our equity compensation plans in effect as of December 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:25.0%;"></td>
    <td style="width:25.0%;"></td>
    <td style="width:25.0%;"></td>
    <td style="width:25.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(a)</span></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(b)</span></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(c)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Plan category</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number of securities to be issued upon exercise of outstanding options, warrants and rights</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted-average exercise price of outstanding options, warrants and rights</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Equity compensation plans approved by security holders</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,639,652</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$3.21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,286,741</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Equity compensation plans not approved by security holders</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">_</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">_</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:top;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">_</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,639,652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$3.21</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;border-right:0.500pt solid;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,286,741</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Consists of (i) 7,348,438 shares to be issued upon exercise of outstanding options and vesting of outstanding RSUs under the Legacy Hyperfine 2014 Employee, Director and Consultant Equity Incentive Plan, as amended (the &#x201c;Legacy Hyperfine Plan&#x201d;), (ii) 173,698 shares to be issued upon exercise of outstanding options and vesting of outstanding RSUs under the Liminal 2021 Employee, Director and Consultant Equity Incentive Plan, as amended (the &#x201c;Liminal Plan&#x201d;), and (iii) 117,516 shares to be issued upon exercise of outstanding options and vesting of outstanding RSUs under the Company&#x2019;s 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;).</span></div></div>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Consists of the weighted-average exercise price of $3.21 for the 7,522,136 stock options outstanding on December 31, 2021.</span></div></div>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Consists of 8,286,741 shares that remained available for future issuance under the 2021 Plan as of December 31, 2021. No shares remained available for future issuance under the Legacy Hyperfine Plan or the Liminal Plan as of December 31, 2021.</span></div></div>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(4)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The 2021 Plan has an evergreen provision that allows for an annual increase in the number of shares available for issuance under the 2021 Plan to be added on the first day of each fiscal year, beginning in fiscal year 2022 and ending on the second day of fiscal year 2031. The evergreen provides for an automatic increase in the number of shares available for issuance equal to the lesser of (i) 4% of the number of outstanding shares of common stock on </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">107</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">such date and (ii) an amount determined by the plan administrator. This total does not reflect the automatic increase in the number of shares available for issuance under the 2021 Plan that was effective on January 1, 2022 pursuant the evergreen provision.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:66.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">108</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_13_certain_relation_and_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 13. CERTAIN RELATIONSHIPS AND RELATED TR</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ANSACTIONS, AND DIRECTOR INDEPENDENCE</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">HealthCor Related Person Transactions</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On November 24, 2020, the Sponsor paid $25,000, or approximately $0.006 per share, to cover certain of HealthCor&#x2019;s offering and formation costs in consideration of 4,312,500 Class B ordinary shares, par value $0.0001. On January 29, 2021, HealthCor consummated the sale of 614,000 Private Placement Shares to the Sponsor at a price of $10.00 per share. In December 2020 and January 2021, the Sponsor transferred 35,000 Class B ordinary shares to each of Dr. Wolfgang, Mr. Weinstein and Mr. Harris, resulting in HealthCor&#x2019;s independent directors holding an aggregate of 105,000 Founder Shares. On January 26, 2021, HealthCor effected a share capitalization pursuant to which it issued 862,500 additional Class B ordinary shares, resulting in its Initial Shareholders holding 5,175,000 Class B ordinary shares. Up to 675,000 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters&#x2019; exercised their over-allotment option in connection with HealthCor&#x2019;s IPO. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option, these Founder Shares were no longer subject to forfeiture.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the Sponsor purchased, pursuant to a written agreement, an aggregate of 614,000 Private Placement Shares for a purchase price of $10.00 per share in a private placement that occurred with the closing of the IPO.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to the completion of the Business Combination, HealthCor maintained its executive offices at 55 Hudson Yards, 28th Floor, New York, NY 10001. The cost for HealthCor&#x2019;s use of this space was included in the up to $10,000 per month fee HealthCor paid to the Sponsor for office space, administrative and support services. Upon completion of the Business Combination, HealthCor ceased paying these monthly fees.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On November 23, 2020, HealthCor issued an unsecured promissory note (the &#x201c;Promissory Note&#x201d;) to the Sponsor, pursuant to which HealthCor could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) March 31, 2021 and (ii) the completion of the IPO. The balance of the Promissory Note was repaid in February 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the IPO, HealthCor entered into a registration and shareholder rights agreement (the &#x201c;Registration and Shareholder Rights Agreement&#x201d;) pursuant to which the Sponsor was entitled to certain registration rights with respect to the Private Placement Shares, the shares issuable upon conversion of working capital loans (if any) and the Class A ordinary shares issuable upon exercise of the foregoing and upon conversion of the Founder Shares, and, upon consummation of an initial business combination, to nominate three individuals for appointment to HealthCor&#x2019;s board of directors, as long as the Sponsor holds any securities covered by the registration and shareholder rights agreement. The Registration and Shareholder Rights Agreement was replaced by the Registration Rights Agreements entered into by and among the Company, the Sponsor, and certain affiliates of the Sponsor, certain Legacy Hyperfine equityholders, certain Liminal equityholders, and certain other parties at the Closing as described below.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine and Liminal</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liminal Series A Reclassification</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On April 1, 2021, the outstanding capital stock of Liminal was reclassified into Series A-1 preferred stock and Series A-2 preferred stock, all of which was held by 4Bionics. The Series A-1 preferred stock is entitled to 10 votes per share and the Series A-2 preferred stock is entitled to 1 vote per share. On April 2, 2021, 4Bionics distributed its shares of Liminal Series A-1 preferred stock and Series A-2 preferred stock to its members. In connection with the distribution, Jonathan M. Rothberg, Ph.D. received a cash payment from 4Bionics of $480,000 for prior services provided to Liminal, and as of the date hereof, Dr. Rothberg had received 38,239,355 shares of Series A-1 preferred stock and 766,353 shares of Series A-2 preferred stock with an aggregate estimated value, as of April 2, 2021, of $43,296,336.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Lease Arrangements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We occupy office space at 351 New Whitfield Street, Guilford, Connecticut, residential space at 485 Old Whitfield Street, Guilford, Connecticut, and office space at 3000 El Camino Real, Suite 100, Palo Alto, California. Legacy Hyperfine and Liminal previously occupied office space at 251 West 30th Street, New York, New York. The residential space at 485 Old Whitfield Street, Guilford, Connecticut is leased by 4Catalyzer Corporation, or 4Catalyzer, from Oceanco, LLC, of which Jonathan M. Rothberg Children&#x2019;s Trust dated April 24, 1997 is the sole owner and Michael Rothberg, who is a sibling of Jonathan M. Rothberg, Ph.D., the Founder of Legacy Hyperfine and Liminal and Vice Chairman of our board of directors, is the trustee of such trust. We have the right to rent rooms at 485 Old Whitfield Street from 4Catalyzer for $125 per employee per day. The office space at 351 New Whitfield Street, Guilford, Connecticut is leased from an unrelated landlord by</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">109</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4Catalyzer. 4Catalyzer subleases space to us at 351 New Whitfield Street, where we occupy such portions of the space as 4Catalyzer may designate from time to time on a month-to-month basis, and we pay our pro rata share of expenses paid by 4Catalyzer for such space under the master lease. The office space at 3000 El Camino Real is leased from an unrelated landlord by 4Catalyzer. In connection with the Business Combination Agreement, 4Catalyzer granted us a license to use such portions of the office space at 3000 El Camino Real as 4Catalyzer may designate from time to time. The office space at 251 West 30th Street, New York, New York was leased from an unrelated landlord by 4Catalyzer. We paid 4Catalyzer on a month-to-month basis for use of the space in 485 Old Whitfield Street and 351 New Whitfield Street, but no rental or lease agreements are effective. Under these arrangements, Legacy Hyperfine and Liminal paid $7,155, $9,990, and $20,025 for the years ended December 31, 2019, 2020, and 2021, respectively, related to 485 Old Whitfield Street; $100,245, $102,838, and $129,344 for the same time periods, respectively, related to 351 New Whitfield Street; $95,922, $100,969, and $99,854 for the same time periods, respectively, related to Suite 100 at 3000 El Camino Real; and $10,854, $1,950, and $0 for the same time periods, respectively, related to 251 West 30th Street, New York, New York.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Amended and Restated Technology Services Agreement</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On November 11, 2020, Legacy Hyperfine and Liminal entered into an Amended and Restated Technology Services Agreement (the &#x201c;ARTSA&#x201d;) by and among 4Catalyzer, Legacy Hyperfine, Liminal and other participant companies controlled by the Rothbergs, including Butterfly Network, Inc., AI Therapeutics, Inc., Quantum-Si Incorporated, 4Bionics, Tesseract Health, Inc. and Homodeus Inc. Under the ARTSA, Legacy Hyperfine, Liminal and the other participant companies agreed to share certain non-core technologies, which means any technologies, information or equipment owned or otherwise controlled by the participant company that are not specifically related to the core business area of the participant, such as software, hardware, electronics, fabrication and supplier information, vendor lists and contractor lists, subject to certain restrictions on use, with the other participant companies. The ARTSA provides that ownership of each non-core technology shared by 4Catalyzer, Legacy Hyperfine, Liminal or another participant company will remain with the company that originally shared the non-core technology. The ARTSA also provides for 4Catalyzer to perform certain services to Legacy Hyperfine, Liminal and each other participant company, such as general administration, facilities, information technology, financing, legal, human resources and other services. The ARTSA also provides for the participant companies to provide other services to each other. The fees due to 4Catalyzer or the other participants for such services are allocated to Legacy Hyperfine, Liminal and the participant companies based on the total costs and expenses for the relative amount of services and resources used by the participant company, except for services with respect to intellectual property, which are based on a negotiated cost plus methodology. The ARTSA provides that all inventions of 4Catalyzer, Legacy Hyperfine, Liminal or the other participants made in the course of providing such services will be owned by the receiving participant and that the receiving participant will grant to the participant company providing the services a royalty-free, perpetual, limited, worldwide, non-exclusive license to use such inventions only in the core business field of the participating company. The ARTSA has an initial term of five years from the date of the ARTSA and provides that the ARTSA will be automatically extended for additional, consecutive one-year renewal terms. Each participating company, including Legacy Hyperfine and Liminal, has the right to terminate the ARTSA at any time upon 30 days&#x2019; prior notice and 4Catalyzer has the right to terminate the ARTSA at any time upon 90 days&#x2019; prior notice. The Company paid an aggregate of $3,074,195, $2,343,681, and $2,281,792 during the years ended December 31, 2019, 2020, and 2021, respectively, for services under the ARTSA. The Company received an aggregate of $324,404, $363,619, and $11,685 during the years ended December 31, 2019, 2020, and 2021, respectively, for services under the ARTSA. On July 7, 2021, Legacy Hyperfine, Liminal and 4Catalyzer entered into First Addendums to the ARTSA, pursuant to which Legacy Hyperfine and Liminal each terminated its participation under the ARTSA immediately prior to the Closing. Legacy Hyperfine and Liminal each entered into a Master Services Agreement (the &#x201c;Master Services Agreements&#x201d;) with 4Catalyzer effective as of July 7, 2021 pursuant to which Legacy Hyperfine and Liminal may engage 4Catalyzer to provide services such as general administration, facilities, information technology, financing, legal, human resources and other services, through future statements of work and under terms and conditions to be determined by the parties with respect to any services to be provided.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Technology and Services Exchange Agreement</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine and Liminal have entered into Technology and Services Exchange Agreements (each, a &#x201c;TSEA&#x201d; and collectively, the &#x201c;TSEA&#x201d;) with other participant companies controlled by the Rothbergs. A TSEA by and among Butterfly Network, Inc., AI Therapeutics, Inc., Quantum-Si Incorporated, 4Bionics, Tesseract Health, Inc., Detect, Inc. (f/k/a Homodeus Inc.), Legacy Hyperfine and Liminal was signed in November 2020; a TSEA by and among Quantum-Si Incorporated, AI Therapeutics, Inc., 4Bionics, Tesseract Health, Inc., Detect, Inc., Legacy Hyperfine and Liminal was signed in February 2021 (and which Protein Evolution, Inc. joined in August 2021); and a TSEA by and among Legacy Hyperfine, Liminal, AI Therapeutics, Inc., Tesseract Health, Inc. and Detect, Inc. was signed in July 2021 and became effective upon the Closing. Under the TSEA, Legacy Hyperfine, Liminal and the other participant companies may, in their discretion, permit the use of non-core technologies, which include any technologies, information or equipment owned or otherwise controlled by</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">110</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the participant company that are not specifically related to the core business area of the participant, such as software, hardware, electronics, fabrication and supplier information, vendor lists and contractor lists, by other participant companies. The TSEA provides that ownership of each non-core technology shared by Legacy Hyperfine, Liminal or another participant company will remain with the company that originally shared the non-core technology. In addition, any participant company (including Legacy Hyperfine and Liminal) may, in its discretion, permit its personnel to be engaged by another participant company to perform professional, technical or consulting services for such participant. Unless otherwise agreed to by Legacy Hyperfine, Liminal and the other participant company, all rights, title and interest in and to any inventions, works-of-authorship, idea, data or know-how invented, made, created or developed by the personnel (employees, contractors or consultants) in the course of conducting services for a participant company (&#x201c;Created IP&#x201d;) will be owned by the participant company for which the work was performed, and the recipient participant company grants to the party that had its personnel provide the services that resulted in the creation of the Created IP a royalty-free, perpetual, limited, worldwide, non-exclusive, sub-licensable (and with respect to software, sub-licensable in object code only) license to utilize the Created IP only in the core business field of the originating participant company, including a license to create and use derivative works based on the Created IP in the originating participant&#x2019;s core business field, subject to any agreed upon restrictions. Fees or other compensation payable for services or use of technology under the TSEA will be determined at fair market value and set forth in one or more written work orders to be entered into between the applicable participant companies. As of February 15, 2022, the amount of financial obligations Legacy Hyperfine and Liminal have under the TSEA is approximately $10,568.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investors&#x2019; Rights, Voting and Right of First Refusal Agreements with Legacy Hyperfine and Liminal Stockholders</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with Legacy Hyperfine&#x2019;s Series D preferred stock financing, Legacy Hyperfine entered into investors&#x2019; rights, voting and right of first refusal and co-sale agreements containing registration rights, information rights, voting rights and rights of first refusal, among other things, with holders of Legacy Hyperfine&#x2019;s preferred stock and certain holders of its common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2021, Liminal entered into investors&#x2019; rights, voting and right of first refusal and co-sale agreements containing registration rights, information rights, voting rights and rights of first refusal, among other things, with holders of Liminal&#x2019;s preferred stock. In connection with the distribution of Liminal preferred stock by 4Bionics, each recipient of Liminal preferred stock became party to the investors&#x2019; rights, voting and right of first refusal and co-sale agreements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Amended and Restated Registration Rights Agreement</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">At the Closing of the Business Combination, the Company, the Sponsor, certain affiliates of the Sponsor, certain stockholders of Legacy Hyperfine, and certain stockholders of Liminal entered into the Registration Rights Agreement, pursuant to which, among other things, the parties to the Registration Rights Agreement agreed, subject to certain exceptions, not to effect any sale or distribution of any equity securities of the Company held by any of them during the lock-up period described therein and were granted certain registration rights with respect to their respective shares of the Company&#x2019;s common stock, in each case, on the terms and subject to the conditions therein.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Advisory Agreement with Jonathan M. Rothberg, Ph.D.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the consummation of the Business Combination Agreement, Legacy Hyperfine and Dr. Rothberg, the Founder of Legacy Hyperfine and Liminal and a member of the Hyperfine Board, entered into the Advisory Agreement, effective as of the Closing, pursuant to which Dr. Rothberg will advise the Company&#x2019;s Chief Executive Officer and provide guidance to Hyperfine Board. As compensation for Dr. Rothberg&#x2019;s services under the Advisory Agreement, we will pay Dr. Rothberg a consulting fee of $16,667 per month during the term of the Advisory Agreement. The term of the Advisory Agreement will continue until terminated by us or Dr. Rothberg. Any of the parties may terminate the Advisory Agreement for any reason upon giving thirty (30) days&#x2019; advance notice of such termination. In the event of such termination, we will be obligated to pay Dr. Rothberg any earned but unpaid consulting fee as of the termination date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Indemnification Agreements with Officers and Directors and Directors&#x2019; and Officers&#x2019; Liability Insurance</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with this Business Combination, we entered into indemnification agreements with each of our executive officers and directors. The indemnification agreements and our Bylaws require that we indemnify our directors to the fullest extent not prohibited by Delaware law. Subject to certain limitations, the indemnification agreements and the Bylaws also require us to advance expenses incurred by our directors and officers. We also maintain a general liability insurance policy, which covers certain liabilities of its directors and officers arising out of claims based on acts or omissions in their capacities as directors or officers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">111</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Policies and Procedures for Related Party Transactions</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have adopted a written related person transaction policy that sets forth the following policies and procedures for the review and approval or ratification of related person transactions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A &#x201c;Related Person Transaction&#x201d; is a transaction, arrangement or relationship in which the Company or any of its subsidiaries was, is or will be a participant, the amount of which involved exceeds the lesser of (i) $120,000, and (ii) one percent of the average of the Company&#x2019;s total assets at year end for the last two completed fiscal years, and in which any related person had, has or will have a direct or indirect material interest. Transactions involving compensation for services provided to the Company or any of its subsidiaries as an employee, consultant or director will not be considered related person transactions under this policy. A &#x201c;Related Person&#x201d; is:</span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any person who is or was an executive officer, director, or director nominee of the Company at any time since the beginning of the Company&#x2019;s last fiscal year;</span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a person who is or was an Immediate Family Member (as defined below) of an executive officer, director, director nominee at any time since the beginning of the Company&#x2019;s last fiscal year;</span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any person who, at the time of the occurrence or existence of the transaction, is the beneficial owner of more than 5% of any class of the Company&#x2019;s voting securities (a &#x201c;Significant Stockholder&#x201d;); or</span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any person who, at the time of the occurrence or existence of the transaction, is an Immediate Family Member of a Significant Stockholder of the Company.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">An &#x201c;Immediate Family Member&#x201d; of a person is any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law of such person, or any other person sharing the household of such person, other than a tenant or employee.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has implemented policies and procedures designed to minimize potential conflicts of interest arising from any dealings it may have with its affiliates and to provide appropriate procedures for the disclosure of any real or potential conflicts of interest that may exist from time to time. Specifically, pursuant to its charter, the audit committee has the responsibility to review related party transactions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the related person transaction policy, the related person in question or, in the case of transactions with a beneficial holder of more than 5% of the Company&#x2019;s voting stock, an officer with knowledge of a proposed transaction, will be required to present information regarding the proposed related person transaction to the audit committee (or to another independent body of our board of directors) for review.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To identify related person transactions in advance, we expect to rely on information supplied by our executive officers, directors and certain significant stockholders. In considering related person transactions, our audit committee is expected to take into account the relevant available facts and circumstances, which may include, but are not limited to:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the related person&#x2019;s interest in the transaction;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the approximate dollar value of the amount involved in the transaction;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the approximate dollar value of the amount of the related person&#x2019;s interest in the transaction without regard to the amount of any profit or loss;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">whether the transaction was undertaken in the ordinary course of business of the Company;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">whether the transaction with the related person is proposed to be, or was, entered into on terms no less favorable to the Company than terms that could have been reached with an unrelated third party;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the purpose of, and the potential benefits to the Company of, the transaction; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any other information regarding the transaction or the related person in the context of the proposed transaction that would be material to investors in light of the circumstances of the particular transaction.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">112</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The audit committee will approve only those transactions that it determines are fair to the Company and in the Company&#x2019;s best interests.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Independence of the Board of Directors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Nasdaq rules generally require that independent directors must comprise a majority of a listed company&#x2019;s board of directors. As a controlled company, we are largely exempt from such requirements. Based upon information requested from and provided by each proposed director concerning his or her background, employment and affiliations, including family relationships, we have determined that John Dahldorf, Ruth Fattori, Maria Sainz and Daniel J. Wolterman, representing four of our directors, are &#x201c;independent&#x201d; as that term is defined under the applicable rules and regulations of the SEC and the listing requirements and rules of Nasdaq.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_14_principal_acc_fees_and_services"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 14.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our independent registered public accounting firm is </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_232367f5-d90f-4746-b370-d595babb61a9" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:AuditorName"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deloitte &amp; Touche LLP</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_77d517ea-4a85-4c9f-8a09-a817ea72a58b" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:AuditorLocation"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">New York, New York</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, Auditor ID: </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_85720a4f-b2ff-4868-b481-a0829fa5bd0d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="dei:AuditorFirmId"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Our predecessor independent registered public accounting firm was Marcum LLP, New York, New York, Auditor ID: 688.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table presents fees for professional audit services rendered by Deloitte &amp; Touche LLP for the audit of our annual financial statements for the years ended December 31, 2021 and 2020, and fees billed for other services rendered by Deloitte &amp; Touche LLP during those periods ($ Amounts in thousands).</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:66.521%;"></td>
    <td style="width:1.412%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:13.588%;"></td>
    <td style="width:0.577%;"></td>
    <td style="width:1.412%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:13.588%;"></td>
    <td style="width:0.577%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Audit Fees </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">845</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,815</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Audit-Related Fees </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax Fees </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">All Other Fees </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Total</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">845</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,815</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Audit fees consisted of audit work performed in the preparation of financial statements and services in connection with our periodic and current SEC filings and registration statements, as well as work generally only the independent registered public accounting firm can reasonably be expected to provide, such as the provision of consents in connection with the filing of registration statements and related amendments, as well as other filings.</span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our independent registered public accountants did not provide any products and services not disclosed in the table above during the fiscal years ended December 31, 2021 and 2020. As a result, there were no other fees billed or paid during those fiscal years.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the closing of the Business Combination on December 22, 2021, our audit committee appointed  Deloitte &amp; Touche LLP as our independent registered public accounting firm to audit our combined and consolidated financial statements for the year ended December 31, 2021. Marcum LLP served as independent registered public accounting firm of HealthCor prior to the Business Combination. Accordingly, Marcum LLP was replaced as the Company&#x2019;s independent registered public accounting firm upon the closing of the Business Combination. The following table presents fees for professional audit services rendered by Marcum LLP for the audit of HealthCor&#x2019;s financial statements for the period from November 19, 2020 (inception) through December 31, 2020, and fees billed for other services rendered by Marcum LLP during the years ended December 31, 2021 and 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:66.528%;"></td>
    <td style="width:1.61%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:13.387%;"></td>
    <td style="width:0.576%;"></td>
    <td style="width:1.61%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:13.387%;"></td>
    <td style="width:0.576%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Audit Fees </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">147</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">64</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Audit-Related Fees </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax Fees </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">All Other Fees </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:normal;font-size:6.03pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Total</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">147</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">64</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Audit fees consisted of audit work performed in the preparation of financial statements and services in connection with our periodic and current SEC filings and registration statements, as well as work generally only the independent registered public accounting firm can reasonably be expected to provide, such as the provision of consents in connection with the filing of registration statements and related amendments, as well as other filings.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our independent registered public accountants did not provide any products and services not disclosed in the table above during the fiscal years ended December 31, 2021 and 2020. As a result, there were no other fees billed or paid during those fiscal years.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Policy on Audit Committee Pre-Approval of Audit and Permissible Non-audit Services of Independent Public Accountant</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Consistent with SEC policies regarding auditor independence, the audit committee has responsibility for appointing, setting compensation and overseeing the work of our independent registered public accounting firm. In recognition of this responsibility, the audit committee has established a policy to pre-approve all audit and permissible non-audit services provided by our independent registered public accounting firm.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to engagement of an independent registered public accounting firm for the next year&#x2019;s audit, management will submit an aggregate of services expected to be rendered during that year for each of four categories of services to the audit committee for approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Audit</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> services include audit work performed in the preparation of financial statements, as well as work that generally only an independent registered public accounting firm can reasonably be expected to provide, including comfort letters, statutory audits, and attest services and consultation regarding financial accounting and/or reporting standards.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Audit-Related</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> services are for assurance and related services that are traditionally performed by an independent registered public accounting firm, including due diligence related to mergers and acquisitions, employee benefit plan audits, and special procedures required to meet certain regulatory requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Tax</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> services include all services performed by an independent registered public accounting firm&#x2019;s tax personnel except those services specifically related to the audit of the financial statements, and include fees in the areas of tax compliance, tax planning, and tax advice.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Fees</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> are those associated with services not captured in the other categories. We generally do not request such services from our independent registered public accounting firm.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to engagement, the audit committee pre-approves these services by category of service. The fees are budgeted and the audit committee requires our independent registered public accounting firm and management to report actual fees versus the budget periodically throughout the year by category of service. During the year, circumstances may arise when it may become necessary to engage our independent registered public accounting firm for additional services not contemplated in the original pre-approval. In those instances, the audit committee requires specific pre-approval before engaging our independent registered public accounting firm.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The audit committee may delegate pre-approval authority to one or more of its members. The member to whom such authority is delegated must report, for informational purposes only, any pre-approval decisions to the audit committee at its next scheduled meeting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:66.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">114</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> IV</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:12.996%;"></td>
    <td style="width:87.004%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 15.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="partiv_item15"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">EXHIBITS, FI</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">NANCIAL</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">&#160;STATEMENT SCHEDULES</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 15(a)(1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Index to Audited Combined and Consolidated Financial Statements as of December 31, 2021 and 2020 and for the years ended December 31, 2021 and 2020</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:89.148%;"></td>
    <td style="width:10.852%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Page Number</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#report_of_independent_registered"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Report of Independent Registered Public Accounting Firm (Deloitte &amp; Touche LLP, PCAOB ID 34)</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Combined and Consolidated Balance Sheets as of December 31, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_of_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Combined and Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_of_changes_equity"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Combined and Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders&#x2019; Equity (Deficit) for the years ended December 31, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_of_cash_flow"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Combined and Consolidated Statements of Cash Flows for the years ended December 31, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#notes_organization_and_description"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Notes to Combined and Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:12.996%;"></td>
    <td style="width:87.004%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 15(a)(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial statement schedules have not been included because they are not applicable or the information is included in the financial statements or notes thereto.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 15(a)(3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibits</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following is a list of exhibits filed as part of this Annual Report on Form 10-K.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.246%;"></td>
    <td style="width:44.91%;"></td>
    <td style="width:9.168%;"></td>
    <td style="width:15.571%;"></td>
    <td style="width:10.08%;"></td>
    <td style="width:12.024%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Exhibit </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Exhibit Description</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Filed Herewith</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Incorporated by</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Reference Herein</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">from Form or</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Schedule</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Filing Date</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">SEC File/</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Reg. Number</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.1&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921089996/tm2121601d1_ex2-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Business Combination Agreement, dated as of July 7, 2021, by and among Hyperfine, Inc. (formerly HealthCor Catalio Acquisition Corp.), Optimus Merger Sub I, Inc., Optimus Merger Sub II, Inc., Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and Liminal Sciences, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 2.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7/8/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex3-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certificate of Incorporation of Hyperfine, Inc., as amended</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 3.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex3-2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Bylaws of Hyperfine, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 3.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921120431/tm2121883d12_ex4-2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Specimen Class A Common Stock Certificate</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4/A<br />(Exhibit 4.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/29/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="hypr-ex4_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Description of Securities</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921089996/tm2121601d1_ex10-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of PIPE Investor Subscription Agreement for institutional investors, dated as of July 7, 2021, by and between Hyperfine, Inc. (formerly HealthCor Catalio Acquisition Corp.) and the subscriber parties thereto</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7/8/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921089996/tm2121601d1_ex10-2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of PIPE Investor Subscription Agreement for individual investors, dated as of July 7, 2021, by and between Hyperfine, Inc. (formerly HealthCor Catalio Acquisition Corp.) and the subscriber parties thereto</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7/8/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">115</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.246%;"></td>
    <td style="width:44.91%;"></td>
    <td style="width:9.168%;"></td>
    <td style="width:15.571%;"></td>
    <td style="width:10.08%;"></td>
    <td style="width:12.024%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921090293/tm2121601d3_ex10-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Transaction Support Agreement, dated as of July 8, 2021, by and among Hyperfine, Inc. (formerly HealthCor Catalio Acquisition Corp.), Dr. Jonathan M. Rothberg, and certain supporting stockholders of Hyperfine</span></a><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921090293/tm2121601d3_ex10-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Operations, Inc. (formerly Hyperfine, Inc.) and Liminal Sciences, Inc. affiliated with Dr. Rothberg</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7/8/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921089996/tm2121601d1_ex10-3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Sponsor Letter Agreement, dated as of July 7, 2021, by and among Hyperfine, Inc. (formerly HealthCor Catalio Acquisition Corp.), Hyperfine Operations, Inc. (formerly Hyperfine, Inc.), Liminal Sciences, Inc., HC Sponsor LLC, and the other stockholders party thereto</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7/8/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.5+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10-5.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Advisory Agreement, dated as of December 22, 2021, by and between Hyperfine, Inc. and Dr. Jonathan M. Rothberg</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.6+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d15.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Second Amended and Restated Offer Letter, dated as of April 25, 2021, by and between Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and David Scott</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.15)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.7+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d11.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Amended and Restated Offer Letter, dated as of August 27, 2021, by and between Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and Alok Gupta</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.11)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.8+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d12.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Offer Letter, dated as of June 7, 2019, by and between Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and Mark Hughes</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.12)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.9+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d13.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Offer Letter, dated as of January 4, 2020, by and between Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and Khan Siddiqui, M.D.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.13)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.10+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d14.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Offer Letter, dated as of April 13, 2021, by and between Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and Neela Paykel</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.14)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.11+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921120431/tm2121883d12_ex10-20.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Offer Letter, dated as of August 24, 2021, by and between Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and Scott White</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4/A<br />(Exhibit 10.20)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">09/29/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.12+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d16.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consulting Agreement, dated as of April 25, 2021, by and between Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and R. Scott Huennekens</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.16)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.13+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10-13.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Hyperfine, Inc. Executive Severance Plan</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.13)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.14</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d17.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Technology and Services Exchange Agreement, dated as of November 19, 2020, by and among Butterfly Network, Inc., Hyperfine Operations, Inc. (formerly Hyperfine, Inc.), Liminal Sciences, Inc. and the other participants named therein</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.17)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.15</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d18.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Technology and Services Exchange Agreement, dated as of February 17, 2021, by and among Quantum-Si Incorporated, Hyperfine Operations, Inc. (formerly Hyperfine, Inc.), Liminal Sciences, Inc. and the other participants named therein</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.18)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">116</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.246%;"></td>
    <td style="width:44.91%;"></td>
    <td style="width:9.168%;"></td>
    <td style="width:15.571%;"></td>
    <td style="width:10.08%;"></td>
    <td style="width:12.024%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.16</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10-16.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Technology and Services Exchange Agreement, dated as of July 7, 2021, by and among Hyperfine Operations, Inc. (formerly Hyperfine, Inc.), Liminal Sciences, Inc. and the participants named therein</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.16)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.17@</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d8.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">License Agreement, dated as of May 29, 2014, by and between Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and The General Hospital Corporation, d/b/a Massachusetts General Hospital.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.18@</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d9.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">License Agreement, dated as of June 30, 2014, by and between Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and The General Hospital Corporation, d/b/a Massachusetts General Hospital.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.9)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.19@</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921110757/hcaq-20210830xex10d10.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Manufacture and Supply Agreement, dated as of October 15, 2018, by and between Hyperfine, Inc. and Benchmark Electronics, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-4<br />(Exhibit 10.10)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">08/30/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-259148</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.20.1+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10d20-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Hyperfine, Inc. 2021 Equity Incentive Plan</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.20.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.20.2+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10d20-2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of Stock Option Agreement under 2021 Equity Incentive Plan</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.20.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.20.3+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10d20-3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of Restricted Stock Unit Agreement under 2021 Equity Incentive Plan</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.20.3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.21.1+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10d21-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) 2014 Employee, Director and Consultant Equity Incentive Plan, as amended</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.21.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.21.2+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10d21-2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of Stock Option Agreement under Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) 2014 Employee, Director and Consultant Equity Incentive Plan, as amended</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.21.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.22.1+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10d22-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Liminal Sciences, Inc. 2021 Employee, Director and Consultant Equity Incentive Plan, as amended</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.22.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.22.2+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10d22-2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of Stock Option Agreement under Liminal Sciences, Inc. 2021 Employee, Director and Consultant Equity Incentive Plan, as amended</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.22.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.23+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10-23.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Nonemployee Director Compensation Policy</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.23)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.24+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10-24.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of Indemnification Agreement</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.24)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.25+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10-24.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of Indemnity Agreement of HealthCor</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form S-1<br />(Exhibit 10.4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1/8/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-252002</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.25</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10-25.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Amended and Restated Registration Rights Agreement, dated as of December 22, 2021, by and among Hyperfine, Inc. (formerly HealthCor Catalio Acquisition Corp.), HC Sponsor LLC and certain other security holders</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.25)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.26</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10-26.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of Lock-up Agreement</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.26)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">117</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.246%;"></td>
    <td style="width:44.91%;"></td>
    <td style="width:9.168%;"></td>
    <td style="width:15.571%;"></td>
    <td style="width:10.08%;"></td>
    <td style="width:12.024%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.27</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1833769/000110465921153941/tm2136302d1_ex10-27.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Forfeiture Agreement, dated as of December 21, 2021, by and among Hyperfine, Inc. (formerly HealthCor Catalio Acquisition Corp.), HC Sponsor LLC, Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and Liminal Sciences, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Form 8-K<br />(Exhibit 10.27)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/28/2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39949</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="hypr-ex21_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">List of Subsidiaries</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="hypr-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of the Chief Executive Officer</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="hypr-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of the Chief Financial Officer</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><a href="hypr-ex32.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.INS</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Instance Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.SCH</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.CAL</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.DEF</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.LAB</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.PRE</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">X</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-bottom:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#134; Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">+ Management contract or compensatory plan or arrangement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">@ Certain confidential portions of this Exhibit were omitted by means of marking such portions with brackets (&#x201c;[***]&#x201d;) because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">* </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The certification attached as Exhibit 32 that accompanies this Annual Report on Form 10-K is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-K, irrespective of any general incorporation language contained in such filing.</span></p>
  <p style="text-indent:-2.557%;padding-left:2.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;" id="item_16_form_10_k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 16. FORM 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">0-K SUMMARY</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">118</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SIGNAT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">URES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:47.018%;"></td>
    <td style="width:2.217%;"></td>
    <td style="width:5.179%;"></td>
    <td style="width:45.586%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">HYPERFINE, INC.</span></p></td>
   </tr>
   <tr style="height:15.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: March 25, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.750pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Dave Scott</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dave Scott</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President and Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:7.127%;"></td>
    <td style="width:35.229%;"></td>
    <td style="width:35.318%;"></td>
    <td style="width:22.326%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Signatures</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Title</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Date</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Dave Scott</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dave Scott</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President, Chief Executive Officer and Director</span></p><p style="text-indent:-12.0pt;padding-left:12.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(principal executive officer)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 25, 2022</span></p></td>
   </tr>
   <tr style="height:12.25pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Alok Gupta</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Alok Gupta</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Financial Officer (principal financial officer and principal accounting officer)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 25, 2022</span></p></td>
   </tr>
   <tr style="height:12.25pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ R. Scott Huennekens</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">R. Scott Huennekens</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Executive Chairman of the Board</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 25, 2022</span></p></td>
   </tr>
   <tr style="height:12.25pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Jonathan M. Rothberg, Ph.D.</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Jonathan M. Rothberg, Ph.D.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vice Chairman of the Board</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 25, 2022</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ John Dahldorf</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">John Dahldorf</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 25, 2022</span></p></td>
   </tr>
   <tr style="height:12.25pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Ruth Fattori</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ruth Fattori</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 25, 2022</span></p></td>
   </tr>
   <tr style="height:12.25pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Maria Sainz</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Maria Sainz</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 25, 2022</span></p></td>
   </tr>
   <tr style="height:12.25pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Daniel J. Wolterman</span></p><p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Daniel J. Wolterman</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 25, 2022</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">119</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="report_of_independent_registered"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">REPORT OF INDEPE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">NDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the stockholders and the Board of Directors of Hyperfine, Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Opinion on the Financial Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have audited the accompanying combined and consolidated balance sheets of Hyperfine, Inc. and subsidiaries,  (the &#34;Company&#34;) as of December 31, 2021 and 2020, the related combined and consolidated statements of operations and comprehensive loss, changes in convertible preferred stock and stockholders&#x2019; equity (deficit), and cash flows for each of the two years in the period ended December 31, 2021, and the related notes (collectively referred to as the &#34;financial statements&#34;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Basis for Opinion</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#x201c;PCAOB&#x201d;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Deloitte &amp; Touche LLP</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">New York, New York</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 25, 2022</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have served as the Company's auditor since 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">COMBINED AND CONSOLIDAT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ED BALANCE SHEETS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">AS OF DECEMBER 31, 2021 AND 2020</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(in thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.425%;"></td>
    <td style="width:1.6%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:13.239%;"></td>
    <td style="width:0.785%;"></td>
    <td style="width:1.61%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:13.229%;"></td>
    <td style="width:0.785%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">ASSETS</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">CURRENT ASSETS:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8cd62d5e-1fe7-4049-bd9d-07f3d9efdf81" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">188,498</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_104a0732-5e33-4288-bfb6-58558824d6dd" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,676</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Restricted cash</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_80e91bba-488c-4fc1-8cb2-a30b329cd1f8" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:RestrictedCashCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,662</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_995ffd20-cec9-47a6-ad79-6bf68758c3d3" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:RestrictedCashCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,610</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accounts receivable, less allowance of $</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_78743c0f-8e1b-459b-8a47-12557fdda9c8" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;and $</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c18460d9-e560-416e-9303-33f86c86b4a8" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;in 2021 and 2020, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e2780ce-3cb2-4e63-8623-2a65e6c7dc5d" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">553</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_94c98ec1-9c39-41c2-8c14-89d2e5eaf27a" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">174</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Unbilled receivables</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_30aeb07c-cc4c-41ed-8f88-e3341083541d" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:UnbilledReceivablesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">91</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Inventory</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_153d86df-8356-4d1e-8926-92c399e2ce0f" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,310</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0314d757-3630-4ad0-80f8-30d5a446d372" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,718</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f87df5bd-2092-4807-b4cc-57285cd9daab" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,357</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cf51e7aa-4398-46c7-bb97-e8be09138e84" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">691</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Due from related parties</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_48035cdb-a9d6-47f7-adec-8b11082cb6a1" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DueFromRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f8f454e8-4f85-49bd-a43d-ba33dacf8dfc" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:DueFromRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,465</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Total current assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b76a1a2e-5b68-4451-bfa3-402c29cba42f" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">197,485</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_416efdae-69f2-48bd-818b-148571b2f5f9" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">68,334</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a053d45d-627b-4024-b0ea-ef16022d98aa" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,753</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_380a4707-b276-44a8-8b42-bd78ee9831fb" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,904</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other assets - related party</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2f925b4e-10ae-4c44-bbb1-9ff70d1f93d4" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="hypr:OtherAssetsRelatedPartyNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,244</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other long term assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e885da84-fe2d-4fe5-aef3-758b2d9a6b16" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,235</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a1d7983c-7de9-466f-9dc1-f95bd4906ba8" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">44</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b0599e9a-f929-4593-818f-ad07fc559b22" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">202,473</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9abc5d9e-3220-41ff-89b1-382cc51e740f" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">71,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">CURRENT LIABILITIES:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_13c03bce-a845-4ed0-a26c-ee064941bc83" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,248</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1d6bea93-4ede-4e86-a3fa-c0d017eabe84" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">948</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred grant funding</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_22915681-8780-4483-9483-81fd24e58810" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:DeferredGrantFundingCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,662</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4b74e989-5e90-4c0d-878f-e3dfbb92063b" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="hypr:DeferredGrantFundingCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,610</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9a35bd9d-4671-4e50-935b-6a25242f0716" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">730</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2d7ab551-284e-4c7d-a0b1-308cefd40f20" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Due to related parties</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7601194-8cbb-49ce-93ab-471b3934de02" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,981</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6ed7e5c9-db45-4a8f-8a65-65263d4ad802" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">136</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accrued expenses and other current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7ddbd041-1c72-4157-b6d2-0f14d14b8440" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:AccruedExpensesAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,115</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1db4bd20-407b-4fb6-bceb-f66b051d9945" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="hypr:AccruedExpensesAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,264</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4850db2d-6e82-4554-aa51-457e25070a55" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,736</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a29ca191-af11-4f26-99c9-66b74ff9ca5a" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,116</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Long term notes payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e776299d-5541-4086-b006-d87effabd7e3" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:LongTermNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">178</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Long term deferred revenue</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f2fcd76f-7142-46f0-ab01-c02edc3dfef4" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">510</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_93195b9a-893a-4377-8ca6-45073ec774d8" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,246</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb9a9b69-13f7-4d60-8717-acfa8b9d153d" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,294</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b67239e3-f61f-4cba-b264-e5903882a0e2;"><span style="-sec-ix-hidden:F_6b9cea9f-2dca-4d8b-bc71-1e411360de94;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">COMMITMENTS AND CONTINGENCIES (NOTE 16)</span></span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">CONVERTIBLE PREFERRED STOCK</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Hyperfine convertible preferred stock (Series A, B, C and D): $</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8fbfd5dd-3315-45c7-adf9-86b154f9171d" contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_30836c1e-da5b-4674-814a-32a1103b33d0" contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;par value, aggregate liquidation preference of $</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9485d23b-4de1-4ab1-a1fb-bfe794f766eb" contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;and $</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4eb87df8-6d3a-4f55-951c-a7adc922590b" contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">147,651</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">; </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_35e2dec9-0d84-4962-aa39-c7165d4bfed6" contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d0b2f1ea-e80f-47b2-9fff-fabf43e35e0c" contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">129,788,828</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;shares authorized; </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_136c12e4-ad6a-4f2b-96d9-557dbaba7aba" contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_733506ea-1ed1-4883-8024-69131b67d6f2" contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_732c9eca-b0d9-478e-a283-4b6fbc66d8ad" contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_461689ad-4a80-4be5-9d97-11fe375d59f0" contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">95,010,858</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;shares issued and outstanding at December 31, 2021 and 2020, respectively</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_7ec0eccf-356a-44c9-b3c6-e8a10dd2b780;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8c589011-20d3-452d-b345-a65dd0ed60f4" contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">128,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">STOCKHOLDERS' EQUITY (DEFICIT):</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Class A Common stock, $</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1c2d339f-e9c4-4565-817d-38eb6a3f15b2" contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_d742fa60-3b57-4b8d-8060-ce4ac0350c54" contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;par value; </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d81902c7-40f9-4abf-9743-99b77f8331a1" contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">600,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f3f65d1c-7a17-4bbb-9a48-db5a254dcdb8" contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">130,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;shares authorized; </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_deabe5b4-e33c-4053-91b1-5fdeb7cf287d" contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_8719322e-6c48-48e4-b091-77d9286d3069" contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">55,277,061</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ac75f00f-0137-4493-9327-92a5685e05c8" contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_1075b9a0-37b8-451c-bbba-317537167954" contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,576,137</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;shares issued and outstanding at December 31, 2021 and 2020, respectively</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f09dd260-8663-4396-8ab3-47d89c7bb79a" contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_34fdc04b-c2cb-413b-abda-23a19ba3ed8d;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Class B Common stock, $</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a5738ec9-71c3-4f96-ac75-459fd9cd243b" contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_0055f4ee-91d3-4344-81dc-66279f14f06d" contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;par value; </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bf7d41f2-7595-47da-a625-f9694866ad10" contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">27,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8c330abe-99c7-4e2c-809b-346695545ff3" contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;shares authorized; </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c71413a8-b8e1-4043-919e-dfceb9a1f160" contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_88129681-3a32-411d-8edb-0d2cfc094718" contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,055,288</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d60e28bd-4cdb-4eb5-8964-46911f4a29d0" contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_0aa9a941-4f83-430c-851a-74ada39ef747" contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;shares issued and outstanding at December 31, 2021 and 2020, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_299c2379-9c6f-4986-864a-080de2d4f6b4" contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1c13b237-b33f-482f-9778-a6fd264becc6;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a10590c6-405a-4f73-8da1-b85ddb4e2433" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">322,540</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f976a77-ef25-4926-8366-145420d64f01" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,415</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bacadb17-7298-450e-9dc5-b06fdea979bc" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">136,320</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e31ea62-3a9d-4f5b-92fc-8db7ee3212e7" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">71,469</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total stockholders' equity (deficit)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2b7b6484-bdb4-4372-a4ba-885db8745d91" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">186,227</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1ecfac94-cde7-4388-8d63-43433cabfadd" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">61,054</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5e20b390-c976-4b96-830d-74dfb176e9f7" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">202,473</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_34855d0d-4c40-4ae2-bee6-5303fc1d721c" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">71,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">        </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these combined and consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p>
  <p style="margin-left:1.733%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.0%;text-align:center;" id="consolidated_stmts_ops_comp_loss"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> COMBINED AND CONSOLIDATED STATEMENTS</span><span id="consolidated_statements_of_operations"></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> OF OPERATIONS AND COMPREHENSIVE LOSS</span></p>
  <p style="margin-left:1.733%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.0%;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(in thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:62.926%;"></td>
    <td style="width:1.779%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:14.81%;"></td>
    <td style="width:0.785%;"></td>
    <td style="width:1.779%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:14.81%;"></td>
    <td style="width:0.785%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Device</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8de84dc2-a680-44f5-b0a0-61d07c67ff40" contextRef="C_cb3f4280-8358-43b6-8ea1-38d00c89ec05" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">715</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b0e52e25-53fa-4888-b52b-1c37d36c5469" contextRef="C_9f4271cf-301e-459f-8dfd-8d9530cbb4eb" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">200</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Service</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a9ae7c9e-9ea1-47af-b062-16eb9b3905a8" contextRef="C_77379a12-290a-4832-afc5-a9209e02e808" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">781</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a83cc988-ecd4-4cda-a33c-a425b85dd6d3" contextRef="C_f64f1671-f740-47b2-bdee-89e73fc16d87" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">94</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Total sales</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6c44aa31-5d2e-4f94-b53c-d1e116630912" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,496</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_22a9c6c6-257b-44df-8763-46872461031b" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">294</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cost of sales</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Device</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_84138df9-a13d-44c5-9e2a-f11846f0be8e" contextRef="C_cb3f4280-8358-43b6-8ea1-38d00c89ec05" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,058</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_55ab87cf-73a7-4ad0-880a-4b3a20008e65" contextRef="C_9f4271cf-301e-459f-8dfd-8d9530cbb4eb" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">763</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Service</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c153076b-d6fb-4615-b764-e91ffa1335f0" contextRef="C_77379a12-290a-4832-afc5-a9209e02e808" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">605</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5c1f3def-2e28-4029-ba47-9cb8588dffa9" contextRef="C_f64f1671-f740-47b2-bdee-89e73fc16d87" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Total cost of sales</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_75044b98-7bd2-400f-997f-25d8ad9cb863" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,663</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e96004d9-c7b3-49ef-8ac7-6e236d8a01a6" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">771</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Gross margin</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_365efb07-bded-4498-b3c1-551235eabd68" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:GrossProfit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,167</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_865669c5-cc73-4574-aa01-37e3711eb7be" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:GrossProfit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">477</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Operating Expenses:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_058be85b-33e5-4645-af42-3181633b2b36" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,842</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1a4ed5fd-97e6-4f2e-bdb0-b5f500f2679d" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,593</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cf4c7543-69bc-4986-89b9-b92152e00e20" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,497</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c225e7e6-a644-45bb-8318-48e9c3578508" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,921</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20655820-f860-45f4-89ee-8ecbdb1ab15c" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:SellingAndMarketingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,362</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e5bec5d7-9dbd-4812-b51b-d7c4c8e01df8" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:SellingAndMarketingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,500</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e16c7735-f24b-4e21-9288-04ca0e709b95" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">63,701</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7c48c689-0660-4301-8fcc-7f729f3a65b6" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,014</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c56cb172-75a3-43f0-869a-3435aaae53db" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">64,868</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ff025013-6569-438d-bab5-dd8b5e666dc1" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">23,491</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Interest income</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d2e6a94-e1bb-4297-9ed1-6690bbe668f5" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c51d5a7a-0412-4cf6-a352-c24e9f0c6954" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">70</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other expense, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d3539ee7-cafc-4b0f-8f3e-d54c9c52be4a" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2f5ad299-1dd2-4ad2-a1d6-31a629c9db8f" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Loss before provision for income taxes</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b26901c3-ba6c-4522-bdb2-62bc4ab5d564" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">64,851</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8e1b9f0f-d8d5-48cd-bb53-8058dc4d921f" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">23,427</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Provision for income taxes</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e9f4b57-bcc9-4f87-99bb-11a9dd8c8e43" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_30138270-ef84-453b-af3c-a94b07124d59;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Net loss and comprehensive loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9da015c0-e4b6-44a9-acac-56c491f9ab4e" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">64,851</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f372068-43e0-46e1-926d-b269f9991183" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">23,427</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net loss per common share attributable to common stockholders, basic and diluted</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2499428d-8d7f-4dde-88c1-ea8f35b3ac4c" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">17.57</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb5af1af-6eab-40e6-a983-06d611f5f883" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">15.38</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1c3df562-1cac-48e8-a314-2908c5b8a18d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,690,523</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f56ae4f-dbfb-46e8-8c05-0da3171f5f62" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,523,096</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these combined and consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_of_changes_equity"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">COMBINED AND CONSOLIDATED STATEMENTS OF CHANGES IN CO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#x2019; EQUITY (DEFICIT)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(in thousands, except share amounts)</span></p>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:16.031%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:6.006%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:4.004%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:5.005%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:3.003%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:5.005%;"></td>
    <td style="width:1.14%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:0.904%;"></td>
    <td style="width:4.407%;"></td>
    <td style="width:0.417%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:0.417%;"></td>
    <td style="width:4.644%;"></td>
    <td style="width:0.417%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:0.904%;"></td>
    <td style="width:4.407%;"></td>
    <td style="width:0.417%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:0.904%;"></td>
    <td style="width:5.763%;"></td>
    <td style="width:0.584%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:0.904%;"></td>
    <td style="width:5.005%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:6.104%;"></td>
    <td style="width:0.584%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Hyperfine Convertible Preferred Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Liminal Convertible Preferred Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Class A Common Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Class B Common Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Additional</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Accumulated</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Total<br />Shareholders'</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Paid-in Capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Equity (Deficit)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">December 31, 2019</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3baa6d49-93e2-402f-83ae-69a8f30727aa" contextRef="C_a1217e52-b226-462c-8502-52f8c592156b" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">67,211,210</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ba61e76-3ce9-4032-a916-70351799f560" contextRef="C_a1217e52-b226-462c-8502-52f8c592156b" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">68,646</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5988f5fb-41e4-40f8-a2f6-fe8e6f7c9ad8" contextRef="C_a27dd307-2fcd-40ef-8e2c-ce7ce0a4e528" name="us-gaap:SharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,508,415</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b836ccfd-f16f-47b4-bcd0-f5f1514bad62" contextRef="C_592456c7-7eda-4630-a583-9725554adb90" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,178</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a1c21133-0b90-4ca7-9c65-e7029d641e3a" contextRef="C_a54c8d03-257a-444a-adcc-4832043c42ed" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">48,042</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8e325e7a-b8b4-453a-8caa-a46fadcba205" contextRef="C_3c9581e7-07d4-4e55-bccf-5e8bd25bbbb7" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">39,864</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_656ac925-337b-45c1-9422-b7bbf123810f" contextRef="C_834be932-c2f9-4d94-9f67-fbab4d5554fc" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">23,427</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bdcb91c8-bbae-458e-a8f6-60a2f9ddf3e3" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">23,427</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of Series D convertible preferred stock, net of issuance costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_03e3eee1-aa3f-446f-8dbf-b4c87edbe456" contextRef="C_fcabd41f-ce0d-46f0-bf8c-30aa40ebb4df" name="hypr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">27,799,648</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a78bd0f7-0ade-4ffd-8e63-afeb00c58ee0" contextRef="C_fcabd41f-ce0d-46f0-bf8c-30aa40ebb4df" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,640</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Investment from 4Bionics, LLC</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dbb86fce-87ee-4935-a4dc-6f9eb3c93774" contextRef="C_a77bfc0c-9f2a-400b-b003-b38132751429" name="hypr:AdjustmentsToAdditionalPaidInCapitalInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c740876d-4a6d-4297-b3e4-0c0d80c70ac8" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="hypr:AdjustmentsToAdditionalPaidInCapitalInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6f76a453-f6d8-459f-9fa7-4fd89d70cae8" contextRef="C_f284e816-cacb-4f3c-bea6-47fac4904183" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">67,722</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ac25350c-9d5b-4535-a679-3e1eb4afd9fa" contextRef="C_a77bfc0c-9f2a-400b-b003-b38132751429" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">120</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ad063cee-fe61-4e7f-97c9-282cef479fd7" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">120</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_595b0004-52b3-429e-8f08-81ce54e424e0" contextRef="C_a77bfc0c-9f2a-400b-b003-b38132751429" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,117</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_22c3993e-9ecf-463d-9196-8a71ab4431a0" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,117</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Balance, December 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c505671c-dea6-46d0-8127-7997cf40c106" contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">95,010,858</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f33012ca-f186-437c-a020-b11fe238bb79" contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">128,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_93e6a52f-68bb-46a6-b070-e44d2bda6b38" contextRef="C_464908b0-1fa1-4326-90d3-0c2106209a10" name="us-gaap:SharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,576,137</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0dc87a9b-a6d5-4594-943a-c4cc0ec5fdd6" contextRef="C_a545f35c-3630-4b98-a6b2-43950943b602" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,415</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b08a9000-2d8e-4205-a611-a878f711b220" contextRef="C_37fd5a65-0913-4f4d-81f7-910f82c3ea2e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">71,469</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_43681277-5dfd-4092-8488-e0fe0d4277ea" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">61,054</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c313e144-bc00-4b90-a2b9-f1b5300ee552" contextRef="C_32845ad3-df15-4c41-a913-d909409b7057" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">64,851</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f4ab625d-7ab4-4fff-be95-b0b4cd241079" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">64,851</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of Series D convertible preferred stock, net of issuance costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7526c786-3853-4766-b378-beab7ad6f369" contextRef="C_06ca1284-0a43-490c-94fa-34c74c4f5fbd" name="hypr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">14,171,333</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1032adb7-86c6-429d-8d9d-bb4ba92188f0" contextRef="C_06ca1284-0a43-490c-94fa-34c74c4f5fbd" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,461</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Investment from 4Bionics, LLC</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e43cd4e6-594e-413d-80af-2b918f37915d" contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2" name="hypr:AdjustmentsToAdditionalPaidInCapitalInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,516</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8b441337-89f9-4b1d-a717-008b43f935a7" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:AdjustmentsToAdditionalPaidInCapitalInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,516</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Conversion of Liminal Common stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20883fb0-9fee-43d5-8f6c-41bd961ae7c2" contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee" name="hypr:RecapitalizationOfPermanentToTemporaryEquityShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">57,500,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_964b1536-7877-46f4-bd3c-e47b3b84ceb4" contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee" name="hypr:RecapitalizationOfPermanentToTemporaryEquityValues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,350</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d340c41-2d55-4a19-9e29-0f5d37d1b7e9" contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="INF" sign="-" format="ixt:numdotdecimal">180</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c1dec154-ac90-4d46-88c4-bd2a50d28fe8" contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2" name="hypr:ConversionOfLiminalCommonStock" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,350</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_71a29924-2570-44db-9aa8-f1c98a93d415" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:ConversionOfLiminalCommonStock" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,350</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Exercise of stock options</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_87463ff3-bc90-4b25-8cd1-a0b8e7fb8d07" contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">565,533</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5f19c1ef-c05d-4ecc-b44a-2dad1003d4c9" contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,497</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c3e61301-0e18-4494-9c4f-6034da9a31c5" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,497</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Conversion of the convertible preferred stock into Class A and Class B common stock at the Business Combination</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3a5a2c8d-b48f-40f0-8504-7834f671ba95" contextRef="C_06ca1284-0a43-490c-94fa-34c74c4f5fbd" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" sign="-" format="ixt:numdotdecimal">109,182,191</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_25f2bc9e-8a03-4227-b2db-fff85f3b1711" contextRef="C_06ca1284-0a43-490c-94fa-34c74c4f5fbd" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">158,747</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_adfdfc04-361e-4487-a5da-54bfeade54f0" contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" sign="-" format="ixt:numdotdecimal">57,500,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_22da1b27-b1eb-4dc0-9d55-2b3afeb9aac4" contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,350</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f0e4f34-ba60-4b8d-b633-3cef94fe41c9" contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">31,028,815</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_86188305-a19c-4bdd-acbd-b5e6819eaa4a" contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_538cdc9d-cdfc-455c-9dbe-3fb6886ce28c" contextRef="C_14ca06d1-7275-41cf-91d6-7ff75a37e6d9" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,055,288</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7cb70078-c5dc-4820-97c7-03e2383020cf" contextRef="C_14ca06d1-7275-41cf-91d6-7ff75a37e6d9" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_628854cf-8298-4fb3-bdce-676d202cfb41" contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">168,092</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a37707a5-847f-4902-9ca9-196434d39a48" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">168,097</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net equity infusion from the Business Combination</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5ddc6448-c455-466a-aba6-72337839bb08" contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">21,806,756</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_25cc864a-6280-43d1-8afd-bd1f22e453d8" contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_adea3356-fab4-40c1-9fef-f60602fed2bd" contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">141,469</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_221004e2-08eb-430b-9f2c-c922f22a2f9d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">141,471</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of Class A common stock to a service provider</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_612c252a-8899-4857-9532-940beeaac6cf" contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">300,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f59bde9d-5998-4ff9-9aa9-60b4492b88c3" contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,901</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8be51c47-d66c-4ec6-bb7b-52ac63f6b5cd" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,901</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Balance, December 31, 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.500pt solid rgba(0,0,0,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_02236a64-28f5-451f-b167-c0f64df12e42" contextRef="C_58ed8b62-4e40-4fb5-b611-d1a03002120d" name="us-gaap:SharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">55,277,061</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f19fc0fe-9335-452f-ad11-cfcdf186b1a4" contextRef="C_58ed8b62-4e40-4fb5-b611-d1a03002120d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b85e3379-37d8-41ce-98be-a8b46a1b4260" contextRef="C_9f696af7-210f-43ef-9b46-8a8e5818aaa6" name="us-gaap:SharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,055,288</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7e40aa8e-d1de-40b0-b3b1-665a40334ae8" contextRef="C_9f696af7-210f-43ef-9b46-8a8e5818aaa6" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a4877cd9-227d-409b-a465-e0a671463858" contextRef="C_6b4b4ea7-d957-4077-89a8-2769e16523e4" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">322,540</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8adbc363-2ce6-4c8f-b504-af83f540af53" contextRef="C_19fcd92e-329b-4a10-8362-cba65df265a9" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">136,320</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f7b505ab-30fd-42bb-9f7e-845ceed5d7d8" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">186,227</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these combined and consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.06708333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:1.773%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.037%;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p>
  <p style="margin-left:1.733%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.0%;text-align:center;" id="consolidated_statements_of_cash_flow"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">COMBINED AND CONSOLIDATED STATEME</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">NTS OF CASH FLOWS</span></p>
  <p style="margin-left:1.733%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.0%;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">(in thousands)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.345%;"></td>
    <td style="width:1.6%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:13.209%;"></td>
    <td style="width:0.785%;"></td>
    <td style="width:1.739%;"></td>
    <td style="width:1.163%;"></td>
    <td style="width:13.209%;"></td>
    <td style="width:0.785%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Year ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Cash flows from operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ae71af5c-a85d-46b3-a7b7-71a13b3380f1" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">64,851</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ee66ac7-06f2-4dba-b4db-a4bc8f600c0f" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">23,427</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Depreciation and amortization</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_72daf6f2-b3de-415f-a3a6-f1162797da34" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">726</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2fcce5fa-ce49-48ff-94d3-4276ac5c4313" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">289</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_792b8bc9-5ed3-4ff7-9dba-2bdf59ba9b4a" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,901</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e3920718-4ed4-4597-baa9-bb427b5498ac" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,117</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Write-down of inventory</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2a8966b7-83ea-417f-8ad6-9f78376d2c5c" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:InventoryWriteDown" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">75</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_721a2f7e-828c-42d5-879e-8f6257cfd29f" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:InventoryWriteDown" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">213</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Write-off of other assets - related party</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e670c578-8f8d-4470-a71f-d953eb91a639" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:WriteOffOfOtherAssetsRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">984</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales under sales type leases</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c34a5d3a-5a6f-47ee-ad6d-defd5b965c00" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:SalesTypeLeaseSellingProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">46</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Payments received on net investment in lease</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dd3c9cc4-a84f-4f60-8787-c8eba100ca11" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NetInvestmentInLeasePurchase" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_714cb24c-14bb-4e25-a174-a5a2a77a9d03" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:NetInvestmentInLeasePurchase" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Changes in assets and liabilities:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_23b19d59-2149-48d8-b1d0-395d8188ac4e" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">379</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7429dc25-dabe-42a8-b48b-13f20c63a959" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">174</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Unbilled receivables</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3820dde5-8901-4961-bd2b-a3c417ab5ac7" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:UnbilledReceivables" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">91</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Inventory</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d8e042d-5952-4901-b972-840d454a9277" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseInInventories" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,667</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_088bcd07-ea9a-4b9e-80a8-e6dacf33d26b" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseInInventories" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,931</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b625a7eb-d51a-4b5f-ba3f-f7d699a2c4e7" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">666</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c716021b-22d2-44e3-9416-3bc9ae52c1cc" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">146</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Due from related parties</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_681becb3-c73f-44c0-8ea3-c74357ced205" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,451</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_95baaff0-c8b2-4045-a446-c935d7a322ac" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">782</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other assets - related party</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0263a942-46a9-468f-aa3b-afa9ce909c9c" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseDueFromOtherRelatedParties" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">260</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0e862f17-6a29-40b2-9c19-c92ede5735d1" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseDueFromOtherRelatedParties" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">226</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Prepaid inventory</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e1e1ba1-f3ac-4aa7-9c2d-02f420c0532b" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseInPrepaidSupplies" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">651</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other long term assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20a0d6c8-9c19-4075-a38a-40d30cfd650f" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,201</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_35b6e8ca-1be4-4ab7-b8ae-cbd70e70aae0" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,436</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f9511050-2753-4abf-8ceb-94a87118be1a" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">377</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred grant funding</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d437c6c0-1aba-430a-9b44-c45a072294df" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseInDeferredLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,052</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f241b77e-c689-4a52-9773-1a00d1a13cd4" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseInDeferredLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,610</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ae856e72-e30c-43b7-92ed-722a51139a4d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,082</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d436e335-d749-45ea-969a-fcf638d08daf" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Due to related parties</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d86143d9-f3d2-43a3-b886-8ca6159cb735" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseInDueToRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,845</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7dd6ce60-3832-4c93-b4a2-469fb030387f" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseInDueToRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accrued expenses and other current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f6be8ad4-07f8-4d9e-9ef7-b002ad6a693e" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,851</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_05de999c-8a82-447b-a9db-14e2eb2de62c" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">773</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:40.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:40.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5787a3d9-b86e-4afb-a55a-90889e904fa7" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">47,182</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2389836d-bcd4-43b2-adda-a78754e0979d" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">21,525</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Cash flows from investing activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Purchases of fixed assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_020b7393-4f7e-4a2e-80d9-87452a660282" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,711</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_54f55593-62f0-4224-a63f-a6d4ea29ccf6" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,568</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Net cash used in investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f89f90de-8090-4017-9c66-d6dacbe113ad" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,711</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8e20ce22-bec8-4352-b3ee-715c8c8d32b2" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,568</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Cash flows from financing activities:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Proceeds from exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ad573347-3236-4f97-b2ec-9fc4e51b1b83" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,497</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_732bf4fd-6d28-4389-a7f6-8dc7f4d8065b" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">120</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Proceeds from issuance of Series D convertible preferred stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3a6ff5ce-f12d-4f15-8c3e-3cf418e71d8e" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,468</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d33ac3b2-f450-4c47-8f49-57f209fdc035" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,769</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock issuance costs related to Series D convertible preferred stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_091c3f94-4c67-43c5-b58e-6e06ee7d9e4a" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ef4648ce-9458-4b73-8354-51ce6f49f29e" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">129</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Proceeds from issuance of notes payable</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a50a198c-8f2a-44ee-9c99-3a77d53d2d40" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ProceedsFromNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,067</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Repayment of notes payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_81c0affc-c5d7-4152-823d-0d32ba353859" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:RepaymentsOfNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">178</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5c5affdf-91d5-48e8-a81f-c8c2f0e84571" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:RepaymentsOfNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">889</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Investment from 4Bionics, LLC</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d2de99c1-fd0b-451d-99aa-0cb367594383" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ProceedsFromContributionsFromAffiliates" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,516</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_12334a89-bb3d-430b-ae1d-d286cb1c0df1" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ProceedsFromContributionsFromAffiliates" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net proceeds from equity infusion from the Business Combination</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_da0b37ce-8e44-4c8c-bbab-bc1ab8cb5757" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:ProceedsFromBusinessCombination" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">141,471</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e373f0e-32cf-4c40-8c6f-cbfc86ed957f" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">176,767</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_71b988e6-d083-4e31-90ad-f8c7a9df93f8" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60,938</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Net increase in cash and cash equivalents and restricted cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7e3af3dd-250e-496a-ba7d-a37ac1a164bc" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">126,874</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_703aeead-69a9-4630-8c92-a4da578f8814" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">37,845</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cash, cash equivalents and restricted cash, beginning of year</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_47cdd84a-5098-46d4-90ca-049524a7c811" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f8f52ef5-f3d7-4831-9a52-432cd84ba35d" contextRef="C_3c9581e7-07d4-4e55-bccf-5e8bd25bbbb7" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,441</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Cash, cash equivalents and restricted cash, end of year</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2abcbaba-b52a-495b-bc42-fc3f6971af63" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">191,160</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7b6b71d4-bcfd-41d0-be2c-8615018869d5" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Reconciliation of cash, cash equivalents, and restricted cash reported in the statement<br />of financial position</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_08221114-545a-4b94-ab92-8a43a49bf475" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">188,498</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bd6d31a7-922f-4b81-b066-0aeb6a7ccff3" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,676</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Restricted cash</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4672945d-2068-41d3-bea5-ec164f609d53" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:RestrictedCashAndCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,662</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_81f6f845-74b3-4425-a710-7b8e8eee99c5" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:RestrictedCashAndCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,610</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total cash, cash equivalents and restricted cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_334a76ae-3996-40f3-b448-0dc20a8565ac" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">191,160</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_580fb796-0cc5-42c3-af04-3d3ed06401b0" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Supplemental disclosure of cash flow information:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cash received from exchange of research and development tax credits</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dc1dde8d-ade4-4736-8990-ddf8074253d3" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">374</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1359e6e5-b905-4081-8f6d-eb4a7274bb47" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="hypr:CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">261</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Supplemental disclosure of noncash information:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Noncash acquisition of fixed assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e2956a7c-67f0-43c6-abe9-6d44e3424d0e" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">136</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Issuance of Class A Common Stock to a service provider in exchange for the service provided in connection with the Business Combination</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b79e073d-1e6c-449e-b4c8-42dbc09ed787" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:StockIssued1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these combined and consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_53d80188-894b-4378-97db-a88e27e5261f" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;" id="notes_organization_and_description"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1. ORGANIZ</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ATION AND DESCRIPTION OF BUSINESS</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Hyperfine, Inc. (together with its subsidiaries, as applicable, &#x201c;Hyperfine&#x201d;, the &#x201c;Company&#x201d;), formerly known as HealthCor Catalio Acquisition Corp. (&#x201c;HealthCor&#x201d;), was incorporated as a Cayman Islands exempted company on November 18, 2020. The Company&#x2019;s legal name became Hyperfine, Inc. in connection with the closing of the Business Combination (the &#x201c;Closing&#x201d;) on December 22, 2021 (the &#x201c;Closing Date&#x201d;), as defined and described in Note 3. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In connection with the Closing, Hyperfine, Inc., a Delaware corporation (&#x201c;Legacy Hyperfine&#x201d;), and Liminal Sciences, Inc., a Delaware corporation (&#x201c;Liminal&#x201d;), merged with and into separate wholly owned subsidiaries of HealthCor and became wholly-owned subsidiaries of the Company, and changed their names to Hyperfine Operations, Inc. and Liminal Operations, Inc., respectively. Liminal subsequently changed its name to Liminal Sciences, Inc. The prior period financial information represents the combined financial results of Legacy Hyperfine and Liminal.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is an innovative digital health business with a mission to provide affordable and accessible imaging and monitoring through magnetic resonance imaging (&#34;MRI&#34;) to revolutionize healthcare for people around the world. Hyperfine's Swoop&#174; Portable Magnetic Resonance (&#x201c;MR&#x201d;) </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Imaging System</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">TM </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">produces high-quality images at a lower magnetic field strength than conventional MRI systems, and can be used by healthcare professionals to make effective clinical diagnoses on a patient in a variety of settings where MRI devices have previously been inaccessible. Hyperfine received 510(k) clearance from the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) in 2020 for its Swoop Portable MR Imaging System, which is commercially available in the United States. In 2021, Hyperfine also obtained a Medical Device License issued by Health Canada and expanded into the Canadian market, and also obtained regulatory authorization in New Zealand and Pakistan. All of the Company&#x2019;s revenue to date has been generated from sales of this machine and related services. Additionally, the Company is in the process of developing a device to non-invasively measure key vital signs in the brain to enable unprecedented access to dramatically improve patient outcomes. The Company is in the early research and development stage of such device and has not generated any revenue to date for it. In addition to Legacy Hyperfine and Liminal, the Company has an indirect wholly-owned subsidiary in the United Kingdom that did not have any significant operations during 2021.</span></p></ix:nonNumeric></div>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_35c2adc1-a400-48ea-9212-bd44d23fd754" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_acd32112-af42-4d32-bd24-c6aba07b5ad5" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying combined and consolidated financial statements include the accounts of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the accounting disclosure rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). All intercompany transactions and balances have been eliminated.</span></p></ix:nonNumeric></div><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_860e2255-8d02-46bc-aca8-0ccda2bcb806" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:Covid19OutbreakPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">COVID-19 Outbreak</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The recent outbreak of the novel coronavirus (&#x201c;COVID-19&#x201d;), which was declared a pandemic by the World Health Organization on March 11, 2020 and declared a National Emergency by the President of the United States on March 13, 2020, has led to adverse impacts on the U.S. and global economies and created uncertainty regarding potential impacts on the Company&#x2019;s operating results, financial condition and cash flows. The COVID-19 pandemic has had, and is expected to continue to have, an adverse impact on the Company&#x2019;s operations, particularly as a result of preventive and precautionary measures that the Company, other businesses, and governments are taking. Governmental mandates related to COVID-19 or other infectious diseases, or public health crises, have impacted, and the Company expects them to continue to impact, its personnel and personnel at third-party manufacturing facilities in the United States and other countries, and the availability or cost of materials, which could disrupt or delay the Company&#x2019;s receipt of instruments, components and supplies from the third parties the Company relies on to, among other things, produce its products. The COVID-19 pandemic has also had an adverse effect on the Company&#x2019;s ability to attract, recruit, interview and hire at the pace the Company would typically expect to support its rapidly expanding operations. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company&#x2019;s business, results of operations and financial condition, including expenses and research and development costs, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or address the COVID-19 pandemic, as well as its economic impacts.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In adjusting to the COVID-19 market and manufacturing conditions, the Company did not have to materially adjust its existing resource allocation or its factors of production. The Company has not incurred any significant impairment losses in the carrying values of its assets as a result of the COVID-19 pandemic and is not aware of any specific related event or circumstance that would require the Company to revise its estimates reflected in its combined and consolidated financial statements.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The estimates of the impact on the Company&#x2019;s business may change based on new information that may emerge concerning COVID-19 and the actions to contain it or address its impact and the economic impact on local, regional, national and international markets. While the Company is unable to predict the full impact that the COVID-19 pandemic will have on its future results of operations, liquidity and financial condition due to numerous uncertainties, including the duration of the pandemic, and the actions that may be taken by government authorities across the United States and elsewhere, it is not expected to result in any significant changes in costs going forward.</span></p></ix:nonNumeric></div><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_18e3bcd9-1544-4ba8-a650-1b7378579c0d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of Credit Risk</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents. At December 31, 2021 and 2020, substantially all the Company&#x2019;s cash and cash equivalents were invested at two financial institutions. The Company also maintains balances in various operating accounts above federally insured limits. The Company has not experienced any losses on such accounts and does not believe it is exposed to any significant credit risk on cash and cash equivalents.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1e39c93b-e5c8-462f-96c1-042f8f986229" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant customers are those that represent more than 10% of the Company&#x2019;s total revenues or gross accounts receivable balances for the periods and as of each balance sheet date presented. For each significant customer, revenue as a percentage of total revenues and gross accounts receivable as a percentage of total gross accounts receivable were as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:17.622%;"></td>
          <td style="width:1.915%;"></td>
          <td style="width:21.98%;"></td>
          <td style="width:1.735%;"></td>
          <td style="width:18.5%;"></td>
          <td style="width:1.735%;"></td>
          <td style="width:17.389%;"></td>
          <td style="width:1.735%;"></td>
          <td style="width:17.389%;"></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;">&#160;</span></p></td>
          <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Revenue</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the year ended December 31, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the year ended December 31, 2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer A</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb656e5b-66bb-4697-9962-2a99e415370d" contextRef="C_09eef7e3-8ef7-4872-9505-3cdfab129205" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">12</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_acbc9236-bc6a-4014-8025-8810d84013bd" contextRef="C_474a603f-d6db-4d8d-92d3-70cb2d1e090f" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">21</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_718e850b-f1f1-409d-816d-8c1842a4702c" contextRef="C_7ccf2627-1cdc-47b7-ba29-626a157390fb" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bdb35a09-8058-4c3e-8eb6-63357a631027" contextRef="C_3157ed03-ddbf-421e-bca7-442ffc10828a" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer B</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e104c2f8-30bf-4626-82e5-d623aadc4848" contextRef="C_f8f8bfd0-b2c9-4228-859d-e035e36fdaff" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0f434cc1-366e-462d-a3a6-04919df91af4" contextRef="C_567125e1-75b2-41be-99d3-e7b8a2774dc7" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b753fa7e-7b4f-409f-9ac4-d8166dafd80d" contextRef="C_6fdadebf-3247-42bc-88ce-f78d1aae83b2" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">24</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_77b5934f-0ed2-4a1a-a4f2-477b9a1b026e" contextRef="C_dca47efa-de44-4ea2-a6f7-5e416bbbb918" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer C</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d5afb4ab-f5d3-4b3d-8512-179cad7d5486" contextRef="C_bba669ae-db49-4d96-9060-d3c7c8e07261" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e1b650b3-b67f-4985-9e13-24999edd0c03" contextRef="C_1dd44ac9-6110-4a83-a30a-28c9fbf87799" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">21</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6bb1939d-59d1-4dc0-a16d-26e7774f3837" contextRef="C_c9211565-b84a-4c97-88de-605f5525382b" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b3664402-0555-44b4-bacb-019d529e695f" contextRef="C_49d0dcc9-816b-4e28-8bc4-f9b5575f3a10" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer D</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4cda0b51-bf28-4634-8c0e-76f0ab77feec" contextRef="C_62a0c92e-5cb0-440b-9b64-ce1f6af679d3" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b38fb769-94e8-4c52-a3ff-67c60396e96d" contextRef="C_e9c6aa3c-7348-4f82-973e-f19a18dd2b91" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">11</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_462c78d4-734d-476f-acbc-80138413e4fc" contextRef="C_5cc0bd53-ddda-46e6-831e-25d4e45fd73a" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b8015af2-46c8-4eb5-8136-efec81f6bf68" contextRef="C_32bbb1e2-b724-403f-b397-48d9add24af7" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer E</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1a38a925-20dd-4839-b331-473209d845e5" contextRef="C_605093d2-ac5d-4510-b28c-7b383c6172c0" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5ead3339-ea7a-4aee-a31c-6d249f64f635" contextRef="C_167b678f-7a7b-434b-9324-e4fb5b75ab31" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cc13729d-18be-4251-860b-1352e4b49a8c" contextRef="C_c41d64ad-bb4c-4c76-99f9-e336bc1ab030" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5bc7eb4f-dd02-4aa0-add3-56380f7e3077" contextRef="C_8ce579da-efe4-411c-8e78-a08e6c50c59f" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">53</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer F</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_06fcd96a-aa2e-4961-bf56-701a9c7909b7" contextRef="C_3b17a194-f917-4277-981e-1a50762d4429" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_80444894-d329-4f84-bac4-f1f53b0a1469" contextRef="C_fba03c4e-b08a-41a6-8e92-9f1c641cb1f1" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d057c945-73d9-44e5-a3b7-92ebb785446f" contextRef="C_734af1ad-a0ec-4f29-bf39-f1b5327db6c7" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">41</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5e2f448c-3270-448b-8a09-019db9fb3eb8" contextRef="C_d03d8509-9cd9-41c6-ad48-7df3d9451e56" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer G</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3d156616-a3bb-4efa-90ee-f11f1ff9e153" contextRef="C_89e586a8-ee0a-4268-89f0-554f600718eb" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9a3ff426-b865-4c99-86d4-bf1d960c6642" contextRef="C_25f955f4-3de2-435b-8a68-92a8fb8291b4" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">14</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee67ffb4-31b4-4b34-917f-ab93b4f39c94" contextRef="C_931d86b2-1bb0-4d61-bc67-022ee2881f97" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bdca397e-3a1d-47ec-b01d-d00a26dc5cd0" contextRef="C_1ae6ab52-d904-4842-a161-d9892fd7ed09" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">32</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer H</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0ddcea94-6fe4-47f9-9eb2-68abff460e20" contextRef="C_d78a6553-a61c-42e1-b9da-7148c3162bcc" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_afe4dc20-ba79-4bec-a0a3-fefd348c50af" contextRef="C_6be4d64c-5ea1-40cf-ab05-f2d63f1883e8" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d40c9a27-5a34-4d06-b5f1-62e8129a53b8" contextRef="C_bb1fde1a-0016-49f0-92be-2a618f68f12f" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">26</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eee69d3e-55ee-46ff-adc6-91d601c6ddc6" contextRef="C_1a8cf60f-453e-465e-86fc-c6ed0ff3919e" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
        </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilizes a single exclusive manufacturer for its Swoop MRI scanner. Additionally, the Company purchases raw materials from this manufacturer.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_616dd041-cc6e-44cd-bf8c-5da8e02e8163" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segment Information</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s Chief Operating Decision Maker (&#x201c;CODM&#x201d;) is its Chief Executive Officer (&#x201c;CEO&#x201d;). Legacy Hyperfine and Liminal represent two operating segments. Given the similar qualitative and economic characteristics of the </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_43db31a9-0c99-4e54-ab20-021b4b451129" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NumberOfOperatingSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> operating segments, such that both are focused upon the development and commercialization of existing and new products and services, Legacy Hyperfine and Liminal are aggregated into </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cc4ea095-a15d-499f-935d-053f74993aca" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NumberOfReportableSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> reporting segment. All of the Company&#x2019;s long-lived assets are located in the United States. Other than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9311ebca-f213-42e9-a15a-ad47ddabbf43" contextRef="C_02ac6247-634e-47e7-9137-1d9fcf817084" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">78</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of revenue recognized in Australia, all of the revenues were earned in the United States. Since the Company is aggregated into a single operating segment, all required financial segment information is provided in the combined and consolidated financial statements.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_42ef55f7-6dd4-4fec-b5a6-ed073442c912" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:UseOfEstimates" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the combined and consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions about future events that affect the amounts reported in its combined and consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates and assumptions. Significant estimates and assumptions included:</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="margin-left:6.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue recognition, including determination of the timing and pattern of satisfaction of performance obligations, determination of the standalone selling price (&#x201c;SSP&#x201d;) of performance obligations and estimation of variable consideration;</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Allowance for doubtful accounts;</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net realizable value (the selling price as well as estimated costs of disposal and transportation) of inventory, and demand and future use of inventory;</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowances with respect to deferred tax assets; and</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assumptions underlying the fair value used in calculation of the stock-based compensation expense.</span></div></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company bases these estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company&#x2019;s combined and consolidated financial statements.	</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9a2f92ac-ceb5-4d7d-b658-5b31d69167db" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and Cash Equivalents</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All highly liquid investments purchased with a maturity of three months or less are cash equivalents. As of December 31, 2021 and 2020, cash and cash equivalents consist principally of cash and money market accounts.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_906d5ab1-e7a0-4721-8861-7ca6910d4ad1" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Cash</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted cash balance represents funds received as part of grant funding and restricted in use to the purpose of the funding. For details, see the Note 2. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies - Grant Funding</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and Note 16. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Commitments and Contingencies</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f8f4f151-c28e-49a5-a200-5fa607a18c56" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ReceivablesPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounts Receivable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts receivable are stated as the amount the Company expects to collect. The Company maintains allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. As of December 31, 2021 and 2020, the allowance for doubtful accounts was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7fd2e31a-767c-4a92-8624-2e400d2608d7" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ProvisionForDoubtfulAccounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f031630-9e45-4135-8cb9-fbac59889171" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ProvisionForDoubtfulAccounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9f34a124-be83-414f-b070-a8f3a28b4f7c" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:InventoryPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Inventories</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inventories primarily consist of finished goods which are produced by the Company&#x2019;s third-party contract manufacturers as well as raw materials ordered in advance by the third-party contract manufacturer due to long delivery-lead time and which were billed to the Company. Inventories are stated at the lower of actual cost, determined using the average cost method, or net realizable value. Cost includes an allocation of wages, taxes and benefits for employees involved in warehousing, logistics coordination, material sourcing, and production planning activities. Net realizable value is based upon an estimated average selling price reduced by the estimated costs of disposal and transportation.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">valuation of inventory also requires the Company to estimate excess and obsolete inventory. The Company considers sales forecasts and historical experience to identify excess, close out, or slow-moving items as well as new</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">development schedules, product obsolescence and product merchantability, including whether older products can be remanufactured into new products, among other factors. The Company reduces the value of inventory for estimated obsolescence or lack of marketability by the difference between the cost of the affected inventory and the net realizable value.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b259274b-b999-4440-8b3c-27fef2470761" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" escape="true"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Prepaid Expenses and Other Current Assets</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets include amounts paid in advance for operating expenses as well as monies to be received from the State of Connecticut for research and development tax credits. These research and development tax credits are exchanged for a cash refund and are typically collected within one year from the date the tax return is filed with the state. The credits are recognized as an offset to research and development expenses in the combined and consolidated statements of operations and comprehensive loss in the annual period in which the corresponding expenses were incurred.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_580cb61c-b5d3-4811-b66e-e1865fce5e33" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Property and Equipment, Net</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation expense is computed using the straight-line method over the estimated useful lives of the related assets.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ec5d6d3c-7a33-4028-98f1-0522f7c29265" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock" escape="true"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Useful lives of property and equipment are as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:79.609%;"></td>
          <td style="width:1.925%;"></td>
          <td style="width:0.624%;"></td>
          <td style="width:17.229%;"></td>
          <td style="width:0.613%;"></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Property and equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Estimated useful life</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93bfe0c5-1981-4f70-8de1-2567bf8b753b" contextRef="C_7bcd7cb4-1dc9-4c68-a43e-62994fd1ac21" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></ix:nonNumeric></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research devices</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_096e1b53-1025-42c1-8607-74084f9bd17c" contextRef="C_10346531-8b79-4c49-b961-3e5de4647ca2" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></ix:nonNumeric></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing devices</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_54bad0c1-1349-4104-8950-fb14864e186f" contextRef="C_aa627098-fe3c-4ac0-80bb-2be20fe7c7a5" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></ix:nonNumeric></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6119409a-20b7-4a0a-9318-d26df6aea61e" contextRef="C_1c800ff0-677d-4568-ac8b-02a9fb77a094" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></ix:nonNumeric></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tooling</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4b7b2db2-7458-4a21-bc3f-08f22be8fc0e" contextRef="C_7cb5eab9-0fdd-4dc3-8931-9772493bd16f" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></ix:nonNumeric></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Trade show assets</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0dfc5b09-7f44-471a-8334-925886be4ee8" contextRef="C_caae9469-5585-4e17-9b3f-2def45052046" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></ix:nonNumeric></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Leased devices</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aec27221-fccd-4ff3-a93b-ac460ca9023a" contextRef="C_3ef7cc75-c5bb-4fbe-b9a3-8cee4d7281da" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></ix:nonNumeric></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d8159f4f-0289-4c7e-a1fe-b7970bde2d0f" contextRef="C_aeb82c50-d014-42e5-8b78-49b806cb3896" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">-</span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_48051f63-34cb-401a-9dcf-a396f8f9623e" contextRef="C_d27d7f2c-d654-4af6-9a83-2fc82df0f902" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7</span></ix:nonNumeric></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other property and equipment include furniture and fixtures, software, vehicles, and machinery and equipment.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expenditures for major renewals and improvements are capitalized. Expenditures for repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation is eliminated from the balance sheet, and any resulting gains or losses are included in the combined and consolidated statements of operations and comprehensive loss in the period of disposal.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5f15ee23-839a-4806-b6ef-d2540c847529" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Impairment of Long-Lived Assets</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company reviews its long-lived assets for impairment at least annually or when the Company determines a triggering event has occurred. When a triggering event has occurred, each impairment test is based on a comparison of the future expected undiscounted cash flow to the recorded value of the asset. If the recorded value of the asset is less than the undiscounted cash flow, the asset is written down to its estimated fair value. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_251c28c7-f5f3-450f-b0b5-9f60784c4510" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_739eabdd-8d8c-4113-822d-d1d7618504f6" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> impairments were recorded for the years ended December 31, 2021 and 2020.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4337cf3e-e881-47ad-93a3-b037a31d7f76" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Capitalized Software Development Costs</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the costs incurred in developing the firmware embedded in the hardware devices that the Company sells and leases to its customers, the Company applies the principles of Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 985-20, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting for the Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;ASC 985-20&#x201d;). ASC 985-20 requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established. Thereafter, until the product is released for sale, software development costs must be capitalized and reported at the lower of unamortized cost or net realizable value of the related product. The Company has adopted the &#x201c;tested working model&#x201d; approach to establishing technological feasibility for its software products. Under this</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">approach, the Company does not consider a product in development to have passed the technological feasibility milestone until the Company has completed a model of the product that contains essentially all the functionality and features of the final product and has tested the model to ensure that it works as expected. The Company&#x2019;s hardware device, with the embedded firmware, was released for sale during the fourth quarter of the year ended December 31, 2020, when the Company had completed all of the research and development activity to establish the technological feasibility of the product. As of December 31, 2021 and 2020, the Company had not incurred significant costs between the establishment of technological feasibility and the release of a product for sale; thus, the Company had expensed all software development costs as incurred.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For software developed or acquired for internal use, including software used in the provision of subscription services to the Company&#x2019;s customers, the Company applies the principles of ASC 350-40, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting for the Cost of Computer Software Developed or Obtained for Internal Use</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;ASC 350-40&#x201d;). ASC 350-40 requires that software development costs incurred before the preliminary project stage be expensed as incurred. The Company capitalizes development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed, and the software will be used to perform the function intended. Costs incurred during the preliminary project and post-implementation stages, including training and maintenance, are expensed as incurred. Capitalized costs are amortized on a project-by-project basis using the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9f7ce6d1-3b38-4eb4-8b03-b829ac53ec22" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:CapitalizedContractCostAmortizationMethod"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">straight-line method</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> over the estimated economic life of the application, which is</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ac14605d-e14f-4aec-8e27-3934c4273781" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> three years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, beginning when the asset is substantially ready for use. As of December 31, 2021 and 2020, the Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_99f28e14-c878-497d-9fc1-6618f64487e3" contextRef="C_fad97c6a-6c78-4438-bbf2-78f5774e74c3" name="us-gaap:CapitalizedComputerSoftwareNet" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_78f9db54-cce7-4860-8cf2-efc100c6d492" contextRef="C_8befb59f-1789-41eb-a34c-a140ffe80389" name="us-gaap:CapitalizedComputerSoftwareNet" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have any amount of capitalized internal-use software development costs.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_02a05c33-096b-44f4-afb8-1a9123aea271" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" escape="true"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue Recognition</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes revenue in accordance with ASC Topic 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#x201c;Revenue from Contracts with Customers.&#x201d;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue is recognized when or as a customer obtains control of the promised goods and services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for these goods and services. To achieve this core principle, the Company applies the following 5 steps:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 1: Identify Contracts with Customers:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company executes signed contracts with its customers for the sale of hardware devices and subscription services.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 2: Identify Performance Obligations:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company&#x2019;s contracts with customers primarily include two performance obligations, namely the hardware device and subscription services, which include access to the Company&#x2019;s hosted cloud-based software applications and hardware maintenance and support on an ongoing basis throughout the subscription period.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 3: Determine Transaction Price:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company&#x2019;s contracts with customers include variable consideration in the form of discounts and price concessions. The Company estimates variable consideration using the expected value method based on the data available as of the end of each reporting period.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 4: Allocate Transaction Price to Performance Obligations:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company allocates transaction price to the performance obligations in a contract with a customer, based on the relative standalone selling prices of the goods and services. The standalone selling prices of the hardware devices and subscription services are determined based on the observable standalone selling prices for which the Company sells the respective goods and services on a standalone basis, including renewals of subscription services.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 5: Recognize Revenue as Performance Obligations are Satisfied:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Each unit of hardware devices is a performance obligation satisfied at a point in time, when control of the good transfers from the Company to the customer, which is usually upon delivery of the good to the customer. For sales of hardware where control of the product transfers to the customer upon shipment, the Company has made an accounting policy election to account for shipping and handling as fulfillment activities rather than a performance obligation. The subscription services are stand-ready obligations that are satisfied over time by providing the customer with ongoing access to the Company&#x2019;s resources throughout the subscription period. The Company uses the time elapsed (straight line) measure of progress to recognize revenue as these performance obligations are satisfied evenly over the respective service period.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company offers alternative payment structures and &#x201c;as-a-service&#x201d; offerings that are assessed to determine whether an embedded lease arrangement exists. The Company accounts for those contracts as a lease arrangement under the current lease standard if it is determined that the contract contains an identified asset and that the right to direct the use of that asset has transferred to the customer. When a contract includes lease and non-lease components, the Company allocates consideration under the contract to each component based on the relative standalone selling price and subsequently assesses lease classification for each lease component within a contract as a sales-type lease or an operating lease. On commencement of sales-type leases, the Company recognizes revenue up-front, and amounts due from the customer under the lease contract are recognized as financing receivables on the combined and consolidated balance sheets. Interest income is recognized as revenue over the term of the lease based on the effective interest method. The Company has elected not to include sales and other taxes collected from the lessee as part of lease revenue.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All other leases that do not meet the definition of a sales-type lease are classified as operating leases. The underlying asset in an operating lease arrangement is carried at depreciated cost within Property and equipment, net on the combined and consolidated balance sheets. Depreciation is calculated using the straight-line method over the term of the underlying lease contract and is recognized as cost of revenue. The depreciable basis is the original cost of the equipment less the estimated residual value of the equipment at the end of the lease term. The Company recognizes operating lease income to product revenue on a straight-line basis over the lease term. Impairment of equipment under operating leases is assessed on the same basis as other long-lived assets.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3e18a3ba-20ac-46e1-945c-01a5b5cb43b1" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:DeferredRevenuePolicyPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Deferred Revenue</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from subscription services described above and is reduced as the revenue recognition criteria are met. Deferred revenue is classified as current based on expected revenue recognition timing. Specifically, deferred revenue that will be recognized as revenue within the succeeding twelve-month period is recorded as current in the Company&#x2019;s combined and consolidated balance sheets.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4ce764cd-b637-4cb5-9506-5d7435a35fe7" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:WarrantiesPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Warranties</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company offers a device warranty to customers for the longer of (a) twelve (12) months from delivery of the device for devices obtained through a capital purchase, or (b) the term of the subscription agreement for devices obtained on a subscription basis (subject to continued payment of fees for the subscription service). The Company&#x2019;s subscription services include hardware maintenance and support. As noted in the accounting policy for revenue recognition, the Company recognizes revenue for subscription service over time using the time elapsed measure of progress. The costs of hardware maintenance are recognized in costs of revenue as they are incurred.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ed5f92e6-4e28-4aed-854d-a1c447836142" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development costs consists of production costs for prototype, test and pre-production units, lab supplies, consulting and personnel costs, including salaries, stock-based compensation, bonuses, benefit costs and depreciation. Certain research and development grant funding is recognized as a reduction to research and development costs (see Note 2. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies - Grant Funding</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">). The Company recognizes these costs as they are incurred.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9127a48d-ca23-4dc3-8cbb-fcb4f9577310" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:GrantFundingPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Grant Funding</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company received certain research and development funding through a grant issued by the Bill &amp; Melinda Gates Foundation (&#x201c;BMGF&#x201d;). Funding is recorded on the combined and consolidated balance sheet as restricted cash upon receipt. The funding is recognized in the combined and consolidated statements of operations and comprehensive loss as a reduction to research and development expense as the related costs are incurred to meet those obligations over the grant period. Grant funding payments received in advance of research and development expenses incurred are recorded as deferred grant funding as a current liability in the Company&#x2019;s combined and consolidated balance sheets.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93d3f4c9-1545-436b-94f8-83420f84d654" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:CostOfSalesPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cost of Sales</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cost of sales consists of product and service costs including personnel cost and benefits including stock-based compensation, product costs, production setup expenses, depreciation and amortization expenses, inventory excess and obsolescence expenses.</span></p></ix:nonNumeric></div><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cfc71c73-b662-4771-b81c-6ce240100338" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:PatentCostsPolicyTextBlock" escape="true"><p style="text-indent:2.603%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent Costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patent costs have been charged to operations as incurred, as their realization is uncertain. These costs are included in general and administrative expenses in the combined and consolidated statements of operations and comprehensive loss.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c0441e1a-7265-4bf5-9cd4-d3b0d0b2624e" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and Administrative</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses primarily consist of personnel costs and benefits including stock-based compensation, patent and filing fees, office expenses and outside services. Outside services consist of professional services, legal and other professional fees.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aa23d4fc-6312-416b-adcf-3f6bf0cf8d88" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:AdvertisingCostsPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sales and Marketing</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sales and marketing costs primarily consist of personnel costs and benefits including stock-based compensation, advertising, promotional, as well as conferences, meetings, and other events. Advertising costs are expensed as incurred. For the years ended December 31, 2021 and 2020, advertising expenses were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_96da21ac-598d-47e4-84b6-d2a44f48243d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:AdvertisingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,459</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f52dcd49-1fe1-42b7-b7e7-f64c8d695efa" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:AdvertisingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">437</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9fbf0c03-f727-474d-a670-5912423712cd" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net Loss per Common Share</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per common share is calculated by dividing the net loss attributed to common stockholders by the weighted average number of common shares outstanding during the period, without consideration of potentially dilutive securities.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares plus the common equivalent shares of the period, including any dilutive effect from such shares. The Company&#x2019;s diluted net loss per common share is the same as basic net loss per common share for all periods presented since the effect of potentially dilutive securities is anti-dilutive. Refer to Note 13. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net Loss Per Share</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for further discussion.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_59528c93-0305-4dd0-85ff-79b2fdc83123" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Convertible Preferred Stock</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has applied the guidance in ASC Topic 480-10-S99-3A, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">SEC Staff Announcement: Classification and Measurement of Redeemable Securities,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and has therefore classified the Series A, Series B, Series C and Series D Convertible Preferred Stock (&#x201c;Convertible Preferred Stock&#x201d;) (see Note 10. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Convertible Preferred Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) as mezzanine equity. The Convertible Preferred Stock was recorded outside of stockholders&#x2019; equity (deficit) because the Convertible Preferred Stock included a redemption provision upon a change of control, which is deemed a liquidation event that is considered outside the Company&#x2019;s control. The Convertible Preferred Stock has been recorded at its original issue price, net of issuance costs. The Company did not adjust the carrying value of the Convertible Preferred Stock to the liquidation price associated with a change of control at December 31, 2020 because a change of control of the Company was not considered probable at the reporting date (see Note 10. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Convertible Preferred Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">). Subsequent adjustments to increase or decrease the carrying values to their respective liquidation prices were made only when it became probable that such a change of control would occur.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e76258c7-4889-4813-b988-b6dca146a783" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The measurement of stock-based compensation expense for all stock-based payment awards, including stock options granted to employees, directors, and consultants, is based on the estimated fair value of the awards on the date of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes stock-based compensation expense for stock option grants and incentive unit grants with only service conditions on a straight-line basis over the requisite service period of the individual grants, which is generally the vesting period, based on the estimated grant date fair values. Generally, stock option grants and incentive unit grants fully vest </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_21437414-9df9-48f3-872e-53ac72e1a3ca" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">four years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> after the grant date, and stock option grants generally have a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_84f34145-1bfa-4d97-a4fa-83a98da2f7ae" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10 years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes the effect of forfeiture in compensation costs based on actual forfeitures when they occur.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company's stock-based compensation program includes stock option grants to its employees, directors, and consultants. Stock options are granted at exercise prices not less than the estimated fair market value of the Company&#x2019;s common stock at the date of grant.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair values of stock option grants are estimated using a Black-Scholes option-pricing model. Key inputs and assumptions include the expected term of the option, stock price volatility, risk free interest rate, dividend yield, stock price and exercise price. Many of the assumptions require significant judgment and any changes could have a material impact in the determination of stock-based compensation expense.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the year ended December 31, 2020, Liminal was a wholly owned subsidiary of 4Bionics, and as such, 4Bionics granted equity awards in the form of incentive units to Liminal employees and nonemployees under 4Bionics&#x2019; stock-based compensation program.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On April 2, 2021, 4Bionics executed a plan of liquidation and dissolution and its ownership in Liminal was distributed to its members and to the holders of incentive units. Immediately subsequent to the dissolution, all outstanding unvested incentive unit awards under 4Bionic&#x2019;s 2019 Equity Incentive Plan were replaced with preferred stock awards indexed to and settled in the preferred stock of the former 4Bionics subsidiaries Liminal, Detect, Inc. (f/k/a Homodeus Inc.), Tesseract Health, Inc. and Protein Evolution, Inc. The preferred stock awards are subject to service vesting conditions only. No incremental value was provided to participants as a result of the modification of the awards as the modification date fair value of the incentive unit awards was equal to the modification date fair value of the stock underlying the restricted stock awards. Moreover, the remaining vesting period before and after modification was unchanged.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f84c3abf-f065-4a12-a875-fce86e6f3599" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:EarnOutSharesPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Earn-Out Shares</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Earn-Out Shares, as defined in Note 3.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, to which the Companies&#x2019; pre-closing equity holders are entitled, fall within the scope of ASC 815,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Derivatives and Hedging</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;ASC 815&#x201d;) pursuant to which such Earn-Out Shares are equity classified and are to be recognized upon achievement of the market price milestone.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Earn-Out Shares to which certain employees are entitled to fall within the scope of ASC 718, pursuant to which such Earn-Out Shares are equity classified and their grant date fair value will be recognized as compensation expense over the vesting period.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_05085b84-304d-4c2d-9ad1-eafe18d0a436" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:ResearchAndDevelopmentTaxCreditsPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development Tax Credits</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes research and development tax credits as a reduction of Research and Development expense as earned. For State of Connecticut research and development tax credits, which are exchanged for a cash refund from the State of Connecticut, such exchanged credits are recognized as earned as a reduction of Research and Development expense in the combined and consolidated statements of operations and comprehensive loss.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7d94dea0-0e4c-4bf7-892f-e49080980a7f" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilizes the asset and liability method of accounting for income taxes, as set forth in ASC Topic 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Under this method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities using the enacted statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established against net deferred tax assets if, based on</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the weight of available evidence, it is more likely than not that some or all of the net deferred tax assets will not be realized. The Company has recorded a full valuation allowance as of December 31, 2021 and 2020. Based on the available evidence, the Company believes that it is more likely than not that it will be unable to utilize all of its deferred tax assets in the future.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In accordance with the provisions of ASC Topic 740, the Company accrues for the estimated amount of taxes for uncertain tax positions if it is more likely than not that the Company would be required to pay such additional taxes. An uncertain tax position will not be recognized if it has a less than 50% likelihood of being sustained. The Company&#x2019;s policy is to recognize any interest and penalties related to income taxes in income tax expense in the combined and consolidated statements of operations and comprehensive loss. The Company&#x2019;s open tax years subject to examination by the relevant taxing authorities are </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0d93ec06-e2be-489a-ac3b-531777fb08ff;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2017 through 2019</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As of December 31, 2021 and 2020, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_587ec53f-9394-41f2-961d-752e7b6e936a" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:UncertainTaxPositions" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_63dad002-c634-49e4-99e9-01035107a6fe" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="hypr:UncertainTaxPositions" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> uncertain tax positions.</span></p></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_feb4e6ed-c33d-400d-8c45-cf10b6c29c1f" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent Accounting Pronouncements</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting pronouncements adopted</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Intangibles &#x2014; Goodwill and Other &#x2014; Internal-Use Software Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The guidance requires certain costs incurred during the application development stage to be capitalized and other costs incurred during the preliminary project and post-implementation stages to be expensed as they are incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. A customer&#x2019;s accounting for the hosting component of the arrangement is not affected. This new guidance is effective for the Company for the annual reporting period beginning January 1, 2021 and interim periods beginning January 1, 2022. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_005f87eb-d302-4e42-8be6-c899f3089545" contextRef="C_cb31b9d8-c1f7-4a18-b802-8fbd3122b173" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopted this guidance</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4eb1f761-1796-4ee6-9070-302b911d6bad" contextRef="C_cb31b9d8-c1f7-4a18-b802-8fbd3122b173" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and there was </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_696c0816-b211-4e4d-8249-69633a7a54a0" contextRef="C_cb31b9d8-c1f7-4a18-b802-8fbd3122b173" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no material effect of adoption on the combined and consolidated financial statements</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2020, the FASB issued ASU 2020-06, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which simplifies the accounting for convertible instruments by removing the separation models for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. These changes will reduce reported interest expense and increase reported net income for entities that have issued a convertible instrument that was bifurcated according to previously existing rules. ASU 2020-06 also requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will be no longer available. For public entities, this guidance is effective for annual reporting periods beginning January 1, 2022, including interim periods within that annual reporting period. For the Company, this guidance is effective for annual reporting periods beginning January 1, 2024, and interim reporting periods within annual reporting periods beginning January 1, 2024, with early adoption permitted. The Company elected to early </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b874449e-6fc1-488e-a2c2-55c85730bdd4" contextRef="C_01fa950d-ab40-4e18-a2a5-4c14c465c02f" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopt this accounting pronouncement</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_28f751a1-ab38-4c9e-b6ec-220ed8c5b8ac" contextRef="C_01fa950d-ab40-4e18-a2a5-4c14c465c02f" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and there was </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_884b61b5-272e-4ec4-8e76-2b28fdbc0c39" contextRef="C_01fa950d-ab40-4e18-a2a5-4c14c465c02f" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no material impact on the Company&#x2019;s combined and consolidated financial statements and disclosures</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, the FASB issued ASU 2019-12, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and improves consistent application of and simplifies U.S. GAAP for other areas of Topic 740 by clarifying existing guidance. For the Company, this ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b32c8fcd-69f2-45d9-90f6-ba750b8004dc" contextRef="C_94219b96-2190-45cb-82d0-1a597525c988" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopted</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> this guidance on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a1da6c1c-ff81-4e01-a600-918beb9cce14" contextRef="C_94219b96-2190-45cb-82d0-1a597525c988" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and there was </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2e14d364-6a7a-4b49-ac12-577e4e6a31b3" contextRef="C_94219b96-2190-45cb-82d0-1a597525c988" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> material effect of adoption on the Company&#x2019;s combined and consolidated financial statements.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting pronouncements issued but not yet adopted</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2016, the FASB issued ASU 2016-02, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases (Topic 842),</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which outlines a comprehensive lease accounting model and supersedes the current lease guidance. The new guidance requires lessees to recognize almost all of their leases on the balance sheet by recording a lease liability and corresponding right-of-use assets. It also</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes the definition of a lease and expands the disclosure requirements of lease arrangements. As per the latest ASU 2020-05 issued by FASB, entities that have not yet issued or made available for issuance the financial statements as of June 3, 2020 can defer the new guidance for one year. For public entities, this guidance is effective for annual reporting periods beginning January 1, 2020, including interim periods within that annual reporting period. For the Company, this guidance is effective for annual reporting periods beginning January 1, 2022, and interim reporting periods within annual reporting periods beginning January 1, 2023. The Company is in the process of evaluating the impact that the adoption of this pronouncement will have on the Company&#x2019;s combined and consolidated financial statements and does not expect it to be material.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#x201c;Financial Instruments &#x2014; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#x201d;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which was subsequently amended in November 2018 through ASU No. 2018-19, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#x201c;Codification Improvements to Topic 326, Financial Instruments &#x2014; Credit Losses.&#x201d;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. ASU No. 2018-19 further clarifies that receivables arising from operating leases are not within the scope of Topic 326. Instead, impairment from receivables of operating leases should be accounted for in accordance with Topic 842, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As per the latest ASU 2020-02, the FASB deferred the timelines for certain small public and private entities, thus the new guidance will be adopted by the Company for the annual reporting period beginning January 1, 2023, including interim periods within that annual reporting period. The standard will apply as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company is in the process of evaluating the impact that the adoption of this pronouncement will have on the Company&#x2019;s combined and consolidated financial statements and disclosures.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7386d86d-daa2-418b-a643-46a48999a7b6" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:BusinessCombinationDisclosureTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3. BUSINESS COMBINATION</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">At the Closing, Legacy Hyperfine and Liminal merged with and into separate wholly owned subsidiaries of HealthCor and each became a wholly-owned subsidiary of the Company. The Business Combination is accounted for as a reverse recapitalization in accordance with U.S. GAAP primarily due to the fact that Legacy Hyperfine and Liminal stockholders continued to control the Company following the closing of the Business Combination. Under this method of accounting, HealthCor is treated as the &#x201c;acquired&#x201d; company for accounting purposes and the Business Combination is treated as the equivalent of Legacy Hyperfine and Liminal issuing stock for the net assets of HealthCor, accompanied by a recapitalization. The net assets of HealthCor are stated at historical cost, with no goodwill or other intangible assets recorded. Reported shares and loss per share available to holders of the Company&#x2019;s capital stock and equity awards prior to the Business Combination have been retroactively restated reflecting the exchange ratios established pursuant to the Business Combination Agreement dated as of July 7, 2021 (the &#x201c;Business Combination Agreement&#x201d;).</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the Business Combination Agreement, at the effective time of the Business Combination (the &#x201c;Effective Time&#x201d;):</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each share of Legacy Hyperfine capital stock (other than shares of Legacy Hyperfine Series A preferred stock) that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class A common stock equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8b623e35-9d66-4b29-bc7f-965001f237e0" contextRef="C_9bef19fe-1963-493a-8639-cca45451e242" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" unitRef="U_pure" scale="0" decimals="4" format="ixt:numdotdecimal">0.3275</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (the &#x201c;Hyperfine Exchange Ratio&#x201d;), rounded down to the nearest whole number of shares;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each share of Legacy Hyperfine Series A preferred stock that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class B common stock equal to the Hyperfine Exchange Ratio, rounded down to the nearest whole number of shares;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each share of Liminal capital stock (other than shares of Liminal Series A-1 preferred stock) that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class A common stock equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_46d41b1e-c25d-4009-8efa-bf95735a2aa4" contextRef="C_0449cc1b-e603-4161-b7c3-fb5362667dbf" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" unitRef="U_pure" scale="0" decimals="4" format="ixt:numdotdecimal">0.1796</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (the &#x201c;Liminal Exchange Ratio&#x201d;), rounded down to the nearest whole number of shares;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each share of Liminal Series A-1 preferred stock that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class B common stock equal to the Liminal Exchange Ratio, rounded down to the nearest whole number of shares;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each option to purchase shares of Legacy Hyperfine common stock and each option to purchase shares of Liminal common stock, whether vested or unvested, that was outstanding and unexercised as of immediately prior to the Effective Time was assumed by the Company and became an option (vested or unvested, as applicable) to purchase a number of shares of the Company&#x2019;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such option immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Effective Time divided by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded up to the nearest whole cent; and</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	</span>&#160;</p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each Legacy Hyperfine restricted stock unit and each Liminal restricted stock unit outstanding immediately prior to the Effective Time was assumed by the Company and became a restricted stock unit with respect to a number of shares of the Company&#x2019;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such Legacy Hyperfine restricted stock unit or Liminal restricted stock unit immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole share.</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the Business Combination Agreement, the Company will issue to holders of Legacy Hyperfine and Liminal securities as of immediately prior to the Effective Time, in accordance with their pro rata share, up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_87ea0cb9-889e-4849-bfd9-c57db830780b" contextRef="C_0449cc1b-e603-4161-b7c3-fb5362667dbf" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock as earn-out consideration (the &#x201c;Earn-Out Shares&#x201d;), if at any time during the period between the Closing Date and the third anniversary of the Closing Date (the &#x201c;Earn-Out Period&#x201d;), (i) the last share price of the Class A common stock is greater than or equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_936e8c94-1b80-4f03-b202-6b66c54a1b38" contextRef="C_1e1d998b-c680-42bd-bbd7-9bc2ff70463c" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">15.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for any </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_616f6f3e-d4ae-472f-8763-623e181dffe0" contextRef="C_adbc5d68-9134-4f22-9fcc-4c8fff3121d2" name="hypr:BusinessCombinationTransactionThresholdTradingDays" unitRef="U_D" decimals="INF" format="ixt:numdotdecimal">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> trading days within any </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ce0ce46a-22b4-4d60-aec7-a1b0d08e81b1" contextRef="C_adbc5d68-9134-4f22-9fcc-4c8fff3121d2" name="hypr:BusinessCombinationTransactionThresholdConsecutiveTradingDays" unitRef="U_D" decimals="INF" format="ixt:numdotdecimal">30</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> consecutive trading day period, or (ii) there is a transaction that will result in shares of Class A common stock being converted or exchanged into the right to receive cash or other consideration having a value greater than or equal to $15.00. During the Earn-Out Period, if there is a transaction (other than for stock splits, stock dividends, special cash dividends, reorganizations, recapitalizations or similar transactions affecting the Class A common stock) that will result in the shares of Class A common stock being converted or exchanged into the right to receive cash or other consideration having a value less than $15.00, then the right to receive Earn-Out Shares will terminate.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 21, 2021, HealthCor filed the Certificate of Incorporation (the &#x201c;Certificate&#x201d;) with the Secretary of State of the State of Delaware, which became effective after the Domestication. As a consequence of filing the Certificate, the Company adopted a dual class structure, comprised of the Company&#x2019;s Class A common stock, which is entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_7c1f6cb9-db4f-44a0-8eef-0eeaa1e8c6da;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> vote per share, and the Company&#x2019;s Class B common stock, which is entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ff52442f-9186-428d-a86c-f5de47dc045d" contextRef="C_b5a4b802-89f3-4579-863a-5eecf71671f8" name="hypr:NumberOfVotesPerShareEntitledToClassOfCommonStock" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> votes per share. The Company&#x2019;s Class B common stock has the same economic terms as the Company&#x2019;s Class A common stock, but is subject to a &#x201c;sunset&#x201d; provision if Jonathan M. Rothberg, Ph.D., the founder of Legacy Hyperfine and Liminal, and a Director of the Company (&#x201c;Dr. Rothberg&#x201d;), and other permitted holders of the Company&#x2019;s Class B common stock collectively cease to beneficially own at least twenty percent (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_57c163a1-1f2d-4659-a3f9-026a6a80b6a3" contextRef="C_3ad8f729-5552-455b-b2fb-acfa4b71867b" name="hypr:PercentageNumberOfSharesCeasesToBeneficiallyOwned" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%) of the number of shares of the Company&#x2019;s Class B common stock (as such number of shares is equitably adjusted in respect of any reclassification, stock dividend, subdivision, combination or recapitalization of the Company&#x2019;s Class B common stock) collectively held by Dr. Rothberg and permitted transferees of the Company&#x2019;s Class B common stock as of the Effective Time. At the Effective Time, the Company amended the Certificate to change the name of the Company from HealthCor Catalio Acquisition Corp. to &#x201c;Hyperfine, Inc.&#x201d; (the Certificate, as amended, the &#x201c;Amended Certificate&#x201d;).</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Concurrently </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">with the execution of the Business Combination Agreement, HealthCor entered into subscription agreements (the &#x201c;Subscription Agreements&#x201d;) with certain institutional investors and accredited investors (the &#x201c;PIPE</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investors&#x201d;), </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pursuant to which the PIPE Investors purchased, immediately prior to the Closing, an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4308e789-3a51-4f7c-a3fb-62cfaa57ff7e" contextRef="C_422b1f66-f3bb-40cb-87eb-764fff40d1b1" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">12,610,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of HealthCor Class A common stock at a purchase price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2df1f1ba-f9a3-4884-9dd6-90445eaa3d95" contextRef="C_f9ad2466-6588-4aad-9c83-c52d2116818a" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">10.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share (the &#x201c;PIPE Investment&#x201d;).</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, on December 22, 2021, HealthCor, HC Sponsor LLC (the &#x201c;Sponsor&#x201d;), Legacy Hyperfine and Liminal entered into a Forfeiture Agreement (the &#x201c;Forfeiture Agreement&#x201d;), pursuant to which, immediately prior to the Closing, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_28560ea9-2c50-4d8f-9d09-383afcc785bf" contextRef="C_7e37528b-2b21-4306-ae2b-4ba44246def5" name="us-gaap:SharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">150,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of HealthCor&#x2019;s Class B common stock held by the Sponsor were irrevocably forfeited and automatically cancelled (the &#x201c;Forfeiture&#x201d;).</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The total number of shares of the Company&#x2019;s Class A common stock outstanding immediately following the Closing was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_87136780-9973-411a-99ad-a94535df67f8" contextRef="C_3666fba2-b98c-4e2a-8471-61fd11c1c18a" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">54,977,061</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> comprising:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7b49dc22-65cd-4b8f-9d79-f42b3ab56daf" contextRef="C_00411e89-7f5a-45df-b336-70ea9ce55a9e" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">29,711,224</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued to Hyperfine stockholders (other than certain holders of Hyperfine Series A preferred stock);</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e6c6df09-14f0-4169-b5ac-fac8545b648c" contextRef="C_0a6a19d6-344a-4cea-bec3-409efe86ebfd" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,459,081</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued to Liminal stockholders (other than certain holders of Liminal Series A-1 preferred stock);</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ed471d79-5b84-4c27-88f4-662e3a09fd27" contextRef="C_f3f7bbf1-1516-476a-9c86-2591116d1012" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">12,610,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued in connection with the Closing to the PIPE Investors pursuant to the PIPE Investment;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7211dfdd-101a-4039-8a34-d6d8507d38f3" contextRef="C_a7656f8d-8697-4470-947f-f125a450641a" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,025,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued immediately prior to the Effective Time to the initial shareholders upon conversion of the </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_16465251-1c49-4443-96c9-6d94348e7325" contextRef="C_2d6850ed-6867-4384-9a94-ec4d712f20d1" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,025,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class B common stock outstanding immediately prior to the Effective Time (following the issuance of the </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fd1a83ff-77a7-4e70-a267-12b3a1611174" contextRef="C_ac74fc9c-0276-46e3-b74a-5c86d622563b" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,175,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class B common stock upon the Conversion of the </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eb65d005-8292-47a3-b9dd-f47187ac07d4" contextRef="C_42721900-2218-40df-95d4-cb7a647e1a07" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,175,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Class B ordinary shares held by the initial shareholders and after reflecting the irrevocable forfeiture by the Sponsor to HealthCor of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_34a3a0a4-1c72-47d6-b5ad-d1d11bf0c5cf" contextRef="C_06522640-5ead-4ce5-b43c-dc8582220df8" name="us-gaap:SharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">150,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class B common stock for no consideration and automatic cancellation as of immediately prior to the Closing);</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_022a80f8-09a4-40d4-afce-b5086019c4c7" contextRef="C_8e87568d-825c-49a7-8077-18ebeca513ba" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">614,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued to the Sponsor; and</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a1ba7682-685a-4041-a2a5-7a348a68b75a" contextRef="C_07853f31-4dbf-448b-a757-6ceeb0365107" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,557,756</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued to the Company&#x2019;s public stockholders holding </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b58d9c82-ed65-4b94-b8bd-5e30933133d3" contextRef="C_07853f31-4dbf-448b-a757-6ceeb0365107" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,557,756</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Class A ordinary shares outstanding at the Effective Time, after reflecting redemptions of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_170198a5-8afb-4acd-9bf1-359d2fdf280a" contextRef="C_d9e344e0-6fb0-4ac2-9f20-f9805be8a275" name="hypr:CommonStockSubjectToRedemption" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">17,142,244</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of HealthCor Class A common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The total number of shares of the Company&#x2019;s Class B common stock outstanding immediately following the Closing was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1618f601-f51a-4cad-98c4-e8fdab2d10e2" contextRef="C_cd314d5f-1d0e-45e6-bee2-447dde950094" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,055,288</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares. Immediately following the Closing, Dr. Rothberg held approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5b131b5c-5785-483b-8413-c32606099195" contextRef="C_6b7f94c9-9ecc-4502-b9fd-362b0c906fa7" name="hypr:PercentageOfCommonStockVotingPower" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">84.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the combined voting power of the Company. Accordingly, Dr. Rothberg and his permitted transferees control the Company, and the Company is a controlled company within the meaning of the Nasdaq listing rules.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net equity infusion from the Business Combination was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c31f2e32-98a2-42d6-ac46-3ab63732caba" contextRef="C_df21cc65-f66b-40a5-900a-c433563430fa" name="hypr:ProceedsFromBusinessCombination" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">141,471</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which consists of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_db38e173-3782-4152-bd66-2cb9ad2d639a" contextRef="C_216ba9b6-bd20-4c7c-bc41-1051866b4a16" name="hypr:ProceedsFromBusinessCombination" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">207,448</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> proceeds from HealthCor, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f613553-b61f-41e9-ab4c-09676bcf7983" contextRef="C_f5b7fd28-718c-44aa-9bed-942c827825a4" name="hypr:ProceedsFromBusinessCombination" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">126,100</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> proceeds from the PIPE Investors, net of payments to redeeming HealthCor shareholders of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_44e76630-4664-4704-800d-f44841279a26" contextRef="C_df21cc65-f66b-40a5-900a-c433563430fa" name="hypr:InterestAndPaymentsToRedeemingCompanyShareholders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">171,437</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and payment of transaction costs of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_682d61b2-bef6-4edf-9da4-a2af30bcd60f" contextRef="C_df21cc65-f66b-40a5-900a-c433563430fa" name="hypr:BusinessCombinationPaymentOfTransactionCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,640</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Additionally, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7c173292-cb95-4e38-99d8-1909c5763662" contextRef="C_f47f49e7-ad5a-4384-8c30-4bc6120b30ac" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">300,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A Common Stock were issued to a service provider in exchange for the services provided in connection with the Business Combination.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2021, in connection with the closing of the Business Combination, the Company prepaid directors and officers insurance policy in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7b05b60d-ecbb-41d4-ab34-8784df60dbee" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:PrepaidInsurancePolicyInConnectionWithBusinessCombination" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,244</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and repaid the Liminal Paycheck Protection Program (&#34;PPP&#34;) loan in full in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_735ae83c-45f1-4c08-850d-683ec0962e8a" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:PaymentOfPaycheckProtectionProgramLoan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">113</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p></ix:nonNumeric></div>
  <p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div><ix:nonNumeric id="F_107667d4-dc99-497f-8ffc-0f4ae907c751" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4. REVENUE RECOGNITION</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Disaggregation of Revenue</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company disaggregates revenue from contracts with customers by product type. The Company believes that these categories aggregate the payor types by nature, amount, timing and uncertainty of its revenue streams. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5285d59a-91c3-4bae-a6d9-37caf0135c7b" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" escape="true" continuedAt="F_5285d59a-91c3-4bae-a6d9-37caf0135c7b_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the Company&#x2019;s disaggregated revenues:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_5285d59a-91c3-4bae-a6d9-37caf0135c7b_1"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.786%;"></td>
        <td style="width:1.354%;"></td>
        <td style="width:13.243%;"></td>
        <td style="width:1.238%;"></td>
        <td style="width:1.28%;"></td>
        <td style="width:11.762%;"></td>
        <td style="width:0.603%;"></td>
        <td style="width:1.238%;"></td>
        <td style="width:1.28%;"></td>
        <td style="width:11.614%;"></td>
        <td style="width:0.603%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Pattern of Recognition</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Device</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Point in time</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_61604aad-8ac1-4444-a6a6-685c87411ee2" contextRef="C_0e92975e-291a-4d95-b890-e43efecfb475" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">715</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_26448297-b511-4c21-9db1-22db683aa239" contextRef="C_7ee4d8d9-a42c-47a9-ae5d-57c993f15c61" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">200</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Service</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Over time</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8f4ba4f9-43fe-4216-82f3-ce789c4b7cef" contextRef="C_90c968b9-9872-40c2-9fd2-339d167beac3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">781</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_df4021d5-7abc-4369-ae2b-ec4568e836dc" contextRef="C_37f84241-8f15-4d3a-a3bf-88a442090df1" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">94</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total revenue</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0293ab3c-c0c2-468b-8290-ec3f0a251459" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,496</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_862cb316-07c5-488c-b885-885c215d6d51" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">294</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Contract Balances</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Contract balances represent amounts presented in the combined and consolidated balance sheets when either the Company has transferred goods or services to the customer, or the customer has paid consideration to the Company under the contract. These contract balances include trade accounts receivable and deferred revenue. Deferred revenue represents consideration received from customers at the beginning of the subscription period for services that are transferred to the customer over the respective subscription period. The accounts receivable balances represent amounts billed to customers for goods and services where the Company has an unconditional right to payment of the amount billed.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a4685e26-5f24-4fc5-8a67-0364c3f1cf57" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table provides information about receivables and deferred revenue from contracts with customers:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.275%;"></td>
        <td style="width:1.597%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.42%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:1.481%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.42%;"></td>
        <td style="width:0.613%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_29324c4e-f0a7-4212-b609-a322f0ef6055" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">553</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a0f25110-ef5e-49b1-bfb2-3e0196756c5b" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">174</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Unbilled receivables</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_17180b02-236d-4de6-bcf9-8254061120b5" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:UnbilledReceivablesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">91</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b48ffe2a-60ec-4ea2-9ce5-56b9610ae816" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">730</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fd819b3b-918e-4088-a76c-af53ca89bded" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Long term deferred revenue</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7d49594c-29da-4592-833e-eb6135b89302" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">510</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes a receivable when it has an unconditional right to payment, and payment terms range from </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a8f5364-8eb9-4b06-96e4-11d69fcd2329" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:RevenueRecognizeReceivablePaymentTermsRangeMinimum" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20 </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">days to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_375a8368-4a75-4f2a-8001-e08c222771b6" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:RevenueRecognizeReceivablePaymentTermsRangeMaximum" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6 </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">months based on the terms agreed upon with the respective customer.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The amount of revenue recognized during the years ended December 31, 2021 and 2020 that was included in the deferred revenue balance at the beginning of the period was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_db34a1ce-4c6a-4eb7-8cc6-9b4b863d9c3a" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_88e7f9cd-18fa-42a1-b55a-da1ce6021c63" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue from leasing arrangements is not subject to the revenue standard for contracts with customers and remains separately accounted for under existing lease accounting guidance. The Company records operating lease rental revenue as service revenue on a straight-line basis over the lease term. The Company records revenue from the sale of equipment under sales-type leases as product revenue in an amount equal to the present value of minimum lease payments at the inception of the lease. Sales-type leases also produce financing income, which is included in products net revenue in the combined and consolidated statements of operations and comprehensive loss and is recognized at effective rates of return over the lease term.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Costs of Obtaining or Fulfilling Contracts</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company incurs incremental costs of obtaining contracts with customers. Incremental costs of obtaining contracts, which include commissions paid as a result of obtaining contracts with customers, are capitalized to the extent that the Company expects to recover such costs. Capitalized costs are amortized in a pattern that is consistent with the Company&#x2019;s transfer to the customer of the related goods and services. Such costs are recorded in Other long term assets and were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3c62ee70-22de-45b3-a5e1-3c16ff4b4530" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:CapitalizedContractCostNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as of December 31, 2021. Capitalized costs were not material for the year ended December 31, 2020.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Transaction price allocated to remaining performance obligations</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 202</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7c84426d-d80e-4725-8438-cba3f7426b00" contextRef="C_ef2546a8-4c0e-4b36-9c52-90a9b0abd33f" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and 2020, the Company had remaining performance obligations amounting to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2b4fce5f-848e-4f14-bbfb-9b191c815247" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:RevenueRemainingPerformanceObligation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,800</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_997e7b07-88ce-4a3d-b36a-51d0d7a6d387" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:RevenueRemainingPerformanceObligation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">859</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. The Company expects to recognize approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_23b46e47-ad0f-4655-8fec-a301ce56b137" contextRef="C_ef2546a8-4c0e-4b36-9c52-90a9b0abd33f" name="hypr:RevenueRemainingPerformanceObligationExpectedTimingPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">43</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of its remaining performance obligations as revenue in fiscal year 2022, and an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8225ed49-ac9f-4236-9c55-938c1a0ff383" contextRef="C_7bf581fe-f268-40a4-9d35-1ecba7754739" name="hypr:RevenueRemainingPerformanceObligationExpectedTimingPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">57</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_82c7fa41-ba63-47ec-bb72-bbe45f458cc5;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">fiscal year</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> 2023 and thereafter.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Significant Judgements</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company makes significant judgments applying the guidance related to the determination of the timing and pattern of satisfaction of performance obligations, determination of the standalone selling price of performance obligations and estimation of variable consideration.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Practical Expedients and Accounting Policy Elections</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a practical expedient, the Company does not adjust transaction price for the effects of a significant financing component in contracts in which the period between when the Company transfers the promised good or service to the customer and when the customer pays for that good or service is a year or less.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has made an accounting policy election to exclude all sales taxes from the transaction price of its contracts with customers. Accordingly, sales taxes collected from customers and remitted to government authorities is not included in revenue and is accounted for as a liability until it has been remitted to the respective government authority.</span></p></ix:nonNumeric></div>
  <p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_57d4fa12-c85b-448e-bfc6-82afb244e8d4" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5. FAIR VALUE OF FINANCIAL INSTRUMENTS</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value estimates of financial instruments are made at a specific point in time, based on relevant information about financial markets and specific financial instruments. As these estimates are subjective in nature, involving uncertainties and matters of significant judgment, they cannot be determined with precision. Changes in assumptions can significantly affect estimated fair value.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company measures fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The Company utilizes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> &#x2014; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access.</span></p><p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> &#x2014; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> &#x2014; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company has no assets or liabilities valued with Level 3 inputs.</span></p><p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The carrying value of cash and cash equivalents, notes receivable, accounts payable and accrued expenses and other current liabilities approximates their fair values due to the short-term or on demand nature of these instruments.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e3141a80-5d25-47d7-bd3b-3f4848a085a9" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_2fb259a9-2f81-446b-8b74-8ca24a50f61e" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_b1666df8-5484-4f11-8e48-c942501b4208" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_c5cfee3c-a229-40dc-8424-fa1c7664e10a" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> transfers between fair value measurement levels during the years ended December 31, 2</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_df60632e-24cc-4558-8324-0d2d3dcfb12c" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:FairValueLiabilitiesLevel1ToLevel2TransfersAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_803feab5-7c79-4db4-9869-1658b26b7364" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:FairValueLiabilitiesLevel1ToLevel2TransfersAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_a4b420a3-bca2-429b-956d-d57a5e3326d0" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:FairValueLiabilitiesLevel2ToLevel1TransfersAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_a2b8849f-1b01-46f2-9e15-1645d9abecfd" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:FairValueLiabilitiesLevel2ToLevel1TransfersAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21 and 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company had $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_255053fc-9d12-48e8-a5e7-403d352d123d" contextRef="C_fca29af6-e6e3-4712-95bc-d0e946d2ca70" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">48,625</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b5424371-ecf3-457d-afed-3f86b0bbb175" contextRef="C_a16400b6-45e9-4557-826d-8a135305733f" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,418</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of money market funds included in cash and cash equivalents and restricted cash as of December 31, 2021 and 2020, respectively. These assets were valued using quoted market prices and accordingly were classified as Level 1.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company determines that notes payable as of December 31, 2020 was classified as Level 2 and the relevant fair value approximates its carrying amount since it bore interest at rates that approximate current market rates.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d66edc36-a5f2-4724-ab03-bdb200edeccf" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:InventoryDisclosureTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6. INVENTORIES</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_95c498ff-9ab3-458b-b2aa-972519f456dc" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of inventories are as follows at December 31:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.184%;"></td>
        <td style="width:1.682%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:14.322%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:1.682%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:14.322%;"></td>
        <td style="width:0.613%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Raw materials</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8d3bf1b7-0ecf-4f58-8e25-3d87a23ee356" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:InventoryRawMaterialsNetOfReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,355</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Finished goods</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_00c95a0e-4277-433c-944a-3857fda433a5" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:InventoryFinishedGoodsNetOfReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,955</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3b169125-74ba-445e-836b-b6cb114be0db" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:InventoryFinishedGoodsNetOfReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,718</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total inventories</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c956fff2-0593-4482-9492-38dfca7c2a57" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,310</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0306404b-3df0-4ac5-9e42-6052f34f9e03" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,718</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Manufacturing overhead costs primarily include management&#x2019;s best estimate and allocation of the labor costs incurred related to acquiring finished goods from the Company&#x2019;s contract manufacturer. Labor costs include wages, taxes and benefits for employees involved in warehousing, logistics coordination, material sourcing, and production planning activities. The majority of these costs have been written off based on the Company&#x2019;s analysis of net realizable value.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the years ended December 31, 2021 and 2020, net realizable value inventory adjustments and excess and obsolete inventory charges were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d297168e-52d1-4476-a075-f83a6086a3a3" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:InventoryWriteDown" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">75</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d533b589-11e3-43e2-93af-a34e7c709d13" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:InventoryWriteDown" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">213</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, and were recognized in cost of sales.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bed17df0-21af-4999-9eee-3ada62d2d069" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7. PROPERTY AND EQUIPMENT, NET</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e6997333-ed72-4682-af62-cb23fe0720df" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net, are recorded at historical cost and consist of the following at December 31:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.895%;"></td>
        <td style="width:1.586%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.346%;"></td>
        <td style="width:0.857%;"></td>
        <td style="width:1.586%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.293%;"></td>
        <td style="width:0.857%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1a5d910e-03bc-40c6-b3fc-700af042af0d" contextRef="C_9bead3a6-4985-410f-99b5-30235563115f" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">989</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_58c3afe9-ab5b-47ba-98ea-b2606c5ec004" contextRef="C_9e7001e3-4007-4798-9dd4-73bb5ecbae12" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">572</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research devices</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e348f9a-ee03-40e4-b1e4-ac1645a0211b" contextRef="C_a2443b46-1c16-4eec-bafc-07f659935c43" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,422</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b6fcc33f-acdf-48e3-9a55-00caa316aa0b" contextRef="C_0748c7ce-7d19-4746-8d34-695f218ca5aa" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">486</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing devices</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_99d44aea-681f-445c-a678-7eafde5fdd9a" contextRef="C_883d8081-2c10-4853-b218-6c373ae4a619" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">669</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a5f4be8f-76bd-4a8e-838f-95f71c962046" contextRef="C_39161efa-1760-453a-85f8-4f68df3f9557" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">575</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_19d159f3-3629-4e04-bbe4-1d894491c55d" contextRef="C_b4ed0d3a-434f-44d7-b565-e029c1f85e01" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">385</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Construction in progress</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e7a4117e-d064-45f0-bc28-d9593b6c090b" contextRef="C_8b92779c-b81b-4034-9f67-08e85cb2c22d" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">341</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a93f08d6-8771-45ca-ae49-e4be1dab1bab" contextRef="C_2f407302-608a-4972-886c-07025c0d9e38" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">613</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tooling</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_942564de-b71a-423d-8edc-232a3478552d" contextRef="C_c3117b2a-9a28-41fd-bf6c-462cc8023630" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">302</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bfadda53-c74b-4074-9c4f-5a5d3a577773" contextRef="C_1de70b38-0a9c-4b91-b7ee-29ac5dddc712" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">270</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Trade show assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f2dab86-53ed-4226-b0d7-6e2a0ed825a6" contextRef="C_fa39ca24-c5b2-4cc3-9108-625304c8561d" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">293</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Leased devices</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6f5ddf4e-3152-4313-92b4-561f374e6148" contextRef="C_9dd1a0ec-1e2f-4d91-be47-e5f4b90724e9" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">396</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0e94c96b-0001-45bd-99dc-0a1cb7ba09ca" contextRef="C_8798fe66-4ab2-4809-8278-b52ed9e1d7cb" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">127</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c1fe6108-fd35-4831-8467-552a3b0f3586" contextRef="C_7ff32017-f2ed-48aa-9ebf-c6e5f3edd992" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">176</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_68839bb1-d3dd-4d31-9cd9-9eedf4fc0692" contextRef="C_78bf0f13-f3b7-455a-a4d0-d20db26ececd" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">167</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_db59f7e2-a3bb-41ab-8de7-f4bdb78c59f5" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,163</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9e745fef-779c-48a1-9e0c-b638eccd78be" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,620</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Less: Accumulated depreciation and amortization</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_31963050-1571-4c4b-92d6-10fb50335007" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,410</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8f8f9957-d0b5-46d5-9ae8-2262160b9e15" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">716</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e351a39e-2443-40a6-b49f-e7f9f34d772d" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,753</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ba7cf1b3-f460-4c20-95c6-ad2c1f5829ef" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,904</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation and amortization expense amounted to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_848b1e3f-1fc0-4e4a-a52a-58b6d48ffe82" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">726</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eaaf35ac-71f8-4ebd-8395-0b2c095c2cde" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">289</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the years ended December 31, 2021 and 2020, respectively.</span></p></ix:nonNumeric></div>
  <p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_73f59f7a-164c-4d87-bcb6-991ab7cbe5bd" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" escape="true"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fcea091c-179a-42e3-896b-2fb76b09f851" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses and other current liabilities consist of the following at December 31:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.316%;"></td>
        <td style="width:1.544%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.899%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:0.994%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:14.438%;"></td>
        <td style="width:0.613%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Bonus</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_12e31fab-5905-4697-a2bf-75f4668d94da" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:AccruedBonusesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,421</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6a34b6d6-88d3-45f0-8a36-c86ae8f053cc" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:AccruedBonusesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">501</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Contracted services</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cfb78c56-32c3-4527-ad4c-a1f5725f5694" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:AccruedContractedServicesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,711</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7bd913a-5c1c-4af8-9802-c69a1eacb5c8" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="hypr:AccruedContractedServicesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">456</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">SPAC bonus and other costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8d4528c9-45fe-4852-ab31-dd914aba95d5" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:AccruedBonusAndOtherCostsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,071</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Legal fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e26ff824-94dc-4ee1-91c7-8d4dc12ad8c0" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">452</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_17a38357-bd54-4206-9469-04a7f17aa36a" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">282</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Payroll and related benefits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f91c2baf-3a8a-49a1-9606-b8de9e404288" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">441</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5e8f92f1-34c9-4afd-8bc4-ab35f5ec5af4" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bc48966f-3944-40f5-bed9-dc354bd55abd" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6cdddf2d-980c-4d52-aa6c-79e8197ab552" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:AccruedExpensesAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,115</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_70f3abbf-9af8-4313-9c33-ad5e3e8b5a92" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="hypr:AccruedExpensesAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,264</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9222f6e5-c525-43c3-9262-b736624e367c" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:LongTermDebtTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9. NOTES PAYABLE</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2020, the Company received loan proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dc56c53a-1e82-49a1-b7eb-e486970886b2" contextRef="C_1e797df8-f52f-4d4a-b1a1-ccf242640db1" name="us-gaap:ProceedsFromNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,067</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> under the PPP. The Legacy Hyperfine PPP loan in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_07646f22-df95-4714-bf47-866745f298ce" contextRef="C_c45f29de-244b-43b1-84da-2f83aa0a16d5" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">889</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">evidenced by a promissory note dated August 10, 2020 and was fully paid off during the fourth</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">quarter </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of 2020. The Liminal PPP loan in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b57bf368-94be-441d-8029-09ee9f742d05" contextRef="C_1fb3196d-7a74-43b8-be05-e3fb252761c5" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">178</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> is evidenced by a promissory note dated May 1, 2020. The Company used the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintaining its payroll levels. The Company accounted for the loan as debt.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the closing of the Business Combination as discussed in Note 3. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company repaid the Liminal PPP loan in full in December 2021. The Company recognized an insignificant amount of interest expense in the combined and consolidated statements of operations and comprehensive loss related to the loan.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_373995cb-053b-40aa-adc7-cea1f921363d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:PreferredStockTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">10. CONVERTIBLE PREFERRED STOCK</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Legacy Hyperfine Convertible Preferred Stock</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine had issued four series of Convertible Preferred Stock, Series A through Series D. </span><span><ix:nonNumeric id="F_5240a432-b08a-4741-995a-d6167314781e" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:TemporaryEquityTableTextBlock" escape="true" continuedAt="F_5240a432-b08a-4741-995a-d6167314781e_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the authorized, issued and outstanding Convertible Preferred Stock of Legacy Hyperfine immediately prior to the Business Combination:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_5240a432-b08a-4741-995a-d6167314781e_1" continuedAt="F_5240a432-b08a-4741-995a-d6167314781e_2"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:11.212%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:8.631%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:1.121%;"></td>
        <td style="width:8.504%;"></td>
        <td style="width:0.931%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:0.931%;"></td>
        <td style="width:9.848%;"></td>
        <td style="width:0.508%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:0.561%;"></td>
        <td style="width:9.615%;"></td>
        <td style="width:0.931%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:1.132%;"></td>
        <td style="width:7.954%;"></td>
        <td style="width:0.931%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:1.121%;"></td>
        <td style="width:7.383%;"></td>
        <td style="width:0.508%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:1.121%;"></td>
        <td style="width:8.377%;"></td>
        <td style="width:0.508%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:1.153%;"></td>
        <td style="width:8.642%;"></td>
        <td style="width:0.508%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Class</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year<br />of Class<br />Issuance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br />Price per<br />share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br />Authorized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br />Issued and<br />Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total<br />Proceeds or<br />Exchange<br />Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br />Costs</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Net<br />Carrying<br />Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Initial<br />Liquidation<br />Price per<br />share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fd9035b5-e979-45e9-a28a-e13708e99324" contextRef="C_88d7f310-a8d6-4fc6-888b-0a034f2de16c" name="hypr:TemporaryEquityYearOfClassIssuance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2014</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6333fba4-231f-47f3-ac71-6c0511fd5546" contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.04</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3675b38e-4116-40c5-81ed-ca2b1feeb3a2" contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">25,000,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f71ffe05-a4ae-4ddd-bad8-f813dcabe794" contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_7902badc-a337-481b-834b-a6add4d3c826" contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">25,000,000</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_010948f2-6213-4341-a593-711a29b6c56e" contextRef="C_88d7f310-a8d6-4fc6-888b-0a034f2de16c" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d20a179-015f-4242-88c7-3a2d158e3ed8" contextRef="C_88d7f310-a8d6-4fc6-888b-0a034f2de16c" name="hypr:TemporaryEquitySharesIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5dd2f4c1-ba9a-40f6-ab4a-1cfd5b9772ba" contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">998</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1c12acd2-7071-4fb7-bc28-304b2f501260" contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series B</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_99143f31-cb6c-4893-8a26-3b3ccec6ddd8" contextRef="C_0e50299d-06bc-4ca9-8fae-2ba1b516eb00" name="hypr:TemporaryEquityYearOfClassIssuance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6aee5802-a44e-418d-917b-ff7de1c00e5c" contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f9a054f3-5acf-44b4-8e93-a28f595818c2" contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,625,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_19fd5704-979b-4935-bed2-b4d9b2154141" contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_743b0ef2-9c20-4bdc-bf49-b858424c9219" contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,625,000</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fac10a61-6cb9-4d22-a04a-3f9d8ca41df9" contextRef="C_0e50299d-06bc-4ca9-8fae-2ba1b516eb00" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,500</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d282f12-0092-4702-9f98-dbb42e8416da" contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,500</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0891423c-d373-4267-a37a-b3341637436d" contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series C</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a385e3f6-a135-48d2-9dd1-76dcc690aaea" contextRef="C_c5071d04-a665-4335-a174-7aa1af89882e" name="hypr:TemporaryEquityYearOfClassIssuance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1a126fa6-102b-4a11-925f-c592d1dd4b39" contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">1.88</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d45daa7-49e6-48de-ac9b-0f63c2fd00b2" contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">31,586,210</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_969e595c-c081-43cc-be2d-8152bf5469c6" contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_520457e8-e747-4116-9eab-669471d8b2c2" contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">31,586,210</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9b5f9fab-8d5e-47e9-ac5c-0436f4320cb1" contextRef="C_c5071d04-a665-4335-a174-7aa1af89882e" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,382</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_132d9004-7aaf-40aa-9fb0-cfd8759b1e60" contextRef="C_c5071d04-a665-4335-a174-7aa1af89882e" name="hypr:TemporaryEquitySharesIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">234</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d6b95b12-5b26-459d-bb84-8da501d07cb4" contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,148</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ce91108a-3955-4ee8-a8d8-ebab0b946928" contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">1.88</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series D</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_67dd8d75-22b2-475f-ad63-028ccca420c6" contextRef="C_1c2f3fc1-c9e7-40c0-86e4-fd3a7bdf44bd" name="hypr:TemporaryEquityYearOfClassIssuance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2020</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">-</span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_804ad981-e6fd-4d59-822c-c1ab0b343dd7" contextRef="C_a1f35ddb-eb58-49b6-a2b6-56b35e52474f" name="hypr:TemporaryEquityYearOfClassIssuance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2021</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bafa6f0d-c848-433c-9704-8cd3baaa4693" contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">2.15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b74e62e9-61a2-402e-9afd-d0a1c69dfde2" contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">62,577,618</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bb0d6414-b3c3-46b7-ac38-705e42332d14" contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_aefcd498-306a-4242-9956-7f14b6ebff4a" contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">41,970,981</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5cf5e03b-321b-46c9-8d66-90a4c5ef93fa" contextRef="C_c4a978a0-dd7d-4dae-a821-3df28ca4dc3d" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">90,237</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_642074a7-8c98-4fd7-879d-47d871d9508d" contextRef="C_c4a978a0-dd7d-4dae-a821-3df28ca4dc3d" name="hypr:TemporaryEquitySharesIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9c1a7c29-c834-4d88-8e43-b58a5dcc2778" contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">90,101</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c297efa-b801-4d42-b6f4-0e7cf245c28b" contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3af766a3-d0da-4eb7-9a60-ee87df32c496" contextRef="C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">129,788,828</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_77bc1478-9481-4dac-a75d-acb3232d90f0" contextRef="C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_acfc93d6-66a5-4d8f-98db-6538f68cc947" contextRef="C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">109,182,191</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c593143b-0fe1-4342-bb27-fe5e25457516" contextRef="C_e7a1c7aa-d329-429a-b3c9-637f64056a81" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">159,119</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0f7294c9-dbd8-44d4-85e3-1ec231d633d3" contextRef="C_e7a1c7aa-d329-429a-b3c9-637f64056a81" name="hypr:TemporaryEquitySharesIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">372</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b8144c37-a66b-454b-a290-61c7c2216a3a" contextRef="C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158,747</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_5240a432-b08a-4741-995a-d6167314781e_2"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the authorized, issued and outstanding Convertible Preferred Stock of Legacy Hyperfine as of December 31, 2020:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:11.225%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:8.633%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:1.121%;"></td>
        <td style="width:8.506%;"></td>
        <td style="width:0.931%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:0.931%;"></td>
        <td style="width:9.395%;"></td>
        <td style="width:0.931%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:0.561%;"></td>
        <td style="width:9.617%;"></td>
        <td style="width:0.931%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:1.132%;"></td>
        <td style="width:7.956%;"></td>
        <td style="width:0.931%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:1.121%;"></td>
        <td style="width:7.385%;"></td>
        <td style="width:0.508%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:1.121%;"></td>
        <td style="width:8.379%;"></td>
        <td style="width:0.508%;"></td>
        <td style="width:0.984%;"></td>
        <td style="width:1.153%;"></td>
        <td style="width:8.644%;"></td>
        <td style="width:0.508%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Class</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year<br />of Class<br />Issuance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br />Price per<br />share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br />Authorized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br />Issued and<br />Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total<br />Proceeds or<br />Exchange<br />Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br />Costs</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Net<br />Carrying<br />Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Initial<br />Liquidation<br />Price per<br />share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cfce8213-777e-4fb4-8460-c5efb330f31f" contextRef="C_66a4ed44-133c-453e-b237-1b588d0b3bee" name="hypr:TemporaryEquityYearOfClassIssuance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2014</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7c8b2801-8f0c-4bac-8f98-cfb4eefa1f95" contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.04</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a29cbbb6-334c-439d-96f1-5498a674dba7" contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">25,000,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_75fd5763-209a-4885-95b7-776fe271b252" contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_4df36a34-7061-4722-a40b-323b2151ce3f" contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">25,000,000</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_48e1dbb5-d3bf-465a-b44f-94bec10143a3" contextRef="C_66a4ed44-133c-453e-b237-1b588d0b3bee" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bd8b859f-b5bf-4dee-b986-51a5544b503b" contextRef="C_66a4ed44-133c-453e-b237-1b588d0b3bee" name="hypr:TemporaryEquitySharesIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb48374d-77f3-4c39-a45c-e2617b8cb801" contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">998</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_07b19d8c-256c-4bb9-9014-70bdcc983b78" contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series B</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8fc6a98f-d911-41cc-8079-eb1932d7046f" contextRef="C_36c4ccc8-ec82-451c-9859-29fefff0e27b" name="hypr:TemporaryEquityYearOfClassIssuance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_158db39f-58a7-40fd-be92-2cd1593d999f" contextRef="C_851619a8-8879-4e00-8eac-c603bca28425" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a6a4f32e-043f-4c36-a23d-0c59b7e75026" contextRef="C_851619a8-8879-4e00-8eac-c603bca28425" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,625,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0aa68d2e-7052-4ba9-a041-73dda509d464" contextRef="C_851619a8-8879-4e00-8eac-c603bca28425" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_4658036f-3040-4352-a7b7-0c1cbd7a3f7a" contextRef="C_851619a8-8879-4e00-8eac-c603bca28425" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,625,000</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_968c2f4b-7f12-4069-b9f5-7a7e9e896022" contextRef="C_36c4ccc8-ec82-451c-9859-29fefff0e27b" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,500</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b63eb45b-1b0c-43e0-b609-019a9bde9749" contextRef="C_851619a8-8879-4e00-8eac-c603bca28425" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,500</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e436ecf7-7236-4c61-99de-a33df27392f4" contextRef="C_851619a8-8879-4e00-8eac-c603bca28425" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series C</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8bece4a1-1117-4311-9a3a-4cda77ed16ff" contextRef="C_a1fab29a-58b5-4b1a-9ccd-64a673d6e459" name="hypr:TemporaryEquityYearOfClassIssuance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_092ccbd1-87f5-487f-a2a9-c140afaac851" contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">1.88</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7a79086d-5b9a-4120-b7a3-e448e62b37f8" contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">31,586,210</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6d8ca8d1-613e-4130-ac15-a37242538812" contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_ef9700c4-7b17-4aa9-b133-7e17e4ba32fb" contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">31,586,210</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b3ea8d6b-452d-4471-84e2-2a4e79578c01" contextRef="C_a1fab29a-58b5-4b1a-9ccd-64a673d6e459" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,382</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_992709f3-2495-4816-b51b-1a75dd9d9713" contextRef="C_a1fab29a-58b5-4b1a-9ccd-64a673d6e459" name="hypr:TemporaryEquitySharesIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">234</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ff6270b8-40f1-4898-9376-eeb24ad9ebe8" contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,148</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cae1c096-b146-4d9c-861c-ac36758846e4" contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">1.88</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series D</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_38e0a2d2-3464-4ce3-a3c2-2856814bd2bf" contextRef="C_56f1b540-02fa-40f2-9894-b43cec93b036" name="hypr:TemporaryEquityYearOfClassIssuance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2020</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fd2858af-e524-4013-bbf9-e5d68cc31cab" contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">2.15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c66d3510-894f-4005-a1f9-d632e791b2bb" contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">62,577,618</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_81cdde86-4d8e-4e47-888c-7e3c965a97d1" contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_c8e72c84-dd3c-44b9-a2f3-23758d0a3a61" contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">27,799,648</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0a257f17-4e7d-47a2-8545-8029b09a0243" contextRef="C_9644069d-7efd-4fd5-a809-33471f45d26c" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,769</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_47c6dc53-574d-4565-8fed-37872bce6bd1" contextRef="C_56f1b540-02fa-40f2-9894-b43cec93b036" name="hypr:TemporaryEquitySharesIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">129</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5e5ee377-c4a3-4f80-8ce2-b2f37f9725af" contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,640</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5333c833-eaaf-46d6-bbea-afbb1af4e25c" contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb807faa-5597-4186-8d38-0ef9a9ce58f5" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">129,788,828</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9e267503-d6c7-46fb-b5e3-3f8e040dd38d" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_1f1e6e14-c3b5-4879-ae20-1072be887244" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">95,010,858</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eddfa5e3-2549-4910-a00a-5b346126e0c0" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">128,651</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2e666771-f954-4efb-8e6c-fbe511070ea3" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="hypr:TemporaryEquitySharesIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">365</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d1045b21-0edd-4286-8f68-d4596d256cba" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">128,286</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The powers, preferences, rights, qualifications, limitations and restrictions of the shares of Convertible Preferred Stock are as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividends</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dividends shall accrue to holders of the Convertible Preferred Stock at the rate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ec90584e-98e1-4b4c-bf39-8a131c50cc9e" contextRef="C_815be668-99bc-4c0f-839f-a4c555f975bf" name="us-gaap:PreferredStockDividendRatePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal"><ix:nonFraction id="F_b0c5c9f6-0b0e-4dbe-991c-4d7cca7ff860" contextRef="C_604f763d-b166-4d76-93fc-9435e4fa41ff" name="us-gaap:PreferredStockDividendRatePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">8</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the original issue price for the applicable series of Convertible Preferred Stock, per annum subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization, reclassification and other similar events payable only when, and if, declared by Legacy Hyperfine&#x2019;s board of directors. The right to receive dividends on Convertible Preferred Stock is not cumulative, and therefore, if not declared in any year, the right to such dividends shall terminate and shall not carry forward into the next year. There have been </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4fd9f83a-7a3e-4b45-a34b-05a8e8d3deff" contextRef="C_59ee9e89-2d6f-4237-ae48-00fdfeea2299" name="us-gaap:DividendsPayableCurrentAndNoncurrent" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_edea71b9-6c1c-4031-a9e7-25f5cc7dc63b" contextRef="C_1d288b0c-2753-40e9-b635-efa4cad33f7f" name="us-gaap:DividendsPayableCurrentAndNoncurrent" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> dividends declared to date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidation Rights</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ff6f50aa-69c4-488f-9b79-088f1e964f0f" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:LiquidationBasisOfAccountingLiquidationPlan" continuedAt="F_ff6f50aa-69c4-488f-9b79-088f1e964f0f_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the event of any liquidation, dissolution or winding up of Legacy Hyperfine, whether voluntary or involuntary or a deemed liquidation event (which includes a merger, the sale of all of Legacy Hyperfine&#x2019;s assets, or a transaction which the holders of capital stock of Legacy Hyperfine hold less than 50% of the voting securities) (each a &#x201c;Liquidation Event&#x201d;), the holders of the Convertible Preferred Stock are entitled to be paid out of the assets of Legacy Hyperfine available for distribution to stockholders, pari passu, at a liquidation price per share equal to the greater of: </span></ix:nonNumeric></span><span style=""></span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_ff6f50aa-69c4-488f-9b79-088f1e964f0f_1"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the applicable original issue price of such Convertible Preferred Stock, plus any declared and unpaid dividends or (2) an amount that would have been payable had all the shares of the Convertible Preferred Stock been converted into Legacy Hyperfine common stock. These payments will be made to or set aside prior to the holders of shares of any other class or series of capital stock that is not, by its terms, senior to the Convertible Preferred Stock.</span></p></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting Rights</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of shares of the Convertible Preferred Stock shall be entitled to vote on all matters on which the holders of shares of Legacy Hyperfine common stock shall be entitled to vote.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each holder of record of shares of Series A Convertible Preferred Stock shall be entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_be5d222d-0cef-454a-9838-edde4712ad2d" contextRef="C_1405c4fb-fd46-4fa7-b51a-b3abdd66f278" name="hypr:NumberOfVotesPerShare" unitRef="U_Vote" decimals="INF" format="ixt-sec:numwordsen">ten</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> votes per share of Legacy Hyperfine Special-voting common stock into which such Series A Convertible Preferred Stock are convertible, as discussed below under &#x201c;Conversion,&#x201d; on all matters to be voted on by Legacy Hyperfine&#x2019;s stockholders. Each holder of record of shares of Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock shall be entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d6181b2b-6b21-4b2b-a610-bfb77ddb69cd" contextRef="C_ac456664-e171-4780-a346-eaa8d31a6318" name="hypr:NumberOfVotesPerShare" unitRef="U_Vote" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_88dfc5bd-72ed-4d98-ad81-c439f9f2c8ff" contextRef="C_e6d3149f-9dd6-457f-8d72-4c2c61b3f90a" name="hypr:NumberOfVotesPerShare" unitRef="U_Vote" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ea7bb84c-9895-457b-9b3b-2fd0043d322a" contextRef="C_79b8e3d1-0c6c-4ae4-9639-ebe2dada5fbe" name="hypr:NumberOfVotesPerShare" unitRef="U_Vote" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> vote per share of Legacy Hyperfine common stock into which such Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, and Series D Convertible Preferred Stock are convertible, as discussed below under Conversion, on all matters to be voted on by Legacy Hyperfine&#x2019;s stockholders. The holders of Convertible Preferred Stock and the holders of Legacy Hyperfine common stock shall vote together and not as separate classes. There shall be no series voting.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Conversion</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_613937bb-5222-423d-881f-69fa2ea79592" contextRef="C_f483c871-8db6-4367-9cdb-c9ee827a41fe" name="us-gaap:PreferredStockConversionBasis"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of Series A Convertible Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of Legacy Hyperfine Special-voting common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional common shares for no consideration or consideration less than the conversion price of the Series A Convertible Preferred Stock.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_75a00957-22a5-43d8-880a-a3e13bcb4ab5" contextRef="C_c87cc42e-ffd7-45c9-913f-2f4babc09628" name="us-gaap:PreferredStockConversionBasis"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock shall be convertible, at the option of the holder, at any time after the date of issuance into shares of Legacy Hyperfine common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional common shares for no consideration or consideration less than the conversion price of the respective series of Convertible Preferred Stock, which is equal to the original issuance price for each series of Convertible Preferred Stock.</span></ix:nonNumeric></span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon the earlier to occur of (i) election of the Convertible Preferred Stock by (A) the consent or vote of the majority holders of the Convertible Preferred Stock (voting together as a single class and not as separate series, and on an as-converted basis), (B) the consent or vote of the majority holders of Series C Convertible Preferred Stock (voting separately as a single class) and (C) the consent or vote of the majority holders of Series D Convertible Preferred Stock (voting separately as a single class) or (ii) the closing of a firm commitment underwritten initial public offering pursuant to an effective registration statement filed under the Securities Act of 1933 covering the offer and sale of shares of Legacy Hyperfine common stock in which the aggregate gross proceeds to Legacy Hyperfine are at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_17c4c866-57f3-4c07-b533-e7a61e81ca9e" contextRef="C_a3cbddd1-811a-44fb-b01c-1b817fbb617d" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">80,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (1) each share of Series A Convertible Preferred Stock shall automatically be converted into shares of Legacy Hyperfine Special-voting common stock on a 1 for 1 basis and (2) each share of Series B, Series C and Series D Convertible Preferred Stock shall automatically be converted into Legacy Hyperfine common stock on a 1 for 1 basis.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon the closing of the Business Combination, the Convertible Preferred Stock converted into Class A and Class B common stock based on the Business Combination&#x2019;s Hyperfine Exchange Ratio of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f4121f8f-057c-403e-a14e-44bc6a4efdac" contextRef="C_b788d1a7-f5e7-4c74-b5e4-0cd24b556c97" name="hypr:BusinessCombinationExchangeRatio" unitRef="U_pure" scale="0" decimals="4" format="ixt:numdotdecimal">0.3275</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the Company&#x2019;s shares for each Legacy Hyperfine share. The Company recorded the conversion at the carrying value of the Convertible Preferred Stock at the time of the Closing. There are </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_67781ad2-2a86-40b8-b2ec-41292fbab3a5" contextRef="C_b788d1a7-f5e7-4c74-b5e4-0cd24b556c97" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Convertible Preferred Stock outstanding as of December 31, 2021.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liminal Convertible Preferred Stock</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_31fdbb1c-0b1d-4662-af6b-7def69e8963b" contextRef="C_bf3fc9fc-c2f0-475a-be3e-816156a07b77" name="us-gaap:PreferredStockConversionBasis" continuedAt="F_31fdbb1c-0b1d-4662-af6b-7def69e8963b_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">April 1, 2021 Liminal effected a recapitalization whereby each share of Liminal common stock outstanding was exchanged for shares of Liminal Series A-1 preferred stock and Liminal Series A-2 preferred stock. The value </span></ix:nonNumeric></span><span style=""></span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_31fdbb1c-0b1d-4662-af6b-7def69e8963b_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ascribed </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to the preferred stock is equivalent to the total amount of historical equity investments contributed by the common shareholder.</span></ix:continuation></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> There were no new investments or changes in control in conjunction with the recapitalization.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The powers, preferences, rights, qualifications, limitations and restrictions of the shares of Liminal Convertible Preferred Stock are as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividends</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dividends shall accrue to holders of the Convertible Preferred Stock at the rate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5c28beca-31bf-423f-95ef-51fee9f9e33e" contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee" name="us-gaap:PreferredStockDividendRatePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the original issue price for the applicable series of Convertible Preferred Stock, per annum subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization, reclassification and other similar events payable only when, and if, declared by Liminal&#x2019;s board of directors. The right to receive dividends on Convertible Preferred Stock is not cumulative, and therefore, if not declared in any year, the right to such dividends shall terminate and shall not carry forward into the next year. There have been </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_21a0a3bb-5147-4375-9742-e9c2f3c46e2f" contextRef="C_9975d5e6-b660-419f-abf6-e2a46827db35" name="us-gaap:DividendsPayableCurrentAndNoncurrent" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> dividends declared to date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidation Rights</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ef4d7b01-0897-41d5-86de-4f57b33f7801" contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee" name="us-gaap:LiquidationBasisOfAccountingLiquidationPlan"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event of any liquidation, dissolution or winding up of Liminal, whether voluntary or involuntary or a deemed liquidation event (which includes a merger, the sale of all of Liminal&#x2019;s assets, or a transaction which the holders of capital stock of Liminal hold less than 50% of the voting securities) (each a &#x201c;Liquidation Event&#x201d;), the holders of the Convertible Preferred Stock are entitled to be paid out of the assets of Liminal available for distribution to stockholders, pari passu, at a liquidation price per share equal to the greater of: (1) the applicable original issuance price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ef3b1f3d-1a3b-4ee0-9120-0e777c28e46c" contextRef="C_05f68334-93da-4481-827d-a3e3770c9d3d" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4"><ix:nonFraction id="F_97b82eeb-a641-4698-90eb-16a2cde01943" contextRef="C_e1bced35-5643-4d57-a6ea-b24e0a212bf8" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4">.1287</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share for Series A-1 and Series A-2 Convertible Preferred Stock, plus any declared and unpaid dividends or (2) an amount that would have been payable had all the shares of the Convertible Preferred Stock been converted into Liminal common stock. These payments will be made to or set aside prior to the holders of shares of any other class or series of capital stock that is not, by its terms, senior to the Convertible Preferred Stock.</span></ix:nonNumeric></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting Rights</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of shares of the Convertible Preferred Stock shall be entitled to vote on all matters on which the holders of shares of Liminal common stock shall be entitled to vote.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each holder of record of shares of Series A-1 Convertible Preferred Stock shall be entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_40b0dd5e-95a7-4ff3-bc86-14db3df63fa9" contextRef="C_05f68334-93da-4481-827d-a3e3770c9d3d" name="hypr:NumberOfVotesPerShare" unitRef="U_Vote" decimals="INF" format="ixt-sec:numwordsen">ten</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> votes per share of Liminal Special-voting common stock into which such Series A-1 Convertible Preferred Stock are convertible, as discussed below under &#x201c;Conversion,&#x201d; on all matters to be voted on by Liminal&#x2019;s stockholders. Each holder of record of shares of Series A-2 Convertible Preferred Stock shall be entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0ab9ff54-17af-4a72-b3d4-ef6ad729c4e4" contextRef="C_e1bced35-5643-4d57-a6ea-b24e0a212bf8" name="hypr:NumberOfVotesPerShare" unitRef="U_Vote" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> vote per share of Liminal common stock into which such Series A-2 Convertible Preferred Stock are convertible, as discussed below under Conversion, on all matters to be voted on by Liminal&#x2019;s stockholders. The holders of Convertible Preferred Stock and the holders of Liminal common stock shall vote together and not as separate classes. There shall be no series voting.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Conversion</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_363feff2-02ef-4c49-af8f-5071221faae7" contextRef="C_04f3284a-f447-4bbf-92f2-20e3aa560cb7" name="us-gaap:PreferredStockConversionBasis"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of Series A-1 Convertible Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of Liminal Special-voting common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional shares of Liminal common stock for no consideration or consideration less than the conversion price of the Series A Convertible Preferred Stock.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_56a3dda7-5e5e-43f1-bcbd-1120df673f61" contextRef="C_d0d9904d-6ebb-411f-ae8e-b672fda8238c" name="us-gaap:PreferredStockConversionBasis"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of Series A-2 Convertible Preferred Stock shall be convertible, at the option of the holder, at any time after the date of issuance into shares of Liminal common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional shares of common stock for no consideration or consideration less than the conversion price of the respective series of Convertible Preferred Stock, which is equal to the original issuance price for each series of Convertible Preferred Stock.</span></ix:nonNumeric></span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the earlier to occur of (i) election of the Convertible Preferred Stock by the consent or vote of the majority holders of the Convertible Preferred Stock (voting together as a single class and not as separate series, and on an as-converted basis) or (ii) the closing of a firm commitment underwritten initial public offering pursuant to an effective</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">registration </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">statement filed under the Securities Act of 1933, as amended, covering the offer and sale of shares of Liminal common stock in which the aggregate gross proceeds to Liminal are at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee55ffdb-69a6-4b76-9be5-84a0420a6bbc" contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">80,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (1) each share of Series A-1 Convertible Preferred Stock shall automatically be converted into shares of Liminal Special-voting common stock on a 1 for 1 basis and (2) each share of Series A-2 Convertible Preferred Stock shall automatically be converted into Liminal common stock on a 1 for 1 basis.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon the closing of the Business Combination, the Liminal Convertible Preferred Stock converted into Class A and Class B common stock based on the Business Combination&#x2019;s Liminal Exchange Ratio of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_28aa27be-cc03-46ce-9bf3-908b31a09a82" contextRef="C_29df5b7f-0392-4e69-85ba-668edf603563" name="hypr:BusinessCombinationExchangeRatio" unitRef="U_pure" scale="0" decimals="4" format="ixt:numdotdecimal">0.1796</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the Company&#x2019;s shares for each Liminal share. The Company recorded the conversion at the carrying value of the Convertible Preferred Stock at the time of the Closing. There are </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b3b7de3e-b905-406d-b3a9-452483c4b89b" contextRef="C_29df5b7f-0392-4e69-85ba-668edf603563" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Convertible Preferred Stock outstanding as of December 31, 2021.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6c5f54e8-44d0-441a-a163-e2c32f962364" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true"><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">11. STOCKHOLDERS&#x2019; EQUITY (DEFICIT)</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Common Stock</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, and 2020, the Company had authorized </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e6edfb64-3c4e-49a3-8544-1bfd09497ad4" contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">600,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_47af9636-b499-43bc-9076-4a43e74ed643" contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">130,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock at $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0665e27e-305c-4289-b23f-6ffe419b988c" contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_81f95b99-c119-46c2-a37e-0dfe37daea56" contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value per share, of which a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_74698698-1b59-4d40-9dae-ec855ad321cd" contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">55,277,061</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_86ec1075-d255-4b43-8628-c1d0eebf8d1f" contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,576,137</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were outstanding, respectively.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, and 2020, the Company had authorized </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_609f60cc-96c5-4828-abd9-0d8687082dde" contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">27,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_71dc7227-89f6-4474-9190-93bd0e61aacd" contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class B common stock at $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5c851166-b3a2-49a4-9be4-d14d212b8429" contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_db3cdd04-2320-4e11-b29d-238ecf6d9e5d" contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value per share, of which a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ec7f8d8f-1ff3-4059-b650-e6e8743cac42" contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,055,288</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_86b4c3d9-b223-40db-9e6b-403a36691bb1" contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were outstanding, respectively.</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividends</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Holders of the Company&#x2019;s common stock are not entitled to receive dividends unless declared by the Company&#x2019;s board of directors. There have been </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_538de8a6-a5a6-4dcc-a5db-d6c4cc2b637a" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:DividendsCommonStock" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> dividends declared to date.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting Rights</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of shares of the Company's Class A common stock are entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dcd81106-8515-41ec-b3df-24aa1504d958" contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01" name="hypr:CommonStockNumberOfVotesPerShare" unitRef="U_Vote" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> vote per share on all matters on which the Company's Class A common stock shall be entitled to vote. The holders of shares of the Company's Class B common stock are entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_507c77ff-0a53-4a55-95d9-4d218e015159" contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2" name="hypr:CommonStockNumberOfVotesPerShare" unitRef="U_Vote" decimals="INF" format="ixt:numdotdecimal">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> votes per share on all matters on which the Company's Class B common stock shall be entitled to vote. The holders of the Company's Class A common stock and Class B common stock shall vote together and not as separate classes.</span></p></ix:nonNumeric></div>
  <p style="margin-left:3.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div><ix:nonNumeric id="F_d4349a4f-3b61-46e9-b37e-e1e741242815" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">12. EQUITY INCENTIVE PLAN</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Hyperfine Inc. 2021 Equity Incentive Plan</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c82a5170-c8b3-40ab-a4a9-237e89af5c59" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">16,013,762</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock are reserved for issuance under the Company's 2021 Equity Incentive Plan (the &#x201c;Hyperfine Plan&#x201d;). The Hyperfine Plan is administered by the Company's board of directors. The board of directors may grant restricted stock and options to purchase shares either as incentive stock options or non-qualified stock options. The option grants are subject to certain terms and conditions, option periods and conditions, exercise rights and privileges as set forth in the Hyperfine Plan. At December 31, 2021, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e6d5e028-4ca9-41f1-b507-c899706d8a02" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="hypr:CommonStockRemainsAvailableForIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">8,256,741</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> common shares remain available for issuance under the Hyperfine Plan.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to the Business Combination, Legacy Hyperfine and Liminal were distinct entities with separate equity incentive plans for their employees and nonemployees. Both plans were subsequently adopted and assumed by the Company as a consequence of the Business Combination.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine option from Legacy Hyperfine&#x2019;s 2014 Employee, Director and Consultant Equity Incentive Plan as amended on October 9, 2020 (the &#x201c;Legacy Hyperfine Plan&#x201d;) outstanding immediately prior to the Closing, whether vested or unvested, was converted into an option to purchase shares of the Company's Class A common stock equal to the number of shares of Legacy Hyperfine common stock subject to such option multiplied by the Hyperfine</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exchange </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ratio of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e5e71036-1f8a-4439-b12b-1c9ee3b43246" contextRef="C_bcf76ade-60dc-4368-aef5-2520cbade643" name="hypr:ExchangeRatio" unitRef="U_pure" scale="0" decimals="4" format="ixt:numdotdecimal">0.3275</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, rounded down to the nearest whole number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Closing divided by </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a4a18beb-3f34-4a43-b26d-06abae16641f" contextRef="C_bcf76ade-60dc-4368-aef5-2520cbade643" name="hypr:ExchangeRatio" unitRef="U_pure" scale="0" decimals="4" format="ixt:numdotdecimal">0.3275</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, rounded up to the nearest whole cent.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each Liminal option from Liminal&#x2019;s 2021 Employee, Director, and Consultant Equity Incentive Plan (the &#x201c;Liminal Plan&#34;) outstanding immediately prior to the Closing, whether vested or unvested, was converted into an option to purchase shares of the Company's Class A common stock equal to the number of shares of Liminal common stock subject to such option multiplied by the Liminal Exchange Ratio of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e0711f2e-e1d1-4d3f-8463-efcadc110d3a" contextRef="C_51a3f382-19a1-459c-833b-5929003f7207" name="hypr:ExchangeRatio" unitRef="U_pure" scale="0" decimals="4" format="ixt:numdotdecimal">0.1796</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, rounded down to the nearest whole number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Closing divided by </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a2795d34-02d6-4671-9066-d77b893aecb0" contextRef="C_51a3f382-19a1-459c-833b-5929003f7207" name="hypr:ExchangeRatio" unitRef="U_pure" scale="0" decimals="4" format="ixt:numdotdecimal">0.1796</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, rounded up to the nearest whole cent.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each exchanged option will continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding option immediately prior to the Closing. All activity was retroactively restated to reflect the exchange that occurred.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, each Legacy Hyperfine restricted stock unit and each Liminal restricted stock unit outstanding immediately prior to the Effective Time was assumed by the Company and became a restricted stock unit with respect to a number of shares of the Company&#x2019;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such Legacy Hyperfine restricted stock unit or Liminal restricted stock unit immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole share.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock option activity</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each stock option grant carries varying vesting schedules whereby the options become exercisable at the participant&#x2019;s sole discretion provided they are an employee, director or consultant of the Company on the applicable vesting date. Each option shall terminate not more than ten years from the date of the grant.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the year ended December 31, 2021, the Company granted certain equity awards to the newly hired Chief Executive Officer. These awards include (1) an option award to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f206e525-1f84-4a73-b7bb-3b24e32fa6af" contextRef="C_e3d3098a-c48a-4d18-a4a7-21241395278d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,899,500</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock which will vest based on continued service over a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_65cbda19-68fa-4424-bd39-e5456d00fd94" contextRef="C_e3d3098a-c48a-4d18-a4a7-21241395278d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">four year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period, (2) a separate option award to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bea3967c-4a5b-4f34-81b1-f2c2e92bea8a" contextRef="C_9328b463-fd12-44fd-b26c-a8b2835078a1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">474,875</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock, which will be fully vested upon the occurrence of various service, performance, and market conditions. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d787db53-d8d3-4a08-a381-5b9a21b41856" contextRef="C_1cf87dff-a097-4d35-8816-c1468d5730fb" name="hypr:NumberOfSeparateOptionAwards" unitRef="U_Option" decimals="INF" format="ixt-sec:numwordsen">Two</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9a08fa27-f692-48fe-b0f7-964ada76bd72" contextRef="C_ccc706be-2158-4bcc-a2db-096a92c02315" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_9ca3c77e-3223-488d-84a6-6ba4b1fac97c" contextRef="C_f5de6d93-0dcb-4c74-a001-200800fe2bd9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">474,875</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> share option awards (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4bfe8bb8-cd26-43b1-a1b3-233239987dc3" contextRef="C_329773ff-8990-4d8c-9536-2fe5f936e9fd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">949,750</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> options total) with terms similar to those described above will be granted pursuant to the terms of the offer letter. Certain equity awards were also granted to the Executive Chairman of the Legacy Hyperfine board of directors. The equity compensation included (1) an option award to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_47eac50d-8764-48c6-a28b-48a91f1cb1a4" contextRef="C_164ab371-7976-4ab1-b472-197262c28f3c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">712,312</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock which will vest based on continued service, over </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_429637e9-6e25-4395-8d92-e65270d4171d" contextRef="C_164ab371-7976-4ab1-b472-197262c28f3c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">four years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, (2) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5e122343-ed7f-4bbe-bf74-1be4507d6f79" contextRef="C_7f6ecd42-2a1a-4c28-acf6-496ab6a2707e" name="hypr:NumberOfSeparateOptionAwards" unitRef="U_Option" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> separate option awards to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_04b116b4-18fa-4ecd-a244-83c3d7353b37" contextRef="C_61d98dd2-ccb5-4863-8e6c-5b1ad14f4dab" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">237,437</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares each of Class A common stock (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4502e22a-7a05-4f6b-99cc-e0d2919d8382" contextRef="C_7c1ef51b-34f4-4a4a-a6cd-9433c0850ab4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">474,874</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares in total), which will be fully vested upon the occurrence of various certain service, performance, and market conditions.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The service condition for these awards is satisfied by providing service to the Company based on the defined service period per the award agreement. The performance-based condition is satisfied upon the occurrence of a special purpose acquisition company (&#x201c;SPAC&#x201d;) transaction, initial public offering (&#x201c;IPO&#x201d;), or financing event as defined in the award agreement. The market condition is satisfied by achieving various multiples of a defined price per share. The achievement of the performance condition and the commencement of the related expense recognition event cannot occur until the event is deemed probable, which only occurs once a SPAC transaction, IPO, or financing event has occurred. The performance condition was satisfied as a result of the Business Combination and the Company recognized stock-based compensation expense of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e981b819-b000-406e-93f8-4294ae38096d" contextRef="C_19b3a16d-0fb7-4f0f-9123-775d37384548" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,772</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in connection with these awards during the year ended December 31, 2021. None of the market conditions have been satisfied and as such, none of the awards are exercisable as of December 31, 2021.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to the above, restricted stock units with a value of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_301bad35-4cf4-4305-9c76-06b09a01ffc5" contextRef="C_4ee5d355-9181-4953-8217-8e5ef9995358" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,500</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> will be granted to the Chief Executive Officer following the Business Combination and within two years of the Chief Executive Officer&#x2019;s start date, subject to continued service and which will vest on a schedule to be agreed upon between the Company and the Chief Executive Officer. These restricted stock units were not yet approved by the Board of Directors and therefore had not yet been granted as of December 31, 2021.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the year ended December 31, 2021, the Company also granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4dadcbe1-0366-4c94-85ee-0e425356ad8e" contextRef="C_bae04bbe-9b11-42f5-97ae-1c488ef30d01" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">258,833</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> option awards subject to certain service and performance conditions. The service condition required the participant&#x2019;s continued employment with the Company through the applicable vesting date, and the performance condition required the consummation of a Sale, IPO, or SPAC transaction as defined in the option award agreement. These awards were forfeited and cancelled prior to the consummation of the Business Combination. As a Sale, IPO, or SPAC transaction did not occur prior to forfeiture, the Company did not record any stock-based compensation expense related to these option awards.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All options granted by the Company during the years ended December 31, 2021 and 2020 were granted with exercise prices equal to the estimated fair value of the Company's common stock at the date of grant, as determined by the Company's board of directors.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d9578805-fcb7-40d9-af35-8e6c989cf5b2" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the stock option activity under the Hyperfine Plan is presented in the table below:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.969%;"></td>
        <td style="width:1.153%;"></td>
        <td style="width:0.592%;"></td>
        <td style="width:10.345%;"></td>
        <td style="width:0.846%;"></td>
        <td style="width:1.153%;"></td>
        <td style="width:1.269%;"></td>
        <td style="width:9.953%;"></td>
        <td style="width:0.592%;"></td>
        <td style="width:1.153%;"></td>
        <td style="width:0.645%;"></td>
        <td style="width:10.704%;"></td>
        <td style="width:0.592%;"></td>
        <td style="width:1.153%;"></td>
        <td style="width:1.269%;"></td>
        <td style="width:10.017%;"></td>
        <td style="width:0.592%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Number of Options</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Weighted Average Exercise Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Weighted Average Remaining Contractual Term</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Aggregate Intrinsic Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding at January 1, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c8f037de-8234-439c-b96c-dc0f151eac09" contextRef="C_8a9c17f1-6da6-4401-8abe-806f2a333b9e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,903,479</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bc961bcc-4b27-434d-8c9a-1bba388c98d1" contextRef="C_8a9c17f1-6da6-4401-8abe-806f2a333b9e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">0.87</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3481d70d-a8d6-40f5-a9db-9e5ba7687c85" contextRef="C_2d523d48-3880-4f1d-9796-c510fd76bd9c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7.07</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5f78beb9-6199-4c18-ab99-677a17470cf0" contextRef="C_8a9c17f1-6da6-4401-8abe-806f2a333b9e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,073</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7d426645-96df-46a8-acf5-00d2673ae6fc" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,771,237</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_62ebe258-05e2-490f-98aa-9f1316d08022" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">3.37</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_44f87bae-bd88-4ad5-9836-4758da168545" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">565,533</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a1661007-ff10-42e6-a791-006b66ce7241" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.65</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8d9d4d8c-ef00-4251-b6e8-997ff40bc4c8" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">587,047</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a05fa0f2-a87c-4ae2-a71e-aba9a79712d2" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">3.86</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8c671b46-4006-40d8-8211-ffd5076b680e" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,522,136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d370b5fc-ce85-4785-9511-e75171a0e815" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">3.21</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_68808a72-9b2d-46f7-9a74-4b4b95f5a096" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8.79</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b94e0129-89b8-487a-ac7c-75919b4eb073" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,052</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Options exercisable at December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_05deb5a0-747c-495b-8a71-6021a68cb338" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,332,624</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f9123522-3979-4dda-8257-f217ed75c837" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.98</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3e1956e9-2655-4136-8f05-ab7f08f1ec67" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7.82</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0ec519e4-89d8-4125-91de-f7fa395e9e8f" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,785</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Vested and expected to vest at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_345979e6-b346-4070-a4b0-20cdf3bd9f5b" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,117,220</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c20944b3-d5eb-4752-9b03-cdfc74da5e01" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">3.20</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ec7503ab-3624-4521-baf1-563539842a3b" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8.77</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_68bed2a3-6dc8-4386-9d10-e7ecbcd9acba" contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,445</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company received cash proceeds from the exercise of stock options of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6bcc48be-0463-426c-bc9a-4e1115bfc0ce" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,497</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f0d009d7-fe25-4201-b345-2b2f86dcf1b8" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">120</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> during the years ended December 31, 2021 and 2020, respectively. The total intrinsic value (the amount by which the stock price exceeds the exercise price of the option on the date of exercise) of the stock options exercised during the years ended December 31, 2021 and 2020, was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1ecc61e1-e78d-4fe2-ac11-9824851181d8" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,752</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7adc7385-57c2-49e5-bd05-721c65093c2d" contextRef="C_2d523d48-3880-4f1d-9796-c510fd76bd9c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">167</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. The weighted-average grant date fair value of options granted during the year ended December 31, 2021 and 2020, was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_07abe8ef-d8bd-49a1-b5d6-4bc7a29f2272" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">0.66</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_23930238-a1a6-41e6-8275-0de1c93baa56" contextRef="C_2d523d48-3880-4f1d-9796-c510fd76bd9c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">0.69</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock option valuation inputs</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilized the Black-Scholes option pricing model for determining the estimated fair value for service awards. The Black-Scholes model requires the use of subjective assumptions which determine the fair value of stock-based awards. </span><span><ix:nonNumeric id="F_f439fe19-8e69-4c74-9c48-ed740a2831b3" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true" continuedAt="F_f439fe19-8e69-4c74-9c48-ed740a2831b3_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The assumptions used to value option grants to employees and nonemployees for the years ended December 31, 2021 and 2020 were as follows:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_f439fe19-8e69-4c74-9c48-ed740a2831b3_1"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.495%;"></td>
        <td style="width:1.252%;"></td>
        <td style="width:21.252%;"></td>
        <td style="width:1.252%;"></td>
        <td style="width:18.748%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Risk Free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9151bc76-5ecd-49bb-8597-eeba435ed91f" contextRef="C_19b3a16d-0fb7-4f0f-9123-775d37384548" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.95</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">% - </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d3963910-e325-485a-8cca-c544a9ac9758" contextRef="C_19b3a16d-0fb7-4f0f-9123-775d37384548" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.13</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0e751715-300f-45cd-8c64-cb923c14bfb3" contextRef="C_b9bd646d-669a-4b5c-9bdd-74063cca61b6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">% - </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_51e4397e-1c8c-45ad-ac07-fdf5132a971d" contextRef="C_b9bd646d-669a-4b5c-9bdd-74063cca61b6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_12c16ce0-c545-4a9d-8e66-3b79493c2759" contextRef="C_19b3a16d-0fb7-4f0f-9123-775d37384548" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_56508a28-1dac-4332-8ead-e1faf1675986" contextRef="C_b9bd646d-669a-4b5c-9bdd-74063cca61b6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected term</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b17e4866-5fc2-4c5b-a75f-a0e1409e3456" contextRef="C_12fc5c7b-599e-4371-aa1e-7952b537da56" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5.40</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years - </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dc0ddbf0-1a72-4265-96f4-6d75376324c6" contextRef="C_97df9222-63f0-4205-8539-e49cb6ad1192" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">6.17</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cec84f0a-f314-46d0-b2a4-b2a3d00e2ff7" contextRef="C_9d460b90-c42a-4930-b08d-e43fe406d95b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5.8</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years - </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_852b9cc5-7fbd-47ff-9493-8b00f88f4fe8" contextRef="C_e0c91aab-9546-4751-89ce-b88e18335be2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">6.0</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_26c0da29-92c1-4b63-afa9-47d59350547c" contextRef="C_19b3a16d-0fb7-4f0f-9123-775d37384548" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">70</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_765a64b3-f489-47cd-807f-adfb9b44c83b" contextRef="C_b9bd646d-669a-4b5c-9bdd-74063cca61b6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">60</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risk free interest rate</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The risk free interest rate for periods within the expected term of the awards is based on the U.S. Treasury yield curve in effect at the time of the grant.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected dividend yield</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has never declared or paid any cash dividends and does not expect to pay any cash dividends in the foreseeable future.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected term</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For employee awards, the Company calculates the expected term using the &#x201c;simplified&#x201d; method, which is the simple average of the vesting period and the contractual term. The simplified method is applied as the Company does not have sufficient historical data to provide a reasonable basis for an estimate of the expected term. The Company calculates expected term for employee awards that take into account the effects of employee&#x2019;s expected exercise and post-vesting employment termination behavior.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected volatility</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As Legacy Hyperfine was privately held from inception through the Closing and all option grants occurred prior to the Closing Date, there was no specific historical or implied volatility information available.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accordingly, the Company estimates the expected volatility on the historical stock volatility of a group of similar companies that are publicly traded over a period equivalent to the expected term of the stock-based awards. Point estimates of expected annual equity volatility of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dd5c1cb1-c433-4f93-9a70-e4970d128106" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">70</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4eb5a69c-d1aa-4372-8788-a550445b24d7" contextRef="C_2d523d48-3880-4f1d-9796-c510fd76bd9c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">60</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% for December 31, 2021 and 2020, respectively, were selected in the guideline companies&#x2019; historical range.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Exercise price</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The exercise price is taken directly from the grant notice issued to employees and nonemployees.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e3e5ffde-90c3-43ce-a2e4-a947dea13b9a" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The stock options granted to the Company's employees and nonemployees for the periods presented were as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.99%;"></td>
        <td style="width:1.586%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:14.192%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:1.586%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:14.192%;"></td>
        <td style="width:0.613%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock options granted to employee</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b4204495-5d7b-47c8-821d-b242bcd4f93c" contextRef="C_97ecd105-2e03-4bed-bb2d-15098fa42355" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,534,844</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4d3a1772-9d96-47c3-95bd-c0bb7b597cbe" contextRef="C_44f21ac9-708e-4b24-aef7-cd1a9620d836" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">897,240</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock options granted to nonemployee</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a38ca5f0-b3e7-4751-a24e-38797af005a7" contextRef="C_7b149139-c5d8-4447-a71e-c7ede770bd5e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,236,393</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c045a691-54a6-41e0-b4c7-0317ed88ce7b" contextRef="C_5e5c7322-5a27-4422-aed8-e69929560490" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">284,816</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total stock options granted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7188e414-dd7d-46a3-8fec-64dc7809073b" contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,771,237</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ddf9974b-4bd0-49d1-85a0-5de2faeb0c6b" contextRef="C_2d523d48-3880-4f1d-9796-c510fd76bd9c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,182,056</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Incentive Unit and Preferred Stock Award Activity</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Incentive unit grants typically vest over a</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5438108a-3953-45dc-ba0b-d7ce7c53c52e" contextRef="C_36b0658e-9bd7-419a-b34b-1d6173b955ca" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> four year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period provided the holder is an employee, director or consultant of the Company on the applicable vesting date. Upon termination of service, pursuant to the terms of the grant, the participant 1) immediately forfeits any unvested (but issued) incentive units and 2) the Company has the right, but not the obligation, to repurchase at the fair market value on the date of termination, any vested incentive units. The repurchase right is valid for </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_af9dfbd0-f133-4879-82e7-240bff2c6d4f" contextRef="C_36b0658e-9bd7-419a-b34b-1d6173b955ca" name="hypr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18 months</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> commencing with the date of service.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On April 2, 2021, 4Bionics executed a plan of liquidation and dissolution and its ownership in Liminal was distributed to its members and to the holders of incentive units. Immediately subsequent to the dissolution, all outstanding unvested incentive unit awards under 4Bionic&#x2019;s 2019 Equity Incentive Plan were replaced with preferred stock awards indexed to and settled in the preferred stock of the former 4Bionics subsidiaries Liminal, Detect, Inc. (f/k/a Homodeus Inc.), and Tesseract Health. The preferred stock awards are subject to service vesting conditions only. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_68de8a0b-8fa0-43b7-98c9-c5150ede1033" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:ShareBasedPaymentArrangementPlanModificationIncrementalValue" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> incremental value was provided to participants as a result of the modification of the awards as the modification date fair value of the incentive unit awards was equal to modification date fair value of the stock underlying the restricted stock awards. Moreover, the remaining vesting period before and after modification was unchanged. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_455413f1-aeea-4fc4-98d7-be01709cb8bb" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> incremental compensation expense was recognized as a result of the modification.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to the dissolution of 4Bionics, a portion of total 4Bionics stock-based compensation expense was allocated to Liminal based on the level of service provided by the relevant employees and nonemployees to Liminal over the term of the award. Subsequent to the dissolution of 4Bionics, the Company recognizes the stock-based compensation expense related to the replacement preferred stock awards and no allocation methodology is required. In connection with the Business Combination, all replacement preferred stock awards were accelerated to fully vest. The Company recognized stock-based compensation expense of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4853e6d6-d68a-4c3b-9572-5ede632452af" contextRef="C_00ed74b2-7850-4508-bc80-e83b416ee826" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">578</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0970c33e-56ff-4343-8b4f-11bfb3f3408b" contextRef="C_1db82a87-b4de-4246-b8c2-3df23f8b625f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> related to the incentive unit awards and replacement preferred stock awards during the years ended December 31, 2021 and December 31, 2020, respectively.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Stock Units</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2021, immediately following the Business Combination, the Company granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5486511e-ff91-4683-a1a0-b0cd9c05e66e" contextRef="C_952282ac-2ad8-4203-8f79-2b4a0432930d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">117,516</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> restricted stock units (&#x201c;RSUs&#x201d;) to members of the Company&#x2019;s Board of Directors. The RSUs vest over a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_52476bc7-2e0f-4090-ad2b-a47cb5724375" contextRef="C_952282ac-2ad8-4203-8f79-2b4a0432930d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period, contingent on the ongoing service of the Directors. The grant date fair value of the RSUs was measured using the fair value of the underlying Class A common stock, which was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d6d6649b-727a-4b84-a495-a25846008adf" contextRef="C_def64c3f-dcfb-4af6-bc2f-54f251b76af2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">9.19</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share on the grant date. The total grant date fair value of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b47b7217-6d8a-4eac-af8d-a546173063ab" contextRef="C_952282ac-2ad8-4203-8f79-2b4a0432930d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,080</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> will be recognized evenly over the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_09403632-cd74-4b06-9f5d-373a9d656e3f" contextRef="C_952282ac-2ad8-4203-8f79-2b4a0432930d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period as the service condition is satisfied.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Earn-Out Shares</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Subject to the achievement of certain milestones, certain employees are entitled to a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_525d9291-0541-4904-8ecc-12c9eac8ff63" contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">933,933</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Earn-Out Shares. These Earn-Out Shares fall within the scope of ASC 718, pursuant to which such Earn-Out Shares are equity classified and their grant date fair value will be recognized as compensation expense over the vesting period.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Earn-out valuation inputs</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilized a Monte Carlo Simulation pricing model for determining the estimated fair value for Earn-Out Shares. The fair value is based on the simulated price of the Company over the maturity date of the Earn-Out Shares. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a2189a5-0e73-4435-8707-a220664c45c5" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock" escape="true" continuedAt="F_2a2189a5-0e73-4435-8707-a220664c45c5_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The key assumptions used in the valuation were as follows:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_2a2189a5-0e73-4435-8707-a220664c45c5_1"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.473%;"></td>
        <td style="width:1.925%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:15.831%;"></td>
        <td style="width:2.157%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock Price</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9fae18af-e9cb-492e-a3fa-9df8efe070c2" contextRef="C_017a55aa-4d9f-4145-84bc-31cdf605a0fd" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">10.92</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Risk Free interest rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4d98162f-cb9c-4978-84f5-2c79bb96f9a4" contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.96</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b49b0d26-b79c-4b58-a41f-b13e437ec9fa" contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Term (years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_858aabac-2e03-4e13-a5c4-3f1075203267" contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_48937982-303f-421c-a5af-115fb2bc2c3f" contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">54.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risk free interest rate</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The risk free interest rate for periods within the expected term of the awards is based on the U.S. Treasury yield curve in effect at the time of the grant.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected dividend yield</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has never declared or paid any cash dividends and does not expect to pay any cash dividends in the foreseeable future.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected term</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For Earn-Out Shares, the expected term is determined to be </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9986bc79-f04c-4e1e-9b7a-1cb3f2c83b96" contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 </span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">years from the Closing as this is the period over which the market price milestone may be achieved. As there is no dependent vesting period, the shares are exercisable at the point that the market milestone is reached.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected volatility</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As Legacy Hyperfine was privately held from inception through the Closing, there was no specific historical or implied volatility information available.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accordingly, the Company estimates the expected volatility on the historical stock volatility of a group of similar companies that are publicly traded over a period equivalent to the expected term of the earn-out awards. A point estimate of expected annual equity volatility of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a47204c1-a63e-4df2-ac19-55a29f068085" contextRef="C_d6171afc-03fd-445e-ac62-3ae933435993" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">55</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% for December 31, 2021 was selected in the guideline companies&#x2019; historical range.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation Expense</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cfb6d36e-2c79-44e9-bc7d-d5e9720f0e08" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s stock-based compensation expense for the periods presented was as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.092%;"></td>
        <td style="width:1.586%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.464%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:1.586%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.464%;"></td>
        <td style="width:0.613%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cost of sales - Device</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_37c4d0bf-66d8-4608-90a4-9704e3ad83d7" contextRef="C_e027434a-4a2f-4bf7-b6ac-ecd878be99df" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cost of sales - Service</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d6279295-e587-485f-b80e-d7d0a38bb97c" contextRef="C_e06069a2-6817-48a5-94fd-de1580cc4fdc" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b069190a-0427-49a8-8cbb-e90f19d988b7" contextRef="C_bbc35c1e-828e-43bf-b1bb-089209526261" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,327</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f072027b-bda4-4014-92f9-09fd80f5c165" contextRef="C_297a1e64-a6f1-490a-8a0d-a68d408b9cba" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">864</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9b0051d2-03dc-41a5-9664-0c994f555875" contextRef="C_565f6ec5-b566-4aa1-8ca6-fbee686327c0" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,482</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1a68a4ef-3ccf-4ce0-ad46-6d65e57f2977" contextRef="C_f61cbd06-6f47-40f0-bf5b-f5c8aaa869bd" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">231</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0cfa2d3f-c35a-4d7f-af09-59938e76ad3f" contextRef="C_ccfbba15-73af-4c55-9b92-86db3883e6e4" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">68</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b74ee80f-4bb9-42f2-8e9b-fde7e2f912f3" contextRef="C_c4fe83e0-a6cc-4633-9e60-f7fc58c68e23" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_01a6d200-8083-4ddf-8fc5-923f8c7cb3c1" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,901</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e6393f81-4782-4fad-9468-3e77ccfd6031" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,117</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total unrecognized stock-based compensation expense as of December 31, 2021 was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_19b41fb8-4f91-4a58-a7c6-9c55a1c1d2cb" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,650</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which will be recognized over the remaining vesting period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_11dac282-7acc-43cf-ba22-882348c3c0c7" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.66</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> years.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_d3279713-2910-42ed-a979-445a7c0c95be" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">13. NET LOSS PER SHARE</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all common equivalent shares of the Company, including convertible preferred stock, outstanding stock options, RSUs and Earn-Out Shares, to the extent dilutive. Basic and diluted net loss per share was the same for each period presented as the inclusion of all common equivalent shares of the Company outstanding would have been anti-dilutive.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3bea8068-163b-4968-95a9-63214ecc6700" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table presents the calculation of basic and diluted net loss per share for the Company&#x2019;s common stock:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.503%;"></td>
        <td style="width:1.565%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.536%;"></td>
        <td style="width:0.857%;"></td>
        <td style="width:1.565%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.536%;"></td>
        <td style="width:0.857%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net Loss</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0dc4e4ff-341f-40fa-b006-bfef66614f6c" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">64,851</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f54e5eeb-e1f4-47a6-8810-092a1486ef1b" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">23,427</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Numerator for Basic and Dilutive EPS &#x2013; Loss available to common<br />stockholders</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a87b5af1-b68d-4d44-8f3a-1a5726cdafa1" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">64,851</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cd866fdc-0bac-4705-939d-dba0425fea0e" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">23,427</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Denominator:</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Common Stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b8031f59-6112-4f57-a996-e6a128d0dfd2" contextRef="C_391814da-f713-4ae8-a4bf-709c59085048" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,690,523</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fa1c948f-344d-4da5-9df1-d7f41db5d8d6" contextRef="C_6a857b9a-6bad-404d-9dcd-a5265f3492cb" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,523,096</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Denominator for Basic and Dilutive EPS - Weighted-average common stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_29b721ed-a9d8-4e52-9551-a7b398080f86" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,690,523</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ddc4dd9d-85d2-458b-a100-5ba32b44d3e0" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,523,096</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Basic and dilutive loss per share</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e8127d83-0cbe-4b5a-bf69-5beee6ee7fc9" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">17.57</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e71ba7d9-a9d5-4c55-97e9-e4403e900f53" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">15.38</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since the Company was in a net loss position for all periods presented, the basic loss per share calculation excludes preferred stock as it does not participate in net losses of the Company. Additionally, net loss per share attributable to Class A and Class B common stockholders was the same on a basic and diluted basis, as the inclusion of all common equivalent shares outstanding would have been anti-dilutive. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9926c6aa-c3ca-4c52-8524-2cd0c304d68d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true" continuedAt="F_9926c6aa-c3ca-4c52-8524-2cd0c304d68d_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Anti-dilutive common equivalent shares were as follows:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_9926c6aa-c3ca-4c52-8524-2cd0c304d68d_1"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.824%;"></td>
        <td style="width:1.586%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:14.275%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:1.586%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:14.275%;"></td>
        <td style="width:0.613%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding options to purchase common stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8e99ad58-0449-47e8-80d9-7d5053759bb0" contextRef="C_8947e16c-53a9-404b-b4aa-6eea41055362" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,522,136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a7b79b26-eb38-4b89-bae8-4547709dcbbf" contextRef="C_6def0aef-40a2-42c1-9b66-b534c9b3b53f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,903,479</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding Legacy Hyperfine convertible preferred stock (Series A through D)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_97726580-3ae0-4017-8910-dbdcbdd3e110" contextRef="C_93ccae92-7e08-46e4-9661-cf630796ab3f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">31,116,056</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding RSUs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f83e4959-fc1c-4c93-b765-89c31555ba3c" contextRef="C_7c17d825-000e-4c3d-a83a-3be01c1f2e4e" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">117,516</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Earn-Out Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5136d43f-e469-450d-af4d-0011f4c62529" contextRef="C_b6b6072c-15e7-4e45-9a9f-aea0353e0e42" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total anti-dilutive common equivalent shares</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ff7a80d2-d7d7-42d6-acba-4b46034ab070" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">17,639,652</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0209640f-f6d3-4c24-a744-4b2d6fe41c0e" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">33,019,535</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:nonNumeric></div>
  <p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div><ix:nonNumeric id="F_035f1e24-7f32-4444-9267-881edd19c9ed" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">14. INCOME TAXES</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6a5cba9b-9951-4aea-8cd5-9b3fc2879f55" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant components of the Company's deferred tax assets (liabilities) are as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.782%;"></td>
        <td style="width:1.576%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.387%;"></td>
        <td style="width:0.857%;"></td>
        <td style="width:1.576%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.387%;"></td>
        <td style="width:0.857%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Gross deferred tax assets (liabilities):</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e3eb143b-98aa-44b1-a956-3ae7a52e7065" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2d2cb06b-01f5-44ee-be05-ce53f3ee647d" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,512</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax credit carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3e0eeaaa-c08b-4e07-988d-c9905c517ca1" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,429</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7515bff7-3fbd-4b7a-9eff-8da811bb30ad" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,238</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Fixed assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e11a239b-f94d-42a5-8bf3-8d77701cfccc" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">117</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_86c9d782-1dce-44c9-b55b-b44ac9627d65" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b0ec6894-2d18-4db3-8523-3130d7888217" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,634</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_569b96b2-8217-4896-a249-84f1ba11e94a" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">522</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0ad04eb2-f28c-46e1-b202-63c564684af4" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DeferredTaxAssetsDeferredIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">949</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2553f80a-5266-4a47-8831-8f462cf829c0" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:DeferredTaxAssetsDeferredIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">421</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accrued bonuses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5a8f2e6e-5c4a-415f-b9b4-2dc95cce0dc5" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">857</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ebc0719c-2881-4ef8-886b-4bd4daafd997" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">84</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_975f1754-05e9-429b-9e6d-cbe542c0712c" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">90</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_da3602e0-fc7a-4b34-8e0c-b0b1f99de979" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_41e4ef1b-83fd-4649-96bf-c790c8fdbe63" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,788</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_756cb822-d8ec-4408-8032-20fe8773fc69" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_43350a1b-6ea6-40f1-a1a6-ed0374474ddc" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,788</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Net deferred tax assets (liabilities)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_90819e2a-0d99-4cc8-b6ae-156271d16ea3" contextRef="C_f684ca2d-8a75-4e94-959f-b7de192cf33e" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_360f9b1a-dad9-44b4-9a52-fe88a8a8cf43" contextRef="C_46f6a47d-e180-42ed-8d1e-464d0ec632b1" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> income tax expense due to federal and state net operating losses incurred for the years ended December 31, 2021 and 2020. The Company has also not recorded any income tax benefits for its federal and state net operating losses incurred in each period due to uncertainty of realizing the benefit from those items. All of the Company&#x2019;s losses before income taxes were generated in the United States. The effective tax rate for the Company for the years ended December 31, 2021 and 2020 was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7a2c2221-aea2-4346-b515-48005f52844c" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_d1e6cba5-9534-4f73-b809-e3c17ee66b6d" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> percent. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8e17f06c-fabf-4aa8-a469-bd779585da3f" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true" continuedAt="F_8e17f06c-fabf-4aa8-a469-bd779585da3f_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A reconciliation of the income tax expense at the federal statutory tax rate to the Company&#x2019;s effective income tax rate follows:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_8e17f06c-fabf-4aa8-a469-bd779585da3f_1"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.373%;"></td>
        <td style="width:1.576%;"></td>
        <td style="width:0.603%;"></td>
        <td style="width:12.089%;"></td>
        <td style="width:2.983%;"></td>
        <td style="width:1.576%;"></td>
        <td style="width:0.603%;"></td>
        <td style="width:12.216%;"></td>
        <td style="width:2.983%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Statutory tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3784982b-8322-40f6-9b64-405a8d51be1a" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_237da103-0307-4840-a95c-d3ebb6bceb26" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">State taxes, net of federal benefit</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0324d6d8-1aa4-4923-acdb-0e56c6a8ab82" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cc45ee63-6ed2-430d-b1bb-1424c5165076" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal research and development credit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e33c3e2e-ec6e-4ad8-8b1c-f141fb7e9bd4" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_60d634d5-90c3-4944-8540-50a0648f3aa0" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">3.2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb295dcf-3cca-4912-ab64-6d90cebafb6c" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ae1c91b-ce0a-41ee-9215-c600858c39bb" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Write down of federal NOL due to 382 limitation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_42104ee0-2111-4d8b-a953-0f07bea6fbb7" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="hypr:Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">2.8</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Write down of federal R&amp;D credits due to 382 limitation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_62babf43-d70a-4eef-a065-7bb5e7e32e50" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="hypr:Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred tax adjustment resulting from tax rate change</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5e76739f-8bd8-4d6f-b2b3-6b29b5b66caa" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a5cc70ad-1c69-4f38-8f4d-b9cce077989f" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">5.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_830a3fd3-f354-4d52-909f-bd0dcdbe5a0d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f5e6e17f-7062-44ca-8a1e-f345e2e67ad7" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_543885e5-13ba-46ea-89c9-060e852e27ae" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">28.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0b14316c-1330-483c-859f-ed3ad07a8a1e" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">15.9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Effective tax rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_736031f2-61c6-49f9-aade-7eac5b410352" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ecbea565-ac56-4f4b-94a6-4ace1b0b2a90" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s effective tax rate for December 31, 2021 and 2020 differs from the federal statutory tax rate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9fcf0ba8-e319-471b-8ca1-d7063a6d76f5" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_79cafc53-6b29-45ed-b227-cf90732ace0b" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">21</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% mainly due to the effect of deferred state income tax benefits resulting from state net operating loss carryforwards and the tax benefits related to research and development tax credits. These benefits to the effective tax rate are fully offset by the increase in the Company&#x2019;s valuation allowance from the prior year.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has established a full valuation allowance against its net deferred tax assets due to the uncertainty of the Company&#x2019;s ability to generate sufficient taxable income to realize the deferred tax assets, and therefore has not recognized any benefits from the net operating losses, tax credits and other deferred tax assets. The Company&#x2019;s valuation allowance increased $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a59a59d4-ca94-4dc9-9d16-407a50270a11" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:DeferredTaxAssetsValuationAllowanceIncreased" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,348</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bfe6fbb5-201a-43ef-aa57-4bc23cc1140f" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="hypr:DeferredTaxAssetsValuationAllowanceIncreased" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,729</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the years ended December 31, 2021 and 2020, respectively.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d86f83dd-0060-4429-8832-791bbb1c6234" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, the Company had the following tax net operating loss carryforwards available to reduce future federal and Connecticut taxable income, and tax credit carryforwards available to offset future federal and Connecticut income taxes:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.159%;"></td>
        <td style="width:1.586%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.589%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:1.586%;"></td>
        <td style="width:15.176%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Hyperfine</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Begin to Expire in</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Hyperfine tax net operating loss carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (pre-2018 NOLs)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8411b12b-e4a5-42ec-b052-10b159d2a8f3" contextRef="C_6cfe4f83-75d3-42af-b919-f037bac001d8" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,084</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9d0871f1-0546-4986-9d31-09bfb361e046" contextRef="C_ab4a120e-032e-4174-ab0f-41881ca87629" name="hypr:OperatingLossCarryforwardsBeginToExpireYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2034</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (post-2017 NOLs)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dcf5e95f-6cc0-44fd-9e3d-b65e754efc46" contextRef="C_f7c260f7-942b-467a-a100-8891e93ffd0a" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">91,306</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">States</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5512a823-08cf-429c-ba19-2dde03f02ccd" contextRef="C_f04be01a-f1c8-4197-9e8c-a8e60e22ac2c" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">72,621</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2b0598a6-1dd4-47fa-897d-056829806536" contextRef="C_f544b39f-f467-43d9-bd6c-b63e721ee22c" name="hypr:OperatingLossCarryforwardsBeginToExpireYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2034</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax credit carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa4f9255-9df2-4c90-8a08-664de1f9ed3b" contextRef="C_1f1550e6-aea9-41b1-944e-48553f861650" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,338</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_56a96d00-4f75-452b-95c4-eb27f0df0a3e" contextRef="C_e01451b3-5582-4ac0-8725-58320e1c8896" name="hypr:TaxCreditCarryforwardBeginToExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2034</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Connecticut research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_67bb17e6-b6bc-4594-ad20-81d535a260c9" contextRef="C_018e05a7-18c4-47ac-8a4f-82f9d45da649" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">752</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Connecticut others</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_442f4c62-5c72-4af6-be08-35802e4fa1a2" contextRef="C_b5d108c6-9922-4ef6-a9f4-1b52927fa472" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2f76a512-5790-4087-8ec7-405c3e2ea16e" contextRef="C_dbe7ddab-0056-49e4-9a0e-48437f4d7b7e" name="hypr:TaxCreditCarryforwardBeginToExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2022</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal others</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7b866970-ea1c-4eaa-b7b5-a80ba12d22d4" contextRef="C_2deb5363-ab1f-4a7d-bf8d-b4b73bf8fc16" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">135</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a873ba48-26b3-478c-b37f-e583e9f62420" contextRef="C_80cfe749-acb3-416a-9bfa-17252d7bfb03" name="hypr:TaxCreditCarryforwardBeginToExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2022</span></ix:nonNumeric></span></p></td>
       </tr>
      </table><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.406%;"></td>
        <td style="width:1.513%;"></td>
        <td style="width:1.29%;"></td>
        <td style="width:13.539%;"></td>
        <td style="width:0.613%;"></td>
        <td style="width:1.513%;"></td>
        <td style="width:15.126%;"></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Liminal</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Begin to Expire in</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Liminal tax net operating loss carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (pre-2018 NOLs)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (post-2017 NOLs)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_46dc4c07-ebac-44f4-94a2-a931f41d9f40" contextRef="C_234b982a-29e0-45ff-b5c3-d5349882acd9" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,304</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">States</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5fd59cd2-c4e4-4592-b6ca-274c00a3e5f8" contextRef="C_cb1f65d2-d11d-4188-86cc-6490cfa8ec4f" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_11d31ec0-a6ee-4b70-90d9-1b323d44a061" contextRef="C_f96e34c7-c8df-43a2-b54b-74085b8e63c1" name="hypr:OperatingLossCarryforwardsBeginToExpireYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2038</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax credit carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5a739afe-ad91-4eba-bcd4-7712eacabb77" contextRef="C_2a19dcc8-c5cc-40ef-8059-d3bbd58d9d5b" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">449</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_47fa4459-e45d-4403-ac67-a1c70223369f" contextRef="C_c727f466-00a1-41e9-b455-84621ea4e2de" name="hypr:TaxCreditCarryforwardBeginToExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2038</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Connecticut research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9c53a6fe-496e-4fba-80e0-bfa81b075943" contextRef="C_2206b217-69b7-412b-a10f-a8ac64842af3" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under Internal Revenue Code Section 382, if a corporation undergoes an &#x201c;ownership change,&#x201d; the corporation&#x2019;s ability to use its pre-change net operating loss and tax credit carryforwards to offset its post-change income and tax liabilities may be limited. Generally, an </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cccfab3a-39e2-4b31-bac2-5806b0925250" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:OwnershipChangeDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ownership change occurs when certain shareholders increase their aggregated ownership by more than 50 percentage points over their lowest ownership percentage in a testing period (typically </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8e248e59-17a3-4391-8ae1-6ba3a893c802" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:OwnershipChangePercentageTestingPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">).</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company performed a Section 382 analysis for Legacy Hyperfine to determine whether an ownership change has occurred. Based on this analysis, Legacy Hyperfine experienced </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_228cfbbd-209f-49d8-8a60-8682ea9f69f1" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:NumberOfConsecutiveOwnershipChanges" unitRef="U_Ownership" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> consecutive ownership changes, one on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e22bf854-9362-4fb7-9290-4cfd0bc59813" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:OwnershipChangesDateOne" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 17, 2017</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and one on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_48813d37-3160-4f19-af79-125fb8f334ca" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:OwnershipChangesDateTwo" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">May 16, 2017</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As a result, Legacy Hyperfine&#x2019;s net operating loss and tax credit carryforwards as of December 31, 2020 are subject to a Section 382 limitation. The January 17, 2017 ownership change resulted in an annual limitation of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8bdf457f-e2ae-44d7-a7b1-8984006f5386" contextRef="C_fa4c4e98-cf41-4a9f-86eb-de3be3b950dd" name="hypr:NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">865</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and the May 16, 2017 ownership change resulted in an annual limitation of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_688714be-c59c-4ad2-a34a-46da78058115" contextRef="C_821ac2f9-b484-46bf-bf7f-00231566dd23" name="hypr:NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,008</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The first (earlier) limitation will limit the deduction of pre-change losses and credits arising before the first ownership change. The second (later) ownership change creates another limit to deduction of those pre-change losses and credits. However, the second ownership change does not allow for a &#x201c;step-up&#x201d; of the first limitation and therefore the pre-January 17, 2017 losses and credits are still subject to the first limitation amount. Due to these limitations, the Company estimates that $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f95f520d-c9f8-46ac-91a4-fdad7affc33c" contextRef="C_309c8fe7-b2ee-4206-93c1-c4ef1763fe17" name="hypr:NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,125</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_39f7908c-0d0b-401b-aa9c-dc653cc88f5b" contextRef="C_39d87f95-6e1f-4dc1-b752-0e7cc15f6e53" name="hypr:NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">249</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the federal net operating loss and research and development credit carryforwards, respectively, will expire before utilization. Accordingly, Legacy Hyperfine&#x2019;s gross deferred tax assets and corresponding valuation allowance have been adjusted to reflect the estimated expirations. In addition, as a result of the Business Combination and any other equity issuances during the year, the Company is currently updating its Section 382 analysis to determine whether any additional ownership changes have occurred through December 31, 2021. This analysis is expected to be completed in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_45adaf83-fea8-44dc-baa1-dfe49c7b636b" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:OwnershipChangesAnalysisExpectedToBeCompletedYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has adopted the accounting guidance within ASC Topic 740 on uncertainties in income taxes. ASC Topic 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, the Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0741c10e-c9f2-4c65-b271-740806cc0012" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_46091089-f9d8-4579-98fe-2a3160217a1c" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have any unrecognized tax benefits. To the extent penalties and interest would be assessed on any underpayment of income tax, the Company&#x2019;s policy is that such amounts would be accrued and classified as a component of income tax expense in the combined and consolidated financial statements. To date, the Company has not recorded any such interest or penalties.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company files income tax returns in the U.S. federal and various state jurisdictions. As a result of the Company&#x2019;s net operating loss carryforwards, the Company&#x2019;s federal and state statutes of limitations generally remain open for all</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">tax years until its net operating loss and tax credit carryforwards are utilized or expire prior to utilization. The Company does not currently have any federal or state income tax examinations in progress.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted which included provisions related to net operating loss carryovers and carrybacks, refundable payroll tax credits, deferral of payroll taxes, alternative minimum tax credit refunds, modifications to the net interest deduction limitations, and technical corrections to tax depreciation methods for qualified improvement property. The Company has evaluated the relevant provisions of the CARES Act and has not recognized any benefit related to these provisions. Therefore, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_43147c91-243b-4c6b-a016-269fbbc2801d" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:IncomeTaxEffectsRecognized" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_27c34fb2-f7f8-46fc-bcfe-33181623daa9" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="hypr:IncomeTaxEffectsRecognized" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> related income tax effects have been recognized in the financial statements for the years ended December 31, 2021 and 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, as a result of legislation in the state of Connecticut, companies have the opportunity to exchange certain research and development tax credit carryforwards for a cash payment of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_21bff87f-965b-48d8-a8aa-a02cf68545e6" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">65</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the research and development tax credit. The research and development expenses that qualify for Connecticut credits are limited to those costs incurred within Connecticut. The Company has elected to participate in the exchange program and, as a result, has recognized net benefits of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_043bcfe7-d83f-4842-bfd7-92ef4d0a5fbf" contextRef="C_bbc35c1e-828e-43bf-b1bb-089209526261" name="hypr:ExchangeProgramRecognizedNetBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">103</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6b0925e9-226f-4562-8e70-6a1da5e8c5b6" contextRef="C_297a1e64-a6f1-490a-8a0d-a68d408b9cba" name="hypr:ExchangeProgramRecognizedNetBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">131</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the years ended December 31, 2021 and 2020, respectively, which is included in research and development expenses in the accompanying statements of operations and comprehensive loss. As of December 31, 2021 and 2020, the Company has recorded $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f18d4ae-c6cc-47ad-8aee-67220f5329d5" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">196</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a07f23b9-f29c-4ac4-9349-5d726cf59e5f" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">467</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the research and development tax credit receivables in Prepaid expenses and other current assets on the Company&#x2019;s combined and consolidated balance sheets, respectively.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">      </span>&#160;</p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_72e6e690-d657-42a2-a36f-f7d3c423e9b2" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true" continuedAt="F_72e6e690-d657-42a2-a36f-f7d3c423e9b2_1"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">15. RELATED PARTY TRANSACTIONS</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilizes and subleases office and lab space in Connecticut which is being leased from an unrelated landlord by 4Catalyzer Corporation, (&#x201c;4C&#x201d;), which is owned by a related party. The Company pays rent to 4C on a month-to-month basis, and no lease agreement was entered into between the parties until June 2021. A total of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_359147cf-2173-41a3-bbad-fea0d1ba5de1" contextRef="C_130e4222-f593-4c10-abb6-2bba9719b0a2" name="hypr:RelatedPartyTransactionPaymentsForRent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">149</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d8ff6516-ef99-4fe4-abea-4393026e36ae" contextRef="C_a7be29aa-140e-44cb-a9f4-ff103f126abe" name="hypr:RelatedPartyTransactionPaymentsForRent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">113</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was paid during 2021 and 2020, respectively.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to 4Bionics executing a plan of liquidation and dissolution on April 2, 2021, certain expenses incurred at 4Bionics were allocated to its subsidiaries, including Liminal. Expenses that broadly benefited 4Bionics and its subsidiaries were allocated evenly amongst its </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6106f4c6-7d6e-4fe4-856d-641ee18c825b" contextRef="C_f655045d-1b98-47a5-91ea-b2ff21c11594" name="hypr:NumberOfSubsidiaries" unitRef="U_Subsidiary" decimals="INF" format="ixt-sec:numwordsen">three</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> subsidiaries. Expenses that were incurred on behalf of the employees of each company were allocated based on each subsidiary&#x2019;s relative headcount. Total proceeds allocated to Liminal upon liquidation and dissolution in 2021 were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b0ccd3ec-9bf3-48e8-aeba-93b2a6b5bf90" contextRef="C_a7d85790-8273-4800-91ae-17cbe035c271" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">101</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and total expenses allocated to Liminal in 2020 were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_86d361da-4eb6-4c5a-9c41-79698392b412" contextRef="C_c6b2444b-b0c0-4bbf-809e-048942ba73c6" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The method used to allocate common expenses of 4Bionics to Liminal is reasonable.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In January 2018, the Company entered into a Promissory Note (the &#x201c;Note&#x201d;) with one of its employees (the &#x201c;Borrower&#x201d;) in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8ddf6286-0cef-4f51-8259-ecb543253a9c" contextRef="C_224ae57f-8193-4d6a-adfd-42c3a9ce9f1a" name="us-gaap:DueFromEmployeesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">90</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Note bears interest at a rate equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4bd7ee1d-97c9-4339-8f82-c8ce42d48f1d" contextRef="C_ecb93ba3-ee1e-4bc3-bfc2-c730d729e8b2" name="us-gaap:RelatedPartyTransactionRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.68</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% per annum. In accordance with the terms of the Note, since the Borrower remained employed with the Company on the maturity date of January 11, 2022, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_94964f42-70b2-47c7-a5ae-84395c53ebbb" contextRef="C_65a01c03-68fd-4859-bbe0-614b1a291979" name="hypr:DueFromEmployeesForgiveness" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">90</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the then outstanding principal amount and all interest accrued to that date was forgiven and Borrower is no longer required to repay the amount. Interest on the Note was payable annually in cash on the anniversary date of the Note, and as of December 31, 2021 and 2020, interest receivable in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_55fc1f9d-50ca-4437-af03-d957b05c9d79" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:InterestReceivableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_26f2c999-c486-406e-97ef-164c2c294c56" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="hypr:InterestReceivableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, are included in Prepaid expenses and other current expenses on the combined and consolidated balance sheets, and interest income of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c4f522f4-6dec-4c96-b931-3aa68c847128" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:InterestIncomeRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6528b819-232e-4e1d-aa0f-94771efebc48" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="us-gaap:InterestIncomeRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, were recognized as of December 31, 2021 and 2020.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company also made payments to 4C to prefund the acquisition of capital assets and these amounts are included in Other assets&#x2009;&#x2014;&#x2009;related party on the combined and consolidated balance sheets. Such prepaid advances were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0cbad092-20c8-4083-bac9-94991b95ca7b" contextRef="C_348458fb-d208-4443-8d7d-e3f7edf293b2" name="hypr:OtherAssetsRelatedPartyNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_83cbdbe5-571e-40d2-95d6-1967da8e7e07" contextRef="C_05b3c083-6683-4f86-ae50-8fd835965199" name="hypr:OtherAssetsRelatedPartyNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,154</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as of December 31, 2021 and 2020, respectively. During 2021, the Company wrote off $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_206bd6e8-36a1-4db8-951c-ed2626b886ac" contextRef="C_130e4222-f593-4c10-abb6-2bba9719b0a2" name="hypr:PrepaidAdvancesUnrecoverable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">983</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of such prepaid advances considered to be unrecoverable.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Company was a party to an Amended and Restated Technology Services Agreement (the &#x201c;ARTSA&#x201d;), most recently amended on November 11, 2020, by and among 4C, the Company and other participant companies controlled by the Rothberg family. Under the ARTSA, the Company and the other participant companies agreed to share certain non-core technologies, which means any technologies, information or equipment owned or otherwise controlled by the participant company that are not specifically related to the core business area of the participant and subject to certain restrictions on use. The ARTSA also provided for 4C to perform certain services for the Company and each other</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">participant </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">company such as monthly administrative, management and technical consulting services to the Company which are pre-funded approximately once a quarter. The Company incurred expenses from 4C of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_907d6a8a-e25d-45c9-8a7f-7eb301975d5b" contextRef="C_130e4222-f593-4c10-abb6-2bba9719b0a2" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,055</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_705dab99-884b-4bd4-9747-28de4efbd043" contextRef="C_a7be29aa-140e-44cb-a9f4-ff103f126abe" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,160</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> during the years ended December 31, 2021 and 2020 respectively. The amounts advanced and due from 4C at December 31, 2021 and 2020, related to operating expenses was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d82a8c37-162a-44e8-851f-d103de74c7fa" contextRef="C_348458fb-d208-4443-8d7d-e3f7edf293b2" name="us-gaap:DueFromRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b630e60f-ad35-41d9-8a04-b18f078523e4" contextRef="C_05b3c083-6683-4f86-ae50-8fd835965199" name="us-gaap:DueFromRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,496</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, and is included in Due from related parties on the combined and consolidated balance sheets. There was also $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3a2a45b2-4781-4714-a299-0f55d58757db" contextRef="C_348458fb-d208-4443-8d7d-e3f7edf293b2" name="us-gaap:AccountsPayableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,872</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aff33569-5567-4054-ad3a-66b478bf3bab" contextRef="C_05b3c083-6683-4f86-ae50-8fd835965199" name="us-gaap:AccountsPayableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of amounts due to 4C for expenses paid on their behalf. These payables are included in Due to related parties on the combined and consolidated balance sheets. On July 7, 2021, Legacy Hyperfine, Liminal and 4C entered into First Addendums to the ARTSA, pursuant to which Legacy Hyperfine and Liminal each terminated its participation under the ARTSA immediately prior to the Closing. Legacy Hyperfine and Liminal each entered into a Master Services Agreement (the &#x201c;Master Services Agreements&#x201d;) with 4C effective as of July 7, 2021 pursuant to which Legacy Hyperfine and Liminal may engage 4C to provide services such as general administration, facilities, information technology, financing, legal, human resources and other services, through future statements of work and under terms and conditions to be determined by the parties with respect to any services to be provided.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The ARTSA also provided for the participant companies to provide other services to each other. The Company also has transactions with other entities under common ownership, which include payments made to third parties on behalf of the Company. The amounts remaining payable at December 31, 2021 and 2020 are $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e98caa85-d553-4d41-8d2e-de6125af22c0" contextRef="C_0b3254eb-3e95-4520-9848-13187dd9cc8a" name="us-gaap:AccountsPayableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">110</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bb5e3c7d-6d7d-4d8a-82f0-8fe888875285" contextRef="C_92873d62-f54e-4814-829f-fd7332644094" name="us-gaap:AccountsPayableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">124</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, and are included in the Due to related parties on the combined and consolidated balance sheets. In addition, the Company has transactions with these other entities under common ownership which include payments made by the Company to third parties on behalf of the other entities and the amounts remaining receivable are in the aggregate $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fe56b454-90c9-4d92-a412-61437c294b07" contextRef="C_0b3254eb-3e95-4520-9848-13187dd9cc8a" name="us-gaap:AccountsReceivableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> at December 31, 2021 and the amounts remaining payable are in the aggregate $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f4afcf96-44bc-4fb3-8af0-de45a94b5bb3" contextRef="C_92873d62-f54e-4814-829f-fd7332644094" name="us-gaap:AccountsReceivableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> at December 31, 2020, and are reflected in the Due from related parties on the combined and consolidated balance sheets. All amounts are paid or received throughout the year within 30 days after the end of each month.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div>
  <p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span><ix:continuation id="F_72e6e690-d657-42a2-a36f-f7d3c423e9b2_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine and Liminal entered into Technology and Services Exchange Agreements (each, a &#x201c;TSEA&#x201d; and collectively, the &#x201c;TSEA&#x201d;) with other participant companies controlled by the Rothbergs. A TSEA by and among Butterfly Network, Inc., AI Therapeutics, Inc., Quantum-Si Incorporated, 4Bionics, Tesseract Health, Inc., Detect, Inc. (f/k/a Homodeus Inc.), Legacy Hyperfine and Liminal was signed in November 2020; a TSEA by and among Quantum-Si Incorporated, AI Therapeutics, Inc., 4Bionics, Tesseract Health, Inc., Detect, Inc., Legacy Hyperfine and Liminal was signed in February 2021 (and which Protein Evolution, Inc. joined in August 2021); and a TSEA by and among Legacy Hyperfine, Liminal, AI Therapeutics, Inc., Tesseract Health, Inc. and Detect, Inc. was signed in July 2021 and is effective upon the Closing. Under the TSEA, Legacy Hyperfine, Liminal and other participant companies may, in their discretion, permit the use of non-core technologies, which include any technologies, information or equipment owned or otherwise controlled by the participant company that are not specifically related to the core business area of the participant, such as software, hardware, electronics, fabrication and supplier information, vendor lists and contractor lists, by other participant companies. As of December 31, 2021, the Company had transactions with other participant companies and had expenses of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5707510e-2b2c-446d-a36d-c7fa4b5a9c04" contextRef="C_73aeac21-ef41-47a9-b437-94807e5860aa" name="us-gaap:AccountsPayableRelatedPartiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> included in Accounts payable.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_21fcf19f-4028-4d04-a559-698036c127d8" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">16. COMMITMENTS AND CONTINGENCIES</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Commitments</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company sponsors a 401(k) defined contribution plan covering all eligible U.S. employees. Contributions to the 401(k) plan are discretionary. The Company did not make any matching contributions to the 401(k) plan for the years ended December 30, 2021 and 2020.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During 2020, the Company was awarded a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e73c1298-e3d5-4fab-8839-c5ffc93853eb" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="hypr:DeferredGrantFundingCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,610</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> grant from the BMGF for the provision and equipping of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_05236e8b-6248-40e6-9b82-947f8db427da" contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c" name="hypr:NumberOfSites" unitRef="U_Site" decimals="INF" format="ixt:numdotdecimal">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> sites with the Hyperfine portable point-of-care MRI system to enable the performance of a multi-site study focused on optimizing diagnostic image quality (the &#x201c;Project&#x201d;). During 2021, the Company was awarded an additional $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0ae6dfd8-785e-4623-9d85-96ad6af43cdd" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:GrantAwarded" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,300</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> grant from the BMGF, of which $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_678b9b1c-c56b-4789-b5f1-addc604593a9" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:GrantAwardedForProvisionAndEquipping" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,500</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was received for the provision and equipping of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_31481bf8-af56-4313-bd42-19392fe15065" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="hypr:NumberOfSites" unitRef="U_Site" decimals="INF" format="ixt:numdotdecimal">5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> sites and other related deliverables, of which the remaining $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_80971253-6223-4a8d-ba37-3918fbcd5514" contextRef="C_ed6f3ccf-47d7-4f6b-a138-e38661edb807" name="hypr:GrantAwardedForOtherRelatedDeliverables" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">800</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> is to be received by April 2022. The funds are accounted for as restricted cash with an offset to deferred grant revenue. At December 31, 2021 and 2020, the Company has $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1da8e916-0179-4f78-a6a2-569165f4ea50" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:DeferredGrantFundingCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,662</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_11ddd692-333f-46f7-a9a8-cd966d5651ea" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="hypr:DeferredGrantFundingCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,610</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">respectively, on the combined and consolidated balance sheets. Any grant funds, plus any income, that have not been used for, or committed to, the Project must be returned promptly to the BMGF upon expiration of or termination of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">HYPERFINE, INC. AND SUBSIDIARIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">NOTES TO THE COMBINED AND CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">(all amounts are in thousands, except share and per share data)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">agreement. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_abf79c46-1e0b-4995-98bc-941e36e80eba" contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d" name="hypr:GrantFundRequiredToReturnUnderProvisions" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_d77fbcee-6c3c-4ad4-804e-12e6f9ac6700" contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd" name="hypr:GrantFundRequiredToReturnUnderProvisions" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> grant fund amounts that were required to be returned under the provisions of the Project.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Contingencies</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company does not have any outstanding or ongoing litigation and legal matters where, based on present information, including its assessment of the merits of the particular claims, the Company believes it is reasonably possible that any asserted or unasserted legal claims or proceedings, individually or in aggregate, will have a material adverse effect on its results of operations or financial condition. The ultimate outcome of any legal matter cannot be predicted with certainty.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has indemnification obligations under some agreements that the Company enters into with other parties in the ordinary course of business, including business partners, investors, contractors, and the Company&#x2019;s officers, directors and certain employees. The Company has agreed to indemnify and defend the indemnified party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claim because of the Company&#x2019;s activities or non-compliance with certain representations and warranties made by the Company. It is not possible to determine the maximum potential loss under these indemnification provisions due to the Company&#x2019;s limited history of prior indemnification claims and the unique facts and circumstances involved in any particular case. To date, losses recorded in the combined and consolidated statements of operations and comprehensive loss in connection with the indemnification provisions have not been material.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company agreed to pay $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2d36052f-c854-4499-b233-1879695eb8a5" contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> to a third party service provider upon the receipt by the Companies&#x2019; pre-closing equity holders of any Earn-Out Shares (see Note 3. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">). The Company determined the probability of such payment to be not probable thus no liability was recognized.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>hypr-ex4_2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<html>
 <head>
  <title>EX-4.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 4.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">DESCRIPTION OF THE REGISTRANT&#x2019;S SECURITIES</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The following summary of the material terms of the capital stock of Hyperfine, Inc. (formerly HealthCor Catalio Acquisition Corp.) is not intended to be a complete summary of the rights and preferences of such securities, and is qualified by reference to our Certificate of Incorporation, as amended (the &#x201c;Charter&#x201d;), and our Bylaws, as amended (the &#x201c;Bylaws&#x201d;), each of which are incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit is a part, and certain provisions of Delaware law. We urge you to read each of our Charter and our Bylaws in their entirety for a complete description of the rights and preferences of our securities. Unless the context requires otherwise, all references to &#x201c;we&#x201d;, &#x201c;us,&#x201d; &#x201c;our,&#x201d; the &#x201c;Company&#x201d; and &#x201c;Hyperfine&#x201d; in this section refer solely to Hyperfine, Inc. (formerly HealthCor Catalio Acquisition Corp.) and not to our subsidiaries.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Authorized Capital Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are authorized to 628,000,000 shares, consisting of 600,000,000 shares of Class A common stock, par value $0.0001 per share, 27,000,000 shares of Class B common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Common Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Class A Common Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting Rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Holders of Class A common stock are entitled to cast one vote per share. Generally, holders of all classes of common stock vote together as a single class, and an action is approved by stockholders if a majority of votes cast affirmatively or negatively on the action are cast in favor of the action, while directors are elected by a plurality of the votes cast. Holders of Class A common stock are not entitled to cumulate their votes in the election of directors.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividend Rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">With limited exceptions in the case of certain stock dividends or disparate dividends approved by the affirmative vote of the holders of a majority of the Class A common stock and Class B common stock, each voting separately as a class, holders of Class A common stock will share ratably (based on the number of shares of Class A common stock held), together with each holder of Class B common stock, if and when any dividend is declared by our board of directors out of funds legally available therefor, subject to restrictions, whether statutory or contractual (including with respect to any outstanding indebtedness), on the declaration and payment of dividends and to any restrictions on the payment of dividends imposed by the terms of any outstanding preferred stock or any class or series of stock having a preference over, or the right to participate with, the Class A common stock with respect to the payment of dividends.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidation, Dissolution and Winding Up</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On the liquidation, dissolution, distribution of assets or winding up of Hyperfine, each holder of Class A common stock, together with each holder of Class B common stock, will be entitled, pro rata on a per share basis, to all assets of Hyperfine of whatever kind available for distribution to the holders of common stock, subject to the designations, preferences, limitations, restrictions and relative rights of any other class or series of preferred stock of Hyperfine then outstanding and unless disparate or different treatment of the shares of Class A common stock and Class B common stock is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A common stock and Class B common stock, each voting separately as a class.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Matters</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Holders of shares of Class A common stock do not have subscription, redemption or conversion rights. All of the outstanding shares of Class A common stock are validly issued, fully paid and non-assessable.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Class B Common Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting Rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Holders of Class B common stock are entitled to cast 20 votes per share of Class B common stock. Generally, holders of all classes of our common stock vote together as a single class, and an action is approved by our stockholders if a majority</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of votes cast affirmatively or negatively on the action are cast in favor of the action, while directors are elected by a plurality of the votes cast. Holders of Class B common stock will not be entitled to cumulate their votes in the election of directors.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividend Rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">With limited exceptions in the case of certain stock dividends or disparate dividends approved by the affirmative vote of the holders of a majority of the Class A common stock and Class B common stock, each voting separately as a class, holders of Class B common stock will share ratably (based on the number of shares of Class B common stock held), together with each holder of Class A common stock, if and when any dividend is declared by our board of directors out of funds legally available therefor, subject to restrictions, whether statutory or contractual (including with respect to any outstanding indebtedness), on the declaration and payment of dividends and to any restrictions on the payment of dividends imposed by the terms of any outstanding preferred stock or any class or series of stock having a preference over, or the right to participate with, the Class B common stock with respect to the payment of dividends.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Optional Conversion</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Holders of Class B common stock have the right to convert shares of their Class B common stock into fully paid and non-assessable shares of Class A common stock, on a one-to-one basis, at the option of the holder at any time upon written notice to us.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Mandatory Conversion</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Holders of Class B common stock can have their shares of Class B common stock automatically converted into shares of Class A common stock, on a one-to-one basis, upon the occurrence of any of the events described below:</font></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any sale, assignment, transfer, conveyance, hypothecation, or other transfer or disposition, directly or indirectly, of any shares of Class B common stock or any legal or beneficial interest in such shares, whether or not for value and whether voluntary or involuntary or by operation of law (including by merger, consolidation, or otherwise), including, without limitation the transfer of shares of Class B common stock to a broker or other nominee or the transfer of, or entering into a binding agreement with respect to, voting control over such shares by proxy or otherwise, other than a permitted transfer.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon the first date on which Dr. Rothberg, together with all other qualified stockholders, collectively cease to beneficially own at least 20% of the number of Class B common stock (as such number of shares is equitably adjusted in respect of any reclassification, stock dividend, subdivision, combination, or recapitalization of the Class B common stock) collectively beneficially owned by Dr. Rothberg and permitted transferees of Class B common stock as of the Closing.</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(3)</font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon the date specified by the affirmative vote of the holders of at least two-thirds (2/3) of the outstanding shares of Class B common stock, voting as a separate class.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidation Rights, Dissolution and Winding Up</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On the liquidation, dissolution, distribution of assets or winding up of Hyperfine, each holder of Class B common stock, together with each holder of Class A common stock, will be entitled, pro rata on a per share basis, to all assets of Hyperfine of whatever kind available for distribution to the holders of common stock, subject to the designations, preferences, limitations, restrictions and relative rights of any other class or series of preferred stock of Hyperfine then outstanding and unless disparate or different treatment of the shares of Class A common stock and Class B common stock is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A common stock and Class B common stock, each voting separately as a class.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Preferred Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Charter provides that our board of directors has the authority, without action by the stockholders, to designate and issue shares of preferred stock in one or more classes or series, and the number of shares constituting any such class or series, and to fix the voting powers, designations, preferences, limitations, restrictions and relative rights of each class or series of preferred stock, including, without limitation, dividend rights, conversion rights, voting rights, redemption privileges and liquidation preferences. There were no shares of preferred stock outstanding as of December 31, 2021.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The purpose of authorizing our board of directors to issue preferred stock and determine the rights and preferences of any classes or series of preferred stock is to eliminate delays associated with a stockholder vote on specific issuances. The simplified issuance of preferred stock, while providing flexibility in connection with possible acquisitions, future financings and other corporate purposes, could have the effect of making it more difficult for a third party to acquire, or</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">could discourage a third party from seeking to acquire, a majority of our outstanding voting stock. Additionally, the issuance of preferred stock may adversely affect the holders of our common stock by restricting dividends on our common stock, diluting the voting power of our common stock or subordinating the dividend or liquidation rights of our common stock. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market price of our common stock.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2021, we completed the Business Combination contemplated by the Business Combination Agreement, pursuant to which Legacy Hyperfine survived the Hyperfine Merger as a wholly-owned subsidiary of HealthCor and Liminal survived the Liminal Merger as a wholly-owned subsidiary of HealthCor. In connection with the Mergers, HealthCor changed its name to Hyperfine, Inc., Legacy Hyperfine changed its name to &#x201c;Hyperfine Operations, Inc.&#x201d; and Liminal changed its name to &#x201c;Liminal Operations, Inc.&#x201d; Liminal subsequently changed its name to &#34;Liminal Sciences, Inc.&#34;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a consequence of the Mergers, at the Effective Time, (i) each share of Legacy Hyperfine capital stock (other than shares of Legacy Hyperfine Series A preferred stock) that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class A common stock equal to the Hyperfine Exchange Ratio, rounded down to the nearest whole number of shares; (ii) each share of Legacy Hyperfine Series A preferred stock that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class B common stock equal to the Hyperfine Exchange Ratio, rounded down to the nearest whole number of shares; (iii) each share of Liminal capital stock (other than shares of Liminal Series A-1 preferred stock) that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class A common stock equal to the Liminal Exchange Ratio, rounded down to the nearest whole number of shares; (iv) each share of Liminal Series A-1 preferred stock that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class B common stock equal to the Liminal Exchange Ratio, rounded down to the nearest whole number of shares; (v) each option to purchase shares of Legacy Hyperfine common stock and each option to purchase shares of Liminal common stock, whether vested or unvested, that was outstanding and unexercised as of immediately prior to the Effective Time was assumed by the Company and became an option (vested or unvested, as applicable) to purchase a number of shares of the Company&#x2019;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such option immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Effective Time divided by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded up to the nearest whole cent; and (vi) each Legacy Hyperfine restricted stock unit and each Liminal restricted stock unit outstanding immediately prior to the Effective Time was assumed by the Company and became a restricted stock unit with respect to a number of shares of the Company&#x2019;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such Legacy Hyperfine restricted stock unit or Liminal restricted stock unit immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole share.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exclusive Forum</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Charter provides that, to the fullest extent permitted by law, unless we otherwise consents in writing, the Court of Chancery (the &#x201c;Chancery Court&#x201d;) of the State of Delaware (or, in the event that the Chancery Court does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for (1) any derivative action or proceeding brought on behalf of Hyperfine, (2) any action asserting a claim of breach of a fiduciary duty owed by, or any other wrongdoing by, any current or former director, officer, other employee or stockholder of Hyperfine, (3) any action asserting a claim against us arising pursuant to any provision of the DGCL, our Charter or Bylaws, or as to which the DGCL confers jurisdiction on the Court of Chancery, (4) any action to interpret, apply, enforce or determine the validity of any provisions of our Charter or Bylaws, or (5) any other action asserting a claim governed by the internal affairs doctrine. Notwithstanding the foregoing, the federal district courts of the United States shall be the exclusive forum for the resolution of any action, suit or proceeding asserting a cause of action arising under the Securities Act and the provisions of our Charter described above will not apply to claims arising under the Exchange Act or other federal securities laws for which there is exclusive federal jurisdiction.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Anti-Takeover Effects of Provisions of our Charter, Bylaws and Applicable Law</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain provisions of our Charter, Bylaws, and laws of the State of Delaware, where we are incorporated, may discourage or make more difficult a takeover attempt that a stockholder might consider in his or her best interest. These provisions</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">may also adversely affect prevailing market prices for the Class A common stock and the Class B common stock. We believe that the benefits of increased protection give us the potential ability to negotiate with the proponent of an unsolicited proposal to acquire or restructure us and outweigh the disadvantage of discouraging those proposals because negotiation of the proposals could result in an improvement of their terms.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Authorized but Unissued Shares</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Delaware law does not require stockholder approval for any issuance of authorized shares. However, the listing requirements of Nasdaq, which apply so long as the Class A common stock remains listed on Nasdaq, require stockholder approval of certain issuances equal to or exceeding 20% of the then outstanding voting power or then outstanding number of shares of common stock. Additional shares that may be issued in the future may be issued for a variety of corporate purposes, including future public offerings, to raise additional capital, or to facilitate acquisitions. The existence of authorized but unissued and unreserved common stock and preferred stock could make more difficult or discourage an attempt to obtain control of Hyperfine by means of a proxy contest, tender offer, merger, or otherwise.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dual Class Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As described above, our Charter provides for a dual class common stock structure which provides Dr. Rothberg with the ability to control the outcome of matters requiring stockholder approval, even though he owns significantly less than a majority of the shares of our outstanding common stock, including the election of directors and significant corporate transactions, such as a merger or other sale of Hyperfine or its assets.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Blank Check Preferred Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Charter provides for 1,000,000 authorized shares of preferred stock. The existence of authorized but unissued shares of preferred stock may enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best interests of Hyperfine or our stockholders, our board of directors could cause shares of preferred stock to be issued without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our Charter grants our board of directors broad power to establish the rights and preferences of authorized and unissued shares of preferred stock. The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The issuance may also adversely affect the rights and powers, including voting rights, of the holders of shares of common stock and may have the effect of delaying, deterring or preventing a change in control of Hyperfine.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Number of Directors</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Charter and Bylaws provide that, subject to any rights of holders of preferred stock to elect additional directors under specified circumstances, the number of directors may be fixed from time to time solely pursuant to a resolution adopted by our board of directors; provided, however, that prior to the first date on which the issued and outstanding shares of Class B common stock represent less than 50% of the voting power of the then outstanding shares of our capital stock that would be entitled to vote for the election of directors at an annual meeting of stockholders, unless approved by the holders of a majority in voting power of the shares of our capital stock that would then be entitled to vote in the election of directors at an annual meeting or by written consent, the number of directors may not exceed nine (9).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Requirements for Advance Notification of Stockholder Meetings, Nominations and Proposals</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Bylaws establish advance notice procedures with respect to stockholder proposals and nomination of candidates for election as directors, other than nominations made by or at the direction of our board of directors or a committee of the board. In order to be &#x201c;properly brought&#x201d; before a meeting, a stockholder will have to comply with advance notice requirements and provide us with certain information. Generally, to be timely, a stockholder&#x2019;s notice must be delivered to, or mailed and received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary of the immediately preceding annual meeting of stockholders. Our Bylaws also specify requirements as to the form and content of a stockholder&#x2019;s notice. Our Bylaws allow the chairperson of the meeting at a meeting of the stockholders to determine whether a proposal to the meeting was properly brought and to adopt rules and regulations for the conduct of meetings, except to the extent inconsistent with such rules, regulations and procedures as adopted by our board of directors, which may have the effect of precluding the conduct of certain business at a meeting if the rules and regulations are not followed. These provisions may also defer, delay, or discourage a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#x2019;s own slate of directors or otherwise attempting to influence or obtain control of Hyperfine.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Limitations on Stockholder Action by Written Consent</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Charter provides that, subject to the terms of any series our preferred stock, any action required or permitted to be taken by our stockholders must be effected at an annual or special meeting of the stockholders and may not be effected by written consent in lieu of a meeting; </font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">provided, however</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, that prior to the first date on which the issued and outstanding shares of Class B common stock represent less than 50% of the voting power of the then outstanding shares of our capital stock that would then be entitled to vote for the election of directors, any action required or permitted to be taken at any annual or special meeting of our stockholders, may be taken by written consent if such written consent is signed by the holders of the outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote on such matter were present and voted.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Amendment of our Charter and Bylaws</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The DGCL provides generally that the affirmative vote of a majority of the outstanding shares entitled to vote thereon, voting together a single class, is required to amend a corporation&#x2019;s certificate of incorporation, unless the certificate of incorporation requires a greater percentage.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Charter provides that it may be amended by us in the manner provided therein or prescribed by statute. Our Charter provides that the affirmative vote of the holders of a majority of the voting power of the then-outstanding shares of our capital stock entitled to vote generally in the election of directors, voting together as a single class, will be required to amend or repeal any provision of our Charter, or adopt any provision of our Charter inconsistent therewith.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any of the Class B common stock shares are outstanding, in addition to any vote required by Delaware law, the affirmative vote of the holders of two-thirds (2/3) of the outstanding shares of Class B common stock, voting as a separate class, is required to amend our Charter (1) in a manner that changes any of the voting, conversion, dividend or liquidation provisions of the shares of Class B common stock, (2) to provide for each share of Class A common stock or any preferred stock to have more than one vote per share or any rights to a separate class vote of the holders of shares of Class A common stock other than as provided by our Charter or required by the DGCL, or (3) to otherwise adversely impact the rights, powers, preferences or privileges of the shares of Class B common stock in a manner that is disparate from the manner in which it affects the rights, powers, preferences or privileges of the shares of Class A common stock.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any shares of the Class A common stock shares are outstanding, we will not, without the prior affirmative vote of the holders of a majority of the outstanding shares of Class A common stock, voting as a separate class, in addition to any other vote required by applicable law or our Charter, directly or indirectly, whether by amendment, or through merger, recapitalization, consolidation or otherwise amend, alter, change, repeal or adopt any provision of our Charter (1) in a manner that is inconsistent with, or that otherwise alters or changes the powers, preferences, or special rights of the shares of Class A common stock so as to affect them adversely; or (2) to provide for each share of Class B common stock to have more than twenty (20) votes per share or any rights to a separate class vote of the holders of shares of Class B common stock other than as provided by our Charter or required by the DGCL.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Charter also provides that our board of directors will have the power to adopt, amend, alter, or repeal our Bylaws by the affirmative vote of a majority of the directors present at any regular or special meeting of our board of directors at which a quorum is present in any manner not inconsistent with the laws of the State of Delaware or our Charter. Our stockholders are prohibited from adopting, amending, altering, or repealing Bylaws, or to adopt any provision inconsistent with Bylaws, unless such action is approved, in addition to any other vote required by our Charter, (i) when the issued and outstanding shares of Class B common stock represents less than 50% of the voting power of the then outstanding shares of capital stock that would be entitled to vote for the election of directors, the affirmative vote of the holders of at least two-thirds of the voting power of the capital stock that would be entitled to vote in the election of directors or, prior to such time, (ii) the affirmative vote of the holders of a majority of the voting power of the shares of capital stock that would be entitled to vote in the election of directors.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Business Combinations</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under Section 203 of the DGCL, a corporation will not be permitted to engage in a business combination with any interested stockholder for a period of three years following the time that such interested stockholder became an interested stockholder, unless:</font></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">prior to such time the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;"></font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">transaction commenced, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</font></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.667%;">(3)</font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">at or subsequent to such time the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 662&#x2215;3% of the outstanding voting stock which is not owned by the interested stockholder.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Generally, a &#x201c;business combination&#x201d; includes a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder. Subject to certain exceptions, an &#x201c;interested stockholder&#x201d; is a person who, together with that person&#x2019;s affiliates and associates, owns, or within the previous three years owned, 15% or more of our outstanding voting stock. For purposes of this section only, &#x201c;voting stock&#x201d; has the meaning given to it in Section 203 of the DGCL.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since we have not opted out of Section 203 of the DGCL, it will apply to us. As a result, this provision will make it more difficult for a person who would be an &#x201c;interested stockholder&#x201d; to effect various business combinations with us for a three-year period. This provision may encourage companies interested in acquiring us to negotiate in advance with our board of directors because the stockholder approval requirement would be avoided if our board of directors approves either the business combination or the transaction which results in the stockholder becoming an interested stockholder. These provisions also may have the effect of preventing changes in our board of directors and may make it more difficult to accomplish transactions, which stockholders may otherwise deem to be in their best interests.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cumulative Voting</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under Delaware law, the right to vote cumulatively does not exist unless the charter specifically authorizes cumulative voting. Our Charter does not authorize cumulative voting.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Limitations on Liability and Indemnification of Officers and Directors</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The DGCL authorizes corporations to limit or eliminate the personal liability of directors of corporations and their stockholders for monetary damages for breaches of directors&#x2019; fiduciary duties, subject to certain exceptions. Our Charter includes a provision that eliminates the personal liability of directors for damages for any breach of fiduciary duty as a director where, in civil proceedings, the person acted in good faith and in a manner that person reasonably believed to be in or not opposed to the best interests of Hyperfine or, in criminal proceedings, where the person had no reasonable cause to believe that his or her conduct was unlawful.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Charter provides that we may indemnify and advance expenses to our directors, officers, employees or agents to the fullest extent permitted by law. Our Bylaws provide that we shall indemnify and advance expenses to our directors and officers to the fullest extent authorized by the DGCL. We are also expressly authorized to carry directors&#x2019; and officers&#x2019; liability insurance providing indemnification for our directors, officers, and certain employees for some liabilities. We believe that these indemnification and advancement provisions and insurance are useful to attract and retain qualified directors and executive officers.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The limitation of liability, advancement and indemnification provisions in our Charter and Bylaws may discourage stockholders from bringing lawsuits against directors for any alleged breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit us and our stockholders. In addition, your investment may be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officer pursuant to these indemnification provisions.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There is currently no pending material litigation or proceeding involving any of our directors, officers, or employees for which indemnification is sought.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Corporate Opportunities</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Charter provides for the renouncement by us of any interest or expectancy of Hyperfine in, or being offered an opportunity to participate in any matter, transaction, or interest that is presented to, or acquired, created, or developed by, or which otherwise comes into possession of, any director of Hyperfine who is not an employee of Hyperfine or any of its subsidiaries, unless such matter, transaction, or interest is presented to, or acquired, created, or developed by, or otherwise comes into the possession of a director of Hyperfine expressly and solely in that director&#x2019;s capacity as a director of Hyperfine.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Dissenters&#x2019; Rights of Appraisal and Payment</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the DGCL, with certain exceptions, our stockholders will have appraisal rights in connection with a merger or consolidation of Hyperfine. Pursuant to the DGCL, stockholders who properly request and perfect appraisal rights in connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of Chancery.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Stockholders&#x2019; Derivative Actions</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the DGCL, any of our stockholders may bring an action in our name to procure a judgment in our favor, also known as a derivative action, provided that the stockholder bringing the action is a holder of our shares at the time of the transaction to which the action relates or such stockholder&#x2019;s stock thereafter devolved by operation of law.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Registration Rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to Subscription Agreements, the PIPE Investors purchased HealthCor Class A ordinary shares immediately prior to the closing of the Business Combination and the PIPE Investors are entitled to certain registration rights. Pursuant to the Letter Agreement, Hyperfine issued the Letter Agreement Shares to Jefferies LLC in lieu of deferred underwriting compensation relating to HealthCor&#x2019;s Initial Public Offering and Jefferies LLC is entitled to certain registration rights. In particular, under the Subscription Agreements and the Letter Agreement, Hyperfine agreed to, within 45 calendar days after the closing of the Business Combination, file with the SEC (at Hyperfine&#x2019;s sole cost and expense) a registration statement registering the resale of the shares of Class A common stock issued to the PIPE Investors and pursuant to the Letter Agreement, and to use its commercially reasonable efforts to have such registration statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) the 45th calendar day (or 60th calendar day if the SEC notifies Hyperfine that it will &#x201c;review&#x201d; such registration statement) following the closing of the Business Combination and (ii) the 10th business day after the date Hyperfine is notified (orally or in writing) by the SEC that such registration statement will not be &#x201c;reviewed&#x201d; or will not be subject to further review. The registration statement was filed on January 24, 2022 and declared effective by the SEC on February 1, 2022.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">At the Closing, Hyperfine, the Sponsor, certain affiliates of the Sponsor (the &#x201c;Sponsor Group Holders&#x201d;) and certain Legacy Hyperfine equityholders and Liminal equityholders (the &#x201c;Legacy Hyperfine Holders&#x201d;) entered into an amended and restated registration rights agreement (the &#x201c;Registration Rights Agreement&#x201d;), pursuant to which, among other things, the parties to the Registration Rights Agreement agreed not to effect any sale or distribution of any equity securities of Hyperfine held by any of them (except with respect to shares of Class A common stock acquired in open market transactions or pursuant to the PIPE Investment) during the lock-up period described therein and below and were granted certain registration rights with respect to their respective shares of our common stock, in each case, on the terms and subject to the conditions therein.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In particular, the Registration Rights Agreement provides for the following registration rights:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Registration rights</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.   Promptly, but in any event within 45 days following the Closing Date, Hyperfine is required to use its commercially reasonable efforts to file a registration statement under the Securities Act to permit the public resale of all registrable securities as permitted by Rule 415 of the Securities Act and to cause such registration statement to be declared effective as soon as practicable after the filing thereof, but in no event later than 45 days following the filing deadline (or 60 days following the filing deadline if the registration statement is reviewed by and receives comments from the SEC). As soon as practicable following the date of effectiveness of the registration statement, but in any event within two business days of such date, Hyperfine will notify the holders of registrable securities of the effectiveness of such registration statement. The registration statement was filed on January 24, 2022 and declared effective by the SEC on February 1, 2022. At any time at which Hyperfine has an effective shelf registration statement with respect to a holder&#x2019;s registrable securities, any such holder may request to sell all or a portion of their registrable securities pursuant to an underwritten offering pursuant to such shelf registration statement, provided that such holder(s) reasonably expect any such sales to generate aggregate gross proceeds in excess of $25 million or reasonably expect to sell all of the registrable securities held by such holder, but in no event for aggregate gross proceeds of less than $5 million in gross proceeds. Hyperfine will enter into an underwriting agreement with a managing underwriter or underwriters selected by the initiating holder(s), after consultation with Hyperfine, and will take all such other reasonable actions as are requested by the managing underwriter to expedite or facilitate the disposition of such registrable securities.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Demand registration rights</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.   At any time after the Closing Date, if Hyperfine does not have an effective registration statement outstanding, Hyperfine will be required, upon the written request of the holders of at least a majority-in-interest of the then-outstanding registrable securities held by the Sponsor Group Holders or the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;"></font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine Holders, as soon as practicable but not more than 45 days after receipt of such written request, to file a registration statement and to effect the registration of all or part of their registrable securities. Hyperfine is not obligated to effect more than an aggregate of (i) one demand registration at the request of one or more Sponsor Group Holders or (ii) an aggregate of three registrations pursuant to a demand registration request.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Piggyback registration rights</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.   At any time after the Closing Date, if Hyperfine proposes to file a registration statement under the Securities Act to register any of its equity securities, or securities or other obligations exchangeable or convertible into equity securities, or to conduct a public offering, either for its own account or for the account of any other person, subject to certain exceptions and reductions as described in the Registration Rights Agreement, then Hyperfine will give written notice of such proposed filing to the holders of registrable securities as soon as practicable but not less than 10 days before the anticipated filing of such registration statement. Upon the written request of any holder of registrable securities in response to such written notice, Hyperfine will, in good faith, cause such registrable securities to be included in the registration statement and use its commercially reasonable efforts to cause the underwriters of any proposed underwritten offering to include such holders&#x2019; registrable securities on the same terms and conditions as any similar securities of Hyperfine included in such registration.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Lock-up Restrictions</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the Registration Rights Agreement, each of the Legacy Hyperfine Holders agreed to not transfer securities of the Company, agreed not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of or distribute any such securities or any securities convertible into, exercisable for, exchangeable for or that represent the right to receive such securities, whether then owned or thereafter acquired, that are owned directly by such holder (including securities held as a custodian) or with respect to which such holder has beneficial ownership within the rules and regulations of the SEC, other than certain permitted transfers, including not to engage in any hedging or other transaction with respect to such securities which is designed to or which reasonably could be expected to lead to or result in a sale or disposition of such securities, for the period ending on the earlier of (a) 180 days after the Closing, subject to certain customary exceptions, and (b) subsequent to the Closing, (x) if the last reported sale price of Hyperfine&#x2019;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 consecutive trading days after the Closing or (y) the date on which Hyperfine completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of Hyperfine&#x2019;s public stockholders having the right to exchange their shares of Hyperfine's common stock for cash, securities or other property. In addition, each Sponsor Group Holder agreed to not transfer any securities of Hyperfine (subject to certain exceptions described above) for the period ending on the earlier of (a) one year after the Closing, and (b) subsequent to the Closing, (x) if the last reported sale price of Hyperfine&#x2019;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 consecutive trading days commencing at least 180 days after the Closing, or (y) the date on which Hyperfine completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of Hyperfine's public stockholders having the right to exchange their shares of Hyperfine&#x2019;s common stock for cash, securities or other property.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Transfer Agent and Registrar</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The transfer agent for our capital stock is Continental Stock Transfer &amp; Trust Company.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Stock Exchange Listing</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Hyperfine&#x2019;s Class A common stock is listed for trading on The Nasdaq Stock Market under the symbol &#x201c;HYPR.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>hypr-ex21_1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html>
 <head>
  <title>EX-21.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 21.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Subsidiaries of Registrant</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:72.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:40.397%;"></td>
    <td style="width:4.407%;"></td>
    <td style="width:2.915%;"></td>
    <td style="width:18.854%;"></td>
    <td style="width:3.154%;"></td>
    <td style="width:4.407%;"></td>
    <td style="width:25.866%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Name</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-bottom:0.014in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Percentage Ownership</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-bottom:0.014in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-bottom:0.014in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">State or Country of<br>Organization</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.003in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Hyperfine Operations, Inc.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.003in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Delaware</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;padding-left:0.003in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Liminal Sciences, Inc.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;padding-left:0.003in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Delaware</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.003in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Hyperfine Enterprise Ltd</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.003in;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">England &amp; Wales</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>hypr-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATIONS UNDER SECTION 302</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I, Dave Scott, certify that:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.  I have reviewed this annual report on Form 10-K of Hyperfine, Inc.;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.  The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">c) evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.  The registrant&#x2019;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: March 25, 2022</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:76.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.750pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Dave Scott</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dave Scott</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President and Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(principal executive officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>hypr-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATIONS UNDER SECTION 302</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I, Alok Gupta, certify that:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.  I have reviewed this annual report on Form 10-K of Hyperfine, Inc.;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.  The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">c) evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.  The registrant&#x2019;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:2.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: March 25, 2022</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:76.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.750pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Alok Gupta</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Alok Gupta</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Financial Officer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"><br></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(principal financial officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>6
<FILENAME>hypr-ex32.htm
<DESCRIPTION>EX-32
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 32</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATIONS UNDER SECTION 906</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Hyperfine, Inc., a Delaware corporation (the &#x201c;Company&#x201d;), does hereby certify, to such officer&#x2019;s knowledge, that:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Annual Report for the year ended December 31, 2021 (the &#x201c;Form 10-K&#x201d;) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:46.002%;"></td>
    <td style="width:53.998%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dated: March 25, 2022</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Dave Scott</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dave Scott</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President and Chief Executive Officer</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(principal executive officer)</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dated: March 25, 2022</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Alok Gupta</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Alok Gupta</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Financial Officer</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(principal financial officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img37592182_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img37592182_0.jpg
M_]C_X  02D9)1@ ! @$ W #<  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_^X #D%D;V)E &3
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M=K6C^$F?>7]F,B^=_P!H\@OFF^?=Y2I\6Q;&1C9VGW&/ZU4IEKVEC/N65/\
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MK)/HCYT]IUE?A#G/VV/_ .J''P1M/]UM_N;/K4]:NO\ 62?1'SK]Q9UE=O\
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M /#P_6*C%<5N=F?\Z=C^7]F\F^?_ -I\AOW;=1E<W'W1_G4N/E+E4Y[9M_\
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M]E?A#G/E_9:__JAS6=GVC^ZVWW)GUJF-N[O_ %LGT1\ZY>TZROPA3G[;'_\
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M*5I;*TD$$4((P((.1"[XKR?1^/'(%PNFVKAX56X\N/F]['*>5=W99!5&/?\
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M"8+!)!*LW):)>+ZC&4XBS1BSA,$.?0_9ES8[8=Z&VW3O^ZKQX::G!DAP8_H
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M6*$K%'&5$<L7K# A3(DA(SCA@+ (6-<DL4+=<SFL82!5Q %7$ "IXDD #B2
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M#Y,?!GZ>.0),E>6_!?3'E^B'XN0WY*]M^"^P?)]#/($BO(,U],>3YO\ DYY
ME5W J4WW_A^/E9*K2%41GO?-\_E9)F590JC,\OS?.QRLDXJRBR5&/\U_5^/E
M;)Z*L8U2#\G]7Z7*^16$2IA_FL_!_P [E9+DK"-4@_S/S?D\KY<U8Q9A4AGD
M^;Y^.5\N95A%FJ0SWOA_+Y!DS5C"J$SR_-\['*^538LE1C_-?-\_/*^7BK&/
M(*B'_7?0^EGE?)FI[>"I1>]]'E=)Q4Z-4@_)GX.07JPCR\:I!^_\'Q<@/5@U
M40O)GX?CQR%(IL:I1^_\/($BL8\_$J07O?1Y!DR*L(U1F>_\'Y?(<BGL5$9\
M>.09,O$I\7!4@_+GZ'_.Y!D5A%DL\:SWV]Z[6LR3A (]2PGB"T35C*%]0]Q=
M6:5E:4  A!!Z1;Q "J1CSD/=4%!"+/AC,"*\Y4YEN.5=[CW&*IMB=,K/GXR<
M1_.;Z33\\!7 D'A_:?[/K'VD\IS[#<:6;@T=Y;2G.*=H.DUST/Q9(,:L<2.T
M&D>I7UKCGJIZ\^F$7JCZO>M?K!XG]SO5ST;Z7],>-V=OF7HSZ_WNS_Q?N\_8
MWKMIZE\(]XWU'NN\U_,]WIU:J]&G'P+^4/P1N?PO\ ]S)\,^L^K]S3M]]K[O
MNZ?/:^S3I7AP_&]MJUSC/M9M+&-S/ RQB..&Q5BMY)H1HG"1R58\P&LBU80B
MR(IRC+(S2([N"Q[I#X6/R9#GGM?LQVT-AN-V>.VYPB:>@"CG^(DM^A7);M+5
MS81D!4^\/E^5>+GGJZIDX12GTZ*JM#<HIY<R*)O\&I^O;0MXJ!31>E3L%IV!
M X*^.E,U<[M1ZA$IE<6G%S9CZ*1M2,].O5Q4;GYL<4:$)@:W=3<FT[FT+FS2
MR,9J:,6-<X![P>!:S46D@@/TUP4BV##(7/TZ6M+J'B0,!UU-,.BJEM5UI]9S
M9,ZQ;)HJR-Z98FU\B>9/) TA,K1B$8IF$2Q]01Y'%ZU@-<.4;C$#C!F<X"WP
M^'MJ5,ACK.K/2MQ+.RK#$59<6_*=@([>[99M,SM(UM8XO<!6KW.!+CTO>22X
M@%Q<\5VM=N$E2PRX8FE1Y!\H>2@5\OE<5_NU,=&KTG$$C](*KKF-Q4!M9':%
MAC)5P+"G&H\/JRUI?>$(B@2U]:5C-;PI2\8VUK4S9'TK GF+,X/V&LPMS&BQ
MI9<3;1#>6D+S,V%L<D)D<7Z6S.>QL;C@Y[8Y(WD5<7%CFLU#35;6PB[ECU]E
M[RX.H*8M%:_YP(K@,:FA6MO8R0T)*+34O&L\"FM95"*"TZW-D-L22HYE,D$R
M8J>@;';;B]2UM3MS;)1R6W6Y]="%R9N9$RI,L+,*:&<L06M'?V$=[';:-P>R
M2ZUO)<T:6EI>XL ::D486BA+B"*:G>D8,AC+ZQ@AE!@? *^[7H\ R4R-_JGU
M!S!:=VUTHB=O593.Q5P;4P)KINX)*QS)TA9-#KZ?<V9W87QI(RO;6631ZZ4I
M.6-Q<)&M:5#89WGUS">$1-3LESNG?3;9N[HI+JWBA<7L!:'=X'U!!P)!9Z0#
M0:^@VF,FZC@#&30!P8_5@>%*#Y,2M8O.B4)9"J:R)!3UFP*THL>(A_@,K9)2
MV]@Q  H-:%Q*HU I[O\ XQ"YIP#3J"\XR$P@T8!8R$6<<R:YS'![?2!J/"%&
MO+6*]M)+285BD86GQBGE&87]!R%RAIG$2B\T8#1GL4OC[+*&4XT( &'-+^VI
M79N-,"68: (S$:L&<X"(6,9S[F<^7G12/$C!(WT7-!\H7@]C ^VG=;2T[R-Y
M::=+20?="N_'EQ\WO8Y52KMK+(*HQ[_P8^GGD-V:O85S^=\&/I<P4QJ_>:W9
MK:G/B)PB_<>]\/,79+?!Z2J ^3Z'(<N:N8."^P?)]'/TL\@29*[M\_&OMCR8
MY!DS5Y;+ECX\_2SR%+DKZWX>)??'QB^EGD"17=NN6?>^#X^0)>*NX<E1&?'C
ME9+F5:19!48_+_5Y62JQB5$/XOCSRLE5E%P\*I!_UWT.5LBL8E2F>4/PX^/E
M=+F5819*D%_7?!\7*Z7)6$:I1_%RNDR\:L(LPJ0SX_BY7OR5C%DJ0WR_-^1R
M _T58,R5"/RY^CR!-DIL7HJD'Y1?!\7*^7Y:LHU1&?-_X6>5TN:G1YA4@_+G
MX/BY7RY*=&J0?Q_E\A29^)6,7!49GDS\WO9Y DS4]F:I!>]\WSN09<RI\:HQ
M^_\ !^7R#(K")4HO?^#XN0)%81\%1C\F?A^/D-^2G-X*B'^7]+D*3CX581YJ
MD'Y,_#\0>0I%81*D'G(18SC.<9QG&<9QGLSC.,YSC.,X]W&<9Y">IL8!)!R7
MJYU7L\ZX: K.=+5 E3RNCY;7(CS18R>?(XZ>>P/2L\.,Y[@G%>VC5!QG_P"I
MG!SY,XY^T>2]Y=OW*]GN4AU7#HM,A.9DC)8\G^<YI=X"%_(WVM<JLY+]HFZ;
M! T,LH[@R0@9"&8":)HZ=#'AAZVD*07.I7G2<(G")PB<(K#G%H5]6@HWB?RU
MFB!<N>\1R/JWY3Z/;ESV)&I7EMPW,X(6]"<>F2&9+RH-*"8/& !SD8@AS3[M
MO^R[$8/AFYBMFW,O=1F0Z6NDTEP;J/9:2 ::B 3@*D@+I>7>3N:.;A=GEBQN
M+Y]C;]_.V%NM[(=36%XC';> YPU:&N+15Q :"1?>,X%C @YP((L8SC.,XSC.
M,X[<9QG'N9QG'+@&N(R7-D$&AS6'MA;GC6N=#W)?DQS_ -V*:K*;66]$X'X9
MJU%#8\X/PVU+G #!#7.@T6$R< 0B&8<:$(0Y%G&,RK&TDOKR*RB^V2R-8/\
M.(%?%F5KD>(XS(<@"5_&MMJT9G=UHV)<5BNICW/+1FDEGTO=1Y-SA;(96[JW
MIU-) <:>82EPK6""25WQ8**P$&,]@<<_4]M;Q6ENRU@%(8V!K1U 4"X][B]Q
M>[TB:K'O-ZQ3A%M$T7:'6>:C]5"K81DP^RG36^I;32,J-(4H=915=';$P"97
M&T-QF<X6!"R,AR*2*BR,#&8ACYPAX\, Q!YS>7L@W/;;F;\7$[V5X-?)&YK"
M?":M'6[I4^U!?;3QM^V%K33J!-?DXK5WSHU 6T?HSI%:3J'4C8ZD!I5?44AL
MB];P=A)@*FMFHJM*VE3U:8GTL_(40VN0QKQ&3!*@02%BEU)2BS]?QC/.\UD'
M8YH!]OF+(XQQ,CG@,I3&H/:PR )X*=MP_M37?,M!)/0*$5]U:N.=$H*<(G"+
M?ET);T5,=G6;KTYJ_P"XL[C_ +0HP0;D60IY;%!)FYZ3HPX'@.#GV,K0G'9$
M$7:!G!V9#[N!VVTS%LSH3Z+AAX1_DK7P!>:^T?;!+9P[JP?9(GZ'?S'Y5\#A
M0?SCXO447^:S]'Z7+6?T0O.-L](KL >3'P9^/E-+Q7?V'HA5 ?BS\7(+UT,/
MRUSQ\?,"IS?EKES6Y;DYBB\PTFVYK?3'J];<VA:#)-WY@?J]:8"C1P%M871X
M+>'1CHN0IU*E/(9+%D0&T"*+* C&%0,W!HR\8+R'(A R JU61B=+;L:VE<#C
MX"J%UW-J_=3J=Z0S:K&&>L#5$5146<D\_:X\U.![@8NDSL$Y"5'93*DQB/"9
M:$.1&&E#[^,X[G9V9SJD:0TG@=/O_P"5;8(W10N8ZE:..'\W_(MCLJW7VEN+
M8VY*!T?KFF'HG7E*<ELF<7HMEX&MVER=0K0&1*+HXBZLQB%>)Y0*4)!BTP1!
MYR,\9@TY(0F"TO#0*R5H:TIU>%;X64:""*X>#'Y/E>')NO6]4^V4UDL.PJOH
MHV0;&UK(#X _TAB81]B:O7, DH278,ME3@QMY,3\W/-4&%B-RMP-&>E+\06"
MU X<L8:\-<X:"*UH<O!\I6\#CI+F@EP-*5&8X5^6HNR+J*;;:ZW31D&VCCFH
M[Y'K??D<<?HS04MEZ^TZG6.+DQ-IOKLG>Y&_-N%L?.>_KA"9*<C<C$IQ:=<7
MW<#SJ=;031/="7ZF"N(%#3HHID5U<031LG$98\TP)J*T%37ACP713GUA_P!N
M*D]4?0WK7\FAZ]6/6/S[U>]8?9C*/0OI[T9_=+T-Z2\+SKS?Z_X'>\/ZKLY'
M-/@HUR[WY05E'J^'6Z::O5S2N5<<U8_2!==FWK9';UR>'*IG:*'VV<#8A>Z+
M+ 7SLZ6IBK.218-1*E1AK:9&$\@($6IP^"RI U@+"3V&8SCFO>!:MM80T/#]
M T94IA75U^#BIG+3K]U_<%YB,?>GO/2U:A4#1PT@_/8T49>F%:VY-=:E[ O.
ML=<4J^1VNID_V7.9+<;Q*C#7LM)7S&)1"H%&8HL8,CD+8UQ[*\Y4X.9*0PM2
M62#&#/=%MWF&PEO8VWCY 7-#0& 8=HXDFN&-* $X+5RQ<[Q!M4[MLCA<V.0O
M<9"['L#LM:VF(I6KG 8T6U3/52CB/I]M&Y3S L@EKM(#JS35RD=1!:UMID'N
M)>22'H].)2GC1S4U&NV>THU22FQE/VFF!\47-/V*1^[G;6O[ &HNIDV@X=.-
M.BJ[-G-<,?+HWQ\?V0G0&5S?4BE>C NRJ!TE?"*[0=1&%3BE#M@]8H1*JGNK
M*0*IRUJCUKRF9TH!S&C\U46NC5G21  +>2Z$F*_-RRD^22E BE C2LILP;C;
M]CGAF]2N'MNHAE*6-;)3YS(XTPK4Y8<5.M-VYGMKJW^$[2-]E<&E8!(YT-:4
M,M:B@J*D4% 36HHLF[&W!O-&Y[(D=05YK17%-Q9F(4@N;::Q!HV6=O9B<E0H
M:(RTP&7IWF,C(\4P!8GL@@H_"0XS)I6!%A%465GL4L -[)=27CW?:X&5+1TD
MO;1W^:32HP.*N-RON9HKAS-MBLXK!C0>^N9"&O/$-;&[4VG2\ &ARPK%ZO>I
M]/[&T)OO8])!H*T7+0SPSQYT:19>WFM)"H=GJ+I4[Z@2IGQ"^)6]2C>U( I,
M.J@19J8!OG)A9N"\;[OE.VMN8K;:G22.L;D$@X"1H =@:@BM0,=(SI044.PY
MWN[OE*[WIL43=RM'!I&+HG&K>T*.#J$..&HTI7405?-+[D;0.-)';=["0^C8
MAK*54#G,4[;!13=;<#G+FPYD9&XD)#L\JHJVL$Y?C5HVTG(E*A(0).6J.P+O
M'&5>Y[!LXW$;%M<ES)O!N RK] B#34G(:BYC::C@":D#@K?9^9=^=M9YDWJ.
MTBV$6IDI'WAG+QI P)T!LAU%HJ2 6AQK4K!I_43W.B51PW;^PZ+I,.JTVDZ5
MO+CD8?I<.[8]&'-V,;&R1N+@XN H<X$K3$IF$P2T9)B@P96#2T@!X,YO=R?R
MY=7\G+UI=7/P[&PG4YK.Y<X"I: !K%..)IC0N."ACGGFNSVR+FF_L[3]FI9
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M_J3_ /M'WM/_ $-__DGWU/\ WNW_ *B?_0G'_J3_ /M'WM/_ $-__DGWU/\
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M?JEZ"J)65#2]CHUZ8-<0M8%1D;GY,7\Z%G&,#%.3HD7"BT&<_P#VV)PPE_\
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M955N6NSP*<.\,.L! W/S7)26TV)D&2(C+B9*"60^*)3SU,57$D(SEQ:U0>4
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M]:W.U=';$@:@YCV@G*I8YVFO"M,<.*L^7^=>5^8KDVFSW;);H-)T%KV.(&9
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MUE+%IF[MKGO8"2=6&%#VJ@EM<]51CZ7S_L-ENUA:Q-O;;;]PAG#X.]<UC'O
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M]QO/-/\ ];?^^?3*U_[U_D)_\U__ .Q!]QO'_P"MO_?/ID_[U_D)_P#-?_\
ML0?<;Q_^MO\ WSZ9/^]?Y"?_ #7_ /[$'W&\?_K;_P!\^F3_ +U_D*Z8+_\
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M *>ZV:NY>3J)JIF@JZ1$%I7EW"XR*2/ZU$2=A06W"D,O>7][);/.,8,RF+4
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M=I3>!58RC:Y3N(XN*3=:)%3$JTE5=N=9F-:1T,TR.:2H2&/NII@4@D U>%6
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M+;81-:X?-!S":GC4T!(R!) )"7;8C''/$"#(7$UZ:Y> 8@=6:P^E;X7K,T6
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M+Z,\]^M>GO,?._,N[]>\?N^%]<[O-#O<U?*\_NJW;J]2[.=#Y-6/N9]2HZ[
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M:VDK+B!L<#H;6'O22Z0/<728G'4]SB7%SG.<<^))6+W M<7.#GNH, 1EX@
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M[77OTE]F+^L"[E+5U%&4V;&1OL;""=:DY:8F-P^/Q%/VDF.+L(!AR=A"8/\
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MXP?83[G5YEYVN=RJY.$3A$X1.$3A%D6IZGG]WS^.UC6,=62B8R=9A(VMJ0.
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M%U<R-R5Y\52[,Z94G4F9,,4-IZD\:H/H/+O/U[M;6VFY!UQ8C &OV1@ZB?2
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MN:MB=..2UF>F3]T*C+RE(;_..\6E6*PA\3/N&R\W;-O;0R*01W9_T;R ZO\
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M,1SO;GZ-WG6T;5MHR@B^A"?)_I+\%<&^UYO_ $'C]I^8?[[<_1N\ZR^#-O\
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M?V,YVD'T \RS_P"(O/G_ (ON'W9_G7#Y,&NV?]"U<?:LU_H',?V<V$YV=O\
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M[LMJ_P"TV?\ \PN'RU]9,?Z3/N-L#]ZG,#[3>2!G??>;C^J68]@?M:.6T_\
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MEW/9RL?OUO\ UJX?*XUZ_"#]RDW_ 'M<P/-6PC.?Z23ZQ9CV5<^G*P^_V_\
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M6OW.2W]0>:RQPS"S'*^^G*#Z>/Z]<?E-4A^S;[FY=^H',"0,"M@Y2Y@.5O\
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MW($,>BQN?-7,X@L7AF+G *@]1W<"[ 9[>VXO.;A81NVWD^,V.W4TF7#UJ?\
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M6!S,!G!H,'"'X?+6&\;UR7ND'+_-LYN]CNY!'9[@X /$AKIMKRE&]XX"D4X
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M!!GB)2NS'>XR_P!JN-O@M[J1T;X+EA<QS"2.R:.::@=IISI48YE3HYFRN<P
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MBFQ]-EW:E6P$5A+U9NFU@*@I@J4CP;(W-G-CF3\&! 4T$]X(3>WD3ENV;O\
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MX)[KDZ^BMF/DD%U$XAH+C0#$T%30<3P&*@S.:R^C+R -!S7>]$Q$D!9W68<
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MAW,<1@R#(1+1.F?./%_-X.Q@>,][&,\F2.<?:8"2:^L-'B[H"GDP6( ^"?\
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M#%'4+<UE+WIY7'JU9P2L&*51PS3,B&,0L\W9W$]SM6^2W+WR2Z815Q+C02D
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M^-,V7-&$RZ;N*UOR,LUQ=C5C@>$XW!QQH3!XSS.R[IN.Z[=NL&Y323Q>IND
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MSPL%DY4IR7DY0;G(C!"%[O/D]S<73^]N9'R24 JYQ<:#(5))H. X(UK6"C
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MOA&:VX#CS 8P"B8V-G'%AL^8\.-#;$0F ; )%EM$QB9LD9;A,XF[/F^4V2_
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MUVU[>6>KU.:6+6*.T.<W4.@Z2*CJ*^OC8^FMH-.D55P0FK:QK11,E=<5S!(
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M7():LF4CT@A^S,B8-07YS<5.5K@0NK=*SYDI"!8K 4/(4KZG,+PG* 6,!8,
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M36HKMJI3&FT19YA4M+T;;L!N^+)JX>V@F3/4^@+NM?27&:2&91R9'2/UF=7
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M"7DT &)).0 Z4) %3DNEA,YA5EQ1BGE<S"+3^#2A 6ZQF9PF0-,JBDB;#1#
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M4*;PZK75<UIJ]OVZORFNG'5E&JB8O-%NF,ON&UX_U"&FNI<O"V-+<K!(36:
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M/]-^<2K/G.+7>IPB<(H0;]6I[(:?A<D^57\C_P!*7O3T2]I7L-^4!ZT>LLH
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M#75FL9N<[;EM*D;$Q!C1-<B4,,QII2^IXX5-HA8);.*NI4FRZ+">\D;W92X
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MQ<&^AWV'@P7HIZU<EK2 T[I=1C?0-)V7,[&VRJ6$ZS16\I;,ZTU1JJ=1%G=
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MPZJ% SEZM<T*%#B>+)BD9IGU7+:VYLYBM+065O=/;;@4 HTD#H#G-+P!P <
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M*Z*4BAI0@CH+2"T^,%8RPQ3-TR@$+'6H?3=TBT.,D:O5#7V+50[RY(6W2*3
M=Y?-9BY-)2H*X+(.:6+(Y=+"&$2XLL\2 I:6C&<24,1>1%%Y#OW/?MWWG2-R
MG=(UIJ!1K6@Y5TM#6UZZ5\JQAMH(*]TT GQ^^IO\J%O3A$X1.$3A$X1.$3A$
MX1.$6KE/_.'=_P#B%QS_ %*)3SP!GQUD_?2/_ I5^R)?X6P?\K9_][+93*U^
M_O3:'\?ES??JX<_6?.WXSMWZEL?S=J_GU[/_ ,4W3]?;C^<O6?.<6N]3A$X1
M83V*V*IO4ZFIGL#L!,/4&HJ]+8S9?+?5^4RKT0"229EA[*+T#"F.1R=?Y[(Y
M"C3=B5$?DOQO$,[I0!C#+L;&ZW*Z9963-=T^NEM0*T!<<7$ 8 G$K"21D3#)
M(:,'_1P684"Y*Z(43FA-\=$XI$RY&?W#"O&2JR0*$YOAG +.+\0DS&>Z((18
M[>S.,9]SD5P+7%IS!6>>*J^?$3A$X18(<MF*1:-C8[J4X37S?8*65:Y73'X!
MZMRTWS^LVA^.C#C)?6HAA,A*7S=\3C(\S/<BW ?9WPD"+S@>9C=ONW6#MS:S
M^Q-D$9=5N#R*@4KJRXTIUK696"3NJ_9"*TZO>510&Q],;1PAPL>BIEZ\PQJF
MDOKU>\^KTKC/@3"!NYK%*VCT=,6./NIOHIU($5YP @24_L[Q)A@,X%Q>V%WM
MTP@O&:)2QKJ5![+A4&K21B.&?2OL<C)6ZF&HK3R+-_(:S3A$X18JLZ\:CIE7
M73?:,_CT+<K=L./51638\*Q!<YQ8DI4>;LD6CC<G+/6N*]2+&1F" 7X*8D(C
M3QEE!R/$FWL[FZ$CK=CGMB87O(R:T9DG@/?R&*Q<]C*:B 2:#K*RKR,LDX1.
M$3A$X18(V2V8I'4.HWZ]MAYK[/:JC"^/-CY*?5N6RSS%=*WYOC# 1Z#@[#)9
M&I\_?'5.1WB49@"O$[YF0%A$/$RPV^[W.Z;9V+-=RX$@5:W($G%Q P /%:Y)
M60L[R0T8/DX+._(:V)PB<(G")PB<(G")PBP1 =F*1M"ZKWUX@LU].7%K-[./
M;=#_ %;EK9ZD^UR-JI=7O_>!X86^+R3U@CR,Q1_<A:O\T[OAJ?!-S@&9DVWW
M=O:0WTS*6MQJ[MU6G5H.EV )(H<.T!7A58-D8Y[HVGMMI7JKDL[\AK-.$3A$
MX1.$4:C-OM=BK8NZCC+#[MHZY5JTV_<T7]4ISGU-KI\:CGIKD/IK$9S'9#YT
MV$#-\T:E:Y<#L[HR0CS@/)_P7?&VAO-']GGD+(SJ;VG T(I6HQXD =:U]]'K
M<RO::*G/)=:P[M:L22L]?[?;+CCQ< VGDL6AVOCH\(9#''.TY1,U9J*.,<<B
M<A9FN7X7K#B!B, H0$>:$@$:HR45C(^9/VG<8[B>U=$[O[9I=*!0A@;F2X$M
MIX#CD*E?!-$6M>"-+CAUJ4_*Y;4X1.$3A%!.,=3#1V:[:N&C$0OEKD^T;2ME
M#8[5HQ0ZQW1,UND*9G%]ES4Y6 CAQM8H'2.(6E0%8F->0'D*RLI1 PJ["<W$
MFP;O%M@WB6$MVX@$/+FBH<0&D-U:Z$D4.G+'+%:!<P.E[@.K+T8\.O+W5.SE
M.MZ<(G")PBB;6'\[O:_]HFL?]HV]SSG8/XE<Q_D>U_4WB]LYP_@;R5^LN8/J
M]L4LN>C+Q-.$3A$X1.$3A$X16K.OUDS']JLA_P 4J^6.S_I>U_*8OJVJKWS]
M"7GY++^#<K7HW^!2GOXK:^^]-HY8\X?&W=/UC<_AGJJY'^)6S_JNT_ 1K*7.
M=74IPB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")
MPB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(HFZB_K?O/^EELI
M_*:[\\Y]FWXEN_[Q[G^=/7MGMQ_2G+G[D[#_ (?$I9<]&7B:<(G")PB<(G")
MPB<(L!ZP?P&0?]TOWWR#G:>T/XX7G]%^ C7!>S#XC6/]-^<2K/G.+7>IPB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(M7*?\ G#N__$+CG^I1*>>
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M%:ZCDHC5^6:Q4/L#=NR\W>W,E#(66N-?I?8'K2VU]7YBY.C7KC6%.JPM+/4
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MH:'O#VC2A"U[>R0&1SGU;WC@108G#M5^5DO4%SSU6:<(G")PBB;6'\[O:_\
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MOR=QMGVUJ"I9_IMLS8* ">S&6[FN0NRY6KCRY?&\+26DHM"O"D2Y $Y.8 W
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ML'"CVZM0[0%:5&(J#P*SM(GQ!X>*5D<1X#1;9.<TI:<(G")PBB;6'\[O:_\
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M7@@Y.HUP%*ZAZ.(6)NY>Y>[2!-&>T,\.D>)30W#WVE$!9]!6/5!) )[9._\
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M&'G=DV_EG='0V19NC]S>.T(^X[L'B078AH&)+E*N);N$.DK"(AE757W.*H*
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M7S>U>PKU?M79M? G.\)3ZR2UU]=UU8L*^,08_P!!O;\Y1R-^@V-T/([K0C0
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MM#?X"A6K<LEE& (PH2C4<Y=&UO.7]MGCN+<2V9<V2)SZ2]J5M"UA]( =IQJ
M!CC0TDLUQW,K2UU'T(-,,&G,J'];:J[C5!HYT1MOJUUQGLYN[IV"O<FVM4WQ
MK<(!<;_66P*MYB,T"PQF7-J9P+F3 Q(2STJ Q+A6H+7A-* 9@O <VMQN6U76
M\;OM=Q.QEI?=WHF!#F!\='-J6FFDG,UH*4*U-BF9!!,UI+XZU;D:'//BI?K)
M+L#U7-T=(9HW:6;0:@ZQZ0VJ_P!]SNP=QX"FI^RK!L,J,DM\%KZN:LR_N[@O
M91.!F37!X\=0CP1D8<B3GD%IUU6([+EO:;N)UW;W6X7<8C:V!VMC6UJYSGT
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MC,+.Q:YD3@\$'6[/!;H.<HIB<(G")PB<(G")PB<(G")PB<(G")PB<(M7*?\
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M'&KY44(;<27[@#3%6 #S@ A9QZ%+/!;#EVXN:"!@JXG( 2MQ/4,_$JUK7/\
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MI8E9EB,4G@[@N*(RZ,ZGQ43BF+R4<4,.>SG7<F6UG<[G*R^C;+;BTE<6D Y
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MMUO=P,#X_5:!X->T) TN!'#,XUITJ!%-HN&-B?*YCC0Z\O%6BE?0.O\ M-U
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MY.P_X?$I9<]&7B:<(G")PB<(G")PB<(L!ZP?P&0?]TOWWR#G:>T/XX7G]%^
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M)H"YH&-:5..%*+ V3F11B)U)HZT)R-<P>I98I313>:Y-N:AW$ZF]OZY/KKK
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M!>:[BWD95Y8=&H8-8 X=BN;G$OH!@:E826]Y-I[US*-<#A7&G$]?4,%Z8><
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M"3#6!3/CM$'QX0-*@20L1N 'F%BR6'(NSNXSGF-S8WUD\1WD,L4CL@]CFD^
M. )\2,DCD%6.#@.@@JP_EO:7=Z !^5YJ_P!ZUTAJ^K0^WVJ>]92 AX6QXY;
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M2"T\0L-1_<O3^6V'[(HKM9K9)K8\]$V^S"/WG6#S8?I$ BP#0>I3=*%,D\]
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MCO(](-:]H&G1Y?<6P_E&I"@CNQNO\CN0Z;,/LS]HORMMP:GU0\Z]<_5'V?\
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MY;V]WK-J;4D/=8\3)78;L-M.2"1*',LL\XLS.,X%*L-TW"'E"]O632>NOO&
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MK=;HWDM!XZ>)Z^!J!HE#C:3S$$->X$ YT!&/C6W'KD@"7T[]<@ "$  ;8Z2
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M63?=K[OQS8"NJ]M.XD4KV'EM1)-8H_"6V+S$YH]FZ^+K43.2M%7RD1;.2[X
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MB6[_ +Q[G^=/7MGMQ_2G+G[D[#_A\2EEST9>)IPB<(G")PB<(G")PBP'K!_
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M1K1[Q/5B2MX3 =#5GXPC(#KUQ'S7X'3NK0S3A3,\)C"3LG6*YF6FJK4YRR)
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M&Q*2H(?([J(<RCG83PJ;5HQMY'FBDPM&29D&W9XH(.6IKS=)+@[2^Z#>ZA#
M7O#0:R2.&H1T[.D$8XC$K&<N==M9"&]\&5U.K@*\!TJ,'2X76L'KQ;KM%V;%
MU)LA;"72F,IK'EU&Q!J@]=MLF9K(JY*3$"F]G// ^R"(M2XH#@N5B&M(6K#D
M9G<\W[F+'F(6W[&VCK2"6WMO6SH;(XN<06O[53D''(#"@!XK5:Z_7GA[@YVC
M&F S"G5^+F!R3TSXZC,R$*IOV V81+B.^$1B167<$D&-.>$.<^&<$!@1=W/N
M]T6,^3.,\I^>OC X\##%]0%OV[\6'\X^^JSJO]A6YO1.4FC+*(#O,]I<FF&
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M5-,"R7IT:D!2IP?$*(]M(4G'&><G\KN8+#8MKD?86,ES)N,<Q#B[0(@W' 4
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M'LBI^7("'64R)8')2!O($8K5FX[I18Q>YRCAMY[@EL#'O<UI<=(+J-&;C2M
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M!;4RMRA8IR20/!"4@PT?=+ (6+?DRXM[7F.">Y>R.$"2KG.#6BL3P*DD 5)
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M;8EKNR'5P.&''H6QV\*JLA\ZW>E=IH*ZG3I4\:TXV*BDLLE!$Y"JK^.R%_>
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M8_,U!(XBF17<6EM*1T?;GZQ52@,2,C9=M>(=^M*681@TA#O=%W'):2LF+,*
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M]M_T>G6=4_5LT=)YN@PU9.'*65_$Y&OF58IFAQ>4U<RM8\-"Q1(H&G=W96J
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M9C(0-Y 0&.;J>L<%&>\,TX8Q"%GR^]W"^W&7OK^:2:3&A<XFE34AH.#17@*
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M1&D<W$DDW*=O=T1*3S<D",*8LL ,7L7.NZQL87QVLE[&W2V=\0=,T4H*/K3
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M372RU%IS6RY-8<1J6VG%-CRW,W8F?7),7&<7%=[TZ( MPI-/;#\-L7C?FTL
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M>2&$&2*;S:3.(LK'Z3O64I(#3A8 6600402640244"KW/=+S=[LWEZX&6@
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M"UD#'NN&,HR)V@5;W9#B6ZLGX"@R)(J<9'7%G"\EVL5 :3BX5Z>GJ6LTN_\
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M&C6V:KV!BD!GB!%')%9+5%E]8QR1I3RLD*&]<\IUB53D)!Q8#A!!F1!ROO\
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M)PB<(G")PB<(M7*?^<.[_P#$+CG^I1*>> ,^.LG[Z1_X%*OV1+_"V#_E;/\
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M7]),\E)B>N&A[E>T5K:W)9)FXIM+F&P+I82UC=I<FC)>,G(6(PI:TX6%E'
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MY8;Y*R3VB,;>&MNRX@ !R TQNIX-1)/#$U6FW!&UDL](M=[Y^4LY1'_9]?\
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M?)')U_GLCD*Q3VJEI^2_&\,ONE   .-]?76Y73[V]?KNGTU.H!6@#1@T #
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M$L4@<4IRM>YC H4%"R 0<]Y9[_MMK!&R#>+MFWL _L[H Z:@I5@G#0 . H:
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M?"F7EE'9"#)@1Y+!W=FW[I?[5(Z6PDT.>PM=@UP<TY@M<'-/C"QEACF $@J
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MH.F5%KB4!9(/2:<\C&34HS!!+UP<HW<F^'9)9&->83(Q[1J:]M*M(Q;@[*O
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MA2*!@E2<M6$UI//L^X,NI[:,OD9W3X^P/2+7.)#J8Y=72%@+N1KVMGB+&O-
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MN;JU87R1ACF@-'I%CR:/ Z0 .O$+X+MXD:V6,L8\T!J#CUC@HR4IL=NJZ_C
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MC?&XT8V4M]-C3J<#3ACVCB, 2OKY) ^.\D80RA!&9;7(G +)#-LA".K+U4M
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M/;SG.<_C/=_[0?4-4JQ_%&>#Y94?_P 8OD:R':6T9+F^,*YLOBV^6K,C0PQ
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M6:B48S@:<XTO.!YIF;?=[<W?(;QFB1T&L8@U:Z4EIP)SZ,QQ 6\R,E]7<PU
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M@D'Q"IXTHL=;8]P(?AK8 .LKT1<X96"<(G")PB<(G")PB<(G")PB<(M7*?\
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M#Z4:6F<,C4O5.<3<W1L_3"<A>4G-/(^N "('N\26]Q%&R65CVQ2 EA+2 X#
MEI(HX X&E4#FN) ()&?5X5?'-*R3A%8DVM*L:T40U)8]C02 *[&F#37E>I9M
M+X_%5$[G[]DW#%!H:2^N" R3S!ZR2/S1L0X/6J>X+PRQ=F>;H;:XN \P1O>(
MVESM+2=+1FYU :-'$G +%SFMIJ(%305XGH5]\TK).$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3
MA%JY3_SAW?\ XA<<_P!2B4\\ 9\=9/WTC_P*5?LB7^%L'_*V?_>RV4RM?O[T
MVA_'Y<WWZN'/UGSM^,[=^I;'\W:OY]>S_P#%-T_7VX_G+UGSG%KO4X1.$6)K
MYNB%:YTK:U]6.H5IH)3T E5BRH;<0%6YFLT39U;PK1M209I %CLO E\!*3D8
M,&J#  [P>WMQ)LK26^NX[*"G?2O#17*KC3'J''J6$CVQL,CO1 JM",8ZB?6@
M=ZI@&\WR"J(F.F=DO4/?V77BI%]RV#OVCH^>.#;B/6:E0,P5=?S#Q&!S)</,
MT#26O$G. :>D2)0'JBNSDV/E1MR_9_79F;K&' RO#&VW>-!JRI[3<12I=2N1
M)H#!%Q>%@G[MIA-,!4NH>/05(2UM]MZ;]VMN#5#I?U!K@XBU?30P&P]^[ENE
MI-%;H)A8,>-DC!6D/A%8@;;"'(&YO3C"N6'A. 2L :G.2I@E%J%,*VV;9[+;
M8MRYAEG'K!=W4< 87:6FA>YSZMH3D!PH036@V.GGDE,5L&]G,NK3'A08JP"N
MKC?K9IWU&WBSJ*@M0;[].-G;3['JUS7O4TIF4D3)#Z;K"PXRH;GV.2I=!9PQ
M)U!Y:;#@%226 DS*G.%&"P;CRS9.W2P;;S/EV6_)TO #7C2:/::@C4TTQI3/
M#!8^MR"&0N:!/'F,QU'P%8*GG5-ZLU&:ZU1U#;TU:TZ9]'I=['G2:P"+3:V5
MNU$4@=LN+ ULMB+%ZT_%6M:1W'(D9J=I\)P7HQK"4RL818-.+F0\N\M7E]+L
M=G<W1W=NL-<6L[ESF DMIZ9I0U=@#0D< M;KJ[9&+A[6=P:5%3JH>/0MJK;N
M#93!U0GW2.S&F )*JLG6-JOW5V9,37(DDND#W%7_ -6+B@$R=5<G>(^^.;;G
M.'IO$B;6C"=I%@!HE1OUSG..VNW?R\-WMR\W,=P8YFDC2 15CFB@(!]$U+JN
MRHI8F<+GN74TEM6_+!41I7UA%]:-_4_V!FL2B3OJ=I-:L)UHI M@3N3+8MW[
M(>:MC/:,;=Y\[RMS@K;%HY8#^@1 4)F;!B%M,4+561Y3> ;9Q\KMN';?91.<
M-RNXW2R5H6QQ8EA#0 XDM!-"[$T SJ-)N]/>R. [IA '23QQRS4)R^NEL?1C
MC#+5VBL7H^VEKW)93'&F;UII)M\"Q]LZ48)<ZHVDE]>8ZZ39[BMN&0@YU*&\
M%14@TLPA*H4 ,(38\8%M^Q]A>-?;;='ND=\UI+7SP:89"T5H"&AS-5.SKZ0,
M3@M/KTC"'2F$QDXAKJN'NXTZE,N_]_.HDNZDMF=/O2NE]79H<P:]U_=359U\
M.UE1R+U\F?%PD$B=["50AZ<G&9M:MQ<&Y&U-;*VH5^!G&GFGFDE#[E59;+L8
MV&/>]VEN& SNC+(PPEU!4!NH -- 22XD<*5*W23W'K)MX6M-&@U-</#3Y2YT
MCU"MA;.H[JMT]N!1U!MFT73[J^1K+!BD3!(YCKA<$;G5'SJP8&:;%)DY#E2R
M$RQMBYQ;FWJUW>5M:TL(A)S##"RUWLEC;WFVW6US3';KV0:2ZC96%LC6NQ:*
M:FDX$# CBC+B1S)63-;WL8QZ#4$C/@L-ROJZ+Z0T_P"FQ!ZDB&F-2;%;@:X0
M^QV1';\X;]8]&]9H$@BC <X/CL2K?B7C,0)=''+;'XHR.!CL>2E/R P64Y92
MJ7'RRV\W2_FN77<MC:SN:=#3+<2N)- ,*:J"KGN%,1TU&!N]$,;6!@D>VN)T
MM:/DR 65M!.K+9%M;8IM*MGI9H9:-ASBOG^Q*ANOIV7F9;U,2(40 %=+*[ES
M"_2!_G<'F3:PC,7ICE^2$K@2B4^"#. @&*-O7+4%MMOPMM[;V.!CPU\=U'HD
M&KT7-( :YI.!IB*BJR@NW/E[F4QEQ%06&H\'2"HPT1U+^M=MG05I[#:_:SZ(
MI8'1,XM>,R559[Q=;6_W<"N7QS4K6^E(FR3%6E85[#%"TJ98ND#SYBO>,G>:
M!#@LQ,587NP<I;9>QV-[<7AFF8PC0(R(]0&,CBW$$U(#6U#:5Z3KCN;V6,R1
MM9I:3G7&G1_E4QI]UD#,:#Z8[*4O2(K V,WYD\3J;7^@5TG+0,!=NO+BXQ^5
MXE,XRG2$$P6#OS0>68IR%(H68,3X'A& :A0DJX>5O^^KNPNYM%A9-<^20"IT
M  BC?GG Y8@8YX [77GV!DC&UDD- .OP] 5UT/MMU+:JOQ+474IUUI,FLY95
M4VM%DVJTL8KT?J,JH=<,"R3R:&7VX6&2^F11V7,S<H$W*\J$I"Q8$I(D+6C.
MR83JO-LV"YLC=;!/-ZPV1K##.8Q(_4:!T8;34*D5%#05)I3'*.6Y9)HN6MTD
M$ZFUH*<#5:U%'7;VJLF./VQ]*2WH[P6@T!SRXQ+6#9'=%'&M\+ B+ H-**<A
M)6::HJNKB3S)(7YPB8GDC*Y ( B#,*1#(,.OQR=MMN]MA=MW1]Z:!TL4%;=K
MCPQ;K<&Y%S<#GAC2-Z]*X=XPPB/YTN[1^4*]"]'VHNS$(W'UIIK9RNTJ]NB=
MQPM#*D30ZB),<X^X>,H;)%&7(Y/^EE"^,R-N5MYQI7UHTQ-D8/J!8YPFY[?-
MM5_+M\Y!EB?2HR(S!'400?&K&*1LT;96Y$*1O("V)PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"*)M8?SN]K_VB:Q_VC;W/.=@_
MB5S'^1[7]3>+VSG#^!O)7ZRY@^KVQ2RYZ,O$TX1.$3A$X1.$3A%:LZ_63,?V
MJR'_ !2KY8[/^E[7\IB^K:JO?/T)>?DLOX-RM>C?X%*>_BMK[[TVCECSA\;=
MT_6-S^&>JKD?XE;/^J[3\!&LI<YU=2G")PB<(G")PB<(G")PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<
M(G")PB<(G")PBB;J+^M^\_Z66RG\IKOSSGV;?B6[_O'N?YT]>V>W']*<N?N3
ML/\ A\2EEST9>)IPB<(G")PB<(G")PBP'K!_ 9!_W2_??(.=I[0_CA>?T7X"
M-<%[,/B-8_TWYQ*L^<XM=ZG")PB@)U&-UEND5(1N50RN3KDO*YK7@VO>NE2%
M.@&8F<W)92A83'4KRY8 <J0QQI1MRI8L&27D1O@EIO$3^<84DW6Q;2-WNW1R
MR=U9Q1.EE?2NEC,Z#I-0!Y<:4.BXF[E@+15Y( '22M!6YT_ZE)^UO1Z@74#J
M;6%J [=0ZEY]7EG:E/\ 9"Z$(5:$\3-(JIL9DM(Q6^H9ZB*>DJ]*M0J#6A>E
M"H 0,P:<W(>SVJ#8!MNZ3[)+<&EC(US)@W5CB'M+,-.!!!&H&E<PH$SKGO86
MW ;]L!!;6G@->*G0X=1=/K:X=<6Y%&N--BSIA/Z7(1'U/$,5_8]^.\T@C6E9
M'*^YYYV_"E*]B>'LA.!T"A -N9 &X"0<(.,9J&[$;]NT6HGE_M;)/3=J;&&N
M-1&W"E0":5Q=3$+>;CNS._2.P1E@34<3\F"NO3G;OJTV]):1L";U=TY]C-6;
M?<6I-,9/H]>4A/L/6YK?VI([)GNS16W,\Q"='1P#H24YM<6$L<193J!D 'VI
MP':MUVSEJUCF@ADOX-QB!TBXC&F4@THS0W4VM,"^@Q%>-/L,UV\M<X1NB/SI
MQ'AKGXE7VWOIOU?&VM^ZJ=+^HM87@C44F+-^P5X[?O5EI((KL*8LZYY;*NKF
M,5:K:I2I>$)"$P![FI$<@\Y3GE&!3E>:JE?RVV;9;/;(=RYAEN ;JIBC@#-6
MEI +W%]13' #&A&>(!\\\DKHK8-[&9=6E>@46M_J*;<;%6OKOTL;HMO3VPZM
MV9J7K!U!%7K71[3N\*26E8M=-\D6,9E0RV;-1 7*M;66J4J=H?LEK4))QIY>
M#E@4HC3;[8]LL;:^W&TMKIDFWR[6\B44=H:XBNMK3@]F)<W Y8"M%'N)9'QQ
M/>PB43##*I'17@>E;%:XWIZC]);JZS:R]1.F-2T$)W536,CI"<ZHRFS'!=74
MUKN.CF+C!K:(LY49B1N.6@](D$L9TB-O$J5!.(./ $XDFBGV?8;O:;C<-CEN
M3-::>\;,&#4UQTAS-&0K4T<2:"A P)D-GN&3-CN&LTOK337 C@:_*57L/N;U
M.GBW+F9-6J@T\UPH:CID361=X]3ITO&KT&P\W"SGN[LLH5NB9$52+H2WF(U)
M"1U-5+D+P2F$K3J @R841\L=JY?;;1/W&6ZGO9F:^[M!&\Q-K0=X37M'"HH"
MVM".)237)>X1!C8VFE7U%3U=2P8Z=;ZQ77H]S_J'0NLJS*N"GKUC]$V'#!+G
MJ?U,[O:>UH)$I2]UX\L$EB[H^,;_  F:$.#*?E>(LA6<$ Q+"2N^?,;RC WF
MAFQRR2>JRPF1KL&O T.< X$$ AS:.PRZ#E@;UQLS<- UAU#Q&8R\1P67K%WT
MZD.L='MTIV2H/5^2[&;5W#5U.:&:TT9)+-"]M<IL5MD;R\-FTLOGQJ1B"97+
M:D28<EL<\W;!*2C@".3DGEJ"(L&S;#N%V8[":X;8VT3WW$L@90AI !A:W'M&
MM ZII3 D4.;I[F)E9&M,CR UHKQ^>KT=2L!PW[ZL6NVTNC6M6Y5':7A0;;W+
MZIF7!KLX7$^Q B,HF-2KD<+3,D]DC0_1*TF)8H;U!:Y3Z997!&>>$@KQ$XQ\
MWMV7EJ^VZ\O]JFNZVT6K1*&!U:X.JT$.8<10:7 TJ<5CW]U'*R.9K*/=F*^3
M'C[BM[9/K&W,Z[07AKMJ+9G2XHECUHE(J]L6T^I9LDNKH-C6.D2I#)-%ZEK.
M"21BG);9!W!0-$L>EP#FY6L3*"2LEC)Q@S.PY6M&[=#?;G'N,S[ANIK+6+5I
M;P+WN!;5PQ#1B 03FODEX\RNCB,30TT)>:5/4!CATKOT/7B;@=-S8[;E=5D)
MD%[:OV@R4-/J\KBUF2=T@\6!+WY@8H98T1NF,">V=YIE_2R##@$X@PY868D/
M0"'@62EH\'<FN^'H-L;(]MG<1F1KG,+9 UH)<UT9H0\4IT8AW4OOKW]F=+0%
M[30@&HKP->A2(TVV0ZJLZLFOU-\UST]]AM8[)2.9"Z^.GK=KXZ)Z1=D[*F?6
M51/6VY)@:"R6R0!7ID_A1+*D]*6HPMSDTK!9)\'=;#ER&W>+.2^@W",C['<Q
M@=X*T.DL;V",3VZ TIGB-D,ETYP[P1NB/%AR\-<_$MSG.44Q.$3A$X1.$3A$
MX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1:N4_\X=W_
M .(7'/\ 4HE// &?'63]](_\"E7[(E_A;!_RMG_WLME,K7[^]-H?Q^7-]^KA
MS]9\[?C.W?J6Q_-VK^?7L_\ Q3=/U]N/YR]9\YQ:[U.$3A%%3>77=7MII]LA
MK:V.R1A>;DJ*90J.O3CYQEL:Y.XM1PXPN=<)0&*A-*:0$)A*L%!$9E/@> XS
MGLQFRV>^&V[I!?N!<R*5KB!F0#C3KI6G6M4\?>PNC&9%%H^J#?;J55/J]4&D
ME>]*S8T6\E11:LJ"(LZS8%DS00UJK]*PPI3:;G>L:G#&6^H%\9;,*Q(&T\@G
M"@T8REA@"?-S.NNMEV"YW&7=Y]R@^!Y7/DT,=_::NJ[0(RTT()I4UPS&-5"9
M/<LB$#8G=^ !4CLX85K57*UO^U/2HW0VYLR9:?[!;G:][S2&N+<2S?1ZM16;
M-*WNF.P$3'949D-0+9("1M,/>WS.5#6N6.F4I" )!85*I8)223K<S;N8]IM;
M>*Z@M+ZS:YFFX?H:Z,NJPA]*%P&! %:UP H3]!EM9GN+'/C>0:M%2#3'!1\F
M.LNWMW:K]<'=6S-;9U6%K;]UU64,HW5)L;W";W,AKRA(J7"(RXR:+1E,Z.?K
MU.DAA1YC427YRF,2'9\$)1I.<SHMPVRTW':-IM[ADEM92/=),2&LU2.U$ F@
MTM^>R-1C6JUF*9\4\SFD/D HW,T&'E*EKU2:5N.P?Q?0VEX%4MF3>XLT5I.T
M8J>(0.4R6R\NT4GU#K)0UX@C,U+91EQC:-G5FKR/-?%1EI3A'! $H>0UG+MW
M:P<[>MS2QLM>^N#K<X!E"V2AU$TH:BF.-11;;ICW;?H:"7Z6X4QS'!94ZSU5
M["M]3ZU;KZ@0"2V-M7HS;*"6Q*!12,OLOD4YK*V&/%86]"$T4BJ<V5/9;@E<
M&U4K*2X,\-N0JQF$C#C.01N5+FQ=<W&T[H]L>VWD6ESB0T->PZV.U' 4H0*\
M2,5G>,DTMFA!,K#ET@X$*,LFZ3ENS7H+1?4B/I&[.VSH3%=J)6V3P:()$WV+
M>)P3;\WA,^4/8"6L3BM3.BB-8,69*0@4I4_G)F$P33,V$?,MK%SF[<WD_!@K
M"TM^9B#=#7-IC3 /PQH33%:C:/=8B(?;?2QXFM2#[RP Q*&N^PU;3=%_BUM4
M4;L4\R=@;+LL[<'I_P!2L.G=51Q$YD%3V2Q"<M">'2&X X;"U!C6F2&-R@T>
M2_! O]P)DUX=9=Y=7F_R36(:3&R"Y>9WFG9#FG4&8TJ34=-%K%)*,9;!LE<2
MYHTCIQXK9Q4=566U==?:ZVUM;SIMJ.0:)TQ#HW9JJ'OZ.N7N4M,Y;E3C%629
MG-Q<9<I V(R\F'H2%(U))0<B$# <=O.?N;FW=R=;6PD8;IMX]Q9J&H M-"6U
MJ >FE%*8UPOGOH=&@8\,^E1E#1UU_*F_&69#['[2] 7OK'0#!1[Y[/Y9Z'N5
M]9M+;-BKPRU2Y^B/,K#=FJ3KR&U2F:!K#B%YQ:<80FC"#-AZY:?!VP,[V/7#
M<2&0:FU8#.P@O%>R"!4%U,,<EJT/[VY-#1S13#/LG+I4.9UI1;D%ICH\;C2G
M1%3NI&M<M)H_KUM9I/-*I9Y-;+(U.D+1.+),(I4MCL3B:\SJ#2Y4I L:LMWI
M4H911)8 @/4*$=K#NUM-=[IM4=X+22>[,L,[7D,)#J%I>TBC7-I0UIF> !TN
MA>UD,QCUAK*.:1CET'B%L'T":V^U-NP6?271QJOIZ:S5S6[N5[5[[T[K_7O<
MV:6O),J&3T!6+1!UJ84(KY&P&J\.RU5ARRYD#"2 1.%.0@H]Z<ZVVSU>[W62
M^W"20=B.=TL#6#&KR[TG5I0"E,\:*1  Z;4R$1Q@9EH#B>JF07=='BH+:K'I
MD7/ ;)JZQ:]G3I;>X3DV0N<0F2Q.6.+=)G]].C:]!''YL0/"Q%(23@#0FEDB
M+5A%C)61XSCF'--U;7',$4UO)&^$10 N:X.:" *BH)&''HXK[9L>VV<UP(=5
MV!"UV5GIGM['NE7T>;LKZB)LZ['=.VZI9;\RU8FC,X5O:,TKF16O/,3B-,[5
M-$C>K:9L='0(53>F5I,&J4:@9J;!AV"$ZJ]N-UVQ_,>Z6D\S!87T08V9I#F-
M<&-TDEM:MK4$@X$4.%2([89A:PO:T]Y&ZI:<"14USXK9)&]M]QNHM88:)K[1
MB]]0M09345MQ3:"X]Z*;=JZM8YRF<+6QV(1?7F!(;-:BW \E<XB-6O*X#HC&
MG&,(DZ(U,6%?0R;9M>Q0>N37D-UNC96&%EN\.91KJN,KM!IE@T4->)![,@2S
M7#M#6.9"0=1<*''H%5J*HF _(_H,>GUZ?B[XMI]QJL;I##JWV*B&FU,VUK=?
M1HWE^-@D^M#81Y8B7.))A-)B4*\"L2UR, 1C*CT><=X)'37DWPI>_"EGOGJV
MU2$.=$Z>1DL> U-9$#1V-:4H.C4!4Q&-[F/N7V^J89'2"#T$GY/$O5QJ+ 97
M6&M--0>>5W1E23EGA:$Z9UGK3#@P*BX1*WDY0^R*/5Q%@.+J%$RM[PYG!&=@
M\>%RKQ578'QNX'SC<YHKB_EFA?-+"7]E\KM4C@, 7&@Q('1@*#@K6)I;&UK@
MT.IB!@!X%(WD!;$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A%$VL/YW>U_[1-8_P"T;>YYSL'\2N8_R/:_J;Q>V<X?P-Y*_67,
M'U>V*67/1EXFG")PB<(G")PB<(K5G7ZR9C^U60_XI5\L=G_2]K^4Q?5M57OG
MZ$O/R67\&Y6O1O\  I3W\5M??>FT<L></C;NGZQN?PSU5<C_ !*V?]5VGX"-
M92YSJZE.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%$W47];]Y_T
MLME/Y37?GG/LV_$MW_>/<_SIZ]L]N/Z4Y<_<G8?\/B4LN>C+Q-.$3A$X1.$3
MA$X1.$6 ]8/X#(/^Z7[[Y!SM/:'\<+S^B_ 1K@O9A\1K'^F_.)5GSG%KO4X1
M.$6I'J\ZX79<%7:[7?K;#DUFWCI%M+5^U44J-6[$,N+;8X,8X)9A &UP5"+3
M)7]Q:W *I&,0\#'E&,DH)AYQ18NFY8O[2UN)[2_?W=G=VSX2^E=!=32XCH!%
M#X:F@!42[C>]K7QBKV.#J=-."U@;+;%[7=039#I9N4/Z;>[-%4M1F]E+V!<,
MMO\ IMRB\C;)24-8G5*FV-,Q<@<D=,PU@$L-7S%S-;&]0J5IR1)RAE9SGH;"
MQVW9+#<6RW]I-=S6<C6-C>"".LF@[QQI1@J0 34J-))+<21$1O:QKP34?)@.
ME2GI^%; U9='7BL1KT\?+_Q8UITLZ593ME8-JV";/Q)+4),=GS)$IU-X/*8=
M*6XEI4K21E@0N"%8M !O/$3YQDTNMNIK*XM-F@=="#NXY ][.VZ)VNK2YK7!
MP-:<00.T*T6UC9&OG<&:JD4!P#L,<2%J/9]5H]/]G-<IGTQ>EWU)^FWL8QW5
M7KS=EK6ZU2"G=6F2KFMV"IM5H$"4SJ8MEEL;H@),3E-+.E9T[L007^DCO.1D
M#Z9^Y20;?/%S#N-A?V)A<(V,(?,7D=@X-:6$''4XN(/$4JH@B#I6NMHI(Y-0
MJ3@VG'B:K9HC?]@^E%O/O9/U^FFTNW^L6\L]B-YU],-.:W3V_/*\LQ*Q.:&=
MPBQ:^P^-3JV-:Q:K\5*ZB4A18()(\()AR@\A'0%EES)L]G +NVM=PLV.C<V=
MVAKF5&ES74()IF*5K6N !,FLEK.]VASXGFHTBI!X@A8_V#QU%]M6+ICVYL)J
MFKK5Q9>LS1EG1ZGJPA4UF$TI#5..J'KT/.=FI"WO\P:6M^3EJ1"=U^$4=;&\
MK!0E"=,<>-,GW6/P%MC]PM;&Y$C3M4C"][FM;),:5;$"&DCYT5<3C0D"IQD]
M8E$3Y&4^S T -0WI=G\I3BZB%6V=-NHGT9)M#*YG<NAE77/LHZV;+HQ$) _Q
MBNFQ]JF,MS&XSM_:F]6U1% \N"<PA(<X&IRU!P! +R(6,XQ4;'<6\.Q[K#+(
MQLLD408TN +B'DD-!-7$#$TK1;[AKG7$+@"6@FO5AQ6EV=4DCB&WF[4BZ@_2
M&W9ZD.P5@7S,'75FW*[CTKL_60&N#TM('359*I*"7-T)II-$\)!!6#/;'9<V
ME*C FED%8$%3U<-V9=LM(]DW2TL+%D+1,QQ:R7O1Z;Z:2Y]>%"T&F%3E"<RD
MSS<0ODD+NR1BVG = 6*(QJKMN1T ]ZM?GS3VZ(-?3EU!V^9M-!Q2G)JM5JHJ
MX6#KV^&.%3,T>8EZ69UQ'R6AQ3D+V(:]N*2M@Q^+@H.!<DR;EMAYTL[UEU$^
MR%CI,CGMS#9!1Y)&EQJ#1U#4Y+$12^H21ECA)WE:4/2,ND>!>ASJW4->$S:-
M2]I-<X$=<5H:+[)L-[GTBC6%H'JV*X4-2I@L2,P]4;C)>)T4V&$J&T L#\7P
MS0@*//R2G-XCEF]LXG7.W7S^ZM[RW,?>9ACJU:7?R:X'Q9"I%A=L>0R6,5<Q
MU:=(X^-:H-BMX[7W(ZA'1_;S]'-K]5:MANU[BXGR';6NRZGFLUL-5 CQJ62$
M04QT<G)PA\2CI*E0L>L#&2<:J*+&6D$5V*.DL=GMMJV3='"\MKFX?;4I"[6U
MK=6;G4 #G&@#>KC7"+).^:XA[#V-#_FA0DTX#Y:X2C7YCT5W:W>>]F^D%*>I
M10VUUV/FRM(W?2^IM9;86;7TAL(2AUGM3S*/2ULR\Q:-(9":8-&9E>0F+\/Q
MBBE(UYF$R.]?O&TVC-OW1MA>VT(BDCDF?"QP;@U[2TT)IG@3P)%,?AC$$SS+
M"9(WNJ"&AQ%<PIZT3%;NB>@NQ$^=>CUJA&Q6O/W)S9>G75<3KZE)7+]<$IZ1
MO;U%YK1,4RKVR+W)8A*EQ3)EG90'$$E)@83KCL)2J:\DM)=Z@@;NER[NF &Z
M>YT@;+F>[Q:YL=:#5J=Q.+15;XP\0.<86"I] 4&'7P)ZL%JEHC59BD^]FIEI
M=,?IO]1KIOK8C=D7EFXDMV8:9)3NOK]0R$]V63N#1N'S2Q)JOL-^G1:\QJ2I
M&@Q"@:B $F!;08/,6(^CO-Q?'LUS;\P7]A?AT1$#8B'RB3#2XN:UH:&YDNJ3
MCVL*&*R(&=CK:.2.CNU7 4XBA)K7Y O:)SRE7*<(G")PB<(G")PB<(G")PB<
M(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PBU<I_P"<.[_\0N.?ZE$I
MYX SXZR?OI'_ (%*OV1+_"V#_E;/_O9;*96OW]Z;0_C\N;[]7#GZSYV_&=N_
M4MC^;M7\^O9_^*;I^OMQ_.7K/G.+7>IPB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(HFUA_.[VO\ VB:Q_P!HV]SSG8/XE<Q_D>U_4WB]LYP_@;R5
M^LN8/J]L4LN>C+Q-.$3A$X1.$3A$X16K.OUDS']JLA_Q2KY8[/\ I>U_*8OJ
MVJKWS]"7GY++^#<K7HW^!2GOXK:^^]-HY8\X?&W=/UC<_AGJJY'^)6S_ *KM
M/P$:RESG5U*<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB
M<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"*)NHOZW
M[S_I9;*?RFN_/.?9M^);O^\>Y_G3U[9[<?TIRY^Y.P_X?$I9<]&7B:<(G")P
MB<(G")PB<(L!ZP?P&0?]TOWWR#G:>T/XX7G]%^ C7!>S#XC6/]-^<2K/G.+7
M>IPB<(G")PB<(G")PB<(G")PB<(HB[FZ2TAO76#36-U%3!L]4Y@TV)75@UI*
MUT%L^L)^R$+4;;,()*T(%&&YV)0.2DC(%*=6D&$WOB)R:62859[5NUWL]P;B
MTT'4PM<U[=3'M.;7#B*@9$'KI5:IH63MTOK@:@C @]2C;K/TE:/UWNZ/['RJ
M]-P]N[N@['(8Y65A;G7\X7<[U4S2Q)YA)4E?)PL,7:F43RB,.*.-&G/.\-2<
M$(PX'GLG[AS+=WUHZPCAM;6T>07M@C$8>6XC5B2:>$9!:HK1D;^\+GO>,BXU
MIX%M,YSJE)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G"+5RG_ )P[O_Q"XY_J42GG@#/CK)^^D?\ @4J_9$O\
M+8/^5L_^]ELID4$+!15PM9GU"QLOJSQJ2LX%@02WUT(D[:;C PA%DL]K>B18
M%V=W(N]C&<]G/UISH-3MKN&XQ2;+:4/7&PQ.'A#XW89Y+^?/()T,WBU=A-%O
MU[J'5*\3,/@+)&FN5:TR6?N<4N^3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1
M.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X11(ITWTIM-M^\IL!&W(2* @WG(!]\LUZCD.E$C=R<"[H<!,1D3I
M*6,..]W1XSVY[>T(?-^6'>L>T+F:ZCQ@8-N@KTOBAEE>/\T7# 1P/&N ]PY\
M9ZG[&N1=OFJ+J1V]7FDBA$4]U;P1'P.-G(X'"H(PI0F6_/2%X>G")PB<(G")
MPB<(NBE" ]UC4B;$N,94N+$[($^!9[ Y/6(%"<K L^]C)AF.WDS;IF6^X07$
MGVN.9CCX&N!/N!0=S@?=;;<6T7VR2"1H\+F$#W2L=:]N2=THRI5"87> 17\7
M:C?G@6,;2F95Y0L9QC.!E+F\P.<>]G'9R]YW@?;\X;FR3-U],\?S9'F1I\;7
M KG?9]<1W7(VTR1^BW;X&'^='&V-P\3FD+,7.678)PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB
M<(G")PB<(G")PB<(G")PB<(HDZ:&!<ZWGDN39"-HGVPNP<S8#0YSGQV1SM:2
MID:CMS@/:$X2 8@Y[.P0,XSCW,\\X]E[A/L5YN4>-M>;UN,\9Z6.NY0T^/22
M.JB]O]OC#9\V;;L<M1?;9RMLEK,/G98]MMW.;X@\ ]!J."EMST=>()PB<(G"
M)PB<(G")PBP#K&/!5/LK29G 5\;?YU&W8CMSD25S:9Q(2#RA^YCLR,O(#,8]
MX)F.WW>=K[01JYHEN6_:;B&WE8>EC[>(@^6H\(*X'V9'3R?#:.^WVUQ=0R#Y
MU\=S,"#XJ'P$+/W.*7?)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB
M<(M493NE+M)=/LB!F/*NIJU1,"O!F/#"L0:Z/-1F'B,[.YX YPY 1![/=\8.
M0Y]SL%G\[MN8QS _>,/4G<^LAK7"K=M?9DUZ._<&?SJCK7[5?8S.Y-CY9 /P
MHSV0R7);3'2_?(MS IG46D9E/\@@YX*84C6!IZZ2YFMSA/7ERD,\;E+@+'8E
MC5C,A8D46>'$[/U")JDK,/S PSLP6!2G+&:,(<XY^R+&(\T<IG:HNUOFU.?+
M"WC+:R'5,QH^:?%)]D S+7.#035?SAW"4<H\YC>9NSR_O#8X9W_,PW<8TPR/
M/S+)H_L1.0>UI<0"%)KGGZ])3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3
MA$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1
M.$3A%BVYK8CU*UZ^3V0A.5X0@*1,3"A#DUXEDI<A>:QZ)L24.!FJW=]<A )*
M"$(NX'(C!=@ #%CG^:.8[+E799MXO:NT -CC;B^:5V$<,8S+Y'4: ,L7' $K
MLN0>2=T]H/-%MRUM9:PR$OFF?A%;6\?:GN9G9-BA95SB2*FC15SF@V5K%6T@
MKFL\GSGP!6;8\E?[5L\Q-G.4Y<TFRH*U2TI\Y$9GS:,M121K+[!B!D*+M!GN
MYQC%5R#L5[LFPZ]WH=_OIY+NZ(R$\YU%@SPB8&1#$BC,,%T/M@YMVOFKF_N^
M7-0Y0VFTAV[;P[TC:6C=#9'9=JXD,MP[ &LM'"H*D/SM5Y8G")PB<(G")PB<
M(G"*-5=K U99$EIYV%YJP2UU>; J-8;C!2,\AW4"<IG"$PL8"06MCSVH-5D$
M8R(P:-5W\_F>SG?;Y$>8MAM^:+;M7MM&RVO6C%P+!I@N#Q+98P&.=D'LIQ7G
M'+THY7YBN>4;KLV%W+)=6+C@TB0Z[BV' .BD+GM;F8WUX*2O.!7HZ<(G")PB
M<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(HR;/VB[P^)(:]KP85EVW*>H@U7-
M10Q^<-ZI<1DI\GJ_P0F&HV" -!IC@H4B!DL)A90,]O?YP7/_ #!<[9MK-EV3
MM<U[HXV]HP9M+A22X=2I;';L)D<ZE 0T'->O^Q[DZQWW?).:.:08_9YL#6WF
MX2$#2]K#6&S96@?->RAL#(P0XM<]P]%9?JZO66IZZA5:Q[OB9X3&VJ.HSS0!
M >M]')2R5#DJ"#.086.:K U!W=]S)IHNSW.=+R_LMKRYLEIL5E7U:T@9&TG-
MVD %Q_E/-7.ZR5PO.7-&X<[<U;AS;NE!?[A=R3N -0S6XEL;:XZ8VT8VN.EH
MJK\Y<+FDX1.$3A$X1.$3A$X11I;58:AN=Y97(64T$O%S!(8PXF?4(6JTP(RT
MLBC:@[.,@),EZ%$2N1Y&(/BJ2SB@8$+..=]/&>9^5(KN#M;QM$?=2M'I/M-1
M,4H&9$#G.C?0&C"QQ("\WMI1RESC-97'9V/>Y>]A>?19>Z0V:$G(&X:ULL=2
M-3P]H!*DMS@5Z0G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"+!>PEQ
M%4U #W5M18D%@R981$:KA1/:-?,I^]9\V9&M.0#.#,H4IP_.5QO:$)*,D><B
MP+(,"Y+G3F9O*^S&X@9WV\SN$-I /2FN'X1L ^=![4AR:QI-:TKZ-[+^0W\_
M<SMLKN3U7EBT8;G<;LX,M;*+M32.)PUN [N%N)?*YHI341BOY+I_R2/8/Z>_
M[^^B?6KUZ^H\?VV^L'M$]<?./ \?S?VA?5]O9XWH_P"L]O9SG?\ A^[_ (;_
M +(=]_WQW?>^L<?7N\]9[ZM*T]9QZ>[[-5VG_&./_CA_Q)]6_P#Z:[_U;U/&
MGP3W/J/JNFM-7J6&>GONW12Q?V!FE#,Y1Z0MJ5W97=*8B<6Y:7@U.J3FX^J
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M83E:2^0>=<<[.T%CRVE&/<_^OJ?L7FLD#-9CE+F0Y6<WD'G7'Y4&O_X5(O\
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/3A$X1.$3A$X1.$3A%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img37592182_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img37592182_1.jpg
M_]C_X0].17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    ?    <@$R  (    4
M    D8=I  0    !    J    -0 '3+=   G$  =,MT  "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C(@*%=I;F1O=W,I #(P,C(Z,#(Z,3 @,3 Z-3DZ-3(
M  .@ 0 #     ?__  "@ @ $     0   MZ@ P $     0   5$
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   .%         !(     0   $@
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M?8Z$CTO0C[7DB3SZFNF[3Z/\M!39^T-_<?\ YCO[D[+F/:YS9.SZ38(<#S]
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M*22224__V?_M%R)0:&]T;W-H;W @,RXP #A"24T$!       !QP"   "
M.$))300E       0Z/%<\R_!&*&B>V>MQ635NCA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!GZV@@        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 +];
M00 !  ( OUM!  $  CA"24T$)@      #@             _@   .$))300-
M       $    6CA"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #00    8              5$   +>    !@!G
M #  ,0!G #  -0    $                          0             "
MW@   5$                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   5$     4F=H=&QO;F<   +>    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   "W@    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
M   $     3A"24T$#      .,     $   "?    20   >   (C@   .%  8
M  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(
M# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,
M# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ 20"? P$B
M  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*
M"P$  04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&" 4#
M##,!  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q
M8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75
MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
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M) '379%]UEW36!IBP[+K &_I\AI&^[WM_1K;Z?TO+?;;:2ZNNYXL.\0!%=5
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M '0 ;P!S &@ ;P!P    % !! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\
M<  @ #( ,  R #     ! #A"24T$!@      !P (     0$ _^$0^6AT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+ON[\B
M(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T82!X
M;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0($-O
M<F4@-BXP+6,P,#(@-SDN,38T-#8P+" R,#(P+S U+S$R+3$V.C T.C$W(" @
M(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G
M+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(B!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO
M<&1F+S$N,R\B('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+R(@>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]M;2\B('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(B!X;6QN
M<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS
M.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W O,2XP
M+R(@<&1F.E!R;V1U8V5R/2)-:6-R;W-O9G3"KB!7;W)D(&9O<B!-:6-R;W-O
M9G0@,S8U(B!X;7 Z0W)E871O<E1O;VP](DUI8W)O<V]F=,*N(%=O<F0@9F]R
M($UI8W)O<V]F=" S-C4B('AM<#I#<F5A=&5$871E/2(R,#(R+3 R+3$P5# Y
M.C4P.C$V*S U.C,P(B!X;7 Z36]D:69Y1&%T93TB,C R,BTP,BTQ,%0Q,#HU
M.3HU,BLP-3HS,"(@>&UP.DUE=&%D871A1&%T93TB,C R,BTP,BTQ,%0Q,#HU
M.3HU,BLP-3HS,"(@>&UP34TZ1&]C=6UE;G1)1#TB861O8F4Z9&]C:60Z<&AO
M=&]S:&]P.F$Y,#AF9#,T+61A8V(M8F4T9BUA-6,T+3)C,#DT-6(P-&)E.2(@
M>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#IF83AD,3EF82TU.&0R+34W-#<M
M.6$V,BTR9#-B,S!F969D,3 B('AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#TB
M=75I9#HW0C5&-C-#."U%-4)&+31$030M.$1",RU#.$,U-$1".#@U,#0B(&1C
M.F9O<FUA=#TB:6UA9V4O:G!E9R(@<&AO=&]S:&]P.D-O;&]R36]D93TB,R(^
M(#QX;7!-33I(:7-T;W)Y/B \<F1F.E-E<3X@/')D9CIL:2!S=$5V=#IA8W1I
M;VX](G-A=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7 N:6ED.F,V.&0X.&1A
M+3(P.&0M,V(T82UA8C,U+3-A,S-E.6%D9#@T-"(@<W1%=G0Z=VAE;CTB,C R
M,BTP,BTQ,%0Q,#HU.3HT-"LP-3HS,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB
M061O8F4@4&AO=&]S:&]P(#(Q+C(@*%=I;F1O=W,I(B!S=$5V=#IC:&%N9V5D
M/2(O(B\^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)S879E9"(@<W1%=G0Z:6YS
M=&%N8V5)1#TB>&UP+FEI9#HQ.&1E,#EB-RUD8CDR+64X-# M.#,W,BTW-V,S
M.64R8C8X,3$B('-T179T.G=H96X](C(P,C(M,#(M,3!4,3 Z-3DZ-3(K,#4Z
M,S B('-T179T.G-O9G1W87)E06=E;G0](D%D;V)E(%!H;W1O<VAO<" R,2XR
M("A7:6YD;W=S*2(@<W1%=G0Z8VAA;F=E9#TB+R(O/B \<F1F.FQI('-T179T
M.F%C=&EO;CTB8V]N=F5R=&5D(B!S=$5V=#IP87)A;65T97)S/2)F<F]M(&%P
M<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O:G!E9R(O
M/B \<F1F.FQI('-T179T.F%C=&EO;CTB9&5R:79E9"(@<W1%=G0Z<&%R86UE
M=&5R<STB8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H
M;W1O<VAO<"!T;R!I;6%G92]J<&5G(B\^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N
M/2)S879E9"(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#IF83AD,3EF82TU
M.&0R+34W-#<M.6$V,BTR9#-B,S!F969D,3 B('-T179T.G=H96X](C(P,C(M
M,#(M,3!4,3 Z-3DZ-3(K,#4Z,S B('-T179T.G-O9G1W87)E06=E;G0](D%D
M;V)E(%!H;W1O<VAO<" R,2XR("A7:6YD;W=S*2(@<W1%=G0Z8VAA;F=E9#TB
M+R(O/B \+W)D9CI397$^(#PO>&UP34TZ2&ES=&]R>3X@/'AM<$U-.D1E<FEV
M961&<F]M('-T4F5F.FEN<W1A;F-E240](GAM<"YI:60Z,3AD93 Y8C<M9&(Y
M,BUE.#0P+3@S-S(M-S=C,SEE,F(V.#$Q(B!S=%)E9CID;V-U;65N=$E$/2)U
M=6ED.C="-48V,T,X+44U0D8M-$1!-"TX1$(S+4,X0S4T1$(X.#4P-"(@<W12
M968Z;W)I9VEN86Q$;V-U;65N=$E$/2)U=6ED.C="-48V,T,X+44U0D8M-$1!
M-"TX1$(S+4,X0S4T1$(X.#4P-"(O/B \+W)D9CI$97-C<FEP=&EO;CX@/"]R
M9&8Z4D1&/B \+W@Z>&UP;65T83X@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" \
M/WAP86-K970@96YD/2)W(C\^_^X #D%D;V)E &1      ?_; (0  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @("
M @(" P,# P,# P,# P$! 0$! 0$! 0$! @(! @(# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\  $0@!40+> P$1
M  (1 0,1 ?_=  0 7/_$ :(    & @,!              <(!@4$"0,* @$
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MHW\O6^/W;N?"M_',)LYLVY09]-TCG^%W)(!L"; @NT0UX9_XOHY;X3U5C_*
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M\A>V]N83;?<&U^R/D9_!^V:3<AQNYL#_ '%S1_N-FO\ ;^ZWED/$TZ<4&?\
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M^7^4=>\^E?TU\,.CNB.X^Y^Z>LL5E=M9_OFFVPF^\3298_W(.5V\S_P3,X/
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M:_Q\S&7S>Q!M+?F:V]EEW1F\T-P9K>6=S 429_<TF>LW\2(U"]O;PW,YJ/\
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M1M_KL!<^_';)!PS_ *OF0.M>)T<K&Y[$Y:&GGQ==2Y&FJKFDK*2K_B(_Q/\
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M3V/V0FV&ZZVINSL#,92KW0,O@-IUF%R38#%[%S6 P.>S'\<&XAMC/J#FP?\
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MLG*TF'&Y\?E,&^WWP@_CPW)_=G^[;;>WM090Y3Z'Z>]C9/\ 5_J;KWU_F/\
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MW)AAD_\ B/9?)O35R?\ 5_O/1;N$266%'^'Y?;Z]4[]V=D?)/#U60@KLKO\
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M/,XW&?\ O-^U/^N9!Z?X?^M719_4:Y]?\'_6SJ1A_E=V-F*6H\^P.[,;4?\
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MN>!_JX?(>G2@A]FVCPL]%4DI8=/$/_&O^*>_?O018_U?X.D+QACGIXA'[O\
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M]U[J/-%YH[?G_8_[&WOW7NB*?S /AAU_\Z_C1O?H'?$(_P!RE&:S;F64WR.
MW4ITX7,#Z<JP_/LPY?N!L,JL#VY_P,/Z7\72>X%5I_J\NOE5?,SX6]X?"'N3
M<'4G>&U<EMNHI:S*?W;W#]G_ +]G=N+_ .7%FL'G/>16P;]%NT2@M_A]6_HC
MTZ#EQ;LQK_J\NBSX'<FX]GYFGSFSLYDMMYBE_P MHZO$UG^Y/V)KQH[O /\
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M *7)\R?_ +=?OW7NN_\ 9&^H_P#GO_EG_P"ER_,?_P"W9[]U[KK_ &1SJ/\
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M&#E;N4?X?G_2?^/_ %>3A#_OO];\>S7;K;QA4_ZN/SZ475U^]\#_ %</DO\
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MT_\ H"=D?_9/[]U[KW\(^<'_ #VWQI_] 3LC_P"R?W[KW7OX1\X/^>V^-/\
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M2=W0WX?(_P 2H()_]WD?3_;\_P"V]@RZMS4T&/\ BOGT(H).T>O2AF_S-_\
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M^A_WC_BGOW7NLWZ$_KI'OW7NL<T/E_WWU]^Z]U%_AL']#[3^&W6Z]9_M(?\
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MBV,_Y7Z3_P Z5_XK[]U[KW\6QG_*_2?^=*_\5]^Z]U[^,XK_ )V-!_YUP_\
M%??NO=8OXQB_^5ZE_P#.P?\ %??NO=9?XMC/^5^D_P#.E?\ BOOW7NO?Q;&?
M\K])_P"=*_\ %??NO=8OXQB_^5ZE_P#.P?\ %??NO=9?XMC/^5^D_P#.E?\
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M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=8)O\
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MP^+_ /=+[,(^'7N@O^3DWV?07>$__*KU7OS_ -TN?][ZU)PZ&#K>'P]<]?\
M_AG[7_\ =+[]T7R<>EU[4=%O7&#_ #@][\^M'AU(F_S7^Q]^\NDPX=28?K_L
M1[\.O#AUG]IND?7O?NO=/&-F^SEIY_:2[C.G_5\NEVTR")A7_5\70W31C(T(
M4_FY'L&W,5&('0R+^,E1U0=_,,_D!_$?YU9C+[^H:*JZ3[@RH%;6=A;)H<0,
M;G<G:X_C^"(OG>!^;>Q!8^X5W&%4YH*<14X/GX9J?4]-21'C3_5\NM='??\
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M'X?_ *-]^Z]U[_9%?AY_WCEU)_Z!^'_Z-]^Z]U[_ &17X>?]XY=2?^@?A_\
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M]^ZWT1_O+YC97N"EQ^#Q6W*;;>W\71_9?:?>>U/6N@'P^2KLE5?Y=/\ <_\
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M+Z]3Y]>_C%%_ROX[_P [![UX)^?[/]GK7Y]>_C%%_P K^._\[![]X)^?[/\
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M-G_#/NF:J_?VYC:;_P C'OWT!_U?\7U[Z\?ZO^*Z/!\>_B+V-MOL;9^<RO\
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M((+*XE%:X_+_ #]15&8HW(_S].'['^^/_&_:OZE/3_5^SI)HB_U5ZD0PT/\
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MWN?^^OYI_P!;.H_^E3_LZLE_O7NT>]+7C_J_WGHV_P!:^X7\/^#_ *V]-_\
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M2WSVP_FS1U^Z-QT']_\ "8?/4>PZ+,;AJZ/,Y+?-?M?!?W@&"_W![>_W\_\
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M<=PGO+HCO#JK8.:W+NCH?X^;IK-MTE'1_P# [=.<WKU'@,_LH_\ AU]=9S.
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M/R\SU7_G'[\)#U[I/S4>ZO\ CO\ T_Y0_?OKS_J_XKI1X8ZD4>-ROE_?@_\
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M>"H]/^+^?1;)(5/SZ:?9GT7=9H/\X/>_/K1X=2/?NDUGY?ZO7J1!^?\ 8_\
M$>_=>O//_5Z=2/:;I'UZ#_.CWH\>K^OV=3X/\[_MO:B/@>MW''_5\NESM?\
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M+_+OBOV0*@<_Y+F</D?]YXM]??NO=2?]/G;O_>,':7_G9A/_ +(??NO=9O\
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M3V7R?BZ7K\ Z SY$X'^\G4.]\4(14SU.V\J*4?3U673^?Z>R_?H_$M](&?\
M97H7\DS_ $F[PL6HF:_[P]/7UZUHO\S+X+_X>X?NHS%(:_ZN'6>UK.+K:XZ?
M/_CY^STZ<(?\U_O ]NI&>ETG =/$/'LPC0TZ02<?]7RZ>(?^1^SR/CTW))\^
MG'Z_X>S%/+HN>09IU/A_S7^O[LD9Z)9. Z<*/V81H:=%TGQ=3_9Y'Q7HGF_L
MV_U>?2IW)\8]N=Y=7U%=_"J:IW1BZS*?9U?LPCX=8]<[?VC?ZO*/JK?,3=X=
M,Y2HVY!O'=N-Q]+6?9?W3W9_N2QG_KP>]2?#U'7Y=1YMR5VY/WZZAVWMO(?7
M^+;3K/[M^T,O'KW3Q1[V^36!Q>0H=J]TY+)8>J_Y=.6_W)?[S[?Z4?1GU_U?
MMZ _?G9WR%K*7^%97*XVIQ_WF+^\^T_W&^_=>^C(\_\ 5^WH)Z/OBNVW7U$^
M5P=-3?Y9][_DF8]^COQ7Y?ZOET7_ $!_U?\ %]&@V'_,FVY@:7^%97;E-DO^
MFO\ O)[,8[_'^K_-U[]W_P"K_4>H^2^771^Y,I496?:M335%5_V>'LR_>8_U
M?\5T6_NP_P"K_B^A0VK\QNG:/[>"AV=]S_Y.&&]^_>:^O^K]G7OW9\O]7[>A
MXP/S>VK_ )/!BNN:;_T),-[4_O,>O^K]G2?]V'T_U?MZ&C#_ "NWCDO^+'US
MMO\ ZJ]R>_?O,?ZO^*ZU^[#Z?ZOV]#1B.R/DGO:+]B#K?"?=?\I>6W)ALE_\
MLGLM\0=*?#/2XAZ3[IWM%X-U=[[)PE/5?\HFWO?O$'7M'RZD8'X*_'/&U_\
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M (S_ )!S[?Z4?6G_ %?\5T%^S_C?\K\/_P ?'NKK?>V/^S_R/_?A_P -R?\
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M!>U^>0#_ (>U,EN4_P!7^STFQT*%7O/;E%23UM1EL;!!2T8KB35 7QMOUV'
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MX/\ )_XQN@_^MK/^W_6O7NA8AA/VO_(O?L=>Z]-^S_OO]M[4P5@()Z]T0_\
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M_FO?+B?*?Y3_  O>&U\)1_=_\ZO!;+P'N=.0740J!P'_ %TZ+GXGH!_Y>_\
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M,?\ %>GIU[H-M^4?RU_T:]?P;.W'\O?N?[R97_9@ZO<.Y.R\;E*#=']S,]_
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M,8P>XC_(,\.I%V.W61 2,?\ 171MY>(_]@?^*^P+,Q4K3H2R?!U\SG_A3?\
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M #)^I\Y!0U-3M?I&CRG9V8J_L_\ G1?\6+_UX_8%YVE A8L:#'^&/JVV<?\
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MP"M?\/\ G/KUXR'H6.L>M^S?D)V-M_KGKG;FY.R.P-Y5G\%P^)Q/^Y+)U_\
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M.^/^,7TO9&4PO]]ZO_?R8RO_ ([\?<_GMBX7^_&W^MMH\_Z1L'_"_P#BS_\
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M_P#9+[]U[KW^S$]I_P#>*_<?_)6S_P#[)??NO=>_V8GL[_O%?N/_ )*V9_\
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MW ?[NH?^7/[&UIS[*BBI_P 'S_X7U7Z=>E#T_P#\)&)ZROQ]=W3\IZ>IV_\
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MZIJ?\C]B*1-('1=;R"O5"_P/V'L#>TNX*[.;5PF;R&![@WY1?=U='_N3H/\
M?Z>P.EO_ (JW^KS^WH:1R8/6Q1ORCVKMO*;'V=MS%8W"5']P_P"\]924G_:Y
M_@/_ ,@_9CR; #=R"G _\^OT'MS?/^KY=)^+Z?[;V-Q'I.>'0(ZS#W?Q M.J
M].5'1SUE5]C!!]S457^'O5W=QVT9)/\ A]1\OGTFMX)+EQC_ %?ZAT?7J'JV
MGVI0C*5T0GR]5;DV_P BO<67D<@CW"_,6]":4JI[?\.%QPZE/8MJ,<89_P#5
M\7SZ'OP?X_[S_P :]A;H6]>\_P#A_O'_ !OW[KW2%W5EYZ04V*Q0%1F,J+4@
M%C]C:X_BYX/ O_M_:@?/I-T[[>Q*XO'T\$-BQ!-347%V(_"C\\^_,0,'KW2K
M]I^E/1'_ .97_P!N]OF__P"*K][_ /OL]P>_=>Z-_@?%_!\1_P!JC%VM]+:1
M;_8ZO?NO=//OW7NI'OW7NH\L5_\ ??3W[KW05TNX\]-O3+[4EV=N.EH,;B!6
M4F^:K^"_W:KBQ .) &X'W*S!C?E=-_K8>_=>Z!+YE=I9WK;I#,_W6@R&1WQO
M*LQFR=G4F'_XN5=N;.?I_@G]2!_MK^_=>ZK7ZR^7'<.(PVQ^B-R[IINN-[[-
M.^Z/?G8/?5'ALGDJ\X X!L!ALX#N0@;CW7M[-W_U_9S],./^K_#UX'H,._OG
M?WOG>ENW]J[<WCMO978&!VU\R*RLJ]OTA.3P.+Z+[._@.Q<U<_\ %@_O9MSW
MOZ<?ZO\ B^O=&>^//R^[O[ ^0,'7.;H<=4[/ICEMLUNJEP^/RE!_!,/@7P>]
M+MN4[HSZ[K+&P_@]E' X]Z-NH!/^K_#T7>&3T1GO[Y1?(79]?\R.I<'OC>W]
MX.T-^;HK>G]PTG_---K]487/9[?7\#_\ES!?^K]%[W]../\ J_P]>T'H7\E_
M,-^2>'W1V1MS%;<QO\/ZYP_\%HZ3<-%AOXG_ +@NE\!OS^^G_'R?WGW /[QY
MS_G3^W_ C-<<?]7^3I1U@SWS%^25)F.N,WOCL;;>$Q^SLQE*S<O\)VV1C-V8
MO.]+_P!_,%A<YA/P??O!7/SZ]TK^A_F7W1W+\E.M]B[AW$%PV [>RF$JA1T6
M&VV-U[7SGQ\S^_%&<7;VY-VBPW'@_I[+OIO0_P"K]O2GIY[-[-[,VU\M,P%[
M:R.1PU5V3MC;.W-O;=W?_#,EL,G#$MALYU7G_P#F8.WB3<Y7$^]_3C_5_P 7
MU[H!]G_/;O?9.!Z?VY/V-3;_ -P5.8VO1;\^[VWAOXG_ +G>SL]@?]SF<_O'
M_P \Y_SJ</[4?3C_ %?\7UZO4CK?^8#WMUOU+3T.\=\;;W;N#^[F_,WB,MNR
MCMD\ANC!?)S/["_N6?Z_[]O['WOZ<?ZO^+Z]U8;\4/D/V7V]O[M':.]\WA:J
MJVQ2'-4>*P&)Q#?PX-F<Y@&5,Y@=RGQH?&#;*6S!(O:_/LL-F1_J_P!GK?14
M*/M3+?Z)J_LS+?(K=V%^1^>'<E'N3IZDK%R2X X'#;]MA#L8G5U_M[:G\#H2
M,K:W'U_R\>]_1FO^K_/UKI+T?SG^0?6_5(VWO+>V"R6]Z7$]75^V]P4FSL+D
MLEGL;OGK//[A&'MN#<>T=KZM>"O?^O/LX^GCK6G_ !?&O6Z]<NM_YAWR3W5A
MJ?L:>AVEDMOTN_-K]?5G7M)MO_<GGLIG>E_[^?QK!YS_ ,./WOP5H.M=,E=_
M,0^05-MNGIXLUU_V!7YZMZ9;^]>R<-ACB]A-VGLW/;AS6'S?]X-R?W8#(^!&
M,!RW(-?<<CW6=XJ&BC('\N'6ZD]71?%_?FZ^SNGM@;_WOBZ7&;IW1AC6Y>EI
M?H#:P/\ 0\^R"<:F-.'_ !76NC,^_=>Z][]U[KWOW7NBF_-:0#XX;Y/]:O:H
M_P >-Z8$?ZWT]^Z]T::D_P" T/\ U#K_ +U[]U[J9[]U[K__T-^^3Z>]GCTF
M/1+OCO"-U=B]\]BSFV0/8YZ^HZL6O_"MB\'#C_!;^]#CU[I:_*?O:G^.'369
M[2FV[/NIL9F-B[:HMNIF!MLUV5WWO7;VQ,.?XXX*X+]W.W)TCZ^_(^K[.O=%
MYR_RV[3QN0ZXVKB?CU@]Q[V['&ZZVCP^([WPPQ5#C-DX?5(S;V&V]#%F_)%^
M3_4^S!(@PX^7^K_5]O6^HV;^?VQL%A>D<[+LS<%1)VWN,87<>,?*85\EUIC4
MSF!V-F,WG@&0L(]SYVAQH%QS]"/K[T8@?3K?B'HPW>/>U1UC4[%V[M39-5V1
MV!V=ELI0;0VI2YC#;>QVG X/^.Y[,YW.9YBF P2[?6]['\C\^ZB,>IX?ZOS!
M^77O$/1<A_,'V5M7===M3N39.Z^ILE@=AXO>F<I<I0YO>F2;*9S>9V'_  7
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M]U[W[KW24R>WL'EZ"OHLKB:7)4E6&I*ZFK*09#[U18^H-SS_ +"WY]^Z]T6
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MDQ;R_P#ND/?NO=>_N+\VO^\A?CS_ .DQ;R_^Z0]^Z]UR_N3\V/\ O(7X\_\
MI,N\_P#[I#W[KW7O[D_-C_O(7X\_^DR[S_\ ND/?NO=<?[B_-K_O(7X\_P#I
M,6\O_ND/?NO=>_N+\VO^\A?CS_Z3%O+_ .Z0]^Z]UR_N3\V/^\A?CS_Z3+O/
M_P"Z0]^Z]UQ_N+\VO^\A?CS_ .DQ;R_^Z0]^Z]U[^XOS:_[R%^//_I,6\O\
M[I#W[KW7O[B_-K_O(7X\_P#I,6\O_ND/?NO=<O[D_-C_ +R%^//_ *3+O/\
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MIA.OUJZO_<ADOI^6-^/8.N][DN@5,M%^0I_.E?\ !T=6^WZ#6G^K]O0ODZ;
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M?]7\N@@S'PZW_#+YX(,)DJBE_P" =7[]=7EB;M&5<9_B_A'RZ=GW L*?ZO\
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:KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img37592182_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img37592182_2.jpg
M_]C_X1$:17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    ?    <@$R  (    4
M    D8=I  0    !    J    -0 &'"*   G$  8<(H  "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C(@*%=I;F1O=W,I #(P,C(Z,#(Z,3 @,3$Z,# Z,3D
M  .@ 0 #     ?__  "@ @ $     0   O:@ P $     0   3\
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   /X         !(     0   $@
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MK&%SI]4UGW&R-OI^DMA&.BR=&1IYSZH=*Z%TEEM73\S[=F90%N3>YP+W"O\
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M*?JI)?*J22GZJ27RJDDI_]G_[1CN4&AO=&]S:&]P(#,N,  X0DE-! 0
M  << @   @   #A"24T$)0      $.CQ7/,OP1BAHGMGK<5DU;HX0DE-!#H
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M8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M     $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^            !"
M<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M  !2<VQT56YT1B-0>&Q 9 5;(         IV96-T;W)$871A8F]O; $
M4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M         %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O
M='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!2
M96-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#
M[0      $ "@*MD  0 " * JV0 !  (X0DE-!"8       X
M/X   #A"24T$#0      !    %HX0DE-!!D       0    >.$))30/S
M   )           ! #A"24TG$       "@ !          (X0DE- _4
M $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $
M6@    8       $ -0    $ +0    8       $X0DE- _@      '   /__
M__________________________\#Z     #_________________________
M____ ^@     _____________________________P/H     /__________
M__________________\#Z   .$))300(       0     0   D    )
M #A"24T$'@      !      X0DE-!!H      T$    &              $_
M   "]@    8 9P P #$ 9P P #8    !                          $
M             O8   $_                      $
M        $     $       !N=6QL     @    9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   $_     %)G:'1L;VYG   "]@    9S;&EC97-6;$QS
M     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M      =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/
M<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54
M>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !
M/P    !29VAT;&]N9P   O8    #=7)L5$585     $       !N=6QL5$58
M5     $       !-<V=E5$585     $       9A;'1486=415A4     0
M    #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0
M    "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U
M;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F
M875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4
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M$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_
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MJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI_]DX0DE-!"$      %<    ! 0
M  \ 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '     4 $$ 9 !O &(
M90 @ %  : !O '0 ;P!S &@ ;P!P "  ,@ P #( ,     $ .$))300&
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M P,# P,# P/_P  1" $_ O8# 1$  A$! Q$!_]T ! !?_\0!H@    8" P$
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MCW '^T_DORZ1\/\ ,W_G 4?[&<S>_L;4?]->VO?OI]L'^@#_ (UTI2WW"O\
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M_P"._P#073?#V1OB:7_F8W9'Y_YCS,^_> .O?U8O/XOY+_T'TX3;\WCXO/\
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M^_=>ZC05L$T<$\%=3U-/4\FK^[Q%C_K<68G_  ]^Z]UW-604<7^?IO\ *O\
ME;_Y3_P;>_=>Z<,=_P!5/_57_K_[U[]U[I0>_=>ZP3?YG_8#_>O?NO=)>CK(
M*R+S4,]-4T])_P J?^^_I[]U[KHUE#-^\)Z84]C]Y]K5WYYM?Z>W_H?EG_5\
M^O=2/XC3^(^"M'J_X"?F_P"/Z<^_?0''^K_+U[K!-64$,U/_ )=3?['VQU[I
MWQ__  )JO]A_O8]^Z]TZW]H/$/KU:G4>4_LR\^'@^KC_ &_''/NNL]:Z8IIO
M#_GZW[>"IN?NOZFW^/T_WCV8]:Z]5UL-&H^XL(#R?NC_  \7Y^AL+^_=>Z]1
MY*"L_P Q_E/VO_*I[+O$/6\]/%&?VO>Q(>J^O4CV8=;Z;\C-!XOW_P#,?['G
MW[KW31#6?[H\_P#E'V7^^_Q]^Z]UUYH)O]WC[C[R]'_O7OW7NNY:R"&7]^?_
M ,Z_^*_U]^Z]UU63?:?<S3VIZ?[3G_EWV/!YS8_I[]U[I3T?_ :'_@@_WL^_
M=>ZD^_=>Z][]U[J+5*)8S#^6^OOW7NF"CFIZL0&"85 Y-)6?>#)#_7/T]^Z]
MTJ??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__1W4OES63X
M_H;>]33_ .?"XX#_ %FS,!'LXV'^W7_2MT'MX^'\Q_DZI-P^>\W^^_WWY]B7
M<. _U>G5-H_U?\:Z%# UGF^W_?\ 9?T=YZ&C UGOW7OLZ4&>P.W,EBZC^*X/
M&Y+_ *C*/V6R;]=_P_\ '?\ H'I-]#_J_P!1Z3^'V?L?Q?L;.VWQ_P!6?V7R
M;]=_P_X/^@>O?0_ZO]1Z7&V^O=CT8J)Y]J[;^XJO^F/VF_?]W_#_ ,=_Z!Z5
M_NQO]7_%]"!C>L>LO+Y_[@;2_P#//[U^_P"[_A_X[_T#U[]V-Z?ZOV]+#_1O
MUS64M10S[.VW]O5?Y%_P#]F%O?A34_ZOY=)9-L('^K_/U5?\EOC3N/J67(;X
MV/\ <Y+8]56?Y924G_+A]B*#=U4#/^K/]'HODVMJ\/\ 5^WHG^'[(GK*^G_Y
M2?8BDW)/7_5^SHNC+5Z,!@=^>&7]^#V72;DE>/\ J_9T81EO3H_'QU[^V/@9
M<A!N/!TU-]U1_P# O_?7]ATQ ^?1U]0/X>@?WMV=BL]GLA_ Z'&XVG^\_P C
M^T_V/OWA+U[Z@?P_ZOV=!ODMR3S2^"#W;Z@'_5_L=>^M'I_J_9U(QN2_YL>Z
M_%U[ZP?ZO^*Z?YLQ/XO\Q_OO\?;URFH]4\33T(.!R4_V%/Q[76%HS</]7'Y]
M;^K5<?ZO\'5?_?W:FU=D]H9"AW'G/X;]U1_>^[[GRR\X('^KA_2'IT=6',Z>
MO^K/]'H+ZSY4=+8V+P?WJ_\ 5/\ 'L.Q\HR1G(_U?[WT87',R4_U?] ](?/=
MV8//8OS[5KJFI^Z]H;O8&@S_ *O+^ET?;18638#?\>^?SZ#^C\]9%45WG_RC
MW:S_ $,?ZO/[?7K6\;1:-G5_A_H_/K;&^"TT\WQJV+///45,]\I>_P!2/XNW
MT_Q_XB_NE_Y_ZO3J,+'A_J^?1RO]U?[#_BOLOM^#=&%QT&G:?677?;6RLOLW
MLW9V#WQM;*4I^]V_N"D&1QE:+7 93<G_ %Q[]:=K#_5Z]7ZU<?AUU9UETEUK
M_-&[^V!UUU_2]H?'7M7?M9T]N'+8C^(G:>,P6$)_@H_KMZP/L7VUSH,8K@U!
M_F?\G\_EUKR/0WP_.'YGXCXO?&?=^=^1.V<WW?\ *K$C=6S^O-D](X7)[X_A
MPP_D&'V/@B/[K_W?#^K^+;LS&&-^?K[1)MM6(SC_ %>O^K[>D_U@]/\ 5^SH
M/^F/YE7S#^36,^,'4F)W5M+K;L?L:L[XHNR-[978>%W(*\]49LX(X?\ @?\
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M?;?_ )Y_9?)N3UX_ZOV=&,>T+_J_XOK.>H.GLB+S[&VV:BJ'XH_:\;FU>/\
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M?^\\/E_/KWTB_P"K_B^F[;?\I3XI;5JL!/13=LSX?:_:?^E[;6U*W?3Y+:^
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MK,35_P#%S]SERSIEC!K_ *JMT -[E,3D?ZOP]$/^2/86#A[!H)YX*G_*L/\
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MG]G=;]93;HP^*J-N4V2R'\'_ .!=7[=W/=VB!H?]6/Z/0\Y-Y*34"1_J[_\
MAG15]^;#Q.S\IC_X'!4TV.JO^->P]%N[2G/^K^74@[IL*6J@ ?X?E_2/KU[
M?L_],W_*[5^R?<)"1_J^719;QZ1_J^?2@FWY@\;09""AH?XED*JC^R^[J_\
ME ]H+:/4:_ZO/HMW"0K_ *OLZV3OY<[>3XC=3GS$_P"X<?3_ %_;U]_:</+H
M 6?PG_5Z]'A;V7P\#UNZ_#_J].I/OW2CKWOW7NHWW4.O3?GZ7M_OOS[]U[J/
M-D::+ZS _P"P'_%![]U[KC_%L9_ROTG_ )TK_P 5]^Z]U+^ZI_\ CJO^\_\
M%/?NO=>@F@EOXC?_ &'OW7NI'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NHG[2CD@_[?V7ZZ\.M1VR^0KTA\OOO%X[]DS_<S\\4MC_3_#^OO?B4P./1
M_;[4TAU-@>G^H])F;M.#_=-#?_7JQ_Q0>RWZ@^71K/RC=(OQ_P"#_H/J?CNQ
M\562^":"HIC_ %(O[\+@_E_J^70?GY;NE)&K'Y?]!="329*BK8Q/!,+'Z\\_
M[8W]B'HLZD^?_#_>/^-^_=>ZD>_=>Z][]U[KWOW7NO>_=>Z][]U[J/Y_\/\
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M<IF- =(KYG%3QSANBZ2X!.3CJK#_ &=CYB4>9_CD'R:[U_B'_*W_ *2-Y?\
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M%=3T^[Z?&;BP_P#RF5=& ,F/];BWY]B'8?>6XA'=G]G]+_A/0-YB^[C!/41
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MS_I=6^H4<>/^KY=:-/RB_GD?S$?DYGLA75W=^;ZWVO55G^1;'Z\_W[6,H/\
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M_<-?]7GT,&!K/]]_OOI[+NE=C_J_GT,&'K/VO]]_O?OW1C<</]7RZ4&>F_W
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M'V_TOZ70<DN&]?\ 5^SIGP_PYV=A]N4^X]\=C?;5%51XNM_N1B:/^&Y.O_\
M(Y[&-Y,EFM /]6/M]>B^2<U^?3Q_LG^P-X8;[[8_8QQNX*7^*?[].KK,-N/*
M>RC:^:!<FA_U<?Z ].M>.?7JO?,4<^-K\ABI_P#*:C%UGV7W?L2R&.Y%2/\
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MT3?Y+397)=@_QS*Y6IS=/E,/BZW#_=_\H'_5E_'LXO?]R!_J\ATJCM/"-?\
M5_AZN'_X34]OGK'^8OB,36948W ;\V=E<+E]5[$X,'/ &PO:_P#O'N/.?A6V
M(]0?\,?1A'>>%0?ZO\'SZ^C3#WQU9_N_>.-_V]O]YM[AGZ,_ZO\ B^K#=/\
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M^NM_*QZ>K>E/@=\9^NLM!]MD<5UOBJVKI3^#GKYP'_8ZO>-.\W.K<)2../\
MCH^7SZ,8K2G^K_9ZL0^S@_XY0_[Q_P 4]DOU)_B_U?LZ5_1?(?ZOSZ[^T7_C
MD/\ DK_C?OWU1]?]7[.O?1GT_P!7[>N/VR_\<E_VX_XK[W]2?4]4_=:?ZO\
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M''8VVL5N3;&0QF5HH,C3L!P3?Z?[>Q]^&ZB FA_U?LZ]_5T3 ?ZO^?AUK_\
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MY=<W]^_5J/\ 5^'I314JK'S$ +<#_6X]F$]T3YYZ#MCM:MW.:?ZC\^N?V?\
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M^\GUZ>.O=JP8W='G[-^2?5VTLA_SR=)O##?Q.@]R'RQMCJPQ_J[_ )]$6_\
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MNT>*>,9_P^I^SH/3QFO1D-J_+3>.U=D?W _N/LG-[?\ L_LOM-V8?^)?8?\
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MO#]ZEJ/8,AM_'E,)X#_-7U^70@@O=(_U?/Y=%_R4.*Z]VYD-\96NIJ:GI?\
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MZ+8[NJ<>\?Y>^$SV3K\YUU74VV\C5#[VLQ55QC/Q^+D_GWC7S;[;P>,S*O\
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M0W+WW@=P@%7D#,/15'\7K ?\/0?X'^6GUW25)GRFX]R9F#\4K 8\?[97%_\
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M$@#Z6]A+<.>IIE9$%,<32GE_0K_@^WK<<"];;VRMB[4Z\V[B-J[/P>,V[MW
MT?V.'Q.(I/X?CJ#' WT! "+BU_K?W'][<R7[-(S&I_V/LIPZ7I"H'#'2\]L=
M7Z][]U[KWOW7NO_3W,_G%*(/C#VO7#C[;#8VK_/]G.8+_BOL0<L,4NX ?,-_
M@8]!;>K75=+C@3_QU1Z_+K44FSW\2K_/_E/W'N6I;A505/\ J_9T>O9_XFOY
M_P#'OMZ'CJO,3T>>IYY\K44U/[=V2X#?ZO\ 3=,06G^*-_J\S\^CH;JWYYI?
M!!75/_+K_P" GM=NG</]7RZ+]AL_\;;_ %?A;Y] OV=O;*XW8>8KOXY4TWVM
M'_D?^6>_<N[^)[]%/S_XZW]'JV[V'T]B[#RI_P >7YGJD_\ EL]V8/JOM#M#
MMO?$]3F_NJ/*?9U?_%RR?N7^9-G_ 'C8HP^?_'E_I#TZB#9^9QMM^ZGY?\=;
M^@?7JQBC_FN; R7:NX-N3[<S?]Q\#MO^-?Q;[/\ W)_Q3_;>X?LO;AHU)(_U
M9_X;U*LO/Z/05_U?\X^D/O#^:5L?<E5M_![.V/N2IS&>S&+HO]RPPWL)<Q<D
MB-J?ZOP_\,Z/=MYN\05'^KC_ $.I'\V+L+*[;^+77^*Q4]3C<AO+<G^6?:?]
MJ7W"5Y9?6R #_5@?,>G0F>06Z9_U?X?7JI?X]Y+8_6-+3[C[&@ILEN#_ )AO
M;U)_N2R?_:Z]S'R-L8@C!;_5F3^EU'N][H6:@X?]$_+H_&]OF!/656/Q6*G_
M .!5']E1XFD_W&_88OW*]E9)$":_X?G\ST3'>&E:E/\ 5_O/1^/A#O;N+,=@
M['RNW*[-XW9_\8^RS%75UG^XRO\ 8.YCNHXR03C_ *)^70QV@M*H/^KSZOH^
M0>\,5UCLC>'9N5@^Y_NOL_[W_)/</)&.A=9W!BX_ZN/RZUK]AY+LSY+;WJ,Y
M_>/);)V/_&/\C^T_Y3_9A'&*=>O+@R\/]7#Y=;-&V]MP?P;;]#//]S4TN'Q?
MWE7[C*\L];?ZOE\^A9&= KU2?\J._N]^G^\\A!BL5C<EL_*5G^X>KRW_ !;/
M8SY=C$"@'_5\70<W3<"C4_U>7RZ+_P!>[/[^SW?'^S&8K^Y/W%+_ );F-O4F
M\+_?_P#:C]GG]60JFG^K_C76K3F_R/\ JX_T.K:*/OC*S?W7H<Y]SM+(9[^%
MT7VM768;_(/8+WCE\JQ _P!7P_TNO7>\?5G'^KA_1'ITJ-X=S4.PZ#,8/<=#
M4[DJ*7_(ONZ3V&K^,_ZORZ&\?'HI\/<V<W5F:C%8K%?PW#_]-?\ R@>R^WCS
M_J^?1A'PZ,3M78>#FH*?.;<RM-4U'_37_P [3V<WG^K^73X^$]%&_F0PSP_%
M\SUT'VU12[PQ=;[]9^7^KUZ!V[_$?]7IU<?_ "SI0?AETO\ ^&V#_MO8UOAW
M?EU#FUG/^KY]'X:01BQ_/LMA&KH0/\)ZX_=0^+S$W7\?U_K[:MG,HI_J\^MZ
MU]>L)R$!_)_Q]ZND:@H/]6.MAE'GU'_BU/KT_P"'O7@]:UBM:]=^;RVG_'OW
M@_ZO]1Z]J'6#_=7[_OWBMUK4OKUUYO#+_OK>_>*W7M2YSUGCJZ>,&7\$>T\>
MI>(Z]J'KUZ*K$TG@B@J+6M]V?I_K\^UZ3#%>'6]8]>GGWOK?7O?NO=>]^Z]U
M[W[KW44"WO9->G68$'/7<\@3D_[[Z>_ TZ1R(S$TZ;_*)A;V01@.>C1E,%6I
MTE\EM7!Y*7S3T0)M_P "OS_O?LRCV^.05K_A_P _6OZQRVV*8_U?T3Z])C_1
MMBO]T5U3_P!0EO\ '_7]DMYLZR\/]7#Y]".WYTDI0C_5G^AT[T>R,)1_;^:&
MIJ?M?IQ_QOG_ 'CWZSV=8B*_ZN/]+I!?[W+=DD4_U4^0].EA1P4-)%^S#]L/
M9K8((^''_B^B>2Z;@_#IWL+<_P"^Y]K9[D19_P!7^#I&Z_44_P!7^;TZY0?G
M_8_\1[<Z<ZD>_=>Z][]U[KWOW7NFX5< B\WX]V+ <3CIUD9A0<.NC-^?"?\
M>/\ BGO9M8I0"3_A_P _1;))+":%>O&6P]-O#;_B?]C_ %]L_3J>)Q_J^?7K
MJ\8>6/\ BOEUAFF_:Y]^^G7U_P!7[>O6=Z_I_JS\NFV;&8N;]^>CIO\ 7L/^
M(]ET>UI4_P"S_GZ-OJ8?X_Y'_-UW%C:&DDXHJ<?T( _XGCVOBVV.E:U_;_GZ
MV;F X#T/Y_YNG"&4'VI[/7HH.XR'BO\ @_S=2-8_H/\ >?\ BOO=8_XNM?O%
M_P"'_!_FZZ%9"?KS_OO]A[0V<RR"@-/]1Z>^H,9R.I D%O\ B?\ D?M7(I Q
MTX&\;AU*]UZ<Z][]U[KWOW7NO>_=>ZC>V22Q^?6^F S0_P"[ON?^J7Z>Z&W9
MN''_ %?/K7V]2/-!#_Q'M2+1UXKC_5\^DW7H/#-%^Q]S_P!5?_&_=M!'EU[J
M?216CF']20/]M_L3[KTIZ<??NO=>]^Z]U[W[KW7O?NO=>]^Z]TVRU?B$Q\)-
MOR/[7'U-A[:$RDTX=.O"=(*]8#5C_=4-_P#7X_V]O;JZ7/15/?2VYTE/\'^8
M^O6>67CZ6X]LW*)*H75G_BNC(10>9_P]8?-_QPA_WW]?>[6V2/C_ *N/SZV&
MMU !;_#TW2T>*K/WYZ*F8_U-A_O0 ]M?2KZ_ZOV])TO)(2"5Q_J^74>'#XJ+
M_E"IA_K^_?2KZ_ZOV]&*;I)(HT\?R_S=.H\<7[/AX_V'M08HQY=.&-9!JU=<
M_NAY?"8.?]?_ (@>Z^&O21[.$^?^'_/UGAJA-[O=0*X !_U8^SI$#)%\0_P=
M2891*#;@?[S[:AC,2T/3H82#J3[>ZOU[W[KW7O?NO=>]^Z]TW_=P?[X^T_BG
MUZUJ7IOFK(/+Y_?O%;K6M?7KN&83>R^,M7AU[4OKUZ\ _I_L?9C%JI\NMZAZ
M]=0S00RGVE^A=<T_U?MZWU-AR$$OT-O]Y]N>"R\1_J_;UNO3G[6]:Z][]U[K
MWOW7NO_4W*OG.W_.+W;(_IAS_O&6@_XK[$7+PTW0(_A;H+[W=:;A/]7D/EUI
MZP_\"OV/8VO9RJC_ %>GRZ/'O/\ $U_/_CWV=#1MOS_:T\\_MWER=F8?ZOXO
METQ!=_XHW^K\7V=&HR4/A^WKO^ U/54>+^S^T_[4M_\ 8^QE>#4H_P!7IT7[
M#>?XVW^K\+?+H#^X)H,ELVHP<\'_ "AY3[SV&MLL&LMP0CY_\=/S/KT9SSB^
MV]P1Z?\ 'A\AZ=:G]9GMU;/_ (Q@]J_Q+&U'\8RE%]I2?[U[R#EW?P]O13\_
M^/?Z7K'V?8"^X.1\O^._Z;H2-DX'Y)[J_P"+'0Y*F_CW^15F6RU'_#?83?F]
M8XS_ *O/_2="*TY?>20 _P"K!_I=7 ?#_P"(L&V]Q[?W'NJ#^\FX*7_+?NZO
M_BV>X)YR]P#'*0/]6$_X7U,O+O)_B1@_ZOQ?T^C<?S5MMP9+J_J^N\'_ !:\
MQ_D?^1_[C/XIQ[B?9;OQ&!/^KXOET8[E(6! _P!7#JI? _!OO[L+*8?%;'V!
MDJG<.Z*S_+-V;AK/[M[9H,7[D!.:SMR@+_J_XP?7HABV07IJ?]7_ !H>G5E$
MW\C?MN:JP^ZO]F3ZEQN0_@^+^\V]5UG\2^PRG_:\]G%GSS)*M*_X/G_POI\\
MHK$P/^K_ (_U8QT/T/VITGNWI^ASG9O5U3L?8?\ Q\F)Q.8_X'^P=S'S%)*U
M:_X/Z/\ 1Z&&T;0L2@?ZO/Y]6D=Y9CK+>^W-P; W5O\ VGC</OSK<T7^65G_
M #O<+]?]8^P^FYFHS_J_9TLNK#P^ IG_ %>?58_QU^,=#U+E-OT.ZODGUODM
MCX&LQ=;1TF)_XN?\+P7LP3=#3CG_ %?+K=G8"7C_ *N/SZM0H^SNLO\ <Q74
M/;>R?MZK_(O^!GL*)=ZSG_5_+HZL_P!?'^KSZ*?W9UOU)V1@:BAKNV]DU-1_
MTU^UT>YF#A_J_EU:[Y?$^?\ 5Y?TAU4/GOY=<\,N8RO4GR:PF$_BE9_Q:?O,
MR/9WM_.YN2%)_P!6?^%CTZ#=WRC])D?ZN'],^O2'H_Y?O?U'V#UOO'.=_83-
MX_:^Y,76YC_<QO+_ "_%X+V:3[@+C)'^K'RZ]9[/Y'_5Q_I=6X;\H]G;DI<A
M!_>JFQM155GWOW=7[ ^X1_ZOV=#>/CT!]9A_[M_Q">A_W-T]5_P#RU)[+K=/
M]7[>C!.'1@>I<]]G@<A_P)^XI:/[W[3VHN_/_5Z=/CX3T'WRZWAM7>'Q+[ G
M[&@^V_R/_</_ -K3_EQ>]V?^K^?0.W;XO]7]'JT_^5[;_9+>EO#_ ,!_[N"W
M^OS[&U]Q'K_Q74.;7\7R_P"+ZL JK^&?PVU<7M[+H./0@?X3U6+_ #"_DQVG
M\<:KX\9;K\XNGV_N?M887M/^*XC^),-AX3!9W<&<_@P/*O;"_P"V(]F^U[<L
MAXX_V#\\=(?$/5>7;7\Q3O>LWEW16['WQA-D]7XO<G5^V-AY:DV'_I(W-0?Q
MW_B^YK^!V_W\'L1OLBE!7C_J_I=:\0]#O\8_E]WKO;='7.*RN\,9V1L?=7?&
M4Z^Q/9M7UM_HWR>?Q>"V4,YG<*=C_P!Y/]P']T]Q"WL.& 4..O>(>CB]L_.W
M:'3_ &3F-A9#KS>^Y,/M8;6H=]=@X@X@;9VED]\_\6/"N _]XW+?UTBWNOTU
M>)I_J^VG\L=>\0]%H[ _F@Y7(=>SYOK+HGLFGR]2,E646X<P=G-MK'[77-?P
M#^^N=PK;D+/MXV')N?=_W9DDG'^KY]>\0]9\/_-XZ7GR.2VXVUMUY.NP.(%=
M'E</58C('=>4TC^/87#836VY<&VH7!TBW'YY][_=G'./]7SZ]XAZ4=9_-AZ=
MP6]J#K_>6R-W;2O1?>;EJ\K6[.!VEE#A?X]_!<YA!N0$'_8^U$FSJF1P_P!7
MSZ]XAZ$_XO?+G>'?OR WQM6MV-N/8&Q\5UOM;<^T*3=O\&.4SXSEKYK"' ?7
M;Y ^I/LMELM J3@?ZO7K8D/5G7LOZ,.O>_=>Z][]U[KWOW7NN"L2?=B*=,HY
M8]-.7,_BM">?>NEL48<9X]5/9?Y!]T2]L[WP>W,I_$?[K=O[5VO1[3.S_P#<
M;7;6SF9_W.9DYW\Z=N'W&,N[M!4@_P"K_>>I$MMCCNPJZ:"G\A7SU#A3I8=A
M?..HQM-N_![>V?D3N_ T6*K;5F7PN1QG\-SF;P&"U7^G_+\^GLMDYV>"H'^K
M_JG\^A%;>UHNZ,S @BGYYS_;#TX4ZSTGS=Q>V*6OJ-T4>;S67JLODZ.CP H\
M+CLG0_P+# YS_"W'M39\WF3#<?\ B_Z'1CN7M,( K1N E*UXU^'_ (<<9]>G
M^;YP[>K:OPX/:&Y,E07Q5'_%@,,,8<GG=7\#!N?S_!??KSG P\!_JQ_0Z+8/
M;JIR_GZ>6:C^U^?'H:?C7VWNGMK94VX-U;<GPE?_ !C*45*IL/OEP>8>QM^
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M=35/6>:_C&VMH;8W+N*K.8PV-QE$<ZK-@U'^P4G_ %A[UM?-LEP22>'V?/\
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MH_CF#PF[?XI68NBP^)RW^Y+[#*?\[K\^R&P'@'/^KC_GZ$FU[+:J?B_P_/\
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MZ8'^A_YA/;BG_;>P]M_*&\W1J7/[$^?],=9$VWN;REM\2I(JD_Z>7U/I&?\
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MP?+H:VFY;&U%JNH^6IOG_F/[#UZL^._<U7%N#;M1A=PU&T*7#]GC;E)5YG,
MU_\ '.<"#?Z'GC_7]A^WY8WRU<&:0D?8GS]&/J.C:3G+E^]C;PPH? /<_K6F
M4'SQ\^K-/COBJW!=5;6P>3PF2VYD,;AL;15.,RM5KR",@-R[ _F]OQ[E38IA
M:QA)_B_V6\OSZ@SFYA<3%[9@8SPIG@$!S^WHPWL2=!SKWOW7NHW^ZS_K?\1[
M+[>0L1_J]>M^753'\S[I_O?M3K[8]#U)!F\W3XO<GWN\-O;>H\SDLGGL7_Y+
M^Y-H^Q! BE02:=:Z(?MSH'Y3XV79^5RO67=F]MOX'9_V.Y-IY?>&9VW_ 'MW
MX<+_ +@<U_ _[R?\>]M/_M<>S/\ ?]I_#_A_Z!Z3=!-U9\._E;N_.U.WNQ^N
M^Q]D=39WM/8>;S.WZ7,[RVV*[%#";^.>+'^\N[MS #<7V)_UO?OW_:?P_P"'
M_H'KW0LY'X9_*'9^!P\&P-N=D?Q#/4?^_P#*NKWYF<EDZ_\ @7]_OX%_S$G_
M % ^U/[SL_3/Y_YNO==;J^(WR#ZWZZW1MK8_4N]=VT._=A=.'<>(J]X[RW(W
M^D]<UOW^_>;M_>6]AJH+_P"O[]^\[3^'_CW^;KW0/]/_  N^6NV\A@-T97K/
M?V-[2R?56*VS2;JI-RYG^&[2R>#[.[>SPPV<']Y/H=N9O"?[;WJ3<[.GP_X?
M\W2?Q#T*&-^('R+W)7G!?Z,^XMI8^IS&UJ+Y"[ARV_,S_P 9HR?]],_GL[FM
MD?[^3_?O[=_W.?\ +I]E[[E:@Y7_ (]_FZ]K;JWCX1=9[NZDZYW/L+=5#F\;
MC\7V_P!QUNSJ7*U>9R9H-A-O7.C8MLWGP20=ND>R3HQZ/S[]U[KWOW7NO__7
MW?OD'UZ.U.G=\[ F_P"8GPV3HO\ 8'Z?[U[7[+?*DXD/&A'^'Y?+HNW=-48I
M_JX=:#/?W4N_^A]T;PV/NK9V2QO\+S&4_@^6^S_W&?PO_?'W(R2+<J*'_5_+
MTZ!?UC6S</\ 5^P^O11Z//3_ '5/Y_8-W#;PPX_ZL?/H16^Z%6_U?/Y=#!MS
M/"&OQ\\'LM@V?4<?ZN/]+H16^]A10_ZN/]'HP'WG\>RE/!0S_P"457LR_=8_
MU?\ %]>_?@_U?]$]"Q_>K^#XNGQ7_*K[]^ZQ_J_XOKW[['^K_HGKT.\*Z;_I
MI]DW]6#_ *O^B^AI_65?]7_1/4@S9RL_S$%34_\ 4)^/?OZL'_5_T7U[^LJ_
MZO\ HGHH_:FP]_[D[!V_/0X.IJ:?[S_E3]^_J:?]7_1?1:G/RU_U?]:^I&\.
ML=\8V6GKOL:G_)?^F/W[^IA_U?\ 1?1C'S\M/]7_ %KZ!>:'^&[MI]U5U#_O
MX,7_ )%[)'V TX?ZO]ZZ3V_,04U]/]G^CT.&V^\MXT=4?L8,)_YQ^RZ38#_J
M_P"BNA'!S4BCC_J_WCH>,/W9OBLI?WY\;_YQ^U/[@/\ J_Z*Z?\ Z]1_Q?X?
M^M?3?6=P;QHZK[[[ZF_\X_?OW ?]7_177OZ]1>O^'_K7T\4??VZIO\_E?_5/
M_>/9=^Z&_P!7_%]*OZVIZ_ZO]XZ5]'WQN/Q?\#O_ %3]^_=+?ZO^BNO?UMC]
M?]7^\=*&C^0F5A_S_P!S4^TW]6W]/]7^]=>_K:GK_J_WCH4-A]V09[<?@RN*
MIOM_L\I_E?O?]6V]/]7^]=:_K;'Z_P"'_H#HU&R>[,5#2X_SX+_)_L_^42L/
ML4_N0_ZO^BNE/U]A_'_)O\W2XSW;5=68;S['VK35%1_U=O>_W(?]7_176OK]
MO_C_ )-_FZ8.M^X,Y@8LA@]\;<^VR&4YHZOV'-PV=G((&/\ BOGTJBW"P2Y%
M7_DWI]G03?);9/8W?'5^X.J]CXJIR68WY68NB_R3\8O^->Q%L%@8!G_5\7S/
MKT'/<&>QGMA1_P"3>L?RZV3OB-U*.B.@>N.K. =K87&T/V_'I_KS_A_Q'LXN
M7#4-,T_S=0ARS 4M6K_JRW1EXA=C_L/]Z/LAN(]7^K[.C.R[9R/]7 ].?M?T
M8=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U'
M_P!V_P"^_P!5[]U[IDR6-H,C2S45?14V0IJCBJI*JD.04W' *DVX_'M/]$*5
MK@^O_%])^I,5) (C#]O3P06^@M_Q-O>OH1P_U?X>O=1Z_#XO(TL]%E:*ER--
M4W+4M92#(+;_ !N#_3_#_7]^Z4].44,,/TAM_L+^_=:Z]X?\?]]_MO:GIB/X
MNO'_ #O^9M_OO^*CW[I:GP\>O>_=%W7O#_ON/?J?/JU1U(@_/^Q_XCW[I3U(
M]^Z]U[W[KW4?W[KW4?Q0_P!/]X]^Z?\ $'77/]/?NM^(O7?OW2?KOPC_ )5S
M_MQ_Q7W[KW77OW7NH]O^;'^\_P#&O?NO=9_#!_G_ /??ZWO?3$?'K!#^[_NF
MW^/O72Z.@7)Z]X8)OKQ_OK6Y]^Z8Z</?NO=>@_/^Q_XCW[KW4CW[KW7O?NO=
M1_?NO=>\'^/^\_\ &O?NO=>\'^/^\_\ &O?NO=>\'^/^\_\ &O?NO=2/?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=-\W_+#^G^^O[]U[KWBA_I_OO\
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M\1I_ZGW[KW7OO*?^A_V__&_?NO=>_B-/_4^_=>ZX?Q#_ )M-[]U[KG_$:?\
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MO==39 1?[J8_['_C7OW7NNX<E!-^;>_=>ZY?Q&G_ *GW[KW7$5?^9_9/-_\
M8?ZWOW7NH_\ %O7I\)^G^Q_V_P#K^_=>ZD?Q&#R6O_A_OO\ 8^_=>ZZ_B*_Z
MC_>_^*>_=>Z]_$(#%#,3^J_^]<^_=>Z[ER,$)I[_ /*2;C^O(_XK[]U[KE_$
M:?\ J??NO=>_B-/_ %/OW7NNON_^;/\ O'_&O?NO=<?XA_S:;W[KW7OXA_S:
M;W[KW6'^(_YG]@\WO_A^#;^A]^Z]UGAR"S?@#_??Z_OW7NO39*"'\W]^Z]U&
M_BT.NH6**_VW!( %Q_A8<"_OW7NI'\0'A\WA;_6OS:_^M[]U[K!_%Q_QP?\
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M[S6,W/6K;ZYW-$!L\./S;GW[KW7MX?%39V]NN=G]8Y3=7:6-V_L[_@%E=O\
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MZ:]_WR?V#KW[VL?]_?R;_-UQ_B^)_P"=G2_^=0_XK[KX5W_OK_CO3_[QLO\
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M(:'H0L"PZ0/8^_=M=7[%W=V+O&N_A>U]G;>RNY=PY;[<D4>,PJ^9R1S=@ 2
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M/2 VKA]Q]>_S#^\(-U4-33? ?:_S8Q>R^R,3MZLS.-_@._/[EX# [%S6^/\
MOW>T_P#(?9S]>GK_ *OV=>\,],_=G3.P-M_&[^;AN/;FU?X;D,7_ #4.K]EX
MBK_W,@T.V,%W1M__ '"_[S[J+_N4%A2A_;CACAQ_:,]>\,YZ,]\H=T3564_F
M(;I[+WANO!?,WJ_NS8U'\$,/1Y;,XS<QVSA<Y@'ZJ;8^#%AN [N8T1/%R3?_
M %T\=Z@-!30:U%.).?3[:X-2>/K[0?SZ+C\NH?F)C>^-\?%#;F<WMA,QGJS_
M (<$_O#25F9_AG\+V+TOO[?F=ZQP?_E1OL?9G'?H1Q_U?LZ]X9ZO5_E YK>_
M=?3'R%^7FZXLUC-P?([?I7;6W=PU9)P>VMBX,X/ VPM[ #<&9/X_XV&KV[74
MN?Y>>/EZ5_V.O>&>@9FAH<#\5?AAWA7;XVELGM_KGY";\W/EZOM>_P#<;/;[
MSHW]@<[AM\YRP_N\?[N_9?[E/>[.Z!U G'RK7S\_\W7O#/1=ND\GNG;?;?7'
MR?[HK\'A>F-X_+_O?-TFZ@1C>M:!<]UCL+ 8'-VO?^[A.!K['_#V9->)1@/B
MIY<?]7IU[PST&.U>MX.SNY-GXK=7\;J>K]^4?S([.V?B:3,9G&XS/8O^-8#^
M!9K_ -"/[[W;ZQ?7_5^SKWAD=,^-P-=U[T/\?^QMN;CW;_?CN3H?Y&479&6J
M]R9G_<]_<7-9_ X+_P!!/;F#]I?JU_U?\5U[PSTH/]'M#O;8?R([-W57;DR6
M^.F_CW\7]S];Y;^\F9_WZ6Z/[E["_P!S6#]^^K7_ %?\5U[PST8C9^Y,'#\F
M^O\ ?^X]QX3M'LC='9&PZW[NDWAF=M_(78?\=PO_ !9?[C_\Q!UW[#OB#I1U
ML6Y/-[9[#Z_WA#A=PTF3H*O#[FPM9EMOU:Y,T)3$'"9G_8HQN/Z'GW4, :GA
M_LU'[.O?EUK);5W)VW6;\^,_3O1^<ZW[1_T#[\[0W/MNDV1_Q_-?S_Q9>U/Q
MU_[//'6M>O=._0.Q.Q=R?S"=T;/[AZ7[(VGV!WO\;\I_I(W%ELQAOJ,W;^-8
M/_LW@?>OJ5I6N.O=8.R.O=__ ![WCOC=6SNU,;NW#[#[(ZOPN_.PMP[;PW]Q
ML#NC^"_P'!?QS!_\>P-N[3VY@Z'_ ,[_ &IGO%=?//\ L?+I/X9'5IV6[EWS
MV]_*[[1[%W4/MMVY3JO?E)1;BV_3-C\=GVPC-@\)O/"!@;+NJXR@YL+VL ![
M#D[58YQ_J_U#KV@]5,]G;#@Z]Z^^!^U8,5LG_0_OSH?*;GWY5]L=D;QV3L;/
M=R9W"_\ %ZSF<'_,1>S..<5Z]X9Z;MGS4.2Q?2^#^:/9HR72^!^*^Z/]">[/
MXQO+&XS/=H?QK_<%_P ?!_Q\&X_[M^S".=0"0!4G_5Y>@Z]X9\^@O^/?;6*Z
M3^-W8']ZM_U.TL?O+^4O]EU729;+_P -_CVZ/[E_\P/_ ,]!N+WHW2DK7R/^
MKRZ]H/1H>L<QTMO#=&0G^;&]\WMNGZZZK^.>:^)E75YC,XW)VM_'L[FMC_\
M/0;B_O&*'^OO1N@"-(&3G]G_ !0\\?R]X9Z ?&X';G5??M1BNEO]QN^,I_.
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MZOV=>Z9][;C[3WA\@NT-U;JWCL#9/?\ @>[.F_\ 0_NS=F\-Y8WLR@V'_<O
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M_%_+KV@>G7$]7=9TV!H-JML#:7]V<35&NPV ;;N(_A-#D4_MX?#"(1QL;DD
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ML;NS=&8WQVIO'-[VW1E/\MK,MN&L_B63]S3:;"3&"1_JJ?Z71=;VXE->@_\
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M6IJ_X[\OZ717]^?#/O>CBJ(((.G-[4^+HO\ +/[O5F9_B?N7.7KG>[PBL?\
M./\ I?(>G0&?:+W3\7_'?^@NB+XVCROES%#_ '<R6-R&!K/LJRDJ_P#<E[%U
MZV_6R]B?SC^7V]1]O6T7NL]W\E_H_/HP&V_V=N?],_L5VEW8RXA6A^UOGZCH
M.W=G_J_9\^O8>;]VHG_WW]?^)]TO+.^FS"^/]K\O4]>L[3_5^WY];!'P_P#O
MH>EMCX.NG_RBJS'WM'[Q^W:\U+_J^7RZR"VRSTG_ %?/Y]:U_P#,RF^S_GP=
M+T/_  )IZ7,=-T592?\ *_\ \7_V$!(&;AT?21E /3K=0P_GR5545T__ !;Z
M7_(J/_D7M08@N1UOZAC@\.A(_NK_ !BEW!705W_+G^RH_=?%*X\NK_%T&_7N
M2\W['G^Y^Z]V^K^HX_ZOY#TZ<MJL,_ZN/0P>'PQ?[;W7PV7ATAOX U/]7I\^
MC2_&7_F7<_\ X>&Z/_=P_L^W/^T'V#H.[7Q'V?Y^C%R_0>R*/CT?R?">HLGT
M'^Q_XCV]=?"/]7ITID^$]% ^;W?$'QI^+7<_=,YIJ:HV;L/*5N'M;G*<C! \
M?U/^\>[6?E_J]>D,O'KY#'86_-Q]M=H;H[&WC75.2S&\MX93-9C[N_\ R_<U
M[R1L$2,U _U9Z(I).K2,QGL'UOMS#[<VKL#;=34939_\:K-PU=9AMMY.@Q>"
M_P"KY[6W-YX8H/\ 5P^71?(YKU(Z]WABNPHJ?9VZMC[2J:?*4?WO]X?XQ_>3
M)^VXTO&/Q?R7K4?'JH_=5'!1[HW!0P?\!Z7,93[/_P _7^\^S*.TNV S_P =
M_P _1A'PZ6'3/9VZND^T-C]J;'RM3A-T;#W)B]SX>KI/^K%FO9)OUND\1J,_
M[*_9U:.3/'KZ_OQ3[HQ_R#^//3_<-%44U3_?O:&(S595#_G:OB ,T?I_JA[Q
MXWRR$<SHN* '\C3Y_;T91R&GSZ-'[2]&/7O/_A_O'_&_?NO=>\_^'^\?\;]^
MZ]U[S_X?[Q_QOW[KW7O/_A_O'_&_::>4I@=>Z#OL7=V#V!LW=.]MPS?:[=VO
MB,MG<Q6?BAQV&Q#O(?I>^HW_ -C[,+%/'(SG_B_\@ZWU\>OY@?)#=7RT^2/;
M'?V\)JFIR^^]X92L^T'_ "[\7_&A_N%P?O)G:]GBM JHH"C 'IQ'J>@U?P&(
M5)_U8^?27Z'R6W*/=N0Q6<V!_I(J-T8?*87;>)_Y4,IG?^7U[/Y=P%L* ?ZO
MV'UZ+K>_,1I_J\_ET,&-Z!V/#0>?*S[DW)_EG_ O;U9AMM[9H/\ JR_QS<']
M[O[P>RKQ-7'KWB'H:,/L/9U9LVGZKKH/[M[/I<QE-Z;DJ\M1X;)=F4'_ &H\
MY_Q[&X-N^[>&&Z]XAZKW_C']R=YU&5V=G*G_ ' [D^]P^6I/]QN3_P"UU[2[
ME EQ$<?ZJC[/3HRCD->OK%?RE_DPORS^"'1/:M?6+4[H.W5VUO A=-MS;?)P
MOJ(_4?X#]D?^0O>.W,^U"*Y=0**:4_,+7S]:G\^C..0TQU9MY_\ #_>/^-^R
M;HPZ]Y_\/]X_XW[]U[KWG_P_WC_C?OW7NO>?_#_>/^-^_=>Z]Y_\/]X_XW[]
MU[I/9*KH<925^3K)Z84U'1Y.LJ_R-(M]?]@+>_=>Z^4!_.,^6FX_EU\Z^Z-T
MUU=4U6S]FYC*;+V'B?\ EV4&+P7Y]S]RA;IVCC0?]!\>B2WD/^K\^B#]*;;@
MWMVKL?;D]#4Y*GJLQB_O*3$_\7/_ %_8OWFY^F6B_P"KX?D?7HOOY#7_ %?+
MJPC9_6._][=C9#KG<>5Z<R5/]YE,+6=3[>_W&Y/:6+_YW6#_ -^W_P ?%[+8
MY#7JG1/^SL/UEL.JZGQ4&SLE4U'\'Q>Y]^5=76?\7[^._P"Y[^"X/V81R&G6
M^D?W]M7;FU>R\Q@]JT-3C=O_ .XNLH\35UG_   ]J;:Y2_C(;_5D_(>G2N.0
M];SO_"6/Y<9WM;XY=C_&S>&6&1R/36:Q.<V>:M58G:N<-W4!N!_=?<'V2W^H
MU>X,Y\V](IBRKW?[$?S^9Z,(Y#PZVZ(_T+_K>X^Z,NN?OW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z__U=QS^8%^U\2>WO\ #;4G_0R?\4]GG+?;=1_Z4_Y>
M@QS8=4#_ &_Y5ZTR\/-YOX?_ .0OW.]C<*L8_P!7F?EU#8MRTA_U>73A\;]M
MXK)=J[PW5G/\FVOL.L_C595U?_%L_BGL%;_=JB$@_P"KM^74C<LVY5Q_J_C^
M?1^)N^-N;;E_BN<[&QM-49ZL^]H_X3F/^ '_ *#X]Q9/O0C?_5\OZ/4B7':E
M*?ZJ]"AC?D50S?;_ &/<533?^1CVDM-P\*M?]7'Y=)_WF?\ 5_Q70L;;[^WC
M-+^QVI35-/Q_SILE[U=[AXG Y_XKY=>_>9]?]7[.A8P/?&^/\_\ WCPF2J*7
M_+?M/X/LW)<^]]*/KQ_J_P"*Z;]R0YON;#9C=65VKA*G(;#P_P#&OXM2;;PV
M-W-08OZ?\7SW[KWUX_U?\5UI?_/;?F5H_E+O#*[<W5F\;M_*?Y;AZ3$[D_AO
MV'^^'N<>7.4[)V'?_P >_I?T^E'[_$6?]7_'>B[T?R0[;AB_8[;W_P#;TO\
MD7_'X9GV-+SD6Q=0=?\ )OE_PSKW]=Q%C_5_U;ZCP_);N+#U^/KJ'N+>W\0Q
M?^6T=75[D_XU[9C]J]G0U\3^3_\ 6[HMD]P;F44I_@_ZU]2=R?-CY0YB7_+N
MZ=[5/_D8]KD]N=G3'B?R?_K;T72<U74I)T_X/^@.@>K/EIW]#7U%=!W%O:FR
M%51_9?Y)N3VG'+X@6O\ J_X]TGM+P(?]7S^75R'\@W?FZNX/F'D-G;_G_O\
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MOS^-?P'.X7!_^2YG/?O$'7NJU^PJ.AQO8.\*&A_XM]+F,I]G_7V:,X@C)/\
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MI>A\?T#U)/4U/9'<G\4W/O"KQ-9_N3H,7[CG=KMIU(K_ *NWY=2/L%N%-?\
M5^+Y]:[^S\]V;MO^'_Q6?LC&T_\ Q>O]Q.Y,S_Q:_80&UF=B?]7^'Y='VX]H
M_P!7RZ,!A_DMVWL^JIY_]*G;6-J,71Y2MS%)ELQF<E_N4_Y<6%]HKNW\+A_J
MX?/I9^Y!_J_Z*Z&C&_-+O"C_ (A/_IW_ -R&+P^+^\I,MMO#?Y?NCWZSMS+Q
M_P!7'Y];_<@_U?\ 171F-G_S&ODUTS_>C>.W.S>M]R9# T>+PO\ QY^S?]SV
MZ,[_ ,N7V8]$OTY]?]7[>MOC/=\=@?'7^4YC^U.U/X;C>^/D%MO%T7\)I/\
ME _OU[]U[Z<]:7^]NC8.SMT9C?\ /!DLW]K_ )%_Q>/8TV3?+V#.K_CO]+^C
MTG_=QEQ_J_P]5OY*CRLV\LABL5@\W3;?I:S[*LJZ2L_Y>GM=NG/=] *:_P"2
M_+_A?7OZKF;-?]7^]]& ZQZQW'N3/?P.?KG=NY,?_P [;$_QGVLM.8=YG:GB
M?R3Y_P!'HKDBMHJFG^'HY&-^!^\<]BZ>>AZRW)]Q_P IGW=9_7V,[1MWG4'Q
M/Y)\^B^3<K6(TI_A_P W3Q1_%':NU8O!O'K*IIJC_IK_ .-^S:?F<NA_U?\
M/G1))>,C<?\ 5^SJ^#^2?T/M78?=V^-X[<VY383[K8>4_P" GN+-_P!W:1R:
M_P"KM_H]"/;)#.!7_5QZ(?V%DO-NWL#_ )5SO#='_NZ]R)L UC_5_2ZC7?\
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M4TIPX\&ZU=V@?)'^K'SZ^4?_ #F/B7N/XC?/#MC:M;BOMMK[\W)E.SMGU?\
MR[*_%YWWD1LN^M=E<X/_ $-_1'IT2R[>L8./]7[>@@ZQZKVKVU\;J?S[C_AN
MZ-KUFZ*VCV]]Y_#?O\I[&WT?U*ZO]7^$>G15(?#..F_IG#]Q=/Q;@Q5#M79.
M;I]T4?\ !:S^\-9ALE_#_P#[(/99PZOT('S,S$^R=I8?8&W-Q[;J=OU59NBB
MK,3M[;>&VW]A_N:_[-_W[KW59_U_S_LWMNV-O]7F>C*.,5Z^@K_PEB^(V<ZD
M^-W9'R3WAB!C\CWO78BCV@OVH%MJX-K%^3]-U#[(_P"-N/<$<_7($^@2#4*&
MGG0A ,?,_P"#Y=&,<>.MN/W'O1GU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=?_]?<X^9W/QRW^W]:+'?^[J ?\1[,=MO DFK_ %</L^70=YJMO$=#ZG_(
M/GUJ;_(K&[<P-5C^QLY/3?P?:^'RGWGL12;NJCC_ *OV=4&V%K5?]7G]O6I/
MW!V=!\BNR]T=FS]C4VVZC*9C*87;>)I*S_@!M?!?_99[#LV[+&AK_J_ET;6R
MO?R  ?ZL_9Z=#AT;\2^_NYMQX^#;FXZ:FV_E*S%UM9ELMA_]QG\+P7N,=^YF
MCC>A/^'^C_1ZE[E[E:62,&G^#U;^GU;QDOB+MSXZ]<[HWQN/8 [LW!B_]_/6
M9:KH_P#<9_%/8+VKFI+F0*#_ *J'^@/3H:;KRJ]M&21_JJ/Z9]>J1]^=S3[J
MW;_%<Y\<Z:FV_B_XIFJ.DV]AL-_Q=/<O[4_U,88'_54_YNHAW5/II"I_U8'V
M^O1D?Y=?QOV=\V/FE\=^G=N; R6-Q^!W)_I.[4J\MA_^=%_N>_@OLS-5)KT5
MO(*=7G_S^.\I]W]R=?\ QEV=NJIVWL_J_9_WM9_":S_EZ>]?3M/@#_5^WY=%
MSR"ISU3/\1=M[JR55O#;D^ZJG-X^J_Y2_P#E0]K)+!KYJ ?ZOVCTZ*Y+Q;$5
MK_J_8?7JQCXT_!78'7N+^^WC]MNW,568RF:H_N_^+9[$>V<DEUU-_JX_\,Z+
M9.<@AH/]7_&.K$,##L[&_<8K;E#C<;3TO_ S[2C_ (;_ ,3[$.Y[7868UA_Y
M-\OF?7H'0;SN&XG1HX_-?^@1Z=+"');'FI?//N/&TW_59_QKV01<];?M!T%_
MY-_UK;UZ/X.2MRW(:O#_ )K_ -;!Z=)>LVYL'>U+44/WV-S?LQVWFW;+DZ?$
M_D_S_H#TZ?W+E'<K8:O#_FOR_IGUZ$#XWS4/QIW;N#*_8U-3A\IMO*45'2?\
M:]GLNW;?N8U!_P"3?YQZ=$<6X[AM;:2G\U_S'UZH'[.FRN!W'O#^.4-3C?NM
MR92MH_N_^4__ '->QSMPCL8BU?\ #ZG[?7H';C(]]*JT_P!5!]GIU9Q\.?DM
ML?HWJ#(8K['^^W9&4_X![(Q-9_P _P"KUG/>/?N;S*J2L ?]5(OZ/60OMERZ
M9(E8C_567^ET:# _*C%?Z/L?O'LV#[;L#^^&+POVG_%M^PQ?L [#S)XYI_J_
M%_1Z&F[\L?1C4?\ 5\/],^O03_#/M3;FY/YV?RPKO^!.0_V6_8=%1_\ GZ_W
M.^S_ '"0SBM/]6/L].@B+<!J>?\ J^?5X$U9!-GLA^_]S_EGMGPSTWT)$,WF
MI:>?_E5]^\,]>Z*/WE]C6?<3UT'W.'^\_P L]F/6K?BW^KUZ,QLG=6QYL#A_
M[N;CPE33_9_94=)25GOW1?N'^K^71[OC!_S+%/\ PY=T?^[A_9A>_$>B;;//
M_5Z]&1/^=_V'_%?9=%\+='[?"?\ 5Y]2?>^K=1OM(?Z'_>/^*>_=>ZU#OY[W
M\C*N^2^3R'RO^+V*ICVR*.V_=D4E)<[[QE@?XSA+$VW'8^Y"V3F<#PU=JL!Q
M_)OZ/1=)'QQUH4[VV3O'8>Z,QL[?&#S>V]T8&L^RK-O;AH_X;DZ#*>YIVCF*
M%HQ5O\/J?Z/1<\>>D_#-/#_F/\FJ/^4S[2L]JK>ZAB%=7^'Y_+HMC@->EQL/
MKWL;N#=N'V=USM7<F]MT92L^RP^)V]1_Q+)U^4_WP]EVX<PPQ5&K_#\OZ/1B
MD!_U?\7UO^_R(OY'T_P^DI_DW\D\735'=^4P_P#OT-JD778.*S8+$M<\;@L/
M\/K[AWFCFM;]-,9\^/\ O']$>E.C*+CUM7Q4L40NHY_Q]QU&^LEAT8J* =9/
M=^O=2/?NO=>]^Z]U[W[KW7O?NO=-U9]8/]?_ (@^_=>ZUO?YXO\ )BHOY@6R
M\=VUT^,;@_DCL*CTT@J@VGLG;  )PF:)52<__0VL?8YY:YD6W95<]O[ ,-C"
MX'IZ<*\*ETD9X]?.J[@Z?[4Z!WYD.NNXMCYO8&^,#6?99C;VX:/^&Y.@]S59
M[_#/&I#?X?G_ $>BV2,@]!O#63^6_GJ?M_\ J,]J:;?_ !_R;HNC@-?]7^?I
MXP^'W5O#*8?![<@S>;R.4S'V6'Q-)1YG)9.ORG_5C]^IM_\ '_)NC&. TZW7
MOY%?\A7>&RMY[8^8?R\VL,)DL5_N9ZYZGRM(#E%RA%QFLZ/QQ]/<1\Q<QQRH
M\4;_ *G_ !VNFA(*_L'G]F>CSPCQ(QUNPT?@^UI_!_P'_P!]_C[BV:]#R%N)
M_P!7RZ]X9Z>?=NG^O>_=>Z][]U[KWOW7NO>_=>ZC2P0S?JM_K_3_ 'OW[KW5
M-W\W/^5ML;^8_P!-?P/_ '&[:[8V+2??=;[VXX)Y.%SEO^8>)O\ U]BKEK=E
MLIE+DT)_R-\O.O1=)&:$=?-)^5WP_P#D+\,^P<QUSWAL?<FR:C%UG^1Y;[/,
M_P!V<]B_^=U@\Y[GC;^;H?"7NQ^?J?Z'1<\9Z*_]Y7?Y1!]]4_;U7_39[6>-
M#_%_AZ3> >O333UDO[\_W-1_P-_ROWKQHO7_  ]>^G/^K_B^MA?^4;_(M[H^
M:&]MH=G=U;5W+UO\;\55XS-UE7N"B..RG9F+%_\ <)@5%V;;Q'TR@%_8 YDY
MHADC/=_L_#_1&<=*;>W(/^K_ #]?2&Z]Z^VKUALW;.P=CX3';=V]L[$8W#8?
M$8FD_AV.Q^-4 :$4 @CTDV^M_<,75[XLK'.3_D'RZ$4':H'^KSZ%/VQU[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__0W//FIZ?C?V0O]*+%G_;YW!^W
M+6WIG_5Y_/H,\PW-)XUIYG_ I].M/OYI=#]C?*+J6HZYZYWCC=MU'\8_W,?=
M_P#.K_YTONEYJ4G/^K'0DMI%:S3_ %?BZH_S'\M/>/4N]]GS]C;.V3F\/E*S
M[+#_ -WO]R7^XO!>R'=@8X20?]51T,.3ME5YEJ/]5'_I=7D?&_;>*V?@:?P0
M4V-_R/[+[2DH_>-/-U_)',P!_P 'HGRZRGV7;(H(%Q_A]6^?SZ,QGOX'N3 Y
M#9V<H?XEC\]_P,I/99RS&ZS+4_ZJ/U?F61&@./\ 55.M,_Y.9+MOH'OC>'7-
M#!A,ECZ7>']]*/;W_5K_ .7%[RGY:?3  ?\ 5ENL6.94K,U/]6$ZVP/^$Z/5
M?^BOH+Y$?S&.XJ&FQN0SU'E/[N5?V?\ P VO@O9_?]AH/]7#H'/(:$]:_P#\
MEODY!W9\OMP96>"IS>0[&K/LO^H#%_QKV(]@MQ.,_P"KXOGT722&O1J.I<E@
M^MZ#^[F*P=3MNG_YVV)H_P")??W]BRTL4@[J?ZL_,] K<[MISI!_U8^71J)O
ME1BMJTM/!/\ Y34?9_Y'24G^Y+[_ -ZO.:!MW:/]7#^@?7HQV3E/]XC4?]7Q
M?TQZ=(^C[:RN8K_[U9S[FFV_]Y_Q::3_ )3_ '"3[U?[FI77_)?^@1Z=3;8<
MI;?8N&T?S;Y_TSZ]&(V?O#%;DH,?7?W'W_C?NO\ @'25>V\S_E__ !OW'F]\
MN;A</J#_ ,E_H_TAZ=2)8;AMUBH7P_YM\_D?7HV&U=D[QWM09#*[<V/D:;'X
M'_(O^ ?L.V@W*SD!$G\D]#]OKT=79VV\C(\/^;>H^STZ'#I/8>_^PLI4;<SE
M#DL;CZ7_ )>V6P__   ]S-RYOM^L8!?^2^K?T>H9YBV+;VD)5/YM_1_I=& W
M5_+-ZR[.Q=10[QW5C<E]U_RJ4?N4EYN>="M?\'K_ *3J)6Y52"0-3_53_3_/
MHM^V_P"3S/U+%D)^LNV\E34]56?>_P"_AV?ALE_ZW/\ CY_</\VVS;DY8G_5
MV?9Z=3!RC>KMT85?]67^1]>B'_-[XW]_=/X''YS*XK^\G7^+K/O:/=FT_P#<
MEC*#_M>>]\L<NA'!/^KX_P"ET;\[;^%0T_U?V?\ 1ZJ0^$_?N6V?_.>Q&6KJ
M[[;'=M;/R>UZ2L_Y7R<+@2 ?]<8'W(5QM81/]7R^?46;=N!N7)_U<#\AZ=;H
M^'ST&2JJC]^F^X'LFTKZ=+^AHHYI_L*?\>_:5].O=)#<FV\564M1_%8/N?\
M7]VZU;\6Z+=L/K?9V!SV0GQ4%33?=5GWM'_TP>_=%]_Q_P!7RZN>^)E_]$5!
MYI_N#_>/<_J_\C36'^P/^]^S&]^,_8.B;:_+_5Z]&A_!_P!]^?9=#Y]'[_">
MI/OW5NO>_=>Z;9:/S#_/SC_6/M/!$]N=0/\ J_GZ]5=*\>/1'?DO_+I^'?RY
MAU=[]';*WMEQ2Z:3<-7A,5_>>A^@NF:"EFY_IQ_C[/8>8)[8 !QCY#_H'Y](
M7B!)ZK>@_P"$T'\JZ/,#++U5NYR1?[2HWYFFQ1_P&'XC_P!Y]K8>=[B2N<?8
M/^@.JI;@'AC_ %>75F7QN_E\?$+XEP0-T%T=L#8&6^S^SJ]PXG;6(&YZ]?\
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M#U5+=0<?ZOY]'W^-'\K?X+?$VHI\[TMT#L+![GIAQO>LPN)K]T6_[714./\
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M+H_\CJ\L?XE_K^TVX4N4*C_5P^STZ/8'\-P>E!W9\/Z'>%!_?'JN"FQNX/\
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MK$%/]":5\O\ 5\^O=&OSW<W4VV]U4&R,UV9L/";VSE']QB-HY;=V'QFYL@+
MADP;2+N'2+_4*?Z>ZBR8@T4UK_JXD5Z]T#O8?S;^+_7^W<AN*?NKJ[<-7252
MXFDVIMSM'KG([DR&8&H#"X;#C<Z"3/ G_-DWM_A[V+(DZ:>7SZUTN\3\F>@<
ME-7T-/VWUO39_!8?'YK<VVJO?FS5W'M7&..&W!@QN$G <<&_'/Y-O>C8OBB^
M?6^I]+\COCYF<OB-O8/NSJ3-[DS^..8VUM_%=E;-K\MG\80?]RN%Q$>X2^<C
M#']2@V^OXYHUDQ&5_P /'_5Y\.E'28Z_^4O4'<':N\>K>L-V8/>N2V'A<7F-
MQ[@VGN/";DVU1'-DZ,(\F!W#(1G^?]22+W'M&]AZX_U?;UNO1IO;_6NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[J+Y!HU?G_ (GWY#KH!TG_ ,/59>8_F6]%X'9'
MRQWSE,+O2EA^(._3L#=^*^RQ)R6[<LV;. P7]RU61!,-U;@LHO8BU_\ 6,(]
MH:6A_P!7^$=:KTP5G\RG&P5>1RM!\;^],GU?MG,[8PV\>V(,KTUCML[17.@Z
M,NN#SG9,6Y]P*C&_^XK#L3<B_P#3;[>P!I_J_GTHU+Z]'8Z<[VVMW;A=T;BV
MI15])0;8WEE-F:\L@QS5W\$PN!S?\:7U#3@BN=L&Y_UO9?)8T.1C_5\^O:E]
M>A^A_P S_L#_ +U[UUOK/[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z"'MSL7
M%]3=?;N[$R>,R>1QVSL0<U64N).)&2K8UX**<VT85[VL2;_7ZV]^Z]T4[KCY
MX[6W3DY\)VSUYO#XS,-H+V%B:ON/=W5YQF4V+8+_ !R3-; [&W8-O ?4_P 3
MT7_'M5])XW 5_P!7VCI-T8&?Y0?&Z&EVS6S=X=2BGWE_QYI_TE;.'][?3:V"
M_P!_#;.?\@W_ -O[9_JU).S 1</MI^VH!_*O5J] ONSY[]$XCXY[R^36QZ^?
MMKK[9N8RV$J1U]58G*9"OR6&S(P+C#KY0DI9^1P+#C_'W6/9C6G^K_#UJO2&
M[3_F4=%]5U.'IZC&;KWL<[T/NGY T5;M487^'G:VQ\/_ !^3#$YS<D0&XW7\
M <$7-_:^/9GH3IIG^7[>O#IHI/YD^$QV1I\)VE\?.ZNF\_E:'8F:V]B-VU'6
M>4;<.VM\=H;<ZGBSF%?8'9&[21'N+>U$+?4ZOJ"/:;Z"G^K_ &>E'5FD-8*N
ME@G@X%0+C_ ?GW7P@I8-P ZW3IR]L]:Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO_]+<L^='V/\ LL':_P#$(/N:'^[;_=4O]5U+_P :]JMMI0?ZO7H.
M[YFZ05Q4_P" =:\?3^-VKC:#'_P."FQN'_Y5*3_G:?\ (_9;O?'_ %?T>I"V
M^W#62?G_ ,>/SZL(V?\ 8S8O]C_E*]H@:<>BVQ<S_P"K[>AHVKF)_M?!//3?
MY+[N+A!Y?ZOV=+;F-X_A/^K'6D?_ ,*$.R.Z>I?G#M?.=5UVY,)_'MAXO-?=
M[>H_XGC/XI[4H8V- N?SZ3/?RRX)_P '^;H)_BC_ #U/YENS\]L_:N\=C[;[
M(VO]YBZ*LJ][[#S(R=!B_P#M>>UB0AA4<.DC6WBG/^K^?1X/GY\BNV_E%V#3
M[C[&P?\ N/P.'_W#XG$T?^XR@]IHQ0@=)F^$]:H_RBZW@VKV7NBNP=#4TN'^
M\_RRD_Y>=!E/:Y+AE\O]7[.D$G'AT''6,V_\]N3'[=V/09O=NX,I_D5'B*.C
M_B62KO\ #DD^T5_>6D@I3_#\OETNAM+M#4&@/V?/YGK<'_EI_P CW<>\-N;7
M[&^6U=DL)4559][_ *,L3_L?^+Y[16T5E(<K_P >^?1[#+>QB@;^2];@'6_7
MNSNM\#C]J[.P>-PF'I:/%T5'24E'[527XC';_J_ET6[>AD.3_JST-$,WA]E<
MMPTYS_J_ET:3N(!PZD?Y[VI^H'262WQTJ(:/PQ?]-'^\^]_4#T_U?LZ+Y+<U
MZCRXVNF_S%=_QK_#_#Z^_=&'2/S^-RD,7_.RI_\ "C]^Z]T'\T.*FE_?_P F
MJ/=KT>!E?]7#_/TDM$$QS_JX]-_]U8)HJC[&NIO^JOW6TN"_'A_Q?RZW=QB$
MX_U<.@GW)U+G)J_'Y7%5W\-J*7_E4]^DD-.MV^6IT$_?WR*V!\5\#A]Q]J5U
M3DJ?*?Y%1TF)H_\ <G7^R^1S7H16]NI'#_5GY] ?T;\_.G?DYF<QL#;E=N38
M.0_Y0\3NS_<;_'OZ_P #]II+@DCHQ_JXL"D^?^K^E\^CH8W _9Q4\'_*K[$6
MUC4!_J]>@9NZ> 2M/]7;_GZ/[\65\/6%/#_3<FZ#_MLPX_Z*]G5[\?Y=!7:^
M('^KSZ,E-Y?'^S:]A_K_ .\^RV&GGT?O\)ZKL^=7Q/W=\H,=UOB]KY?!X+^Y
MV8W5FZNJRQU$Y/-[*W!@L%H Y;_?P9J_'LRV_<@E?3_8(].F>B(8+^5%VCD<
M-3XKMS<FP-[?WHK-J9KLC_*\UCOX]E,+FK9HBP-P^WN ?H3[,9]U!P/]7\NM
M=&!ZN^ N\.E^P-CXO9%#L*EZ7ZZ[MR/;&&JZK<6;??5=C-P;-&WLWALX%VTW
M&TV;_<(3F+ <FP]I3<*0<Y./]0I_J\^O=,OR1^"?<_:7<6[\]MC_ $7S;&[&
MJ]AUU=OC=N8S)[+V!_<07;"[*PB[<9,\-TV]1_C.' _K[\+I<5X_ZOMZ]Z]
MQN_^6CW;CMC;0VOL#;OQXW7/4;-R>VMXU>^LOFL4=HY([R_O!_&]DC!=;[L;
M/;AM];_P:Q!_(][%R#7_ %?Y.O=!]C/Y2WR!Q^[<^9MR[:SFW:L(<-N3+=V;
MRT,)#;,_QGJ[_0GH;4?Z9D_4?U'O7U2]>Z679'\K+N#,=R5.X]JY;'4O7V3P
MWVA:E[>S>R,CM+)?P3^!7P>RL!UMNU=P<?\ 5YP_OSW2D8_U?RZ4]&M^$WQ,
M[OZ4[1WEO[M/:W3NTZ"MZWVOUUASU?N7-[CRN=.QSH.]M\'.]=;.<;AW03<D
M'+D <'V7R7'IU[JVWVGZ]U[W[KW7O?NO=>]^Z]U&,T,7Y_V/U_Q]^Z]U@FK*
M.&/]^<6M_C?_ %N/I]/?NO=<9I8?%S/]O_C]#_MO>THE".DWV=:_G9W\KKN#
M?>_^SL]1;WV3B]@]M[E^3VYMY;/9LJ&W3EM^*'Z-S#D;?*:MGY\T3-9CP+B_
MLPCW<Q8(_P!7^\]>Z7=1_*Q\G]X.SJ^GV5DN]L5OO8F]-B9:IW%O2@V37XO8
MI%L+O94#,1]?H/:Z2Z%?EY_RI_EZ3ZSU8?\ %_J7=?3^W.P*+>$^WCD=Y=O[
MHW_1KMS^+9'&T&+SV'V\/X1Z[?H&#O\ 6Q'X/'M!+."2:_ZO7AUO6>C<Q5<,
M*"&><>8 W^M^?Z?ZWLOZ,.I,M5!3_P"=E _WW^'OW7NO0S0S#]F6_P#OK?0@
M7]^Z]U)]^Z]U[W[KW7O?NO=1_+#_ %_WW^W]^Z]T7;Y"]?5W;_3_ &1UUBJC
M"4^0WEA_X+_N6J[XW_;#GW[KW1%=W_RXM@;<Z4Q^%Z!V-L+&=G4V7V#NG+5F
M[<MFQMO?HV.+_P $SN8*[M==O[K/U!''^W 4V]X8V%?]7\NDW16:S^7;\IIL
MSL#<>*/4FTLP-R[HS.\:O;W9&\L;C-H8O.[SS^X/[E[)V/\ Z$_]_P#;<MG/
MSF,-[$5OO@04_P!7_'>O=&NVK\*NS*3XF;G^/.:_T78[(Y/LC)[GI*K;U9F1
MMNLVLV\CN %U.W R[A-OZ7O[)H]S[AC_ %?LZ]T3D_RG^]9=D=K;5J=_];YF
MIR^Q.X^L.M:FL.8!P6Q,]UAN#8G5"YO_ '[EBP HOXY;^A]KTW44&/\ 5^S_
M %>77NA?R/\ +)GZ^S&1@Z(H-@87 ;Q/1&9WA5;JW+O(Y3 93JCLW8.X,WA-
MD7VWNS3M_=JX.MX/]?\ 8^TTUS1>&:_\5_*GY]*NKN<:!#0P0S3"]-8$W_ ^
MG/\ L?8>N+[0Q(_U</EUJO2A]J>O=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7__3W,OF[")OC3VC#-^<-CKV_K_&(/\ B/:O:/[#_:G_ (]T0[Q0W"_;
M_P ^]4.];[#\VTO/!!]M_D?WOL)_\36_+_CO0L/^X2_ZOQ=*#9/9T^V]T8?%
M3T_W./RG^19C_I@_WP]G&/7IKHW'\8_AO[\ _P!]_M_Z^_=>ZI&_FK18JLW'
MU?G*[!XVIS%5A\I]G5U=&?\ ??7WNG7NJ@,EDH/X?X/\G_Y=?_*'[UY]>Z$C
MN#Y"4.P][Y?%Y6#_ ''TM'BR:O\ Q]J>DW55^2Z9WQ\S/DCF-G=608W)8?='
M\+K<QEJO_BV8'_?'W[KW6U1_+X_E@]'_ !+PV/KJ'!TVY.R*K_CY-[Y:C_W)
MU_\ VH_:5^'5EXCJ^#9]'/#%X(/\EI_9?)QZ7Q\.AHQLWA_WW^Q/^]^U'6^E
MA1T?F_S_ /K?\2#_ $]^Z]TJ(8:&C_V__(O?NO=289H/]W_['_#_ (GW[KW3
MA#5P?[H_S_\ M_?NO=1IOWO\_P#\"/\ ??\ %??NO=(_,;5H<E_NC_*/?NDW
MET$^8VK78V7]B>IIO?NO=)^;^]4/['@J<E[]UN/CT$_;74NU>\MKU&SNS=@?
MWDP__*W]G_N3P/\ VH_?NC!.'5%^]OY5/=.U=QY"NZ=WCA*G;]+6?[\^KRU9
MF=M[YH/]OMOV#/W0RL*_ZO\ C70KL^8U9:5_U9_H]64?%W_9R^J\#3[<^1F#
MVWO_ &_2_P#%GRVWLQ_OYJ#_ +7GUX]C/:+ JH'^KS^?0+YCD%XU1_J^'[/3
MJ\3XOSBKZU%=#J_RC<NZ&_RFC.//.8D'*@$VL#;^I]B2^/=T#=KXU_U>?1FC
M]#_OOS[*X^C]_A/7+W;JW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]T6SY,]G93IGI#M#M7;>#J-VY_KO8>Y]T46WJ.
MB&1R.?.$&LX=1R?46_/_ "-1;VM"/0_YJ^O6^J+\3_,N^5M!UGF-_P"Y:?K?
M=M1M;,8RC&W\KB-F[:RG9)SV#*$IA>GN[/D2=MMU1N%CD\X1_&#_  6A]B""
MWC"TIG^8^STK\J?MZ]7J?OO^9%W/L+M[8^S<5VGUSW)C\_B<?2;DJ]E]18FA
MV1_>B39YD?>6#WT_=S;I"'<IX7^Z&D* !D@ ![5#:+,C)I^W_(W2;ZP?ZO\
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M_P"^_K[+Y./#I?'PZ6%'-!1C_,?\:]J.M]*"CK)ZS_E6I@+^_=>Z4,,-0/\
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MR?K[T#>5^+_!U[Z,>O\ J_;U&'5G6<--7^#8&T:>GRE&*&N%)MK#J*[%VO\
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M6G\7_'O^@^C#][_ZO]0Z)/W]O;Y>X>@S&W.B.@=[9+,4M'][_>'<.'_W&?\
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JNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img37592182_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img37592182_3.jpg
M_]C_X0M,17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    ?    <@$R  (    4
M    D8=I  0    !    J    -0 $D*:   G$  20IH  "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C(@*%=I;F1O=W,I #(P,C(Z,#(Z,3 @,3$Z,#0Z,#$
M  .@ 0 #     ?__  "@ @ $     0   @:@ P $     0   )<
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   *$@        !(     0   $@
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MM]=FXL#@TR1 >WTK./WJW;%YK_CK@6]!T! ^U:1I'ZJDIV__ !X/J=^]D_\
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M=^=].IOI_P"C24O@V],+,M_4F^I92SUL&F"&6W?1^R9#J_\ M*YK:_T7Y_\
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MD@$%MAV9%4.G=^AWTU[E8KR>GV]0LQ\6MM73P'UXM8&TAD&T/MO<766V^O\
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MS]F[<]=.DI2\ ^OMKZ?KYU2ZMVU[+&%IT.OI5>TM=[7-=]%[%[^N$Z_]5_\
M%QF=8R<KK'4:J>H6N!OJ?F5U%I#6M:/1>X.9[ U)3P6%]9.FV$?:*W8NL'8[
M=M83[V4V7^IO8QG\Q7>[U*_H>M:BY'5ND4;LAKQ<XEQK8X!T D^F[T6.=ZEK
M6_OO]%=2WZF_XI?S>JT3Y9]?_DTY^IO^*COU6G_V/K_\FDI\KSLJS*L=:_2
M6M;R0V2[4_G/<YSGV._?7TQB_P!&I_J-_(%YR?J9_BD/_>K0//[?5_Y->D5-
M:VIC6&6-: TS.@&FJ2G_V?_M$JQ0:&]T;W-H;W @,RXP #A"24T$!
M!QP"   "    .$))300E       0Z/%<\R_!&*&B>V>MQ635NCA"24T$.@
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M36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP
M     $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C
M:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M    1W)N(&1O=6) ;^            !";" @9&]U8D!OX            $)R
M9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M %)S;'15;G1&(U!X;$!=ZMW         "G9E8W1O<D1A=&%B;V]L 0    !0
M9U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M        5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
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M!!D       0    >.$))30/S       )           ! #A"24TG$
M"@ !          (X0DE- _0      !( -0    $ +0    8       $X0DE-
M _<      !P  /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M T$    &              "7   "!@    8 9P P #$ 9P P #<    !
M                      $              @8   "7
M      $                         $     $       !N=6QL     @
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M      !,969T;&]N9P          0G1O;6QO;F<   "7     %)G:'1L;VYG
M   "!@    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I
M9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4
M>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG    EP    !29VAT;&]N9P   @8    #=7)L5$58
M5     $       !N=6QL5$585     $       !-<V=E5$585     $
M  9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (
M8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E
M2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI
M8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    1
M15-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M      IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M       +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M       X0DE-!!$       $! #A"24T$%       !     $X0DE-! P
M"BX    !    H    "\   '@  !8(   "A( &  !_]C_[0 ,061O8F5?0TT
M ?_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3
M$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+
M#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,
M# P,# P,# P,# P,# P,#/_  !$( "\ H ,!(@ "$0$#$0'_W0 $  K_Q $_
M   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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ML_PGM]WT-CUS7_CQ_5#PRO\ MH?^E%=^OV#BXOU*ZL:&;)IK9I^ZVUI:-?\
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M &\ <    !0 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  (  R #
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M P,# P/_P  +" "7 @8! 1$ _]T ! !!_\0 T@    8" P$
M!P@&!00) PH" 0 +$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$4
M03(C%0E10A9A)#,74G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W
M1V,H5597&K+"TN+R9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY
M>H6&AXB)BI25EI>8F9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7F
MY^CIZO3U]O?X^?K_V@ ( 0$  #\ W^/?O?O?O?O?O?O?O?O?O?O?O?O?O?O?
MO?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?
MO?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?O?_]#?X]^]^]^]^]^]^]^]
M^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]
M^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]^]__T=_C
MV!V\^W.N=BU0QV^]^;6V_4UHYH<]NK!XAEY_MAPK\?X^P:S'?!P'R+VET?O2
MGHL71=IX3*[@ZIW315H?$;ERVWF(.WV5@R#<SACEO];'<?7V<+S_ /*3]5OQ
M_0K:W]3Q_P 3[T5?^%6OSS^7OQ&[M^/NW/CGWSV?TSA]P[/K\IN"+9&YMQ83
M%Y&IDJ?&[C[>2,,2!8_B_P#MO>HW_P /7_S3>?\ G.KY!?[#LK=H_P"NWO"/
MYUG\TH?]SQ_(0V^G_&2]T_F__33;Z?ZWN1_P]G_-,-O^<Y/D)_7_ )F7ND?[
M#B<>^_\ AZO^:?S_ ,YP_(SD_P#/S=UW_P!8?NV]YXOYTW\U:K_S7S<^1@_Q
M;LW=7^V#"<@_[ ^\_P#P\[_-9_[S<^1?U_Y^;NG^OT_SMO>&7^=#_-:A'_9;
MOR,_IZ.R]UO^?^HC^H]]G^=/_-5/%1\XOD=]O86'^DG=C6M:W'W'U'^\>XO_
M  ])_-._[SC^0?\ 4@=D[MM];?0S'WU_P]?_ #3?^\ZOD'_Z,K=@_P!ZE]^_
MX>O_ )IG_>=/R#_V'9>[?\1]/-[.U_+N_F\_S)NQ?FS\:=C[Y^8O?&[-J[K[
M?V1A-Q8#-;ZW+F,9D<8^Y(49'ADJ)%D"ZC:P]_6SH/P.?[7];?C_ 'GVZ>_>
M_>_>_>_>^$G^;?\ UOQ[K,^8OS)W'\6>V?BGLV7#[)_T>]]=I?W$W=O+=&Z6
MQ;;?Q!:$-G2P(5+1S!M5R+WY_H(?;GRKVAL7J^@^0&W,WMCL3I+&Y.W8N^]M
M9O"YK&;=VF94VWGM^(J^93MS9DA7^.K^H7 4"Q]F?FRU/7;8K-QXVKI*VEK,
M(<E05]%7:>&P)(W ;6!TCTC\VM[^.KWA_-1_F68GN;MO%X;YX?*^@QV+[/["
MQE#CZ7O/L2@H*.AQN[\[,V+*KNH*H+R%B .3<_0FP-?\.Q_S-O\ O8'\O?\
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M7&8L2+DE1H!XL+GG^G/M,_'/O:@[EH=XXZJI*7%;]ZVW6=H]C[6^G]W<Q<V
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M3JW*J?K<<?\ %?9&.P>G<]M.JK$GQU13FF8 P$<\_P"N+<>P3DADUGR<<_\
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M!S'^34V.!_X!@\#_ ! ]X<W%CJ;;_P!K_%3_ !FG/^4C_ _3\VO[AQU6*R.
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M.;_3Z\^^\G04U/M^$H?W9R?V.+"QXY(//UO['7^5R1_PXI\3OS_QGC8O]/\
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MM8ZGQN39O]X]D8[1E$F[-WS6X&8R;<\_VF/T^H'OZ]G_  G_ /\ MTI\//\
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MKORS8;3;Z"Q%Q[J8WWDVVS\7ZBAFA@AE[2[ K]Q4OU)_AL":;B_U&LFWNO\
M=(WBD<_3P?[S_3@W/)//OZW'_"9?_MS3\4O^6/87_OP=Q^[[_?O?O?\ _]/?
MX]^]^]^]_.*_X6G@?[,5\7C_ -^_K;6O]/O6^O\ 3WIR8=!5T\']" >;?3_;
MCBW^O[&W"XJ8R8W%TLL,U945'W -P/M>/]Y]J*MQL5+NFD!B\T-Q39,4X/\
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MQXL+CD?TY]AGWAC\77U=!M_;T&.IZ[&C_*_M#Q?\F]S^/8(#8$65S4%/,/\
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M15X 'L.1^@?[ _XC@#VG-Q?\!$_X,O/]1<?6QM?W]<O_ (3(?]N:/BI_RR[
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M-UM[4=-7[J@3Q'%[@I_K_P N[(!?ZW!%_K[=$W3OB/\ 9_AFXIN>;8ZO(/\
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MH???_#>?P0_[PO\ B]_7_F1/5G]/H;[7]]?\-Y_ D\_[)A\701_3H7JP<_\
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M -C/O!_PWI\$/Q\+OB]_Z(CJOGZ?]FP??'_AO'X(_P#>'7QG_P#1#]6?X_\
M9J>Q^V!L'8O5>UJ#9'7NR\%U_M3$!CB-L;:P>&Q6)Q[-S^WA=MZ$<DGEA];"
MYX'L3O?O?O?_T=_CW[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[
MW[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[W[
5W[W[W[W[W[W[W[W[W[W[W[W[W__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img37592182_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img37592182_4.jpg
M_]C_X12^17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    ?    <@$R  (    4
M    D8=I  0    !    J    -0 &1@H   G$  9&"@  "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C(@*%=I;F1O=W,I #(P,C(Z,#(Z,3 @,3$Z,#$Z,3(
M  .@ 0 #     ?__  "@ @ $     0   9N@ P $     0   2,
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   3A         !(     0   $@
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MP$$#LHA3;R$E/__4]!S/Z59\O^I"#"+F3]JL[:C_ *EJ"21V/Q4\=AY(1Y!
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M<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,
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M      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M     %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6)
M;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M             $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X
M;$!DCJM         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !0
M9U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N
M=$8C4FQT                4V-L(%5N=$8C4')C0%D            08W)O
M<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M   ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M        "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 *1U6@ !
M  ( I'5:  $  CA"24T$)@      #@             _@   .$))300-
M   $    6CA"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #00    8              2,   &;    !@!G #
M,0!G #  .     $                          0             !FP
M 2,                      0                         0     0
M     &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M 2,     4F=H=&QO;F<   &;    !G-L:6-E<U9L3',    !3V)J8P    $
M      5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L
M;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O
M1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M-]T..NRO_2W_ .EM_FZ6?\'^D6.S*;3^NY8L<8V8N.T$NE^GM;^=EW?0_P"
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M &@ ;P!P    % !! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ #(
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M'PN#V9A-E2;HVQNC?VV]K;>.0RN8Q-[9=?L5464>PCLKF0Y\O^AO\W0EOCI
M-* _['V\:U^73C_/NWOT?\R?^$^VZ/EE@MG[<S=/N;8'QQ[IZ=W!N+;V&RNZ
M.M,GVOV=U$N>_@N;8%MO[@.W,W78O-G%DECJOP/9EN$AB*Z1BO\ AIZ]&6RP
M+.VEN-#_ )?\'^?TZ-!_+J^-WQ@KL7M#OS"_RY-I_!_MSXZX_8N%V+N'%;%Z
M!V3V7W-B^U_CWMP9W,[VS/06X-W;6[!VYNK<6]S_  4G,?QG^-8^UJ#)_P 0
MQP7W?GC_ %8Z#]IPH3C_ (OJO;^3AC>D?YE7QX^5G\S+^91U?M#YB]GU/R/[
M,V7B-F[UZ?S?RT'QYZ?V3A=@9_ =*=)?'3"[=[9_@!1L]79!QM/"_P :SG\0
MOD3D2-7O5KCA_JX];N_+_5Z=&PZP^1/\OS<O\OS^99W)\=ODEO3LWJ"J_P!/
M%:W:WRDVYWSLW&]<;E[7Z7PG7Z] ;&[O^7.!VJ-]:]R;%H,<N*QF9+85,CA<
M6RAOX=]^5[A:.VQ;=&4 (5J4I4@R"E0/V#S)KYUZ45$0J. Z8-ITGP;^1?\
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M[_;M_P 4]^Z]UU_>C*?\<,=_R4__ !7WOHP\(?/_ %?GU[^]%;_QQQW^W/\
MQ7W[\NM>&OK_ (>O?WHK?^..._VY_P"*^_?EU[PU]?\ #U@_O=6_\<,;_MV_
MXK[U^75O"7U/[?\ 9ZC_ -]*W_E7QW_)1][ZUX8_U$_Y^F\]@96'_@118_\
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M>Z]+52@< #_?<?[?W[KW3?-EIHOK]O\ X\G_ &_U]^Z]TVT6<K:NOA@F@IA
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MV/\ "JG)9#%UG_ 3[SW?M7SZ+)-P=3@?X/\ -TE\;_/LRN-EJ*ZNP>-QM/\
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MO^O[,'C-,]>QUZ:L\/\ N_V7O'GK?7ILEX?]]_Q7VCC[3T9_%TX4>2]F4=P
M!_J_R=5^G+<.E/1RW]L1\>DDHJ.G'_=O^^_J?:]> Z+WXC_5Z=2/=NK=>]^Z
M]U[W[KW77B_UO]Y]^IU6OSZ[]^ZMU'F_WW^W]^/EU4<>O0?G_8_\1[]TFZD0
M?G_8_P#$>_=>ZD2RV_WWU]^Z]U'\L/\ 7_??[?W[KW7O?NO=>\L/]?\ ??[?
MW[KW4B#\_P"Q_P"(]^Z]TW5G^:'^L?\ >S[]U[J!!^?]C_Q'OW7NG#W[KW1
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MX/3JNLMPST8C:M9V;O:@R&^*'=53M*GP-'B\+MO^$UF9QOW^4]G;\N-;"O\
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M #7^\^T_B+UOPS3KT/\ FO\ >??O$7KWAFG3?+_G?]O_ +U[8\^C#RZ]X?\
M?<^_4^?7JGIPAA_=_P!]_P BO[]TFZ>/?NO=?__0WOM]?\6B'_J*7_>F]ISY
M]*8OB;H(9IO>NC&/AT%_9W:F#Z]H*>"N_P IR&4_X!XFD_XN?M-)(?7HRLX
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MITHV_P")/M_S]%@R4/\ N4J/^HSW'M_\1_U>G4J[;\ _U>O2WVW#:2G/GO\
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M5']W[/-QV=KX57_5P_I#TZ#^Y[V(C3_5Y?T>APV'VU\DX8O]P?\ &\E3XO\
MX&?:?[DO_>@]J=KV2_I\'\U^?]+IBTW>PBM#5_Y-_$?Z/2XA^45=-_OW.QMC
M[;S=12_\[;#_ ,-W-[+M[V2__@_FO]'^EUOEW>+&6[8A\?8WHW]'H6.M_D)M
MS;=5F*[:N\>T=@9"J_X]O^Y&_,SC<90>R>/CT;]6?_"+^=?\X/CAV_L?^]79
MNY>X^CZK,8O"[PVGV"3N/)_PO.\_QK!YWZ^S!?A'7NOH[;*W9BMZ;3VMOC!S
MBHPVZL/B]SX@C\8W/89<V@X'U;5_O'O?2;H0_?NO=?_2W=?D)EOX#L_'5_\
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M_P"XRO\ ^*>R^7CT9[G>*XH#_JQ\NAAV?LGJ3=40G@SFY,)F*7_@'24GM+T
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M'5$WT&Y* '_7.)SMO]Z/LRV*Y_QE&_HG_5P^72:3A3[.J<^\L]/#B\A]C/\
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MZND_C/\ $Z_V7R(*]&,=Y_J_U#H/ZS=7R3R7^3T/4E33?]1=9F?;S[8*</\
M5^WHN^O/^K_BNF_^Y_S$S'^8V=38W_??\1[+Y-L'^K_B^O?7G_5_Q73Q1_%?
MYL[JE\'GIJ;[K_IC]J?H!_J_XOKWUY_U?\5T-&U?Y8/R3W)5?[_'LVIQM/\
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M/\A/LMDC/Y])<]$@WYTS@]GU]1YZ'[G#U7_ .K/LO>.M:#'6^DA!L/:OE/\
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M#E>T>MZ;*5GV5%5_9_WDV-_%!_RY;_GW[KW0';VFGJ\SD/OLK39O_IKI"?\
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M0"O#'^KY]%G["Z!P?878U1O'?\_]Y,?2UG^X?:=76?[C*#_J]>[1[F:_ZO\
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M^KTZMGZ4H\5216H:&FIJCGZ?TY'L4[+)IE!_U?BZ@WF1RT1'E_T3T6_^8_\
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M^?K'\^MDC Y[^,8NGKH)_P#@51_>T?O+C;8A- I/S_PGK 7FV]^EN7"C&/\
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M_P!7#Y'UZ5V<95O]7SZT[]^=_;<["JMP5V#H:G&Y"JS&4K?_ "%^P==;^-1
M/^K']'H96D@5?]7SZ+/--0UD60GG@]QO*CSW( '^JG3K6X2V/^KSZ'+X6Y>?
M#_(#;_@FIZG[HVO^/SQ_A[(^==NI8 'B#_A*_/H7^W=P8[HC_5PDZV]NJ_\
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M5>Q%;QA@.O=:-_\ /"WM79GL'8^Q_P#@3C\71_QJLQ/WG_+T]QOS'.=- ?\
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M[KV[^[]OP#?X?E_PGHP&U?A#W3-+3P5U=A,)3G_E;K/8LL/:N:OP_P"#Y_\
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MBGN-9.>(=C(.K_#_ -:V_BZ$TFTR4X?ZO]ZZ3^[^F:[);RP^ZMJY6F^WI?\
M(LQ25?\ R/V(MK]P(-X4#5_A^?\ PM?X>BZ3:9*UI_@_S]&(V'A_X;0?PK*P
M?Y/_ --?_%/9#>\PQS,"#G\_E_1Z"T^VNHX8_P!7SZ1W874L$T7\5PG^8]C#
MESF1(@$8]W_17]$^O1#/:LI/^K_+T"$,T^-JO!/_ ,"/8_EG204!_P!7[.K^
M&>EA#DO-%[*Y+;Q#7_5_AZ]X9ZG^;_?<?\4]D'T_R_U?MZ4]2/-_ON/^*>_?
M3_+_ %?MZ]UWYK?2_M]T-/\ 5_GZUGKW^[O]O[+Y(SU[_/TH(:SVDN+ L/\
M5\OGT8ZE]>E!1UD\/^8G]AV?9V8U'^KA_2ZUJ7UZ5%)N3PQ?O_[[_7]DGT#K
MFG^K]O6]2^O2@AK()O\ ,>]B KU[4OKU[S?X?[Q_QOVET-Z=;Z</-_A_O'_&
M_?M#>G7NG##_ / ^G_Y!_P")]UZ]T('OW7NO_]+=V^0?_'IX_P#\.3'?^ZG/
M^SGEO_<F+_2-UIOA/Y=%);W(UQ\(_P!7IT7/Q'6?V[U;KWOW7NO>_=>ZP3?Y
MH^_#AU4>727S$WAB_P!]_K^S*",:NE$G#HE_=F2_R"H@_P /8A@C&D=%\G'K
M4?\ YGWQ+WC\A.U>KY^I,5]SOC/;D_NQ6?\ :KSO_+Z_\E/V1[IRHA%:?ZL?
MT^E6W[TS'C_JS_1ZV6/A#\5]N?%'HSK_ *KVW]M4Y#:^'_W\F6J_^4_='_+]
M]AN/9?ICV_ZO^-'UZ,[C<RPK_J\OET>#[,0_[OIO;[RF+I6R^+T*&!ST^-BI
M_!/_ )/_ ,JGM(\B2_$.F3XD/PM_@Z$BCK,'GHOW_N::H_ZM/M':;7!\17^9
M^?SZ6?OBYX!O\'_0/3A_H]GF_P"+5N.I_P"JNL]^NWM[0T"_S/R^WUZ\3<76
M2W\A_L>G3?-U[NK&_P"8GJ?_ #L_WU_:S;[J&OP_X?G\NBL&X;\?\AU(HZ/>
M.-_S\'LPN+J&GP_X?\W5A!.WG_@Z$##]A9RCB\$^*_WUO9=*D %=.?SZ212S
ML?B_P="!C=^05D7[]#4TWLLDEB4_ZO\ -T91I*P^+_!T_P .>@F_S$%3[?:Q
MCH:C_#_GZ](DJCC_ (.G'^)?\=Z&I]H)+*&OP_X?\_19)-.I^+_!U[S4)_W1
M4_[Q[31K#_#_ (>E.J4?B_D.F?)8?%5G^[ZGV81B*F5_P]>U2^3?R'27K-M_
M]77)?[[_ (GVH3<8CP'^'_-TT]E-!P/^#_/TGZR'*T?^8KJFI]K$NE/ ?ZOV
M=(WA=SD]2(:S*S2_Y_GVD$A;HR@CT_ZOMZ6%'63_ .[Y_=A&#T67\A4\?]6.
ME1##!-_N_P"Y]EG1GU(FF@AB_P"5GW[KQZ1^2R4$/^Z/:GKW2/K,]X?\Q[]U
M[I'S9C*YC[BAH?9?)OY@S_J_XZ>CFWVP3G3_ *O/YCH'MX=';QWMNW;^XY]X
MTV$I\#6?\!*2Y^_]ETG/KP4 /^#_ *U]"*#DU)EJ1_A_Z#Z4&7Z.V-F?MSN/
M[G-_],EO9,_NG,%I7_!_UIZ.I.1XXR& _P /_6SH0<##@]MQ4]#BL'38VGI?
M\BH_M/<?;WSY-=O4M_@_H_\ "QZ="+;.78XA2G^'Y_TNG_[V&;_E-_V-_8'O
M+F7>>#?R'R^2_P /0C?:EIE/Y_[/3Q29+[/_ '?4>ZV>XS[%^+^0^?R;^+I!
M)M*>G\S_ )^A1QV8@K(OW_I_OOQ^?8VM+J24Y/\ JS\N@1?[8JJ<?ZL?/I44
M=9X?V//3?;\V]C&SNI(EP?\ !\_EU'E_:*KG'^K'SZ"[L'9U#D:7^.8J"]1_
MRJ4G_&_<BV&^2$*C.21YG\_Z/1(4%>@@\/V?^?\ \F_ZB_8XL[[Q%%?]7'Y=
M>\,=2(:SS?L?[[_;^UW@#_5_Q?2?[>G'S_Z_^\>_> /E_J_/KU/GU&\W^^X_
MXU[32(*<.O=.$/'/^/LO=!7_ %?+KWGTX^;VC%P&_P!7^QU[Q#U/AK)_]]_O
MOZ^[]K=;\0].$-9_QW]H[BP116G^K'SZ]XAZ>/WX?^ ,_P#D_L.7$ 4_ZOEU
M[Q#TX4>8\/[$_LE\,=&/2HAR7^^_/^^'OWACKW2HP-;YJ^G_ ,?]]_M_9=U[
MH2/?NO=?_]/=V^0?_'IX_P#\.3'?^ZG/^SGEO_<F+_2-UIOA/Y=%);W(UQ\(
M_P!7IT7/Q'4C[N'^O^^_WGVW'2O7J=>\W]/9A&,=>Z]Y3_C_ +?VJJ/3KW3?
M--[]U[H)]X9Z"&EJ/9C;QEB#TGD[AU7/W-O">:6HH:&"IR60JO\ (J.DI/8D
MM[Q;84;_ %<?D?7HMDMRQQ_J_GT\?'7X]P8>7^_^ZJ&FJ=X9ZC_R,U?_ "X<
M7[#5YO:.M ?]6/Z/1E;VY4UI_JS\^C\8W;=#-2T_@]@J\N_$8G_5Y?+H1V_:
M /\ 5Y]*B'9/F^O_ "+WOI1)PZ<?[G_[[CW[\^B]OB.>G>CV37?[HG_P]^_P
M=*.E1#MO.4?V\_G^Y]^]>O="AMO<D]'^QE8/::2,TZ]TN/XEM7)2_P"?IO9=
M(AKU[KU9L^AK(O/!]M[4?6?ZO]0Z3=)>;9-=#_F/?OK/G_J_9UOI+UF'W'C9
M?\_4_P"^O[4?7B7'^K_!UKJ1C=X9RC_8G]^^G$N?]7^'KW2@AWM/_P </:?K
MW3Q1[V@/^?HJ;W5A7%2.M]*>CSV*R7^Z?>M+>3=>_+KNLP\%9%^Q[M6F#UKH
M/\EC9Z.7WOKW3A1^#Q>_=>Z4%'-!#_OO];W6[L_J/]7V?,>G3)3Z;)'^K_4>
MF?/9[[/_ #_NUGL@7)_U<?Z75?K&; '^K]G0+[DWA!-+^Q[/YIH-LB+%O\/K
M^?KT9V/)\-U( #_A]#_3'IT ^\-[5U'+3T,'W/W&4]X]<Z\V1-*55O\ #Z)_
M0ZG+EKVXA\,$G_#ZO_PWI0;;R65\7[_W/N%;B<5_U?+J0;>T;_5^?SZ$"CS%
M=_QW_P!]_P 4]F%A<"G^KY]%]_:-7_5\OGTX39+P_P"[_N?;'B#I-<0&6E.F
M>LK9YHO\_P"_:QT86$!B&?\ 5Q^?27H\Q/#+X()_N?9- _<.C&2,^G2PH\Q7
M$_O_ .'_ !OV(8'&G_5\^BYXSTN,#NK_ ([^U'AV>PM4M_Q[_H;^+H#7]A>R
M72@+G_:^@^?0J[;W)359, GI[FU^&_VH_P!#[&VT7ECO"@%_^/?/Y+_#T3<S
M;!>FWJL9J?L]5_I=+.>:>&+_ )1O:N2[6H(/^K]G0+LX'7!'^K/3/-C<'DOV
M)Z&WL0[9S$MJ #_JX_T3Z]7N]I:XR/\ 5P^8].@WW)U[X?\ +L5/[E.QYIBG
M8"O^'Y_T.@=/L+P"M/\ 5_O7SZ#?]^&7P3^Y L+J.= U?]6?ET03ZH#0_P"K
M_#U(^\M_R/\ WP]F3LM,#I#'D]2(:S_BG^^^OLNDC+=&$?#IP^\_WU_:?PSU
MNG3A#6>_>&>O=/$-9!_OO\?:22S_ -7^H]:CL]/^K_9Z<(:R?_='T_WUOQ[+
MY+,U_P!7^?HRCC"C)ZD>6>;_ #WM-/1EH!C_ (KIN.R!-?\ 5_AZD0S>'_,3
M^PY<6#2-4#_5^WHTC>.V&3_A_P!GUZ6^U\QY\Q0P$?;C[HW']1;Z?ZQ]D$NT
M26BEB,#[/^@CZ],7-]!<$:6S^?R^0Z&^P_WC_B?:2O36I:<<4_R_Y^O_U-V[
MY'U?V6SL-/\ TW?CA_M\-G?^*>SKEO\ W)B_TC?X>M-\+?ET3G]^L_S$_N1K
MCX1_J].B^3CTX0T?A_S_ /OO\?;<?'K74C]B'VOCX=>ZCS9*#VJZ]TC\EF/#
M]Q_OO]Y][]>O?X.BK]G;P\-+]C_P)J*K_E$I/8DL(P0?]7KTEC[B!TS]>]5P
M0RT^X\Y0_P 2W!5?\ Z3_E0]AOF"\:V-%/\ J[?D?7HRC@# 5Z'#PSPRU'_J
MY_TW^P3'(\AH3T9FW"]/$.8GA_?]FD5EX@K_ *O\/5/@Z6&-W)/-]N/./=.E
M<G#I8?QZNA_?\'OW1>WQ'IO_ +[3PR_Z_OW2CJ1_?R?_ #'G_P![_P![]^\^
MO=1X,]]Y+_G_ &_)&.O=-]9DI\;+YZ&?_??\C]E[QBO7NA VWVUX8O!//4TW
MM-]'\O\ 5^WI-T.&'WYYOM_//]S3_P"^_P!?W[Z/C_J_R]>Z$#S8K/1?Y[VE
M,#0YIU[I+YC9_P#RD0>[?7F+'^K_  =>Z0\V'GA_S\'M1U[IO\,'^^M[]UZO
M4BCK/#_N_P!^Z]TN,;N3P_L?[[_6]Z(!I7KW4C)5D%9%^_[WU[IOH_!_F/?N
MO=-_WD%'5>#WZ.[TBI_U?RZ4;@@9M/\ J\NDON3,4,U+_P I-34?\;]AS<^:
MC9'2O#_BOZ!]>A'L'+JW@J1_J[OZ0].@GK,E@\/2^>N@'^5?\K?_ #M/<%\V
M^Y<[1E0W^#U3_A74J<M<GS^("3_@]&_I]%OS&ZH(MQT\]=!35.0_Y5*O_E '
MN(!NLN[2%F;_  ?YA_#U.5CLTUI& #_@]3_2/KT(T/8^W9Z:\#4_G_Y3!Q_Q
M0D^W[BX./7_BNF[>RJ2=1IZ?ZCT]4F>GR7_ *"IJ?^H0^U^WSFG^KY](=PM5
M&?+_ (KY]2(9JZ;]^?\ R:G]J1(>B6PMUE.1_JSUZ;)>;]B"?W[Q#T8W%NL7
M#_5PZ;X8?#^_!_P(]DL$AK_J^?7I(QTJ</-431?O^Q#!)CHODC%>D+V=VGM7
MJO"U&;W)G,9A:?\ Y0ZO+5G\-O\ [>_NFX;)>;OD-_)?E_27^'I -_LI+M59
M >/\7\/^EZ*=U[\MTWCG;;6K%JJ?[S_@52+ER+<_BWLLM[7<-@.)/^._YV_B
MZ&6[W>URV*AH%(_VW\0^75L'7.\:W<>'IIIS4U%Z0?\  JB_AQ_/XM_A[D':
M[IKLT/\ JX_9U"N[;''8@4-"3_F_I'I=39'Q?Y__ ";_ 'GV?R6;4J#_ *OV
M]$"%58@CJ1!GOZ>_;3N4J2#/^#^E\ND=_;HZ$4_U8Z#_ '5AX)HOXK0_\"/^
M53W,FT<PR1Q@$_X/5OZ/4>W^TJ[''^K'SZ#>&;_?#W,,<FKH Q]2!_C]/9E'
M'7HQCX=.$/\ O''^\W]I?#'#SZ]Y=2(IO#[]X8Z]TX0_O>R1[S'^K_-UN2[T
MC_5_FZ>*.&N]E\EYG_5_FZ+9-S*XK_J_9TX3304<0GGG_P!]_P 4]I+<^(:=
M(+/F)BM:_P"K/]'I#YCLC%8&@J*Z>"I_R7V(8-O$@K7'^KY] OF/G*6V:BG_
M  ?T?Z!]>@$ZM^1-3O7MS:4$LM1AL#5;B;#893P,BUC8'@CD^[<X[+'8VK*@
MJU/VGL^?SZ O)_/TNYW"*[T%?ECX_P#A8].K9?/Z;_[1?_K)I_I[A?1W4_I4
M_P",UZR%^K/AU_H5_P"-T].O_]7=N^1\/FV=AA_V=^./^VP^>_XK[.N6S_C,
M?^D;_#UYOA8_9T4F&'W(US\(_P!7IT72<>I'AGF]WZUU'_AOF_S\_OW7ORZ9
M\EX*.+_/^W+2X\5J?ZO/Y=*)).B[]A=A8K#Q5$'WU-[&%I8&50?]7G\^BYY!
M6E>@7ZW_ -_ME,AOB?\ RG'TM9]EA_:02")37JVV(:_ZOGT:C;<,$W_3-457
ML'[M()F-/]7P]"&6,T'2@K,#_P </]\?^*>TGRZWTEYL#/#_ +[_ (U[]QZ]
MU'AAGAE]^Z]T9#:M'0Y+#?O^_=>Z9\EL."LE\%#[31QZ3GKV*=)_)=8YRCE_
MS'^3^S*.0*.O=)_^#SPR^#WK6.O=>K(9_P#,>_>(.O=(^LH_#*/]]_OC[VD@
MKU[IPQNZJ[&_YB?_ "?V81OUKY=#AL_LB";[?SS_ &WLFDC-.D_0\8'>'F_W
M?]S_ ,C]ETD=?+KW2HR7@R47_*-_OO\ #V71QGKW0;S8>>&7_??7V81QGKW4
M?P_\=X/]]S[4]>ZCY*']K]CZ_P"^_P!Y]^Z]TG_XQ70_Y^?VG\,];CC*GI84
M>Y(/%Y_/[]X9Z,8Y-(ZK^WC\UZC#[LS%#783&TU/2UGV5&1:_P#O((]XR\[\
MUW^TW*]G\U](_P"@?7K+;E/VMLQ:FDG\CZO_ ,-Z1^>^??7.-P]145V6PM,+
M?9?=4EK'*7_XLWTO?V$KGFR[W6U&I?\ !ZC^@/3H6[5[9VPNB=9IZ9]#_P ,
MKTS[:WKNCL:+^^V:%1@]KU/_ !9\15<9.O\ Q^/81N+P.":_ZL?+H4P[<L=%
M50 /(?\ %]!AV'GIZ.JJ)_\ *?\ )?\ IL_WW/L-W#AC_J^71I';A13_ %?X
M>D?MO=5=-%]]!!]S3_\ *W[)8.T]&5Y!K4T_U</GT:CKCM.>*+P'[;V([>X"
MC_5\_ET"KW9S*3C'_%?TNA0R.]H,C4T].)Z;_*O]]_Q'LR2[6M:_ZOV=%MM9
M%5  Q_J^?3A--]G]O_RL>S!+M:<?]7[.B^_M&_U?E\^E11P_[O\ :NWMPISP
M_P"+^?17<;@) :?ZN'RZ4&8R6*P.!R&5KIZ;&X_%T?WM95U?_%LH,7[$=N%4
M<>@W<:G)(_U<.M9_9/6_;?\ -B^06X.]]X[CS>TOA/M?<F4PO5>WJ3_<;_I+
MQ>"_Y?/_ (;OL:V>_HJG/^K/]'H!1[&Z.*C_ %?[UUL =;]>[.Z?P%!M79VS
ML)@]KXO_ (!VH_ZCV"^8[\7+57_5\/R'IU(FRV>F,#A_J;Y]#_MO=-#DJHT0
MRE1304WU^TX_V_%_:K:Y &%3C_B^DV_V&E&95&K_ *)^?1B8?LH:6GFA@^Y_
MZBC_ +S[$4MXJ@9_U?LZBJ>"0.PITE\C]CDA4?P0WJ*4?\!:2L ]FDL:S-CI
M9%&T*T8YZ1]'GO#5>"N@J:;_ *B_8AVN-8@*_P"KCT']S0S''^KATG\P((:_
M]C\^\@^7=+-@_P"KNZC#<KO4N?\ 5P^73?YO8OO;<,/]7R^?1%%(I.3TX?Q*
MAAB_?G^V]HNB.[WZ*Q4L3_A^7]$^O3/-O#%0_P"[[^_= V[]Q$1B ?\ #\O^
M%=,^-[(@R5?]C0P>R6X34/\ 5\NBZWYJ%X:5_P!7^\#TZ'"CF_R#SS_<TWW7
M_*)[#MQ:,QX?ZOV]"2WNT85)_P!6?ETE]R34.'_?RM=]M3^W(#([B@_P=!)H
M8MOB))_P^OVGUZ)?VUDO[X15$'G_ +M[7Q?^6UF6RW_*?[E38;EH$%1_J[OD
M>H,YQYIBBD*AO\/HG]#JJW8'R+H>P?YC_P 8NL^NLM3#8VUM\XTYDXJM_B.+
MSN3&9-S?\6]^YR@*;+>-_0/^%>@7[5;OXWN/ *<2?^T:7Y=;BVD7_P"0[?\
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MI/Y=$?\ Z^Y'N?A'^KTZKTTUDWM9UOH+]U5G[51[]U[_  =%/WY#!XO///\
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MH\Z<(<E!#5?O\>_>(>O=2(?X5DHOWX*;WOQSZ]>X]>_N'BJR+]BAIO?O'/\
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M]7Y?+J/60_>?O_[[_>/?O#'6K.=O]7Y_+IG\,\/M/'8"O^K_ #]/R7Y_U?\
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'3I[]U[K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>hypr-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-25T14:35:28.1878+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="hypr-20211231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails" xlink:href="hypr-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="hypr-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureBusinessCombinationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails" xlink:href="hypr-20211231.xsd#DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2" xlink:href="hypr-20211231.xsd#DisclosureRevenueRecognitionAdditionalInformationDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1" xlink:href="hypr-20211231.xsd#DisclosureRevenueRecognitionAdditionalInformationDetails1" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails" xlink:href="hypr-20211231.xsd#Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureNOTESPAYABLEAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails" xlink:href="hypr-20211231.xsd#DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureStockholdersEquityDeficitAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:href="hypr-20211231.xsd#DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails" xlink:href="hypr-20211231.xsd#DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails" xlink:href="hypr-20211231.xsd#DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineConvertiblePreferredStockMember" xlink:label="hypr_HyperfineConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredGrantFundingCurrent" xlink:label="hypr_DeferredGrantFundingCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OtherAssetsRelatedPartyNoncurrent" xlink:label="hypr_OtherAssetsRelatedPartyNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="us-gaap_UnbilledReceivablesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:label="hypr_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_HyperfineConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="hypr_DeferredGrantFundingCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermNotesPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="hypr_OtherAssetsRelatedPartyNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_UnbilledReceivablesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="hypr_AccruedExpensesAndOtherCurrentLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineConvertiblePreferredStockMember" xlink:label="hypr_HyperfineConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_HyperfineConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember" xlink:label="us-gaap_ServiceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ServiceMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSoldAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GrossProfit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineConvertiblePreferredStockMember" xlink:label="hypr_HyperfineConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalConvertiblePreferredStockMember" xlink:label="hypr_LiminalConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AdjustmentsToAdditionalPaidInCapitalInvestments" xlink:label="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ConversionOfLiminalCommonStock" xlink:label="hypr_ConversionOfLiminalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RecapitalizationOfPermanentToTemporaryEquityShares" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityShares"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RecapitalizationOfPermanentToTemporaryEquityValues" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityValues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_HyperfineConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_LiminalConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="hypr_ConversionOfLiminalCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="hypr_RecapitalizationOfPermanentToTemporaryEquityShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="hypr_RecapitalizationOfPermanentToTemporaryEquityValues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits" xlink:label="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_UnbilledReceivables" xlink:label="hypr_UnbilledReceivables"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_WriteOffOfOtherAssetsRelatedParty" xlink:label="hypr_WriteOffOfOtherAssetsRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseSellingProfitLoss" xlink:label="us-gaap_SalesTypeLeaseSellingProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentInLeasePurchase" xlink:label="us-gaap_NetInvestmentInLeasePurchase"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidSupplies" xlink:label="us-gaap_IncreaseDecreaseInPrepaidSupplies"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ProceedsFromBusinessCombination" xlink:label="hypr_ProceedsFromBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="us-gaap_IncreaseDecreaseInDeferredLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_StockIssued1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="hypr_UnbilledReceivables" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalents" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryWriteDown" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="hypr_WriteOffOfOtherAssetsRelatedParty" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromNotesPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_SalesTypeLeaseSellingProfitLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromContributionsFromAffiliates" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetInvestmentInLeasePurchase" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidSupplies" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="hypr_ProceedsFromBusinessCombination" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerAMember" xlink:label="hypr_CustomerAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerBMember" xlink:label="hypr_CustomerBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerCMember" xlink:label="hypr_CustomerCMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerDMember" xlink:label="hypr_CustomerDMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerEMember" xlink:label="hypr_CustomerEMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerFMember" xlink:label="hypr_CustomerFMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerGMember" xlink:label="hypr_CustomerGMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerHMember" xlink:label="hypr_CustomerHMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="srt_MajorCustomersAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerAMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerBMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerCMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerDMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerEMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerFMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerGMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerHMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU" xlink:label="country_AU"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201815Member" xlink:label="us-gaap_AccountingStandardsUpdate201815Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationMethod" xlink:label="us-gaap_CapitalizedContractCostAmortizationMethod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:label="us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_UncertainTaxPositions" xlink:label="hypr_UncertainTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="hypr_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_AU" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201815Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202006Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfReportableSegments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CapitalizedContractCostAmortizationMethod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CapitalizedContractCostAmortizationPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CapitalizedComputerSoftwareNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AdvertisingExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OpenTaxYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="hypr_UncertainTaxPositions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LaboratoryEquipmentMember" xlink:label="hypr_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ResearchDevicesMember" xlink:label="hypr_ResearchDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SalesAndMarketingDevicesMember" xlink:label="hypr_SalesAndMarketingDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember" xlink:label="us-gaap_ToolsDiesAndMoldsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TradeShowAssetsMember" xlink:label="hypr_TradeShowAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LeasedDevicesMember" xlink:label="hypr_LeasedDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" xlink:label="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_LaboratoryEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_ResearchDevicesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_SalesAndMarketingDevicesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ToolsDiesAndMoldsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_TradeShowAssetsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_LeasedDevicesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ImmediatelyPriorToEffectiveTimeMember" xlink:label="hypr_ImmediatelyPriorToEffectiveTimeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LegacyHyperfineMember" xlink:label="hypr_LegacyHyperfineMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SubscriptionAgreementsMember" xlink:label="hypr_SubscriptionAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SponsorMember" xlink:label="hypr_SponsorMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalMember" xlink:label="hypr_LiminalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PIPEInvestorsMember" xlink:label="hypr_PIPEInvestorsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ClassBOrdinarySharesMember" xlink:label="hypr_ClassBOrdinarySharesMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HealthCorCatalioAcquisitionCorpMember" xlink:label="hypr_HealthCorCatalioAcquisitionCorpMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationTransactionThresholdTradingDays" xlink:label="hypr_BusinessCombinationTransactionThresholdTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ClassAOrdinarySharesMember" xlink:label="hypr_ClassAOrdinarySharesMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HealthCorMember" xlink:label="hypr_HealthCorMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays" xlink:label="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesA1PreferredStockMember" xlink:label="hypr_SeriesA1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock" xlink:label="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned" xlink:label="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CommonStockSubjectToRedemption" xlink:label="hypr_CommonStockSubjectToRedemption"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PercentageOfCommonStockVotingPower" xlink:label="hypr_PercentageOfCommonStockVotingPower"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination" xlink:label="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PaymentOfPaycheckProtectionProgramLoan" xlink:label="hypr_PaymentOfPaycheckProtectionProgramLoan"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_InterestAndPaymentsToRedeemingCompanyShareholders" xlink:label="hypr_InterestAndPaymentsToRedeemingCompanyShareholders"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ProceedsFromBusinessCombination" xlink:label="hypr_ProceedsFromBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationPaymentOfTransactionCosts" xlink:label="hypr_BusinessCombinationPaymentOfTransactionCosts"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="hypr_ImmediatelyPriorToEffectiveTimeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="hypr_LegacyHyperfineMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="hypr_SubscriptionAgreementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="hypr_SponsorMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="hypr_LiminalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="hypr_PIPEInvestorsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_ClassBOrdinarySharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="hypr_HealthCorCatalioAcquisitionCorpMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_BusinessCombinationTransactionThresholdTradingDays" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_ClassAOrdinarySharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="hypr_HealthCorMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_SeriesA1PreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_SharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_CommonStockSubjectToRedemption" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_PercentageOfCommonStockVotingPower" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_PaymentOfPaycheckProtectionProgramLoan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_InterestAndPaymentsToRedeemingCompanyShareholders" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_ProceedsFromBusinessCombination" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_BusinessCombinationPaymentOfTransactionCosts" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="us-gaap_TransferredAtPointInTimeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember" xlink:label="us-gaap_ServiceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember" xlink:label="us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredAtPointInTimeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ServiceMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredOverTimeMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum" xlink:label="hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum" xlink:label="hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_CapitalizedContractCostNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage" xlink:label="hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount" xlink:label="us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount" xlink:label="us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ResearchDevicesMember" xlink:label="hypr_ResearchDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SalesAndMarketingDevicesMember" xlink:label="hypr_SalesAndMarketingDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember" xlink:label="us-gaap_ToolsDiesAndMoldsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TradeShowAssetsMember" xlink:label="hypr_TradeShowAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" xlink:label="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_ResearchDevicesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_SalesAndMarketingDevicesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ToolsDiesAndMoldsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_TradeShowAssetsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfinePayrollProtectionProgramLoanMember" xlink:label="hypr_HyperfinePayrollProtectionProgramLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PayrollProtectionProgramLoanMember" xlink:label="hypr_PayrollProtectionProgramLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalPayrollProtectionProgramLoanMember" xlink:label="hypr_LiminalPayrollProtectionProgramLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="hypr_HyperfinePayrollProtectionProgramLoanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="hypr_PayrollProtectionProgramLoanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromNotesPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="hypr_LiminalPayrollProtectionProgramLoanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LegacyHyperfineMember" xlink:label="hypr_LegacyHyperfineMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain" xlink:label="us-gaap_DividendsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendDeclaredMember" xlink:label="us-gaap_DividendDeclaredMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis" xlink:label="us-gaap_DividendsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain" xlink:label="us-gaap_DividendsDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalConvertiblePreferredStockMember" xlink:label="hypr_LiminalConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiquidationBasisOfAccountingLiquidationPlan" xlink:label="us-gaap_LiquidationBasisOfAccountingLiquidationPlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfVotesPerShare" xlink:label="hypr_NumberOfVotesPerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationExchangeRatio" xlink:label="hypr_BusinessCombinationExchangeRatio"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="us-gaap_PreferredStockConversionBasis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesBCAndDConvertiblePreferredStockMember" xlink:label="hypr_SeriesBCAndDConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesA1PreferredStockMember" xlink:label="hypr_SeriesA1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesATwoConvertiblePreferredStockMember" xlink:label="hypr_SeriesATwoConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="hypr_LegacyHyperfineMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DividendsDomain" xlink:to="us-gaap_DividendDeclaredMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_LiminalConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_LiquidationBasisOfAccountingLiquidationPlan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_DividendsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="hypr_NumberOfVotesPerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="hypr_BusinessCombinationExchangeRatio" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesDPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockConversionBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_SeriesBCAndDConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_SeriesA1PreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_SeriesATwoConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TemporaryEquityYearOfClassIssuance" xlink:label="hypr_TemporaryEquityYearOfClassIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TemporaryEquitySharesIssuanceCost" xlink:label="hypr_TemporaryEquitySharesIssuanceCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="hypr_TemporaryEquityYearOfClassIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesDPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="hypr_TemporaryEquitySharesIssuanceCost" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreferencePerShare" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock" xlink:label="us-gaap_DividendsCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CommonStockNumberOfVotesPerShare" xlink:label="hypr_CommonStockNumberOfVotesPerShare"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DividendsCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="hypr_CommonStockNumberOfVotesPerShare" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineEquityIncentivePlanMember" xlink:label="hypr_HyperfineEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalMember" xlink:label="hypr_LiminalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CommonStockRemainsAvailableForIssuance" xlink:label="hypr_CommonStockRemainsAvailableForIssuance"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember" xlink:label="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_IncentiveUnitActivityMember" xlink:label="hypr_IncentiveUnitActivityMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ExchangeRatio" xlink:label="hypr_ExchangeRatio"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember" xlink:label="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_EarnOutSharesMember" xlink:label="hypr_EarnOutSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfSeparateOptionAwards" xlink:label="hypr_NumberOfSeparateOptionAwards"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_StockOptionsOneMember" xlink:label="hypr_StockOptionsOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_StockOptionsTwoMember" xlink:label="hypr_StockOptionsTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember" xlink:label="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember" xlink:label="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ServiceAndPerformanceSharesMember" xlink:label="hypr_ServiceAndPerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue" xlink:label="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="hypr_HyperfineEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="hypr_LiminalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_CommonStockRemainsAvailableForIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_IncentiveUnitActivityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_ExchangeRatio" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_EarnOutSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_NumberOfSeparateOptionAwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_StockOptionsOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_StockOptionsTwoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_ServiceAndPerformanceSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineEquityIncentivePlanMember" xlink:label="hypr_HyperfineEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="hypr_HyperfineEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineEquityIncentivePlanMember" xlink:label="hypr_HyperfineEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="hypr_HyperfineEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_GranteeStatusAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementNonemployeeMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_EarnOutSharesMember" xlink:label="hypr_EarnOutSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_EarnOutSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember" xlink:label="us-gaap_ServiceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ServiceMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember" xlink:label="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_EarnOutSharesMember" xlink:label="hypr_EarnOutSharesMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="hypr_EarnOutSharesMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FederalAndStateNetOperatingLossesMember" xlink:label="hypr_FederalAndStateNetOperatingLossesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FederalNetOperatingLossMember" xlink:label="hypr_FederalNetOperatingLossMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredTaxAssetsValuationAllowanceIncreased" xlink:label="hypr_DeferredTaxAssetsValuationAllowanceIncreased"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangePercentageTestingPeriod" xlink:label="hypr_OwnershipChangePercentageTestingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangeDescription" xlink:label="hypr_OwnershipChangeDescription"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfConsecutiveOwnershipChanges" xlink:label="hypr_NumberOfConsecutiveOwnershipChanges"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangesDateOne" xlink:label="hypr_OwnershipChangesDateOne"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangesDateTwo" xlink:label="hypr_OwnershipChangesDateTwo"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear" xlink:label="hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_IncomeTaxEffectsRecognized" xlink:label="hypr_IncomeTaxEffectsRecognized"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards" xlink:label="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ExchangeProgramRecognizedNetBenefits" xlink:label="hypr_ExchangeProgramRecognizedNetBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="hypr_FederalAndStateNetOperatingLossesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="hypr_FederalNetOperatingLossMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_DeferredTaxAssetsValuationAllowanceIncreased" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OwnershipChangePercentageTestingPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OwnershipChangeDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_NumberOfConsecutiveOwnershipChanges" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OwnershipChangesDateOne" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OwnershipChangesDateTwo" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_IncomeTaxEffectsRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_ExchangeProgramRecognizedNetBenefits" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineMember" xlink:label="hypr_HyperfineMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PreTwoThaousandEighteenMember" xlink:label="hypr_PreTwoThaousandEighteenMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OperatingLossCarryforwardsBeginToExpireYear" xlink:label="hypr_OperatingLossCarryforwardsBeginToExpireYear"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalMember" xlink:label="hypr_LiminalMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ConnecticutResearchAndDevelopmentMember" xlink:label="hypr_ConnecticutResearchAndDevelopmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PostTwoThaousandSeventeenMember" xlink:label="hypr_PostTwoThaousandSeventeenMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ConnecticutOthersMember" xlink:label="hypr_ConnecticutOthersMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FederalOtherMember" xlink:label="hypr_FederalOtherMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TaxCreditCarryforwardBeginToExpirationYear" xlink:label="hypr_TaxCreditCarryforwardBeginToExpirationYear"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="hypr_HyperfineMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="hypr_PreTwoThaousandEighteenMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OperatingLossCarryforwardsBeginToExpireYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="hypr_LiminalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="hypr_ConnecticutResearchAndDevelopmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="hypr_PostTwoThaousandSeventeenMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_TaxPeriodAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="hypr_ConnecticutOthersMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="hypr_FederalOtherMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_TaxCreditCarryforwardBeginToExpirationYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CatalyzerCorporation4Member" xlink:label="hypr_CatalyzerCorporation4Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AllocationOfExpenseIncurredMember" xlink:label="hypr_AllocationOfExpenseIncurredMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RelatedPartyTransactionPaymentsForRent" xlink:label="hypr_RelatedPartyTransactionPaymentsForRent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FourBionicsMember" xlink:label="hypr_FourBionicsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AmendedAndRestatedTechnologyServicesAgreementMember" xlink:label="hypr_AmendedAndRestatedTechnologyServicesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfSubsidiaries" xlink:label="hypr_NumberOfSubsidiaries"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalMember" xlink:label="hypr_LiminalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TechnologyAndServicesExchangeAgreementMember" xlink:label="hypr_TechnologyAndServicesExchangeAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromEmployeesNoncurrent" xlink:label="us-gaap_DueFromEmployeesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="us-gaap_RelatedPartyTransactionRate"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DueFromEmployeesForgiveness" xlink:label="hypr_DueFromEmployeesForgiveness"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_InterestReceivableRelatedPartiesCurrent" xlink:label="hypr_InterestReceivableRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeRelatedParty" xlink:label="us-gaap_InterestIncomeRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OtherAssetsRelatedPartyNoncurrent" xlink:label="hypr_OtherAssetsRelatedPartyNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PrepaidAdvancesUnrecoverable" xlink:label="hypr_PrepaidAdvancesUnrecoverable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="hypr_CatalyzerCorporation4Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="hypr_AllocationOfExpenseIncurredMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_RelatedPartyTransactionPaymentsForRent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="hypr_FourBionicsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="hypr_AmendedAndRestatedTechnologyServicesAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_NumberOfSubsidiaries" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="hypr_LiminalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="hypr_TechnologyAndServicesExchangeAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueFromEmployeesNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_DueFromEmployeesForgiveness" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_InterestReceivableRelatedPartiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_InterestIncomeRelatedParty" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_OtherAssetsRelatedPartyNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_PrepaidAdvancesUnrecoverable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsReceivableRelatedPartiesCurrent" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems" xlink:label="us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable" xlink:label="us-gaap_ProductLiabilityContingencyTable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredGrantFundingCurrent" xlink:label="hypr_DeferredGrantFundingCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfSites" xlink:label="hypr_NumberOfSites"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantAwarded" xlink:label="hypr_GrantAwarded"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantAwardedForProvisionAndEquipping" xlink:label="hypr_GrantAwardedForProvisionAndEquipping"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantAwardedForOtherRelatedDeliverables" xlink:label="hypr_GrantAwardedForOtherRelatedDeliverables"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantFundRequiredToReturnUnderProvisions" xlink:label="hypr_GrantFundRequiredToReturnUnderProvisions"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="us-gaap_ProductLiabilityContingencyTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_DeferredGrantFundingCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ProductLiabilityContingencyTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_NumberOfSites" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_GrantAwarded" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_GrantAwardedForProvisionAndEquipping" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_GrantAwardedForOtherRelatedDeliverables" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_GrantFundRequiredToReturnUnderProvisions" priority="2" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>hypr-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-25T14:35:28.3779+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails" xlink:href="hypr-20211231.xsd#DisclosureInventoriesSummaryOfInventoriesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails" xlink:href="hypr-20211231.xsd#Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" xlink:href="hypr-20211231.xsd#DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails" xlink:href="hypr-20211231.xsd#DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermNotesPayable" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="hypr_DeferredGrantFundingCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="hypr_OtherAssetsRelatedPartyNoncurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_UnbilledReceivablesCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="hypr_AccruedExpensesAndOtherCurrentLiabilities" order="5" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="5" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="7" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="11" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredGrantFundingCurrent" xlink:label="hypr_DeferredGrantFundingCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OtherAssetsRelatedPartyNoncurrent" xlink:label="hypr_OtherAssetsRelatedPartyNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="us-gaap_UnbilledReceivablesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:label="hypr_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InvestmentIncomeInterest" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingAndMarketingExpense" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_RestrictedCashAndCashEquivalents" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="3" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InventoryWriteDown" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="hypr_WriteOffOfOtherAssetsRelatedParty" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromContributionsFromAffiliates" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetInvestmentInLeasePurchase" order="6" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromNotesPayable" order="6" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_SalesTypeLeaseSellingProfitLoss" order="7" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="8" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="9" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="hypr_UnbilledReceivables" order="10" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="hypr_ProceedsFromBusinessCombination" order="10" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" order="11" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="13" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" order="14" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidSupplies" order="15" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="16" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredLiabilities" order="18" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="21" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="23" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="24" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="26" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties" order="27" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_WriteOffOfOtherAssetsRelatedParty" xlink:label="hypr_WriteOffOfOtherAssetsRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentInLeasePurchase" xlink:label="us-gaap_NetInvestmentInLeasePurchase"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseSellingProfitLoss" xlink:label="us-gaap_SalesTypeLeaseSellingProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_UnbilledReceivables" xlink:label="hypr_UnbilledReceivables"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ProceedsFromBusinessCombination" xlink:label="hypr_ProceedsFromBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidSupplies" xlink:label="us-gaap_IncreaseDecreaseInPrepaidSupplies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="us-gaap_IncreaseDecreaseInDeferredLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="us-gaap_AccruedBonusesCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="hypr_AccruedContractedServicesCurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="hypr_AccruedBonusAndOtherCostsCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="5" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="6" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:label="hypr_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="us-gaap_AccruedBonusesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedContractedServicesCurrent" xlink:label="hypr_AccruedContractedServicesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedBonusAndOtherCostsCurrent" xlink:label="hypr_AccruedBonusAndOtherCostsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="3" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="6" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="7" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="6" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="7" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation" xlink:label="hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation" xlink:label="hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>hypr-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-25T14:35:24.4609+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://hyperfine.io/20211231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:hypr="http://hyperfine.io/20211231" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" namespace="http://xbrl.sec.gov/country/2021"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hypr-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hypr-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hypr-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hypr-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets" id="StatementCombinedAndConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - COMBINED AND CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical" id="StatementCombinedAndConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - COMBINED AND CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100030 - Statement - COMBINED AND CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit" id="StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit">
        <link:definition>100040 - Statement - COMBINED AND CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows" id="StatementCombinedAndConsolidatedStatementsOfCashFlows">
        <link:definition>100050 - Statement - COMBINED AND CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureORGANIZATIONANDDESCRIPTIONOFBUSINESS" id="Role_DisclosureORGANIZATIONANDDESCRIPTIONOFBUSINESS">
        <link:definition>100060 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1" id="DisclosureSummaryOfSignificantAccountingPolicies1">
        <link:definition>100070 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombination1" id="DisclosureBusinessCombination1">
        <link:definition>100080 - Disclosure - BUSINESS COMBINATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITION" id="Role_DisclosureREVENUERECOGNITION">
        <link:definition>100090 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTS" id="Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTS">
        <link:definition>100100 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIES" id="Role_DisclosureINVENTORIES">
        <link:definition>100110 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNET" id="Role_DisclosurePROPERTYANDEQUIPMENTNET">
        <link:definition>100120 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES" id="Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES">
        <link:definition>100130 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLE" id="Role_DisclosureNOTESPAYABLE">
        <link:definition>100140 - Disclosure - NOTES PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStock1" id="DisclosureConvertiblePreferredStock1">
        <link:definition>100150 - Disclosure - CONVERTIBLE PREFERRED STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficit" id="DisclosureStockholdersEquityDeficit">
        <link:definition>100160 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlan1" id="DisclosureEquityIncentivePlan1">
        <link:definition>100170 - Disclosure - EQUITY INCENTIVE PLAN</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARE" id="Role_DisclosureNETLOSSPERSHARE">
        <link:definition>100180 - Disclosure - NET LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINCOMETAXES" id="Role_DisclosureINCOMETAXES">
        <link:definition>100190 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONS" id="Role_DisclosureRELATEDPARTYTRANSACTIONS">
        <link:definition>100200 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES" id="Role_DisclosureCOMMITMENTSANDCONTINGENCIES">
        <link:definition>100210 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureSUBSEQUENTEVENTS" id="Role_DisclosureSUBSEQUENTEVENTS">
        <link:definition>100220 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100230 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100240 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables" id="Role_DisclosureREVENUERECOGNITIONTables">
        <link:definition>100250 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIinventoriesTables" id="DisclosureIinventoriesTables">
        <link:definition>100260 - Disclosure - IINVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETTables" id="Role_DisclosurePROPERTYANDEQUIPMENTNETTables">
        <link:definition>100270 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables" id="Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables">
        <link:definition>100280 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockTables" id="DisclosureConvertiblePreferredStockTables">
        <link:definition>100290 - Disclosure - CONVERTIBLE PREFERRED STOCK (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanTables" id="DisclosureEquityIncentivePlanTables">
        <link:definition>100300 - Disclosure - EQUITY INCENTIVE PLAN (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARETables" id="Role_DisclosureNETLOSSPERSHARETables">
        <link:definition>100310 - Disclosure - NET LOSS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>100320 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails">
        <link:definition>100330 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Significant customer, percentage of revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100340 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails">
        <link:definition>100350 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful lives of property and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails" id="DisclosureBusinessCombinationAdditionalInformationDetails">
        <link:definition>100360 - Disclosure - BUSINESS COMBINATION - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails" id="DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails">
        <link:definition>100370 - Disclosure - REVENUE RECOGNITION - Summary of Disaggregated Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails" id="DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails">
        <link:definition>100380 - Disclosure - REVENUE RECOGNITION - Information about Receivables and Deferred Revenue from Contracts with Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2" id="DisclosureRevenueRecognitionAdditionalInformationDetails2">
        <link:definition>100390 - Disclosure - REVENUE RECOGNITION - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1" id="DisclosureRevenueRecognitionAdditionalInformationDetails1">
        <link:definition>100400 - Disclosure - REVENUE RECOGNITION - Additional Information (Details1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails" id="Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails">
        <link:definition>100410 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails" id="DisclosureInventoriesSummaryOfInventoriesDetails">
        <link:definition>100420 - Disclosure - INVENTORIES - Summary of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIESAdditionalInformationDetails" id="Role_DisclosureINVENTORIESAdditionalInformationDetails">
        <link:definition>100430 - Disclosure - INVENTORIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails" id="Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails">
        <link:definition>100440 - Disclosure - PROPERTY AND EQUIPMENT, NET - Schedule of Property and equipment, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETAdditionalInformationDetails" id="Role_DisclosurePROPERTYANDEQUIPMENTNETAdditionalInformationDetails">
        <link:definition>100450 - Disclosure - PROPERTY AND EQUIPMENT, NET - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" id="Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
        <link:definition>100460 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES - Schedule of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails" id="Role_DisclosureNOTESPAYABLEAdditionalInformationDetails">
        <link:definition>100470 - Disclosure - NOTES PAYABLE - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails" id="DisclosureConvertiblePreferredStockAdditionalInformationDetails">
        <link:definition>100480 - Disclosure - CONVERTIBLE PREFERRED STOCK - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails" id="DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails">
        <link:definition>100490 - Disclosure - CONVERTIBLE PREFERRED STOCK - Summary of Authorized, Issued and Outstanding Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails" id="DisclosureStockholdersEquityDeficitAdditionalInformationDetails">
        <link:definition>100500 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails" id="DisclosureEquityIncentivePlanAdditionalInformationDetails">
        <link:definition>100510 - Disclosure - EQUITY INCENTIVE PLAN - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails" id="DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails">
        <link:definition>100520 - Disclosure - EQUITY INCENTIVE PLAN - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails" id="DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails">
        <link:definition>100530 - Disclosure - EQUITY INCENTIVE PLAN - Assumptions Used to Value Option Grants to Employees and Nonemployees (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails" id="DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails">
        <link:definition>100540 - Disclosure - EQUITY INCENTIVE PLAN - Summary of Stock Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails" id="DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails">
        <link:definition>100550 - Disclosure - EQUITY INCENTIVE PLAN - Key Assumptions Used in Valuation for Earn-Out Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails" id="DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails">
        <link:definition>100560 - Disclosure - EQUITY INCENTIVE PLAN - Summary of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails" id="DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails">
        <link:definition>100570 - Disclosure - NET LOSS PER SHARE - Schedule of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails" id="DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails">
        <link:definition>100580 - Disclosure - NET LOSS PER SHARE - Schedule of Anti-dilutive Common Equivalent Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" id="DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails">
        <link:definition>100590 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets (Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100600 - Disclosure - INCOME TAXES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails" id="DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails">
        <link:definition>100610 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Anticipated Income Tax Expense Benefit Computed by Statutory Federal Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails" id="DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails">
        <link:definition>100620 - Disclosure - INCOME TAXES - Schedule of Tax Net Operating Loss Carryforward and Tax Credit Carryforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails" id="Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails">
        <link:definition>100630 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails" id="Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>100640 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_AccruedBonusAndOtherCostsCurrent" name="AccruedBonusAndOtherCostsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_AccruedContractedServicesCurrent" name="AccruedContractedServicesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_AccruedExpensesAndOtherCurrentLiabilities" name="AccruedExpensesAndOtherCurrentLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments" name="AdjustmentsToAdditionalPaidInCapitalInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_BusinessCombinationExchangeRatio" name="BusinessCombinationExchangeRatio" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="hypr_BusinessCombinationPaymentOfTransactionCosts" name="BusinessCombinationPaymentOfTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays" name="BusinessCombinationTransactionThresholdConsecutiveTradingDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_BusinessCombinationTransactionThresholdTradingDays" name="BusinessCombinationTransactionThresholdTradingDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits" name="CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_CommonStockNumberOfVotesPerShare" name="CommonStockNumberOfVotesPerShare" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="hypr_CommonStockRemainsAvailableForIssuance" name="CommonStockRemainsAvailableForIssuance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="hypr_CommonStockSubjectToRedemption" name="CommonStockSubjectToRedemption" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_ConversionOfLiminalCommonStock" name="ConversionOfLiminalCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_DeferredGrantFundingCurrent" name="DeferredGrantFundingCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_DeferredTaxAssetsValuationAllowanceIncreased" name="DeferredTaxAssetsValuationAllowanceIncreased" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_DueFromEmployeesForgiveness" name="DueFromEmployeesForgiveness" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation" name="Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation" name="Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_ExchangeProgramRecognizedNetBenefits" name="ExchangeProgramRecognizedNetBenefits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_ExchangeRatio" name="ExchangeRatio" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_GrantAwarded" name="GrantAwarded" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_GrantAwardedForOtherRelatedDeliverables" name="GrantAwardedForOtherRelatedDeliverables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_GrantAwardedForProvisionAndEquipping" name="GrantAwardedForProvisionAndEquipping" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_GrantFundRequiredToReturnUnderProvisions" name="GrantFundRequiredToReturnUnderProvisions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_IncomeTaxEffectsRecognized" name="IncomeTaxEffectsRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_InterestAndPaymentsToRedeemingCompanyShareholders" name="InterestAndPaymentsToRedeemingCompanyShareholders" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_InterestReceivableRelatedPartiesCurrent" name="InterestReceivableRelatedPartiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation" name="NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation" name="NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_NumberOfConsecutiveOwnershipChanges" name="NumberOfConsecutiveOwnershipChanges" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="hypr_NumberOfSeparateOptionAwards" name="NumberOfSeparateOptionAwards" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="hypr_NumberOfSites" name="NumberOfSites" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_NumberOfSubsidiaries" name="NumberOfSubsidiaries" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_NumberOfVotesPerShare" name="NumberOfVotesPerShare" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock" name="NumberOfVotesPerShareEntitledToClassOfCommonStock" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_OperatingLossCarryforwardsBeginToExpireYear" name="OperatingLossCarryforwardsBeginToExpireYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_OtherAssetsRelatedPartyNoncurrent" name="OtherAssetsRelatedPartyNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_OwnershipChangeDescription" name="OwnershipChangeDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_OwnershipChangePercentageTestingPeriod" name="OwnershipChangePercentageTestingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear" name="OwnershipChangesAnalysisExpectedToBeCompletedYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="hypr_OwnershipChangesDateOne" name="OwnershipChangesDateOne" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_OwnershipChangesDateTwo" name="OwnershipChangesDateTwo" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_PaymentOfPaycheckProtectionProgramLoan" name="PaymentOfPaycheckProtectionProgramLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned" name="PercentageNumberOfSharesCeasesToBeneficiallyOwned" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards" name="PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_PercentageOfCommonStockVotingPower" name="PercentageOfCommonStockVotingPower" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_PrepaidAdvancesUnrecoverable" name="PrepaidAdvancesUnrecoverable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination" name="PrepaidInsurancePolicyInConnectionWithBusinessCombination" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_ProceedsFromBusinessCombination" name="ProceedsFromBusinessCombination" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_RecapitalizationOfPermanentToTemporaryEquityShares" name="RecapitalizationOfPermanentToTemporaryEquityShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_RecapitalizationOfPermanentToTemporaryEquityValues" name="RecapitalizationOfPermanentToTemporaryEquityValues" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_RelatedPartyTransactionPaymentsForRent" name="RelatedPartyTransactionPaymentsForRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum" name="RevenueRecognizeReceivablePaymentTermsRangeMaximum" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum" name="RevenueRecognizeReceivablePaymentTermsRangeMinimum" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage" name="RevenueRemainingPerformanceObligationExpectedTimingPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue" name="ShareBasedPaymentArrangementPlanModificationIncrementalValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_TaxCreditCarryforwardBeginToExpirationYear" name="TaxCreditCarryforwardBeginToExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_TemporaryEquitySharesIssuanceCost" name="TemporaryEquitySharesIssuanceCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_TemporaryEquityYearOfClassIssuance" name="TemporaryEquityYearOfClassIssuance" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_UnbilledReceivables" name="UnbilledReceivables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="hypr_UncertainTaxPositions" name="UncertainTaxPositions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_WriteOffOfOtherAssetsRelatedParty" name="WriteOffOfOtherAssetsRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="hypr_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_AllocationOfExpenseIncurredMember" name="AllocationOfExpenseIncurredMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_AmendedAndRestatedTechnologyServicesAgreementMember" name="AmendedAndRestatedTechnologyServicesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_CatalyzerCorporation4Member" name="CatalyzerCorporation4Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_ClassAOrdinarySharesMember" name="ClassAOrdinarySharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_ClassBOrdinarySharesMember" name="ClassBOrdinarySharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_ConnecticutOthersMember" name="ConnecticutOthersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_ConnecticutResearchAndDevelopmentMember" name="ConnecticutResearchAndDevelopmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_CustomerAMember" name="CustomerAMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_CustomerBMember" name="CustomerBMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_CustomerCMember" name="CustomerCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_CustomerDMember" name="CustomerDMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_CustomerEMember" name="CustomerEMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_CustomerFMember" name="CustomerFMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_CustomerGMember" name="CustomerGMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_CustomerHMember" name="CustomerHMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_EarnOutSharesMember" name="EarnOutSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_FederalAndStateNetOperatingLossesMember" name="FederalAndStateNetOperatingLossesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_FederalNetOperatingLossMember" name="FederalNetOperatingLossMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_FederalOtherMember" name="FederalOtherMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_FourBionicsMember" name="FourBionicsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember" name="FourBionicsTwoThousandNineteenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_HealthCorCatalioAcquisitionCorpMember" name="HealthCorCatalioAcquisitionCorpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_HealthCorMember" name="HealthCorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_HyperfineConvertiblePreferredStockMember" name="HyperfineConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_HyperfineEquityIncentivePlanMember" name="HyperfineEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_HyperfineMember" name="HyperfineMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_HyperfinePayrollProtectionProgramLoanMember" name="HyperfinePayrollProtectionProgramLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_ImmediatelyPriorToEffectiveTimeMember" name="ImmediatelyPriorToEffectiveTimeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_IncentiveUnitActivityMember" name="IncentiveUnitActivityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember" name="IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_LeasedDevicesMember" name="LeasedDevicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_LegacyHyperfineMember" name="LegacyHyperfineMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_LiminalConvertiblePreferredStockMember" name="LiminalConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_LiminalMember" name="LiminalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_LiminalPayrollProtectionProgramLoanMember" name="LiminalPayrollProtectionProgramLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember" name="OutstandingLegacyHyperfineConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_PayrollProtectionProgramLoanMember" name="PayrollProtectionProgramLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_PIPEInvestorsMember" name="PIPEInvestorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_PostTwoThaousandSeventeenMember" name="PostTwoThaousandSeventeenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_PreTwoThaousandEighteenMember" name="PreTwoThaousandEighteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_ResearchDevicesMember" name="ResearchDevicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_SalesAndMarketingDevicesMember" name="SalesAndMarketingDevicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_SeriesA1PreferredStockMember" name="SeriesA1PreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_SeriesATwoConvertiblePreferredStockMember" name="SeriesATwoConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_SeriesBCAndDConvertiblePreferredStockMember" name="SeriesBCAndDConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_ServiceAndPerformanceSharesMember" name="ServiceAndPerformanceSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember" name="ShareBasedPaymentArrangementSeparateOptionAwardsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember" name="ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_SponsorMember" name="SponsorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_StockOptionsOneMember" name="StockOptionsOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_StockOptionsTwoMember" name="StockOptionsTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_SubscriptionAgreementsMember" name="SubscriptionAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_TechnologyAndServicesExchangeAgreementMember" name="TechnologyAndServicesExchangeAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_TradeShowAssetsMember" name="TradeShowAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="hypr_Covid19OutbreakPolicyTextBlock" name="Covid19OutbreakPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_DeferredRevenuePolicyPolicyTextBlock" name="DeferredRevenuePolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_EarnOutSharesPolicyTextBlock" name="EarnOutSharesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_GrantFundingPolicyTextBlock" name="GrantFundingPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_PatentCostsPolicyTextBlock" name="PatentCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" name="PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock" name="ResearchAndDevelopmentTaxCreditsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock" name="ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock" name="ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock" name="ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock" name="ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="hypr_WarrantiesPolicyTextBlock" name="WarrantiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>hypr-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-25T14:35:27.9400+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="hypr-20211231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows" xlink:href="hypr-20211231.xsd#StatementCombinedAndConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureORGANIZATIONANDDESCRIPTIONOFBUSINESS" xlink:href="hypr-20211231.xsd#Role_DisclosureORGANIZATIONANDDESCRIPTIONOFBUSINESS" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1" xlink:href="hypr-20211231.xsd#DisclosureSummaryOfSignificantAccountingPolicies1" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombination1" xlink:href="hypr-20211231.xsd#DisclosureBusinessCombination1" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITION" xlink:href="hypr-20211231.xsd#Role_DisclosureREVENUERECOGNITION" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTS" xlink:href="hypr-20211231.xsd#Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTS" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIES" xlink:href="hypr-20211231.xsd#Role_DisclosureINVENTORIES" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNET" xlink:href="hypr-20211231.xsd#Role_DisclosurePROPERTYANDEQUIPMENTNET" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES" xlink:href="hypr-20211231.xsd#Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLE" xlink:href="hypr-20211231.xsd#Role_DisclosureNOTESPAYABLE" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStock1" xlink:href="hypr-20211231.xsd#DisclosureConvertiblePreferredStock1" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficit" xlink:href="hypr-20211231.xsd#DisclosureStockholdersEquityDeficit" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlan1" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlan1" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARE" xlink:href="hypr-20211231.xsd#Role_DisclosureNETLOSSPERSHARE" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINCOMETAXES" xlink:href="hypr-20211231.xsd#Role_DisclosureINCOMETAXES" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONS" xlink:href="hypr-20211231.xsd#Role_DisclosureRELATEDPARTYTRANSACTIONS" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES" xlink:href="hypr-20211231.xsd#Role_DisclosureCOMMITMENTSANDCONTINGENCIES" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureSUBSEQUENTEVENTS" xlink:href="hypr-20211231.xsd#Role_DisclosureSUBSEQUENTEVENTS" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="hypr-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="hypr-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables" xlink:href="hypr-20211231.xsd#Role_DisclosureREVENUERECOGNITIONTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIinventoriesTables" xlink:href="hypr-20211231.xsd#DisclosureIinventoriesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETTables" xlink:href="hypr-20211231.xsd#Role_DisclosurePROPERTYANDEQUIPMENTNETTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables" xlink:href="hypr-20211231.xsd#Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockTables" xlink:href="hypr-20211231.xsd#DisclosureConvertiblePreferredStockTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanTables" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARETables" xlink:href="hypr-20211231.xsd#Role_DisclosureNETLOSSPERSHARETables" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="hypr-20211231.xsd#DisclosureIncomeTaxesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails" xlink:href="hypr-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="hypr-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureBusinessCombinationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails" xlink:href="hypr-20211231.xsd#DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails" xlink:href="hypr-20211231.xsd#DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2" xlink:href="hypr-20211231.xsd#DisclosureRevenueRecognitionAdditionalInformationDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1" xlink:href="hypr-20211231.xsd#DisclosureRevenueRecognitionAdditionalInformationDetails1" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails" xlink:href="hypr-20211231.xsd#DisclosureInventoriesSummaryOfInventoriesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIESAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureINVENTORIESAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails" xlink:href="hypr-20211231.xsd#Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#Role_DisclosurePROPERTYANDEQUIPMENTNETAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureNOTESPAYABLEAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails" xlink:href="hypr-20211231.xsd#DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureStockholdersEquityDeficitAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails" xlink:href="hypr-20211231.xsd#DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:href="hypr-20211231.xsd#DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails" xlink:href="hypr-20211231.xsd#DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" xlink:href="hypr-20211231.xsd#DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails" xlink:href="hypr-20211231.xsd#DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails" xlink:href="hypr-20211231.xsd#DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails" xlink:href="hypr-20211231.xsd#Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentInformationTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineConvertiblePreferredStockMember" xlink:label="hypr_HyperfineConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredGrantFundingCurrent" xlink:label="hypr_DeferredGrantFundingCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OtherAssetsRelatedPartyNoncurrent" xlink:label="hypr_OtherAssetsRelatedPartyNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="us-gaap_UnbilledReceivablesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:label="hypr_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_HyperfineConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="hypr_DeferredGrantFundingCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermNotesPayable" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="hypr_OtherAssetsRelatedPartyNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_UnbilledReceivablesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="hypr_AccruedExpensesAndOtherCurrentLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineConvertiblePreferredStockMember" xlink:label="hypr_HyperfineConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_HyperfineConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember" xlink:label="us-gaap_ServiceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSoldAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ServiceMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GrossProfit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineConvertiblePreferredStockMember" xlink:label="hypr_HyperfineConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalConvertiblePreferredStockMember" xlink:label="hypr_LiminalConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AdjustmentsToAdditionalPaidInCapitalInvestments" xlink:label="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ConversionOfLiminalCommonStock" xlink:label="hypr_ConversionOfLiminalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RecapitalizationOfPermanentToTemporaryEquityShares" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityShares"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RecapitalizationOfPermanentToTemporaryEquityValues" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityValues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_22"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_23"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_24"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_25"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_HyperfineConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_LiminalConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="hypr_ConversionOfLiminalCommonStock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="hypr_RecapitalizationOfPermanentToTemporaryEquityShares" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="hypr_RecapitalizationOfPermanentToTemporaryEquityValues" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_22" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_23" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_24" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued_25" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits" xlink:label="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_UnbilledReceivables" xlink:label="hypr_UnbilledReceivables"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_WriteOffOfOtherAssetsRelatedParty" xlink:label="hypr_WriteOffOfOtherAssetsRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseSellingProfitLoss" xlink:label="us-gaap_SalesTypeLeaseSellingProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentInLeasePurchase" xlink:label="us-gaap_NetInvestmentInLeasePurchase"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ProceedsFromBusinessCombination" xlink:label="hypr_ProceedsFromBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidSupplies" xlink:label="us-gaap_IncreaseDecreaseInPrepaidSupplies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="us-gaap_IncreaseDecreaseInDeferredLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_StockIssued1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalents" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="hypr_UnbilledReceivables" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryWriteDown" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromNotesPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="hypr_WriteOffOfOtherAssetsRelatedParty" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_SalesTypeLeaseSellingProfitLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetInvestmentInLeasePurchase" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromContributionsFromAffiliates" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="hypr_ProceedsFromBusinessCombination" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidSupplies" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredLiabilities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureORGANIZATIONANDDESCRIPTIONOFBUSINESS" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombination1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITION" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTS" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIES" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNET" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLE" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStock1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_PreferredStockTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficit" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlan1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARE" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINCOMETAXES" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONS" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureSUBSEQUENTEVENTS" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_Covid19OutbreakPolicyTextBlock" xlink:label="hypr_Covid19OutbreakPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:label="hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredRevenuePolicyPolicyTextBlock" xlink:label="hypr_DeferredRevenuePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_WarrantiesPolicyTextBlock" xlink:label="hypr_WarrantiesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantFundingPolicyTextBlock" xlink:label="hypr_GrantFundingPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PatentCostsPolicyTextBlock" xlink:label="hypr_PatentCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_EarnOutSharesPolicyTextBlock" xlink:label="hypr_EarnOutSharesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock" xlink:label="hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="hypr_Covid19OutbreakPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="hypr_DeferredRevenuePolicyPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="hypr_WarrantiesPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="hypr_GrantFundingPolicyTextBlock" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="hypr_PatentCostsPolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="hypr_EarnOutSharesPolicyTextBlock" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock" xlink:label="hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureIinventoriesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock" xlink:label="hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock" xlink:label="hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock" xlink:label="hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARETables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerAMember" xlink:label="hypr_CustomerAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerBMember" xlink:label="hypr_CustomerBMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerCMember" xlink:label="hypr_CustomerCMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerDMember" xlink:label="hypr_CustomerDMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerEMember" xlink:label="hypr_CustomerEMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerFMember" xlink:label="hypr_CustomerFMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerGMember" xlink:label="hypr_CustomerGMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerHMember" xlink:label="hypr_CustomerHMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="srt_MajorCustomersAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerBMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerCMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerDMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerEMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerFMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerGMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="hypr_CustomerHMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU" xlink:label="country_AU"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201815Member" xlink:label="us-gaap_AccountingStandardsUpdate201815Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationMethod" xlink:label="us-gaap_CapitalizedContractCostAmortizationMethod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:label="us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_UncertainTaxPositions" xlink:label="hypr_UncertainTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="hypr_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_AU" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201815Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202006Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_StatementGeographicalAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="hypr_SummaryOfSignificantAccountingPoliciesLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CapitalizedContractCostAmortizationMethod" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CapitalizedContractCostAmortizationPeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CapitalizedComputerSoftwareNet" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AdvertisingExpense" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OpenTaxYear" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="hypr_UncertainTaxPositions" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LaboratoryEquipmentMember" xlink:label="hypr_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ResearchDevicesMember" xlink:label="hypr_ResearchDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SalesAndMarketingDevicesMember" xlink:label="hypr_SalesAndMarketingDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember" xlink:label="us-gaap_ToolsDiesAndMoldsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TradeShowAssetsMember" xlink:label="hypr_TradeShowAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LeasedDevicesMember" xlink:label="hypr_LeasedDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" xlink:label="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_LaboratoryEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_ResearchDevicesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_SalesAndMarketingDevicesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ToolsDiesAndMoldsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_TradeShowAssetsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_LeasedDevicesMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LegacyHyperfineMember" xlink:label="hypr_LegacyHyperfineMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ImmediatelyPriorToEffectiveTimeMember" xlink:label="hypr_ImmediatelyPriorToEffectiveTimeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SubscriptionAgreementsMember" xlink:label="hypr_SubscriptionAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalMember" xlink:label="hypr_LiminalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SponsorMember" xlink:label="hypr_SponsorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HealthCorCatalioAcquisitionCorpMember" xlink:label="hypr_HealthCorCatalioAcquisitionCorpMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PIPEInvestorsMember" xlink:label="hypr_PIPEInvestorsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ClassBOrdinarySharesMember" xlink:label="hypr_ClassBOrdinarySharesMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ClassAOrdinarySharesMember" xlink:label="hypr_ClassAOrdinarySharesMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationTransactionThresholdTradingDays" xlink:label="hypr_BusinessCombinationTransactionThresholdTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HealthCorMember" xlink:label="hypr_HealthCorMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays" xlink:label="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesA1PreferredStockMember" xlink:label="hypr_SeriesA1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock" xlink:label="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned" xlink:label="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CommonStockSubjectToRedemption" xlink:label="hypr_CommonStockSubjectToRedemption"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PercentageOfCommonStockVotingPower" xlink:label="hypr_PercentageOfCommonStockVotingPower"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination" xlink:label="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PaymentOfPaycheckProtectionProgramLoan" xlink:label="hypr_PaymentOfPaycheckProtectionProgramLoan"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_InterestAndPaymentsToRedeemingCompanyShareholders" xlink:label="hypr_InterestAndPaymentsToRedeemingCompanyShareholders"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ProceedsFromBusinessCombination" xlink:label="hypr_ProceedsFromBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationPaymentOfTransactionCosts" xlink:label="hypr_BusinessCombinationPaymentOfTransactionCosts"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="hypr_LegacyHyperfineMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="hypr_ImmediatelyPriorToEffectiveTimeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="hypr_SubscriptionAgreementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="hypr_LiminalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="hypr_SponsorMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="hypr_HealthCorCatalioAcquisitionCorpMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="hypr_PIPEInvestorsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_ClassBOrdinarySharesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_ClassAOrdinarySharesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_BusinessCombinationTransactionThresholdTradingDays" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="hypr_HealthCorMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_SeriesA1PreferredStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_TitleOfIndividualAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_SharesIssued" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_CommonStockSubjectToRedemption" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_PercentageOfCommonStockVotingPower" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_PaymentOfPaycheckProtectionProgramLoan" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_InterestAndPaymentsToRedeemingCompanyShareholders" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_ProceedsFromBusinessCombination" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="hypr_BusinessCombinationPaymentOfTransactionCosts" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="us-gaap_TransferredAtPointInTimeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember" xlink:label="us-gaap_ServiceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember" xlink:label="us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredAtPointInTimeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ServiceMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredOverTimeMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="us-gaap_UnbilledReceivablesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_UnbilledReceivablesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum" xlink:label="hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum" xlink:label="hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_CapitalizedContractCostNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage" xlink:label="hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount" xlink:label="us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount" xlink:label="us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIESAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryWriteDown" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ResearchDevicesMember" xlink:label="hypr_ResearchDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SalesAndMarketingDevicesMember" xlink:label="hypr_SalesAndMarketingDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember" xlink:label="us-gaap_ToolsDiesAndMoldsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TradeShowAssetsMember" xlink:label="hypr_TradeShowAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" xlink:label="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_ResearchDevicesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_SalesAndMarketingDevicesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ToolsDiesAndMoldsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="hypr_TradeShowAssetsMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="us-gaap_AccruedBonusesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedContractedServicesCurrent" xlink:label="hypr_AccruedContractedServicesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedBonusAndOtherCostsCurrent" xlink:label="hypr_AccruedBonusAndOtherCostsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:label="hypr_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedBonusesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="hypr_AccruedContractedServicesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="hypr_AccruedBonusAndOtherCostsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="hypr_AccruedExpensesAndOtherCurrentLiabilities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PayrollProtectionProgramLoanMember" xlink:label="hypr_PayrollProtectionProgramLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfinePayrollProtectionProgramLoanMember" xlink:label="hypr_HyperfinePayrollProtectionProgramLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalPayrollProtectionProgramLoanMember" xlink:label="hypr_LiminalPayrollProtectionProgramLoanMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="hypr_PayrollProtectionProgramLoanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="hypr_HyperfinePayrollProtectionProgramLoanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromNotesPayable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="hypr_LiminalPayrollProtectionProgramLoanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis" xlink:label="us-gaap_DividendsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain" xlink:label="us-gaap_DividendsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LegacyHyperfineMember" xlink:label="hypr_LegacyHyperfineMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendDeclaredMember" xlink:label="us-gaap_DividendDeclaredMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalConvertiblePreferredStockMember" xlink:label="hypr_LiminalConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiquidationBasisOfAccountingLiquidationPlan" xlink:label="us-gaap_LiquidationBasisOfAccountingLiquidationPlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfVotesPerShare" xlink:label="hypr_NumberOfVotesPerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationExchangeRatio" xlink:label="hypr_BusinessCombinationExchangeRatio"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesBCAndDConvertiblePreferredStockMember" xlink:label="hypr_SeriesBCAndDConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="us-gaap_PreferredStockConversionBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesA1PreferredStockMember" xlink:label="hypr_SeriesA1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesATwoConvertiblePreferredStockMember" xlink:label="hypr_SeriesATwoConvertiblePreferredStockMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="hypr_LegacyHyperfineMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DividendsDomain" xlink:to="us-gaap_DividendDeclaredMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_LiminalConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_DividendsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_LiquidationBasisOfAccountingLiquidationPlan" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="hypr_NumberOfVotesPerShare" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="hypr_BusinessCombinationExchangeRatio" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesDPreferredStockMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_SeriesBCAndDConvertiblePreferredStockMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockConversionBasis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_SeriesA1PreferredStockMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hypr_SeriesATwoConvertiblePreferredStockMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TemporaryEquityYearOfClassIssuance" xlink:label="hypr_TemporaryEquityYearOfClassIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TemporaryEquitySharesIssuanceCost" xlink:label="hypr_TemporaryEquitySharesIssuanceCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="hypr_TemporaryEquityYearOfClassIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesDPreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="hypr_TemporaryEquitySharesIssuanceCost" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreferencePerShare" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock" xlink:label="us-gaap_DividendsCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CommonStockNumberOfVotesPerShare" xlink:label="hypr_CommonStockNumberOfVotesPerShare"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DividendsCommonStock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="hypr_CommonStockNumberOfVotesPerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineEquityIncentivePlanMember" xlink:label="hypr_HyperfineEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalMember" xlink:label="hypr_LiminalMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CommonStockRemainsAvailableForIssuance" xlink:label="hypr_CommonStockRemainsAvailableForIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_IncentiveUnitActivityMember" xlink:label="hypr_IncentiveUnitActivityMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember" xlink:label="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ExchangeRatio" xlink:label="hypr_ExchangeRatio"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember" xlink:label="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_EarnOutSharesMember" xlink:label="hypr_EarnOutSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_StockOptionsOneMember" xlink:label="hypr_StockOptionsOneMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfSeparateOptionAwards" xlink:label="hypr_NumberOfSeparateOptionAwards"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_StockOptionsTwoMember" xlink:label="hypr_StockOptionsTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember" xlink:label="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember" xlink:label="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ServiceAndPerformanceSharesMember" xlink:label="hypr_ServiceAndPerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue" xlink:label="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="hypr_HyperfineEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="hypr_LiminalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_CommonStockRemainsAvailableForIssuance" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_IncentiveUnitActivityMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_ExchangeRatio" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_EarnOutSharesMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_StockOptionsOneMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_NumberOfSeparateOptionAwards" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_StockOptionsTwoMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_ServiceAndPerformanceSharesMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineEquityIncentivePlanMember" xlink:label="hypr_HyperfineEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="hypr_HyperfineEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineEquityIncentivePlanMember" xlink:label="hypr_HyperfineEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="hypr_HyperfineEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_GranteeStatusAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementNonemployeeMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_EarnOutSharesMember" xlink:label="hypr_EarnOutSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="hypr_EarnOutSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember" xlink:label="us-gaap_ServiceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ServiceMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember" xlink:label="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_EarnOutSharesMember" xlink:label="hypr_EarnOutSharesMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="hypr_EarnOutSharesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FederalAndStateNetOperatingLossesMember" xlink:label="hypr_FederalAndStateNetOperatingLossesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FederalNetOperatingLossMember" xlink:label="hypr_FederalNetOperatingLossMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredTaxAssetsValuationAllowanceIncreased" xlink:label="hypr_DeferredTaxAssetsValuationAllowanceIncreased"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangePercentageTestingPeriod" xlink:label="hypr_OwnershipChangePercentageTestingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangeDescription" xlink:label="hypr_OwnershipChangeDescription"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfConsecutiveOwnershipChanges" xlink:label="hypr_NumberOfConsecutiveOwnershipChanges"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangesDateOne" xlink:label="hypr_OwnershipChangesDateOne"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangesDateTwo" xlink:label="hypr_OwnershipChangesDateTwo"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear" xlink:label="hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_IncomeTaxEffectsRecognized" xlink:label="hypr_IncomeTaxEffectsRecognized"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards" xlink:label="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ExchangeProgramRecognizedNetBenefits" xlink:label="hypr_ExchangeProgramRecognizedNetBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_OperatingLossCarryforwardsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="hypr_FederalAndStateNetOperatingLossesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="hypr_FederalNetOperatingLossMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_DeferredTaxAssetsValuationAllowanceIncreased" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OwnershipChangePercentageTestingPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OwnershipChangeDescription" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_NumberOfConsecutiveOwnershipChanges" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OwnershipChangesDateOne" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OwnershipChangesDateTwo" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_IncomeTaxEffectsRecognized" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_ExchangeProgramRecognizedNetBenefits" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation" xlink:label="hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation" xlink:label="hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineMember" xlink:label="hypr_HyperfineMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PreTwoThaousandEighteenMember" xlink:label="hypr_PreTwoThaousandEighteenMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ConnecticutResearchAndDevelopmentMember" xlink:label="hypr_ConnecticutResearchAndDevelopmentMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalMember" xlink:label="hypr_LiminalMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OperatingLossCarryforwardsBeginToExpireYear" xlink:label="hypr_OperatingLossCarryforwardsBeginToExpireYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PostTwoThaousandSeventeenMember" xlink:label="hypr_PostTwoThaousandSeventeenMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ConnecticutOthersMember" xlink:label="hypr_ConnecticutOthersMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FederalOtherMember" xlink:label="hypr_FederalOtherMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TaxCreditCarryforwardBeginToExpirationYear" xlink:label="hypr_TaxCreditCarryforwardBeginToExpirationYear"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_OperatingLossCarryforwardsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="hypr_HyperfineMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="hypr_PreTwoThaousandEighteenMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="hypr_ConnecticutResearchAndDevelopmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="hypr_LiminalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_OperatingLossCarryforwardsBeginToExpireYear" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="hypr_PostTwoThaousandSeventeenMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_TaxPeriodAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="hypr_ConnecticutOthersMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="hypr_FederalOtherMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="hypr_TaxCreditCarryforwardBeginToExpirationYear" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RelatedPartyTransactionPaymentsForRent" xlink:label="hypr_RelatedPartyTransactionPaymentsForRent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CatalyzerCorporation4Member" xlink:label="hypr_CatalyzerCorporation4Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AllocationOfExpenseIncurredMember" xlink:label="hypr_AllocationOfExpenseIncurredMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfSubsidiaries" xlink:label="hypr_NumberOfSubsidiaries"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AmendedAndRestatedTechnologyServicesAgreementMember" xlink:label="hypr_AmendedAndRestatedTechnologyServicesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FourBionicsMember" xlink:label="hypr_FourBionicsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalMember" xlink:label="hypr_LiminalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TechnologyAndServicesExchangeAgreementMember" xlink:label="hypr_TechnologyAndServicesExchangeAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromEmployeesNoncurrent" xlink:label="us-gaap_DueFromEmployeesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="us-gaap_RelatedPartyTransactionRate"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DueFromEmployeesForgiveness" xlink:label="hypr_DueFromEmployeesForgiveness"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_InterestReceivableRelatedPartiesCurrent" xlink:label="hypr_InterestReceivableRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeRelatedParty" xlink:label="us-gaap_InterestIncomeRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OtherAssetsRelatedPartyNoncurrent" xlink:label="hypr_OtherAssetsRelatedPartyNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PrepaidAdvancesUnrecoverable" xlink:label="hypr_PrepaidAdvancesUnrecoverable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_RelatedPartyTransactionPaymentsForRent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="hypr_CatalyzerCorporation4Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="hypr_AllocationOfExpenseIncurredMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_NumberOfSubsidiaries" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="hypr_AmendedAndRestatedTechnologyServicesAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="hypr_FourBionicsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="hypr_LiminalMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="hypr_TechnologyAndServicesExchangeAgreementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueFromEmployeesNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionRate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_DueFromEmployeesForgiveness" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_InterestReceivableRelatedPartiesCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_InterestIncomeRelatedParty" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_OtherAssetsRelatedPartyNoncurrent" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="hypr_PrepaidAdvancesUnrecoverable" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsReceivableRelatedPartiesCurrent" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable" xlink:label="us-gaap_ProductLiabilityContingencyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems" xlink:label="us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredGrantFundingCurrent" xlink:label="hypr_DeferredGrantFundingCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfSites" xlink:label="hypr_NumberOfSites"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantAwarded" xlink:label="hypr_GrantAwarded"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantAwardedForProvisionAndEquipping" xlink:label="hypr_GrantAwardedForProvisionAndEquipping"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantAwardedForOtherRelatedDeliverables" xlink:label="hypr_GrantAwardedForOtherRelatedDeliverables"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantFundRequiredToReturnUnderProvisions" xlink:label="hypr_GrantFundRequiredToReturnUnderProvisions"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductLiabilityContingencyTable" xlink:to="srt_StatementScenarioAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_DeferredGrantFundingCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ProductLiabilityContingencyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_NumberOfSites" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductLiabilityContingencyTable" xlink:to="us-gaap_ProductLiabilityContingencyLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_GrantAwarded" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_GrantAwardedForProvisionAndEquipping" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_GrantAwardedForOtherRelatedDeliverables" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="hypr_GrantFundRequiredToReturnUnderProvisions" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>hypr-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-25T14:35:27.4414+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PreTwoThaousandEighteenMember" xlink:label="hypr_PreTwoThaousandEighteenMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount" xlink:label="us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum" xlink:label="hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock" xlink:label="hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits" xlink:label="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangePercentageTestingPeriod" xlink:label="hypr_OwnershipChangePercentageTestingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiquidationBasisOfAccountingLiquidationPlan" xlink:label="us-gaap_LiquidationBasisOfAccountingLiquidationPlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TemporaryEquitySharesIssuanceCost" xlink:label="hypr_TemporaryEquitySharesIssuanceCost"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ServiceAndPerformanceSharesMember" xlink:label="hypr_ServiceAndPerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineMember" xlink:label="hypr_HyperfineMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PaymentOfPaycheckProtectionProgramLoan" xlink:label="hypr_PaymentOfPaycheckProtectionProgramLoan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FederalNetOperatingLossMember" xlink:label="hypr_FederalNetOperatingLossMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidSupplies" xlink:label="us-gaap_IncreaseDecreaseInPrepaidSupplies"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LeasedDevicesMember" xlink:label="hypr_LeasedDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredGrantFundingCurrent" xlink:label="hypr_DeferredGrantFundingCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FourBionicsMember" xlink:label="hypr_FourBionicsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards" xlink:label="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfSubsidiaries" xlink:label="hypr_NumberOfSubsidiaries"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ExchangeProgramRecognizedNetBenefits" xlink:label="hypr_ExchangeProgramRecognizedNetBenefits"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" xlink:label="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ImmediatelyPriorToEffectiveTimeMember" xlink:label="hypr_ImmediatelyPriorToEffectiveTimeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TechnologyAndServicesExchangeAgreementMember" xlink:label="hypr_TechnologyAndServicesExchangeAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalConvertiblePreferredStockMember" xlink:label="hypr_LiminalConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfVotesPerShare" xlink:label="hypr_NumberOfVotesPerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesA1PreferredStockMember" xlink:label="hypr_SeriesA1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ExchangeRatio" xlink:label="hypr_ExchangeRatio"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CatalyzerCorporation4Member" xlink:label="hypr_CatalyzerCorporation4Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredTaxAssetsValuationAllowanceIncreased" xlink:label="hypr_DeferredTaxAssetsValuationAllowanceIncreased"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PIPEInvestorsMember" xlink:label="hypr_PIPEInvestorsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DeferredRevenuePolicyPolicyTextBlock" xlink:label="hypr_DeferredRevenuePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangeDescription" xlink:label="hypr_OwnershipChangeDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="us-gaap_PreferredStockConversionBasis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ResearchDevicesMember" xlink:label="hypr_ResearchDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HealthCorMember" xlink:label="hypr_HealthCorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerGMember" xlink:label="hypr_CustomerGMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock" xlink:label="hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ConnecticutOthersMember" xlink:label="hypr_ConnecticutOthersMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LegacyHyperfineMember" xlink:label="hypr_LegacyHyperfineMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RelatedPartyTransactionPaymentsForRent" xlink:label="hypr_RelatedPartyTransactionPaymentsForRent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems" xlink:label="us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerHMember" xlink:label="hypr_CustomerHMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedBonusAndOtherCostsCurrent" xlink:label="hypr_AccruedBonusAndOtherCostsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ConversionOfLiminalCommonStock" xlink:label="hypr_ConversionOfLiminalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ClassAOrdinarySharesMember" xlink:label="hypr_ClassAOrdinarySharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromEmployeesNoncurrent" xlink:label="us-gaap_DueFromEmployeesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TaxCreditCarryforwardBeginToExpirationYear" xlink:label="hypr_TaxCreditCarryforwardBeginToExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember" xlink:label="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_WriteOffOfOtherAssetsRelatedParty" xlink:label="hypr_WriteOffOfOtherAssetsRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FederalOtherMember" xlink:label="hypr_FederalOtherMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineConvertiblePreferredStockMember" xlink:label="hypr_HyperfineConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantFundingPolicyTextBlock" xlink:label="hypr_GrantFundingPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CommonStockNumberOfVotesPerShare" xlink:label="hypr_CommonStockNumberOfVotesPerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_StockOptionsTwoMember" xlink:label="hypr_StockOptionsTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_EarnOutSharesMember" xlink:label="hypr_EarnOutSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantAwardedForProvisionAndEquipping" xlink:label="hypr_GrantAwardedForProvisionAndEquipping"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue" xlink:label="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SubscriptionAgreementsMember" xlink:label="hypr_SubscriptionAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangesDateTwo" xlink:label="hypr_OwnershipChangesDateTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationTransactionThresholdTradingDays" xlink:label="hypr_BusinessCombinationTransactionThresholdTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesBCAndDConvertiblePreferredStockMember" xlink:label="hypr_SeriesBCAndDConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation" xlink:label="hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerFMember" xlink:label="hypr_CustomerFMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable" xlink:label="us-gaap_ProductLiabilityContingencyTable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock" xlink:label="hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfSites" xlink:label="hypr_NumberOfSites"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HealthCorCatalioAcquisitionCorpMember" xlink:label="hypr_HealthCorCatalioAcquisitionCorpMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember" xlink:label="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock" xlink:label="hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PatentCostsPolicyTextBlock" xlink:label="hypr_PatentCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:label="us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_InterestReceivableRelatedPartiesCurrent" xlink:label="hypr_InterestReceivableRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationExchangeRatio" xlink:label="hypr_BusinessCombinationExchangeRatio"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="us-gaap_TransferredAtPointInTimeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock" xlink:label="hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember" xlink:label="us-gaap_ToolsDiesAndMoldsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AllocationOfExpenseIncurredMember" xlink:label="hypr_AllocationOfExpenseIncurredMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember" xlink:label="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedContractedServicesCurrent" xlink:label="hypr_AccruedContractedServicesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfinePayrollProtectionProgramLoanMember" xlink:label="hypr_HyperfinePayrollProtectionProgramLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="us-gaap_AccruedBonusesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentInLeasePurchase" xlink:label="us-gaap_NetInvestmentInLeasePurchase"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SalesAndMarketingDevicesMember" xlink:label="hypr_SalesAndMarketingDevicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember" xlink:label="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalPayrollProtectionProgramLoanMember" xlink:label="hypr_LiminalPayrollProtectionProgramLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PrepaidAdvancesUnrecoverable" xlink:label="hypr_PrepaidAdvancesUnrecoverable"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:label="hypr_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangesDateOne" xlink:label="hypr_OwnershipChangesDateOne"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage" xlink:label="hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RecapitalizationOfPermanentToTemporaryEquityValues" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityValues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember" xlink:label="us-gaap_ServiceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerDMember" xlink:label="hypr_CustomerDMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_HyperfineEquityIncentivePlanMember" xlink:label="hypr_HyperfineEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_UncertainTaxPositions" xlink:label="hypr_UncertainTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SeriesATwoConvertiblePreferredStockMember" xlink:label="hypr_SeriesATwoConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationPaymentOfTransactionCosts" xlink:label="hypr_BusinessCombinationPaymentOfTransactionCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfConsecutiveOwnershipChanges" xlink:label="hypr_NumberOfConsecutiveOwnershipChanges"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerEMember" xlink:label="hypr_CustomerEMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_DueFromEmployeesForgiveness" xlink:label="hypr_DueFromEmployeesForgiveness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LaboratoryEquipmentMember" xlink:label="hypr_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember" xlink:label="us-gaap_TransferredOverTimeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TemporaryEquityYearOfClassIssuance" xlink:label="hypr_TemporaryEquityYearOfClassIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OperatingLossCarryforwardsBeginToExpireYear" xlink:label="hypr_OperatingLossCarryforwardsBeginToExpireYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:label="hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendDeclaredMember" xlink:label="us-gaap_DividendDeclaredMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RecapitalizationOfPermanentToTemporaryEquityShares" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AmendedAndRestatedTechnologyServicesAgreementMember" xlink:label="hypr_AmendedAndRestatedTechnologyServicesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CommonStockSubjectToRedemption" xlink:label="hypr_CommonStockSubjectToRedemption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_LiminalMember" xlink:label="hypr_LiminalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ConnecticutResearchAndDevelopmentMember" xlink:label="hypr_ConnecticutResearchAndDevelopmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock" xlink:label="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_InterestAndPaymentsToRedeemingCompanyShareholders" xlink:label="hypr_InterestAndPaymentsToRedeemingCompanyShareholders"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned" xlink:label="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis" xlink:label="us-gaap_DividendsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_FederalAndStateNetOperatingLossesMember" xlink:label="hypr_FederalAndStateNetOperatingLossesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantAwarded" xlink:label="hypr_GrantAwarded"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="us-gaap_UnbilledReceivablesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_IncentiveUnitActivityMember" xlink:label="hypr_IncentiveUnitActivityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_StockOptionsOneMember" xlink:label="hypr_StockOptionsOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerCMember" xlink:label="hypr_CustomerCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_EarnOutSharesPolicyTextBlock" xlink:label="hypr_EarnOutSharesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation" xlink:label="hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PostTwoThaousandSeventeenMember" xlink:label="hypr_PostTwoThaousandSeventeenMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ProceedsFromBusinessCombination" xlink:label="hypr_ProceedsFromBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationMethod" xlink:label="us-gaap_CapitalizedContractCostAmortizationMethod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_Covid19OutbreakPolicyTextBlock" xlink:label="hypr_Covid19OutbreakPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember" xlink:label="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination" xlink:label="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="us-gaap_RelatedPartyTransactionRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear" xlink:label="hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_NumberOfSeparateOptionAwards" xlink:label="hypr_NumberOfSeparateOptionAwards"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum" xlink:label="hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_IncomeTaxEffectsRecognized" xlink:label="hypr_IncomeTaxEffectsRecognized"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantFundRequiredToReturnUnderProvisions" xlink:label="hypr_GrantFundRequiredToReturnUnderProvisions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock" xlink:label="us-gaap_DividendsCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount" xlink:label="us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_GrantAwardedForOtherRelatedDeliverables" xlink:label="hypr_GrantAwardedForOtherRelatedDeliverables"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PayrollProtectionProgramLoanMember" xlink:label="hypr_PayrollProtectionProgramLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_AdjustmentsToAdditionalPaidInCapitalInvestments" xlink:label="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_PercentageOfCommonStockVotingPower" xlink:label="hypr_PercentageOfCommonStockVotingPower"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="us-gaap_IncreaseDecreaseInDeferredLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201815Member" xlink:label="us-gaap_AccountingStandardsUpdate201815Member"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerBMember" xlink:label="hypr_CustomerBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ClassBOrdinarySharesMember" xlink:label="hypr_ClassBOrdinarySharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_AU" xlink:label="country_AU"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CommonStockRemainsAvailableForIssuance" xlink:label="hypr_CommonStockRemainsAvailableForIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseSellingProfitLoss" xlink:label="us-gaap_SalesTypeLeaseSellingProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_UnbilledReceivables" xlink:label="hypr_UnbilledReceivables"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeRelatedParty" xlink:label="us-gaap_InterestIncomeRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays" xlink:label="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TradeShowAssetsMember" xlink:label="hypr_TradeShowAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_OtherAssetsRelatedPartyNoncurrent" xlink:label="hypr_OtherAssetsRelatedPartyNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_SponsorMember" xlink:label="hypr_SponsorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_CustomerAMember" xlink:label="hypr_CustomerAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="hypr-20211231.xsd#hypr_WarrantiesPolicyTextBlock" xlink:label="hypr_WarrantiesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain" xlink:label="us-gaap_DividendsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PreTwoThaousandEighteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-2018</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PreTwoThaousandEighteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Two Thaousand Eighteen [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PreTwoThaousandEighteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre two thaousand eighteen.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Policy Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gross Profit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gross margin</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Liabilities Level1 To Level2 Transfers Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value liabilities transfers, Level 1 to Level 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Accounting Principle Accounting Standards Update Early Adoption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, early adoption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax net operating loss carryforward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Loss Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forecast</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Forecast [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Executive Chairman</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Board of Directors Chairman [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Notes Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Notes Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of notes payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment terms range, minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The minimum payment term agreed upon with the respective customer.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Due to Related Parties, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Due To Related Parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due to related parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of stock options granted to employees and nonemployees.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Stock Options Granted To Employees And Nonemployees Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Options Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CONVERTIBLE PREFERRED STOCK</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash received from exchange of research and development tax credits.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Received From Exchange Of Research And Development Tax Credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash received from exchange of research and development tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Reportable Segments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reporting segment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of fixed assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangePercentageTestingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership change percentage testing period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangePercentageTestingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership Change percentage testing period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangePercentageTestingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Ownership Change percentage testing period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Class A Common stock, $.0001 par value; 600,000,000 and 130,000,000 shares authorized; 55,277,061 and 1,576,137 shares issued and outstanding at December 31, 2021 and 2020, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiquidationBasisOfAccountingLiquidationPlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liquidation rights, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiquidationBasisOfAccountingLiquidationPlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liquidation Basis of Accounting, Liquidation Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TemporaryEquitySharesIssuanceCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, shares, issuance cost.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TemporaryEquitySharesIssuanceCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Shares Issuance Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TemporaryEquitySharesIssuanceCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ServiceAndPerformanceSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Service and Performance Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ServiceAndPerformanceSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Service And Performance Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ServiceAndPerformanceSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Service and performance shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfineMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Hyperfine</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfineMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Hyperfine [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfineMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Hyperfine.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Disaggregated Revenues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PaymentOfPaycheckProtectionProgramLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of paycheck protection program loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PaymentOfPaycheckProtectionProgramLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of Paycheck Protection Program Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PaymentOfPaycheckProtectionProgramLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of paycheck protection program loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk Free interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Related Parties Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due from related parties for payments made on behalf of the other entities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FederalNetOperatingLossMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal Net Operating Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FederalNetOperatingLossMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Federal Net Operating Loss [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FederalNetOperatingLossMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Federal Net Operating Loss.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidSupplies_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid inventory</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidSupplies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Supplies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LeasedDevicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leased Devices</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LeasedDevicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leased Devices [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LeasedDevicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">This member stands for leased devices.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DeferredGrantFundingCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred grant funding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DeferredGrantFundingCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Grant Funding Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DeferredGrantFundingCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the carrying amount of deferred grant funding as of balance sheet date, classified as current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FourBionicsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Four bionics.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FourBionicsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Four Bionics [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FourBionicsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">4Bionics</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of cash payment in research and development tax credit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Cash Payment in Research and Development Tax Credit Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of cash payment in research and development tax credit carryforwards.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfSubsidiaries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of subsidiaries.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfSubsidiaries_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Subsidiaries</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfSubsidiaries_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of subsidiaries</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ExchangeProgramRecognizedNetBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exchange program recognized net benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ExchangeProgramRecognizedNetBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exchange program Recognized Net Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ExchangeProgramRecognizedNetBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exchange program recognized net benefits.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Denominator for Basic and Dilutive EPS - Weighted-average common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Share Outstanding Basic And Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Capitalized Property Plant And Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Fixed assets (liabilities)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fixed assets, liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ImmediatelyPriorToEffectiveTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Immediately prior to effective time.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ImmediatelyPriorToEffectiveTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Immediately Prior To Effective Time [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ImmediatelyPriorToEffectiveTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Immediately Prior To Effective Time</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finished goods</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock issued to service provider in exchange for services</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TechnologyAndServicesExchangeAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Technology and services exchange agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TechnologyAndServicesExchangeAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Technology And Services Exchange Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TechnologyAndServicesExchangeAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">TESA</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LiminalConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Liminal convertible preferred stock .</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LiminalConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liminal Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LiminalConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liminal Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series B Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Device</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfVotesPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of votes per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfVotesPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Votes Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfVotesPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of votes per share.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accounts receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Receivable, after Allowance for Credit Loss, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Net Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, less allowance of $32 and $0 in 2021 and 2020, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other assets - related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) Due from Other Related Parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue recognized that was included in the deferred revenue balance at the beginning of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SeriesA1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A-1 Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SeriesA1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A-1 preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SeriesA1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A-1 preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assumptions Used to Value Option Grants to Employees and Nonemployees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Par Or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance Price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ExchangeRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exchange ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ExchangeRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exchange ratio.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ExchangeRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exchange Ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CatalyzerCorporation4Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Catalyzer corporation 4.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CatalyzerCorporation4Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Catalyzer Corporation4 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CatalyzerCorporation4Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">4C</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Accounting Principle Accounting Standards Update Adopted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adopted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Due from Related Parties, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Due From Related Parties Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due from related parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of cash, cash equivalents, and restricted cash reported in the statement of financial position</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">COMMITMENTS AND CONTINGENCIES (NOTE 16)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DeferredTaxAssetsValuationAllowanceIncreased_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets valuation allowance increased</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DeferredTaxAssetsValuationAllowanceIncreased_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Valuation Allowance Increased</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DeferredTaxAssetsValuationAllowanceIncreased_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets valuation allowance increased.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Anti-dilutive Common Equivalent Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Tax Net Operating Loss Carryforward and Tax Credit Carryforward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Operating Loss Carryforwards [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credit receivables</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Class A common stock to a service provider (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedComputerSoftwareNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized internal-use software development costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedComputerSoftwareNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Capitalized internal-use software development costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedComputerSoftwareNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Computer Software, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedComputerSoftwareNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Capitalized Computer Software, Net, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedComputerSoftwareNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Capitalized Computer Software, Net, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of Series D convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total Proceeds or Exchange Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PIPEInvestorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PIPE Investors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PIPEInvestorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">PIPE investors.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PIPEInvestorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">P I P E Investors [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">BUSINESS COMBINATION</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales Revenue Net [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DeferredRevenuePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DeferredRevenuePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DeferredRevenuePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the Deferred revenue policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Accounting Policy Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash, end of year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash, beginning of year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Accounting Principle Accounting Standards Update Immaterial Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, immaterial effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Conversion Of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of the convertible preferred stock into Class A and Class B common stock at the Business Combination</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncash acquisition of fixed assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Related Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payroll and related benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangeDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership change, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangeDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership Change description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangeDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Ownership Change description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common shares, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConversionBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, conversion basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConversionBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Conversion Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ResearchDevicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research devices.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ResearchDevicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Devices [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ResearchDevicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research Devices</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer Concentration Risk [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Concentration Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HealthCorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">HealthCor.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HealthCorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Health Cor [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HealthCorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">HealthCor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss) Available to Common Stockholders, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss Available To Common Stockholders Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator for Basic and Dilutive EPS &#8211; Loss available to common stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerGMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer G.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerGMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer G [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerGMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer G</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of Series D convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Redeemable Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201912Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2019-12</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201912Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2019-12 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series C Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for research and development tax credits.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Tax Credits Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Tax Credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ConnecticutOthersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Connecticut Others</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ConnecticutOthersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Connecticut Others [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ConnecticutOthersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Connecticut others.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Expenses From Transactions With Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expenses incurred</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common shares, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use Of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions By Related Party [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Class Of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Benchmark</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total anti-dilutive common equivalent shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LegacyHyperfineMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Legacy hyperfine.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LegacyHyperfineMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legacy Hyperfine [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LegacyHyperfineMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legacy Hyperfine</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RelatedPartyTransactionPaymentsForRent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party transaction payments for rent.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RelatedPartyTransactionPaymentsForRent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Payments For Rent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RelatedPartyTransactionPaymentsForRent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments for rent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductLiabilityContingencyLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product Liability Contingency [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductLiabilityContingencyLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product Liability Contingency [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Timing Of Transfer Of Good Or Service [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Timing of Transfer of Good or Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerHMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer H.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerHMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer H [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerHMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer H</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AccruedBonusAndOtherCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SPAC bonus and other costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AccruedBonusAndOtherCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Bonus and Other Costs Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AccruedBonusAndOtherCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued bonus and other costs current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective tax rate percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Percent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Remaining performance obligation expected to be recognized, duration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GranteeStatusAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grantee Status [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GranteeStatusAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grantee Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ConversionOfLiminalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Liminal Common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ConversionOfLiminalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of Liminal Common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation Of Revenue [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ClassAOrdinarySharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class A ordinary shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ClassAOrdinarySharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class A Ordinary Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ClassAOrdinarySharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A Ordinary Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion Of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of the convertible preferred stock into Class A and Class B common stock at the Business Combination (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incremental compensation expense recognized as a result of the modification</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Level2 To Level1 Transfers Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value asset transfers, Level 2 to Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Face Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of note payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common shares, par value, (per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Federal research and development credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Sales Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueFromEmployeesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Due From Employees Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueFromEmployeesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Promissory Note with one of the employees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TaxCreditCarryforwardBeginToExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Begin to Expire in</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TaxCreditCarryforwardBeginToExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Begin to Expiration Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TaxCreditCarryforwardBeginToExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward begin to expiration year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">States</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Two Separate Option Awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Payment Arrangement Two Separate Option Awards [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based payment arrangement two separate option awards.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense Policy</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Software And Software Development Costs [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Software Development Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before provision for income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Authority [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowance for doubtful accounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_WriteOffOfOtherAssetsRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Write-off of other assets - related party.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_WriteOffOfOtherAssetsRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Write Off Of Other Assets Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_WriteOffOfOtherAssetsRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Write-off of other assets - related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FederalOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FederalOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Federal Other [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FederalOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Federal other.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation Of Revenue [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Payment Arrangement Employee [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfineConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Hyperfine convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfineConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Hyperfine Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfineConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Hyperfine Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Outstanding Options to Purchase Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Option Grants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-term Debt, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock option grants, term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantFundingPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for grant funding.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantFundingPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grant Funding Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantFundingPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant Funding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Income tax expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Expense (Benefit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic and dilutive loss per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic and Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per common share attributable to common stockholders, basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CommonStockNumberOfVotesPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock number of votes per share.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CommonStockNumberOfVotesPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Number Of Votes Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CommonStockNumberOfVotesPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common shares, votes per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_StockOptionsTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_StockOptionsTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Options Two [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_StockOptionsTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock options two.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Class A Common Stock to a service provider in exchange for the service provided in connection with the Business Combination</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common shares, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation Depletion And Amortization Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Accumulated depreciation and amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_EarnOutSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Earn-Out Shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_EarnOutSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earn Out Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_EarnOutSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earn-Out Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantAwardedForProvisionAndEquipping_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of grant awarded for provision and equipping.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantAwardedForProvisionAndEquipping_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grant Awarded For Provision And Equipping</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantAwardedForProvisionAndEquipping_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant awarded for provision and equipping</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incremental value as a result of the modification of the awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Payment Arrangement Plan Modification Incremental Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based payment arrangement plan modification incremental value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss and comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Reconciliation of Anticipated Income Tax Expense Benefit Computed by Statutory Federal Income Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202006Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update202006 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202006Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2020-06</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Credit Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Value New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series D convertible preferred stock, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of estimated net operating loss and tax credit carryforwards will expire before utilization due to ownership change</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss And Tax Credit Carry forwards Will Expire Estimation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of estimated net operating loss and tax credit carryforwards will expire before utilization due to ownership change, under Internal Revenue Code Section 382.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SubscriptionAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Subscription agreements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SubscriptionAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subscription Agreements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SubscriptionAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subscription Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total intrinsic value of stock options exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of annual limitation of net operating loss and tax credit carryforwards due to ownership change, Under Internal Revenue Code Section 382.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of annual limitation of net operating loss and tax credit carryforwards due to ownership change</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss And Tax Credit Carry forwards Annual Limitation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Profit Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangesDateTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership changes date, two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangesDateTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership changes Date two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangesDateTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Ownership changes Date two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk Free interest rate, maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Products And Services [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Carrying Amount Attributable To Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Hyperfine convertible preferred stock (Series A, B, C and D): $.0001 par value, aggregate liquidation preference of $0 and $147,651; 0 and 129,788,828 shares authorized; 0 and 95,010,858 shares issued and outstanding at December 31, 2021 and 2020, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized Software Development Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research, Development, and Computer Software, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationTransactionThresholdTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination transaction threshold trading days.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationTransactionThresholdTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Transaction Threshold Trading Days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationTransactionThresholdTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination transaction threshold trading days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Goods And Services Sold [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Arrangements And Nonarrangement Transactions [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxPeriodAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Period [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CURRENT ASSETS:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock dividend rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Notes Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repayment of notes payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SeriesBCAndDConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B, C and D Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SeriesBCAndDConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B, C and D Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SeriesBCAndDConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B, C and D convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Write down of federal NOL due to 382 limitation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">EffectiveIncomeTaxRateReconciliationWriteDownOfFederalNolDueTo382Limitation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series A Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">STOCKHOLDERS' EQUITY (DEFICIT)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total grant date fair value recognized period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Class B [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class B Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MajorCustomersAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Major Customers [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MajorCustomersAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerFMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer F.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerFMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer F [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerFMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer F</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductLiabilityContingencyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product Liability Contingency [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductLiabilityContingencyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product Liability Contingency [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of estimated useful lives of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of useful lives for property, plant and equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Useful Lives For Property Plant And Equipment Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfSites_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of sites for equipping Hyperfine portable point-of-care MRI system</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfSites_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of sites for equipping Hyperfine portable point-of-care MRI system.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfSites_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Sites</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfSites_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of sites for provision and equipping</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HealthCorCatalioAcquisitionCorpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">HealthCor catalio acquisition corp.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HealthCorCatalioAcquisitionCorpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Health Cor Catalio Acquisition Corp [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HealthCorCatalioAcquisitionCorpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">HealthCor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue, remaining performance obligation, percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Capitalized Contract Cost, Net, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized contract cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Separate Option Award</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Payment Arrangement Separate Option Awards [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based payment arrangement separate option awards.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of share-based payment award, earn-out shares, valuation assumptions.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Payment Award Earn Out Shares Valuation Assumptions Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Key Assumptions Used in Valuation for Earn-Out Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term (years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Expected term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for patent costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patent Costs Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RELATED PARTY TRANSACTIONS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Rollforward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk By Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Allowance For Doubtful Accounts Receivable Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowance for doubtful accounts receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Allowance for doubtful accounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAmortizationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost Amortization Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAmortizationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized costs, amortization period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdvertisingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Advertising Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdvertisingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Advertising expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_InterestReceivableRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest receivable related parties current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_InterestReceivableRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Receivable Related Parties Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_InterestReceivableRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest receivable from the Note</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity (deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationExchangeRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination, exchange ratio.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationExchangeRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Exchange Ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationExchangeRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exchange ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransferredAtPointInTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transferred At Point In Time [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransferredAtPointInTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Point In Time</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination And Asset Acquisition [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized Tax Benefits, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized Tax Benefits, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tabular disclosure for accrued liabilities and other current liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Liabilities And Other Liabilities Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Accrued Expenses and Other Current Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Class A [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ToolsDiesAndMoldsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tools Dies And Molds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ToolsDiesAndMoldsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tooling</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Tax Credit Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AllocationOfExpenseIncurredMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Allocation of expense incurred.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AllocationOfExpenseIncurredMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Allocation Of Expense Incurred [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AllocationOfExpenseIncurredMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allocation of Expense Incurred</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Deferred Tax Assets (Liabilities)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Or Disposal Of Long Lived Assets Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Tax Credit Carryforward [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling And Marketing Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales and Marketing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding Legacy Hyperfine Convertible Preferred Stock (Series A through D)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Outstanding Legacy Hyperfine Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Outstanding legacy hyperfine convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated useful life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AccruedContractedServicesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Carrying value as of the balance sheet date of obligations incurred through that date and payable for contracted services.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AccruedContractedServicesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Contracted Services Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AccruedContractedServicesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contracted services</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfinePayrollProtectionProgramLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Hyperfine payroll protection program loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfinePayrollProtectionProgramLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Hyperfine Payroll Protection Program Loan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfinePayrollProtectionProgramLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Hyperfine PPP loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares entitle to certain employees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Stock Shares Issued1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Additional Paid in Capital, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Amounts Of Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expenses allocated</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedBonusesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Bonuses Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedBonusesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Bonus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementNonemployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Payment Arrangement Nonemployee [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementNonemployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonemployee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetInvestmentInLeasePurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments received on net investment in lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetInvestmentInLeasePurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Investment in Lease, Purchase</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SalesAndMarketingDevicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales and marketing devices.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SalesAndMarketingDevicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales And Marketing Devices [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SalesAndMarketingDevicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales and Marketing Devices</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">4Bionics Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Four Bionics Two Thousand Nineteen Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Four Bionics 2019 Equity Incentive Plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity By Class Of Stock [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity By Class Of Stock [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LiminalPayrollProtectionProgramLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Liminal payroll protection program loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LiminalPayrollProtectionProgramLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liminal Payroll Protection Program Loan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LiminalPayrollProtectionProgramLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liminal PPP loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State taxes, net of federal benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Class A common stock to a service provider</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PrepaidAdvancesUnrecoverable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid advances unrecoverable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PrepaidAdvancesUnrecoverable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Advances Unrecoverable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PrepaidAdvancesUnrecoverable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid advances unrecoverable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AccruedExpensesAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued expenses and other current liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AccruedExpensesAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Expenses And Other Current Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AccruedExpensesAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AccruedExpensesAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OpenTaxYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Open Tax Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OpenTaxYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Open tax year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Due to Related Parties, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Due To Related Parties Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due to related parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangesDateOne_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership changes date, one</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangesDateOne_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership changes Date one</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangesDateOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Ownership changes Date one</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Remaining performance obligation expected to be recognized, percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityValues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recapitalization of permanent to temporary equity values.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityValues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recapitalization Of Permanent To Temporary Equity Values</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityValues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Liminal Common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination, shares issued as earn out consideration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Authorized, Issued and Outstanding Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Notes Payable, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Notes Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long term notes payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ServiceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Service [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ServiceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax adjustment resulting from tax rate change</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well Known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer D.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer D [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer D</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfineEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Hyperfine Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfineEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">This member stands for Hyperfine equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfineEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Hyperfine Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_HyperfineEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Hyperfine Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_UncertainTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Uncertain tax positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_UncertainTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Uncertain Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_UncertainTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of uncertain tax positions.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Fair Value Hierarchy Level [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SeriesATwoConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A-2 Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SeriesATwoConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A-Two Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SeriesATwoConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A-two convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationPaymentOfTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of transaction costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationPaymentOfTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Payment of Transaction Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationPaymentOfTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination payment of transaction costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets (liabilities)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding RSUs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, aggregate liquidation preference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Liquidation Preference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Receivable [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Option award to purchase shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">REVENUE RECOGNITION</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfConsecutiveOwnershipChanges_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of consecutive ownership changes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfConsecutiveOwnershipChanges_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of consecutive ownership changes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Remaining performance obligation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing And Financing Items [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of noncash information:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk Free interest rate, minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerEMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer E.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerEMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer E [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerEMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer E</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DueFromEmployeesForgiveness_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Due from employees forgiveness.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DueFromEmployeesForgiveness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Due From Employees Forgiveness</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_DueFromEmployeesForgiveness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Promissory Note with one of the employees will be forgiven</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant date fair value per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">This member stands for laboratory equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransferredOverTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transferred Over Time [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransferredOverTimeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Over Time</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss per Common Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TemporaryEquityYearOfClassIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, year of class issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TemporaryEquityYearOfClassIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Year Of Class Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TemporaryEquityYearOfClassIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Year of Class Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm Id</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-term Debt, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregate Intrinsic Value Rollforward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options outstanding aggregate intrinsic value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OperatingLossCarryforwardsBeginToExpireYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Begin to Expire in</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OperatingLossCarryforwardsBeginToExpireYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Begin to Expire Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OperatingLossCarryforwardsBeginToExpireYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carryforwards begin to expire year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock units ("RSU") granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Timing Of Transfer Of Good Or Service [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Timing of Transfer of Good or Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ORGANIZATION AND DESCRIPTION OF BUSINESS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Valuation Allowance, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total unrecognized stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for prepaid expenses and other current assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses And Other Current Assets Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses and Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendDeclaredMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend Declared</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendDeclaredMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividend Declared [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recapitalization of permanent to temporary equity shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recapitalization Of Permanent To Temporary Equity Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RecapitalizationOfPermanentToTemporaryEquityShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Liminal Common stock (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Construction In Progress [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction In Progress</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average grant date fair value of options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AmendedAndRestatedTechnologyServicesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amended and restated technology services agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AmendedAndRestatedTechnologyServicesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amended And Restated Technology Services Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AmendedAndRestatedTechnologyServicesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ARTSA</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">INCOME TAXES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Related Parties Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due to related parties for payments paid on their behalf</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PROPERTY AND EQUIPMENT, NET</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Information about Receivables and Deferred Revenue from Contracts with Customers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Asset And Liability Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CommonStockSubjectToRedemption_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock subject to redemption.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CommonStockSubjectToRedemption_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Subject To Redemption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CommonStockSubjectToRedemption_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock subject to redemption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LiminalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Liminal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LiminalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Liminal.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LiminalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liminal [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_LiminalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legacy Hyperfine</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Acquiree [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition, Acquiree</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payables And Accruals [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Acquisitions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net equity infusion from the Business Combination</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ConnecticutResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Connecticut Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ConnecticutResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Connecticut Research and Development [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ConnecticutResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Connecticut research and development.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Expected annual equity volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of votes per share entitled to class of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Votes Per Share Entitled To Class Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of votes per share entitled to class of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_InterestAndPaymentsToRedeemingCompanyShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest and payments to redeeming company shareholders.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_InterestAndPaymentsToRedeemingCompanyShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest And Payments To Redeeming Company Shareholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_InterestAndPaymentsToRedeemingCompanyShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and payments to redeeming company shareholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage number of shares ceases to beneficially owned.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Number Of Shares Ceases To Beneficially Owned</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage number of shares ceases to beneficially owned</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note Stock Split Conversion Ratio1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock split, conversion ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FederalAndStateNetOperatingLossesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal And State Net Operating Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FederalAndStateNetOperatingLossesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Federal and state net operating losses [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_FederalAndStateNetOperatingLossesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Federal and state net operating losses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantAwarded_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant awarded from the BMGF</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantAwarded_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of grant awarded.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantAwarded_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grant Awarded</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Chief Executive Officer [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Chief Executive Officer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NOTES PAYABLE</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Accounting Principle Accounting Standards Update Adoption Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adoption date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnbilledReceivablesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unbilled Receivables Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnbilledReceivablesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unbilled receivables</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leased Devices</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_IncentiveUnitActivityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Incentive unit activity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_IncentiveUnitActivityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incentive Unit Activity [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_IncentiveUnitActivityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incentive Unit Grants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk, Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Percentage1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Noncurrent Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other long term assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Original issuance price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Granted During Period Value Sharebased Compensation Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Adoption [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments For New Accounting Pronouncements [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Revenue from Contract with Customer, Excluding Assessed Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Stock issuance costs related to Series D convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issuance costs related to Series D convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_StockOptionsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_StockOptionsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Options One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_StockOptionsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock options one.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares held by sponsor , irrevocably forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer C.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer C [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer C</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_EarnOutSharesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Earn-Out shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_EarnOutSharesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earn Out Shares Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_EarnOutSharesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earn-Out Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment from 4Bionics, LLC</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Contributions from Affiliates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Presentation And Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CURRENT LIABILITIES:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">EQUITY INCENTIVE PLAN</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Share Based Payments [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Director [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dr. Rothberg</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Restricted Cash and Cash Equivalents, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Write down of federal R&amp;D credits due to 382 limitation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">EffectiveIncomeTaxRateReconciliationWriteDownOfFederalResearchAndDevelopmentCreditsDueTo382Limitation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Asset Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Operating Segments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PostTwoThaousandSeventeenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Post-2017</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PostTwoThaousandSeventeenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Post Two Thaousand Seventeen [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PostTwoThaousandSeventeenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Post two thaousand seventeen.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ProceedsFromBusinessCombination_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from business combination.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ProceedsFromBusinessCombination_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Business Combination</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ProceedsFromBusinessCombination_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from equity infusion from the Business Combination</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAmortizationMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost Amortization Method</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedContractCostAmortizationMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized costs, amortization method</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units R S U [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_Covid19OutbreakPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">COVID-19 Outbreak</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_Covid19OutbreakPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Covid 19 Outbreak [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_Covid19OutbreakPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for Covid 19 outbreak.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Fixed assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fixed assets, assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GranteeStatusDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grantee Status [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GranteeStatusDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grantee Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash proceeds from exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales and Marketing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Advertising Cost [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Incentive unit awards and replacement preferred stock awards.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incentive Unit Awards And Replacement Preferred Stock Awards [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incentive Unit Awards and Replacement Preferred Stock Awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid directors and officers insurance policy in connection with closing of business combination</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Insurance Policy in Connection With Business Combination</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid insurance policy in connection with business combination.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate of the Note</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long term deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership changes analysis expected to be completed year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Ownership changes analysis expected to be completed year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Acquisitions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net equity infusion from the Business Combination (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cost of Goods and Services Sold, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Goods And Services Sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cost of sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Stockholders Equity Roll Forward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfSeparateOptionAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of separate option awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfSeparateOptionAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Separate Option Awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_NumberOfSeparateOptionAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of separate option awards.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment terms range, maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The maximum payment term agreed upon with the respective customer.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_IncomeTaxEffectsRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax effects recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_IncomeTaxEffectsRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income tax Effects Recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_IncomeTaxEffectsRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax effects recognized.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantFundRequiredToReturnUnderProvisions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant fund amounts required to be returned under provisions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantFundRequiredToReturnUnderProvisions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grant Fund Required To Return Under Provisions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantFundRequiredToReturnUnderProvisions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Grant Fund Required To Return Under Provisions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Dividends, Common Stock, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends declared common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Liquidation Preference Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Initial Liquidation Price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Liabilities Level2 To Level1 Transfers Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value liabilities transfers, Level 2 to Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk By Benchmark [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Benchmark</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWriteDown_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Inventory adjustments and excess and obsolete inventory charges</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWriteDown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Write Down</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWriteDown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Write-down of inventory</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantAwardedForOtherRelatedDeliverables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant awarded for other related deliverables</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantAwardedForOtherRelatedDeliverables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grant Awarded For Other Related Deliverables</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_GrantAwardedForOtherRelatedDeliverables_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Grant awarded for other related deliverables.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Depreciation and amortization expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation Depletion And Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued bonuses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase in cash and cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesDPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series D</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesDPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series D Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesDPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series D Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PayrollProtectionProgramLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payroll protection program loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PayrollProtectionProgramLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payroll Protection Program Loan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PayrollProtectionProgramLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payroll Protection Program</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of long-lived assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statutory tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statutory federal income tax rate (in percent)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital investments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment from 4Bionics, LLC</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">STOCKHOLDERS' EQUITY (DEFICIT):</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Stock Shares Converted1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Liminal Common stock (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Selling and Marketing Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling And Marketing Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales and marketing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Due from related parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due from related parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Receivable, Related Parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PercentageOfCommonStockVotingPower_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of common stock voting power.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PercentageOfCommonStockVotingPower_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Common Stock Voting Power</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_PercentageOfCommonStockVotingPower_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of common stock voting power</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred grant funding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Deferred Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Deferred Liabilities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201815Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update201815 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201815Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU No. 2018-15</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer B.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer B [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer B</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Basic and Diluted Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ClassBOrdinarySharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class B ordinary shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ClassBOrdinarySharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class B Ordinary Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ClassBOrdinarySharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class B Ordinary Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Inventories, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Inventory</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_AU_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Australia</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_AU_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AUSTRALIA</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, capital shares reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Shares Reserved For Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CommonStockRemainsAvailableForIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock remain available for issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CommonStockRemainsAvailableForIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock remains available for issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CommonStockRemainsAvailableForIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Remains Available For Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesTypeLeaseSellingProfitLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Sales under sales type leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesTypeLeaseSellingProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales under sales type leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesTypeLeaseSellingProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales-type Lease, Selling Profit (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Icfr Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_UnbilledReceivables_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unbilled receivables</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_UnbilledReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unbilled Receivables</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_UnbilledReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unbilled receivables</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NET LOSS PER SHARE</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, award repurchase right valid period commencing with date of service.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Repurchase Right Valid Period Commencing With Date Of Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repurchase right valid period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Stock By Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product Or Service [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other expense, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination transaction threshold consecutive trading days.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Transaction Threshold Consecutive Trading Days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination transaction threshold consecutive trading days.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TradeShowAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Trade show assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TradeShowAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trade Show Assets [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TradeShowAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trade Show Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Contract With Customer Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Number Of Shares Issued In Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate number of shares issued in transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock issued during period shares new issues.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series D convertible preferred stock, net of issuance costs (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements Policy Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual With Relationship To Entity [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OtherAssetsRelatedPartyNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other assets - related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OtherAssetsRelatedPartyNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other assets related party noncurrent.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OtherAssetsRelatedPartyNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Related Party Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_OtherAssetsRelatedPartyNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid advances</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SponsorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sponsor.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SponsorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sponsor [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_SponsorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sponsor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SUBSEQUENT EVENTS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer A.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer A [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_CustomerAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer A</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Level1 To Level2 Transfers Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value asset transfers, Level 1 to Level 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_WarrantiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for warranties.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_WarrantiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warranties Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="hypr_WarrantiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warranties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxPeriodDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Period [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long term assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Arrangement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Name Of Major Customer [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost Of Sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Sales [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of each significant customer, revenue as a percentage of total revenues and gross accounts receivable as a percentage of total gross accounts receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedules Of Concentration Of Risk By Risk Factor [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Raw materials</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">FAIR VALUE OF FINANCIAL INSTRUMENTS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate gross proceeds of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PreTwoThaousandEighteenMember" xlink:to="hypr_PreTwoThaousandEighteenMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount" xlink:to="us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum" xlink:to="hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock" xlink:to="hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits" xlink:to="hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_OwnershipChangePercentageTestingPeriod" xlink:to="hypr_OwnershipChangePercentageTestingPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiquidationBasisOfAccountingLiquidationPlan" xlink:to="us-gaap_LiquidationBasisOfAccountingLiquidationPlan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_TemporaryEquitySharesIssuanceCost" xlink:to="hypr_TemporaryEquitySharesIssuanceCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ServiceAndPerformanceSharesMember" xlink:to="hypr_ServiceAndPerformanceSharesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_HyperfineMember" xlink:to="hypr_HyperfineMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PaymentOfPaycheckProtectionProgramLoan" xlink:to="hypr_PaymentOfPaycheckProtectionProgramLoan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:to="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_FederalNetOperatingLossMember" xlink:to="hypr_FederalNetOperatingLossMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidSupplies" xlink:to="us-gaap_IncreaseDecreaseInPrepaidSupplies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_LeasedDevicesMember" xlink:to="hypr_LeasedDevicesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_DeferredGrantFundingCurrent" xlink:to="hypr_DeferredGrantFundingCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_FourBionicsMember" xlink:to="hypr_FourBionicsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards" xlink:to="hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_NumberOfSubsidiaries" xlink:to="hypr_NumberOfSubsidiaries_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ExchangeProgramRecognizedNetBenefits" xlink:to="hypr_ExchangeProgramRecognizedNetBenefits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="hypr_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember" xlink:to="us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ImmediatelyPriorToEffectiveTimeMember" xlink:to="hypr_ImmediatelyPriorToEffectiveTimeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_TechnologyAndServicesExchangeAgreementMember" xlink:to="hypr_TechnologyAndServicesExchangeAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_LiminalConvertiblePreferredStockMember" xlink:to="hypr_LiminalConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_NumberOfVotesPerShare" xlink:to="hypr_NumberOfVotesPerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_SeriesA1PreferredStockMember" xlink:to="hypr_SeriesA1PreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ExchangeRatio" xlink:to="hypr_ExchangeRatio_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CatalyzerCorporation4Member" xlink:to="hypr_CatalyzerCorporation4Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_DeferredTaxAssetsValuationAllowanceIncreased" xlink:to="hypr_DeferredTaxAssetsValuationAllowanceIncreased_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareNet" xlink:to="us-gaap_CapitalizedComputerSoftwareNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PIPEInvestorsMember" xlink:to="hypr_PIPEInvestorsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_DeferredRevenuePolicyPolicyTextBlock" xlink:to="hypr_DeferredRevenuePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_OwnershipChangeDescription" xlink:to="hypr_OwnershipChangeDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConversionBasis" xlink:to="us-gaap_PreferredStockConversionBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ResearchDevicesMember" xlink:to="hypr_ResearchDevicesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_HealthCorMember" xlink:to="hypr_HealthCorMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CustomerGMember" xlink:to="hypr_CustomerGMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201912Member" xlink:to="us-gaap_AccountingStandardsUpdate201912Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock" xlink:to="hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ConnecticutOthersMember" xlink:to="hypr_ConnecticutOthersMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_LegacyHyperfineMember" xlink:to="hypr_LegacyHyperfineMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_RelatedPartyTransactionPaymentsForRent" xlink:to="hypr_RelatedPartyTransactionPaymentsForRent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductLiabilityContingencyLineItems" xlink:to="us-gaap_ProductLiabilityContingencyLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CustomerHMember" xlink:to="hypr_CustomerHMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_AccruedBonusAndOtherCostsCurrent" xlink:to="hypr_AccruedBonusAndOtherCostsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ConversionOfLiminalCommonStock" xlink:to="hypr_ConversionOfLiminalCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ClassAOrdinarySharesMember" xlink:to="hypr_ClassAOrdinarySharesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:to="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromEmployeesNoncurrent" xlink:to="us-gaap_DueFromEmployeesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_TaxCreditCarryforwardBeginToExpirationYear" xlink:to="hypr_TaxCreditCarryforwardBeginToExpirationYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember" xlink:to="hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_WriteOffOfOtherAssetsRelatedParty" xlink:to="hypr_WriteOffOfOtherAssetsRelatedParty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_FederalOtherMember" xlink:to="hypr_FederalOtherMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_HyperfineConvertiblePreferredStockMember" xlink:to="hypr_HyperfineConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_GrantFundingPolicyTextBlock" xlink:to="hypr_GrantFundingPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CommonStockNumberOfVotesPerShare" xlink:to="hypr_CommonStockNumberOfVotesPerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_StockOptionsTwoMember" xlink:to="hypr_StockOptionsTwoMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_EarnOutSharesMember" xlink:to="hypr_EarnOutSharesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_GrantAwardedForProvisionAndEquipping" xlink:to="hypr_GrantAwardedForProvisionAndEquipping_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue" xlink:to="hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate202006Member" xlink:to="us-gaap_AccountingStandardsUpdate202006Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation" xlink:to="hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_SubscriptionAgreementsMember" xlink:to="hypr_SubscriptionAgreementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation" xlink:to="hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_OwnershipChangesDateTwo" xlink:to="hypr_OwnershipChangesDateTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="hypr_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_BusinessCombinationTransactionThresholdTradingDays" xlink:to="hypr_BusinessCombinationTransactionThresholdTradingDays_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSoldAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_SeriesBCAndDConvertiblePreferredStockMember" xlink:to="hypr_SeriesBCAndDConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation" xlink:to="hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CustomerFMember" xlink:to="hypr_CustomerFMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductLiabilityContingencyTable" xlink:to="us-gaap_ProductLiabilityContingencyTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock" xlink:to="hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_NumberOfSites" xlink:to="hypr_NumberOfSites_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_HealthCorCatalioAcquisitionCorpMember" xlink:to="hypr_HealthCorCatalioAcquisitionCorpMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostNet" xlink:to="us-gaap_CapitalizedContractCostNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember" xlink:to="hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock" xlink:to="hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PatentCostsPolicyTextBlock" xlink:to="hypr_PatentCostsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward" xlink:to="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="us-gaap_CapitalizedContractCostAmortizationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_InterestReceivableRelatedPartiesCurrent" xlink:to="hypr_InterestReceivableRelatedPartiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_BusinessCombinationExchangeRatio" xlink:to="hypr_BusinessCombinationExchangeRatio_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredAtPointInTimeMember" xlink:to="us-gaap_TransferredAtPointInTimeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock" xlink:to="hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ToolsDiesAndMoldsMember" xlink:to="us-gaap_ToolsDiesAndMoldsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_AllocationOfExpenseIncurredMember" xlink:to="hypr_AllocationOfExpenseIncurredMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember" xlink:to="hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_AccruedContractedServicesCurrent" xlink:to="hypr_AccruedContractedServicesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_HyperfinePayrollProtectionProgramLoanMember" xlink:to="hypr_HyperfinePayrollProtectionProgramLoanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrent" xlink:to="us-gaap_AccruedBonusesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="us-gaap_ShareBasedPaymentArrangementNonemployeeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetInvestmentInLeasePurchase" xlink:to="us-gaap_NetInvestmentInLeasePurchase_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_SalesAndMarketingDevicesMember" xlink:to="hypr_SalesAndMarketingDevicesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember" xlink:to="hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_LiminalPayrollProtectionProgramLoanMember" xlink:to="hypr_LiminalPayrollProtectionProgramLoanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PrepaidAdvancesUnrecoverable" xlink:to="hypr_PrepaidAdvancesUnrecoverable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="hypr_AccruedExpensesAndOtherCurrentLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OpenTaxYear" xlink:to="us-gaap_OpenTaxYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_OwnershipChangesDateOne" xlink:to="hypr_OwnershipChangesDateOne_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage" xlink:to="hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_RecapitalizationOfPermanentToTemporaryEquityValues" xlink:to="hypr_RecapitalizationOfPermanentToTemporaryEquityValues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServiceMember" xlink:to="us-gaap_ServiceMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CustomerDMember" xlink:to="hypr_CustomerDMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_HyperfineEquityIncentivePlanMember" xlink:to="hypr_HyperfineEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_UncertainTaxPositions" xlink:to="hypr_UncertainTaxPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_SeriesATwoConvertiblePreferredStockMember" xlink:to="hypr_SeriesATwoConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_BusinessCombinationPaymentOfTransactionCosts" xlink:to="hypr_BusinessCombinationPaymentOfTransactionCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_NumberOfConsecutiveOwnershipChanges" xlink:to="hypr_NumberOfConsecutiveOwnershipChanges_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CustomerEMember" xlink:to="hypr_CustomerEMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_DueFromEmployeesForgiveness" xlink:to="hypr_DueFromEmployeesForgiveness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_LaboratoryEquipmentMember" xlink:to="hypr_LaboratoryEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredOverTimeMember" xlink:to="us-gaap_TransferredOverTimeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_TemporaryEquityYearOfClassIssuance" xlink:to="hypr_TemporaryEquityYearOfClassIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward" xlink:to="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_OperatingLossCarryforwardsBeginToExpireYear" xlink:to="hypr_OperatingLossCarryforwardsBeginToExpireYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:to="hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendDeclaredMember" xlink:to="us-gaap_DividendDeclaredMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_RecapitalizationOfPermanentToTemporaryEquityShares" xlink:to="hypr_RecapitalizationOfPermanentToTemporaryEquityShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_AmendedAndRestatedTechnologyServicesAgreementMember" xlink:to="hypr_AmendedAndRestatedTechnologyServicesAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CommonStockSubjectToRedemption" xlink:to="hypr_CommonStockSubjectToRedemption_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_LiminalMember" xlink:to="hypr_LiminalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ConnecticutResearchAndDevelopmentMember" xlink:to="hypr_ConnecticutResearchAndDevelopmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock" xlink:to="hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_InterestAndPaymentsToRedeemingCompanyShareholders" xlink:to="hypr_InterestAndPaymentsToRedeemingCompanyShareholders_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned" xlink:to="hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_FederalAndStateNetOperatingLossesMember" xlink:to="hypr_FederalAndStateNetOperatingLossesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_GrantAwarded" xlink:to="hypr_GrantAwarded_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnbilledReceivablesCurrent" xlink:to="us-gaap_UnbilledReceivablesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_IncentiveUnitActivityMember" xlink:to="hypr_IncentiveUnitActivityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_StockOptionsOneMember" xlink:to="hypr_StockOptionsOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CustomerCMember" xlink:to="hypr_CustomerCMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_EarnOutSharesPolicyTextBlock" xlink:to="hypr_EarnOutSharesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="us-gaap_ProceedsFromContributionsFromAffiliates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalents" xlink:to="us-gaap_RestrictedCashAndCashEquivalents_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation" xlink:to="hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PostTwoThaousandSeventeenMember" xlink:to="hypr_PostTwoThaousandSeventeenMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ProceedsFromBusinessCombination" xlink:to="hypr_ProceedsFromBusinessCombination_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostAmortizationMethod" xlink:to="us-gaap_CapitalizedContractCostAmortizationMethod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_Covid19OutbreakPolicyTextBlock" xlink:to="hypr_Covid19OutbreakPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_GranteeStatusDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember" xlink:to="hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination" xlink:to="hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionRate" xlink:to="us-gaap_RelatedPartyTransactionRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear" xlink:to="hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_NumberOfSeparateOptionAwards" xlink:to="hypr_NumberOfSeparateOptionAwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum" xlink:to="hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_IncomeTaxEffectsRecognized" xlink:to="hypr_IncomeTaxEffectsRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_GrantFundRequiredToReturnUnderProvisions" xlink:to="hypr_GrantFundRequiredToReturnUnderProvisions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStock" xlink:to="us-gaap_DividendsCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:to="us-gaap_TemporaryEquityLiquidationPreferencePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount" xlink:to="us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_GrantAwardedForOtherRelatedDeliverables" xlink:to="hypr_GrantAwardedForOtherRelatedDeliverables_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesDPreferredStockMember" xlink:to="us-gaap_SeriesDPreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PayrollProtectionProgramLoanMember" xlink:to="hypr_PayrollProtectionProgramLoanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments" xlink:to="hypr_AdjustmentsToAdditionalPaidInCapitalInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_PercentageOfCommonStockVotingPower" xlink:to="hypr_PercentageOfCommonStockVotingPower_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDeferredLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201815Member" xlink:to="us-gaap_AccountingStandardsUpdate201815Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CustomerBMember" xlink:to="hypr_CustomerBMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ClassBOrdinarySharesMember" xlink:to="hypr_ClassBOrdinarySharesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AU" xlink:to="country_AU_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CommonStockRemainsAvailableForIssuance" xlink:to="hypr_CommonStockRemainsAvailableForIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesTypeLeaseSellingProfitLoss" xlink:to="us-gaap_SalesTypeLeaseSellingProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_UnbilledReceivables" xlink:to="hypr_UnbilledReceivables_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService" xlink:to="hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeRelatedParty" xlink:to="us-gaap_InterestIncomeRelatedParty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays" xlink:to="hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_TradeShowAssetsMember" xlink:to="hypr_TradeShowAssetsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_OtherAssetsRelatedPartyNoncurrent" xlink:to="hypr_OtherAssetsRelatedPartyNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_SponsorMember" xlink:to="hypr_SponsorMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_CustomerAMember" xlink:to="hypr_CustomerAMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:to="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hypr_WarrantiesPolicyTextBlock" xlink:to="hypr_WarrantiesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_TaxPeriodDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsDomain" xlink:to="us-gaap_DividendsDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029733100104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 01, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HYPR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Hyperfine, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001833769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 203.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1569027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">351 New Whitfield Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Guilford<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">458-7100 <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,277,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,055,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029732779192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMBINED AND CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 188,498<span></span>
</td>
<td class="nump">$ 62,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">2,662<span></span>
</td>
<td class="nump">1,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowance of $32 and $0 in 2021 and 2020, respectively</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled receivables</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">4,310<span></span>
</td>
<td class="nump">1,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,357<span></span>
</td>
<td class="nump">691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from related parties</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">1,465<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">197,485<span></span>
</td>
<td class="nump">68,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,753<span></span>
</td>
<td class="nump">1,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OtherAssetsRelatedPartyNoncurrent', window );">Other assets - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long term assets</a></td>
<td class="nump">1,235<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">202,473<span></span>
</td>
<td class="nump">71,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,248<span></span>
</td>
<td class="nump">948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_DeferredGrantFundingCurrent', window );">Deferred grant funding</a></td>
<td class="nump">2,662<span></span>
</td>
<td class="nump">1,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">730<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="nump">1,981<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">8,115<span></span>
</td>
<td class="nump">1,264<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">15,736<span></span>
</td>
<td class="nump">4,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Long term notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long term deferred revenue</a></td>
<td class="nump">510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">16,246<span></span>
</td>
<td class="nump">4,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES (NOTE 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Hyperfine convertible preferred stock (Series A, B, C and D): $.0001 par value, aggregate liquidation preference of $0 and $147,651; 0 and 129,788,828 shares authorized; 0 and 95,010,858 shares issued and outstanding at December 31, 2021 and 2020, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY (DEFICIT):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">322,540<span></span>
</td>
<td class="nump">10,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(136,320)<span></span>
</td>
<td class="num">(71,469)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">186,227<span></span>
</td>
<td class="num">(61,054)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</a></td>
<td class="nump">202,473<span></span>
</td>
<td class="nump">71,526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hypr_HyperfineConvertiblePreferredStockMember', window );">Hyperfine Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Hyperfine convertible preferred stock (Series A, B, C and D): $.0001 par value, aggregate liquidation preference of $0 and $147,651; 0 and 129,788,828 shares authorized; 0 and 95,010,858 shares issued and outstanding at December 31, 2021 and 2020, respectively</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">128,286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY (DEFICIT):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">5<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY (DEFICIT):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_DeferredGrantFundingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the carrying amount of deferred grant funding as of balance sheet date, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_DeferredGrantFundingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_OtherAssetsRelatedPartyNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other assets related party noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_OtherAssetsRelatedPartyNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hypr_HyperfineConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hypr_HyperfineConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029820595832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMBINED AND CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts receivable</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,788,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,010,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,010,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hypr_HyperfineConvertiblePreferredStockMember', window );">Hyperfine Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Convertible preferred stock, aggregate liquidation preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 147,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">129,788,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">95,010,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">95,010,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value, (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized</a></td>
<td class="nump">600,000,000<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="nump">55,277,061<span></span>
</td>
<td class="nump">1,576,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">55,277,061<span></span>
</td>
<td class="nump">1,576,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value, (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized</a></td>
<td class="nump">27,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="nump">15,055,288<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">15,055,288<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hypr_HyperfineConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hypr_HyperfineConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736275080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMBINED AND CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sales</a></td>
<td class="nump">$ 1,496<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Cost of sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of sales</a></td>
<td class="nump">2,663<span></span>
</td>
<td class="nump">771<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="num">(1,167)<span></span>
</td>
<td class="num">(477)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">25,842<span></span>
</td>
<td class="nump">14,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">27,497<span></span>
</td>
<td class="nump">5,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">10,362<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">63,701<span></span>
</td>
<td class="nump">23,014<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(64,868)<span></span>
</td>
<td class="num">(23,491)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before provision for income taxes</a></td>
<td class="num">(64,851)<span></span>
</td>
<td class="num">(23,427)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">$ (64,851)<span></span>
</td>
<td class="num">$ (23,427)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per common share attributable to common stockholders, basic and diluted</a></td>
<td class="num">$ (17.57)<span></span>
</td>
<td class="num">$ (15.38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted</a></td>
<td class="nump">3,690,523<span></span>
</td>
<td class="nump">1,523,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Device</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sales</a></td>
<td class="nump">$ 715<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Cost of sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of sales</a></td>
<td class="nump">2,058<span></span>
</td>
<td class="nump">763<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sales</a></td>
<td class="nump">781<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Cost of sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of sales</a></td>
<td class="nump">$ 605<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029730012920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMBINED AND CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Hyperfine Convertible Preferred Stock</div></th>
<th class="th"><div>Liminal Convertible Preferred Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Common Stock </div>
<div>Class A Common Stock</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Class B Common Stock</div>
</th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="num">$ (39,864)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,178<span></span>
</td>
<td class="num">$ (48,042)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,211,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,508,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(23,427)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,427)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series D convertible preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series D convertible preferred stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,799,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_AdjustmentsToAdditionalPaidInCapitalInvestments', window );">Investment from 4Bionics, LLC</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="num">$ (61,054)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,415<span></span>
</td>
<td class="num">(71,469)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">95,010,858<span></span>
</td>
<td class="nump">95,010,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 128,286<span></span>
</td>
<td class="nump">$ 128,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,576,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(64,851)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,851)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series D convertible preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series D convertible preferred stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,171,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_AdjustmentsToAdditionalPaidInCapitalInvestments', window );">Investment from 4Bionics, LLC</a></td>
<td class="nump">3,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ConversionOfLiminalCommonStock', window );">Conversion of Liminal Common stock</a></td>
<td class="num">(9,350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_RecapitalizationOfPermanentToTemporaryEquityShares', window );">Conversion of Liminal Common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_RecapitalizationOfPermanentToTemporaryEquityValues', window );">Conversion of Liminal Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Liminal Common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of the convertible preferred stock into Class A and Class B common stock at the Business Combination</a></td>
<td class="nump">168,097<span></span>
</td>
<td class="num">$ (158,747)<span></span>
</td>
<td class="num">$ (9,350)<span></span>
</td>
<td class="nump">168,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of the convertible preferred stock into Class A and Class B common stock at the Business Combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(109,182,191)<span></span>
</td>
<td class="num">(57,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,028,815<span></span>
</td>
<td class="nump">15,055,288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Net equity infusion from the Business Combination</a></td>
<td class="nump">141,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Net equity infusion from the Business Combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,806,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Class A common stock to a service provider (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">6,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 186,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 322,540<span></span>
</td>
<td class="num">$ (136,320)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,277,061<span></span>
</td>
<td class="nump">15,055,288<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_AdjustmentsToAdditionalPaidInCapitalInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_AdjustmentsToAdditionalPaidInCapitalInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ConversionOfLiminalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion of Liminal Common stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ConversionOfLiminalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_RecapitalizationOfPermanentToTemporaryEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization of permanent to temporary equity shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_RecapitalizationOfPermanentToTemporaryEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_RecapitalizationOfPermanentToTemporaryEquityValues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization of permanent to temporary equity values.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_RecapitalizationOfPermanentToTemporaryEquityValues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period shares new issues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029734707688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMBINED AND CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (64,851)<span></span>
</td>
<td class="num">$ (23,427)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">726<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">6,901<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Write-down of inventory</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_WriteOffOfOtherAssetsRelatedParty', window );">Write-off of other assets - related party</a></td>
<td class="nump">984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseSellingProfitLoss', window );">Sales under sales type leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentInLeasePurchase', window );">Payments received on net investment in lease</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(379)<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_UnbilledReceivables', window );">Unbilled receivables</a></td>
<td class="num">(91)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(2,667)<span></span>
</td>
<td class="num">(1,931)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(666)<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties', window );">Due from related parties</a></td>
<td class="nump">1,451<span></span>
</td>
<td class="num">(782)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseDueFromOtherRelatedParties', window );">Other assets - related party</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidSupplies', window );">Prepaid inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long term assets</a></td>
<td class="num">(1,201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,436<span></span>
</td>
<td class="num">(377)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredLiabilities', window );">Deferred grant funding</a></td>
<td class="nump">1,052<span></span>
</td>
<td class="nump">1,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">1,082<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedParties', window );">Due to related parties</a></td>
<td class="nump">1,845<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">6,851<span></span>
</td>
<td class="nump">773<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(47,182)<span></span>
</td>
<td class="num">(21,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of fixed assets</a></td>
<td class="num">(2,711)<span></span>
</td>
<td class="num">(1,568)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(2,711)<span></span>
</td>
<td class="num">(1,568)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,497<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock', window );">Proceeds from issuance of Series D convertible preferred stock</a></td>
<td class="nump">30,468<span></span>
</td>
<td class="nump">59,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance costs related to Series D convertible preferred stock</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of notes payable</a></td>
<td class="num">(178)<span></span>
</td>
<td class="num">(889)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Investment from 4Bionics, LLC</a></td>
<td class="nump">3,516<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ProceedsFromBusinessCombination', window );">Net proceeds from equity infusion from the Business Combination</a></td>
<td class="nump">141,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">176,767<span></span>
</td>
<td class="nump">60,938<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase in cash and cash equivalents and restricted cash</a></td>
<td class="nump">126,874<span></span>
</td>
<td class="nump">37,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of year</a></td>
<td class="nump">64,286<span></span>
</td>
<td class="nump">26,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of year</a></td>
<td class="nump">191,160<span></span>
</td>
<td class="nump">64,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents, and restricted cash reported in the statement of financial position</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">188,498<span></span>
</td>
<td class="nump">62,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">2,662<span></span>
</td>
<td class="nump">1,610<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">191,160<span></span>
</td>
<td class="nump">64,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits', window );">Cash received from exchange of research and development tax credits</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of noncash information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Noncash acquisition of fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of Class A Common Stock to a service provider in exchange for the service provided in connection with the Business Combination</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from exchange of research and development tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ProceedsFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ProceedsFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_UnbilledReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_UnbilledReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_WriteOffOfOtherAssetsRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of other assets - related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_WriteOffOfOtherAssetsRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseDueFromOtherRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables due from related parties classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseDueFromOtherRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for supplies that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentInLeasePurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase from purchase of net investment in sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentInLeasePurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stock that is classified as callable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseSellingProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of profit (loss) recognized at commencement from sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseSellingProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736966936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND DESCRIPTION OF BUSINESS</a></td>
<td class="text"><p id="notes_organization_and_description" style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1. ORGANIZ</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ATION AND DESCRIPTION OF BUSINESS</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Hyperfine, Inc. (together with its subsidiaries, as applicable, &#8220;Hyperfine&#8221;, the &#8220;Company&#8221;), formerly known as HealthCor Catalio Acquisition Corp. (&#8220;HealthCor&#8221;), was incorporated as a Cayman Islands exempted company on November 18, 2020. The Company&#8217;s legal name became Hyperfine, Inc. in connection with the closing of the Business Combination (the &#8220;Closing&#8221;) on December 22, 2021 (the &#8220;Closing Date&#8221;), as defined and described in Note 3. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In connection with the Closing, Hyperfine, Inc., a Delaware corporation (&#8220;Legacy Hyperfine&#8221;), and Liminal Sciences, Inc., a Delaware corporation (&#8220;Liminal&#8221;), merged with and into separate wholly owned subsidiaries of HealthCor and became wholly-owned subsidiaries of the Company, and changed their names to Hyperfine Operations, Inc. and Liminal Operations, Inc., respectively. Liminal subsequently changed its name to Liminal Sciences, Inc. The prior period financial information represents the combined financial results of Legacy Hyperfine and Liminal.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is an innovative digital health business with a mission to provide affordable and accessible imaging and monitoring through magnetic resonance imaging ("MRI") to revolutionize healthcare for people around the world. Hyperfine's Swoop&#174; Portable Magnetic Resonance (&#8220;MR&#8221;) </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Imaging System</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">TM </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">produces high-quality images at a lower magnetic field strength than conventional MRI systems, and can be used by healthcare professionals to make effective clinical diagnoses on a patient in a variety of settings where MRI devices have previously been inaccessible. Hyperfine received 510(k) clearance from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) in 2020 for its Swoop Portable MR Imaging System, which is commercially available in the United States. In 2021, Hyperfine also obtained a Medical Device License issued by Health Canada and expanded into the Canadian market, and also obtained regulatory authorization in New Zealand and Pakistan. All of the Company&#8217;s revenue to date has been generated from sales of this machine and related services. Additionally, the Company is in the process of developing a device to non-invasively measure key vital signs in the brain to enable unprecedented access to dramatically improve patient outcomes. The Company is in the early research and development stage of such device and has not generated any revenue to date for it. In addition to Legacy Hyperfine and Liminal, the Company has an indirect wholly-owned subsidiary in the United Kingdom that did not have any significant operations during 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736963640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying combined and consolidated financial statements include the accounts of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and pursuant to the accounting disclosure rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). All intercompany transactions and balances have been eliminated.</span></p></div><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">COVID-19 Outbreak</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The recent outbreak of the novel coronavirus (&#8220;COVID-19&#8221;), which was declared a pandemic by the World Health Organization on March 11, 2020 and declared a National Emergency by the President of the United States on March 13, 2020, has led to adverse impacts on the U.S. and global economies and created uncertainty regarding potential impacts on the Company&#8217;s operating results, financial condition and cash flows. The COVID-19 pandemic has had, and is expected to continue to have, an adverse impact on the Company&#8217;s operations, particularly as a result of preventive and precautionary measures that the Company, other businesses, and governments are taking. Governmental mandates related to COVID-19 or other infectious diseases, or public health crises, have impacted, and the Company expects them to continue to impact, its personnel and personnel at third-party manufacturing facilities in the United States and other countries, and the availability or cost of materials, which could disrupt or delay the Company&#8217;s receipt of instruments, components and supplies from the third parties the Company relies on to, among other things, produce its products. The COVID-19 pandemic has also had an adverse effect on the Company&#8217;s ability to attract, recruit, interview and hire at the pace the Company would typically expect to support its rapidly expanding operations. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company&#8217;s business, results of operations and financial condition, including expenses and research and development costs, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or address the COVID-19 pandemic, as well as its economic impacts.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In adjusting to the COVID-19 market and manufacturing conditions, the Company did not have to materially adjust its existing resource allocation or its factors of production. The Company has not incurred any significant impairment losses in the carrying values of its assets as a result of the COVID-19 pandemic and is not aware of any specific related event or circumstance that would require the Company to revise its estimates reflected in its combined and consolidated financial statements.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The estimates of the impact on the Company&#8217;s business may change based on new information that may emerge concerning COVID-19 and the actions to contain it or address its impact and the economic impact on local, regional, national and international markets. While the Company is unable to predict the full impact that the COVID-19 pandemic will have on its future results of operations, liquidity and financial condition due to numerous uncertainties, including the duration of the pandemic, and the actions that may be taken by government authorities across the United States and elsewhere, it is not expected to result in any significant changes in costs going forward.</span></p></div><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of Credit Risk</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents. At December 31, 2021 and 2020, substantially all the Company&#8217;s cash and cash equivalents were invested at two financial institutions. The Company also maintains balances in various operating accounts above federally insured limits. The Company has not experienced any losses on such accounts and does not believe it is exposed to any significant credit risk on cash and cash equivalents.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant customers are those that represent more than 10% of the Company&#8217;s total revenues or gross accounts receivable balances for the periods and as of each balance sheet date presented. For each significant customer, revenue as a percentage of total revenues and gross accounts receivable as a percentage of total gross accounts receivable were as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:17.622%;"/>
          <td style="width:1.915%;"/>
          <td style="width:21.98%;"/>
          <td style="width:1.735%;"/>
          <td style="width:18.5%;"/>
          <td style="width:1.735%;"/>
          <td style="width:17.389%;"/>
          <td style="width:1.735%;"/>
          <td style="width:17.389%;"/>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;">&#160;</span></p></td>
          <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Revenue</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the year ended December 31, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the year ended December 31, 2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer A</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer B</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">24</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer C</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer D</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer E</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">53</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer F</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">41</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer G</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">32</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer H</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">26</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
        </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilizes a single exclusive manufacturer for its Swoop MRI scanner. Additionally, the Company purchases raw materials from this manufacturer.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segment Information</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s Chief Operating Decision Maker (&#8220;CODM&#8221;) is its Chief Executive Officer (&#8220;CEO&#8221;). Legacy Hyperfine and Liminal represent two operating segments. Given the similar qualitative and economic characteristics of the </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> operating segments, such that both are focused upon the development and commercialization of existing and new products and services, Legacy Hyperfine and Liminal are aggregated into </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> reporting segment. All of the Company&#8217;s long-lived assets are located in the United States. Other than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of revenue recognized in Australia, all of the revenues were earned in the United States. Since the Company is aggregated into a single operating segment, all required financial segment information is provided in the combined and consolidated financial statements.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the combined and consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions about future events that affect the amounts reported in its combined and consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates and assumptions. Significant estimates and assumptions included:</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="margin-left:6.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue recognition, including determination of the timing and pattern of satisfaction of performance obligations, determination of the standalone selling price (&#8220;SSP&#8221;) of performance obligations and estimation of variable consideration;</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Allowance for doubtful accounts;</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net realizable value (the selling price as well as estimated costs of disposal and transportation) of inventory, and demand and future use of inventory;</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowances with respect to deferred tax assets; and</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assumptions underlying the fair value used in calculation of the stock-based compensation expense.</span></div></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company bases these estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company&#8217;s combined and consolidated financial statements.	</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and Cash Equivalents</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All highly liquid investments purchased with a maturity of three months or less are cash equivalents. As of December 31, 2021 and 2020, cash and cash equivalents consist principally of cash and money market accounts.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Cash</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted cash balance represents funds received as part of grant funding and restricted in use to the purpose of the funding. For details, see the Note 2. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies - Grant Funding</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and Note 16. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Commitments and Contingencies</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounts Receivable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts receivable are stated as the amount the Company expects to collect. The Company maintains allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. As of December 31, 2021 and 2020, the allowance for doubtful accounts was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Inventories</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inventories primarily consist of finished goods which are produced by the Company&#8217;s third-party contract manufacturers as well as raw materials ordered in advance by the third-party contract manufacturer due to long delivery-lead time and which were billed to the Company. Inventories are stated at the lower of actual cost, determined using the average cost method, or net realizable value. Cost includes an allocation of wages, taxes and benefits for employees involved in warehousing, logistics coordination, material sourcing, and production planning activities. Net realizable value is based upon an estimated average selling price reduced by the estimated costs of disposal and transportation.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">valuation of inventory also requires the Company to estimate excess and obsolete inventory. The Company considers sales forecasts and historical experience to identify excess, close out, or slow-moving items as well as new</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">development schedules, product obsolescence and product merchantability, including whether older products can be remanufactured into new products, among other factors. The Company reduces the value of inventory for estimated obsolescence or lack of marketability by the difference between the cost of the affected inventory and the net realizable value.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Prepaid Expenses and Other Current Assets</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets include amounts paid in advance for operating expenses as well as monies to be received from the State of Connecticut for research and development tax credits. These research and development tax credits are exchanged for a cash refund and are typically collected within one year from the date the tax return is filed with the state. The credits are recognized as an offset to research and development expenses in the combined and consolidated statements of operations and comprehensive loss in the annual period in which the corresponding expenses were incurred.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Property and Equipment, Net</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation expense is computed using the straight-line method over the estimated useful lives of the related assets.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Useful lives of property and equipment are as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:79.609%;"/>
          <td style="width:1.925%;"/>
          <td style="width:0.624%;"/>
          <td style="width:17.229%;"/>
          <td style="width:0.613%;"/>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Property and equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Estimated useful life</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research devices</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing devices</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tooling</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Trade show assets</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Leased devices</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">-</span><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other property and equipment include furniture and fixtures, software, vehicles, and machinery and equipment.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expenditures for major renewals and improvements are capitalized. Expenditures for repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation is eliminated from the balance sheet, and any resulting gains or losses are included in the combined and consolidated statements of operations and comprehensive loss in the period of disposal.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Impairment of Long-Lived Assets</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company reviews its long-lived assets for impairment at least annually or when the Company determines a triggering event has occurred. When a triggering event has occurred, each impairment test is based on a comparison of the future expected undiscounted cash flow to the recorded value of the asset. If the recorded value of the asset is less than the undiscounted cash flow, the asset is written down to its estimated fair value. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> impairments were recorded for the years ended December 31, 2021 and 2020.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Capitalized Software Development Costs</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the costs incurred in developing the firmware embedded in the hardware devices that the Company sells and leases to its customers, the Company applies the principles of Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 985-20, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting for the Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 985-20&#8221;). ASC 985-20 requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established. Thereafter, until the product is released for sale, software development costs must be capitalized and reported at the lower of unamortized cost or net realizable value of the related product. The Company has adopted the &#8220;tested working model&#8221; approach to establishing technological feasibility for its software products. Under this</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">approach, the Company does not consider a product in development to have passed the technological feasibility milestone until the Company has completed a model of the product that contains essentially all the functionality and features of the final product and has tested the model to ensure that it works as expected. The Company&#8217;s hardware device, with the embedded firmware, was released for sale during the fourth quarter of the year ended December 31, 2020, when the Company had completed all of the research and development activity to establish the technological feasibility of the product. As of December 31, 2021 and 2020, the Company had not incurred significant costs between the establishment of technological feasibility and the release of a product for sale; thus, the Company had expensed all software development costs as incurred.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For software developed or acquired for internal use, including software used in the provision of subscription services to the Company&#8217;s customers, the Company applies the principles of ASC 350-40, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting for the Cost of Computer Software Developed or Obtained for Internal Use</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 350-40&#8221;). ASC 350-40 requires that software development costs incurred before the preliminary project stage be expensed as incurred. The Company capitalizes development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed, and the software will be used to perform the function intended. Costs incurred during the preliminary project and post-implementation stages, including training and maintenance, are expensed as incurred. Capitalized costs are amortized on a project-by-project basis using the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">straight-line method</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> over the estimated economic life of the application, which is</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> three years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, beginning when the asset is substantially ready for use. As of December 31, 2021 and 2020, the Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have any amount of capitalized internal-use software development costs.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue Recognition</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes revenue in accordance with ASC Topic 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#8220;Revenue from Contracts with Customers.&#8221;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue is recognized when or as a customer obtains control of the promised goods and services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for these goods and services. To achieve this core principle, the Company applies the following 5 steps:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 1: Identify Contracts with Customers:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company executes signed contracts with its customers for the sale of hardware devices and subscription services.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 2: Identify Performance Obligations:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company&#8217;s contracts with customers primarily include two performance obligations, namely the hardware device and subscription services, which include access to the Company&#8217;s hosted cloud-based software applications and hardware maintenance and support on an ongoing basis throughout the subscription period.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 3: Determine Transaction Price:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company&#8217;s contracts with customers include variable consideration in the form of discounts and price concessions. The Company estimates variable consideration using the expected value method based on the data available as of the end of each reporting period.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 4: Allocate Transaction Price to Performance Obligations:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company allocates transaction price to the performance obligations in a contract with a customer, based on the relative standalone selling prices of the goods and services. The standalone selling prices of the hardware devices and subscription services are determined based on the observable standalone selling prices for which the Company sells the respective goods and services on a standalone basis, including renewals of subscription services.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 5: Recognize Revenue as Performance Obligations are Satisfied:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Each unit of hardware devices is a performance obligation satisfied at a point in time, when control of the good transfers from the Company to the customer, which is usually upon delivery of the good to the customer. For sales of hardware where control of the product transfers to the customer upon shipment, the Company has made an accounting policy election to account for shipping and handling as fulfillment activities rather than a performance obligation. The subscription services are stand-ready obligations that are satisfied over time by providing the customer with ongoing access to the Company&#8217;s resources throughout the subscription period. The Company uses the time elapsed (straight line) measure of progress to recognize revenue as these performance obligations are satisfied evenly over the respective service period.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company offers alternative payment structures and &#8220;as-a-service&#8221; offerings that are assessed to determine whether an embedded lease arrangement exists. The Company accounts for those contracts as a lease arrangement under the current lease standard if it is determined that the contract contains an identified asset and that the right to direct the use of that asset has transferred to the customer. When a contract includes lease and non-lease components, the Company allocates consideration under the contract to each component based on the relative standalone selling price and subsequently assesses lease classification for each lease component within a contract as a sales-type lease or an operating lease. On commencement of sales-type leases, the Company recognizes revenue up-front, and amounts due from the customer under the lease contract are recognized as financing receivables on the combined and consolidated balance sheets. Interest income is recognized as revenue over the term of the lease based on the effective interest method. The Company has elected not to include sales and other taxes collected from the lessee as part of lease revenue.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All other leases that do not meet the definition of a sales-type lease are classified as operating leases. The underlying asset in an operating lease arrangement is carried at depreciated cost within Property and equipment, net on the combined and consolidated balance sheets. Depreciation is calculated using the straight-line method over the term of the underlying lease contract and is recognized as cost of revenue. The depreciable basis is the original cost of the equipment less the estimated residual value of the equipment at the end of the lease term. The Company recognizes operating lease income to product revenue on a straight-line basis over the lease term. Impairment of equipment under operating leases is assessed on the same basis as other long-lived assets.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Deferred Revenue</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from subscription services described above and is reduced as the revenue recognition criteria are met. Deferred revenue is classified as current based on expected revenue recognition timing. Specifically, deferred revenue that will be recognized as revenue within the succeeding twelve-month period is recorded as current in the Company&#8217;s combined and consolidated balance sheets.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Warranties</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company offers a device warranty to customers for the longer of (a) twelve (12) months from delivery of the device for devices obtained through a capital purchase, or (b) the term of the subscription agreement for devices obtained on a subscription basis (subject to continued payment of fees for the subscription service). The Company&#8217;s subscription services include hardware maintenance and support. As noted in the accounting policy for revenue recognition, the Company recognizes revenue for subscription service over time using the time elapsed measure of progress. The costs of hardware maintenance are recognized in costs of revenue as they are incurred.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development costs consists of production costs for prototype, test and pre-production units, lab supplies, consulting and personnel costs, including salaries, stock-based compensation, bonuses, benefit costs and depreciation. Certain research and development grant funding is recognized as a reduction to research and development costs (see Note 2. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies - Grant Funding</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">). The Company recognizes these costs as they are incurred.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Grant Funding</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company received certain research and development funding through a grant issued by the Bill &amp; Melinda Gates Foundation (&#8220;BMGF&#8221;). Funding is recorded on the combined and consolidated balance sheet as restricted cash upon receipt. The funding is recognized in the combined and consolidated statements of operations and comprehensive loss as a reduction to research and development expense as the related costs are incurred to meet those obligations over the grant period. Grant funding payments received in advance of research and development expenses incurred are recorded as deferred grant funding as a current liability in the Company&#8217;s combined and consolidated balance sheets.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cost of Sales</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cost of sales consists of product and service costs including personnel cost and benefits including stock-based compensation, product costs, production setup expenses, depreciation and amortization expenses, inventory excess and obsolescence expenses.</span></p></div><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:2.603%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent Costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patent costs have been charged to operations as incurred, as their realization is uncertain. These costs are included in general and administrative expenses in the combined and consolidated statements of operations and comprehensive loss.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and Administrative</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses primarily consist of personnel costs and benefits including stock-based compensation, patent and filing fees, office expenses and outside services. Outside services consist of professional services, legal and other professional fees.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sales and Marketing</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sales and marketing costs primarily consist of personnel costs and benefits including stock-based compensation, advertising, promotional, as well as conferences, meetings, and other events. Advertising costs are expensed as incurred. For the years ended December 31, 2021 and 2020, advertising expenses were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,459</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">437</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net Loss per Common Share</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per common share is calculated by dividing the net loss attributed to common stockholders by the weighted average number of common shares outstanding during the period, without consideration of potentially dilutive securities.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares plus the common equivalent shares of the period, including any dilutive effect from such shares. The Company&#8217;s diluted net loss per common share is the same as basic net loss per common share for all periods presented since the effect of potentially dilutive securities is anti-dilutive. Refer to Note 13. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net Loss Per Share</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for further discussion.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Convertible Preferred Stock</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has applied the guidance in ASC Topic 480-10-S99-3A, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">SEC Staff Announcement: Classification and Measurement of Redeemable Securities,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and has therefore classified the Series A, Series B, Series C and Series D Convertible Preferred Stock (&#8220;Convertible Preferred Stock&#8221;) (see Note 10. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Convertible Preferred Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) as mezzanine equity. The Convertible Preferred Stock was recorded outside of stockholders&#8217; equity (deficit) because the Convertible Preferred Stock included a redemption provision upon a change of control, which is deemed a liquidation event that is considered outside the Company&#8217;s control. The Convertible Preferred Stock has been recorded at its original issue price, net of issuance costs. The Company did not adjust the carrying value of the Convertible Preferred Stock to the liquidation price associated with a change of control at December 31, 2020 because a change of control of the Company was not considered probable at the reporting date (see Note 10. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Convertible Preferred Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">). Subsequent adjustments to increase or decrease the carrying values to their respective liquidation prices were made only when it became probable that such a change of control would occur.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The measurement of stock-based compensation expense for all stock-based payment awards, including stock options granted to employees, directors, and consultants, is based on the estimated fair value of the awards on the date of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes stock-based compensation expense for stock option grants and incentive unit grants with only service conditions on a straight-line basis over the requisite service period of the individual grants, which is generally the vesting period, based on the estimated grant date fair values. Generally, stock option grants and incentive unit grants fully vest </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">four years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> after the grant date, and stock option grants generally have a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes the effect of forfeiture in compensation costs based on actual forfeitures when they occur.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company's stock-based compensation program includes stock option grants to its employees, directors, and consultants. Stock options are granted at exercise prices not less than the estimated fair market value of the Company&#8217;s common stock at the date of grant.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair values of stock option grants are estimated using a Black-Scholes option-pricing model. Key inputs and assumptions include the expected term of the option, stock price volatility, risk free interest rate, dividend yield, stock price and exercise price. Many of the assumptions require significant judgment and any changes could have a material impact in the determination of stock-based compensation expense.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the year ended December 31, 2020, Liminal was a wholly owned subsidiary of 4Bionics, and as such, 4Bionics granted equity awards in the form of incentive units to Liminal employees and nonemployees under 4Bionics&#8217; stock-based compensation program.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On April 2, 2021, 4Bionics executed a plan of liquidation and dissolution and its ownership in Liminal was distributed to its members and to the holders of incentive units. Immediately subsequent to the dissolution, all outstanding unvested incentive unit awards under 4Bionic&#8217;s 2019 Equity Incentive Plan were replaced with preferred stock awards indexed to and settled in the preferred stock of the former 4Bionics subsidiaries Liminal, Detect, Inc. (f/k/a Homodeus Inc.), Tesseract Health, Inc. and Protein Evolution, Inc. The preferred stock awards are subject to service vesting conditions only. No incremental value was provided to participants as a result of the modification of the awards as the modification date fair value of the incentive unit awards was equal to the modification date fair value of the stock underlying the restricted stock awards. Moreover, the remaining vesting period before and after modification was unchanged.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Earn-Out Shares</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Earn-Out Shares, as defined in Note 3.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, to which the Companies&#8217; pre-closing equity holders are entitled, fall within the scope of ASC 815,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Derivatives and Hedging</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 815&#8221;) pursuant to which such Earn-Out Shares are equity classified and are to be recognized upon achievement of the market price milestone.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Earn-Out Shares to which certain employees are entitled to fall within the scope of ASC 718, pursuant to which such Earn-Out Shares are equity classified and their grant date fair value will be recognized as compensation expense over the vesting period.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development Tax Credits</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes research and development tax credits as a reduction of Research and Development expense as earned. For State of Connecticut research and development tax credits, which are exchanged for a cash refund from the State of Connecticut, such exchanged credits are recognized as earned as a reduction of Research and Development expense in the combined and consolidated statements of operations and comprehensive loss.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilizes the asset and liability method of accounting for income taxes, as set forth in ASC Topic 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Under this method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities using the enacted statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established against net deferred tax assets if, based on</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the weight of available evidence, it is more likely than not that some or all of the net deferred tax assets will not be realized. The Company has recorded a full valuation allowance as of December 31, 2021 and 2020. Based on the available evidence, the Company believes that it is more likely than not that it will be unable to utilize all of its deferred tax assets in the future.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In accordance with the provisions of ASC Topic 740, the Company accrues for the estimated amount of taxes for uncertain tax positions if it is more likely than not that the Company would be required to pay such additional taxes. An uncertain tax position will not be recognized if it has a less than 50% likelihood of being sustained. The Company&#8217;s policy is to recognize any interest and penalties related to income taxes in income tax expense in the combined and consolidated statements of operations and comprehensive loss. The Company&#8217;s open tax years subject to examination by the relevant taxing authorities are </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0d93ec06-e2be-489a-ac3b-531777fb08ff;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2017 through 2019</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As of December 31, 2021 and 2020, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> uncertain tax positions.</span></p></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent Accounting Pronouncements</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting pronouncements adopted</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Intangibles &#8212; Goodwill and Other &#8212; Internal-Use Software Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The guidance requires certain costs incurred during the application development stage to be capitalized and other costs incurred during the preliminary project and post-implementation stages to be expensed as they are incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. A customer&#8217;s accounting for the hosting component of the arrangement is not affected. This new guidance is effective for the Company for the annual reporting period beginning January 1, 2021 and interim periods beginning January 1, 2022. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopted this guidance</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and there was </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no material effect of adoption on the combined and consolidated financial statements</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2020, the FASB issued ASU 2020-06, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which simplifies the accounting for convertible instruments by removing the separation models for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. These changes will reduce reported interest expense and increase reported net income for entities that have issued a convertible instrument that was bifurcated according to previously existing rules. ASU 2020-06 also requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will be no longer available. For public entities, this guidance is effective for annual reporting periods beginning January 1, 2022, including interim periods within that annual reporting period. For the Company, this guidance is effective for annual reporting periods beginning January 1, 2024, and interim reporting periods within annual reporting periods beginning January 1, 2024, with early adoption permitted. The Company elected to early </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopt this accounting pronouncement</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and there was </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no material impact on the Company&#8217;s combined and consolidated financial statements and disclosures</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, the FASB issued ASU 2019-12, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and improves consistent application of and simplifies U.S. GAAP for other areas of Topic 740 by clarifying existing guidance. For the Company, this ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopted</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> this guidance on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and there was </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> material effect of adoption on the Company&#8217;s combined and consolidated financial statements.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting pronouncements issued but not yet adopted</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2016, the FASB issued ASU 2016-02, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases (Topic 842),</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which outlines a comprehensive lease accounting model and supersedes the current lease guidance. The new guidance requires lessees to recognize almost all of their leases on the balance sheet by recording a lease liability and corresponding right-of-use assets. It also</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes the definition of a lease and expands the disclosure requirements of lease arrangements. As per the latest ASU 2020-05 issued by FASB, entities that have not yet issued or made available for issuance the financial statements as of June 3, 2020 can defer the new guidance for one year. For public entities, this guidance is effective for annual reporting periods beginning January 1, 2020, including interim periods within that annual reporting period. For the Company, this guidance is effective for annual reporting periods beginning January 1, 2022, and interim reporting periods within annual reporting periods beginning January 1, 2023. The Company is in the process of evaluating the impact that the adoption of this pronouncement will have on the Company&#8217;s combined and consolidated financial statements and does not expect it to be material.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#8220;Financial Instruments &#8212; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#8221;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which was subsequently amended in November 2018 through ASU No. 2018-19, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#8220;Codification Improvements to Topic 326, Financial Instruments &#8212; Credit Losses.&#8221;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. ASU No. 2018-19 further clarifies that receivables arising from operating leases are not within the scope of Topic 326. Instead, impairment from receivables of operating leases should be accounted for in accordance with Topic 842, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As per the latest ASU 2020-02, the FASB deferred the timelines for certain small public and private entities, thus the new guidance will be adopted by the Company for the annual reporting period beginning January 1, 2023, including interim periods within that annual reporting period. The standard will apply as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company is in the process of evaluating the impact that the adoption of this pronouncement will have on the Company&#8217;s combined and consolidated financial statements and disclosures.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736890952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination And Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATION</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3. BUSINESS COMBINATION</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">At the Closing, Legacy Hyperfine and Liminal merged with and into separate wholly owned subsidiaries of HealthCor and each became a wholly-owned subsidiary of the Company. The Business Combination is accounted for as a reverse recapitalization in accordance with U.S. GAAP primarily due to the fact that Legacy Hyperfine and Liminal stockholders continued to control the Company following the closing of the Business Combination. Under this method of accounting, HealthCor is treated as the &#8220;acquired&#8221; company for accounting purposes and the Business Combination is treated as the equivalent of Legacy Hyperfine and Liminal issuing stock for the net assets of HealthCor, accompanied by a recapitalization. The net assets of HealthCor are stated at historical cost, with no goodwill or other intangible assets recorded. Reported shares and loss per share available to holders of the Company&#8217;s capital stock and equity awards prior to the Business Combination have been retroactively restated reflecting the exchange ratios established pursuant to the Business Combination Agreement dated as of July 7, 2021 (the &#8220;Business Combination Agreement&#8221;).</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the Business Combination Agreement, at the effective time of the Business Combination (the &#8220;Effective Time&#8221;):</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each share of Legacy Hyperfine capital stock (other than shares of Legacy Hyperfine Series A preferred stock) that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#8217;s Class A common stock equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3275</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (the &#8220;Hyperfine Exchange Ratio&#8221;), rounded down to the nearest whole number of shares;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each share of Legacy Hyperfine Series A preferred stock that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#8217;s Class B common stock equal to the Hyperfine Exchange Ratio, rounded down to the nearest whole number of shares;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each share of Liminal capital stock (other than shares of Liminal Series A-1 preferred stock) that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#8217;s Class A common stock equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.1796</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (the &#8220;Liminal Exchange Ratio&#8221;), rounded down to the nearest whole number of shares;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each share of Liminal Series A-1 preferred stock that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#8217;s Class B common stock equal to the Liminal Exchange Ratio, rounded down to the nearest whole number of shares;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each option to purchase shares of Legacy Hyperfine common stock and each option to purchase shares of Liminal common stock, whether vested or unvested, that was outstanding and unexercised as of immediately prior to the Effective Time was assumed by the Company and became an option (vested or unvested, as applicable) to purchase a number of shares of the Company&#8217;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such option immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Effective Time divided by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded up to the nearest whole cent; and</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	</span>&#160;</p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; each Legacy Hyperfine restricted stock unit and each Liminal restricted stock unit outstanding immediately prior to the Effective Time was assumed by the Company and became a restricted stock unit with respect to a number of shares of the Company&#8217;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such Legacy Hyperfine restricted stock unit or Liminal restricted stock unit immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole share.</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the Business Combination Agreement, the Company will issue to holders of Legacy Hyperfine and Liminal securities as of immediately prior to the Effective Time, in accordance with their pro rata share, up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock as earn-out consideration (the &#8220;Earn-Out Shares&#8221;), if at any time during the period between the Closing Date and the third anniversary of the Closing Date (the &#8220;Earn-Out Period&#8221;), (i) the last share price of the Class A common stock is greater than or equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for any </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> trading days within any </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> consecutive trading day period, or (ii) there is a transaction that will result in shares of Class A common stock being converted or exchanged into the right to receive cash or other consideration having a value greater than or equal to $15.00. During the Earn-Out Period, if there is a transaction (other than for stock splits, stock dividends, special cash dividends, reorganizations, recapitalizations or similar transactions affecting the Class A common stock) that will result in the shares of Class A common stock being converted or exchanged into the right to receive cash or other consideration having a value less than $15.00, then the right to receive Earn-Out Shares will terminate.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 21, 2021, HealthCor filed the Certificate of Incorporation (the &#8220;Certificate&#8221;) with the Secretary of State of the State of Delaware, which became effective after the Domestication. As a consequence of filing the Certificate, the Company adopted a dual class structure, comprised of the Company&#8217;s Class A common stock, which is entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_7c1f6cb9-db4f-44a0-8eef-0eeaa1e8c6da;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> vote per share, and the Company&#8217;s Class B common stock, which is entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> votes per share. The Company&#8217;s Class B common stock has the same economic terms as the Company&#8217;s Class A common stock, but is subject to a &#8220;sunset&#8221; provision if Jonathan M. Rothberg, Ph.D., the founder of Legacy Hyperfine and Liminal, and a Director of the Company (&#8220;Dr. Rothberg&#8221;), and other permitted holders of the Company&#8217;s Class B common stock collectively cease to beneficially own at least twenty percent (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%) of the number of shares of the Company&#8217;s Class B common stock (as such number of shares is equitably adjusted in respect of any reclassification, stock dividend, subdivision, combination or recapitalization of the Company&#8217;s Class B common stock) collectively held by Dr. Rothberg and permitted transferees of the Company&#8217;s Class B common stock as of the Effective Time. At the Effective Time, the Company amended the Certificate to change the name of the Company from HealthCor Catalio Acquisition Corp. to &#8220;Hyperfine, Inc.&#8221; (the Certificate, as amended, the &#8220;Amended Certificate&#8221;).</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Concurrently </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">with the execution of the Business Combination Agreement, HealthCor entered into subscription agreements (the &#8220;Subscription Agreements&#8221;) with certain institutional investors and accredited investors (the &#8220;PIPE</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investors&#8221;), </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pursuant to which the PIPE Investors purchased, immediately prior to the Closing, an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,610,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of HealthCor Class A common stock at a purchase price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share (the &#8220;PIPE Investment&#8221;).</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, on December 22, 2021, HealthCor, HC Sponsor LLC (the &#8220;Sponsor&#8221;), Legacy Hyperfine and Liminal entered into a Forfeiture Agreement (the &#8220;Forfeiture Agreement&#8221;), pursuant to which, immediately prior to the Closing, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">150,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of HealthCor&#8217;s Class B common stock held by the Sponsor were irrevocably forfeited and automatically cancelled (the &#8220;Forfeiture&#8221;).</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The total number of shares of the Company&#8217;s Class A common stock outstanding immediately following the Closing was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">54,977,061</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> comprising:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29,711,224</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued to Hyperfine stockholders (other than certain holders of Hyperfine Series A preferred stock);</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,459,081</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued to Liminal stockholders (other than certain holders of Liminal Series A-1 preferred stock);</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,610,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued in connection with the Closing to the PIPE Investors pursuant to the PIPE Investment;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,025,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued immediately prior to the Effective Time to the initial shareholders upon conversion of the </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,025,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class B common stock outstanding immediately prior to the Effective Time (following the issuance of the </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,175,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class B common stock upon the Conversion of the </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,175,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Class B ordinary shares held by the initial shareholders and after reflecting the irrevocable forfeiture by the Sponsor to HealthCor of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">150,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class B common stock for no consideration and automatic cancellation as of immediately prior to the Closing);</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">614,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued to the Sponsor; and</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,557,756</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock issued to the Company&#8217;s public stockholders holding </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,557,756</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Class A ordinary shares outstanding at the Effective Time, after reflecting redemptions of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,142,244</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of HealthCor Class A common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The total number of shares of the Company&#8217;s Class B common stock outstanding immediately following the Closing was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,055,288</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares. Immediately following the Closing, Dr. Rothberg held approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the combined voting power of the Company. Accordingly, Dr. Rothberg and his permitted transferees control the Company, and the Company is a controlled company within the meaning of the Nasdaq listing rules.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net equity infusion from the Business Combination was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">141,471</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which consists of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">207,448</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> proceeds from HealthCor, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">126,100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> proceeds from the PIPE Investors, net of payments to redeeming HealthCor shareholders of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">171,437</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and payment of transaction costs of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20,640</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Additionally, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">300,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A Common Stock were issued to a service provider in exchange for the services provided in connection with the Business Combination.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2021, in connection with the closing of the Business Combination, the Company prepaid directors and officers insurance policy in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,244</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and repaid the Liminal Paycheck Protection Program ("PPP") loan in full in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736904568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4. REVENUE RECOGNITION</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Disaggregation of Revenue</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company disaggregates revenue from contracts with customers by product type. The Company believes that these categories aggregate the payor types by nature, amount, timing and uncertainty of its revenue streams. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the Company&#8217;s disaggregated revenues:</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.786%;"/>
        <td style="width:1.354%;"/>
        <td style="width:13.243%;"/>
        <td style="width:1.238%;"/>
        <td style="width:1.28%;"/>
        <td style="width:11.762%;"/>
        <td style="width:0.603%;"/>
        <td style="width:1.238%;"/>
        <td style="width:1.28%;"/>
        <td style="width:11.614%;"/>
        <td style="width:0.603%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Pattern of Recognition</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Device</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Point in time</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">715</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">200</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Service</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Over time</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">781</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">94</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total revenue</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,496</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">294</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Contract Balances</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Contract balances represent amounts presented in the combined and consolidated balance sheets when either the Company has transferred goods or services to the customer, or the customer has paid consideration to the Company under the contract. These contract balances include trade accounts receivable and deferred revenue. Deferred revenue represents consideration received from customers at the beginning of the subscription period for services that are transferred to the customer over the respective subscription period. The accounts receivable balances represent amounts billed to customers for goods and services where the Company has an unconditional right to payment of the amount billed.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table provides information about receivables and deferred revenue from contracts with customers:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.275%;"/>
        <td style="width:1.597%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.42%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.481%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.42%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">553</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">174</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Unbilled receivables</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">91</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">730</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">158</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Long term deferred revenue</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">510</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes a receivable when it has an unconditional right to payment, and payment terms range from </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">days to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">months based on the terms agreed upon with the respective customer.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The amount of revenue recognized during the years ended December 31, 2021 and 2020 that was included in the deferred revenue balance at the beginning of the period was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">158</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue from leasing arrangements is not subject to the revenue standard for contracts with customers and remains separately accounted for under existing lease accounting guidance. The Company records operating lease rental revenue as service revenue on a straight-line basis over the lease term. The Company records revenue from the sale of equipment under sales-type leases as product revenue in an amount equal to the present value of minimum lease payments at the inception of the lease. Sales-type leases also produce financing income, which is included in products net revenue in the combined and consolidated statements of operations and comprehensive loss and is recognized at effective rates of return over the lease term.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Costs of Obtaining or Fulfilling Contracts</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company incurs incremental costs of obtaining contracts with customers. Incremental costs of obtaining contracts, which include commissions paid as a result of obtaining contracts with customers, are capitalized to the extent that the Company expects to recover such costs. Capitalized costs are amortized in a pattern that is consistent with the Company&#8217;s transfer to the customer of the related goods and services. Such costs are recorded in Other long term assets and were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">158</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as of December 31, 2021. Capitalized costs were not material for the year ended December 31, 2020.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Transaction price allocated to remaining performance obligations</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 202</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and 2020, the Company had remaining performance obligations amounting to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,800</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">859</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. The Company expects to recognize approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of its remaining performance obligations as revenue in fiscal year 2022, and an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_82c7fa41-ba63-47ec-bb72-bbe45f458cc5;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">fiscal year</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> 2023 and thereafter.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Significant Judgements</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company makes significant judgments applying the guidance related to the determination of the timing and pattern of satisfaction of performance obligations, determination of the standalone selling price of performance obligations and estimation of variable consideration.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Practical Expedients and Accounting Policy Elections</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a practical expedient, the Company does not adjust transaction price for the effects of a significant financing component in contracts in which the period between when the Company transfers the promised good or service to the customer and when the customer pays for that good or service is a year or less.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has made an accounting policy election to exclude all sales taxes from the transaction price of its contracts with customers. Accordingly, sales taxes collected from customers and remitted to government authorities is not included in revenue and is accounted for as a liability until it has been remitted to the respective government authority.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736896424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE OF FINANCIAL INSTRUMENTS</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5. FAIR VALUE OF FINANCIAL INSTRUMENTS</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value estimates of financial instruments are made at a specific point in time, based on relevant information about financial markets and specific financial instruments. As these estimates are subjective in nature, involving uncertainties and matters of significant judgment, they cannot be determined with precision. Changes in assumptions can significantly affect estimated fair value.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company measures fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The Company utilizes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> &#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access.</span></p><p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> &#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> &#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company has no assets or liabilities valued with Level 3 inputs.</span></p><p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The carrying value of cash and cash equivalents, notes receivable, accounts payable and accrued expenses and other current liabilities approximates their fair values due to the short-term or on demand nature of these instruments.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> transfers between fair value measurement levels during the years ended December 31, 2</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21 and 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company had $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48,625</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">58,418</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of money market funds included in cash and cash equivalents and restricted cash as of December 31, 2021 and 2020, respectively. These assets were valued using quoted market prices and accordingly were classified as Level 1.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company determines that notes payable as of December 31, 2020 was classified as Level 2 and the relevant fair value approximates its carrying amount since it bore interest at rates that approximate current market rates.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736884184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6. INVENTORIES</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of inventories are as follows at December 31:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.184%;"/>
        <td style="width:1.682%;"/>
        <td style="width:1.29%;"/>
        <td style="width:14.322%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.682%;"/>
        <td style="width:1.29%;"/>
        <td style="width:14.322%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Raw materials</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,355</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Finished goods</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,955</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,718</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total inventories</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">4,310</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,718</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Manufacturing overhead costs primarily include management&#8217;s best estimate and allocation of the labor costs incurred related to acquiring finished goods from the Company&#8217;s contract manufacturer. Labor costs include wages, taxes and benefits for employees involved in warehousing, logistics coordination, material sourcing, and production planning activities. The majority of these costs have been written off based on the Company&#8217;s analysis of net realizable value.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the years ended December 31, 2021 and 2020, net realizable value inventory adjustments and excess and obsolete inventory charges were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">213</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, and were recognized in cost of sales.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736730152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7. PROPERTY AND EQUIPMENT, NET</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net, are recorded at historical cost and consist of the following at December 31:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.895%;"/>
        <td style="width:1.586%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.346%;"/>
        <td style="width:0.857%;"/>
        <td style="width:1.586%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.293%;"/>
        <td style="width:0.857%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">989</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">572</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research devices</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,422</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">486</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing devices</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">669</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">575</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">385</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Construction in progress</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">341</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">613</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tooling</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">302</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">270</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Trade show assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">293</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Leased devices</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">396</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">127</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">176</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">167</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5,163</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,620</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Less: Accumulated depreciation and amortization</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,410</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">716</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">3,753</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,904</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation and amortization expense amounted to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">726</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">289</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the years ended December 31, 2021 and 2020, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736922104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses and other current liabilities consist of the following at December 31:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.316%;"/>
        <td style="width:1.544%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.899%;"/>
        <td style="width:0.613%;"/>
        <td style="width:0.994%;"/>
        <td style="width:1.29%;"/>
        <td style="width:14.438%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Bonus</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3,421</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">501</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Contracted services</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,711</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">456</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">SPAC bonus and other costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,071</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Legal fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">452</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">282</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Payroll and related benefits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">441</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">19</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">25</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">8,115</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,264</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029816817576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">NOTES PAYABLE</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9. NOTES PAYABLE</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2020, the Company received loan proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,067</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> under the PPP. The Legacy Hyperfine PPP loan in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">889</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">evidenced by a promissory note dated August 10, 2020 and was fully paid off during the fourth</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">quarter </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of 2020. The Liminal PPP loan in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">178</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> is evidenced by a promissory note dated May 1, 2020. The Company used the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintaining its payroll levels. The Company accounted for the loan as debt.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the closing of the Business Combination as discussed in Note 3. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company repaid the Liminal PPP loan in full in December 2021. The Company recognized an insignificant amount of interest expense in the combined and consolidated statements of operations and comprehensive loss related to the loan.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736310360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE PREFERRED STOCK<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">CONVERTIBLE PREFERRED STOCK</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">10. CONVERTIBLE PREFERRED STOCK</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Legacy Hyperfine Convertible Preferred Stock</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine had issued four series of Convertible Preferred Stock, Series A through Series D. </span><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the authorized, issued and outstanding Convertible Preferred Stock of Legacy Hyperfine immediately prior to the Business Combination:</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:11.212%;"/>
        <td style="width:0.984%;"/>
        <td style="width:8.631%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:8.504%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:0.931%;"/>
        <td style="width:9.848%;"/>
        <td style="width:0.508%;"/>
        <td style="width:0.984%;"/>
        <td style="width:0.561%;"/>
        <td style="width:9.615%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.132%;"/>
        <td style="width:7.954%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:7.383%;"/>
        <td style="width:0.508%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:8.377%;"/>
        <td style="width:0.508%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.153%;"/>
        <td style="width:8.642%;"/>
        <td style="width:0.508%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Class</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year<br/>of Class<br/>Issuance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br/>Price per<br/>share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br/>Authorized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br/>Issued and<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total<br/>Proceeds or<br/>Exchange<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br/>Costs</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Net<br/>Carrying<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Initial<br/>Liquidation<br/>Price per<br/>share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2014</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.04</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">25,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">25,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">998</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series B</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">10,625,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">10,625,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series C</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">31,586,210</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">31,586,210</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,382</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">234</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,148</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series D</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2020</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">-</span><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2021</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.15</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">62,577,618</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">41,970,981</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">90,237</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">136</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">90,101</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.15</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">129,788,828</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">109,182,191</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">159,119</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">372</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">158,747</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the authorized, issued and outstanding Convertible Preferred Stock of Legacy Hyperfine as of December 31, 2020:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:11.225%;"/>
        <td style="width:0.984%;"/>
        <td style="width:8.633%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:8.506%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:0.931%;"/>
        <td style="width:9.395%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:0.561%;"/>
        <td style="width:9.617%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.132%;"/>
        <td style="width:7.956%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:7.385%;"/>
        <td style="width:0.508%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:8.379%;"/>
        <td style="width:0.508%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.153%;"/>
        <td style="width:8.644%;"/>
        <td style="width:0.508%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Class</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year<br/>of Class<br/>Issuance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br/>Price per<br/>share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br/>Authorized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br/>Issued and<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total<br/>Proceeds or<br/>Exchange<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br/>Costs</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Net<br/>Carrying<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Initial<br/>Liquidation<br/>Price per<br/>share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2014</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.04</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">25,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">25,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">998</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series B</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">10,625,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">10,625,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series C</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">31,586,210</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">31,586,210</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,382</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">234</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,148</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series D</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2020</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.15</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">62,577,618</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">27,799,648</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,769</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">129</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,640</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.15</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">129,788,828</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">95,010,858</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">128,651</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">365</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">128,286</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The powers, preferences, rights, qualifications, limitations and restrictions of the shares of Convertible Preferred Stock are as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividends</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dividends shall accrue to holders of the Convertible Preferred Stock at the rate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the original issue price for the applicable series of Convertible Preferred Stock, per annum subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization, reclassification and other similar events payable only when, and if, declared by Legacy Hyperfine&#8217;s board of directors. The right to receive dividends on Convertible Preferred Stock is not cumulative, and therefore, if not declared in any year, the right to such dividends shall terminate and shall not carry forward into the next year. There have been </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> dividends declared to date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidation Rights</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the event of any liquidation, dissolution or winding up of Legacy Hyperfine, whether voluntary or involuntary or a deemed liquidation event (which includes a merger, the sale of all of Legacy Hyperfine&#8217;s assets, or a transaction which the holders of capital stock of Legacy Hyperfine hold less than 50% of the voting securities) (each a &#8220;Liquidation Event&#8221;), the holders of the Convertible Preferred Stock are entitled to be paid out of the assets of Legacy Hyperfine available for distribution to stockholders, pari passu, at a liquidation price per share equal to the greater of: </span></span><span style=""/></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the applicable original issue price of such Convertible Preferred Stock, plus any declared and unpaid dividends or (2) an amount that would have been payable had all the shares of the Convertible Preferred Stock been converted into Legacy Hyperfine common stock. These payments will be made to or set aside prior to the holders of shares of any other class or series of capital stock that is not, by its terms, senior to the Convertible Preferred Stock.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting Rights</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of shares of the Convertible Preferred Stock shall be entitled to vote on all matters on which the holders of shares of Legacy Hyperfine common stock shall be entitled to vote.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each holder of record of shares of Series A Convertible Preferred Stock shall be entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ten</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> votes per share of Legacy Hyperfine Special-voting common stock into which such Series A Convertible Preferred Stock are convertible, as discussed below under &#8220;Conversion,&#8221; on all matters to be voted on by Legacy Hyperfine&#8217;s stockholders. Each holder of record of shares of Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock shall be entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> vote per share of Legacy Hyperfine common stock into which such Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, and Series D Convertible Preferred Stock are convertible, as discussed below under Conversion, on all matters to be voted on by Legacy Hyperfine&#8217;s stockholders. The holders of Convertible Preferred Stock and the holders of Legacy Hyperfine common stock shall vote together and not as separate classes. There shall be no series voting.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Conversion</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of Series A Convertible Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of Legacy Hyperfine Special-voting common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional common shares for no consideration or consideration less than the conversion price of the Series A Convertible Preferred Stock.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock shall be convertible, at the option of the holder, at any time after the date of issuance into shares of Legacy Hyperfine common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional common shares for no consideration or consideration less than the conversion price of the respective series of Convertible Preferred Stock, which is equal to the original issuance price for each series of Convertible Preferred Stock.</span></span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon the earlier to occur of (i) election of the Convertible Preferred Stock by (A) the consent or vote of the majority holders of the Convertible Preferred Stock (voting together as a single class and not as separate series, and on an as-converted basis), (B) the consent or vote of the majority holders of Series C Convertible Preferred Stock (voting separately as a single class) and (C) the consent or vote of the majority holders of Series D Convertible Preferred Stock (voting separately as a single class) or (ii) the closing of a firm commitment underwritten initial public offering pursuant to an effective registration statement filed under the Securities Act of 1933 covering the offer and sale of shares of Legacy Hyperfine common stock in which the aggregate gross proceeds to Legacy Hyperfine are at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (1) each share of Series A Convertible Preferred Stock shall automatically be converted into shares of Legacy Hyperfine Special-voting common stock on a 1 for 1 basis and (2) each share of Series B, Series C and Series D Convertible Preferred Stock shall automatically be converted into Legacy Hyperfine common stock on a 1 for 1 basis.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon the closing of the Business Combination, the Convertible Preferred Stock converted into Class A and Class B common stock based on the Business Combination&#8217;s Hyperfine Exchange Ratio of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3275</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the Company&#8217;s shares for each Legacy Hyperfine share. The Company recorded the conversion at the carrying value of the Convertible Preferred Stock at the time of the Closing. There are </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Convertible Preferred Stock outstanding as of December 31, 2021.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liminal Convertible Preferred Stock</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">April 1, 2021 Liminal effected a recapitalization whereby each share of Liminal common stock outstanding was exchanged for shares of Liminal Series A-1 preferred stock and Liminal Series A-2 preferred stock. The value </span></span><span style=""/></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ascribed </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to the preferred stock is equivalent to the total amount of historical equity investments contributed by the common shareholder.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> There were no new investments or changes in control in conjunction with the recapitalization.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The powers, preferences, rights, qualifications, limitations and restrictions of the shares of Liminal Convertible Preferred Stock are as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividends</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dividends shall accrue to holders of the Convertible Preferred Stock at the rate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the original issue price for the applicable series of Convertible Preferred Stock, per annum subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization, reclassification and other similar events payable only when, and if, declared by Liminal&#8217;s board of directors. The right to receive dividends on Convertible Preferred Stock is not cumulative, and therefore, if not declared in any year, the right to such dividends shall terminate and shall not carry forward into the next year. There have been </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> dividends declared to date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidation Rights</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event of any liquidation, dissolution or winding up of Liminal, whether voluntary or involuntary or a deemed liquidation event (which includes a merger, the sale of all of Liminal&#8217;s assets, or a transaction which the holders of capital stock of Liminal hold less than 50% of the voting securities) (each a &#8220;Liquidation Event&#8221;), the holders of the Convertible Preferred Stock are entitled to be paid out of the assets of Liminal available for distribution to stockholders, pari passu, at a liquidation price per share equal to the greater of: (1) the applicable original issuance price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.1287</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share for Series A-1 and Series A-2 Convertible Preferred Stock, plus any declared and unpaid dividends or (2) an amount that would have been payable had all the shares of the Convertible Preferred Stock been converted into Liminal common stock. These payments will be made to or set aside prior to the holders of shares of any other class or series of capital stock that is not, by its terms, senior to the Convertible Preferred Stock.</span></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting Rights</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of shares of the Convertible Preferred Stock shall be entitled to vote on all matters on which the holders of shares of Liminal common stock shall be entitled to vote.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each holder of record of shares of Series A-1 Convertible Preferred Stock shall be entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ten</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> votes per share of Liminal Special-voting common stock into which such Series A-1 Convertible Preferred Stock are convertible, as discussed below under &#8220;Conversion,&#8221; on all matters to be voted on by Liminal&#8217;s stockholders. Each holder of record of shares of Series A-2 Convertible Preferred Stock shall be entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> vote per share of Liminal common stock into which such Series A-2 Convertible Preferred Stock are convertible, as discussed below under Conversion, on all matters to be voted on by Liminal&#8217;s stockholders. The holders of Convertible Preferred Stock and the holders of Liminal common stock shall vote together and not as separate classes. There shall be no series voting.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Conversion</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of Series A-1 Convertible Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of Liminal Special-voting common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional shares of Liminal common stock for no consideration or consideration less than the conversion price of the Series A Convertible Preferred Stock.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of Series A-2 Convertible Preferred Stock shall be convertible, at the option of the holder, at any time after the date of issuance into shares of Liminal common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional shares of common stock for no consideration or consideration less than the conversion price of the respective series of Convertible Preferred Stock, which is equal to the original issuance price for each series of Convertible Preferred Stock.</span></span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the earlier to occur of (i) election of the Convertible Preferred Stock by the consent or vote of the majority holders of the Convertible Preferred Stock (voting together as a single class and not as separate series, and on an as-converted basis) or (ii) the closing of a firm commitment underwritten initial public offering pursuant to an effective</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">registration </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">statement filed under the Securities Act of 1933, as amended, covering the offer and sale of shares of Liminal common stock in which the aggregate gross proceeds to Liminal are at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (1) each share of Series A-1 Convertible Preferred Stock shall automatically be converted into shares of Liminal Special-voting common stock on a 1 for 1 basis and (2) each share of Series A-2 Convertible Preferred Stock shall automatically be converted into Liminal common stock on a 1 for 1 basis.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon the closing of the Business Combination, the Liminal Convertible Preferred Stock converted into Class A and Class B common stock based on the Business Combination&#8217;s Liminal Exchange Ratio of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.1796</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the Company&#8217;s shares for each Liminal share. The Company recorded the conversion at the carrying value of the Convertible Preferred Stock at the time of the Closing. There are </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Convertible Preferred Stock outstanding as of December 31, 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736298456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (DEFICIT)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY (DEFICIT)</a></td>
<td class="text"><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">11. STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Common Stock</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, and 2020, the Company had authorized </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">600,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">130,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock at $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value per share, of which a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">55,277,061</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,576,137</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were outstanding, respectively.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, and 2020, the Company had authorized </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class B common stock at $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value per share, of which a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,055,288</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were outstanding, respectively.</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividends</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Holders of the Company&#8217;s common stock are not entitled to receive dividends unless declared by the Company&#8217;s board of directors. There have been </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> dividends declared to date.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting Rights</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of shares of the Company's Class A common stock are entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> vote per share on all matters on which the Company's Class A common stock shall be entitled to vote. The holders of shares of the Company's Class B common stock are entitled to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> votes per share on all matters on which the Company's Class B common stock shall be entitled to vote. The holders of the Company's Class A common stock and Class B common stock shall vote together and not as separate classes.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736930552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY INCENTIVE PLAN<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">EQUITY INCENTIVE PLAN</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">12. EQUITY INCENTIVE PLAN</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Hyperfine Inc. 2021 Equity Incentive Plan</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16,013,762</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock are reserved for issuance under the Company's 2021 Equity Incentive Plan (the &#8220;Hyperfine Plan&#8221;). The Hyperfine Plan is administered by the Company's board of directors. The board of directors may grant restricted stock and options to purchase shares either as incentive stock options or non-qualified stock options. The option grants are subject to certain terms and conditions, option periods and conditions, exercise rights and privileges as set forth in the Hyperfine Plan. At December 31, 2021, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,256,741</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> common shares remain available for issuance under the Hyperfine Plan.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to the Business Combination, Legacy Hyperfine and Liminal were distinct entities with separate equity incentive plans for their employees and nonemployees. Both plans were subsequently adopted and assumed by the Company as a consequence of the Business Combination.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine option from Legacy Hyperfine&#8217;s 2014 Employee, Director and Consultant Equity Incentive Plan as amended on October 9, 2020 (the &#8220;Legacy Hyperfine Plan&#8221;) outstanding immediately prior to the Closing, whether vested or unvested, was converted into an option to purchase shares of the Company's Class A common stock equal to the number of shares of Legacy Hyperfine common stock subject to such option multiplied by the Hyperfine</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exchange </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ratio of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3275</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, rounded down to the nearest whole number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Closing divided by </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3275</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, rounded up to the nearest whole cent.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each Liminal option from Liminal&#8217;s 2021 Employee, Director, and Consultant Equity Incentive Plan (the &#8220;Liminal Plan") outstanding immediately prior to the Closing, whether vested or unvested, was converted into an option to purchase shares of the Company's Class A common stock equal to the number of shares of Liminal common stock subject to such option multiplied by the Liminal Exchange Ratio of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.1796</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, rounded down to the nearest whole number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Closing divided by </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.1796</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, rounded up to the nearest whole cent.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each exchanged option will continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding option immediately prior to the Closing. All activity was retroactively restated to reflect the exchange that occurred.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, each Legacy Hyperfine restricted stock unit and each Liminal restricted stock unit outstanding immediately prior to the Effective Time was assumed by the Company and became a restricted stock unit with respect to a number of shares of the Company&#8217;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such Legacy Hyperfine restricted stock unit or Liminal restricted stock unit immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole share.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock option activity</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each stock option grant carries varying vesting schedules whereby the options become exercisable at the participant&#8217;s sole discretion provided they are an employee, director or consultant of the Company on the applicable vesting date. Each option shall terminate not more than ten years from the date of the grant.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the year ended December 31, 2021, the Company granted certain equity awards to the newly hired Chief Executive Officer. These awards include (1) an option award to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,899,500</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock which will vest based on continued service over a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">four year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period, (2) a separate option award to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">474,875</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock, which will be fully vested upon the occurrence of various service, performance, and market conditions. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">474,875</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> share option awards (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">949,750</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> options total) with terms similar to those described above will be granted pursuant to the terms of the offer letter. Certain equity awards were also granted to the Executive Chairman of the Legacy Hyperfine board of directors. The equity compensation included (1) an option award to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">712,312</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Class A common stock which will vest based on continued service, over </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">four years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, (2) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> separate option awards to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">237,437</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares each of Class A common stock (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">474,874</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares in total), which will be fully vested upon the occurrence of various certain service, performance, and market conditions.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The service condition for these awards is satisfied by providing service to the Company based on the defined service period per the award agreement. The performance-based condition is satisfied upon the occurrence of a special purpose acquisition company (&#8220;SPAC&#8221;) transaction, initial public offering (&#8220;IPO&#8221;), or financing event as defined in the award agreement. The market condition is satisfied by achieving various multiples of a defined price per share. The achievement of the performance condition and the commencement of the related expense recognition event cannot occur until the event is deemed probable, which only occurs once a SPAC transaction, IPO, or financing event has occurred. The performance condition was satisfied as a result of the Business Combination and the Company recognized stock-based compensation expense of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,772</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in connection with these awards during the year ended December 31, 2021. None of the market conditions have been satisfied and as such, none of the awards are exercisable as of December 31, 2021.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to the above, restricted stock units with a value of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,500</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> will be granted to the Chief Executive Officer following the Business Combination and within two years of the Chief Executive Officer&#8217;s start date, subject to continued service and which will vest on a schedule to be agreed upon between the Company and the Chief Executive Officer. These restricted stock units were not yet approved by the Board of Directors and therefore had not yet been granted as of December 31, 2021.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the year ended December 31, 2021, the Company also granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">258,833</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> option awards subject to certain service and performance conditions. The service condition required the participant&#8217;s continued employment with the Company through the applicable vesting date, and the performance condition required the consummation of a Sale, IPO, or SPAC transaction as defined in the option award agreement. These awards were forfeited and cancelled prior to the consummation of the Business Combination. As a Sale, IPO, or SPAC transaction did not occur prior to forfeiture, the Company did not record any stock-based compensation expense related to these option awards.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All options granted by the Company during the years ended December 31, 2021 and 2020 were granted with exercise prices equal to the estimated fair value of the Company's common stock at the date of grant, as determined by the Company's board of directors.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the stock option activity under the Hyperfine Plan is presented in the table below:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.969%;"/>
        <td style="width:1.153%;"/>
        <td style="width:0.592%;"/>
        <td style="width:10.345%;"/>
        <td style="width:0.846%;"/>
        <td style="width:1.153%;"/>
        <td style="width:1.269%;"/>
        <td style="width:9.953%;"/>
        <td style="width:0.592%;"/>
        <td style="width:1.153%;"/>
        <td style="width:0.645%;"/>
        <td style="width:10.704%;"/>
        <td style="width:0.592%;"/>
        <td style="width:1.153%;"/>
        <td style="width:1.269%;"/>
        <td style="width:10.017%;"/>
        <td style="width:0.592%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Number of Options</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Weighted Average Exercise Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Weighted Average Remaining Contractual Term</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Aggregate Intrinsic Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding at January 1, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,903,479</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.87</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7.07</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,073</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">6,771,237</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.37</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">565,533</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2.65</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">587,047</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.86</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7,522,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8.79</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">30,052</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Options exercisable at December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,332,624</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2.98</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7.82</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">9,785</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Vested and expected to vest at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7,117,220</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.20</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8.77</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">28,445</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company received cash proceeds from the exercise of stock options of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,497</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">120</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> during the years ended December 31, 2021 and 2020, respectively. The total intrinsic value (the amount by which the stock price exceeds the exercise price of the option on the date of exercise) of the stock options exercised during the years ended December 31, 2021 and 2020, was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,752</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">167</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. The weighted-average grant date fair value of options granted during the year ended December 31, 2021 and 2020, was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.66</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.69</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock option valuation inputs</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilized the Black-Scholes option pricing model for determining the estimated fair value for service awards. The Black-Scholes model requires the use of subjective assumptions which determine the fair value of stock-based awards. </span><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The assumptions used to value option grants to employees and nonemployees for the years ended December 31, 2021 and 2020 were as follows:</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.495%;"/>
        <td style="width:1.252%;"/>
        <td style="width:21.252%;"/>
        <td style="width:1.252%;"/>
        <td style="width:18.748%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Risk Free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.95</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">% - </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">% - </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected term</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5.40</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years - </span><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">6.17</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5.8</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years - </span><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">6.0</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">70</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">60</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risk free interest rate</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The risk free interest rate for periods within the expected term of the awards is based on the U.S. Treasury yield curve in effect at the time of the grant.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected dividend yield</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has never declared or paid any cash dividends and does not expect to pay any cash dividends in the foreseeable future.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected term</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For employee awards, the Company calculates the expected term using the &#8220;simplified&#8221; method, which is the simple average of the vesting period and the contractual term. The simplified method is applied as the Company does not have sufficient historical data to provide a reasonable basis for an estimate of the expected term. The Company calculates expected term for employee awards that take into account the effects of employee&#8217;s expected exercise and post-vesting employment termination behavior.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected volatility</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As Legacy Hyperfine was privately held from inception through the Closing and all option grants occurred prior to the Closing Date, there was no specific historical or implied volatility information available.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accordingly, the Company estimates the expected volatility on the historical stock volatility of a group of similar companies that are publicly traded over a period equivalent to the expected term of the stock-based awards. Point estimates of expected annual equity volatility of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% for December 31, 2021 and 2020, respectively, were selected in the guideline companies&#8217; historical range.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Exercise price</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The exercise price is taken directly from the grant notice issued to employees and nonemployees.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The stock options granted to the Company's employees and nonemployees for the periods presented were as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.99%;"/>
        <td style="width:1.586%;"/>
        <td style="width:0.613%;"/>
        <td style="width:14.192%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.586%;"/>
        <td style="width:0.613%;"/>
        <td style="width:14.192%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock options granted to employee</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3,534,844</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">897,240</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock options granted to nonemployee</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3,236,393</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">284,816</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total stock options granted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">6,771,237</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,182,056</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Incentive Unit and Preferred Stock Award Activity</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Incentive unit grants typically vest over a</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> four year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period provided the holder is an employee, director or consultant of the Company on the applicable vesting date. Upon termination of service, pursuant to the terms of the grant, the participant 1) immediately forfeits any unvested (but issued) incentive units and 2) the Company has the right, but not the obligation, to repurchase at the fair market value on the date of termination, any vested incentive units. The repurchase right is valid for </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18 months</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> commencing with the date of service.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On April 2, 2021, 4Bionics executed a plan of liquidation and dissolution and its ownership in Liminal was distributed to its members and to the holders of incentive units. Immediately subsequent to the dissolution, all outstanding unvested incentive unit awards under 4Bionic&#8217;s 2019 Equity Incentive Plan were replaced with preferred stock awards indexed to and settled in the preferred stock of the former 4Bionics subsidiaries Liminal, Detect, Inc. (f/k/a Homodeus Inc.), and Tesseract Health. The preferred stock awards are subject to service vesting conditions only. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> incremental value was provided to participants as a result of the modification of the awards as the modification date fair value of the incentive unit awards was equal to modification date fair value of the stock underlying the restricted stock awards. Moreover, the remaining vesting period before and after modification was unchanged. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> incremental compensation expense was recognized as a result of the modification.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to the dissolution of 4Bionics, a portion of total 4Bionics stock-based compensation expense was allocated to Liminal based on the level of service provided by the relevant employees and nonemployees to Liminal over the term of the award. Subsequent to the dissolution of 4Bionics, the Company recognizes the stock-based compensation expense related to the replacement preferred stock awards and no allocation methodology is required. In connection with the Business Combination, all replacement preferred stock awards were accelerated to fully vest. The Company recognized stock-based compensation expense of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">578</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> related to the incentive unit awards and replacement preferred stock awards during the years ended December 31, 2021 and December 31, 2020, respectively.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Stock Units</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2021, immediately following the Business Combination, the Company granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">117,516</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> restricted stock units (&#8220;RSUs&#8221;) to members of the Company&#8217;s Board of Directors. The RSUs vest over a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period, contingent on the ongoing service of the Directors. The grant date fair value of the RSUs was measured using the fair value of the underlying Class A common stock, which was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.19</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share on the grant date. The total grant date fair value of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,080</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> will be recognized evenly over the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period as the service condition is satisfied.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Earn-Out Shares</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Subject to the achievement of certain milestones, certain employees are entitled to a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">933,933</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Earn-Out Shares. These Earn-Out Shares fall within the scope of ASC 718, pursuant to which such Earn-Out Shares are equity classified and their grant date fair value will be recognized as compensation expense over the vesting period.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Earn-out valuation inputs</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilized a Monte Carlo Simulation pricing model for determining the estimated fair value for Earn-Out Shares. The fair value is based on the simulated price of the Company over the maturity date of the Earn-Out Shares. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The key assumptions used in the valuation were as follows:</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.473%;"/>
        <td style="width:1.925%;"/>
        <td style="width:0.613%;"/>
        <td style="width:15.831%;"/>
        <td style="width:2.157%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock Price</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.92</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Risk Free interest rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.96</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Term (years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">54.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risk free interest rate</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The risk free interest rate for periods within the expected term of the awards is based on the U.S. Treasury yield curve in effect at the time of the grant.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected dividend yield</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has never declared or paid any cash dividends and does not expect to pay any cash dividends in the foreseeable future.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected term</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For Earn-Out Shares, the expected term is determined to be </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 </span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">years from the Closing as this is the period over which the market price milestone may be achieved. As there is no dependent vesting period, the shares are exercisable at the point that the market milestone is reached.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected volatility</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As Legacy Hyperfine was privately held from inception through the Closing, there was no specific historical or implied volatility information available.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accordingly, the Company estimates the expected volatility on the historical stock volatility of a group of similar companies that are publicly traded over a period equivalent to the expected term of the earn-out awards. A point estimate of expected annual equity volatility of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">55</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% for December 31, 2021 was selected in the guideline companies&#8217; historical range.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation Expense</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s stock-based compensation expense for the periods presented was as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.092%;"/>
        <td style="width:1.586%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.464%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.586%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.464%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cost of sales - Device</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cost of sales - Service</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,327</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">864</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5,482</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">231</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">68</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">22</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">6,901</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,117</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total unrecognized stock-based compensation expense as of December 31, 2021 was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13,650</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which will be recognized over the remaining vesting period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.66</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> years.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736859752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET LOSS PER SHARE</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">13. NET LOSS PER SHARE</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all common equivalent shares of the Company, including convertible preferred stock, outstanding stock options, RSUs and Earn-Out Shares, to the extent dilutive. Basic and diluted net loss per share was the same for each period presented as the inclusion of all common equivalent shares of the Company outstanding would have been anti-dilutive.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.503%;"/>
        <td style="width:1.565%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.536%;"/>
        <td style="width:0.857%;"/>
        <td style="width:1.565%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.536%;"/>
        <td style="width:0.857%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net Loss</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">64,851</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">23,427</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Numerator for Basic and Dilutive EPS &#8211; Loss available to common<br/>stockholders</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">64,851</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">23,427</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Denominator:</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Common Stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3,690,523</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,523,096</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Denominator for Basic and Dilutive EPS - Weighted-average common stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">3,690,523</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,523,096</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Basic and dilutive loss per share</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">17.57</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">15.38</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since the Company was in a net loss position for all periods presented, the basic loss per share calculation excludes preferred stock as it does not participate in net losses of the Company. Additionally, net loss per share attributable to Class A and Class B common stockholders was the same on a basic and diluted basis, as the inclusion of all common equivalent shares outstanding would have been anti-dilutive. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Anti-dilutive common equivalent shares were as follows:</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.824%;"/>
        <td style="width:1.586%;"/>
        <td style="width:0.613%;"/>
        <td style="width:14.275%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.586%;"/>
        <td style="width:0.613%;"/>
        <td style="width:14.275%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding options to purchase common stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7,522,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,903,479</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding Legacy Hyperfine convertible preferred stock (Series A through D)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">31,116,056</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding RSUs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">117,516</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Earn-Out Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10,000,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total anti-dilutive common equivalent shares</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">17,639,652</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">33,019,535</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736854472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">14. INCOME TAXES</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant components of the Company's deferred tax assets (liabilities) are as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.782%;"/>
        <td style="width:1.576%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.387%;"/>
        <td style="width:0.857%;"/>
        <td style="width:1.576%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.387%;"/>
        <td style="width:0.857%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Gross deferred tax assets (liabilities):</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">29,300</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">14,512</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax credit carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3,429</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,238</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Fixed assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">117</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,634</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">522</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">949</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">421</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accrued bonuses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">857</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">84</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">90</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">36,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">17,788</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">36,136</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">17,788</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Net deferred tax assets (liabilities)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> income tax expense due to federal and state net operating losses incurred for the years ended December 31, 2021 and 2020. The Company has also not recorded any income tax benefits for its federal and state net operating losses incurred in each period due to uncertainty of realizing the benefit from those items. All of the Company&#8217;s losses before income taxes were generated in the United States. The effective tax rate for the Company for the years ended December 31, 2021 and 2020 was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> percent. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A reconciliation of the income tax expense at the federal statutory tax rate to the Company&#8217;s effective income tax rate follows:</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.373%;"/>
        <td style="width:1.576%;"/>
        <td style="width:0.603%;"/>
        <td style="width:12.089%;"/>
        <td style="width:2.983%;"/>
        <td style="width:1.576%;"/>
        <td style="width:0.603%;"/>
        <td style="width:12.216%;"/>
        <td style="width:2.983%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Statutory tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">State taxes, net of federal benefit</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4.0</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.8</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal research and development credit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.5</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Write down of federal NOL due to 382 limitation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2.8</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Write down of federal R&amp;D credits due to 382 limitation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred tax adjustment resulting from tax rate change</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2.2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.5</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">28.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">15.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Effective tax rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">0.0</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">0.0</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s effective tax rate for December 31, 2021 and 2020 differs from the federal statutory tax rate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% mainly due to the effect of deferred state income tax benefits resulting from state net operating loss carryforwards and the tax benefits related to research and development tax credits. These benefits to the effective tax rate are fully offset by the increase in the Company&#8217;s valuation allowance from the prior year.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has established a full valuation allowance against its net deferred tax assets due to the uncertainty of the Company&#8217;s ability to generate sufficient taxable income to realize the deferred tax assets, and therefore has not recognized any benefits from the net operating losses, tax credits and other deferred tax assets. The Company&#8217;s valuation allowance increased $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,348</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,729</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the years ended December 31, 2021 and 2020, respectively.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, the Company had the following tax net operating loss carryforwards available to reduce future federal and Connecticut taxable income, and tax credit carryforwards available to offset future federal and Connecticut income taxes:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.159%;"/>
        <td style="width:1.586%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.589%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.586%;"/>
        <td style="width:15.176%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Hyperfine</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Begin to Expire in</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Hyperfine tax net operating loss carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (pre-2018 NOLs)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12,084</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2034</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (post-2017 NOLs)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">91,306</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">States</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">72,621</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2034</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax credit carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,338</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2034</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Connecticut research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">752</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Connecticut others</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2022</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal others</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">135</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2022</span></span></p></td>
       </tr>
      </table><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.406%;"/>
        <td style="width:1.513%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.539%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.513%;"/>
        <td style="width:15.126%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Liminal</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Begin to Expire in</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Liminal tax net operating loss carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (pre-2018 NOLs)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (post-2017 NOLs)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12,304</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">States</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12,300</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2038</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax credit carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">449</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2038</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Connecticut research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">49</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under Internal Revenue Code Section 382, if a corporation undergoes an &#8220;ownership change,&#8221; the corporation&#8217;s ability to use its pre-change net operating loss and tax credit carryforwards to offset its post-change income and tax liabilities may be limited. Generally, an </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ownership change occurs when certain shareholders increase their aggregated ownership by more than 50 percentage points over their lowest ownership percentage in a testing period (typically </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">).</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company performed a Section 382 analysis for Legacy Hyperfine to determine whether an ownership change has occurred. Based on this analysis, Legacy Hyperfine experienced </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> consecutive ownership changes, one on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 17, 2017</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and one on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">May 16, 2017</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As a result, Legacy Hyperfine&#8217;s net operating loss and tax credit carryforwards as of December 31, 2020 are subject to a Section 382 limitation. The January 17, 2017 ownership change resulted in an annual limitation of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">865</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and the May 16, 2017 ownership change resulted in an annual limitation of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,008</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The first (earlier) limitation will limit the deduction of pre-change losses and credits arising before the first ownership change. The second (later) ownership change creates another limit to deduction of those pre-change losses and credits. However, the second ownership change does not allow for a &#8220;step-up&#8221; of the first limitation and therefore the pre-January 17, 2017 losses and credits are still subject to the first limitation amount. Due to these limitations, the Company estimates that $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,125</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">249</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the federal net operating loss and research and development credit carryforwards, respectively, will expire before utilization. Accordingly, Legacy Hyperfine&#8217;s gross deferred tax assets and corresponding valuation allowance have been adjusted to reflect the estimated expirations. In addition, as a result of the Business Combination and any other equity issuances during the year, the Company is currently updating its Section 382 analysis to determine whether any additional ownership changes have occurred through December 31, 2021. This analysis is expected to be completed in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has adopted the accounting guidance within ASC Topic 740 on uncertainties in income taxes. ASC Topic 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, the Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have any unrecognized tax benefits. To the extent penalties and interest would be assessed on any underpayment of income tax, the Company&#8217;s policy is that such amounts would be accrued and classified as a component of income tax expense in the combined and consolidated financial statements. To date, the Company has not recorded any such interest or penalties.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company files income tax returns in the U.S. federal and various state jurisdictions. As a result of the Company&#8217;s net operating loss carryforwards, the Company&#8217;s federal and state statutes of limitations generally remain open for all</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">tax years until its net operating loss and tax credit carryforwards are utilized or expire prior to utilization. The Company does not currently have any federal or state income tax examinations in progress.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted which included provisions related to net operating loss carryovers and carrybacks, refundable payroll tax credits, deferral of payroll taxes, alternative minimum tax credit refunds, modifications to the net interest deduction limitations, and technical corrections to tax depreciation methods for qualified improvement property. The Company has evaluated the relevant provisions of the CARES Act and has not recognized any benefit related to these provisions. Therefore, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> related income tax effects have been recognized in the financial statements for the years ended December 31, 2021 and 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, as a result of legislation in the state of Connecticut, companies have the opportunity to exchange certain research and development tax credit carryforwards for a cash payment of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the research and development tax credit. The research and development expenses that qualify for Connecticut credits are limited to those costs incurred within Connecticut. The Company has elected to participate in the exchange program and, as a result, has recognized net benefits of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">103</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">131</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the years ended December 31, 2021 and 2020, respectively, which is included in research and development expenses in the accompanying statements of operations and comprehensive loss. As of December 31, 2021 and 2020, the Company has recorded $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">196</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">467</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the research and development tax credit receivables in Prepaid expenses and other current assets on the Company&#8217;s combined and consolidated balance sheets, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736313944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">15. RELATED PARTY TRANSACTIONS</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilizes and subleases office and lab space in Connecticut which is being leased from an unrelated landlord by 4Catalyzer Corporation, (&#8220;4C&#8221;), which is owned by a related party. The Company pays rent to 4C on a month-to-month basis, and no lease agreement was entered into between the parties until June 2021. A total of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">149</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was paid during 2021 and 2020, respectively.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to 4Bionics executing a plan of liquidation and dissolution on April 2, 2021, certain expenses incurred at 4Bionics were allocated to its subsidiaries, including Liminal. Expenses that broadly benefited 4Bionics and its subsidiaries were allocated evenly amongst its </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> subsidiaries. Expenses that were incurred on behalf of the employees of each company were allocated based on each subsidiary&#8217;s relative headcount. Total proceeds allocated to Liminal upon liquidation and dissolution in 2021 were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and total expenses allocated to Liminal in 2020 were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">64</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The method used to allocate common expenses of 4Bionics to Liminal is reasonable.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In January 2018, the Company entered into a Promissory Note (the &#8220;Note&#8221;) with one of its employees (the &#8220;Borrower&#8221;) in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Note bears interest at a rate equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.68</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% per annum. In accordance with the terms of the Note, since the Borrower remained employed with the Company on the maturity date of January 11, 2022, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the then outstanding principal amount and all interest accrued to that date was forgiven and Borrower is no longer required to repay the amount. Interest on the Note was payable annually in cash on the anniversary date of the Note, and as of December 31, 2021 and 2020, interest receivable in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, are included in Prepaid expenses and other current expenses on the combined and consolidated balance sheets, and interest income of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, were recognized as of December 31, 2021 and 2020.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company also made payments to 4C to prefund the acquisition of capital assets and these amounts are included in Other assets&#8201;&#8212;&#8201;related party on the combined and consolidated balance sheets. Such prepaid advances were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,154</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as of December 31, 2021 and 2020, respectively. During 2021, the Company wrote off $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">983</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of such prepaid advances considered to be unrecoverable.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Company was a party to an Amended and Restated Technology Services Agreement (the &#8220;ARTSA&#8221;), most recently amended on November 11, 2020, by and among 4C, the Company and other participant companies controlled by the Rothberg family. Under the ARTSA, the Company and the other participant companies agreed to share certain non-core technologies, which means any technologies, information or equipment owned or otherwise controlled by the participant company that are not specifically related to the core business area of the participant and subject to certain restrictions on use. The ARTSA also provided for 4C to perform certain services for the Company and each other</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">participant </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">company such as monthly administrative, management and technical consulting services to the Company which are pre-funded approximately once a quarter. The Company incurred expenses from 4C of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,055</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,160</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> during the years ended December 31, 2021 and 2020 respectively. The amounts advanced and due from 4C at December 31, 2021 and 2020, related to operating expenses was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,496</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, and is included in Due from related parties on the combined and consolidated balance sheets. There was also $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,872</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of amounts due to 4C for expenses paid on their behalf. These payables are included in Due to related parties on the combined and consolidated balance sheets. On July 7, 2021, Legacy Hyperfine, Liminal and 4C entered into First Addendums to the ARTSA, pursuant to which Legacy Hyperfine and Liminal each terminated its participation under the ARTSA immediately prior to the Closing. Legacy Hyperfine and Liminal each entered into a Master Services Agreement (the &#8220;Master Services Agreements&#8221;) with 4C effective as of July 7, 2021 pursuant to which Legacy Hyperfine and Liminal may engage 4C to provide services such as general administration, facilities, information technology, financing, legal, human resources and other services, through future statements of work and under terms and conditions to be determined by the parties with respect to any services to be provided.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The ARTSA also provided for the participant companies to provide other services to each other. The Company also has transactions with other entities under common ownership, which include payments made to third parties on behalf of the Company. The amounts remaining payable at December 31, 2021 and 2020 are $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">110</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">124</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, and are included in the Due to related parties on the combined and consolidated balance sheets. In addition, the Company has transactions with these other entities under common ownership which include payments made by the Company to third parties on behalf of the other entities and the amounts remaining receivable are in the aggregate $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> at December 31, 2021 and the amounts remaining payable are in the aggregate $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> at December 31, 2020, and are reflected in the Due from related parties on the combined and consolidated balance sheets. All amounts are paid or received throughout the year within 30 days after the end of each month.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legacy Hyperfine and Liminal entered into Technology and Services Exchange Agreements (each, a &#8220;TSEA&#8221; and collectively, the &#8220;TSEA&#8221;) with other participant companies controlled by the Rothbergs. A TSEA by and among Butterfly Network, Inc., AI Therapeutics, Inc., Quantum-Si Incorporated, 4Bionics, Tesseract Health, Inc., Detect, Inc. (f/k/a Homodeus Inc.), Legacy Hyperfine and Liminal was signed in November 2020; a TSEA by and among Quantum-Si Incorporated, AI Therapeutics, Inc., 4Bionics, Tesseract Health, Inc., Detect, Inc., Legacy Hyperfine and Liminal was signed in February 2021 (and which Protein Evolution, Inc. joined in August 2021); and a TSEA by and among Legacy Hyperfine, Liminal, AI Therapeutics, Inc., Tesseract Health, Inc. and Detect, Inc. was signed in July 2021 and is effective upon the Closing. Under the TSEA, Legacy Hyperfine, Liminal and other participant companies may, in their discretion, permit the use of non-core technologies, which include any technologies, information or equipment owned or otherwise controlled by the participant company that are not specifically related to the core business area of the participant, such as software, hardware, electronics, fabrication and supplier information, vendor lists and contractor lists, by other participant companies. As of December 31, 2021, the Company had transactions with other participant companies and had expenses of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> included in Accounts payable.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736921544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">16. COMMITMENTS AND CONTINGENCIES</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Commitments</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company sponsors a 401(k) defined contribution plan covering all eligible U.S. employees. Contributions to the 401(k) plan are discretionary. The Company did not make any matching contributions to the 401(k) plan for the years ended December 30, 2021 and 2020.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During 2020, the Company was awarded a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,610</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> grant from the BMGF for the provision and equipping of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> sites with the Hyperfine portable point-of-care MRI system to enable the performance of a multi-site study focused on optimizing diagnostic image quality (the &#8220;Project&#8221;). During 2021, the Company was awarded an additional $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,300</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> grant from the BMGF, of which $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,500</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was received for the provision and equipping of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> sites and other related deliverables, of which the remaining $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">800</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> is to be received by April 2022. The funds are accounted for as restricted cash with an offset to deferred grant revenue. At December 31, 2021 and 2020, the Company has $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,662</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,610</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">respectively, on the combined and consolidated balance sheets. Any grant funds, plus any income, that have not been used for, or committed to, the Project must be returned promptly to the BMGF upon expiration of or termination of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">agreement. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> grant fund amounts that were required to be returned under the provisions of the Project.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Contingencies</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company does not have any outstanding or ongoing litigation and legal matters where, based on present information, including its assessment of the merits of the particular claims, the Company believes it is reasonably possible that any asserted or unasserted legal claims or proceedings, individually or in aggregate, will have a material adverse effect on its results of operations or financial condition. The ultimate outcome of any legal matter cannot be predicted with certainty.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has indemnification obligations under some agreements that the Company enters into with other parties in the ordinary course of business, including business partners, investors, contractors, and the Company&#8217;s officers, directors and certain employees. The Company has agreed to indemnify and defend the indemnified party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claim because of the Company&#8217;s activities or non-compliance with certain representations and warranties made by the Company. It is not possible to determine the maximum potential loss under these indemnification provisions due to the Company&#8217;s limited history of prior indemnification claims and the unique facts and circumstances involved in any particular case. To date, losses recorded in the combined and consolidated statements of operations and comprehensive loss in connection with the indemnification provisions have not been material.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company agreed to pay $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> to a third party service provider upon the receipt by the Companies&#8217; pre-closing equity holders of any Earn-Out Shares (see Note 3. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">). The Company determined the probability of such payment to be not probable thus no liability was recognized.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029734742792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying combined and consolidated financial statements include the accounts of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and pursuant to the accounting disclosure rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). All intercompany transactions and balances have been eliminated.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_Covid19OutbreakPolicyTextBlock', window );">COVID-19 Outbreak</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">COVID-19 Outbreak</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The recent outbreak of the novel coronavirus (&#8220;COVID-19&#8221;), which was declared a pandemic by the World Health Organization on March 11, 2020 and declared a National Emergency by the President of the United States on March 13, 2020, has led to adverse impacts on the U.S. and global economies and created uncertainty regarding potential impacts on the Company&#8217;s operating results, financial condition and cash flows. The COVID-19 pandemic has had, and is expected to continue to have, an adverse impact on the Company&#8217;s operations, particularly as a result of preventive and precautionary measures that the Company, other businesses, and governments are taking. Governmental mandates related to COVID-19 or other infectious diseases, or public health crises, have impacted, and the Company expects them to continue to impact, its personnel and personnel at third-party manufacturing facilities in the United States and other countries, and the availability or cost of materials, which could disrupt or delay the Company&#8217;s receipt of instruments, components and supplies from the third parties the Company relies on to, among other things, produce its products. The COVID-19 pandemic has also had an adverse effect on the Company&#8217;s ability to attract, recruit, interview and hire at the pace the Company would typically expect to support its rapidly expanding operations. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company&#8217;s business, results of operations and financial condition, including expenses and research and development costs, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or address the COVID-19 pandemic, as well as its economic impacts.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In adjusting to the COVID-19 market and manufacturing conditions, the Company did not have to materially adjust its existing resource allocation or its factors of production. The Company has not incurred any significant impairment losses in the carrying values of its assets as a result of the COVID-19 pandemic and is not aware of any specific related event or circumstance that would require the Company to revise its estimates reflected in its combined and consolidated financial statements.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The estimates of the impact on the Company&#8217;s business may change based on new information that may emerge concerning COVID-19 and the actions to contain it or address its impact and the economic impact on local, regional, national and international markets. While the Company is unable to predict the full impact that the COVID-19 pandemic will have on its future results of operations, liquidity and financial condition due to numerous uncertainties, including the duration of the pandemic, and the actions that may be taken by government authorities across the United States and elsewhere, it is not expected to result in any significant changes in costs going forward.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of Credit Risk</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents. At December 31, 2021 and 2020, substantially all the Company&#8217;s cash and cash equivalents were invested at two financial institutions. The Company also maintains balances in various operating accounts above federally insured limits. The Company has not experienced any losses on such accounts and does not believe it is exposed to any significant credit risk on cash and cash equivalents.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant customers are those that represent more than 10% of the Company&#8217;s total revenues or gross accounts receivable balances for the periods and as of each balance sheet date presented. For each significant customer, revenue as a percentage of total revenues and gross accounts receivable as a percentage of total gross accounts receivable were as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:17.622%;"/>
          <td style="width:1.915%;"/>
          <td style="width:21.98%;"/>
          <td style="width:1.735%;"/>
          <td style="width:18.5%;"/>
          <td style="width:1.735%;"/>
          <td style="width:17.389%;"/>
          <td style="width:1.735%;"/>
          <td style="width:17.389%;"/>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;">&#160;</span></p></td>
          <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Revenue</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the year ended December 31, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the year ended December 31, 2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer A</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer B</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">24</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer C</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer D</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer E</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">53</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer F</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">41</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer G</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">32</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer H</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">26</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
        </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilizes a single exclusive manufacturer for its Swoop MRI scanner. Additionally, the Company purchases raw materials from this manufacturer.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segment Information</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s Chief Operating Decision Maker (&#8220;CODM&#8221;) is its Chief Executive Officer (&#8220;CEO&#8221;). Legacy Hyperfine and Liminal represent two operating segments. Given the similar qualitative and economic characteristics of the </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> operating segments, such that both are focused upon the development and commercialization of existing and new products and services, Legacy Hyperfine and Liminal are aggregated into </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> reporting segment. All of the Company&#8217;s long-lived assets are located in the United States. Other than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of revenue recognized in Australia, all of the revenues were earned in the United States. Since the Company is aggregated into a single operating segment, all required financial segment information is provided in the combined and consolidated financial statements.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the combined and consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions about future events that affect the amounts reported in its combined and consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates and assumptions. Significant estimates and assumptions included:</span></p><p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="margin-left:6.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue recognition, including determination of the timing and pattern of satisfaction of performance obligations, determination of the standalone selling price (&#8220;SSP&#8221;) of performance obligations and estimation of variable consideration;</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Allowance for doubtful accounts;</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net realizable value (the selling price as well as estimated costs of disposal and transportation) of inventory, and demand and future use of inventory;</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowances with respect to deferred tax assets; and</span></div></div><div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assumptions underlying the fair value used in calculation of the stock-based compensation expense.</span></div></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company bases these estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company&#8217;s combined and consolidated financial statements.	</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and Cash Equivalents</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All highly liquid investments purchased with a maturity of three months or less are cash equivalents. As of December 31, 2021 and 2020, cash and cash equivalents consist principally of cash and money market accounts.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Cash</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted cash balance represents funds received as part of grant funding and restricted in use to the purpose of the funding. For details, see the Note 2. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies - Grant Funding</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and Note 16. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Commitments and Contingencies</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounts Receivable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts receivable are stated as the amount the Company expects to collect. The Company maintains allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. As of December 31, 2021 and 2020, the allowance for doubtful accounts was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Inventories</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inventories primarily consist of finished goods which are produced by the Company&#8217;s third-party contract manufacturers as well as raw materials ordered in advance by the third-party contract manufacturer due to long delivery-lead time and which were billed to the Company. Inventories are stated at the lower of actual cost, determined using the average cost method, or net realizable value. Cost includes an allocation of wages, taxes and benefits for employees involved in warehousing, logistics coordination, material sourcing, and production planning activities. Net realizable value is based upon an estimated average selling price reduced by the estimated costs of disposal and transportation.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">valuation of inventory also requires the Company to estimate excess and obsolete inventory. The Company considers sales forecasts and historical experience to identify excess, close out, or slow-moving items as well as new</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">development schedules, product obsolescence and product merchantability, including whether older products can be remanufactured into new products, among other factors. The Company reduces the value of inventory for estimated obsolescence or lack of marketability by the difference between the cost of the affected inventory and the net realizable value.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Prepaid Expenses and Other Current Assets</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets include amounts paid in advance for operating expenses as well as monies to be received from the State of Connecticut for research and development tax credits. These research and development tax credits are exchanged for a cash refund and are typically collected within one year from the date the tax return is filed with the state. The credits are recognized as an offset to research and development expenses in the combined and consolidated statements of operations and comprehensive loss in the annual period in which the corresponding expenses were incurred.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Property and Equipment, Net</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation expense is computed using the straight-line method over the estimated useful lives of the related assets.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Useful lives of property and equipment are as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:79.609%;"/>
          <td style="width:1.925%;"/>
          <td style="width:0.624%;"/>
          <td style="width:17.229%;"/>
          <td style="width:0.613%;"/>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Property and equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Estimated useful life</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research devices</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing devices</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tooling</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Trade show assets</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Leased devices</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">-</span><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table></div><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other property and equipment include furniture and fixtures, software, vehicles, and machinery and equipment.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expenditures for major renewals and improvements are capitalized. Expenditures for repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation is eliminated from the balance sheet, and any resulting gains or losses are included in the combined and consolidated statements of operations and comprehensive loss in the period of disposal.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Impairment of Long-Lived Assets</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company reviews its long-lived assets for impairment at least annually or when the Company determines a triggering event has occurred. When a triggering event has occurred, each impairment test is based on a comparison of the future expected undiscounted cash flow to the recorded value of the asset. If the recorded value of the asset is less than the undiscounted cash flow, the asset is written down to its estimated fair value. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> impairments were recorded for the years ended December 31, 2021 and 2020.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">Capitalized Software Development Costs</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Capitalized Software Development Costs</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the costs incurred in developing the firmware embedded in the hardware devices that the Company sells and leases to its customers, the Company applies the principles of Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 985-20, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting for the Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 985-20&#8221;). ASC 985-20 requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established. Thereafter, until the product is released for sale, software development costs must be capitalized and reported at the lower of unamortized cost or net realizable value of the related product. The Company has adopted the &#8220;tested working model&#8221; approach to establishing technological feasibility for its software products. Under this</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">approach, the Company does not consider a product in development to have passed the technological feasibility milestone until the Company has completed a model of the product that contains essentially all the functionality and features of the final product and has tested the model to ensure that it works as expected. The Company&#8217;s hardware device, with the embedded firmware, was released for sale during the fourth quarter of the year ended December 31, 2020, when the Company had completed all of the research and development activity to establish the technological feasibility of the product. As of December 31, 2021 and 2020, the Company had not incurred significant costs between the establishment of technological feasibility and the release of a product for sale; thus, the Company had expensed all software development costs as incurred.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For software developed or acquired for internal use, including software used in the provision of subscription services to the Company&#8217;s customers, the Company applies the principles of ASC 350-40, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting for the Cost of Computer Software Developed or Obtained for Internal Use</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 350-40&#8221;). ASC 350-40 requires that software development costs incurred before the preliminary project stage be expensed as incurred. The Company capitalizes development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed, and the software will be used to perform the function intended. Costs incurred during the preliminary project and post-implementation stages, including training and maintenance, are expensed as incurred. Capitalized costs are amortized on a project-by-project basis using the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">straight-line method</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> over the estimated economic life of the application, which is</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> three years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, beginning when the asset is substantially ready for use. As of December 31, 2021 and 2020, the Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have any amount of capitalized internal-use software development costs.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue Recognition</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes revenue in accordance with ASC Topic 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#8220;Revenue from Contracts with Customers.&#8221;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue is recognized when or as a customer obtains control of the promised goods and services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for these goods and services. To achieve this core principle, the Company applies the following 5 steps:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 1: Identify Contracts with Customers:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company executes signed contracts with its customers for the sale of hardware devices and subscription services.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 2: Identify Performance Obligations:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company&#8217;s contracts with customers primarily include two performance obligations, namely the hardware device and subscription services, which include access to the Company&#8217;s hosted cloud-based software applications and hardware maintenance and support on an ongoing basis throughout the subscription period.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 3: Determine Transaction Price:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company&#8217;s contracts with customers include variable consideration in the form of discounts and price concessions. The Company estimates variable consideration using the expected value method based on the data available as of the end of each reporting period.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 4: Allocate Transaction Price to Performance Obligations:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company allocates transaction price to the performance obligations in a contract with a customer, based on the relative standalone selling prices of the goods and services. The standalone selling prices of the hardware devices and subscription services are determined based on the observable standalone selling prices for which the Company sells the respective goods and services on a standalone basis, including renewals of subscription services.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Step 5: Recognize Revenue as Performance Obligations are Satisfied:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Each unit of hardware devices is a performance obligation satisfied at a point in time, when control of the good transfers from the Company to the customer, which is usually upon delivery of the good to the customer. For sales of hardware where control of the product transfers to the customer upon shipment, the Company has made an accounting policy election to account for shipping and handling as fulfillment activities rather than a performance obligation. The subscription services are stand-ready obligations that are satisfied over time by providing the customer with ongoing access to the Company&#8217;s resources throughout the subscription period. The Company uses the time elapsed (straight line) measure of progress to recognize revenue as these performance obligations are satisfied evenly over the respective service period.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company offers alternative payment structures and &#8220;as-a-service&#8221; offerings that are assessed to determine whether an embedded lease arrangement exists. The Company accounts for those contracts as a lease arrangement under the current lease standard if it is determined that the contract contains an identified asset and that the right to direct the use of that asset has transferred to the customer. When a contract includes lease and non-lease components, the Company allocates consideration under the contract to each component based on the relative standalone selling price and subsequently assesses lease classification for each lease component within a contract as a sales-type lease or an operating lease. On commencement of sales-type leases, the Company recognizes revenue up-front, and amounts due from the customer under the lease contract are recognized as financing receivables on the combined and consolidated balance sheets. Interest income is recognized as revenue over the term of the lease based on the effective interest method. The Company has elected not to include sales and other taxes collected from the lessee as part of lease revenue.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All other leases that do not meet the definition of a sales-type lease are classified as operating leases. The underlying asset in an operating lease arrangement is carried at depreciated cost within Property and equipment, net on the combined and consolidated balance sheets. Depreciation is calculated using the straight-line method over the term of the underlying lease contract and is recognized as cost of revenue. The depreciable basis is the original cost of the equipment less the estimated residual value of the equipment at the end of the lease term. The Company recognizes operating lease income to product revenue on a straight-line basis over the lease term. Impairment of equipment under operating leases is assessed on the same basis as other long-lived assets.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_DeferredRevenuePolicyPolicyTextBlock', window );">Deferred Revenue</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Deferred Revenue</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from subscription services described above and is reduced as the revenue recognition criteria are met. Deferred revenue is classified as current based on expected revenue recognition timing. Specifically, deferred revenue that will be recognized as revenue within the succeeding twelve-month period is recorded as current in the Company&#8217;s combined and consolidated balance sheets.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_WarrantiesPolicyTextBlock', window );">Warranties</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Warranties</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company offers a device warranty to customers for the longer of (a) twelve (12) months from delivery of the device for devices obtained through a capital purchase, or (b) the term of the subscription agreement for devices obtained on a subscription basis (subject to continued payment of fees for the subscription service). The Company&#8217;s subscription services include hardware maintenance and support. As noted in the accounting policy for revenue recognition, the Company recognizes revenue for subscription service over time using the time elapsed measure of progress. The costs of hardware maintenance are recognized in costs of revenue as they are incurred.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development costs consists of production costs for prototype, test and pre-production units, lab supplies, consulting and personnel costs, including salaries, stock-based compensation, bonuses, benefit costs and depreciation. Certain research and development grant funding is recognized as a reduction to research and development costs (see Note 2. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies - Grant Funding</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">). The Company recognizes these costs as they are incurred.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_GrantFundingPolicyTextBlock', window );">Grant Funding</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Grant Funding</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company received certain research and development funding through a grant issued by the Bill &amp; Melinda Gates Foundation (&#8220;BMGF&#8221;). Funding is recorded on the combined and consolidated balance sheet as restricted cash upon receipt. The funding is recognized in the combined and consolidated statements of operations and comprehensive loss as a reduction to research and development expense as the related costs are incurred to meet those obligations over the grant period. Grant funding payments received in advance of research and development expenses incurred are recorded as deferred grant funding as a current liability in the Company&#8217;s combined and consolidated balance sheets.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cost of Sales</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cost of sales consists of product and service costs including personnel cost and benefits including stock-based compensation, product costs, production setup expenses, depreciation and amortization expenses, inventory excess and obsolescence expenses.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_PatentCostsPolicyTextBlock', window );">Patent Costs</a></td>
<td class="text"><p style="text-indent:2.603%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent Costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patent costs have been charged to operations as incurred, as their realization is uncertain. These costs are included in general and administrative expenses in the combined and consolidated statements of operations and comprehensive loss.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">General and Administrative</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and Administrative</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses primarily consist of personnel costs and benefits including stock-based compensation, patent and filing fees, office expenses and outside services. Outside services consist of professional services, legal and other professional fees.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Sales and Marketing</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sales and Marketing</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sales and marketing costs primarily consist of personnel costs and benefits including stock-based compensation, advertising, promotional, as well as conferences, meetings, and other events. Advertising costs are expensed as incurred. For the years ended December 31, 2021 and 2020, advertising expenses were $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,459</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">437</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Common Share</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net Loss per Common Share</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per common share is calculated by dividing the net loss attributed to common stockholders by the weighted average number of common shares outstanding during the period, without consideration of potentially dilutive securities.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares plus the common equivalent shares of the period, including any dilutive effect from such shares. The Company&#8217;s diluted net loss per common share is the same as basic net loss per common share for all periods presented since the effect of potentially dilutive securities is anti-dilutive. Refer to Note 13. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net Loss Per Share</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for further discussion.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy', window );">Convertible Preferred Stock</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Convertible Preferred Stock</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has applied the guidance in ASC Topic 480-10-S99-3A, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">SEC Staff Announcement: Classification and Measurement of Redeemable Securities,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and has therefore classified the Series A, Series B, Series C and Series D Convertible Preferred Stock (&#8220;Convertible Preferred Stock&#8221;) (see Note 10. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Convertible Preferred Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) as mezzanine equity. The Convertible Preferred Stock was recorded outside of stockholders&#8217; equity (deficit) because the Convertible Preferred Stock included a redemption provision upon a change of control, which is deemed a liquidation event that is considered outside the Company&#8217;s control. The Convertible Preferred Stock has been recorded at its original issue price, net of issuance costs. The Company did not adjust the carrying value of the Convertible Preferred Stock to the liquidation price associated with a change of control at December 31, 2020 because a change of control of the Company was not considered probable at the reporting date (see Note 10. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Convertible Preferred Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">). Subsequent adjustments to increase or decrease the carrying values to their respective liquidation prices were made only when it became probable that such a change of control would occur.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The measurement of stock-based compensation expense for all stock-based payment awards, including stock options granted to employees, directors, and consultants, is based on the estimated fair value of the awards on the date of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes stock-based compensation expense for stock option grants and incentive unit grants with only service conditions on a straight-line basis over the requisite service period of the individual grants, which is generally the vesting period, based on the estimated grant date fair values. Generally, stock option grants and incentive unit grants fully vest </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">four years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> after the grant date, and stock option grants generally have a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes the effect of forfeiture in compensation costs based on actual forfeitures when they occur.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company's stock-based compensation program includes stock option grants to its employees, directors, and consultants. Stock options are granted at exercise prices not less than the estimated fair market value of the Company&#8217;s common stock at the date of grant.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair values of stock option grants are estimated using a Black-Scholes option-pricing model. Key inputs and assumptions include the expected term of the option, stock price volatility, risk free interest rate, dividend yield, stock price and exercise price. Many of the assumptions require significant judgment and any changes could have a material impact in the determination of stock-based compensation expense.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the year ended December 31, 2020, Liminal was a wholly owned subsidiary of 4Bionics, and as such, 4Bionics granted equity awards in the form of incentive units to Liminal employees and nonemployees under 4Bionics&#8217; stock-based compensation program.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On April 2, 2021, 4Bionics executed a plan of liquidation and dissolution and its ownership in Liminal was distributed to its members and to the holders of incentive units. Immediately subsequent to the dissolution, all outstanding unvested incentive unit awards under 4Bionic&#8217;s 2019 Equity Incentive Plan were replaced with preferred stock awards indexed to and settled in the preferred stock of the former 4Bionics subsidiaries Liminal, Detect, Inc. (f/k/a Homodeus Inc.), Tesseract Health, Inc. and Protein Evolution, Inc. The preferred stock awards are subject to service vesting conditions only. No incremental value was provided to participants as a result of the modification of the awards as the modification date fair value of the incentive unit awards was equal to the modification date fair value of the stock underlying the restricted stock awards. Moreover, the remaining vesting period before and after modification was unchanged.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_EarnOutSharesPolicyTextBlock', window );">Earn-Out Shares</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Earn-Out Shares</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Earn-Out Shares, as defined in Note 3.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, to which the Companies&#8217; pre-closing equity holders are entitled, fall within the scope of ASC 815,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Derivatives and Hedging</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 815&#8221;) pursuant to which such Earn-Out Shares are equity classified and are to be recognized upon achievement of the market price milestone.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Earn-Out Shares to which certain employees are entitled to fall within the scope of ASC 718, pursuant to which such Earn-Out Shares are equity classified and their grant date fair value will be recognized as compensation expense over the vesting period.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock', window );">Research and Development Tax Credits</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development Tax Credits</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognizes research and development tax credits as a reduction of Research and Development expense as earned. For State of Connecticut research and development tax credits, which are exchanged for a cash refund from the State of Connecticut, such exchanged credits are recognized as earned as a reduction of Research and Development expense in the combined and consolidated statements of operations and comprehensive loss.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company utilizes the asset and liability method of accounting for income taxes, as set forth in ASC Topic 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Under this method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities using the enacted statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established against net deferred tax assets if, based on</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the weight of available evidence, it is more likely than not that some or all of the net deferred tax assets will not be realized. The Company has recorded a full valuation allowance as of December 31, 2021 and 2020. Based on the available evidence, the Company believes that it is more likely than not that it will be unable to utilize all of its deferred tax assets in the future.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In accordance with the provisions of ASC Topic 740, the Company accrues for the estimated amount of taxes for uncertain tax positions if it is more likely than not that the Company would be required to pay such additional taxes. An uncertain tax position will not be recognized if it has a less than 50% likelihood of being sustained. The Company&#8217;s policy is to recognize any interest and penalties related to income taxes in income tax expense in the combined and consolidated statements of operations and comprehensive loss. The Company&#8217;s open tax years subject to examination by the relevant taxing authorities are </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_0d93ec06-e2be-489a-ac3b-531777fb08ff;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2017 through 2019</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As of December 31, 2021 and 2020, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> uncertain tax positions.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent Accounting Pronouncements</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting pronouncements adopted</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2018, the FASB issued ASU No. 2018-15, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Intangibles &#8212; Goodwill and Other &#8212; Internal-Use Software Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The guidance requires certain costs incurred during the application development stage to be capitalized and other costs incurred during the preliminary project and post-implementation stages to be expensed as they are incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. A customer&#8217;s accounting for the hosting component of the arrangement is not affected. This new guidance is effective for the Company for the annual reporting period beginning January 1, 2021 and interim periods beginning January 1, 2022. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopted this guidance</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and there was </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no material effect of adoption on the combined and consolidated financial statements</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2020, the FASB issued ASU 2020-06, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which simplifies the accounting for convertible instruments by removing the separation models for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. These changes will reduce reported interest expense and increase reported net income for entities that have issued a convertible instrument that was bifurcated according to previously existing rules. ASU 2020-06 also requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will be no longer available. For public entities, this guidance is effective for annual reporting periods beginning January 1, 2022, including interim periods within that annual reporting period. For the Company, this guidance is effective for annual reporting periods beginning January 1, 2024, and interim reporting periods within annual reporting periods beginning January 1, 2024, with early adoption permitted. The Company elected to early </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopt this accounting pronouncement</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and there was </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no material impact on the Company&#8217;s combined and consolidated financial statements and disclosures</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, the FASB issued ASU 2019-12, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and improves consistent application of and simplifies U.S. GAAP for other areas of Topic 740 by clarifying existing guidance. For the Company, this ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopted</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> this guidance on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and there was </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> material effect of adoption on the Company&#8217;s combined and consolidated financial statements.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting pronouncements issued but not yet adopted</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2016, the FASB issued ASU 2016-02, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases (Topic 842),</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which outlines a comprehensive lease accounting model and supersedes the current lease guidance. The new guidance requires lessees to recognize almost all of their leases on the balance sheet by recording a lease liability and corresponding right-of-use assets. It also</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes the definition of a lease and expands the disclosure requirements of lease arrangements. As per the latest ASU 2020-05 issued by FASB, entities that have not yet issued or made available for issuance the financial statements as of June 3, 2020 can defer the new guidance for one year. For public entities, this guidance is effective for annual reporting periods beginning January 1, 2020, including interim periods within that annual reporting period. For the Company, this guidance is effective for annual reporting periods beginning January 1, 2022, and interim reporting periods within annual reporting periods beginning January 1, 2023. The Company is in the process of evaluating the impact that the adoption of this pronouncement will have on the Company&#8217;s combined and consolidated financial statements and does not expect it to be material.</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#8220;Financial Instruments &#8212; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#8221;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which was subsequently amended in November 2018 through ASU No. 2018-19, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">&#8220;Codification Improvements to Topic 326, Financial Instruments &#8212; Credit Losses.&#8221;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. ASU No. 2018-19 further clarifies that receivables arising from operating leases are not within the scope of Topic 326. Instead, impairment from receivables of operating leases should be accounted for in accordance with Topic 842, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As per the latest ASU 2020-02, the FASB deferred the timelines for certain small public and private entities, thus the new guidance will be adopted by the Company for the annual reporting period beginning January 1, 2023, including interim periods within that annual reporting period. The standard will apply as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company is in the process of evaluating the impact that the adoption of this pronouncement will have on the Company&#8217;s combined and consolidated financial statements and disclosures.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_Covid19OutbreakPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for Covid 19 outbreak.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_Covid19OutbreakPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_DeferredRevenuePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Deferred revenue policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_DeferredRevenuePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_EarnOutSharesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earn-Out shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_EarnOutSharesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_GrantFundingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for grant funding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_GrantFundingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_PatentCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for patent costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_PatentCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for research and development tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_WarrantiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_WarrantiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19347-109286<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123467743&amp;loc=d3e20905-112640<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736920136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of each significant customer, revenue as a percentage of total revenues and gross accounts receivable as a percentage of total gross accounts receivable</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant customers are those that represent more than 10% of the Company&#8217;s total revenues or gross accounts receivable balances for the periods and as of each balance sheet date presented. For each significant customer, revenue as a percentage of total revenues and gross accounts receivable as a percentage of total gross accounts receivable were as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:17.622%;"/>
          <td style="width:1.915%;"/>
          <td style="width:21.98%;"/>
          <td style="width:1.735%;"/>
          <td style="width:18.5%;"/>
          <td style="width:1.735%;"/>
          <td style="width:17.389%;"/>
          <td style="width:1.735%;"/>
          <td style="width:17.389%;"/>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;">&#160;</span></p></td>
          <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Revenue</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the year ended December 31, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the year ended December 31, 2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31, 2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer A</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer B</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">24</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer C</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer D</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer E</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">53</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer F</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">41</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer G</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">32</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Customer H</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">26</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock', window );">Schedule of estimated useful lives of property and equipment</a></td>
<td class="text"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Useful lives of property and equipment are as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:79.609%;"/>
          <td style="width:1.925%;"/>
          <td style="width:0.624%;"/>
          <td style="width:17.229%;"/>
          <td style="width:0.613%;"/>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Property and equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Estimated useful life</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research devices</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing devices</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tooling</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Trade show assets</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Leased devices</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:9.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">-</span><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7</span></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of useful lives for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029733042904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of Disaggregated Revenues</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the Company&#8217;s disaggregated revenues:</span><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.786%;"/>
        <td style="width:1.354%;"/>
        <td style="width:13.243%;"/>
        <td style="width:1.238%;"/>
        <td style="width:1.28%;"/>
        <td style="width:11.762%;"/>
        <td style="width:0.603%;"/>
        <td style="width:1.238%;"/>
        <td style="width:1.28%;"/>
        <td style="width:11.614%;"/>
        <td style="width:0.603%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Pattern of Recognition</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Device</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Point in time</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">715</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">200</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Service</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Over time</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">781</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">94</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total revenue</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,496</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">294</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Information about Receivables and Deferred Revenue from Contracts with Customers</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table provides information about receivables and deferred revenue from contracts with customers:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.275%;"/>
        <td style="width:1.597%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.42%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.481%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.42%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">553</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">174</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Unbilled receivables</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">91</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">730</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">158</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Long term deferred revenue</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">510</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736914712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IINVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Inventories</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of inventories are as follows at December 31:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.184%;"/>
        <td style="width:1.682%;"/>
        <td style="width:1.29%;"/>
        <td style="width:14.322%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.682%;"/>
        <td style="width:1.29%;"/>
        <td style="width:14.322%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Raw materials</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,355</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Finished goods</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,955</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,718</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total inventories</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">4,310</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,718</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736958744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net, are recorded at historical cost and consist of the following at December 31:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.895%;"/>
        <td style="width:1.586%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.346%;"/>
        <td style="width:0.857%;"/>
        <td style="width:1.586%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.293%;"/>
        <td style="width:0.857%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">989</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">572</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research devices</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,422</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">486</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing devices</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">669</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">575</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">385</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Construction in progress</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">341</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">613</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tooling</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">302</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">270</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Trade show assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">293</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Leased devices</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">396</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">127</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">176</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">167</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5,163</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,620</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Less: Accumulated depreciation and amortization</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,410</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">716</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">3,753</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,904</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736766296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock', window );">Schedule Of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses and other current liabilities consist of the following at December 31:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.316%;"/>
        <td style="width:1.544%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.899%;"/>
        <td style="width:0.613%;"/>
        <td style="width:0.994%;"/>
        <td style="width:1.29%;"/>
        <td style="width:14.438%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Bonus</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3,421</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">501</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Contracted services</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,711</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">456</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">SPAC bonus and other costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,071</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Legal fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">452</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">282</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Payroll and related benefits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">441</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">19</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">25</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">8,115</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,264</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for accrued liabilities and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736965032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE PREFERRED STOCK (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Summary of Authorized, Issued and Outstanding Convertible Preferred Stock</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the authorized, issued and outstanding Convertible Preferred Stock of Legacy Hyperfine immediately prior to the Business Combination:</span><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:11.212%;"/>
        <td style="width:0.984%;"/>
        <td style="width:8.631%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:8.504%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:0.931%;"/>
        <td style="width:9.848%;"/>
        <td style="width:0.508%;"/>
        <td style="width:0.984%;"/>
        <td style="width:0.561%;"/>
        <td style="width:9.615%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.132%;"/>
        <td style="width:7.954%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:7.383%;"/>
        <td style="width:0.508%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:8.377%;"/>
        <td style="width:0.508%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.153%;"/>
        <td style="width:8.642%;"/>
        <td style="width:0.508%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Class</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year<br/>of Class<br/>Issuance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br/>Price per<br/>share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br/>Authorized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br/>Issued and<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total<br/>Proceeds or<br/>Exchange<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br/>Costs</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Net<br/>Carrying<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Initial<br/>Liquidation<br/>Price per<br/>share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2014</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.04</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">25,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">25,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">998</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series B</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">10,625,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">10,625,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series C</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">31,586,210</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">31,586,210</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,382</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">234</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,148</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series D</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2020</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">-</span><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2021</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.15</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">62,577,618</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">41,970,981</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">90,237</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">136</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">90,101</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.15</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">129,788,828</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">109,182,191</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">159,119</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">372</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">158,747</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the authorized, issued and outstanding Convertible Preferred Stock of Legacy Hyperfine as of December 31, 2020:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:11.225%;"/>
        <td style="width:0.984%;"/>
        <td style="width:8.633%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:8.506%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:0.931%;"/>
        <td style="width:9.395%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:0.561%;"/>
        <td style="width:9.617%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.132%;"/>
        <td style="width:7.956%;"/>
        <td style="width:0.931%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:7.385%;"/>
        <td style="width:0.508%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.121%;"/>
        <td style="width:8.379%;"/>
        <td style="width:0.508%;"/>
        <td style="width:0.984%;"/>
        <td style="width:1.153%;"/>
        <td style="width:8.644%;"/>
        <td style="width:0.508%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Class</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year<br/>of Class<br/>Issuance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br/>Price per<br/>share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br/>Authorized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares<br/>Issued and<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total<br/>Proceeds or<br/>Exchange<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Issuance<br/>Costs</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Net<br/>Carrying<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Initial<br/>Liquidation<br/>Price per<br/>share</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series A</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2014</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.04</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">25,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">25,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">998</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series B</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">10,625,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">10,625,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8,500</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">0.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series C</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2017</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">31,586,210</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">31,586,210</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,382</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">234</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,148</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series D</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2020</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.15</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">62,577,618</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">27,799,648</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,769</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">129</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">59,640</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.15</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">129,788,828</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">95,010,858</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">128,651</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">365</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">128,286</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029730141672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY INCENTIVE PLAN (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the stock option activity under the Hyperfine Plan is presented in the table below:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.969%;"/>
        <td style="width:1.153%;"/>
        <td style="width:0.592%;"/>
        <td style="width:10.345%;"/>
        <td style="width:0.846%;"/>
        <td style="width:1.153%;"/>
        <td style="width:1.269%;"/>
        <td style="width:9.953%;"/>
        <td style="width:0.592%;"/>
        <td style="width:1.153%;"/>
        <td style="width:0.645%;"/>
        <td style="width:10.704%;"/>
        <td style="width:0.592%;"/>
        <td style="width:1.153%;"/>
        <td style="width:1.269%;"/>
        <td style="width:10.017%;"/>
        <td style="width:0.592%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Number of Options</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Weighted Average Exercise Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Weighted Average Remaining Contractual Term</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Aggregate Intrinsic Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding at January 1, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,903,479</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.87</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7.07</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,073</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">6,771,237</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.37</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">565,533</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2.65</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">587,047</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.86</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7,522,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8.79</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">30,052</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Options exercisable at December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,332,624</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2.98</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7.82</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">9,785</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Vested and expected to vest at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7,117,220</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.20</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8.77</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">28,445</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Assumptions Used to Value Option Grants to Employees and Nonemployees</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The assumptions used to value option grants to employees and nonemployees for the years ended December 31, 2021 and 2020 were as follows:</span><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.495%;"/>
        <td style="width:1.252%;"/>
        <td style="width:21.252%;"/>
        <td style="width:1.252%;"/>
        <td style="width:18.748%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Risk Free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.95</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">% - </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">% - </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected term</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5.40</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years - </span><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">6.17</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5.8</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years - </span><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">6.0</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;years</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">70</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">60</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock', window );">Summary of Stock Options Granted</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The stock options granted to the Company's employees and nonemployees for the periods presented were as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.99%;"/>
        <td style="width:1.586%;"/>
        <td style="width:0.613%;"/>
        <td style="width:14.192%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.586%;"/>
        <td style="width:0.613%;"/>
        <td style="width:14.192%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock options granted to employee</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3,534,844</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">897,240</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock options granted to nonemployee</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3,236,393</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">284,816</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total stock options granted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">6,771,237</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,182,056</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock', window );">Key Assumptions Used in Valuation for Earn-Out Shares</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The key assumptions used in the valuation were as follows:</span><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.473%;"/>
        <td style="width:1.925%;"/>
        <td style="width:0.613%;"/>
        <td style="width:15.831%;"/>
        <td style="width:2.157%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock Price</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.92</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Risk Free interest rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.96</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Term (years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">54.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation Expense</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s stock-based compensation expense for the periods presented was as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.092%;"/>
        <td style="width:1.586%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.464%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.586%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.464%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cost of sales - Device</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Cost of sales - Service</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,327</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">864</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5,482</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">231</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Sales and marketing</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">68</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">22</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">6,901</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,117</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of share-based payment award, earn-out shares, valuation assumptions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of stock options granted to employees and nonemployees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736779144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.503%;"/>
        <td style="width:1.565%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.536%;"/>
        <td style="width:0.857%;"/>
        <td style="width:1.565%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.536%;"/>
        <td style="width:0.857%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net Loss</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">64,851</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">23,427</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Numerator for Basic and Dilutive EPS &#8211; Loss available to common<br/>stockholders</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">64,851</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">23,427</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Denominator:</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Common Stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3,690,523</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,523,096</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Denominator for Basic and Dilutive EPS - Weighted-average common stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">3,690,523</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">1,523,096</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Basic and dilutive loss per share</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">17.57</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">15.38</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-dilutive Common Equivalent Shares</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Anti-dilutive common equivalent shares were as follows:</span><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.824%;"/>
        <td style="width:1.586%;"/>
        <td style="width:0.613%;"/>
        <td style="width:14.275%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.586%;"/>
        <td style="width:0.613%;"/>
        <td style="width:14.275%;"/>
        <td style="width:0.613%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding options to purchase common stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">7,522,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,903,479</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding Legacy Hyperfine convertible preferred stock (Series A through D)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">31,116,056</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Outstanding RSUs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">117,516</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Earn-Out Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10,000,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total anti-dilutive common equivalent shares</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">17,639,652</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">33,019,535</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029815859464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets (Liabilities)</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant components of the Company's deferred tax assets (liabilities) are as follows:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.782%;"/>
        <td style="width:1.576%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.387%;"/>
        <td style="width:0.857%;"/>
        <td style="width:1.576%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.387%;"/>
        <td style="width:0.857%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Gross deferred tax assets (liabilities):</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">29,300</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">14,512</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax credit carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3,429</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,238</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Fixed assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">117</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1,634</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">522</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">949</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">421</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accrued bonuses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">857</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">84</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">90</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">36,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">17,788</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">36,136</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">17,788</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Net deferred tax assets (liabilities)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Anticipated Income Tax Expense Benefit Computed by Statutory Federal Income Tax Rate</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A reconciliation of the income tax expense at the federal statutory tax rate to the Company&#8217;s effective income tax rate follows:</span><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.373%;"/>
        <td style="width:1.576%;"/>
        <td style="width:0.603%;"/>
        <td style="width:12.089%;"/>
        <td style="width:2.983%;"/>
        <td style="width:1.576%;"/>
        <td style="width:0.603%;"/>
        <td style="width:12.216%;"/>
        <td style="width:2.983%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">As of December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Statutory tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">State taxes, net of federal benefit</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4.0</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.8</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal research and development credit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.5</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Write down of federal NOL due to 382 limitation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2.8</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Write down of federal R&amp;D credits due to 382 limitation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">1.1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Deferred tax adjustment resulting from tax rate change</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2.2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">5.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.5</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">0.2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">28.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">15.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">)%</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Effective tax rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">0.0</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">0.0</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of Tax Net Operating Loss Carryforward and Tax Credit Carryforward</a></td>
<td class="text"><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, the Company had the following tax net operating loss carryforwards available to reduce future federal and Connecticut taxable income, and tax credit carryforwards available to offset future federal and Connecticut income taxes:</span></p><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.159%;"/>
        <td style="width:1.586%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.589%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.586%;"/>
        <td style="width:15.176%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Hyperfine</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Begin to Expire in</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Hyperfine tax net operating loss carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (pre-2018 NOLs)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12,084</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2034</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (post-2017 NOLs)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">91,306</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">States</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">72,621</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2034</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax credit carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,338</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2034</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Connecticut research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">752</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Connecticut others</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2022</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal others</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">135</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2022</span></span></p></td>
       </tr>
      </table><p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.406%;"/>
        <td style="width:1.513%;"/>
        <td style="width:1.29%;"/>
        <td style="width:13.539%;"/>
        <td style="width:0.613%;"/>
        <td style="width:1.513%;"/>
        <td style="width:15.126%;"/>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Liminal</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Amount</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Begin to Expire in</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Liminal tax net operating loss carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (pre-2018 NOLs)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal (post-2017 NOLs)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12,304</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">States</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">12,300</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2038</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Tax credit carryforwards:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Federal research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">449</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2038</span></span></p></td>
       </tr>
       <tr style="height:9.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Connecticut research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">49</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No Expiration</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029732597112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Significant customer, percentage of revenue (Details) - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerAMember', window );">Customer A | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerAMember', window );">Customer A | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerBMember', window );">Customer B | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerBMember', window );">Customer B | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerCMember', window );">Customer C | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerCMember', window );">Customer C | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerDMember', window );">Customer D | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerDMember', window );">Customer D | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerEMember', window );">Customer E | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerEMember', window );">Customer E | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">53.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerFMember', window );">Customer F | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerFMember', window );">Customer F | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerGMember', window );">Customer G | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerGMember', window );">Customer G | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerHMember', window );">Customer H | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=hypr_CustomerHMember', window );">Customer H | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hypr_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hypr_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hypr_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hypr_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hypr_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hypr_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hypr_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hypr_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hypr_CustomerEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hypr_CustomerEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hypr_CustomerFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hypr_CustomerFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hypr_CustomerGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hypr_CustomerGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hypr_CustomerHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hypr_CustomerHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029730114792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | Segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reporting segment | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 158,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">32,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of long-lived assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationMethod', window );">Capitalized costs, amortization method</a></td>
<td class="text">straight-line method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized costs, amortization period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expenses</a></td>
<td class="nump">$ 2,459,000<span></span>
</td>
<td class="nump">437,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Stock option grants, term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open tax year</a></td>
<td class="text">2017 2018 2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_UncertainTaxPositions', window );">Uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201815Member', window );">ASU No. 2018-15</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in accounting principle, accounting standards update, adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in accounting principle, accounting standards update, adoption date</a></td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">ASU 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in accounting principle, accounting standards update, adoption date</a></td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption', window );">Change in accounting principle, accounting standards update, early adoption</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member', window );">ASU 2019-12</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in accounting principle, accounting standards update, adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in accounting principle, accounting standards update, adoption date</a></td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized internal-use software development costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_UncertainTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of uncertain tax positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_UncertainTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of method used for amortizing cost capitalized in obtaining or fulfilling contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123341672&amp;loc=SL120154346-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 33: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date accounting standards update was adopted, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123341672&amp;loc=SL120154346-209984<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was early adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123877278&amp;loc=SL120174030-210619<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123341672&amp;loc=SL120154346-209984<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31010-122693<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201815Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201815Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029730092216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful lives of property and equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_LaboratoryEquipmentMember', window );">Laboratory Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_ResearchDevicesMember', window );">Research Devices</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_SalesAndMarketingDevicesMember', window );">Sales and Marketing Devices</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Tooling</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_TradeShowAssetsMember', window );">Trade Show Assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_LeasedDevicesMember', window );">Leased Devices</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember', window );">Other | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember', window );">Other | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_ResearchDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_ResearchDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_SalesAndMarketingDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_SalesAndMarketingDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_TradeShowAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_TradeShowAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_LeasedDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_LeasedDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029728836088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 22, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 21, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 07, 2021 </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned', window );">Percentage number of shares ceases to beneficially owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination', window );">Prepaid directors and officers insurance policy in connection with closing of business combination | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_PaymentOfPaycheckProtectionProgramLoan', window );">Payment of paycheck protection program loan | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_InterestAndPaymentsToRedeemingCompanyShareholders', window );">Interest and payments to redeeming company shareholders | $</a></td>
<td class="nump">$ 171,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ProceedsFromBusinessCombination', window );">Net proceeds from equity infusion from the Business Combination | $</a></td>
<td class="nump">141,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_BusinessCombinationPaymentOfTransactionCosts', window );">Payment of transaction costs | $</a></td>
<td class="nump">$ 20,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Dr. Rothberg</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_PercentageOfCommonStockVotingPower', window );">Percentage of common stock voting power</a></td>
<td class="nump">84.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=hypr_HealthCorMember', window );">HealthCor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ProceedsFromBusinessCombination', window );">Net proceeds from equity infusion from the Business Combination | $</a></td>
<td class="nump">$ 207,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_BusinessCombinationTransactionThresholdTradingDays', window );">Business combination transaction threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays', window );">Business combination transaction threshold consecutive trading days. | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock', window );">Number of votes per share entitled to class of common stock | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">54,977,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,277,061<span></span>
</td>
<td class="nump">1,576,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,277,061<span></span>
</td>
<td class="nump">1,576,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common Stock issued to service provider in exchange for services</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Immediately Prior To Effective Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="nump">5,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="nump">614,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | HealthCor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_CommonStockSubjectToRedemption', window );">Common stock subject to redemption</a></td>
<td class="nump">17,142,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Subscription Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Aggregate number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,610,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock', window );">Number of votes per share entitled to class of common stock | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares held by sponsor , irrevocably forfeited</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,055,288<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,055,288<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="nump">5,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Dr. Rothberg</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">15,055,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Immediately Prior To Effective Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="nump">5,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hypr_ClassBOrdinarySharesMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares held by sponsor , irrevocably forfeited</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="nump">5,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hypr_ClassAOrdinarySharesMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="nump">3,557,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hypr_SeriesA1PreferredStockMember', window );">Series A-1 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hypr_LegacyHyperfineMember', window );">Legacy Hyperfine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hypr_LegacyHyperfineMember', window );">Legacy Hyperfine | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="nump">29,711,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hypr_LegacyHyperfineMember', window );">Legacy Hyperfine | Series A-1 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="nump">3,459,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hypr_LiminalMember', window );">Liminal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business combination, shares issued as earn out consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hypr_PIPEInvestorsMember', window );">PIPE Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ProceedsFromBusinessCombination', window );">Net proceeds from equity infusion from the Business Combination | $</a></td>
<td class="nump">$ 126,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hypr_PIPEInvestorsMember', window );">PIPE Investors | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="nump">12,610,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_BusinessCombinationPaymentOfTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination payment of transaction costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_BusinessCombinationPaymentOfTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination transaction threshold consecutive trading days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_BusinessCombinationTransactionThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination transaction threshold trading days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_BusinessCombinationTransactionThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_CommonStockSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock subject to redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_CommonStockSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_InterestAndPaymentsToRedeemingCompanyShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and payments to redeeming company shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_InterestAndPaymentsToRedeemingCompanyShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of votes per share entitled to class of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_PaymentOfPaycheckProtectionProgramLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of paycheck protection program loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_PaymentOfPaycheckProtectionProgramLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage number of shares ceases to beneficially owned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_PercentageOfCommonStockVotingPower">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stock voting power.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_PercentageOfCommonStockVotingPower</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid insurance policy in connection with business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ProceedsFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ProceedsFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=hypr_HealthCorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=hypr_HealthCorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=hypr_ImmediatelyPriorToEffectiveTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=hypr_ImmediatelyPriorToEffectiveTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=hypr_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=hypr_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=hypr_HealthCorCatalioAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=hypr_HealthCorCatalioAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=hypr_SubscriptionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=hypr_SubscriptionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hypr_ClassBOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hypr_ClassBOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hypr_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hypr_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hypr_SeriesA1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hypr_SeriesA1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hypr_LegacyHyperfineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hypr_LegacyHyperfineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hypr_LiminalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hypr_LiminalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hypr_PIPEInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hypr_PIPEInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029733199016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION - Summary of Disaggregated Revenues (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,496<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Device</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">715<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Device | Point In Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">715<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">781<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Over Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 781<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029738813224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE RECOGNITION - Information about Receivables and Deferred Revenue from Contracts with Customers (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 553<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled receivables</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">730<span></span>
</td>
<td class="nump">$ 158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long term deferred revenue</a></td>
<td class="nump">$ 510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029733028072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum', window );">Payment terms range, minimum</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum', window );">Payment terms range, maximum</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was included in the deferred revenue balance at the beginning of the period</a></td>
<td class="nump">$ 158<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Capitalized contract cost</a></td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation</a></td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">$ 859<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum payment term agreed upon with the respective customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum payment term agreed upon with the respective customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029732455160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE RECOGNITION - Additional Information (Details1)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage', window );">Remaining performance obligation expected to be recognized, percentage</a></td>
<td class="nump">43.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation expected to be recognized, duration</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage', window );">Remaining performance obligation expected to be recognized, percentage</a></td>
<td class="nump">57.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation expected to be recognized, duration</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029734301768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount', window );">Fair value asset transfers, Level 1 to Level 2</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount', window );">Fair value asset transfers, Level 2 to Level 1</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount', window );">Fair value liabilities transfers, Level 1 to Level 2</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount', window );">Fair value liabilities transfers, Level 2 to Level 1</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 48,625,000<span></span>
</td>
<td class="nump">$ 58,418,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of liabilities measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of liabilities measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029734811352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Summary of Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 2,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">1,955<span></span>
</td>
<td class="nump">$ 1,718<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 4,310<span></span>
</td>
<td class="nump">$ 1,718<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029730082792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory adjustments and excess and obsolete inventory charges</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029732681608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET - Schedule of Property and equipment, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 5,163<span></span>
</td>
<td class="nump">$ 2,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(1,410)<span></span>
</td>
<td class="num">(716)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,753<span></span>
</td>
<td class="nump">1,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">989<span></span>
</td>
<td class="nump">572<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_ResearchDevicesMember', window );">Research Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,422<span></span>
</td>
<td class="nump">486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_SalesAndMarketingDevicesMember', window );">Sales and Marketing Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction In Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">613<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Tooling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">302<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_TradeShowAssetsMember', window );">Trade Show Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leased Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 176<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_ResearchDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_ResearchDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_SalesAndMarketingDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_SalesAndMarketingDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_TradeShowAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hypr_TradeShowAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736833048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 726<span></span>
</td>
<td class="nump">$ 289<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029732478392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Bonus</a></td>
<td class="nump">$ 3,421<span></span>
</td>
<td class="nump">$ 501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_AccruedContractedServicesCurrent', window );">Contracted services</a></td>
<td class="nump">2,711<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_AccruedBonusAndOtherCostsCurrent', window );">SPAC bonus and other costs</a></td>
<td class="nump">1,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal fees</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related benefits</a></td>
<td class="nump">441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_AccruedExpensesAndOtherCurrentLiabilities', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 8,115<span></span>
</td>
<td class="nump">$ 1,264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_AccruedBonusAndOtherCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued bonus and other costs current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_AccruedBonusAndOtherCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_AccruedContractedServicesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for contracted services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_AccruedContractedServicesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029728771784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 10, 2020</div></th>
<th class="th"><div>May 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=hypr_HyperfinePayrollProtectionProgramLoanMember', window );">Hyperfine PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount of note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=hypr_LiminalPayrollProtectionProgramLoanMember', window );">Liminal PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount of note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hypr_PayrollProtectionProgramLoanMember', window );">Payroll Protection Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of notes payable</a></td>
<td class="nump">$ 1,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=hypr_HyperfinePayrollProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=hypr_HyperfinePayrollProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=hypr_LiminalPayrollProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=hypr_LiminalPayrollProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hypr_PayrollProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hypr_PayrollProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029729656424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE PREFERRED STOCK - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 07, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 06, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiquidationBasisOfAccountingLiquidationPlan', window );">Liquidation rights, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In the event of any liquidation, dissolution or winding up of Legacy Hyperfine, whether voluntary or involuntary or a deemed liquidation event (which includes a merger, the sale of all of Legacy Hyperfine&#8217;s assets, or a transaction which the holders of capital stock of Legacy Hyperfine hold less than 50% of the voting securities) (each a &#8220;Liquidation Event&#8221;), the holders of the Convertible Preferred Stock are entitled to be paid out of the assets of Legacy Hyperfine available for distribution to stockholders, pari passu, at a liquidation price per share equal to the greater of: (1) the applicable original issue price of such Convertible Preferred Stock, plus any declared and unpaid dividends or (2) an amount that would have been payable had all the shares of the Convertible Preferred Stock been converted into Legacy Hyperfine common stock. These payments will be made to or set aside prior to the holders of shares of any other class or series of capital stock that is not, by its terms, senior to the Convertible Preferred Stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,010,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,182,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Original issuance price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=us-gaap_DividendDeclaredMember', window );">Dividend Declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends Payable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hypr_LegacyHyperfineMember', window );">Legacy Hyperfine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Aggregate gross proceeds of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Convertible preferred stock dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_BusinessCombinationExchangeRatio', window );">Exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hypr_LiminalConvertiblePreferredStockMember', window );">Liminal Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Convertible preferred stock dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiquidationBasisOfAccountingLiquidationPlan', window );">Liquidation rights, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In the event of any liquidation, dissolution or winding up of Liminal, whether voluntary or involuntary or a deemed liquidation event (which includes a merger, the sale of all of Liminal&#8217;s assets, or a transaction which the holders of capital stock of Liminal hold less than 50% of the voting securities) (each a &#8220;Liquidation Event&#8221;), the holders of the Convertible Preferred Stock are entitled to be paid out of the assets of Liminal available for distribution to stockholders, pari passu, at a liquidation price per share equal to the greater of: (1) the applicable original issuance price of $.1287 per share for Series A-1 and Series A-2 Convertible Preferred Stock, plus any declared and unpaid dividends or (2) an amount that would have been payable had all the shares of the Convertible Preferred Stock been converted into Liminal common stock. These payments will be made to or set aside prior to the holders of shares of any other class or series of capital stock that is not, by its terms, senior to the Convertible Preferred Stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_BusinessCombinationExchangeRatio', window );">Exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockConversionBasis', window );">Convertible preferred stock, conversion basis</a></td>
<td class="text">On April 1, 2021 Liminal effected a recapitalization whereby each share of Liminal common stock outstanding was exchanged for shares of Liminal Series A-1 preferred stock and Liminal Series A-2 preferred stock. The value ascribed to the preferred stock is equivalent to the total amount of historical equity investments contributed by the common shareholder.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Aggregate gross proceeds of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hypr_LiminalConvertiblePreferredStockMember', window );">Liminal Convertible Preferred Stock | Dividend Declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends Payable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfVotesPerShare', window );">Number of votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockConversionBasis', window );">Convertible preferred stock, conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each share of Series A Convertible Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of Legacy Hyperfine Special-voting common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional common shares for no consideration or consideration less than the conversion price of the Series A Convertible Preferred Stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfVotesPerShare', window );">Number of votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,625,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfVotesPerShare', window );">Number of votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,586,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,586,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfVotesPerShare', window );">Number of votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,799,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,970,981<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hypr_SeriesBCAndDConvertiblePreferredStockMember', window );">Series B, C and D Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockConversionBasis', window );">Convertible preferred stock, conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each share of Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock shall be convertible, at the option of the holder, at any time after the date of issuance into shares of Legacy Hyperfine common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional common shares for no consideration or consideration less than the conversion price of the respective series of Convertible Preferred Stock, which is equal to the original issuance price for each series of Convertible Preferred Stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hypr_SeriesA1PreferredStockMember', window );">Series A-1 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfVotesPerShare', window );">Number of votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockConversionBasis', window );">Convertible preferred stock, conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each share of Series A-1 Convertible Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of Liminal Special-voting common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional shares of Liminal common stock for no consideration or consideration less than the conversion price of the Series A Convertible Preferred Stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Original issuance price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hypr_SeriesATwoConvertiblePreferredStockMember', window );">Series A-2 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfVotesPerShare', window );">Number of votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockConversionBasis', window );">Convertible preferred stock, conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each share of Series A-2 Convertible Preferred Stock shall be convertible, at the option of the holder, at any time after the date of issuance into shares of Liminal common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional shares of common stock for no consideration or consideration less than the conversion price of the respective series of Convertible Preferred Stock, which is equal to the original issuance price for each series of Convertible Preferred Stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Original issuance price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_BusinessCombinationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination, exchange ratio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_BusinessCombinationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_NumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of votes per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_NumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiquidationBasisOfAccountingLiquidationPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the plan of liquidation. Includes, but is not limited to, the manner by which assets are expected to be disposed of and other items expected to be sold that had not been previously recognized as assets, the manner by which liabilities are expected to be settled, and the expected date by which liquidation is expected to be complete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686388-199418<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiquidationBasisOfAccountingLiquidationPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConversionBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConversionBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=us-gaap_DividendDeclaredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=us-gaap_DividendDeclaredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hypr_LegacyHyperfineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hypr_LegacyHyperfineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hypr_LiminalConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hypr_LiminalConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hypr_SeriesBCAndDConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hypr_SeriesBCAndDConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hypr_SeriesA1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hypr_SeriesA1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hypr_SeriesATwoConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hypr_SeriesATwoConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029729948040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE PREFERRED STOCK - Summary of Authorized, Issued and Outstanding Convertible Preferred Stock (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 06, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">129,788,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,788,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued</a></td>
<td class="nump">109,182,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,010,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding</a></td>
<td class="nump">109,182,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,010,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Total Proceeds or Exchange Value</a></td>
<td class="nump">$ 159,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquitySharesIssuanceCost', window );">Issuance Costs</a></td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Net Carrying Value</a></td>
<td class="nump">$ 158,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquityYearOfClassIssuance', window );">Year of Class Issuance</a></td>
<td class="text">2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Issuance Price per share</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Total Proceeds or Exchange Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquitySharesIssuanceCost', window );">Issuance Costs</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Net Carrying Value</a></td>
<td class="nump">$ 998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Initial Liquidation Price per share</a></td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquityYearOfClassIssuance', window );">Year of Class Issuance</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Issuance Price per share</a></td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">10,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,625,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued</a></td>
<td class="nump">10,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,625,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding</a></td>
<td class="nump">10,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,625,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Total Proceeds or Exchange Value</a></td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Net Carrying Value</a></td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Initial Liquidation Price per share</a></td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquityYearOfClassIssuance', window );">Year of Class Issuance</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Issuance Price per share</a></td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">31,586,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,586,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued</a></td>
<td class="nump">31,586,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,586,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding</a></td>
<td class="nump">31,586,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,586,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Total Proceeds or Exchange Value</a></td>
<td class="nump">$ 59,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquitySharesIssuanceCost', window );">Issuance Costs</a></td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Net Carrying Value</a></td>
<td class="nump">$ 59,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Initial Liquidation Price per share</a></td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquityYearOfClassIssuance', window );">Year of Class Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Issuance Price per share</a></td>
<td class="nump">$ 2.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized</a></td>
<td class="nump">62,577,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,577,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued</a></td>
<td class="nump">41,970,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,799,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding</a></td>
<td class="nump">41,970,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,799,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Total Proceeds or Exchange Value</a></td>
<td class="nump">$ 90,237<span></span>
</td>
<td class="nump">$ 59,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquitySharesIssuanceCost', window );">Issuance Costs</a></td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Net Carrying Value</a></td>
<td class="nump">$ 90,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Initial Liquidation Price per share</a></td>
<td class="nump">$ 2.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquityYearOfClassIssuance', window );">Year of Class Issuance</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TemporaryEquityYearOfClassIssuance', window );">Year of Class Issuance</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_TemporaryEquitySharesIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, shares, issuance cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_TemporaryEquitySharesIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_TemporaryEquityYearOfClassIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, year of class issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_TemporaryEquityYearOfClassIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029729587160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (DEFICIT) - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 22, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared common stock | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized</a></td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value, (per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">55,277,061<span></span>
</td>
<td class="nump">54,977,061<span></span>
</td>
<td class="nump">1,576,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_CommonStockNumberOfVotesPerShare', window );">Common shares, votes per share | Vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized</a></td>
<td class="nump">27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value, (per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">15,055,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_CommonStockNumberOfVotesPerShare', window );">Common shares, votes per share | Vote</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_CommonStockNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock number of votes per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_CommonStockNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029729240376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY INCENTIVE PLAN - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Option </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Option </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,901,000<span></span>
</td>
<td class="nump">$ 1,117,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash proceeds from exercise of stock options | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,497,000<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue', window );">Incremental value as a result of the modification of the awards | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental compensation expense recognized as a result of the modification | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized stock-based compensation expense | $</a></td>
<td class="nump">$ 13,650,000<span></span>
</td>
<td class="nump">$ 13,650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option award to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">949,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfSeparateOptionAwards', window );">Number of separate option awards | Option</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Executive Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option award to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option Grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,772,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected annual equity volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units ("RSU") granted</a></td>
<td class="nump">117,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total grant date fair value | $</a></td>
<td class="nump">$ 1,080,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Total grant date fair value recognized period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Granted value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hypr_IncentiveUnitActivityMember', window );">Incentive Unit Grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService', window );">Repurchase right valid period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember', window );">Incentive Unit Awards and Replacement Preferred Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected annual equity volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hypr_EarnOutSharesMember', window );">Earn-Out Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected annual equity volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares entitle to certain employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">933,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hypr_StockOptionsOneMember', window );">Stock Options One | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option award to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hypr_StockOptionsTwoMember', window );">Stock Options Two | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option award to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember', window );">Two Separate Option Awards | Executive Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfSeparateOptionAwards', window );">Number of separate option awards | Option</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option award to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,899,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Executive Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option award to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant date fair value per share | $ / shares</a></td>
<td class="nump">$ 9.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Stock Options One | Executive Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option award to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Separate Option Award | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option award to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember', window );">Hyperfine Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance</a></td>
<td class="nump">16,013,762<span></span>
</td>
<td class="nump">16,013,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_CommonStockRemainsAvailableForIssuance', window );">Common stock remain available for issuance</a></td>
<td class="nump">8,256,741<span></span>
</td>
<td class="nump">8,256,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option award to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,771,237<span></span>
</td>
<td class="nump">1,182,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of stock options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,752,000<span></span>
</td>
<td class="nump">$ 167,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of options granted | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected annual equity volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember', window );">Hyperfine Plan | Service and Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option award to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember', window );">Hyperfine Plan | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ExchangeRatio', window );">Exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hypr_LiminalMember', window );">Liminal | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ExchangeRatio', window );">Exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember', window );">4Bionics Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 578,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_CommonStockRemainsAvailableForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock remains available for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_CommonStockRemainsAvailableForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange ratio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_NumberOfSeparateOptionAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of separate option awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_NumberOfSeparateOptionAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, award repurchase right valid period commencing with date of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based payment arrangement plan modification incremental value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hypr_IncentiveUnitActivityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hypr_IncentiveUnitActivityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hypr_EarnOutSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hypr_EarnOutSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hypr_StockOptionsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hypr_StockOptionsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hypr_StockOptionsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hypr_StockOptionsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hypr_ServiceAndPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hypr_ServiceAndPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hypr_LiminalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hypr_LiminalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029728826936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY INCENTIVE PLAN - Summary of Stock Option Activity (Details) - Hyperfine Plan - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding</a></td>
<td class="nump">1,903,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">6,771,237<span></span>
</td>
<td class="nump">1,182,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(565,533)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(587,047)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding</a></td>
<td class="nump">7,522,136<span></span>
</td>
<td class="nump">1,903,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable</a></td>
<td class="nump">2,332,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest</a></td>
<td class="nump">7,117,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding</a></td>
<td class="nump">$ 0.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">3.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">2.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">3.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding</a></td>
<td class="nump">3.21<span></span>
</td>
<td class="nump">$ 0.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable</a></td>
<td class="nump">2.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest</a></td>
<td class="nump">$ 3.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward', window );"><strong>Weighted Average Remaining Contractual Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">8 years 9 months 14 days<span></span>
</td>
<td class="text">7 years 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable</a></td>
<td class="text">7 years 9 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest</a></td>
<td class="text">8 years 9 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 30,052<span></span>
</td>
<td class="nump">$ 2,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable</a></td>
<td class="nump">9,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest</a></td>
<td class="nump">$ 28,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options outstanding aggregate intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029736200872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY INCENTIVE PLAN - Assumptions Used to Value Option Grants to Employees and Nonemployees (Details) - Stock Option Grants<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk Free interest rate, minimum</a></td>
<td class="nump">0.95%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk Free interest rate, maximum</a></td>
<td class="nump">1.13%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 years 2 months 1 day<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029729229624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY INCENTIVE PLAN - Summary of Stock Options Granted (Details) - Hyperfine Plan - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="nump">6,771,237<span></span>
</td>
<td class="nump">1,182,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember', window );">Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="nump">3,534,844<span></span>
</td>
<td class="nump">897,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember', window );">Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="nump">3,236,393<span></span>
</td>
<td class="nump">284,816<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hypr_HyperfineEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029732539176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY INCENTIVE PLAN - Key Assumptions Used in Valuation for Earn-Out Shares (Details) - Earn-Out Shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock Price</a></td>
<td class="nump">$ 10.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk Free interest rate</a></td>
<td class="nump">0.96%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">54.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hypr_EarnOutSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hypr_EarnOutSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029734840616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY INCENTIVE PLAN - Summary of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 6,901<span></span>
</td>
<td class="nump">$ 1,117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">5,482<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and Marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Device | Cost Of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Cost Of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029737722600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (64,851)<span></span>
</td>
<td class="num">$ (23,427)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Numerator for Basic and Dilutive EPS &#8211; Loss available to common stockholders</a></td>
<td class="num">$ (64,851)<span></span>
</td>
<td class="num">$ (23,427)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Denominator for Basic and Dilutive EPS - Weighted-average common stock</a></td>
<td class="nump">3,690,523<span></span>
</td>
<td class="nump">1,523,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and dilutive loss per share</a></td>
<td class="num">$ (17.57)<span></span>
</td>
<td class="num">$ (15.38)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Denominator for Basic and Dilutive EPS - Weighted-average common stock</a></td>
<td class="nump">3,690,523<span></span>
</td>
<td class="nump">1,523,096<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029732572520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE - Schedule of Anti-dilutive Common Equivalent Shares (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive common equivalent shares</a></td>
<td class="nump">17,639,652<span></span>
</td>
<td class="nump">33,019,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding Options to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive common equivalent shares</a></td>
<td class="nump">7,522,136<span></span>
</td>
<td class="nump">1,903,479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember', window );">Outstanding Legacy Hyperfine Convertible Preferred Stock (Series A through D)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive common equivalent shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,116,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Outstanding RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive common equivalent shares</a></td>
<td class="nump">117,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hypr_EarnOutSharesMember', window );">Earn-Out Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive common equivalent shares</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hypr_EarnOutSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hypr_EarnOutSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029728825048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Deferred Tax Assets (Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Components of Deferred Tax Assets and Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 29,300<span></span>
</td>
<td class="nump">$ 14,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carryforwards</a></td>
<td class="nump">3,429<span></span>
</td>
<td class="nump">2,238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets (liabilities)</a></td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">1,634<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred Revenue</a></td>
<td class="nump">949<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued bonuses</a></td>
<td class="nump">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">36,136<span></span>
</td>
<td class="nump">17,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">$ (36,136)<span></span>
</td>
<td class="num">$ (17,788)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029732500648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Ownership</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 16, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 17, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate percent</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_DeferredTaxAssetsValuationAllowanceIncreased', window );">Deferred tax assets valuation allowance increased</a></td>
<td class="nump">$ 18,348,000<span></span>
</td>
<td class="nump">$ 3,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OwnershipChangePercentageTestingPeriod', window );">Ownership change percentage testing period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OwnershipChangeDescription', window );">Ownership change, description</a></td>
<td class="text">ownership change occurs when certain shareholders increase their aggregated ownership by more than 50 percentage points over their lowest ownership percentage in a testing period (typically three years).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfConsecutiveOwnershipChanges', window );">Number of consecutive ownership changes | Ownership</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OwnershipChangesDateOne', window );">Ownership changes date, one</a></td>
<td class="text">Jan. 17,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OwnershipChangesDateTwo', window );">Ownership changes date, two</a></td>
<td class="text">May 16,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation', window );">Amount of annual limitation of net operating loss and tax credit carryforwards due to ownership change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,008,000<span></span>
</td>
<td class="nump">$ 865,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear', window );">Ownership changes analysis expected to be completed year</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_IncomeTaxEffectsRecognized', window );">Income tax effects recognized</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards', window );">Percentage of cash payment in research and development tax credit</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development tax credit receivables</a></td>
<td class="nump">$ 196,000<span></span>
</td>
<td class="nump">467,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_ExchangeProgramRecognizedNetBenefits', window );">Exchange program recognized net benefits</a></td>
<td class="nump">103,000<span></span>
</td>
<td class="nump">131,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=hypr_FederalAndStateNetOperatingLossesMember', window );">Federal And State Net Operating Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=hypr_FederalNetOperatingLossMember', window );">Federal Net Operating Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation', window );">Amount of estimated net operating loss and tax credit carryforwards will expire before utilization due to ownership change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,125,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Federal Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation', window );">Amount of estimated net operating loss and tax credit carryforwards will expire before utilization due to ownership change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 249,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_DeferredTaxAssetsValuationAllowanceIncreased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets valuation allowance increased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_DeferredTaxAssetsValuationAllowanceIncreased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_ExchangeProgramRecognizedNetBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange program recognized net benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_ExchangeProgramRecognizedNetBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_IncomeTaxEffectsRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax effects recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_IncomeTaxEffectsRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of annual limitation of net operating loss and tax credit carryforwards due to ownership change, Under Internal Revenue Code Section 382.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated net operating loss and tax credit carryforwards will expire before utilization due to ownership change, under Internal Revenue Code Section 382.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_NumberOfConsecutiveOwnershipChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of consecutive ownership changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_NumberOfConsecutiveOwnershipChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_OwnershipChangeDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership Change description</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_OwnershipChangeDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_OwnershipChangePercentageTestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership Change percentage testing period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_OwnershipChangePercentageTestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership changes analysis expected to be completed year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_OwnershipChangesDateOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership changes Date one</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_OwnershipChangesDateOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_OwnershipChangesDateTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership changes Date two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_OwnershipChangesDateTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of cash payment in research and development tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=hypr_FederalAndStateNetOperatingLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=hypr_FederalAndStateNetOperatingLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=hypr_FederalNetOperatingLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=hypr_FederalNetOperatingLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029732485688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Reconciliation of Anticipated Income Tax Expense Benefit Computed by Statutory Federal Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Federal research and development credits</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation', window );">Write down of federal NOL due to 382 limitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.80%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation', window );">Write down of federal R&amp;D credits due to 382 limitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Deferred tax adjustment resulting from tax rate change</a></td>
<td class="nump">2.20%<span></span>
</td>
<td class="num">(5.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(28.10%)<span></span>
</td>
<td class="num">(15.90%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>EffectiveIncomeTaxRateReconciliationWriteDownOfFederalNolDueTo382Limitation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>EffectiveIncomeTaxRateReconciliationWriteDownOfFederalResearchAndDevelopmentCreditsDueTo382Limitation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029728731416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Tax Net Operating Loss Carryforward and Tax Credit Carryforward (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_HyperfineMember', window );">Hyperfine | Federal Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 2,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TaxCreditCarryforwardBeginToExpirationYear', window );">Begin to Expire in</a></td>
<td class="text">2034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_HyperfineMember', window );">Hyperfine | Connecticut Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_HyperfineMember', window );">Hyperfine | Connecticut Others</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TaxCreditCarryforwardBeginToExpirationYear', window );">Begin to Expire in</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_HyperfineMember', window );">Hyperfine | Federal | Pre-2018</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Tax net operating loss carryforward</a></td>
<td class="nump">$ 12,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OperatingLossCarryforwardsBeginToExpireYear', window );">Begin to Expire in</a></td>
<td class="text">2034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_HyperfineMember', window );">Hyperfine | Federal | Post-2017</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Tax net operating loss carryforward</a></td>
<td class="nump">$ 91,306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_HyperfineMember', window );">Hyperfine | States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Tax net operating loss carryforward</a></td>
<td class="nump">$ 72,621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OperatingLossCarryforwardsBeginToExpireYear', window );">Begin to Expire in</a></td>
<td class="text">2034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_HyperfineMember', window );">Hyperfine | Federal Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TaxCreditCarryforwardBeginToExpirationYear', window );">Begin to Expire in</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_LiminalMember', window );">Liminal | Federal Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_TaxCreditCarryforwardBeginToExpirationYear', window );">Begin to Expire in</a></td>
<td class="text">2038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_LiminalMember', window );">Liminal | Connecticut Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_LiminalMember', window );">Liminal | Federal | Post-2017</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Tax net operating loss carryforward</a></td>
<td class="nump">12,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hypr_LiminalMember', window );">Liminal | States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Tax net operating loss carryforward</a></td>
<td class="nump">$ 12,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OperatingLossCarryforwardsBeginToExpireYear', window );">Begin to Expire in</a></td>
<td class="text">2038<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_OperatingLossCarryforwardsBeginToExpireYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards begin to expire year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_OperatingLossCarryforwardsBeginToExpireYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_TaxCreditCarryforwardBeginToExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward begin to expiration year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_TaxCreditCarryforwardBeginToExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hypr_HyperfineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hypr_HyperfineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=hypr_ConnecticutResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=hypr_ConnecticutResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=hypr_ConnecticutOthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=hypr_ConnecticutOthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=hypr_PreTwoThaousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=hypr_PreTwoThaousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=hypr_PostTwoThaousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=hypr_PostTwoThaousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=hypr_FederalOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=hypr_FederalOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hypr_LiminalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hypr_LiminalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029732785592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 11, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Subsidiary</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Expenses allocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromEmployeesNoncurrent', window );">Promissory Note with one of the employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Interest rate of the Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_InterestReceivableRelatedPartiesCurrent', window );">Interest receivable from the Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeRelatedParty', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OtherAssetsRelatedPartyNoncurrent', window );">Prepaid advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">1,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_DueFromEmployeesForgiveness', window );">Promissory Note with one of the employees will be forgiven</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=hypr_AmendedAndRestatedTechnologyServicesAgreementMember', window );">ARTSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Due to related parties for payments paid on their behalf</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Due from related parties for payments made on behalf of the other entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_CatalyzerCorporation4Member', window );">4C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_RelatedPartyTransactionPaymentsForRent', window );">Payments for rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_OtherAssetsRelatedPartyNoncurrent', window );">Prepaid advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_PrepaidAdvancesUnrecoverable', window );">Prepaid advances unrecoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,055<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Due to related parties for payments paid on their behalf</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,872<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_FourBionicsMember', window );">4Bionics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfSubsidiaries', window );">Number of subsidiaries | Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_LiminalMember', window );">Liminal | Allocation of Expense Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Expenses allocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_TechnologyAndServicesExchangeAgreementMember', window );">TESA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Due to related parties for payments paid on their behalf</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_DueFromEmployeesForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Due from employees forgiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_DueFromEmployeesForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_InterestReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest receivable related parties current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_InterestReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_NumberOfSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_NumberOfSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_OtherAssetsRelatedPartyNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other assets related party noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_OtherAssetsRelatedPartyNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_PrepaidAdvancesUnrecoverable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid advances unrecoverable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_PrepaidAdvancesUnrecoverable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_RelatedPartyTransactionPaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transaction payments for rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_RelatedPartyTransactionPaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromEmployeesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from an Entity employee, not to include stockholders or officers, which are usually due after 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39599-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromEmployeesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest-bearing assets owed to the entity by related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=hypr_AmendedAndRestatedTechnologyServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=hypr_AmendedAndRestatedTechnologyServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_CatalyzerCorporation4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_CatalyzerCorporation4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_FourBionicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_FourBionicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_LiminalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_LiminalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=hypr_AllocationOfExpenseIncurredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=hypr_AllocationOfExpenseIncurredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_TechnologyAndServicesExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hypr_TechnologyAndServicesExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140029728767064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">241 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Site</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Site</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_DeferredGrantFundingCurrent', window );">Deferred grant funding</a></td>
<td class="nump">$ 2,662,000<span></span>
</td>
<td class="nump">$ 1,610,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_NumberOfSites', window );">Number of sites for equipping Hyperfine portable point-of-care MRI system | Site</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_GrantAwarded', window );">Grant awarded from the BMGF</a></td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_GrantAwardedForProvisionAndEquipping', window );">Grant awarded for provision and equipping</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Expenses allocated</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_GrantFundRequiredToReturnUnderProvisions', window );">Grant fund amounts required to be returned under provisions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hypr_GrantAwardedForOtherRelatedDeliverables', window );">Grant awarded for other related deliverables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_DeferredGrantFundingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the carrying amount of deferred grant funding as of balance sheet date, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_DeferredGrantFundingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_GrantAwarded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of grant awarded.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_GrantAwarded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_GrantAwardedForOtherRelatedDeliverables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grant awarded for other related deliverables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_GrantAwardedForOtherRelatedDeliverables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_GrantAwardedForProvisionAndEquipping">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of grant awarded for provision and equipping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_GrantAwardedForProvisionAndEquipping</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_GrantFundRequiredToReturnUnderProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grant Fund Required To Return Under Provisions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_GrantFundRequiredToReturnUnderProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hypr_NumberOfSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of sites for equipping Hyperfine portable point-of-care MRI system.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hypr_NumberOfSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hypr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>hypr-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:hypr="http://hyperfine.io/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="hypr-20211231.xsd" xlink:type="simple"/>
    <context id="C_ccfbba15-73af-4c55-9b92-86db3883e6e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1c2f3fc1-c9e7-40c0-86e4-fd3a7bdf44bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="C_e9c6aa3c-7348-4f82-973e-f19a18dd2b91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_42721900-2218-40df-95d4-cb7a647e1a07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="C_89e586a8-ee0a-4268-89f0-554f600718eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_fad97c6a-6c78-4438-bbf2-78f5774e74c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7ff32017-f2ed-48aa-9ebf-c6e5f3edd992">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_a7d85790-8273-4800-91ae-17cbe035c271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hypr:AllocationOfExpenseIncurredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:LiminalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_e7a1c7aa-d329-429a-b3c9-637f64056a81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="C_ed6f3ccf-47d7-4f6b-a138-e38661edb807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2002-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_f483c871-8db6-4367-9cdb-c9ee827a41fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f3f7bbf1-1516-476a-9c86-2591116d1012">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:PIPEInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="C_88d7f310-a8d6-4fc6-888b-0a034f2de16c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="C_3c9581e7-07d4-4e55-bccf-5e8bd25bbbb7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_d03d8509-9cd9-41c6-ad48-7df3d9451e56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_09eef7e3-8ef7-4872-9505-3cdfab129205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a1217e52-b226-462c-8502-52f8c592156b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:HyperfineConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_9328b463-fd12-44fd-b26c-a8b2835078a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:ShareBasedPaymentArrangementSeparateOptionAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0748c7ce-7d19-4746-8d34-695f218ca5aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:ResearchDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_3666fba2-b98c-4e2a-8471-61fd11c1c18a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="C_474a603f-d6db-4d8d-92d3-70cb2d1e090f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_f64f1671-f740-47b2-bdee-89e73fc16d87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_eb4d058b-3288-420e-9ec3-612fad7d2de5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_00ed74b2-7850-4508-bc80-e83b416ee826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:FourBionicsTwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_4ee5d355-9181-4953-8217-8e5ef9995358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_604f763d-b166-4d76-93fc-9435e4fa41ff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_f5b7fd28-718c-44aa-9bed-942c827825a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:PIPEInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="C_d3db78a5-9170-438c-85d3-79a5e0440f3d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_b6b6072c-15e7-4e45-9a9f-aea0353e0e42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hypr:EarnOutSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a1f35ddb-eb58-49b6-a2b6-56b35e52474f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="C_fca29af6-e6e3-4712-95bc-d0e946d2ca70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9975d5e6-b660-419f-abf6-e2a46827db35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">us-gaap:DividendDeclaredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:LiminalConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_caae9469-5585-4e17-9b3f-2def45052046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:TradeShowAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0449cc1b-e603-4161-b7c3-fb5362667dbf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:LiminalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-07</startDate>
            <endDate>2021-07-07</endDate>
        </period>
    </context>
    <context id="C_e0c91aab-9546-4751-89ce-b88e18335be2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_b5a4b802-89f3-4579-863a-5eecf71671f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-21</startDate>
            <endDate>2021-12-21</endDate>
        </period>
    </context>
    <context id="C_9bead3a6-4985-410f-99b5-30235563115f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ef2546a8-4c0e-4b36-9c52-90a9b0abd33f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_464908b0-1fa1-4326-90d3-0c2106209a10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_3b17a194-f917-4277-981e-1a50762d4429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_7bcd7cb4-1dc9-4c68-a43e-62994fd1ac21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1ae6ab52-d904-4842-a161-d9892fd7ed09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_79b8e3d1-0c6c-4ae4-9639-ebe2dada5fbe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_d6171afc-03fd-445e-ac62-3ae933435993">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_96dd3b27-0bd2-4e00-a097-4fc98922b833">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-21</startDate>
            <endDate>2021-12-21</endDate>
        </period>
    </context>
    <context id="C_37fd5a65-0913-4f4d-81f7-910f82c3ea2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_80cfe749-acb3-416a-9bfa-17252d7bfb03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">hypr:FederalOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c45f29de-244b-43b1-84da-2f83aa0a16d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hypr:HyperfinePayrollProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-10</instant>
        </period>
    </context>
    <context id="C_f284e816-cacb-4f3c-bea6-47fac4904183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_e01451b3-5582-4ac0-8725-58320e1c8896">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_9f696af7-210f-43ef-9b46-8a8e5818aaa6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7cb5eab9-0fdd-4dc3-8931-9772493bd16f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f96e34c7-c8df-43a2-b54b-74085b8e63c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0e92975e-291a-4d95-b890-e43efecfb475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_164ab371-7976-4ab1-b472-197262c28f3c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f61cbd06-6f47-40f0-bf5b-f5c8aaa869bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_8798fe66-4ab2-4809-8278-b52ed9e1d7cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f9ad2466-6588-4aad-9c83-c52d2116818a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">hypr:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-21</instant>
        </period>
    </context>
    <context id="C_2f407302-608a-4972-886c-07025c0d9e38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f5de6d93-0dcb-4c74-a001-200800fe2bd9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:StockOptionsTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_8b92779c-b81b-4034-9f67-08e85cb2c22d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_2deb5363-ab1f-4a7d-bf8d-b4b73bf8fc16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">hypr:FederalOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e1bced35-5643-4d57-a6ea-b24e0a212bf8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1e1d998b-c680-42bd-bbd7-9bc2ff70463c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <instant>2021-07-07</instant>
        </period>
    </context>
    <context id="C_07853f31-4dbf-448b-a757-6ceeb0365107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="C_7f6ecd42-2a1a-4c28-acf6-496ab6a2707e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_3ad8f729-5552-455b-b2fb-acfa4b71867b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <startDate>2021-12-21</startDate>
            <endDate>2021-12-21</endDate>
        </period>
    </context>
    <context id="C_e8929d7a-f4b3-4599-a490-21ed76128b01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_8947e16c-53a9-404b-b4aa-6eea41055362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c41d64ad-bb4c-4c76-99f9-e336bc1ab030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1a8cf60f-453e-465e-86fc-c6ed0ff3919e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerHMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_06ca1284-0a43-490c-94fa-34c74c4f5fbd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:HyperfineConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f8f8bfd0-b2c9-4228-859d-e035e36fdaff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:LiminalConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_fa39ca24-c5b2-4cc3-9108-625304c8561d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:TradeShowAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b9bd646d-669a-4b5c-9bdd-74063cca61b6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_a7be29aa-140e-44cb-a9f4-ff103f126abe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:CatalyzerCorporation4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_dbe7ddab-0056-49e4-9a0e-48437f4d7b7e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:ConnecticutOthersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_8e87568d-825c-49a7-8077-18ebeca513ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hypr:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="C_bbc35c1e-828e-43bf-b1bb-089209526261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1dd44ac9-6110-4a83-a30a-28c9fbf87799">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_cd314d5f-1d0e-45e6-bee2-447dde950094">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="C_a27dd307-2fcd-40ef-8e2c-ce7ce0a4e528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_bae04bbe-9b11-42f5-97ae-1c488ef30d01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:ServiceAndPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1cf87dff-a097-4d35-8816-c1468d5730fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7c17d825-000e-4c3d-a83a-3be01c1f2e4e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_8dd83f7f-8142-464d-9d9c-cf5fce19a67d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-01</instant>
        </period>
    </context>
    <context id="C_77379a12-290a-4832-afc5-a9209e02e808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_7e37528b-2b21-4306-ae2b-4ba44246def5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="C_9d669f38-72cc-427b-8ddb-8ad088a985fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f544b39f-f467-43d9-bd6c-b63e721ee22c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a5356276-34ee-4730-b9c0-7fa02ce0c4f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_78bf0f13-f3b7-455a-a4d0-d20db26ececd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_66a4ed44-133c-453e-b237-1b588d0b3bee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_bb1fde1a-0016-49f0-92be-2a618f68f12f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerHMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_931d86b2-1bb0-4d61-bc67-022ee2881f97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_bcf76ade-60dc-4368-aef5-2520cbade643">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_61d98dd2-ccb5-4863-8e6c-5b1ad14f4dab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:StockOptionsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="C_b7398889-0087-4e71-ba2b-1aa0b09285fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_018e05a7-18c4-47ac-8a4f-82f9d45da649">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:ConnecticutResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="C_6a857b9a-6bad-404d-9dcd-a5265f3492cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_6f66f0df-20b7-4c2e-926e-312d15b30150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_ab4a120e-032e-4174-ab0f-41881ca87629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">hypr:PreTwoThaousandEighteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_9e7001e3-4007-4798-9dd4-73bb5ecbae12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_567125e1-75b2-41be-99d3-e7b8a2774dc7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_fcabd41f-ce0d-46f0-bf8c-30aa40ebb4df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:HyperfineConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_29df5b7f-0392-4e69-85ba-668edf603563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:LiminalConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_821ac2f9-b484-46bf-bf7f-00231566dd23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <instant>2017-05-16</instant>
        </period>
    </context>
    <context id="C_565f6ec5-b566-4aa1-8ca6-fbee686327c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_6def0aef-40a2-42c1-9b66-b534c9b3b53f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_5e5c7322-5a27-4422-aed8-e69929560490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_734af1ad-a0ec-4f29-bf39-f1b5327db6c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_6cfe4f83-75d3-42af-b919-f037bac001d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">hypr:PreTwoThaousandEighteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_32bbb1e2-b724-403f-b397-48d9add24af7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="C_d78a6553-a61c-42e1-b9da-7148c3162bcc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerHMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_234b982a-29e0-45ff-b5c3-d5349882acd9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">hypr:PostTwoThaousandSeventeenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b788d1a7-f5e7-4c74-b5e4-0cd24b556c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_aa627098-fe3c-4ac0-80bb-2be20fe7c7a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:SalesAndMarketingDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_7bf581fe-f268-40a4-9d35-1ecba7754739">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1405c4fb-fd46-4fa7-b51a-b3abdd66f278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_d9e344e0-6fb0-4ac2-9f20-f9805be8a275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hypr:HealthCorCatalioAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="C_130e4222-f593-4c10-abb6-2bba9719b0a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:CatalyzerCorporation4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_952282ac-2ad8-4203-8f79-2b4a0432930d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_834be932-c2f9-4d94-9f67-fbab4d5554fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_6b4b4ea7-d957-4077-89a8-2769e16523e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_a2443b46-1c16-4eec-bafc-07f659935c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:ResearchDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1c800ff0-677d-4568-ac8b-02a9fb77a094">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_6b7f94c9-9ecc-4502-b9fd-362b0c906fa7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="C_9f4271cf-301e-459f-8dfd-8d9530cbb4eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_49d0dcc9-816b-4e28-8bc4-f9b5575f3a10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_c5071d04-a665-4335-a174-7aa1af89882e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="C_e027434a-4a2f-4bf7-b6ac-ecd878be99df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_7ccf2627-1cdc-47b7-ba29-626a157390fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_8ce579da-efe4-411c-8e78-a08e6c50c59f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_c727f466-00a1-41e9-b455-84621ea4e2de">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a1fab29a-58b5-4b1a-9ccd-64a673d6e459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_297a1e64-a6f1-490a-8a0d-a68d408b9cba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_ecb93ba3-ee1e-4bc3-bfc2-c730d729e8b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-01-31</endDate>
        </period>
    </context>
    <context id="C_e06069a2-6817-48a5-94fd-de1580cc4fdc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_422b1f66-f3bb-40cb-87eb-764fff40d1b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">hypr:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-21</startDate>
            <endDate>2021-12-21</endDate>
        </period>
    </context>
    <context id="C_9dd1a0ec-1e2f-4d91-be47-e5f4b90724e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_02ac6247-634e-47e7-9137-1d9fcf817084">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_b4ed0d3a-434f-44d7-b565-e029c1f85e01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_62a0c92e-5cb0-440b-9b64-ce1f6af679d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f655045d-1b98-47a5-91ea-b2ff21c11594">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:FourBionicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_aeb82c50-d014-42e5-8b78-49b806cb3896">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_65a01c03-68fd-4859-bbe0-614b1a291979">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="C_12fc5c7b-599e-4371-aa1e-7952b537da56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_19b3a16d-0fb7-4f0f-9123-775d37384548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_3157ed03-ddbf-421e-bca7-442ffc10828a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_9d460b90-c42a-4930-b08d-e43fe406d95b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_37f84241-8f15-4d3a-a3bf-88a442090df1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_8a9c17f1-6da6-4401-8abe-806f2a333b9e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_3ef7cc75-c5bb-4fbe-b9a3-8cee4d7281da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:LeasedDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5cc0bd53-ddda-46e6-831e-25d4e45fd73a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_d0d9904d-6ebb-411f-ae8e-b672fda8238c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1fb3196d-7a74-43b8-be05-e3fb252761c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hypr:LiminalPayrollProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-01</instant>
        </period>
    </context>
    <context id="C_ccc706be-2158-4bcc-a2db-096a92c02315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:StockOptionsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_2d523d48-3880-4f1d-9796-c510fd76bd9c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_329773ff-8990-4d8c-9536-2fe5f936e9fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_73aeac21-ef41-47a9-b437-94807e5860aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:TechnologyAndServicesExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_a3cbddd1-811a-44fb-b01c-1b817fbb617d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:LegacyHyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0b3254eb-3e95-4520-9848-13187dd9cc8a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hypr:AmendedAndRestatedTechnologyServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_8befb59f-1789-41eb-a34c-a140ffe80389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_fba03c4e-b08a-41a6-8e92-9f1c641cb1f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_7ee4d8d9-a42c-47a9-ae5d-57c993f15c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_ac74fc9c-0276-46e3-b74a-5c86d622563b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hypr:ImmediatelyPriorToEffectiveTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="C_44f21ac9-708e-4b24-aef7-cd1a9620d836">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_ac456664-e171-4780-a346-eaa8d31a6318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="C_51a3f382-19a1-459c-833b-5929003f7207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:LiminalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_883d8081-2c10-4853-b218-6c373ae4a619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:SalesAndMarketingDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_309c8fe7-b2ee-4206-93c1-c4ef1763fe17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:FederalNetOperatingLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-01-17</instant>
        </period>
    </context>
    <context id="C_cb3f4280-8358-43b6-8ea1-38d00c89ec05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_10346531-8b79-4c49-b961-3e5de4647ca2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hypr:ResearchDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_bf3fc9fc-c2f0-475a-be3e-816156a07b77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:LiminalConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="C_a16400b6-45e9-4557-826d-8a135305733f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_167b678f-7a7b-434b-9324-e4fb5b75ab31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_05b3c083-6683-4f86-ae50-8fd835965199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:CatalyzerCorporation4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f47f49e7-ad5a-4384-8c30-4bc6120b30ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="C_851619a8-8879-4e00-8eac-c603bca28425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_d8b08268-c399-4392-8b30-13c303f13c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:EarnOutSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_39d87f95-6e1f-4dc1-b752-0e7cc15f6e53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-01-17</instant>
        </period>
    </context>
    <context id="C_a54c8d03-257a-444a-adcc-4832043c42ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_605093d2-ac5d-4510-b28c-7b383c6172c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_05f68334-93da-4481-827d-a3e3770c9d3d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_97ecd105-2e03-4bed-bb2d-15098fa42355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:HyperfineConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_815be668-99bc-4c0f-839f-a4c555f975bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_36c4ccc8-ec82-451c-9859-29fefff0e27b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_19fcd92e-329b-4a10-8362-cba65df265a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1d288b0c-2753-40e9-b635-efa4cad33f7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">us-gaap:DividendDeclaredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_c4fe83e0-a6cc-4633-9e60-f7fc58c68e23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_01fa950d-ab40-4e18-a2a5-4c14c465c02f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_391814da-f713-4ae8-a4bf-709c59085048">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_7b149139-c5d8-4447-a71e-c7ede770bd5e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1db82a87-b4de-4246-b8c2-3df23f8b625f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:FourBionicsTwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_216ba9b6-bd20-4c7c-bc41-1051866b4a16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hypr:HealthCorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="C_e6d3149f-9dd6-457f-8d72-4c2c61b3f90a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_017a55aa-4d9f-4145-84bc-31cdf605a0fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:EarnOutSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_25f955f4-3de2-435b-8a68-92a8fb8291b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_94219b96-2190-45cb-82d0-1a597525c988">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201912Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_32845ad3-df15-4c41-a913-d909409b7057">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a545f35c-3630-4b98-a6b2-43950943b602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_39161efa-1760-453a-85f8-4f68df3f9557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="C_c6b2444b-b0c0-4bbf-809e-048942ba73c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hypr:AllocationOfExpenseIncurredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:LiminalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_e3d3098a-c48a-4d18-a4a7-21241395278d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_dca47efa-de44-4ea2-a6f7-5e416bbbb918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_6be4d64c-5ea1-40cf-ab05-f2d63f1883e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerHMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_adbc5d68-9134-4f22-9fcc-4c8fff3121d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-07</startDate>
            <endDate>2021-07-07</endDate>
        </period>
    </context>
    <context id="C_7c1ef51b-34f4-4a4a-a6cd-9433c0850ab4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_06522640-5ead-4ce5-b43c-dc8582220df8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="C_76318e1f-9e53-4997-93eb-1c3580b52cb2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f04be01a-f1c8-4197-9e8c-a8e60e22ac2c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_93ccae92-7e08-46e4-9661-cf630796ab3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hypr:OutstandingLegacyHyperfineConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_2a19dcc8-c5cc-40ef-8059-d3bbd58d9d5b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:HyperfineConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_04f3284a-f447-4bbf-92f2-20e3aa560cb7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c4a978a0-dd7d-4dae-a821-3df28ca4dc3d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="C_12b01c47-dcb3-417b-b622-c5939ecfea7d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_fa4c4e98-cf41-4a9f-86eb-de3be3b950dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <instant>2017-01-17</instant>
        </period>
    </context>
    <context id="C_1de70b38-0a9c-4b91-b7ee-29ac5dddc712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_c87cc42e-ffd7-45c9-913f-2f4babc09628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesBCAndDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1f1550e6-aea9-41b1-944e-48553f861650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9bef19fe-1963-493a-8639-cca45451e242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:LegacyHyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-07</startDate>
            <endDate>2021-07-07</endDate>
        </period>
    </context>
    <context id="C_0e50299d-06bc-4ca9-8fae-2ba1b516eb00">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="C_36b0658e-9bd7-419a-b34b-1d6173b955ca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hypr:IncentiveUnitActivityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c3117b2a-9a28-41fd-bf6c-462cc8023630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b4699d10-1e01-42d1-a12d-ef54497a4f0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-01</instant>
        </period>
    </context>
    <context id="C_f7c260f7-942b-467a-a100-8891e93ffd0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">hypr:PostTwoThaousandSeventeenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_90c968b9-9872-40c2-9fd2-339d167beac3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_348458fb-d208-4443-8d7d-e3f7edf293b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hypr:CatalyzerCorporation4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_def64c3f-dcfb-4af6-bc2f-54f251b76af2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_40866da5-dfe6-427d-8f75-d38b502866b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f684ca2d-8a75-4e94-959f-b7de192cf33e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:FederalAndStateNetOperatingLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_d27d7f2c-d654-4af6-9a83-2fc82df0f902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_592456c7-7eda-4630-a583-9725554adb90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_bba669ae-db49-4d96-9060-d3c7c8e07261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_59ee9e89-2d6f-4237-ae48-00fdfeea2299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">us-gaap:DividendDeclaredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_cb1f65d2-d11d-4188-86cc-6490cfa8ec4f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_58ed8b62-4e40-4fb5-b611-d1a03002120d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_92873d62-f54e-4814-829f-fd7332644094">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hypr:AmendedAndRestatedTechnologyServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_97df9222-63f0-4205-8539-e49cb6ad1192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a7656f8d-8697-4470-947f-f125a450641a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hypr:ImmediatelyPriorToEffectiveTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="C_6fdadebf-3247-42bc-88ce-f78d1aae83b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_9644069d-7efd-4fd5-a809-33471f45d26c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a77bfc0c-9f2a-400b-b003-b38132751429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_46f6a47d-e180-42ed-8d1e-464d0ec632b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:FederalAndStateNetOperatingLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hypr:HyperfineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_56f1b540-02fa-40f2-9894-b43cec93b036">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_2d6850ed-6867-4384-9a94-ec4d712f20d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="C_2206b217-69b7-412b-a10f-a8ac64842af3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:ConnecticutResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:LiminalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b5d108c6-9922-4ef6-a9f4-1b52927fa472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">hypr:ConnecticutOthersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hypr:HyperfineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_cb31b9d8-c1f7-4a18-b802-8fbd3122b173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201815Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1e797df8-f52f-4d4a-b1a1-ccf242640db1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hypr:PayrollProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="C_df21cc65-f66b-40a5-900a-c433563430fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="C_00411e89-7f5a-45df-b336-70ea9ce55a9e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:LegacyHyperfineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="C_224ae57f-8193-4d6a-adfd-42c3a9ce9f1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <instant>2018-01-31</instant>
        </period>
    </context>
    <context id="C_14ca06d1-7275-41cf-91d6-7ff75a37e6d9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c9211565-b84a-4c97-88de-605f5525382b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hypr:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0a6a19d6-344a-4cea-bec3-409efe86ebfd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hypr:LegacyHyperfineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hypr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <unit id="U_Ownership">
        <measure>hypr:Ownership</measure>
    </unit>
    <unit id="U_Segment">
        <measure>hypr:Segment</measure>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Vote">
        <measure>hypr:Vote</measure>
    </unit>
    <unit id="U_D">
        <measure>utr:D</measure>
    </unit>
    <unit id="U_Option">
        <measure>hypr:Option</measure>
    </unit>
    <unit id="U_Site">
        <measure>hypr:Site</measure>
    </unit>
    <unit id="U_Subsidiary">
        <measure>hypr:Subsidiary</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_02a11929-03c5-47f7-a6dc-944d24429dd7">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      id="F_30138270-ef84-453b-af3c-a94b07124d59"
      unitRef="U_USD"
      xsi:nil="true"/>
    <hypr:NumberOfVotesPerShareEntitledToClassOfCommonStock
      contextRef="C_96dd3b27-0bd2-4e00-a097-4fc98922b833"
      decimals="INF"
      id="F_7c1f6cb9-db4f-44a0-8eef-0eeaa1e8c6da"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1</hypr:NumberOfVotesPerShareEntitledToClassOfCommonStock>
    <us-gaap:CommonStockValue
      contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9"
      id="F_1c13b237-b33f-482f-9778-a6fd264becc6"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd"
      id="F_34fdc04b-c2cb-413b-abda-23a19ba3ed8d"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      id="F_6b9cea9f-2dca-4d8b-bc71-1e411360de94"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:OpenTaxYear
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_0d93ec06-e2be-489a-ac3b-531777fb08ff">2017 2018 2019</us-gaap:OpenTaxYear>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_7bf581fe-f268-40a4-9d35-1ecba7754739"
      id="F_82c7fa41-ba63-47ec-bb72-bbe45f458cc5"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      id="F_b67239e3-f61f-4cba-b264-e5903882a0e2"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282"
      id="F_7ec0eccf-356a-44c9-b3c6-e8a10dd2b780"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_081f21bd-0581-46af-927f-65563961f468">0001833769</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_6916c379-e209-4d81-bc90-d4c44d60c3de">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_35e6d3b9-ba42-4c4f-bb33-b726b39c18b2">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_7212d12c-c4dc-4ba6-8007-92570ab98058">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_8112b994-85fc-4a7a-8419-53460e58d5ec">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_72ec8536-069c-4f27-a590-6ca7b3dcf863">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_aabadddf-5e46-4c67-8433-709bb078f964">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_e92e6d3e-86d8-47fd-8506-636c4b126499">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_7637299d-9a3c-4ff4-8f69-fcdf143cbdf2">001-39949</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_63d28d4f-b864-4931-9bfa-466bfb521202">Hyperfine, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_45055ce4-160a-4b44-b9a3-48833c0b9993">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_c6de790c-fcb8-4fee-b570-4ec0bd3509d6">98-1569027</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_90877108-d721-48f0-b57e-e84baecefaed">351 New Whitfield Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_6e8badd1-37f1-47ec-837e-501f2c040a87">Guilford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_e912afae-18c6-4eb7-87ef-6ab6c3803984">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_4b40f3a6-1bc7-42fb-be5f-44a268bb445d">06437</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_4277faa6-3347-4ed0-8377-96b0849cc857">203</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_7036112f-5e20-4697-97fa-735c6e7a6296">458-7100 </dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_5c40ecb4-c14d-41fe-a578-471165108b52">Class A common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_a0110460-0600-479f-b358-3ddbd160b162">HYPR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_da9bc3b3-dff8-4735-9bb7-831f28321f6e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_c578b406-7152-4dc4-ae62-4da121ed8724">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_72860667-757d-4ea0-9d52-93936fed7107">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_cfeb45ba-d20a-4291-ba0b-9b0f7de3a321">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_0140f587-42da-4441-8da8-38bb0541b03a">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_e1dcf1be-5746-4a88-95b7-027f088de87d">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_993bedc6-5cdd-4aa8-8a10-d00a6efd0b86">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_582db811-147d-4d80-92ba-f4b1ab6cbc27">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_fd6b7361-2ebd-448a-b250-9ceabb4f1ecf">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_cdcd58ea-41b9-448a-ab31-b389de500fd7">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_fa84b7d4-984d-4d2a-ac69-e317c46fea52">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_a5356276-34ee-4730-b9c0-7fa02ce0c4f2"
      decimals="-5"
      id="F_40a48208-f2b2-48e5-b104-95514ea0ea02"
      unitRef="U_USD">203900000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_8dd83f7f-8142-464d-9d9c-cf5fce19a67d"
      decimals="INF"
      id="F_50c88836-4529-4696-8d16-858af7957f8c"
      unitRef="U_shares">55277061</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_b4699d10-1e01-42d1-a12d-ef54497a4f0a"
      decimals="INF"
      id="F_bfbd3e58-6d2d-43c2-b94d-f99e534486a1"
      unitRef="U_shares">15055288</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_232367f5-d90f-4746-b370-d595babb61a9">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_77d517ea-4a85-4c9f-8a09-a817ea72a58b">New York, New York</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_85720a4f-b2ff-4868-b481-a0829fa5bd0d">34</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_8cd62d5e-1fe7-4049-bd9d-07f3d9efdf81"
      unitRef="U_USD">188498000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_104a0732-5e33-4288-bfb6-58558824d6dd"
      unitRef="U_USD">62676000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_80e91bba-488c-4fc1-8cb2-a30b329cd1f8"
      unitRef="U_USD">2662000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_995ffd20-cec9-47a6-ad79-6bf68758c3d3"
      unitRef="U_USD">1610000</us-gaap:RestrictedCashCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_78743c0f-8e1b-459b-8a47-12557fdda9c8"
      unitRef="U_USD">32000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_c18460d9-e560-416e-9303-33f86c86b4a8"
      unitRef="U_USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_1e2780ce-3cb2-4e63-8623-2a65e6c7dc5d"
      unitRef="U_USD">553000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_94c98ec1-9c39-41c2-8c14-89d2e5eaf27a"
      unitRef="U_USD">174000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_30aeb07c-cc4c-41ed-8f88-e3341083541d"
      unitRef="U_USD">91000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:InventoryNet
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_153d86df-8356-4d1e-8926-92c399e2ce0f"
      unitRef="U_USD">4310000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_0314d757-3630-4ad0-80f8-30d5a446d372"
      unitRef="U_USD">1718000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_f87df5bd-2092-4807-b4cc-57285cd9daab"
      unitRef="U_USD">1357000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_cf51e7aa-4398-46c7-bb97-e8be09138e84"
      unitRef="U_USD">691000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_48035cdb-a9d6-47f7-adec-8b11082cb6a1"
      unitRef="U_USD">14000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_f8f454e8-4f85-49bd-a43d-ba33dacf8dfc"
      unitRef="U_USD">1465000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_b76a1a2e-5b68-4451-bfa3-402c29cba42f"
      unitRef="U_USD">197485000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_416efdae-69f2-48bd-818b-148571b2f5f9"
      unitRef="U_USD">68334000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_a053d45d-627b-4024-b0ea-ef16022d98aa"
      unitRef="U_USD">3753000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_380a4707-b276-44a8-8b42-bd78ee9831fb"
      unitRef="U_USD">1904000</us-gaap:PropertyPlantAndEquipmentNet>
    <hypr:OtherAssetsRelatedPartyNoncurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_2f925b4e-10ae-4c44-bbb1-9ff70d1f93d4"
      unitRef="U_USD">1244000</hypr:OtherAssetsRelatedPartyNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_e885da84-fe2d-4fe5-aef3-758b2d9a6b16"
      unitRef="U_USD">1235000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_a1d7983c-7de9-466f-9dc1-f95bd4906ba8"
      unitRef="U_USD">44000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_b0599e9a-f929-4593-818f-ad07fc559b22"
      unitRef="U_USD">202473000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_9abc5d9e-3220-41ff-89b1-382cc51e740f"
      unitRef="U_USD">71526000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_13c03bce-a845-4ed0-a26c-ee064941bc83"
      unitRef="U_USD">2248000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_1d6bea93-4ede-4e86-a3fa-c0d017eabe84"
      unitRef="U_USD">948000</us-gaap:AccountsPayableCurrent>
    <hypr:DeferredGrantFundingCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_22915681-8780-4483-9483-81fd24e58810"
      unitRef="U_USD">2662000</hypr:DeferredGrantFundingCurrent>
    <hypr:DeferredGrantFundingCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_4b74e989-5e90-4c0d-878f-e3dfbb92063b"
      unitRef="U_USD">1610000</hypr:DeferredGrantFundingCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_9a35bd9d-4671-4e50-935b-6a25242f0716"
      unitRef="U_USD">730000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_2d7ab551-284e-4c7d-a0b1-308cefd40f20"
      unitRef="U_USD">158000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_b7601194-8cbb-49ce-93ab-471b3934de02"
      unitRef="U_USD">1981000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_6ed7e5c9-db45-4a8f-8a65-65263d4ad802"
      unitRef="U_USD">136000</us-gaap:DueToRelatedPartiesCurrent>
    <hypr:AccruedExpensesAndOtherCurrentLiabilities
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_7ddbd041-1c72-4157-b6d2-0f14d14b8440"
      unitRef="U_USD">8115000</hypr:AccruedExpensesAndOtherCurrentLiabilities>
    <hypr:AccruedExpensesAndOtherCurrentLiabilities
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_1db4bd20-407b-4fb6-bceb-f66b051d9945"
      unitRef="U_USD">1264000</hypr:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_4850db2d-6e82-4554-aa51-457e25070a55"
      unitRef="U_USD">15736000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_a29ca191-af11-4f26-99c9-66b74ff9ca5a"
      unitRef="U_USD">4116000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_e776299d-5541-4086-b006-d87effabd7e3"
      unitRef="U_USD">178000</us-gaap:LongTermNotesPayable>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_f2fcd76f-7142-46f0-ab01-c02edc3dfef4"
      unitRef="U_USD">510000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_93195b9a-893a-4377-8ca6-45073ec774d8"
      unitRef="U_USD">16246000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_fb9a9b69-13f7-4d60-8717-acfa8b9d153d"
      unitRef="U_USD">4294000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282"
      decimals="INF"
      id="F_8fbfd5dd-3315-45c7-adf9-86b154f9171d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf"
      decimals="INF"
      id="F_30836c1e-da5b-4674-814a-32a1103b33d0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282"
      decimals="-3"
      id="F_9485d23b-4de1-4ab1-a1fb-bfe794f766eb"
      unitRef="U_USD">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf"
      decimals="-3"
      id="F_4eb87df8-6d3a-4f55-951c-a7adc922590b"
      unitRef="U_USD">147651000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282"
      decimals="INF"
      id="F_35e2dec9-0d84-4962-aa39-c7165d4bfed6"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf"
      decimals="INF"
      id="F_d0b2f1ea-e80f-47b2-9fff-fabf43e35e0c"
      unitRef="U_shares">129788828</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282"
      decimals="INF"
      id="F_136c12e4-ad6a-4f2b-96d9-557dbaba7aba"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_5d1b4a42-9947-4459-9c6d-b9a103bf3282"
      decimals="INF"
      id="F_733506ea-1ed1-4883-8024-69131b67d6f2"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf"
      decimals="INF"
      id="F_732c9eca-b0d9-478e-a283-4b6fbc66d8ad"
      unitRef="U_shares">95010858</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf"
      decimals="INF"
      id="F_461689ad-4a80-4be5-9d97-11fe375d59f0"
      unitRef="U_shares">95010858</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf"
      decimals="-3"
      id="F_8c589011-20d3-452d-b345-a65dd0ed60f4"
      unitRef="U_USD">128286000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01"
      decimals="INF"
      id="F_1c2d339f-e9c4-4565-817d-38eb6a3f15b2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd"
      decimals="INF"
      id="F_d742fa60-3b57-4b8d-8060-ce4ac0350c54"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01"
      decimals="INF"
      id="F_d81902c7-40f9-4abf-9743-99b77f8331a1"
      unitRef="U_shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd"
      decimals="INF"
      id="F_f3f65d1c-7a17-4bbb-9a48-db5a254dcdb8"
      unitRef="U_shares">130000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01"
      decimals="INF"
      id="F_deabe5b4-e33c-4053-91b1-5fdeb7cf287d"
      unitRef="U_shares">55277061</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01"
      decimals="INF"
      id="F_8719322e-6c48-48e4-b091-77d9286d3069"
      unitRef="U_shares">55277061</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd"
      decimals="INF"
      id="F_ac75f00f-0137-4493-9327-92a5685e05c8"
      unitRef="U_shares">1576137</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd"
      decimals="INF"
      id="F_1075b9a0-37b8-451c-bbba-317537167954"
      unitRef="U_shares">1576137</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01"
      decimals="-3"
      id="F_f09dd260-8663-4396-8ab3-47d89c7bb79a"
      unitRef="U_USD">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2"
      decimals="INF"
      id="F_a5738ec9-71c3-4f96-ac75-459fd9cd243b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9"
      decimals="INF"
      id="F_0055f4ee-91d3-4344-81dc-66279f14f06d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2"
      decimals="INF"
      id="F_bf7d41f2-7595-47da-a625-f9694866ad10"
      unitRef="U_shares">27000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9"
      decimals="INF"
      id="F_8c330abe-99c7-4e2c-809b-346695545ff3"
      unitRef="U_shares">0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2"
      decimals="INF"
      id="F_c71413a8-b8e1-4043-919e-dfceb9a1f160"
      unitRef="U_shares">15055288</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2"
      decimals="INF"
      id="F_88129681-3a32-411d-8edb-0d2cfc094718"
      unitRef="U_shares">15055288</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9"
      decimals="INF"
      id="F_d60e28bd-4cdb-4eb5-8964-46911f4a29d0"
      unitRef="U_shares">0</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9"
      decimals="INF"
      id="F_0aa9a941-4f83-430c-851a-74ada39ef747"
      unitRef="U_shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2"
      decimals="-3"
      id="F_299c2379-9c6f-4986-864a-080de2d4f6b4"
      unitRef="U_USD">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_a10590c6-405a-4f73-8da1-b85ddb4e2433"
      unitRef="U_USD">322540000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_4f976a77-ef25-4926-8366-145420d64f01"
      unitRef="U_USD">10415000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_bacadb17-7298-450e-9dc5-b06fdea979bc"
      unitRef="U_USD">-136320000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_1e31ea62-3a9d-4f5b-92fc-8db7ee3212e7"
      unitRef="U_USD">-71469000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_2b7b6484-bdb4-4372-a4ba-885db8745d91"
      unitRef="U_USD">186227000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_1ecfac94-cde7-4388-8d63-43433cabfadd"
      unitRef="U_USD">-61054000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_5e20b390-c976-4b96-830d-74dfb176e9f7"
      unitRef="U_USD">202473000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_34855d0d-4c40-4ae2-bee6-5303fc1d721c"
      unitRef="U_USD">71526000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_cb3f4280-8358-43b6-8ea1-38d00c89ec05"
      decimals="-3"
      id="F_8de84dc2-a680-44f5-b0a0-61d07c67ff40"
      unitRef="U_USD">715000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_9f4271cf-301e-459f-8dfd-8d9530cbb4eb"
      decimals="-3"
      id="F_b0e52e25-53fa-4888-b52b-1c37d36c5469"
      unitRef="U_USD">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_77379a12-290a-4832-afc5-a9209e02e808"
      decimals="-3"
      id="F_a9ae7c9e-9ea1-47af-b062-16eb9b3905a8"
      unitRef="U_USD">781000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_f64f1671-f740-47b2-bdee-89e73fc16d87"
      decimals="-3"
      id="F_a83cc988-ecd4-4cda-a33c-a425b85dd6d3"
      unitRef="U_USD">94000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_6c44aa31-5d2e-4f94-b53c-d1e116630912"
      unitRef="U_USD">1496000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_22a9c6c6-257b-44df-8763-46872461031b"
      unitRef="U_USD">294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_cb3f4280-8358-43b6-8ea1-38d00c89ec05"
      decimals="-3"
      id="F_84138df9-a13d-44c5-9e2a-f11846f0be8e"
      unitRef="U_USD">2058000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_9f4271cf-301e-459f-8dfd-8d9530cbb4eb"
      decimals="-3"
      id="F_55ab87cf-73a7-4ad0-880a-4b3a20008e65"
      unitRef="U_USD">763000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_77379a12-290a-4832-afc5-a9209e02e808"
      decimals="-3"
      id="F_c153076b-d6fb-4615-b764-e91ffa1335f0"
      unitRef="U_USD">605000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_f64f1671-f740-47b2-bdee-89e73fc16d87"
      decimals="-3"
      id="F_5c1f3def-2e28-4029-ba47-9cb8588dffa9"
      unitRef="U_USD">8000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_75044b98-7bd2-400f-997f-25d8ad9cb863"
      unitRef="U_USD">2663000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_e96004d9-c7b3-49ef-8ac7-6e236d8a01a6"
      unitRef="U_USD">771000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_365efb07-bded-4498-b3c1-551235eabd68"
      unitRef="U_USD">-1167000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_865669c5-cc73-4574-aa01-37e3711eb7be"
      unitRef="U_USD">-477000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_058be85b-33e5-4645-af42-3181633b2b36"
      unitRef="U_USD">25842000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_1a4ed5fd-97e6-4f2e-bdb0-b5f500f2679d"
      unitRef="U_USD">14593000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_cf4c7543-69bc-4986-89b9-b92152e00e20"
      unitRef="U_USD">27497000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_c225e7e6-a644-45bb-8318-48e9c3578508"
      unitRef="U_USD">5921000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_20655820-f860-45f4-89ee-8ecbdb1ab15c"
      unitRef="U_USD">10362000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_e5bec5d7-9dbd-4812-b51b-d7c4c8e01df8"
      unitRef="U_USD">2500000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_e16c7735-f24b-4e21-9288-04ca0e709b95"
      unitRef="U_USD">63701000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_7c48c689-0660-4301-8fcc-7f729f3a65b6"
      unitRef="U_USD">23014000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_c56cb172-75a3-43f0-869a-3435aaae53db"
      unitRef="U_USD">-64868000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_ff025013-6569-438d-bab5-dd8b5e666dc1"
      unitRef="U_USD">-23491000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_9d2e6a94-e1bb-4297-9ed1-6690bbe668f5"
      unitRef="U_USD">18000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_c51d5a7a-0412-4cf6-a352-c24e9f0c6954"
      unitRef="U_USD">70000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_d3539ee7-cafc-4b0f-8f3e-d54c9c52be4a"
      unitRef="U_USD">-1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_2f5ad299-1dd2-4ad2-a1d6-31a629c9db8f"
      unitRef="U_USD">-6000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_b26901c3-ba6c-4522-bdb2-62bc4ab5d564"
      unitRef="U_USD">-64851000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_8e1b9f0f-d8d5-48cd-bb53-8058dc4d921f"
      unitRef="U_USD">-23427000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_1e9f4b57-bcc9-4f87-99bb-11a9dd8c8e43"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_9da015c0-e4b6-44a9-acac-56c491f9ab4e"
      unitRef="U_USD">-64851000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_3f372068-43e0-46e1-926d-b269f9991183"
      unitRef="U_USD">-23427000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="2"
      id="F_2499428d-8d7f-4dde-88c1-ea8f35b3ac4c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-17.57</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="2"
      id="F_fb5af1af-6eab-40e6-a983-06d611f5f883"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-15.38</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="0"
      id="F_1c3df562-1cac-48e8-a314-2908c5b8a18d"
      unitRef="U_shares">3690523</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="0"
      id="F_3f56ae4f-dbfb-46e8-8c05-0da3171f5f62"
      unitRef="U_shares">1523096</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_a1217e52-b226-462c-8502-52f8c592156b"
      decimals="INF"
      id="F_3baa6d49-93e2-402f-83ae-69a8f30727aa"
      unitRef="U_shares">67211210</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_a1217e52-b226-462c-8502-52f8c592156b"
      decimals="-3"
      id="F_4ba61e76-3ce9-4032-a916-70351799f560"
      unitRef="U_USD">68646000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesIssued
      contextRef="C_a27dd307-2fcd-40ef-8e2c-ce7ce0a4e528"
      decimals="INF"
      id="F_5988f5fb-41e4-40f8-a2f6-fe8e6f7c9ad8"
      unitRef="U_shares">1508415</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_592456c7-7eda-4630-a583-9725554adb90"
      decimals="-3"
      id="F_b836ccfd-f16f-47b4-bcd0-f5f1514bad62"
      unitRef="U_USD">8178000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a54c8d03-257a-444a-adcc-4832043c42ed"
      decimals="-3"
      id="F_a1c21133-0b90-4ca7-9c65-e7029d641e3a"
      unitRef="U_USD">-48042000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3c9581e7-07d4-4e55-bccf-5e8bd25bbbb7"
      decimals="-3"
      id="F_8e325e7a-b8b4-453a-8caa-a46fadcba205"
      unitRef="U_USD">-39864000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_834be932-c2f9-4d94-9f67-fbab4d5554fc"
      decimals="-3"
      id="F_656ac925-337b-45c1-9422-b7bbf123810f"
      unitRef="U_USD">-23427000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_bdcb91c8-bbae-458e-a8f6-60a2f9ddf3e3"
      unitRef="U_USD">-23427000</us-gaap:NetIncomeLoss>
    <hypr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_fcabd41f-ce0d-46f0-bf8c-30aa40ebb4df"
      decimals="INF"
      id="F_03e3eee1-aa3f-446f-8dbf-b4c87edbe456"
      unitRef="U_shares">27799648</hypr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_fcabd41f-ce0d-46f0-bf8c-30aa40ebb4df"
      decimals="-3"
      id="F_a78bd0f7-0ade-4ffd-8e63-afeb00c58ee0"
      unitRef="U_USD">59640000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <hypr:AdjustmentsToAdditionalPaidInCapitalInvestments
      contextRef="C_a77bfc0c-9f2a-400b-b003-b38132751429"
      decimals="-3"
      id="F_dbb86fce-87ee-4935-a4dc-6f9eb3c93774"
      unitRef="U_USD">1000000</hypr:AdjustmentsToAdditionalPaidInCapitalInvestments>
    <hypr:AdjustmentsToAdditionalPaidInCapitalInvestments
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_c740876d-4a6d-4297-b3e4-0c0d80c70ac8"
      unitRef="U_USD">1000000</hypr:AdjustmentsToAdditionalPaidInCapitalInvestments>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_f284e816-cacb-4f3c-bea6-47fac4904183"
      decimals="INF"
      id="F_6f76a453-f6d8-459f-9fa7-4fd89d70cae8"
      unitRef="U_shares">67722</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_a77bfc0c-9f2a-400b-b003-b38132751429"
      decimals="-3"
      id="F_ac25350c-9d5b-4535-a679-3e1eb4afd9fa"
      unitRef="U_USD">120000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_ad063cee-fe61-4e7f-97c9-282cef479fd7"
      unitRef="U_USD">120000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_a77bfc0c-9f2a-400b-b003-b38132751429"
      decimals="-3"
      id="F_595b0004-52b3-429e-8f08-81ce54e424e0"
      unitRef="U_USD">1117000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_22c3993e-9ecf-463d-9196-8a71ab4431a0"
      unitRef="U_USD">1117000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf"
      decimals="INF"
      id="F_c505671c-dea6-46d0-8127-7997cf40c106"
      unitRef="U_shares">95010858</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_ce7fe8a0-8d68-4380-8a02-ab7b8f10f3bf"
      decimals="-3"
      id="F_f33012ca-f186-437c-a020-b11fe238bb79"
      unitRef="U_USD">128286000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesIssued
      contextRef="C_464908b0-1fa1-4326-90d3-0c2106209a10"
      decimals="INF"
      id="F_93e6a52f-68bb-46a6-b070-e44d2bda6b38"
      unitRef="U_shares">1576137</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_a545f35c-3630-4b98-a6b2-43950943b602"
      decimals="-3"
      id="F_0dc87a9b-a6d5-4594-943a-c4cc0ec5fdd6"
      unitRef="U_USD">10415000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_37fd5a65-0913-4f4d-81f7-910f82c3ea2e"
      decimals="-3"
      id="F_b08a9000-2d8e-4205-a611-a878f711b220"
      unitRef="U_USD">-71469000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_43681277-5dfd-4092-8488-e0fe0d4277ea"
      unitRef="U_USD">-61054000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_32845ad3-df15-4c41-a913-d909409b7057"
      decimals="-3"
      id="F_c313e144-bc00-4b90-a2b9-f1b5300ee552"
      unitRef="U_USD">-64851000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_f4ab625d-7ab4-4fff-be95-b0b4cd241079"
      unitRef="U_USD">-64851000</us-gaap:NetIncomeLoss>
    <hypr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_06ca1284-0a43-490c-94fa-34c74c4f5fbd"
      decimals="INF"
      id="F_7526c786-3853-4766-b378-beab7ad6f369"
      unitRef="U_shares">14171333</hypr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_06ca1284-0a43-490c-94fa-34c74c4f5fbd"
      decimals="-3"
      id="F_1032adb7-86c6-429d-8d9d-bb4ba92188f0"
      unitRef="U_USD">30461000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <hypr:AdjustmentsToAdditionalPaidInCapitalInvestments
      contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2"
      decimals="-3"
      id="F_e43cd4e6-594e-413d-80af-2b918f37915d"
      unitRef="U_USD">3516000</hypr:AdjustmentsToAdditionalPaidInCapitalInvestments>
    <hypr:AdjustmentsToAdditionalPaidInCapitalInvestments
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_8b441337-89f9-4b1d-a717-008b43f935a7"
      unitRef="U_USD">3516000</hypr:AdjustmentsToAdditionalPaidInCapitalInvestments>
    <hypr:RecapitalizationOfPermanentToTemporaryEquityShares
      contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee"
      decimals="INF"
      id="F_20883fb0-9fee-43d5-8f6c-41bd961ae7c2"
      unitRef="U_shares">57500000</hypr:RecapitalizationOfPermanentToTemporaryEquityShares>
    <hypr:RecapitalizationOfPermanentToTemporaryEquityValues
      contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee"
      decimals="-3"
      id="F_964b1536-7877-46f4-bd3c-e47b3b84ceb4"
      unitRef="U_USD">9350000</hypr:RecapitalizationOfPermanentToTemporaryEquityValues>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb"
      decimals="INF"
      id="F_0d340c41-2d55-4a19-9e29-0f5d37d1b7e9"
      unitRef="U_shares">-180</us-gaap:ConversionOfStockSharesConverted1>
    <hypr:ConversionOfLiminalCommonStock
      contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2"
      decimals="-3"
      id="F_c1dec154-ac90-4d46-88c4-bd2a50d28fe8"
      unitRef="U_USD">-9350000</hypr:ConversionOfLiminalCommonStock>
    <hypr:ConversionOfLiminalCommonStock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_71a29924-2570-44db-9aa8-f1c98a93d415"
      unitRef="U_USD">-9350000</hypr:ConversionOfLiminalCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb"
      decimals="INF"
      id="F_87463ff3-bc90-4b25-8cd1-a0b8e7fb8d07"
      unitRef="U_shares">565533</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2"
      decimals="-3"
      id="F_5f19c1ef-c05d-4ecc-b44a-2dad1003d4c9"
      unitRef="U_USD">1497000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_c3e61301-0e18-4494-9c4f-6034da9a31c5"
      unitRef="U_USD">1497000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_06ca1284-0a43-490c-94fa-34c74c4f5fbd"
      decimals="INF"
      id="F_3a5a2c8d-b48f-40f0-8504-7834f671ba95"
      unitRef="U_shares">-109182191</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_06ca1284-0a43-490c-94fa-34c74c4f5fbd"
      decimals="-3"
      id="F_25f2bc9e-8a03-4227-b2db-fff85f3b1711"
      unitRef="U_USD">-158747000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee"
      decimals="INF"
      id="F_adfdfc04-361e-4487-a5da-54bfeade54f0"
      unitRef="U_shares">-57500000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee"
      decimals="-3"
      id="F_22da1b27-b1eb-4dc0-9d55-2b3afeb9aac4"
      unitRef="U_USD">-9350000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb"
      decimals="INF"
      id="F_3f0e4f34-ba60-4b8d-b633-3cef94fe41c9"
      unitRef="U_shares">31028815</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb"
      decimals="-3"
      id="F_86188305-a19c-4bdd-acbd-b5e6819eaa4a"
      unitRef="U_USD">3000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_14ca06d1-7275-41cf-91d6-7ff75a37e6d9"
      decimals="INF"
      id="F_538cdc9d-cdfc-455c-9dbe-3fb6886ce28c"
      unitRef="U_shares">15055288</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_14ca06d1-7275-41cf-91d6-7ff75a37e6d9"
      decimals="-3"
      id="F_7cb70078-c5dc-4820-97c7-03e2383020cf"
      unitRef="U_USD">2000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2"
      decimals="-3"
      id="F_628854cf-8298-4fb3-bdce-676d202cfb41"
      unitRef="U_USD">168092000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_a37707a5-847f-4902-9ca9-196434d39a48"
      unitRef="U_USD">168097000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb"
      decimals="INF"
      id="F_5ddc6448-c455-466a-aba6-72337839bb08"
      unitRef="U_shares">21806756</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb"
      decimals="-3"
      id="F_25cc864a-6280-43d1-8afd-bd1f22e453d8"
      unitRef="U_USD">2000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2"
      decimals="-3"
      id="F_adea3356-fab4-40c1-9fef-f60602fed2bd"
      unitRef="U_USD">141469000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_221004e2-08eb-430b-9f2c-c922f22a2f9d"
      unitRef="U_USD">141471000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_b7398889-0087-4e71-ba2b-1aa0b09285fb"
      decimals="INF"
      id="F_612c252a-8899-4857-9532-940beeaac6cf"
      unitRef="U_shares">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_76318e1f-9e53-4997-93eb-1c3580b52cb2"
      decimals="-3"
      id="F_f59bde9d-5998-4ff9-9aa9-60b4492b88c3"
      unitRef="U_USD">6901000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_8be51c47-d66c-4ec6-bb7b-52ac63f6b5cd"
      unitRef="U_USD">6901000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesIssued
      contextRef="C_58ed8b62-4e40-4fb5-b611-d1a03002120d"
      decimals="INF"
      id="F_02236a64-28f5-451f-b167-c0f64df12e42"
      unitRef="U_shares">55277061</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_58ed8b62-4e40-4fb5-b611-d1a03002120d"
      decimals="-3"
      id="F_f19fc0fe-9335-452f-ad11-cfcdf186b1a4"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="C_9f696af7-210f-43ef-9b46-8a8e5818aaa6"
      decimals="INF"
      id="F_b85e3379-37d8-41ce-98be-a8b46a1b4260"
      unitRef="U_shares">15055288</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_9f696af7-210f-43ef-9b46-8a8e5818aaa6"
      decimals="-3"
      id="F_7e40aa8e-d1de-40b0-b3b1-665a40334ae8"
      unitRef="U_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_6b4b4ea7-d957-4077-89a8-2769e16523e4"
      decimals="-3"
      id="F_a4877cd9-227d-409b-a465-e0a671463858"
      unitRef="U_USD">322540000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_19fcd92e-329b-4a10-8362-cba65df265a9"
      decimals="-3"
      id="F_8adbc363-2ce6-4c8f-b504-af83f540af53"
      unitRef="U_USD">-136320000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_f7b505ab-30fd-42bb-9f7e-845ceed5d7d8"
      unitRef="U_USD">186227000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_ae71af5c-a85d-46b3-a7b7-71a13b3380f1"
      unitRef="U_USD">-64851000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_4ee66ac7-06f2-4dba-b4db-a4bc8f600c0f"
      unitRef="U_USD">-23427000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_72daf6f2-b3de-415f-a3a6-f1162797da34"
      unitRef="U_USD">726000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_2fcce5fa-ce49-48ff-94d3-4276ac5c4313"
      unitRef="U_USD">289000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_792b8bc9-5ed3-4ff7-9dba-2bdf59ba9b4a"
      unitRef="U_USD">6901000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_e3920718-4ed4-4597-baa9-bb427b5498ac"
      unitRef="U_USD">1117000</us-gaap:ShareBasedCompensation>
    <us-gaap:InventoryWriteDown
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_2a8966b7-83ea-417f-8ad6-9f78376d2c5c"
      unitRef="U_USD">75000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_721a2f7e-828c-42d5-879e-8f6257cfd29f"
      unitRef="U_USD">213000</us-gaap:InventoryWriteDown>
    <hypr:WriteOffOfOtherAssetsRelatedParty
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_e670c578-8f8d-4470-a71f-d953eb91a639"
      unitRef="U_USD">984000</hypr:WriteOffOfOtherAssetsRelatedParty>
    <us-gaap:SalesTypeLeaseSellingProfitLoss
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_c34a5d3a-5a6f-47ee-ad6d-defd5b965c00"
      unitRef="U_USD">46000</us-gaap:SalesTypeLeaseSellingProfitLoss>
    <us-gaap:NetInvestmentInLeasePurchase
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_dd3c9cc4-a84f-4f60-8787-c8eba100ca11"
      unitRef="U_USD">10000</us-gaap:NetInvestmentInLeasePurchase>
    <us-gaap:NetInvestmentInLeasePurchase
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_714cb24c-14bb-4e25-a174-a5a2a77a9d03"
      unitRef="U_USD">2000</us-gaap:NetInvestmentInLeasePurchase>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_23b19d59-2149-48d8-b1d0-395d8188ac4e"
      unitRef="U_USD">379000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_7429dc25-dabe-42a8-b48b-13f20c63a959"
      unitRef="U_USD">174000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <hypr:UnbilledReceivables
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_3820dde5-8901-4961-bd2b-a3c417ab5ac7"
      unitRef="U_USD">91000</hypr:UnbilledReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_9d8e042d-5952-4901-b972-840d454a9277"
      unitRef="U_USD">2667000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_088bcd07-ea9a-4b9e-80a8-e6dacf33d26b"
      unitRef="U_USD">1931000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_b625a7eb-d51a-4b5f-ba3f-f7d699a2c4e7"
      unitRef="U_USD">666000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_c716021b-22d2-44e3-9416-3bc9ae52c1cc"
      unitRef="U_USD">-146000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_681becb3-c73f-44c0-8ea3-c74357ced205"
      unitRef="U_USD">-1451000</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_95baaff0-c8b2-4045-a446-c935d7a322ac"
      unitRef="U_USD">782000</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseDueFromOtherRelatedParties
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_0263a942-46a9-468f-aa3b-afa9ce909c9c"
      unitRef="U_USD">-260000</us-gaap:IncreaseDecreaseDueFromOtherRelatedParties>
    <us-gaap:IncreaseDecreaseDueFromOtherRelatedParties
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_0e862f17-6a29-40b2-9c19-c92ede5735d1"
      unitRef="U_USD">-226000</us-gaap:IncreaseDecreaseDueFromOtherRelatedParties>
    <us-gaap:IncreaseDecreaseInPrepaidSupplies
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_1e1e1ba1-f3ac-4aa7-9c2d-02f420c0532b"
      unitRef="U_USD">-651000</us-gaap:IncreaseDecreaseInPrepaidSupplies>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_20a0d6c8-9c19-4075-a38a-40d30cfd650f"
      unitRef="U_USD">1201000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_35b6e8ca-1be4-4ab7-b8ae-cbd70e70aae0"
      unitRef="U_USD">1436000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_f9511050-2753-4abf-8ceb-94a87118be1a"
      unitRef="U_USD">-377000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDeferredLiabilities
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_d437c6c0-1aba-430a-9b44-c45a072294df"
      unitRef="U_USD">1052000</us-gaap:IncreaseDecreaseInDeferredLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredLiabilities
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_f241b77e-c689-4a52-9773-1a00d1a13cd4"
      unitRef="U_USD">1610000</us-gaap:IncreaseDecreaseInDeferredLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_ae856e72-e30c-43b7-92ed-722a51139a4d"
      unitRef="U_USD">1082000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_d436e335-d749-45ea-969a-fcf638d08daf"
      unitRef="U_USD">158000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_d86143d9-f3d2-43a3-b886-8ca6159cb735"
      unitRef="U_USD">1845000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_7dd6ce60-3832-4c93-b4a2-469fb030387f"
      unitRef="U_USD">27000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_f6be8ad4-07f8-4d9e-9ef7-b002ad6a693e"
      unitRef="U_USD">6851000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_05de999c-8a82-447b-a9db-14e2eb2de62c"
      unitRef="U_USD">773000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_5787a3d9-b86e-4afb-a55a-90889e904fa7"
      unitRef="U_USD">-47182000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_2389836d-bcd4-43b2-adda-a78754e0979d"
      unitRef="U_USD">-21525000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_020b7393-4f7e-4a2e-80d9-87452a660282"
      unitRef="U_USD">2711000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_54f55593-62f0-4224-a63f-a6d4ea29ccf6"
      unitRef="U_USD">1568000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_f89f90de-8090-4017-9c66-d6dacbe113ad"
      unitRef="U_USD">-2711000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_8e20ce22-bec8-4352-b3ee-715c8c8d32b2"
      unitRef="U_USD">-1568000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_ad573347-3236-4f97-b2ec-9fc4e51b1b83"
      unitRef="U_USD">1497000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_732bf4fd-6d28-4389-a7f6-8dc7f4d8065b"
      unitRef="U_USD">120000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_3a6ff5ce-f12d-4f15-8c3e-3cf418e71d8e"
      unitRef="U_USD">30468000</us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_d33ac3b2-f450-4c47-8f49-57f209fdc035"
      unitRef="U_USD">59769000</us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_091c3f94-4c67-43c5-b58e-6e06ee7d9e4a"
      unitRef="U_USD">7000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_ef4648ce-9458-4b73-8354-51ce6f49f29e"
      unitRef="U_USD">129000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_a50a198c-8f2a-44ee-9c99-3a77d53d2d40"
      unitRef="U_USD">1067000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_81c0affc-c5d7-4152-823d-0d32ba353859"
      unitRef="U_USD">178000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_5c5affdf-91d5-48e8-a81f-c8c2f0e84571"
      unitRef="U_USD">889000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_d2de99c1-fd0b-451d-99aa-0cb367594383"
      unitRef="U_USD">3516000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_12334a89-bb3d-430b-ae1d-d286cb1c0df1"
      unitRef="U_USD">1000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <hypr:ProceedsFromBusinessCombination
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_da0b37ce-8e44-4c8c-bbab-bc1ab8cb5757"
      unitRef="U_USD">141471000</hypr:ProceedsFromBusinessCombination>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_1e373f0e-32cf-4c40-8c6f-cbfc86ed957f"
      unitRef="U_USD">176767000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_71b988e6-d083-4e31-90ad-f8c7a9df93f8"
      unitRef="U_USD">60938000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_7e3af3dd-250e-496a-ba7d-a37ac1a164bc"
      unitRef="U_USD">126874000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_703aeead-69a9-4630-8c92-a4da578f8814"
      unitRef="U_USD">37845000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_47cdd84a-5098-46d4-90ca-049524a7c811"
      unitRef="U_USD">64286000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_3c9581e7-07d4-4e55-bccf-5e8bd25bbbb7"
      decimals="-3"
      id="F_f8f52ef5-f3d7-4831-9a52-432cd84ba35d"
      unitRef="U_USD">26441000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_2abcbaba-b52a-495b-bc42-fc3f6971af63"
      unitRef="U_USD">191160000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_7b6b71d4-bcfd-41d0-be2c-8615018869d5"
      unitRef="U_USD">64286000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_08221114-545a-4b94-ab92-8a43a49bf475"
      unitRef="U_USD">188498000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_bd6d31a7-922f-4b81-b066-0aeb6a7ccff3"
      unitRef="U_USD">62676000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_4672945d-2068-41d3-bea5-ec164f609d53"
      unitRef="U_USD">2662000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_81f6f845-74b3-4425-a710-7b8e8eee99c5"
      unitRef="U_USD">1610000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_334a76ae-3996-40f3-b448-0dc20a8565ac"
      unitRef="U_USD">191160000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_580fb796-0cc5-42c3-af04-3d3ed06401b0"
      unitRef="U_USD">64286000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <hypr:CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_dc1dde8d-ade4-4736-8990-ddf8074253d3"
      unitRef="U_USD">374000</hypr:CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits>
    <hypr:CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_1359e6e5-b905-4081-8f6d-eb4a7274bb47"
      unitRef="U_USD">261000</hypr:CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_e2956a7c-67f0-43c6-abe9-6d44e3424d0e"
      unitRef="U_USD">136000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:StockIssued1
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_b79e073d-1e6c-449e-b4c8-42dbc09ed787"
      unitRef="U_USD">3000000</us-gaap:StockIssued1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_53d80188-894b-4378-97db-a88e27e5261f">&lt;p id="notes_organization_and_description" style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;1. ORGANIZ&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;ATION AND DESCRIPTION OF BUSINESS&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Hyperfine, Inc. (together with its subsidiaries, as applicable, &#x201c;Hyperfine&#x201d;, the &#x201c;Company&#x201d;), formerly known as HealthCor Catalio Acquisition Corp. (&#x201c;HealthCor&#x201d;), was incorporated as a Cayman Islands exempted company on November 18, 2020. The Company&#x2019;s legal name became Hyperfine, Inc. in connection with the closing of the Business Combination (the &#x201c;Closing&#x201d;) on December 22, 2021 (the &#x201c;Closing Date&#x201d;), as defined and described in Note 3. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Business Combination&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. In connection with the Closing, Hyperfine, Inc., a Delaware corporation (&#x201c;Legacy Hyperfine&#x201d;), and Liminal Sciences, Inc., a Delaware corporation (&#x201c;Liminal&#x201d;), merged with and into separate wholly owned subsidiaries of HealthCor and became wholly-owned subsidiaries of the Company, and changed their names to Hyperfine Operations, Inc. and Liminal Operations, Inc., respectively. Liminal subsequently changed its name to Liminal Sciences, Inc. The prior period financial information represents the combined financial results of Legacy Hyperfine and Liminal.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is an innovative digital health business with a mission to provide affordable and accessible imaging and monitoring through magnetic resonance imaging ("MRI") to revolutionize healthcare for people around the world. Hyperfine's Swoop&#xae; Portable Magnetic Resonance (&#x201c;MR&#x201d;) &lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Imaging System&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;"&gt;TM &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;produces high-quality images at a lower magnetic field strength than conventional MRI systems, and can be used by healthcare professionals to make effective clinical diagnoses on a patient in a variety of settings where MRI devices have previously been inaccessible. Hyperfine received 510(k) clearance from the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) in 2020 for its Swoop Portable MR Imaging System, which is commercially available in the United States. In 2021, Hyperfine also obtained a Medical Device License issued by Health Canada and expanded into the Canadian market, and also obtained regulatory authorization in New Zealand and Pakistan. All of the Company&#x2019;s revenue to date has been generated from sales of this machine and related services. Additionally, the Company is in the process of developing a device to non-invasively measure key vital signs in the brain to enable unprecedented access to dramatically improve patient outcomes. The Company is in the early research and development stage of such device and has not generated any revenue to date for it. In addition to Legacy Hyperfine and Liminal, the Company has an indirect wholly-owned subsidiary in the United Kingdom that did not have any significant operations during 2021.&lt;/span&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_35c2adc1-a400-48ea-9212-bd44d23fd754">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying combined and consolidated financial statements include the accounts of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the accounting disclosure rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). All intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;COVID-19 Outbreak&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The recent outbreak of the novel coronavirus (&#x201c;COVID-19&#x201d;), which was declared a pandemic by the World Health Organization on March 11, 2020 and declared a National Emergency by the President of the United States on March 13, 2020, has led to adverse impacts on the U.S. and global economies and created uncertainty regarding potential impacts on the Company&#x2019;s operating results, financial condition and cash flows. The COVID-19 pandemic has had, and is expected to continue to have, an adverse impact on the Company&#x2019;s operations, particularly as a result of preventive and precautionary measures that the Company, other businesses, and governments are taking. Governmental mandates related to COVID-19 or other infectious diseases, or public health crises, have impacted, and the Company expects them to continue to impact, its personnel and personnel at third-party manufacturing facilities in the United States and other countries, and the availability or cost of materials, which could disrupt or delay the Company&#x2019;s receipt of instruments, components and supplies from the third parties the Company relies on to, among other things, produce its products. The COVID-19 pandemic has also had an adverse effect on the Company&#x2019;s ability to attract, recruit, interview and hire at the pace the Company would typically expect to support its rapidly expanding operations. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company&#x2019;s business, results of operations and financial condition, including expenses and research and development costs, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or address the COVID-19 pandemic, as well as its economic impacts.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In adjusting to the COVID-19 market and manufacturing conditions, the Company did not have to materially adjust its existing resource allocation or its factors of production. The Company has not incurred any significant impairment losses in the carrying values of its assets as a result of the COVID-19 pandemic and is not aware of any specific related event or circumstance that would require the Company to revise its estimates reflected in its combined and consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The estimates of the impact on the Company&#x2019;s business may change based on new information that may emerge concerning COVID-19 and the actions to contain it or address its impact and the economic impact on local, regional, national and international markets. While the Company is unable to predict the full impact that the COVID-19 pandemic will have on its future results of operations, liquidity and financial condition due to numerous uncertainties, including the duration of the pandemic, and the actions that may be taken by government authorities across the United States and elsewhere, it is not expected to result in any significant changes in costs going forward.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents. At December 31, 2021 and 2020, substantially all the Company&#x2019;s cash and cash equivalents were invested at two financial institutions. The Company also maintains balances in various operating accounts above federally insured limits. The Company has not experienced any losses on such accounts and does not believe it is exposed to any significant credit risk on cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Significant customers are those that represent more than 10% of the Company&#x2019;s total revenues or gross accounts receivable balances for the periods and as of each balance sheet date presented. For each significant customer, revenue as a percentage of total revenues and gross accounts receivable as a percentage of total gross accounts receivable were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:17.622%;"/&gt;
          &lt;td style="width:1.915%;"/&gt;
          &lt;td style="width:21.98%;"/&gt;
          &lt;td style="width:1.735%;"/&gt;
          &lt;td style="width:18.5%;"/&gt;
          &lt;td style="width:1.735%;"/&gt;
          &lt;td style="width:17.389%;"/&gt;
          &lt;td style="width:1.735%;"/&gt;
          &lt;td style="width:17.389%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Accounts receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;For the year ended December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;For the year ended December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;21&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;24&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer C&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;21&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;11&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer E&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;53&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer F&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;41&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer G&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;14&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;32&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer H&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;26&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company utilizes a single exclusive manufacturer for its Swoop MRI scanner. Additionally, the Company purchases raw materials from this manufacturer.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s Chief Operating Decision Maker (&#x201c;CODM&#x201d;) is its Chief Executive Officer (&#x201c;CEO&#x201d;). Legacy Hyperfine and Liminal represent two operating segments. Given the similar qualitative and economic characteristics of the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;two&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; operating segments, such that both are focused upon the development and commercialization of existing and new products and services, Legacy Hyperfine and Liminal are aggregated into &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; reporting segment. All of the Company&#x2019;s long-lived assets are located in the United States. Other than $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;78&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of revenue recognized in Australia, all of the revenues were earned in the United States. Since the Company is aggregated into a single operating segment, all required financial segment information is provided in the combined and consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The preparation of the combined and consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions about future events that affect the amounts reported in its combined and consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates and assumptions. Significant estimates and assumptions included:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:6.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Revenue recognition, including determination of the timing and pattern of satisfaction of performance obligations, determination of the standalone selling price (&#x201c;SSP&#x201d;) of performance obligations and estimation of variable consideration;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Allowance for doubtful accounts;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net realizable value (the selling price as well as estimated costs of disposal and transportation) of inventory, and demand and future use of inventory;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Valuation allowances with respect to deferred tax assets; and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Assumptions underlying the fair value used in calculation of the stock-based compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company bases these estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company&#x2019;s combined and consolidated financial statements.	&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All highly liquid investments purchased with a maturity of three months or less are cash equivalents. As of December 31, 2021 and 2020, cash and cash equivalents consist principally of cash and money market accounts.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Restricted cash balance represents funds received as part of grant funding and restricted in use to the purpose of the funding. For details, see the Note 2. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Summary of Significant Accounting Policies - Grant Funding&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and Note 16. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Commitments and Contingencies&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounts Receivable&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accounts receivable are stated as the amount the Company expects to collect. The Company maintains allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. As of December 31, 2021 and 2020, the allowance for doubtful accounts was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;32&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Inventories&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Inventories primarily consist of finished goods which are produced by the Company&#x2019;s third-party contract manufacturers as well as raw materials ordered in advance by the third-party contract manufacturer due to long delivery-lead time and which were billed to the Company. Inventories are stated at the lower of actual cost, determined using the average cost method, or net realizable value. Cost includes an allocation of wages, taxes and benefits for employees involved in warehousing, logistics coordination, material sourcing, and production planning activities. Net realizable value is based upon an estimated average selling price reduced by the estimated costs of disposal and transportation.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;valuation of inventory also requires the Company to estimate excess and obsolete inventory. The Company considers sales forecasts and historical experience to identify excess, close out, or slow-moving items as well as new&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;product &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;development schedules, product obsolescence and product merchantability, including whether older products can be remanufactured into new products, among other factors. The Company reduces the value of inventory for estimated obsolescence or lack of marketability by the difference between the cost of the affected inventory and the net realizable value.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prepaid expenses and other current assets include amounts paid in advance for operating expenses as well as monies to be received from the State of Connecticut for research and development tax credits. These research and development tax credits are exchanged for a cash refund and are typically collected within one year from the date the tax return is filed with the state. The credits are recognized as an offset to research and development expenses in the combined and consolidated statements of operations and comprehensive loss in the annual period in which the corresponding expenses were incurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation expense is computed using the straight-line method over the estimated useful lives of the related assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Useful lives of property and equipment are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:79.609%;"/&gt;
          &lt;td style="width:1.925%;"/&gt;
          &lt;td style="width:0.624%;"/&gt;
          &lt;td style="width:17.229%;"/&gt;
          &lt;td style="width:0.613%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;"&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Estimated useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Research devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Sales and marketing devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tooling&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Trade show assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Leased devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other property and equipment include furniture and fixtures, software, vehicles, and machinery and equipment.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expenditures for major renewals and improvements are capitalized. Expenditures for repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation is eliminated from the balance sheet, and any resulting gains or losses are included in the combined and consolidated statements of operations and comprehensive loss in the period of disposal.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company reviews its long-lived assets for impairment at least annually or when the Company determines a triggering event has occurred. When a triggering event has occurred, each impairment test is based on a comparison of the future expected undiscounted cash flow to the recorded value of the asset. If the recorded value of the asset is less than the undiscounted cash flow, the asset is written down to its estimated fair value. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; impairments were recorded for the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Capitalized Software Development Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For the costs incurred in developing the firmware embedded in the hardware devices that the Company sells and leases to its customers, the Company applies the principles of Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 985-20, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounting for the Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 985-20&#x201d;). ASC 985-20 requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established. Thereafter, until the product is released for sale, software development costs must be capitalized and reported at the lower of unamortized cost or net realizable value of the related product. The Company has adopted the &#x201c;tested working model&#x201d; approach to establishing technological feasibility for its software products. Under this&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;approach, the Company does not consider a product in development to have passed the technological feasibility milestone until the Company has completed a model of the product that contains essentially all the functionality and features of the final product and has tested the model to ensure that it works as expected. The Company&#x2019;s hardware device, with the embedded firmware, was released for sale during the fourth quarter of the year ended December 31, 2020, when the Company had completed all of the research and development activity to establish the technological feasibility of the product. As of December 31, 2021 and 2020, the Company had not incurred significant costs between the establishment of technological feasibility and the release of a product for sale; thus, the Company had expensed all software development costs as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For software developed or acquired for internal use, including software used in the provision of subscription services to the Company&#x2019;s customers, the Company applies the principles of ASC 350-40, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounting for the Cost of Computer Software Developed or Obtained for Internal Use&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 350-40&#x201d;). ASC 350-40 requires that software development costs incurred before the preliminary project stage be expensed as incurred. The Company capitalizes development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed, and the software will be used to perform the function intended. Costs incurred during the preliminary project and post-implementation stages, including training and maintenance, are expensed as incurred. Capitalized costs are amortized on a project-by-project basis using the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;straight-line method&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; over the estimated economic life of the application, which is&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; three years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, beginning when the asset is substantially ready for use. As of December 31, 2021 and 2020, the Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t have any amount of capitalized internal-use software development costs.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company recognizes revenue in accordance with ASC Topic 606, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;&#x201c;Revenue from Contracts with Customers.&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Revenue is recognized when or as a customer obtains control of the promised goods and services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for these goods and services. To achieve this core principle, the Company applies the following 5 steps:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Step 1: Identify Contracts with Customers:&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The Company executes signed contracts with its customers for the sale of hardware devices and subscription services.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Step 2: Identify Performance Obligations:&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The Company&#x2019;s contracts with customers primarily include two performance obligations, namely the hardware device and subscription services, which include access to the Company&#x2019;s hosted cloud-based software applications and hardware maintenance and support on an ongoing basis throughout the subscription period.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Step 3: Determine Transaction Price:&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The Company&#x2019;s contracts with customers include variable consideration in the form of discounts and price concessions. The Company estimates variable consideration using the expected value method based on the data available as of the end of each reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Step 4: Allocate Transaction Price to Performance Obligations:&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The Company allocates transaction price to the performance obligations in a contract with a customer, based on the relative standalone selling prices of the goods and services. The standalone selling prices of the hardware devices and subscription services are determined based on the observable standalone selling prices for which the Company sells the respective goods and services on a standalone basis, including renewals of subscription services.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Step 5: Recognize Revenue as Performance Obligations are Satisfied:&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; Each unit of hardware devices is a performance obligation satisfied at a point in time, when control of the good transfers from the Company to the customer, which is usually upon delivery of the good to the customer. For sales of hardware where control of the product transfers to the customer upon shipment, the Company has made an accounting policy election to account for shipping and handling as fulfillment activities rather than a performance obligation. The subscription services are stand-ready obligations that are satisfied over time by providing the customer with ongoing access to the Company&#x2019;s resources throughout the subscription period. The Company uses the time elapsed (straight line) measure of progress to recognize revenue as these performance obligations are satisfied evenly over the respective service period.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company offers alternative payment structures and &#x201c;as-a-service&#x201d; offerings that are assessed to determine whether an embedded lease arrangement exists. The Company accounts for those contracts as a lease arrangement under the current lease standard if it is determined that the contract contains an identified asset and that the right to direct the use of that asset has transferred to the customer. When a contract includes lease and non-lease components, the Company allocates consideration under the contract to each component based on the relative standalone selling price and subsequently assesses lease classification for each lease component within a contract as a sales-type lease or an operating lease. On commencement of sales-type leases, the Company recognizes revenue up-front, and amounts due from the customer under the lease contract are recognized as financing receivables on the combined and consolidated balance sheets. Interest income is recognized as revenue over the term of the lease based on the effective interest method. The Company has elected not to include sales and other taxes collected from the lessee as part of lease revenue.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All other leases that do not meet the definition of a sales-type lease are classified as operating leases. The underlying asset in an operating lease arrangement is carried at depreciated cost within Property and equipment, net on the combined and consolidated balance sheets. Depreciation is calculated using the straight-line method over the term of the underlying lease contract and is recognized as cost of revenue. The depreciable basis is the original cost of the equipment less the estimated residual value of the equipment at the end of the lease term. The Company recognizes operating lease income to product revenue on a straight-line basis over the lease term. Impairment of equipment under operating leases is assessed on the same basis as other long-lived assets.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Deferred Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from subscription services described above and is reduced as the revenue recognition criteria are met. Deferred revenue is classified as current based on expected revenue recognition timing. Specifically, deferred revenue that will be recognized as revenue within the succeeding twelve-month period is recorded as current in the Company&#x2019;s combined and consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Warranties&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company offers a device warranty to customers for the longer of (a) twelve (12) months from delivery of the device for devices obtained through a capital purchase, or (b) the term of the subscription agreement for devices obtained on a subscription basis (subject to continued payment of fees for the subscription service). The Company&#x2019;s subscription services include hardware maintenance and support. As noted in the accounting policy for revenue recognition, the Company recognizes revenue for subscription service over time using the time elapsed measure of progress. The costs of hardware maintenance are recognized in costs of revenue as they are incurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Research and Development&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development costs consists of production costs for prototype, test and pre-production units, lab supplies, consulting and personnel costs, including salaries, stock-based compensation, bonuses, benefit costs and depreciation. Certain research and development grant funding is recognized as a reduction to research and development costs (see Note 2. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Summary of Significant Accounting Policies - Grant Funding&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;). The Company recognizes these costs as they are incurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Grant Funding&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company received certain research and development funding through a grant issued by the Bill &amp;amp; Melinda Gates Foundation (&#x201c;BMGF&#x201d;). Funding is recorded on the combined and consolidated balance sheet as restricted cash upon receipt. The funding is recognized in the combined and consolidated statements of operations and comprehensive loss as a reduction to research and development expense as the related costs are incurred to meet those obligations over the grant period. Grant funding payments received in advance of research and development expenses incurred are recorded as deferred grant funding as a current liability in the Company&#x2019;s combined and consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cost of Sales&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cost of sales consists of product and service costs including personnel cost and benefits including stock-based compensation, product costs, production setup expenses, depreciation and amortization expenses, inventory excess and obsolescence expenses.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:2.603%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Patent Costs&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Patent costs have been charged to operations as incurred, as their realization is uncertain. These costs are included in general and administrative expenses in the combined and consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;General and Administrative&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;General and administrative expenses primarily consist of personnel costs and benefits including stock-based compensation, patent and filing fees, office expenses and outside services. Outside services consist of professional services, legal and other professional fees.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Sales and Marketing&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Sales and marketing costs primarily consist of personnel costs and benefits including stock-based compensation, advertising, promotional, as well as conferences, meetings, and other events. Advertising costs are expensed as incurred. For the years ended December 31, 2021 and 2020, advertising expenses were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,459&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;437&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Net Loss per Common Share&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Basic net loss per common share is calculated by dividing the net loss attributed to common stockholders by the weighted average number of common shares outstanding during the period, without consideration of potentially dilutive securities.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares plus the common equivalent shares of the period, including any dilutive effect from such shares. The Company&#x2019;s diluted net loss per common share is the same as basic net loss per common share for all periods presented since the effect of potentially dilutive securities is anti-dilutive. Refer to Note 13. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for further discussion.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has applied the guidance in ASC Topic 480-10-S99-3A, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;SEC Staff Announcement: Classification and Measurement of Redeemable Securities,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and has therefore classified the Series A, Series B, Series C and Series D Convertible Preferred Stock (&#x201c;Convertible Preferred Stock&#x201d;) (see Note 10. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) as mezzanine equity. The Convertible Preferred Stock was recorded outside of stockholders&#x2019; equity (deficit) because the Convertible Preferred Stock included a redemption provision upon a change of control, which is deemed a liquidation event that is considered outside the Company&#x2019;s control. The Convertible Preferred Stock has been recorded at its original issue price, net of issuance costs. The Company did not adjust the carrying value of the Convertible Preferred Stock to the liquidation price associated with a change of control at December 31, 2020 because a change of control of the Company was not considered probable at the reporting date (see Note 10. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;). Subsequent adjustments to increase or decrease the carrying values to their respective liquidation prices were made only when it became probable that such a change of control would occur.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The measurement of stock-based compensation expense for all stock-based payment awards, including stock options granted to employees, directors, and consultants, is based on the estimated fair value of the awards on the date of grant.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company recognizes stock-based compensation expense for stock option grants and incentive unit grants with only service conditions on a straight-line basis over the requisite service period of the individual grants, which is generally the vesting period, based on the estimated grant date fair values. Generally, stock option grants and incentive unit grants fully vest &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; after the grant date, and stock option grants generally have a term of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company recognizes the effect of forfeiture in compensation costs based on actual forfeitures when they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company's stock-based compensation program includes stock option grants to its employees, directors, and consultants. Stock options are granted at exercise prices not less than the estimated fair market value of the Company&#x2019;s common stock at the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The fair values of stock option grants are estimated using a Black-Scholes option-pricing model. Key inputs and assumptions include the expected term of the option, stock price volatility, risk free interest rate, dividend yield, stock price and exercise price. Many of the assumptions require significant judgment and any changes could have a material impact in the determination of stock-based compensation expense.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;During the year ended December 31, 2020, Liminal was a wholly owned subsidiary of 4Bionics, and as such, 4Bionics granted equity awards in the form of incentive units to Liminal employees and nonemployees under 4Bionics&#x2019; stock-based compensation program.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On April 2, 2021, 4Bionics executed a plan of liquidation and dissolution and its ownership in Liminal was distributed to its members and to the holders of incentive units. Immediately subsequent to the dissolution, all outstanding unvested incentive unit awards under 4Bionic&#x2019;s 2019 Equity Incentive Plan were replaced with preferred stock awards indexed to and settled in the preferred stock of the former 4Bionics subsidiaries Liminal, Detect, Inc. (f/k/a Homodeus Inc.), Tesseract Health, Inc. and Protein Evolution, Inc. The preferred stock awards are subject to service vesting conditions only. No incremental value was provided to participants as a result of the modification of the awards as the modification date fair value of the incentive unit awards was equal to the modification date fair value of the stock underlying the restricted stock awards. Moreover, the remaining vesting period before and after modification was unchanged.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Earn-Out Shares&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Earn-Out Shares, as defined in Note 3.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; Business Combination&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, to which the Companies&#x2019; pre-closing equity holders are entitled, fall within the scope of ASC 815,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; Derivatives and Hedging&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 815&#x201d;) pursuant to which such Earn-Out Shares are equity classified and are to be recognized upon achievement of the market price milestone.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Earn-Out Shares to which certain employees are entitled to fall within the scope of ASC 718, pursuant to which such Earn-Out Shares are equity classified and their grant date fair value will be recognized as compensation expense over the vesting period.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Research and Development Tax Credits&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company recognizes research and development tax credits as a reduction of Research and Development expense as earned. For State of Connecticut research and development tax credits, which are exchanged for a cash refund from the State of Connecticut, such exchanged credits are recognized as earned as a reduction of Research and Development expense in the combined and consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company utilizes the asset and liability method of accounting for income taxes, as set forth in ASC Topic 740, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. Under this method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities using the enacted statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established against net deferred tax assets if, based on&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;the weight of available evidence, it is more likely than not that some or all of the net deferred tax assets will not be realized. The Company has recorded a full valuation allowance as of December 31, 2021 and 2020. Based on the available evidence, the Company believes that it is more likely than not that it will be unable to utilize all of its deferred tax assets in the future.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In accordance with the provisions of ASC Topic 740, the Company accrues for the estimated amount of taxes for uncertain tax positions if it is more likely than not that the Company would be required to pay such additional taxes. An uncertain tax position will not be recognized if it has a less than 50% likelihood of being sustained. The Company&#x2019;s policy is to recognize any interest and penalties related to income taxes in income tax expense in the combined and consolidated statements of operations and comprehensive loss. The Company&#x2019;s open tax years subject to examination by the relevant taxing authorities are &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_0d93ec06-e2be-489a-ac3b-531777fb08ff;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2017 through 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. As of December 31, 2021 and 2020, the Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; uncertain tax positions.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounting pronouncements adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In August 2018, the FASB issued ASU No. 2018-15, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Intangibles &#x2014; Goodwill and Other &#x2014; Internal-Use Software Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The guidance requires certain costs incurred during the application development stage to be capitalized and other costs incurred during the preliminary project and post-implementation stages to be expensed as they are incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. A customer&#x2019;s accounting for the hosting component of the arrangement is not affected. This new guidance is effective for the Company for the annual reporting period beginning January 1, 2021 and interim periods beginning January 1, 2022. The Company &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;adopted this guidance&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and there was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no material effect of adoption on the combined and consolidated financial statements&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, which simplifies the accounting for convertible instruments by removing the separation models for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. These changes will reduce reported interest expense and increase reported net income for entities that have issued a convertible instrument that was bifurcated according to previously existing rules. ASU 2020-06 also requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will be no longer available. For public entities, this guidance is effective for annual reporting periods beginning January 1, 2022, including interim periods within that annual reporting period. For the Company, this guidance is effective for annual reporting periods beginning January 1, 2024, and interim reporting periods within annual reporting periods beginning January 1, 2024, with early adoption permitted. The Company elected to early &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;adopt this accounting pronouncement&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and there was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no material impact on the Company&#x2019;s combined and consolidated financial statements and disclosures&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and improves consistent application of and simplifies U.S. GAAP for other areas of Topic 740 by clarifying existing guidance. For the Company, this ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; this guidance on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and there was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; material effect of adoption on the Company&#x2019;s combined and consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounting pronouncements issued but not yet adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In February 2016, the FASB issued ASU 2016-02, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Leases (Topic 842),&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which outlines a comprehensive lease accounting model and supersedes the current lease guidance. The new guidance requires lessees to recognize almost all of their leases on the balance sheet by recording a lease liability and corresponding right-of-use assets. It also&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;changes the definition of a lease and expands the disclosure requirements of lease arrangements. As per the latest ASU 2020-05 issued by FASB, entities that have not yet issued or made available for issuance the financial statements as of June 3, 2020 can defer the new guidance for one year. For public entities, this guidance is effective for annual reporting periods beginning January 1, 2020, including interim periods within that annual reporting period. For the Company, this guidance is effective for annual reporting periods beginning January 1, 2022, and interim reporting periods within annual reporting periods beginning January 1, 2023. The Company is in the process of evaluating the impact that the adoption of this pronouncement will have on the Company&#x2019;s combined and consolidated financial statements and does not expect it to be material.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;&#x201c;Financial Instruments &#x2014; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#x201d;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which was subsequently amended in November 2018 through ASU No. 2018-19, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;&#x201c;Codification Improvements to Topic 326, Financial Instruments &#x2014; Credit Losses.&#x201d;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. ASU No. 2018-19 further clarifies that receivables arising from operating leases are not within the scope of Topic 326. Instead, impairment from receivables of operating leases should be accounted for in accordance with Topic 842, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Leases&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. As per the latest ASU 2020-02, the FASB deferred the timelines for certain small public and private entities, thus the new guidance will be adopted by the Company for the annual reporting period beginning January 1, 2023, including interim periods within that annual reporting period. The standard will apply as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company is in the process of evaluating the impact that the adoption of this pronouncement will have on the Company&#x2019;s combined and consolidated financial statements and disclosures.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_acd32112-af42-4d32-bd24-c6aba07b5ad5">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying combined and consolidated financial statements include the accounts of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the accounting disclosure rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). All intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <hypr:Covid19OutbreakPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_860e2255-8d02-46bc-aca8-0ccda2bcb806">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;COVID-19 Outbreak&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The recent outbreak of the novel coronavirus (&#x201c;COVID-19&#x201d;), which was declared a pandemic by the World Health Organization on March 11, 2020 and declared a National Emergency by the President of the United States on March 13, 2020, has led to adverse impacts on the U.S. and global economies and created uncertainty regarding potential impacts on the Company&#x2019;s operating results, financial condition and cash flows. The COVID-19 pandemic has had, and is expected to continue to have, an adverse impact on the Company&#x2019;s operations, particularly as a result of preventive and precautionary measures that the Company, other businesses, and governments are taking. Governmental mandates related to COVID-19 or other infectious diseases, or public health crises, have impacted, and the Company expects them to continue to impact, its personnel and personnel at third-party manufacturing facilities in the United States and other countries, and the availability or cost of materials, which could disrupt or delay the Company&#x2019;s receipt of instruments, components and supplies from the third parties the Company relies on to, among other things, produce its products. The COVID-19 pandemic has also had an adverse effect on the Company&#x2019;s ability to attract, recruit, interview and hire at the pace the Company would typically expect to support its rapidly expanding operations. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company&#x2019;s business, results of operations and financial condition, including expenses and research and development costs, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or address the COVID-19 pandemic, as well as its economic impacts.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In adjusting to the COVID-19 market and manufacturing conditions, the Company did not have to materially adjust its existing resource allocation or its factors of production. The Company has not incurred any significant impairment losses in the carrying values of its assets as a result of the COVID-19 pandemic and is not aware of any specific related event or circumstance that would require the Company to revise its estimates reflected in its combined and consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The estimates of the impact on the Company&#x2019;s business may change based on new information that may emerge concerning COVID-19 and the actions to contain it or address its impact and the economic impact on local, regional, national and international markets. While the Company is unable to predict the full impact that the COVID-19 pandemic will have on its future results of operations, liquidity and financial condition due to numerous uncertainties, including the duration of the pandemic, and the actions that may be taken by government authorities across the United States and elsewhere, it is not expected to result in any significant changes in costs going forward.&lt;/span&gt;&lt;/p&gt;</hypr:Covid19OutbreakPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_18e3bcd9-1544-4ba8-a650-1b7378579c0d">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents. At December 31, 2021 and 2020, substantially all the Company&#x2019;s cash and cash equivalents were invested at two financial institutions. The Company also maintains balances in various operating accounts above federally insured limits. The Company has not experienced any losses on such accounts and does not believe it is exposed to any significant credit risk on cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Significant customers are those that represent more than 10% of the Company&#x2019;s total revenues or gross accounts receivable balances for the periods and as of each balance sheet date presented. For each significant customer, revenue as a percentage of total revenues and gross accounts receivable as a percentage of total gross accounts receivable were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:17.622%;"/&gt;
          &lt;td style="width:1.915%;"/&gt;
          &lt;td style="width:21.98%;"/&gt;
          &lt;td style="width:1.735%;"/&gt;
          &lt;td style="width:18.5%;"/&gt;
          &lt;td style="width:1.735%;"/&gt;
          &lt;td style="width:17.389%;"/&gt;
          &lt;td style="width:1.735%;"/&gt;
          &lt;td style="width:17.389%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Accounts receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;For the year ended December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;For the year ended December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;21&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;24&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer C&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;21&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;11&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer E&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;53&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer F&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;41&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer G&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;14&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;32&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer H&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;26&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company utilizes a single exclusive manufacturer for its Swoop MRI scanner. Additionally, the Company purchases raw materials from this manufacturer.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_1e39c93b-e5c8-462f-96c1-042f8f986229">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Significant customers are those that represent more than 10% of the Company&#x2019;s total revenues or gross accounts receivable balances for the periods and as of each balance sheet date presented. For each significant customer, revenue as a percentage of total revenues and gross accounts receivable as a percentage of total gross accounts receivable were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:17.622%;"/&gt;
          &lt;td style="width:1.915%;"/&gt;
          &lt;td style="width:21.98%;"/&gt;
          &lt;td style="width:1.735%;"/&gt;
          &lt;td style="width:18.5%;"/&gt;
          &lt;td style="width:1.735%;"/&gt;
          &lt;td style="width:17.389%;"/&gt;
          &lt;td style="width:1.735%;"/&gt;
          &lt;td style="width:17.389%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Arial;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Accounts receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;For the year ended December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;For the year ended December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;21&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;24&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer C&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;21&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;11&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer E&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;53&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer F&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;41&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer G&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;14&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;32&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Customer H&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:right;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;26&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_09eef7e3-8ef7-4872-9505-3cdfab129205"
      decimals="2"
      id="F_cb656e5b-66bb-4697-9962-2a99e415370d"
      unitRef="U_pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_474a603f-d6db-4d8d-92d3-70cb2d1e090f"
      decimals="2"
      id="F_acbc9236-bc6a-4014-8025-8810d84013bd"
      unitRef="U_pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_7ccf2627-1cdc-47b7-ba29-626a157390fb"
      decimals="2"
      id="F_718e850b-f1f1-409d-816d-8c1842a4702c"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_3157ed03-ddbf-421e-bca7-442ffc10828a"
      decimals="2"
      id="F_bdb35a09-8058-4c3e-8eb6-63357a631027"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_f8f8bfd0-b2c9-4228-859d-e035e36fdaff"
      decimals="2"
      id="F_e104c2f8-30bf-4626-82e5-d623aadc4848"
      unitRef="U_pure">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_567125e1-75b2-41be-99d3-e7b8a2774dc7"
      decimals="2"
      id="F_0f434cc1-366e-462d-a3a6-04919df91af4"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_6fdadebf-3247-42bc-88ce-f78d1aae83b2"
      decimals="2"
      id="F_b753fa7e-7b4f-409f-9ac4-d8166dafd80d"
      unitRef="U_pure">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_dca47efa-de44-4ea2-a6f7-5e416bbbb918"
      decimals="2"
      id="F_77b5934f-0ed2-4a1a-a4f2-477b9a1b026e"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_bba669ae-db49-4d96-9060-d3c7c8e07261"
      decimals="2"
      id="F_d5afb4ab-f5d3-4b3d-8512-179cad7d5486"
      unitRef="U_pure">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_1dd44ac9-6110-4a83-a30a-28c9fbf87799"
      decimals="2"
      id="F_e1b650b3-b67f-4985-9e13-24999edd0c03"
      unitRef="U_pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_c9211565-b84a-4c97-88de-605f5525382b"
      decimals="2"
      id="F_6bb1939d-59d1-4dc0-a16d-26e7774f3837"
      unitRef="U_pure">0.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_49d0dcc9-816b-4e28-8bc4-f9b5575f3a10"
      decimals="2"
      id="F_b3664402-0555-44b4-bacb-019d529e695f"
      unitRef="U_pure">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_62a0c92e-5cb0-440b-9b64-ce1f6af679d3"
      decimals="2"
      id="F_4cda0b51-bf28-4634-8c0e-76f0ab77feec"
      unitRef="U_pure">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_e9c6aa3c-7348-4f82-973e-f19a18dd2b91"
      decimals="2"
      id="F_b38fb769-94e8-4c52-a3ff-67c60396e96d"
      unitRef="U_pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_5cc0bd53-ddda-46e6-831e-25d4e45fd73a"
      decimals="2"
      id="F_462c78d4-734d-476f-acbc-80138413e4fc"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_32bbb1e2-b724-403f-b397-48d9add24af7"
      decimals="2"
      id="F_b8015af2-46c8-4eb5-8136-efec81f6bf68"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_605093d2-ac5d-4510-b28c-7b383c6172c0"
      decimals="2"
      id="F_1a38a925-20dd-4839-b331-473209d845e5"
      unitRef="U_pure">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_167b678f-7a7b-434b-9324-e4fb5b75ab31"
      decimals="2"
      id="F_5ead3339-ea7a-4aee-a31c-6d249f64f635"
      unitRef="U_pure">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_c41d64ad-bb4c-4c76-99f9-e336bc1ab030"
      decimals="2"
      id="F_cc13729d-18be-4251-860b-1352e4b49a8c"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_8ce579da-efe4-411c-8e78-a08e6c50c59f"
      decimals="2"
      id="F_5bc7eb4f-dd02-4aa0-add3-56380f7e3077"
      unitRef="U_pure">0.53</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_3b17a194-f917-4277-981e-1a50762d4429"
      decimals="2"
      id="F_06fcd96a-aa2e-4961-bf56-701a9c7909b7"
      unitRef="U_pure">0.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_fba03c4e-b08a-41a6-8e92-9f1c641cb1f1"
      decimals="2"
      id="F_80444894-d329-4f84-bac4-f1f53b0a1469"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_734af1ad-a0ec-4f29-bf39-f1b5327db6c7"
      decimals="2"
      id="F_d057c945-73d9-44e5-a3b7-92ebb785446f"
      unitRef="U_pure">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_d03d8509-9cd9-41c6-ad48-7df3d9451e56"
      decimals="2"
      id="F_5e2f448c-3270-448b-8a09-019db9fb3eb8"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_89e586a8-ee0a-4268-89f0-554f600718eb"
      decimals="2"
      id="F_3d156616-a3bb-4efa-90ee-f11f1ff9e153"
      unitRef="U_pure">0.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_25f955f4-3de2-435b-8a68-92a8fb8291b4"
      decimals="2"
      id="F_9a3ff426-b865-4c99-86d4-bf1d960c6642"
      unitRef="U_pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_931d86b2-1bb0-4d61-bc67-022ee2881f97"
      decimals="2"
      id="F_ee67ffb4-31b4-4b34-917f-ab93b4f39c94"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_1ae6ab52-d904-4842-a161-d9892fd7ed09"
      decimals="2"
      id="F_bdca397e-3a1d-47ec-b01d-d00a26dc5cd0"
      unitRef="U_pure">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_d78a6553-a61c-42e1-b9da-7148c3162bcc"
      decimals="2"
      id="F_0ddcea94-6fe4-47f9-9eb2-68abff460e20"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_6be4d64c-5ea1-40cf-ab05-f2d63f1883e8"
      decimals="2"
      id="F_afe4dc20-ba79-4bec-a0a3-fefd348c50af"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_bb1fde1a-0016-49f0-92be-2a618f68f12f"
      decimals="2"
      id="F_d40c9a27-5a34-4d06-b5f1-62e8129a53b8"
      unitRef="U_pure">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_1a8cf60f-453e-465e-86fc-c6ed0ff3919e"
      decimals="2"
      id="F_eee69d3e-55ee-46ff-adc6-91d601c6ddc6"
      unitRef="U_pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_616dd041-cc6e-44cd-bf8c-5da8e02e8163">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s Chief Operating Decision Maker (&#x201c;CODM&#x201d;) is its Chief Executive Officer (&#x201c;CEO&#x201d;). Legacy Hyperfine and Liminal represent two operating segments. Given the similar qualitative and economic characteristics of the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;two&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; operating segments, such that both are focused upon the development and commercialization of existing and new products and services, Legacy Hyperfine and Liminal are aggregated into &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; reporting segment. All of the Company&#x2019;s long-lived assets are located in the United States. Other than $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;78&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of revenue recognized in Australia, all of the revenues were earned in the United States. Since the Company is aggregated into a single operating segment, all required financial segment information is provided in the combined and consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_43db31a9-0c99-4e54-ab20-021b4b451129"
      unitRef="U_Segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_cc4ea095-a15d-499f-935d-053f74993aca"
      unitRef="U_Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_02ac6247-634e-47e7-9137-1d9fcf817084"
      decimals="-3"
      id="F_9311ebca-f213-42e9-a15a-ad47ddabbf43"
      unitRef="U_USD">78000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:UseOfEstimates
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_42ef55f7-6dd4-4fec-b5a6-ed073442c912">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The preparation of the combined and consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions about future events that affect the amounts reported in its combined and consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates and assumptions. Significant estimates and assumptions included:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:6.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Revenue recognition, including determination of the timing and pattern of satisfaction of performance obligations, determination of the standalone selling price (&#x201c;SSP&#x201d;) of performance obligations and estimation of variable consideration;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Allowance for doubtful accounts;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net realizable value (the selling price as well as estimated costs of disposal and transportation) of inventory, and demand and future use of inventory;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Valuation allowances with respect to deferred tax assets; and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:6.667%;display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:2.667%;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Assumptions underlying the fair value used in calculation of the stock-based compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company bases these estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company&#x2019;s combined and consolidated financial statements.	&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_9a2f92ac-ceb5-4d7d-b658-5b31d69167db">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All highly liquid investments purchased with a maturity of three months or less are cash equivalents. As of December 31, 2021 and 2020, cash and cash equivalents consist principally of cash and money market accounts.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_906d5ab1-e7a0-4721-8861-7ca6910d4ad1">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Restricted cash balance represents funds received as part of grant funding and restricted in use to the purpose of the funding. For details, see the Note 2. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Summary of Significant Accounting Policies - Grant Funding&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and Note 16. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Commitments and Contingencies&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_f8f4f151-c28e-49a5-a200-5fa607a18c56">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounts Receivable&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accounts receivable are stated as the amount the Company expects to collect. The Company maintains allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. As of December 31, 2021 and 2020, the allowance for doubtful accounts was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;32&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_7fd2e31a-767c-4a92-8624-2e400d2608d7"
      unitRef="U_USD">32000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_4f031630-9e45-4135-8cb9-fbac59889171"
      unitRef="U_USD">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_9f34a124-be83-414f-b070-a8f3a28b4f7c">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Inventories&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Inventories primarily consist of finished goods which are produced by the Company&#x2019;s third-party contract manufacturers as well as raw materials ordered in advance by the third-party contract manufacturer due to long delivery-lead time and which were billed to the Company. Inventories are stated at the lower of actual cost, determined using the average cost method, or net realizable value. Cost includes an allocation of wages, taxes and benefits for employees involved in warehousing, logistics coordination, material sourcing, and production planning activities. Net realizable value is based upon an estimated average selling price reduced by the estimated costs of disposal and transportation.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;valuation of inventory also requires the Company to estimate excess and obsolete inventory. The Company considers sales forecasts and historical experience to identify excess, close out, or slow-moving items as well as new&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;product &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;development schedules, product obsolescence and product merchantability, including whether older products can be remanufactured into new products, among other factors. The Company reduces the value of inventory for estimated obsolescence or lack of marketability by the difference between the cost of the affected inventory and the net realizable value.&lt;/span&gt;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <hypr:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_b259274b-b999-4440-8b3c-27fef2470761">&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prepaid expenses and other current assets include amounts paid in advance for operating expenses as well as monies to be received from the State of Connecticut for research and development tax credits. These research and development tax credits are exchanged for a cash refund and are typically collected within one year from the date the tax return is filed with the state. The credits are recognized as an offset to research and development expenses in the combined and consolidated statements of operations and comprehensive loss in the annual period in which the corresponding expenses were incurred.&lt;/span&gt;&lt;/p&gt;</hypr:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_580cb61c-b5d3-4811-b66e-e1865fce5e33">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation expense is computed using the straight-line method over the estimated useful lives of the related assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Useful lives of property and equipment are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:79.609%;"/&gt;
          &lt;td style="width:1.925%;"/&gt;
          &lt;td style="width:0.624%;"/&gt;
          &lt;td style="width:17.229%;"/&gt;
          &lt;td style="width:0.613%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;"&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Estimated useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Research devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Sales and marketing devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tooling&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Trade show assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Leased devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other property and equipment include furniture and fixtures, software, vehicles, and machinery and equipment.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expenditures for major renewals and improvements are capitalized. Expenditures for repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation is eliminated from the balance sheet, and any resulting gains or losses are included in the combined and consolidated statements of operations and comprehensive loss in the period of disposal.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <hypr:ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_ec5d6d3c-7a33-4028-98f1-0522f7c29265">&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Useful lives of property and equipment are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:79.609%;"/&gt;
          &lt;td style="width:1.925%;"/&gt;
          &lt;td style="width:0.624%;"/&gt;
          &lt;td style="width:17.229%;"/&gt;
          &lt;td style="width:0.613%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;"&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Estimated useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Research devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Sales and marketing devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tooling&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Trade show assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Leased devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</hypr:ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_7bcd7cb4-1dc9-4c68-a43e-62994fd1ac21"
      id="F_93bfe0c5-1981-4f70-8de1-2567bf8b753b">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_10346531-8b79-4c49-b961-3e5de4647ca2"
      id="F_096e1b53-1025-42c1-8607-74084f9bd17c">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_aa627098-fe3c-4ac0-80bb-2be20fe7c7a5"
      id="F_54bad0c1-1349-4104-8950-fb14864e186f">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_1c800ff0-677d-4568-ac8b-02a9fb77a094"
      id="F_6119409a-20b7-4a0a-9318-d26df6aea61e">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_7cb5eab9-0fdd-4dc3-8931-9772493bd16f"
      id="F_4b7b2db2-7458-4a21-bc3f-08f22be8fc0e">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_caae9469-5585-4e17-9b3f-2def45052046"
      id="F_0dfc5b09-7f44-471a-8334-925886be4ee8">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_3ef7cc75-c5bb-4fbe-b9a3-8cee4d7281da"
      id="F_aec27221-fccd-4ff3-a93b-ac460ca9023a">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_aeb82c50-d014-42e5-8b78-49b806cb3896"
      id="F_d8159f4f-0289-4c7e-a1fe-b7970bde2d0f">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_d27d7f2c-d654-4af6-9a83-2fc82df0f902"
      id="F_48051f63-34cb-401a-9dcf-a396f8f9623e">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_5f15ee23-839a-4806-b6ef-d2540c847529">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company reviews its long-lived assets for impairment at least annually or when the Company determines a triggering event has occurred. When a triggering event has occurred, each impairment test is based on a comparison of the future expected undiscounted cash flow to the recorded value of the asset. If the recorded value of the asset is less than the undiscounted cash flow, the asset is written down to its estimated fair value. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; impairments were recorded for the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_251c28c7-f5f3-450f-b0b5-9f60784c4510"
      unitRef="U_USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="INF"
      id="F_739eabdd-8d8c-4113-822d-d1d7618504f6"
      unitRef="U_USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_4337cf3e-e881-47ad-93a3-b037a31d7f76">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Capitalized Software Development Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For the costs incurred in developing the firmware embedded in the hardware devices that the Company sells and leases to its customers, the Company applies the principles of Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 985-20, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounting for the Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 985-20&#x201d;). ASC 985-20 requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established. Thereafter, until the product is released for sale, software development costs must be capitalized and reported at the lower of unamortized cost or net realizable value of the related product. The Company has adopted the &#x201c;tested working model&#x201d; approach to establishing technological feasibility for its software products. Under this&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;approach, the Company does not consider a product in development to have passed the technological feasibility milestone until the Company has completed a model of the product that contains essentially all the functionality and features of the final product and has tested the model to ensure that it works as expected. The Company&#x2019;s hardware device, with the embedded firmware, was released for sale during the fourth quarter of the year ended December 31, 2020, when the Company had completed all of the research and development activity to establish the technological feasibility of the product. As of December 31, 2021 and 2020, the Company had not incurred significant costs between the establishment of technological feasibility and the release of a product for sale; thus, the Company had expensed all software development costs as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For software developed or acquired for internal use, including software used in the provision of subscription services to the Company&#x2019;s customers, the Company applies the principles of ASC 350-40, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounting for the Cost of Computer Software Developed or Obtained for Internal Use&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 350-40&#x201d;). ASC 350-40 requires that software development costs incurred before the preliminary project stage be expensed as incurred. The Company capitalizes development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed, and the software will be used to perform the function intended. Costs incurred during the preliminary project and post-implementation stages, including training and maintenance, are expensed as incurred. Capitalized costs are amortized on a project-by-project basis using the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;straight-line method&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; over the estimated economic life of the application, which is&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; three years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, beginning when the asset is substantially ready for use. As of December 31, 2021 and 2020, the Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t have any amount of capitalized internal-use software development costs.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:CapitalizedContractCostAmortizationMethod
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_9f7ce6d1-3b38-4eb4-8b03-b829ac53ec22">straight-line method</us-gaap:CapitalizedContractCostAmortizationMethod>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      id="F_ac14605d-e14f-4aec-8e27-3934c4273781">P3Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="C_fad97c6a-6c78-4438-bbf2-78f5774e74c3"
      decimals="INF"
      id="F_99f28e14-c878-497d-9fc1-6618f64487e3"
      unitRef="U_USD">0</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="C_8befb59f-1789-41eb-a34c-a140ffe80389"
      decimals="INF"
      id="F_78f9db54-cce7-4860-8cf2-efc100c6d492"
      unitRef="U_USD">0</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_02a05c33-096b-44f4-afb8-1a9123aea271">&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company recognizes revenue in accordance with ASC Topic 606, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;&#x201c;Revenue from Contracts with Customers.&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Revenue is recognized when or as a customer obtains control of the promised goods and services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for these goods and services. To achieve this core principle, the Company applies the following 5 steps:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Step 1: Identify Contracts with Customers:&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The Company executes signed contracts with its customers for the sale of hardware devices and subscription services.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Step 2: Identify Performance Obligations:&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The Company&#x2019;s contracts with customers primarily include two performance obligations, namely the hardware device and subscription services, which include access to the Company&#x2019;s hosted cloud-based software applications and hardware maintenance and support on an ongoing basis throughout the subscription period.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Step 3: Determine Transaction Price:&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The Company&#x2019;s contracts with customers include variable consideration in the form of discounts and price concessions. The Company estimates variable consideration using the expected value method based on the data available as of the end of each reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Step 4: Allocate Transaction Price to Performance Obligations:&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The Company allocates transaction price to the performance obligations in a contract with a customer, based on the relative standalone selling prices of the goods and services. The standalone selling prices of the hardware devices and subscription services are determined based on the observable standalone selling prices for which the Company sells the respective goods and services on a standalone basis, including renewals of subscription services.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:4.36%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Step 5: Recognize Revenue as Performance Obligations are Satisfied:&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; Each unit of hardware devices is a performance obligation satisfied at a point in time, when control of the good transfers from the Company to the customer, which is usually upon delivery of the good to the customer. For sales of hardware where control of the product transfers to the customer upon shipment, the Company has made an accounting policy election to account for shipping and handling as fulfillment activities rather than a performance obligation. The subscription services are stand-ready obligations that are satisfied over time by providing the customer with ongoing access to the Company&#x2019;s resources throughout the subscription period. The Company uses the time elapsed (straight line) measure of progress to recognize revenue as these performance obligations are satisfied evenly over the respective service period.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company offers alternative payment structures and &#x201c;as-a-service&#x201d; offerings that are assessed to determine whether an embedded lease arrangement exists. The Company accounts for those contracts as a lease arrangement under the current lease standard if it is determined that the contract contains an identified asset and that the right to direct the use of that asset has transferred to the customer. When a contract includes lease and non-lease components, the Company allocates consideration under the contract to each component based on the relative standalone selling price and subsequently assesses lease classification for each lease component within a contract as a sales-type lease or an operating lease. On commencement of sales-type leases, the Company recognizes revenue up-front, and amounts due from the customer under the lease contract are recognized as financing receivables on the combined and consolidated balance sheets. Interest income is recognized as revenue over the term of the lease based on the effective interest method. The Company has elected not to include sales and other taxes collected from the lessee as part of lease revenue.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All other leases that do not meet the definition of a sales-type lease are classified as operating leases. The underlying asset in an operating lease arrangement is carried at depreciated cost within Property and equipment, net on the combined and consolidated balance sheets. Depreciation is calculated using the straight-line method over the term of the underlying lease contract and is recognized as cost of revenue. The depreciable basis is the original cost of the equipment less the estimated residual value of the equipment at the end of the lease term. The Company recognizes operating lease income to product revenue on a straight-line basis over the lease term. Impairment of equipment under operating leases is assessed on the same basis as other long-lived assets.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <hypr:DeferredRevenuePolicyPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_3e18a3ba-20ac-46e1-945c-01a5b5cb43b1">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Deferred Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from subscription services described above and is reduced as the revenue recognition criteria are met. Deferred revenue is classified as current based on expected revenue recognition timing. Specifically, deferred revenue that will be recognized as revenue within the succeeding twelve-month period is recorded as current in the Company&#x2019;s combined and consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;</hypr:DeferredRevenuePolicyPolicyTextBlock>
    <hypr:WarrantiesPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_4ce764cd-b637-4cb5-9506-5d7435a35fe7">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Warranties&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company offers a device warranty to customers for the longer of (a) twelve (12) months from delivery of the device for devices obtained through a capital purchase, or (b) the term of the subscription agreement for devices obtained on a subscription basis (subject to continued payment of fees for the subscription service). The Company&#x2019;s subscription services include hardware maintenance and support. As noted in the accounting policy for revenue recognition, the Company recognizes revenue for subscription service over time using the time elapsed measure of progress. The costs of hardware maintenance are recognized in costs of revenue as they are incurred.&lt;/span&gt;&lt;/p&gt;</hypr:WarrantiesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_ed5f92e6-4e28-4aed-854d-a1c447836142">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Research and Development&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development costs consists of production costs for prototype, test and pre-production units, lab supplies, consulting and personnel costs, including salaries, stock-based compensation, bonuses, benefit costs and depreciation. Certain research and development grant funding is recognized as a reduction to research and development costs (see Note 2. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Summary of Significant Accounting Policies - Grant Funding&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;). The Company recognizes these costs as they are incurred.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <hypr:GrantFundingPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_9127a48d-ca23-4dc3-8cbb-fcb4f9577310">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Grant Funding&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company received certain research and development funding through a grant issued by the Bill &amp;amp; Melinda Gates Foundation (&#x201c;BMGF&#x201d;). Funding is recorded on the combined and consolidated balance sheet as restricted cash upon receipt. The funding is recognized in the combined and consolidated statements of operations and comprehensive loss as a reduction to research and development expense as the related costs are incurred to meet those obligations over the grant period. Grant funding payments received in advance of research and development expenses incurred are recorded as deferred grant funding as a current liability in the Company&#x2019;s combined and consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;</hypr:GrantFundingPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_93d3f4c9-1545-436b-94f8-83420f84d654">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cost of Sales&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cost of sales consists of product and service costs including personnel cost and benefits including stock-based compensation, product costs, production setup expenses, depreciation and amortization expenses, inventory excess and obsolescence expenses.&lt;/span&gt;&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <hypr:PatentCostsPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_cfc71c73-b662-4771-b81c-6ce240100338">&lt;p style="text-indent:2.603%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Patent Costs&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Patent costs have been charged to operations as incurred, as their realization is uncertain. These costs are included in general and administrative expenses in the combined and consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;</hypr:PatentCostsPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_c0441e1a-7265-4bf5-9cd4-d3b0d0b2624e">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;General and Administrative&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;General and administrative expenses primarily consist of personnel costs and benefits including stock-based compensation, patent and filing fees, office expenses and outside services. Outside services consist of professional services, legal and other professional fees.&lt;/span&gt;&lt;/p&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_aa23d4fc-6312-416b-adcf-3f6bf0cf8d88">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Sales and Marketing&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Sales and marketing costs primarily consist of personnel costs and benefits including stock-based compensation, advertising, promotional, as well as conferences, meetings, and other events. Advertising costs are expensed as incurred. For the years ended December 31, 2021 and 2020, advertising expenses were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,459&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;437&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_96da21ac-598d-47e4-84b6-d2a44f48243d"
      unitRef="U_USD">2459000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_f52dcd49-1fe1-42b7-b7e7-f64c8d695efa"
      unitRef="U_USD">437000</us-gaap:AdvertisingExpense>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_9fbf0c03-f727-474d-a670-5912423712cd">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Net Loss per Common Share&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Basic net loss per common share is calculated by dividing the net loss attributed to common stockholders by the weighted average number of common shares outstanding during the period, without consideration of potentially dilutive securities.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares plus the common equivalent shares of the period, including any dilutive effect from such shares. The Company&#x2019;s diluted net loss per common share is the same as basic net loss per common share for all periods presented since the effect of potentially dilutive securities is anti-dilutive. Refer to Note 13. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for further discussion.&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_59528c93-0305-4dd0-85ff-79b2fdc83123">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has applied the guidance in ASC Topic 480-10-S99-3A, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;SEC Staff Announcement: Classification and Measurement of Redeemable Securities,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and has therefore classified the Series A, Series B, Series C and Series D Convertible Preferred Stock (&#x201c;Convertible Preferred Stock&#x201d;) (see Note 10. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) as mezzanine equity. The Convertible Preferred Stock was recorded outside of stockholders&#x2019; equity (deficit) because the Convertible Preferred Stock included a redemption provision upon a change of control, which is deemed a liquidation event that is considered outside the Company&#x2019;s control. The Convertible Preferred Stock has been recorded at its original issue price, net of issuance costs. The Company did not adjust the carrying value of the Convertible Preferred Stock to the liquidation price associated with a change of control at December 31, 2020 because a change of control of the Company was not considered probable at the reporting date (see Note 10. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;). Subsequent adjustments to increase or decrease the carrying values to their respective liquidation prices were made only when it became probable that such a change of control would occur.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_e76258c7-4889-4813-b988-b6dca146a783">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The measurement of stock-based compensation expense for all stock-based payment awards, including stock options granted to employees, directors, and consultants, is based on the estimated fair value of the awards on the date of grant.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company recognizes stock-based compensation expense for stock option grants and incentive unit grants with only service conditions on a straight-line basis over the requisite service period of the individual grants, which is generally the vesting period, based on the estimated grant date fair values. Generally, stock option grants and incentive unit grants fully vest &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; after the grant date, and stock option grants generally have a term of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company recognizes the effect of forfeiture in compensation costs based on actual forfeitures when they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company's stock-based compensation program includes stock option grants to its employees, directors, and consultants. Stock options are granted at exercise prices not less than the estimated fair market value of the Company&#x2019;s common stock at the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The fair values of stock option grants are estimated using a Black-Scholes option-pricing model. Key inputs and assumptions include the expected term of the option, stock price volatility, risk free interest rate, dividend yield, stock price and exercise price. Many of the assumptions require significant judgment and any changes could have a material impact in the determination of stock-based compensation expense.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;During the year ended December 31, 2020, Liminal was a wholly owned subsidiary of 4Bionics, and as such, 4Bionics granted equity awards in the form of incentive units to Liminal employees and nonemployees under 4Bionics&#x2019; stock-based compensation program.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On April 2, 2021, 4Bionics executed a plan of liquidation and dissolution and its ownership in Liminal was distributed to its members and to the holders of incentive units. Immediately subsequent to the dissolution, all outstanding unvested incentive unit awards under 4Bionic&#x2019;s 2019 Equity Incentive Plan were replaced with preferred stock awards indexed to and settled in the preferred stock of the former 4Bionics subsidiaries Liminal, Detect, Inc. (f/k/a Homodeus Inc.), Tesseract Health, Inc. and Protein Evolution, Inc. The preferred stock awards are subject to service vesting conditions only. No incremental value was provided to participants as a result of the modification of the awards as the modification date fair value of the incentive unit awards was equal to the modification date fair value of the stock underlying the restricted stock awards. Moreover, the remaining vesting period before and after modification was unchanged.&lt;/span&gt;&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_21437414-9df9-48f3-872e-53ac72e1a3ca">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_84f34145-1bfa-4d97-a4fa-83a98da2f7ae">10 years</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <hypr:EarnOutSharesPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_f84c3abf-f065-4a12-a875-fce86e6f3599">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Earn-Out Shares&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Earn-Out Shares, as defined in Note 3.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; Business Combination&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, to which the Companies&#x2019; pre-closing equity holders are entitled, fall within the scope of ASC 815,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; Derivatives and Hedging&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 815&#x201d;) pursuant to which such Earn-Out Shares are equity classified and are to be recognized upon achievement of the market price milestone.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Earn-Out Shares to which certain employees are entitled to fall within the scope of ASC 718, pursuant to which such Earn-Out Shares are equity classified and their grant date fair value will be recognized as compensation expense over the vesting period.&lt;/span&gt;&lt;/p&gt;</hypr:EarnOutSharesPolicyTextBlock>
    <hypr:ResearchAndDevelopmentTaxCreditsPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_05085b84-304d-4c2d-9ad1-eafe18d0a436">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Research and Development Tax Credits&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company recognizes research and development tax credits as a reduction of Research and Development expense as earned. For State of Connecticut research and development tax credits, which are exchanged for a cash refund from the State of Connecticut, such exchanged credits are recognized as earned as a reduction of Research and Development expense in the combined and consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;</hypr:ResearchAndDevelopmentTaxCreditsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_7d94dea0-0e4c-4bf7-892f-e49080980a7f">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company utilizes the asset and liability method of accounting for income taxes, as set forth in ASC Topic 740, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. Under this method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities using the enacted statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established against net deferred tax assets if, based on&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;the weight of available evidence, it is more likely than not that some or all of the net deferred tax assets will not be realized. The Company has recorded a full valuation allowance as of December 31, 2021 and 2020. Based on the available evidence, the Company believes that it is more likely than not that it will be unable to utilize all of its deferred tax assets in the future.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In accordance with the provisions of ASC Topic 740, the Company accrues for the estimated amount of taxes for uncertain tax positions if it is more likely than not that the Company would be required to pay such additional taxes. An uncertain tax position will not be recognized if it has a less than 50% likelihood of being sustained. The Company&#x2019;s policy is to recognize any interest and penalties related to income taxes in income tax expense in the combined and consolidated statements of operations and comprehensive loss. The Company&#x2019;s open tax years subject to examination by the relevant taxing authorities are &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_0d93ec06-e2be-489a-ac3b-531777fb08ff;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2017 through 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. As of December 31, 2021 and 2020, the Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; uncertain tax positions.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <hypr:UncertainTaxPositions
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_587ec53f-9394-41f2-961d-752e7b6e936a"
      unitRef="U_USD">0</hypr:UncertainTaxPositions>
    <hypr:UncertainTaxPositions
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="INF"
      id="F_63dad002-c634-49e4-99e9-01035107a6fe"
      unitRef="U_USD">0</hypr:UncertainTaxPositions>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_feb4e6ed-c33d-400d-8c45-cf10b6c29c1f">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounting pronouncements adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In August 2018, the FASB issued ASU No. 2018-15, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Intangibles &#x2014; Goodwill and Other &#x2014; Internal-Use Software Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The guidance requires certain costs incurred during the application development stage to be capitalized and other costs incurred during the preliminary project and post-implementation stages to be expensed as they are incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. A customer&#x2019;s accounting for the hosting component of the arrangement is not affected. This new guidance is effective for the Company for the annual reporting period beginning January 1, 2021 and interim periods beginning January 1, 2022. The Company &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;adopted this guidance&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and there was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no material effect of adoption on the combined and consolidated financial statements&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, which simplifies the accounting for convertible instruments by removing the separation models for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. These changes will reduce reported interest expense and increase reported net income for entities that have issued a convertible instrument that was bifurcated according to previously existing rules. ASU 2020-06 also requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will be no longer available. For public entities, this guidance is effective for annual reporting periods beginning January 1, 2022, including interim periods within that annual reporting period. For the Company, this guidance is effective for annual reporting periods beginning January 1, 2024, and interim reporting periods within annual reporting periods beginning January 1, 2024, with early adoption permitted. The Company elected to early &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;adopt this accounting pronouncement&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and there was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no material impact on the Company&#x2019;s combined and consolidated financial statements and disclosures&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and improves consistent application of and simplifies U.S. GAAP for other areas of Topic 740 by clarifying existing guidance. For the Company, this ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; this guidance on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and there was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; material effect of adoption on the Company&#x2019;s combined and consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounting pronouncements issued but not yet adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In February 2016, the FASB issued ASU 2016-02, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Leases (Topic 842),&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which outlines a comprehensive lease accounting model and supersedes the current lease guidance. The new guidance requires lessees to recognize almost all of their leases on the balance sheet by recording a lease liability and corresponding right-of-use assets. It also&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;changes the definition of a lease and expands the disclosure requirements of lease arrangements. As per the latest ASU 2020-05 issued by FASB, entities that have not yet issued or made available for issuance the financial statements as of June 3, 2020 can defer the new guidance for one year. For public entities, this guidance is effective for annual reporting periods beginning January 1, 2020, including interim periods within that annual reporting period. For the Company, this guidance is effective for annual reporting periods beginning January 1, 2022, and interim reporting periods within annual reporting periods beginning January 1, 2023. The Company is in the process of evaluating the impact that the adoption of this pronouncement will have on the Company&#x2019;s combined and consolidated financial statements and does not expect it to be material.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;&#x201c;Financial Instruments &#x2014; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#x201d;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which was subsequently amended in November 2018 through ASU No. 2018-19, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;&#x201c;Codification Improvements to Topic 326, Financial Instruments &#x2014; Credit Losses.&#x201d;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. ASU No. 2018-19 further clarifies that receivables arising from operating leases are not within the scope of Topic 326. Instead, impairment from receivables of operating leases should be accounted for in accordance with Topic 842, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Leases&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. As per the latest ASU 2020-02, the FASB deferred the timelines for certain small public and private entities, thus the new guidance will be adopted by the Company for the annual reporting period beginning January 1, 2023, including interim periods within that annual reporting period. The standard will apply as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company is in the process of evaluating the impact that the adoption of this pronouncement will have on the Company&#x2019;s combined and consolidated financial statements and disclosures.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_cb31b9d8-c1f7-4a18-b802-8fbd3122b173"
      id="F_005f87eb-d302-4e42-8be6-c899f3089545">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_cb31b9d8-c1f7-4a18-b802-8fbd3122b173"
      id="F_4eb1f761-1796-4ee6-9070-302b911d6bad">2021-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_cb31b9d8-c1f7-4a18-b802-8fbd3122b173"
      id="F_696c0816-b211-4e4d-8249-69633a7a54a0">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption
      contextRef="C_01fa950d-ab40-4e18-a2a5-4c14c465c02f"
      id="F_b874449e-6fc1-488e-a2c2-55c85730bdd4">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_01fa950d-ab40-4e18-a2a5-4c14c465c02f"
      id="F_28f751a1-ab38-4c9e-b6ec-220ed8c5b8ac">2021-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_01fa950d-ab40-4e18-a2a5-4c14c465c02f"
      id="F_884b61b5-272e-4ec4-8e76-2b28fdbc0c39">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_94219b96-2190-45cb-82d0-1a597525c988"
      id="F_b32c8fcd-69f2-45d9-90f6-ba750b8004dc">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_94219b96-2190-45cb-82d0-1a597525c988"
      id="F_a1da6c1c-ff81-4e01-a600-918beb9cce14">2021-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_94219b96-2190-45cb-82d0-1a597525c988"
      id="F_2e14d364-6a7a-4b49-ac12-577e4e6a31b3">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_7386d86d-daa2-418b-a643-46a48999a7b6">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;3. BUSINESS COMBINATION&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;At the Closing, Legacy Hyperfine and Liminal merged with and into separate wholly owned subsidiaries of HealthCor and each became a wholly-owned subsidiary of the Company. The Business Combination is accounted for as a reverse recapitalization in accordance with U.S. GAAP primarily due to the fact that Legacy Hyperfine and Liminal stockholders continued to control the Company following the closing of the Business Combination. Under this method of accounting, HealthCor is treated as the &#x201c;acquired&#x201d; company for accounting purposes and the Business Combination is treated as the equivalent of Legacy Hyperfine and Liminal issuing stock for the net assets of HealthCor, accompanied by a recapitalization. The net assets of HealthCor are stated at historical cost, with no goodwill or other intangible assets recorded. Reported shares and loss per share available to holders of the Company&#x2019;s capital stock and equity awards prior to the Business Combination have been retroactively restated reflecting the exchange ratios established pursuant to the Business Combination Agreement dated as of July 7, 2021 (the &#x201c;Business Combination Agreement&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Pursuant to the Business Combination Agreement, at the effective time of the Business Combination (the &#x201c;Effective Time&#x201d;):&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; each share of Legacy Hyperfine capital stock (other than shares of Legacy Hyperfine Series A preferred stock) that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class A common stock equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3275&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (the &#x201c;Hyperfine Exchange Ratio&#x201d;), rounded down to the nearest whole number of shares;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; each share of Legacy Hyperfine Series A preferred stock that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class B common stock equal to the Hyperfine Exchange Ratio, rounded down to the nearest whole number of shares;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; each share of Liminal capital stock (other than shares of Liminal Series A-1 preferred stock) that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class A common stock equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.1796&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (the &#x201c;Liminal Exchange Ratio&#x201d;), rounded down to the nearest whole number of shares;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; each share of Liminal Series A-1 preferred stock that was issued and outstanding as of immediately prior to the Effective Time was automatically cancelled and extinguished and converted into the right to receive a number of shares of the Company&#x2019;s Class B common stock equal to the Liminal Exchange Ratio, rounded down to the nearest whole number of shares;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; each option to purchase shares of Legacy Hyperfine common stock and each option to purchase shares of Liminal common stock, whether vested or unvested, that was outstanding and unexercised as of immediately prior to the Effective Time was assumed by the Company and became an option (vested or unvested, as applicable) to purchase a number of shares of the Company&#x2019;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such option immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Effective Time divided by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded up to the nearest whole cent; and&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;	&lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; each Legacy Hyperfine restricted stock unit and each Liminal restricted stock unit outstanding immediately prior to the Effective Time was assumed by the Company and became a restricted stock unit with respect to a number of shares of the Company&#x2019;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such Legacy Hyperfine restricted stock unit or Liminal restricted stock unit immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole share.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Pursuant to the Business Combination Agreement, the Company will issue to holders of Legacy Hyperfine and Liminal securities as of immediately prior to the Effective Time, in accordance with their pro rata share, up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock as earn-out consideration (the &#x201c;Earn-Out Shares&#x201d;), if at any time during the period between the Closing Date and the third anniversary of the Closing Date (the &#x201c;Earn-Out Period&#x201d;), (i) the last share price of the Class A common stock is greater than or equal to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for any &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; trading days within any &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; consecutive trading day period, or (ii) there is a transaction that will result in shares of Class A common stock being converted or exchanged into the right to receive cash or other consideration having a value greater than or equal to $15.00. During the Earn-Out Period, if there is a transaction (other than for stock splits, stock dividends, special cash dividends, reorganizations, recapitalizations or similar transactions affecting the Class A common stock) that will result in the shares of Class A common stock being converted or exchanged into the right to receive cash or other consideration having a value less than $15.00, then the right to receive Earn-Out Shares will terminate.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On December 21, 2021, HealthCor filed the Certificate of Incorporation (the &#x201c;Certificate&#x201d;) with the Secretary of State of the State of Delaware, which became effective after the Domestication. As a consequence of filing the Certificate, the Company adopted a dual class structure, comprised of the Company&#x2019;s Class A common stock, which is entitled to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_7c1f6cb9-db4f-44a0-8eef-0eeaa1e8c6da;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; vote per share, and the Company&#x2019;s Class B common stock, which is entitled to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; votes per share. The Company&#x2019;s Class B common stock has the same economic terms as the Company&#x2019;s Class A common stock, but is subject to a &#x201c;sunset&#x201d; provision if Jonathan M. Rothberg, Ph.D., the founder of Legacy Hyperfine and Liminal, and a Director of the Company (&#x201c;Dr. Rothberg&#x201d;), and other permitted holders of the Company&#x2019;s Class B common stock collectively cease to beneficially own at least twenty percent (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%) of the number of shares of the Company&#x2019;s Class B common stock (as such number of shares is equitably adjusted in respect of any reclassification, stock dividend, subdivision, combination or recapitalization of the Company&#x2019;s Class B common stock) collectively held by Dr. Rothberg and permitted transferees of the Company&#x2019;s Class B common stock as of the Effective Time. At the Effective Time, the Company amended the Certificate to change the name of the Company from HealthCor Catalio Acquisition Corp. to &#x201c;Hyperfine, Inc.&#x201d; (the Certificate, as amended, the &#x201c;Amended Certificate&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Concurrently &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;with the execution of the Business Combination Agreement, HealthCor entered into subscription agreements (the &#x201c;Subscription Agreements&#x201d;) with certain institutional investors and accredited investors (the &#x201c;PIPE&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Investors&#x201d;), &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;pursuant to which the PIPE Investors purchased, immediately prior to the Closing, an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,610,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of HealthCor Class A common stock at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share (the &#x201c;PIPE Investment&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Additionally, on December 22, 2021, HealthCor, HC Sponsor LLC (the &#x201c;Sponsor&#x201d;), Legacy Hyperfine and Liminal entered into a Forfeiture Agreement (the &#x201c;Forfeiture Agreement&#x201d;), pursuant to which, immediately prior to the Closing, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;150,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of HealthCor&#x2019;s Class B common stock held by the Sponsor were irrevocably forfeited and automatically cancelled (the &#x201c;Forfeiture&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The total number of shares of the Company&#x2019;s Class A common stock outstanding immediately following the Closing was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;54,977,061&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; comprising:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;29,711,224&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock issued to Hyperfine stockholders (other than certain holders of Hyperfine Series A preferred stock);&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,459,081&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock issued to Liminal stockholders (other than certain holders of Liminal Series A-1 preferred stock);&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,610,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock issued in connection with the Closing to the PIPE Investors pursuant to the PIPE Investment;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,025,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock issued immediately prior to the Effective Time to the initial shareholders upon conversion of the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,025,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class B common stock outstanding immediately prior to the Effective Time (following the issuance of the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,175,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class B common stock upon the Conversion of the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,175,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; Class B ordinary shares held by the initial shareholders and after reflecting the irrevocable forfeiture by the Sponsor to HealthCor of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;150,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class B common stock for no consideration and automatic cancellation as of immediately prior to the Closing);&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;614,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock issued to the Sponsor; and&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x95; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,557,756&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock issued to the Company&#x2019;s public stockholders holding &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,557,756&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; Class A ordinary shares outstanding at the Effective Time, after reflecting redemptions of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,142,244&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of HealthCor Class A common stock.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The total number of shares of the Company&#x2019;s Class B common stock outstanding immediately following the Closing was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,055,288&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares. Immediately following the Closing, Dr. Rothberg held approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;84.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the combined voting power of the Company. Accordingly, Dr. Rothberg and his permitted transferees control the Company, and the Company is a controlled company within the meaning of the Nasdaq listing rules.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net equity infusion from the Business Combination was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;141,471&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, which consists of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;207,448&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; proceeds from HealthCor, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;126,100&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; proceeds from the PIPE Investors, net of payments to redeeming HealthCor shareholders of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;171,437&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and payment of transaction costs of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20,640&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. Additionally, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;300,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A Common Stock were issued to a service provider in exchange for the services provided in connection with the Business Combination.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In December 2021, in connection with the closing of the Business Combination, the Company prepaid directors and officers insurance policy in the amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,244&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and repaid the Liminal Paycheck Protection Program ("PPP") loan in full in the amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;113&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_9bef19fe-1963-493a-8639-cca45451e242"
      decimals="4"
      id="F_8b623e35-9d66-4b29-bc7f-965001f237e0"
      unitRef="U_pure">0.3275</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_0449cc1b-e603-4161-b7c3-fb5362667dbf"
      decimals="4"
      id="F_46d41b1e-c25d-4009-8efa-bf95735a2aa4"
      unitRef="U_pure">0.1796</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="C_0449cc1b-e603-4161-b7c3-fb5362667dbf"
      decimals="INF"
      id="F_87ea0cb9-889e-4849-bfd9-c57db830780b"
      unitRef="U_shares">10000000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_1e1d998b-c680-42bd-bbd7-9bc2ff70463c"
      decimals="INF"
      id="F_936e8c94-1b80-4f03-b202-6b66c54a1b38"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.00</us-gaap:SharesIssuedPricePerShare>
    <hypr:BusinessCombinationTransactionThresholdTradingDays
      contextRef="C_adbc5d68-9134-4f22-9fcc-4c8fff3121d2"
      decimals="INF"
      id="F_616f6f3e-d4ae-472f-8763-623e181dffe0"
      unitRef="U_D">20</hypr:BusinessCombinationTransactionThresholdTradingDays>
    <hypr:BusinessCombinationTransactionThresholdConsecutiveTradingDays
      contextRef="C_adbc5d68-9134-4f22-9fcc-4c8fff3121d2"
      decimals="INF"
      id="F_ce0ce46a-22b4-4d60-aec7-a1b0d08e81b1"
      unitRef="U_D">30</hypr:BusinessCombinationTransactionThresholdConsecutiveTradingDays>
    <hypr:NumberOfVotesPerShareEntitledToClassOfCommonStock
      contextRef="C_b5a4b802-89f3-4579-863a-5eecf71671f8"
      decimals="INF"
      id="F_ff52442f-9186-428d-a86c-f5de47dc045d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">20</hypr:NumberOfVotesPerShareEntitledToClassOfCommonStock>
    <hypr:PercentageNumberOfSharesCeasesToBeneficiallyOwned
      contextRef="C_3ad8f729-5552-455b-b2fb-acfa4b71867b"
      decimals="2"
      id="F_57c163a1-1f2d-4659-a3f9-026a6a80b6a3"
      unitRef="U_pure">0.20</hypr:PercentageNumberOfSharesCeasesToBeneficiallyOwned>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_422b1f66-f3bb-40cb-87eb-764fff40d1b1"
      decimals="INF"
      id="F_4308e789-3a51-4f7c-a3fb-62cfaa57ff7e"
      unitRef="U_shares">12610000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_f9ad2466-6588-4aad-9c83-c52d2116818a"
      decimals="INF"
      id="F_2df1f1ba-f9a3-4884-9dd6-90445eaa3d95"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssued
      contextRef="C_7e37528b-2b21-4306-ae2b-4ba44246def5"
      decimals="INF"
      id="F_28560ea9-2c50-4d8f-9d09-383afcc785bf"
      unitRef="U_shares">150000</us-gaap:SharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_3666fba2-b98c-4e2a-8471-61fd11c1c18a"
      decimals="0"
      id="F_87136780-9973-411a-99ad-a94535df67f8"
      unitRef="U_shares">54977061</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_00411e89-7f5a-45df-b336-70ea9ce55a9e"
      decimals="INF"
      id="F_7b49dc22-65cd-4b8f-9d79-f42b3ab56daf"
      unitRef="U_shares">29711224</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0a6a19d6-344a-4cea-bec3-409efe86ebfd"
      decimals="INF"
      id="F_e6c6df09-14f0-4169-b5ac-fac8545b648c"
      unitRef="U_shares">3459081</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_f3f7bbf1-1516-476a-9c86-2591116d1012"
      decimals="INF"
      id="F_ed471d79-5b84-4c27-88f4-662e3a09fd27"
      unitRef="U_shares">12610000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_a7656f8d-8697-4470-947f-f125a450641a"
      decimals="INF"
      id="F_7211dfdd-101a-4039-8a34-d6d8507d38f3"
      unitRef="U_shares">5025000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_2d6850ed-6867-4384-9a94-ec4d712f20d1"
      decimals="INF"
      id="F_16465251-1c49-4443-96c9-6d94348e7325"
      unitRef="U_shares">5025000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_ac74fc9c-0276-46e3-b74a-5c86d622563b"
      decimals="INF"
      id="F_fd1a83ff-77a7-4e70-a267-12b3a1611174"
      unitRef="U_shares">5175000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_42721900-2218-40df-95d4-cb7a647e1a07"
      decimals="INF"
      id="F_eb65d005-8292-47a3-b9dd-f47187ac07d4"
      unitRef="U_shares">5175000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:SharesIssued
      contextRef="C_06522640-5ead-4ce5-b43c-dc8582220df8"
      decimals="INF"
      id="F_34a3a0a4-1c72-47d6-b5ad-d1d11bf0c5cf"
      unitRef="U_shares">150000</us-gaap:SharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_8e87568d-825c-49a7-8077-18ebeca513ba"
      decimals="INF"
      id="F_022a80f8-09a4-40d4-afce-b5086019c4c7"
      unitRef="U_shares">614000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_07853f31-4dbf-448b-a757-6ceeb0365107"
      decimals="INF"
      id="F_a1ba7682-685a-4041-a2a5-7a348a68b75a"
      unitRef="U_shares">3557756</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_07853f31-4dbf-448b-a757-6ceeb0365107"
      decimals="INF"
      id="F_b58d9c82-ed65-4b94-b8bd-5e30933133d3"
      unitRef="U_shares">3557756</us-gaap:CommonStockSharesIssued>
    <hypr:CommonStockSubjectToRedemption
      contextRef="C_d9e344e0-6fb0-4ac2-9f20-f9805be8a275"
      decimals="INF"
      id="F_170198a5-8afb-4acd-9bf1-359d2fdf280a"
      unitRef="U_shares">17142244</hypr:CommonStockSubjectToRedemption>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_cd314d5f-1d0e-45e6-bee2-447dde950094"
      decimals="INF"
      id="F_1618f601-f51a-4cad-98c4-e8fdab2d10e2"
      unitRef="U_shares">15055288</us-gaap:CommonStockSharesOutstanding>
    <hypr:PercentageOfCommonStockVotingPower
      contextRef="C_6b7f94c9-9ecc-4502-b9fd-362b0c906fa7"
      decimals="3"
      id="F_5b131b5c-5785-483b-8413-c32606099195"
      unitRef="U_pure">0.848</hypr:PercentageOfCommonStockVotingPower>
    <hypr:ProceedsFromBusinessCombination
      contextRef="C_df21cc65-f66b-40a5-900a-c433563430fa"
      decimals="-3"
      id="F_c31f2e32-98a2-42d6-ac46-3ab63732caba"
      unitRef="U_USD">141471000</hypr:ProceedsFromBusinessCombination>
    <hypr:ProceedsFromBusinessCombination
      contextRef="C_216ba9b6-bd20-4c7c-bc41-1051866b4a16"
      decimals="-3"
      id="F_db38e173-3782-4152-bd66-2cb9ad2d639a"
      unitRef="U_USD">207448000</hypr:ProceedsFromBusinessCombination>
    <hypr:ProceedsFromBusinessCombination
      contextRef="C_f5b7fd28-718c-44aa-9bed-942c827825a4"
      decimals="-3"
      id="F_4f613553-b61f-41e9-ab4c-09676bcf7983"
      unitRef="U_USD">126100000</hypr:ProceedsFromBusinessCombination>
    <hypr:InterestAndPaymentsToRedeemingCompanyShareholders
      contextRef="C_df21cc65-f66b-40a5-900a-c433563430fa"
      decimals="-3"
      id="F_44e76630-4664-4704-800d-f44841279a26"
      unitRef="U_USD">171437000</hypr:InterestAndPaymentsToRedeemingCompanyShareholders>
    <hypr:BusinessCombinationPaymentOfTransactionCosts
      contextRef="C_df21cc65-f66b-40a5-900a-c433563430fa"
      decimals="-3"
      id="F_682d61b2-bef6-4edf-9da4-a2af30bcd60f"
      unitRef="U_USD">20640000</hypr:BusinessCombinationPaymentOfTransactionCosts>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="C_f47f49e7-ad5a-4384-8c30-4bc6120b30ac"
      decimals="INF"
      id="F_7c173292-cb95-4e38-99d8-1909c5763662"
      unitRef="U_shares">300000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <hypr:PrepaidInsurancePolicyInConnectionWithBusinessCombination
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_7b05b60d-ecbb-41d4-ab34-8784df60dbee"
      unitRef="U_USD">1244000</hypr:PrepaidInsurancePolicyInConnectionWithBusinessCombination>
    <hypr:PaymentOfPaycheckProtectionProgramLoan
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_735ae83c-45f1-4c08-850d-683ec0962e8a"
      unitRef="U_USD">113000</hypr:PaymentOfPaycheckProtectionProgramLoan>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_107667d4-dc99-497f-8ffc-0f4ae907c751">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;4. REVENUE RECOGNITION&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company disaggregates revenue from contracts with customers by product type. The Company believes that these categories aggregate the payor types by nature, amount, timing and uncertainty of its revenue streams. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table summarizes the Company&#x2019;s disaggregated revenues:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.786%;"/&gt;
        &lt;td style="width:1.354%;"/&gt;
        &lt;td style="width:13.243%;"/&gt;
        &lt;td style="width:1.238%;"/&gt;
        &lt;td style="width:1.28%;"/&gt;
        &lt;td style="width:11.762%;"/&gt;
        &lt;td style="width:0.603%;"/&gt;
        &lt;td style="width:1.238%;"/&gt;
        &lt;td style="width:1.28%;"/&gt;
        &lt;td style="width:11.614%;"/&gt;
        &lt;td style="width:0.603%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Pattern of Recognition&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Device&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Point in time&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;715&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Service&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Over time&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;781&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;94&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,496&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;  &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Contract Balances&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Contract balances represent amounts presented in the combined and consolidated balance sheets when either the Company has transferred goods or services to the customer, or the customer has paid consideration to the Company under the contract. These contract balances include trade accounts receivable and deferred revenue. Deferred revenue represents consideration received from customers at the beginning of the subscription period for services that are transferred to the customer over the respective subscription period. The accounts receivable balances represent amounts billed to customers for goods and services where the Company has an unconditional right to payment of the amount billed.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table provides information about receivables and deferred revenue from contracts with customers:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.275%;"/&gt;
        &lt;td style="width:1.597%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.42%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.481%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.42%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Accounts receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;553&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;174&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Unbilled receivables&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;91&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;730&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Long term deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;510&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company recognizes a receivable when it has an unconditional right to payment, and payment terms range from &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;days to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;months based on the terms agreed upon with the respective customer.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The amount of revenue recognized during the years ended December 31, 2021 and 2020 that was included in the deferred revenue balance at the beginning of the period was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;158&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Revenue from leasing arrangements is not subject to the revenue standard for contracts with customers and remains separately accounted for under existing lease accounting guidance. The Company records operating lease rental revenue as service revenue on a straight-line basis over the lease term. The Company records revenue from the sale of equipment under sales-type leases as product revenue in an amount equal to the present value of minimum lease payments at the inception of the lease. Sales-type leases also produce financing income, which is included in products net revenue in the combined and consolidated statements of operations and comprehensive loss and is recognized at effective rates of return over the lease term.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Costs of Obtaining or Fulfilling Contracts&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company incurs incremental costs of obtaining contracts with customers. Incremental costs of obtaining contracts, which include commissions paid as a result of obtaining contracts with customers, are capitalized to the extent that the Company expects to recover such costs. Capitalized costs are amortized in a pattern that is consistent with the Company&#x2019;s transfer to the customer of the related goods and services. Such costs are recorded in Other long term assets and were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;158&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; as of December 31, 2021. Capitalized costs were not material for the year ended December 31, 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Transaction price allocated to remaining performance obligations&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 202&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and 2020, the Company had remaining performance obligations amounting to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,800&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;859&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively. The Company expects to recognize approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;43&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of its remaining performance obligations as revenue in fiscal year 2022, and an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;57&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_82c7fa41-ba63-47ec-bb72-bbe45f458cc5;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;fiscal year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; 2023 and thereafter.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Significant Judgements&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company makes significant judgments applying the guidance related to the determination of the timing and pattern of satisfaction of performance obligations, determination of the standalone selling price of performance obligations and estimation of variable consideration.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Practical Expedients and Accounting Policy Elections&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As a practical expedient, the Company does not adjust transaction price for the effects of a significant financing component in contracts in which the period between when the Company transfers the promised good or service to the customer and when the customer pays for that good or service is a year or less.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has made an accounting policy election to exclude all sales taxes from the transaction price of its contracts with customers. Accordingly, sales taxes collected from customers and remitted to government authorities is not included in revenue and is accounted for as a liability until it has been remitted to the respective government authority.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_5285d59a-91c3-4bae-a6d9-37caf0135c7b">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table summarizes the Company&#x2019;s disaggregated revenues:&lt;/span&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.786%;"/&gt;
        &lt;td style="width:1.354%;"/&gt;
        &lt;td style="width:13.243%;"/&gt;
        &lt;td style="width:1.238%;"/&gt;
        &lt;td style="width:1.28%;"/&gt;
        &lt;td style="width:11.762%;"/&gt;
        &lt;td style="width:0.603%;"/&gt;
        &lt;td style="width:1.238%;"/&gt;
        &lt;td style="width:1.28%;"/&gt;
        &lt;td style="width:11.614%;"/&gt;
        &lt;td style="width:0.603%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Pattern of Recognition&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Device&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Point in time&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;715&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Service&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Over time&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;781&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;94&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,496&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0e92975e-291a-4d95-b890-e43efecfb475"
      decimals="-3"
      id="F_61604aad-8ac1-4444-a6a6-685c87411ee2"
      unitRef="U_USD">715000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_7ee4d8d9-a42c-47a9-ae5d-57c993f15c61"
      decimals="-3"
      id="F_26448297-b511-4c21-9db1-22db683aa239"
      unitRef="U_USD">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_90c968b9-9872-40c2-9fd2-339d167beac3"
      decimals="-3"
      id="F_8f4ba4f9-43fe-4216-82f3-ce789c4b7cef"
      unitRef="U_USD">781000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_37f84241-8f15-4d3a-a3bf-88a442090df1"
      decimals="-3"
      id="F_df4021d5-7abc-4369-ae2b-ec4568e836dc"
      unitRef="U_USD">94000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_0293ab3c-c0c2-468b-8290-ec3f0a251459"
      unitRef="U_USD">1496000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_862cb316-07c5-488c-b885-885c215d6d51"
      unitRef="U_USD">294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_a4685e26-5f24-4fc5-8a67-0364c3f1cf57">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table provides information about receivables and deferred revenue from contracts with customers:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.275%;"/&gt;
        &lt;td style="width:1.597%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.42%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.481%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.42%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Accounts receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;553&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;174&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Unbilled receivables&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;91&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;730&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Long term deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;510&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_29324c4e-f0a7-4212-b609-a322f0ef6055"
      unitRef="U_USD">553000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_a0f25110-ef5e-49b1-bfb2-3e0196756c5b"
      unitRef="U_USD">174000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_17180b02-236d-4de6-bcf9-8254061120b5"
      unitRef="U_USD">91000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_b48ffe2a-60ec-4ea2-9ce5-56b9610ae816"
      unitRef="U_USD">730000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_fd819b3b-918e-4088-a76c-af53ca89bded"
      unitRef="U_USD">158000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_7d49594c-29da-4592-833e-eb6135b89302"
      unitRef="U_USD">510000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <hypr:RevenueRecognizeReceivablePaymentTermsRangeMinimum
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_2a8f5364-8eb9-4b06-96e4-11d69fcd2329">P20D</hypr:RevenueRecognizeReceivablePaymentTermsRangeMinimum>
    <hypr:RevenueRecognizeReceivablePaymentTermsRangeMaximum
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_375a8368-4a75-4f2a-8001-e08c222771b6">P6M</hypr:RevenueRecognizeReceivablePaymentTermsRangeMaximum>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_db34a1ce-4c6a-4eb7-8cc6-9b4b863d9c3a"
      unitRef="U_USD">158000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_88e7f9cd-18fa-42a1-b55a-da1ce6021c63"
      unitRef="U_USD">0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:CapitalizedContractCostNet
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_3c62ee70-22de-45b3-a5e1-3c16ff4b4530"
      unitRef="U_USD">158000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_ef2546a8-4c0e-4b36-9c52-90a9b0abd33f"
      id="F_7c84426d-d80e-4725-8438-cba3f7426b00">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_2b4fce5f-848e-4f14-bbfb-9b191c815247"
      unitRef="U_USD">2800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_997e7b07-88ce-4a3d-b36a-51d0d7a6d387"
      unitRef="U_USD">859000</us-gaap:RevenueRemainingPerformanceObligation>
    <hypr:RevenueRemainingPerformanceObligationExpectedTimingPercentage
      contextRef="C_ef2546a8-4c0e-4b36-9c52-90a9b0abd33f"
      decimals="2"
      id="F_23b46e47-ad0f-4655-8fec-a301ce56b137"
      unitRef="U_pure">0.43</hypr:RevenueRemainingPerformanceObligationExpectedTimingPercentage>
    <hypr:RevenueRemainingPerformanceObligationExpectedTimingPercentage
      contextRef="C_7bf581fe-f268-40a4-9d35-1ecba7754739"
      decimals="2"
      id="F_8225ed49-ac9f-4236-9c55-938c1a0ff383"
      unitRef="U_pure">0.57</hypr:RevenueRemainingPerformanceObligationExpectedTimingPercentage>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_57d4fa12-c85b-448e-bfc6-82afb244e8d4">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;5. FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair value estimates of financial instruments are made at a specific point in time, based on relevant information about financial markets and specific financial instruments. As these estimates are subjective in nature, involving uncertainties and matters of significant judgment, they cannot be determined with precision. Changes in assumptions can significantly affect estimated fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company measures fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The Company utilizes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &#x2014; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &#x2014; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &#x2014; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company has no assets or liabilities valued with Level 3 inputs.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:3.516%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The carrying value of cash and cash equivalents, notes receivable, accounts payable and accrued expenses and other current liabilities approximates their fair values due to the short-term or on demand nature of these instruments.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; transfers between fair value measurement levels during the years ended December 31, 2&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21 and 2020.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company had $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;48,625&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;58,418&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of money market funds included in cash and cash equivalents and restricted cash as of December 31, 2021 and 2020, respectively. These assets were valued using quoted market prices and accordingly were classified as Level 1.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company determines that notes payable as of December 31, 2020 was classified as Level 2 and the relevant fair value approximates its carrying amount since it bore interest at rates that approximate current market rates.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="INF"
      id="F_e3141a80-5d25-47d7-bd3b-3f4848a085a9"
      unitRef="U_USD">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
    <us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="INF"
      id="F_2fb259a9-2f81-446b-8b74-8ca24a50f61e"
      unitRef="U_USD">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
    <us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="INF"
      id="F_b1666df8-5484-4f11-8e48-c942501b4208"
      unitRef="U_USD">0</us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount>
    <us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="INF"
      id="F_c5cfee3c-a229-40dc-8424-fa1c7664e10a"
      unitRef="U_USD">0</us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount>
    <us-gaap:FairValueLiabilitiesLevel1ToLevel2TransfersAmount
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="INF"
      id="F_df60632e-24cc-4558-8324-0d2d3dcfb12c"
      unitRef="U_USD">0</us-gaap:FairValueLiabilitiesLevel1ToLevel2TransfersAmount>
    <us-gaap:FairValueLiabilitiesLevel1ToLevel2TransfersAmount
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="INF"
      id="F_803feab5-7c79-4db4-9869-1658b26b7364"
      unitRef="U_USD">0</us-gaap:FairValueLiabilitiesLevel1ToLevel2TransfersAmount>
    <us-gaap:FairValueLiabilitiesLevel2ToLevel1TransfersAmount
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="INF"
      id="F_a4b420a3-bca2-429b-956d-d57a5e3326d0"
      unitRef="U_USD">0</us-gaap:FairValueLiabilitiesLevel2ToLevel1TransfersAmount>
    <us-gaap:FairValueLiabilitiesLevel2ToLevel1TransfersAmount
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="INF"
      id="F_a2b8849f-1b01-46f2-9e15-1645d9abecfd"
      unitRef="U_USD">0</us-gaap:FairValueLiabilitiesLevel2ToLevel1TransfersAmount>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_fca29af6-e6e3-4712-95bc-d0e946d2ca70"
      decimals="-3"
      id="F_255053fc-9d12-48e8-a5e7-403d352d123d"
      unitRef="U_USD">48625000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_a16400b6-45e9-4557-826d-8a135305733f"
      decimals="-3"
      id="F_b5424371-ecf3-457d-afed-3f86b0bbb175"
      unitRef="U_USD">58418000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_d66edc36-a5f2-4724-ab03-bdb200edeccf">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;6. INVENTORIES&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A summary of inventories are as follows at December 31:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.184%;"/&gt;
        &lt;td style="width:1.682%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:14.322%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.682%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:14.322%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,355&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Finished goods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total inventories&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;4,310&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Manufacturing overhead costs primarily include management&#x2019;s best estimate and allocation of the labor costs incurred related to acquiring finished goods from the Company&#x2019;s contract manufacturer. Labor costs include wages, taxes and benefits for employees involved in warehousing, logistics coordination, material sourcing, and production planning activities. The majority of these costs have been written off based on the Company&#x2019;s analysis of net realizable value.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For the years ended December 31, 2021 and 2020, net realizable value inventory adjustments and excess and obsolete inventory charges were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;75&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;213&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively, and were recognized in cost of sales.&lt;/span&gt;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_95c498ff-9ab3-458b-b2aa-972519f456dc">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A summary of inventories are as follows at December 31:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.184%;"/&gt;
        &lt;td style="width:1.682%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:14.322%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.682%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:14.322%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,355&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Finished goods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total inventories&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;4,310&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_8d3bf1b7-0ecf-4f58-8e25-3d87a23ee356"
      unitRef="U_USD">2355000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_00c95a0e-4277-433c-944a-3857fda433a5"
      unitRef="U_USD">1955000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_3b169125-74ba-445e-836b-b6cb114be0db"
      unitRef="U_USD">1718000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_c956fff2-0593-4482-9492-38dfca7c2a57"
      unitRef="U_USD">4310000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_0306404b-3df0-4ac5-9e42-6052f34f9e03"
      unitRef="U_USD">1718000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_d297168e-52d1-4476-a075-f83a6086a3a3"
      unitRef="U_USD">75000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_d533b589-11e3-43e2-93af-a34e7c709d13"
      unitRef="U_USD">213000</us-gaap:InventoryWriteDown>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_bed17df0-21af-4999-9eee-3ada62d2d069">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;7. PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net, are recorded at historical cost and consist of the following at December 31:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.895%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.346%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.293%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;572&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Research devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,422&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Sales and marketing devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;669&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;385&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;341&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tooling&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;302&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;270&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Trade show assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Leased devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;396&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;176&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;167&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5,163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,620&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;716&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;3,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,904&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Depreciation and amortization expense amounted to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;726&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;289&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_e6997333-ed72-4682-af62-cb23fe0720df">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net, are recorded at historical cost and consist of the following at December 31:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.895%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.346%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.293%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;572&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Research devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,422&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Sales and marketing devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;669&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;385&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;341&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tooling&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;302&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;270&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Trade show assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Leased devices&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;396&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;176&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;167&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5,163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,620&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;716&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;3,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,904&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_9bead3a6-4985-410f-99b5-30235563115f"
      decimals="-3"
      id="F_1a5d910e-03bc-40c6-b3fc-700af042af0d"
      unitRef="U_USD">989000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_9e7001e3-4007-4798-9dd4-73bb5ecbae12"
      decimals="-3"
      id="F_58c3afe9-ab5b-47ba-98ea-b2606c5ec004"
      unitRef="U_USD">572000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_a2443b46-1c16-4eec-bafc-07f659935c43"
      decimals="-3"
      id="F_1e348f9a-ee03-40e4-b1e4-ac1645a0211b"
      unitRef="U_USD">1422000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0748c7ce-7d19-4746-8d34-695f218ca5aa"
      decimals="-3"
      id="F_b6fcc33f-acdf-48e3-9a55-00caa316aa0b"
      unitRef="U_USD">486000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_883d8081-2c10-4853-b218-6c373ae4a619"
      decimals="-3"
      id="F_99d44aea-681f-445c-a678-7eafde5fdd9a"
      unitRef="U_USD">669000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_39161efa-1760-453a-85f8-4f68df3f9557"
      decimals="-3"
      id="F_a5f4be8f-76bd-4a8e-838f-95f71c962046"
      unitRef="U_USD">575000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_b4ed0d3a-434f-44d7-b565-e029c1f85e01"
      decimals="-3"
      id="F_19d159f3-3629-4e04-bbe4-1d894491c55d"
      unitRef="U_USD">385000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_8b92779c-b81b-4034-9f67-08e85cb2c22d"
      decimals="-3"
      id="F_e7a4117e-d064-45f0-bc28-d9593b6c090b"
      unitRef="U_USD">341000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_2f407302-608a-4972-886c-07025c0d9e38"
      decimals="-3"
      id="F_a93f08d6-8771-45ca-ae49-e4be1dab1bab"
      unitRef="U_USD">613000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_c3117b2a-9a28-41fd-bf6c-462cc8023630"
      decimals="-3"
      id="F_942564de-b71a-423d-8edc-232a3478552d"
      unitRef="U_USD">302000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_1de70b38-0a9c-4b91-b7ee-29ac5dddc712"
      decimals="-3"
      id="F_bfadda53-c74b-4074-9c4f-5a5d3a577773"
      unitRef="U_USD">270000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_fa39ca24-c5b2-4cc3-9108-625304c8561d"
      decimals="-3"
      id="F_4f2dab86-53ed-4226-b0d7-6e2a0ed825a6"
      unitRef="U_USD">293000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_9dd1a0ec-1e2f-4d91-be47-e5f4b90724e9"
      decimals="-3"
      id="F_6f5ddf4e-3152-4313-92b4-561f374e6148"
      unitRef="U_USD">396000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_8798fe66-4ab2-4809-8278-b52ed9e1d7cb"
      decimals="-3"
      id="F_0e94c96b-0001-45bd-99dc-0a1cb7ba09ca"
      unitRef="U_USD">127000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_7ff32017-f2ed-48aa-9ebf-c6e5f3edd992"
      decimals="-3"
      id="F_c1fe6108-fd35-4831-8467-552a3b0f3586"
      unitRef="U_USD">176000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_78bf0f13-f3b7-455a-a4d0-d20db26ececd"
      decimals="-3"
      id="F_68839bb1-d3dd-4d31-9cd9-9eedf4fc0692"
      unitRef="U_USD">167000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_db59f7e2-a3bb-41ab-8de7-f4bdb78c59f5"
      unitRef="U_USD">5163000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_9e745fef-779c-48a1-9e0c-b638eccd78be"
      unitRef="U_USD">2620000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_31963050-1571-4c4b-92d6-10fb50335007"
      unitRef="U_USD">1410000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_8f8f9957-d0b5-46d5-9ae8-2262160b9e15"
      unitRef="U_USD">716000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_e351a39e-2443-40a6-b49f-e7f9f34d772d"
      unitRef="U_USD">3753000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_ba7cf1b3-f460-4c20-95c6-ad2c1f5829ef"
      unitRef="U_USD">1904000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_848b1e3f-1fc0-4e4a-a52a-58b6d48ffe82"
      unitRef="U_USD">726000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_eaaf35ac-71f8-4ebd-8395-0b2c095c2cde"
      unitRef="U_USD">289000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_73f59f7a-164c-4d87-bcb6-991ab7cbe5bd">&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;8. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses and other current liabilities consist of the following at December 31:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.316%;"/&gt;
        &lt;td style="width:1.544%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.899%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:0.994%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:14.438%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Bonus&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3,421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Contracted services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,711&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;456&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;SPAC bonus and other costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,071&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Legal fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;282&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Payroll and related benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;8,115&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <hypr:ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_fcea091c-179a-42e3-896b-2fb76b09f851">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses and other current liabilities consist of the following at December 31:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.316%;"/&gt;
        &lt;td style="width:1.544%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.899%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:0.994%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:14.438%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Bonus&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3,421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Contracted services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,711&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;456&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;SPAC bonus and other costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,071&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Legal fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;282&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Payroll and related benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;8,115&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</hypr:ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock>
    <us-gaap:AccruedBonusesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_12e31fab-5905-4697-a2bf-75f4668d94da"
      unitRef="U_USD">3421000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_6a34b6d6-88d3-45f0-8a36-c86ae8f053cc"
      unitRef="U_USD">501000</us-gaap:AccruedBonusesCurrent>
    <hypr:AccruedContractedServicesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_cfb78c56-32c3-4527-ad4c-a1f5725f5694"
      unitRef="U_USD">2711000</hypr:AccruedContractedServicesCurrent>
    <hypr:AccruedContractedServicesCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_b7bd913a-5c1c-4af8-9802-c69a1eacb5c8"
      unitRef="U_USD">456000</hypr:AccruedContractedServicesCurrent>
    <hypr:AccruedBonusAndOtherCostsCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_8d4528c9-45fe-4852-ab31-dd914aba95d5"
      unitRef="U_USD">1071000</hypr:AccruedBonusAndOtherCostsCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_e26ff824-94dc-4ee1-91c7-8d4dc12ad8c0"
      unitRef="U_USD">452000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_17a38357-bd54-4206-9469-04a7f17aa36a"
      unitRef="U_USD">282000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_f91c2baf-3a8a-49a1-9606-b8de9e404288"
      unitRef="U_USD">441000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_5e8f92f1-34c9-4afd-8bc4-ab35f5ec5af4"
      unitRef="U_USD">19000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_bc48966f-3944-40f5-bed9-dc354bd55abd"
      unitRef="U_USD">25000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <hypr:AccruedExpensesAndOtherCurrentLiabilities
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_6cdddf2d-980c-4d52-aa6c-79e8197ab552"
      unitRef="U_USD">8115000</hypr:AccruedExpensesAndOtherCurrentLiabilities>
    <hypr:AccruedExpensesAndOtherCurrentLiabilities
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_70f3abbf-9af8-4313-9c33-ad5e3e8b5a92"
      unitRef="U_USD">1264000</hypr:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:LongTermDebtTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_9222f6e5-c525-43c3-9262-b736624e367c">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;9. NOTES PAYABLE&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In August 2020, the Company received loan proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,067&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; under the PPP. The Legacy Hyperfine PPP loan in the amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;889&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;evidenced by a promissory note dated August 10, 2020 and was fully paid off during the fourth&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;quarter &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;of 2020. The Liminal PPP loan in the amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;178&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; is evidenced by a promissory note dated May 1, 2020. The Company used the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintaining its payroll levels. The Company accounted for the loan as debt.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In connection with the closing of the Business Combination as discussed in Note 3. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Business Combination&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the Company repaid the Liminal PPP loan in full in December 2021. The Company recognized an insignificant amount of interest expense in the combined and consolidated statements of operations and comprehensive loss related to the loan.&lt;/span&gt;&lt;/p&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_1e797df8-f52f-4d4a-b1a1-ccf242640db1"
      decimals="-3"
      id="F_dc56c53a-1e82-49a1-b7eb-e486970886b2"
      unitRef="U_USD">1067000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_c45f29de-244b-43b1-84da-2f83aa0a16d5"
      decimals="-3"
      id="F_07646f22-df95-4714-bf47-866745f298ce"
      unitRef="U_USD">889000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_1fb3196d-7a74-43b8-be05-e3fb252761c5"
      decimals="-3"
      id="F_b57bf368-94be-441d-8029-09ee9f742d05"
      unitRef="U_USD">178000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PreferredStockTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_373995cb-053b-40aa-adc7-cea1f921363d">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;10. CONVERTIBLE PREFERRED STOCK&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Legacy Hyperfine Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Legacy Hyperfine had issued four series of Convertible Preferred Stock, Series A through Series D. &lt;/span&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table summarizes the authorized, issued and outstanding Convertible Preferred Stock of Legacy Hyperfine immediately prior to the Business Combination:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:11.212%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:8.631%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:8.504%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:9.848%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:0.561%;"/&gt;
        &lt;td style="width:9.615%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.132%;"/&gt;
        &lt;td style="width:7.954%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:7.383%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:8.377%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:8.642%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Class&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year&lt;br/&gt;of Class&lt;br/&gt;Issuance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Issuance&lt;br/&gt;Price per&lt;br/&gt;share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Total&lt;br/&gt;Proceeds or&lt;br/&gt;Exchange&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Issuance&lt;br/&gt;Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Initial&lt;br/&gt;Liquidation&lt;br/&gt;Price per&lt;br/&gt;share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2014&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.04&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;25,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;25,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2017&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;10,625,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;10,625,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series C&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2017&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;31,586,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;31,586,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,382&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,148&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;62,577,618&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;41,970,981&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;90,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;90,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;129,788,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;109,182,191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;159,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;158,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table summarizes the authorized, issued and outstanding Convertible Preferred Stock of Legacy Hyperfine as of December 31, 2020:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:11.225%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:8.633%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:8.506%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:9.395%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:0.561%;"/&gt;
        &lt;td style="width:9.617%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.132%;"/&gt;
        &lt;td style="width:7.956%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:7.385%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:8.379%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:8.644%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Class&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year&lt;br/&gt;of Class&lt;br/&gt;Issuance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Issuance&lt;br/&gt;Price per&lt;br/&gt;share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Total&lt;br/&gt;Proceeds or&lt;br/&gt;Exchange&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Issuance&lt;br/&gt;Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Initial&lt;br/&gt;Liquidation&lt;br/&gt;Price per&lt;br/&gt;share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2014&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.04&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;25,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;25,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2017&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;10,625,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;10,625,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series C&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2017&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;31,586,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;31,586,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,382&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,148&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;62,577,618&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;27,799,648&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;129,788,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;95,010,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;128,651&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;365&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;128,286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The powers, preferences, rights, qualifications, limitations and restrictions of the shares of Convertible Preferred Stock are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Dividends&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Dividends shall accrue to holders of the Convertible Preferred Stock at the rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the original issue price for the applicable series of Convertible Preferred Stock, per annum subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization, reclassification and other similar events payable only when, and if, declared by Legacy Hyperfine&#x2019;s board of directors. The right to receive dividends on Convertible Preferred Stock is not cumulative, and therefore, if not declared in any year, the right to such dividends shall terminate and shall not carry forward into the next year. There have been &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; dividends declared to date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Liquidation Rights&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;the event of any liquidation, dissolution or winding up of Legacy Hyperfine, whether voluntary or involuntary or a deemed liquidation event (which includes a merger, the sale of all of Legacy Hyperfine&#x2019;s assets, or a transaction which the holders of capital stock of Legacy Hyperfine hold less than 50% of the voting securities) (each a &#x201c;Liquidation Event&#x201d;), the holders of the Convertible Preferred Stock are entitled to be paid out of the assets of Legacy Hyperfine available for distribution to stockholders, pari passu, at a liquidation price per share equal to the greater of: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(1) &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;the applicable original issue price of such Convertible Preferred Stock, plus any declared and unpaid dividends or (2) an amount that would have been payable had all the shares of the Convertible Preferred Stock been converted into Legacy Hyperfine common stock. These payments will be made to or set aside prior to the holders of shares of any other class or series of capital stock that is not, by its terms, senior to the Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Voting Rights&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The holders of shares of the Convertible Preferred Stock shall be entitled to vote on all matters on which the holders of shares of Legacy Hyperfine common stock shall be entitled to vote.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each holder of record of shares of Series A Convertible Preferred Stock shall be entitled to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ten&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; votes per share of Legacy Hyperfine Special-voting common stock into which such Series A Convertible Preferred Stock are convertible, as discussed below under &#x201c;Conversion,&#x201d; on all matters to be voted on by Legacy Hyperfine&#x2019;s stockholders. Each holder of record of shares of Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock shall be entitled to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; vote per share of Legacy Hyperfine common stock into which such Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, and Series D Convertible Preferred Stock are convertible, as discussed below under Conversion, on all matters to be voted on by Legacy Hyperfine&#x2019;s stockholders. The holders of Convertible Preferred Stock and the holders of Legacy Hyperfine common stock shall vote together and not as separate classes. There shall be no series voting.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Conversion&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each share of Series A Convertible Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of Legacy Hyperfine Special-voting common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional common shares for no consideration or consideration less than the conversion price of the Series A Convertible Preferred Stock.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each share of Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock shall be convertible, at the option of the holder, at any time after the date of issuance into shares of Legacy Hyperfine common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional common shares for no consideration or consideration less than the conversion price of the respective series of Convertible Preferred Stock, which is equal to the original issuance price for each series of Convertible Preferred Stock.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon the earlier to occur of (i) election of the Convertible Preferred Stock by (A) the consent or vote of the majority holders of the Convertible Preferred Stock (voting together as a single class and not as separate series, and on an as-converted basis), (B) the consent or vote of the majority holders of Series C Convertible Preferred Stock (voting separately as a single class) and (C) the consent or vote of the majority holders of Series D Convertible Preferred Stock (voting separately as a single class) or (ii) the closing of a firm commitment underwritten initial public offering pursuant to an effective registration statement filed under the Securities Act of 1933 covering the offer and sale of shares of Legacy Hyperfine common stock in which the aggregate gross proceeds to Legacy Hyperfine are at least $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (1) each share of Series A Convertible Preferred Stock shall automatically be converted into shares of Legacy Hyperfine Special-voting common stock on a 1 for 1 basis and (2) each share of Series B, Series C and Series D Convertible Preferred Stock shall automatically be converted into Legacy Hyperfine common stock on a 1 for 1 basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon the closing of the Business Combination, the Convertible Preferred Stock converted into Class A and Class B common stock based on the Business Combination&#x2019;s Hyperfine Exchange Ratio of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3275&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of the Company&#x2019;s shares for each Legacy Hyperfine share. The Company recorded the conversion at the carrying value of the Convertible Preferred Stock at the time of the Closing. There are &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Convertible Preferred Stock outstanding as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Liminal Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;April 1, 2021 Liminal effected a recapitalization whereby each share of Liminal common stock outstanding was exchanged for shares of Liminal Series A-1 preferred stock and Liminal Series A-2 preferred stock. The value &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ascribed &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;to the preferred stock is equivalent to the total amount of historical equity investments contributed by the common shareholder.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; There were no new investments or changes in control in conjunction with the recapitalization.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The powers, preferences, rights, qualifications, limitations and restrictions of the shares of Liminal Convertible Preferred Stock are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Dividends&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Dividends shall accrue to holders of the Convertible Preferred Stock at the rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the original issue price for the applicable series of Convertible Preferred Stock, per annum subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization, reclassification and other similar events payable only when, and if, declared by Liminal&#x2019;s board of directors. The right to receive dividends on Convertible Preferred Stock is not cumulative, and therefore, if not declared in any year, the right to such dividends shall terminate and shall not carry forward into the next year. There have been &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; dividends declared to date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Liquidation Rights&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In the event of any liquidation, dissolution or winding up of Liminal, whether voluntary or involuntary or a deemed liquidation event (which includes a merger, the sale of all of Liminal&#x2019;s assets, or a transaction which the holders of capital stock of Liminal hold less than 50% of the voting securities) (each a &#x201c;Liquidation Event&#x201d;), the holders of the Convertible Preferred Stock are entitled to be paid out of the assets of Liminal available for distribution to stockholders, pari passu, at a liquidation price per share equal to the greater of: (1) the applicable original issuance price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.1287&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share for Series A-1 and Series A-2 Convertible Preferred Stock, plus any declared and unpaid dividends or (2) an amount that would have been payable had all the shares of the Convertible Preferred Stock been converted into Liminal common stock. These payments will be made to or set aside prior to the holders of shares of any other class or series of capital stock that is not, by its terms, senior to the Convertible Preferred Stock.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Voting Rights&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The holders of shares of the Convertible Preferred Stock shall be entitled to vote on all matters on which the holders of shares of Liminal common stock shall be entitled to vote.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each holder of record of shares of Series A-1 Convertible Preferred Stock shall be entitled to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ten&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; votes per share of Liminal Special-voting common stock into which such Series A-1 Convertible Preferred Stock are convertible, as discussed below under &#x201c;Conversion,&#x201d; on all matters to be voted on by Liminal&#x2019;s stockholders. Each holder of record of shares of Series A-2 Convertible Preferred Stock shall be entitled to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; vote per share of Liminal common stock into which such Series A-2 Convertible Preferred Stock are convertible, as discussed below under Conversion, on all matters to be voted on by Liminal&#x2019;s stockholders. The holders of Convertible Preferred Stock and the holders of Liminal common stock shall vote together and not as separate classes. There shall be no series voting.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Conversion&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each share of Series A-1 Convertible Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of Liminal Special-voting common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional shares of Liminal common stock for no consideration or consideration less than the conversion price of the Series A Convertible Preferred Stock.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each share of Series A-2 Convertible Preferred Stock shall be convertible, at the option of the holder, at any time after the date of issuance into shares of Liminal common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional shares of common stock for no consideration or consideration less than the conversion price of the respective series of Convertible Preferred Stock, which is equal to the original issuance price for each series of Convertible Preferred Stock.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;the earlier to occur of (i) election of the Convertible Preferred Stock by the consent or vote of the majority holders of the Convertible Preferred Stock (voting together as a single class and not as separate series, and on an as-converted basis) or (ii) the closing of a firm commitment underwritten initial public offering pursuant to an effective&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;registration &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;statement filed under the Securities Act of 1933, as amended, covering the offer and sale of shares of Liminal common stock in which the aggregate gross proceeds to Liminal are at least $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (1) each share of Series A-1 Convertible Preferred Stock shall automatically be converted into shares of Liminal Special-voting common stock on a 1 for 1 basis and (2) each share of Series A-2 Convertible Preferred Stock shall automatically be converted into Liminal common stock on a 1 for 1 basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon the closing of the Business Combination, the Liminal Convertible Preferred Stock converted into Class A and Class B common stock based on the Business Combination&#x2019;s Liminal Exchange Ratio of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.1796&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of the Company&#x2019;s shares for each Liminal share. The Company recorded the conversion at the carrying value of the Convertible Preferred Stock at the time of the Closing. There are &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Convertible Preferred Stock outstanding as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_5240a432-b08a-4741-995a-d6167314781e">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table summarizes the authorized, issued and outstanding Convertible Preferred Stock of Legacy Hyperfine immediately prior to the Business Combination:&lt;/span&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:11.212%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:8.631%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:8.504%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:9.848%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:0.561%;"/&gt;
        &lt;td style="width:9.615%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.132%;"/&gt;
        &lt;td style="width:7.954%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:7.383%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:8.377%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:8.642%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Class&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year&lt;br/&gt;of Class&lt;br/&gt;Issuance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Issuance&lt;br/&gt;Price per&lt;br/&gt;share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Total&lt;br/&gt;Proceeds or&lt;br/&gt;Exchange&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Issuance&lt;br/&gt;Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Initial&lt;br/&gt;Liquidation&lt;br/&gt;Price per&lt;br/&gt;share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2014&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.04&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;25,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;25,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2017&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;10,625,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;10,625,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series C&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2017&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;31,586,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;31,586,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,382&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,148&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;62,577,618&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;41,970,981&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;90,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;90,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;129,788,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;109,182,191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;159,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;158,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table summarizes the authorized, issued and outstanding Convertible Preferred Stock of Legacy Hyperfine as of December 31, 2020:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:11.225%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:8.633%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:8.506%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:9.395%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:0.561%;"/&gt;
        &lt;td style="width:9.617%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.132%;"/&gt;
        &lt;td style="width:7.956%;"/&gt;
        &lt;td style="width:0.931%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:7.385%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.121%;"/&gt;
        &lt;td style="width:8.379%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
        &lt;td style="width:0.984%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:8.644%;"/&gt;
        &lt;td style="width:0.508%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Class&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year&lt;br/&gt;of Class&lt;br/&gt;Issuance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Issuance&lt;br/&gt;Price per&lt;br/&gt;share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Total&lt;br/&gt;Proceeds or&lt;br/&gt;Exchange&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Issuance&lt;br/&gt;Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Initial&lt;br/&gt;Liquidation&lt;br/&gt;Price per&lt;br/&gt;share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2014&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.04&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;25,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;25,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2017&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;10,625,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;10,625,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;0.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series C&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2017&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;31,586,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;31,586,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,382&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,148&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Series D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;62,577,618&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;27,799,648&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;59,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;129,788,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;95,010,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;128,651&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;365&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;128,286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <hypr:TemporaryEquityYearOfClassIssuance
      contextRef="C_88d7f310-a8d6-4fc6-888b-0a034f2de16c"
      id="F_fd9035b5-e979-45e9-a28a-e13708e99324">2014</hypr:TemporaryEquityYearOfClassIssuance>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc"
      decimals="INF"
      id="F_6333fba4-231f-47f3-ac71-6c0511fd5546"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.04</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc"
      decimals="INF"
      id="F_3675b38e-4116-40c5-81ed-ca2b1feeb3a2"
      unitRef="U_shares">25000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc"
      decimals="INF"
      id="F_f71ffe05-a4ae-4ddd-bad8-f813dcabe794"
      unitRef="U_shares">25000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc"
      decimals="INF"
      id="F_7902badc-a337-481b-834b-a6add4d3c826"
      unitRef="U_shares">25000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_88d7f310-a8d6-4fc6-888b-0a034f2de16c"
      decimals="-3"
      id="F_010948f2-6213-4341-a593-711a29b6c56e"
      unitRef="U_USD">1000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <hypr:TemporaryEquitySharesIssuanceCost
      contextRef="C_88d7f310-a8d6-4fc6-888b-0a034f2de16c"
      decimals="-3"
      id="F_0d20a179-015f-4242-88c7-3a2d158e3ed8"
      unitRef="U_USD">2000</hypr:TemporaryEquitySharesIssuanceCost>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc"
      decimals="-3"
      id="F_5dd2f4c1-ba9a-40f6-ab4a-1cfd5b9772ba"
      unitRef="U_USD">998000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_7e5d6022-69f1-4307-bc50-bd2fe80a1fcc"
      decimals="INF"
      id="F_1c12acd2-7071-4fb7-bc28-304b2f501260"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.80</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <hypr:TemporaryEquityYearOfClassIssuance
      contextRef="C_0e50299d-06bc-4ca9-8fae-2ba1b516eb00"
      id="F_99143f31-cb6c-4893-8a26-3b3ccec6ddd8">2017</hypr:TemporaryEquityYearOfClassIssuance>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3"
      decimals="INF"
      id="F_6aee5802-a44e-418d-917b-ff7de1c00e5c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.80</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3"
      decimals="INF"
      id="F_f9a054f3-5acf-44b4-8e93-a28f595818c2"
      unitRef="U_shares">10625000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3"
      decimals="INF"
      id="F_19fd5704-979b-4935-bed2-b4d9b2154141"
      unitRef="U_shares">10625000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3"
      decimals="INF"
      id="F_743b0ef2-9c20-4bdc-bf49-b858424c9219"
      unitRef="U_shares">10625000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_0e50299d-06bc-4ca9-8fae-2ba1b516eb00"
      decimals="-3"
      id="F_fac10a61-6cb9-4d22-a04a-3f9d8ca41df9"
      unitRef="U_USD">8500000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3"
      decimals="-3"
      id="F_0d282f12-0092-4702-9f98-dbb42e8416da"
      unitRef="U_USD">8500000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_7f01ae48-d850-4ba7-b2a3-81f68a7815f3"
      decimals="INF"
      id="F_0891423c-d373-4267-a37a-b3341637436d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.80</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <hypr:TemporaryEquityYearOfClassIssuance
      contextRef="C_c5071d04-a665-4335-a174-7aa1af89882e"
      id="F_a385e3f6-a135-48d2-9dd1-76dcc690aaea">2017</hypr:TemporaryEquityYearOfClassIssuance>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea"
      decimals="INF"
      id="F_1a126fa6-102b-4a11-925f-c592d1dd4b39"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.88</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea"
      decimals="INF"
      id="F_0d45daa7-49e6-48de-ac9b-0f63c2fd00b2"
      unitRef="U_shares">31586210</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea"
      decimals="INF"
      id="F_969e595c-c081-43cc-be2d-8152bf5469c6"
      unitRef="U_shares">31586210</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea"
      decimals="INF"
      id="F_520457e8-e747-4116-9eab-669471d8b2c2"
      unitRef="U_shares">31586210</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_c5071d04-a665-4335-a174-7aa1af89882e"
      decimals="-3"
      id="F_9b5f9fab-8d5e-47e9-ac5c-0436f4320cb1"
      unitRef="U_USD">59382000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <hypr:TemporaryEquitySharesIssuanceCost
      contextRef="C_c5071d04-a665-4335-a174-7aa1af89882e"
      decimals="-3"
      id="F_132d9004-7aaf-40aa-9fb0-cfd8759b1e60"
      unitRef="U_USD">234000</hypr:TemporaryEquitySharesIssuanceCost>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea"
      decimals="-3"
      id="F_d6b95b12-5b26-459d-bb84-8da501d07cb4"
      unitRef="U_USD">59148000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_e5f02f00-cae6-4fc8-9fc2-b8d5109e8dea"
      decimals="2"
      id="F_ce91108a-3955-4ee8-a8d8-ebab0b946928"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.88</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <hypr:TemporaryEquityYearOfClassIssuance
      contextRef="C_1c2f3fc1-c9e7-40c0-86e4-fd3a7bdf44bd"
      id="F_67dd8d75-22b2-475f-ad63-028ccca420c6">2020</hypr:TemporaryEquityYearOfClassIssuance>
    <hypr:TemporaryEquityYearOfClassIssuance
      contextRef="C_a1f35ddb-eb58-49b6-a2b6-56b35e52474f"
      id="F_804ad981-e6fd-4d59-822c-c1ab0b343dd7">2021</hypr:TemporaryEquityYearOfClassIssuance>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7"
      decimals="INF"
      id="F_bafa6f0d-c848-433c-9704-8cd3baaa4693"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.15</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7"
      decimals="INF"
      id="F_b74e62e9-61a2-402e-9afd-d0a1c69dfde2"
      unitRef="U_shares">62577618</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7"
      decimals="INF"
      id="F_bb0d6414-b3c3-46b7-ac38-705e42332d14"
      unitRef="U_shares">41970981</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7"
      decimals="INF"
      id="F_aefcd498-306a-4242-9956-7f14b6ebff4a"
      unitRef="U_shares">41970981</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_c4a978a0-dd7d-4dae-a821-3df28ca4dc3d"
      decimals="-3"
      id="F_5cf5e03b-321b-46c9-8d66-90a4c5ef93fa"
      unitRef="U_USD">90237000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <hypr:TemporaryEquitySharesIssuanceCost
      contextRef="C_c4a978a0-dd7d-4dae-a821-3df28ca4dc3d"
      decimals="-3"
      id="F_642074a7-8c98-4fd7-879d-47d871d9508d"
      unitRef="U_USD">136000</hypr:TemporaryEquitySharesIssuanceCost>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7"
      decimals="-3"
      id="F_9c1a7c29-c834-4d88-8e43-b58a5dcc2778"
      unitRef="U_USD">90101000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_474e4916-0ebb-41f9-97f5-d5ac551d10d7"
      decimals="2"
      id="F_0c297efa-b801-4d42-b6f4-0e7cf245c28b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.15</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5"
      decimals="INF"
      id="F_3af766a3-d0da-4eb7-9a60-ee87df32c496"
      unitRef="U_shares">129788828</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5"
      decimals="INF"
      id="F_77bc1478-9481-4dac-a75d-acb3232d90f0"
      unitRef="U_shares">109182191</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5"
      decimals="INF"
      id="F_acfc93d6-66a5-4d8f-98db-6538f68cc947"
      unitRef="U_shares">109182191</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_e7a1c7aa-d329-429a-b3c9-637f64056a81"
      decimals="-3"
      id="F_c593143b-0fe1-4342-bb27-fe5e25457516"
      unitRef="U_USD">159119000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <hypr:TemporaryEquitySharesIssuanceCost
      contextRef="C_e7a1c7aa-d329-429a-b3c9-637f64056a81"
      decimals="-3"
      id="F_0f7294c9-dbd8-44d4-85e3-1ec231d633d3"
      unitRef="U_USD">372000</hypr:TemporaryEquitySharesIssuanceCost>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5"
      decimals="-3"
      id="F_b8144c37-a66b-454b-a290-61c7c2216a3a"
      unitRef="U_USD">158747000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <hypr:TemporaryEquityYearOfClassIssuance
      contextRef="C_66a4ed44-133c-453e-b237-1b588d0b3bee"
      id="F_cfce8213-777e-4fb4-8460-c5efb330f31f">2014</hypr:TemporaryEquityYearOfClassIssuance>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150"
      decimals="INF"
      id="F_7c8b2801-8f0c-4bac-8f98-cfb4eefa1f95"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.04</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150"
      decimals="INF"
      id="F_a29cbbb6-334c-439d-96f1-5498a674dba7"
      unitRef="U_shares">25000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150"
      decimals="INF"
      id="F_75fd5763-209a-4885-95b7-776fe271b252"
      unitRef="U_shares">25000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150"
      decimals="INF"
      id="F_4df36a34-7061-4722-a40b-323b2151ce3f"
      unitRef="U_shares">25000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_66a4ed44-133c-453e-b237-1b588d0b3bee"
      decimals="-3"
      id="F_48e1dbb5-d3bf-465a-b44f-94bec10143a3"
      unitRef="U_USD">1000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <hypr:TemporaryEquitySharesIssuanceCost
      contextRef="C_66a4ed44-133c-453e-b237-1b588d0b3bee"
      decimals="-3"
      id="F_bd8b859f-b5bf-4dee-b986-51a5544b503b"
      unitRef="U_USD">2000</hypr:TemporaryEquitySharesIssuanceCost>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150"
      decimals="-3"
      id="F_cb48374d-77f3-4c39-a45c-e2617b8cb801"
      unitRef="U_USD">998000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_6f66f0df-20b7-4c2e-926e-312d15b30150"
      decimals="INF"
      id="F_07b19d8c-256c-4bb9-9014-70bdcc983b78"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.80</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <hypr:TemporaryEquityYearOfClassIssuance
      contextRef="C_36c4ccc8-ec82-451c-9859-29fefff0e27b"
      id="F_8fc6a98f-d911-41cc-8079-eb1932d7046f">2017</hypr:TemporaryEquityYearOfClassIssuance>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_851619a8-8879-4e00-8eac-c603bca28425"
      decimals="INF"
      id="F_158db39f-58a7-40fd-be92-2cd1593d999f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.80</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_851619a8-8879-4e00-8eac-c603bca28425"
      decimals="INF"
      id="F_a6a4f32e-043f-4c36-a23d-0c59b7e75026"
      unitRef="U_shares">10625000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_851619a8-8879-4e00-8eac-c603bca28425"
      decimals="INF"
      id="F_0aa68d2e-7052-4ba9-a041-73dda509d464"
      unitRef="U_shares">10625000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_851619a8-8879-4e00-8eac-c603bca28425"
      decimals="INF"
      id="F_4658036f-3040-4352-a7b7-0c1cbd7a3f7a"
      unitRef="U_shares">10625000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_36c4ccc8-ec82-451c-9859-29fefff0e27b"
      decimals="-3"
      id="F_968c2f4b-7f12-4069-b9f5-7a7e9e896022"
      unitRef="U_USD">8500000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_851619a8-8879-4e00-8eac-c603bca28425"
      decimals="-3"
      id="F_b63eb45b-1b0c-43e0-b609-019a9bde9749"
      unitRef="U_USD">8500000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_851619a8-8879-4e00-8eac-c603bca28425"
      decimals="INF"
      id="F_e436ecf7-7236-4c61-99de-a33df27392f4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.80</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <hypr:TemporaryEquityYearOfClassIssuance
      contextRef="C_a1fab29a-58b5-4b1a-9ccd-64a673d6e459"
      id="F_8bece4a1-1117-4311-9a3a-4cda77ed16ff">2017</hypr:TemporaryEquityYearOfClassIssuance>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d"
      decimals="INF"
      id="F_092ccbd1-87f5-487f-a2a9-c140afaac851"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.88</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d"
      decimals="INF"
      id="F_7a79086d-5b9a-4120-b7a3-e448e62b37f8"
      unitRef="U_shares">31586210</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d"
      decimals="INF"
      id="F_6d8ca8d1-613e-4130-ac15-a37242538812"
      unitRef="U_shares">31586210</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d"
      decimals="INF"
      id="F_ef9700c4-7b17-4aa9-b133-7e17e4ba32fb"
      unitRef="U_shares">31586210</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_a1fab29a-58b5-4b1a-9ccd-64a673d6e459"
      decimals="-3"
      id="F_b3ea8d6b-452d-4471-84e2-2a4e79578c01"
      unitRef="U_USD">59382000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <hypr:TemporaryEquitySharesIssuanceCost
      contextRef="C_a1fab29a-58b5-4b1a-9ccd-64a673d6e459"
      decimals="-3"
      id="F_992709f3-2495-4816-b51b-1a75dd9d9713"
      unitRef="U_USD">234000</hypr:TemporaryEquitySharesIssuanceCost>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d"
      decimals="-3"
      id="F_ff6270b8-40f1-4898-9376-eeb24ad9ebe8"
      unitRef="U_USD">59148000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_d3db78a5-9170-438c-85d3-79a5e0440f3d"
      decimals="2"
      id="F_cae1c096-b146-4d9c-861c-ac36758846e4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.88</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <hypr:TemporaryEquityYearOfClassIssuance
      contextRef="C_56f1b540-02fa-40f2-9894-b43cec93b036"
      id="F_38e0a2d2-3464-4ce3-a3c2-2856814bd2bf">2020</hypr:TemporaryEquityYearOfClassIssuance>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc"
      decimals="INF"
      id="F_fd2858af-e524-4013-bbf9-e5d68cc31cab"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.15</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc"
      decimals="INF"
      id="F_c66d3510-894f-4005-a1f9-d632e791b2bb"
      unitRef="U_shares">62577618</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc"
      decimals="INF"
      id="F_81cdde86-4d8e-4e47-888c-7e3c965a97d1"
      unitRef="U_shares">27799648</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc"
      decimals="INF"
      id="F_c8e72c84-dd3c-44b9-a2f3-23758d0a3a61"
      unitRef="U_shares">27799648</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_9644069d-7efd-4fd5-a809-33471f45d26c"
      decimals="-3"
      id="F_0a257f17-4e7d-47a2-8545-8029b09a0243"
      unitRef="U_USD">59769000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <hypr:TemporaryEquitySharesIssuanceCost
      contextRef="C_56f1b540-02fa-40f2-9894-b43cec93b036"
      decimals="-3"
      id="F_47c6dc53-574d-4565-8fed-37872bce6bd1"
      unitRef="U_USD">129000</hypr:TemporaryEquitySharesIssuanceCost>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc"
      decimals="-3"
      id="F_5e5ee377-c4a3-4f80-8ce2-b2f37f9725af"
      unitRef="U_USD">59640000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="C_7a08ca8c-a823-421b-9114-e57b09ed1dfc"
      decimals="2"
      id="F_5333c833-eaaf-46d6-bbea-afbb1af4e25c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.15</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="INF"
      id="F_cb807faa-5597-4186-8d38-0ef9a9ce58f5"
      unitRef="U_shares">129788828</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="INF"
      id="F_9e267503-d6c7-46fb-b5e3-3f8e040dd38d"
      unitRef="U_shares">95010858</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="INF"
      id="F_1f1e6e14-c3b5-4879-ae20-1072be887244"
      unitRef="U_shares">95010858</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_eddfa5e3-2549-4910-a00a-5b346126e0c0"
      unitRef="U_USD">128651000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <hypr:TemporaryEquitySharesIssuanceCost
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_2e666771-f954-4efb-8e6c-fbe511070ea3"
      unitRef="U_USD">365000</hypr:TemporaryEquitySharesIssuanceCost>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_d1045b21-0edd-4286-8f68-d4596d256cba"
      unitRef="U_USD">128286000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="C_815be668-99bc-4c0f-839f-a4c555f975bf"
      decimals="2"
      id="F_ec90584e-98e1-4b4c-bf39-8a131c50cc9e"
      unitRef="U_pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="C_604f763d-b166-4d76-93fc-9435e4fa41ff"
      decimals="2"
      id="F_b0c5c9f6-0b0e-4dbe-991c-4d7cca7ff860"
      unitRef="U_pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="C_59ee9e89-2d6f-4237-ae48-00fdfeea2299"
      decimals="INF"
      id="F_4fd9f83a-7a3e-4b45-a34b-05a8e8d3deff"
      unitRef="U_USD">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="C_1d288b0c-2753-40e9-b635-efa4cad33f7f"
      decimals="INF"
      id="F_edea71b9-6c1c-4031-a9e7-25f5cc7dc63b"
      unitRef="U_USD">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:LiquidationBasisOfAccountingLiquidationPlan
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_ff6f50aa-69c4-488f-9b79-088f1e964f0f">In the event of any liquidation, dissolution or winding up of Legacy Hyperfine, whether voluntary or involuntary or a deemed liquidation event (which includes a merger, the sale of all of Legacy Hyperfine&#x2019;s assets, or a transaction which the holders of capital stock of Legacy Hyperfine hold less than 50% of the voting securities) (each a &#x201c;Liquidation Event&#x201d;), the holders of the Convertible Preferred Stock are entitled to be paid out of the assets of Legacy Hyperfine available for distribution to stockholders, pari passu, at a liquidation price per share equal to the greater of: (1) the applicable original issue price of such Convertible Preferred Stock, plus any declared and unpaid dividends or (2) an amount that would have been payable had all the shares of the Convertible Preferred Stock been converted into Legacy Hyperfine common stock. These payments will be made to or set aside prior to the holders of shares of any other class or series of capital stock that is not, by its terms, senior to the Convertible Preferred Stock.</us-gaap:LiquidationBasisOfAccountingLiquidationPlan>
    <hypr:NumberOfVotesPerShare
      contextRef="C_1405c4fb-fd46-4fa7-b51a-b3abdd66f278"
      decimals="INF"
      id="F_be5d222d-0cef-454a-9838-edde4712ad2d"
      unitRef="U_Vote">10</hypr:NumberOfVotesPerShare>
    <hypr:NumberOfVotesPerShare
      contextRef="C_ac456664-e171-4780-a346-eaa8d31a6318"
      decimals="INF"
      id="F_d6181b2b-6b21-4b2b-a610-bfb77ddb69cd"
      unitRef="U_Vote">1</hypr:NumberOfVotesPerShare>
    <hypr:NumberOfVotesPerShare
      contextRef="C_e6d3149f-9dd6-457f-8d72-4c2c61b3f90a"
      decimals="INF"
      id="F_88dfc5bd-72ed-4d98-ad81-c439f9f2c8ff"
      unitRef="U_Vote">1</hypr:NumberOfVotesPerShare>
    <hypr:NumberOfVotesPerShare
      contextRef="C_79b8e3d1-0c6c-4ae4-9639-ebe2dada5fbe"
      decimals="INF"
      id="F_ea7bb84c-9895-457b-9b3b-2fd0043d322a"
      unitRef="U_Vote">1</hypr:NumberOfVotesPerShare>
    <us-gaap:PreferredStockConversionBasis
      contextRef="C_f483c871-8db6-4367-9cdb-c9ee827a41fe"
      id="F_613937bb-5222-423d-881f-69fa2ea79592">Each share of Series A Convertible Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of Legacy Hyperfine Special-voting common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional common shares for no consideration or consideration less than the conversion price of the Series A Convertible Preferred Stock.</us-gaap:PreferredStockConversionBasis>
    <us-gaap:PreferredStockConversionBasis
      contextRef="C_c87cc42e-ffd7-45c9-913f-2f4babc09628"
      id="F_75a00957-22a5-43d8-880a-a3e13bcb4ab5">Each share of Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock shall be convertible, at the option of the holder, at any time after the date of issuance into shares of Legacy Hyperfine common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional common shares for no consideration or consideration less than the conversion price of the respective series of Convertible Preferred Stock, which is equal to the original issuance price for each series of Convertible Preferred Stock.</us-gaap:PreferredStockConversionBasis>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_a3cbddd1-811a-44fb-b01c-1b817fbb617d"
      decimals="-3"
      id="F_17c4c866-57f3-4c07-b533-e7a61e81ca9e"
      unitRef="U_USD">80000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <hypr:BusinessCombinationExchangeRatio
      contextRef="C_b788d1a7-f5e7-4c74-b5e4-0cd24b556c97"
      decimals="4"
      id="F_f4121f8f-057c-403e-a14e-44bc6a4efdac"
      unitRef="U_pure">0.3275</hypr:BusinessCombinationExchangeRatio>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_b788d1a7-f5e7-4c74-b5e4-0cd24b556c97"
      decimals="INF"
      id="F_67781ad2-2a86-40b8-b2ec-41292fbab3a5"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:PreferredStockConversionBasis
      contextRef="C_bf3fc9fc-c2f0-475a-be3e-816156a07b77"
      id="F_31fdbb1c-0b1d-4662-af6b-7def69e8963b">On April 1, 2021 Liminal effected a recapitalization whereby each share of Liminal common stock outstanding was exchanged for shares of Liminal Series A-1 preferred stock and Liminal Series A-2 preferred stock. The value ascribed to the preferred stock is equivalent to the total amount of historical equity investments contributed by the common shareholder.</us-gaap:PreferredStockConversionBasis>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee"
      decimals="2"
      id="F_5c28beca-31bf-423f-95ef-51fee9f9e33e"
      unitRef="U_pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="C_9975d5e6-b660-419f-abf6-e2a46827db35"
      decimals="INF"
      id="F_21a0a3bb-5147-4375-9742-e9c2f3c46e2f"
      unitRef="U_USD">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:LiquidationBasisOfAccountingLiquidationPlan
      contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee"
      id="F_ef4d7b01-0897-41d5-86de-4f57b33f7801">In the event of any liquidation, dissolution or winding up of Liminal, whether voluntary or involuntary or a deemed liquidation event (which includes a merger, the sale of all of Liminal&#x2019;s assets, or a transaction which the holders of capital stock of Liminal hold less than 50% of the voting securities) (each a &#x201c;Liquidation Event&#x201d;), the holders of the Convertible Preferred Stock are entitled to be paid out of the assets of Liminal available for distribution to stockholders, pari passu, at a liquidation price per share equal to the greater of: (1) the applicable original issuance price of $.1287 per share for Series A-1 and Series A-2 Convertible Preferred Stock, plus any declared and unpaid dividends or (2) an amount that would have been payable had all the shares of the Convertible Preferred Stock been converted into Liminal common stock. These payments will be made to or set aside prior to the holders of shares of any other class or series of capital stock that is not, by its terms, senior to the Convertible Preferred Stock.</us-gaap:LiquidationBasisOfAccountingLiquidationPlan>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_05f68334-93da-4481-827d-a3e3770c9d3d"
      decimals="4"
      id="F_ef3b1f3d-1a3b-4ee0-9120-0e777c28e46c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.1287</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_e1bced35-5643-4d57-a6ea-b24e0a212bf8"
      decimals="4"
      id="F_97b82eeb-a641-4698-90eb-16a2cde01943"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.1287</us-gaap:SharesIssuedPricePerShare>
    <hypr:NumberOfVotesPerShare
      contextRef="C_05f68334-93da-4481-827d-a3e3770c9d3d"
      decimals="INF"
      id="F_40b0dd5e-95a7-4ff3-bc86-14db3df63fa9"
      unitRef="U_Vote">10</hypr:NumberOfVotesPerShare>
    <hypr:NumberOfVotesPerShare
      contextRef="C_e1bced35-5643-4d57-a6ea-b24e0a212bf8"
      decimals="INF"
      id="F_0ab9ff54-17af-4a72-b3d4-ef6ad729c4e4"
      unitRef="U_Vote">1</hypr:NumberOfVotesPerShare>
    <us-gaap:PreferredStockConversionBasis
      contextRef="C_04f3284a-f447-4bbf-92f2-20e3aa560cb7"
      id="F_363feff2-02ef-4c49-af8f-5071221faae7">Each share of Series A-1 Convertible Preferred Stock is convertible, at the option of the holder, at any time after the date of issuance of such share, into shares of Liminal Special-voting common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional shares of Liminal common stock for no consideration or consideration less than the conversion price of the Series A Convertible Preferred Stock.</us-gaap:PreferredStockConversionBasis>
    <us-gaap:PreferredStockConversionBasis
      contextRef="C_d0d9904d-6ebb-411f-ae8e-b672fda8238c"
      id="F_56a3dda7-5e5e-43f1-bcbd-1120df673f61">Each share of Series A-2 Convertible Preferred Stock shall be convertible, at the option of the holder, at any time after the date of issuance into shares of Liminal common stock on a 1 to 1 conversion rate subject to customary anti-dilution adjustments and upon the issuance of additional shares of common stock for no consideration or consideration less than the conversion price of the respective series of Convertible Preferred Stock, which is equal to the original issuance price for each series of Convertible Preferred Stock.</us-gaap:PreferredStockConversionBasis>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_6075123f-e8ea-4b6a-a56e-6e4782bdcdee"
      decimals="-3"
      id="F_ee55ffdb-69a6-4b76-9be5-84a0420a6bbc"
      unitRef="U_USD">80000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <hypr:BusinessCombinationExchangeRatio
      contextRef="C_29df5b7f-0392-4e69-85ba-668edf603563"
      decimals="4"
      id="F_28aa27be-cc03-46ce-9bf3-908b31a09a82"
      unitRef="U_pure">0.1796</hypr:BusinessCombinationExchangeRatio>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_29df5b7f-0392-4e69-85ba-668edf603563"
      decimals="INF"
      id="F_b3b7de3e-b905-406d-b3a9-452483c4b89b"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_6c5f54e8-44d0-441a-a163-e2c32f962364">&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;11. STOCKHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021, and 2020, the Company had authorized &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;600,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;130,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock at $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; par value per share, of which a total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;55,277,061&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,576,137&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares were outstanding, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021, and 2020, the Company had authorized &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;27,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class B common stock at $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; par value per share, of which a total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,055,288&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares were outstanding, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:12.867%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Dividends&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Holders of the Company&#x2019;s common stock are not entitled to receive dividends unless declared by the Company&#x2019;s board of directors. There have been &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; dividends declared to date.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Voting Rights&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The holders of shares of the Company's Class A common stock are entitled to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; vote per share on all matters on which the Company's Class A common stock shall be entitled to vote. The holders of shares of the Company's Class B common stock are entitled to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; votes per share on all matters on which the Company's Class B common stock shall be entitled to vote. The holders of the Company's Class A common stock and Class B common stock shall vote together and not as separate classes.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01"
      decimals="INF"
      id="F_e6edfb64-3c4e-49a3-8544-1bfd09497ad4"
      unitRef="U_shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd"
      decimals="INF"
      id="F_47af9636-b499-43bc-9076-4a43e74ed643"
      unitRef="U_shares">130000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01"
      decimals="INF"
      id="F_0665e27e-305c-4289-b23f-6ffe419b988c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd"
      decimals="INF"
      id="F_81f95b99-c119-46c2-a37e-0dfe37daea56"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01"
      decimals="INF"
      id="F_74698698-1b59-4d40-9dae-ec855ad321cd"
      unitRef="U_shares">55277061</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_36433cb7-b0b7-492d-8b8c-e464e42ab4dd"
      decimals="INF"
      id="F_86ec1075-d255-4b43-8628-c1d0eebf8d1f"
      unitRef="U_shares">1576137</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2"
      decimals="INF"
      id="F_609f60cc-96c5-4828-abd9-0d8687082dde"
      unitRef="U_shares">27000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9"
      decimals="INF"
      id="F_71dc7227-89f6-4474-9190-93bd0e61aacd"
      unitRef="U_shares">0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2"
      decimals="INF"
      id="F_5c851166-b3a2-49a4-9be4-d14d212b8429"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9"
      decimals="INF"
      id="F_db3cdd04-2320-4e11-b29d-238ecf6d9e5d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2"
      decimals="INF"
      id="F_ec7f8d8f-1ff3-4059-b650-e6e8743cac42"
      unitRef="U_shares">15055288</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_bd6eec2c-fcfa-4914-883f-6b6afac511a9"
      decimals="INF"
      id="F_86b4c3d9-b223-40db-9e6b-403a36691bb1"
      unitRef="U_shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:DividendsCommonStock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_538de8a6-a5a6-4dcc-a5db-d6c4cc2b637a"
      unitRef="U_USD">0</us-gaap:DividendsCommonStock>
    <hypr:CommonStockNumberOfVotesPerShare
      contextRef="C_e8929d7a-f4b3-4599-a490-21ed76128b01"
      decimals="INF"
      id="F_dcd81106-8515-41ec-b3df-24aa1504d958"
      unitRef="U_Vote">1</hypr:CommonStockNumberOfVotesPerShare>
    <hypr:CommonStockNumberOfVotesPerShare
      contextRef="C_40866da5-dfe6-427d-8f75-d38b502866b2"
      decimals="INF"
      id="F_507c77ff-0a53-4a55-95d9-4d218e015159"
      unitRef="U_Vote">20</hypr:CommonStockNumberOfVotesPerShare>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_d4349a4f-3b61-46e9-b37e-e1e741242815">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;12. EQUITY INCENTIVE PLAN&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Hyperfine Inc. 2021 Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;16,013,762&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock are reserved for issuance under the Company's 2021 Equity Incentive Plan (the &#x201c;Hyperfine Plan&#x201d;). The Hyperfine Plan is administered by the Company's board of directors. The board of directors may grant restricted stock and options to purchase shares either as incentive stock options or non-qualified stock options. The option grants are subject to certain terms and conditions, option periods and conditions, exercise rights and privileges as set forth in the Hyperfine Plan. At December 31, 2021, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,256,741&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; common shares remain available for issuance under the Hyperfine Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prior to the Business Combination, Legacy Hyperfine and Liminal were distinct entities with separate equity incentive plans for their employees and nonemployees. Both plans were subsequently adopted and assumed by the Company as a consequence of the Business Combination.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Legacy Hyperfine option from Legacy Hyperfine&#x2019;s 2014 Employee, Director and Consultant Equity Incentive Plan as amended on October 9, 2020 (the &#x201c;Legacy Hyperfine Plan&#x201d;) outstanding immediately prior to the Closing, whether vested or unvested, was converted into an option to purchase shares of the Company's Class A common stock equal to the number of shares of Legacy Hyperfine common stock subject to such option multiplied by the Hyperfine&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Exchange &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Ratio of&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3275&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, rounded down to the nearest whole number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Closing divided by &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3275&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, rounded up to the nearest whole cent.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each Liminal option from Liminal&#x2019;s 2021 Employee, Director, and Consultant Equity Incentive Plan (the &#x201c;Liminal Plan") outstanding immediately prior to the Closing, whether vested or unvested, was converted into an option to purchase shares of the Company's Class A common stock equal to the number of shares of Liminal common stock subject to such option multiplied by the Liminal Exchange Ratio of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.1796&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, rounded down to the nearest whole number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Closing divided by &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.1796&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, rounded up to the nearest whole cent.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each exchanged option will continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding option immediately prior to the Closing. All activity was retroactively restated to reflect the exchange that occurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In addition, each Legacy Hyperfine restricted stock unit and each Liminal restricted stock unit outstanding immediately prior to the Effective Time was assumed by the Company and became a restricted stock unit with respect to a number of shares of the Company&#x2019;s Class A common stock equal to the number of shares of Legacy Hyperfine common stock or Liminal common stock subject to such Legacy Hyperfine restricted stock unit or Liminal restricted stock unit immediately prior to the Effective Time multiplied by the Hyperfine Exchange Ratio or the Liminal Exchange Ratio, as applicable, rounded down to the nearest whole share.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock option activity&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each stock option grant carries varying vesting schedules whereby the options become exercisable at the participant&#x2019;s sole discretion provided they are an employee, director or consultant of the Company on the applicable vesting date. Each option shall terminate not more than ten years from the date of the grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;During the year ended December 31, 2021, the Company granted certain equity awards to the newly hired Chief Executive Officer. These awards include (1) an option award to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,899,500&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock which will vest based on continued service over a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;four year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; period, (2) a separate option award to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;474,875&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock, which will be fully vested upon the occurrence of various service, performance, and market conditions. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Two&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;474,875&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; share option awards (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;949,750&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; options total) with terms similar to those described above will be granted pursuant to the terms of the offer letter. Certain equity awards were also granted to the Executive Chairman of the Legacy Hyperfine board of directors. The equity compensation included (1) an option award to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;712,312&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Class A common stock which will vest based on continued service, over &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, (2) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;two&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; separate option awards to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;237,437&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares each of Class A common stock (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;474,874&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares in total), which will be fully vested upon the occurrence of various certain service, performance, and market conditions.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The service condition for these awards is satisfied by providing service to the Company based on the defined service period per the award agreement. The performance-based condition is satisfied upon the occurrence of a special purpose acquisition company (&#x201c;SPAC&#x201d;) transaction, initial public offering (&#x201c;IPO&#x201d;), or financing event as defined in the award agreement. The market condition is satisfied by achieving various multiples of a defined price per share. The achievement of the performance condition and the commencement of the related expense recognition event cannot occur until the event is deemed probable, which only occurs once a SPAC transaction, IPO, or financing event has occurred. The performance condition was satisfied as a result of the Business Combination and the Company recognized stock-based compensation expense of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,772&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; in connection with these awards during the year ended December 31, 2021. None of the market conditions have been satisfied and as such, none of the awards are exercisable as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In addition to the above, restricted stock units with a value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,500&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; will be granted to the Chief Executive Officer following the Business Combination and within two years of the Chief Executive Officer&#x2019;s start date, subject to continued service and which will vest on a schedule to be agreed upon between the Company and the Chief Executive Officer. These restricted stock units were not yet approved by the Board of Directors and therefore had not yet been granted as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;During the year ended December 31, 2021, the Company also granted &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;258,833&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; option awards subject to certain service and performance conditions. The service condition required the participant&#x2019;s continued employment with the Company through the applicable vesting date, and the performance condition required the consummation of a Sale, IPO, or SPAC transaction as defined in the option award agreement. These awards were forfeited and cancelled prior to the consummation of the Business Combination. As a Sale, IPO, or SPAC transaction did not occur prior to forfeiture, the Company did not record any stock-based compensation expense related to these option awards.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All options granted by the Company during the years ended December 31, 2021 and 2020 were granted with exercise prices equal to the estimated fair value of the Company's common stock at the date of grant, as determined by the Company's board of directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A summary of the stock option activity under the Hyperfine Plan is presented in the table below:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.969%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:0.592%;"/&gt;
        &lt;td style="width:10.345%;"/&gt;
        &lt;td style="width:0.846%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:1.269%;"/&gt;
        &lt;td style="width:9.953%;"/&gt;
        &lt;td style="width:0.592%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:0.645%;"/&gt;
        &lt;td style="width:10.704%;"/&gt;
        &lt;td style="width:0.592%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:1.269%;"/&gt;
        &lt;td style="width:10.017%;"/&gt;
        &lt;td style="width:0.592%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Number of Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Weighted Average Remaining Contractual Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,903,479&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7.07&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,073&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;6,771,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;565,533&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;587,047&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3.86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7,522,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;8.79&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;30,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Options exercisable at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,332,624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7.82&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;9,785&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Vested and expected to vest at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7,117,220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;8.77&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;28,445&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company received cash proceeds from the exercise of stock options of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,497&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;120&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; during the years ended December 31, 2021 and 2020, respectively. The total intrinsic value (the amount by which the stock price exceeds the exercise price of the option on the date of exercise) of the stock options exercised during the years ended December 31, 2021 and 2020, was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,752&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;167&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively. The weighted-average grant date fair value of options granted during the year ended December 31, 2021 and 2020, was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.66&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.69&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock option valuation inputs&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company utilized the Black-Scholes option pricing model for determining the estimated fair value for service awards. The Black-Scholes model requires the use of subjective assumptions which determine the fair value of stock-based awards. &lt;/span&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The assumptions used to value option grants to employees and nonemployees for the years ended December 31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.495%;"/&gt;
        &lt;td style="width:1.252%;"/&gt;
        &lt;td style="width:21.252%;"/&gt;
        &lt;td style="width:1.252%;"/&gt;
        &lt;td style="width:18.748%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Risk Free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.95&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;% - &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.13&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;% - &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Expected term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5.40&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;years - &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;6.17&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5.8&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;years - &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;70&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;60&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Risk free interest rate&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The risk free interest rate for periods within the expected term of the awards is based on the U.S. Treasury yield curve in effect at the time of the grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has never declared or paid any cash dividends and does not expect to pay any cash dividends in the foreseeable future.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected term&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For employee awards, the Company calculates the expected term using the &#x201c;simplified&#x201d; method, which is the simple average of the vesting period and the contractual term. The simplified method is applied as the Company does not have sufficient historical data to provide a reasonable basis for an estimate of the expected term. The Company calculates expected term for employee awards that take into account the effects of employee&#x2019;s expected exercise and post-vesting employment termination behavior.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As Legacy Hyperfine was privately held from inception through the Closing and all option grants occurred prior to the Closing Date, there was no specific historical or implied volatility information available.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accordingly, the Company estimates the expected volatility on the historical stock volatility of a group of similar companies that are publicly traded over a period equivalent to the expected term of the stock-based awards. Point estimates of expected annual equity volatility of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;70&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;60&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% for December 31, 2021 and 2020, respectively, were selected in the guideline companies&#x2019; historical range.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Exercise price&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The exercise price is taken directly from the grant notice issued to employees and nonemployees.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The stock options granted to the Company's employees and nonemployees for the periods presented were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.99%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:14.192%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:14.192%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Stock options granted to employee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3,534,844&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;897,240&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Stock options granted to nonemployee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3,236,393&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;284,816&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total stock options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;6,771,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,182,056&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Incentive Unit and Preferred Stock Award Activity&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Incentive unit grants typically vest over a&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; four year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; period provided the holder is an employee, director or consultant of the Company on the applicable vesting date. Upon termination of service, pursuant to the terms of the grant, the participant 1) immediately forfeits any unvested (but issued) incentive units and 2) the Company has the right, but not the obligation, to repurchase at the fair market value on the date of termination, any vested incentive units. The repurchase right is valid for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18 months&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; commencing with the date of service.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On April 2, 2021, 4Bionics executed a plan of liquidation and dissolution and its ownership in Liminal was distributed to its members and to the holders of incentive units. Immediately subsequent to the dissolution, all outstanding unvested incentive unit awards under 4Bionic&#x2019;s 2019 Equity Incentive Plan were replaced with preferred stock awards indexed to and settled in the preferred stock of the former 4Bionics subsidiaries Liminal, Detect, Inc. (f/k/a Homodeus Inc.), and Tesseract Health. The preferred stock awards are subject to service vesting conditions only. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; incremental value was provided to participants as a result of the modification of the awards as the modification date fair value of the incentive unit awards was equal to modification date fair value of the stock underlying the restricted stock awards. Moreover, the remaining vesting period before and after modification was unchanged. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; incremental compensation expense was recognized as a result of the modification.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prior to the dissolution of 4Bionics, a portion of total 4Bionics stock-based compensation expense was allocated to Liminal based on the level of service provided by the relevant employees and nonemployees to Liminal over the term of the award. Subsequent to the dissolution of 4Bionics, the Company recognizes the stock-based compensation expense related to the replacement preferred stock awards and no allocation methodology is required. In connection with the Business Combination, all replacement preferred stock awards were accelerated to fully vest. The Company recognized stock-based compensation expense of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;578&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; related to the incentive unit awards and replacement preferred stock awards during the years ended December 31, 2021 and December 31, 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In December 2021, immediately following the Business Combination, the Company granted &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;117,516&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; restricted stock units (&#x201c;RSUs&#x201d;) to members of the Company&#x2019;s Board of Directors. The RSUs vest over a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;three year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; period, contingent on the ongoing service of the Directors. The grant date fair value of the RSUs was measured using the fair value of the underlying Class A common stock, which was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.19&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share on the grant date. The total grant date fair value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,080&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; will be recognized evenly over the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;three year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; period as the service condition is satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Earn-Out Shares&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Subject to the achievement of certain milestones, certain employees are entitled to a total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;933,933&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; Earn-Out Shares. These Earn-Out Shares fall within the scope of ASC 718, pursuant to which such Earn-Out Shares are equity classified and their grant date fair value will be recognized as compensation expense over the vesting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Earn-out valuation inputs&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company utilized a Monte Carlo Simulation pricing model for determining the estimated fair value for Earn-Out Shares. The fair value is based on the simulated price of the Company over the maturity date of the Earn-Out Shares. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.473%;"/&gt;
        &lt;td style="width:1.925%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:15.831%;"/&gt;
        &lt;td style="width:2.157%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Stock Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;10.92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Risk Free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;54.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Risk free interest rate&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The risk free interest rate for periods within the expected term of the awards is based on the U.S. Treasury yield curve in effect at the time of the grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has never declared or paid any cash dividends and does not expect to pay any cash dividends in the foreseeable future.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected term&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For Earn-Out Shares, the expected term is determined to be &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;years from the Closing as this is the period over which the market price milestone may be achieved. As there is no dependent vesting period, the shares are exercisable at the point that the market milestone is reached.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As Legacy Hyperfine was privately held from inception through the Closing, there was no specific historical or implied volatility information available.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accordingly, the Company estimates the expected volatility on the historical stock volatility of a group of similar companies that are publicly traded over a period equivalent to the expected term of the earn-out awards. A point estimate of expected annual equity volatility of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;55&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% for December 31, 2021 was selected in the guideline companies&#x2019; historical range.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s stock-based compensation expense for the periods presented was as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.092%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.464%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.464%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Cost of sales - Device&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Cost of sales - Service&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,327&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5,482&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;231&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Sales and marketing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;68&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;6,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total unrecognized stock-based compensation expense as of December 31, 2021 was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;13,650&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, which will be recognized over the remaining vesting period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.66&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; years.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="INF"
      id="F_c82a5170-c8b3-40ab-a4a9-237e89af5c59"
      unitRef="U_shares">16013762</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <hypr:CommonStockRemainsAvailableForIssuance
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="INF"
      id="F_e6d5e028-4ca9-41f1-b507-c899706d8a02"
      unitRef="U_shares">8256741</hypr:CommonStockRemainsAvailableForIssuance>
    <hypr:ExchangeRatio
      contextRef="C_bcf76ade-60dc-4368-aef5-2520cbade643"
      decimals="4"
      id="F_e5e71036-1f8a-4439-b12b-1c9ee3b43246"
      unitRef="U_pure">0.3275</hypr:ExchangeRatio>
    <hypr:ExchangeRatio
      contextRef="C_bcf76ade-60dc-4368-aef5-2520cbade643"
      decimals="4"
      id="F_a4a18beb-3f34-4a43-b26d-06abae16641f"
      unitRef="U_pure">0.3275</hypr:ExchangeRatio>
    <hypr:ExchangeRatio
      contextRef="C_51a3f382-19a1-459c-833b-5929003f7207"
      decimals="4"
      id="F_e0711f2e-e1d1-4d3f-8463-efcadc110d3a"
      unitRef="U_pure">0.1796</hypr:ExchangeRatio>
    <hypr:ExchangeRatio
      contextRef="C_51a3f382-19a1-459c-833b-5929003f7207"
      decimals="4"
      id="F_a2795d34-02d6-4671-9066-d77b893aecb0"
      unitRef="U_pure">0.1796</hypr:ExchangeRatio>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_e3d3098a-c48a-4d18-a4a7-21241395278d"
      decimals="INF"
      id="F_f206e525-1f84-4a73-b7bb-3b24e32fa6af"
      unitRef="U_shares">1899500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_e3d3098a-c48a-4d18-a4a7-21241395278d"
      id="F_65cbda19-68fa-4424-bd39-e5456d00fd94">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_9328b463-fd12-44fd-b26c-a8b2835078a1"
      decimals="INF"
      id="F_bea3967c-4a5b-4f34-81b1-f2c2e92bea8a"
      unitRef="U_shares">474875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <hypr:NumberOfSeparateOptionAwards
      contextRef="C_1cf87dff-a097-4d35-8816-c1468d5730fb"
      decimals="INF"
      id="F_d787db53-d8d3-4a08-a381-5b9a21b41856"
      unitRef="U_Option">2</hypr:NumberOfSeparateOptionAwards>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_ccc706be-2158-4bcc-a2db-096a92c02315"
      decimals="INF"
      id="F_9a08fa27-f692-48fe-b0f7-964ada76bd72"
      unitRef="U_shares">474875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_f5de6d93-0dcb-4c74-a001-200800fe2bd9"
      decimals="INF"
      id="F_9ca3c77e-3223-488d-84a6-6ba4b1fac97c"
      unitRef="U_shares">474875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_329773ff-8990-4d8c-9536-2fe5f936e9fd"
      decimals="INF"
      id="F_4bfe8bb8-cd26-43b1-a1b3-233239987dc3"
      unitRef="U_shares">949750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_164ab371-7976-4ab1-b472-197262c28f3c"
      decimals="INF"
      id="F_47eac50d-8764-48c6-a28b-48a91f1cb1a4"
      unitRef="U_shares">712312</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_164ab371-7976-4ab1-b472-197262c28f3c"
      id="F_429637e9-6e25-4395-8d92-e65270d4171d">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hypr:NumberOfSeparateOptionAwards
      contextRef="C_7f6ecd42-2a1a-4c28-acf6-496ab6a2707e"
      decimals="INF"
      id="F_5e122343-ed7f-4bbe-bf74-1be4507d6f79"
      unitRef="U_Option">2</hypr:NumberOfSeparateOptionAwards>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_61d98dd2-ccb5-4863-8e6c-5b1ad14f4dab"
      decimals="INF"
      id="F_04b116b4-18fa-4ecd-a244-83c3d7353b37"
      unitRef="U_shares">237437</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_7c1ef51b-34f4-4a4a-a6cd-9433c0850ab4"
      decimals="INF"
      id="F_4502e22a-7a05-4f6b-99cc-e0d2919d8382"
      unitRef="U_shares">474874</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_19b3a16d-0fb7-4f0f-9123-775d37384548"
      decimals="-3"
      id="F_e981b819-b000-406e-93f8-4294ae38096d"
      unitRef="U_USD">1772000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="C_4ee5d355-9181-4953-8217-8e5ef9995358"
      decimals="-3"
      id="F_301bad35-4cf4-4305-9c76-06b09a01ffc5"
      unitRef="U_USD">2500000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_bae04bbe-9b11-42f5-97ae-1c488ef30d01"
      decimals="INF"
      id="F_4dadcbe1-0366-4c94-85ee-0e425356ad8e"
      unitRef="U_shares">258833</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_d9578805-fcb7-40d9-af35-8e6c989cf5b2">&lt;p style="text-indent:2.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A summary of the stock option activity under the Hyperfine Plan is presented in the table below:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.969%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:0.592%;"/&gt;
        &lt;td style="width:10.345%;"/&gt;
        &lt;td style="width:0.846%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:1.269%;"/&gt;
        &lt;td style="width:9.953%;"/&gt;
        &lt;td style="width:0.592%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:0.645%;"/&gt;
        &lt;td style="width:10.704%;"/&gt;
        &lt;td style="width:0.592%;"/&gt;
        &lt;td style="width:1.153%;"/&gt;
        &lt;td style="width:1.269%;"/&gt;
        &lt;td style="width:10.017%;"/&gt;
        &lt;td style="width:0.592%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Number of Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Weighted Average Remaining Contractual Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,903,479&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7.07&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,073&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;6,771,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;565,533&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;587,047&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3.86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7,522,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;8.79&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;30,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Options exercisable at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,332,624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7.82&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;9,785&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Vested and expected to vest at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7,117,220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;8.77&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;28,445&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_8a9c17f1-6da6-4401-8abe-806f2a333b9e"
      decimals="INF"
      id="F_c8f037de-8234-439c-b96c-dc0f151eac09"
      unitRef="U_shares">1903479</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_8a9c17f1-6da6-4401-8abe-806f2a333b9e"
      decimals="2"
      id="F_bc961bcc-4b27-434d-8c9a-1bba388c98d1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_2d523d48-3880-4f1d-9796-c510fd76bd9c"
      id="F_3481d70d-a8d6-40f5-a9db-9e5ba7687c85">P7Y25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_8a9c17f1-6da6-4401-8abe-806f2a333b9e"
      decimals="-3"
      id="F_5f78beb9-6199-4c18-ab99-677a17470cf0"
      unitRef="U_USD">2073000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      decimals="INF"
      id="F_7d426645-96df-46a8-acf5-00d2673ae6fc"
      unitRef="U_shares">6771237</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      decimals="2"
      id="F_62ebe258-05e2-490f-98aa-9f1316d08022"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      decimals="INF"
      id="F_44f87bae-bd88-4ad5-9836-4758da168545"
      unitRef="U_shares">565533</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      decimals="2"
      id="F_a1661007-ff10-42e6-a791-006b66ce7241"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      decimals="INF"
      id="F_8d9d4d8c-ef00-4251-b6e8-997ff40bc4c8"
      unitRef="U_shares">587047</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      decimals="2"
      id="F_a05fa0f2-a87c-4ae2-a71e-aba9a79712d2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.86</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="INF"
      id="F_8c671b46-4006-40d8-8211-ffd5076b680e"
      unitRef="U_shares">7522136</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="2"
      id="F_d370b5fc-ce85-4785-9511-e75171a0e815"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      id="F_68808a72-9b2d-46f7-9a74-4b4b95f5a096">P8Y9M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="-3"
      id="F_b94e0129-89b8-487a-ac7c-75919b4eb073"
      unitRef="U_USD">30052000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="INF"
      id="F_05deb5a0-747c-495b-8a71-6021a68cb338"
      unitRef="U_shares">2332624</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="2"
      id="F_f9123522-3979-4dda-8257-f217ed75c837"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      id="F_3e1956e9-2655-4136-8f05-ab7f08f1ec67">P7Y9M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="-3"
      id="F_0ec519e4-89d8-4125-91de-f7fa395e9e8f"
      unitRef="U_USD">9785000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="INF"
      id="F_345979e6-b346-4070-a4b0-20cdf3bd9f5b"
      unitRef="U_shares">7117220</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="2"
      id="F_c20944b3-d5eb-4752-9b03-cdfc74da5e01"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      id="F_ec7503ab-3624-4521-baf1-563539842a3b">P8Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_75701b04-3ed8-4552-b34e-b6a9e92e3eb8"
      decimals="-3"
      id="F_68bed2a3-6dc8-4386-9d10-e7ecbcd9acba"
      unitRef="U_USD">28445000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_6bcc48be-0463-426c-bc9a-4e1115bfc0ce"
      unitRef="U_USD">1497000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_f0d009d7-fe25-4201-b345-2b2f86dcf1b8"
      unitRef="U_USD">120000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      decimals="-3"
      id="F_1ecc61e1-e78d-4fe2-ac11-9824851181d8"
      unitRef="U_USD">2752000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_2d523d48-3880-4f1d-9796-c510fd76bd9c"
      decimals="-3"
      id="F_7adc7385-57c2-49e5-bd05-721c65093c2d"
      unitRef="U_USD">167000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      decimals="2"
      id="F_07abe8ef-d8bd-49a1-b5d6-4bc7a29f2272"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_2d523d48-3880-4f1d-9796-c510fd76bd9c"
      decimals="2"
      id="F_23930238-a1a6-41e6-8275-0de1c93baa56"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_f439fe19-8e69-4c74-9c48-ed740a2831b3">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The assumptions used to value option grants to employees and nonemployees for the years ended December 31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.495%;"/&gt;
        &lt;td style="width:1.252%;"/&gt;
        &lt;td style="width:21.252%;"/&gt;
        &lt;td style="width:1.252%;"/&gt;
        &lt;td style="width:18.748%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Risk Free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.95&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;% - &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.13&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;% - &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Expected term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5.40&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;years - &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;6.17&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5.8&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;years - &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;70&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;60&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_19b3a16d-0fb7-4f0f-9123-775d37384548"
      decimals="4"
      id="F_9151bc76-5ecd-49bb-8597-eeba435ed91f"
      unitRef="U_pure">0.0095</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_19b3a16d-0fb7-4f0f-9123-775d37384548"
      decimals="4"
      id="F_d3963910-e325-485a-8cca-c544a9ac9758"
      unitRef="U_pure">0.0113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_b9bd646d-669a-4b5c-9bdd-74063cca61b6"
      decimals="3"
      id="F_0e751715-300f-45cd-8c64-cb923c14bfb3"
      unitRef="U_pure">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_b9bd646d-669a-4b5c-9bdd-74063cca61b6"
      decimals="3"
      id="F_51e4397e-1c8c-45ad-ac07-fdf5132a971d"
      unitRef="U_pure">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_19b3a16d-0fb7-4f0f-9123-775d37384548"
      decimals="2"
      id="F_12c16ce0-c545-4a9d-8e66-3b79493c2759"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_b9bd646d-669a-4b5c-9bdd-74063cca61b6"
      decimals="2"
      id="F_56508a28-1dac-4332-8ead-e1faf1675986"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_12fc5c7b-599e-4371-aa1e-7952b537da56"
      id="F_b17e4866-5fc2-4c5b-a75f-a0e1409e3456">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_97df9222-63f0-4205-8539-e49cb6ad1192"
      id="F_dc0ddbf0-1a72-4265-96f4-6d75376324c6">P6Y2M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_9d460b90-c42a-4930-b08d-e43fe406d95b"
      id="F_cec84f0a-f314-46d0-b2a4-b2a3d00e2ff7">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_e0c91aab-9546-4751-89ce-b88e18335be2"
      id="F_852b9cc5-7fbd-47ff-9493-8b00f88f4fe8">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_19b3a16d-0fb7-4f0f-9123-775d37384548"
      decimals="2"
      id="F_26c0da29-92c1-4b63-afa9-47d59350547c"
      unitRef="U_pure">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_b9bd646d-669a-4b5c-9bdd-74063cca61b6"
      decimals="2"
      id="F_765a64b3-f489-47cd-807f-adfb9b44c83b"
      unitRef="U_pure">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      decimals="2"
      id="F_dd5c1cb1-c433-4f93-9a70-e4970d128106"
      unitRef="U_pure">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_2d523d48-3880-4f1d-9796-c510fd76bd9c"
      decimals="2"
      id="F_4eb5a69c-d1aa-4372-8788-a550445b24d7"
      unitRef="U_pure">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <hypr:ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_e3e5ffde-90c3-43ce-a2e4-a947dea13b9a">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The stock options granted to the Company's employees and nonemployees for the periods presented were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.99%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:14.192%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:14.192%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Stock options granted to employee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3,534,844&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;897,240&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Stock options granted to nonemployee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3,236,393&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;284,816&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total stock options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;6,771,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,182,056&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</hypr:ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_97ecd105-2e03-4bed-bb2d-15098fa42355"
      decimals="INF"
      id="F_b4204495-5d7b-47c8-821d-b242bcd4f93c"
      unitRef="U_shares">3534844</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_44f21ac9-708e-4b24-aef7-cd1a9620d836"
      decimals="INF"
      id="F_4d3a1772-9d96-47c3-95bd-c0bb7b597cbe"
      unitRef="U_shares">897240</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_7b149139-c5d8-4447-a71e-c7ede770bd5e"
      decimals="INF"
      id="F_a38ca5f0-b3e7-4751-a24e-38797af005a7"
      unitRef="U_shares">3236393</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_5e5c7322-5a27-4422-aed8-e69929560490"
      decimals="INF"
      id="F_c045a691-54a6-41e0-b4c7-0317ed88ce7b"
      unitRef="U_shares">284816</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_eb4d058b-3288-420e-9ec3-612fad7d2de5"
      decimals="INF"
      id="F_7188e414-dd7d-46a3-8fec-64dc7809073b"
      unitRef="U_shares">6771237</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_2d523d48-3880-4f1d-9796-c510fd76bd9c"
      decimals="INF"
      id="F_ddf9974b-4bd0-49d1-85a0-5de2faeb0c6b"
      unitRef="U_shares">1182056</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_36b0658e-9bd7-419a-b34b-1d6173b955ca"
      id="F_5438108a-3953-45dc-ba0b-d7ce7c53c52e">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hypr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService
      contextRef="C_36b0658e-9bd7-419a-b34b-1d6173b955ca"
      id="F_af9dfbd0-f133-4879-82e7-240bff2c6d4f">P18M</hypr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService>
    <hypr:ShareBasedPaymentArrangementPlanModificationIncrementalValue
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_68de8a0b-8fa0-43b7-98c9-c5150ede1033"
      unitRef="U_USD">0</hypr:ShareBasedPaymentArrangementPlanModificationIncrementalValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_455413f1-aeea-4fc4-98d7-be01709cb8bb"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_00ed74b2-7850-4508-bc80-e83b416ee826"
      decimals="-3"
      id="F_4853e6d6-d68a-4c3b-9572-5ede632452af"
      unitRef="U_USD">578000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_1db82a87-b4de-4246-b8c2-3df23f8b625f"
      decimals="-3"
      id="F_0970c33e-56ff-4343-8b4f-11bfb3f3408b"
      unitRef="U_USD">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_952282ac-2ad8-4203-8f79-2b4a0432930d"
      decimals="INF"
      id="F_5486511e-ff91-4683-a1a0-b0cd9c05e66e"
      unitRef="U_shares">117516</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_952282ac-2ad8-4203-8f79-2b4a0432930d"
      id="F_52476bc7-2e0f-4090-ad2b-a47cb5724375">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_def64c3f-dcfb-4af6-bc2f-54f251b76af2"
      decimals="2"
      id="F_d6d6649b-727a-4b84-a495-a25846008adf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">9.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_952282ac-2ad8-4203-8f79-2b4a0432930d"
      decimals="-3"
      id="F_b47b7217-6d8a-4eac-af8d-a546173063ab"
      unitRef="U_USD">1080000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="C_952282ac-2ad8-4203-8f79-2b4a0432930d"
      id="F_09403632-cd74-4b06-9f5d-373a9d656e3f">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89"
      decimals="INF"
      id="F_525d9291-0541-4904-8ecc-12c9eac8ff63"
      unitRef="U_shares">933933</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <hypr:ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_2a2189a5-0e73-4435-8707-a220664c45c5">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The key assumptions used in the valuation were as follows:&lt;/span&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.473%;"/&gt;
        &lt;td style="width:1.925%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:15.831%;"/&gt;
        &lt;td style="width:2.157%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Stock Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;10.92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Risk Free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;54.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</hypr:ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="C_017a55aa-4d9f-4145-84bc-31cdf605a0fd"
      decimals="2"
      id="F_9fae18af-e9cb-492e-a3fa-9df8efe070c2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">10.92</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89"
      decimals="4"
      id="F_4d98162f-cb9c-4978-84f5-2c79bb96f9a4"
      unitRef="U_pure">0.0096</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89"
      decimals="3"
      id="F_b49b0d26-b79c-4b58-a41f-b13e437ec9fa"
      unitRef="U_pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89"
      id="F_858aabac-2e03-4e13-a5c4-3f1075203267">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89"
      decimals="3"
      id="F_48937982-303f-421c-a5af-115fb2bc2c3f"
      unitRef="U_pure">0.545</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_d8b08268-c399-4392-8b30-13c303f13c89"
      id="F_9986bc79-f04c-4e1e-9b7a-1cb3f2c83b96">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_d6171afc-03fd-445e-ac62-3ae933435993"
      decimals="2"
      id="F_a47204c1-a63e-4df2-ac19-55a29f068085"
      unitRef="U_pure">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_cfb6d36e-2c79-44e9-bc7d-d5e9720f0e08">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s stock-based compensation expense for the periods presented was as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.092%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.464%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.464%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Cost of sales - Device&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Cost of sales - Service&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,327&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5,482&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;231&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Sales and marketing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;68&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;6,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e027434a-4a2f-4bf7-b6ac-ecd878be99df"
      decimals="-3"
      id="F_37c4d0bf-66d8-4608-90a4-9704e3ad83d7"
      unitRef="U_USD">12000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e06069a2-6817-48a5-94fd-de1580cc4fdc"
      decimals="-3"
      id="F_d6279295-e587-485f-b80e-d7d0a38bb97c"
      unitRef="U_USD">12000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_bbc35c1e-828e-43bf-b1bb-089209526261"
      decimals="-3"
      id="F_b069190a-0427-49a8-8cbb-e90f19d988b7"
      unitRef="U_USD">1327000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_297a1e64-a6f1-490a-8a0d-a68d408b9cba"
      decimals="-3"
      id="F_f072027b-bda4-4014-92f9-09fd80f5c165"
      unitRef="U_USD">864000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_565f6ec5-b566-4aa1-8ca6-fbee686327c0"
      decimals="-3"
      id="F_9b0051d2-03dc-41a5-9664-0c994f555875"
      unitRef="U_USD">5482000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_f61cbd06-6f47-40f0-bf5b-f5c8aaa869bd"
      decimals="-3"
      id="F_1a68a4ef-3ccf-4ce0-ad46-6d65e57f2977"
      unitRef="U_USD">231000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ccfbba15-73af-4c55-9b92-86db3883e6e4"
      decimals="-3"
      id="F_0cfa2d3f-c35a-4d7f-af09-59938e76ad3f"
      unitRef="U_USD">68000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c4fe83e0-a6cc-4633-9e60-f7fc58c68e23"
      decimals="-3"
      id="F_b74ee80f-4bb9-42f2-8e9b-fde7e2f912f3"
      unitRef="U_USD">22000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_01a6d200-8083-4ddf-8fc5-923f8c7cb3c1"
      unitRef="U_USD">6901000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_e6393f81-4782-4fad-9468-3e77ccfd6031"
      unitRef="U_USD">1117000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_19b41fb8-4f91-4a58-a7c6-9c55a1c1d2cb"
      unitRef="U_USD">13650000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_11dac282-7acc-43cf-ba22-882348c3c0c7">P2Y7M28D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_d3279713-2910-42ed-a979-445a7c0c95be">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;13. NET LOSS PER SHARE&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all common equivalent shares of the Company, including convertible preferred stock, outstanding stock options, RSUs and Earn-Out Shares, to the extent dilutive. Basic and diluted net loss per share was the same for each period presented as the inclusion of all common equivalent shares of the Company outstanding would have been anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table presents the calculation of basic and diluted net loss per share for the Company&#x2019;s common stock:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.503%;"/&gt;
        &lt;td style="width:1.565%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.536%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
        &lt;td style="width:1.565%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.536%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Net Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;64,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;23,427&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Numerator for Basic and Dilutive EPS &#x2013; Loss available to common&lt;br/&gt;stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;64,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;23,427&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3,690,523&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,523,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Denominator for Basic and Dilutive EPS - Weighted-average common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;3,690,523&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,523,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Basic and dilutive loss per share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;17.57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;15.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Since the Company was in a net loss position for all periods presented, the basic loss per share calculation excludes preferred stock as it does not participate in net losses of the Company. Additionally, net loss per share attributable to Class A and Class B common stockholders was the same on a basic and diluted basis, as the inclusion of all common equivalent shares outstanding would have been anti-dilutive. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Anti-dilutive common equivalent shares were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.824%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:14.275%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:14.275%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Outstanding options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7,522,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,903,479&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Outstanding Legacy Hyperfine convertible preferred stock (Series A through D)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;31,116,056&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Outstanding RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;117,516&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Earn-Out Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;10,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total anti-dilutive common equivalent shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;17,639,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;33,019,535&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_3bea8068-163b-4968-95a9-63214ecc6700">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table presents the calculation of basic and diluted net loss per share for the Company&#x2019;s common stock:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.503%;"/&gt;
        &lt;td style="width:1.565%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.536%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
        &lt;td style="width:1.565%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.536%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Net Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;64,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;23,427&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Numerator for Basic and Dilutive EPS &#x2013; Loss available to common&lt;br/&gt;stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;64,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;23,427&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3,690,523&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,523,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Denominator for Basic and Dilutive EPS - Weighted-average common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;3,690,523&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;1,523,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Basic and dilutive loss per share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;17.57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;15.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_0dc4e4ff-341f-40fa-b006-bfef66614f6c"
      unitRef="U_USD">-64851000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_f54e5eeb-e1f4-47a6-8810-092a1486ef1b"
      unitRef="U_USD">-23427000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_a87b5af1-b68d-4d44-8f3a-1a5726cdafa1"
      unitRef="U_USD">-64851000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_cd866fdc-0bac-4705-939d-dba0425fea0e"
      unitRef="U_USD">-23427000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_391814da-f713-4ae8-a4bf-709c59085048"
      decimals="INF"
      id="F_b8031f59-6112-4f57-a996-e6a128d0dfd2"
      unitRef="U_shares">3690523</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_6a857b9a-6bad-404d-9dcd-a5265f3492cb"
      decimals="INF"
      id="F_fa1c948f-344d-4da5-9df1-d7f41db5d8d6"
      unitRef="U_shares">1523096</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="0"
      id="F_29b721ed-a9d8-4e52-9551-a7b398080f86"
      unitRef="U_shares">3690523</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="0"
      id="F_ddc4dd9d-85d2-458b-a100-5ba32b44d3e0"
      unitRef="U_shares">1523096</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="2"
      id="F_e8127d83-0cbe-4b5a-bf69-5beee6ee7fc9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-17.57</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="2"
      id="F_e71ba7d9-a9d5-4c55-97e9-e4403e900f53"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-15.38</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_9926c6aa-c3ca-4c52-8524-2cd0c304d68d">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Anti-dilutive common equivalent shares were as follows:&lt;/span&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.824%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:14.275%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:14.275%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Outstanding options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;7,522,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,903,479&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Outstanding Legacy Hyperfine convertible preferred stock (Series A through D)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;31,116,056&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Outstanding RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;117,516&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Earn-Out Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;10,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total anti-dilutive common equivalent shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;17,639,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;33,019,535&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_8947e16c-53a9-404b-b4aa-6eea41055362"
      decimals="INF"
      id="F_8e99ad58-0449-47e8-80d9-7d5053759bb0"
      unitRef="U_shares">7522136</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_6def0aef-40a2-42c1-9b66-b534c9b3b53f"
      decimals="INF"
      id="F_a7b79b26-eb38-4b89-bae8-4547709dcbbf"
      unitRef="U_shares">1903479</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_93ccae92-7e08-46e4-9661-cf630796ab3f"
      decimals="INF"
      id="F_97726580-3ae0-4017-8910-dbdcbdd3e110"
      unitRef="U_shares">31116056</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_7c17d825-000e-4c3d-a83a-3be01c1f2e4e"
      decimals="INF"
      id="F_f83e4959-fc1c-4c93-b765-89c31555ba3c"
      unitRef="U_shares">117516</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b6b6072c-15e7-4e45-9a9f-aea0353e0e42"
      decimals="INF"
      id="F_5136d43f-e469-450d-af4d-0011f4c62529"
      unitRef="U_shares">10000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_ff7a80d2-d7d7-42d6-acba-4b46034ab070"
      unitRef="U_shares">17639652</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="INF"
      id="F_0209640f-f6d3-4c24-a744-4b2d6fe41c0e"
      unitRef="U_shares">33019535</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_035f1e24-7f32-4444-9267-881edd19c9ed">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;14. INCOME TAXES&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Significant components of the Company's deferred tax assets (liabilities) are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.782%;"/&gt;
        &lt;td style="width:1.576%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.387%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
        &lt;td style="width:1.576%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.387%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Gross deferred tax assets (liabilities):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;29,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;14,512&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3,429&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Fixed assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;522&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Accrued bonuses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;857&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;36,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;17,788&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;36,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;17,788&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; income tax expense due to federal and state net operating losses incurred for the years ended December 31, 2021 and 2020. The Company has also not recorded any income tax benefits for its federal and state net operating losses incurred in each period due to uncertainty of realizing the benefit from those items. All of the Company&#x2019;s losses before income taxes were generated in the United States. The effective tax rate for the Company for the years ended December 31, 2021 and 2020 was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; percent. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A reconciliation of the income tax expense at the federal statutory tax rate to the Company&#x2019;s effective income tax rate follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.373%;"/&gt;
        &lt;td style="width:1.576%;"/&gt;
        &lt;td style="width:0.603%;"/&gt;
        &lt;td style="width:12.089%;"/&gt;
        &lt;td style="width:2.983%;"/&gt;
        &lt;td style="width:1.576%;"/&gt;
        &lt;td style="width:0.603%;"/&gt;
        &lt;td style="width:12.216%;"/&gt;
        &lt;td style="width:2.983%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Statutory tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;4.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal research and development credit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Write down of federal NOL due to 382 limitation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Write down of federal R&amp;amp;D credits due to 382 limitation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Deferred tax adjustment resulting from tax rate change&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;28.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;15.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Effective tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s effective tax rate for December 31, 2021 and 2020 differs from the federal statutory tax rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% mainly due to the effect of deferred state income tax benefits resulting from state net operating loss carryforwards and the tax benefits related to research and development tax credits. These benefits to the effective tax rate are fully offset by the increase in the Company&#x2019;s valuation allowance from the prior year.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has established a full valuation allowance against its net deferred tax assets due to the uncertainty of the Company&#x2019;s ability to generate sufficient taxable income to realize the deferred tax assets, and therefore has not recognized any benefits from the net operating losses, tax credits and other deferred tax assets. The Company&#x2019;s valuation allowance increased $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,348&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,729&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021, the Company had the following tax net operating loss carryforwards available to reduce future federal and Connecticut taxable income, and tax credit carryforwards available to offset future federal and Connecticut income taxes:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.159%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.589%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:15.176%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="5" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Hyperfine&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Begin to Expire in&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Hyperfine tax net operating loss carryforwards:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal (pre-2018 NOLs)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2034&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal (post-2017 NOLs)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;91,306&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;No Expiration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;72,621&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2034&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tax credit carryforwards:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,338&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2034&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Connecticut research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;No Expiration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Connecticut others&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal others&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;135&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.406%;"/&gt;
        &lt;td style="width:1.513%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.539%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.513%;"/&gt;
        &lt;td style="width:15.126%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="5" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Liminal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Begin to Expire in&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Liminal tax net operating loss carryforwards:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal (pre-2018 NOLs)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal (post-2017 NOLs)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12,304&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;No Expiration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2038&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tax credit carryforwards:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;449&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2038&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Connecticut research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;No Expiration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Under Internal Revenue Code Section 382, if a corporation undergoes an &#x201c;ownership change,&#x201d; the corporation&#x2019;s ability to use its pre-change net operating loss and tax credit carryforwards to offset its post-change income and tax liabilities may be limited. Generally, an &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ownership change occurs when certain shareholders increase their aggregated ownership by more than 50 percentage points over their lowest ownership percentage in a testing period (typically &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;).&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The Company performed a Section 382 analysis for Legacy Hyperfine to determine whether an ownership change has occurred. Based on this analysis, Legacy Hyperfine experienced &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;two&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; consecutive ownership changes, one on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 17, 2017&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, and one on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;May 16, 2017&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. As a result, Legacy Hyperfine&#x2019;s net operating loss and tax credit carryforwards as of December 31, 2020 are subject to a Section 382 limitation. The January 17, 2017 ownership change resulted in an annual limitation of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;865&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and the May 16, 2017 ownership change resulted in an annual limitation of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,008&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The first (earlier) limitation will limit the deduction of pre-change losses and credits arising before the first ownership change. The second (later) ownership change creates another limit to deduction of those pre-change losses and credits. However, the second ownership change does not allow for a &#x201c;step-up&#x201d; of the first limitation and therefore the pre-January 17, 2017 losses and credits are still subject to the first limitation amount. Due to these limitations, the Company estimates that $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,125&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;249&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of the federal net operating loss and research and development credit carryforwards, respectively, will expire before utilization. Accordingly, Legacy Hyperfine&#x2019;s gross deferred tax assets and corresponding valuation allowance have been adjusted to reflect the estimated expirations. In addition, as a result of the Business Combination and any other equity issuances during the year, the Company is currently updating its Section 382 analysis to determine whether any additional ownership changes have occurred through December 31, 2021. This analysis is expected to be completed in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has adopted the accounting guidance within ASC Topic 740 on uncertainties in income taxes. ASC Topic 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021 and 2020, the Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t have any unrecognized tax benefits. To the extent penalties and interest would be assessed on any underpayment of income tax, the Company&#x2019;s policy is that such amounts would be accrued and classified as a component of income tax expense in the combined and consolidated financial statements. To date, the Company has not recorded any such interest or penalties.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company files income tax returns in the U.S. federal and various state jurisdictions. As a result of the Company&#x2019;s net operating loss carryforwards, the Company&#x2019;s federal and state statutes of limitations generally remain open for all&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;tax years until its net operating loss and tax credit carryforwards are utilized or expire prior to utilization. The Company does not currently have any federal or state income tax examinations in progress.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted which included provisions related to net operating loss carryovers and carrybacks, refundable payroll tax credits, deferral of payroll taxes, alternative minimum tax credit refunds, modifications to the net interest deduction limitations, and technical corrections to tax depreciation methods for qualified improvement property. The Company has evaluated the relevant provisions of the CARES Act and has not recognized any benefit related to these provisions. Therefore, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; related income tax effects have been recognized in the financial statements for the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Additionally, as a result of legislation in the state of Connecticut, companies have the opportunity to exchange certain research and development tax credit carryforwards for a cash payment of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;65&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the research and development tax credit. The research and development expenses that qualify for Connecticut credits are limited to those costs incurred within Connecticut. The Company has elected to participate in the exchange program and, as a result, has recognized net benefits of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;103&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;131&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for the years ended December 31, 2021 and 2020, respectively, which is included in research and development expenses in the accompanying statements of operations and comprehensive loss. As of December 31, 2021 and 2020, the Company has recorded $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;196&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;467&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of the research and development tax credit receivables in Prepaid expenses and other current assets on the Company&#x2019;s combined and consolidated balance sheets, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_6a5cba9b-9951-4aea-8cd5-9b3fc2879f55">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Significant components of the Company's deferred tax assets (liabilities) are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.782%;"/&gt;
        &lt;td style="width:1.576%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.387%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
        &lt;td style="width:1.576%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.387%;"/&gt;
        &lt;td style="width:0.857%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Gross deferred tax assets (liabilities):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;29,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;14,512&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3,429&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Fixed assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;522&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Accrued bonuses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;857&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;36,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;17,788&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;36,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;17,788&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_e3eb143b-98aa-44b1-a956-3ae7a52e7065"
      unitRef="U_USD">29300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_2d2cb06b-01f5-44ee-be05-ce53f3ee647d"
      unitRef="U_USD">14512000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_3e0eeaaa-c08b-4e07-988d-c9905c517ca1"
      unitRef="U_USD">3429000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_7515bff7-3fbd-4b7a-9eff-8da811bb30ad"
      unitRef="U_USD">2238000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_e11a239b-f94d-42a5-8bf3-8d77701cfccc"
      unitRef="U_USD">117000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_86c9d782-1dce-44c9-b55b-b44ac9627d65"
      unitRef="U_USD">5000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_b0ec6894-2d18-4db3-8523-3130d7888217"
      unitRef="U_USD">1634000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_569b96b2-8217-4896-a249-84f1ba11e94a"
      unitRef="U_USD">522000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_0ad04eb2-f28c-46e1-b202-63c564684af4"
      unitRef="U_USD">949000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_2553f80a-5266-4a47-8831-8f462cf829c0"
      unitRef="U_USD">421000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_5a8f2e6e-5c4a-415f-b9b4-2dc95cce0dc5"
      unitRef="U_USD">857000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_ebc0719c-2881-4ef8-886b-4bd4daafd997"
      unitRef="U_USD">84000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_975f1754-05e9-429b-9e6d-cbe542c0712c"
      unitRef="U_USD">90000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_da3602e0-fc7a-4b34-8e0c-b0b1f99de979"
      unitRef="U_USD">36136000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_41e4ef1b-83fd-4649-96bf-c790c8fdbe63"
      unitRef="U_USD">17788000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_756cb822-d8ec-4408-8032-20fe8773fc69"
      unitRef="U_USD">36136000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_43350a1b-6ea6-40f1-a1a6-ed0374474ddc"
      unitRef="U_USD">17788000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_f684ca2d-8a75-4e94-959f-b7de192cf33e"
      decimals="INF"
      id="F_90819e2a-0d99-4cc8-b6ae-156271d16ea3"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_46f6a47d-e180-42ed-8d1e-464d0ec632b1"
      decimals="INF"
      id="F_360f9b1a-dad9-44b4-9a52-fe88a8a8cf43"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_7a2c2221-aea2-4346-b515-48005f52844c"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="INF"
      id="F_d1e6cba5-9534-4f73-b809-e3c17ee66b6d"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_8e17f06c-fabf-4aa8-a469-bd779585da3f">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A reconciliation of the income tax expense at the federal statutory tax rate to the Company&#x2019;s effective income tax rate follows:&lt;/span&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.373%;"/&gt;
        &lt;td style="width:1.576%;"/&gt;
        &lt;td style="width:0.603%;"/&gt;
        &lt;td style="width:12.089%;"/&gt;
        &lt;td style="width:2.983%;"/&gt;
        &lt;td style="width:1.576%;"/&gt;
        &lt;td style="width:0.603%;"/&gt;
        &lt;td style="width:12.216%;"/&gt;
        &lt;td style="width:2.983%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Statutory tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;4.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal research and development credit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;3.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Write down of federal NOL due to 382 limitation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Write down of federal R&amp;amp;D credits due to 382 limitation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;1.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Deferred tax adjustment resulting from tax rate change&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;5.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;0.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;28.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;15.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Effective tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="3"
      id="F_3784982b-8322-40f6-9b64-405a8d51be1a"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="3"
      id="F_237da103-0307-4840-a95c-d3ebb6bceb26"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="3"
      id="F_0324d6d8-1aa4-4923-acdb-0e56c6a8ab82"
      unitRef="U_pure">0.040</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="3"
      id="F_cc45ee63-6ed2-430d-b1bb-1424c5165076"
      unitRef="U_pure">0.018</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="3"
      id="F_e33c3e2e-ec6e-4ad8-8b1c-f141fb7e9bd4"
      unitRef="U_pure">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="3"
      id="F_60d634d5-90c3-4944-8540-50a0648f3aa0"
      unitRef="U_pure">0.032</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="3"
      id="F_cb295dcf-3cca-4912-ab64-6d90cebafb6c"
      unitRef="U_pure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="3"
      id="F_4ae1c91b-ce0a-41ee-9215-c600858c39bb"
      unitRef="U_pure">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <hypr:Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="3"
      id="F_42104ee0-2111-4d8b-a953-0f07bea6fbb7"
      unitRef="U_pure">-0.028</hypr:Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation>
    <hypr:Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="3"
      id="F_62babf43-d70a-4eef-a065-7bb5e7e32e50"
      unitRef="U_pure">-0.011</hypr:Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="3"
      id="F_5e76739f-8bd8-4d6f-b2b3-6b29b5b66caa"
      unitRef="U_pure">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="3"
      id="F_a5cc70ad-1c69-4f38-8f4d-b9cce077989f"
      unitRef="U_pure">-0.055</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="3"
      id="F_830a3fd3-f354-4d52-909f-bd0dcdbe5a0d"
      unitRef="U_pure">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="3"
      id="F_f5e6e17f-7062-44ca-8a1e-f345e2e67ad7"
      unitRef="U_pure">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="3"
      id="F_543885e5-13ba-46ea-89c9-060e852e27ae"
      unitRef="U_pure">0.281</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="3"
      id="F_0b14316c-1330-483c-859f-ed3ad07a8a1e"
      unitRef="U_pure">0.159</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="3"
      id="F_736031f2-61c6-49f9-aade-7eac5b410352"
      unitRef="U_pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="3"
      id="F_ecbea565-ac56-4f4b-94a6-4ace1b0b2a90"
      unitRef="U_pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_9fcf0ba8-e319-471b-8ca1-d7063a6d76f5"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="INF"
      id="F_79cafc53-6b29-45ed-b227-cf90732ace0b"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <hypr:DeferredTaxAssetsValuationAllowanceIncreased
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_a59a59d4-ca94-4dc9-9d16-407a50270a11"
      unitRef="U_USD">18348000</hypr:DeferredTaxAssetsValuationAllowanceIncreased>
    <hypr:DeferredTaxAssetsValuationAllowanceIncreased
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_bfe6fbb5-201a-43ef-aa57-4bc23cc1140f"
      unitRef="U_USD">3729000</hypr:DeferredTaxAssetsValuationAllowanceIncreased>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_d86f83dd-0060-4429-8832-791bbb1c6234">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021, the Company had the following tax net operating loss carryforwards available to reduce future federal and Connecticut taxable income, and tax credit carryforwards available to offset future federal and Connecticut income taxes:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.159%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.589%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.586%;"/&gt;
        &lt;td style="width:15.176%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="5" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Hyperfine&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Begin to Expire in&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Hyperfine tax net operating loss carryforwards:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal (pre-2018 NOLs)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2034&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal (post-2017 NOLs)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;91,306&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;No Expiration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;72,621&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2034&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tax credit carryforwards:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2,338&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2034&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Connecticut research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;No Expiration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Connecticut others&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal others&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;135&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.406%;"/&gt;
        &lt;td style="width:1.513%;"/&gt;
        &lt;td style="width:1.29%;"/&gt;
        &lt;td style="width:13.539%;"/&gt;
        &lt;td style="width:0.613%;"/&gt;
        &lt;td style="width:1.513%;"/&gt;
        &lt;td style="width:15.126%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="5" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Liminal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"&gt;Begin to Expire in&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Liminal tax net operating loss carryforwards:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal (pre-2018 NOLs)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal (post-2017 NOLs)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12,304&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;No Expiration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;12,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2038&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Tax credit carryforwards:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Federal research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;449&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;2038&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Connecticut research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;No Expiration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_6cfe4f83-75d3-42af-b919-f037bac001d8"
      decimals="-3"
      id="F_8411b12b-e4a5-42ec-b052-10b159d2a8f3"
      unitRef="U_USD">12084000</us-gaap:OperatingLossCarryforwards>
    <hypr:OperatingLossCarryforwardsBeginToExpireYear
      contextRef="C_ab4a120e-032e-4174-ab0f-41881ca87629"
      id="F_9d0871f1-0546-4986-9d31-09bfb361e046">2034</hypr:OperatingLossCarryforwardsBeginToExpireYear>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_f7c260f7-942b-467a-a100-8891e93ffd0a"
      decimals="-3"
      id="F_dcf5e95f-6cc0-44fd-9e3d-b65e754efc46"
      unitRef="U_USD">91306000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_f04be01a-f1c8-4197-9e8c-a8e60e22ac2c"
      decimals="-3"
      id="F_5512a823-08cf-429c-ba19-2dde03f02ccd"
      unitRef="U_USD">72621000</us-gaap:OperatingLossCarryforwards>
    <hypr:OperatingLossCarryforwardsBeginToExpireYear
      contextRef="C_f544b39f-f467-43d9-bd6c-b63e721ee22c"
      id="F_2b0598a6-1dd4-47fa-897d-056829806536">2034</hypr:OperatingLossCarryforwardsBeginToExpireYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_1f1550e6-aea9-41b1-944e-48553f861650"
      decimals="-3"
      id="F_aa4f9255-9df2-4c90-8a08-664de1f9ed3b"
      unitRef="U_USD">2338000</us-gaap:TaxCreditCarryforwardAmount>
    <hypr:TaxCreditCarryforwardBeginToExpirationYear
      contextRef="C_e01451b3-5582-4ac0-8725-58320e1c8896"
      id="F_56a96d00-4f75-452b-95c4-eb27f0df0a3e">2034</hypr:TaxCreditCarryforwardBeginToExpirationYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_018e05a7-18c4-47ac-8a4f-82f9d45da649"
      decimals="-3"
      id="F_67bb17e6-b6bc-4594-ad20-81d535a260c9"
      unitRef="U_USD">752000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_b5d108c6-9922-4ef6-a9f4-1b52927fa472"
      decimals="-3"
      id="F_442f4c62-5c72-4af6-be08-35802e4fa1a2"
      unitRef="U_USD">12000</us-gaap:TaxCreditCarryforwardAmount>
    <hypr:TaxCreditCarryforwardBeginToExpirationYear
      contextRef="C_dbe7ddab-0056-49e4-9a0e-48437f4d7b7e"
      id="F_2f76a512-5790-4087-8ec7-405c3e2ea16e">2022</hypr:TaxCreditCarryforwardBeginToExpirationYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_2deb5363-ab1f-4a7d-bf8d-b4b73bf8fc16"
      decimals="-3"
      id="F_7b866970-ea1c-4eaa-b7b5-a80ba12d22d4"
      unitRef="U_USD">135000</us-gaap:TaxCreditCarryforwardAmount>
    <hypr:TaxCreditCarryforwardBeginToExpirationYear
      contextRef="C_80cfe749-acb3-416a-9bfa-17252d7bfb03"
      id="F_a873ba48-26b3-478c-b37f-e583e9f62420">2022</hypr:TaxCreditCarryforwardBeginToExpirationYear>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_234b982a-29e0-45ff-b5c3-d5349882acd9"
      decimals="-3"
      id="F_46dc4c07-ebac-44f4-94a2-a931f41d9f40"
      unitRef="U_USD">12304000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_cb1f65d2-d11d-4188-86cc-6490cfa8ec4f"
      decimals="-3"
      id="F_5fd59cd2-c4e4-4592-b6ca-274c00a3e5f8"
      unitRef="U_USD">12300000</us-gaap:OperatingLossCarryforwards>
    <hypr:OperatingLossCarryforwardsBeginToExpireYear
      contextRef="C_f96e34c7-c8df-43a2-b54b-74085b8e63c1"
      id="F_11d31ec0-a6ee-4b70-90d9-1b323d44a061">2038</hypr:OperatingLossCarryforwardsBeginToExpireYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_2a19dcc8-c5cc-40ef-8059-d3bbd58d9d5b"
      decimals="-3"
      id="F_5a739afe-ad91-4eba-bcd4-7712eacabb77"
      unitRef="U_USD">449000</us-gaap:TaxCreditCarryforwardAmount>
    <hypr:TaxCreditCarryforwardBeginToExpirationYear
      contextRef="C_c727f466-00a1-41e9-b455-84621ea4e2de"
      id="F_47fa4459-e45d-4403-ac67-a1c70223369f">2038</hypr:TaxCreditCarryforwardBeginToExpirationYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_2206b217-69b7-412b-a10f-a8ac64842af3"
      decimals="-3"
      id="F_9c53a6fe-496e-4fba-80e0-bfa81b075943"
      unitRef="U_USD">49000</us-gaap:TaxCreditCarryforwardAmount>
    <hypr:OwnershipChangeDescription
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_cccfab3a-39e2-4b31-bac2-5806b0925250">ownership change occurs when certain shareholders increase their aggregated ownership by more than 50 percentage points over their lowest ownership percentage in a testing period (typically three years).</hypr:OwnershipChangeDescription>
    <hypr:OwnershipChangePercentageTestingPeriod
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_8e248e59-17a3-4391-8ae1-6ba3a893c802">P3Y</hypr:OwnershipChangePercentageTestingPeriod>
    <hypr:NumberOfConsecutiveOwnershipChanges
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="INF"
      id="F_228cfbbd-209f-49d8-8a60-8682ea9f69f1"
      unitRef="U_Ownership">2</hypr:NumberOfConsecutiveOwnershipChanges>
    <hypr:OwnershipChangesDateOne
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_e22bf854-9362-4fb7-9290-4cfd0bc59813">2017-01-17</hypr:OwnershipChangesDateOne>
    <hypr:OwnershipChangesDateTwo
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_48813d37-3160-4f19-af79-125fb8f334ca">2017-05-16</hypr:OwnershipChangesDateTwo>
    <hypr:NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation
      contextRef="C_fa4c4e98-cf41-4a9f-86eb-de3be3b950dd"
      decimals="-3"
      id="F_8bdf457f-e2ae-44d7-a7b1-8984006f5386"
      unitRef="U_USD">865000</hypr:NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation>
    <hypr:NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation
      contextRef="C_821ac2f9-b484-46bf-bf7f-00231566dd23"
      decimals="-3"
      id="F_688714be-c59c-4ad2-a34a-46da78058115"
      unitRef="U_USD">3008000</hypr:NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation>
    <hypr:NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation
      contextRef="C_309c8fe7-b2ee-4206-93c1-c4ef1763fe17"
      decimals="-3"
      id="F_f95f520d-c9f8-46ac-91a4-fdad7affc33c"
      unitRef="U_USD">3125000</hypr:NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation>
    <hypr:NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation
      contextRef="C_39d87f95-6e1f-4dc1-b752-0e7cc15f6e53"
      decimals="-3"
      id="F_39f7908c-0d0b-401b-aa9c-dc653cc88f5b"
      unitRef="U_USD">249000</hypr:NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation>
    <hypr:OwnershipChangesAnalysisExpectedToBeCompletedYear
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      id="F_45adaf83-fea8-44dc-baa1-dfe49c7b636b">2022</hypr:OwnershipChangesAnalysisExpectedToBeCompletedYear>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="INF"
      id="F_0741c10e-c9f2-4c65-b271-740806cc0012"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="INF"
      id="F_46091089-f9d8-4579-98fe-2a3160217a1c"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <hypr:IncomeTaxEffectsRecognized
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_43147c91-243b-4c6b-a016-269fbbc2801d"
      unitRef="U_USD">0</hypr:IncomeTaxEffectsRecognized>
    <hypr:IncomeTaxEffectsRecognized
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="INF"
      id="F_27c34fb2-f7f8-46fc-bcfe-33181623daa9"
      unitRef="U_USD">0</hypr:IncomeTaxEffectsRecognized>
    <hypr:PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="2"
      id="F_21bff87f-965b-48d8-a8aa-a02cf68545e6"
      unitRef="U_pure">0.65</hypr:PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards>
    <hypr:ExchangeProgramRecognizedNetBenefits
      contextRef="C_bbc35c1e-828e-43bf-b1bb-089209526261"
      decimals="-3"
      id="F_043bcfe7-d83f-4842-bfd7-92ef4d0a5fbf"
      unitRef="U_USD">103000</hypr:ExchangeProgramRecognizedNetBenefits>
    <hypr:ExchangeProgramRecognizedNetBenefits
      contextRef="C_297a1e64-a6f1-490a-8a0d-a68d408b9cba"
      decimals="-3"
      id="F_6b0925e9-226f-4562-8e70-6a1da5e8c5b6"
      unitRef="U_USD">131000</hypr:ExchangeProgramRecognizedNetBenefits>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_3f18d4ae-c6cc-47ad-8aee-67220f5329d5"
      unitRef="U_USD">196000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_a07f23b9-f29c-4ac4-9349-5d726cf59e5f"
      unitRef="U_USD">467000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_72e6e690-d657-42a2-a36f-f7d3c423e9b2">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;15. RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company utilizes and subleases office and lab space in Connecticut which is being leased from an unrelated landlord by 4Catalyzer Corporation, (&#x201c;4C&#x201d;), which is owned by a related party. The Company pays rent to 4C on a month-to-month basis, and no lease agreement was entered into between the parties until June 2021. A total of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;149&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;113&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; was paid during 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prior to 4Bionics executing a plan of liquidation and dissolution on April 2, 2021, certain expenses incurred at 4Bionics were allocated to its subsidiaries, including Liminal. Expenses that broadly benefited 4Bionics and its subsidiaries were allocated evenly amongst its &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;three&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; subsidiaries. Expenses that were incurred on behalf of the employees of each company were allocated based on each subsidiary&#x2019;s relative headcount. Total proceeds allocated to Liminal upon liquidation and dissolution in 2021 were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;101&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and total expenses allocated to Liminal in 2020 were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;64&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The method used to allocate common expenses of 4Bionics to Liminal is reasonable.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In January 2018, the Company entered into a Promissory Note (the &#x201c;Note&#x201d;) with one of its employees (the &#x201c;Borrower&#x201d;) in the amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;90&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The Note bears interest at a rate equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.68&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% per annum. In accordance with the terms of the Note, since the Borrower remained employed with the Company on the maturity date of January 11, 2022, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;90&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of the then outstanding principal amount and all interest accrued to that date was forgiven and Borrower is no longer required to repay the amount. Interest on the Note was payable annually in cash on the anniversary date of the Note, and as of December 31, 2021 and 2020, interest receivable in the amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively, are included in Prepaid expenses and other current expenses on the combined and consolidated balance sheets, and interest income of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively, were recognized as of December 31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company also made payments to 4C to prefund the acquisition of capital assets and these amounts are included in Other assets&#x2009;&#x2014;&#x2009;related party on the combined and consolidated balance sheets. Such prepaid advances were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,154&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; as of December 31, 2021 and 2020, respectively. During 2021, the Company wrote off $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;983&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of such prepaid advances considered to be unrecoverable.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Company was a party to an Amended and Restated Technology Services Agreement (the &#x201c;ARTSA&#x201d;), most recently amended on November 11, 2020, by and among 4C, the Company and other participant companies controlled by the Rothberg family. Under the ARTSA, the Company and the other participant companies agreed to share certain non-core technologies, which means any technologies, information or equipment owned or otherwise controlled by the participant company that are not specifically related to the core business area of the participant and subject to certain restrictions on use. The ARTSA also provided for 4C to perform certain services for the Company and each other&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;participant &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;company such as monthly administrative, management and technical consulting services to the Company which are pre-funded approximately once a quarter. The Company incurred expenses from 4C of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,055&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,160&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; during the years ended December 31, 2021 and 2020 respectively. The amounts advanced and due from 4C at December 31, 2021 and 2020, related to operating expenses was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,496&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively, and is included in Due from related parties on the combined and consolidated balance sheets. There was also $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,872&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of amounts due to 4C for expenses paid on their behalf. These payables are included in Due to related parties on the combined and consolidated balance sheets. On July 7, 2021, Legacy Hyperfine, Liminal and 4C entered into First Addendums to the ARTSA, pursuant to which Legacy Hyperfine and Liminal each terminated its participation under the ARTSA immediately prior to the Closing. Legacy Hyperfine and Liminal each entered into a Master Services Agreement (the &#x201c;Master Services Agreements&#x201d;) with 4C effective as of July 7, 2021 pursuant to which Legacy Hyperfine and Liminal may engage 4C to provide services such as general administration, facilities, information technology, financing, legal, human resources and other services, through future statements of work and under terms and conditions to be determined by the parties with respect to any services to be provided.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The ARTSA also provided for the participant companies to provide other services to each other. The Company also has transactions with other entities under common ownership, which include payments made to third parties on behalf of the Company. The amounts remaining payable at December 31, 2021 and 2020 are $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;110&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;124&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively, and are included in the Due to related parties on the combined and consolidated balance sheets. In addition, the Company has transactions with these other entities under common ownership which include payments made by the Company to third parties on behalf of the other entities and the amounts remaining receivable are in the aggregate $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; at December 31, 2021 and the amounts remaining payable are in the aggregate $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; at December 31, 2020, and are reflected in the Due from related parties on the combined and consolidated balance sheets. All amounts are paid or received throughout the year within 30 days after the end of each month.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Legacy Hyperfine and Liminal entered into Technology and Services Exchange Agreements (each, a &#x201c;TSEA&#x201d; and collectively, the &#x201c;TSEA&#x201d;) with other participant companies controlled by the Rothbergs. A TSEA by and among Butterfly Network, Inc., AI Therapeutics, Inc., Quantum-Si Incorporated, 4Bionics, Tesseract Health, Inc., Detect, Inc. (f/k/a Homodeus Inc.), Legacy Hyperfine and Liminal was signed in November 2020; a TSEA by and among Quantum-Si Incorporated, AI Therapeutics, Inc., 4Bionics, Tesseract Health, Inc., Detect, Inc., Legacy Hyperfine and Liminal was signed in February 2021 (and which Protein Evolution, Inc. joined in August 2021); and a TSEA by and among Legacy Hyperfine, Liminal, AI Therapeutics, Inc., Tesseract Health, Inc. and Detect, Inc. was signed in July 2021 and is effective upon the Closing. Under the TSEA, Legacy Hyperfine, Liminal and other participant companies may, in their discretion, permit the use of non-core technologies, which include any technologies, information or equipment owned or otherwise controlled by the participant company that are not specifically related to the core business area of the participant, such as software, hardware, electronics, fabrication and supplier information, vendor lists and contractor lists, by other participant companies. As of December 31, 2021, the Company had transactions with other participant companies and had expenses of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; included in Accounts payable.&lt;/span&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <hypr:RelatedPartyTransactionPaymentsForRent
      contextRef="C_130e4222-f593-4c10-abb6-2bba9719b0a2"
      decimals="-3"
      id="F_359147cf-2173-41a3-bbad-fea0d1ba5de1"
      unitRef="U_USD">149000</hypr:RelatedPartyTransactionPaymentsForRent>
    <hypr:RelatedPartyTransactionPaymentsForRent
      contextRef="C_a7be29aa-140e-44cb-a9f4-ff103f126abe"
      decimals="-3"
      id="F_d8ff6516-ef99-4fe4-abea-4393026e36ae"
      unitRef="U_USD">113000</hypr:RelatedPartyTransactionPaymentsForRent>
    <hypr:NumberOfSubsidiaries
      contextRef="C_f655045d-1b98-47a5-91ea-b2ff21c11594"
      decimals="INF"
      id="F_6106f4c6-7d6e-4fe4-856d-641ee18c825b"
      unitRef="U_Subsidiary">3</hypr:NumberOfSubsidiaries>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_a7d85790-8273-4800-91ae-17cbe035c271"
      decimals="-3"
      id="F_b0ccd3ec-9bf3-48e8-aeba-93b2a6b5bf90"
      unitRef="U_USD">101000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_c6b2444b-b0c0-4bbf-809e-048942ba73c6"
      decimals="-3"
      id="F_86d361da-4eb6-4c5a-9c41-79698392b412"
      unitRef="U_USD">64000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:DueFromEmployeesNoncurrent
      contextRef="C_224ae57f-8193-4d6a-adfd-42c3a9ce9f1a"
      decimals="-3"
      id="F_8ddf6286-0cef-4f51-8259-ecb543253a9c"
      unitRef="U_USD">90000</us-gaap:DueFromEmployeesNoncurrent>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="C_ecb93ba3-ee1e-4bc3-bfc2-c730d729e8b2"
      decimals="4"
      id="F_4bd7ee1d-97c9-4339-8f82-c8ce42d48f1d"
      unitRef="U_pure">0.0168</us-gaap:RelatedPartyTransactionRate>
    <hypr:DueFromEmployeesForgiveness
      contextRef="C_65a01c03-68fd-4859-bbe0-614b1a291979"
      decimals="-3"
      id="F_94964f42-70b2-47c7-a5ae-84395c53ebbb"
      unitRef="U_USD">90000</hypr:DueFromEmployeesForgiveness>
    <hypr:InterestReceivableRelatedPartiesCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_55fc1f9d-50ca-4437-af03-d957b05c9d79"
      unitRef="U_USD">0</hypr:InterestReceivableRelatedPartiesCurrent>
    <hypr:InterestReceivableRelatedPartiesCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_26f2c999-c486-406e-97ef-164c2c294c56"
      unitRef="U_USD">2000</hypr:InterestReceivableRelatedPartiesCurrent>
    <us-gaap:InterestIncomeRelatedParty
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_c4f522f4-6dec-4c96-b931-3aa68c847128"
      unitRef="U_USD">0</us-gaap:InterestIncomeRelatedParty>
    <us-gaap:InterestIncomeRelatedParty
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="-3"
      id="F_6528b819-232e-4e1d-aa0f-94771efebc48"
      unitRef="U_USD">2000</us-gaap:InterestIncomeRelatedParty>
    <hypr:OtherAssetsRelatedPartyNoncurrent
      contextRef="C_348458fb-d208-4443-8d7d-e3f7edf293b2"
      decimals="-3"
      id="F_0cbad092-20c8-4083-bac9-94991b95ca7b"
      unitRef="U_USD">0</hypr:OtherAssetsRelatedPartyNoncurrent>
    <hypr:OtherAssetsRelatedPartyNoncurrent
      contextRef="C_05b3c083-6683-4f86-ae50-8fd835965199"
      decimals="-3"
      id="F_83cbdbe5-571e-40d2-95d6-1967da8e7e07"
      unitRef="U_USD">1154000</hypr:OtherAssetsRelatedPartyNoncurrent>
    <hypr:PrepaidAdvancesUnrecoverable
      contextRef="C_130e4222-f593-4c10-abb6-2bba9719b0a2"
      decimals="-3"
      id="F_206bd6e8-36a1-4db8-951c-ed2626b886ac"
      unitRef="U_USD">983000</hypr:PrepaidAdvancesUnrecoverable>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="C_130e4222-f593-4c10-abb6-2bba9719b0a2"
      decimals="-3"
      id="F_907d6a8a-e25d-45c9-8a7f-7eb301975d5b"
      unitRef="U_USD">4055000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="C_a7be29aa-140e-44cb-a9f4-ff103f126abe"
      decimals="-3"
      id="F_705dab99-884b-4bd4-9747-28de4efbd043"
      unitRef="U_USD">2160000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="C_348458fb-d208-4443-8d7d-e3f7edf293b2"
      decimals="-3"
      id="F_d82a8c37-162a-44e8-851f-d103de74c7fa"
      unitRef="U_USD">0</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="C_05b3c083-6683-4f86-ae50-8fd835965199"
      decimals="-3"
      id="F_b630e60f-ad35-41d9-8a04-b18f078523e4"
      unitRef="U_USD">1496000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="C_348458fb-d208-4443-8d7d-e3f7edf293b2"
      decimals="-3"
      id="F_3a2a45b2-4781-4714-a299-0f55d58757db"
      unitRef="U_USD">1872000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="C_05b3c083-6683-4f86-ae50-8fd835965199"
      decimals="-3"
      id="F_aff33569-5567-4054-ad3a-66b478bf3bab"
      unitRef="U_USD">11000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="C_0b3254eb-3e95-4520-9848-13187dd9cc8a"
      decimals="-3"
      id="F_e98caa85-d553-4d41-8d2e-de6125af22c0"
      unitRef="U_USD">110000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="C_92873d62-f54e-4814-829f-fd7332644094"
      decimals="-3"
      id="F_bb5e3c7d-6d7d-4d8a-82f0-8fe888875285"
      unitRef="U_USD">124000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent
      contextRef="C_0b3254eb-3e95-4520-9848-13187dd9cc8a"
      decimals="-3"
      id="F_fe56b454-90c9-4d92-a412-61437c294b07"
      unitRef="U_USD">14000</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent
      contextRef="C_92873d62-f54e-4814-829f-fd7332644094"
      decimals="-3"
      id="F_f4afcf96-44bc-4fb3-8af0-de45a94b5bb3"
      unitRef="U_USD">30000</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="C_73aeac21-ef41-47a9-b437-94807e5860aa"
      decimals="-3"
      id="F_5707510e-2b2c-446d-a36d-c7fa4b5a9c04"
      unitRef="U_USD">11000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      id="F_21fcf19f-4028-4d04-a559-698036c127d8">&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;16. COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Commitments&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company sponsors a 401(k) defined contribution plan covering all eligible U.S. employees. Contributions to the 401(k) plan are discretionary. The Company did not make any matching contributions to the 401(k) plan for the years ended December 30, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;During 2020, the Company was awarded a $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,610&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; grant from the BMGF for the provision and equipping of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; sites with the Hyperfine portable point-of-care MRI system to enable the performance of a multi-site study focused on optimizing diagnostic image quality (the &#x201c;Project&#x201d;). During 2021, the Company was awarded an additional $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,300&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; grant from the BMGF, of which $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,500&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; was received for the provision and equipping of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; sites and other related deliverables, of which the remaining $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;800&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; is to be received by April 2022. The funds are accounted for as restricted cash with an offset to deferred grant revenue. At December 31, 2021 and 2020, the Company has $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,662&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,610&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;respectively, on the combined and consolidated balance sheets. Any grant funds, plus any income, that have not been used for, or committed to, the Project must be returned promptly to the BMGF upon expiration of or termination of the&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;agreement. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021 and 2020, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; grant fund amounts that were required to be returned under the provisions of the Project.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company does not have any outstanding or ongoing litigation and legal matters where, based on present information, including its assessment of the merits of the particular claims, the Company believes it is reasonably possible that any asserted or unasserted legal claims or proceedings, individually or in aggregate, will have a material adverse effect on its results of operations or financial condition. The ultimate outcome of any legal matter cannot be predicted with certainty.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has indemnification obligations under some agreements that the Company enters into with other parties in the ordinary course of business, including business partners, investors, contractors, and the Company&#x2019;s officers, directors and certain employees. The Company has agreed to indemnify and defend the indemnified party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claim because of the Company&#x2019;s activities or non-compliance with certain representations and warranties made by the Company. It is not possible to determine the maximum potential loss under these indemnification provisions due to the Company&#x2019;s limited history of prior indemnification claims and the unique facts and circumstances involved in any particular case. To date, losses recorded in the combined and consolidated statements of operations and comprehensive loss in connection with the indemnification provisions have not been material.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company agreed to pay $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; to a third party service provider upon the receipt by the Companies&#x2019; pre-closing equity holders of any Earn-Out Shares (see Note 3. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Business Combination&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;). The Company determined the probability of such payment to be not probable thus no liability was recognized.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <hypr:DeferredGrantFundingCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_e73c1298-e3d5-4fab-8839-c5ffc93853eb"
      unitRef="U_USD">1610000</hypr:DeferredGrantFundingCurrent>
    <hypr:NumberOfSites
      contextRef="C_2116b4fc-fe00-449d-a2b0-f9ea4734796c"
      decimals="INF"
      id="F_05236e8b-6248-40e6-9b82-947f8db427da"
      unitRef="U_Site">20</hypr:NumberOfSites>
    <hypr:GrantAwarded
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_0ae6dfd8-785e-4623-9d85-96ad6af43cdd"
      unitRef="U_USD">3300000</hypr:GrantAwarded>
    <hypr:GrantAwardedForProvisionAndEquipping
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_678b9b1c-c56b-4789-b5f1-addc604593a9"
      unitRef="U_USD">2500000</hypr:GrantAwardedForProvisionAndEquipping>
    <hypr:NumberOfSites
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="INF"
      id="F_31481bf8-af56-4313-bd42-19392fe15065"
      unitRef="U_Site">5</hypr:NumberOfSites>
    <hypr:GrantAwardedForOtherRelatedDeliverables
      contextRef="C_ed6f3ccf-47d7-4f6b-a138-e38661edb807"
      decimals="-3"
      id="F_80971253-6223-4a8d-ba37-3918fbcd5514"
      unitRef="U_USD">800000</hypr:GrantAwardedForOtherRelatedDeliverables>
    <hypr:DeferredGrantFundingCurrent
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="-3"
      id="F_1da8e916-0179-4f78-a6a2-569165f4ea50"
      unitRef="U_USD">2662000</hypr:DeferredGrantFundingCurrent>
    <hypr:DeferredGrantFundingCurrent
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="-3"
      id="F_11ddd692-333f-46f7-a9a8-cd966d5651ea"
      unitRef="U_USD">1610000</hypr:DeferredGrantFundingCurrent>
    <hypr:GrantFundRequiredToReturnUnderProvisions
      contextRef="C_12b01c47-dcb3-417b-b622-c5939ecfea7d"
      decimals="INF"
      id="F_abf79c46-1e0b-4995-98bc-941e36e80eba"
      unitRef="U_USD">0</hypr:GrantFundRequiredToReturnUnderProvisions>
    <hypr:GrantFundRequiredToReturnUnderProvisions
      contextRef="C_9d669f38-72cc-427b-8ddb-8ad088a985fd"
      decimals="INF"
      id="F_d77fbcee-6c3c-4ad4-804e-12e6f9ac6700"
      unitRef="U_USD">0</hypr:GrantFundRequiredToReturnUnderProvisions>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1"
      decimals="-3"
      id="F_2d36052f-c854-4499-b233-1879695eb8a5"
      unitRef="U_USD">1000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>82
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#?#[BG.U/]$-E-\QA_\ 4$L#!!0    ( ,* >50*_R'I\@8  )D<   8
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M_LPN XQ\S%(#>7]+J7@?I(?0\D^'V?]02P,$%     @ PH!Y5"] C<\K!0
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MY9IUQ<(V-]6!9?40>NI(N\?J.!^'TM#R/HX3_\T'J11[N#US^,)C1$(^M0J
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M[3$+XZ965&CRH=6<UVT!^^J#5Y-:\:#O[!$$+QFK^G'8"Q-E+9E>6JDWJ9
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M=V][*C1ON&:0?"7OIKE/>(7)3ZAB3H$78'[A<6MJ!^R@>TB?_P-02P,$%
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M>YT4D=85M/_5V-6&F4]YYAF QF<EO %W:(IKVWB;.0!GWM+;- 5>/NY@7=8
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M(E9@F;(C!BJ>PVZ'@.51L\S!<P":KZL*B(> $3_AZ5U3S!&4>SQ!MX)!P X
M"> O5S)?&.51.!6?B5A.XQ1:Q(>NC2O-$B?8X_'RVM.]@&X";,V47BD4Q@()
M BB:;M?BFP5 ;S]Z]\@5W(ZF<17(O8XN9(9\?E=7?#FPO.]VNQ)WO6KJ+4U$
M9V1TH4N/ (2K<DR3;0V;W]9P;CX3C*G6B&1-773 U F,]'=[*\[#T1"IBQ2E
M[0KO? JE%4I(_2U)\QD>M>D<WAXRUVO4&$GT.$ ^05FX7=L[RPU!LMWO0&J@
MA&'DP&D1(G73TAD:LW,%/X49\9XC2?&Y5ATP=?L%F08.YFMJ1P]\X^#5 C:5
MMR5=LZO")Z'CL1,K><V4T>"5QFW044<XSTQ$-&X:#U?Y(-2 D)"E,H\&(5'O
M$#<(ZQ#3:)L61A1X":NN1:&8O"B< $E[ ZHQ[#ZPTG31 8^IX%: G$GA=G2Y
M,,<6D->22,"-PR05C@R@"_0A(A(XB:V4=&$Y!*(I"EC$C\-\AKNX <L _\4+
M%5&0*W=?9)>(>;^#/HXKBUX0Y@%SYC/83[B//KD', / 4K0J7 &"MV56!+,I
M!2//I55X%U^<5]%1=PV@)KQ1YR),&WH'UZH;S^R9* D>"BW)8DA!N!C O&M(
MT,*7WJTKMP*LAAO%0[J&+A=T&Q]Y4VZ:AK2^:U-VK$'AF@;>H7]Z-S>.S2*I
M<'US@[@ ;]+Z0$>X?F#L)%J(J[DF[[:@0U9$BW#]3(2-_:-#4DWA"* #F>0\
MLQ(+T-J*M%B5+!GA)/CHV]16AE^<3DYWNQ15 B1L%74/[44BC[\%K2-"NS;%
M:3R@[$W'#! 8MX"84R)W6)..-<LJU;;HCI GAF\8H0$.OVU<V0<Y7&97F65)
M> LJ0.&$(1&+"PQ*=8!Q]D9X7_/5".<8Y5JSK'1PZP6R\@D&EA4LFBN07 UJ
M %%A(^$9.0WNI^@:(9^5,/S  8;0UAM:6F$HH(I&G24#S6=3JXJ?-[7PED-Q
M;DMO;T#Z650;E!92S4U(".V= 6$R%A$Y$M>%]4F)J!L@)53T$6M 2PA'NL#[
M:+./SG_.W@18)8*=CQ6T5^ WOEO^;OLR13"M/W7.4S<X-1(0L"8UPF@>? 45
MV*#)(KD"WV!Z.F\SL-WM=@E:@-KO]"HKZ[ ))'C9$OQGE,(FYP?>#1CDJFL@
M6:1Q.,U-G2 + L"U72*/@^V)F@7ZKA!A?#2L .+7IB&-,FKPP8 U2\"#;&4+
ML3MA:(>,%6VPUH]S7[QQ4.=@=F; PFD!N+[+-\G<*&YKRX.6J$JAMMJ*NE][
M,6F&F)+<#DQYRTU<I:/(OP3J%"O@&YB=$01L</829-N:GH#B=7ST[X'E'BZF
MK5%7)^N Q$23K8D@PJ%(R[PFKA% #%C,) A@J0L^N"'ZMP8 (N]E[)I$7IW)
MGM#$?0.#Z34_<IR9;H5%%"R J&S6)'P&>R5+9'*SD^.GAQ J&CQ>B:;<T^\^
MRE[.#U_^[HW 8 ^J5F;1239")E_QTE%V3I ['#S^_=%W%P*K[#P[/LG^G<&K
M_\Z.^/_QX<OLD7Q]<C9\=I&=Z3C\_UGZ[%5VBE^/SODZH_7D^^S1:?KP3:9C
MSHZ' ]_2LV/92'9ZDC[\21?*3KZ7/U(J!-HOW9]XWX QU1KNR7X!N>#1EHTJ
M&\RS$KWJZJ:N=]F[CY>9!]RJ; ,\K&")@R3?5^=VH)QMT.H$2^ FFF-J+#G?
M6P-HT*Y)AEPF&L&G$;JZV#B[RMX'!@37Z,AW] X$4I,X:EZ]"PXLQ_H #WW]
MQ>8=&>SO5T DZ9C7[Z/'Z6>[-OD^^VD/*P'79//^9W(HE0DO0*8:N:'G0P!+
M>0L+L$[D84P)6/I'9\#\,L%5$-01 !,:8P ?X,AYT*S&9YXQ:R2.M*S1_P>D
MM:J!S-$OLQ,]++5-6+O; D(@WP]^IU54I?$-5,;4[&3K%LW!'+6%6R&!RYOU
M&KU K%H"(P8;&2$$EF"R<_;A33#+$NSA>0F0*8(B#?.27C_AN5QD[\5\!C;\
MK^SQ$YQ:61QPDQI8X)\\]KQ#WW7IS(RDJ&PA<#MB3L!&JLF5KER5'RA\PT,'
M(CJX,UY65/6><BTHGRK!CJS_:U?$W7RKGOZK)Z;\.JCJ2$;L0N[I>=_LML:7
M<*>H>9+O.;B*]71^J#)M@2@3HX'EF>^V.S' EW77JK9+UHY:R.S)(.5SJR("
M,>JOFB^\=.JU!UT"+_=-;W'1>%TCOA14L"K6.H"H@$:WM"2=/OA  1=13P6\
M9UUTB6&%&?(WD(]TPQ:-18( 3.YO@4A?%YD&G,00BJ?L+?_^6?:QC_M#/X9N
MOH<!+1(QT__.M&CLX!,/[_@5Z_QD0P/9(WXB$=3+TJW5#AF=$W76PI3( [PM
M2XE+P%#ELE=7,;(P/3NS2#Z_S([*)ZD3I&H78@\]"Q X1^6"YD&!5=3=L@7[
M*R@D\<5?+&ISQ MQ.C+D.?30WW'B -&;*,3H@.T4SH/J*:8BA2,0/VE/#]AU
MB"A5-_N9N(NV=(EHL3'*=4RGX;VXP?\0MI /7,_D&>> Q-395MB5)==%:[X(
MUWQ&TP=X)/C2@8K4E'LU^58&,)S/38(#:=N4N41LXE76^><YV^M(.+;R_%R<
M8GVE?DG"?HC?\#;(>C@>.@L9C<&D00,)@:D&+H,0]#CQ]B:6!G'Y%/6'OG0U
M"%AFP+WZFFUQ.C-SNL1]XON.MH07D3>AQXO FHS69D*,#9-9DS!IUMCQ4_!C
MXLX ;#;[7-4W%<@_4'5(=^ SJT,:^$RC6E&=PFXFX-JSR.<W+>&"V."J507G
MV] X_$;)<:$F$OWQ.C$F47:+QY*]#V)9,F]574\8H\&-8:AOSYC46-@J![V!
M,$MTSR (1RSB"84]&L73YNY=]C=LP.Z#5U)XP@+8)B@'CMP.=.CD,PU5DRMH
M?.B<03QEBX44%O+XXV+K!KDV/E>VVL3I #60XN6J &1HN"JIR1@VXH"O&H>1
M"V]9[?@%1%6&H6W.$L%!J9@8B]C/L[>TF3?)9FB:X^\7''%MHUR\H' .!A=Q
MZ"*:91^C#3=BJM$M$OX0%**P'H\=H0.E1!=DGV]$3X.YG8'3MY$1B[. R8E<
M0!J& =S6@! [9Z--KRI)T,9V9K_]6N2C ]ZQ1PP$_POM,!SV+["Y9LJS 5G*
M/3K-F=TCI-._ 6_A;AU@K6(R[ ;(U(&QCX%!= <P:T&H2[2HT%CP@?<AB;:A
M@Q0-C)[!Y5/IUK?0D*]ILD%Q36>55>Z<51V/J,]C@ W.W.SGI34%ZAIL.4C
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M<;.QI-[4)6HJP?P&IH[2O;$):8F5F9KI_3BR!+WZ(./;9>@S@O2NJ,]0>R=
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M$Y3"/KJ]2M'7O!5G4>^=W?0!4P?^!!Q>'ZZ]LM_];)8UW!TR@/CJH^\^*HH
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M+[''P_PJW]04NJ81<SQ *+%:9/_;HC<&-/#)+G3]Q,,T8, S*O*R(+JN,?>
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MV@9?@.>KNF[U RY ;?!P>R_^/U!+ P04    " #"@'E4<2>0X=X,   ?+P
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M+O&#V_WR@:_%/X.9!/NR&.8L\Q(4 0D]:+AFBQ\0FB*@0>KN;>PU4#'=Q^>
M?8)O:'P'PYFP:Y40>&#=J:\1,T L8BQ)!-(@E'_]R\5X/'S)R5"U2-SCZ"5(
MJ\C1+52L*'6A#)1'#.ZBJ&<7 >SW/!6Y)=KVBDL:4])63FQN?T*0PYDXN537
M;B)'')$JL=GBP2FXJUAO(3O6,ZX%=O*D6@816J5E##)B96SDS2!7;*54LI%I
MRK!$@1Y-5L[SE5RDHL*+C6$](AFPCZ)0FE":-?![84&1AH%?_X[Q>RY33JMA
M!Y5Q=$V;5#&:O83->'Z"1)RG0)P6S&ZX3@P9)TE)[5;(FM\+>):@? >+\RD+
MQ@SB/.](62Z?!;,37^(UN(.7T'K#"&R12J2#A$S E!R*W+?A?*6%R$C=264&
M8.Z'$GO.?.QEQRWKVX\CV.3)@-T^:^^(5.K862Z%8YE9)/Y]SM2AZFV]["<L
MJZCX%I]'DQ<O?;CRVNRSZ:[6CKW5(%KDE57T+;H3+C3.H5.Q%%J3#='Z$Q]G
M-I C^0=)%&: 8@B*R1-2FY>PS#*!,&E)N1VSZ/+B$/$210"XAK4#.J:PEZ8!
ML_A"ME!ZC=,+A"K$35*E"^^$4E-A0OAA^((P<Y:7V0)<@I"&QSZ+ODKA,^ 2
MKIM!Z%Y$,&J("_B&@[/Q;-I112.AMY5I?B2%54J)F$:(@O.Q! FC8CH71(1U
MJ40\(N[E@8K<I9,_HTHN=ZB$5NS2P6\I^Y ##O*= %NIYYO1_[G3C&8OSCM.
M4TGH]W>9)U7Q9]3$/E_I%_VO%[DJ7);"2J1AH$8ANR>;=.BK*^S]."H/;"U%
M&;06S@7O02>HAU[*W/^.&LUVU(G-REQ\$3J6IL[_SU(O["3S-5V[/";$58N0
M5ZP<]]%%.(HBA7V@RCKIL/M;^9S37@^F_8H E7U2IA[GWR)V)FG*1D^'"BTK
M4RO!;R.S70&;A9IZEY%V)/=+;-857E!/I7^B&SU54_UV)+@3BO#] D$D\EXF
MOYL4RJ)?!C$*SI?./-O^^L@2: 78M'5@+'-I&]^LB.D':WO8;^Q+.W9T_0\^
M%<$P_QB><Z#46^CZ ?X KN=$]_S&J&T&KJ]U:7FK%]T_U1!QJ:6E?/^LX![U
M#5H )C56*6HXN6<J"JXV&D;#H?O7LI->ZP(=D$W^#=R$$KY!%- ]71V!? #(
MG</6E$-RZ</6@^\2$[ 7VF'P+Q7YBMU0#]T:C;%KFG%5PQ"[EIKJC5S2C*D]
MK&I#]Q)SZ[9HB#F6)VXE^+0A'/KP6&/L$8 T;.7F+J%8A@YJC_N*C:8#R- -
M=,#C>,BLYBZ4)/S!.#V09O#I;.C$!P7[GKD!"Y*("/.Q]"2",IJT$5ANN)^)
M^YJ [ H2AG.0SI]0WD+0'DV=1K0'Y]A7M,7<K)NA3%?K:W[O:A%VSU,8]V[1
M.,D,V'6C\2V]../8P6N[.R'AAI $)[9(A/[)IZ0\H1<(I=*U.""\]5X+I5<\
M#T,K]Z([QS)$LX'WI5RW"0 ]WL$"Z7W2/>G5"$'_S[624I1RPO-J<+$I[T>[
MY;J>'ZB4(I)%%/R0LVN NK0R#C/^]O1S*:E!<$(".W*),&N=1]WDB$>%ZHD6
M+<#*.>N0A7XGUL(&/[^S 9G[4CU<BY2F=()J:-F,MYN)%%]ZFQ3L6F6(Z[25
MFUK.R="<'WXN1>X]'PS4:FX(ZX9SGJ!>HI(;$8SLS*D5V:V,;4ETT+A4NZ+\
M&9F[(A_6C_PA;>H'V I)X5[95M$6U<'PD*9I!UK$)L+:FI?Z(>Y!?=@ZC)R-
MDS,$J#(9.RLQU33Z,(X7,#00UBHN>&45IH1:JKDDY:U[Z4X3$25^4+!%,N=W
M _81]@];7$7L=CVX'G@]+5U.UT\E6"](SJXEK-\JO:4M=AQ(N=;-/DWZ<.VU
M<[Z"W,.203PQ9>X59JS25%33XEA0\P0Y+$0N8'J2AY,=RINIH$R%!)E;ER:H
M'F;'I,JO3ZHM?U5_?<R-K^X>82'KH8$X:B8R_W^7QC?Z=>%*QR$Y3;N=,WBO
M@;JVHW-$NJ8'XS[&K=()\G]T8/0,XD^Z@ER+U%6*;=TYE37*<@%^B83S3"GQ
M&KQ;=@VJ,[WM:JP3.E <)CT1DHZJ?)GJM,B;&7I]:J55U@JT5YSDI#K'GWA?
M# C5]D@WHO [J)SI^%%PHYK8$Q:U3ZSF@=B>"#W 9CG*4PT;3!^:>(U.DVJ:
M1G=/E<D-1W@4NLIY=!H9:^G;4EZ!FT[BN&O#U"A--XG$H)U+.GM$X+>.-#H!
M<S,,I?W!$6IE;"R]25<?VCO=WMR^A0C#IR8&M ]J?)BE15WH>B9")<ZN KX^
M!N;$+5A9A>0V&D?GH^W2O&4%O44Z2NQF$E/7M"A/AU2>-MW_#A:[!T+S))%>
M:ND#JM)V_A\_RO_X><7N"J14ZOQ^O.KJR[]OQ+>W^^F8 V??*;T4DO)KZ^2K
MC;T/8(^F#E'&:+I3\D\DR!!]7)T2I+%QI2T<YE[%+HPN/<%A?+IKUMK/8J,>
M2MI6T23_5XT-=LT]NF?E59-%$X_I)'HQFT7#\U%5[^!+?7(W?A'-1J-H/)X\
M5?^&:35DW]A!YSR_7?U7WMQ*M ><[-4#WK-H,GT1#2]&AQ/5>\7@"9(..#>I
M2>IU\'TT82M47'FX&E4'WDHUP88?QZ#.\&++VVMJIM%P/'T.,0>.;\);F2.4
MD# )>26P$@X2^A_32AR[2;D\S'3WT7/<M6OBAN=-ZS^-1K.#]G:T>R=[3'^%
MHUJI-&BD5B8@;4>)7LFXN.":EZW+ TT8$548H;BW%7'(I>I,0;GD43CKY8DZ
M[%QMM92=$%6%I_!I_VPJ&&9C\>>CR3,L+& )/'7&OV?1=#J+9M/SYZ':CH=%
MN4C!4\?!Z2\)N]FB0KRMQ,Z13'_]]TB%" ,B*\+$ 7J91:/).!I/)@?G^%\>
M]P]TGMUQ?P2CGDZC\<5%V&_ ;IY:&'7K<&?XO$!3]T5F?MG%9'#!OJY(]WT!
M5(8>U=V)4ANQW9ZA,G$C3GRGPN11H4]WM?J+_9X[88]Z:C^$"I"4A^-ZE.N&
M> 2:"9ZW;HZ]YR;AGUDJC5=RF9)LW@M;W262^;)T$<*5\CN+8Q(R:K7)*)K,
M1JSJWYT[&G^WZBN47;-H,KF@OC@6(C%;W4%$",;GT8C*O0[(X]P0N8M;P%KP
M!U]CNW%0@@J*V&CLL!.:?#TY XUG,]]7^=5.&*W1'=WQJFF.SB=#MEU1GNV<
M/%]Y0[USANK+I]J1.3-"W[O#+!H-).ZZ6'.IJKK3%H!,!;4S??9?^[MI5[NN
MTMVQ_(!+A-T^$/5 P66"QMC/'GRP5TMT621>="NE=AFI4 A.#]4LD6=T33!(
MWT4,6A9PM4\];OE#O!:0VZU6-E"+GRO-,W9\='M[>W3"4L7=G<QE2:<3/1N,
MSMB@[R+M:>O2LKN:2E>SR:^PU-]?KM_6M[_G_M)S ^ZOCK_C>@5F62J66#H<
MS*9'?BA9/5A5N"O0"V61?=S/M>#0-P'@^U*!O_! &]1WXM_\%U!+ P04
M" #"@'E44R5L'5@(   W%@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6RE6-MRVS@2??=7H+39?=+H9CEV,HZK',>9S=9.XLIEYF%K'R"R)2%#$AP
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M&Q Y^7=-R+/C#7B_M#:T#ZR@^U9\]5]02P,$%     @ PH!Y5(#_M/J>!0
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MIN\P9LZ:HN<RR:ARGO,$%02] 6,P&$7.(R]H;HBI/3RA-DQGJR@:PZ^_C%C
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MC3>@\UIK][3P#H[_@/$O4$L#!!0    ( ,* >52FFYLV>0,  *P'   9
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MQT[@@*DQ7YK,V70"B.#2YKQZNE-\<W:[X@@SHDN( JL"'2?.K.27Q,'+ N1
MHL4?H%! <,77#.5@B<#%PBD3A,1U+37#S@_N# F>L/WHX"9R;40X2&O#8CN8
M996VSMEX-<5*5=@5:(6R8OOQ =XQGI?P.#*8P<ZO@@%785)C#)6V-@#7<L,N
M.U@2B1L@?%S>6F[@8X[%LNMJXU23M:YSBW%+":8P7\Y3FSU*JJJQSAI:K->F
M+?=8"4C+X+#3@JJ;7J>$=6^VZCL "P@V);@3W,#(6A0M1EL4[K%WSLL]9+R]
M2ZY="^>0;;+NQ8@@ GMK!^RBC:5Z1Z2N6&U=[[L9]=@Y!:<C2720#$J7+E:T
MFXKMWKH8. :QT:WPV"3LY4(DJ T?>_18D]VZD]/>1D4G:8A1LGH?4/V"$$\J
MX '2)?56$"NDLT<E1XQ:)X''HYLV< !#VJ3T:EO*;8/'?5;XM-,.\FR[YD"!
MICB]M\'*PJFXPUY=#/0 R@3=M>EN\):E'\S$-Q!@EWUN1'&7V+5&,>7,%1-$
MA HB**D%DA.52A;ZA*YKH,:\*($\&+KHZK56P/EF8^=.H07P7%]H5[Z7"U<1
M35O:N60)<#8R1]J;4B*DMZDO]66]/ZPSGI4D<!ZU!=NVP069E$5DRLC+Z?JA
MQ+)5]KM6(=5?'.[_.)6^HEMM =RNJ5J4KB!LR\K35-)H9)6:MQ.6*@FL-_A2
MYE+-;F#]P:IP(L(M(9OT3\^[&*.WV8!?!D<>W"MVN<'?T^Z@MQ"V]]YU7^NW
M"'J]\EPK+:T&J_VSK<@[4>^Q7^N5P 8KD\(62&6"\IYF[LL#UIP8="D5K]G^
MR4&MO[9[+.5+'C<[Y^\AN;F^ST9@WP/!"A]IHZ3Q*/.XN!$QW0*X)&-WX'C[
M>%7'3E!^:NQ*]D_O+7"G"-MO]DI.'FSO;\E]8(7;/_NS$FP/W6X2T!9"2B]!
M5M)+&PQL*E5N T&ZGHG-KTM(0F6?=.T^MJ@FV.Q@ CC3S$6ER!U=[P6[7#QW
MSJ[$C/9@+E2T@3B6Z%12:>)2MX/%>F?)3A*[SXO&_3[$N'+TK>L3,]<[\!OD
MKB@BVX4VGV'W-B-/F:D2/K1092)$:NN$V]M):I(9Q#C7ACUB(]?!I"V?N'^.
M]=VTBJ#*8*N8P3(KA*WW6!^7(0D'(N?DSLGB.T0];66,>V:%71IT@O26H"TT
M:GGB76<6P4[@N"&.ZVN?6"W=]>FZ1'2>:;'B+I9-?;A2Z?Q# LB?"79!(TC>
ML->/AX,5L.4+9,-59;E**=8<M];(#G UIY_K]Q0BO9E8?!:V?3-:K"N>5:(+
MHOJ)-D/7P]V"U_4E^4C1]L&MIPNM4XC-IPH1->-RFZ^V$7I=L!.DL8SY6<TD
MAR/4!;G5;*46G!+(/.O>7<]<=[F6H$M(*KSQ4FN/5L#YR74T/XY\4YY$U4T!
M=6M8?'.8LZ.S"]>)DA._<Z9V_PV*+L-+#!8./ZV)[$F+;^Y LCE %-D@H35Q
M1[82RUF7-O -U^9R36/G+JM*QB60VL1+X6Q<B.4:$2IL[*IHPDM+LLS\Y?NJ
M\)U%:>:^GEDW1^]3'V5T\:-O1QI?PY&&,^2WDXPO<I+A%O\S'V#<L/C'GEMX
M)/@:CRN\Z'^]4XK65A)R/F*]*!X-6X1)SE9:;%6,E/Z^ZC.-#17#MZ.,AS_*
MV%28/<P)!OSQP<XPZM+N3QQ=[!#C\QQ>W(#:/WMFL2.H[W7,L,GP=Z[A=K:?
MZCQ@ZZI]Y#' W7[_6;O_.[SS"_3_.X3:9V[_[D"KO\@Y0.?8_.2M^XU[[2]E
MLD]FJK][Z_XK:MM_%5UKFY4X)J3TOW:[M[ WY\FNG>MZ9W'/AG6GVND>+>ON
MH-ZY4]T-[W8VI;> U4?VHKNTICY=3[KFOJDC'0W'QYT[TI[.W[01O>EKEL/6
M%T.V?T'?15$AA.VG^WBH>=I\>G7BOCA:#7??;?W,%<!=(_"FF!KVAH,]UT2J
M;TRYL-\?34H#1[67<X'=I*(!>#\M@;O^AA@T'Z2]^#]02P,$%     @ PH!Y
M5,,)NA6& P  /0D  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&ULK599
M;]M&$/XK [9H6H#@)>N *PG0X<!&F\2UG11%T8<5.1()+W>9W944]==G=DG1
MM!,+;IH'B7O,?,<>'([W4MWK'-' IY(+/?%R8ZKS,-1ICB73@:Q0T,Q:JI(9
MZJI-J"N%+'-))0^3*!J$)2N$-QV[L6LU'<NMX87 :P5Z6Y9,'>;(Y7[BQ=YQ
MX*;8Y,8.A--QQ39XB^9]=:VH%[8H65&BT(44H' ]\6;Q^?S,QKN #P7N=:<-
MULE*RGO;N<HF7F0%(<?46 1&CQTND',+1#(^-IA>2VD3N^TC^FOGG;RLF,:%
MY'\6F<DGWLB##-=LR\V-W%]BXZ=O\5+)M?N'?1W;&WB0;K6199-,"LI"U$_V
MJ5F'3L(H>B8A:1(2I[LF<BJ7S+#I6,D]*!M-:+;AK+IL$E<(NRFW1M%L07EF
M>GOW;O';Y;O?EQ<WMZ_@XH_W5W=_P<_+B]=7BZN[7\:A(0X;&:8-WKS&2Y[!
MBQ-X(X7)-5R(#+/' "&):Q4F1X7SY"3B$M, >K$/293$)_!ZK>.>P^L]Y]C(
M]#Z7/$-%(C]N"W. M](@_#U;::/HF/QS@N6L93ES+&??;5U/XMF[>:XKEN+$
MH\NG4>W0FT(<!]!E^NF'41(/?_V"#Q:R+.D...\PTR#70.N*Y0I5N[8^,)'9
M5N2#R='F5$P<(&<9L*W)I2K^Q0P&4>1']<\EQ+V'OLX9B;/H"\ZTAAFD-;%V
MQ,S CQ %%!E#Q13L&-\B5*3!)?HV<9\7:0X,C#2,VX%^WT^&0S\:Q$=XQ^KW
MAP,_[@V/@WM4"/36T8:F"['QZ96A*W27GA^"_VDZ&3[R_*73^7=P&O?]R+H=
MC;I.HY<Z7!:[(D.1:;AL3C=A=CPUAT,_44J@0AI 80K#R:J1A)LB@4+6(FX%
M1W*98<HI(8/5X:O(*\E49FFS@C",5#J N]SJSAGAK1 %D75P6T!BS9C! #Y(
M0][ 50=MDR%_</.PZAWV5_J9TT:T75=2(.SL16^W 6Q9X)S>I\8X!M%LR@O0
M"8 R5X\I+'SPWT0_/3A/1">1 ]7?*'K^K:)?LKYT.$^PN*4V<H,$I5RP/69,
M@T:Z$;37D-IDU,'77K=AIZ25J#:N<-NCNQ6FKF[M:/MM,*M+XD-X_6'QAJE-
M(31P7%-J% S['JBZ6-<=(RM7(%?24+EUS9R^;U#9 )I?2[+2="Q!^\4T_0Q0
M2P,$%     @ PH!Y5+"),79@%   3$0  !D   !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL[5Q;<]M&EG[7K^C2SNQ853#%.ZG$=I4L.Q-/);;6DC.UM;4/
M3;!)]A@$&#0@F?OK]SNGNX$&"-+R9/(P4_,0AP3Z<OI<OW/Z4"\>L_RSV2A5
MB"_;)#4OSS=%L?ON\M+$&[65II?M5(HWJRS?R@)?\_6EV>5*+GG2-KD<]OO3
MRZW4Z?FK%_SL-G_U(BN+1*?J-A>FW&YEOG^MDNSQY?G@W#_XJ->;@AY<OGJQ
MDVMUIXI/N]L<WRZK599ZJU*CLU3D:O7R_'KPW>LQC><!OVCU:(+/@DZRR++/
M].7=\N5YGPA2B8H+6D'B?P_J1B4)+00R?G5KGE=;TL3PLU_]!SX[SK*01MUD
MR5_ULMB\/)^?BZ5:R3(I/F://RIWG@FM%V>)X7_%HQT[&YZ+N#1%MG630<%6
MI_;_\HOC0S!AWC\R8>@F#)ENNQ%3^486\M6+/'L4.8W&:O2!C\JS09Q.22AW
M18ZW&O.*5V__Z].[^_\6[][?O'U__^Z7M^+VI^OW+RX++$T#+F.WS&N[S/#(
M,H.A^#E+BXT1;].E6C87N 1-%6%#3]CKX<D5WZBX)T:#2 S[P\&)]4;504>\
MWNC8>MK$26;*7(D/*W&3;:'61K)F?%2)+-02#TUAQ-U&YHH$O12W<@_]P[/_
MN5Z8(H<&_>\)2L85)6.F9/Q;67YZF<&P)SJ7$C_N=RI?8;AXEX*)Q$#Q]M=2
M%WMZ@ /!#L1M(E-Q+8JLD(G(5F(PC?J#432;#H4A#AAZ&&?;+1@$+8P_"SR$
M&1J5/X U< ="&U-*+"A*R#P7Q48Q7V6Z_Y,YM>LS&OF?_S$?#OO?U[32*WXX
M^/ZB)^XQI/D.VPFYA EH4Z@<)"SVK2T7F<R71/92YS#Z+#=VG</GL*"]6.<R
M+>A$1:YCDK\[9HJQ.U(, ^Z(79G'&VB#YXK2V#07T@A=G<I.])/ F31+G_]:
MRD2O=+6N>VU)LE\L"88Y:\K%WT <;1FKO( [%3CFUC ]<98N-4^/_%2P1F?+
MP]?JB\IC#7IS\D?V_2[7#SI1:Y /N@U</<17; 3M<<#GGK@N!*Q/;1<XI[?
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MCC&5 C(9V1ZB!SZ%(ZZS@=<^TKZIJN9N-V25!$DW<EE-9CWQ,C@J];\+F38
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M[C#K,"Y:C&0/1IS !UVYPL)UE6.^"S D0EM6R8;51?(BXA5F TCC$)(HB5_
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MHI+@8YAH!6>?K^;ATY_AX.@R?,)M2 :F=:Q $YB/#3W9V=R&S)9L-?^=2"#
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M"_#YPAA7OZ$#FA]DO?H_4$L#!!0    ( ,* >52=D][W#@L  *\?   9
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MDCX_*$L+\'YID.KQAABTW^C?_!=02P,$%     @ PH!Y5) CC3%J!P  [!
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MK31+8[7#R",%8*.TM8JL69NE)?7'Y&&BJ&ZLWQ+%B0#8KXLJ>97@KK,M9C3
M+(%K()Z"SI_L152:4CF?0.K/I'@ K594[+;XD65HDHQM22,C8L8I\(7J)05U
M.,N<@<V2'V83==U*.OPREH5]#!L-0#8ZL &M?E+S\<E\IM9!NZ16P=<R^?+N
MW6\[ETWPCT:4B<W3E]8T#=OV*YA7T220:6-2)9-_WS84&&75^) TH]AXX]*!
M7QT4#,_=QUL5MS%1S6F2DRGB!NM8?%Q!;%JK&FIC#MB^BJDMMP@(*H&P$8EO
MDJG-7QQ&:?3:^9A,H4P-<55?6FU-VJI7;/7G?[Q9+&9O/P3_'XBCO,W?OA[B
M,W\!'Z1<ED9J:8'5X?AP]DVLQASQIC)%A5F+\3%FL9V  D&(R_\%RN,.2?[@
M,3=@M=4)BTOP$>QDH.+ $=L+Q)L16_A)O8%3(]Q9TI/GY59=-,%8SG21V;AJ
M71F%JKHH?.M2%Z $#!TP!8\4.E:YK$#!KU81NR9LHX4H!'S/* 1Z)-?21%VD
M 1WGS^BXCW %1XS2R<E"9O0<'+/[AF3OLMLQEYF7%;Y>2M?RW();VII2@%EJ
M*VR1+0'M>0'C77$XQ3$ZIXW29\;!"G$8.L'_(TD;+HF<$D8A??@+[ M2PK:3
MST%WQ $98\K IC9P-"AEW22[[9M56J:%Y"CZVIB@15M0+*X\!6QGNQ&>K=>!
MB"4+44<>_ %X*-:&_S@_R%#IFLL7<UKR/3"G@L2_%RUFTS,*QCZ6+L7)L_UA
M3[@\!A@RP8Y'<.B)"2$*>P-JM?;\B,8SZYPIQV]IC<:!R@$"B 3G,9:3A30Q
MCE81$* Z^<2%56,NE6W%K$%F.D:*D8'JHZVATVD7>Z,#&K^U&K6SVM1QGVI+
MM X8&F&+>P-'N>A9<;80I1A-EAY@QW/95>#2(YW6[=YR"MDX?P)^!1$'&#G8
MTCR:$H(#D_AHD/8:I04$2'1CL)EDQ!@#! Y+ND0O1U*T6C&O  .G R2@=I(6
M#J&9/>(.4@J.\T)0/TM1[F(61S;*E6!RBV8BC2'D:&*7B<Y8E[FQI:<+) ?E
M2,\V*&Y-Y$2U,RM3=(Q=VJZDL:-19'<[!G?T&\*.4:XW[/OL+@N:%(N+D1O;
M!Z"(/1*9M8P($EBV$:T>XY &_9@L=[#+'U'3Y/E1-DZ<7.2%*3>(@]5^_LM;
M1A79R,H2S2&3LYID%(9;_',T)$UIIQZ7K2QE'>R\[0!C54",VYXM/*\7<9RT
MP&1<"%#VD$F&%%N14FCTM^W('H/DP"_1D0H$3L3]G"H3RH.!-]2XT&U&\5L0
MR)7 "/RPY+P[ &D::T1 AY1 Q%U?=C7G++ ?LNKPZEJ7U$?<.9FH6VDOIMI3
M7_%>D94O[^\XR9NZK3$#*21F-&/RI$R1_HMZ ZTJ6^J5]GEJ%B<!AK@RS(DM
M(X =3P#>-S<H"]MIG?D"JRM T]'!A**M6=8*8>FCM[R%<E.##4.I@8*!*LA0
M^KRK+9CEY=A@?K1QP47J>F>_X?/,&@6H^#((Y1",#!]0G>MN=[NSU@MP[>]Q
MO?CLT_N)VHW>RBX\PQ$"KSK3JR,A=/ 1W9.M<ZUDD\NG#QPRFK3/!G"DJPQK
MS@%?,;B+>5^"L<K;DJ6A$ZL;'=S!^S:IAPKGD:A>12)U#X*HPXFZ[!O_2H#,
M.;Y^=J+N*5;VF]M2+XT<_^ BMC@G(3G9/_*.*!R56:+]+;,6#.H7=:<VOW;F
M+RHGW[H.30<W4&Q&:[EG1R4GJ7P9W8WNKO(7^0;[-#W_#G"GP]J@6I966#J;
M_'(\4B'?K?-+\HW<9Y<^X78LCQ6A 0-/P/>5!U;="SO8_<!Q_C=02P,$%
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MPR %ONE Y^A#Y#1P$ELHZ<)T",0D36&2NA_F$US%-9@A^"\>J(B"I7+WF;E
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MQT?_[+@SW,$T)=H.9*V0V*K,F@C4;8JTWBOB8@[$0%7,$@ L9<H;3X@?V00
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M#A^6LVLXV1 K;A$_MF5J<SE%Q.2J1*;+[@L&#!'4( @U\<B!P1=J?);@%:9
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M9RI'HV8BG:BES\0;&-P+&>?)8M-/I(SS@4D$*=&R?R[_$89!5==2F>3S[/L
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MYGL7>+'@&B-4 ,VG#"IL]JBILF>7G\'DF=&O4[0[+L &+M89%1_2&<]?F+>
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M@-]79=GH!YR KJ[!Y?W\?P%02P,$%     @ PH!Y5/OWLB&Y P  GPD  !D
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M*H^NG@/5QJK"C^"YLM1D?IG1"PJU8R#Z0BF[W3@#NS?9X!]02P,$%     @
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M*#ANF=/+A<H*T'TJI=EMK('V+9S\ 5!+ P04    " #"@'E4[!O+#F@"
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M+/6_5MS2#P=J9T#K:Z7L47$!3K\PHZ]02P,$%     @ PH!Y5+BL\*"#!0
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M4#@M+)ZQ=69@+ LE)2H<%Q9QW8*RW'SWWN[K_=_AJS2%_O@<_F,9<ZC=#P]
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M%(;_RE&N-FEK8E.@K0")TH\A08M*NVF:=N$F!V(UB5/;*:VT'S\G0,RD8;B
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MHRP7F/LS(?1Z4&Y0-^B]OU!+ P04    " #"@'E4@*-6-&X(  #^*P  &0
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MUA\7-($%I6Z WV>,R;<OZGW+[2N_]_\#4$L#!!0    ( ,* >531Z;Z:_@(
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MF6==3S:1;&$:AV<F51MBAI'J%('K /5\SIC<3/0&1>_9^P]02P,$%     @
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M0M_^($R WE]RKEXGYH)I_R?)7U!+ P04    " #"@'E4UMPH^@ #  #3!P
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MIH&I'PV!+NM ER[0Y9% <_QJ?B^--$BFD,0\A7-;,H05[-!W:48+ Y3@5]7
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MH;0.YGPEA-YN;(!N;J:_ 5!+ P04    " #"@'E4LUI<#P0#   W"   &0
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MU'$@V<[L]"&3ZMPPMXDZV8'K #6_84R^#?3A4?Y7&/P'4$L#!!0    ( ,*
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M\=LIEN_AG6'.]C"QD= "1R5G0<AZ$TF2/("W$2'H@;TH#.8)1@TJ4KXU%".
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MW-S28$.S0L"_OTU3]K13O!!S>&-J]C]02P,$%     @ PH!Y5*9PH$^( P
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M,+6WE$]RM>]#P>13(OU$;WA[U?_ZY>HB/+L9?@)GW^X&MS_ ?GAV/N@/;@_
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MP*RSL9=:N RSL6Z%N7S33G-ANKERMFRW3W23:2_,3:]^B=B8Y!RD>"1=G:-
MQH*9]M<,!)WHAO"!"ME>ZMM$?C)@I@SD\Q&50HJ!6J#\".G]!U!+ P04
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M*<)LD49_Z03JBZ##Y^!0GR=;GR>HSU\SX^TZK;F6'Y?GEY/FY#N^9S6R9'I
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MI/BX%'PFI&F@?S_/,O7R@[G ]E6K\_\!4$L#!!0    ( ,* >51%T9X1BP0
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M=H%Y/A-";R?V!47SW?L%4$L#!!0    ( ,* >530!QR)UP(  '4(   9
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MS3DIX=\J]#NT_OM0P32>KT+C;71H<5X(8=FNW;?WA#C@:/F.;^X?!GWG B^
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M33+P>A[$N& K8>[EYC/NZNE8OD@*[9ZPV<4&'D0K;62Z Y."E&?%F[WM?#@
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M,C)ZA;GB$58Y7X O'-C>V_6P&30NPKZ_KLC9*7-V:G/><_T*UPJ1#HI!,M:
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M"   &0   'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6S%5MM2VS 0_94=E^G
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MC#HD@CE;)N:37/\"I4-]BQ?*1.=_R;I<ZW5(N-1&IJ4P6I!R4?QG#V4@GB)
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MTXDS<E ,"2XSN6;[/Z$V--1\$<N$^47[>JSOH*@4DN4U6"G(":W^\7,]$2>
MX/H"(*P!X8^ P05 OP:8F?,J9<;6$DL\'7.V1UR/5FSZP<R-02LWA.IEW$BN
MWA*%D].[#XN'^Q7Z./NZVJ"W:*/2)"XS0"Q!:X@8C4A&L)EPU3.CDD2DP!)B
M=$<CE@/ZB)_1ZEDEE0 T!PH)D6C!\J+48[8O:".Q+"7C+^@]Q,!Q=@I<*R;4
M6X+$)!._CSVI#&E97E2+GU?BPPOB@Q#=,RI3@58TAOB<P%,ST4Q'>)B.>6AE
M7$+DHGYPA4(_#%H$+7X>[EOD])O5Z1N^_@6^59* R?-7LW:^.%?H$7@$5**_
M9ULAN=H<_UC"#YKP Q-^<"'\<?&DBLM5W+8ULG.$@>O[;]JF\M=Q9R:&C8EA
MIPG0!D!<(:H.1I7(29V+VRICVUS920>73-EA@3NR>KIN/%U;>0Y[B8, S*,4
M81JKP^N[.I6+7*=!Q"$F4K09LS,'[K#=F!W6=T.KL9O&V$W'8K'HZ:T^EV.D
M$EZ?*R;!VXS8F7J^&_AOV@Z512=P^ IX9F;4F!E9F;YPHC(O9GMZFG,?'OY"
M<:DRDJ'^*$09R8F\Y'%A#] +=3[9I-XV4F__A]3U;S@O_E@>LNGG9=N#]8*6
MI3F3'?C'Z\NW<BTA :[DF1,*Q_^J&]-L +4SU$5.Z XEG.7-^86B%--=ZS'6
M$2A\G>&5UPY<;]B53L')71U8N1YD"KQ5NQW7FM*U^DYDV*$^/*H/K5R?<596
MI03.5/6(:=2^#G:67CBZN+&[H,'0O>UP<[R9@[Z5['@UV^[&#A+_TC7RZ[C*
MAG=2">; =Z9 %NHH+:FLJJ"FMRG"9Z;T_*%_KHMS4V$>::K*_A[S':$"99 H
M2M^]45<>KXKEJB%98>K-+9.J>C6/J?K  *X'J/<)8_+0T &:3Y;I?U!+ P04
M    " #"@'E4Y6&AM%@$  !^%@  &0   'AL+W=O<FMS:&5E=',O<VAE970V
M,BYX;6RUF%MOHS@8AO^*A>9B1MHIV":G41*I23J:2NVT:CJ[*ZWVP@4GH &<
MM9VFE>;'KPT44R68-%-N$@[V^]G?BQ\?QCO&?XJ(4@F>TB03$R>2<O/%=440
MT92(,[:AF7JS8CPE4MWRM2LVG)(PKY0F+O*\OIN2.'.FX_S9+9^.V58F<49O
M.1#;-"7\>483MILXT'EY<!>O(ZD?N-/QAJSIDLH?FUNN[MQ*)8Q3FHF898#3
MU<0YAU]F/M(5\A)_QG0G:M= =^6!L9_ZYC*<.)YN$4UH(+4$47^/=$Z31"NI
M=OQ7BCI53%VQ?OVB_C7OO.K, Q%TSI*_XE!&$V?H@)"NR#:1=VSWC98=ZFF]
M@"4B_P6[LJSG@& K)$O+RJH%:9P5_^2I3$2M H(-%5!9(4^$6P3*6[D@DDS'
MG.T UZ65FK[(NYK75HV+,^W*4G+U-E;UY/3R^_SF^@+<G_]]L02?P5*Y'FX3
M"M@*W),G\%U]%S<;RHF,LS6X8D* .>'\67T..\)#0+(P+S?G-(SEZW<?%U22
M.!&?P <09^ ^8ENARHNQ*U7#=7@W*!LY*QJ)&AH)$;AFF8P$N,A"&KX6<%6/
MJVZCEV[/D%5Q08,S@.$? 'D(_E@NP,</GRRRN,HFSF7]!MEOSRI7*_40_ )?
M::CREH [*BCA093G:D$?U4#8J,]:6L+Y53@_#X<;PEF<$>"?*]V.2TE3\:\E
M5J^*U;-V3;L<%"X'M3B'S"R$!KF0IL+C%&$\'+N/!\+WJ_!]:_@97:MO2#)P
M\;2).54?U*'(=@WD8=^2B4'5E,'1)L]9EFF^!%MYBM'#*N2P<Z-'5:S1>QD]
MVC-ZT$.'?8:> 9)W4GIO9$2YL'00UI@'.T\G1"8:>J^$EDKUC,*FA!HF03N4
MCALZ+2**D\B6#8,LZ+\9D;_ +:>?D0>'MA"&5+#7O;T&3-!.%6UOIJ9)5D5-
M=-16J_L'K/:&?H/;!D[03J<CW;:+M) 2&F[!X2EN,R&UW0-;#,,K..K<;F3P
MA.QX.M'N4K5N]PABKW_8;F10AN#1"5Y*(JF-D,@P"Z'N<VH(A>QP.36G>'_^
M07T$&W)J$(7LB#IN"+6(M PA9&B&[ NO0T,HGPMMZH9>J-^]T09.R,Z5-TR%
MI=(K/N)>@[6&1\C.HR.MM8NTS(7(D O9EUI7L=K1Y43\C<T"-NC"7N=>8T,F
M;"?3&[PNE>I>^_[HL-?8, S;UUW'>=TBHH:Q;5&":SM#.^.,U[^Y9\"&8[C[
M[2$VG,+OMD'$^SO$1KL-R;!]';8_F(Y;:&!#+SSH/I\&5=A.F1,GQ5*U_VI=
MB;V&=24VK,+'LJIUF>$;(OG=$\DW1/+;B71"1OU].NF,>H<SZAL^^>_!IQ:1
M)CZYM2/!E/)U?O"I^LJVF2Q.!ZNGU>'J>7&D:(H7)[/7A*N&"I#0E:KJG0W4
MZ.7%86=Q(]DF/V!\8%*R-+^,*%%C4!=0[U>,R9<;': Z<I[^#U!+ P04
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M\10M-F*G:!JI@:<!D;'KK0KO=[EWTN#]=YK>((Q_1L0GY--\@MZ_^V"Q,K[
M2I!9P;UF*Q.WE0E;':T07%B9[Y:*1QPZR&)O>KD]WXK*@[4J%XR4"T8RLT'3
M@K&8:A:A&97Z!2TD317->^[?!Q!%]YHEZC^'HZ!T%&2.P@9'TV<@(\44HG$L
M5L:G+:>YC6YFPY#2?HA]WQ]X>XOGL/0<.CW/I$BX4D*^H$>A&72$WB !L8DU
MTAN&6+*-Q0MCMH(;AS5 _08X[1).VPGG/M5,,J61A"0<,1A@-O=N4_BFT_O)
ML3:=$E+G0DALQ?B>+F.&UI U%[1);K)SDIDJ,7E!=VJY(_;4=4N<W<MP\G0E
M$BNJ[JNHZA(-J'HEJMXK]<6VE$>(1GN:KJQE-.W5G&(2AG:__=)OW^EWLBM6
M218]O(4>YE;_DW[=?WB6%YM(IVV'B/UJ/_"=( WEL:\[EFHTW<.OHUKQR2:#
MKTM:N*)'3-Z&/.!-'*,E+ F,63"LI-;MBUQ,)[@B5NQF5MAJYR-7L!51XO#*
M>:U($+NIRQ2O%N>E:Y('UR\P.FJ%LJX"YY!G#O,;V]!X;=V(V_72Q>=M;Q,B
M#1V(*^+$;N9LZL'O TEHQ$P@>0C'TA'P(Q$(\*:NQ76.K;6M129H*JF*9[&;
M:,.Q:Y$K8L2]*]=3Q87838:S8ZY-XF6-:(I\VCBN?YY0BQ .[!DE%0\2-P]>
ML$E,"A.NS<LB@G&[H8Q)1:@$_Q ZM$MA%!![)LTL8,6*:T#ZO:8LG0RC;K8M
MAT38X'=2VF?$PL:IZ]!OM\\S59<BN-/0&:0B6^(FVQ_9= M3SO6LBT!%=AI0
M5D1.W"/O6[(KJ8_ N-<EYX&$EL)L"*/:)(A[DPCO@"OX2KG..155D\YUR8A4
M]$G<]/FX2Y9 [<#SZGCB,^G_AIP'P FICZ9-'551,'$/IP\<3OEPX/Z&1OFY
MRP0,P(I.@X.XK=&^=U:1,.E?^3!9\6G@YM,+CY.^Y3R)STK7(M1I8-2@8M3
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M3,PT!K%I<$P;8F*R,8AET[<.PCXP9[U.7JP7&YAV#&+M]'G[ PMW61:7#ZR
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ PH!Y5)E<G",0!@  G"<  !,
M             ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" #"@'E4HG>Q49 &  #3'   &               @($-"   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ PH!Y5 K_(>GR!@  F1P  !@
M             ("!TPX  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4
M Q0    ( ,* >52BUK,#Z@,  ( 0   8              " @?L5  !X;"]W
M;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #"@'E4+T"-SRL%  #F
M$P  &               @($;&@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL
M4$L! A0#%     @ PH!Y5 S?3&4%!P  O2   !@              ("!?!\
M 'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ,* >51 *L<7
M6@@  /<B   8              " @;<F  !X;"]W;W)K<VAE971S+W-H965T
M-BYX;6Q02P$"% ,4    " #"@'E42V<#S\T&  !4#P  &
M@(%'+P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ PH!Y
M5+ST34(S*0  1H8  !@              ("!2C8  'AL+W=O<FMS:&5E=',O
M<VAE970X+GAM;%!+ 0(4 Q0    ( ,* >51Q)Y#AW@P  !\O   8
M      " @;-?  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,* >516D84?T@(   \&   9              "
M@9Z"  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ PH!Y
M5*:;FS9Y P  K <  !D              ("!IX4  'AL+W=O<FMS:&5E=',O
M<VAE970Q-2YX;6Q02P$"% ,4    " #"@'E4KQ07<W4+  "<-@  &0
M        @(%7B0  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0
M   ( ,* >53#";H5A@,  #T)   9              " @0.5  !X;"]W;W)K
M<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ PH!Y5+"),79@%   3$0
M !D              ("!P)@  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q0
M2P$"% ,4    " #"@'E4@PZ:":<$  "("P  &0              @(%7K0
M>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( ,* >51'XI:L
MXPP  )PE   9              " @36R  !X;"]W;W)K<VAE971S+W-H965T
M,C N>&UL4$L! A0#%     @ PH!Y5)V3WO<."P  KQ\  !D
M ("!3[\  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #"
M@'E4D".-,6H'  #L$   &0              @(&4R@  >&PO=V]R:W-H965T
M<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( ,* >50EP;&2=BX  )VD   9
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M970R-RYX;6Q02P$"% ,4    " #"@'E4D38P4N@"  #R!0  &0
M    @($I#@$ >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    (
M ,* >502A*KIH ,  ,X(   9              " @4@1 0!X;"]W;W)K<VAE
M971S+W-H965T,CDN>&UL4$L! A0#%     @ PH!Y5+BL\*"#!0  ]0T  !D
M             ("!'Q4! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"
M% ,4    " #"@'E4W SE@[4#  !F"   &0              @('9&@$ >&PO
M=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( ,* >52Q3/H/804
M #D.   9              " @<4> 0!X;"]W;W)K<VAE971S+W-H965T,S(N
M>&UL4$L! A0#%     @ PH!Y5%V.==R(!   K!T  !D              ("!
M720! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #"@'E4
MBE%,^$\%  !I&   &0              @($<*0$ >&PO=V]R:W-H965T<R]S
M:&5E=#,T+GAM;%!+ 0(4 Q0    ( ,* >50MPI&Y;0,  *P/   9
M      " @:(N 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%
M  @ PH!Y5("C5C1N"   _BL  !D              ("!1C(! 'AL+W=O<FMS
M:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #"@'E4T>F^FOX"  "'"@
M&0              @('K.@$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+
M 0(4 Q0    ( ,* >528!%.OB0(  %L&   9              " @2 ^ 0!X
M;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ PH!Y5-;<*/H
M P  TP<  !D              ("!X$ ! 'AL+W=O<FMS:&5E=',O<VAE970S
M.2YX;6Q02P$"% ,4    " #"@'E4F+ $*)D"   @"   &0
M@($71 $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( ,*
M>52<?C;PU0(  *8(   9              " @>=& 0!X;"]W;W)K<VAE971S
M+W-H965T-#$N>&UL4$L! A0#%     @ PH!Y5(VMSI5) @  A 4  !D
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M=#0V+GAM;%!+ 0(4 Q0    ( ,* >53MNT&4_ (  ,8)   9
M  " @3!9 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @
MPH!Y5/_U0HAR"0  CC,  !D              ("!8UP! 'AL+W=O<FMS:&5E
M=',O<VAE970T."YX;6Q02P$"% ,4    " #"@'E4L 7^!V8&   ])0  &0
M            @($,9@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4
M Q0    ( ,* >52F<*!/B ,  ) ,   9              " @:EL 0!X;"]W
M;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ PH!Y5!!O_-,-"0
M=C4  !D              ("!:' ! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX
M;6Q02P$"% ,4    " #"@'E41=&>$8L$   ,$0  &0              @(&L
M>0$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( ,* >50#
M")6>00,  (@+   9              " @6Y^ 0!X;"]W;W)K<VAE971S+W-H
M965T-3,N>&UL4$L! A0#%     @ PH!Y5- ''(G7 @  =0@  !D
M     ("!YH$! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,* >50_3J!21 ,  .X)   9              "
M@7.2 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ PH!Y
M5!X93F'0!0  4Q<  !D              ("![I4! 'AL+W=O<FMS:&5E=',O
M<VAE970V,"YX;6Q02P$"% ,4    " #"@'E4&'NW ;4#  "^#   &0
M        @('UFP$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0
M   ( ,* >53E8:&T6 0  'X6   9              " @>&? 0!X;"]W;W)K
M<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ PH!Y5.)U1NKG!   *Q4
M !D              ("!<*0! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q0
M2P$"% ,4    " #"@'E4'*=.Q(,#  !E"@  &0              @(&.J0$
M>&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( ,* >51X19"N
M*0,  !03   -              "  4BM 0!X;"]S='EL97,N>&UL4$L! A0#
M%     @ PH!Y5)>*NQS     $P(   L              ( !G+ ! %]R96QS
M+RYR96QS4$L! A0#%     @ PH!Y5.,^>A8I!0  LBH   \
M ( !A;$! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,* >5322;QM$0(
M !<F   :              "  =NV 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( ,* >53 B&UTZ0$  'XE   3              "
M 22Y 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !( $@ KQ,  #Z[ 0
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>270</ContextCount>
  <ElementCount>376</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>111</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - COMBINED AND CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets</Role>
      <ShortName>COMBINED AND CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - COMBINED AND CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>COMBINED AND CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - COMBINED AND CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>COMBINED AND CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - COMBINED AND CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit</Role>
      <ShortName>COMBINED AND CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - COMBINED AND CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows</Role>
      <ShortName>COMBINED AND CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureORGANIZATIONANDDESCRIPTIONOFBUSINESS</Role>
      <ShortName>ORGANIZATION AND DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - BUSINESS COMBINATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombination1</Role>
      <ShortName>BUSINESS COMBINATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTS</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNET</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES</Role>
      <ShortName>ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLE</Role>
      <ShortName>NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - CONVERTIBLE PREFERRED STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStock1</Role>
      <ShortName>CONVERTIBLE PREFERRED STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficit</Role>
      <ShortName>STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - EQUITY INCENTIVE PLAN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlan1</Role>
      <ShortName>EQUITY INCENTIVE PLAN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - NET LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARE</Role>
      <ShortName>NET LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONS</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100230 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100240 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100250 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITION</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100260 - Disclosure - IINVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureIinventoriesTables</Role>
      <ShortName>IINVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100270 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNET</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100280 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables</Role>
      <ShortName>ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100290 - Disclosure - CONVERTIBLE PREFERRED STOCK (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockTables</Role>
      <ShortName>CONVERTIBLE PREFERRED STOCK (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStock1</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100300 - Disclosure - EQUITY INCENTIVE PLAN (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanTables</Role>
      <ShortName>EQUITY INCENTIVE PLAN (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlan1</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100310 - Disclosure - NET LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARETables</Role>
      <ShortName>NET LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARE</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100320 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINCOMETAXES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100330 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Significant customer, percentage of revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Significant customer, percentage of revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100340 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100350 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful lives of property and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful lives of property and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100360 - Disclosure - BUSINESS COMBINATION - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails</Role>
      <ShortName>BUSINESS COMBINATION - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100370 - Disclosure - REVENUE RECOGNITION - Summary of Disaggregated Revenues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails</Role>
      <ShortName>REVENUE RECOGNITION - Summary of Disaggregated Revenues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100380 - Disclosure - REVENUE RECOGNITION - Information about Receivables and Deferred Revenue from Contracts with Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails</Role>
      <ShortName>REVENUE RECOGNITION - Information about Receivables and Deferred Revenue from Contracts with Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100390 - Disclosure - REVENUE RECOGNITION - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2</Role>
      <ShortName>REVENUE RECOGNITION - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100400 - Disclosure - REVENUE RECOGNITION - Additional Information (Details1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1</Role>
      <ShortName>REVENUE RECOGNITION - Additional Information (Details1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100410 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100420 - Disclosure - INVENTORIES - Summary of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails</Role>
      <ShortName>INVENTORIES - Summary of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100430 - Disclosure - INVENTORIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIESAdditionalInformationDetails</Role>
      <ShortName>INVENTORIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100440 - Disclosure - PROPERTY AND EQUIPMENT, NET - Schedule of Property and equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET - Schedule of Property and equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100450 - Disclosure - PROPERTY AND EQUIPMENT, NET - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETAdditionalInformationDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100460 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES - Schedule of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES - Schedule of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100470 - Disclosure - NOTES PAYABLE - Additional Information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails</Role>
      <ShortName>NOTES PAYABLE - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100480 - Disclosure - CONVERTIBLE PREFERRED STOCK - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails</Role>
      <ShortName>CONVERTIBLE PREFERRED STOCK - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100490 - Disclosure - CONVERTIBLE PREFERRED STOCK - Summary of Authorized, Issued and Outstanding Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails</Role>
      <ShortName>CONVERTIBLE PREFERRED STOCK - Summary of Authorized, Issued and Outstanding Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100500 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (DEFICIT) - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficit</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100510 - Disclosure - EQUITY INCENTIVE PLAN - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails</Role>
      <ShortName>EQUITY INCENTIVE PLAN - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100520 - Disclosure - EQUITY INCENTIVE PLAN - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails</Role>
      <ShortName>EQUITY INCENTIVE PLAN - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100530 - Disclosure - EQUITY INCENTIVE PLAN - Assumptions Used to Value Option Grants to Employees and Nonemployees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails</Role>
      <ShortName>EQUITY INCENTIVE PLAN - Assumptions Used to Value Option Grants to Employees and Nonemployees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100540 - Disclosure - EQUITY INCENTIVE PLAN - Summary of Stock Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails</Role>
      <ShortName>EQUITY INCENTIVE PLAN - Summary of Stock Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100550 - Disclosure - EQUITY INCENTIVE PLAN - Key Assumptions Used in Valuation for Earn-Out Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails</Role>
      <ShortName>EQUITY INCENTIVE PLAN - Key Assumptions Used in Valuation for Earn-Out Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100560 - Disclosure - EQUITY INCENTIVE PLAN - Summary of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails</Role>
      <ShortName>EQUITY INCENTIVE PLAN - Summary of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100570 - Disclosure - NET LOSS PER SHARE - Schedule of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails</Role>
      <ShortName>NET LOSS PER SHARE - Schedule of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100580 - Disclosure - NET LOSS PER SHARE - Schedule of Anti-dilutive Common Equivalent Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails</Role>
      <ShortName>NET LOSS PER SHARE - Schedule of Anti-dilutive Common Equivalent Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100590 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets (Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Deferred Tax Assets (Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100600 - Disclosure - INCOME TAXES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>INCOME TAXES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100610 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Anticipated Income Tax Expense Benefit Computed by Statutory Federal Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Reconciliation of Anticipated Income Tax Expense Benefit Computed by Statutory Federal Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100620 - Disclosure - INCOME TAXES - Schedule of Tax Net Operating Loss Carryforward and Tax Credit Carryforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Tax Net Operating Loss Carryforward and Tax Credit Carryforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100630 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="hypr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100640 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>64</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="hypr-20211231.htm">hypr-20211231.htm</File>
    <File>hypr-20211231.xsd</File>
    <File>hypr-20211231_cal.xml</File>
    <File>hypr-20211231_def.xml</File>
    <File>hypr-20211231_lab.xml</File>
    <File>hypr-20211231_pre.xml</File>
    <File>hypr-ex21_1.htm</File>
    <File>hypr-ex31_1.htm</File>
    <File>hypr-ex31_2.htm</File>
    <File>hypr-ex32.htm</File>
    <File>hypr-ex4_2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img37592182_0.jpg</File>
    <File>img37592182_1.jpg</File>
    <File>img37592182_2.jpg</File>
    <File>img37592182_3.jpg</File>
    <File>img37592182_4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="718">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>88
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hypr-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 34,
   "contextCount": 270,
   "dts": {
    "calculationLink": {
     "local": [
      "hypr-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hypr-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "hypr-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hypr-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hypr-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hypr-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 632,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 8,
    "http://hyperfine.io/20211231": 1,
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 12
   },
   "keyCustom": 76,
   "keyStandard": 300,
   "memberCustom": 55,
   "memberStandard": 51,
   "nsprefix": "hypr",
   "nsuri": "http://hyperfine.io/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - REVENUE RECOGNITION",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTS",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - INVENTORIES",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - PROPERTY AND EQUIPMENT, NET",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNET",
     "shortName": "PROPERTY AND EQUIPMENT, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES",
     "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - NOTES PAYABLE",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLE",
     "shortName": "NOTES PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - CONVERTIBLE PREFERRED STOCK",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStock1",
     "shortName": "CONVERTIBLE PREFERRED STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficit",
     "shortName": "STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - EQUITY INCENTIVE PLAN",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlan1",
     "shortName": "EQUITY INCENTIVE PLAN",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - NET LOSS PER SHARE",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARE",
     "shortName": "NET LOSS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - COMBINED AND CONSOLIDATED BALANCE SHEETS",
     "role": "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
     "shortName": "COMBINED AND CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RestrictedCashCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - INCOME TAXES",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - IINVENTORIES (Tables)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureIinventoriesTables",
     "shortName": "IINVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETTables",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hypr:ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables",
     "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hypr:ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - CONVERTIBLE PREFERRED STOCK (Tables)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockTables",
     "shortName": "CONVERTIBLE PREFERRED STOCK (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - COMBINED AND CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical",
     "shortName": "COMBINED AND CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - EQUITY INCENTIVE PLAN (Tables)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanTables",
     "shortName": "EQUITY INCENTIVE PLAN (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - NET LOSS PER SHARE (Tables)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARETables",
     "shortName": "NET LOSS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_09eef7e3-8ef7-4872-9505-3cdfab129205",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Significant customer, percentage of revenue (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Significant customer, percentage of revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_09eef7e3-8ef7-4872-9505-3cdfab129205",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Segment",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "hypr:ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_7bcd7cb4-1dc9-4c68-a43e-62994fd1ac21",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful lives of property and equipment (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful lives of property and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "hypr:ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_7bcd7cb4-1dc9-4c68-a43e-62994fd1ac21",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1e1d998b-c680-42bd-bbd7-9bc2ff70463c",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - BUSINESS COMBINATION - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
     "shortName": "BUSINESS COMBINATION - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_3ad8f729-5552-455b-b2fb-acfa4b71867b",
      "decimals": "2",
      "lang": null,
      "name": "hypr:PercentageNumberOfSharesCeasesToBeneficiallyOwned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - REVENUE RECOGNITION - Summary of Disaggregated Revenues (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails",
     "shortName": "REVENUE RECOGNITION - Summary of Disaggregated Revenues (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_0e92975e-291a-4d95-b890-e43efecfb475",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - REVENUE RECOGNITION - Information about Receivables and Deferred Revenue from Contracts with Customers (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails",
     "shortName": "REVENUE RECOGNITION - Information about Receivables and Deferred Revenue from Contracts with Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hypr:RevenueRecognizeReceivablePaymentTermsRangeMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - REVENUE RECOGNITION - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2",
     "shortName": "REVENUE RECOGNITION - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hypr:RevenueRecognizeReceivablePaymentTermsRangeMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - COMBINED AND CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "role": "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "COMBINED AND CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_ef2546a8-4c0e-4b36-9c52-90a9b0abd33f",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "hypr:RevenueRemainingPerformanceObligationExpectedTimingPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - REVENUE RECOGNITION - Additional Information (Details1)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1",
     "shortName": "REVENUE RECOGNITION - Additional Information (Details1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_ef2546a8-4c0e-4b36-9c52-90a9b0abd33f",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "hypr:RevenueRemainingPerformanceObligationExpectedTimingPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - INVENTORIES - Summary of Inventories (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails",
     "shortName": "INVENTORIES - Summary of Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryWriteDown",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - INVENTORIES - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIESAdditionalInformationDetails",
     "shortName": "INVENTORIES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - PROPERTY AND EQUIPMENT, NET - Schedule of Property and equipment, net (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails",
     "shortName": "PROPERTY AND EQUIPMENT, NET - Schedule of Property and equipment, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - PROPERTY AND EQUIPMENT, NET - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETAdditionalInformationDetails",
     "shortName": "PROPERTY AND EQUIPMENT, NET - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "hypr:ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedBonusesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
     "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "hypr:ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedBonusesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_2116b4fc-fe00-449d-a2b0-f9ea4734796c",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromNotesPayable",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - NOTES PAYABLE - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails",
     "shortName": "NOTES PAYABLE - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_c45f29de-244b-43b1-84da-2f83aa0a16d5",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiquidationBasisOfAccountingLiquidationPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - CONVERTIBLE PREFERRED STOCK - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
     "shortName": "CONVERTIBLE PREFERRED STOCK - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiquidationBasisOfAccountingLiquidationPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - CONVERTIBLE PREFERRED STOCK - Summary of Authorized, Issued and Outstanding Convertible Preferred Stock (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
     "shortName": "CONVERTIBLE PREFERRED STOCK - Summary of Authorized, Issued and Outstanding Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_9d117686-8c7e-4c05-b93e-dbf2c33d47a5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_3c9581e7-07d4-4e55-bccf-5e8bd25bbbb7",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - COMBINED AND CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit",
     "shortName": "COMBINED AND CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_3c9581e7-07d4-4e55-bccf-5e8bd25bbbb7",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DividendsCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails",
     "shortName": "STOCKHOLDERS' EQUITY (DEFICIT) - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DividendsCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CompensationRelatedCostsPolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - EQUITY INCENTIVE PLAN - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
     "shortName": "EQUITY INCENTIVE PLAN - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "INF",
      "lang": null,
      "name": "hypr:ShareBasedPaymentArrangementPlanModificationIncrementalValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_8a9c17f1-6da6-4401-8abe-806f2a333b9e",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - EQUITY INCENTIVE PLAN - Summary of Stock Option Activity (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails",
     "shortName": "EQUITY INCENTIVE PLAN - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_eb4d058b-3288-420e-9ec3-612fad7d2de5",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_19b3a16d-0fb7-4f0f-9123-775d37384548",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - EQUITY INCENTIVE PLAN - Assumptions Used to Value Option Grants to Employees and Nonemployees (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
     "shortName": "EQUITY INCENTIVE PLAN - Assumptions Used to Value Option Grants to Employees and Nonemployees (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_19b3a16d-0fb7-4f0f-9123-775d37384548",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_eb4d058b-3288-420e-9ec3-612fad7d2de5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - EQUITY INCENTIVE PLAN - Summary of Stock Options Granted (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails",
     "shortName": "EQUITY INCENTIVE PLAN - Summary of Stock Options Granted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "hypr:ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_97ecd105-2e03-4bed-bb2d-15098fa42355",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_017a55aa-4d9f-4145-84bc-31cdf605a0fd",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - EQUITY INCENTIVE PLAN - Key Assumptions Used in Valuation for Earn-Out Shares (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails",
     "shortName": "EQUITY INCENTIVE PLAN - Key Assumptions Used in Valuation for Earn-Out Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_017a55aa-4d9f-4145-84bc-31cdf605a0fd",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - EQUITY INCENTIVE PLAN - Summary of Stock-Based Compensation Expense (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails",
     "shortName": "EQUITY INCENTIVE PLAN - Summary of Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_bbc35c1e-828e-43bf-b1bb-089209526261",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - NET LOSS PER SHARE - Schedule of Basic and Diluted Net Loss Per Share (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
     "shortName": "NET LOSS PER SHARE - Schedule of Basic and Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - NET LOSS PER SHARE - Schedule of Anti-dilutive Common Equivalent Shares (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails",
     "shortName": "NET LOSS PER SHARE - Schedule of Anti-dilutive Common Equivalent Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets (Liabilities) (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails",
     "shortName": "INCOME TAXES - Schedule of Deferred Tax Assets (Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - COMBINED AND CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows",
     "shortName": "COMBINED AND CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - INCOME TAXES - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "INCOME TAXES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Anticipated Income Tax Expense Benefit Computed by Statutory Federal Income Tax Rate (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails",
     "shortName": "INCOME TAXES - Schedule of Reconciliation of Anticipated Income Tax Expense Benefit Computed by Statutory Federal Income Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "3",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1f1550e6-aea9-41b1-944e-48553f861650",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TaxCreditCarryforwardAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - INCOME TAXES - Schedule of Tax Net Operating Loss Carryforward and Tax Credit Carryforward (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails",
     "shortName": "INCOME TAXES - Schedule of Tax Net Operating Loss Carryforward and Tax Credit Carryforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1f1550e6-aea9-41b1-944e-48553f861650",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TaxCreditCarryforwardAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - RELATED PARTY TRANSACTIONS - Additional Information (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails",
     "shortName": "RELATED PARTY TRANSACTIONS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_224ae57f-8193-4d6a-adfd-42c3a9ce9f1a",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DueFromEmployeesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_12b01c47-dcb3-417b-b622-c5939ecfea7d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "hypr:DeferredGrantFundingCurrent",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": "INF",
      "lang": null,
      "name": "hypr:NumberOfSites",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Site",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100060 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS",
     "role": "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureORGANIZATIONANDDESCRIPTIONOFBUSINESS",
     "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100070 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - BUSINESS COMBINATION",
     "role": "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombination1",
     "shortName": "BUSINESS COMBINATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hypr-20211231.htm",
      "contextRef": "C_1a3dd947-ea3d-424c-b4fe-c880aa8048b1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 111,
   "tag": {
    "country_AU": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA",
        "terseLabel": "Australia"
       }
      }
     },
     "localname": "AU",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm Id",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well Known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Icfr Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "hypr_AccruedBonusAndOtherCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "hypr_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued bonus and other costs current.",
        "label": "Accrued Bonus and Other Costs Current",
        "terseLabel": "SPAC bonus and other costs"
       }
      }
     },
     "localname": "AccruedBonusAndOtherCostsCurrent",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_AccruedContractedServicesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "hypr_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contracted services.",
        "label": "Accrued Contracted Services Current",
        "terseLabel": "Contracted services"
       }
      }
     },
     "localname": "AccruedContractedServicesCurrent",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_AccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses and other current liabilities.",
        "label": "Accrued Expenses And Other Current Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Total accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_AdjustmentsToAdditionalPaidInCapitalInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid in capital investments.",
        "label": "Adjustments To Additional Paid In Capital Investments",
        "terseLabel": "Investment from 4Bionics, LLC"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalInvestments",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_AllocationOfExpenseIncurredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of expense incurred.",
        "label": "Allocation Of Expense Incurred [Member]",
        "terseLabel": "Allocation of Expense Incurred"
       }
      }
     },
     "localname": "AllocationOfExpenseIncurredMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_AmendedAndRestatedTechnologyServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended and restated technology services agreement.",
        "label": "Amended And Restated Technology Services Agreement [Member]",
        "terseLabel": "ARTSA"
       }
      }
     },
     "localname": "AmendedAndRestatedTechnologyServicesAgreementMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_BusinessCombinationExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination, exchange ratio.",
        "label": "Business Combination Exchange Ratio",
        "terseLabel": "Exchange ratio"
       }
      }
     },
     "localname": "BusinessCombinationExchangeRatio",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hypr_BusinessCombinationPaymentOfTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination payment of transaction costs.",
        "label": "Business Combination Payment of Transaction Costs",
        "terseLabel": "Payment of transaction costs"
       }
      }
     },
     "localname": "BusinessCombinationPaymentOfTransactionCosts",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_BusinessCombinationTransactionThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination transaction threshold consecutive trading days.",
        "label": "Business Combination Transaction Threshold Consecutive Trading Days",
        "terseLabel": "Business combination transaction threshold consecutive trading days."
       }
      }
     },
     "localname": "BusinessCombinationTransactionThresholdConsecutiveTradingDays",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hypr_BusinessCombinationTransactionThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination transaction threshold trading days.",
        "label": "Business Combination Transaction Threshold Trading Days",
        "terseLabel": "Business combination transaction threshold trading days"
       }
      }
     },
     "localname": "BusinessCombinationTransactionThresholdTradingDays",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hypr_CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from exchange of research and development tax credits.",
        "label": "Cash Received From Exchange Of Research And Development Tax Credits",
        "terseLabel": "Cash received from exchange of research and development tax credits"
       }
      }
     },
     "localname": "CashReceivedFromExchangeOfResearchAndDevelopmentTaxCredits",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_CatalyzerCorporation4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Catalyzer corporation 4.",
        "label": "Catalyzer Corporation4 [Member]",
        "terseLabel": "4C"
       }
      }
     },
     "localname": "CatalyzerCorporation4Member",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_ClassAOrdinarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class A ordinary shares.",
        "label": "Class A Ordinary Shares [Member]",
        "terseLabel": "Class A Ordinary Shares"
       }
      }
     },
     "localname": "ClassAOrdinarySharesMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_ClassBOrdinarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class B ordinary shares.",
        "label": "Class B Ordinary Shares [Member]",
        "terseLabel": "Class B Ordinary Shares"
       }
      }
     },
     "localname": "ClassBOrdinarySharesMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_CommonStockNumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock number of votes per share.",
        "label": "Common Stock Number Of Votes Per Share",
        "terseLabel": "Common shares, votes per share"
       }
      }
     },
     "localname": "CommonStockNumberOfVotesPerShare",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hypr_CommonStockRemainsAvailableForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock remains available for issuance.",
        "label": "Common Stock Remains Available For Issuance",
        "terseLabel": "Common stock remain available for issuance"
       }
      }
     },
     "localname": "CommonStockRemainsAvailableForIssuance",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hypr_CommonStockSubjectToRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock subject to redemption.",
        "label": "Common Stock Subject To Redemption",
        "terseLabel": "Common stock subject to redemption"
       }
      }
     },
     "localname": "CommonStockSubjectToRedemption",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hypr_ConnecticutOthersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Connecticut others.",
        "label": "Connecticut Others [Member]",
        "terseLabel": "Connecticut Others"
       }
      }
     },
     "localname": "ConnecticutOthersMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_ConnecticutResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Connecticut research and development.",
        "label": "Connecticut Research and Development [Member]",
        "terseLabel": "Connecticut Research and Development"
       }
      }
     },
     "localname": "ConnecticutResearchAndDevelopmentMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_ConversionOfLiminalCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of Liminal Common stock",
        "label": "Conversion of Liminal Common stock"
       }
      }
     },
     "localname": "ConversionOfLiminalCommonStock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_Covid19OutbreakPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for Covid 19 outbreak.",
        "label": "Covid 19 Outbreak [Policy Text Block]",
        "terseLabel": "COVID-19 Outbreak"
       }
      }
     },
     "localname": "Covid19OutbreakPolicyTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_CustomerAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer A.",
        "label": "Customer A [Member]",
        "terseLabel": "Customer A"
       }
      }
     },
     "localname": "CustomerAMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_CustomerBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer B.",
        "label": "Customer B [Member]",
        "terseLabel": "Customer B"
       }
      }
     },
     "localname": "CustomerBMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_CustomerCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer C.",
        "label": "Customer C [Member]",
        "terseLabel": "Customer C"
       }
      }
     },
     "localname": "CustomerCMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_CustomerDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer D.",
        "label": "Customer D [Member]",
        "terseLabel": "Customer D"
       }
      }
     },
     "localname": "CustomerDMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_CustomerEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer E.",
        "label": "Customer E [Member]",
        "terseLabel": "Customer E"
       }
      }
     },
     "localname": "CustomerEMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_CustomerFMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer F.",
        "label": "Customer F [Member]",
        "terseLabel": "Customer F"
       }
      }
     },
     "localname": "CustomerFMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_CustomerGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer G.",
        "label": "Customer G [Member]",
        "terseLabel": "Customer G"
       }
      }
     },
     "localname": "CustomerGMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_CustomerHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer H.",
        "label": "Customer H [Member]",
        "terseLabel": "Customer H"
       }
      }
     },
     "localname": "CustomerHMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_DeferredGrantFundingCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the carrying amount of deferred grant funding as of balance sheet date, classified as current.",
        "label": "Deferred Grant Funding Current",
        "terseLabel": "Deferred grant funding"
       }
      }
     },
     "localname": "DeferredGrantFundingCurrent",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_DeferredRevenuePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the Deferred revenue policy.",
        "label": "Deferred Revenue Policy [Policy Text Block]",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenuePolicyPolicyTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_DeferredTaxAssetsValuationAllowanceIncreased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets valuation allowance increased.",
        "label": "Deferred Tax Assets Valuation Allowance Increased",
        "terseLabel": "Deferred tax assets valuation allowance increased"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceIncreased",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_DueFromEmployeesForgiveness": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from employees forgiveness.",
        "label": "Due From Employees Forgiveness",
        "terseLabel": "Promissory Note with one of the employees will be forgiven"
       }
      }
     },
     "localname": "DueFromEmployeesForgiveness",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_EarnOutSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn-Out Shares.",
        "label": "Earn Out Shares [Member]",
        "terseLabel": "Earn-Out Shares"
       }
      }
     },
     "localname": "EarnOutSharesMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_EarnOutSharesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn-Out shares.",
        "label": "Earn Out Shares Policy [Text Block]",
        "terseLabel": "Earn-Out Shares"
       }
      }
     },
     "localname": "EarnOutSharesPolicyTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EffectiveIncomeTaxRateReconciliationWriteDownOfFederalNolDueTo382Limitation",
        "label": "Write down of federal NOL due to 382 limitation"
       }
      }
     },
     "localname": "Effectiveincometaxratereconciliationwritedownoffederalnoldueto382Limitation",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hypr_Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EffectiveIncomeTaxRateReconciliationWriteDownOfFederalResearchAndDevelopmentCreditsDueTo382Limitation",
        "label": "Write down of federal R&amp;D credits due to 382 limitation"
       }
      }
     },
     "localname": "Effectiveincometaxratereconciliationwritedownoffederalresearchanddevelopmentcreditsdueto382Limitation",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hypr_ExchangeProgramRecognizedNetBenefits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange program recognized net benefits.",
        "label": "Exchange program Recognized Net Benefits",
        "terseLabel": "Exchange program recognized net benefits"
       }
      }
     },
     "localname": "ExchangeProgramRecognizedNetBenefits",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_ExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange ratio.",
        "label": "Exchange Ratio",
        "terseLabel": "Exchange ratio"
       }
      }
     },
     "localname": "ExchangeRatio",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hypr_FederalAndStateNetOperatingLossesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal and state net operating losses.",
        "label": "Federal and state net operating losses [Member]",
        "terseLabel": "Federal And State Net Operating Losses"
       }
      }
     },
     "localname": "FederalAndStateNetOperatingLossesMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_FederalNetOperatingLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Net Operating Loss.",
        "label": "Federal Net Operating Loss [Member]",
        "terseLabel": "Federal Net Operating Loss"
       }
      }
     },
     "localname": "FederalNetOperatingLossMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_FederalOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal other.",
        "label": "Federal Other [Member]",
        "terseLabel": "Federal Other"
       }
      }
     },
     "localname": "FederalOtherMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_FourBionicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four bionics.",
        "label": "Four Bionics [Member]",
        "terseLabel": "4Bionics"
       }
      }
     },
     "localname": "FourBionicsMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_FourBionicsTwoThousandNineteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Bionics 2019 Equity Incentive Plan.",
        "label": "Four Bionics Two Thousand Nineteen Equity Incentive Plan [Member]",
        "terseLabel": "4Bionics Plan"
       }
      }
     },
     "localname": "FourBionicsTwoThousandNineteenEquityIncentivePlanMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_GrantAwarded": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of grant awarded.",
        "label": "Grant Awarded",
        "terseLabel": "Grant awarded from the BMGF"
       }
      }
     },
     "localname": "GrantAwarded",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_GrantAwardedForOtherRelatedDeliverables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant awarded for other related deliverables.",
        "label": "Grant Awarded For Other Related Deliverables",
        "terseLabel": "Grant awarded for other related deliverables"
       }
      }
     },
     "localname": "GrantAwardedForOtherRelatedDeliverables",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_GrantAwardedForProvisionAndEquipping": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of grant awarded for provision and equipping.",
        "label": "Grant Awarded For Provision And Equipping",
        "terseLabel": "Grant awarded for provision and equipping"
       }
      }
     },
     "localname": "GrantAwardedForProvisionAndEquipping",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_GrantFundRequiredToReturnUnderProvisions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Fund Required To Return Under Provisions",
        "label": "Grant Fund Required To Return Under Provisions",
        "terseLabel": "Grant fund amounts required to be returned under provisions"
       }
      }
     },
     "localname": "GrantFundRequiredToReturnUnderProvisions",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_GrantFundingPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for grant funding.",
        "label": "Grant Funding Policy [Text Block]",
        "terseLabel": "Grant Funding"
       }
      }
     },
     "localname": "GrantFundingPolicyTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_HealthCorCatalioAcquisitionCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HealthCor catalio acquisition corp.",
        "label": "Health Cor Catalio Acquisition Corp [Member]",
        "terseLabel": "HealthCor"
       }
      }
     },
     "localname": "HealthCorCatalioAcquisitionCorpMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_HealthCorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HealthCor.",
        "label": "Health Cor [Member]",
        "terseLabel": "HealthCor"
       }
      }
     },
     "localname": "HealthCorMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_HyperfineConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hyperfine convertible preferred stock.",
        "label": "Hyperfine Convertible Preferred Stock [Member]",
        "terseLabel": "Hyperfine Convertible Preferred Stock"
       }
      }
     },
     "localname": "HyperfineConvertiblePreferredStockMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_HyperfineEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Hyperfine equity incentive plan.",
        "label": "Hyperfine Equity Incentive Plan [Member]",
        "terseLabel": "Hyperfine Equity Incentive Plan",
        "verboseLabel": "Hyperfine Plan"
       }
      }
     },
     "localname": "HyperfineEquityIncentivePlanMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_HyperfineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hyperfine.",
        "label": "Hyperfine [Member]",
        "terseLabel": "Hyperfine"
       }
      }
     },
     "localname": "HyperfineMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_HyperfinePayrollProtectionProgramLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hyperfine payroll protection program loan.",
        "label": "Hyperfine Payroll Protection Program Loan [Member]",
        "terseLabel": "Hyperfine PPP loan"
       }
      }
     },
     "localname": "HyperfinePayrollProtectionProgramLoanMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_ImmediatelyPriorToEffectiveTimeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immediately prior to effective time.",
        "label": "Immediately Prior To Effective Time [Member]",
        "terseLabel": "Immediately Prior To Effective Time"
       }
      }
     },
     "localname": "ImmediatelyPriorToEffectiveTimeMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_IncentiveUnitActivityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incentive unit activity.",
        "label": "Incentive Unit Activity [Member]",
        "terseLabel": "Incentive Unit Grants"
       }
      }
     },
     "localname": "IncentiveUnitActivityMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incentive unit awards and replacement preferred stock awards.",
        "label": "Incentive Unit Awards And Replacement Preferred Stock Awards [Member]",
        "terseLabel": "Incentive Unit Awards and Replacement Preferred Stock Awards"
       }
      }
     },
     "localname": "IncentiveUnitAwardsAndReplacementPreferredStockAwardsMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_IncomeTaxEffectsRecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax effects recognized.",
        "label": "Income tax Effects Recognized",
        "terseLabel": "Income tax effects recognized"
       }
      }
     },
     "localname": "IncomeTaxEffectsRecognized",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_InterestAndPaymentsToRedeemingCompanyShareholders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest and payments to redeeming company shareholders.",
        "label": "Interest And Payments To Redeeming Company Shareholders",
        "terseLabel": "Interest and payments to redeeming company shareholders"
       }
      }
     },
     "localname": "InterestAndPaymentsToRedeemingCompanyShareholders",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_InterestReceivableRelatedPartiesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest receivable related parties current.",
        "label": "Interest Receivable Related Parties Current",
        "terseLabel": "Interest receivable from the Note"
       }
      }
     },
     "localname": "InterestReceivableRelatedPartiesCurrent",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory Equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_LeasedDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for leased devices.",
        "label": "Leased Devices [Member]",
        "terseLabel": "Leased Devices"
       }
      }
     },
     "localname": "LeasedDevicesMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_LegacyHyperfineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legacy hyperfine.",
        "label": "Legacy Hyperfine [Member]",
        "terseLabel": "Legacy Hyperfine"
       }
      }
     },
     "localname": "LegacyHyperfineMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_LiminalConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liminal convertible preferred stock .",
        "label": "Liminal Convertible Preferred Stock [Member]",
        "terseLabel": "Liminal Convertible Preferred Stock"
       }
      }
     },
     "localname": "LiminalConvertiblePreferredStockMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_LiminalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liminal.",
        "label": "Liminal [Member]",
        "terseLabel": "Legacy Hyperfine",
        "verboseLabel": "Liminal"
       }
      }
     },
     "localname": "LiminalMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_LiminalPayrollProtectionProgramLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liminal payroll protection program loan.",
        "label": "Liminal Payroll Protection Program Loan [Member]",
        "terseLabel": "Liminal PPP loan"
       }
      }
     },
     "localname": "LiminalPayrollProtectionProgramLoanMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of annual limitation of net operating loss and tax credit carryforwards due to ownership change, Under Internal Revenue Code Section 382.",
        "label": "Net Operating Loss And Tax Credit Carry forwards Annual Limitation",
        "terseLabel": "Amount of annual limitation of net operating loss and tax credit carryforwards due to ownership change"
       }
      }
     },
     "localname": "NetOperatingLossAndTaxCreditCarryForwardsAnnualLimitation",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of estimated net operating loss and tax credit carryforwards will expire before utilization due to ownership change, under Internal Revenue Code Section 382.",
        "label": "Net Operating Loss And Tax Credit Carry forwards Will Expire Estimation",
        "terseLabel": "Amount of estimated net operating loss and tax credit carryforwards will expire before utilization due to ownership change"
       }
      }
     },
     "localname": "NetOperatingLossAndTaxCreditCarryForwardsWillExpireEstimation",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_NumberOfConsecutiveOwnershipChanges": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of consecutive ownership changes.",
        "label": "Number of consecutive ownership changes"
       }
      }
     },
     "localname": "NumberOfConsecutiveOwnershipChanges",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hypr_NumberOfSeparateOptionAwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of separate option awards.",
        "label": "Number Of Separate Option Awards",
        "terseLabel": "Number of separate option awards"
       }
      }
     },
     "localname": "NumberOfSeparateOptionAwards",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hypr_NumberOfSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of sites for equipping Hyperfine portable point-of-care MRI system.",
        "label": "Number Of Sites",
        "terseLabel": "Number of sites for provision and equipping",
        "verboseLabel": "Number of sites for equipping Hyperfine portable point-of-care MRI system"
       }
      }
     },
     "localname": "NumberOfSites",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hypr_NumberOfSubsidiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of subsidiaries.",
        "label": "Number Of Subsidiaries",
        "terseLabel": "Number of subsidiaries"
       }
      }
     },
     "localname": "NumberOfSubsidiaries",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hypr_NumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of votes per share.",
        "label": "Number Of Votes Per Share",
        "terseLabel": "Number of votes per share"
       }
      }
     },
     "localname": "NumberOfVotesPerShare",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hypr_NumberOfVotesPerShareEntitledToClassOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of votes per share entitled to class of common stock.",
        "label": "Number Of Votes Per Share Entitled To Class Of Common Stock",
        "terseLabel": "Number of votes per share entitled to class of common stock"
       }
      }
     },
     "localname": "NumberOfVotesPerShareEntitledToClassOfCommonStock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hypr_OperatingLossCarryforwardsBeginToExpireYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carryforwards begin to expire year.",
        "label": "Operating Loss Carryforwards Begin to Expire Year",
        "terseLabel": "Begin to Expire in"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsBeginToExpireYear",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "hypr_OtherAssetsRelatedPartyNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other assets related party noncurrent.",
        "label": "Other Assets Related Party Noncurrent",
        "terseLabel": "Prepaid advances",
        "verboseLabel": "Other assets - related party"
       }
      }
     },
     "localname": "OtherAssetsRelatedPartyNoncurrent",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_OutstandingLegacyHyperfineConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding legacy hyperfine convertible preferred stock.",
        "label": "Outstanding Legacy Hyperfine Convertible Preferred Stock [Member]",
        "terseLabel": "Outstanding Legacy Hyperfine Convertible Preferred Stock (Series A through D)"
       }
      }
     },
     "localname": "OutstandingLegacyHyperfineConvertiblePreferredStockMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_OwnershipChangeDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership Change description",
        "label": "Ownership Change description",
        "terseLabel": "Ownership change, description"
       }
      }
     },
     "localname": "OwnershipChangeDescription",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hypr_OwnershipChangePercentageTestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership Change percentage testing period",
        "label": "Ownership Change percentage testing period",
        "terseLabel": "Ownership change percentage testing period"
       }
      }
     },
     "localname": "OwnershipChangePercentageTestingPeriod",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hypr_OwnershipChangesAnalysisExpectedToBeCompletedYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership changes analysis expected to be completed year.",
        "label": "Ownership changes analysis expected to be completed year"
       }
      }
     },
     "localname": "OwnershipChangesAnalysisExpectedToBeCompletedYear",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "hypr_OwnershipChangesDateOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership changes Date one",
        "label": "Ownership changes Date one",
        "terseLabel": "Ownership changes date, one"
       }
      }
     },
     "localname": "OwnershipChangesDateOne",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "hypr_OwnershipChangesDateTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership changes Date two",
        "label": "Ownership changes Date two",
        "terseLabel": "Ownership changes date, two"
       }
      }
     },
     "localname": "OwnershipChangesDateTwo",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "hypr_PIPEInvestorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PIPE investors.",
        "label": "P I P E Investors [Member]",
        "terseLabel": "PIPE Investors"
       }
      }
     },
     "localname": "PIPEInvestorsMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_PatentCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for patent costs.",
        "label": "Patent Costs Policy [Text Block]",
        "terseLabel": "Patent Costs"
       }
      }
     },
     "localname": "PatentCostsPolicyTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_PaymentOfPaycheckProtectionProgramLoan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of paycheck protection program loan.",
        "label": "Payment Of Paycheck Protection Program Loan",
        "terseLabel": "Payment of paycheck protection program loan"
       }
      }
     },
     "localname": "PaymentOfPaycheckProtectionProgramLoan",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_PayrollProtectionProgramLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payroll protection program loan.",
        "label": "Payroll Protection Program Loan [Member]",
        "terseLabel": "Payroll Protection Program"
       }
      }
     },
     "localname": "PayrollProtectionProgramLoanMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_PercentageNumberOfSharesCeasesToBeneficiallyOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage number of shares ceases to beneficially owned.",
        "label": "Percentage Number Of Shares Ceases To Beneficially Owned",
        "terseLabel": "Percentage number of shares ceases to beneficially owned"
       }
      }
     },
     "localname": "PercentageNumberOfSharesCeasesToBeneficiallyOwned",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hypr_PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of cash payment in research and development tax credit carryforwards.",
        "label": "Percentage of Cash Payment in Research and Development Tax Credit Carryforwards",
        "terseLabel": "Percentage of cash payment in research and development tax credit"
       }
      }
     },
     "localname": "PercentageOfCashPaymentInResearchAndDevelopmentTaxCreditCarryforwards",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hypr_PercentageOfCommonStockVotingPower": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of common stock voting power.",
        "label": "Percentage Of Common Stock Voting Power",
        "terseLabel": "Percentage of common stock voting power"
       }
      }
     },
     "localname": "PercentageOfCommonStockVotingPower",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hypr_PostTwoThaousandSeventeenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Post two thaousand seventeen.",
        "label": "Post Two Thaousand Seventeen [Member]",
        "terseLabel": "Post-2017"
       }
      }
     },
     "localname": "PostTwoThaousandSeventeenMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_PreTwoThaousandEighteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre two thaousand eighteen.",
        "label": "Pre Two Thaousand Eighteen [Member]",
        "terseLabel": "Pre-2018"
       }
      }
     },
     "localname": "PreTwoThaousandEighteenMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_PrepaidAdvancesUnrecoverable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid advances unrecoverable.",
        "label": "Prepaid Advances Unrecoverable",
        "terseLabel": "Prepaid advances unrecoverable"
       }
      }
     },
     "localname": "PrepaidAdvancesUnrecoverable",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for prepaid expenses and other current assets.",
        "label": "Prepaid Expenses And Other Current Assets Policy [Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_PrepaidInsurancePolicyInConnectionWithBusinessCombination": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid insurance policy in connection with business combination.",
        "label": "Prepaid Insurance Policy in Connection With Business Combination",
        "terseLabel": "Prepaid directors and officers insurance policy in connection with closing of business combination"
       }
      }
     },
     "localname": "PrepaidInsurancePolicyInConnectionWithBusinessCombination",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_ProceedsFromBusinessCombination": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from business combination.",
        "label": "Proceeds From Business Combination",
        "terseLabel": "Net proceeds from equity infusion from the Business Combination"
       }
      }
     },
     "localname": "ProceedsFromBusinessCombination",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_RecapitalizationOfPermanentToTemporaryEquityShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recapitalization of permanent to temporary equity shares.",
        "label": "Recapitalization Of Permanent To Temporary Equity Shares",
        "terseLabel": "Conversion of Liminal Common stock (in shares)"
       }
      }
     },
     "localname": "RecapitalizationOfPermanentToTemporaryEquityShares",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "hypr_RecapitalizationOfPermanentToTemporaryEquityValues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recapitalization of permanent to temporary equity values.",
        "label": "Recapitalization Of Permanent To Temporary Equity Values",
        "terseLabel": "Conversion of Liminal Common stock"
       }
      }
     },
     "localname": "RecapitalizationOfPermanentToTemporaryEquityValues",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_RelatedPartyTransactionPaymentsForRent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party transaction payments for rent.",
        "label": "Related Party Transaction Payments For Rent",
        "terseLabel": "Payments for rent"
       }
      }
     },
     "localname": "RelatedPartyTransactionPaymentsForRent",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_ResearchAndDevelopmentTaxCreditsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for research and development tax credits.",
        "label": "Research And Development Tax Credits Policy [Text Block]",
        "terseLabel": "Research and Development Tax Credits"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxCreditsPolicyTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_ResearchDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research devices.",
        "label": "Research Devices [Member]",
        "terseLabel": "Research Devices"
       }
      }
     },
     "localname": "ResearchDevicesMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_RevenueRecognizeReceivablePaymentTermsRangeMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum payment term agreed upon with the respective customer.",
        "label": "Payment terms range, maximum"
       }
      }
     },
     "localname": "RevenueRecognizeReceivablePaymentTermsRangeMaximum",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2"
     ],
     "xbrltype": "durationItemType"
    },
    "hypr_RevenueRecognizeReceivablePaymentTermsRangeMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum payment term agreed upon with the respective customer.",
        "label": "Payment terms range, minimum"
       }
      }
     },
     "localname": "RevenueRecognizeReceivablePaymentTermsRangeMinimum",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2"
     ],
     "xbrltype": "durationItemType"
    },
    "hypr_RevenueRemainingPerformanceObligationExpectedTimingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Remaining performance obligation expected to be recognized, percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingPercentage",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "hypr_SalesAndMarketingDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales and marketing devices.",
        "label": "Sales And Marketing Devices [Member]",
        "terseLabel": "Sales and Marketing Devices"
       }
      }
     },
     "localname": "SalesAndMarketingDevicesMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for accrued liabilities and other current liabilities.",
        "label": "Schedule Of Accrued Liabilities And Other Liabilities Table [Text Block]",
        "terseLabel": "Schedule Of Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesTableTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share-based payment award, earn-out shares, valuation assumptions.",
        "label": "Schedule Of Share Based Payment Award Earn Out Shares Valuation Assumptions Table [Text Block]",
        "terseLabel": "Key Assumptions Used in Valuation for Earn-Out Shares"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEarnOutSharesValuationAssumptionsTableTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of stock options granted to employees and nonemployees.",
        "label": "Schedule Of Stock Options Granted To Employees And Nonemployees Table [Text Block]",
        "terseLabel": "Summary of Stock Options Granted"
       }
      }
     },
     "localname": "ScheduleOfStockOptionsGrantedToEmployeesAndNonemployeesTableTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of useful lives for property, plant and equipment.",
        "label": "Schedule Of Useful Lives For Property Plant And Equipment Table [Text Block]",
        "terseLabel": "Schedule of estimated useful lives of property and equipment"
       }
      }
     },
     "localname": "ScheduleOfUsefulLivesForPropertyPlantAndEquipmentTableTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_SeriesA1PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A-1 preferred stock",
        "label": "Series A-1 preferred stock",
        "terseLabel": "Series A-1 Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesA1PreferredStockMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_SeriesATwoConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A-two convertible preferred stock.",
        "label": "Series A-Two Convertible Preferred Stock [Member]",
        "terseLabel": "Series A-2 Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesATwoConvertiblePreferredStockMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_SeriesBCAndDConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B, C and D convertible preferred stock.",
        "label": "Series B, C and D Convertible Preferred Stock [Member]",
        "terseLabel": "Series B, C and D Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesBCAndDConvertiblePreferredStockMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_ServiceAndPerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service and performance shares.",
        "label": "Service And Performance Shares [Member]",
        "terseLabel": "Service and Performance Shares"
       }
      }
     },
     "localname": "ServiceAndPerformanceSharesMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, award repurchase right valid period commencing with date of service.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Repurchase Right Valid Period Commencing With Date Of Service",
        "terseLabel": "Repurchase right valid period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRepurchaseRightValidPeriodCommencingWithDateOfService",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options outstanding aggregate intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregate Intrinsic Value Rollforward",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollforward",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hypr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Rollforward",
        "terseLabel": "Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermRollforward",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hypr_ShareBasedPaymentArrangementPlanModificationIncrementalValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payment arrangement plan modification incremental value.",
        "label": "Share Based Payment Arrangement Plan Modification Incremental Value",
        "terseLabel": "Incremental value as a result of the modification of the awards"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementPlanModificationIncrementalValue",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_ShareBasedPaymentArrangementSeparateOptionAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payment arrangement separate option awards.",
        "label": "Share Based Payment Arrangement Separate Option Awards [Member]",
        "terseLabel": "Separate Option Award"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementSeparateOptionAwardsMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payment arrangement two separate option awards.",
        "label": "Share Based Payment Arrangement Two Separate Option Awards [Member]",
        "terseLabel": "Two Separate Option Awards"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementTwoSeparateOptionAwardsMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_SponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsor.",
        "label": "Sponsor [Member]",
        "terseLabel": "Sponsor"
       }
      }
     },
     "localname": "SponsorMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_StockOptionsOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock options one.",
        "label": "Stock Options One [Member]",
        "terseLabel": "Stock Options One"
       }
      }
     },
     "localname": "StockOptionsOneMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_StockOptionsTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock options two.",
        "label": "Stock Options Two [Member]",
        "terseLabel": "Stock Options Two"
       }
      }
     },
     "localname": "StockOptionsTwoMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_SubscriptionAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription agreements.",
        "label": "Subscription Agreements [Member]",
        "terseLabel": "Subscription Agreements"
       }
      }
     },
     "localname": "SubscriptionAgreementsMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hypr_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hypr_TaxCreditCarryforwardBeginToExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward begin to expiration year.",
        "label": "Tax Credit Carryforward Begin to Expiration Year",
        "terseLabel": "Begin to Expire in"
       }
      }
     },
     "localname": "TaxCreditCarryforwardBeginToExpirationYear",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "hypr_TechnologyAndServicesExchangeAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology and services exchange agreement.",
        "label": "Technology And Services Exchange Agreement [Member]",
        "terseLabel": "TESA"
       }
      }
     },
     "localname": "TechnologyAndServicesExchangeAgreementMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_TemporaryEquitySharesIssuanceCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, shares, issuance cost.",
        "label": "Temporary Equity Shares Issuance Cost",
        "terseLabel": "Issuance Costs"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssuanceCost",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock issued during period shares new issues.",
        "label": "Temporary Equity Stock Issued During Period Shares New Issues",
        "terseLabel": "Issuance of Series D convertible preferred stock, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "hypr_TemporaryEquityYearOfClassIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, year of class issuance.",
        "label": "Temporary Equity Year Of Class Issuance",
        "terseLabel": "Year of Class Issuance"
       }
      }
     },
     "localname": "TemporaryEquityYearOfClassIssuance",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "hypr_TradeShowAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade show assets.",
        "label": "Trade Show Assets [Member]",
        "terseLabel": "Trade Show Assets"
       }
      }
     },
     "localname": "TradeShowAssetsMember",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hypr_UnbilledReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled receivables",
        "label": "Unbilled Receivables",
        "negatedLabel": "Unbilled receivables"
       }
      }
     },
     "localname": "UnbilledReceivables",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_UncertainTaxPositions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of uncertain tax positions.",
        "label": "Uncertain Tax Positions",
        "terseLabel": "Uncertain tax positions"
       }
      }
     },
     "localname": "UncertainTaxPositions",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hypr_WarrantiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for warranties.",
        "label": "Warranties Policy [Text Block]",
        "terseLabel": "Warranties"
       }
      }
     },
     "localname": "WarrantiesPolicyTextBlock",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hypr_WriteOffOfOtherAssetsRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of other assets - related party.",
        "label": "Write Off Of Other Assets Related Party",
        "terseLabel": "Write-off of other assets - related party"
       }
      }
     },
     "localname": "WriteOffOfOtherAssetsRelatedParty",
     "nsuri": "http://hyperfine.io/20211231",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "terseLabel": "Executive Chairman"
       }
      }
     },
     "localname": "BoardOfDirectorsChairmanMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r110",
      "r250",
      "r255",
      "r261",
      "r455",
      "r456",
      "r459",
      "r460",
      "r519",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r110",
      "r250",
      "r255",
      "r261",
      "r455",
      "r456",
      "r459",
      "r460",
      "r519",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Dr. Rothberg"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r188",
      "r338",
      "r344",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major Customers [Axis]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r266",
      "r293",
      "r362",
      "r365",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r583",
      "r587",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r266",
      "r293",
      "r362",
      "r365",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r583",
      "r587",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r188",
      "r338",
      "r344",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Of Major Customer [Domain]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r185",
      "r338",
      "r342",
      "r540",
      "r582",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Or Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r185",
      "r338",
      "r342",
      "r540",
      "r582",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products And Services [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r266",
      "r293",
      "r351",
      "r362",
      "r365",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r583",
      "r587",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r266",
      "r293",
      "r351",
      "r362",
      "r365",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r583",
      "r587",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Member]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r123",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r123",
      "r128",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r186",
      "r187",
      "r338",
      "r343",
      "r585",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r186",
      "r187",
      "r338",
      "r343",
      "r585",
      "r601",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r123",
      "r128",
      "r240",
      "r363",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r189",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual With Relationship To Entity [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201815Member": {
     "auth_ref": [
      "r225",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-15 Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force).",
        "label": "Accounting Standards Update201815 [Member]",
        "terseLabel": "ASU No. 2018-15"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201815Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201912Member": {
     "auth_ref": [
      "r436",
      "r437",
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.",
        "label": "Accounting Standards Update 2019-12 [Member]",
        "terseLabel": "ASU 2019-12"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201912Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update202006 [Member]",
        "terseLabel": "ASU 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block]",
        "terseLabel": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r54",
      "r522"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrent": {
     "auth_ref": [
      "r54",
      "r109",
      "r514",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Related Parties Current",
        "terseLabel": "Due to related parties for payments paid on their behalf"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r10",
      "r34",
      "r190",
      "r191"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable Net Current",
        "terseLabel": "Accounts receivable, less allowance of $32 and $0 in 2021 and 2020, respectively",
        "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedPartiesCurrent": {
     "auth_ref": [
      "r64",
      "r109",
      "r513",
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.",
        "label": "Accounts Receivable Related Parties Current",
        "terseLabel": "Due from related parties for payments made on behalf of the other entities"
       }
      }
     },
     "localname": "AccountsReceivableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedBonusesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r56"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "hypr_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Bonuses Current",
        "terseLabel": "Bonus"
       }
      }
     },
     "localname": "AccruedBonusesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r56"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "hypr_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees Current",
        "terseLabel": "Legal fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r51",
      "r230"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment",
        "negatedLabel": "Less: Accumulated depreciation and amortization",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r35",
      "r407",
      "r522"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid In Capital",
        "periodEndLabel": "Additional Paid in Capital, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Beginning Balance",
        "terseLabel": "Additional paid-in capital",
        "totalLabel": "Additional Paid in Capital, Total"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r404",
      "r405",
      "r406",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r116",
      "r117",
      "r118",
      "r119",
      "r128",
      "r198",
      "r199",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r249",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r436",
      "r437",
      "r438",
      "r439",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r486",
      "r487",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r509",
      "r541",
      "r542",
      "r543",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Adjustments For New Accounting Pronouncements [Axis]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r367",
      "r370",
      "r410",
      "r411"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value",
        "terseLabel": "Stock-based compensation expense",
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Sales and Marketing"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expenses"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r370",
      "r395",
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share Based Compensation Expense",
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r40",
      "r193",
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowance For Doubtful Accounts Receivable Current",
        "terseLabel": "Allowance for doubtful accounts receivable",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
        "terseLabel": "Total anti-dilutive common equivalent shares"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Arrangements And Nonarrangement Transactions [Member]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r106",
      "r168",
      "r177",
      "r183",
      "r201",
      "r250",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r455",
      "r459",
      "r485",
      "r520",
      "r522",
      "r558",
      "r572"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r67",
      "r106",
      "r201",
      "r250",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r455",
      "r459",
      "r485",
      "r520",
      "r522"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Current [Abstract]",
        "terseLabel": "CURRENT ASSETS:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r371",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis Of Accounting Policy Policy [Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis Of Presentation And Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r361",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r361",
      "r364",
      "r449",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued",
        "terseLabel": "Business combination, shares issued as earn out consideration"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination And Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombination1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r97",
      "r98",
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Noncash acquisition of fixed assets"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "auth_ref": [
      "r620"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
        "label": "Capitalized Computer Software, Net",
        "periodEndLabel": "Capitalized Computer Software, Net, Ending Balance",
        "periodStartLabel": "Capitalized Computer Software, Net, Beginning Balance",
        "terseLabel": "Capitalized internal-use software development costs",
        "totalLabel": "Capitalized internal-use software development costs"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationMethod": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of method used for amortizing cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost Amortization Method",
        "terseLabel": "Capitalized costs, amortization method"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Capitalized Contract Cost Amortization Period",
        "terseLabel": "Capitalized costs, amortization period"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_CapitalizedContractCostNet": {
     "auth_ref": [
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost Net",
        "terseLabel": "Capitalized contract cost",
        "totalLabel": "Capitalized Contract Cost, Net, Total"
       }
      }
     },
     "localname": "CapitalizedContractCostNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r8",
      "r48",
      "r95"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash And Cash Equivalents Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r19",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash And Cash Equivalents Policy [Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r19",
      "r96",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r90",
      "r95",
      "r100"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of year",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash reported in the statement of financial position"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r90",
      "r495"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "auth_ref": [
      "r0",
      "r1",
      "r112",
      "r113",
      "r115",
      "r198",
      "r199",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r249",
      "r400",
      "r401",
      "r402",
      "r436",
      "r464",
      "r465",
      "r466",
      "r486",
      "r488",
      "r489",
      "r490",
      "r493",
      "r494",
      "r507",
      "r509",
      "r541",
      "r542",
      "r588",
      "r589",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether accounting standards update was adopted.",
        "label": "Change In Accounting Principle Accounting Standards Update Adopted",
        "terseLabel": "Change in accounting principle, accounting standards update, adopted"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "auth_ref": [
      "r0",
      "r1",
      "r112",
      "r113",
      "r122",
      "r198",
      "r199",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r249",
      "r400",
      "r401",
      "r402",
      "r436",
      "r464",
      "r465",
      "r466",
      "r467",
      "r470",
      "r486",
      "r488",
      "r489",
      "r490",
      "r493",
      "r494",
      "r507",
      "r509",
      "r541",
      "r542",
      "r588",
      "r589",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.",
        "label": "Change In Accounting Principle Accounting Standards Update Adoption Date",
        "terseLabel": "Change in accounting principle, accounting standards update, adoption date"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption": {
     "auth_ref": [
      "r4",
      "r115",
      "r199",
      "r202",
      "r205",
      "r208",
      "r249",
      "r403",
      "r437",
      "r464",
      "r467",
      "r470",
      "r487",
      "r488",
      "r491",
      "r492",
      "r494",
      "r507",
      "r543",
      "r588",
      "r589",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether accounting standards update was early adopted.",
        "label": "Change In Accounting Principle Accounting Standards Update Early Adoption",
        "terseLabel": "Change in accounting principle, accounting standards update, early adoption"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "auth_ref": [
      "r116",
      "r127",
      "r200",
      "r210",
      "r407",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.",
        "label": "Change In Accounting Principle Accounting Standards Update Immaterial Effect",
        "terseLabel": "Change in accounting principle, accounting standards update, immaterial effect"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r103",
      "r106",
      "r131",
      "r132",
      "r133",
      "r136",
      "r138",
      "r146",
      "r147",
      "r148",
      "r201",
      "r250",
      "r255",
      "r256",
      "r257",
      "r261",
      "r262",
      "r291",
      "r292",
      "r296",
      "r300",
      "r485",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class Of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class Of Stock [Line Items]",
        "terseLabel": "Class Of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r59",
      "r239",
      "r563",
      "r578"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments And Contingencies",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES (NOTE 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r247",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments And Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Class A Common Stock"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Class B Common Stock"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock Capital Shares Reserved For Future Issuance",
        "terseLabel": "Common stock, capital shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r112",
      "r113",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock Par Or Stated Value Per Share",
        "terseLabel": "Common shares, par value, (per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock Shares Authorized",
        "terseLabel": "Common shares, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock Shares Issued",
        "terseLabel": "Common shares, shares issued",
        "totalLabel": "Common Stock, Shares, Issued, Total"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r31",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock Shares Outstanding",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "terseLabel": "Common shares, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r31",
      "r522"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value",
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Common stock",
        "totalLabel": "Common Stock, Value, Issued, Total",
        "verboseLabel": "Class A Common stock, $.0001 par value; 600,000,000 and 130,000,000 shares authorized; 55,277,061 and 1,576,137 shares issued and outstanding at December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r156",
      "r157",
      "r188",
      "r482",
      "r483",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r156",
      "r157",
      "r188",
      "r482",
      "r483",
      "r600",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk By Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r156",
      "r157",
      "r188",
      "r482",
      "r483",
      "r600",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk By Type [Axis]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r151",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk Credit Risk",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r156",
      "r157",
      "r188",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk Percentage1",
        "terseLabel": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r154",
      "r156",
      "r157",
      "r158",
      "r482",
      "r484",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r156",
      "r157",
      "r188",
      "r482",
      "r483",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction In Progress [Member]",
        "terseLabel": "Construction In Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract With Customer Asset And Liability Table [Text Block]",
        "terseLabel": "Information about Receivables and Deferred Revenue from Contracts with Customers"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r317",
      "r318",
      "r339"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract With Customer Liability Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r317",
      "r318",
      "r339"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract With Customer Liability Noncurrent",
        "terseLabel": "Long term deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized",
        "verboseLabel": "Revenue recognized that was included in the deferred revenue balance at the beginning of the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r97",
      "r98",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion Of Stock Shares Converted1",
        "terseLabel": "Conversion of Liminal Common stock (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r97",
      "r98",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion Of Stock Shares Issued1",
        "terseLabel": "Conversion of stock, shares issued"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r291",
      "r292",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r79",
      "r540"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost Of Goods And Services Sold",
        "terseLabel": "Total cost of sales",
        "totalLabel": "Cost of Goods and Services Sold, Total"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Of Goods And Services Sold [Abstract]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost Of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost Of Sales Policy [Text Block]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r155",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r105",
      "r110",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r284",
      "r505",
      "r559",
      "r561",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r263",
      "r281",
      "r282",
      "r504",
      "r505",
      "r506"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument Face Amount",
        "terseLabel": "Amount of note payable"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r58",
      "r105",
      "r110",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r284",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r58",
      "r105",
      "r110",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r308",
      "r311",
      "r312",
      "r313",
      "r503",
      "r504",
      "r505",
      "r506",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Debt Instrument [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Fixed assets, assets",
        "negatedLabel": "Fixed assets",
        "terseLabel": "Fixed assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r431",
      "r433",
      "r434"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Tax credit carryforwards",
        "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued bonuses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Valuation allowance",
        "negatedLabel": "Valuation allowance",
        "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Fixed assets, liabilities",
        "negatedLabel": "Fixed assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r93",
      "r166"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation Depletion And Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation, Depletion and Amortization, Total",
        "verboseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation Of Revenue [Line Items]",
        "terseLabel": "Disaggregation Of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r338",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation Of Revenue [Table]",
        "terseLabel": "Disaggregation Of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation Of Revenue Table [Text Block]",
        "terseLabel": "Summary of Disaggregated Revenues"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]",
        "terseLabel": "EQUITY INCENTIVE PLAN"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlan1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendDeclaredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distribution of earnings in the form of cash, property or capital stock declared by the board of directors to be distributed to shareholders.",
        "label": "Dividend Declared [Member]",
        "terseLabel": "Dividend Declared"
       }
      }
     },
     "localname": "DividendDeclaredMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about distribution of earnings to shareholders including, but not limited to, cash, property or capital stock.",
        "label": "Dividends [Axis]"
       }
      }
     },
     "localname": "DividendsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r314",
      "r568"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends Common Stock",
        "terseLabel": "Dividends declared common stock",
        "totalLabel": "Dividends, Common Stock, Total"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributions of earnings to shareholders including but not limited to cash, property or capital stock.",
        "label": "Dividends [Domain]"
       }
      }
     },
     "localname": "DividendsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r24",
      "r26",
      "r560",
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromEmployeesNoncurrent": {
     "auth_ref": [
      "r20",
      "r33",
      "r513",
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from an Entity employee, not to include stockholders or officers, which are usually due after 1 year (or 1 business cycle).",
        "label": "Due From Employees Noncurrent",
        "terseLabel": "Promissory Note with one of the employees"
       }
      }
     },
     "localname": "DueFromEmployeesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r11",
      "r20",
      "r32",
      "r109",
      "r253",
      "r255",
      "r256",
      "r260",
      "r261",
      "r262",
      "r513"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 11.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due From Related Parties Current",
        "terseLabel": "Due from related parties",
        "totalLabel": "Due from Related Parties, Current, Total"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r54",
      "r109",
      "r253",
      "r255",
      "r256",
      "r260",
      "r261",
      "r262",
      "r513"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due To Related Parties Current",
        "terseLabel": "Due to related parties",
        "totalLabel": "Due to Related Parties, Current, Total"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share Basic And Diluted",
        "terseLabel": "Net loss per common share attributable to common stockholders, basic and diluted",
        "totalLabel": "Earnings Per Share, Basic and Diluted, Total",
        "verboseLabel": "Basic and dilutive loss per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r139",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share Policy [Text Block]",
        "terseLabel": "Net Loss per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate percent",
        "totalLabel": "Effective Income Tax Rate Reconciliation, Percent, Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r107",
      "r420",
      "r443"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Statutory federal income tax rate (in percent)",
        "terseLabel": "Statutory tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r420",
      "r443"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r420",
      "r443"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Deferred tax adjustment resulting from tax rate change"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r420",
      "r443"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r420",
      "r443"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r420",
      "r443"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "auth_ref": [
      "r420",
      "r443"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Tax Rate",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r420",
      "r443"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Federal research and development credits",
        "terseLabel": "Research and development tax credit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfAnticipatedIncomeTaxExpenseBenefitComputedByStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "hypr_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee Related Liabilities Current",
        "terseLabel": "Payroll and related benefits",
        "totalLabel": "Employee-related Liabilities, Current, Total"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized",
        "terseLabel": "Total unrecognized stock-based compensation expense",
        "totalLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1",
        "terseLabel": "Remaining vesting period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock Option Grants",
        "verboseLabel": "Outstanding Options to Purchase Common Stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r71",
      "r72",
      "r73",
      "r112",
      "r113",
      "r114",
      "r117",
      "r124",
      "r126",
      "r145",
      "r209",
      "r307",
      "r314",
      "r404",
      "r405",
      "r406",
      "r438",
      "r439",
      "r473",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r590",
      "r591",
      "r592",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r476",
      "r477",
      "r478",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.",
        "label": "Fair Value Assets Level1 To Level2 Transfers Amount",
        "terseLabel": "Fair value asset transfers, Level 1 to Level 2"
       }
      }
     },
     "localname": "FairValueAssetsLevel1ToLevel2TransfersAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.",
        "label": "Fair Value Assets Level2 To Level1 Transfers Amount",
        "terseLabel": "Fair value asset transfers, Level 2 to Level 1"
       }
      }
     },
     "localname": "FairValueAssetsLevel2ToLevel1TransfersAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r476",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Fair Value By Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r272",
      "r281",
      "r282",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r477",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value By Fair Value Hierarchy Level [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE OF FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r272",
      "r352",
      "r353",
      "r358",
      "r360",
      "r477",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value Inputs Level1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.",
        "label": "Fair Value Liabilities Level1 To Level2 Transfers Amount",
        "terseLabel": "Fair value liabilities transfers, Level 1 to Level 2"
       }
      }
     },
     "localname": "FairValueLiabilitiesLevel1ToLevel2TransfersAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.",
        "label": "Fair Value Liabilities Level2 To Level1 Transfers Amount",
        "terseLabel": "Fair value liabilities transfers, Level 2 to Level 1"
       }
      }
     },
     "localname": "FairValueLiabilitiesLevel2ToLevel1TransfersAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r272",
      "r281",
      "r282",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Measurements Fair Value Hierarchy [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General And Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General And Administrative Expense [Member]",
        "terseLabel": "General and Administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r366",
      "r368",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r78",
      "r106",
      "r168",
      "r176",
      "r179",
      "r182",
      "r184",
      "r201",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r485"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r93",
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r228",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment Or Disposal Of Long Lived Assets Policy [Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r74",
      "r168",
      "r176",
      "r179",
      "r182",
      "r184",
      "r556",
      "r564",
      "r566",
      "r580"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "totalLabel": "Loss before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r232",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r421",
      "r424",
      "r430",
      "r441",
      "r444",
      "r446",
      "r447",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r108",
      "r125",
      "r126",
      "r167",
      "r419",
      "r442",
      "r445",
      "r581"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense Benefit",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Income Tax Expense (Benefit), Total",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r70",
      "r417",
      "r418",
      "r424",
      "r425",
      "r429",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax Policy [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "terseLabel": "Research and development tax credit receivables"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseDueFromOtherRelatedParties": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables due from related parties classified as other.",
        "label": "Increase (Decrease) Due from Other Related Parties",
        "negatedLabel": "Other assets - related party"
       }
      }
     },
     "localname": "IncreaseDecreaseDueFromOtherRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 24.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase Decrease In Accounts Payable",
        "terseLabel": "Accounts payable",
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase Decrease In Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Accounts Receivable, Related Parties",
        "negatedLabel": "Due from related parties",
        "terseLabel": "Due from related parties"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r92",
      "r537"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 26.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase Decrease In Contract With Customer Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredLiabilities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.",
        "label": "Increase (Decrease) in Deferred Liabilities",
        "terseLabel": "Deferred grant funding",
        "totalLabel": "Increase (Decrease) in Deferred Liabilities, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedParties": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 27.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.",
        "label": "Increase Decrease In Due To Related Parties",
        "terseLabel": "Due to related parties",
        "totalLabel": "Increase (Decrease) in Due to Related Parties, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase Decrease In Inventories",
        "negatedLabel": "Inventory",
        "totalLabel": "Increase (Decrease) in Inventories, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 23.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase Decrease In Other Noncurrent Assets",
        "negatedLabel": "Other long term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidSupplies": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for supplies that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Supplies",
        "negatedLabel": "Prepaid inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidSupplies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase Decrease In Stockholders Equity Roll Forward",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestIncomeRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income earned from interest-bearing assets owed to the entity by related party.",
        "label": "Interest Income Related Party",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r41",
      "r219"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r9",
      "r65",
      "r522"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r17",
      "r66",
      "r101",
      "r143",
      "r216",
      "r218",
      "r220",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory Policy [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r42",
      "r219"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write Down",
        "terseLabel": "Write-down of inventory",
        "verboseLabel": "Inventory adjustments and excess and obsolete inventory charges"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureINVENTORIESAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r81",
      "r165"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leased Devices"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r55",
      "r106",
      "r178",
      "r201",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r456",
      "r459",
      "r460",
      "r485",
      "r520",
      "r521"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r39",
      "r106",
      "r201",
      "r485",
      "r522",
      "r562",
      "r576"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity [Abstract]",
        "terseLabel": "LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r57",
      "r106",
      "r201",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r456",
      "r459",
      "r460",
      "r485",
      "r520",
      "r521",
      "r522"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiquidationBasisOfAccountingLiquidationPlan": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the plan of liquidation. Includes, but is not limited to, the manner by which assets are expected to be disposed of and other items expected to be sold that had not been previously recognized as assets, the manner by which liabilities are expected to be settled, and the expected date by which liquidation is expected to be complete.",
        "label": "Liquidation Basis of Accounting, Liquidation Plan",
        "terseLabel": "Liquidation rights, description"
       }
      }
     },
     "localname": "LiquidationBasisOfAccountingLiquidationPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long Term Debt [Text Block]",
        "terseLabel": "NOTES PAYABLE"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Long Term Notes Payable",
        "terseLabel": "Long term notes payable",
        "totalLabel": "Notes Payable, Noncurrent, Total"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r58",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureFAIRVALUEOFFINANCIALINSTRUMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided By Used In Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r90",
      "r91",
      "r94"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided By Used In Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r68",
      "r69",
      "r73",
      "r75",
      "r94",
      "r106",
      "r116",
      "r120",
      "r121",
      "r122",
      "r123",
      "r125",
      "r126",
      "r134",
      "r168",
      "r176",
      "r179",
      "r182",
      "r184",
      "r201",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r475",
      "r485",
      "r565",
      "r579"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income Loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss and comprehensive loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r123",
      "r129",
      "r130",
      "r135",
      "r138",
      "r168",
      "r176",
      "r179",
      "r182",
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income Loss Available To Common Stockholders Basic",
        "terseLabel": "Numerator for Basic and Dilutive EPS \u2013 Loss available to common stockholders",
        "totalLabel": "Net Income (Loss) Available to Common Stockholders, Basic, Total"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentInLeasePurchase": {
     "auth_ref": [
      "r214"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase from purchase of net investment in sales-type and direct financing leases.",
        "label": "Net Investment in Lease, Purchase",
        "terseLabel": "Payments received on net investment in lease"
       }
      }
     },
     "localname": "NetInvestmentInLeasePurchase",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements Policy Policy [Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing And Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of noncash information:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number Of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number Of Reportable Segments",
        "terseLabel": "Number of reporting segment"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OpenTaxYear": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year that remains open to examination under enacted tax laws, in YYYY format.",
        "label": "Open Tax Year",
        "terseLabel": "Open tax year"
       }
      }
     },
     "localname": "OpenTaxYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r168",
      "r176",
      "r179",
      "r182",
      "r184"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income Loss",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r431"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Tax net operating loss carryforward",
        "totalLabel": "Operating Loss Carryforwards, Total"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r7",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]",
        "terseLabel": "ORGANIZATION AND DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureORGANIZATIONANDDESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r56"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "hypr_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureACCRUEDEXPENSESANDOTHERCURRENTLIABILITIESScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets Noncurrent",
        "terseLabel": "Other long term assets",
        "totalLabel": "Other Assets, Noncurrent, Total"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other long term capitalized assets related to property plant and equipment not otherwise previously categorized.",
        "label": "Other Capitalized Property Plant And Equipment [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCapitalizedPropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income Expense",
        "terseLabel": "Other expense, net",
        "totalLabel": "Other Nonoperating Income (Expense), Total"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables And Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Stock issuance costs related to Series D convertible preferred stock",
        "terseLabel": "Stock issuance costs related to Series D convertible preferred stock"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments To Acquire Property Plant And Equipment",
        "negatedLabel": "Purchases of fixed assets",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r371",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockConversionBasis": {
     "auth_ref": [
      "r30",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.",
        "label": "Preferred Stock, Conversion Basis",
        "terseLabel": "Convertible preferred stock, conversion basis"
       }
      }
     },
     "localname": "PreferredStockConversionBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Convertible preferred stock dividend rate"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "Preferred Stock [Text Block]",
        "terseLabel": "CONVERTIBLE PREFERRED STOCK"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStock1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r12",
      "r46",
      "r47"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense And Other Assets Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.",
        "label": "Proceeds from Contributions from Affiliates",
        "terseLabel": "Investment from 4Bionics, LLC"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Aggregate gross proceeds of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds From Issuance Of Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuance of Series D convertible preferred stock",
        "verboseLabel": "Total Proceeds or Exchange Value"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stock that is classified as callable.",
        "label": "Proceeds from Issuance of Redeemable Preferred Stock",
        "terseLabel": "Proceeds from issuance of Series D convertible preferred stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemablePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds From Notes Payable",
        "terseLabel": "Proceeds from issuance of notes payable",
        "totalLabel": "Proceeds from Notes Payable, Total"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNOTESPAYABLEAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r84",
      "r399"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds From Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options",
        "verboseLabel": "Cash proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Liability Contingency [Line Items]",
        "terseLabel": "Product Liability Contingency [Line Items]"
       }
      }
     },
     "localname": "ProductLiabilityContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductLiabilityContingencyTable": {
     "auth_ref": [
      "r239",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.",
        "label": "Product Liability Contingency [Table]",
        "terseLabel": "Product Liability Contingency [Table]"
       }
      }
     },
     "localname": "ProductLiabilityContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Device"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r68",
      "r69",
      "r73",
      "r89",
      "r106",
      "r116",
      "r125",
      "r126",
      "r168",
      "r176",
      "r179",
      "r182",
      "r184",
      "r201",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r454",
      "r457",
      "r458",
      "r461",
      "r462",
      "r475",
      "r485",
      "r566"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Profit Loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant And Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r51",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property Plant And Equipment By Type [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r234",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT, NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r50",
      "r229"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Gross",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "terseLabel": "Property and equipment, gross",
        "totalLabel": "Property, Plant and Equipment, Gross, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property Plant And Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r21",
      "r22",
      "r231",
      "r522",
      "r567",
      "r577"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Net",
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r49",
      "r231",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Policy [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r21",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property Plant And Equipment [Text Block]",
        "terseLabel": "Schedule of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r21",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property Plant And Equipment Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r77",
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r192",
      "r195",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r359",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r512",
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction Amounts Of Transaction",
        "terseLabel": "Expenses allocated"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r359",
      "r512",
      "r513",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction Expenses From Transactions With Related Party",
        "terseLabel": "Expenses incurred"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.",
        "label": "Related Party Transaction Rate",
        "terseLabel": "Interest rate of the Note"
       }
      }
     },
     "localname": "RelatedPartyTransactionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r359",
      "r512",
      "r516",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party Transactions By Related Party [Axis]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r510",
      "r511",
      "r513",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments Of Notes Payable",
        "negatedLabel": "Repayment of notes payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r415",
      "r539",
      "r621"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research And Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research And Development Expense Policy",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "auth_ref": [
      "r52",
      "r224",
      "r227",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "terseLabel": "Capitalized Software Development Costs"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Federal Research and Development"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r19",
      "r95",
      "r100",
      "r557",
      "r574"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash And Cash Equivalents",
        "terseLabel": "Restricted cash",
        "totalLabel": "Restricted Cash and Cash Equivalents, Total"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r8",
      "r19",
      "r100"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Outstanding RSUs"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units R S U [Member]",
        "terseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r36",
      "r314",
      "r407",
      "r522",
      "r575",
      "r594",
      "r599"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings Accumulated Deficit",
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r112",
      "r113",
      "r114",
      "r117",
      "r124",
      "r126",
      "r209",
      "r404",
      "r405",
      "r406",
      "r438",
      "r439",
      "r473",
      "r590",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue From Contract With Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r163",
      "r164",
      "r175",
      "r180",
      "r181",
      "r185",
      "r186",
      "r188",
      "r337",
      "r338",
      "r540"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Total revenue",
        "terseLabel": "Revenue",
        "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total",
        "verboseLabel": "Total sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue From Contract With Customer Policy [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r327",
      "r328",
      "r341",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue From Contract With Customer [Text Block]",
        "terseLabel": "REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureREVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Remaining performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Remaining performance obligation expected to be recognized, duration"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue Remaining Performance Obligation Percentage",
        "terseLabel": "Revenue, remaining performance obligation, percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionAdditionalInformationDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Sales"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale Of Stock Number Of Shares Issued In Transaction",
        "terseLabel": "Aggregate number of shares issued in transaction"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r156",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Sales Revenue Net [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSignificantCustomerPercentageOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesTypeLeaseSellingProfitLoss": {
     "auth_ref": [
      "r144",
      "r508"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of profit (loss) recognized at commencement from sales-type lease.",
        "label": "Sales-type Lease, Selling Profit (Loss)",
        "negatedLabel": "Sales under sales type leases",
        "terseLabel": "Sales under sales type leases"
       }
      }
     },
     "localname": "SalesTypeLeaseSellingProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveCommonEquivalentSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]",
        "terseLabel": "Schedule of Anti-dilutive Common Equivalent Shares"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r449",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule Of Business Acquisitions By Acquisition [Table]",
        "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets (Liabilities)"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureNETLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Anticipated Income Tax Expense Benefit Computed by Statutory Federal Income Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r370",
      "r394",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r370",
      "r394",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r17",
      "r43",
      "r44",
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Summary of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIinventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r51",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule Of Property Plant And Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r514",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule Of Related Party Transactions By Related Party [Table]",
        "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r371",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r376",
      "r383",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]",
        "terseLabel": "Assumptions Used to Value Option Grants to Employees and Nonemployees"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r60",
      "r103",
      "r146",
      "r147",
      "r286",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r300",
      "r305",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule Of Stock By Class [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r154",
      "r156",
      "r157",
      "r158",
      "r482",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules Of Concentration Of Risk By Risk Factor [Text Block]",
        "terseLabel": "Schedule of each significant customer, revenue as a percentage of total revenues and gross accounts receivable as a percentage of total gross accounts receivable"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting Policy Policy [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling And Marketing Expense",
        "terseLabel": "Sales and marketing",
        "totalLabel": "Selling and Marketing Expense, Total"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling And Marketing Expense [Member]",
        "terseLabel": "Sales and Marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "General and Administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A",
        "verboseLabel": "Series A Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B",
        "verboseLabel": "Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series C preferred stock or outstanding series C preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C",
        "verboseLabel": "Series C Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesDPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series D preferred stock or outstanding series D preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series D Preferred Stock [Member]",
        "terseLabel": "Series D Convertible Preferred Stock",
        "verboseLabel": "Series D"
       }
      }
     },
     "localname": "SeriesDPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share Based Compensation",
        "terseLabel": "Stock-based compensation expense",
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1",
        "terseLabel": "Total grant date fair value recognized period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period",
        "terseLabel": "Restricted stock units (\"RSU\") granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Grant date fair value per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value",
        "terseLabel": "Total grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate",
        "terseLabel": "Expected volatility",
        "verboseLabel": "Expected annual equity volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate",
        "terseLabel": "Risk Free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum",
        "terseLabel": "Risk Free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum",
        "terseLabel": "Risk Free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number",
        "terseLabel": "Options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price",
        "terseLabel": "Options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value",
        "terseLabel": "Total intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period",
        "negatedLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Stock options granted",
        "terseLabel": "Granted",
        "verboseLabel": "Option award to purchase shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r378",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number",
        "periodEndLabel": "Outstanding",
        "periodStartLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding",
        "periodStartLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost",
        "terseLabel": "Incremental compensation expense recognized as a result of the modification"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period",
        "terseLabel": "Number of shares entitle to certain employees"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award",
        "terseLabel": "Stock option grants, term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r369",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r368",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share Based Payment Arrangement Employee [Member]",
        "terseLabel": "Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "auth_ref": [
      "r366",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share Based Payment Arrangement Nonemployee [Member]",
        "terseLabel": "Nonemployee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Stock Price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r389",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Term (years)",
        "terseLabel": "Expected term",
        "verboseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAssumptionsUsedToValueOptionGrantsToEmployeesAndNonemployeesDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanKeyAssumptionsUsedInValuationForEarnoutSharesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1",
        "terseLabel": "Options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1",
        "terseLabel": "Options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Shares held by sponsor , irrevocably forfeited"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued Price Per Share",
        "terseLabel": "Shares price",
        "verboseLabel": "Original issuance price"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software And Software Development Costs [Member]",
        "terseLabel": "Software Development Costs"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "States"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r103",
      "r106",
      "r131",
      "r132",
      "r133",
      "r136",
      "r138",
      "r146",
      "r147",
      "r148",
      "r201",
      "r250",
      "r255",
      "r256",
      "r257",
      "r261",
      "r262",
      "r291",
      "r292",
      "r296",
      "r300",
      "r307",
      "r485",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Statement Class Of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r63",
      "r71",
      "r72",
      "r73",
      "r112",
      "r113",
      "r114",
      "r117",
      "r124",
      "r126",
      "r145",
      "r209",
      "r307",
      "r314",
      "r404",
      "r405",
      "r406",
      "r438",
      "r439",
      "r473",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r590",
      "r591",
      "r592",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Statement Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Stockholders Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r145",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Stock Granted During Period Value Sharebased Compensation Gross",
        "terseLabel": "Granted value"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r97",
      "r98",
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Issuance of Class A Common Stock to a service provider in exchange for the service provided in connection with the Business Combination"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r30",
      "r31",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period Shares Acquisitions",
        "terseLabel": "Net equity infusion from the Business Combination (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r62",
      "r274",
      "r307",
      "r308",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period Shares Conversion Of Convertible Securities",
        "terseLabel": "Conversion of the convertible preferred stock into Class A and Class B common stock at the Business Combination (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Common Stock issued to service provider in exchange for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r30",
      "r31",
      "r307",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period Shares New Issues",
        "terseLabel": "Issuance of Class A common stock to a service provider (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r30",
      "r31",
      "r307",
      "r314",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock Issued During Period Shares Stock Options Exercised",
        "negatedLabel": "Exercised",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureEquityIncentivePlanSummaryOfStockOptionActivityDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r63",
      "r307",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period Value Acquisitions",
        "terseLabel": "Net equity infusion from the Business Combination"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r63",
      "r307",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period Value Conversion Of Convertible Securities",
        "terseLabel": "Conversion of the convertible preferred stock into Class A and Class B common stock at the Business Combination"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r30",
      "r31",
      "r307",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of Class A common stock to a service provider"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r63",
      "r307",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period Value Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r31",
      "r37",
      "r38",
      "r106",
      "r194",
      "r201",
      "r485",
      "r522"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders Equity",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "STOCKHOLDERS' EQUITY (DEFICIT):"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r104",
      "r292",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r314",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureStockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy": {
     "auth_ref": [
      "r27",
      "r28",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.",
        "label": "Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteRedeemablePreferredStockIssuePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders Equity Note Stock Split Conversion Ratio1",
        "terseLabel": "Stock split, conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r502",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r502",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r502",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureRELATEDPARTYTRANSACTIONSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r523",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosureSUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Summary of Operating Loss Carryforwards [Table Text Block]",
        "terseLabel": "Schedule of Tax Net Operating Loss Carryforward and Tax Credit Carryforward"
       }
      }
     },
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r431"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTaxNetOperatingLossCarryforwardAndTaxCreditCarryforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r18",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity By Class Of Stock [Table]",
        "terseLabel": "Temporary Equity By Class Of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r250",
      "r255",
      "r256",
      "r257",
      "r261",
      "r262"
     ],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Carrying Amount Attributable To Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "terseLabel": "Hyperfine convertible preferred stock (Series A, B, C and D): $.0001 par value, aggregate liquidation preference of $0 and $147,651; 0 and 129,788,828 shares authorized; 0 and 95,010,858 shares issued and outstanding at December 31, 2021 and 2020, respectively",
        "verboseLabel": "Net Carrying Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Liquidation Preference",
        "terseLabel": "Convertible preferred stock, aggregate liquidation preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreferencePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Liquidation Preference Per Share",
        "verboseLabel": "Initial Liquidation Price per share"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreferencePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r18",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity Par Or Stated Value Per Share",
        "terseLabel": "Convertible preferred stock, par value",
        "verboseLabel": "Issuance Price per share"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Shares Authorized",
        "terseLabel": "Convertible preferred stock, shares authorized",
        "verboseLabel": "Shares Authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Shares Issued",
        "terseLabel": "Convertible preferred stock, shares issued",
        "verboseLabel": "Shares Issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Shares Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Convertible preferred stock, shares outstanding",
        "verboseLabel": "Shares Outstanding"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredStockDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheetsParenthetical",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of Series D convertible preferred stock, net of issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfChangesInConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r18",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity Table [Text Block]",
        "terseLabel": "Summary of Authorized, Issued and Outstanding Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureConvertiblePreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r338",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing Of Transfer Of Good Or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r338",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing Of Transfer Of Good Or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ToolsDiesAndMoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used to cut, shape, and form metal and other materials into goods for sale.",
        "label": "Tools Dies And Molds [Member]",
        "terseLabel": "Tooling"
       }
      }
     },
     "localname": "ToolsDiesAndMoldsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesUsefulLivesOfPropertyAndEquipmentDetails",
      "http://hyperfine.io/20211231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTNETScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred at point in time.",
        "label": "Transferred At Point In Time [Member]",
        "terseLabel": "Point In Time"
       }
      }
     },
     "localname": "TransferredAtPointInTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred Over Time [Member]",
        "terseLabel": "Over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionSummaryOfDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r116",
      "r117",
      "r118",
      "r119",
      "r128",
      "r198",
      "r199",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r249",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r436",
      "r437",
      "r438",
      "r439",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r486",
      "r487",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r509",
      "r541",
      "r542",
      "r543",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Type Of Adoption [Member]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Type Of Arrangement [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureBusinessCombinationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnbilledReceivablesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.",
        "label": "Unbilled Receivables Current",
        "terseLabel": "Unbilled receivables"
       }
      }
     },
     "localname": "UnbilledReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureRevenueRecognitionInformationAboutReceivablesAndDeferredRevenueFromContractsWithCustomersDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r416",
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance",
        "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r149",
      "r150",
      "r152",
      "r153",
      "r159",
      "r160",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use Of Estimates",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number Of Share Outstanding Basic And Diluted",
        "terseLabel": "Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted",
        "verboseLabel": "Denominator for Basic and Dilutive EPS - Weighted-average common stock"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://hyperfine.io/20211231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://hyperfine.io/20211231/taxonomy/role/StatementCombinedAndConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31010-122693"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL77927221-108306"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131251-203054"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120431994&loc=SL118172731-207502"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120431994&loc=SL118172731-207502"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467743&loc=d3e20905-112640"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=SL116886442-113899"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL120154346-209984"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.15)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=77885760&loc=SL35686388-199418"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=123877278&loc=SL120174030-210619"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r622": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r623": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r624": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r625": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r626": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r627": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r628": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r629": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r631": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r632": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>89
<FILENAME>0000950170-22-004670-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-22-004670-xbrl.zip
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M>_WISCJ7GMX?]7SO$PP&Y(]A\PDG GZ$.RWA%Z-)B;_PHUZ"4K&@RUY_-QE
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MI6.EMY8X%0RAW&1J;0)KEE30ICM2VL6-^*%I3RZ)-^LNZK9HG%UT+Z%GMSR
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M&BI!W>.3WF%I#85HT05;YI("@T\8?7W7W@_%H&DFXYY/)2)]&F2. K^@!AI
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MNO?CS3SCG./ZN]F<"MZ/+H#X0>M139\>9_XT"PZ?.F!ZK_"IJ,0CI;;^E0<
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MV./2WF-34@G35]-ZK(4"V=4H\4X$B\9)-W0P[T*#)=Q>4U)G2NI\^J0.-#'
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M/6\;+/"=%1TQ8!S6*$'BAX-A+N>.^!N0^&XXOY&%!Y=CL8A(C$>AC>*;=R#
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M\=B&M@Z90!IE;S2(_W9MPQ]S'#-,YO'C;N8?-U =S[; =L<!KFHNVQF7U6\
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M_O^ ;VI8G[PLIVWQWD[<-Z$1 9",EPUCNS&]WR)5+.BYYYR#GI"P'WI\7TE
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MO<2K/#;/\!$>3@M5J^; )XSE;(H3P:8#;%(2]- +(.5R7ID]KKB3!SQI1>E
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MF$H_&M0</S\<Q!1?8>3!SO/OX_,QIX*!2[3=TN )U=K/N-^8^]4.864'+-?
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MZ@<W%E>7PE8["6^A9>VO 9B<2(A[N,@5.>T>(H66); 4.?4/EN>C*(:!5+H
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MG$1.(B>1T^XN<\(!VDVL"@=HWY%]^DPBM4-'L4AK5]$I'""!J$BKWQ 5#I!
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M4N0D<A(YB9QV<H43'M!N8E5X0/N.[+-G$JL=.HI%6KN*3N$!"5)%6H- JO"
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M?0V/"1R^-QV/SU1TBI72RHP+:.!\V4/)[6[9"+?YR-"B_2!NMB_67AA/"D&
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MKO.-#/R!DZE\>.TF$=BW7A9D]RO=O!9/7+/VK;V=S7<.%O!*?=:^TAEZQO"
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M"Y=-]W"J)NBTQP=ZRH ARS(+\PMN%XJBS(&$V;D4=VJ;%V)B=ME ;@;6(B,
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MO\-/W!O95RC=/C]Q?0^[#Q_?, EK::F>4NP9^ZH)63'GB<ZAJ1=EPSNVQ..
M5"S8N!^EQA]\WG)Q;YHSJ2D(95-H)R#8^1AFXD\N0\2XF]X4#0I,9C<:A.IJ
MPQF\_O0C."1:>:_R4+_%58YUYP#BDY$UUV#(L%O5S%#1Z#K5H9S)8I(GB*K8
M28'U496VA]/5P@U%@>F$QYU?!-4^PD+4?#J"^G7#0O#D^1GFTU-^SS@Z/1D]
M/SI[.HY^NW2=0:Y@M"LRJJ7-6W$>9//2HXT \AQ67V^QH0R$22R<X42EMFW!
M&W>.A;D0E$?,M538K7:8M8=5J><5V/J.VE;P9TA11Z0W>791D)OZVB5[M%^@
M\9PMN'T&]\9**FO?CFSOG,\Z736)]T3,Q[,@7LUA&E1<-7?$TB[8@BKSDK-U
MOKN,#UYI.8MI4:<733VIX UP+4.7 3P\LBN\R\%#)\V=E;'Z'=Z>- JK-2P5
M/?L&KWU&[8C!&^=972MVZ51.K,O]UCQTQE);@O[2;]ZN%PX>57,9RY5= KBO
M-"-_;>?AZR_ASL0>[=J%AW:$;O?:VO]PDIQ?1WA;1NDMGD7>Q)/1JVURTHZ?
MS)X^.6ZEI8TYF8U>%LMU9H9K!:V-%1\6,&+=3AW3)7->)/.KS/T>)HQ*[[P%
M\[1@$SUY?HV)IODLT"1S':+USA^T_K.=\078[;E*D$6INGLBI,_[*P*W?7UF
M=&M:@@,'W//QJ<FRI@-CPK(]3U^?IB)Q1[,-;0!LU6*!6S_[!-CEFR0LUZ1Q
M-YBY7 -+8+%M<CI/>(6V [V:(+VAHU4JHXTZ'4>\<A6R*'9AFZ9S)S):Q:A)
M"Y[\HR]GJZIPY:',O2^]@976YM>U9TNN#,Q'RD/3A5B@!XUY?FB<[M<N5B3)
M2O<V];]AS;\<//R#?'9 U1JQ,ZXKMD2I .0TA5&N+(F"#A6=A&7+& L263?6
M$6M:L;@87SN.UHUY@;/TP5<D:JZT_EOK!TW*C-N!!,>33G4ND6S#AYZONWF_
M0=IOT-)VJ]ERV9^P&EB?L#GM]NQ;Y$NU6L5@[V&\O%6)>Q0U_VH3FEH%R?AF
MW12Q?-U5*^%]RAD7M]X05(,'Q:L-))GNIN])^733--&:V8D*6D*;;E'EVT]P
M=<_QTCRS^;<-ZVO##VW=QE$$KV+2QB'W<49JP$M$@J9J=O/$T686&+R296UT
M7ZQ%J:-JJ]Q@Q::YN20]VDKQZXYLL#X(DSOZ,W4+\XEM;@.%6CN%E8(RSV'^
M#A*]K'RAA3P@=E55FPHWCMZZ\H?AZ4##-//MX#JY-KB_<M4 5=IBUW$3Z:+E
M[[0RNE+PXY.5B]PFN',!V2>UC]]WGHT>57)I2MQ&\8I,7'3D"MI<M;RN<*9:
MH^1S!ES>;2]=GYON6'AKF6U6LA1/QJ+8N, GRK?2MG?O5$)TSVPL!6V27"5-
MS@KTI@)DM+2N4MZ-JU.@CY620MM^G)LJ6?[O^<=1M_/0HI4ZS]NR-&BN1P%5
MZ_<&/9=\BZ,6:S&@-?K2OCZLWFS9Q3.Y3WU"\KH=2C?:CC!F/M7>1B0^L/R\
M"2QW]+DQW99-2NF<*@P3;,L,G>KJ"E=J9#BRE<$D48J4,-'IVGQ//C)S 0 7
M>@Z:#+K;TW)KC5AG]PV: XL!(+[4&,U&Q[D"B6LNZ,VG5#AQY=K$P*3PG@0'
MCT,.JL0HS#I.U6K$K=\YE0-;7'9/#%MBX Y<ODEGV*9-4@PET>.;$*S"?/2
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MYZ!:N$JX,G^$]Q(10+J),3Q0KI3Q<04XXO6PS"E^31K.1>OIG[!OU(Z+W.1
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M"OH2PIO\8< -;.9+:E5>P-# JVB[3:VP>I/!;-N^&O21C&NKC#]U#B#:QO^
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M(DA17<8>Z>4O2J,;V==][XOPY(9-$7XD]9^Z[-7[ G?45=FT:9*Z,VI/^9'
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MJZ%_'!F)MB@/ZX$.40Z^G%40N'3R*-$ZL@5AJ]D7^6&IY"R[[][L/N6C$/K
MJE30-NT[)#7 WN(<C)2[@C-"UTE64K\;$+[X//%E+^F_F"  A=#<J0$J8\"R
M<Y:=<U]V#IT-VT)7-R_X0Z/UE:E[38XYN)AT2W%NM!5'6@.X>:JN -O)$B'+
M;-2B*F!ZE;X4%]0K9\;]2;% #Y>VJ>EJD%+IF+4I"(]1.+K;=0:5PY'9M*87
M1LYR47>RRZ,90 !:<"D+/^BDT#L= R:IV^RG(Q B!.F,DE:WGO7.T'V1CO"Z
MZ*^+HIX9W^=[BF(A$D;6Z\FCQ[]?[,AB1^Z+'9D$<2P5S9V.?4X?A="UEAC1
M]E#<XLMJ7U;[O5SM=AXA5T/_O1D,&%?4*&%;NJ0"MP9X+R\A]=CVY(GB"29Y
MJ&4?+/O@ONR#DW$7$L5G:W+U"HJX),#RPK"L7_&='@'/FQ;"K*N?F,8:F>%G
M$)+EZ,IPIZFW5N5K+AY?*YT:;N;I@EP$M^RF93?=E]T4%G3(EU^&+<'Y?&&
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M=X$*?%=$0$,RK@@TR'/.ZUZ5OC%I0:I;Z-I,O@[:X3.75[1\HNP6/-DT9IY
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M4Q2KN7:<SVOUS9E-6RFO^N*P>DR'O!UF9ZL_%VZ9X0\?NQ0GUM76XF) ;F5
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M([DX\!2UMM ZA:],UQ%'*<:CQ,_F53#\@V6!&@TVJ>FE"UVXC>IN.*#$O4T
MJUY@1N_,N(QV?&WE%..UM"Y\&QRP@^^3(0M9RJ'* ST95B4+GXE,#@,>,:..
MU6F\A)H$)[&8LEMD#AJD- LIUYDQV(W/DGT.8&&A0LZ,)05)UR: 7F\0.)8M
M&KM]HBD<&[]3*_)#]G]P"[/Q&9B>ZS"?B=XT4Y-J'G[-Q:J8P&JJJKF6+>>7
M'V17G!40$ZU2"W:4R_E]%4D8>!VC*(-6Y&*C7?"9+P Q'UMP'L&N$JD<:A%U
M$)3CMECWV0B[<O*@G[!EV\NTR;N:TBX#-P4_&QD!3W#(9ZFG/H<BPW0N@GYW
M[LX^ZR2951OS#_L$G2.'"#/#O! = ZTXXR\$+WH4"8C*JQ!!3@+NPB;W6PG_
MB-/+AQ7-<7,H-\J3,I9]W#+'6'R(H>^0HM,$=L)+MBR,6]AO</=437UQAO!U
M)>R-<'=2)D@!%OKU IF40@!XL5>6S9("JR.*WRE423TLD#.F+'-_II]N&^&?
M>@:4)XUBSC:]+3:B1X/_(*.X/7E-7/(YV>1MGO%K_K]%7AEAZT_YVQ*P405<
MAW<55US*X@64M:JR"SVN1A+"-8O]L2MID0+$U[=<T>653.ZB<CDDSO(-2];<
MM5R$G043J!W!^_)24]/IB#O"RQ?IYDB^QT<<.EUQ%R>GHU*%8;;^,-HUY(?.
M9>2>GC]]^O0_OR$7][+*CW_85<6[#]@U?Z=G)1?PC%DB:??A9V2"R'7[AK?&
M&8W%H?L#ZD7X[?Q..M!?KLMMO[>'N%=;RT:LK'ET>. ^Z@(WC*$?F2^__.KK
MQU\__O*WCQ_][NG77_VG:4P_>1(RBVYJTZ?ZO$?PBS^^&.D;T]O3'\+.K(7K
M:FJ<H@<7LZLT"/J_RVI?5OOG-X)?_/$'+'1I$VOJ755N0K0>"#1F&20,%M7G
M[_@+6>#JE7_!86LEBR!4@$G=G#YG* E'V?(#=[BFTMR!V.L"77?, 09O[A(%
MU!QL68(#4EHWP0TL6W#9@O=F"[XNI.VUD?1:P:QY (&RU'(CYPR#E =)W-."
M9XI%@,2B$C:]$.VO9>DO2__^+/T?UQ;F>$7AJLA;T:Y@YFD]#F;D3FCMQX3T
MLOR7Y7_/EO]K[^AX<E &[!H^58E)E7N8"TX"Z*VY?(_::M5L0A8+!\(@.=9E
M1RP[XG[M"#3.]-V,!M%E41>B\I)&W8%T,/0/A^,BE8=.3PYLF*HZ+EMCV1KW
M96M\%RH9FE6U$!R9=(:023B].6X4RZ-YK&/H<41DO^%SH=.L-HIV&>O*@<W
M@GDCDP8?D>:5=^%+K+!TEF^WV&+T@^[88?U*4=!:SG>RPRQMH$P%4: LZ)TW
M04>$$0+Z#K.::UP#4OU&>Q@M,(+609L_V4;L*BC#+-FX98_?KSW^VN7(K*6E
MPYV:W9D1WV)ON-I[LD5X"VJ-LXL-CPBC9-/$<I+/K#F>EDLT=7$5G/S*9>LL
M6^>^;)V_YB(%1D^=TX&D@--0\ >)BKJ3OGK<##VW"S! I>Q0=\Y6Z^:XH=6%
M+L<!W<V5D2*1 [HMW+Y1-A>?V?YF=6+/+&TO']KV\ONE[65I>_FGC.!RCBWG
MV.<U@E_\\6\Y,_(QHVG9"3 I@-M60XW#)L9^JHK*A5NDPW]YV^;,0"(X2T!@
M?>^Y.P4-!W51->LD-K.,BH5<;>^4B2)YRIC_C.DNCM;7P0ZL>*K^N#5R3O(N
M5V\+XSL[ PF!$TXK)?OSYKIIR')M&-W.X# 6F;BHBX C9>7JD.(1OH<52[:3
MW\P: IZ&8_5R0/%L^A8,@SVE.Z@J"9J2XD:9E;!N">1;QXOI819_>;$S]\3.
MO'9@1LOVE%QU<Q*)$D'ZTH3FD%3XS['W!"X;2*?1SEDACKR2[)%C4X@8$M>E
M_LOY&^8LYI3.\Z;ESK"?.!(%!OV9$55SZYMT=\R"4F XM$=.:Q_G=^J-_YO"
M=4'C'=B=55!$+:?38R;C'P#]VEUV"NW-$532\)!%P<\>/&P?*P*[4 W_JT#]
M:#I[_N/_O'IQ]OCK%;#%!<)M.!Y1.,A(MF$ 3 L^LOI:"3]GAIINW N0"4LP
M)-K!U!)I[,6]2-H_1K08"4&]EXT6[G6!W3@9ZY-R[^.^E5LOSI.RQ4SBNR@4
MWX'5>E6O7A0;XRE\_#58(&LZF2H&X9>U$%.U9)JNRI;6T37[RO!WI7;(L]P-
M+1D\<9[_-NQSFKCG>YI.64QESPN]8VD'54_O]\S<VZ#//[3V=P;(9^:F1(QI
MTEC"J@D^+\4B!Q>\131%)>M$+I_R#INLNJ.:[K)/6K8)=[;H^(HG''96TFIW
M55@[P]:K\3)]\:CGV-H>?*C FN#3W+?%*FH2 O]8D-?B.TU$M\!<T.:8ZH;;
M$%06FKMVN1B6KQO?;9?V^.&W=9<;4E6O!":JP,ZL#+7*:[:") KL"'V_M^M.
MTO,]_OO0V&%X)5/3\!Q(,Y_SF/377C7+!3J:W+30QNB(WH*65_@3.^GF5:7:
MT*.H3$<ZDY&$(K+^.VUIGK)\$UI+=O&&V>AIFM9WBB2]>P=T/.Z;[A(GQLFB
M W,AM5UR4NR:S= IWY'K4N:+MPJ(L9,GBY*#UH0^CGW)H!86OX'P\U!(Q_3T
M\(K$3NYI9/?4+AST)TLG7)!8!^Z]KM!N*>_,()XMESSY2MR8>MET/6+>K15O
ML#NZU063A[0Z 'AA-$2Q*<B-!DK>!JR%9<QK0UE;I-LZ;AP/$NJ9\('@)]RO
M39-CU=>)3("*FF-IN%=!YH!^M/A/=W LY:;++.NJDD9\;_+CLO;=5"&JN?$
M4>>9%1H2!WUJ8<6R:5_+T3<YZVJOZ8X;;HZF[8>"OYJ'<"3H)9(K,SEMH(K1
M']@5MS,D%)%%QC97>KHH6$?2-I'ZT%=Q$JR0LTU9:!:EZ_-Q0*<./>H:NMY3
M"7E.JTU>QFPBOP(GL+8F+Z1:,V/S*8")3[&=+V(SX\0P24.SL_J.Q+W<B50J
M$UU".X&N1SMVX[Z.Q594E^KX"O4EA?K*^Z!/A)NS> 4]RX_N;CH\ZU6/?\2+
M1F,VY0*"";&7$+<F'OF!GC%.\_B0S_R8.6,[&;[(<>1D<43,NGP[6E9B_UT
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MP4[_X_&CI^=?KNCA*T&.6*+\/QX_.7]L?[>D]$59:R*[Y*X<>I6G7P+P@D2
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M+ZO]OJQVXY/KBTZ<Z[JIF7T#7D_7#UN#LX4_]LPTMZSQ98W?ES4^IUBO$0H
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M0C(&GYY80,B>!NSA:/.A/C@"6=^J7D'()L/NB;W)B,^].<2CPVX9T5_?:*H
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MW9\+"+ F+)# $[+@?!;20,[,W]3"V@/G2SD"6OZLLU(?IRY:@+8T.S=S+WY
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M6;Q>O.RZ:8Z<!UGVX'YGJG?.YQ,_EN7LXUJ*OU(VH\OTGHF=OYI.[Q?7MGI
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M#X)L__@YAFG#H=XEI<?VISV=!R<0K@MM=#R@ ST>52/X67'@#YR4MMYA<86
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MT8"6% [EP;J4'IH_SW*]V,G3;)3)X3=YLT,.NPU)/D= ZFI1"^3FYT)N?K]
M;A;(S0*Y>=>3HB_/-Y2NEK,@T9JMZ?.5RJ2J<4S91:ZU$4)EW["I]V>(G&=P
M&(Z,/4'^!!+L?(-;4,.@<;=S- ?(#I;^"V Z%G/QJ<J4PZ%T7%++: X2-2CM
MCEI'YLAF7/,.Y5#X4WK7KA>F;)]$2$VI',^/"I29F'#3DM_0)'CU) -)RI/>
M! 5,"*A]Y $M=8*W<E2]+)=Z(AQB$O&P(R01<-C'(_6Y,N$BRGV21&()78E;
M$ S),@!HGVM ;3B2>!UQ1K9#PY)5/D'H28LF,Y7T7Y39I4R]+80R(Z%^&WG.
MV(W;!O4U_[W2T50 58X?@AG0;<C9.1B*P'I8H551!]!+CS(C1'80)_$6E.UF
M!\IU[".I%YSX"%>.7UV2.=7J+^SN):86,UKQSGT=8^ 3Z)3!)::UG%+=@8+'
M20Q:2DRR$02,KMD%A'<4'_SY3(0"E&XF<BR?HZ-,6W- ^\=9NA?M4@ECUEEQ
M?0*EP+GI6W/'Z_OH&*L=L\0<3*@FG;PI-0I1B@QYR5GWV[XY\O32KR?>YG2,
M=_D' =J%4<.>W2:PZ#L(,6 ['U+:FYYJ$W39&2$98&_'@=G@D=.BA=.UC:4!
M5M$&Q( ).M=A@&"CPO3XA86!EN(52D<:2),R^X0.Y'O*<1(O=B!FA[BQ[T\[
MBO RS XPE$3G25_0;:PD4G[MZL!*!E2)\=?9.6G&0@/:W'I8\R65^!4 H,1#
M%![>"F;08_L$^< \K<Q J\]2PBOCD0LIDF@-..2DW+/VN4W:%LG8LW FQ7.N
MV=7V 1W3<N(0K$6YF&BY,74)I5E7T$&G;0Q0Z]0KH'8"HX,RX2W*"9+T9,FW
M.AX8= +:8'/28(M,;GN4E+4"(IL].P#!J"$X1AO8D,6=/RCH2UI(3JTRN*4T
MABRJ-%.$T[77JE0/D1*X=&S3U_><F]'-'A=1?#[6#(3!Y_8IW>3+(?S<0SC9
M'MGPM)F(2X1W?E;9%,G-RE8*&OLXDWF@MB'E]N6?MN[$BR9\_4JD+NO=-DX?
M3K*;<SK\Q$6D&HH7^=7,O8),!N,HNH(&+YLVMB[7*W8L]%UD:2+[U*RQLD!*
M)I_S27NU[BGVVYAI8ES\R#Q=K[Z3-4J%)[+:]_ ]SZ%&99#N?*5F#F6EFX"!
M1,J8EF^]TZ;L/5B+:U7_)'X@<5]4R8.?A1O<Q(LQ]P;*'(>D<I!1CG,JVE13
MN.J)VJ6\M9IJWJS^L2MGZ-T>=Q-6K7;=D)+0FLE+D^4@Q<FNV7K)TTE3EOCF
M+"N%@HPW71F%)@N-[P/064.W/=)_B:!4DH=(:I[W8=<=A&P2#I=PR_E.52&(
M@ U6,6K\YP!D?N\E)AS+0M_%L=ZK'C,3N+442U'Z'B+%%M-ERTYVYO7J?_Q
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M78J,-'&)E8D'R$\7S_FR"4K?+LN==[?06\6+R6[/QLJ/!A21_=7-XF4I-OK
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M2KMG9H'QXN/>MFG"_.SY[,F(4(%X=Y-'+:MCM&)$\2Z&RM!MU=Y29%-.T?>
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M@N/%D1_H1(KG/]2^]R@/$QT;=K6 TMY34-IO%U#: DI;0&GOFMN6SK!C'\C
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M1<NO\1+.ZXDJ=$]AY@AQD+TV-JA$3V.A>?V2FSS?BR#8?8-7)':*^.)K."8
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M=,H/RT9,=PP> 6;.88#G7,ZWJ/#QQ>[>2RP9U LC4 TH!&]!ZETJVO=$J$K
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M@:#GSYD!0R[D.3,T@,#KY5W/3$2E4 ]9,$<U*"AJO#?X,0K)ZD"X=,$$&I>
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M'6=9!6\[510I!V[[!;XU&&QO_2[:[PY[SX4.KVS! V/ K  KL( ;&O7,]AP
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M]9Y[^KQ(]4K3W:BX$E>H+2851(2YNB2A:%#!N*NK!56Y?UM4X8.HHS("O),
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MT#:*" I@305<U!5M4SS5G!3G[^C.D_R,OQD ,V^<-Y:L^A%K,!4<'NK+5C#
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M.+^&HI!WV"H^5AF RABX,+96U!.20A_[8FB0\Z51J/H'MM_\ E]2E-;1'!#
M8ZG/A3L.Z?B]L@JUT;U"'!ZQ$OORMF>ZZ0*PA@ENR@^D@D]T7^7B]FQY@-^E
M4'1QV01M))9-:1TPA%*L)@ S#8,RB> Q0$IC+=%W>V/07'AEBQ(I0M=8EE,6
M18X!M$'L[6##WQG:@T-8"=DM>1XCFJ#MAVUFU!681K45U4#(@@E-3K(RX/O<
M5L*$RW),22WS^*?KO+$_,1K1^"66[H")IUK[4X5JS@@#H7G!N&-=4EAQ:;HV
M^#DU_ 2"N-'5IA%9=6!ZRKO!95H16Y3FE;S:H$JTY4AOR\EA_W3?2#"3N)/F
M92I]''4_B&QV4<579JY1WSXNO!P<:'S#QH)YB> )+ Y1J$;P2J5>U"7G!IRT
M$ZCZ1-Y!QLT;5E05&"H'#=$*V6-:'3'Y@JGJBVP IE0]DR_$:O)--/EIT69D
M7D/;XR)-/"XB!;^^]5=WD9EP3\@8C>+ZZJ,.JG'J /7H ,2@HXH@U+$$LRG-
M@_*)CIF@7)) %:7#3$G> L@<7XH:EWID>6:[8KS' \8!+Y\20TN:H3IR !*B
M>N_8,(Q$"1H^*+QBXZS%#!3A-Y2[:;3X@;-F3K6>!&T<NAS\1>;#7T8>O:9U
M_O*XY2^@X+]^J#P779>%7K&/G]]=7EV<?/UX67D@U,K5)OA7Y[GU<T$6<5<*
MEJY#_1/9!S!<M',E'8++O)Y>.02.M$PI4*>K4BA0D;>33I9]BD((PR@A+,A\
M?=Z]^ "&\BV*L?,0 "Y$K/V'R[Q"N,4NXI9:;GY!C+I%"P.R+.$!QO[(=I1W
M5;#7O2[%ETOE,'D3C&)7CC&VM.VDEZ N"A%T""*L.-.G0Z/2^6F.N'3_*F+=
M?^5^RE^JH>-??V=QK:7G:6N=+D0$$$(ZZHBC; JTY0*>'_'H>I%@N,J=PW>J
MB^:O62/W%/N)Y[M&8<H761P*MCE%/_%!O?FBWO)[21N.)H"R9EGREUBYTK&5
M*[9RI<8\^0,DD>9),G<P8/N7[_LU-6>^G%S5V07\RCY^K+P>P+I^\R9UIPTF
M=0SV3A0G?^6.PE^Z#T--Z4\V$P3_Z.SCU?GIU\NK:X>=_^O\]'>Z)>+RW;N/
MI^>UIM!K:CEW>GGUY?+JY.LY>W_YQ_D5]I^S+>=J8/&N [I?(O"+9&\HQ4ZR
MQ#M/OJP"6G7K^K,&[J;AH.)XMCY$=B;/9H>5\6YWE?L%J8Y%5FW-A4IHLJ+T
M,*94G<I]EZ^D'<SRVCY]OZZ^\;-(P%&:N.)0DER^64Z32^4[%I!?ZJAO[Q6!
M/-*8H"MK#)$'A-2-E:?S'2<&FGJ+;\K5F?GI*:+SO#2S1=?J44  ;P27^0%L
MNT'9 CK*0/636*]@UCX6I\8P'2GDK0,8RZM @#S(EC,5 >2=&,09ALTZ?1D6
M/)IC+S7WHLG+LS0Z'F E7TQ4"A,?M8_I]9V SZ(L/1KZWX5W?.M[Z1B(D\2=
M^@ (/N#31!PE BPT(#O-6S&1-HW]"N>'!>26.9ZMD*=8C_3WZB5XR\L-7)JN
MN]<Z.#S\";GQY]1;\M)N:Z_=O><=8*K=_=U[7NJU]N\;I]]M[:.'</=DK7ZO
M_ [\)9Z'@Q)7!\3MBP"X1S7KV[64#.RT_?#X%K B?9XCZ?G@#\<W(J8;%I1T
MDV(O_[YP.F@(A=C\U_T^K(Y1N1TK"S;8W3)UJ*47B;.#521VNQ'MH.?TX,$J
M81\^$08K5A)-33%M*C?\J/8H?RR<$OHD3K4+W2S,YM"I &A=$/QX(;DU*.!D
M9)G:,G6],&N9>D,*^*(2VY:SGQEG+V?K.\QRY86O:I=WV_M.=[<-T._B/GX0
M$:R*T=7")(TTNE>+CN1>LRI@28[6XVJ+UA^6;+)8L%BP6+!8L%BP6*C$PO:,
MLQ]MF]<=3_4I9#K#\P_7+JR]GEY6W3'YU'+O1\-_W=C%#\-'*9\%/^UV]DK_
MVRTONNZ%A/U./?'^Y'A^X7Q7=_C7AX/,P_1T6&8AUD )>EWU8M%=/W:S4;_G
MRIPG0?2-O<^F*;=N75VYKRY8L*;F#S8U]^J,_2?'MN7!!F"A/MRTI,F316Y=
M6<Q&+Y\?$_Z&O6VN?8#B/YGOL(O66<OZ=_5CO:>'O[4M?RPC[A[4$^]/CN<7
MSG=UAW]].$C:DQ?"H^:?9N12/KE.\3C/:+:9H?G2\=T4$],Z!/7BSL]"!)Q]
MX;-O(K N7EWYKRY8L-;F#XYD]NJ,_2?'MN7!!F"A/MST7H0BIE;/69B(0*?1
M3ZD).C4D+UFCZGI7N@(P%BF/9Y8,ZLJ,-N;Y_-B5BC79GSBX]0'KQW)/#W]K
M?=I8I^4["__Z<E!N8$Y$O'GR_*7C]?%,2(N0&B#$PM_"W\+?PM_"W\+?PK_)
M,34; ?U1;LDZ+6H^1^'.^60:1#,ABA[)MDU-;1G18L%BP6+!8L%BP6+!)CV;
M8IJM%S&^:LDF->Q#)L)0?!.EN^^L;U03UGMZ^-ODYP\NO=NO)]Z?',\OG._J
M#O_Z<%#1GN9TS'T8H:;]K>N.T:88D=;DKQ?__1J%/,5SPQ<M^"T=#T0\<MB7
M\=IGARV"ZZ#@[,F.9V%>KEE;9WGPY?!@W;%0'V[ZPW<WM3(M2IMD:[YTGZ ^
MK/=K- [9&1\'7A0/K8-7/Z9[>OA;6_+'LN!>OYYX?W(\OW"^JSO\Z\-!MF=V
M??G(!BB?*]==9>F8O>.P]-BW3EM=^:\N6+!6Y ^V(@_KC/TGQ[;EP09@H3[<
MM)E%:;'9)+ORI=O_]>&Z"Q[[G%US/_R/=>7JQW)/#W]K1/[@M/::5Z]8OGO>
M?%=W^->'@VPHLKY\9$.1SY;K>.B+@/W:8G]& 6A86T928S:L"Q:L,5G/O+;E
MP9?#@W7'0GVXR48DZ\Y3VKR$/_D@$/379>#XZ<'0Z#0#&D^XZ<X&'-WM]QW]
M7^?1FOG(EW%=1WX*2W9+Q^Y4L]'$0G=[T#WC %@ZH:^A^CBK7T_FLS%/6"+B
M&^$Q^%N4Q>Q++!(?4<X2'Z\\N."Q.V;==K=+MQZHMV3CV@52TJ]PYBEMPJ(A
M2\>"+E'@X4P-2K\$$?QCI%_X)8-_B23!-P=^R%,_"ID?LC/ABLD AH8E=&C\
M,?>,-2];"0S[28RX.V,?9E,1#V'P?$<S&JP%>_5AA6G$_H[\$-=BK-1A%['N
MM1#@5-X-7@'AL2N1"(()KN5,W(@@FDX07GX81C=RW:G@DX0 $1I+XRD[F4X#
MX;"/H=OZ[__ZWFUW#H\3YD;AD$".'8"OIX(Z 7^)H[\!@@E[#_0R9<,XFK!+
M@*@$1><0EUWLY!T^AI_[^#,^-I=_"PNAG1&H+@$:L$K8K8FT\S^^(,B6;FX(
M@/I#Q -VG0'3@KYV<&\H'*8BE.22\CC=@:6Z"M7PR03@-9BQ]U$T"@2-B>7@
M"4#HO_ED>IS_"Q;MR<E8HL9GTX"G.$3BP#1ND*$]4& A?RV.0'[X;M(R-@P<
M<N-'61+,#$(Y\V_\!) #WZRPUY,!BJ7B&KHISJ')^Y[O <_XOOS68; /!++[
M3P8\0?"H'+P%5,'0[$$*FJ>^CV&:^41$&OX%^>0P\2=\1%0LW'$(0F3D [LC
M*3H,Y <LU /6'H7"<S2T$3*P^ &0& @11 /(Y&\B)7(!<&4@U?XC25JC@Z"#
MCSW._@#$^*"A]W>/-1X*Q"2S)!43$RTH; 9"P"YO>>S!W-$-$G.?30%"(9 Z
ML/N_=F(@:K43ATT4B(#&HL2-IC-:;\ !K323B.$7X"EX"5=9H@)"/8BK4,J7
M".9$M.4=[1!/^.0D&")>+G@8LG<HF^6&2=2 3D!I]@MWQP ODBK7KB]0C,!B
M3T0<D4QFYR&L5X@8P4^LB@/_'@+"XL1/9_C=;SQ,N"(AF"Q)Q4;#G:*6X%[D
MP,ZRP!.QL?6"-OY!# XU=!#!!!4-E$(T2O!(1A-L["= =AQ&3<;^E(GO\%J^
M3/Q0XR4GM1G*@BQ)8Q"<L,M;$03X)P[T+8QN@89' I>-RF.@1'W+&A[;,SQ.
M@N@;>Y]-4]Y0PV/)/?(_RF)8G&BYQ7"2C8"T5S8:" O&A(7N79QT^;VFN)X/
M@-Q(F@ND;T4 HBN.W#'(!)2U0,@I&X$X3'*M.XVC&U_J2H1&"HSHCU KE02X
MQV<!H@_D?<A' M664VUCE/:NS8S=LIDA-XQFQ@4.AY-K*8M"]L+_3S:.\)JL
M+ 8E)I24EE_!:\(G0%5*64^,8D%BYP)$#0])ZBR(QU_]6_ZW;TA(IU+&&H/Q
M,!MR-\UHC&M25<GBN)?? CX&D@7DX$5?A@2>%^,Y,9YX$R"+!)&)]*BF7";$
M43I'<>B#F? I@H_#$:#8"L9M"L;?L,7%M0^&%1A@0*]&>XM&2LC5;T;^4:+S
M 2M8+E-_!0[D,?DO[18[0]-%X8CQ((D,ZXWGU@98NGX2P4<#;<SMGG+ \^P_
M FU2GBKI)R3D8 5D\A@O22E)(NAN.5Y:T!#)0MG*"A@ +,- BB/@6A1U8W_D
M2WE=$OQ5!/>8M+05>=+9?M2P[AFFP^XRR*F-H4 \ZG1;!WO[/QUO*)WAE[W]
M]D'/^%]C(K+CO-YA"N:$C/+O\"$@]X@'MWR6'+]B/UL(VICVMEO':44S5)9I
M5UFF/1+6A>6]7&=]+5S8^<%Z<C"T?$OZH+!90[(G2E;>R8@SLCD,4P^TQ6\\
M!O,6E,,7_@W,0RX##*B/ I&2^3L$4SVZ)7T"[^M@CA^BT<YE^"FML"$O0(L&
M.);>XBD)56M#;M&&K+KUOL[\46$\SEUNO.P*XPUM1F>IV5IQB_)\@L&IL#CG
ME[V%L#[:?H3).1?=$],,6&JD9G0UH%+V)Y]-P W_].F4O'">I5$83:(L83=B
M[+N!,.-@KIZ(I,'GZ$9#IW- _O0T]H,Y=WI/":V#TNITV)Z:%^5I&8?V'["3
MX9#[<:+PF,,65OLECE*18<![A 3,/@@>I..6.?02I_LDED'8CRA )(;A^V6N
M+>WO8P#"(?(3]J=( C$KBSWI)/\*3C:L)J)P@"DIO\+FWHLH'@F ,,B]< 1P
M-;__Q&_!=Q]'46"EV1:E6<7%R0T39LONS?Q1'F_%3,L%T;68IL68JP0,"15S
MTJC,]3C=^R :8(*0HZ^)0;PK/O5![?MN'+%?_$@F7)(\7,A"<1O,V#0; -K9
MP(]02!G9.3=+, <3L@F. ,])?*%PFW"9@])V$ FN^6UIX;5O"*]\+UIV7<AT
M4K$/7#?M'5"A4UD@E>(4A&ZB12RX\?X-JJ4QB2Z7Q\((5+*A'ZN\DIR,X@65
M.3^Y!!625+/D":QW0,&^Q_4:,4ZH,DK2@BKE]$ZCUL+JC"49.4\@T'0* *2<
MJ!I0^KE) 5&=I]TW]W%/*!2H]4Y1O&@:ZAV6@I4/'^;"!]:T$GB;]F3E%5L6
MPMN#\!WW9#1(UR$O+K9)USIM/GN[=>6W?/IYU5=DG//0K)?GV542S3!\4>85
MB"D%?&':B5R46GS%@&BJPJ+ QE4^K]9YY^$-^M;L ] 0[#_)/1R=T/^<_<$3
MV$R14_-(5QG:0Z7&\VFOSO\X*<]#7_WAB]LK/E._D#+,4V52O!O0U<K1V+/6
MD(9A?U=1U3SNY?(6JG(JK(W2<\0ZKJ]R.2LNA:O)"S3]$04N#Z,2M'%IG1Z;
M"1XG"PA?.>GW0$UU#;IW#*Y+*;&V3JKN X]O<(_O8^YEY""3&V)^/K\IS0*;
MU%R S(61$. B!_UB\068:G?47T@^]I'M1B&M@^P3[>F/L.@F)%^Q&-DJ]RVJ
MGA7ZZM=:!?E2,%$IU!)'!TGLDP_<PP.E-DRM5>JV_#C*:EYHEW3%$C^-ZAAT
ME'C)EVJ/^0<',A*LT5KM=2Q7CLO$JG8+=LL!YWP:'XO0$I2.*<@K6C3\-18P
M?2C '[X=1R3!=6$=[NBSCM^ [N(DN8Q(-X[P,:]7=>@#">IBL6,@(@&SC2,@
M).DUY86%E(UU83<WJG9D,#.<O,L!GW#ZP@]O<,U4C4+1;N5&^__!WW &(& !
M*S[[? (0_ >DJ0M/%K<_1Y'X3R.M6RD.W6S J0)%H5A_/J]._30I\L)'"]AS
M-!4X[/]E($NSR<ZUCUI?BU3/ 9I-0;D,@0H^B_0VBK]I^^+D(T:Y@#%%AA%\
M92V\H=+8&%[_=')1\<);!W"5 $%Q-U7A.\/R.!.PS71AJ _1)/(P[D<CM'#8
M1!0;DPX_,DJ6J+P"%A-1:2=8"C+P1W"D/2<9%K8FH!3%%#/=<4CUF"&*9ADA
MI4\+E#DYG!,?Y" ^RZ936)<+H$8*B["X-4;&'LE AN'<PSM!(,(1YN67\5=%
M$I[B,Q*12TT6Y^Y4#^#_(ZSU:Q3'2+G79@Q%LV5;ASC:<K"[5V+,5UF5?@7@
M."/]^]6HTYV;40F"]J$R+3N'AX?JIWVG#"(WVKEG05AH%/#8'WXTS=[AW+A[
M#F!D72C?"^3=_B[PT5!H&Z]DFK?8GWXZ7GQG;J?59<I#/P8A%8(&N^4S:6T1
M30J,Y$>HW518C@-]R86^]P,8,&6W2FU\C@8"*^Y!1^KHD(]")1U'5.G1.3QH
M%VLL)&0A;N96JI?@&2L$*\J_\<&:!,K/$"UR><H'P;&O;T"\@$? ^2!"7(!Q
MFOHH8(Q1 (\C4/H@[,!^&\)BT]*6L;H0Z1C%Z1N,KW\6'(4>V",!YE)@0GVR
MX*WA*]P'^<TH_C2+.<Q==@\4]:D4:WNWS/BEPQ%I[ ^RW)B6L! !:6L)0T,,
MY>:T01H1&)@@2<'6Q;1.$)%;I+#[1O\;%%@ <AZA[?D!3?<V%VERH E/T#;'
MF"J/46 %<VHK'S1_;CR#"9)9"*,EOBIK0CD,:$RR ?D@ L0^[-85TS21U4QC
M/$RDCE&0D<+Q6Z10&)V^H^%3$LNL4BR7#@-46!4A.X]#95+\&[ \ A_:,"R4
MJOTW* !'JV&PC_RIKX+22&-_XFJNX2O@R%^C#+P+XW3".P+=>["LE2&"RS=-
MC^M_7?_)?A'$(>QZ'-TZ:+IDH!4N")IZ"/DO<T7L!,T=1\73P0T#=0;45V7P
MR)?.WO_V"2/EX'%.R%XX@:7.$*;$^\I5#$&5@L6#R5"9M$*WR?!.B70O %:@
M+L N\*MLM7(((S?%3ESNB0FYJD:MZ>(.C/?TK+ T6T76T"JRGJTBLU5DMHJL
M;I&.D@@FL9W&&=C_0I;FQZ$ I0G:) BBQ;*&D)UX?V>A2_460W!K9 @3ZU5T
MK=:_T4@KOFO-VX@ZWET=VYV/12SQ,=F;S_^^/C]BO[S[]&]IL"Q/&%0/O,2K
MA8%YXO%_CMC_N_[X=F[QY8 /U8OXD[MLP&632-O\G1C$NAJ\.S=5'BO&F"9%
MT;"(_\O8#Z0[?-&Z;J'IH!/8I)[G0)_'1']1+^<6@)@_\K$<[\LLU WBO6:(
M5H5WX%^.$?VEXYGTW9WG\38ZAZ=3/2M&_&RP>*O!XHKKL>HL-$W67T+AFX5V
ML<Y615OW99I*@\<0F7<=J4.C&1B*L],X^P_[G*6Q+\WO9/&<_/P,M_>/795Y
M+ ^R)+LE1Y.L='\VBH31GP)?"XLJ.U,:F7-N11H5V:=AOG'2=2[60E(4UZ:,
M?DRU0L5-)R]:"&PCOU,ZN7H]=^B,CJZB0)! GQ,MD_F:,9CEBW"_)51H7Y2K
M<0S8)%E O(%E:<PCL4 QNTB>5Z/8S\*Z'79Z?IFH@%J(8;A<YU-T2(8(8Y&
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M#/!:(N[]G5$07AZ&6+A?*N\M<(6K0]'SR<=RG6#NR<+D9-0-J9]Q^H!-S*6
MK:#:,ON<R#II?3]CK^/097%.%<N$?"(J]?H;7:7PF=Y8* %,\G(%H)?\W?/+
M_/>W9!P=S2'2\V^J8IV]5J_7^^D8N =,E-D19B570"22-9@(.VCB($'@9SO
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MC9:^Z.CVP6+I[3^Z0(+][AY4B\Z! #(A2\>@=.T56NK=A'KWUZ=>?P+F7[!
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M"A!.065@S+Z,NY-LE&%P>U=/CH)W C")\47X8T)Z1\90,?3IB<2-_0$0^4"
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MYBM*3N,H<-8GK7D!32GHS24S*FAI.,MRM8DFV[L$M2.+5]#&9D$VF>)W\%L
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MK]Z!C0L7OG?S]8!8A$]!G24H__+5R9L6MG03ZP^@"3SFZ@]G]>:PZ_RH]!?
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M%D1^4@1B*H4+\MF.J]21F961?7HXFV1!ZD^I>8XGI*S":Z?,V_ZJ!Y:**6;
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M&6+^^6=LGR/6&L4(5K98W5H[W;I9?M8R@%6N%J06I,^"\6LCDZU;V@C5V3G
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MB;7RB+4UF35=R%"@<4F/*Q\II4&X80.868=:S*?-.H)\UW6=>YOQ(N'R%6J
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M)3G^##G>JEO$"X7%SL^$F^K(*0(MJ8 B"AFS;33:;</J]8@EJL,2!%H";?E
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M5 )J.8!*\OHY\4)S4V>QD@Q0',1L&"JL)%9**98(J"3KBR52:*Q6-9B @$I
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M220,UCJ4W<V!L2-V8F"MU_QG_]*?P6T6^^W;.;L, 7.X<%B&_$XNSVJ&L$9
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M01B/DA"4VTCX$K"_@5LU&<G'BRG#C ?>I9TX#_V[L1B#>R31MVP1\$SP@ "
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M%6&:,$V8KCZFR8=^<\.@TI;[#F6/"8^$1\+CKN"Q*LYT]?1I<2RN2VS92D*
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M)E74;IBM)INZ_]5G?#,7+D@G&<5I;4"OHX@!"_OP8G!!5]+%W&9Q_-&)#_?
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MN CPK\0*'EA:3IHY<MQ;8'W'O5EF?;3J;:OW\[[C1A./3_>&GKA[!.O_)XE
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MUSMPI9L]S :3/7&E60]FC)^I!OD1>_\3.Y#%5;J!99!$\,+HPZ-(#P\[-XM
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M"Y=F"YS=TYJ_YW8DX)X0>,Y!+0S.O) B>!CK%SOHZ:?R(@.3P=PP%-%$J'
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M76_W.G,7Y2MAGIH<>E0B:.PZCB<>G^2Q7C[)LPG16:^5<7L1H+Y"YNS5.)F
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MP&?P'V)Z-A[G(N:Q& /0(@+L9A3YAV CG%O-$P>>KS@))PB-8;53G"$$/PX
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MNSHC05^D/CM\HGGGV-VRE<JSHU:3TGS1C)?\@"GA2MS+(4):S:9_RBMV>^@
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MM7:TF'[XYF(:_O&V;*8TFX\:[^;CL$R&Q?'%]2)%+(NIRBT=+K#56-#3W_R
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MV&SH8_.XDXX%4_:2,!D$R02,) *TX2(K3;VS*UX=4<%19@00)]J4,@E@17;
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M<F5$<7OR'2U+P%GQ0(2C! Q7#()W2L;,E'3V"5V*>=E!Y=$?Y^FY&G&&OL6
MZ?<G=$W0-:EM#2JQ#71-,*/P<!6;+FHOG0=.<CNSTGNP62<P0H:4HHPZKF04
M*//D9C9F\!P$U1Z\8D7^I>4VA9R<?JHJ-FK4B#&-LMXW^;@;45G^;IV^Y<,/
M8-R^V?9-/:?LF5'Z3S_? ^A/W\T"]%$ ?22F[X"(DG4P^@R**C_VDPQIL-^
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M(J3U0XJJME552T:Q3#4HQXJJD1+OVT!M"?59BDGJ$O"O7/?91:C_9*K&L,8
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M+C*DC"T!O61@M>9%V B)U%$>HMA,0+\Y)5,4QYE@;0 &XQT&X[/T>YI<8VU
M77J+P-8'++HSVW1G7#)2)<T@<1)*8.XUM--LH,3D3E+*K1-Q,X'Y?OF9[7OY
MVWCQ=O]Z7M!/LSO7YGU7(3I.KQTP<R"P"&R_@$6MVW(26B7.)40M2N@NDP.K
MK(,<LN(F$A/=2A*ZF]#]";1.&E2Z003R>)Z^_?OA%M-N;H?#=%@=*7.$%$\A
MAN7*&$4%CQ8R;Z^^Y8Z#-T:!"4Y1:8/7?$-WP15Z/)]NX*(9.C)"XBG$H#@"
M(45(ZX<4E6R;2J9C5"$I MSPHF3!%B43KKTYQ&9/..%&;R@HWY22L:Y*XY$@
M\#!]ER/QO1!FUR4$3^^NTF1>ONDFL9DN!]G=3D)J+C[6PF"VZ_^S]Z[-;2-)
MNO#G\R\0WIU]NR-8&EP*-WNG(V1)[E&\;<EAN7=BSI>)NDK8)@$V0$K6_/J3
M6060H$C9LDQ+(%4=T=TBB4M55E;FDY?*')0J_@["<OA)U<O)QCX,U6NJ<2&]
M5;YS2_#L2^#0T[-F(R9<94Q2XJ<Z(U3FBN1*IX3[?LADPI(\4C_L:#\*YUXR
MXF$I3:&Z\ZFJV:PH+[>=J)B,LB'4 _[JW@CC>-3]"QSIY)33P3M'6*>#=V@)
MG Y^UK9PL51YG@N2L2PDE*:<L%QR$E 5*AY*E80_K@/\4^O@-(V<!MXQ*?5C
M4Q/HEAPB]$4Y1'@UEM^XP&=JY@G67'GS1F%K.:_J-KF'&_'Z.[P@SM,XC%#$
MWJ"N@6R9_QSDVNT@7!O(>@ZR6M0CYK$92,9IEC),ZN!9H@AE&H!D'#.2^UF6
MJ]RGFJ7;<.: (CD"/?*AKJX+J>3;V]]!H9R6"\QXN- FVRT:1=-1L+4#&3]F
MC^X<<!P(0[OV! YW#('X ]D.#G<XW+$[N".,LCR+$N X(2F> 0T)DY(1!G@D
MILK/TWSM#.AC'%C/A3O"8!2'SYI;ZG#'4^*.'Y4&]"@7EUN[^]8.98&GQ]5-
MX^FZFGA%>:V:.^ZLURZB^-3H$LB(O_SM5?C*$7G78H:.L(ZP3BSL+)$=87<M
M^AEL*?H9O*CHYZ.R+S[,:W'%, ^\TIXN/BOINI@/2T*];-_C?A/?.0]=DYM[
M,^!"GZ=1'A&J4PQ<AHIDOLQ)EM(X9$GBAUFXC<#E!W8[ 0YK/E6'XL]Y4:L/
M->; S&X_C%DY.RSE"7P[Q4NV<Y!OE ;/VAS=N0U=/W6GMQQHV%GB.]#@0,.]
MV4Y4QW$,H"$)M0\ (*2$)9&&_TBJ6)@+H9-M1!V?&#0$HSC95BD^!QJ&M26?
M--K87XAP2UZF\$5YF;:18[\I*.G<MX/",.Z4XV"VSR/SWMPA29?]]FS9;SK+
M=>Y+=%GE@"G]("6Y2!(B$\D$5T$0L:UT0+@G^^VT4S _+/MMBUXL=V9S>+OS
MD9XL!T<<'-GWK>'@B(,CNP9',A7Z0H4AX4IDA$8Q_!4I1=(@%IG(9!3RM5C:
M%I/Q?S@<V:9_S,&1X>W.'^LC^S:/J,O%?VPNOBY*5HJMY.*[D.D/3;=UY!U&
M4-21U)'4"8&=(J\CZ2#S[+\0!W79]D^7;5]70BG9XD'U6=6B:!2FWC>S2OSA
M55,TW%PL=%A2RQ%V>(3=04_?<WO3MMG@7,9I%-&41&&4$*KSE/!0"9)K054<
M\(!GT59RTUMY^0[$Y05*R',K($]:R2FWE%U&\VVUEW&R8GBRPA'6$7:W".NT
MV[-V3XM"KJF6))$A1HNRG+!4)R23(M549GX2\ZTD43^-=@M]I]OVPH9?;!!G
MO0_ >B^:9LY*8:SW"U47</$Q"@5#<SY6'KQ8J[I6TAKWSF,V$+WL2#H,DCJ0
M\YP@)V*)UK%01 <AF.,ZB$DF(D4BH6F0J320V5::G/5!SFDK,L_U1R65FC 0
MDQ\Z*6D0T%803^2/Z/,>%W/2PI'4D?0%DM3IM.?4:3**F,!*RYK&8(0+T%29
MICF)4QWZN9;"C^)M&^Y/I-/B?)0FN=-I.V["NS#\$*2'V99+ UY4S:SQ:C5F
M,S#69]4/-.>="VUXSG9'6!?%&)R(&N1YG&U6M\L#$>F< DI+4D(C$1,>9XHD
MRD^42F6N*-MF=;MS;81^A]:.4.1OIW>K"Z[LBMIWAWKW1K4XPCJ=/3CYLN\Z
M6VF:T$PHDM,X(Y2G$<FBF)(X$"K1--=AOA8R^)[B<C],9P?AMCPI^RO"!L.+
M3W3VU;EB!I93458SN';*;M&CZOR< X$6CJ3#(.GC<=H3$'G8,.V__N-SZ ?4
M;8"=W@".I(ZDPR?I#IK3>V2PLMAG09X)DNF0@?&IP'05>4XBEJ8RCF0HJ;_M
M?( SA*T?+&K=TNDT/]F6D]F)!1?X?\G6YD<UM;ZE+1F8^^O^V5T/MB.L"PT,
M3O#L>V@@"X3/-* F$<N4T" .219&DOA86I-%<93%^3;"^0L!WISK[2.M=  U
M- <NO@;#ARZ8OS>*Q1'6:>S!R9=]U]BQB$%A2TWR0,:$9BHC+ LT:%\1:E]E
M-$Z#;?A&?JC&SC(7R-]MC>T"^7NRNK;&O?&MF% ^?0N;L1#-R/OMMR/GK1P(
MF' D'09)=Q"9[1'VD:%4>2X"HJ7/"8T#2?*<,>(+'B5IG--H^^4+C^!I=<'G
MIL(3?G&H=3$NV.Q;>H%\J>C!* X2%R;:*RGA2.I(.GR2.EWVG+HL"*.(LBPG
MG*->BD"A,04*3899(G@@?*FW8L<_I2X+1KZ_K:*%3DJXE(>7;)=C\_7I:MN!
M/^?%[-8K2CUO4(Z8+V=7RGL+GTO5--Y1->%%R7#7.6_:H!2TZX/Z,I; 8:IG
M]0\PGT>I4"13%"L49&#K<\8)%P'CF>!Q&J??XQ^XNIW6*X"JD[P]P;L=($6#
M$4U=HW(GA9R&'0"3.PT[G"5P!^B>Z0"=TR([9\EOC*V'6[+APQ=EPS^BC31:
M\ );24_;MO(>O]W82]HYR :BP!Y%TKU!#P/9-O\YR+5SAOU3K/T]H1(5I9'V
M%8E"H;$\M$\RD6@BN!99HF0>IWH;87\0V$<@KS^TXOKM[>^-DJ?ENTYD'RXD
M]I:.+22C]'F/B#I@-@0-XDCJE+)3RDXI[Y123@.>9YE*B/2SB% 5!23WF20Z
M$RG+I<XCG6TC?^&)E7+BC_+H67L0.9T\B+2'1_E'!DC\@0@1=(84I0!*-@K^
ML(X15DK[!Z8V7,->+6>-^;)6S:PN!+9UP-]=J&50B.PQA)T44HZ5(^R/(JR#
M0L\(A53$="0E"6-?$9HGC'"6 K:)4B8"%B24BVWX)Q 'X;\G2VGY<2$H\8?#
M4JY^T;OR@ZJ+"H"3%<''RO[_Y+,8SR7 */CCBI67ZB.;J1.ME9AMJ6)S,LI2
M^HR)#$[P.%6Y6X1U'.M4Y=ZJ2C]B2C%)DISEA"81NO+SD# J69QF.LL"N@VO
MP0ZJRB@=931VFG(OG G?YOEYH6Z$1R4QX5X=/<AK,/*X@FF6F&Q1:>]6L=H%
M=0:BOE]V4&>_B>_PU7.>@:"ID#*CC,1^G@'"DI3DOF#$IWD<4I:*+%@[5YK+
M),EUE)$T%(+0,.4DDQ+^PZ2?92S/8BVWBK"V$ZJAHS![UM()+E0S!,GD2.HT
M[<LDOM.TSZEI=:;C4.F8Z AK)V>8 <'BD- H%*"!L7RRO*MI(Y''6:!2XJ>@
MF*F*8\*%T"16&9=AS.&?='B:-DQ&E&[K-*+3M#ODQW!)$3_21_HMO@P%7WZ7
M%\/%> 84BM@HUL*#,$:Q)JLY'ZO= EH#V5&/S%-]FB5T<.WY D\AXX(SS@B/
ML:58'F-5"!H2+2*=Y&G =+)>.C+D?B!H2J3@$:%!"O<D84A$G$>Y$EJQ=(!N
MD2 /1B#,AE8[8M/.<*#-J?!=)ZQ3X4Z%.Q7^)+DC/.%I("DH;BU!'4N?<!4*
MDB5![ =9EN0R=I$-I\'WP.WBTD=^C&#YJ$ \"%/R%N5*I5OGRET7S&B3#P8^
M3ZL:/Q6EJ;O9S-A,8>>,_^:U]]=?X&EM=0\V]J954SR^#J>+@ST&X@$!\9>_
MO0I?.?+N0J3+D=21U F!G2*O(^D@ :.KV3Z$/(&C^PXU.W??H.34_A)V,%OA
MZ;UXSC7WG,E0?A:&01!0$M.8$<IS2AC/0Y(Q&C&:<TW3->?<8^-KA^5=K]OA
M[(C5]6U17OX/&\^WU%4^RT8T=YWEG2QWA-TOP@Y&E#HE^;*4))>)C *6DCP,
M-2C)+"#<3Q+B,\43E@JA]5H2RF,C6$^C))-PE*0#B%0-7.+LAA-AL4^<^^!9
MA,;';50]<SZX8;@UW1&JG2"^ T3/>E@Y2<.<QI*$?I)A2D]$N&(Q42)(J$[\
M7,9;R<I=R]_Y(:>D1DD2ND-2+UWV.)(Z7?HRB>]TZ7/JTBS0B<YH3%**>I&&
M,6%IX).49RI32N6YV$IZ[)/HTF"4!,_:2=[ITD$D,KC\UZWFOWZJ9FQ\3\ZK
M*[P^>/WMCBD-9RNY8TK[A<2V=DPIBBA+$Z9(E.<)H;Z."*<T([X4H<^R.(G9
M>C5X=]+8G5/:$TWC"/O\\G_@:S 0^>U4N%/A&U5XG/F:IZ"]?2%B0D,1$:9]
M2B(9*>DGU ^X[TX:.PV^!_Z6;W..O5!/RZ.\M!?SZ71LC@>SL2>+1HRK9EZK
M[M"QI\?5C5>4=G/"IGOM8E3NE.">D->1U)%T^"1U0L!Q[,Z0U!T5WBMT>&0+
MR@A57"OIZ;J:>*KM*X8(L5:-8K6PIXFENE;C:HI0TINQSYZHE2S<H>*!233G
MV7.>/>?9&[AG3XI 2I5)PJ2BA*910K(\]XF4.O-3&L:17$\X_H96S5>WT]JX
M]3ZVHOT=2/:N8>2Y_MB*]<-2'B^%^B?V^<B*]"TUDGS.?LO.H3<\_>((^_Q2
M?^!K,!"I[12W4]P;%7<0Q;E*5$QX[L>$^EE ,IU(HCAE:9A2SFGZ/8VCAZ"X
MPV1;/9:<XMX]OXR+Q#U#) ZVF@G&N3B<<\'O(7D=21U)AT]2)P0<Q^X,2=U)
MMQU!?6<MM&/BSWEAFS%XID7#9R4]UC3*1= &)HN<(\XYXGZP(^X)%G6C'VX@
MJ_I?__$Y] ,ZQ/WIO$I."^TZ89T6<EK(A8.>(ARDPCS&BKDD2;5/:"02PKC*
M22(I51$-J?35]X2#EB>TIL6,C4\^3U4IB]F\5LUI*>9UK>3;^>RLFOU3S3ZP
M0F[G/'7D3F+MG$)Q\9_!>P).FV;.2F$"/D=C,/V]0^^HFDQ FES,*O&'-ZL\
MYC6JOB[@HFE=71>P!;#+XR(E%W:M;?FX>I%I!0E2IE16.-T4LRMSW=MY ]2%
M-\%[>%$RUPIR0 CO421UV&X8V.Y'+YY#=<^'ZGB:*S^-) E4(A"A*<*IR @-
M)1=^KF2:K27Y?$MV;H?JC-1'K:!DL)V4VY'O#ZA<H4-M+C"V+R1U>M?IW6=?
MSOWUZ3MM\X0^ O@_ Q*9/^\CQE^^&5$&WT6,Y6;[!G($_F/H,?QI/XG+XD'$
M0V:QA!ND2^73E?*8$-4$!H<=Q;RRFL$EK(:O <T#;2]K-O:FK)ZAUV5VI1H%
MP!U](9A]@2V2J])4TV98:U@7)2M% 7<T,_@"4W6;@ZUP3O#R6.<=>3;6>=#X
MXCL+>[7PFT[9I;(ZB# --'[-QC?LMGGSROOK=[! LL,<\ @\\/=_?CCY^.[T
M[&3DG9X='7B'9\?>Q>]O+TZ/3P\_GIY<;&5;O3":GIU_.KGP/IU[G_Y^XAV=
MOW\+Y#TVE#TZ/[LX_^WT^/ 3? %4/SP[.CW\S;OX!%^\/SG[M!UR[[(0>P2Y
M#R^\\W>&O._./QJ:__/D\..%=W)V#%0^/CDZ>?_VY*,7!2,O],/ 7 E_^"^>
MUH_0Y?9:'-)KC'06 L;Y$QN//3:!L<VL3B]*4.'5O '%W8PP*J*P&<:55??2
MFZJZ_03JG/T\T&5X!.Q_/,Z5Q?6Z>_9!CVM=HV?SB:H+T54DC63F!UE&LIQR
M0J,T(WDJ.6%9IL)4Q6$2Z&UX1L_K2U86_S;QJJ,%0H,/AZ7\@$5IRIGY>*[?
M=9#M8H'8CA='JS[!*-Z.*_''*T\U@DUQ\>NYNJ]>4'@01]%?[M8+>AI@UWYG
M+'P82)*D?^DSS?_.FUFA;P&"X$(8E/NOJD>D?P'__TO").MBBI^?7J ^B*F"
M ^_\XZ^'9Z?_]ZFPX6-&>?CI]/S,2//CDXNCCZ<?S&=0!6]_OP"->]%7IMOC
MI"=FI"<00(.CS1 R!1Y$RK_?@BX#:U0!>"[%@??3K+I48+W6-K1?@#YLYKPI
M9,'J0H$N9* @IU-0F^C8&7G6&2?>+)YCOY!O1B8MH/OYR!K.W8\_CTQP2=7C
M6^^/LKHI\;%_5VP\NSJJ:N^(H6*NO,/>20;X?@K#6[RON[CWR!MX2%$*N+"J
MC96-8X6'W<)4O=-FC,H<=+F:3$V['SLD#YY]5EVK"8<Y!YD!6/Z!A_;^RJ#S
M-XTW5I=@L:,"\;@2^+^[Y+LG.P*U!#H-K&=@8[($4+Y/+WO#8G(XRF,E["C#
ML(6!FV[QCF'J/:( #:32"R^$E=S<)G*<@73WHH/G\[P\@$4WP;4O)9L,<0ZO
M?CD ]MC(&>VJC>YR$BP<+/B8W2#([%C:L$FWWK\!,XI;;VWCX9K#0O]63( R
M8^]"%*H4N',?^%A[7^]IL$TO@5_,D/')13FKO$9-&6XR[^:J&L,NACT,U_1%
M!3+[<DOCC>V>L7>0S7?,EOO.SL/F(TG\H:C-WFLP?6DQ;>\<_C!S:*>X,ON[
M/XZPT. 4%^%:C6\/%M?A,-2?<U 1,)?NE2C\S&:']VTFIQ$3T[J "<*+BJKO
MV.N=L(>73BV6;*PXZ/R"RZOAY_EX9DAP=V'[$SK8Q.9/Z:7=J'0=^A@6^O@*
M;8:-2'J:URL:ZUTOJVN&6]:3Q25J >_*"!:/=XK "B=O4C0-[C?8L&W"HL<T
M;$.)8,7L(R9@\S8%?BPF[!(5)GX]J<IB5M7X<78%9+B\\N#74LW ((6M694F
MG;*[ X1E1-^\_WAJ_O\SOJY6U]5XCIL=)MH.3Z"0U48V5%-\OZ&OD0 W53V6
M!\L]_O\UWL5-54V!MU+ZQOM0U29PYKWO!O%Q,8B%I'[_<0D/'J[]^H'*X$D7
M]K2EWL5M _;SLXQX0T[Q<A+)0?IUYGP_:+#TZA=@>SD'%O>NX"'DSSE,='9K
M&!>C53/8(^/J!C#D@KMUH<88,J]5>6DP"3- Y1KD%3 S;#5@<Z\Q2]:T&AFN
MX,J;-Z# ^&V?U^'E6ID=R,9&2T_8'\I36EN%"S"X*)'\L(WA]56#*A^@OS>%
MS8VU?@O\<(U8 ,8,FK!1LQEP#&QO,$B4&8E4F(X,TV/7^#[X5,T;T-E<*104
MR^W=VUS+LL-QX/_TQ\\P#@7@!3>3J4.,&_+W@XL#[UU5691\7,\OO4,)*K<
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M)JYA@!5P%3,!0/1NMH[BQCHT5Y(:*I-=U44N51M4N03FJTL++3&4,F-_ )T
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M=)B$*0F$%(2F/"6<A3E)PH0%<1J!>.-/+]]\)]Z<>'/BS8FWOGCCDD<Q\W,
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M7%4GX!R <^+-B;?5(%*4))3Z(?'C.":4<DI@Q)SX02[C,%=)'NNUHT:Y]*4
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MD<>6W-Y>VW@W"IA:L;J\EZ<OBE*H%8< 0*R[(GOA>%C3./:UM?IS7M1P-2@
M5J(BZ7Z'^Q>&!SX9E,AU(9>C =7#"QR=U4-E ^:B-"_N/0J':J'8B_ ^_!B+
M!JAEW$92W>_N_S)%@BV1Y*ON_N%LO'=DV((A[:VP=6#_]]4B[W?*+I6-"1&F
M@<ROV?B&W39O7GE_?2P+)#O, ;P:RV^,&?S]GQ]./KX[/3L9>:=G1P HSHZ]
MB]_?7IP>GQY^/#VYV.@Q< 2]GZ!GYY].+KQ/Y]ZGOY]X1^?OWP)MCPU9C\[/
M+LY_.ST^_ 1? ,D/SXY.#W_S+C[!%^]/SCYM@=:[++X>0>O#"^_\G:'MN_./
MAN#_/#G\>.&=G!T#B8]/CD[>OSWYZ$7!R O!3#=7PA_^RR;T(V*+F_RN/R$L
M8A,86VM9&+Q3S1O .6 T@R96TYG77!D#&: /X*KV$Z ?]O,0U^#IH,I?^UAE
MR]$0,&1T'&LP4:2D!$QL,+1CEA E_32B-!1YL';X_#'&^>^-.M<GS:S B%KC
MPAY/&_8 ZJ,MM*#_GKGV7<QCX#QI8Q[PN"FK%Q[5;[=W46O 16A!%[-;[Z:8
M77F_'UP<>+\>'G[HK.YFQ7H':WW"_@"COV-]\R;6-//)% <"GWDUGWEZCO%\
M#QT%L\8ZC)D&:3@S3^LTEW6J67,=XR[?.'SS:B'LT-!K4%;&Z?!NY>5X%;RT
MJ#UE1@"O825<Z7%T58/>GYA7FMD+5<]84<YN#[SS$N[TJO*RPB=SUA2@6('X
M8/48SX.Z9N.YH0 \O/D"1= )<ED6NH#7SKY N*(T*DF^_NJF"<*#;,&MP]\U
M/T:<]!1WGS:)'9(LFNF8W;[68_7Y 51H$\N)4<Q 3;P-A#ZK9V_,O C,8-*\
M!BY0>.^#*0.L16X*.;MZ'1U$"T$W? '3D:\H#:D,%;_I 5\@:)\F<1KX&0VR
MD-(H]O._F)7^#&9"N%CKWCJOCFJHM'OUR\=57RIN[U&[O5&6=$)G17+/,*1E
MHV%3-H,+S"\-7-/HUG$.GS$(AD-"IVK%@8W,,T P;7PFT+N4;%R5\*<:C_'Y
M4X"J:AG'OKCXL Q^W_]\&X2VDJM]_C6K"XP)&3%=2&7UT'*'&F^I_>_C=NI]
M[D"W5=U6W=Y6/1R/JQO#[IC=**LYG^GYV* *1"B.GQT_[Q0_GZD9J!V3:8'"
M&3$JB'NC#%8T ,/@'?J0F@4B1<3=S$Q.$<ZV:C#! K%SS<K&I "@A#=JHB@1
M6E?U[<A<(=7$@%GXM\7]<VL@+ZYS^\CMHYW:1_]CC#O$.JS3$(TU$<$BGAH[
MM@*^UZK&N/2,?6[3/-[@+G#,[IA]EYC]L.>%@.&H>FR\*:@U-"OJ5HN8)#_T
M&+&QF(_O&!J5^(,@MYELOZDJ&_N[^HQ_JX--.V(/_('.43IPN;!ZTHF;<TAW
MW77 IE<%<'"-1UFM5ZZ<%:*8&DP$XGX^[KR(M2JE_1-N0@NXFL/])FVO[\DS
M[LZ^UY2#%%;7RH;J )XU56G@F=ELUG%;U&(^08/=9+TNG04KKM4&M<Z*:_7
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M.15Z";-I3!>HJC&M-6RS!10!\H<U@6B[/_1Z5KN^#H,I@QWK(%8JC$@6Y8P
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M:VWJHGNTC5JNEQTU[A1E:]I@/>(VXFK]/#CRRKI)V&?#=./V\@79L+^&,EZ
M*:O-ZMCQM$/>9<_X(!,\!D*;86O#0RP=9?BVJ[2-@EI6ALLGL.ELT%[IPAZU
MLK66UB22Z9[72CF[$>](IU:=&8DQOK7^1G,DNMP@RE:T&*:TP^?6U[OH=]<5
M$VYEYH>-C2Q'IM#P-TN9XSM-]00;B[;?WC+785,UA<UBIS?INW(2RXO<%6%=
M_[].+AC"=?/&Z)Y-&2NL:[("OC,%T'IM WN=/-NF/OU*"2#D"CF'.U:J+B]O
M:95YFX^QE)LXI56IV%,?=U>PE<]8ZJ1U<"\DLXTA]HEG)[2@7?]UJ\W'EH.T
MJN<NDYF808>\VF5OV*1[ [*EY?6[G:+< =[!'."-5)"QB#,2^DP0FJB Y#06
MQ ]8S&/!:<2_ZP#OU>VT?GVL+/AL(VKVM*YK>/*L\<YN3;HPYY[I? >&!LZ3
M/0[L=-4R%=T8D6TS#%X8X\]TS&W=!4UKUMB3>TQ>V]C>V@E!:_^A1; Y5 I6
M+GS)42_QZEHM 0*H4(L.K$6Z_E"X#31FP0P4FV#7O[79())9P6B=6V!A$2WR
M-S>]889UQRX/O NXQABSX_'M"*'AZEL,@.SJG6TVSEK,9F.P0BAE [PW:GRM
MR 26Z*KK#MR"(]/6K#?@8J4::C\]]H$0SZG[H:A[*E2:4"$)3Z*44($M$V,_
M(;%,:12S*-8J_6YU_P]C4& R@]/QSZKCEPNQ9TK,:?>!<^-FQW]W4NS&\J5)
M UL_Y(KFHBW5_1/[N=53WD]!^+-GE%6;378W-:Q]-#ZD2VFKNOJP;282NGIM
MM2EO.J_%%<,JOG#]3_SG-2_""F!@E[6R[I&-C[<V=O\&:P#_!-^9XIPXS0J3
MQ>;8:*D-><"+M%*]L[T;(,K/]]1(WPQG.A_IU\[$F=)W935;UBI>SV;#46V
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M'+H4B0HC8MS,5+7KB@)"F<@XH,+.K]36;$@#M'"W\&5S(,RRPZ.K,-F>*SE
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MUA%.ZJ9M0 U=K6!\KZI8V3)X<!N=M-&V@MHNJ-!>.IUEU\KV82!C^K$.$_G
M;(^ C%NK..(*_WTQ<5G1).(RHR8-KF,+=-GS(F+N<-)@T3]3,6L^_&)6\E3%
MK,5Z(K-:8FO>S*8F8/C!UKD6.[3-JK<U/DM\P570U3?/O1:F:HJ5(S_MLBIH
MZIHNY&8&0< =;#K NZ#P(8=N4Z?0H<KT\TDCY^Z/@+4@'!SAXO"B8-VLX]?+
M8]GOQEE";S2C%;/?IW4O9E80_LN+[&^QG6$YN7C]2I /6^\\ZH8J#YE>RY!;
M2(36"]T,@IF'^I'K!H@A3EK_N"S+$DNDRG5P%GFX?/%R:BO?%0B=-P5$#6^
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MWP,8]##2@W$'SCO#M!?=&[8YTP><7HUR"99TMGR891M:G*5T3V'Q$M%>!6<
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MZ_V4L8-BW+5\9X$*XPXT2@>QT?_..P@I6Y9P>W*W=&<#).U_9-DQ</63'/=
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MPQM9E,?$EP9EC90XE6K^L+9(*C39TS;JZ=A^XR9V8B#&N%PG T;9Q,T3@,7
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M<U173AKC\Y8I4&9(9S*-CH]3'*'J4C9#IZ-B64YNU)N?7RSRZ]K,Y=K_OEC
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MI4D\1;/MD)I+>[I0:,G]V0I7LLJ3%<JK< ]6N+U!TLJ33X\G98PLBT#!.^M
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M^R/62FD[W4=R3IF(E*:)9*6NBP5'! 7-8W22V"B4>#!*>\C\/R4-X2H#)X*
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MO_&?\?^W&=N@@LQ2) -"1(+_4-3UJ>*06. L6\6XZ@0<TQ(.886&A'^ 8"*
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M-J$'-Y#\$[ F)6&),0?:$9R"67FP-@1()#)+;33<=$N@!IJRI!XX3M&21>O
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M@=\(ZVF64E,P+Y_-T6"H2+O)G$<3(OT1QF<QW6RGWRX1NGW0?;RR0/>;V[]
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M_HY-Q<OHZ,IFY-\D$;(FD6RD9N,3PYBHVV:?RJ4:Q'^_G*7'7^M/OLVI0SJ
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MF)V$VTWA)K*S2;+C-,LQ]1@%6VC$#>-(>FR1P88$I9Q7A7J1<,(_AU6]IDX
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M(1+)WY)@_5:?#P<CQHBW&.G<>\1-@9'"3B%B&&6.<XUSLM0/6N6><5L@*UU
MG&DPFX(;5' LA9$^9Y;L8#]HV;'Z6"FI.?6#WG4\30G,'478)._NRSLQR$WK
M]W:$B;<OZ2-%=KN1[I'Z07>'*B6Q;HE84\QWHS%?73"E@T?:*8*X-QH9ZS@J
M"D*]MMJ8HEA*\M!$.6LELL):Q+$/2&*AD&/&."&=<L*\=HU0SE6*^.Z6?4A\
M/45\7S[BRV/_%@[6RW/A$.>8(6WS FEB"TPI8[D*2YM>!2T"SW.$L0:C2;Q"
MA@N!),\I\9I[ZG:O(4+G K[)V=EXN[?4#7JK\#<)MYO"32[0)ET@9073.;A
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M[",L77N;_7(;KP9LCB;=><"GJ_@+&('8F#3:Y24[<:GKUE8,HQ%_#P8!#,
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M260#)X@#>0 6X0URGAGX1PGL[M$"/UHX"K8_<(M[!!\F<[_?3,+'V1RL9;M
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M"8B <^V!03=P&!=B&5,X8]+:YVH,^ 8P$_VW>I(#T]X8O-!K?3M%JSL$75C
M=S[A==4O;>,P-:&\>AQ=U"886,\]Q=KAV+> :OOPS#*4\=>Z21>] I]QZ7$-
M'@[J)I6N30N-GMWT'N 5QB;LC:>X H-;,<0_+YJ=2"YB-#4*;^A\ZQ\V0YY)
M!I!X)K,$MPEN.VH+YBES*/L-W9TMG98LUM.E\_O>^=XLO!27SXT>EM6X;M=+
M]C_C85F[TDYB+?O+X96E1?]7[=P?L!7S8VB?'?\]COL \*2YW8+LTS2Y&D9R
M%5-YX6F#=ONCWU]EI3>@VHU2 X#X+[8_=O[A,S!?UV:R)G7NQB&81TGP ^HV
MT#(R-\7M09R_7\Z.ZE_K3[X]*85T #F_U?W/^K9^]R;[^:DZD&^Q"ACPE.=>
M[C&GH'[YX[>CLP_')T>][/CD $S.R6%V_OO[\^/#X_VSXZ/SE;";!/J58V6G
M%T?GV<5I=O'+479P^NM[D.UA(]:#TY/STX_'A_L7\ &(?/_DX'C_8W9^ 1_\
M>G1RL099;[/]>H*L]\^STP^-;#^<GC4"_^-H_^P\.SHY!!$?'AT<_?K^Z.S.
M 8Y71@?X^Q;T$TY+MM?&(;T%7@!>!HSS1X#_F7L1LQ,:B@-<!B@%L Z 8G\]
M:L_]-"P#.,KD-W &]$]=G(/7BUG_O)*L)#:^!L\<2'=S:BB+H>I^LU'XS:FL
MLTW9Z(T/I]NUUT#5A\VYQ_D-VWGZ/\L1NMNQG,4)IHR[&DX(]X*##:\SF!!N
M6$?7P^H3\/X'O-YYG>"MFKSN.HD;QF6X3=L[6[<Z3@?9KTWJ BUZ"['@8370
M-^40/-']TO6R,]\O?6B/(1S9:E!=E3;NMX-_.KK-]NTH^_%@_PR(#OSX4_99
MUYD?Z&;+! ;>Q' :V^:B)M^4=:/70]_7DTV5AYS6>*1SDL$0?XUR:Q(H H@N
MGKW/KO7ML +<N5NZ\/<V"R(NK3!_03RAH_O-0>GF  ^LL/)J?#6_[-L[PW57
ME2M#:2<K<))9%T<Y"T;=914NI-(U=L3;RT$\3MKF7=B[F\"3G(?ILV6;!W'E
M 2%=>V[NWV-0F";V5EY%*;6[4O 3R&5TNVA78K#,MVD<D[TX$"9\T'YA*N!I
MB& Z,<W@YN-LDR!EO.,D2#D_*6VBX-W]FB&TF8J]W=\AX(SPPBJ"*&<F[A 8
MI#')$<U5,,92B8E[]FF8X\;D7^@O1R& GM1GLTEY@1T"6EC&@Z$H%$VB8X#1
M61@=8T22G#*GM5JJ&T1(#J]@4? 8(\Z50YH:C(+RFA>,%RJWK_%&V[]#,%M9
M\S#?RF@N^6IN54XBA*M"Z+,][I;8^$&TK _O[^UM.BJ7[1A^IV#]SA"@_5D6
M8%,M9#' WO>?RKK?0O5D.;94'?XV5U:RUVR4Z4$Y31R,%U;7U]5P%$U>4QH%
MG+O),85) 8P'DT8?]$+:$P96UY?9W"[@S@,Q)28$602D<@% +)V,5>LTH#&U
M(9>""[]TM.V;@?BN4L9I.  )_]8*^'AP-IFF_8$[O)NDE:7Q%O? K\=#/TN3
M1G0>[>A7TZ2W[IC;#U.B^0B5;FGL@Q=.-I8G&]8M([YM%'^^BNO\$9A)S9^6
MK\:C/;:J1\V.6YNZ.\E'F_OZ"B;=GV5W7>M85*V\;OWQR6[]9.4V3KB^BH->
ML!2]YB9SR!W]A.FF__=Q> \#1[;Q/(R3+*!83Q*9X&)Y A^XPUH$LU24&D@T
M$Y9X)*GT"&X0D"'&("P5Q4K0G.:+:_1H,A&_M?-PQRQ/_.CA-)2G-&3%;,N6
MX'=R4*8MJ^45HC0'-1,Y1=(7&.6:."V\M,(L00%5A28^YTCG@2"NL$928W!C
M<NDXED99HS>D9G$O<[O4[-O\CJ6C+FTHJ+Z+!GV-!\VP8&*'8[9Q8[-CB&C.
M%P(#.PD=Q9A'FX)T!2]]"=^.89X836I2)[XA!W)JT)M$I-U?5RP06 P:^%%L
MA<T+[6)M,H_R@E(<!*/*+9V]_A:*-<T=G 4'XJ("I[;?AL%F;*J>LJWUK"^5
M;]OZ^C[,N,9%H,PH%&ASU-_&BD9<(>$*FML@E!=+;.%; E&;43>>%]NF;H_G
M[=$:^O(FQMP;@_S;T%_KTMT9Z:8^47.V;K+5-3U^6 U6)YP]G#1J=+\Y2E)?
M>C^Z=UYR[_ZFZ5+=W?\GRS:[?]SQ>-*D=/&]H%*4&DAOG8<2"^ISGRN,7"X*
M  @="WH ;0N%8Y93YI5Y5L'+Z2H_:^.JOX'G=GLQU(.Z77OU85E;P'YPPR_@
M >_[E?WS3>9A85]'Q1B.??OP<C#V;G_TV!'_-WFH%4N*P-W+V'F4ZA"QEYT=
M?6QRH'[;/[OX(_O_V[NVWK:1+/T^OX)88($$4+G)8I&L0B\:<.?2D\%VDDTR
MV,=%76U.2Z*:E)S6_/H]IZI(49(O<<>=6++R$-@R29'%4^?ZG>]\^G#^]N/Y
MBT]OWKV]'@%UN(M^*H@_^GSP.#<4(1_!N'4KL'VR\WAH5^N 89I*E?A;2+9S
M3)M01UE?T;:>S-2U#::/?(M(* :!I3/P; ;IC=D+N933];\M9KL&HNU)\JPG
ME6$O>CZ9YZ-@"IO7_?ER*#%A%FNG8KR0:PQIYIXFAKWP/26)Y]B#5T_\#V!X
M/<$J/MB\"?><R(O6ADIT*.IC]=LWJV GY/(SUJP\:PWFS6R/L?G':FYC?_PY
M?-\RE.+E8M$V?W@.@>GZ";BY>2&PA.P(S2KL%Y,Y40I"*V=E:C(E"V/WJ5KS
MU#)**0$O&,[164JD4B6A<*:H,J%22;>R%3=8OYB_[EXW[0?[0/-:LL/C[W@:
M\93ASI5%5A+KA"#@+S$0&BN19#Q/:6GS4MI=09.5LE1(23*6(F&@5D0*QXAS
M69J[C)9PA>\F:-G!Y5]1.?J *%*7W)('.[;.M9-3\^B=FO<]4)7]#'NIULA2
MXVFL05)ELIC*>6CR^AU9' 9R!%-W$)2O G/>/#E?M&#::<B;3H8Z]BA-&TMN
M<KGYGL\6T=Y3"+YZ5!G6Q,"7ZFI3R[9&3%[(!N.](-_B7$[/<!#/J ZHVD::
MZ8!1@^L,U_>=LSM7W/U2'(D"9TMP<BZZ,%?DZ$U"F:6E8[HDE?$SXL D\*(T
MI&29M1G7G.Y3BH$-*5(<*ILIP3$+7!"1@1E1U#F:Z2PK!+N6)O[C:/&W#,#P
MA_7]B.%QU,.A68"Q!.X*L!?(87_ 2U+V4DY=GW^SL\6T6=O0:FDEN/6QTK$K
MR:H?B> /&KYQE%7S$0!6/2ZM-#KP/G[R#CCXWMI:!+./=V/<<<EJX8&L-RL
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M9;PZ:-.W2(N*9B=6)\':8.,;%E<0W0T!P[:-V>0+!V(G',L[L+6AQD5ZV-!
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M/'BKG>//^Q.%?5]XH"X^IAR]HK&@H_F$PE3#I[?4,VQGS_1 O2H4%G)0Y@B
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MW07.BD'&ZM\'W5BB7?L1N: \FO0KV.'JN$%!O".WOQ/\CAQ\1WXCNKKJ(PV
MF=-)#M#RV$% 76"'.J@?=YNG*&" 5_W[("#EJM$<K?PXH9Z@J;-AL2%SV(
MCLFF8:I,>^CE;VC'A; ^;A 0QRG&%>[G'V?NT %I>><'"(_)1U<1YE.R.FI
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M3!YPRFG7!!W-] &CIZKG[&BF!!CUM$5RCV92@%%.%9. -/OQP*BIJ@E#FND
M1CL=+K?H7#I ./'Z+HB^79Y^:P>T#<T<: \CLLVYKR+O=7='#/C0I1V-*!T;
MG@&2GV^N-"$_TEFW(G+84^K(#EWZ0+EWG2;3*/D=)?3P<S"4GFZR@HT>U0<<
M/?M$-ESOOA"Y-0D/_=Q&;N(_9PI@TV:J+V3RT;.EGPAJ]DH#8*2QTGN"G(L
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M!@S%MF<:*0NEI2]X_VOZ/T].C/[S_P-02P,$%     @ PH!Y5$XH#E&?S0
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M'>6(-3N>#[L,9\CQ+!\B$FIN_ER3(0-&DFV")ID;N@NIS:UV[.\>%:D'TVW
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MN9K+YI2W':]DU&"<_\38H0Y<*M)9'\"/6F)8&?(8=)S46)Q+=R[[@\.Z< &
M5I^E5ET'/" 2 +(EJD)-A[,]*OG$M/=A=:E[$R/U:",0KOLEW0'&J[\!&U]2
M#:95T7SH@-ZJ_(_FK=NRN_92*P $1>T$7M1BZ&*9U-NFV] ?H3Y K$NP]("^
M6";>6-%S!MSN.ZD;%2TY34#PK?OW>.8_!5[BQ^S]N74]MH4J#WNQW?G=YF5U
M)P!8_3:DJ6H+<NP'MO>VR5;W%7_L\-H-K;-F0^M,LU3;"DKRT::^Q=Z[CW[$
MA#YW[5*GU%!7WU;;<MWP)V FTK"A!M>&W; EL)*-S0<[(Q\"G^YYMO-MXC?
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MX%X?(VM/DOZ$>,S"N(DGQP,;L:C2I@C#99OA>"+:YB]S.R$@AB]EQ.5TNL6
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MSM/.P37GYMZC@09EWE.Q2:&ON1#VM*36'=Q+EJ=$;9[N&U=*:0FR$CS$$!2
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MB_4]EF3E>#HGF]0D.5"U[WEQ6=.@O)UY*"WGD5+% '5>5=84)]Q'B-;_JVM
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MC?!A]X%O6]&SE&V,7UYZ6/04[DIB-<<^_7$ :0G-1'QY*69Q-)]N#XK4>22
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M4_;NH5EZ1*GG&6! ,2CRJY_\2C*K7L^1^1#G2Z'*;3F7$WVJ17ZPHC%[:)@
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M[WL_^75 1I<&I>'VZ!64K2=SC<U6#4FIP9ND?8'*506^V]"K1A;A\H._YJE
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MFUF&ZK^.!936$C;LC:; Q%I3AJ+^NTH'$<"I"4JZ\8II>W+>J!((Q[5%S8!
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M /&Z7VF Y32@"R)T"+MK#RWL$N-.*WGF ;S /VXH_OM%ZERIV?!U2G_7EYC
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MUZ@C9'^@B9\<>=!Q6S6SUI+ Y]!QJ1"S![PB1;'M5<T66 B)ZN<PBC!7@ A
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M\O6A!VWMG;I;_(@;C*4F=$]0 C(%6;<V=VTKKX$1*V^=UEYN;NXZ&04GU%I
MH=+"Y09:T#RY9?=4N(6Z=YMWFJ=,Z7QDPF=&2,SGN<2PN_"#8)D@0_7Y\^A,
M4P1X:"O%T-7'.4N8 +-(H-0I5XQ^#K-WF3/8MBM[=G5M8! %^,SF[VJ+:=UJ
MMT?T]0IYWI@@V=W+M3*CS*?UN&@;NKSQ ',"-9&3]?+>/5V;OV4&XRS/WFD"
M+XW!"J1OZ?KY[)&)B9Y2\$! '&O13@^)-82>:YG\W,(.4Z[D<%*J9I%[!6?O
MC=TC[+?ICC^Y[*,E&< ;F[;WN",XS?Q*R,$/@UGP 9-/>> 7Z) Z8-2VQA,P
M\,KZC#* 2]@9%&>BR=+;W=-U, F;'[LW?B&^5D-6_NPZK"<G&]H9K][=>FJ
MZ*NX>1P,[5Q?[5K#4G\3E&LIG-\QXD3* UE!#-2[^3J[N?XNFJQK==W52O$B
MK_%X2AS%N51=GK0SWE$]2L-P:LZWO0FTA0W;HI%V=W,NC.E3EMOM!>U]W&[9
MK4S3$P&); ^Q/09K3FO:-4K%3:'C=!+.]3Z165KFF;=]OI;FSC<CFT8(QQ_2
MREN>$VW#*U!?^:M71B&>J[;6Z4PO_D1:?GG.H[#/KQ+X%YZW D.JP]@_#N5I
MF0*[I8;6#J[EI''JMY6?:M3P#],@KJM[T?@-(!BZL))U[=Q[3'48'R)WX4Q8
M>DUOUW9MNM^'F2P54.(25BHIMY>T.(& Z\ 0U+NTD2#X%]=7# _G:X5A+ANX
MGJS>XLJ?'U6]DS$?^GBWDZDX9UND+#VT.8&:K5Q?Q)4\TGY@!UU]IJJ:MMU6
MG9VFLKU6.W@_%A'];%5)V]J[OFSU09 MT,1M'1P&PS^3;0ZNPB\_OF+11G7N
MNK]?@3[&+</+>!YC'+EH<ZY6IJ?FVN)/7K-ES$Y"WGE;&YHZS[_XF431O\?T
M,WXF?DIC)D#"0]G -FIM/ 5<[_L.7._[20@TE?+)E8SMULW3H]LD\C+ZA[9U
M=W']2)X=HXS_0;"@..B.J[(QCLN]\,+^G&1L$E"=BW*K4M,,K&TUE0SQVV,S
MK?L!ZF2:0B+Z]71?DVFV^:2GIDSV[CD!.[V,) <A0MHP349Z7=N)X:R)PU[)
M>D'PX<9'.J7S5#6J5J-M=Z^I7![+^)!G*1[Z+V8UI*6Y<Y&V!DF@:.@&"/V.
M+E>DJC0X*1'@)1#K4/VEQQ"3<11V%&S3-IRZV-;AW/C&>"(!W# R5H+"KWH"
MWMEPMPR;T;2\<P\A^X<#-G$1@AA.5)]^SH^)A)KM@WIB;GWE!Z::BOE30E.]
ML7K\89R;3D1HQ)H< *0Z?@,[:6[ S].W=;Z%6W.3.C9TO[Y3*+4%2'%DF\,+
M78];;8C2/?I,XZNUA_JU?++VCJX]XJR)G[Z752[BH/!GHYVKM61&W\[.KXYO
M-,KCC+UOBS!B>TM_9]0:7>M#H:O^ X4F%@DI-&^0E[^R3;G/]Z.^'B>./05#
M]KS#D#UWCFC[O"6QSY[AESAE$FFX"TG0M&^V-G2YSO?\T9H+Y 2H&OG&+ODZ
M]&U76\>G\2N-R9$C#BSRN T"5]_R6B\3Z2Z0CK04HS4W[&'N PV"?X14E>)>
M&/6V&7MR3C-Z_5>F@$$D<V%K,V7PFEJZUCW+L@<KML*]:R14&[NV7OD)B&HI
MVS$<2K=;U>SHXOKD%TD[\E85 6>&4Z>@'Z\+7'Y^?M"<W3-#:.3!W =4'G(F
MO;0<S8ZF+J^6FG$',C>9O@60!AAG7C,)]>SB4*2?Y4'(KK]%F.R7E0#$QA]=
M!^C1^(UMA3W$HK05OM&U<^[> \MZ&?(HSJG9K][:P?UF 6>]8:O GYSZBL<K
M#C-[>TO(&_L$3-=*PC@-MRC7K"]3NK%[=-=OX7B9&)?V2O0<VJ&6*E3ZYLO8
M^.,4=L$Y997/=1"9:IB.6_1Y]-FY_DPMZ"]#4Q',1%PS;4T5YOM"JL(;FOF1
M(Z6\;29.H3B,09^WY"V,-Y2=J# A=5R44_O^9G=8U=CBTM#CVA B0)BDC6.U
M^XG28)4(7=@L0_?JZ#JB>DA%J)ZEY\<>P_61*ZPBF@SP]/:H_)\12_%4&@XU
MKGNZQ4,ZBV,F2G /?%WUTK696B!>OUBTZ<>7]4];;O7UGDS%M26WCP7RD:+O
MFO#@_A2%$?7O8(5\I-DO)"OMDUH;L*W!G!\*-8O*9+]JMG+N\$<7_AU[$]YH
M<JS?/IHF$\!%-  #=A;Z.I?&)"R,F(_27</,T-;UZ0CA+HR#>[*-?&U%R?:6
MUX(MQ3/W&WON=!(3D$H63#ST(U#$%NPWC4@@0S/7:=?LP@K""*/C1&8R>VCG
MW[=1SMYB'A,(;B=9MK3FD7QHRW4<B[9K(=MZV+<]A)^^8[M>XK*0^; ]TT/+
M&6,$YTYC%(DP$VS)\=69VM;F.3:W=_WE1XTFOVR0T%6% I6APY"L2P*YKV=;
M]BSEB%3)%,YP&QJ0!+MZ.47.9I\DP&L.$IE@4ANR?8]I1-^.LNCAC.UYTA+[
M= :-J8BY/6U?;>V=:U7S[VB:1#-3T\S;ULZU +7=8D4[ 4/7&S2\3[^I9,*6
M&Z;5D-/6?JJYRCW/SBG]77K*_>\MGG+UC^XEF&8!)3 E*&73>R" GD'&:6(
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M:6[MW ,L;P*,)2D>1)& @F]?0]=O_Z@#2;I^J:H&9K-.HVWHW&:XWX=<)X%
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MN 4YY\:^=65I ZFLA[YU8TK:C5(#C;*AG+',]47&B@@,H-$D)[:-CM8(*KC
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M% ] ^AK$8T15Z O#%ODQ((%9/IM29!GK^O'6T328_FR[!<C O_#ERD*/+NW
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MDMPW0^6AAHII&>V;H?*IAHIIN>J;H?)+#956,]-K&T4U<1PWF^+<WP;A(25
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M+4,%D/ZV@PMW0Z&3?3+@+L,,#=B7H=<*"DI#D91XR)8O+4>T1.Y!#7T:(4O
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M<+82W&N<@6F&/Z@7]OZ1P]Z&AQ1#=\#&XQF.D@R93K @#4>.+L^9P94C.K1
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MT%P MA7AX[$I#;LE%MUQ(!]#00SF216YG;)8M:<P0%5"'UWKQ?7@ILWJ<.V
M;U,?NC"[Z3BA*TG'/ZE'^>^7BVIPGZ HCA\2WX&?HD1HTYHK WL:' YN5D1P
MXCL7O.#)P%WH26P,^6^EW)CQ2"IM(.V[Z?I-4)H$X. ^6_E]*U^%4A)R^JL;
M(=7#=V;_3-SC$6+.HH;8KRTJ4PLUUS?N@>?FEA9VM7B[ZA;%KOM+J;.X60&X
MWJAX9; "<1+ZSU"#N? #>4UX^JK2C+GT(J0.T[010V-CF#I-'1<,@.8FCN55
MF\X@X9$<)$!D_QI5)3)TG]VD2I5-=39+&HY@(Y:KJ8'&I^05$5QBP!H>8=6(
MNZK*ON'Q+C<C1#9,# ] D($<V5@R/!I!%+Q;0M5,#5)HSH!<IF$7D0K$NX'\
M%^@_+U8$_OW_ U!+ P04    " #"@'E4FC20-7P#  #B-   #P   &AY<'(M
M97@R,5\Q+FAT;>U;;6^;,!#^OE]A96JU226!-.D+T'S9*FU2U4[MI.WK$2Y@
MU=C(N$W37S\#H>K:M$G?$D!6E/!V^,[/<W><'>/'*F&C3\2/$4*]);ZBBN'H
M^*_5=[J.WRL/M4!O+N$'(IP5DBG)U(SA44?AC;(H#Y$KU^[:6]Y$<&5E]!9=
M1Q^GRDM 1I1;2J1N>8)1CE:,-(J5J_4,RULFD% V<W_3!#-RBE-R+A+@U=V!
M4$HD\P8*G<!HQ%V9M^)U1G[>1F53 ./+2(HK'EICP81T913 E_YPN%-]G:_>
MO2OV3O[1YZ8Q56AE*8S1325:4PEI:=VT-#<0+'S<P^?L[XR.;V(:4$5*3'/9
MD=]+:X7B6.M%^1#&M2%$YK!L?W;V;*\9X-3+QRZN@HR&%"35%\2$G&-$,R6!
MJ_9['!<R ?8^/J<@8%A9,^\"PXERX4H)+Q R1%G80GGDVEXA;C&8B2OE3N@-
MAMZ4ABIV]_LYI'-YW2L&:89NABE(4%B!4R2OLNE.KE[KEY7R:YKIK,&HFKG5
M_7,A+1564J6V@=W=/=S?RM'LJ? IH>[ 7B;3[QXZPR4RSD'W8#A8(K2KW6.9
MS$H&#;L'>WO_">D=^1"LRBE+XA_#M#A82Q>SM8MIGJQ (ERZQ:^5G_"N42HZ
M!C;WV-*3<TN>BJ'*YUX01/:;@BCWS-7RTEU7UY:13B'!>[EG(<?O2$L*8:AC
M\AY4SH#R16#5AKW%*?!I,E;'OLII3Z"OL=;M\Z-.O_,!3#0/\KJ$S"^4N8$0
M(3F;<I193%,30K4,(8-^N]!O'LQU25H72A>T1$CR3=NBY$R//OQ CLYD!)S>
M@J*"+^)Q;55<%5=%%:];MG=U5)G2[FV#IQ^S%.5$=Y><Z9V"Y&R'_.3C[AIC
MMNYT;70P:\!O,?@+'PZUH>,%4[*;R%V.;9LD54->M@PK;<M>IO;Z ,*^(X,I
MR(63:^]753_X(\/PNS9^3VA".3!R,:;(Q_BFNGHE%IM)6%-2I*&@R1282GL3
ME7:+8Z8^[+RRWFXQ-ZW*9Z8V:VSM;495FYS1/LX?\ZFD&9(3%9I)B<:E1P-^
MT\ W5;:9SV[=$\7,9[<N>YG*ZP,(.^81 QZ2;4A2C_P!AMESY;7>YHNN:[68
M?1' '[(,JDZ=?MWJK_YKNQW?#:I2B+",30LFV@07V!1F63&\\GOE&TI^KWBW
MZ1]02P,$%     @ PH!Y5+Z@KHE!!P  6"T   \   !H>7!R+65X,S%?,2YH
M=&WM6FUOVS@2_KZ_@NAB=V/ CE]Z:;&R+\!>F\4%A^L>VAZP7REI9!&A1"U)
MV?']^GN&E%\2)ZG3%FU:& 'L2!H.AS//S#RD-2M]I<]_$+.29(YO,?/*:SJ_
M^'/P?'PZG@WC)02&G<0L-?DJ2#;"^96FOS_S=.T'JLZI]LGH=/33M#"U'SCU
M/TK&N&[\M))VKNJ!-TT2;VA5TZ D-2]]@GG.XI!"5DJODO>J(B?>T%*\-96L
MUZ-3X[VI.@5A3JG5O$XL:YD^.Y^QCK5-J<RNYM:T=3[(C#8VL?-4GHSZX:\W
MW;LW[DV7I?(T<(W,*&DL#996-M&N930T-3K?7]M#EC\[O[@N5:J\B-YDV?/9
ML'E2_LLP+]DOX<#:V$KJQ[KPU<7;]Y>_7[[Z[?WE'V_>B?^^>7WQ5KR[>,67
MXOEH\D3=JJG80^7]'CK<'3__.'XQFCZ-1;\X9-%/!TF7??%:+DB\RV!^7V1D
MO2I6PI?2)T>'?H1#QZ="7(J2?6IIH6A).;RIG)!UW4J-FXVQ7IA:_ []8CP:
M_$N80OQSU9 MX*6^N*RSTR.8/\;W$_C^']+!XW!OM1)7M5EJRN=P:@A!Y_O<
M8%QMO,B@3:H:H5F)MO:V):Q)>JK@70Z*%!6NK$+8"IGAEA6F0N?R)LKM"=24
MD7/2KEBDDE>$>7=T.MS+80RFU+Q,GH,%,F6SMH)8C>&P)"<KX**L%*[EC^WX
M)5GJE/ "*N4T.(BJYV*I?(D%NH:R8"#K!:24R;',!8;E(EWMNF$#L=U8?L%@
MB2/$/\)KSQ^". E4$("(\;@%31_XAC@>VYWGJB[8 *^@1]69;G/H!#!W$-('
MJ)75*P'[':<$IXK66\QW<'.WID9:Y8H5]UFBU1  T W0&*9SP9Y,NE(4VBS=
M.@LLS97S5F(BR3>CW;"ROP-FMS9FS]HCGK]%//\->'Y_(_@__W@]&8U_G;H.
MLATEX1IGBD+A\L3U C0NA;040 A0J503@T40D)]JY4H>P6(52CR7>;[.E<NT
M<2W&<?&W1D<T-M9DE..V$R< 7T[<B@/"+JZS4M9S$K^AKKYM-23&S^5@?'9"
MT8KQ61ZOXJ7BG4,=LX#U"RZ^.\D1P<JV'#Q1<6.B A/Q.F^G#"28==S+VCJ8
M,!R2R>G9Z.5/TR,R'T"F[ F$Q\%0Q"?TX0^#I\\4(9.M.WP(]^J4MC/%[F]:
M"P4H>0OE0B&%%-5!#U/S;0G>+>.6M S(ZMK_%AW]KL3S0X5R#%N<T2J7/AB:
M.I4K:14O0$62$AI+S9I:Q\0AY*(++".47>,(!GF4>1[42$ Z:[7D;H%E!2.V
M! 0C(IW996'X+R461,PPGO)[.>\1N8]#;KJ'W(.+TAZ #R]G!^,8V%^HG.$I
MG:DEUVWI &UFOXQ9:?,U?H!H)5.EE5\Q2[AK6LZF +6 HI@(-T1WV'-H#]?=
M@IK6-D"Q"ZPFRXS-@P&!1\^I!EG1 #.>4,-9PB+8(T3 (IM4@PI]A.QG@FS6
M$[20N@T%B<-)10%FJ18(A+N#(6Y)P@$5-E[>S1H#0C$0U=%%;IJ:UM]OPB$]
M0&ZDB8EW\>&]F$C7E#XD7><*V#-EY4^5V!Y!_CA'YKTU?/9AR$<0'?\+3W;!
M_HM[3!EF>F"RK+4,LYU>?$-?99S''3[GAA:70<5?+9HXE)[L"1?($13%6W*=
MF=C'43@KJ6^></6B):5T&[+"Y33D%.6ASX35=SU@);2Z(MT=G-R2[W^"0YYT
M!AW3Y0&OG7W2UC"<P&[2K;^ML%SP=^&_+;8,XT<PI3V6O35/@FI[8]V&G80;
MT%E5RGNBAQI::D" 6"!7L#!H.4&RH'\X[D]\3 QWKK.:_FH5%A#RN*VS<+[2
M.^X!/^,>D$^\F-,J (PWVKQESQ0!#AVUV.S%EB2OF"M$3AG80F##X=QX??KU
M*)!UVZ9XS'%'I90Y!CK:%,K[ =F1:(P!J,!U^Y&Q.- 5UU8($GP25M/UHSL/
M"F_4TB.V/GV7QEV_L"@.?42:0DT#5L+)?@>J?FRCJEX8O2#NI;6<=S]0V*X,
M4M5HLR(\798F%CYY [* V!VT8HN.@_%X^ED:V7CR17Y9?CJA?HU@)N+?TB*7
M)V=],1E-OJ6?Z+\"4UK_HA^=X\,AP3JLJ%YDP]1 9#*:AJ<#+5?8N"6%NJ9\
MNE2Y+Y.7+]A_G3P6H67C*''QG( P&W1#N5UKYC.*6">3M70G!*E\\\)"T#T>
MA># 4T.?1T5#;V]K7 <E+GU?UP<@NH3I@Q25_RH)GP.^,5TPZP$3[R(&'*S7
MN GJRS/,)\(1G[@9-QA\']36P7D$UD;?<=(.W7#GU8B==/WJ$8_^/(;R$?7W
M&,;O((S_L:#3[)M 5%^5B@IQ<4U9RX=TXH^X ]R-\-?RZ_C;\NM)=Z -ID<;
M=W8;ZMY#&8-O[KU/GL!\;^\8'OB^ZH>6/?G899>;.ME@,Q(+W4 6,"&1>BE7
M+E3,V3"^%ST;AC>J_P]02P,$%     @ PH!Y5#B"'EA(!P  :2T   \   !H
M>7!R+65X,S%?,BYH=&WM6FUOVS@2_GZ_@NAB]V+ 3FQWT^)D7X!>-]T+#ML%
MNCW@OE+2R")"B5J2LN/[]?<,*;\D3E)G6VR=GE$@J:CA<#CSS,Q#1M/25_KB
M+V):DLSQ6TR]\IHN+O\S>#DZ'4_/XB,$SCJ):6KR99!LA/-+37]_X>G&#U2=
M4^V3X>GP^TEA:C]PZK^4C/#<^$DE[4S5 V^:) YH5=.@)#4K?3(Z'9W'*86L
ME%XF'U5%3KRGA?A@*EFO9J?&>U-U"L*:4JM9G5C6,GEQ,64=*YM2F5W/K&GK
M?) 9;6QB9ZD\&?;#O]YD9VS4FRQ*Y6G@&IE1TE@:+*QLHEV+:&AJ=+Z[M\<L
M?W%Q>5.J5'D1O<FR%].SYJ#\EV%=LG^& VMC*ZF?ZL*WEQ\^7KV[>OOFX]6O
M[W\3_W[_T^4'\=OE6WX4+X>'ZE9-Q0XJ'_;0_N[XX;O1J^'D&6WZ<)!TU1=O
MM+D6/[>-EWV1D?6J6 I?2I]\$8>^^ER'OGI>#AV="G$E2CDG86FN:$$YO*F<
MD'7=2HW!QE@O3"W>0;\8#0?_$J80_UPV9 MXJ2^NZNST0,#\S'P_AN__(1T\
M#O=62W%=FX6F? :GAA!TOL\-YM7&BPS:I*H1FJ5H:V];PIZDIPK>Y:!(4>')
M*H2MD!F&K# 5.I<W46Y'H*:,G)-VR2*5O":LNZ7382R',5A2\S9Y#1;(E,W:
M"F(UIL.2G*R B[)2N)9_;.8OR%*GA#=0*:?!050]$POE2VS0-90% UDO(*5,
MCFW.,2T7Z7+;#6N(;<?R3PR6.$+\#WCMY6,0)X$* A Q'C>@Z0/?$,=KN_5>
MU04;X!7TJ#K3;0Z= .860OH M;)Z*6"_XY3@5-%Z@_D.;N[.TDBK7+'B/DNT
M&@( N@$:PW(NV)-)5XI"FX5;98&EF7+>2BPD>3#:#2O[6V!V*V-VK#WB^3GB
M^4?@^>.MX/_PW<UX./K;Q'60[2@)USA3% J/)ZX7H'$EI*4 0H!*I9H8+(*
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MQ18DKYDK1$X9V$)@P^'>>'7[]220=<>F>,UQ3Z64.28Z6A?*AP'9D6C, :C
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M;KM<%\X&IY-8^0:R@ F)U NY=*&$3L_BA]+3L_")]?\ 4$L#!!0    ( ,*
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M9QU!?+U4LA2)&TLN5:"6$0P\QWZ&X;UG_C!\'*AU[6@D>?)<Y!:;C$5,$Y-
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M(FB I5ZZOTB]MF_ M=(CH&<NU"7\5#1J_CY%4P!FEX%^/&\J>"UM3@%_\)3
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M]XU(AHR07FQ> 9.R#$H+?))I]3BR!5I!Z)@%3K&N:NW3_BPGXF2^P0@X.G6
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M>D&9:XQAZ2P.]MGT0DVY.' J;<G_3OVY]N-;^I.NYSD6^MS@<.&6K+T&*P=
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M#(+I .-6VT5;3"SUBU38;1G8-1?&RFS6:O?ZTT:7AC%Q4&,-$;^$[:;.V\S
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M1IU>PI[2**"P@%92[^Z))/FC;_)-N$: O>OYQBMOPS,>[Z1:WR&K" S)7I8
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MYW?Y<KG#:?ZO4J Q9[N2(ON;NWEMSDY8B-0+KW+WML!O9^$+A142L[$HLL1
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MQ]$]C'2&;[^>5=GNQ;]]^_6J61<O_@=02P,$%     @ PH!Y5-6/;6S25@0
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MJ[W%>;A(JLW8!>(P3.0]1.9D8_$AP^VUP!ATN.!I53F53%>$&OD.CNI^#&.
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MR01HL;6XXU(:10.6FK8@UJUKEK5\:U.)E3(J2#U2EG6:L1Z*3NG# $\WZ_'
MR4R+U6#K,*?$Q\@8C/"R!0(J=8$[W !=T 'XUDUV&"+]TLEZ%?(5NM:QT$5
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MU%+Y8LGCY&WNK'L((FUV"-W2#@3DG; L09:0<4,8;'"SH5>D';HFVR2FVJ&
MK"++S29)T(UAF9IN(*&#L:?GR]+&3%IXSQ],I(<WI$)YB!QKK2%AN1@NP&@
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M59%*:>4X06Y%E#%T(A=F?% OZLPRL0-]=#<9*H_#Y60DJ,<T$1:U J6X &Q
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M6PZISIG :P?VXXI<FLH"F18+.. Z'9T2;;G+B?6$G"#XB.^$,D:'3,#KMC"
M5^*IB 'I4%D<QH916"JDP^Q:%MHDUOA,UF8- *NC6EL!<L@%=MX"4C\[K72
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M)1BLN-,5I+L\U1V5OLW#T=*R1\"V98L]Z8[$98>O2&4=NP? K!AXUDLG?#C
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MERZ"(]N<C.$.3B@82A5L:2X<6=F'HR \?:QIG3311"EVM./GX<!6L^7 -@A
M:C4@:OD>B#J9D'L0'X.$NCI[YA)/!%F>=K4V<<S#*1ME4=JM9G[A\G<\M;O+
MHSLP8#U M8S%=ND%:?\E0(S$&? XN2L0.^'#"@,K<>?OB6%U$8+"GII4VI"C
M1Z,(3NAC#B1RMLL#"!&\ &&[C@IT3#GB2./U.G%4<<L$3*\CH2.NG0KC**&@
M1V<3F?Q<X<<]M&QQ.R=%G"F&!&0N,[Q"%W@/.*J,H\($FPXNILYV750LFTSB
M6,+.,ZJ'XU%S#$[/I*#).(@@8%ZM$5(99]5@R+,! U=N5(HL$2,"OK.JL8+
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M:@7#6+\Y]:*6'M\ &1YLKVJ"+_^=>K[V07#79?\#([NIA>>%T[*[5P7?P^=
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M$LH=KV)D%US[/U'+LB1_W8N5Q\Z2=3!O1R+L9MVOO$IV->?!*9"OS-SD?@R
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M5Z719NGXE?G^7</P1[.2!@YI)L_]A]5 1E/%**68C7LAIE@3=71:)<\W .S
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M=3%PLN6?UV\]/H"%WZP,&ER'^&)-Q\LNRUG 6 *[=X4$Y@Q9)E_PG1\D#(G
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MG!I;1/?2S]/?54\PL_PA [IY53B<.I2.T&F2!DJP.(T/"FVEIQ2Z=%7M?&R
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M$\VLSI'.%S):]F!JET0U9]=?O90:>&+ M$E,*/K(4-)X6OI()#.2F$R2G9^
M7X1.'I[$J[<K:3U8G[J2-A=&\-+[O2BK".P.54Y%O!LO6TZ#J]B/H!9VMYO<
M)J.$=:0.)N.T%?+^1$47PB09*$G;1,Q?N'[\1FMMEE\ANZSZU_+'3</59S'K
MV,%.2?F/N2(D1BG*RA%"!H-LD]=:L,;I$+</$6210%:>3=;$P=S;VN$/[C0K
M#J]_%KS&1,AO$- -7*QVLCX&@$D^PD</WEY"WM4EHT;!Z@W0VM#Z!FBD[H/9
MU4+PL/DJDY&=4( "Z[<)6AS]G>DJCN[JGTF0AMKAOV++ACE^H)B_%1KD&]]T
M ;W?/7W;QY#)5P&[1.H3ZLORH-&[)?*\L_WWL\%^PXU/"H/YC>AUU/^+UX1,
MS#.V;54W0Q7SJ\N8@>1K#_Z/799^!5(0MH;.[@Q;T]$1L27*1?PA<ICB,+])
M(ZCA!C$@N6 B.[]UAI*BL7ZH4I>DDK,;;$[JW=FD#5YPLGKY<^16R&95%_*]
M=PY=555KA/^EFO_/IJ=_1.%D'P^\TI)\&4O819J%6!RVI=CY#O>9JZLY;Z$E
M,I7_[/D;(,DV@$L",?5(/9K;E^LYPKB^:F%9)\+83A96ZCC=\"#+0]91AQ+X
MG2'%OVI9-TNT$48\_V";L7*01)\J$>%KK-$LE B(C-\,F8<$/F#FXC<=A86U
MK(N[^KV69 !<-2&2CV+2UDC[WRZ5T\1Y.93^BH,"$SP\[6%4/Z$9[%2IQ?0N
M)T!\4,JW,5,%)-O=7\^KUZK8FE&CJ\@XAW*7T %_4/#K0CHY)G'AJBP<+[R*
M["&CX_<#=)%IE%*W#)+S3R)*BU>LJV8E19JC>4K/XXZ]'_"!CVPB<J;'I[Q9
MQA$)GRR[.Z@\XWHXMVR\0#W5:&DTPZN1LD#+!:RUWNNR^=]?/JW!^Q0C;$,C
M\U(72[@ H:;K@3C&$\R4^8T8'%LQT-,*WH9O #M:155OY&.#D;SCN1C-YZ>Y
M<TWOU%$!Q,-S25_G+N1#)L3)SHWC5UC/GX_5DU+L]]0+C'=[T*:$-:$ZQ>E=
MNC-M&OAS,3/0"V;KS5+VNMGXY>86>;=+O8O!9Q'TT-<-167A#?$2@4JTJH95
MQ9*?AN'0K1SNZ<L@-1'A!4*,N?>[-K6;Y]%^7[Q 2JH68\PM;&X7.\[6K/DZ
MZ!NQW)5TWC1984!*(1,_W[(KI11C5+5QS!>=($[6+7RNV'5M3Q-:<DIC&+RD
M95ZHG]$8-U)"\)<TBL!FY4$TUO6DFU3=W)<50U0&DS'2G42+1TB_SN**^P.$
MDYCP-VS7:/+TK2AJ"&X&W3JG3I$FA=-Z;MW%729@; =A[TE353%I4D4F#+N.
MZI0:];9@CBU>XO6'88KJ&<@*]KE1*27H*MMBD3.*W7C"& 4*FATI#@[<T^R9
M*&59&U,ARV+8 2SVEW"I,Y"M]1/ BK'X2^[6;!0O;0>GDR[+U<$&$=$2_&\<
MW0UE&OU(Q/I2 @HOT@Z1/Y(8W$4HBP)&0;+EGA4T'\K&M OF.XO-92'&+9[G
M)*JCM&;$ 8@>C$&I-1-C-((R-,+A7\ED1VWZ6E=N>;8R_E03KI2&*"=SU*N
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M1W-NZ6CH3%Z\!+'BV^RIV-@:#)#O>N/\[K)\K#NR)GE,:=T8WVA=IBQFSH7
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MV*75WC]OLA?WC]ON=?,KN(=D+ "ON!K%\#@>I&EYE36[.>KSSV^!<<KB!#'
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ME5 WNY&PD*)BM-KHJ"P/LT72=Z.O5.KY-NS0#!@@L X)3%<>>JF!;"6Y:::
M>48$(I:AQ$59Q#;A+VR3-N@#0%?KHMG1;QNK:17.Q+74H:63;.R]S.JN 9M-
MX_/U/?AXA/"QPYGI.< H3"X=^E<*\XK-YVJ%%Z56,I0W*4/L$(7^4RCTXT\
M0TE\JS%/36*<MR!52CC5X0MCD3'+LL8>]N;I (LN\@Z)L[ND;1C*X( 2YA?
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M)VYTY+(+ .1*X7'N(*O:QJ6)YM]D)9ECIW_LFZ)*,D?Z(%B./1$GW^:>M(,
M<!" @ OS9OSGSKJIAZU/P/07C14JM\HCH/%3W&M&Y<I*QQWVA8Q"B'JNZA&2
MF48D+:8)"K,8IX,XL<X/=@NQ<47J_DB!YT%F:])CE\FXXEO@KR>Z'=_3EQ2B
M][J"G8@5R6(L95Z=V;HW"\0NP@LA\Y41DU@H8(\?EG:S&)]$TU<FYX$WS5=%
M51>,7Z,BTRV6QDZ=)\1O;!4?<V+G_WP-U6=CH"5#3:_2ZOKM<K4EM,&^-K[
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M7287,"2,8Y=)#"E%/S>/ E6R*9=EX6@*1W#V)$SR#>,%(2!IZY;K\N_/69V
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MV&[5-ZRF@G;>K%]QE"S#[SE%G#2;#POV<:D_((LO4V7T1QJCEE*(U$>9(WG
M5**?LAKMS!1,Z[:UH6-83;AGR,8"4X5AK>J">LA,NO:VK'Z479!U4XN"&\!!
M6E8Q/:U.X]OJGEK*V=S+D0D/;V!/=LDC:T3@,?R=FXLCN^%\<(1B:5!.,"Q(
M!M%,_9N&1*8.W8!,/XT7KEC\<4M"AKFKT]Q)NMPW)^)G+,UAE[I&)_.!P)J3
M/.IA8>M]G:)HD])5(M'J/^:-QF=E!_ XK:U*?2<Z# H'7#^.QJ,,34#H11B!
MB.T(8V)RD)59+#A!MZPA/)6I""&=O;;MO^:2!]TTGS2G@I>"UW_M8)2W*EM&
M]6(YJL:0@DL8-:J\O[.T39)H&C?%%*UQ\H<GWQY]K9>U:"[QSE(5'-D[ZGCO
MFRNFE)Y6MPJ"%&6%YYYJKZI^AY^8DQ0W98/GN Z0(>:DZT_G\@$/-F(T3B@
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M12B]4@9TE@(\Y,^C@H1.Q7MA9I4E5CMU??I#>+R-S"$JO!X]&=E74#CLN9#
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MS>;0V.09D(BM#Z,@"X1JR/]@#P-FK 7M_TOL 7;52SU$J,K):M/R'-^P;)9
M[CMC\E+]MIQ6K/-I"]5U[$&06+VU/0$F:6BVC8<63QLM"H6A?X)8G R)'+<A
M2Q*/L6_/HI&##V)'%1U-<OYAT*VZ('CI!O?":B]A%:.2$8--A;63ZKLLD#G
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ML+?X(Z2"GQ7M$E;V_&-[!IN0Q/)9'Z.7W:J&HROWEY(],0=S 5W>-:^E5%P
M]0A^_9Z/J0-+T7<G![F[.IR?N.)L)^C8IT-M5L@</+$"6&J-&[Q[&!3YR"C]
MBN4)H9* *+7BX.H4'7*?ZA]H2*N3N2V\_N=3;3HVE5II)?2_XA*E*T:AR_E2
MZ+-!'J!QO5P$?UO1@<#7A\-].DV6'&$7S+" &6PK,$Y7X-)YU..71HA5IYID
M\\7Y^: &^\YUIL)<NU1JGN'F8>4$82>>AQM[MD'G<DH-P]O[@P[ZC#M[N )
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M8E@'*1'*Q G-\J"XASGU+]M#9G'-DM.GE;&NXR$$V8JT;Q\G[;G!8;"1@:5
M\ +/ APZQ FI<:]%D>ZL#(EOR6J_L<%9+P$@?[3XO5Y.;+<. 3*LCNS!CGDE
M(JX)L@#I1CR8VD_+IWMKB#W*FME!HJP>^7W,P( #[WXIY4E+!'O=S''H2.>M
ME5W:W>!D/RSS]&:N GTS$Z*D'8%^XFBUH* >P;LH%68.N\7:C'9RGQ*N5>46
M!E4'VI:-TAP=D(JQ[-W;"P0P0_8 4/?X";;.OO9_KIRR,X#F[/'BA%+"PA[O
MTEUIT0EY6CKWW=!'2E>ZBR;<-.2M!#U5N9DNTM3H+VA]LK+6J!K%7^@Q'>(>
M))"7CIPDF-7I6VD[\@Q:S+J,:*+##)56I^/K8 ^SD&<G+_PM^\*W':)'$7,"
M#,_D7DI^_BDI&: :'-3QF\+^ASV?7)[5>A:-]EJC:M-S(OR >KR-HLUBDHU@
MIYS5$:-=_/)6?)$IF0T2D'D)W*;$AH2?E-*TO\2AJCXW*&CS\R;Z;'SBZO$1
MI1-D2ABQ>>8:]+Q>J3KW-K"XIFVK(K;*.'])J^KR/NO>Q&Z60Z1G"B5LT1)E
M/> 1''Q]YAFJE]J59'.XBATH=OZ24*XXJLV:!^IUH0:;BLU#^]4A:M[+#XYI
M&ZT=(OV(D@=US:4P\,/BDJ!ZH66,W&$OI[=D-WL[,)2X C,&IWL+>8;1W<!%
M/Q>. ">C,IV'!L&>+5'+SLUV"<(S*W^4;#-G ,7-K?Q1$('.U9988CHG[Q5S
M=X\5O!6EF3_G+:1_1=136^"<?C,[8JM "*6CG(QWP< E7BI#R-77;J(+#48%
M,/Q(P#84@W(YLG]R;G"/>>@O:G+MCW#5=L9367/G<(>$]3)1WZQ)]O:TZ738
M;]&M)Q@:TB9<YO],S=NBF88Q. 6S:AJ@H;S)NU3^@F6FY1Q55=BJT+'WQ1:;
MZ_&"*HUK5#\<=$"/S*3_^)L#MN0+!$<N![HOJA? VF\> &'2]B?#<[R]E=FB
MU;-*CRL!G%?)2$04UMPTLM2$!0>ID;,]EM5M;NUL#-,@H'AQ.%<W>(7BO.<.
M7CC%MQ83I9'09 MP.YQKJS;;_BIJY8')UISR_?M"YYK8EU2@G2%&W\_0BXG$
M4[$S1*R1:638K+TDZ(&^(3;EP"S3F/$<<(U3DWO,XOYD0RB\K:DQ!3E2^E!K
M\ "&V%#%YXK5;2I[S\D-AG,*^_7/NOJGQ/BVNDWU A/0A!%6C+L2[!/_]1 @
M4-G.&O\_UT/ O,!XMKF!UL1)KGYP=%#%B_UX3SNIV>2R:+$34H9.24K!(YH"
M]XD4 "",$)UB!7G<,KL#;[EP=8\G;J%T(8!) 8!/,M0 R!3*R<[L]LO+K9$J
M$V/7K3W\I:;\:M<L*RAAZ$0%P$"-&.^7$I&?J_+9T_"RQ2M)7P("2^"<190]
M-(CQAEB+5-% 29M+\!!CAS!ODFR$J,HAVI+&V\5^V;>DAZ7(AV#8[%\6<QD1
MVLXSR!+#1QLLSZF)$$SO[C[>CS-^>4:?@],V'F]C*E/*2K^H@J"K': E-WR*
M"17DXR &JRSZO$_/[C+_/TOE+/)B[1B** F%2P0U)F$PZ\E2OK:(;"*#=&D>
M:A%=X7"(6:G\SX0(*$!_/(AGBAVTS_^"8(UL71!DT9W1;; 5[;*5ZY&T^2 ]
MC,-_:I]"@7<>I6PL%K@@GGU]0W"^ILO\28HJ*J=Q%H? E4,,H= 3C?8+/0 *
MZ\\3M:N9WF9K?;L30:/]4*MG@._\MW<OKR$\5\\EB\W-?;@5)?#BD:$'>*/\
MX'\?%<"6*/OE_;8M%+O$"7(WRS>EU@F)J2J#"@BHA<-CU8N.:F##G*SZ'!E$
MD4+'+0P,$B8#:0_Q9#EW:47L0W=DP8W>PJ"_O"S;-_E=G/4SKM#)/ 'P$A7_
M_F,]S([X!F7*;WS%NF<>4!CMHVGI<./HYB%Y9/+5FBY.V-Y%3W7[\0,+AORK
M8):&7.B  Y,+[ODPP>JYQ>;XDYX19^=30>/^\0SZN^:W;J4)@H3VQ*K $GF[
MFOQM'Y7)X9)/ :JO_^-;:BR4C^UC6:CU%85*\-.K;W%:U-6Y &HYU(WEW@%.
M=1A)*GA__PA&T7%<'UPU[N**^0_XCL?EW=],QXY:DA1W]=Z:GOCQNP#!]!$X
M&T+$@DPB25$=P9SW*/]4Z')X(.53#KMA[H?33L+W#KX<U-C__G=Z1XP_D/S?
M0\-)1Q^ I!SA%(.>,H6G=Y*XE,0*:0VTG*?)NV<=*G,=T=*)_[P5*I.BZO\S
M5_#7VC^TRXFJ^V>B\&94-/:,%2*;_K>L[/T \*4D_L/ P:_3D\_\-6F<IO]0
M\,%SUW<>(R9S;8G,0O:MW_[,\6:3VGW_SSDV&)7J+;>W4MC8B)>-3H[JNC%>
MG*AE5MD<ED_V(J@"984E74+ID'&% 0 >U- L4]R+ \-?,@=V+$W3&0>PC9!_
M QF ^_?]@*&3^^'#Y[FYV9F@.]!WW#G 664KH7_,/0,;@ #,A(@T#'-S5 P6
MJ<_@RT%-4:BC<H2 4D3>"_IY7L[/#C*5+:3 HVZO1(5*&4-Z 9EQD^;!UX+Z
MN^7_\!V(C"L3C;M\YEN8+&)'K=W_21@=-]EJ?,<(A#1X_?5X=_'SCV@7 1PS
M^.*00(=>3=FA"!=!?P,^IO5)GCLS@Q@J6G<RY&Y^^9CC;W@8FO 6OS-JP+1.
MN>@UJ&_B<N::$"OIWI&:8!B_]U=1#QH4$]<])R0GX6BQ?:'TOE%O9R]6SY;)
M8!G\7%+&;Q-\PM\^O=RNIV<-AM/7!D'4K.+R1MX'["RC2L$!:"J8FE>.*O;.
M1R])V&ZP6HCHGO:E4]N.WI<1SN1%*J50N"H5&D<OI//PC-15=[552-M8V&%4
MA/0A+<50F>%9F-&XH2%"!,'-KL3C[8&_U&K'OAL/R[WB&XCZDA=4J8[;\@O9
M69<HFHXUG8TW$7%+)- CABVW4R)\O=\T_ZJ'P=EZ!8Q<FCG]M"7Y$W?Z:PQM
M*L?6T1ZYR)O3J^")\^4Q]S"'OH&>KM2V@?1(/@G'$VP<+2E#YC+_;$#2 OT5
M8^^9I]C9N^9]S+"UC/-/"FCX4+I=6;5$O]I?PB!L%]!0OZ_FB@4R$.^"QT&=
M#JC3(Q[-<V6&0^"P?1VB (Z5)) R(5SF?+BV!GHK$L%XE[#[2#2L%OJ%@I32
M7.Q%EI8EAX@3":&RXP  (?Y.VKF%4(.:>,FQO8+(+^+DDWVC>XH@<D[7BLB?
M#$W,2I?ET+;!^W.UB8#T(IDPO-T F' RFOH>XGQ<\N:X]@B5KE,!X(W0O5F'
MYA^WKBWFSY>[9(F>WH"=)5#F[ SW0F:B[+C(4Q>AGZ#)>>I(@T:HMV#<<*S6
M!E.)S>ZN1NOM_M%3W9BWEJ=YO ;NT_LG/_Y;@@:MVFI_OIWAN2-$4ZTKSG;.
M)IX;C!"CUJ<NXK]C_!:@5":AGCG@<=5B<3+Z^BP8^SW5^V\"V>SZSODXG$08
M3&5SN^HR/)Q;E".:1NGGV#_0]?OWX'W#"#I]N_NXX%/OS2UTA\8&SW^K9[W^
M6&,T:>GPX7L-/:4F*QW9JQ&QMPY=?71XJ"K*RU7>V"H62#9YFN8[H:]O=1I;
M)?FH*M++5?#>H1N8'GZ1YIU)2R8M1ELB73W,UQ^'?CNQ+II2VC'MZ#56V#^_
M$B\QCR1-2"J>:E0A>E8]^#9ZYS?8B'E<4Z6<0M#QE>&V37_AY XQ_KO^ZS]U
M^]%_&63_M4LT20B]+CJH@'TT]\?6-*E,9L[$(FGGU8]CET_@%$%.2:%_A+7(
M/^EDB?^2C'0EQ4YKD6C3J H-04*YDW[I!GH*.O"H7+-PUO*7+!DK@&4?A&/9
MBKK/,TWAZ2*[2ZC %'\ *!,$L-+))_7:H[6"?2@"@ZI=(VR%3X$S$$OJ2\7?
M?+8>$TYQ9'0;-,4G1F!=*SMY0H4()7W N'KDW'B*>RH!2'A#FL^1Y$/?"WLM
M\5#X!-)6:UBND-$-V!?.1XG*X.SB#H9/M9[7X'1ONES^.3^0W1:0P*XR][77
M5E&TD Z@?/;$9)U_R_VV.YC?I->1U]1<L^R!UB2B*VY:OQ>-] I>[].@],?E
MR^_18$20"*3W-D5FTQ7?I>5FCWT4I6!CA[GB!X^U2S'H/?&YTO.%.VB94KQ2
M!W_#7^.P%+51VKWT?TR;%)QM@?#L5I#C'KVLVJ\PCB#)MI=QG9Z4OCW.*L>'
MDO0]ENYX^]_,]/_[@EW3EG:?L?A>DO)BH6=?^=N^#D>T3,#65VR6?."(F*)#
M+&#NE\X[NG<EX6+!C9*E[M>_F+VW4  _F*T@&[EWHCV.6:EZY:S9^6+H2F+3
M]-A@9G<?^FN!_IJ$RYH0'"B.Y#;T]<;S3S[5[_LW9Q_O3,WHJBB9#AL4,;_Y
M$T)SY0!.= B:.W"%B=M^XI)EL=(F(JBCB*Q[BF^P2+N2[(;]DH#YB]WZNAAY
MO)2'_VQ'P*\/ /#@O8JJ<0)F>MI< %P1JC/']@$@7Z#F=?_\;S8B%;]L)2\R
M.)?=+CPY&RT=Q7KP\U'AQP?JQ5N(:<5!>YDZZ(PZ1X7I7OQJ]9\P-6% ()'A
M]DD<'*['!+S+G)%=//  A[?L:)7K5"JDP6+4=G6%&W7]_G25R\5I''\/:C%+
MRHC5^Z ,R78/(6#'Q)A"TMAZ+3-TC? SO<YQ.3?Y%'013? F4=<H3.H%;GN8
M5U%SM4IGC2 <=E))[ZD%'Y"9[EC1MVWUP&.Y97V2:!?:LW[H"&*9P'"VIFS
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MG3?=YO-NC65;.3HYPK6,:>QI@IIR0K2:#,7;KO?B_8Z+F3O?S3HG,CX-.]6
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M%9Z><PJ:S<((O";G&FDK[-"?=\<L&!\%V_X2&/]XIO.D3(826JCJVU DG''
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M$@!3#=S<:/\BV0E+!"..2]O.J$XBG_C/#XT'E*VVCPX=SC1:6-D]/V//!25
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MVFCUWN@*^QLNKB*KK<(=XN>T-.D=7: W&2*/Z2UOR<<'VC#X]BZNQDD=^%6
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M/B:1V(B6:H!RMKOI<H,89T5I=0B77P^LH2AZG)8WGP\+8),(%=NMXG?Z4CU
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M8)?;:<F/04\HGJ3)6NJ[Q:[Y.-*/;]36.RR]=ABS]<^^1RMO\*.44\--6&_
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MI.?G'.UUM<<]6XJ1N"3L0R3I83J7OK6"=R:*:%WB%++B0Y7TA2R1Z(%INH(
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M)F65P<1%VJ[:9819-ROE77&*8MHGH'RKSS'6-W)O@.=]/&G[1>V<EBSHU]A
MM+HI E2W2(KL6"II6ZFSY,3('L:XI&R/-I%U,K^B$--N)I+DB# \F$) 2T5>
M#\Q^#>.GJF*JDRZ:X2*C57AH(\#'+YYQ*]I?\[WDE'AVI!;'O;3GLQ\28YVD
MG,AX!&_0K+)Q5M/O"UP!7C?,+]<WQ8^V$:90\8-98P<*,E[CV16):UND:Q6D
M5S6" >%\(],P:>SF +/Y2+ACI0_W-[W//0I?OFUZE9-H 1\]&--K#18N??<N
M O3=O#3V)9,QT[N/1BVWHMQTTEL>J6,%L^)T6I"YPD0&3B'K1I1>B8]GY9^^
MGFH?)?U"[DGQD3U+=^:S0U/-5(PKQ39+0;%YZ^2.1/F<0%5#I!ZQ9^DW5]BC
M:?:O'G 3)@)'^T%_+6N<<"K*!^8O$4\H9]*. (HD.I4\Y-GQ6-(DMSE^:7IF
M1R*][ZA@Q4KHA3OI&^>+3#,9QTH#['J3*7KMWR]_]%"!R!(DKNJUQ>W,EC=C
M8;7G?)S4&2ML]B@3^_S"QL[]:Z(^/<Q\7NX$GS!ZXE&N0JQV[8:NN1O!DSTG
M)0V!J)=)JY+1M/>/4LH=/H<F*CDY\M KJ+&64*SICA/8O!^L*27H3'7MGZ8,
MM[?]7H/PH2P6QX6)7*X:ZH8-+XK8:(7[5%B*--Y:$TF,K]S/VGBVP/[^7EJ^
M\+N'8K%.N+-&><X#/ \4!VYE=-BUAJ9Y/G%I4G.OK9U#Y,WOK<WWB.M'X3I]
MO:<$6LCUW%EVY2"A?E!'Z@]U+Q?8Z9.1[Q%_?*($!>K\3\HIHC;\J'GN"C#'
M7GD%L)V''66'_$H&!\4C@K2\6ZNS9();DL^'TJ3+'32'<J);5/]+AU)\$T=;
M@H->5S'^5&[3V[L"?$($/8S:F?N*A(ZDYB8,_1+E-(FYQ'UXL%K7AE%*&W%B
M_HX+,GJP2YJ=;_&7; Y7@*\(F?^'KZ]@:@-@V@Q6G.(.Q=W=B[M+@.!.".Z0
M0G%W=W<(3G!:W-W=H6@+%&B!MO=^]\W-W-W<W%_8F7UD=I]=!/(ITW-#W0*Z
MY%ZGGW<4JV:YJ4IF!1NV6&*O7I*\4JU-^FL_IGZLFTZ2"(D+=)<*1,+F7*:5
M$4:HE;^"F4+H_R.$;"0*X;QIKL"[":2<BV-D/&T9]QKZ& G9=58Z9KRB].^<
M*(X?U<%1R^"H=F>S\-7PAF&)K=.:,KT+<5/AP%V*HPGJ#RDHNB,S+$4'?"2V
ML,C<HJ&04L]RC^194H[7ONOG(LMXUUU7#LMMWW(LW>Z2GAU\:0G' _8#!.FP
MC6E,6^\V)[J![-_$\^;[AW\^>!_)B+14ORYV"ZY(>>M=WTZT,[7L1O99WM6&
M19WYX)-4*SUCC#P:R#."K.4#?9=(NDHQEM]CV"@/GA',\Z8]*%YN6-H5-MS:
MD:\)C%+$.SD"WM_T5BR0ZY8LM<82IUQZ0+=P&/)2OUL2:V?Z8)4:-_6;K)."
MP*/+UC<%'-,@-+;81K%7BAA=(^G"2<%=>ZDO4V4GXQ!#^6K,&7U&I+C3LS0Z
MO0J>0T(D^M&6O8&IH[^Z$R7PX&@( XE*MN]7A/IQ7,=WMDOU]!ZDJ2UQW?-$
MA-\N)%6)U,4>+V>"/0)6%S%0_=PHY$P;V>VKX5>7Q&$N;16\0DX^@4(!C ?7
M-O)O<$4GA=E'G1B3 E-B>F]16;TWX!'F.RRB=M/<K@%25[N\)8J (YN-"P8.
MY#Y]1;:M7,!("%HIH0=(XTUFSA&R<Y:&AMCM,<^=%F=-?^E56?]S4.J-L7.1
MHM$I'5!&_77ETK9Y$YR48\G5SH:EJS.IV8J5ZC 3LH*(;!4V1PB052A@G34^
M_;/9V_2UBO[J.%)!8*GGT:XJ9ZW?^* S<$9R_K-%RUN.7J45!E*#_9==/V3R
MM/Q%:&;-TK2[4G6Y:2>%!<G2(N;L3)AT$U9F1/D:&;M7^1#\&%#*B\D7SO;#
MRHX@G3!/!RD;.K4.SVKJC8*8U)2]6H9IWBTF9<<AHK@+P/A%$(%=W^FAPY3K
MS04=&(9?>UV*+N^:0,N!DA O'[6.7G'W(1ML?H@]<RVATW;!BR[UDPK&]DE6
MZ:E4,\$'5]YN:Q^Y03)@@$HF+F_6!](^3*HO6=R=F+S!%RZP&_.C-3&P^,#=
M,,\,MH:3B/5[&0N[WB3A9V]H$8IF*L@?6 S&/DX @<S6MJTY.;-W&7L.*7;M
M' S6WG49:ZI#,4'Z^&2,3MZ"8:$&CKTTK@TFK94WHFQ;7E'WZ9W4S<7(S [=
M<V7?'=/V?;<X7&YN4%YAXBZ9(2//(7\4-0#9!3PB*R$0!;ST:#F!9*_7YC<T
MD=!(5M.,Q(V]*E^8P>H_@+[/9EC5G@J,-"S):R2*WF)YHJ+&-< N^4,LAV4W
MV4[:0(F9Y?K**_0OOAJEA@3:\7>TM9/VJCQS#4H*:@MX]RDT_WS2?GJ8I[S@
MQ<\%+&A%2-L80&0Y.TN/E[;).)WON_$UP+X(2>SN"BE9MC"?8/4ELJS1V 45
MK=R/Q+WA<B6"V62FQT*:NW=Q>4R4D=-30(A]SQ8ORK>:ETZB#5LSY]2^ZOL!
MZD&Y.]VPALTT26<6K#\/8F(2((DD$2;I/=S*HD)EGWD8ML^XXQR0"(/N\"^Q
M:V',7A>J"MR\:GQXGN5LD'7QB8%S25D_'2U<1NG@I0F),-A:F$Y8.3"-A Z,
M,RD?%+9C&S,HUNE7A#+C55"KC,D'#_;P^[C.V/S=.=X$Q(G@:1]<QSNB-P&P
M'64P>;W0H[\T;8Q/JGK#"-RJC9FVI^AKFGLT>0?(72PUA+/U]XR2N]ECL[H_
ME7;<7#P>PHT. >F*E9J<3RCV9\)9!4W2M2JT1K)E6%-Z:H 1"ZLVS_J&TYZL
MFS4_[=8Y2V_1UF?=$$P?1 3(*)7L.V1*V7#)L^:O@_24YCNC;&(]LH_)\T+
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MHMO.:=N*43J*-JLKB23^FJ5H!2?YV"X-N&CC% ,XC=M(9_1@- '\:7]VEKP
MU]B:FO/#I'@;Z(Q/36F_HZ<0R>Z=I<AJ>Q65IF!-)3#U,XZMA*)6A<GF_3]
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ME&-24D,RR17+S0E)F\*4IWVB!9H]:JHSG=Y71NONYESR>X%:2R6_Z4.!ULE
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M4#E8YB/XK/XT2"NO+5K8S/5MMW713F,FFC+&2[A1OV-V&&5%R_DXNI]OED#
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MTU)4-TF:J]T$#M'QQ]OD2X)%IY+XQHY^)_1M/6,/Y7V_3C!DRE@9?T+:X;G
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M;S6K24W)#A5X $;+"P0X\D,:P>#)ILT%P)7CKQ5['_BRG/DNS9]O[M7[*,3
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M?B-L^G,H(V3V.?]\M3'8QG80]Z<.R]ZR4;KE& 7 P$4P?#Z%,V^"RV)"4"Z
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M/:C UW;QS92*$+[WI\V*BDCDBDG6]WW$B[O7!^/BXH7DY*V/:[5@3>>(S:R
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ML<Q'7DG,IF'J[XQ',='4=;2EF9@\]N//DP_28D=24@GM)(C/>VW_FQ:'*9$
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M_@/L3CL)(EY>EET_T.>*?6V,>V=^UW4@%7AN23^+_%0*G/\'(-EY9^/YKFC
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ME\="N_\_R"']7Z[^7TF[_-\VVD1]IG\ 1<+?_D@=?3W79#H-^WS4^'4@_1]
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M;ZUTU=KW9Q# LE1I-&M86-%']L5/"/5,'Q<SSH:;^3RMC7.U1 Y!1VSC(63
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M!,<BZ'>]#]33]2-PN4=="/Q=-&[[A5EIN%XE;#@XFK.G5$MJ$7<2^"W&X=*
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M;[QM]EYL]*,.,,A83"^Y)'7H$U?8^PG;"^ZA+'?9I P0Z:>/G$6H=@K,Q/\
MK6O]ZS@=CIE=Q#A,78BA\X*[Q^IW1D:?@A:R5UT(-FPR[$ZY*=I#RIBQ'WP7
M+CLL-I;I7WV0TEITW]B86= T>==\F*-&5\@N#YIEZSD,;*?0_),^*J6H2 FY
M%+)^43+F)+0%ULAHA(??^ IZ3 F7K;Q54-9?\I/'02&^48B&I?&OY"$3S<H5
M'A5,S&S$[I.,KY^$K%"@HD#!1&(LLK"01.^_JY=PFS6Q^(;\$EW&/F>BB,;
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MV\3CO"U]H?YL6I'&:WKK\MC$</)6L"<J(6F>8&@PN- >0??4,+I=RDS\'P<
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MG2- [1/Y!#CCV =,C[@9N770+!=F,)PIVINAHR$S1?_TG;9 @R L]5Q39G0
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M=X6$@)MJ3D:V9'_ H2_,>NJ#LWQ/,L*4T)U3@58!/1KAS0CU&9^I$ORTPF,
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M] XTBS'HT/F:198EX.Z+B[%Q2#=\TC3#UI8ZDIK+3(E"X$^_;'EPHRJ"CT[
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M(E$[;XG2,#*@)W/&[P4>Z7,:3*MV=Z7T@?$&K02JUNIZ3B?_ &<<E$+M64)
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M 6VTJ'J0-#W AL'6#1WK2VID0R7(^: !C&VI0)HK_"8>2!_G".R0>8+9%/*
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M)_4KGZ6JI^7'&+3H%UR[+85<F6[DU% /Z\_DC^NJ3OG+:H:VK[W9GK[7V83
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M<IB'<"8;E\"E*9-4@7H"4RP93XZ.W5V";1VB'.I;BXN(2$E'=NWBRFG&='0
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MA(1B \SNG%DOC1XG)OY3P\FDI_1'?;%]R3,//&]?(/W!1@]UG B:_ $$W9Z
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M"[7#%WCE#EA&F$9>OOKSGZW\CU49?4F_/@_\ ]3DSG[@:OG]K<SY<X+G/\!
M:-GY.^OMVZGO=?SO3V[>'G[E<EI2M6;_/U<9O%C-#,..#,]:SY\9S]UN7Q_'
MG'^WB4CQMIZ78S'[!]#Y.=[T/[8G\8'\U=:2I ,NJ3/AC66V&<];Y&LKIM&C
M_1B+\HC56@ZS@5Z)3^+P,MIDS0TZ)A/%X4,JU71-!ZSD@['9*6??#W/]T*&5
M0-YGICN'V^ID-T#).P"JNRJ=3$ABBC]NG2V(2^\ <F5DI24B!>Z9%S&.4[+
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M-PPT>.P"0[+M_'S/->:)&[K-SK<!7-.;C V0;W%YE8PM6K^0KOM3>9,-YJD
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MRF 6WRO=HA(KG*W8?9OUJ TSK(+6XUSM*(;WV<5=+2EL#->,A=Q6(51=AMM
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M?D34SQRXK$49:AF\GWE]%XH8!>R I*I];ZF,T>O*36KKXQQM8LWB@-KSEV5
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M_-GFB $_;^YM8'#7,WMD>'L51HQJ RX,Q%PTVG^( J/S%+*([BDI7>^_2[^
MASY3?C4M>#KLRVME79!)4.SX1RV=\8BB&RL5[JT[Z8&%<A!YRXB/B^L_0Y+4
MOXBN<V/IF.,'S@0=$94R#HEL':PL?!CCS";2VQAT]JHV8I^I9> KF$(HQDP)
M+6%AASGBHTB/76*.^8@H_6CB?=-K@]752D D7Z050!+%Z[\*2A1N,-4!:PX-
M!LI PD1M/-LP'3GX!+8FS/Q4080F.!-7WY%?[0T*]$3\\'R2.B*?]E@I.:?]
M'X1^;95MRY$_585'V^.XQZ/HCC>!P-9S6>%@Q]TB[V*_">.J)LY%"_VQTPM5
MR.FB[OIC#Y><:4FM2^@9)$_:]A>S]0JQLXD,GJ^!K1AV7[&$8@+?<,Y6]CP%
M4!X;$[[+Q7A"+3M\CO@S>!^RX-+:V-!6'\XZX+J,F(@F8M:,QDF&ZE+.Z\I<
M&U*;D @XMP >X SI8:,)U<JO\TW?%[KE5K9M-=UMJ(KB4+N0/_V:)5-<UJW(
MGJ_')9BL'IN;=]H31A]H3?A$ZFB(^=IC>#S:(O,'W7):##Z_'5N+1+?IM 2D
MP#DR!_9<@+_MWWZ<B>T">%?H_M+*,TS;0F6<4"OK[B%IF$>[6VDYJY3IA3BH
M9(+;CH@T]6T.7EQ?PP.KAA/]XG#^Z#XY:D+T\6PHUR:5PY/'1?-P?C@*;Z1[
M]?O873NU0,;=65O:T^L;A%)BVCO:H$NX\*TJ0XN8</W 40;_$,].(-?B>CPZ
M+=MNX2.LI;40IOED4X,^L:PQO2O#]XJW\. 5FZ+HNL"D+"R[X*(8F<SL_9NH
M%,F,=%UI9G*T\PWTK^1O19*DO0>1+=NUS/L=40T/WNO2)^H=\RSE9-$RO(M?
M8.I<,5OK]@4Z_2<*W(C "RU&+>659^N36A9:FF#>2_!U[BHRP+&TKK/R!!$J
M*>0@7&&>PH4I$3<]O<A9MC@RDND^$&@"G5,X[:/XRZ<Q@\B>,G%=16J$TFWX
MEGUQ4Z@??PQ\D!NR])D0PUHJQC73;$$Q<#Y"_'HF6M;^8OIW8U:X2:YM[,S:
M1 U*OP2.>&L9WJG7?-'&&A'107A**9D7-9&W&6X$NQ,CFTA20N+]EL?[UCJW
MWNBJ24/T4KWX%&90@AN#C# 64$U6O39^0^H3"_QT_+&^C=:RQH*83BF)2+Z0
MC"'FA$L=UY:GW8_I9;$D/$:W VS;E!"JO2O_U_FPIT9(^6;Q\V&E_Z7L]R2<
M/&&[I CH5:F>:TS;N%5=O7.E'X76;JBB\VC XOA/.&!0#!K&AJ0]_%BM)SQ_
MIS"N6H<?S].%3RS8//7[^_?Z%F"8!,L2:=_%[\/U[KN:6(--K,6[L0+FZ<,0
MS'$9IEN\$HH\;N7/F,*RF*&',UF2'WZ-GRA;,,= =$4'">T''B'-I'NXA"OP
MSR#/DP(WL8T$A&#/)>ZLQ[4"U[[QT0Q6F>NHZZ.6>2JKAF<48+5+C5ZI$;X=
MYX%NP316B)W\U)CI*/O/]A0&N#]>>TDIILH42)@_/0S>7MQLG83JQ8"8590A
M[91 OE;D),,&!;82!JU1NZ+08GR^$_8#M5WE0HG7+H#\[]"^8-HF'CRNVH4%
MFNNS9A:N.AM5FTL$-X[ON]E1#(AJ-5%ME!*<(7Q?!Z)(]7'XN(MUTZ,SH^_E
M^@0A<3DOEGCR9LUN%YRQKT//5EQ-EWQ/)&FH)"*?X/;1&64V]KCLC+8RGT%K
M<'>PQ8YZ@07 T>$.E<<G>&3]WV?HQ1<$S"JXSLF5#GK4CK$K<ZFC5>QK,,.I
M$,EF)5F]S"A $3:EM,@T1@.,'+HCJO-+BZJ1H9P/JW4JD/@>WAHE@B:%:KX,
M.6E/]< X)I#[<!8QP>LI[W'=90.]D:C$=#K%;KM#:OU4R(F$J/GM@BY#Y>9H
M3"X:@<]DR-A]55N_$ NCQHI3AC2K3G<N%>J@$RLD=MM]]F9JPTMS'LE/TR.C
MY(8\F5M4=JEDLMQQ!"];T 86'-T2Y]+<!,1Q'!@0NP'G:7[0/LZW+6XX*'8I
M)DY?3/FS@7+NN.J/:K!\(G?2JO@ 30]KX(B] GW?YI2Q9O;A RRL! !\L/$^
MMO\ .F;GX^^Q]IDVB780B#8(:7W9?YCG1'>S*5Z:JX(2QEE5#X1BRCJ;VL'N
M(F1>SLCZ6Q]-IG'OT\5&EDU[C,&=]H8LC7=![OHZIQI")!L[5OAWD4KM_<K5
M]"I:MP1ZA55J&T2<DD(Z**9\)%Y2%M.3KNEM^S_+Z_V$Q#;WHZX9C \G!HJ\
MNZ*UN,57<WSMAK^(>376/%G59BS:+=4W.(26+YRFC]?.?QPL([AAEBLT?]>-
M63K<5\!SA%4V/, ^DA3; 1BL'DIRO60CB\=T,/06WTLRE7'TH;'L3.(+^')L
M<#-ZV=FCZ8\1Z,]*6.NMPV'J,RC0H7N"[_78I;@.6X7:,*Q];:YC74^7APM;
M5&I4E\B;]@6N!-E_^O396EQ>8_Z4!O0G?CMM-3:KQDR#( P>%M#+NL3H@J<
M^[T%_ W13)U!^EE7[S%%1<RQ>C3 F"DX@&:SFPS<@9@_G/'W-^8#0-^@M(WH
M+UGBQ2Z$9O;&C.7/#7I9+K5OU_$)"<PE3P,F[K@2035<H'?G'6DVIHAEH.G<
M?;^ZG[8(Y]DRHV;ZS6<"==UH<X,+N5SGS1J*A(0A(-P#CWSB$%Z&(3JBVKG+
MO@AB890<DRDH@/H:I B5&;"O!Q-]-F2&L]G!X;F19V6EAU?"@U-TR'94X_3
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MW5R2 9G?D%V$19[?%KT[Z00II>%IR)TP)EN.,K@CVB+^%,$_IA5U8DUQ^)>
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M6GKR\VN5R&X=K=567^']PSQ/3E&>Y98]]<:.*U,.8Q3G9F@,5W_,C02B!F*
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M9%QF>:!%Z8*3(S1/A$-FQJC.9IMEZ@OVSA.XTDYY(J%-<-%Z'5TT= C+4;-
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MMYK2T83"+RNTXH*+F8C<O:VS*UK3!4/55*4WN3Z,0*2D9K(GX7\$SLJU&?\
ML_2[?YF@<P^<&=_[J>^0NKMJ_P#]Y=;-;'\I!OX!>)S^ 8+X,B97;V^U2WY_
MM-C]6$_WQVEV-^%ZM]KUD[C+W^"@M[\-?/X$=_SU>O@L.5+_/SF^Y.5OPI7K
M?O(N(@I:G[U(;8?+/,'A D4=;8'O^?B<3 <8(3_2I=J>'/\!U( =="9)&?=D
MF;NW%#98(?&TMGF: ;E0G+)I3V\=S,B*XOEE&N)AO0_>BGF@6Z4XSJ/U4JFJ
MZ7:]+7.7KV)FI0G"5+,UA9<C27[-HY*&RA78O^.'WEB!#3Z]C6LJUSQ0&[R!
M6E'&F?9[1ME42@=L%?&#S@5[/$5\S3>91H9.@H"L1;.?F9&,,<Z,@0Q)'(0,
M;VDF'"XC!8W'JC:]]GNW(XPT,QM4UQ@:)[\?&!QIM[S/?/5@() ;@=4M-%<4
M*,?7X3/WEX?[ Q'<6[5A.Y\H7/0?P);DJ<M95E8*9IS72\<%@I8;6VY*SSY^
MME_2>##NPU_)R]>$?8C,!S9>Q"9N'J>4MUI-%J=)JK-I^<9.WPT,;P:ST*?U
M2C4VI65&?"3$ VO]Q\.I@/(3 S@Y&WYN_?&>;"PKD.UW #.#JOD0G+&RHH0L
MV6G+.EF9YV4\E]_6.LF\,_=9PX$F%)+  2:UP@18BX?)*GI$6L,<0**EY;CL
MX!+3)+UWH,I>LN<N\Z&$B"U8E=]R=FO^273T>L5V,"&!B H?90?+$#KC3$$1
M]D5NK.[7MSM>D14/ _Z7DH/B:,0/Y&I2&:@6.R)E;0K-9RU I=Y-V_R-@N,K
MALYNF]>5L>:6E^(=]Q1;=#$IQQ->PQ7'OBJO.(!>G1Y>"(1]<]??((*1VVK/
M&&V\S2*AJ&49FL,4+$(>O*JB>T!BLQ*FT>+>!]$)GV .*8L^O>;>J@Y^-[LZ
M& 57(RSA3438!8:=BY2YZD"-6(0 YC0%*%L!=LK[>=W 1+4X9-4P"178;.#$
M)"A[H&#\86I:JR=I [EXH%G-F+HHY=<H8C #/$LJS +BQQSN-TR9ZP^>]I:$
M#H86(\/K[MC<9+]4/GX11%SDTQIIGL #57J#BAK9'NYGWJZGG2I1N5I\2JIP
M](JM3(J0P/)5$+?!^BX_BG'SO=#WH;-W5<"G%;:&:C4E[2/Z6F1][-2G6F'G
M%15@H"B)@\CO-<VD\+93F9/)C'J+5Y5)N0 N5Q24NN9DIUGSW7/=A+W8<:ES
M_$K;Z1&4\JM6N]/0'=T[7LFW)S'4"L_U*O&>W5&SEGWBBXM.P%Z$.UL4?#A1
M(;HX[LZ,*N<<O<QW$_2:$#)]LGDF-FE!RV&OPU<4!8KM,*8=GO"*^^X&29Q/
MN93U[!,ZE7,+Z78E[.XQE<]<%^Z8D@Y4M,\!3',-I\1R,R73A\U]:O,PIF@C
M'G+KL03U4V]$SN-8$+H33]*JH*HO+>0:-0^P'/%_P ^J#0^ODJKA20;M5&H6
MBOK/SW!4MRX:/KQ.T5DGR-&\$I>(,W@U],>WB>W60+RB*HS%@&G2?]A# ."J
M_%E<^S E@<,^S,M1@^CUM'FM>.&&^=E0/LXB,CH0!)J?MT2"#6)G,[EA=>S8
M2DZ+A_L2M=F>@>Y@AI<XYH_K[Z OEI/8Y$HCUG=,!0-L?,[&1P/53M/-K1E#
M]K6'AS(+]%''W+,*&,P3 SR8IU]G@JS^=%]U16V*?(%\)X.$7BY^VR,R):\@
M+WT118@L];J!]QGN+Q[:*RABSO_$1*TB$X-L*T_/($8PXN0[L'9DLK;<:I^X
M.GF[)LU6^>6Z8_U8+Y!5FO_F/%OF8Q8GE5'8% ":^0\@>"M=AKGI6;@X:+^J
M0!L>P@QG*D:\*YI2<^= 3]K MJP76UBNI.L#=<-V*T\^7\#*/;:ZKC7;C+(P
MOA5SNXEC4BM=*]+%+&YGO\G.>!<=JYE!PVVF4Z]! *#>? =@$ Q/L*&^^6[Y
M^-3E;GP'VM6P#WLM]VHC ? CA% "Y9RD;\P#7T<@$>'=,K<S82$-*7ON[!5]
ML;1NS631;L5_GU*9V51B^L 3U]7\MD*CG(*R9;*XX2[ SKJ Q5@X@TSA8,+0
MRI,TQ!&5SLYJO=M=6N;DT"UCA,N-D( Q*8P.6];4=B XBZK2/5=9=6*^]J)7
M9E5#?RG-$E88:.\[EVTLVBO)DI$O_/EMWJF%82+V6NW9KT0O,\TA)G;!UF+.
MGGHN03IC>]D'U2(A;+-?WEW6EIMMB_O/\$V6'<RL.,F3>E$ G?HD@@Z@,D1+
M9[6PP4@HB9\=8''QA]S ].FX%24T;>KM^E/,U,/%8\E?PV>ENT6&\69)!IE'
M+M)+!"PB@[<>ZQ4S31H3DPI6*AT:5@(>E6Z'E<4  6*N3FPO9@2P2.<"!9#&
MU+,NA3VOY8Q)7M-7.B%+>#U**35B$B>+7I+!F9Z[=J4IJ3P>(D3&)%4BYL_*
MX&P6JP4]>"Y7-<V'"1>%&<:R:0<2]9SQ$,"1PG5;>GYGDKFU?O!6%.H&'6U5
M4M@?J;G$*;7F5J);-,P&>IG<H'B7_XEU/R4L/2O1MLY'6=;P6.8Q7'.XHC ^
M&>=+=,VD?<_EG-)CXN&JOE@+P@H$C8)S1(7KK7)0:47.8_]VT=%FY%"N?._N
M.MFLY>&A\M7,%KW;P-0 +F.A+;!HJO\U@.P;33?;IZE=1AE2+ML-#0<_=+7#
MWR!Q"#N<WFU7;7R[=AX. %K4N$8QF^]/@/0%\+HL2M2V,^+>2;_ZB2\1.1RN
M"1W*=IE[/>N=[CW1XK-E]NE;ON.G09K:^E886 N24T$VF:.?PU5!E1 \X7SS
M3$88ZT-P_AI3=U_YQUUDJ^GK'/OQS]$NUH3"CR8=4WD<60Y-$[7E%6V6U-^=
M*.ZC;-TNTTF*)5X1HD0FV))/]YQ.+]%,^!P 4[6)HU*4"4#497O^X3IX<HT(
M=ZTGW:]&_*X[G_,^05WAUAUB!/QKM\V&NZ6]GS?<[F./S+;;\5U6ZIS0IBPT
M],=H<[.V7 [#U*P6)"+0J9BAR7BRL\;FMT'E\(A\"Y)46SZ88%0*I! OE*_A
M7NU\Q@W6(Y"B=?(GQ1[ZBRC1;_Z::46-CU0:J<+M(E,1U6)=T0S>!O-8,Q<U
M3KQVY4A5*T_"PR^45=N*%_*^\6P,20MP:*]"L5,C03<5IF/;?N)JH.YX8Q)X
MY>8,&:&1<RZF3\$TA25<],4P0_#E@A.07V1^\V"X_ =DZ@NZP(ZOO2!)#2.,
MQM#8+%95(<\,TT>\N@_1)%GLT(>W&_:S[[-(O,/(3]EE1KWF<[P4E0K>$TM^
M^R4"/0E^@K4_F+]$O]GIBR%P!DX91[4;<5FM0,=$(XRSOG5;N*'LB-P>E6N;
MU/U(Y+#9,2ZTPWUP#&C6'XV=67RY9&T]7974Q+.=OM8I2DAY*RVB^F&E4V[J
M&XU!L<Z;G6]3KYI"W[>=>G9WA]%"HB^BMLN;XH!@].6X__##:2R/';,=W2E0
M;U94UF4\_NRF9JCV3V)-K@MFJDD^Q&[=&#FDM/N:;;&MEF&@/:U$W5:-'-6(
M*4 R?*FLC6.<!)B(2H9)1DJ<5C#MU]FEO0O-\N>WYKJ]_F+'[$F  7<J%41%
M5(^L<,3R[(4QK@()IR8XZ@I6@VHV$AL"=8THU2&L@$ED([?"'0\WOV3$C2O)
MY\_?T@DO<?T:C^Y7[Z?,,MA.63&,24-,QT-,E82.3-W-"Q^OO2^#PE^F$AE-
M-,U#IC"CDKUJK_14\8!*G+O43\N:7Z7X? ;6IRPW;KM@_"SL+4>$C/ZI$]3E
MCXD?+7*WF%D=N]77>'*7-41981;"@FPN)BSOO ;LS614[.UNS=:]G02O'P<7
M%X]GVIV+,>I@6'+\D!AZ +$.GE:6[^)7\S6\'KL=GO>PXP",:EOB0&1SK.J>
M)[:!E-IOG=<4KAK3_?VS$?3#X[3FJ5GZ/D?AVZ]:$OP2J"*$[!5?M>1QG>:=
M.%E82,[EGM1#15E_I)6UPNT409SS#?PNU@;_IX6[,BF$Z-2O]1\ H6WW=Z&]
M\U0:ZXXGYQ^ 9>-OQ5V0D\0GM ">AVS!8*NU\FQ9:O^\_^\%B\<8]CR1\W?%
M_NU!YH>F]7\ S8V_!I0KK4:WGTL$WK)E?W,W[J7]C6NP.^(6_%2Q,,7@^7.S
MZV-3YV^1%1.6WQK_-1AM?$05!5SQQP4+P\U_[3H[=2V=7RX\^^\Z2NL$-[NB
M61=J;R"9/16>+J9$:[:)6/J-M]1^K[5]8Z7T;E2VEZ00>21T/<&#,+4K0BMF
MZG@)%JBO"KCT!V\DD;TN?Y#&<^F]WD$PN(OW/;S2NT _(WC3V"26O>9JVE=J
M\>0/X\?5S=S,V-A,U$K5Z,IHC1.UR*;R\B8<53C4&PKRQV$,DQ/1 =H"T%*=
MJ(ZNFZZ2O=K3%&A&YZA9\P!HD>HR@ /C3GDA"?P?GP.<>>2?"Z9%G;1$OUCR
M,J3_<61@7UY1)@F9V&;JXCS;I[#Z-AC"9<QE"WIZDRS-[2HX[9LABJV?7_#1
MN?%TZ]2IY_ZW>=(E-!CSN!7;(7,6917P"N=0)=4:A1N=DIW3G+8T_QW9CT^3
M];-5;?#"9;\OL\-)GQ=[3^J=8F_BWO.NJEF!#AECK/013;5B%3G=VLQ&=9:C
M7O<OZ#K(,V?A VL;N2"7+7P4U _)4K]\-W;?G\3(NMS,J@55XZ1)*GXAM]N@
M.4V9I]?+-CTWLY1<I7"?'XLVM%&13  GX;H_!*SRE.[4MF[<K7(&&#NLE]%J
MFES;OR^7'*X8XJO YMPBU=HCP$VF9J5D@8*MR-6ZM7"B8JEB6-D9H,IQ7[($
MX'SN'"U?_?S  :X_-<\M,987#Y>Q2[XM[^%N^]'N(/N$3)H&EL\K,2K=ONYJ
M)GOY;I:AVUP3;"::U-G1_@.H3]I[!3? 6XS56(VK)2Q,F3.W3!\@EJPI:\M:
M3Z*UKUO"%)BP&^DRV>7P/R^[!8G6K[2YI^%-0?*CS=0 D<_]CO25=.&QQ03W
MI(-T2WU@6_K-C07&'Y%"%Q>7^A\[BERCU0I3=JF&XU7$AMQ@8ZYM+I\Z# NS
M*UHGQ!4OZ9!;;(@).-1Q&,_'R3>6V5FV("T&"CQ4X"4.)9/_:5"0;BTC1C=G
MZ\0BP =ON(9OHB<4;J_Q.?AT)I40PKTNA^/L6NO3%M51['9IMRSPE*&28:7(
M_O.*/<UG8UA(=R7-+Z#=VFQ)>Z^XJZ*H<)\;M(UW7-L-LXO[_7L"7<X2KFUD
MKRX6%=/ S+X4<#LFK7*@DB+GHV<F6V+69>O(=)!E@4CCFND0"[U(C!W=D\H?
M)9=R6A!F&I0]K(.T1LU1K$5V1O8H"4MM. 3[[* M&JE1B;@F("TI)2^'O&UB
M2WB1K!*XN?,'BBGSI8HVJ3AP9JCM%)B9TA;0I2#&EL)9+,H6PS3D[)B!\F/=
MLT&9[F[PI]SRCM348;=30.= <9H@( U#%V4L+--_3 HS*DRGXJCQ3XWC\(^=
M"V]$?LQ0M=_C]@7RR20#2FKCDJ N6N*S[#N#1B@&Z,_5MO(.5PQ?!JDMEPU-
MF^HCSL>_-^&QC"_9A#N8!R;]F7I\,;^Q;=URW64O^K7!$L3J^V6S!! >R:E#
M#Z-ZV]/>Z3.0]$$?Q5(B186:<YN[5*S%9>^/K?A?MSJQ3)IV>Q_1,3.8DZF]
M:YRUF+ 9=9)B84'FQ"GY[Z!%_H7.B!I]LO--E@'=;,8]1S+AD;!8PZX/?OGN
MFV*KS4-0NIFP;YK XD7VM#W.51K4>6[-6AU91HC0%(]CA[<F3+4<?IA-?)_E
ML8TK=9GQ@VF).TQ(=T-?VI$/]QR1I6W2N'H_%D0B58.7E[[J,]>8]1A)8ASY
MZE:E^D<5&3NO]E]WIP*;OKUNIFOQK-3OF2O+::.;3F\NDOF=P2L-VG3:A#5Q
M[PXM*+R%3D82 )<H.09T7!9D;1>*9F8BA0/G!.P1JTNQ$>Z(3;."M-$4Y5*/
M14P)=)B156NOR(_U]7)4!+&Q$<]8&)YASR V]7J_(&_\UK'C$-2#<+5+561M
MG;7-V9D?T'$)I\&I!NYQMVVUSN:1S*L1C=42\IAGB>M*7T+.;[X"O;!YB_"X
M>ML.B!PNEU;"^G_AQZV?K&+;M)"QQ(U_?E?J_"%Y8D5YUA$O%Y-F)U._#G])
M/FPD95>^S\RMW9QO/\B:3JS>OJ1,HL6X(B\TAKFK.A<-@QYYKS$5]2[L-(PG
M$JS[3%80^\!]H0YMTP>*"BSA_JYL,],<EDVVN;[^6EN8ZW/2E2P6*16$:XU5
MJ'SZ[E339BF6=X1@?"%GRU>Y@$)/4SD!W>C>E9:@MJ*G>XLIV^-+@E;DWNQ!
M,$5G>3W^&>MJ?;Q-9^?'+&$.'(ELPO'SDGH>UY1>1,R,&/)TJ=%$G,PQ0'-U
M7EK2\,+ZE:MC=9U_8H@>0.'08.*.U?"[ %OB*3=-P2SI>\/J0O.5"IP*_%#O
MO&RW++YFOJ6>V/G))Q%-"\V-DQ,&+I7E=PGJC.%:AFV3]#PE)83.F#T$@63,
ME^MF9N)$&G^2&[BEGJ'@N5V&*A$SQI5I[6</07^N_/<7?F/>-(="&80>.ABM
MPNV<II6L*3*O,L()7OLT8INV'TW%!UG9A05E-TO(I=5[AX-X2/NK65'TY>@=
MXY5?+%Y,1$.R;4/&8BQY?>$M,;]M>%!/I#H+TW7AYZ I*Y;6Q!@U/'CFW.1Z
MEOBAS42EHL>PQ:]05V4"YWS46A[/%$EIMI_^XYT%V6*G:;G.K$YP@N%NE9(&
M71\5N&A]WCY(OX,1TONA+UH5IO&MOJX&+A68TDH&<[\X%?"IKW2%S0S! WL)
MZZ^B_=,O+7!=?NP:5-M]<H^9+J =3QS/'K,@&M",4RO;_R)^H=,O<N/ML++=
M>%S8S#X^)&,P?0J4H 12+E,":4)4C*B^F38E/W3&8JE#G/WI*"H8#54V+ NQ
M"!?6_GZ^"O9#///8K"[!]#2[NH0[HW9=J-MP1YJRF58[\^/KWX'8@,JQ5)F)
M;_,!*^P<7%0KMN\5"<\K>C;Y)*?V_;;E_G3=);G9^5:JFN8M["!PFRNY5W'3
M-6B47;WZQCKP/3,CZ)1Y8B48>*3<=4:N/^M15VJ%]C\[NU_S&"S):HARSW>Q
MMJ_(G5-F-8U3[UBB5MNA4V<+W*.=<WZ VI5&=PY5\UY79Q#@H'&6%/"^9UBQ
M:[N"NM,_[H/YIMM(A85H!\#H^%O.TF,TF*.B)-S0TEDP6X</R"[(=)U&6W7R
MC$XCNXG>M_.8UO+GJ/.=F4Y>[J-C =)?F9X[.%%*];U8_KC/X'!H=RI*]M<*
M]_B)<(9,Z930X>6:1+9.O5 ^M3B*($D3OH>R(/?AH%%*\RF>,D#8">&?>IH\
M;F4Y5L/WPC5;+ %9AVBJHL6P1[4!N2CVQ)#VP/<^O24?58+B+=<W/)99E)C;
M6@B2Y377A?=IZA/37_-T,'4J:#97!KJEE+-%0I[3]-B4?(,(;K*8$X6/;YI;
M3^A'OR.O[=N[FCN\\>S!)3#.,0?5(@)RCK!Y].2V.%DB0OM$N*KJ:RQ0IJRO
M\_:03:$AK5WQRM;&</N52]C!^8M/L]QA\J*)?HWY3+GY,(T/(F?2F[Q)%$GJ
M<YE-L/T1WU6N58$X/PV:]+.V4^H[Y(/P=??2VI3IL<.TPS!*O8BJ.-W4IGS9
M>SE@S?J'B?"(1E0K>=M*^?&?<9W/D3X#627SU[CAD$A5K#6_OOSO<34^^_7I
MAKQ)Q,%9X2-V"H[M!]%BDWH,D^=,A3SC6SWD2J>SOXWD6-/)<W)2(6N_HC@\
MQ%NL)W]2?QQ#:"Q"2 M<AO1B"*;P&ZO+-28/UIZ(VP3I[!CG[^@^U-)>[M;2
MHC4''D6;2:&:@*"4$9IK5P1Q:P2+\Y.#N7XA7Q+L!7! K?X_^[^D<6'D2'(K
M[3NDV6&B(*Y0]*X=LDP3,%]N[B<'O3L\=+M2K_GB)/A?,\(\ZUJK\,MAXDGR
M4U3GK(DWQ?B Y6P@[B?QAN*7^(7>XBC74Y!I8NN7-'8(_2 >GZ)UC^2GH+R*
MR34Z[#A)@3_\#3_2*)>P@;MPVH?&TPN,HSD\=UNW8?<.]'Z&;3E'<[UW,D;&
MA,L@Q6!NVWTK4O/6:BEMS<9JIYLHVB'8@V[VL*M_:WJK7\$;1;&*K+5F'R\Q
MMG8+G6\9NMNER;K$)Z<^EZ8+;:(5C*OH(S3DE0PZ1H57.ELX6[F^,P>S#!:0
M/'-\=X)TM9*;:=N2?A+. _7^ @"0+'AW+1Z?"+: 62\1]P/9I]P2QQWW55;H
M9Q/>%J=F9T)B<,BUS\>G']>Z;QW)^?>"^4ACA+,AH8M2"; U^UNM4PHDQP<6
MO"1H0L5$QZQ(4>#]_92J8&N+@M9MQ)@JXBF\QSLICF$%94P;/!JG2<WF%@OI
M9EKIWX]FB&S:'*QI?BVU?6Y9$=95*&5X!Y=8JRIKGI G3:EI.&RF? I)+)7Z
M!P!JA$!/3,;"1%+9-$K4-8B(NDR5CX_)"Z?QCVF[G=0&O"ZKXDTM1%]ALHJU
M,D(9]=2#+#Q,]PA#AI(QT!"/L]LZ6<O#\140)UV^K#7US&!9!"WB^WONLTOO
MI";35R]2WFR?E8^R'VKV]E().'W<!D%.91.B4G='Z$<%Z$WH[(7>7>;7,B.^
M.S:PAQYBV021X7LEN#<-C9(KVE4FP1#QTC)0X1QN=C$H+ME?R!K(7M%1A/OA
M!R:<]SFZG*'%Y(DM2*J6U]$$;_D7/LU$S%=Y=JWUP#6(T4/CF#\BL[/ZN)$_
MD5")5_>@4@"+7:9%?L-TD'?Q>_E([ZJPA:[+HSH*\<*TI[<VLPV0,<59'HMN
M<-=F57@%[L^TMN<IF1G:CA ?K8%9%C_'*,.L_FYT<1GG3CZHC-NL_#3F??%Z
M]7)MM#CI\(FYCV^BQ"#?KGKV/&9@1X(T2X\[PC8R 3WBO%N\^L:B76R,;9IB
M->Q*:TD$(30D9TM3Y:R,,]D)6\)Y&:_/]Z0Y;5%)+S-,@*0U^RQ\W-<-+/3X
MNZ7E4S%?9>YJR5>K?WD=[(E]%J>>MU92&<>%4@1RIBJ;IXH,YS5-QBVBU2<X
M5])FB77@X?R^1$?LOFW>.C2%-+<W@4Z>W>SN2!;"17\4( TE9]RU.=0"R,G0
M>6U%I$[4-;%K,5 .EW6,GK+*'WG,;4T&P[9$64JM]65)+IQK5':JTU;@@&;X
M\L:-;ZE*JD'+/F5@P'N:SEGF4*9H/Z.64;L 0U X*JG& -N1+%OB;Z2=SFGW
MFI77WW3CM^TB^5I8?F4]TM5S,*XL;M[4_YBT2Y3:#21GH/BGUQ/J6M&!R_24
M5?MZ-^S6#<!1TTKK"]$VTK.$_B0@0N_CRPM[A,O-SKHEHU55:.,)WU'EM; P
M*+$R>0S82<S72#*!8P8G91N@<2\.TMJ%MP/M*5NR=]EJ9VL_=PW*Y\#]B!^K
MD2C59;&E0G.[;]X\)#ECAI!@'V"!>FN[=MP@D+>&Z]>6BU$U\S7U;N5/,.6Z
M;[YP\Z05\V._/C5N:H7L-%?L$5<FVWK@.1.>E[%_I]N%":_/N'<D%G:(36!E
M$:W;D'O4H5?:XW$VM,^$.O[Z$.4@3[.%T;#S 4"(6GL).AWAR7^56!X!!'])
MH@/?\H6XU!?U"\RF;)17O83KJQDKFT#$>ILWC.A:E9X;T]O';;07<(15G'X+
M2BDZI68[XKBZ"457W"WFAV-/<$0S$D?&I7MMLS>?!!7.03)+Y:%<=IOE>]&4
MN''1P+!%:,ELR7\[<,)YO((*3$Z54'VHCZ?=Y0UNT#VH4X!1%#QJ6-;;OUO_
M&5P"2I_337I%3<5\<-WB1"HD^BPHO$H$I3"PN95XOHW=S]Z*[+KMKG_:+IRU
M>NJJ+YJBU39L*$8BNU1@4Q@%8M\V5[O(ZOW3LR,RQ7Z]:Z_\?PVP_B\&D1HL
M5I+QWDR9;?R1N$IL"JQHLY9E:EDBY%K,<V'_JLZ-O23^+*^&:I+D*&QF^?=;
M4X&=S*$IC05:(HT.AQ1A'K3TEM#4L;6VSEQO.6VIW6Q_DV7QRU&U(=SU@^&M
MU^].9\C4?!(GK:[AY.K5/1:#>YID8/!P(]O=I#A&^9V,HE!*M,3QW_UV5S%D
MA3G!%-)=GLRI=H)>7J)0AQ47/W#9O[S3^YP51+U4]=J3K\B[2-\XX1^ FO;/
M3!#X'^#SY>WSU-+6E231H5%[F.Z K,+6)])/\1=A\;35#:(,<[#H<P&3G7>/
M4[AML^66BV,Y/'?O#6@RX#'"&4^O%=G=;M$KHPR]T">R<A)NGAW8V0"$*)'V
M#G%CX+[.S5_6WATM4(>QNE&T*#N]DI(]L)[%B.>(2YZ89@"I%?<V%L8J9D_D
M.1'(LBGY@MZ#N,K4_@]I!2VVU&QGDLA(L<N-,]]&C2Q)L&L$@EF3W,,@0FLD
M?3_T=1A3]3N9<$F9G4?+W]U?N<W?^J0N]G:WO$<>:':WJYJ@'L;.58:<X9UD
M#?C?80.H<(HGBW_P&%2*:_,7F>LNS/)X7F5X,1S:[-Q!WAQ];3?Z8P\F/\7/
M$5LC%6U>[Y(>_!CY>QS'$W4-'2-<G,E)D#/)L".\&7K(,//T:5?L!@R#AQ<Q
M1D[;>^+F;"TBSSU\-UQ6+-Y 7J&0X1WWMO:TV=ZC5/>GW8A6CU9R\\\J-SS/
MM5AZ(@XH!;T3W>EI<<X.1CCBU)UF[VC3V&#5T5;>53SH-[[5U>R0;GGS6%VG
M+CJ_7!S$ZL>+TAA>Y<RP.X>;_?;[Q.4%+-#.6QC30,FT3^ 72+RYU1*7G$A]
M 8XBG?Y.(XUL&(/$*@FW/SEM7?"G=8*"2Y0>HT@FE1_]S:; FZ:5FM&<\N<H
MA7K*BY.J+[O<2CI@G-7 )+A:1;?6H$^H7CA,%F+3O,5&4%8\P4@<.OU3P%7L
MKTE+1W<^-/%)7^L7:YLWVF?&X#>33X^U6E70+_$UK5V2;-U!IFLQ-LXH>_.X
MGFA$*7J.\(]5IU($&@\QF*L[&]EF!C<P)1=+,612EIA%K^&2:7E+3OB6PPP2
MQWSG+CN3#!CVVP'J,26W@HV\X^5MQ8Y3R&22Y&:[GI9>V5G]YBHN;(F#9\ZW
M25MAW-H?<JJBZL_">%$![%].MSBT*[;?OLRAU@(-Q4/F"8U M3MN_FV0V6S4
M1KM"3I\7]>H.?-^X#Z&N%J,KT3I=X3)4%1[8VM3I)T&FR@>$>'5!9*M[#=X>
M7A,.HF+'T  M]7/BB*1DI[ZVSSG=L>(\M=V577)G>6-B:[Z6>N7'0YI@.17'
MG!3M]W.TFY JI5%!_:C6CW8Q!\:W4I'..QO;)E&U'G!Q.8C .S(]2TV72G:I
MR#:&*/P/PC@D(RWEE#* SO1P90O7SNE5_4UDSI4S>D[$B#]K%7&(;$OJVE-B
M\^+LJ6-WT<%XUU%ORQ!HWC>H'8SQK,P-/#70%_;9C&$+6I>F6>><!/MEE79\
M*-+VMP@RLS*A%Y!J,NK:+?=UT@K^'#_.F7V=5J*3,U5&C*DV.CS'E-*. P<!
M74!V@H^2,OB'>=D<-K;)K+@8ZBKJ3NALL;+']9LROX?:MJRWQSK<;ES#N( (
MB9R\4\ROP@?T,<NG-.$@:-(OT*:9.2V^?IRAOQHY/94/H.])0!.^G'SIJF&:
M)?"S.]#R%7P9B<3PZX)I[BPM&F=^[&7YSGRFA)"F%W'U0?M65H/D4"%6G_'7
MZ9X;"$&;[5E;S.H90?3]6:#TR/::@->''E!3[2M6]RZIE0O))K(:E):\A@@F
MT)@WXK[:KR)>B/T%L4M]=FS;ZNLPQR'=5K,,"/BR\H=S]9 S<-07N21<39:T
MI%$XN]^R?MG)S(:?9H>7(XG34SZE_SJB7U1,.:1(@YBC)'A[=&524!W1^RT_
MOE-Z#)'UM2F<RD*(/A6$EB2#4Y<R.A.X+TBX."#G-2:BK+WX-[:BM:5NUS@O
M*E(M-JG-IN[!:*:- ED\0D#^DM'\9I\W.%J$@C>F[<2'<$ZE*),X8$(-1Y]L
MO]_3Q.=M0-3]Q3] IN]4[:*EYSD[QI@X9@I:LGKQ\%VY_GI"TKVQZME"AP]O
MP\_1U&7A/UQES.Y. CJ;G#O7%DD=#,N(DU7A5[T]ZN9&!1L'GR5D4>_']9E(
M/$5",QP%>8,ZQEB\>*/X-L#FVMHM.7$'@H #B<BL QX\^4,60\-+]0;B25^F
MI2%-X$'NRF1@_7IBKP>XR"1M[?*/70-RZX"%Q%G=2+6- )F"1A#/[QH,$Z06
M;]6[+#1I_T)\*,X:S=1\+'W.7]ZWW6[FSM;9WLI6#R9*3?1.:J%*@X/1:D)(
M-8Q<>A($5?'YG"&?8\9)!Q'#M<;42R\^8,O3A9?9#\DE22DUMJUWY*+Y6D@K
MF@<;UP2"/X*+:X;?'?SXDBI#S>\Q$O PJTD\1/F&(R,J16;C.8L/:=EVVO)[
MB^YG27NLL)1!<]N3:P6RE-G "YMZ=&1&/=ZAVXG]55!WE-UW4?0DYESR+9"Y
MAJKJYN<Z(PTT$F$QR]8#^N?%+%LJ8(3T-B5T LS#SCL8@BHX)GILA0KQQH-\
M\AFD(6'PB-*SML 4VX2>Q&O7GY*<6;E5RA*//:JD^1/>E%:>Q.!=EC^H3L^B
MNWA$[ 6O4+>]&-37Z)#/?ZJPX/ML;8^66]S'T?9!P)42Q':IW(* OUK[\6N$
MK:.BTC@-S$VK->C[3'6A%3.X*E&KHM%(E=UGQ7$=E%F^U3TGJ.'D'DYK>N;C
M5Q?1@7!>72>'F%=] Z3&K0!U[6S:W M<U&#.EAJ'NCBEF5UWI2^)#9;JH@S[
M3;IGK942 >ZMQ<TTYBK;-WD:D#;RO^\Q.V54%_33*U"9*8+*;>XB!#H,-S3(
M$_='B4 !(V0YS9<-[8GU+[:=K>'[D!H*"75/EM3&;B.46QJ8H(P10A2+$4-C
MDXY4U6NLN]/Q?6(5/P-:H8B%E)+/KR6WW->&YKKO6Y^[>MB)Z#6>:#(UNF:3
MB[/".%!=8<GC<D6HE,($8CB,^G=25OX[-%&9:YC^"FSR9@+4A[E/O:L>/Z5V
M1@.88DSEV:A\+J#HOM7GN$ "=O@Y#M@#O_>RS!EZ2R=T=G$V [G_^A'Z]@N'
MZ@\BG<H:%_CSWO+\2>9-C9?-)M-==Y!-\YK"\5@\ %6EE/RH&-MR<)*1$5,H
M))JN*S>1;K5+,BPIW3DH4:*CF?N7H6_ZA><JD\2](?P,9FT5TWMP%H5\7PHX
M:(&Q\RR6$!</EF/G0X[ JS6L!:=]MMAS,"TTC 1?@&HX]6^D=  A"&LO<7OY
M*E[EI1[X%%<(>_R)=?]7?YG^D_R-X^4#^D6A@_RY3GH^#F.M[Z"F,M7F<A]M
MT/H2[C,\*N%D,I;-"2>.Y4/]P3>.GY>,*R0]G!,^5H>1A\2EK/ZW/M]WKLUU
M)MK-9\2.T5C;2(Q7%IKJ@YH^MM-(=)!J&(> #TK%)"LZ,F=<=9A^7"_/>Q9/
MQGM;DG":^YE!9HHK7+OC=2L)4J]C@[P3E[H\G&?KJACJNWO;LWP>"T%),^J7
MQQY[X^F_[OTOPT;"55PBV1^S1*)#O7HV@R =NAY^'N1+=&< @<)$NPK H_7:
M53<^7@AY\9D![Y</;MYTIBIU>>H$YU0',GB8L,HOU>J/NS\"884&#ZX+BP%=
M^*+V^Y-FUL-'D!.C.,=HRHR5:;C=D,(("2>-GY^#2\A\HZIXJ,87[0%3ZG *
M1Z_"XRUIQ[,UA]1$AY(@18L]FN?0JG=[%P!1?&=,'LM+JO,2?D#:,YV$CS^%
M3#WBUI1_MN>EG:KM;')TI.$\46'%/K/50#!R[/6%Q&HRL7.".)>F:6=;=63.
MA_? !&?JE[-A<Y #!X8@WG@8X^UGGRT^2;%937!94H![!?*Q([IH@:.-L$Z'
M?XP$PV1TB/2VB&$>A!0+RPD0MBQ*N&3HO/GX#P!S:1&[*8)[Q!-FK%.X>=0R
M(G_+IGF05L,NV&@D:JX$+^YU4@?YAY7Z(QRK40\6;!;R"KX;Y%@9UDZL>=!&
M/JXT7V>]V#<KHB-/3#J3^+R/H=<NGB527N7^(5YD\F3>%AKG<MYY%P!H\7[8
MJG(AG4,98O4N$T93(@0*-E]](0SW+CM\DVWU>P(U=6.2VIJ?D]5M)+"\@LTU
M43UGD8R5@3,JX2J>_;$('$[_T)/<O>U+,'OQ&7N.+DQ1@Q+34&C8)T5'QM]6
MF;Y?F#8G][$B5:?FA.+_X>TMH^+JOG7/0D-P=W=/@,(E$!R">^$.55A1.('@
MP=TMP;5PM^ .00LGN+N&$))^_]VCSSWWW'MZ=)_1]WZ:G]:'O<=><\WG6;\]
MI^<)T?R =N4+Q['9D\$B]OW4%\FU.,EJ)RP$58KU8_-GZN6CR3B:49L_*V!"
MY>(^A%7!Y"*C=K-1!(.P%"5WJ4824:8Q[5/[NLM:#"\+OW$#PKM%V)KJ@YS#
MW,"*@S.'--^N3O3TSB;K (%#4<SJZQU(GCK8 M115N.7A"@K^NH9G1.D67ZV
M.O*1OH7)5(_*.5Q0W9"+DZ;]%UV6'SKST6A*-[WW)^!M;L:V;,@ ICK+*ZK4
MO3T2K[6TA\-Q_[)^PAYKZO0+1U]>GC>)GQW9&&14,)'BT%E</FH-^>)YH("I
M<=["D=<^:=,]>E_6WKU9U=@3@TU#+%]$;9],WH6!,V _N[Y,>G<99%74:O"(
MQP7RQ 1<)4<&4=4A+ZIT6D1]4[>F7RNA"3D0@?51R-I]22E5LE9S2$5K%^?C
MPG+@>&T(( R5NA3_Z3TUIQX@9&?_*Z.Z1^KBF_6<(+;143*,M[3R6J^F-<QY
MXR!ITP&]"[+]I/*Q.DUY7:S"8R(GLL1])7LS6?]WN5RE9L'[8V">JHW1#Q8.
M?8=X7;_6,JT'[#X;.PP[&Z/I?\15Y*XKKPO^UG+$0=\6"=,Z5H &7 [F[:$;
M<-Q9Z&?<0L/$*B[?X*8D^;G^&3_4VCGFA[V=#:-'.U>GD+#%LI7Z$_$7=GQ;
M$N4KN>L%+O>X;FW"[[T":18BH8-(:C]:\]:<#^R<$7C^W/1\_"(YH=3]B"WC
ME'O=Z$2_\O=+SJC\JQ0V@-&3Y-U,00D?+1DD_=G3C"+7G8L%[;\ R4F%F1,9
M\Z6YAC4#;B<W*0&^5B%DJ3]91"E^855K"Y4.;B)UM,I!P"0L%%PW;NL,J;IG
M,\<?O(5E_C2AN5R15484Y-2X# YS=/8N(S8V*.,JJS7SX.%VQQ]Z9M$W. 8E
M$/A'MSI68SX]C0&MX9RM2+;$TNC@8D03D?[HL1*^2JXV[<_BR39>[D<T= QD
MB5UW95HZT587X><R7I?)=;MDK_HDR8XQ*"1FRB-%&QT%*6@+326-6VO \W54
M03,O>J:N3C0BONK4Y=)5+^U;:[%?S-%MW8T]SE3G2=:O/X57+U'UKN#U-OX=
M2L;[,[4&[BP$E[$TX[4>,ZLM7W63BQ4!:]CM)*&VF]J?W4]-3@\/^NYJ'3+D
M37'GI#51]9V:%;"HHMP=L"DH/CBJVJ$HWUN9WHE7;%3L1*D,MV"FTHLVNM%Q
M.J+Q%^WX-\&&)?6AA=77=&&OU,[;/0O,( M&OUSQ0!T13DEJVFP90\PD85,K
MRSN4U'@F6\M)8)/\XGD%WLL)J@G_&C?;_2YA@@SG"][+9828-N6)DJP_LV1!
M=X&T$I#8W,8ZR\H:EATXSE&\@.T^\K764I>U_K0'+C?T:DE,O;Z$Z57ZXF>A
M7SN4(V1"<B5I3>D1C[ZP%"M^4SM^?.%$?/*#$[\1-(I+[/D(/@RCF^>-_F=H
M1L^W;.7BX?!IUC1!AJ];LV;(06Z8FR)%D8YQ!445]E*R1F7_Z]KP_O\X>\G9
M\O?%P[>'J.I/JT*/$H<6?UA@='O^Y@N;;YP.\;9<60(;#O"JUH@;#HO>$/T[
M,@8\_<U(@&ZU^O-O[=IT\7?'_N;_Z@)<V7U[QW*XU_ '9WRIZ%.PBO]/>&W/
MW:JH]30=E;<&0OA=A%_EWJ<HXW<GG1J]"@T9HHL+_[>)5-+VRU[Y4OZ]FJ!O
M4<HOG$I;ZOH=0D-@WD<Q3Z2Z'2,0^=TJ!9-,*.H*O9/*477(L"5;VC:G0%//
MHX=,PVJK<7?^*:)ZPC.=M$WDE>"4E[.;:*C,;/(BD#LOFPZDWV:'IZ2E:.KW
M?E97;X-HN6+JMMTXQG6)/5]+S[U[;IEER:?RFT8QE7_E*).#]:Q7Z1()1BH[
M-QNM2E)*F@)VSW8^>9]MP.1C1GI\?025JK$1!H(^4K$F,TZA. ED^R&]_)Q\
M)(KZL'N71Z'IB@=^FZ.=\M_!1*3"EN60S*D,"Y,/LV%CU6OR-=1#(IFY]5-]
MBQLA@*PQH)34ESFNM%+KA/JH8\?] E<>3AFX28E6>)Q*:!SMXX8&2R>/V>79
M=09I*P#)4Y!:@#5(=V$&*1')BGQFYTI<\1WA&/5,P_^ +_T_!V*U!7/$R^$+
M=XO.DYKW8>ZST&]5[Y?=];\ ,;^'[R[O2D1ACVR6?P%X4:J\?OS7P'^_W$+2
MX@\*_5] AWG/TRMQ#8=/U&_>%?Y&A80\6%Y3COQRG68QNLT%7?X+J9+G69T_
MF0\0+!Q<A 3<>%+7.C5:CDAU(::=L&^90\*FK6$/U4 1Y5T!]/?(!0>\N26T
M M"7NX&W]%<CB9E8/$4>;2NMZ"Y"!?'YDKIXJ*U-<_.:6.IR\P3_U/L\^4Q$
M)Y1^ KV+GOPTK)7%G5JU_CX=,A9I-J>V1L+E7R>C:*S#^S:L88C?PA*\Z4)Y
MQ))/L!TKOM7,!1<'HJ# HS$!VD-^NTL8[8;4,J)Q\8(9LN[@B3RO58P(\E@@
M0O20&]HZ+9\XT'M8==(E#5G?;#T%^'EYG\?LC=QHW;O.0?\"[/*G7TK]]>Z^
M%[P8WA<M:1C^LW5ILV[I^'\E"%P'=D\&DK3]9-H""2P&6/? <;M!0.WFTFRW
M>=#U5L\CS^7S;\_C^465I?'FE;=':*7)WD\A"L8Z[A!,]*'4'+ZZN_Z*Y:5(
MLR(U6H0(VN+,"+A=@#!#SI%Z79EYO<S56TY%0Y@9HS^SH1?;;&BZL]K)\J-7
M@]GP!D_>]:L/LRJ84DV]'DV(TF:MJ3#F;++(L:&OLV6#9;&?9-F7TY<-<GR)
MJ%L$WE8)"J)G]G.5ZM7O-1/Q",V^I1[*Y=A]BJ5@Y7T_5\:@D#LC$8R!3PSP
M+?TPK#8E\)@SYK5T[G[LH6V2M;YK:KO?H2Y8@FO?^,\#M4:2LQ!AAE 4XQ)/
M6=%\.]:J-?9W'O(B/WX8A"@,#^Y&,T2UO-*"ASI"3%>I S^,5/&_VN(;31(3
M)M0.C4(*42()='*+'%MA9DE_;6S.]\/9:[H>.V2G;WIQ8W+Z.GB#7E?SY[&)
MHUX8HG[RFL5D!5 "<C#P5?-H6 #!C'G5+ ?!QHY#0A*M EZL >X?3.S)2#;O
MCH)X^E,TG-[AU/O\R%$%J+M20=7VA*HO.56T.+&!L]N>D_YYB[^-(TI'F(DO
MLH<C&M[R%1E'%NR"%BR4B;%.>:QL[#@):;)$4K8YT<;^ LBHM)U$C$BZFYM>
M%'A5;B06_&V-D9N\4J,^\"9/:[UN[O;4(17J5!\>+TEJ8V%3 <U1:ULD8R$5
M9U-C(;<GY#^*L%R>PZNM\H9K80Q%Q3NRTY79N6KL?A@@W VBG)*+Q"8;K#I:
M;.*.9=RD!9J'<VWUY'5C8^E-030MNN(U+V'#"S<=@P_]'7'%R#;<L*52AX;R
MSN4/0!6\MS9 YFGTNAFR=:9^YLH)7KON!J>Z3'AI8[H.0[3A_? 2+0_J@MM3
M4>*N=LN8(W686"VD]Y^WYXBH=?YX;%\)I-$+T(LQ+GM&RBOG9CYK3FJX+<,R
M6^I29J@P%O"%M2?M"41^ERTT"]1ZC>S!I/1UFYU=YEV''7#SEG3?'X8SRAVZ
MV+,PFDT^>ETQMPXK%60MPD[76AVBHEXWK9UC7OB"&>-9)OVB6+OGN?RE)FZA
MPS$Z6B[9P !LNE&ORD99BQ8(AF)U8@Z#JS,[WWY7']S_ 2R.(:M4*&+-)+'E
M  Q2+Z_#\@^![@[1<USMQHI3U" [-\:(VHI)*("@-[RBA0 8W7YA,5:\6#18
M8G9X-UG8JN]J:OQ]OO/9_'*UHF1< ',Y0+^96*>5RX9O:U&%AH%UK'>6_GT'
M$/Y^'Z7/GI'B^*9" 0/XM4*3".)58]&U:IF\&!OBSX'!&VT'L70;6R@?X169
MT:7$=,Y>21&1R!"227(L*'M_<E=4$M'JH%?B:IR:\S)XSM;%F*BT&$0EYA[A
MKEKX4_%+N98PWXJN,W6WQZK+U4E)W['*H:#CE&Z@6VI8&"IJ*,]:9NUCC@^\
M9@T_GDRD55;5@49]BJM8\"M@!@"<3(E^PJEV$^E.JPJ"J[GO;DOH>ZZKB51[
MNW2'Z2.JSBZDAI#;N7+Z\DP_'M*!O72XJPVJH):N[E**Y&E%8A+5]R']_='T
M::PHY'WV:?GK![1+'>O.1#W^%B.2UV("Y83 ;\CR&"-%G[6,6<,;FP3OO])O
M+W3&M2UPLGD?9X#9+*T^*V^K;E Q.X-S3-+J51ANT=^(W&'/43!)T_-:I#1:
M&O6RWSSWO@V=5G?#48<.X=$T>G2M\@[MQS2-(Z$7%DR)-O<>X&5&XV.J8L,:
MY4+@FJ>&8N\@#RWKLS3!B>O/T!:O17MJSZCYFZF1KL\>5&I\/4P\[8L\%NL?
MK#CG*0E;ULF_?-NBY(^2F,E(M##;+]V>(FM]B&^PT6]!S(F0M6 \]US%*C1J
MJXO M4"*5(/AW_U[![3@$E@\%W1J- Z;7*[Z-3'-W$W:&RIY\=XHC-P]8JNS
M;\CS=QJXY<[F3*V^U_ K&;F^O2M#H]13V\7]H$E-M:[I($\%^7'Y$ /)4563
M7)P =GQ-7L>H8I?&+8IGIB6W:,A>Y=A<ZFFV+/\+>*,]*@XO7+W_I@?&K+4@
MIR5FC1^=^;"E$VD]6Z_*VI39\A ,S'[-K?X^A=+$73K,J"1;)?7SY\Z4U^3C
MS/)'J]XQY^E[ZRLB>E-S!VUZM8Y;VX.^>&80CJ_Q7L<IP>5,?%N& CH=>EK9
MM:Z\RXI<,$>OCA=BJ F_H/N%WD+I59[!S!(WP;'#))J9H;4:]$Z]G^WT1&)F
M\0]!&3X:0!TZ&&^W/^F=$U=>[Z3_@  UD\K0>2V)V)A&L>:1E"JD :H9FVTT
M+E_#]DI=!)EZBUF+'8>L2YV60FG,GL4#E0//XHJ:=(C8:J"/\CB-ST[<2$F-
MPY]I8^4G%/'D(X]IK?(T27G>=+TC,=HHN.A;?S2.6[SJV>(K):? \@CA1.B'
M+>0C1))D9I!7B'G"1(2ZR\BLYW2-78Y.RVT=QO._-*#P<,#?<N$\+-HGCY8X
M1?$8%K^<F&T#657)TN4*H5[#S6<N+M$8RE\4LH(91/J)+:6Q!;Y973BN_R'_
MZ9RWQGN'CH\T<Q 1,=,\S1P"J!'=86_&$O%/,!#DAON=9H\L'LKQ.(6![N2O
M67M:5>X[!2_Z5,4^@W)P EA:]B]XIJ:J<E9.%<.U,32RA!#.K.WE^JC<<OQ5
MDD:9E&F*6X72^D]/'7\@CM5%$7-4RBLED]&2.*C9&='B9-E(!F#B46Q]GH:X
M6J?P[[!5B#9D9^(-&LEYHREM\Z[5949>7LPZE6UYZV!W."IXI,%C^I(_):")
M8G4N,;P=^(BN4,*>%ZL216GE[LC""KR92PH-LP_#G1+_!#0W7(GK48+75*^>
M-*>,;*(3Y>?*B]P=.&:/&ROMI72CG24>@!S-,3/]HLJ)O1+FU>Z<4>B@=E'X
M/V]Y/GHD2L"3)UEO?1G"*!ASIHJG&<='CL41VLDHZJ0 (QM\+=1T+=143<Y'
MR;E;[T[AC!IT$ ! # 'Q0Z1'\40%F>%U_:,4A1+=MW,&!O6K4,.S^_"JE@]/
M#UXSSQ4&C)#^=F5\6,)71[]T%IFCG;6#04D%.H2H8H."O[LVRIKNX\LZ7:Q_
M[OB 9]O:5EL(?O]$9F<K&#5Q_6250':[_$29P:D&D@>J6_B41O\+:M@K].MJ
M0\%[935'_4\M5P?"JO?@D$X,L#IDE&B$S;FKIFR-L:>TD1;496L4G:=/:/?I
MVI9D< T^^&PBKCH@"7K5/D5/(_=-+'LNCQAE."X<GC6/>>*&4H5&[I52;-=S
MUKW>:DO.,P5?J'J0IY,EKG.. W;I:R=7J0#GDL1([?Q?#5JF 262%^(H6$BA
MRCI<P-2]5-_25!D [XC+ 62C9\90B@N2P]JI8R01L&4IFKZ#41L6JP:H )4T
MQ2L^!G4G0WF M>'>&'Y*)\2?%,[5D,.$U+?2:)8MX_5C%Z.UT^;VL\87.]]*
MB$[3V1/I*UL)<ZAF71>7D NL32JI6/@HSR=CHR#UW@H=O>Q(GEB-;,B&4LHS
M.10@%< 9@W2OX5#FVIX*C*"UEH+XR>NKA>K%CPY3JG6+7FT+*<HXT2O4"*S
MV(ZO7%87L\4:+C=YG]3]',"O_3(<8E;1KA_Y%^QY;1D_;!:?[=(B'5]?V+&D
M7\.LH9*3:K%C4.*DCJ\SKR495T7P%3&3Q62,>M"5$/6+14I,@S7^&EH0",S^
MWL#))@$6IL];P-REA:BN=OG 4: 1;CZ3?D0]J).^?UW&ML1$!:)2Y6MDI\YY
MJY(;J;@M+1!R7;,&:VM>N_!:'L F4Y"T"2WW=N%U2<9 +M[5=!N/.=V&[-N4
M=F2!/*S8P0U3*[J*KMEVZT6VIV8Y5MZ"UI*5++A\S1A:HXF*3DI533+G$.16
MA<.(A5IE8S,<2AUB9EUI/ PY2]90"D 1R&3,WIMD3YK"*JD6L*>JY ;' )8/
MA_GHNUHDA7]F0Y:H!(YZ(.<F'S$&YDX4MUCJ1H/U^>1"M),.N$TK,F.UN%2$
M#@FZ\["E6+(HA@1(4N(': DCWY-YBO#E6@AA;]84;?;00*SO>^[&5&@H\T#1
MX,4/@7[=$*W@"#R#BMG2O$]L45XX(#:M)B?23J=H1Y)XT>E&R$1-4^]J@G=L
M-/LYF@]+>1KOW![+(*:W.0\ A'7U7:$=6<+F_;D*[[HWU.O:XYGC#,OZPH6-
ML&UF0<0 _:&<*E[N'XD12<[LE":6O8J'?!/@K\E1H@V/B(4??T;\2JWG50[+
M&X=4=.2!F9(]&MOM@KQ!_DX(&)@A3D&%)T+_1)U&GTTICE..\;5\41^2 #)>
M\<IFYFZ(P@657)U<+Q5PLF2-Z@,(H;N#CER<,EQ9J71B(EZ1O0.%:%C<)[?.
M5DFR&1D#S4O52.H;*&"2:86D85@.!,4US 0)<CD>]<HEL,G^$JSUG3E^YK?I
M&<H-89S=Y%9$B[XMZ.]G/HN0MTV-9)F=[[IUU4'4NO=<8IIP_!M0/ $819$.
MC,TE4$P/_="V:%&N2GZ:S^H>5U9E&Z=E)/%]9JM?ZF#"*VLVW]5+4I[2;%;(
M80F%L5+MR]>E/QNWB9K4Z[W+#("OC==4*:5;X9"WKVR,WMI]%D'G<'I4C>$2
MSR$/Q390@Y@I"2(5)Y6& <#0<D[9;:=D?EG3#ZSY4FDX0F2%B&8S@X^G%@49
MM)M@R2B75C^Q*V'U6JUY;F\?^642S.IAV<*;U/A*@Z3XG>_ 6\;T!$9):1Q=
MR\_QB)'LR[-S"EMN_59-.0C=)SH?ZS^6Y24B^DVCEB'S+*FNOHED]2.2K&E7
MU3E\Q\(5_&I"H4==GCU0 VU\T=]BWZ4] ^C!]_L7SO@IO[:$5TQ*G:FS#Z1[
MM/\P4!Y!QW[#L$@QU8%#I)I8"63\%]"+VDU:(Y;=Y0.OX#G*[=(@8$L0=OVI
MH*"1V!P31I#N6\KMO(^>QF_WD9/_3W^$QZ3LC]O%7\ U5ORG"KFR?,#W^(;
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M1'YRS&SC!I,-HM\/Y[B_-<%BRX! LK??*R3+*P1>:X<ZG/#T'.=PSDDVO*M
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M^"Q/WAKY< >Q,BN&ZPO)NTZLW<<M]3VX-G0WMWKT1IES42.TX5X=FE^R2L3
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MX?WBJI;=80S@*#+=R&N"K] YZ3B!&#5:E4Z5>%#-(9':AY/%MR.PR ,#\\"
MQ&H72089A4A9JBE$# 8JN'0V(D *D6= U#/O(/P$X]AK^:U70[T'5>%U6C.T
MJ:OFK'JOR$78[G+F05F0ZI)--37!#\"]]E6E/]6''G"IH!F7DB+(A7^:L-'6
M5B>:Y>:'TIL9_^#DMK[[D6^<M8=&:P8L ?DIC6SQ&W.S7WLN*\'KS@YH-IV3
M,#H; +P9@BB%M+L$$*]W<$QO93);P7/C%?[]<:8H.N\?;/>9UI&*LIJC<9O@
M'=RJDL0ELNF4J7*L$A?O(G.P$X.6Z!:G**1B;BXS(;F<S9O]<HRH;EIH,P(
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MP@5EYJ@SYT>W0^W&)=.J@&>A;&B##"Y_:+^=SW_#EDX+NQ>%P9(6QN:,RW^
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MX'2G'_W]^WHF+P:?!&&9<41B&RI/@\S.T]1V[//#*JH)NJ69%K8#(.^1S 5
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MMGNO#&^%I_<D4$YAQ7/)D:*2\U3 ^7ZL;O?J0P+K6$D_V_?$=B<?=3]=T6E
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M#88 /Q&!3D3GASJ$WOZ/.&J Z70#&G9]V>CD^%VA [(Y-[#S^#M51SK'4%D
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M!_F.D[M9K5?OSK9+&,!58RDKD/,;L"0$&V^@%B=^^/5-2I]WC3Q%(*FT)]T
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M9P<;Q1H?PO<@O"WYDMR' &L**7H2_E88Y?">1OP9L/07A:7 &$)1GF5"]$_
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M+@L)F)@^ U0X&.!1%@3L&@>@#^[X2/% W:;]7;>K@+H=M]IY'N#3;AC83HK
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M)K7^KRN] S\!>Z6R7<!MZ8L>;!5K<K@1WNK0='J#<T76&( 9F=YPB%LZP=]
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MR@4=0J [[OK)2,$)/>*"5CBE=IV@)*3.[^3[AO7[W049X-&' Y7].X6 ;<U
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M8)]%;UK^BEF63U*&L\ 2\#V?]$3N,*3])I?V#;C3QUK4;=Y*<HI2,,SKDL2
M8?CIB_661?H$U#G+"Z2E,4%]L=>[7AH2K3"!&M/]#?2\\FWEZ<>5R3:"%?5K
M$MB+"L:VBJ\Q,8]-@\[.:@3_%=,QSIN-0FX6)3)BL+ 6:FE3@A"X6%AR!8JI
M;#%,0NCVLO"%F7G!SL?GQ=7,L&?KEC9]HN/Y3&[_>$6%G.KVCJMOH.TTVRM-
MHI2H-F#O1*=%0;O?CBT$$!W/>AQ7#R>4R^E40'Z*X;1Q":E$K.D2?)!(R(4=
M+A/EVM8%(Y_#!L%^1_[L52B )I-*5!M_BS.X_U@(J-Y^_E0(O*AS%P)8@LBC
M'"Q5HG4E%3S?)P_F?VC"$[I\P+3FT.?MS9''5HT(@76DHI4J_*3HC/Z=@GX/
MP_O<;3?)A\O'NA9JA.S:\"&JK=FFF<R!H2:Q],D'A G\<@Z]*  Z[Z^$X^AZ
MDQ5D_JG(IUZ7MR<I+JUO?;MKA"RP>J%[8/_@NPAICH#YC#ZQI2G5-$HWEXB3
M+JR>X()O+-DAQX5 ?BY_+'.VX/T@C8W#%*8DGC":+2T4Y6A"_L<=92USV]B(
M,44)5HKZK6;2O,7>/(;,>J%N9VM[,M3?LS,<"O^Q)]VU%2.87[8_]OXD^(TS
M^ R\@<IJP_<9W,6_]_7ZO&YA\!O9#M)01Z1GKZT.Y)'K-N+ ,[%RNB93Q<@O
MX$=MA%O8Y:Y":;:]P4Q[J"<47 F^=!@R]O*4L_F(O:5]4O?A[3M&0'97D! 0
MW#:M1@C:#6N((7@$'2R9Q8]4<8A]'"9WFQQ<"!A(?Y#F[XJ[B>=G\;G,NR+W
M/S[6+<DA-N/J!-66%N!G*E$(S+Z(. (R:IC$9[ *Z/[5)-@Y1AF_-3O$F^0*
M 2A.3ON2)@2\B!&<BSS1Z15::1 DJ ZR!#\SYX@-(>*/3$*W&Q\Q:^E( ULL
M2O^YF_I+=Y$0<$E+@P\%480 YR1\&YR+XE*:I7N_<O?O3A[*OREX( 0>#(%"
M8.0$[Y80F(BG(DJ22'Q$=F8P")\"\00P"]%$G"FA"@'^+KQ(_' N,QX'^2-&
M %5Z2" ]0Z=PMSGH"P'],M$LC2_8.X4 >7<WSW=N%FV+5T(@RPH:HOC;$!1H
MB+'1=4VB.9"D#.)X I;*HQKN!T=.A-V&.+A-!4ND(<T7A59"_/]3)^5K)_,J
MB=B^=X3"[F(R14MG*6B/:(Z8!D6!R"=2"7P$-B"($&G/0@A 2T/\JKT:2'N6
MHW \NX@9Q=_"(]:U2C..Z(4*@A[PA< 3JVE[(9!G28R8,21"K&,JY2 %122(
M%!0A4M <!PE42BGLJX)*#T/J+TX#OZD?!JG?)=22#D*^Z_@(O@Y2G<,/N><L
MQX +=;4(4DA$PY^L?5_9#TQJ.K1NG"A''J=?4 T_!GX>^]%9PR1DS'7:5QT.
M9](2^M/.3EQKI77+5A6K%(>*7:D>5)<Y2_@(WB16^++>&!R\T6X::[IV?JA*
MKBDQ8/%NKF%$SNS(MG>1EC69B\%$TLSS;OWX$$QL%DNU)-0SO2@YC?6TK88:
MEA\8Z,CH),^LFRV3YBN@S;OXW>0\PT%Y1%NM;TK &HG'EZ6#"97O+^/Q1NU?
MJB&&TLZP7+6W!7XA//\XF?'RJ';B"\A;W_7*=:/MP7/[)P]DYTQ!)TQZ7%T:
MSZ@Q0N;A9<0^V)>6=1 2-ID?XM8'':*VTGC'5KT"<&" -RPXPUO>M1[,HK27
M58^ )5REZF8N195W5(:G+*@-&^)5#+69!@_X;W5]L4RZ9F"T"ZV[ \<QY>UD
MIS<C=(M@F* H&]1.V66W4E??O6:".JYK\.2.M92G]/V"WMNW3G,O,[V?'K7=
MU0Y/J*G'.UY#QLNM)VH&3B64SZ>O)H,"FUU"8 ",A,(?:9<NF=DMR->K=3Z<
M2TN)G.AY.E]L5I$_2!D3G?8^Z[[P#4I_E]LWN66-0<#6].4]8*D0>,=-40@S
M35WIH*IAA:>'%7E4NYQ7;>[&C4;C@B7II5'<>D9-T>\I.B.]N34^S>)\1 [6
M+C_NP[B43K,SXY7,KGM6F&(AD'".J%5Z,3]KZ(91?WV=^\#T:D\$W8WCL'8I
M]=SD@ZYM!]N//=G_E&=M11/0)I0^3E?K"H$,RMXG8W()YR]8G19CP.LX#MOW
MU8/Q["%&6;FN<R2,'C340I!H6:LI!!396-HRU%+XT-ASXDPVV2RGT^0>& GM
M&,-H1ZY'6# >6M)/39=T]]CR"$@0-GUW_*VZ[]J= JGK'[2BZO[@X9\O'WJ-
MF,F%#L+/=9Y;\A='($;9L[:;LHP<$-5%/E&JT42>@R^1W3[^T6"7&DXIWC?;
MV!Q!H\Y@:5)'H@2VHED[[$/3G^C">MB\(N6;HZWX=2P0FE+S%GRZU%SP-KLM
MFN)78%7!@PT.%QU-0O0)@3@P*6VAIP(MXMUL=PU2>W$P&)G:K4F@@5%ITC,4
M*O%+1&U_X0-3Z2DPB1"<1ZP4R*<:"[A01""-BQT$+2%P:J-FGC\$1O"\!6\%
MM<C"@H>KA8 DNT@Y,(]>-=1\!4S+$2A5I;'T]G#L,0C()O%IU]"'BN64[T5[
M1#L)#$<G]EQ]4K]F5F.,8H[>)P0J!!&_A\'/F:\;1SV'=K<YM@2*OT*ES+QU
M/\<-PNM:&W>?\Z'T#I^L&G#/L@JO7#IUPHAOO!RZMR>8K:Y^9\/ GKMA9'F5
M9V 8ZIDY=S2:W+DI UK/"+@T*&Q[.+3M0M(*!QX&#;[Y3<GNCW7K.[@"(]X*
M$$+<Z1/R06VVZ.V5K2?A04??:!RB'/!:\ >S2/ Y'ON4B<YO16!'3/^[SW81
M !2V4MZ"55QIENB5UXIQ_E9^[_2"O#+[D[:VLVV5I$%5 "%;'#3H:SJUZ9Y5
MM6#4?A@N"E2LP\HF-U*JXF+X*9WZ\#67JUT#I61E;*,?U38,^NF0\YQ4?C_M
MW1.TZK1.H20/3L@O2WLWLQ7$#U@DTF0?^>8;ADQFWLX-W>W'/"6[[,';B6ME
M&ZYZ8[J(437T[:U=YG??H14_]]DN(I,O'4WW!.<#OU5ZG]FS@'Q2<+V& :8/
MD4I.C5R^RG[A?69GD$40=H+2D[3Y1;J3LF7K*5<5LC^7S6>U1T6X4A]TRB9P
M<R\*1B9JE<!FT>9G3AH)")S=J7@'48K]TD+X78H]:M1W-5?=G7KVLSX\1Z\&
MVZ?MW-!KZU4O3ZZ8E&A?[S60K[#IP:O4>+9B-]$/3.>;D\J*^8A1N87ZMH,Q
MWK#WR4\G^;17VHK,QWF>JJ<]E&[D@Y$N?F"E.MXRK=EWEDE]")M[38V([MKF
MBZ\E$J:73X8\;..2R[,# TF=W,H7PZ\N]# M.-U)D<[GBC[E3*H0N]4+?:)D
M9G/KFBAED=!D!E 8L%5-"-12Q7.UC62O(ET"6ZO(ZV.XID2/Z=Q@J_B.4";2
M]=7Z+=F'!32RS<8):?@LA4HIA+<(GHYU[\86M%-J+9&, ]Z7QS*?%^N+J]Y*
M[Q)7OM 1D'@V_IQJZ#K-"V^&LF%5$GVR2,.'@^5"P'<KI*LC_35\1",4H?36
M&V03[[UO>G_NDR76NV[28A@*5,)IN4+@DC7:X&[,>GY4BT%+@1Y^21*LBKE>
M/]+W@T]RAN-V9JX;,7S!3@%AFDY=4:1BOVKP2U=F=RCR9:#%IP_EI'8:\53\
M*S_>2W#;:^@P?BM>+M'-GX6<+BT\]!TZO@5?&__B%3DAN%=[;4MWV[Z()?P=
M5GW:"T[*KV(Y4FL"#KEASFE_WK(8+,%=W=O;W:S@#QT*3ABY>"AHH;W,4:;-
MB%YGI.:![%L3&:NSA<":]N)X&9L+F5TZWI0LOYQ$WT(:^YCL!/.M='^%'Q@(
M%GOGY^=*'!\PC!JA(EU$!WD2(1Q,A"K3(S8/!*Y=.R]TR6&R_;+!9;68CP8$
M>[O#0=L_*<X/^HSD$G_;^N"#1:^B#RW,RI ^*UIRJQ'30^)9$4>0C"CG_J(J
MF5QM5T8GK*O$<;8;UL51 8OL$?IW=9:N=6L!6PK,)'D[I(GAD@0.$6\_3&@1
M AH1+R)])Y<],,_-W^[FW\?4TO:VZM,:1+BBC]W9/S03&BEYB<@$??&3?/(B
MD+D;'9XHZ($N4.G\L53!SA$PMRS$RX&:2&Y[4)RKG6>!<\B-[G:(-S,WNP(?
M)GL,J<M&87JR9026U^4JLZ"8NX\4<5Z9SJ1VZD#Q=+]#:"7Z:H0;^S5]<* #
MK,(A8-<Z[TI3][[;'+\[L>)+!-.9^J9_T0/$).,+K*MZO5,'JS;S#Z)B!]@)
MPNE@:0"!,!<&'9%KX=6_EL6@OZAB];59%"^IVYW\E"AR<VB"VU[U+7?*O>++
MP$C#I6BKPBE[?Y,HVB%B/6B$B>C_*D=F>! 4N>O93& &]>/T0Y?9%.6A/;>5
M^ 6$/LTC>'CKK5'$3,3$9.5)<2EW2\AR[P[KG\!$+Q$"S<%,0J<;"38J2#A%
MLSQ /,[CC,4.3 SC\M'G\KV5:4=*GD(\=;S89T2^R[LCOB2R4^:-C$5Q3.F#
M1Z\&*?L-1O+.7?D<=A%>P]>VI\FFK[KBV-]NE"/^QUP*BM8:OJ6[[*X!V,+%
M,5Z6IH8RFQ2A1<,XMK0N,LDP&#\C_D84=M/[6Q]0IIY3'^C'91;59)9M]5K:
M]OY$X(?JR8@/Z8\S8.\ND\I/]TQ=L+]8+%UH?"/PY#T'B\<##"LHP!W5VU)P
MO9[^.,ZR@?[Y*/;$.2YF=]);;QX#MM,DJBOQ'KP/T:74( 3V[FD5_9!"5:*+
MJ>;X:()VX3'_-#<<)U6WB6!J_#!"IH_8^-(Y8NKC!'$6S#X/W=2AP1?5@@6?
MV%<_"X'*.$V>O\ @;I):ZM =?!;>4C'0&+=\%L]>U%RJWV:%CJ'1[A0E3>H-
M20L!F2V$B#H61F"1!!/@EA536Q.2E6%T7W8 =3D=,268+:O-?'F*=G@+WXXM
M;5%R<T-L'L37)6I8VT=>*/M)/@>N>_^Y@>7T$CY7-\S<X9Q QJ@(/E!YCPGS
M/]1XS>ZV1S?">]U0PS4_^;(DUFBP\Z/?-FT$%O!W2=P$%:^CP]^$+]+S$Z4R
M?!*NAN*,4E<U>CY?HF(51Y>ZZ/AI8ES1T;HCS]<*N@#<.N:@N,=R;6EY?_NR
MRG*;F6%434E1T.*5._"SMG<>[BO:K/\X6SOJG.UBC]J'[Y$O/"J?5<&,!/)O
MK:FQ?I8<8C?NGG>(X<+E"XZ(,:!H*ZWAW,0Q>+!5Y75!?_U$T?UP9=Z\]-3.
M1*=X(7"%@=@^VR(*K;EU)L67S%"_PWK9X66E-L3 0-/J?0:G#BP>?RD$W@N!
MINW=M4ZEEUX:D+^\@$(6Z.Z@S+(\L!ONS;3S[0.W0H9>@5NK19DYWE&LZ-G+
M&*0-RY&3/CA#J"B[.P)5(2 .[<VR6B^('@_Q"+FT2_2QNO/:=OX$MF*-0*X1
MW,;K+<*:"!P:V$1.^N-:KGY<]Y(0\YT"&*>I'DUM#^]8\)+X!:_, NM22]UF
M4H<Y>B_B7K.&DIY#]\QG^^JRU_.K\V^=PD.WT4P'\;W\O*X>YS+%:<L$GL8L
MS93WI2@0,P.3+QL2'"=6:V^7;6-3/[*'H'MYI-7$NNQ^VVD$9\E <TPO;ZI,
M;<+.0]4&>T@(/.U<C9]2NWDSKMTEJ5@<.G$E'^]@;Y_V=4#T0+/@]T:R0'Q5
MU3-P\ (5PZ2PE;@N,Y6OIJ&(GN\Y$CJ]IO5\NQ" ?)*]GD\4I* P_VF!$-C/
M,-'F'[#B$C@]9$(""QQ#F#3ZK2'%@Y&"/.RSQP(0MG%0"-Q3(I^@L"69[@8?
M\JW.@%&"7.QC/N8E\2H/1L].$9?FT?4V9_.J[()@@I 9PQH7IN&"?? *(7"F
MB,FAG.4( =%H6\^!]YG6KO!:+ZD.(5"/49]LX.(7!,^-QDONZOR&M@?:@^J3
MA77AQ$BWP!AM@=&,8>T6YH'%8*40:'UY]0MC=#"M&)HW_SD=OV^'WPDBM:6-
MGVMS'3)4O2-%^SYKRT#Q*"47/G97,@V2Q]8$W^R)1TR!K9]3G02V@5K.=Q[7
MO=+/EH6V[:E[M75" !G!%Q3>$7Q=JE!.C/^80)K3WN@(NX78/=B)G=771P>V
M'H6=% (&KA#ZER$FIH-M4)Z75@$9 ZDA+.QV@%67B*3AU5C<'7"'BIV>6$E1
MG(;O^XSHSDPEV&H%P4*X%0:5-<-_?-+.(VT"FB=\O6FU+;P2HI).O]Y1W.;R
M*"U25]#OMT8#G%K%B\"/180_P,H-'X^&+N5?D[RB7Q8]KEDC!"ASN:'+M>=0
MT<\&I^ZDU4ROEUV!\/VPA8\)'=&V:-LW8>BX=I.Y@;EFV?3-I^7/XGH0<4QB
MA%SH$V4JF,,E'<%]^A^0SA:2?HF05TE'"X'2D]UKFH1 _(F30>]YW#HF95PD
MIRH39COQ<F LLZ$UE,B*8R*PULA#2)8Y8HJ7N.2NS*-HS C]D+)@"S\W(<ZL
M:*D^I3_B+7O5-?)J_3JE8I5(ST&UVP4>I3<2!#+Q0U(^NJ_]\^,87H9X!*.[
M]?WA*DX6V#+0RMF="ZNIZX]07)?G@TVZ"GK?NV=*7F\>%9]*23P6:(-QR=N^
MSB#_/69Q^T09)W]I4I V(K8V"15[&7BFP#7ACLZPP'[BK+0C1W5,0"#7YTJ7
MHZ-GV&D)82Z#3^60IG;VM[O887>.9/-7;1Q^D^Y 7POVIPYF*-T53Y)%4,H(
M\"B!/K01Z=1'\J+_VU!AK*LX:S$ZBBX8^?2@C9OO?DZO/\(Y_^46'[# Z\[0
M^@P9W8;+Y8."/$6M$([O!/4YQI(>\3FYV0"'_XVUAC8FG9L?T9(2%=!LPS"L
M[RA&^+6THM7\;-O:2R:YY1B5<#BU7S].EW<,-B8@=PM2^'K=*6.-@01V8%AX
MM5-'E)(#,<NOY4'3O1KTAM*N/\Z^'/N(R?CHIG[WVJ371-Y*],HV/?7T1N#5
MZR_<?&IZ76\=%\&1S/1 .-Y_)M@R.R&O[3:Y0;YC8@_:=('=[0JIBG>,&U5H
M<W+TI\$$UF3M9[??F[VIU.VK?:-?:VGU(+J)X8[RNX6 G!!XB.M^0A_5 &OZ
MG_H6WLTJ"&_J^/^H>_.H)K(M7#PVK;1CVG9 98B*BA,@HJ!@J*9II1T0%0$5
M(2H",D9&@9"4B@TJ0E1$5(2@B*@,01'"8 B(S$-$9@()<YA"") Y57D5[GWO
MW;5^]ZWU>\.Z;[T__,-*U3FG3NVSO^\[9^_-N1-_N\Q.0EPG)YHX?/!I/L$I
M7!NB=,4FP?Q7\%3!0*/CU5L:C8MJVE<]V@P+A<M581\_2'>PT=/<K.+JSSOD
MINH)'$2@& 4GO::A/\^PXB5/JQ >06(,R!5H=3[G%#N9\,: T&];F=SOXG_P
M6$/*<2-Q,N_"GM4E%4OVZNU@9]]JXC.;,E/+3[W40UW.V0UFE+ZBFXE/"")^
M'O/:\.)M3(2HT0!&$&MUDP,^DK$GLRNLX>EU7^@\39\6U FJO:Y:I=#RYW/.
MJ/(UD@GI1S!]N!.^7^"ZW@.'F&Z7C34-R&NL'<\?_>):%3NH0!LKP$6F[V"^
MRT310D;/.9U.2!BF  0<F7KZAL2.]"J99*S#N:UHU/R,-I<^W15)6U1?/QQ>
M352B0JIDB%.M<CP(U36ZE[5ER&MVD>7W#T3"0V@3F?V-F,^G/CS[B1)=/S/1
M79T3OLBD8Z9;(J09KXO@<D*.'-]T,ZNRW9<YP&(L?R17N]7X<FH)A\^"BQA>
M2A3191"C&@$5^<8)]=/D-R%1%_1YAPM-X9K5H>2/')N[G S? ?%4>[F[<9AB
MK0;1RUX7SSO"=&393B<@=&HHLDRL,A0E*@[Q^EC"&=G@&S\-:<3<52>3>"^M
MCFNMD_=/%V2&/%V425P6M<MS,$3:<KOKW%;?4F>3J4Y@:C_H<'6[*7!<+A:.
M&"$.4_VMF5<%J \\F'48SO0/8U?55HH($SZ.OH+27*F6_6*.^6Z?0] 3W@_'
MZ\F%!X98"N*$6,B=5H'+K0GG'5SX8N^:_=O6OO1SZ4BG5AE,E(ZG]RI1_+&:
M 7%3 ZL$'>$S6;^\1(G288^SDC;?^=4Q_H_EE5FL^2_1IS)3\(QL;E-PXE?V
MO7%?\4T.Z\*R-@-7M2+3(]R*,VTCA@]2Z_!?MG'*N'Z[=X,EA6:88.( K^WA
MVU\R^E5/=[K]K$->MO^Z%=>X"0T(<&**YY=%. -:RYU5EOH*!.55;B]8=6)U
M;AL"A' 92%?YS!$$N)<$-[@%@ T51H<!A=.TLWW^Z#0\H\DJ^75WPMCC!=!;
M6\KA1)V@">?%;R&JNIPOKNB\?_GU*%EX75O=8Q"F)CI>?E8A?,J21+;(U89V
MK]_I8V&'SATMT.G_AO!6YN6I6"$$<Y[W=$ O-6]X\AI&VN"#]T6V6FZV%T8I
M<TPGKIGI4 '@X?=^[),32/*!I)]$(Y,LSM1QGZD>%UE7F&+%TOV12E0;QOUT
MS>K@J;OP<4T+S(YGE8Z6HK9UQ<Q/6:)T):H'^>>8>"Q<QV+S4&:N$K6#! S[
MXP+%J^GEN3"3!_"";\*E]6'U4"5.&);A,C&9?#NQ,;*B$?ME)$8S$P)M2BG]
M_ TO.H]<LT;4 ?.5'=OS9[00-$AQ?['=%8Z$0"$]/4SW00OS[8NC'MJW&7E0
MW#UJ< 0YVK>523.)X 0^RY47YS691=\2%FIQ)B9?\(EWLS44#,-1H6$ ;6./
M7T[V9KM9G5@E:MG%P==;SS_.:; 'U]1UG!WZL),Q;$"%32<UPL"!_=:RPHAB
MRFX3W?I'*+ M'MH&&[RQ4J),L'G]S_V;\WM>/$%8:4LJ(S@HI8?]6ZNMF!7O
M>]8>+*NCTY\U#!+EXDV) ")FR4'+OCS(<X4NFNG+,_ML5@S%B,SQ!%=PW%!B
M<KSKQ)?H6HW--Y6H;FO(1R<9YS=R_-U?6\'R69AL>8A3C_&7@C6$&$T[A,HX
M^E*B1(YZ>2^?!P0[PHA.;!>,-7]6R/?]<0>A<OES:)%&>6EK9Q"#:.'H.W4"
M5&3_"&84\*"_8VT5.";L8A:'AT:>;L+-1C#ZM1=(R3$E _%JT#C%E<= C#X4
M[,EW8<*:DX?QDS['+$ *]#D(A^?/Y;X D[C(&N>^YC]+*^\?>/>*DA'R]#CL
M"/143W/$.V#Q5.BP]IWRCS9^%=LH0G^F $Q\9YY4E._!N5+H\A-#Z*L^'5&\
MN!^ABCK4&D?'X*<_E*B=#6Z[P#X/@2%\'ENNSEI_E>-6V!)I:RON!3B,H?%0
MG:D*G<HU](!=$[""*N<JZ ? 0!$W42RC>H)<#R7J94K]&]%M=PQ: DS<L">S
M"\\J<"INI[W3J 1 '!HS$Q$0W$$EJLG6[1/!R!P3+27+.,TO25+6.PD#&8H/
MM'YY_'=C[L<@:9U.\E<0_4&)2J#71B%K,YX]A4U-\<\X"1HF*LR'$;XRP<3_
ML_GURS-;BRX"+(E9O*^J@^4P"[:PO<PB7_+SV-^BJ*Y'9EDLFV4I41HS@##M
ME:OFXY[0#=2/E)R0Q!ZP+D/.J^7I4WK?'6G+D.4A@L99KU"<TINX7$&&KHU^
M\SDD&J]U;/G.S"LX:3K%&/8C+R/&^L#\TU6O&<,(G:]G6M:3;_2[.N/ZI>#7
M\$/KM*,[OU?: M/8=!LEZM03TK>U.HV5/F64&56T"K<C50%/V1Y(!\H1EAZ^
M=ONH'*\I0K@PQ%(=] (!!IR:$%'- J!?):705$M67$3ARW9*']*V[*R--2OX
M"4,@&?1OP\S51HO<,#2'MD&$#7?].'_PN6<UA.-KZX[*JB.N9HXA_!7[WNYQ
M!<25NNNMBH8UQ7##*E:FE[]*E_B.%DF?'^@ QN'H([J-AXQ BOP%6>HDTJ>Q
MEEVTEN7-CNX80+O<\:72]>[_M3T@7CJPN;SL9_(8W"G79W0WW$DXC9-0*4Z_
MW;(]&17J?ON:XGMML"D7WHF-BO@M0Q>K'5KW-6$<1Q=.8:V?A"TLC>04<RQA
MPDKG..KZGI5T(J-^!S@,(J[VF(^%"\7PJ#B7:)$BOC"'T[$)/T7.H =]N3[!
M($T0_R^>&>.4W^?/BO^D?)@YY7,2XL5EYKRT R.\@1\C39@9>DQ3CP=#.*@*
M:2,_>\9K2Y1 7><@\L/>9[RJ:Q]_>DI\=$PS:(O'_GL^[;L67_L2,\RJJP/^
M?O1T W&;>%']MZ"D#QVLZV*ASN@H1%XTR)$<B_O."CNFWT_[Q*HP?MS#.J[Q
M,?"\0K0T'&1$0HCE\">5J!A<OF!ZHG?A;!"EQKGV>(>PC158.!NVHDBZ.*;Q
M])1V19%IHD*N#=V"]RO0U_ULJP:;3B&XD-@55P(@*X4<S,A2;>3='P,^%=>/
MP 0-FL")>K WM(%D9]0VAWUT]&B1Z5-C/86=>A03) 4"U0 WF:$8!WL,&=YY
ML)8253#!.3^C.N8='8K0[ 1U34X2@BP[VWH?Q5</FX$:YZWA^!O;/ *(40IX
M/P5FB/R(Y,]5E8<76X#CLV.F=\.WR1VS2.%#!7ZCE?@'7/\6=V/6[&#R6@6\
MZAG[7 ]%8#N':-#UN/T?9RFS:!YGBCO?.1U:,O@=\>H=U-#HEO?:?]^2IL>F
MCT-%D>7BG..;\KPMZB4T<84QC(M1HFP0$2HI!9F62M0Z[B0XP)NL=J8@'*2Z
M6'S7^B@OK1FSS5-@;X[#^\!=Z5^;IZ"/2>P#]%DGA;6/HY]_+Z9Z.HS^Z,XA
ME G2-7'BVZ?TOS+D'2[MX?Y=6,)LBDXI9Q5?P466T#J$S*[G/'MIXX[,!XB_
M!A*-$87XI1U]4(G: _?V4D2>2E0ASDV)^B,_/0!LF_@1EX7+?2?WPL<Z&QYV
MOC^9A+31/5AH9$XP>E$;XB$^AX.^/AA!2#-HRF67W@OVS ';9I4H=9>9\3RY
M;KJ%HW:MW8MQ>@G[V8F3(3'$^,*=LP!?MB"7L_[ZNE4O&Z$C_>8W%B;39&QH
M[J<W*X!QJ:)8_,??N(L1%=^&Y%:+;V/S[/-RS<5!WR<5^0X>QO$]:5G&'N_R
M'NP):U"BY-*<+./(Q;"%:/?J:4"5X)PCM].<.>E7/XXX52_%\ZI)A8MKYH3G
M3G'I=,,0@T.%YI"1=@@:,+ F9;9 E/;/2;8=T/G;_[9T<2M#3;!:,ZXTR>W2
M'G7OV/I[W]P#S?%Y1A+F7-,*F?I!"=";=X$H=TX@821B%P'Z\&#&*'QT*CNI
MV-Q4':@A\O+'PCF?@69G/?&L<6PMEQ$G/@)*-& MS1A(2W[&A8DHOU["M_UC
MF)0)\%E29BIM4=ND;Q&G2Y_Q)$WJ^3>+8(OWLQE^W,.I-"Z\J"Y;"A^$^GHH
M;&)Y!RB(0%823671F!&D#:P6FDS0&R[ #(LI$8Y^/7@< H6K7ZM"G(P?=[;)
MT?+$F_! /\A]5N9GR,=\XKS+F\%-SZ4&.<N]WY+<N#1&S7U>)A!R><<803?(
MCT3+[";$&\=6.2*JX&0G4,:81G"<Q.40!"G_&'7&BM8N)6KO-.1)[I0[KF$7
M[7R \XIX '.G,/PHQ)HV5BI1&\K U^1!"L*/Q;-3:"D)_!G6A_N)SR;RJ&B)
M^*C"Z@<@KYWQ-N)H1GKUB<E7SXK5Q?BB7=Y&^Y(J$*E5S0.G7-3D,3#2]0BF
M!\<&2L7T$+!"P:)Z8[?OD>N-;,'B\KA-CN(<OS1HB]_]7MKG,6/->LVB=\
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M-4YP9#O8N@N75\^;Z%V&6RA3*S3S]@ZQ</P2$'J,/MLEGYX*+[8I>0;/N!;
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MOQH,DPDTPT(MKI\BH5)Z&Z_Y6&TC')-*@=$ODLY<XQ1-WOOXM:B]6X?%CQC
MRK$U+RS^=I^5U5T!0YJW!P^#O\K%N;4D/J'ZEV?@Y3Z+WEE&?[3;."'3#E+I
MZABYF%E+D)@];G'O>%79,7KL8H*O2.-&:*&F\BE.38531I2KAQ^X* .UN$M:
MG',RW*28.&M5833F.AP^YT#]H0;PBXEIBQ;WJUJ3^J%]!8UFJY.J8H0V!>L!
M"THL@NPM"!(;V?M[#'V49&C,X&[ZI/$ZHOMW?\D:\=^RG5YG@J?YGQ;'N'FU
M4%]W9E2K'0AX9F/&R<[G-R()FC4B*!*F*PFMX#?&)+G<+O\B49LF2[!=MT)
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MB*(:1RUX%LN!F44:CM2LP[)/#D#P0@5)D<J*&/F1Q2R5DP4,7PE?B?[I/L"
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M(<?K@7EIKV3FK9; ]"D( WCDV&\SW)18XZ-'5\@SP#H'+)=A4H8/410Y'%L
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M"... ]M>)!N&9.TVON1TLX('7SD!\&C>[J^V],Q#\-'U70-_$AS.%KIO"1)
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M]I=^WX&;OAR9=/.GXC?/,\<CI)Z;61U0CCE!_O\Q6?Y/FWYW7O[^8+[#"LP
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M6G/))^5U>[4SEJK9BM"C:VFUO%!S3!\47&G\HRMZ-_"@&'<1D+:*#OJO(GU
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M7UJV]@;"C7PBU,UA4#:KYIZ>1K\W:93])JPC);WV#Z.(VF>7$C)1<X65U/
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M,OI?.V)ED=LGW\D=%42Y5S^P+C!1IQ)W^82!/P(BV0!!4#9@CFL6OB!- P/
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M"&TE95!2CMP4HL_Q-MAT97S#RJM:F2_P5.2+!H\.EV'4@3W\!]7'#:[Z'<I
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M!\K^>L?=H59B=KB8+7#PXK: [_KM]VLY$_5+15N=X2*(O2I14/ 3%:Y$MX^
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M"3M?H-90BMU\>.L\]<NL ]P++N6\*U]>M=?EVMQ#&^"7),1]$PD#?42\3:Y
MEHFLLY EDWOWY3FX9MTL")FFBG^Q/_Y==ZI1<1 ^'7FTOH+*KZKZ/SGO_6\O
MI(K1]8H)</^_#CC^CQ'\$X@4+#91Q<"1W_H_7[92Q'+G\"J^]HR+JK#KBV?F
MJ3.&9 .'JZJM"-56^  D]W:Q[D%FV$?54.PJDY.JA4*?;;9J[8ZVNX[+3;<
ML4_[!IIH+OL:TBW^ #4>FLR363H6( A]L,6OX$,HX<#[0[#%C;+]/Z*J <X7
MW^0H*D1R-I:Q?WW:8AO]?IU-8_^:P.#O/&:VM=S9S[7FPF#_7<=GKC S.KQ
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M6T^=<'?"L3&O!DA9Y[#GS*_2:GOBPI+3AMJ&V4\B4L)]LWR3BFU*D'4=XT)
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MS:=Z3S609ON%P&DA,(S$J]!D=O++[=:SML@H0^# R#,+!%,(!* F3?U4NH2
M)-^?+Y"W?5\Z*P3N@=')L1=(=92^!H8U]D #)^UH,ZM&P!-U2OA$:1%\%0)E
M.O0HL(3?$J^;V"#@\$F< G8DDOV.1U5"A7+2++@5]FSV%'8:3XM$E%%:!B'Y
MC@=Y0H (JC0<\\:<,H),6A#,XEA!*G8?Y>'PQ4Z;GG#R&R$0G1R);!#T\=C7
M!(J/A,!:F$*$W1N(S)"GO54:QC,F[>TGF.55B%DP!R;<?20?[E((J#2@3KE
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M=T(=?.J&<@?0E,11XG #A8!)3'1_O!"X'5U$^4(9[:OD*7$-9H2 Y=C0"-N
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MFAYR<QYHZD)NJD#UB-2OUI801\H&']I72I-S=#?XLYW'B7>*_"2K@W4'GW_
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MX_[T\14C<6M2Y&92JZD=MV082FNK-9D<X93SLQC$2=(P/8CZ,G0THHVS" Y
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MI(9-I[)8(J)#H#2$O]4Y_$GS[=N4U%W*G)LN!JHI29,AMAN#0TZ3?S%FUX:
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MSZ2F[7Q*!A*FEN^&0#?UNT)**!]X5+MEZE4GA+,VJK2CO24HU(PNUT%$?H5
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MXJU+2U R@*-F"U,&*A[NDD>?2!CT/FXV%O/!K$AT$5C2=+_;[: AV.T#C*P
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MC_GS/B1$-.,,O]Q)F!)K0BIE_DS67PU-L>QDN\;?% ;^:J@?U GBAW'N7+7
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M_<,#?(1-3K75/(X#%<4I@:?:"!^Q,M>I @*//H<WY'.8,2=F*(,Z0/&](%1
MVQK3#TL44<R\3OG-DZ%D:1DL;G;U;PB9'IV.%C<+(N#G[O3IJ5O6>.H])\J/
M:F8T?!-@A99I1PD,RS)A0=!]"4KC"WP,5AA%EN(WMNP1N=YB;3@-?K$R RSB
M1C<(6*/0*+WMZGCAC@M4QC5\U3L$^B4H856@WF224^1X\&3W(E0=@.;+9BR!
M\6DWB\GD[\;"BFJ\[3_:ET=G@C:>NG3)S$2"RE89::%[KBL#D/7/,I+[^+X3
MX?O,-P*-'[2W#_EJC:*U<@LR.Q%M4;D"KODV?QP,@9_, DNSN]YB"X#!SN[
M33]+]WY= &8AHD;4>MV2)C!'0+1+J3VV473P[7V=F9K]+EZ9]9-_/D?"TZHJ
M>NJ;I>F_4YI/Z5&\[-'R;S?V^%?-:JU$;I>>[<!4'7S-#S,^2Q]7JT_,&7KO
M'#;]9WH]:QV6+VLM0:G#XZZ$^)0OEU,EJ% AM@U396Q#/Z3#CI(55H"(L$,4
MH'+P:3=,]#!V&BC-R(+1/*)C:),E0@YEBX;H+HH>B>A9?K!#YR>30+:2=!M"
MX.V\^4YEUQ=V#2!&3.UPB@2%1R* 5L4"[L'N3 G*"N/4FV5QJW1S,E5846X\
M>>38B0/NG'ZLX&PNX+2@'+H))MD1?$_(R"-S=\;H HZO,")![<M(X]I[U";/
M>T0%F#!S8X?QE8O6%A9W,-0P,_LF*@?4>!9_\RYQ5L#)IK OS_!US8([65#9
MF4N70A>R 8;E6V*<7+L$I4D/+I+61TU7!+[JA;#M<W?!B420>[$<VR)!_094
M/('K>\48<,GVGQ(  RSAT42$1#K O/ER^I@T:93RAY GRI$F3-(U>;O G"7O
M#'Y .G4JK>^#:1%\';N')R\?$.><$#E4M^# I7""F_=MAL@D1/7N[9Q;8Y )
M?H5VQQ*P![,!OB)!@LJD\(G^)]3DPXB/9[L,XERNZM@ ?!(/)X[-7B8Z69>Z
M3^V5H)( QV6/Z6I30VUQ8//M0AMI$Q&9?)K_P;!<0.#$"W25H.1$"B*[0!./
M/TG":MO]LQ21JDS,5Q:^?8W5\PPE&+Z8(=AKBX;L*&.&[UV7'2 LIJH-E* 2
M <YYF%+\A KU_A2 #=7#);$($; 6E M)X'YZ=#SP$)DPA? =+:Q*CQ1W2^_2
M3U7F!24*(7S=S[R(P+H/T-A($(61,C71_LKW"1'@!)47$E>@+@J;Q@ 0ZMJ!
M^1G\2DS!78"+A-@F$IC!3$,>AKX#IL-O>*P40)/66RV]DD_IY"%2G^H:+D%%
M$2 E%MUHR()7*):@N@7>=*'?+%:PL(1=-D?4'%XT36OSQ@W/S8).(F4C"<IL
MZ.;>S\-]E)G;XV"[+#UO_FD(A 6(9_4"6YKWW.J$2$T3[2 S'YK+/0(?EK]\
M-RXN<N6+UYTWP;)=C\!APV1*_^H$L+M6:+M>X)F@<6OUP1'BM 1E(I3-NV40
MN-LF87Z!'OWSL;FNI\>=V:_H5U;NUQ3FOJH(6$QFOTV>Y4\)ZAB J;#GN=(U
M3Q!IE%6,SNVH599?%?6.;;\*R[]54M!<XZMH5L1^?\$E=F"49^@TY('C%X'D
M20F*I5)3<>Q)3Q\B3<BTN2Y"Q7)=3%+C\L65?>^IHL4 +<YTYTJ^0Q[0_MSG
MC\R"+_T!-\T$FD/+IB8FM\!7L*L/N:"U&^=@E(,G*F8).+^QW]K$<"=6MVO>
M3<&&/G^FXL66^30J=G)SL/!D;5 9DJ#48!YC_^*<%3"B('K6RH9K8;7^8![.
M,8D%S 25O^&&TWH+PX83NUQ\IBKC%I>1E?\;X>><& ["S[_BRG-%]"6><O_@
MFE(LQQ\=>^6IS75R811%D\^C=7/%6Q8.7556?Q(TZ187ER(;\V-DFLIINR-!
M!72S= SS]/-4T=KBYJJ'L2R#6TI>I:\57EX.KL&QETE6:<;#D.480J_!YWIQ
M9K/&_,"?Z!2WSXV7^H.0" (Z79>@_FT<]N%D,8)F[=6<%6-I3X4_HWVWCH&(
M@?0*@V=Q@GDMXH*T>4Z@4'46Z!9P6,--T]*K31#@[23F]E$%ZK ."_R'KLD)
MQC_@%0J)G&!;/U^6)2&=5P^2):A4?.^Y($T;(77]GE]U&+M\%'_DY]0O!-5Y
M*67'[VT0KTZAB"V&*%Y^OU(>QC?@@A=2MGF:8T1OEBV[IS>,SO?P(Y6E?[?:
ME>Y6Q&Q802EP>W@ODI@#P2]5B%.A4[VFP=,EJE[6'M^)(A>5%'Z FK*:G-R=
MZPH8!2;8!(S88L7)P8:,NTU.PA:8M$_ >2^>\H6P 6#.8E \OUQG2R!./6J
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M;SU*':!W"#A9X,.%QB%2OTB"PEF]=JIW.YFX70=[6B[76,@87BV*J(K/>:V
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M[E;XPN1/$90(<7JZ%5$DSSU9;D@^/B8IW6$C@&TYL[)Z,>YM[)#\L*+V73^
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MG5Y=[3%SW'ZF0N"$GP+N*Z79;M%*=_(%[M/]3R+\H0VYJY<9^ZOMST@ YD\
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M2!B-W<"9W?S1;??<:^B5XB*'$AS%8YIO>?%6\,:Z[L3@X/T!L4%-U@1Y&=@
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M_$;VUR9/X]QQC 7E]^R#95/!.(_NN]1Q8(_$:'%"43N]L,K28"X^D9<5]K*
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M4KI*#N;!GB899G?]BW9@DH!UD20M]/PWG,>WU'OL'2'8 5?39Q\T^P@UJ,L
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M'*$-$PG9$V9&5UV'L?RR@ALE2)Y%PL[&*=?!--QP+.&<!B70!]>("'7#0_F
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M=E*O)7.\A@>_:E"[(628)@->:;NT$I\5L6:&OD\BF%/!?7[WH-;5+'?P"PE
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MA.RR]$/FMO["INBOW_R%>"CS1CE-',-@BB*,$BZY:1<BP![.^7S16AAH2%U
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MF[7( UR6")%%2B?U,E%')UL9ENX'-B^BZ:IS.+=Y!D0_@"V*D[JHEY7:Z4>
MOV1WE2N3<I5;+TET<"I,*_@RM?%1FT]]CC6&=Q906B=(R6_.GZF"-?EL&A7V
M:B-IFFS(TZ["HI:"+%%N+9BK72RAZ+$:P/ 2NQR9^=QF_?DVE JW+$P V^X%
M3' TB,N!=1[H QI$Z<(T<-/I3/8CH=<BB]LJ>HO3QR(KAZI="K@/'G@F8WJL
M $-2R%8KY+=U<PD)9<*"E.<3'R0E")R>2Y_O4VW"9G*0_6EZ8,A^6RFY7D=P
MUL+36(T4=22UAN'E'BS#>W71+DWTF.U:<^H73EP!VP[-=M@TQL'@&,9</#%6
MBC=/E.<P<[9URU!WE#GJ;X5TGL%G@Q1Z=-(\6;I"@T#IJ.(-B$K*[ >;WJ]_
M76>L]O9.A-&8_IS&XX9>K''EQ?P!QE'4+MW-(O-Q<XF7QY%'GS4(7<B^!J@&
M%Y=I$/2#5=2IH9TFZ*T0V8SZ?"DHKMFBF]40Y6<L+Z4NXL)(Q35DWK/@47\O
M;U_+U)9!;G-Y=1%1@[!?.0K-WT'Q18>GOMZ;D$YB:A!K#\RKX$5V+3Y,)PR+
M)O1>K/%4-XE2\A:O*;DC0!-P<VQQ@"8YIERT2X!L$C6(9S'*9B'W#.W+_B9G
MXXR#3H2/1548B8WWK[/>?FR\::%!U?R7O/3VRS;MJ_U$'PTB0@H3J0V / GF
M?3BB3@5X'>P%J?BS!1Y)6K^E#5<V?%QB!(&[4WO*^91M#N!8((RL]QYF-[@_
M8C]YFB&MW5E:;G](M<HRVR 1N@KP'G(^G\?ZW[4ZM)_@M6,:J6(66*;'E\^F
M5A^JHFPW1Z9/$6]?+R:N>=SF&POS2$+*""]YG;[T9=;1723SN:M7X[!"^[,:
MQ/O0I-O3L H ]BF,_5:G61?^LBX+&1E*+?#(:/,KK5*]POD/ VG7CHR.(>/N
M^PQ<.H7<?!K_4+QW.F$CW=WR7,* (:[&X72(R-ZJ>T8EI;>3#RW\188;Y45$
M&5IG0U\]TR8V6:0+N&$R7E%LX$O5@-'+EFBRQ_@?RA!N(Z%:7IK\8>G9;'Y;
MP&'F\T$Y5U8_<N4J77X+X#;/OO.Z\]U3,0P\&5D55A/'QHANHM2$E:P/ 99#
M;P8-?"/\:=W%"^QL&CH96D5ZIT&L$!R'%X,!&*;D]I$5M-$:26)?513@/8Y;
M)3_I.Q=K.Y,9^OY895D6*;2O^PS,V5>_6K5/%8MS$A\KKC@ ](V/DUB,.DN7
M6PXZ);76%=9AW.M))M4.O/'< //9^7W8)Z0%Y)(^#'"1-(401^DCPXT$PI-W
M1%WPN-%G(1M\RLHB6D,=>(_X:,* X(#S=E_+^VSNU#L?<%S^M]=4"P[6G/I]
M;P^1!>6[P=[^W-NH=.@LYYX,J+?UA *;5 *7L:)"MEV2Q=]9%T8U"!%X1GMU
M7C:N8=^T#Y/J.T_!!D3?G&<:1.0IZ>[SR^I-<$9DDXRVL1@KH'S.T5X5(Q-M
M5Z9)I2]B'KU9N\"#);8I:$8=(=%?*QOL*=L'<#R3(;N";95*7Q\59KJ&FQA+
MXL$ [D*+ N%E^1BEHT%8:)>(DMMO!G,K%WAAW%PM#@P/O=#A^$?8@6+)!S_;
M#(L**$SHNM!&5\&16KC,OKZ$ILR&1M6O_@<6GPGM91V(UE^8%@H8M*G+>\X9
M20>\<IG5\>[^WKZ0V9-9L]CA=X!W5*<&42GI&2(4AB!?CTA0E&L+<H\B6:#]
M";VQK'4)TYL=.OB[QUVL,7WQOC.*7:W.>=66P-A&5TF@;;),5,']VSI URW.
MD$%%]!!(OR.H=AA[E3<5#WRL[X!]6RJ#8_,?,1,*#DFD:/]#@YB;A70<1?^J
MB'N%%U0I76/CKPMT^VHH:>^8]AI$@K C"Q8&RO)HC.YXZFRK;I+Z\SNPK6!
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MV9+PZ]*5W%, 0U)F_V0B=XU1A0:Q,E*>T*]"VXI/7D7)3B,7VIH"P01PG?!
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M,(RD2H^X]P@9@2/.*Q$#![<=3T^24[CHZ&EFDK6HG4C^65-E$KQAD\+S-?/
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M#?=L^;=-NILR(/?,T?:7[,L&I^Y$,:*IZ)*4\C.*R$&(-VH]S@V0Q"D1&NT
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M5)5F6@A_4BP+Z#X&6UP=D9:]%.9+'F;&0O2H8=]&K[ITAN9>V#]R)Z[WE3Z
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M"NNE,-%'TU3ZX_2F9"5B'*J$/\87/[?&SJ/PD$P1"^)YA>(;120>L1A6\!]
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M?SP_^S;^HNY'>]UT353_UTH_2LQT9CP#<P84 :69_QK +Q7^6_D#-C,FYK]
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M3@%+Q;(7#D@72&^QPI*V5%_< ;453Z)8/AZ3>M63:W:1=+A)20+F\ :21(V
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M _'9916T-N&#U"2C5WG#"PL">F/OOY#W#S,Y'IDFR+)_S?B^RY">=X\9I,[
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M[,'*,R\PEUX5R"S914I.WA6]9^?Q\M'+&2_DKC,4Z1+GP'DE+IP0NM,].MY
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M8KJ)]YOQ/]EPM_O;5]8PF#_,% UV6XC;#:\#1O3/X=NLY+GD"O]=OG[-<%7
MX?O^VY+/ICZ3W7R*9U&:TNY,P15)@JJ?O*G+EYAWU!1H?FCU8D-BC$NIZL->
MC-F5TEN$>41+EVL+<=EX A,NK3+"O8-,> C<.28Z#.7+2$'_RN6[G**HW]ZQ
M(LDCTJ7N\>=D81X6VDI<B:MP:H XHT$8P8=)#M^Z^38[ST?\547IOLT)KTUL
M+_V<5II_*AYXK(H,::$J9? (%>/;D:5X=,<4W'^FTE4.8[Y27:*91).'D^6F
MYT84HX'KE3AM?[Q,B,#^#D+_EL#QNL_+L(G\CSV<99JXD.Q8SI-9&MC^1U(Q
M8MS#O^DZ<?4H2N_5N#85J\1Y2B\/IJ7[)>1MPN"CJ8A@EL:]I0NS$=.3O0S%
M-88S)JN8S2I=OJDWX,2+DTZGU3,( ^5:YU!3?ZQ\JE>  =)F5+W, ,V6!MO;
MP T3$E6I&D^)>[3T-,1>>N(.HJX[\EJ3:/,U6%>DHE #]<$:Q*- -CO%]U%$
M\K)>H/;4K[,^1[Y(#3W(-TPM&//P'H]>]4*)>\:5$9F52?_ZB&O(G69#1J!0
MW1]#=JZ8Z"T1WD].U;]L+_DV0V_,:>4Y3KHIC^)[ 1&\ RJV?F1U$7V^MKE9
MAE([>YZ="?O5J>BY*^O^' (UZ&P5(J Y9S.G0-=]ZQK"*ZJ0]IYT'_F<J<0E
M!"WEN#1U#%'$?3WN'#CVHJ>"<Q?L@KQKY'7[C#3431+M;_H2@N'.45]36-;7
M?\+YK *_^_A9R8JGZ>0_O@F%JPYZTA0KT*IIS,*JD-+Q])?C.Z%^DQ&%55:X
MJORJ&4*"!@PQS_R'^<X?SZG/D.M [R.;5+I<*.E^A,Q*Z<)/_:O5@G,V#C(J
MSU\/B\ IW1JU.BDL5.+*QHGW'[':S1Q[2KKN;XZL+)1-N$UE/E&1T0>[)1Y@
M.V.,;Z;$10ND6$:'$H617&E$127"0V1]B!*WNG<:1*=Y@TH<&NN?J\3Q7;CP
M0!5],56>!,1'+QPV'"Q"IN2Y4]SI7NYB<$K-W$")&XT>YZ*-\&,)5V%"K567
MUREQ\=Q.U!WO!.$?TSLEG=CCFB2F?#N@:0&P'M_(#\1*%+B3:S5_78'!L.I[
M:;D(F+6X48;@T6\5W(49R<LP_30-$F(>^4<K1^P="+;G4*0$0@060S2H"<U9
M!H4H<9=T%V(6+,3,&!S#6&DU&UZX,Z[;O! +K0:%1E:1]T + 4HH$KY\8M&T
M\P"YJX476'EBD,:HSBV;OO]T2_1;01^UJTOQ7,UN;?+>$6>_0UK4:=ZT65JL
M_H[^8:<1)%\1CI.%_UN()>N?K+'3@;?7=/-&KY=0^KF?7+.D%X5[2KUO3="-
MKCF>M_'S>IV3FS/^*#H@Z!T-L93G::TKEZT$Q!+) R0)B 4E\>&8QCPA7")*
M!WM.D_AA>Z51_N:[Y]3ENJE=,'[L78=D2GR2C&5=W^XY;)U:3 KP\KX.K-H.
M S_MD&(_/[3HO8I"U<;W!%0EH#+I$/^APJ):B?OD,@I@0/C=I #.:^?V^H?+
M%^8#*-A\;@0ESM#G$E8C\H-I<BY]RP"^GBEO3+^I@-JTNJC([Y1P):[PDE 5
M%1(RRI0X&!N#@;;YD*86AM!#APD9&"IB"9>@:IW<J;Q_PM,$))_%)G. V(<T
M@+X!&O#R)MTH)>Z#8[X2)]\H-A6L?EIBO)[+\+-)B6@4G"^(?;S?P?2<L1GQ
M=$[H^JWZCG@FCD,5FG>@_\AQ?:^P()AVT>_<9!O7=-5/XSV'XB*N['MXN'?E
M,/&,MN=A;=U2T7??:Z^,- CDET/U00KUA59::3O$0%2#( P:0#RW#R_UYT8"
MDAA@ [@ &#E3+D(?2-ZCYV$5)0X#[_> (J/WO!+712L'I_NX"P__Q@O:%"[Z
M$UM)Z!M*(U<$OS=Q0L%,N1@REL2@6LS^F$[D+H;T!B7.\H/9&12@3L)5W+]'
M,=_S)2_ZR-1.7SD%&ZAGVC)><4!: \U$+2#7#;,#V%+7!W^)VU1:BR$!R(;E
MZR5;4*V>?@@9B&ED(E_WNF#!,:N Z3[J8A!823> 1F/'Z62JV!<(@Q;2!%M]
MG3!/;*75V52,5"]G%LA_\=6)9Y/.1KD'3;;6!J$?&Y::WBXHS0_U==+3;6,*
M!H+[?@TX-AS343<2P;?]PB8?_C_^D^;3_P!02P,$%     @ PH!Y5(?*ET*V
MR0  V_T  !$   !I;6<S-S4Y,C$X,E\T+FIP9^R[=UQ3V](PO!$$"Q 1410A
M6+'1>XV*@(J(BA1%B! "(B2A))0$R%&.X%$!*R@($5$!$4)1.D1$005$>B=4
MZ9TDD/KM8#OGWG.?YWF?>]_WG\_%+WNO-:O-S)J9-6O-AM?*ZUU7:A+@[@H
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M:+FPR(J5JU8+_&,ER"'![Y5K  $A <%E0LN6BPBO6"XHJ@Y62@@*;5FKNOS
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M \LPBH-!4I+SYC?:53WY/7&'P1<CL^9,KRLO1;2^]!4I<N,$4C_!!E=I,7F
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M\^V)6QGH#TSJSU^(IS39+'JH:B>9Q6880N(>MZ2&;K&-+RPHMUR^Q=<T-C=
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M")8LND:<)\_"^C>HNUE]]#,NM#4E^.CEVA:IZ]9L+7QDEL*!9K]PU7=54EZ
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MK7\[_N)\E_Z0Z_F<HNO:2I*8E"OJ'4E>0WMF=3U_&WP8+7_;#C]19$JB>?&
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M2;AK>*9-YCI>\<#'.B?W@W/<OE1UZ-2.*=!2E#>0-2XN]RCG. :+P?VUKW/
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M>,_\:&&55ZWIMHO-?FCZH_>8:[)-5B]3IS4"BI4ZN))G'E1PN%9M';/]]JO
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M=[&]HN"!H#^D:J"_I= +/!6QB+B82R.'XG7*N6X<T(O!TR^5;JL7[L-7$VM
MG3L1RIGJL*6NY-NPHUJ@^3*BSLW;J9W@ 05'HY@W&')4MAG',?YH$>8U*#KU
M5%2Y^^[:!/[5!K4]+E \L=ZA##"%@4OOGQA'IWSB :4%]"UAQL<-S?QOU=6B
M]"8](T0-+$]:CL\]:9Q7>+'FRR[0ZJO"0#^!A!_#5N#]&*5I2XY$>'>A;\K<
MUP-Y9=7S2$,\I);O682,:)^"=5&F*$U\T_D%U(=5Z$G!-DIUW):LX33NF$1#
MO'>N5BU[=:[ZPC."V*7:(9$-<C=1WTSCJ_Q8*,,LF]%?]WN0W@DG>G=G)W@
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M<Z:ND1J[9$%7*=!R,(Y$3F6W4.VGE:BOCJ:KUV:U#C0.;FS?/AMXUG537M'
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M#\1MVC04TG#6>CRR_^(O8 =+\2NG@^I\(R4[&K*JK.WB)_8CA><9-RQ\]J]
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M!@VZ:"E'$?S*/('*+0M0N<5.PYU%\:6HCVN2OIV1&B(]L<L)A5FPM+F01)\
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M@:2BEEM'YIO9U>:WD]NT12<G+/$FA)SAU29X\H?<EI!5"4JZBMYVNG]KB/0
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M2V/5K?\/4$L! A0#%     @ PH!Y5.^U,Z)J-04 G]]( !$
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M+65X,C%?,2YH=&U02P$"% ,4    " #"@'E4OJ"NB4$'  !8+0  #P
M        @ %ET@8 :'EP<BUE>#,Q7S$N:'1M4$L! A0#%     @ PH!Y5#B"
M'EA(!P  :2T   \              ( !T]D& &AY<'(M97@S,5\R+FAT;5!+
M 0(4 Q0    ( ,* >52E_<QX=P0  'HL   -              "  4CA!@!H
M>7!R+65X,S(N:'1M4$L! A0#%     @ PH!Y5#8AHSVI+@  93T!  X
M         ( !ZN4& &AY<'(M97@T7S(N:'1M4$L! A0#%     @ PH!Y5-6/
M;6S25@0 OK4$ !$              ( !OQ0' &EM9S,W-3DR,3@R7S N:G!G
M4$L! A0#%     @ PH!Y5+&<35"+'@$ C6T! !$              ( !P&L+
M &EM9S,W-3DR,3@R7S$N:G!G4$L! A0#%     @ PH!Y5)G^6.V.6 $ 2Z$!
M !$              ( !>HH, &EM9S,W-3DR,3@R7S(N:G!G4$L! A0#%
M  @ PH!Y5,!D^'BW5@  G7<  !$              ( !-^,- &EM9S,W-3DR
M,3@R7S,N:G!G4$L! A0#%     @ PH!Y5(?*ET*VR0  V_T  !$
M     ( !'3H. &EM9S,W-3DR,3@R7S0N:G!G4$L%!@     0 !  \P,   ($
$#P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
